FN Clarivate Analytics Web of Science
VR 1.0
PT S
AU Ouyang, HB
   Shen, B
AF Ouyang Hua-bing
   Shen Bin
BE Zhou, X
TI RETRACTED: Intelligent Manufacturing system based on machining features
   and its application (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE design features; machining features; intelligent manufacturing; feature
   recognition
AB Intelligent manufacturing is an orientation in the future manufacturing. In order to achieve this goal, the integration of CAD/CAM systems is the key. However, feature technology, which is regarded as a medium of information transmission in the integration of CAD/CAM systems, is expected the critical technology between the design and manufacturing environment. To simplify the manufacturing process and improve its efficiency, an intelligent manufacturing system based on machining features is presented in this paper. The key technologies related to the intelligent manufacturing, including feature recognition, machining operations based on machining features, knowledge-based machining database, are discussed respectively. The detailed implementation of the intelligent manufacturing system is also used to illustrate the superiority of the intelligent manufacturing than the commonly-used one. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Ouyang Hua-bing] Tongji Univ, Dept Mech Engn, Shanghai 200092, Peoples R China.
RP Ouyang, HB (reprint author), Tongji Univ, Dept Mech Engn, Shanghai 200092, Peoples R China.
EM oyhuabing@163.com
CR Alvares AJ, 2008, INT J ADV MANUF TECH, V35, P646, DOI 10.1007/s00170-006-0743-8
   Babic B, 2008, COMPUT IND, V59, P321, DOI 10.1016/j.compind.2007.09.001
   Geometric Ltd, 2010, CAMWORKS 2010 TUT
   Kasim N., 2009, EUROPEAN J SCI RES, P445
   Kramer TR, 2001, COMPUT AIDED DESIGN, V33, P653, DOI 10.1016/S0010-4485(01)00070-7
   Lee JY, 1999, INT J ADV MANUF TECH, V15, P38, DOI 10.1007/s001700050037
   SUBRAHMANYAM S, 1995, COMPUT IND, V26, P1, DOI 10.1016/0166-3615(95)80003-4
NR 7
TC 0
Z9 0
U1 2
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.266
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400066
DA 2018-12-27
ER

PT S
AU Pan, WJ
   Li, XK
AF Pan, Wenjuan
   Li, Xinke
BE Zhou, X
TI RETRACTED: Reach on Service-oriented Coverage Testing Approach
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Service-oriented architecture; service-oriented coverage testing;
   coverage adequacy criteria; testable services
AB The emerging paradigm of service-oriented architecture is increasingly popular and powerful that is its flexibility, high dynamism and loose coupling. However, oriented-services pose new and difficult challenges to external testers, because it just provides a WSDL interface for test. It is not sufficient to understand quality of integration among application and independent web services. To address this limitation, some researchers have proposed a novel methodology, namely SOCT (service-oriented coverage testing). This is a notion of coverage testing to the service-oriented application that makes web services more transparent. In this paper, upon the basic of introduced SOCT, we improve the coverage testing framework by using the testing coverage analyzer (TCA) which can calculate coverage measures for supplying a gap to TCov service (only records and retrieves the coverage information) and adding a services pool convenient for testable services collection. Finally we illustrate a case study of ticket reservation system that applies SOCT approach to BPEL (business process execution language) process. The results of this study reveal the testability and feasibility of this approach and attract more and more interested pursuers to investigate it. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Pan, Wenjuan; Li, Xinke] HeFei Univ Technol Hefei, Dept Comp & Informat, Hefei, Anhui, Peoples R China.
RP Pan, WJ (reprint author), HeFei Univ Technol Hefei, Dept Comp & Informat, Hefei, Anhui, Peoples R China.
EM jashpwj@163.com
CR Bartolini C., 2008, WORKSH AUT ENGINEERI, P57
   Bartolini C., 2009, ESEC FSE 09
   Bertolino A., 2009, WORKSH WEB TEST, P277
   Bertolino A, 2006, LECT NOTES COMPUT SC, V3938, P1
   Canfora G., 2006, IT Professional, V8, P10, DOI 10.1109/MITP.2006.51
   Canfora G., 2009, LNCS, P78, DOI DOI 10.1007/978-3-540-95888-8_4
   Felderer M., 2009, 9 INT C QUAL SOFTW, P155
   Foster H, 2003, 18TH IEEE INTERNATIONAL CONFERENCE ON AUTOMATED SOFTWARE ENGINEERING, PROCEEDINGS, P152, DOI 10.1109/ASE.2003.1240303
   Garcia-Fanjul J., 2006, INT WORKSH WEB SERV
   lubke D., 2009, AST 2009, P115
   Mei L., 2008, LNCS, P371
NR 11
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.855
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404072
DA 2018-12-27
ER

PT S
AU Pang, B
   Zhang, HZ
   Li, F
   Chen, SF
AF Pang, Bo
   Zhang, Huanzhen
   Li, Fei
   Chen, Shuifei
BE Zhou, X
TI RETRACTED: Remediation of Substantial Hexavalent Chromium-contaminated
   Soil by Washing with EDTA Solution (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Chromium(VI); Soil washing; EDTA; Complexation
ID HEAVY-METALS
AB The remediation of soil contaminated with substantial hexavalent chromium was studied by soil washing with EDTA. It was effective for the removal of hexavalent chromium from soil. In this study, the influence of reaction time, ratio of soil and liquid, concentration of EDTA solution and pH were all discussed. The conditions of remediation of Cr (VI) were optimized. The results indicated that 5 minutes was optimum reaction time. When the concentration of EDTA solution was 0.01mol/l, the removal was up to the maximum (83.49%). However, if the concentration continued to add up, the Cr (VI) removal efficiency would not increase with the concentration. When the ratio was 1:40, 92.75% Cr (VI) was washed from soil, rising to the peak. But the removal slightly decreased when the ratio rose to 1:50. The effect of pH of EDTA solution on Cr (VI) removal was not very obvious. So, the pH was elected at 6.53. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Pang, Bo; Zhang, Huanzhen; Li, Fei; Chen, Shuifei] China Univ Geosci, Sch Water Resources & Environm, Xueyuan Rd 29th, Beijing 100083, Peoples R China.
RP Pang, B (reprint author), China Univ Geosci, Sch Water Resources & Environm, Xueyuan Rd 29th, Beijing 100083, Peoples R China.
EM pangbo1252291@sina.com
CR Abumaizar R, 1996, J AIR WASTE MANAGE, V46, P765, DOI 10.1080/10473289.1996.10467512
   ALLEN HE, 1993, ENVIRON PROG, V12, P284, DOI 10.1002/ep.670120409
   HONG JJ, 1995, J COLLOID INTERF SCI, V173, P92, DOI 10.1006/jcis.1995.1301
   Hong P K Andrew, 2000, AGENTS EXTRACTION HE
   M Stoeppler, 1992, HAZARDOUS METALS ENV, V12, P373
   Peters R.W, 1999, CHELANT EXTRACTION H
   Reddy KR, 2000, SOIL SEDIMENT CONTAM, V9, P449, DOI 10.1080/10588330091134347
   Riyad JA, 1999, J HAZARD MATER, VB70, P71
   Schramel O, 2000, SCI TOTAL ENVIRON, V263, P11, DOI 10.1016/S0048-9697(00)00606-9
   Schramel O, 2000, J HAZARD MATER, V66, P151
   Sun B, 2001, ENVIRON POLLUT, V113, P111, DOI 10.1016/S0269-7491(00)00176-7
   Zhou J. G, 2009, GUANGZHOU ENV SCI, V24, P32
NR 12
TC 0
Z9 0
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.874
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404091
DA 2018-12-27
ER

PT S
AU Peng, JW
   Han, XK
   Zhang, H
   Wang, HZ
AF Peng Ju-wei
   Han Xiang-kui
   Zhang Hao
   Wang Hong-zhe
BE Zhou, X
TI RETRACTED: Study on Operating Effect for Different Influent Mode of
   Anaerobic Baffled Reactor (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Anaerobic baffled reactor; Divisional influent; Hydraulic retention
   time; Organic loading
ID SHOCK LOADS; PERFORMANCE; ABR; STEP
AB The performance of a laboratory scale divisional influent anaerobic baffled reactor (DI-ABR) was studied, which adopted four spots and three spots influent, in order to prevent volatile fatty acids (VFA) from accumulating overly that which is brought by high organic loading in the first compartment, and compared with single influent anaerobic baffled reactor (SI-ABR) under the different conditions of the hydraulic retention time (HRT) and organic loading. The experimental results showed that the difference of microorganism was very apparent between DI-ABR and SI-ABR, the most microorganism in DI-ABR was hydrolysis-acidification bacteria, the divisional influent could increase the function of hydrolysis and acidification, and the COD removal rate of DI-ABR was improved about 5%similar to 10% as compared to SI-ABR through adjusting properly operating parameter and influent manner for different wastewater, the effluent B/C value of DI-ABR was up to 56%. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Peng Ju-wei; Han Xiang-kui; Wang Hong-zhe] Jilin Architectural & Civil Engn Inst, Changchun 130021, Peoples R China.
RP Peng, JW (reprint author), Jilin Architectural & Civil Engn Inst, Changchun 130021, Peoples R China.
EM pjw_lsh@126.com
CR BACHMANN A, 1985, WATER RES, V19, P99, DOI 10.1016/0043-1354(85)90330-6
   GROBICKI A, 1989, WATER RES, V23, P1599, DOI 10.1016/0043-1354(89)90126-7
   [胡细全 Hu Xiquan], 2006, [环境污染治理技术与设备, Techniques and equipment for environmental pollution control], V7, P79
   Jing Guo, 1997, CHINA WATER WASTEWAT, V13, P17
   Nachaiyasit S, 1997, WATER RES, V31, P2737, DOI 10.1016/S0043-1354(97)00133-4
   Nachaiyasit S, 1997, WATER RES, V31, P2747, DOI 10.1016/S0043-1354(97)00134-6
   Nachaiyasit S, 1997, J CHEM TECHNOL BIOT, V69, P276, DOI 10.1002/(SICI)1097-4660(199706)69:2<276::AID-JCTB711>3.0.CO;2-T
   [孙寓姣 SUN Yujiao], 2007, [中国环境科学, China Environmental Science], V27, P44
   [张林生 Zhang Linsheng], 2002, [环境污染治理技术与设备, Techniques and equipment for environmental pollution control], V3, P51
NR 9
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.834
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404051
DA 2018-12-27
ER

PT S
AU Ping, Y
   Dong, W
AF Ping, Yu
   Dong, Wang
BE Zhou, X
TI RETRACTED: Determination of 1-Naphthylamine by Flow Injection
   Chemiluminescence (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Flow injection chemiluminescence; Potassium permanganate;
   1-Naphthylamine; Formaldehyde
ID PESTICIDE NAPTALAM; CHROMATOGRAPHY; WATER
AB Chemiluminescence reaction of 1-naphthylamine (NAP) with potassium permanganate in the presence of formaldehyde as an enhancer was investigated. A new chemiluminescence (CL) method for the determination of 1-naphthylamine with flow injection technique was developed. The linear range for 1-naphthylamine is 5.0x10(-8)-8.0x10(-5)mol/L with a detection limit of 7.6x10(-9) mol/L, and the relative standard deviation (n=11) is 3.6%. The method has been used to determine the content of 1-naphthylamine in real water with satisfactory results. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Ping, Yu; Dong, Wang] Shenyang Ligong Univ, Sch Environm & Chem Engn, Shenyang 110159, Peoples R China.
RP Ping, Y (reprint author), Shenyang Ligong Univ, Sch Environm & Chem Engn, Shenyang 110159, Peoples R China.
EM yuping6587@sina.com
CR Diaz TG, 1999, ANAL CHIM ACTA, V384, P185
   DIAZ TG, 1994, ANALYST, V119, P1151, DOI 10.1039/an9941901151
   Gao JZ, 2007, J HAZARD MATER, V144, P67, DOI 10.1016/j.jhazmat.2006.09.093
   Kargosha K, 1999, ANALYST, V124, P367, DOI 10.1039/a807023g
   Liang S.P, 1998, ANAL LAB, V17, P40
   Long W.Q, 2008, ANAL LAB, V27, P19
   [龙文清 Long Wenqing], 2003, [分析科学学报, Journal of Analytical Science], V19, P258
   Perkow IG, 1987, ANAL KHIM, V42, P1010
   [张伟亚 Zhang Weiya], 2003, [分析试验室, Analytical Laboratory], V22, P68
   Zhu Y, 2002, CHINESE J ANAL CHEM, V30, P774
NR 10
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.839
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404056
DA 2018-12-27
ER

PT S
AU Qi, JX
   Wang, HL
   Sun, HC
   Shen, L
   Lian, XY
AF Qi, Jingxian
   Wang, Heli
   Sun, Huichao
   Shen, Liang
   Lian, Xinying
BE Zhou, X
TI RETRACTED: Operating Variables in Chemical Extraction of Heavy metals
   from Contaminated Soils (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE soil washing; heavy metals; chelating agents; ultrasonic
ID EDTA; LEAD
AB Heavy metals contamination in soils is widespread across the world, and the remediation of these soils is a difficult task. One possible technique for remediation of soils contaminated by heavy metals is soil washing using chelating agents. Ethylenediaminetetraacetic acid (EDTA) and Citric acid (CA) are very effective chelating agents for this purpose. The aim of this study is to investigate the optimum conditions for extraction of Cu, Pb, Ni, Zn and Cd considering tow factors-contact time and pH value and to evaluate the possibility of ultrasonic extraction as potential alternatives compared with oscillation for speedy. With the increase of molar ratio (chelating agents/heavy metal), the amounts of heavy metals extracted from these artificial contaminated soils increased. A ratio of 10 between chelating agents and the heavy metal is required for a higher extraction rate no matter the agent is EDTA or CA. Experiments showed for all heavy metals that acidity was benefit for extraction. A higher removal efficiency was easily achieved at a pH value of 3 similar to 4. Extractions of metals reached satisfactory efficiency in a relatively short time by ultrasonic compared with that by oscillation. In apply of soil washing for soils contaminated by heavy metals, the use of ultrasonic has a great potential to achieve rapid extraction purposes. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Qi, Jingxian; Wang, Heli; Sun, Huichao; Shen, Liang; Lian, Xinying] China Univ Geosci, Sch Water Resource & Environm, Beijing 100083, Peoples R China.
RP Wang, HL (reprint author), China Univ Geosci, Sch Water Resource & Environm, Beijing 100083, Peoples R China.
EM wangheli@cugb.edu.cn
CR COUGHLIN BR, 1995, ENVIRON SCI TECHNOL, V29, P2445, DOI 10.1021/es00009a042
   Hwang SS, 2007, J IND ENG CHEM, V13, P650
   Kim C, 2003, CHEMOSPHERE, V51, P845, DOI 10.1016/S0045-6535(03)00155-3
   Kim CS, 1999, J HAZARD MATER, V69, P273, DOI 10.1016/S0304-3894(99)00115-6
   Mason TJ, 2004, ULTRASON SONOCHEM, V11, P205, DOI 10.1016/j.ultsonch.2004.01.025
   Peters RW, 1999, J HAZARD MATER, V66, P151, DOI 10.1016/S0304-3894(99)00010-2
   RAMAN B, 2000, ENVIRON PROG, V19, P275
   Satroutdinov AD, 2003, MICROBIOLOGY+, V72, P8, DOI 10.1023/A:1022209602723
   Sun B, 2001, ENVIRON POLLUT, V113, P111, DOI 10.1016/S0269-7491(00)00176-7
   Zhang WH, 2006, J ENVIRON ENG-ASCE, V132, P1282, DOI 10.1061/(ASCE)0733-9372(2006)132:10(1282)
   Zhou Q.X., 2004, PRINCIPLES METHODS R
   Zou Z, 2009, ENVIRON POLLUT, V157, P229, DOI 10.1016/j.envpol.2008.07.009
NR 12
TC 1
Z9 1
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.916
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404133
DA 2018-12-27
ER

PT S
AU Qi, K
   Xie, DQ
AF Qi Ke
   Xie Dong-qing
BE Zhou, X
TI RETRACTED: A steganographic scheme for 3D point cloud models (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE steganography; 3D point cloud models; self-similarity patch chain;
   spatial domain
ID COMPRESSION
AB This paper presents a new steganographic scheme for 3D point cloud models using self-similarity segmentation. The new scheme segments the 3D point cloud model to patches using self-similarity measures, and generates the codebook. The representative patches and similar patches are then taken from the codebook for every similar patch chain as the reference patches and the message patches. Finally, every message point in the similar message patches which has the point-to-point correspondence with a certain reference point in the reference patch can embed at least three bits by shifting the message point from current point to the corresponding embedding position using space subdivision. Experimental results show that the proposed technique is secure, has high capacity and low distortion, and is robust against uniform affine transformations such as transformation, rotation, scaling. The technique can be considered as a side-match steganography and has proven to be a feasible alternative to other steganographic schemes for 3D point cloud model. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Qi Ke; Xie Dong-qing] Guangzhou Univ, Sch Comp Sci & Educ Software, Guangzhou 510006, Guangdong, Peoples R China.
RP Qi, K (reprint author), Guangzhou Univ, Sch Comp Sci & Educ Software, Guangzhou 510006, Guangdong, Peoples R China.
EM qikersa@163.com
CR Ai QS, 2009, SIGNAL PROCESS, V89, P2159, DOI 10.1016/j.sigpro.2009.04.031
   B Tamy, 2005, IEEE P INT C SHAP MO, P23
   Cheng SC, 2010, PATTERN RECOGN, V43, P267, DOI 10.1016/j.patcog.2009.05.016
   Cotting D, 2004, PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON SHAPE MODELING AND APPLICATIONS, P233, DOI 10.1109/SMI.2004.1314510
   Hubo E, 2008, COMPUT GRAPH-UK, V32, P221, DOI 10.1016/j.cag.2008.01.012
   Johnson AE, 1999, IEEE T PATTERN ANAL, V21, P433, DOI 10.1109/34.765655
   Luo H., 2006, P IEEE INT S SIGN PR, P863
   Pauly M., 2002, P IEEE VIS, P163, DOI DOI 10.1109/VISUAL.2002.1183771
   Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423
   Wang CM, 2005, IEICE T COMMUN, VE88B, P190, DOI 10.1093/ietcom/E88-B.1.190
   YM Cheng, 2006, LNCS, P469
   YM Cheng, 2006, IEEE T VIS COMPUT GR, V8, P845
NR 12
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.249
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400049
DA 2018-12-27
ER

PT S
AU Qi, ZH
   Gao, ZF
   Shen, YM
   Han, BX
AF Qi, Zhao-Hui
   Gao, Zhan-Feng
   Shen, Ying-Ming
   Han, Bing-Xin
BE Zhou, X
TI RETRACTED: Digital Evidence Protection Model with Batch-verifying and
   Public Verifiability for Computer Forensics (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE cryptography; computer forensics; batch signing; public verifiability;
   message integrity
AB The traditional integrity protection of evidence currently available only accounts for the entire time between seizure and presentation. Few people focus their eyes on the time before seizure. Here, through analyzing in detail the relation between digital evidence and intrusion process, a digital evidence protection model with batch-verifying and public verifiability is proposed to protect the generated digital evidence in time. The new protection model can reasonably account for the entire time between generation and presentation. The digital evidence based on the new model is valid and acceptable. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Qi, Zhao-Hui; Gao, Zhan-Feng; Shen, Ying-Ming; Han, Bing-Xin] Shijiazhuang Tiedao Univ, Coll Informat Sci & Technol, Shijiazhuang 050043, Peoples R China.
RP Qi, ZH (reprint author), Shijiazhuang Tiedao Univ, Coll Informat Sci & Technol, Shijiazhuang 050043, Peoples R China.
EM zhqi_yh2004@yahoo.com.cn
CR D Ayers, 2009, DIGIT INVEST, pS34
   ELGAMAL T, 1985, IEEE T INFORM THEORY, V31, P469, DOI 10.1109/TIT.1985.1057074
   Federal Information Processing Standards Publication 186, 1994, FED INF PROC STAND P
   Haggerty J, 2006, COMPUT FRAUD SECUR, P14, DOI 10.1016/S1361-3723(06)70368-2
   KR Marcus, 2004, COMPUTER SECURITY, V23, P12
   Ma CS, 2003, ELECTRON LETT, V39, P281, DOI 10.1049/el:20030190
   Pal P, 2001, P NEW SEC PAR WORKSH, P71
   RIVEST RL, 1978, COMMUN ACM, V21, P120, DOI 10.1145/359340.359342
   Wang Y, 2005, COMPUTER LAW SECURIT, V21, P119, DOI DOI 10.1016/J.CLSR.2005.02.007
   Wolfe HB, 2003, COMPUT SECUR, V22, P26
NR 10
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.278
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400078
DA 2018-12-27
ER

PT S
AU Qian, HW
   Yin, XJ
AF Qian Hong-wei
   Yin Xiang-ju
BE Zhou, X
TI RETRACTED: Study of Environmental Impact of Borax Production Process
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE borax; Compression to alkaline degradation method; Alkali carbonate
   method; Environmental management; LCA
AB Study the situation of environmental impact in borax's production process,(compression to alkaline degradation method and alkali carbonate method). Improves and perfects the AT&T matrix system evaluation method, contrasting borax's production process (compression to alkaline degradation method and alkali carbonate method), and outlines the legend of the corresponding factor (stage)-environmental effects. Result shows that the life-cycle analysis based on the framework of LCA is a practical analysis theory of resources utility and environmental management. Actively explore the leading technical path of borax's preparation using alkali carbonate method, and taking into account compression to alkaline degradation method as borax industrial ecological technology, would be more directional approach to solve boron industrial resources and environmental problems. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Qian Hong-wei] Henan Polytech Univ, Inst Emergency Management, Hpu, Jiaozuo, Peoples R China.
RP Qian, HW (reprint author), Henan Polytech Univ, Inst Emergency Management, Hpu, Jiaozuo, Peoples R China.
EM hwqian@hpu.edu.cn
CR Aston J. D. Kalina. A. R., 1978, AMBIO CHINA, V7, P3
   Cheng S. W., 1988, MODERN CHEM IND CHIN, V8, P11
   Graedel TE, 1995, IND ECOLOGY
   Lu B. L., 2006, INORGANIC CHEM IND C, V38, P17
   Lu Z. W., 2006, CHINA ENG SCI CHINA, V8, P18
   Mouche C., 2000, CHEM PROCESSING, V61, P32
   Robert U. A., 1989, TECHNOLOGY ENV
   Tao L. Y., 1992, BORON COMPOUNDS PROD
   Zheng X. J., 2006, BORON COMPOUNDS PROD
NR 9
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.836
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404053
DA 2018-12-27
ER

PT S
AU Qin, GJ
   Zhang, W
AF Qin Gangjun
   Zhang Wei
BE Zhou, X
TI RETRACTED: TCPW-AA: An Enhanced TCP Protocol for Hybrid Networks
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE TCP Westwood; TIBET; Heterogeneous Networks; Bandwidth Estimation;
   Efficiency and Friendliness; simulation
AB In this paper, we propose an enhanced TCP protocol aiming at improving efficiency in heterogeneous networks while maintaining friendliness to existing protocols, such as NewReno. This scheme, named TCPW-AA, uses the idea of congestion control algorithm in TCP-Westwood and a totally different bandwidth estimation method based on an unbiased technique TIBET. We make some improvement to achieve good tradeoff between efficiency and friendliness. Simulations on ns2 and comparisons with TCPW, TIBET and NewReno show its advantages and effectiveness. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Qin Gangjun; Zhang Wei] E China Normal Univ, Dept Comp Sci & Technol, Shanghai 200241, Peoples R China.
RP Qin, GJ (reprint author), E China Normal Univ, Dept Comp Sci & Technol, Shanghai 200241, Peoples R China.
EM gangjunqin@hotmail.com
CR Balakrishnan H., MOBICOM 95 BERK CA U
   Balakrishnan H., P IEEE GLOBECOM 98 I
   Balakrishnan H., 1997, CIEEE ACM T NETWORKI, V5, P759
   Capone A, 2004, IEEE T MOBILE COMPUT, V3, P129, DOI 10.1109/TMC.2004.5
   Capone A., 2001, P TYRRH INT WORKSH D
   Gerla M., 1999, 990012 CSDTR UCLA
   JACOBSON V, 1988, COMPUT COMMUN REV, V18, P314
   Jain R., 1991, ART COMPUTER SYSTEMS
   Lakshman TV, 1997, IEEE ACM T NETWORK, V5, P336, DOI 10.1109/90.611099
   MASCOLO S, 2001, P 7 ANN INT C MOB CO, P287, DOI DOI 10.1145/381677.381704
   Mathis M., 1997, ACM COMPUTER COMM RE, V27
   Wang R., 2002, P GLOBECOM
   Wang R., 2002, P IEEE S COMP COMM
   NETWORK SIMULATOR NS
NR 14
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.323
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400123
DA 2018-12-27
ER

PT S
AU Qu, ZJ
   Liu, MG
   Wang, J
   Liu, L
AF Qu Zhijian
   Liu Mingguang
   Wang Jian
   Liu Li
BE Zhou, X
TI RETRACTED: Web Service AJAX Intelligent Engine Based on XFire and DWR
   Framework (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE intelligent monitoring engine; real-time process; scalable vector
   graphics; web service; AJAX
AB In order to solve process technology and application problems of real-time data interface in power monitoring system, this paper studies scalable vector graphics. XFire and DWR framework, and designs new power automation monitoring web service ajax intelligent engine based on XFire and DWR framework. Using proxool database connection pool to improve process sequence of tele-signal, tele-metering, tele-control of supervisory control and data acquisition system. This paper has completed a new system architecture, and achieves real-time data communication from communication component to SVG graphic elements based on web service ajax intelligent monitoring engine. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Qu Zhijian; Liu Mingguang; Wang Jian] Beijing Jiaotong Univ, Sch Elect Engn, Beijing, Peoples R China.
RP Qu, ZJ (reprint author), Beijing Jiaotong Univ, Sch Elect Engn, Beijing, Peoples R China.
EM 08117324@bjtu.edu.cn
CR Cao Yang, 2002, Automation of Electric Power Systems, V26, P73
   Han Xiao-tao, 2003, Power System Technology, V27, P58
   He Zhi-min, 2004, Relay, V32, P13
   Jin Min, 2002, Automation of Electric Power Systems, V26, P65
   Li Ya-ping, 2005, Automation of Electric Power Systems, V29, P80
   Shi Dong-yuan, 2004, Relay, V32, P37
   Wang Zhi-nan, 2005, Automation of Electric Power Systems, V29, P60
   Wu Wenchuan, 2001, Automation of Electric Power Systems, V25, P45
   Zhang Shenming, 2002, Automation of Electric Power Systems, V26, P45
   Zhong WANG, 2000, J IMAGE GRAPHICS A, V5A, P1039
NR 10
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.240
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400040
DA 2018-12-27
ER

PT S
AU Ren, GJ
   Li, SH
AF Ren, Guangjun
   Li, Sihao
BE Zhou, X
TI RETRACTED: Study on the Adsorption of Nitrobenzene from Aqueous Solution
   by Inorgano-Organo-Montmorillonites (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE norgano-organo-montmorillonites; Adsorption; Nitrobenzene; Kinetic;
   Thermodynamics
ID SORPTION; WATER
AB On condition that OH-/Al3+ molar ration was 2.4, inorgano and inorgano -organo- montmorillonites was synthesized by titrating Na-montmorillonite with hydroxyl aluminum solution. From powder XRD data, it was shown that the interlayer of montmorillonites was increased to 1.9 nm and over. The adsorption of nitrobenzene by four modified montmorillonite samples was also studied and the results showed that the adsorbability of inorgano-organo-montmorillonites was much better than Na-montmorillonites. The adsorption dynamics follows the laws of Bangham and Langmuir. The relation between adsorbing quantity(q(e)) and equilibrium concentration (C-e) tallies with the isothermal adsorption equations of Freundlich and Langmuir. The adsorption is presented by heat evolution physisorption and organic partion. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Ren, Guangjun; Li, Sihao] Shenyang Ligong Univ, Sch Environm & Chem Engn, Shenyang 110159, Liaoning, Peoples R China.
RP Ren, GJ (reprint author), Shenyang Ligong Univ, Sch Environm & Chem Engn, Shenyang 110159, Liaoning, Peoples R China.
EM rgjhjx@163.com
CR Keeran R, 1990, CLAYS CLAY MINERALS, V38, P287
   SMITH JA, 1995, ENVIRON SCI TECHNOL, V29, P685, DOI 10.1021/es00003a016
   SMITH JA, 1990, ENVIRON SCI TECHNOL, V24, P1167, DOI 10.1021/es00078a003
   SRINIVASAN KR, 1990, CLAY CLAY MINER, V38, P277, DOI 10.1346/CCMN.1990.0380306
   Wang X. R., 1997, ENVIRON CHEM, V16, P1
   XU SH, 1995, ENVIRON SCI TECHNOL, V29, P3022, DOI 10.1021/es00012a020
   Zhang D., 2008, J CHEM IND ENG, V58, P1535
   Zhang Dong, 2009, China Environmental Science, V29, P713
NR 8
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.825
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404042
DA 2018-12-27
ER

PT S
AU Ren, W
   Wang, P
   Lv, J
AF Ren, Wei
   Wang, Peng
   Lv, Jing
BE Zhou, X
TI RETRACTED: Comprehensive Evaluation on Air Quality of Ro-Ro Ship Cabins
   Based on Grey Matter Elements Analysis (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Grey matter elements analysis; Comprehensive evaluation; Ro-ro ship;
   In-cabin air quality
AB In-cabin air quality may affect the health of people on board ship to a great extent. Common methodologies to assess indoor air quality include index evaluation method, fuzzy comprehensive assessment method, grey correlation analysis method, etc. In this study, several main air pollutants in cabins of different classes of six ro-ro ships are measured and analyzed; a questionnaire survey about warm feeling, humidity, air quality, sanitary condition is carried out to the passengers. By adopting grey matter elements analysis and mathematics statistics, in-cabin air quality is integrated evaluated according to the detecting results and the results of questionnaire survey. The integrated evaluation results point out: air quality of the fifth class cabins is the poorest in all cabins investigated. Finally, a few control methods and suggestions have been brought forward to improve the in-cabin air quality. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Ren, Wei; Wang, Peng; Lv, Jing] Shandong Jiaotong Univ, Maritime Coll, Weihai, Peoples R China.
RP Ren, W (reprint author), Shandong Jiaotong Univ, Maritime Coll, Weihai, Peoples R China.
EM renwly@163.com
CR [Anonymous], CHINESE STANDARD PUB
   Julong Deng, 1990, THEORY COURSE GREY S
   [马卫武 Ma Weiwu], 2003, [环境与健康杂志, Journal of Environment and Health], V20, P146
   Wen Cai, 1994, MATTER MODELS APPL
NR 4
TC 0
Z9 1
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.812
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404029
DA 2018-12-27
ER

PT S
AU Shan, R
   Zhang, G
AF Shan Rong
   Zhang Guojun
BE Zhou, X
TI RETRACTED: Research on Unrepeated and Ultra-long Span Transmission
   Technologies in Communication Network Based on SDH (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE communication network; ultra-long span transmission; dispersion;
   noliner; RFA
AB The paper briefly introduces the limiting factors of ultra-long span and unrepeated for optical transmission system, Which are fiber of loss, dispersion, nonlinear. Introduces the current status of technology development in international. Then proposes some solutions, including Raman Fiber Amplifier and technology of FEC. Finally, it puts forward the scheme of 2.5G/bit unrepeated and ultra-long span transmission based on SDH. The scheme adopts mature technique, uses devices easily available, therefore has high ratio of quality over price. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Shan Rong] Weinan Teachers Univ, Coll Math & Informat Sci, Weinan 714000, Shaanxi, Peoples R China.
RP Shan, R (reprint author), Weinan Teachers Univ, Coll Math & Informat Sci, Weinan 714000, Shaanxi, Peoples R China.
EM gsshanrong@126.com
CR Deng Da-peng, 2009, OPTICAL COMMUNICATIO
   Ma MX, 1998, IEEE PHOTONIC TECH L, V10, P893, DOI 10.1109/68.681521
   Sano A., 1998, LIGHTWAVE TECH, V16, P977
   WANG Yu-dong, 2010, TELECOMMUNICATIONS E, V5, P52
   YU Zhang-wei, 2005, TELECOMMUNICATIONS E, V5, P6
   Zhu Y., OFC 2002, P608
NR 6
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.280
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400080
DA 2018-12-27
ER

PT S
AU Shan, XM
   Zhang, P
   Zhong, L
AF Shan, Xianming
   Zhang, Peng
   Zhong, Ling
BE Zhou, X
TI RETRACTED: Implementation of Visual Simulation Training System of
   Artillery Radar (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Visual simulation; Artillery radar; Azimuth calibration; Model
AB In order to deal with the difficulties in the azimuth calibration training of some type artillery radar, such as limited training field, serious radar loss and expensive training outlay, a training simulator system of artillery radar azimuth calibration is realized based on scene simulation technologies. Composition structure, function module and key technologies of the system are discussed first. This system is then developed with tools of Multigen-Creator, Vega, VC++6.0, and a living virtual battlefield environment is created. The system possesses the functions of battlefield scene display, azimuth calibration training and training result evaluation. At last the simulation pictures are listed, the results show that the simulation system simulates the azimuth calibration operation process of artillery radar livingly and can meet the requirements of real time simulation. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Shan, Xianming; Zhang, Peng; Zhong, Ling] Shenyang Artillery Acad, Dept Elect Reconnaissance, Shenyang 110161, Peoples R China.
RP Shan, XM (reprint author), Shenyang Artillery Acad, Dept Elect Reconnaissance, Shenyang 110161, Peoples R China.
EM neusxm@139.com
CR Cai X B, 2005, P SPIE
   [杭燚 HANG Yi], 2007, [弹箭与制导学报, Journal of Projectiles, Rockets, Missiles and Guidance], V27, P339
   LIU Hua-feng, 2001, SCENE SIMULATION TEC
   LUO Yun, 2005, COMPUTER ENG DESIGN, V26, P362
   Unbescheiden M, 1998, VIRT REAL ANN INT S
   ZHANG Lei, 1994, AERONAUTICAL COMPUTI, V10, P28
   ZHANG Xi-en, 2004, COMPUTER ENG
NR 7
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.310
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400110
DA 2018-12-27
ER

PT S
AU Shao, XY
   Li, X
AF Shao, Xiaoyan
   Li, Xiang
BE Zhou, X
TI RETRACTED: Soil Heavy Metal Pollution Evaluation using Grey Relational
   Analysis (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Grey Theory; Relational Analysis; Evaluation on Heavy Metal Pollution
AB In gray system theory, Grey relational analysis is very important. In this paper this method was applied in the soil heavy metal pollution. firstly, the study makes it possible to apply the grey relational analysis model to the reliability analysis of environmental impact assessment of regional area. Secondly we proved by the research that grey relational analysis is suitable for evaluation on soil heavy metal pollution due to its simple calculation and good operability, and evaluation results conform to real conditions. The results show that the grey relational analysis method will reduce the calculation of environmental quality to some extent. In this paper, we made the conclusion that the method of grey relational analysis is a very useful optimizing method for the soil heavy metal pollution. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Shao, Xiaoyan; Li, Xiang] Zhengzhou Inst Aeronaut Ind Management, Zhengzhou, Peoples R China.
RP Li, X (reprint author), Zhengzhou Inst Aeronaut Ind Management, Zhengzhou, Peoples R China.
EM xiaoyanshao@126.com
CR CHEN NX, 2007, J N CHINA U WATER RE, V1, P85
   CHEN X, 2008, COMPUTER APPL SOFTWA, V12, P231
   DENG JL, FUNDAMENTALS GREY TH
   LI ZY, 2004, THEORY METHOD EVALUA, P115
   LIU YD, J NE U WATER RESOURC
NR 5
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.924
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404141
DA 2018-12-27
ER

PT S
AU Shen, B
   Ouyang, HB
AF Shen Bin
   Ouyang Hua-bing
BE Zhou, X
TI RETRACTED: Research on the intelligent process planning technology based
   on STEP-NC (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE STEP-NC; Intelligent Machining; Process Planning; Neural networks; Fuzzy
   logic
AB STEP-NC has the characteristics of workingsteps, which can be used easily in the intelligent CNC machining system. Based on the characteristics of STEP-NC data structure, an intelligent process planning system is presented in this paper. Geometric information translation, feature information extraction, process planning, STEP-NC file generation are all involved. The lexical analysis of the AP203 files, and the translation from AP203 to geometric information database are also studied. The proposed system maps a STEP AP224 data file, without using a complex feature recognition process, and produces the corresponding machining operations to generate the process plan and the corresponding STEP-NC file. The system carries out several stages of process planning such as operations selection, tool selection, machining parameters determination, machine tools selection and setup planning. A hybrid approach of most recent techniques (neural networks, fuzzy logic and rule-based) of artificial intelligence is used as the inference engine of the developed system. An example part is tested and the corresponding process plan is presented to demonstrate and verify the proposed intelligent CAPP system. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Ouyang Hua-bing] Tongji Univ, Dept Mech Engn, Shanghai 200092, Peoples R China.
RP Ouyang, HB (reprint author), Tongji Univ, Dept Mech Engn, Shanghai 200092, Peoples R China.
EM oyhuabing@163.com
CR Amaitik SM, 2007, INT J ADV MANUF TECH, V31, P978, DOI 10.1007/s00170-005-0269-5
   Asiabanpour B, 2009, J ADV MANUF SYST, V8, P89, DOI 10.1142/S0219686709001687
   Bhandarkar MP, 2000, COMPUT IND, V41, P3, DOI 10.1016/S0166-3615(99)00040-8
   JuhaSaaski J, 2005, INTEGRATION CAD CAM, V23, P951
   Kumar S, 2007, ROBOT CIM-INT MANUF, V23, P667, DOI 10.1016/j.rcim.2007.02.015
   [田锡天 Tian Xitian], 2007, [西北工业大学学报, Journal of Northwestern Polytechnical University], V25, P261
   Xu XW, 2005, INT J PROD RES, V43, P3703, DOI 10.1080/00207540500137530
   Yusof Y., 2009, EUROPEAN J SCI RES, V36, P445
NR 8
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.267
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400067
DA 2018-12-27
ER

PT S
AU Shen, JH
   Fu, XY
AF Shen Jihong
   Fu Xiaoyan
BE Zhou, X
TI RETRACTED: The fuzzy comprehensive evaluation method based on improved
   super-standard weight (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE fuzzy comprehensive evaluation; membership; super-standard weight; fuzzy
   composite operator
AB Weights identifying and fuzzy composite operator selection are two key technologies of the fuzzy comprehensive evaluation. Super-standard weight has been widely used in the water quality evaluation and environmental assessment. However, the super-standard weight present determination methods are related to the introduced comparison base point. And the linear super-standard weight does not reflect that the fluctuation of the index value near the critical point of the classification will lead to a wrong judgement. And the S-type super-standard weight is associated with the human psychology. So it is difficult to grasp. In this paper the super-standard weight determination method was improved for the shortcomings of the present methods, and it's proposed that super-standard weight was determined by membership. At last, the fuzzy composite operator matched with super-standard weight was decided. And actual examples demonstrated the improved fuzzy comprehensive evaluation method had good performance. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Shen Jihong] Harbin Engn Univ, Coll Sci, Harbin 150001, Peoples R China.
RP Fu, XY (reprint author), Harbin Engn Univ, Coll Automat, Harbin 150001, Peoples R China.
EM fuxiaoyan_0326@126.com
CR Bu Quan-min, 2007, RESERCH APPL FUZZY A
   Guan Yan-hai, 2008, GROUND WATER, V30
   Guan Yan-hai, 2008, GROUND WATER, V30, p[27, 87]
   Hu Bao-qing, 2004, BASIS FUZZY THEORY, P198
   Liu Xin, 2009, J LANZHOU U TECHNOLO, V35, P63
   Mei Xue-bin, 2000, WORLD GEOLOGY, V19, P172
   Su Hua-wei, 2003, BUSINESS EC ADM, V138, P32
   Zhou Sui-hua, 2003, Journal of Wuhan University of Technology (Information & Management Engineering), V25, P4
   Zhou Xue-song, 2005, MATH PRACTICE THEORY, V35, P209
NR 9
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.224
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400024
DA 2018-12-27
ER

PT S
AU Shen, L
   Wang, HL
   Qi, JX
   Lian, XY
   Sun, HC
AF Shen, Liang
   Wang, Heli
   Qi, Jingxian
   Lian, Xinying
   Sun, Huichao
BE Zhou, X
TI RETRACTED: Study on Biological Aerated Filter as Enhanced Pretreatment
   Process of Coagulation and Sedimentation (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE BAF; coagulation and sedimentation; pretreatment; circulating cooling
   water; secondary effluent
AB Using coagulation and sedimentation process in the advanced treatment of urban secondary effluent which can be recycled to circulating cooling water system in power plant is only perform well on CODCr and turbidity removal. But the concentrations of organic matter and NH3 in effluent can not meet the requirements of circulating cooling water. Therefore, in this study, the feasibility of biological aerated filter (BAF) as a pretreatment enhancing coagulation and sedimentation process was discussed. Achieved by controlling the two operating modes: (1) secondary effluent -> coagulation and sedimentation -> effluent; (2) secondary effluent -> BAF -> coagulation and sedimentation -> effluent. The results show that the BAF pretreatment removes ammonia nitrogen effectively, and the turbidity and CODCr of effluent of BAF-coagulation sedimentation process is much lower than individual coagulation and sedimentation process. The final effluent qualities meet the requirements of circulating cooling water system in power plant. And the flocculant's dosage is effectively reduced. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Shen, Liang; Wang, Heli; Qi, Jingxian; Lian, Xinying; Sun, Huichao] China Univ Geosci, Sch Water Resource & Environm, Beijing 100083, Peoples R China.
RP Wang, HL (reprint author), China Univ Geosci, Sch Water Resource & Environm, Beijing 100083, Peoples R China.
EM wangheli@cugb.edu.cn
CR Feng Shangyou, 2000, INTRO SUSTAINABLE US
   Kumar M, 2009, CURR SCI INDIA, V96, P886
   PUJOL R, 1994, WATER SCI TECHNOL, V29, P33
   Rebhu Mjenahem, 1988, J WATER POLLUTION CO, V60, P28
   [徐亚明 Xu Yaming], 2002, [工业水处理, Industrial Water Treatment], V22, P1
   Yue Chen, 2007, WATER WASTEWATER ENG, V33, P33
   王鹤立, 1999, [给水排水, Water & Wastewater Engineering], V25, P1
NR 7
TC 0
Z9 0
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.875
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404092
DA 2018-12-27
ER

PT S
AU Sheng, W
   Jia, GY
   Xi, L
   Zhou, XH
AF Sheng, Wei
   Jia, Gangyong
   Xi, Li
   Zhou, Xuehai
BE Zhou, X
TI RETRACTED: A multicore scheduling algorithm considering cache warm-up
   overheads (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE real-time systems; scheduling algorithm; cache warm-up overheads
AB With the development of multicore architectures, multicore real-time scheduling has become a hot topic. Cache warm-up overheads introduced by task migration between two cores lead to some tasks miss deadlines in time-critical systems. In this paper, we propose a scheduling algorithm based on push-assisted model, which is a hardware mechanism used to proactive migrate cache lines of tasks. Our scheduling algorithm provides software support for proactive migration. It is shown that our algorithm is effective in some examples. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Sheng, Wei; Jia, Gangyong; Xi, Li; Zhou, Xuehai] Univ Sci & Technol China, Sch Comp Sci & Technol, Hefei 230026, Peoples R China.
RP Sheng, W (reprint author), Univ Sci & Technol China, Sch Comp Sci & Technol, Hefei 230026, Peoples R China.
EM shw@mail.ustc.edu.cn
CR Anderson J. H., 2006, REAL TIM EMB TECHN A, P179
   Anderson JH, 2000, SEVENTH INTERNATIONAL CONFERENCE ON REAL-TIME COMPUTING SYSTEMS AND APPLICATIONS, PROCEEDINGS, P297, DOI 10.1109/RTCSA.2000.896405
   Andersson, 2001, RTSS, P193
   Baker TP, 2005, IEEE T PARALL DISTR, V16, P760, DOI 10.1109/TPDS.2005.88
   Baruah SK, 1996, ALGORITHMICA, V15, P600
   Bertogna M, 2009, IEEE T PARALL DISTR, V20, P553, DOI 10.1109/TPDS.2008.129
   Goossens J., 2003, REAL TIME SYSTEMS, V25
   Guan N., 2009, EMSOFT 09, P245
   Katre Kedar M, 2009, REAL TIM SYST S, P17
   Sarkar, 2009, LCTES, P80
NR 10
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.341
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400141
DA 2018-12-27
ER

PT S
AU Shi, K
   Chen, XM
AF Shi, Ke
   Chen, Xinmiao
BE Zhou, X
TI RETRACTED: Implementing Autonomous Control for Mixed Model Production
   Systems using Wireless Sensor/Actuator Networks (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE mixed-model production; autonomous control; wireless sensor/actuator
   network
AB In mixed model production, autonomous control method, which has been proved more responsive, robust and adaptive, is proposed to cope with rising complexity and dynamics. However, the implementation of autonomous control method is still a challenge. This paper focuses on implementing autonomous mixed model production control with wireless sensor/actuator networking technologies. The system architectures and design issues of wireless sensor/actuator network for autonomous mixed production control are presented, and a case study on which experiments are being made with an autonomous control application prototype shows its feasibility. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Shi, Ke; Chen, Xinmiao] Huazhong Univ Sci & Technol, 1037 Luoyu Rd, Wuhan 430074, Peoples R China.
RP Shi, K (reprint author), Huazhong Univ Sci & Technol, 1037 Luoyu Rd, Wuhan 430074, Peoples R China.
EM keshi@mail.hust.edu.cn
OI Shi, Ke/0000-0002-4250-6208
CR Armbruster D, 2006, PHYSICA A, V363, P104, DOI 10.1016/j.physa.2006.01.052
   Hulsmann M., 2007, UNDERSTANDING AUTONO
   Leitao P, 2009, ENG APPL ARTIF INTEL, V22, P979, DOI 10.1016/j.engappai.2008.09.005
   Nayak A, 2009, WIRELESS SENSOR ACTU
   Scholz-Reiter B., 2004, P 37 CIRP INT SEM MA, P357
   Takahashi K, 2007, INT FED INFO PROC, V246, P405
   Windt K, 2008, ROBOT CIM-INT MANUF, V24, P572, DOI 10.1016/j.rcim.2007.07.008
NR 7
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.287
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400087
DA 2018-12-27
ER

PT S
AU Shuai, R
   Huang, SZ
AF Shuai, Ruan
   Huang, Sheng-zhong
BE Zhou, X
TI RETRACTED: Data Mining Algorithm Based on Decision Tree Application and
   Research (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE data mining; decision tree algorithm; ID3 algorithm; customer management
AB Data mining is to extract large amounts of data in the potential, unknown useful information. Based on decision tree classification algorithm in data mining is widely used, Compared with other classification algorithms, Decision tree algorithm has a computation is relatively small, easy to extract explicit rules, you can display important decision attributes and advantages of the classification accuracy. This article is for specific customer relationship management system, decision tree algorithm for data mining research and analysis, data mining and decision tree techniques are described in detail. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Shuai, Ruan] Guangxi Normal Univ, Guilin 541004, Peoples R China.
RP Shuai, R (reprint author), Guangxi Normal Univ, Guilin 541004, Peoples R China.
EM e-today-1982@163.com
CR Chen Feng, 2009, COMPUTER APPL, V29, P2250
   Domingos P., 2000, ACM SIGKDD INT C KNO
   Han J., 2006, DATA MINING CONCEPTS
   Hulen G, 2001, P T ACM SIGKDD INT C
   Jie Liuguang, 2009, NE NORMAL U NATURAL, V43, P36
   MAO Guo-jun, 2005, DATA MINING PRINCIPL
   Pan Baojuan, 2009, COMPUTER APPL SOFTWA, V26, P267
   Pan Baojuan, 2009, COMPUTER APPL, V26, p[225, 267]
   Ping Duxiu, 2009, COMPUTER APPL SOFTWA, V26, P230
   SHAFER J, 1996, SPR INT SCALABLE PAR
   Sun Chao-Li, 2006, J TAIYUAN U TECHNOLO, P268
   Teng Hao, 2008, IMPROVED DECISION TR, P231
   Wang H, 2003, P 2003 ACM SIGKDD IN
   Yang Ming, 2007, COMPUTER TECHNOLOGY, P6
NR 14
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.219
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400019
DA 2018-12-27
ER

PT S
AU Song, C
   Zhang, XM
   Ma, Z
AF Song Cheng
   Zhang Xi-ming
   Ma Zhao
BE Zhou, X
TI RETRACTED: Framework Construction of Traffic Environmental Monitoring
   and Early-Warning System (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE traffic safety; traffic environmental safety; environmental monitoring;
   early-warning system
AB In order to establish the traffic environmental monitoring and early-warning system, which is the important groundwork for the environmental protection and traffic safety system, theories and methods of auto-monitoring and alarming were used in the paper. Firstly, the existing problems of traffic environmental monitoring and early-warning were analyzed in this paper, then the framework of traffic environmental monitoring and early-warning system was constructed, which was composed of four sub-systems: the foundation support system, the technical support system, the environmental management system and the public participation system. The establishment of traffic environmental monitoring and early-warning system can fully reflect the environmental quality and change trends, track timely the changes of pollution emission, as accurately as possible alarm and respond to all kinds of environmental emergencies in time, meet the needs of traffic environmental management and safety management. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Song Cheng] Changan Univ, Inst Environm Sci & Engn, 126 Yanta Rd, Xian 710061, Peoples R China.
RP Song, C (reprint author), Changan Univ, Inst Environm Sci & Engn, 126 Yanta Rd, Xian 710061, Peoples R China.
EM song_cheng88@163.com
CR [Anonymous], 2009, FRAM ADV ENV MON FOR
   Ben-Shang Wan, 1996, TECHNOLOGIES EMERGEN
   BILDSTEIN O, 1994, WATER SCI TECHNOL, V29, P181
   Chao-yang FU, 2008, ENV SCI, V29, p206~213
   United Nations, 2006, GLOB SURV EARL WARN
   周生贤, 2007, [中国环境监测, Environmental Monitoring in China], V23, P1
NR 6
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.865
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404082
DA 2018-12-27
ER

PT S
AU Song, HS
AF Song Hai-Sheng
BE Zhou, X
TI RETRACTED: Applicat(a)ion of Support Vector Regression in Network
   Performance Evaluation (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Support Vector Regression; Evaluation; Network performance; Grid
AB It is well-known that network performance evaluation is very important for safe and stable using of computer network. Support vector regression is applied to evaluate network performance in the paper. The parameters in the support vector regression model have a great influence on the evaluation ability of support vector regression model. Grid is applied to select the optimal combination of the parameters of support vector regression model. In order to testify the superiority of support vector regression evaluation model for network performance compared with the traditional evaluation methods such as BP neural network. The testing results indicate that the network evaluation model based on support vector regression has better evaluation performance than BP neural network. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 NW Normal Univ, Phys & Elect Engn Coll, Lan Zhou, Peoples R China.
RP Song, HS (reprint author), NW Normal Univ, Phys & Elect Engn Coll, Lan Zhou, Peoples R China.
EM songhs@nwnu.edu.cn
CR Hernandez N, 2009, ANAL CHIM ACTA, V642, P110, DOI 10.1016/j.aca.2008.10.063
   Levis AA, 2005, CHEM ENG RES DES, V83, P1009, DOI 10.1205/cherd.04246
   Shen RM, 2005, J SYST SOFTWARE, V78, P1, DOI 10.1016/j.jss.2005.02.013
   Yu SW, 2008, APPL MATH COMPUT, V195, P66, DOI 10.1016/j.amc.2007.04.088
NR 4
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.799
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404016
DA 2018-12-27
ER

PT S
AU Song, Q
   Wang, AM
   Shi, HC
AF Song Qiang
   Wang Ai-min
   Shi Hui-chao
BE Zhou, X
TI RETRACTED: Risk assessment of the mine environment information based on
   multi-sensor information fusion (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE neural network fusion; risk assessment; multi-sensor information fusion
AB In recent years China's frequent mine incidents, the scene of the accident left a lot of information and the remnants of environmental information, with mine difficult after coal mine accident dangerous environment of many characteristics, based on multi-sensor information fusion (MSF) of the coal mine environment Risk assessment of the new algorithm, which adopts BP neural network algorithm and establishes model of coal mine environmental information risk of neural network model predicted the three-layer back propagation neural network, the neural network to connect the entire network structure is 5 x 12 x 5, the five input variables are the H2S (%), temperature (degrees C), wind speed (m / s), methane (%), CO (%), the five output value is the level of security. The simulation experiments show that the model can accurately assess environmental risk coal mine the extent of the model and can verify the effectiveness and feasibility. The application result shows that the prediction with this method can achieve higher better utility and expensive value. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Song Qiang; Shi Hui-chao] Anyang Inst Technol, Mech Engn Dept, Anyang, Peoples R China.
RP Shi, HC (reprint author), Anyang Inst Technol, Mech Engn Dept, Anyang, Peoples R China.
EM songqiang01@126.com
CR Duan Haini, 2010 6 INT C NAT COM, V2, p636~639
   Hall D. L., P 9 NAT S SENS FUS N
   Hansen R. J., 1995, T ASME           APR, P320
   Zhao Wencang, 2010 6 INT C NAT COM, V2, p631~636
NR 4
TC 0
Z9 0
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.208
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400008
DA 2018-12-27
ER

PT S
AU Song, ZH
   Liu, L
   Song, Y
AF Song Zhihui
   Liu Lin
   Song Yang
BE Zhou, X
TI RETRACTED: Environment Policy: Tighten or Loosen?-A case study of China
   textile and clothing industry (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Environment policy; International competitiveness of industry;
   Environmental protection stringency; Coefficient
AB Does a much strict environment policy do good or harm to the economy, especially to a export-oriented country like China. Taking the textile and clothing industry for example, this paper analyzes the industry competitiveness via TC and RCA, and establishes an estimative index system of the intensity of environmental protection - EPS. By determining the coefficients between EPS and TC or RCA of China Textile and clothing industry, finally it shows that there is no regular relation between the intensity of environmental protection and the international competitiveness of the industry. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Song Zhihui; Liu Lin; Song Yang] Shijiazhuang Tiedao Univ, Sch Econ & Management, Shijiazhuang 050043, Peoples R China.
RP Song, ZH (reprint author), Shijiazhuang Tiedao Univ, Sch Econ & Management, Shijiazhuang 050043, Peoples R China.
EM wisdom6461@hotmail.com
CR Hong Xiao, 2006, J INT TRADE      DEC, P92
   Jie Zhang, 2008, J INT TRADE      SEP, P96
   Wenjun Wang, 2007, J INT TRADE      SEP, V64-9
   Xikang Zhao, 2001, CHINA POPULATION APR, P12
NR 4
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.835
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404052
DA 2018-12-27
ER

PT S
AU Su, DG
   Zhang, FH
   Sun, LJ
AF Su, Deguo
   Zhang, Fuhao
   Sun, Lijian
BE Zhou, X
TI RETRACTED: Key Technologies of Statistical Mapping Based on RIA
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Online Thematic Map; RIA; Active; Knowledge
AB This paper analyzes two important problems of online thematic map cartography facing, namely which technique solution is appropriate and how to simplify the cartography process. Firstly, contrasts some popular technique solutions of thematic map, and points out the bottlenecks and inconveniences of thematic map cartography process nowadays, then brings out active online thematic map cartography based on the technique solution of RIA (Rich Internet Applications). In addition, this paper gives out RIA-based implementation framework of active online thematic maps mapping, which is contrasted with RIA-based implementation framework of general online thematic maps mapping, and main methods of building knowledge of active cartography of thematic map. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Su, Deguo; Zhang, Fuhao; Sun, Lijian] Chinese Acad Surveying & Mapping, 28 Lianhuachi Xilu, Beijing 100830, Peoples R China.
RP Su, DG (reprint author), Chinese Acad Surveying & Mapping, 28 Lianhuachi Xilu, Beijing 100830, Peoples R China.
EM sdg@casm.ac.cn
CR Alessandro Cecconi, 1998, TOOLS CARTOGRAPHIC V, V190, P8057
   Cerba Otakar, 2008, APPL MARKUP LANGUAGE
   Cerba Otakar, 2009, THEMATIC MAPS BROWSE
   Friendly M., 2008, MILESTONES HIST THEM
   Guo-Rui Zhu, 1996, MAP DESIGN DRAWING, P219
   Harrower Mark, 2003, CARTOGRAPHIC PE WINT, P63
   Monmonier Mark, 1989, INT YB CARTOGRAPHY, V19, P77
   Robinson A. H, 1982, EARLY THEMATIC MAPPI
NR 8
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.252
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400052
DA 2018-12-27
ER

PT S
AU Su, LL
   Su, J
   Xu, G
   Peng, T
   Li, Z
AF Su Lili
   Su Jian
   Xu Guan
   Peng Tao
   Li Zhuo
BE Zhou, X
TI RETRACTED: Design and Research of Detecting Equipment of the Bogie
   Wheelset Alignment Parameters for Railway Vehicles (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE railway vehicle; bogie; wheelset; wheelbase difference; diagonal
   difference; alignment parameter
AB In view of weak points of low precision, single test items, and inability in measuring wheelset diagonal difference, detecting equipment of bogie wheelset alignment parameters for railway vehicle could not meet the technique demands of high-speed trains. Four virtual prototypes of wheelset alignment parameters detecting equipment are described, which can measure wheelbase difference and diagonal difference with the same equipment. The methods of wheel center direct measurement and indirect measurement are used. As the main measuring instruments, grating encoder and laser distance meter can detect more precisely. The Device of Wheel Center Positioning Fixture Integrated with Grating Encoder complies with the request of bogie manufacturer after comparison of four designed equipment prototypes, because of satisfied precision and reasonable price. Besides, measurement and control system and database of detecting equipment of bogie wheelset alignment parameters are designed. The research provides a theoretical basis for the bogie design and structure improvement. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Su Lili] Jilin Univ, State Key Lab Automot Dynam Simulat, Changchun 130025, Peoples R China.
RP Su, J (reprint author), Jilin Univ, Coll Transportat, Changchun 130025, Peoples R China.
EM sujianjd@163.com
CR [Anonymous], UIC518
   [Anonymous], 1999, 122991999 BS ENV
   EICKHOFF BM, 1995, VEHICLE SYST DYN, V24, P469, DOI 10.1080/00423119508969105
   Zeng J, 1999, VEHICLE SYST DYN, V33, P552
   Zeng Jing, 2001, Chinese Journal of Mechanical Engineering, V14, P97
NR 5
TC 0
Z9 0
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.302
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400102
DA 2018-12-27
ER

PT S
AU Sun, B
   Zeng, FM
   Zhang, WD
   Zhao, H
AF Sun Bin
   Zeng Fan-ming
   Zhang Wei-dong
   Zhao Hua
BE Zhou, X
TI RETRACTED: Development of Frequency and Power Control System
   Hardware-in-loop Simulation Platform for Ship Power Plant (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Ship power plant; Hardware-in-loop Simulation; frequency and power
   controller
ID THE-LOOP
AB In order to research the dynamic and static performance of ship power plant, the status quo of frequency and power control are analyzed. A hardware-in-loop simulator was built based on LabVIEW platform and Programmable Logic Controller (PLC), and the hardware-in-loop simulations were performed for frequency and power control in ship power plant. Before choosing the frequency and power controller, the value of the deviation of the real load from the desired load is basically big, diesel error is 39.5%, and turbine error is 19.5%. When controller is adopted, diesel error is 12.8%, and turbine error is 5.3%. The experiment results show the platform provides a new effective method for development of the frequency and power control, because of its merit such as shortening lead time and saving development funds. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental
C1 [Sun Bin; Zeng Fan-ming] Naval Univ Engn, Coll Naval Architecture & Marine Power, Wuhan 430033, Peoples R China.
RP Sun, B (reprint author), Naval Univ Engn, Coll Naval Architecture & Marine Power, Wuhan 430033, Peoples R China.
EM sun544@163.com
CR Ayasun S, 2007, SIMUL MODEL PRACT TH, V15, P734, DOI 10.1016/j.simpat.2007.03.002
   Brendecke T., 2002, INT J VEHICLE DES, P84
   Bullock D, 2004, TRANSPORT RES C-EMER, V12, P73, DOI 10.1016/j.trc.2002.10.002
   Gawthrop PJ, 2008, CONTROL ENG PRACT, V16, P897, DOI 10.1016/j.conengprac.2007.10.009
   Guojun CHEN, 2001, MODERN MARINE ENGINE
   [李长文 Li Changwen], 2004, [兵工学报, Acta Armamentarii], V25, P402
   Li Shengbo, 2007, China Mechanical Engineering, V18, P2012
   Ren W., 2006, U POW ENG C NEWC, P669
   Tsai wen T., 2006, CONTROL ENG PRACT, V14, P1467
   Xing FANG, 2008, J HUAZHONG U SCI TEC, V36, P258
NR 10
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.959
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096405026
DA 2018-12-27
ER

PT S
AU Sun, HJ
   Peng, CH
   Liu, G
AF Sun, H. J.
   Peng, C. H.
   Liu, G.
BE Zhou, X
TI RETRACTED: Economic/environmental dispatch for wind-thermal power system
   using a multi-objective differential evolution algorithm (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Environmental/economic dispatch; wind power; differential evolution;
   entropy weight
AB With consideration of the increased costs for maintaining power system stable due to the incorporation of wind power, in this paper, an economic/environmental dispatch stochastic optimization model for power system integrated with large scale wind farms was formulated based on in-depth analysis of the random nature and probability calculations of overestimation and underestimation of available wind power output. The optimization goals are to minimize both the total polluting emission and operational cost as much as possible. An excellent multi-objective optimization algorithm based on the non-dominated sorting differential evolution was proposed to solve this model, and entropy weights and fuzzy set theory were employed to extract the comprehensive optimal solution. The simulation results on a power system with large scale wind farms demonstrate the effectiveness of the proposed method, and the impacts of wind power to power systems optimal dispatch were analyzed from the points of energy saving and emission reduction. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Sun, H. J.; Peng, C. H.; Liu, G.] E China Jiaotong Univ, Dept Elect & Elect Engn, Nanchang City, Jiangxi, Peoples R China.
RP Sun, HJ (reprint author), E China Jiaotong Univ, Dept Elect & Elect Engn, Nanchang City, Jiangxi, Peoples R China.
EM chinapch@163.com
CR Abido MA, 2003, IEEE T POWER SYST, V18, P1529, DOI 10.1109/TPWRS.2003.818693
   Correia PF, 2010, ELECTR POW SYST RES, V80, P592, DOI 10.1016/j.epsr.2009.10.031
   Farina M, 2004, IEEE T SYST MAN CY A, V34, P315, DOI 10.1109/TSMCA.2004.824873
   Hetzer J, 2008, IEEE T ENERGY CONVER, V23, P603, DOI 10.1109/TEC.2007.914171
   Hwang C. L., 1981, MULTIPLE ATTRIBUTE D
   Peng Chun-hua, 2009, Proceedings of the CSEE, V29, P71
   Roy S, 2002, IEEE T ENERGY CONVER, V17, P124, DOI 10.1109/60.986449
NR 7
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.217
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400017
DA 2018-12-27
ER

PT S
AU Tan, HC
   Feng, JS
   Zhang, J
   Zhang, YJ
   Wang, WH
AF Tan, Huachun
   Feng, Jianshuai
   Zhang, Jie
   Zhang, Yujin
   Wang, Wuhong
BE Zhou, X
TI RETRACTED: Dicriminative Feature Weighted Hausdorff Distance for Face
   Recognition (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Hausdorff distance; face recognition; LDA; weighting function
AB The different face regions have different degrees of importance for face recognition. In previous weighted Hausdorff distance (HD) measures for face recognition, the weighting function are proposed to try to describe the discriminative properties of face images effectively. Motivated by the basic idea of weighting function for HD, a new weighting function based on Linear Discriminant Analysis (LDA), due to its efficient discriminative ability, is proposed to weight different face edge points. The new weighted HD, termed Edge LDA Weighted HD (ELWHD), is applied to face recognition. Experiments comparing with pervious HD measures on ORL face database show the new method achieves higher recognition rate. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Tan, Huachun; Feng, Jianshuai; Wang, Wuhong] Beijing Inst Technol, Dept Transportat Engn, Beijing 100081, Peoples R China.
RP Tan, HC (reprint author), Beijing Inst Technol, Dept Transportat Engn, Beijing 100081, Peoples R China.
EM tanhc@bit.edu.cn
CR Aiger D, 2010, PATTERN RECOGN, V43, P153, DOI 10.1016/j.patcog.2009.05.014
   [Anonymous], ORL DATABASE
   BIEDERMAN I, 1988, COGNITIVE PSYCHOL, V20, P38, DOI 10.1016/0010-0285(88)90024-2
   DUBUISSON MP, 1994, INT C PATT RECOG, P566, DOI 10.1109/ICPR.1994.576361
   Gao Y, 2003, IEE P-VIS IMAGE SIGN, V150, P346, DOI 10.1049/ip-vis:20030805
   Gao YS, 2002, PATTERN RECOGN, V35, P361, DOI 10.1016/S0031-3203(01)00049-8
   HUTTENLOCHER DP, 1993, IEEE T PATTERN ANAL, V15, P850, DOI 10.1109/34.232073
   Jesorsky O, 2001, LECT NOTES COMPUT SC, V2091, P90
   Lin KH, 2003, PATTERN RECOGN, V36, P1827, DOI 10.1016/S0031-3203(03)00011-6
   Lin KH, 2001, PROCEEDINGS OF 2001 INTERNATIONAL SYMPOSIUM ON INTELLIGENT MULTIMEDIA, VIDEO AND SPEECH PROCESSING, P477, DOI 10.1109/ISIMP.2001.925437
   Sim DG, 1999, IEEE T IMAGE PROCESS, V8, P425, DOI 10.1109/83.748897
   Takacs B, 1998, PATTERN RECOGN, V31, P1873, DOI 10.1016/S0031-3203(98)00076-4
   Tan HC, 2007, PROCEEDINGS OF THE FOURTH INTERNATIONAL CONFERENCE ON IMAGE AND GRAPHICS, P639, DOI 10.1109/ICIG.2007.70
   Tan HC, 2006, IMAGE VISION COMPUT, V24, P656, DOI 10.1016/j.imavis.2005.05.011
   Zhang S, 2007, IEEE T PATTERN ANAL, V29, P1732, DOI 10.1109/TPAMI.2007.1089
   Zhao CJ, 2005, PATTERN RECOGN LETT, V26, P581, DOI 10.1016/j.patrec.2004.09.022
   Zhao W, 2003, ACM COMPUT SURV, V35, P399, DOI 10.1145/954339.954342
   Zhou ZQ, 2009, PROCEEDINGS OF 2009 INTERNATIONAL CONFERENCE ON IMAGE ANALYSIS AND SIGNAL PROCESSING, P250
NR 18
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.232
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400032
DA 2018-12-27
ER

PT S
AU Tan, HC
   Feng, JS
   Li, F
   Zhang, YJ
   Chen, T
AF Tan, Huachun
   Feng, Jianshuai
   Li, Feng
   Zhang, Yujin
   Chen, Tao
BE Zhou, X
TI RETRACTED: Low Multilinear Rank Tensor Completion with Missing Data
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE tensor completion; matrix completion; missing data; low rank; image
   inpainting
AB We present a novel method for tensor completion with missing data. The problem of missing data comes up in many areas of science and engineering including data mining, machine learning, biomedical signal, and computer vision. These data are always very large and have multi-modes. Therefore, we need a well method to find the missing data of multi-way arrays (i.e., tensors). In this paper we propose an algorithm to solve the problem by tensor multilinear rank minimization. The contribution of our paper is that we convert tensor rank minimization to minimize the mode-n rank of a tensor along each mode and then formulate as low rank matrix completion for mode-n matricization of a tensor. The resulting nuclear norm related minimization problem can be efficiently solved by many recent developed methods. Our numerical results on randomly generated data demonstrate that our algorithm is quick and provides much better recoverability than a few state-of-art tensor completion algorithms. Numerical experiments on image inpainting problems demonstrate the effectiveness of our method in real world. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Tan, Huachun; Feng, Jianshuai] Beijing Inst Technol, Dept Transportat Engn, Beijing 100081, Peoples R China.
RP Tan, HC (reprint author), Beijing Inst Technol, Dept Transportat Engn, Beijing 100081, Peoples R China.
EM tanhc@bit.edu.cn
CR Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99
   Bertalmio M., 2000, P SIGGRAPH 2000 NEW
   Cai J. F., 2008, ARXIV08103286
   Candes E. J., 2008, ARXIV08054471
   Deprettere E. F., 1988, SVD SIGNAL PROCESSIN
   Fazel M., 2002, THESIS STANFORD U
   Keshavan R. H., 2009, ARXIV09013150
   Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X
   Kurucz M., KDD
   Lee K., 2009, ARXIV09050044
   Liu Ji, 2009, ICCV
   Ma S., 2009, ARXIV09051643
   Mazumder R., 2009, SPECTRAL REGULARIZAT
   Navasca C., 2009, P 17 EUR SIGN PROC C
   Recht B., GUARANTEED MINIMUM R
   TOH KC, 2009, ACCELERATED PROXIMAL
NR 16
TC 0
Z9 0
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.231
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400031
DA 2018-12-27
ER

PT S
AU Tang, XB
   Fang, G
AF Tang, Xiao-Bin
   Fang, Gang
BE Zhou, X
TI RETRACTED: "An Algorithm of Mining Spatial Topology Association Rules
   Based on Complement Set" (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE spatial data mining; topology association rules; multilayer transverse
   association; double search; complement set
AB According to these shortcomings when Apriori is used to mining spatial topology association rules. This paper proposes an algorithm of mining spatial topology association rules based on complement set, which is used to mining spatial multilayer transverse association rules from spatial database. This algorithm generate candidate frequent topological itemsets not only by up search strategy as Apriori, but also by computing complement set of candidate from up search strategy, which is suitable for mining any spatial topological frequent itemsets. This algorithm compresses a kind of spatial topological relation to form an integer. By the way, firstly, the algorithm may efficiently reduce some storage space when creating mining database. Secondly, the algorithm is fast to obtain topological relation between two spatial objects, namely, it may easily compute support of candidate frequent itemsets. Finally, the algorithm may fast generate candidate via double search strategy, i.e. one is that it connects ( k+1)-candidate frequent itemsets of k-frequent itemsets as up search strategy, the other is that it computes complement set of (k+1)-candidate frequent itemsets. The result of experiment indicates that the algorithm is able to extract spatial multilayer transverse association rules from spatial database via efficient data store, and it is very efficient to extract any frequent topology association rules. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Tang, Xiao-Bin; Fang, Gang] Chongqing Three Gorges Univ, Chongqing 404000, Peoples R China.
RP Tang, XB (reprint author), Chongqing Three Gorges Univ, Chongqing 404000, Peoples R China.
EM soupmy74@163.com
CR FANG G, 2008, IEEE INF C INF AUT, P1571
   FANG G, 2010, IEEE INF C INT COMP, P101
   FANG G, 2008, J COMPUTER ENG APPL, V44, P168
   [方刚 FANG Gang], 2009, [西南大学学报. 自然科学版, Journal of Southwest University. Natural Science Edition], V31, P95
   MA R.H., 2007, GIS SPATIAL ASS PATT
   ZHANG X.W., 2007, J PROGR GEOGRAPHY, V26, P119
NR 6
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.285
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400085
DA 2018-12-27
ER

PT S
AU Tang, XL
   Gu, YK
AF Tang Xiuli
   Gu Yingkang
BE Zhou, X
TI RETRACTED: Research on Development of Green Catering in China in the
   Context of Low Carbon Economy (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Low carbon economy; Green catering; Green food; Environment protection
AB With the global warming, environment protection and low carbon economy increasingly concerned by public, green catering obtains a rare development opportunity in China. Based on the concept of low carbon economy, this research clarified the green catering, analyzed its developing status in China, disclosed the existing problems and put forward some suggestions so as to speed up its development in the context of low carbon economy. This research is helpful to discover the barriers in this industry, give supports to green catering managers and green food producers, and also provide a better way to understand the Chinese catering industry. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Gu Yingkang] Shanghai Univ Finance & Econ, Sch Int Business Adm, Shanghai 200433, Peoples R China.
RP Gu, YK (reprint author), Shanghai Univ Finance & Econ, Sch Int Business Adm, Shanghai 200433, Peoples R China.
EM gykcx@163.com
CR Chen Sheng, 1999, ENERG ENG, V5, P50
   Chen Wei, 2004, J MINJIANG U, V25, P135
   Li Xiaoying, 2007, J DALIAN U, V28, P130
   Zhao Yaping, 2006, J TIANJIN U COMMERCE, V26, P15
NR 4
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.793
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404010
DA 2018-12-27
ER

PT S
AU Tao, FF
   Tian, Q
   Li, F
   Yang, B
AF Tao, Feifei
   Tian, Qing
   Li, Fang
   Yang, Bo
BE Zhou, X
TI RETRACTED: Kinetics of Phosphorus Removal and Recovery as Struvite from
   Wastewaters with Medium-low Phosphorous Concentration (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE phosphorus removal and recovery; low phosphorous contained wastewater;
   crystallization kinetics
ID CRYSTALLIZATION; PRECIPITATION
AB Batch experiments with simulated low-phosphorous-containing wastewater were carried out to observe the effects of environmental conditions on MAP nucleation and crystallization kinetics. Results showed that higher pH and lower temperature enhanced the process of the MAP crystallization. The kinetics of phosphorus removal as struvite (magnesium ammonium phosphate, MAP) in its crystallization under various conditions, including pH, initial phosphorus concentration, molar ratio of Mg/N and N/P, were investigated. The nucleation of MAP followed a first-order reaction in wastewaters with the initial phosphate<80mg.L-1, compared with those followed second-order reactions in wastewater with initial phosphate >100mg.L-1. The crystallization rate of MAP increased with the improving of ammonium and magnesium dosage. The ammonium amendment has a more significant effect on MAP crystallization kinetics than that of magnesium. When the initial phosphate concentrations of the wastewater were low, the factor of supersaturation level has an effect of exponential order on the induction times for MAP nucleation. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Tao, Feifei; Tian, Qing; Li, Fang; Yang, Bo] Donghua Univ, Sch Environm Sci & Engn, N Peoples Rd 2999, Shanghai 201620, Peoples R China.
RP Tian, Q (reprint author), Donghua Univ, Sch Environm Sci & Engn, N Peoples Rd 2999, Shanghai 201620, Peoples R China.
EM tq2004@dhu.edu.cn
CR [Anonymous], 2007, BIORESOURCE TECHNOLO, V98, P1573
   Bouropoulos NC, 2000, J CRYST GROWTH, V213, P381, DOI 10.1016/S0022-0248(00)00351-1
   Doyle JD, 2002, WATER RES, V36, P3925, DOI 10.1016/S0043-1354(02)00126-4
   Edward D, 1998, J ENV ENG, V32, P0730
   Iqbal M., 2008, J CRYST GROWTH, V310, P1187
   Le Corre KS, 2007, ENVIRON TECHNOL, V28, P1317, DOI 10.1080/09593332808618891
   Marti N, 2008, CHEM ENG J, V141, P67, DOI 10.1016/j.cej.2007.10.023
   Matsumoto K, 2008, BBA-GEN SUBJECTS, V1780, P233, DOI 10.1016/j.bbagen.2007.09.013
   Nielsen A.E., 1971, J CRYST GROWTH, P11
   Quintana M, 2005, CHEM ENG J, V111, P45, DOI 10.1016/j.cej.2005.05.005
   Suzuki K, 2007, BIORESOURCE TECHNOL, V98, P1573, DOI 10.1016/j.biortech.2006.06.008
   Wang JS, 2006, CHEMOSPHERE, V65, P1182, DOI 10.1016/j.chemosphere.2006.03.062
NR 12
TC 0
Z9 0
U1 1
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.871
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404088
DA 2018-12-27
ER

PT S
AU Tao, W
AF Tao, Wang
BE Zhou, X
TI RETRACTED: A More Realistic Highway Traffic Simulation Model Considering
   the Following Car Horning (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Traffic Simulation; Cellular Automaton; Following Car Horning
ID CELLULAR-AUTOMATON MODEL; FLOW
AB In the present paper, a new CA-based model considering the following car horning is established and is analyzed in great detail. Firstly, how the following car horning can influence the traffic system is discussed. Secondly, by applying the cross-covariance method, proper parameters are indicated to explore the phase transition features of the model. The results show that the model proposed in this paper can simulate complex and realistic traffic phenomena. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Sichuan Univ, Shool Comp Sci, Chengdu 610041, Peoples R China.
RP Tao, W (reprint author), Sichuan Univ, Shool Comp Sci, Chengdu 610041, Peoples R China.
EM anshangcun163@163.com
CR Barlovic R, 1998, EUR PHYS J B, V5, P793, DOI 10.1007/s100510050504
   Benjamin SC, 1996, J PHYS A-MATH GEN, V29, P3119, DOI 10.1088/0305-4470/29/12/018
   Emmerich H, 1997, PHYSICA A, V234, P676, DOI 10.1016/S0378-4371(96)00310-X
   Fukui M, 1996, J PHYS SOC JPN, V65, P1868, DOI 10.1143/JPSJ.65.1868
   Jiang R, 2003, J PHYS A-MATH GEN, V36, P381, DOI 10.1088/0305-4470/36/2/307
   Kerner BS, 1998, PHYS REV LETT, V81, P3797, DOI 10.1103/PhysRevLett.81.3797
   Kerner BS, 2004, PHYSICA A, V333, P379, DOI 10.1016/j.physa.2003.10.017
   Kerner BS, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.046138
   Kerner BS, 2002, J PHYS A-MATH GEN, V35, P9971, DOI 10.1088/0305-4470/35/47/303
   Kerner BS, 1997, PHYS REV LETT, V79, P4030, DOI 10.1103/PhysRevLett.79.4030
   Knospe W, 2000, J PHYS A-MATH GEN, V33, pL477, DOI 10.1088/0305-4470/33/48/103
   Li KP, 2006, COMMUN THEOR PHYS, V45, P113
   Li L, 2003, ACTA PHYS SIN-CH ED, V52, P2121
   Li XB, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066128
   NAGEL K, 1992, J PHYS I, V2, P2221
   Neubrt L., 1999, PHYS REW E, V60, P6
   Schadschneider A, 1997, ANN PHYS-LEIPZIG, V6, P541, DOI 10.1002/andp.19975090703
   Takayasu M, 1993, FRACTALS, V1, P860, DOI 10.1142/S0218348X93000885
   Wang BH, 1996, J PHYS A-MATH GEN, V29, pL31, DOI 10.1088/0305-4470/29/2/002
   Wolfram S., 1986, THEORY APPL CELLULAR
NR 20
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.239
PG 10
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400039
DA 2018-12-27
ER

PT S
AU Tong, XH
   Qin, XQ
AF Tong, Xiaohong
   Qin, Xinqiang
BE Zhou, X
TI RETRACTED: A New Numerical Method for Heat Conduction Equations
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Heat conduction equations; Meshless method; Ridge basis function;
   Collocation method
ID RIDGE FUNCTIONS; APPROXIMATION
AB A new numerical method for heat conduction equations has been developed by utilizing the collocation method and a new ridge basis function interpolation. The method is applied to 1/2-dimensional equations to examine its appropriateness, and influence factors of accuracy for numerical solutions are analyzed. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Tong, Xiaohong; Qin, Xinqiang] Xian Univ Technol, Sch Sci, Xian 710054, Shaanxi, Peoples R China.
RP Tong, XH (reprint author), Xian Univ Technol, Sch Sci, Xian 710054, Shaanxi, Peoples R China.
EM xiaohtong@163.com
CR Gordon Y, 2002, CONSTR APPROX, V18, P61
   Ismailov VE, 2007, J COMPUT APPL MATH, V205, P105, DOI 10.1016/j.cam.2006.04.043
   Konovalov VN, 2008, J APPROX THEORY, V152, P20, DOI 10.1016/j.jat.2007.10.001
   Onate E, 1998, COMPUT MECH, V21, P283, DOI 10.1007/s004660050304
   Stein E. M., 1971, INTRO FOURIER ANAL E
   [王志刚 WANG Zhi-gang], 2010, [山东大学学报. 理学版, Journal of Shangdong University], V45, P44
   Wang ZQ, 2010, APPL MATH COMPUT, V217, P1870, DOI 10.1016/j.amc.2010.06.042
   Wang Zhigang, 2010, MESHLESS METHOD RIDG
   Wendland H, 1999, MATH COMPUT, V68, P1521, DOI 10.1090/S0025-5718-99-01102-3
NR 9
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.342
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400142
DA 2018-12-27
ER

PT S
AU Wang, B
   Han, HJ
   Ma, WC
   Li, YF
   Liu, YS
AF Wang, Bing
   Han, Hongjun
   Ma, Wencheng
   Li, Yufei
   Liu, Yinsong
BE Zhou, X
TI RETRACTED: Study on Nitrogen Removal in A(2)O reactor with fluidized
   carriers (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE A(2)O process; fluidized carrier; nitrogen removal; municipal wastewater
AB A(2)O process with fluidized carriers was used to treat municipal wastewater. Put fluidized carriers sharing 40% volume into aerobic zone to enhance nitrifying capacity of the system. The average of NH4+-N removel rate was about 83.7%, and the tiptop could reach 95.16%. The average of TN removal rate was 60.3%, and the tiptop could reach 73.7%. The TN removal was beyond the bacteria assimilation. TN removal rate could be as high as 16.3% of the whole reactor. The system showed a significant phenomenon of simultaneous nitrification and denitrification. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, Bing; Han, Hongjun; Ma, Wencheng; Li, Yufei; Liu, Yinsong] Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150090, Peoples R China.
RP Han, HJ (reprint author), Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150090, Peoples R China.
EM han13946003379@163.com
CR B Li, 2008, ENV SCI MANAGEMENT, V9, P97
   Baek SH, 2008, WATER ENVIRON RES, V80, P109, DOI 10.2175/106143007X220725
   H Masahito, 2008, SOIL SCI PLANT NUTR, V54, P33
   Li YZ, 2008, BIORESOURCE TECHNOL, V99, P5867, DOI 10.1016/j.biortech.2007.10.001
   Rajesh J., 2009, BIORESOURCE TECHNOLO, V100, P3820, DOI DOI 10.1016/J.BIORTECH.2008.12.054
   RT Trine, 2007, FEMS MICROBIOLOGY EC, V60, P370
   SK Sujay, 2008, ECOLOGICAL APPL, V18, P789
   W Evalyn, 2009, WATER RES, V43, P4461
   Wu Chang-yong, 2009, Huanjing Kexue, V30, P798
   Y Gulsum, 2008, BIOTECHNOL BIOENG, V100, P529
NR 10
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.784
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404001
DA 2018-12-27
ER

PT S
AU Wang, C
   Zhang, FD
   Hua, J
AF Wang, Chuang
   Zhang, Fengdeng
   Hua, Jun
BE Zhou, X
TI RETRACTED: Measurement and transmission of steering wheel angle based on
   FlexRay (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE FlexRay; steer-by-wire; photoelectric encoder; phase discriminator;
   steering angle
AB FlexRay is one of the next communication standard of automobile network system. Compare with traditional CAN bus, it has many advantages like dererministic communication and support fault-tolerance. This paper chooses steer-by-wire (SBW) system as application object of FlexRay bus, show that FlexRay is better than CAN in safety-critical system. First, analyze the characteristics of FlexRay and desigan a simplified SBW system. Then, Measure the steering wheel angle and design FlexRay communication network, include the configuration of key parameters and distribution of tasks for two nodes of SBW system. Finally, the experiment of simplified SBW was performed. The experiment result shows that the characteristics of FlexRay are more suitable than CAN in safety-critical system. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, Chuang; Zhang, Fengdeng; Hua, Jun] Shanghai Univ Sci & Technol, 516 Jun Gong Rd, Shanghai 200093, Peoples R China.
RP Wang, C (reprint author), Shanghai Univ Sci & Technol, 516 Jun Gong Rd, Shanghai 200093, Peoples R China.
EM wangchuang61@gmail.com
CR Duan JM, 2009, IEEE INT VEH SYM, P824, DOI 10.1109/IVS.2009.5164385
   FlexRay Consortium, 2005, FLEXRAY PROT SPEC V2
   Freescale Semiconductor, 2010, MC9S12XF512 REF MAN
   Freescale Semiconductor, FLEXRAY COMM SYST
   ming Sun Xiang, 2005, J U PETROLEUM CHINA, V29, P91
   Shapiro J, 2005, EE-EVAL ENG, V44, P54
   Waraus D, 2009, APPLIED ELECTRONICS, P269
   yu cheng An, 2010, 2010 INT C MECH AUT, P5426
NR 8
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.315
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400115
DA 2018-12-27
ER

PT S
AU Wang, H
   Li, HB
AF Wang, H.
   Li, H. B.
BE Zhou, X
TI RETRACTED: Design and Application of Biofilter to Control Odor in
   Wastewater Treatment Plant (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE odor control: biofilter; wastewater treatment plant; biological
   deodorization
ID AIR-POLLUTION CONTROL; REMOVAL
AB The biofilter was introduced to control odor gas in wastewater treatment plant through the analysis to the characteristics of odor gas and the process of biological deodorization. The collection and transportation of odorous gas and the operations of the odor control systems were described in detail. The running practice indicated that the process has steady and reliable treatment effect, and the pollutants can meet the requirement of the secondary standard of discharge standard of pollutants for municipal wastewater treatment plant (GB 18918-2002) in China. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, H.; Li, H. B.] Shenyang Univ, Minist Educ, Key Lab Reg Environm & Ecoremediat, Shenyang, Peoples R China.
RP Wang, H (reprint author), Shenyang Univ, Minist Educ, Key Lab Reg Environm & Ecoremediat, Shenyang, Peoples R China.
EM wh51@163.com
CR Delhomenie MC, 2005, CRIT REV BIOTECHNOL, V25, P53, DOI 10.1080/07388550590935814
   Iranpour R, 2005, ENVIRON PROG, V24, P254, DOI 10.1002/ep.10077
   [蒋岚岚 Jiang Lanlan], 2007, [环境污染与防治, Environmental Pollution & Control], V29, P781
   Kan E, 2003, BIOTECHNOL BIOENG, V84, P240, DOI 10.1002/bit.10767
   Martinez Alvaro, 2008, CLEAN TECHNOL ENVIR, V10, P181
   [王丽燕 Wang Liyan], 2004, [哈尔滨工业大学学报, Journal of Harbin Institute of Technology], V36, P732
   Zilli M, 2001, PROCESS BIOCHEM, V37, P423, DOI 10.1016/S0032-9592(01)00228-X
NR 7
TC 2
Z9 2
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.786
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404003
DA 2018-12-27
ER

PT S
AU Wang, HB
   Bao, YM
   Zhang, J
   Chen, HY
   Ma, LZ
   Yang, M
AF Wang Hong-Bin
   Bao Yan-min
   Zhang Jing
   Chen Haiyun
   Ma Linzhuan
   Yang Min
BE Zhou, X
TI RETRACTED: Study on the Preparation and Properties of Na-modified
   Zeolites (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Zeolites; Modify; Properties; Adsorption
AB This paper has discussed the modification of zeolite, its removal of ammonia nitrogen, and adsorption and regeneration. Its structure is characterized by XRD and TEM. The results show that the modified zeolite is improved greatly by he removal of ammonia, and the adsorption fits with Freundlich isotherm equation. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yang Min] Yunnan Univ Nationalities, Sch Chem & Biotechnol, Kunming 650500, Peoples R China.
RP Yang, M (reprint author), Yunnan Univ Nationalities, Sch Chem & Biotechnol, Kunming 650500, Peoples R China.
EM 595530820@qq.com
CR He Ji-Xiu, 2006, SCI TECH INFORM DEV, V16, P149
   Jiang Zhe, 2004, J SAFETY ENV, V4.4
   Mumpon Frederick A., 1999, ROCA MAGICA USES NAT
   Pan Jia-fen, 2005, NONMETALLIC MINES, V11.28, P57
   State Environmental Protection Administration, 2002, WAT WAST MON METH, P279
   Xiao Wen-Jun, 2003, THESIS WUHAN U TECHN, P5
   Yan Chunxiao, 2008, IND CATALYSIS, V10.16
   Zhang Dong-Mei, 2008, ENV PROTECTION SCI, V2.31
   Zhang Xiu-ying, 2006, IND MINERALS PROCESS
NR 9
TC 0
Z9 0
U1 2
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.828
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404045
DA 2018-12-27
ER

PT S
AU Wang, HB
   Yu, JJ
   Yang, M
   Liu, TC
   Fan, J
   Ning, P
AF Wang Hongbin
   Yu Jiajin
   Yang Min
   Liu Tiancheng
   Fan Jing
   Ning Ping
BE Zhou, X
TI RETRACTED: Study on Preparation and Characterization of Lanthanum-loaded
   Bentonite Sorbent (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Lanthanum oxide; Load; Characterizing
AB This paper studies the preparation method of Lanthanum-loaded bentonite sorbent. By XRD and TEM, the paper explored the structure of bentonite and its modification mechanism and the adsorptive property of Phosphate of modified bentonite was studied as well. The result suggests that the unmodified bentonite has little adsorptivity of Phosphate, but the modified Bentonite by lanthanum oxide can adsorb phosphorus well, and it may be made into a potential dephosphorization absorbent. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang Hongbin; Yang Min; Liu Tiancheng; Fan Jing; Ning Ping] Kunming Univ Sci & Technol, Fac Environm Sci & Engn, Kunming, Peoples R China.
RP Ning, P (reprint author), Kunming Univ Sci & Technol, Fac Environm Sci & Engn, Kunming, Peoples R China.
EM 595530820@qq.com
CR Du Dong-Yun, 1997, CHEM ENG, P34
   Environmental Protection Agency, 2002, WAT WAST MON AN METH, P12
   Ma Gang-Ping, 1999, CHIN ENV SCI, V19, P345
   Sun Jia-Shou, 1992, NONMETALLIC MINERALS, P33
   Wasay SA, 1996, WATER ENVIRON RES, V68, P295, DOI 10.2175/106143096X127730
   Xie Xiao-Mei, 1999, AGR ENV PROTECTION, V18, P159
   Zhang Ying heart, 2002, IND WATER TREATMENT, V22, P9
NR 7
TC 0
Z9 0
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.827
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404044
DA 2018-12-27
ER

PT S
AU Wang, HM
AF Wang Hongmei
BE Zhou, X
TI RETRACTED: Marginal Analysis Model of Economic Growth and Environmental
   Pollution (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Marginal Analysis Model; Economic Growth; Environmental Pollution
AB The development of industry economy cans not get away from nature environment to prop up. It is big, researching on economic growth and environment pollution. Economic growth action has been object for many countries. The traditional mode of economic growth led to serious environmental pollution. Facing three major scientific issues that called economic growth, resources and environment, we will strengthen marginal analysis of economic growth on theory. According to traditional marginal analysis model, we propose a model of marginal analysis model of economic growth and environmental pollution. Analysis by adding environmental pollution, this paper, we propose a cost of economy growth, and gives control of economic growth for the cost of environment pollution. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 N China Univ Water Conservancy Elect Power, Dept Informat Engn, Zhengzhou 450011, Peoples R China.
RP Wang, HM (reprint author), N China Univ Water Conservancy Elect Power, Dept Informat Engn, Zhengzhou 450011, Peoples R China.
EM tjg8612905@163.com
CR ADELMAN, 1961, THEORIES EEONOMIC GR
   Dinda S, 2004, ECOL ECON, V49, P431, DOI 10.1016/j.ecolecon.2004.02.011
   Grossman GM, 1991, 3914 NBER
   James D. E., 1978, EC APPROACHES ENV PR
   Pepper D., 1996, MODERN ENV
   TAILOR, 1986, RESPECT NATURE THEOR
   *UN, 1993, INT ENV EC AC
   URNET RK, 1994, ENV EC ELEMENTARY IN
NR 8
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.923
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404140
DA 2018-12-27
ER

PT S
AU Wang, HM
AF Wang Hongmei
BE Zhou, X
TI RETRACTED: The Analysis of Economic Growth based on Green Economic
   Growth Model (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE economic growth; green; output and input; environment
AB Economic growth action is object for many country. The traditional mode of economic growth led to serious environmental pollution. Facing three major scientific issues that called economic growth, resources and environment, we will strengthen green economics growth analysis on theory. According to traditional economic growth model, we propose a model of green growth. Analysis by adding environmental costs, this paper, we propose a green economy growth, and gives control of economic growth for the green key economic parameters. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 N China Univ Water Conservancy & Elect Power, Dept Informat Engn, Zhengzhou 450011, Peoples R China.
RP Wang, HM (reprint author), N China Univ Water Conservancy & Elect Power, Dept Informat Engn, Zhengzhou 450011, Peoples R China.
EM tjg8612905@163.com
CR Chen C J, 2002, P 4 AS PAC C IND ENG, P1048
   ENGER R, 1987, ECONOMETRICA, V35, P391
   JEROEN CJM, 2000, ENVIRON RESOUR ECON, V9, P37
   ODUM HT, 1996, ENV ACCOUNTING ENERG, P48
   *UN COMM SUST DEV, 1996, IND SUST DEV FRAM ME, P56
   *UNDP, HUM DEV REPORT 2001
NR 6
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.922
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404139
DA 2018-12-27
ER

PT S
AU Wang, JG
   Hua, JZ
   Zhou, CY
AF Wang, Jianguo
   Hua, Jizhao
   Zhou, Changying
BE Zhou, X
TI RETRACTED: Supervised Discriminant Projection for Feature Extraction
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE unsupervised discriminant projection (UDP); supervised discriminant
   projection (SDP); feature extraction; face recognition
ID RECOGNITION; FACE
AB Unsupervised discriminant projection (UDP) finds an embedding subspace that preserves local structure information, and uncovers and separates embedding corresponding to different manifolds. Though UDP has been applied in many fields, it has limits to solve the classification tasks, such as the ignorance of the class information. Thus, a novel subspace method, called supervised discriminant projection (SDP), is proposed for face recognition in this paper. In our method, the class information was utilized in the procedure of feature extraction. In SDP, the local structure of the original data is constructed according to a certain kind of similarity between data points, which takes special consideration of both the local information and class information. Experiments conducted on two popular face image databases (Yale and AR) demonstrate the effectiveness of the proposed method. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, Jianguo; Zhou, Changying] Tangshan Coll, Dept Comp Sci & Technol, Tangshan 063000, Peoples R China.
RP Wang, JG (reprint author), Tangshan Coll, Dept Comp Sci & Technol, Tangshan 063000, Peoples R China.
EM wjgfwjg@163.com
CR Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228
   Yang J, 2005, PATTERN RECOGN, V38, P1125, DOI 10.1016/j.patcog.2004.11.019
   Yang J, 2007, IEEE T PATTERN ANAL, V29, P650, DOI 10.1109/TPAMI.2007.1008
   Zhu M., 2006, RROC INT C COMP VIS, V1, P132
NR 4
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.223
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400023
DA 2018-12-27
ER

PT S
AU Wang, JG
   Zhou, CY
   Yao, HB
AF Wang, Jianguo
   Zhou, Changying
   Yao, Hongbo
BE Zhou, X
TI RETRACTED: Fuzzy 2D Maximum Scatter Discriminant Analysis For Feature
   Extraction (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE feature extraction; face recognition; 2DMSD; fuzzy 2DMSD; fuzzy
   k-nearest neighbor (FKNN)
ID HIGH-DIMENSIONAL DATA; SAMPLE-SIZE PROBLEM; FACE RECOGNITION; LDA;
   ALGORITHM; PCA
AB A novel method of face image feature extraction, called the fuzzy 2DMSD (F2DMSD) based on the 2D maximum scatter discriminant analysis and fuzzy set theory, is proposed. In the proposed one, the membership degree matrix is calculated by FKNN, then the membership degree is incorporated into the definition of the between-class scatter matrix and the within-class scatter matrix. Then the fuzzy between-class scatter matrix and the fuzzy within-class scatter matrix are obtained. Experiments conducted on the FERET face databases and the Yale face database demonstrate the effectiveness of the proposed method. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, Jianguo; Zhou, Changying; Yao, Hongbo] Tangshan Coll, Dept Comp Sci & Technol, Tangshan 063000, Peoples R China.
RP Wang, JG (reprint author), Tangshan Coll, Dept Comp Sci & Technol, Tangshan 063000, Peoples R China.
EM wjgfwjg@163.com
CR Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228
   Chen LF, 2000, PATTERN RECOGN, V33, P1713, DOI 10.1016/S0031-3203(99)00139-9
   Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x
   KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426
   Li M, 2005, PATTERN RECOGN LETT, V26, P527, DOI 10.1016/j.patrec.2004.09.007
   Liu K., 1992, INT J PATTERN RECOGN, V6, P817
   Song Feng-Xi, 2004, Acta Automatica Sinica, V30, P890
   Swets DL, 1996, IEEE T PATTERN ANAL, V18, P831, DOI 10.1109/34.531802
   Wang JG, 2008, NEUROCOMPUTING, V72, P352, DOI 10.1016/j.neucom.2008.01.004
   Yang H, 2003, PATTERN RECOGN, V36, P563
   Yang J, 2005, PATTERN RECOGN, V38, P1125, DOI 10.1016/j.patcog.2004.11.019
   Yang J, 2004, IEEE T PATTERN ANAL, V26, P131, DOI 10.1109/TPAMI.2004.1261097
   Yu H, 2001, PATTERN RECOGN, V34, P2067, DOI 10.1016/S0031-3203(00)00162-X
   ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X
   Zhao W., 1999, CSTR4009 U MAR
   Zhuang XS, 2007, PATTERN RECOGN, V40, P1570, DOI 10.1016/j.patcog.2006.11.015
   Zhuang XS, 2005, PATTERN RECOGN, V38, P2192, DOI 10.1016/j.patcog.2005.02.011
NR 17
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.207
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400007
DA 2018-12-27
ER

PT S
AU Wang, JH
   Chen, CF
   Huang, PP
   Gu, W
   Chu, JX
AF Wang, Jianhua
   Chen, Changfeng
   Huang, Pingping
   Gu, Wei
   Chu, Jianxin
BE Zhou, X
TI RETRACTED: Modeling, Simulating and Experiment of an Autonomous Surface
   Vehicle (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Nonlinear Modeling; Autonomous Surface Vehicle; Simulating; Experiment
AB This paper presents a nonlinear model of a catamaran-style Autonomous Surface Vehicle (ASV) thrust with twin fixed propellers, which are driven by DC electric motors. A total model including resistance of boat body, propulsion force and driving characteristics of motor is established. Response for a full range of the ASV motion is simulated according to the model, based on which the performance of the ASV is discussed. Experiment results from sea test are in accord with the ones from simulating, which validate the nonlinear model. Compared with the classical linearized models, the advantage of the nonlinear model lies in convenience for dealing with system response for the full range of ASV motion. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, Jianhua; Chen, Changfeng; Huang, Pingping; Gu, Wei; Chu, Jianxin] Shanghai Maritime Univ, Marine Technol & Control Engn Key Lab, 1550 Haigang Av, Shanghai 201306, Peoples R China.
RP Wang, JH (reprint author), Shanghai Maritime Univ, Marine Technol & Control Engn Key Lab, 1550 Haigang Av, Shanghai 201306, Peoples R China.
EM jhwang@shmtu.edu.cn
CR Alves J, 2006, MED C CONTR AUTOMAT, P924
   BLANK J, 2008, P 40 SE S SYST THEOR
   Caccia M, 2005, IEEE ROBOT AUTOM MAG, V12, P95, DOI 10.1109/MRA.2005.1511873
   CACCIA M, 2006, P 14 IEEE MED C CONT
   Caccia M, 2008, IEEE J OCEANIC ENG, V33, P133, DOI 10.1109/JOE.2008.920157
   Fahimi F, 2009, AUTONOMOUS ROBOTS: MODELING, PATH PLANNING, AND CONTROL, P221, DOI 10.1007/978-0-387-09538-7_7
   Ferreira H., 2006, ENC CIENT ROB 2006 P
   Majohr J., 2006, IEE CONTROL SERIES, P329
   Manley J., 2000, P OC 2000 MTS IEEE
   Manley J., 2008, P OC 08 MTS IEEE
   Muske KR., 2008, USV MOD P 2008 AM CO
   Naeem W., 2006, P UKACC INT CONTR C
NR 12
TC 1
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.247
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400047
DA 2018-12-27
ER

PT S
AU Wang, JW
   Zhu, B
   Yang, B
AF Wang Jin-wu
   Zhu Bing
   Yang Bo
BE Zhou, X
TI RETRACTED: Morphological filter based correlation matching tracking
   algorithm (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Image Segmentation; BMCD; Correlation Tracking; Morpholog
AB This paper focuses on the template matching problem which is a classic arithmetic in the field of TV tracking. In the proposed scheme, we first make use of the average grey method to do image segmentation, and get the birnarized image. Then, filter the image with some math morphology. At last, a newly designed correlation matching arithmetic based on BMCD is used to do TV tracking. Experimental results show that our method has strong anti-interference capability, so it can be used for target tracking under complex backgrounds, and our method fits for real-time image processing. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang Jin-wu; Zhu Bing; Yang Bo] Yangzhou Marine Elect Instruments Inst, Yangzhou 225001, Peoples R China.
RP Wang, JW (reprint author), Yangzhou Marine Elect Instruments Inst, Yangzhou 225001, Peoples R China.
EM jwwang@mail.ustc.edu.cn
CR Beucher S., 1993, MATH MORPHOLOGY IMAG, P433
   Cheng F, 1992, IEEE T IMAGE PROCESS, V1, P533, DOI 10.1109/83.199924
   Ikeuchi K, 1996, PROC CVPR IEEE, P100, DOI 10.1109/CVPR.1996.517060
   Lu JH, 1997, IEEE T CIRC SYST VID, V7, P429, DOI 10.1109/76.564122
   Luo Shi-tu, 2004, J INSTRUMENTATION TE, V25, P633
   SHI JB, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P593, DOI 10.1109/CVPR.1994.323794
   Xu JB, 1999, IEEE T CIRC SYST VID, V9, P1025, DOI 10.1109/76.795056
NR 7
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.216
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400016
DA 2018-12-27
ER

PT S
AU Wang, JF
   Fan, XL
AF Wang, JinFeng
   Fan, XiaoLiang
BE Zhou, X
TI RETRACTED: Optimization of Process Plan by Genetic Algorithms (GAs)
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE computer-aided process planning(CAPP); process plan; genetic algorithm;
   optimization
AB Optimization of process plan is very complex and difficult in CAPP. Based on the analysis of part features and process constraints among the features, a GA is applied to optimization of process plan. Process plan is optimized using the reasonable coding strategy, objective function, operators of selection, crossover and mutation. An application sample is developed to illuminate the process of optimization of process plan by the GA. The results show that the algorithm can obtain optimal or near-optimal process plan which meets specific production requirements. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, JinFeng; Fan, XiaoLiang] N China Elect Power Univ, Dept Mech Engn, Baoding 071003, Peoples R China.
RP Wang, JF (reprint author), N China Elect Power Univ, Dept Mech Engn, Baoding 071003, Peoples R China.
EM wjf266@163.com
CR Li WD, 2004, INT J PROD RES, V42, P1955, DOI 10.1080/00207540310001652897
   Ma G. H., 2002, P ASME DES ENG TECHN, V3, P57
   Salehi M, 2009, ENG APPL ARTIF INTEL, V22, P1179, DOI 10.1016/j.engappai.2009.04.005
   Wang Zhongbin, 2004, Journal of Tsinghua University (Science and Technology), V44, P988
   Zhang WB, 2006, ROBOTICS COMPUTER IN, V22, P180
NR 5
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.279
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400079
DA 2018-12-27
ER

PT S
AU Wang, J
   Huang, SL
   He, CD
   Ng, CO
AF Wang Jun
   Huang Suiliang
   He Chengda
   Ng, Chiu On
BE Zhou, X
TI RETRACTED: Development and Validation of a Numerical Model of Subsurface
   Flow Constructed Wetlands (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE numerical model; constructed wetland; TP; removal
ID MULTICOMPONENT REACTIVE TRANSPORT; PERFORMANCE
AB In this paper a three dimensional numerical model was developed for modeling solute removal in subsurface flow constructed wetlands. The numerical model was applied to modeling TP removal in the horizontal subsurface constructed wetland (HSSF) and the wavy subsurface constructed wetland (WSSF). The simulated values of TP at the outlet had a good agreement with the experimental results in both HSSF and WSSF. The numerical model could be used as a practical tool for design and operation optimization. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang Jun] Tianjin Inst Urban Construct, Tianjin 300384, Peoples R China.
RP Wang, J (reprint author), Tianjin Inst Urban Construct, Tianjin 300384, Peoples R China.
EM wjwangjun0901@yahoo.cn
RI Ng, Chiu-On/B-9205-2009
OI Ng, Chiu-On/0000-0002-3142-6691
CR Dogan A, 2005, J HYDROL ENG, V10, P492, DOI 10.1061/(ASCE)1084-0699(2005)10:6(492)
   He CD, 2006, SCIENCE, V25, P175
   Langergraber G, 2008, VADOSE ZONE J, V7, P830, DOI 10.2136/vzj2007.0054
   Langergraber G, 2009, SCI TOTAL ENVIRON, V407, P3931, DOI 10.1016/j.scitotenv.2008.07.057
   Langergraber G, 2007, SCI TOTAL ENVIRON, V380, P210, DOI 10.1016/j.scitotenv.2006.10.030
   Mao X, 2006, ENVIRON MODELL SOFTW, V21, P615, DOI 10.1016/j.envsoft.2004.11.008
   Mayer KU, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000862
   Simunek J, 2009, ECOL MODEL, V220, P505, DOI 10.1016/j.ecolmodel.2008.11.004
   Tomenko V, 2007, ECOL MODEL, V205, P355, DOI 10.1016/j.ecolmodel.2007.02.030
   Toscano A, 2009, ECOL ENG, V35, P281, DOI 10.1016/j.ecoleng.2008.07.011
NR 10
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.791
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404008
DA 2018-12-27
ER

PT S
AU Wang, L
   Cui, XL
   Tan, YY
   Ma, AH
AF Wang, Lin
   Cui, Xiaolong
   Tan, Yingying
   Ma, Aihua
BE Zhou, X
TI RETRACTED: Energy Evaluation of Multi Split Air Conditioners with Indoor
   Compressors (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Air conditioner; heat exchanger; compressor; energy conservation
AB An air-conditioning system is developed to solve the problems occurring in the conventional split or multi-split air conditioners. The compressors of the system are installed indoors. In each air-conditioned room, the compressor was controlled independently. The cycle performance is evaluated based on the thermodynamic mathematical model. Results indicated that, at the part load, cooling capacity that the system produces increases, and higher COP obtains. Obviously, energy conservation for the proposed system is better than that for the conventional split or multi-split air conditioner. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, Lin; Cui, Xiaolong; Tan, Yingying; Ma, Aihua] Henan Univ Sci & Technol, Inst Air Conditioning & Refrigerat, Luoyang 471003, Peoples R China.
RP Ma, AH (reprint author), Henan Univ Sci & Technol, Inst Air Conditioning & Refrigerat, Luoyang 471003, Peoples R China.
EM wlhaust@163.com
CR Chiou CB, 2009, APPL THERM ENG, V29, P310, DOI 10.1016/j.applthermaleng.2008.02.031
   Kang H, 2009, INT J REFRIG, V32, P1452, DOI 10.1016/j.ijrefrig.2009.02.015
   Korna D., 2009, ENERG BUILDINGS, V41, P1143
   Wang L., 2005, Chinese invention patent, Patent No. [ZL200310122908.1, 2003101229081]
NR 4
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.946
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096405013
DA 2018-12-27
ER

PT S
AU Wang, L
   Ma, AH
   Cui, XL
   Tan, YY
AF Wang, Lin
   Ma, Aihua
   Cui, Xiaolong
   Tan, Yingying
BE Zhou, X
TI RETRACTED: Analysis of Energy Conservation in a Hybrid Groundwater
   Source Heat Pump (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Heat pump; energy conservation; coefficient of performance (COP);
   groundwater; fresh air load
ID SYSTEMS
AB The hybrid GWSHP air conditioning system uses low grade geothermal energy stored in groundwater to handle outdoor air directly. It is the GWSHP air conditioning coupled with the groundwater pretreatment fresh air system. Based on the thermodynamic mathematical model, cycle performance and energy consumption of the proposed system are evaluated. The results indicate that outdoor air fraction (OAF) has an obvious influence on the effect of energy saving in the hybrid GWSHP air conditioning system. The hybrid GWSHP is especially suitable for the building with large spaces or with the large fresh air fraction. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, Lin; Ma, Aihua; Cui, Xiaolong; Tan, Yingying] Henan Univ Sci & Technol, Inst Air Conditioning & Refrigerat, Luoyang 471003, Peoples R China.
RP Tan, YY (reprint author), Henan Univ Sci & Technol, Inst Air Conditioning & Refrigerat, Luoyang 471003, Peoples R China.
EM wlhaust@163.com
CR Chen C., 2008, HEAT VENTILATION AIR, V38, P87
   Hepbasli A, 2009, RENEW SUST ENERG REV, V13, P1211, DOI 10.1016/j.rser.2008.08.002
   Li X. G., 2001, ACTA ENERGIAE SOLARI, V22, P418
   [刘雪玲 Liu Xueling], 2005, [太阳能学报, Acta Energiae Solaris Sinica], V26, P262
   Nam Y, 2010, ENERG BUILDINGS, V42, P909, DOI 10.1016/j.enbuild.2009.12.013
   Omer AM, 2008, RENEW SUST ENERG REV, V12, P344, DOI 10.1016/j.rser.2006.10.003
   Wang L., 2009, Chinese invention patent, Patent No. [ZL200910304101.7, 2009103041017]
   Zhao Y., 2002, ACTA ENERGIAE SOLARI, V23, P688
NR 8
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.945
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096405012
DA 2018-12-27
ER

PT S
AU Wang, P
   Lv, ZG
AF Wang, Peng
   Lv, Zhigang
BE Zhou, X
TI RETRACTED: Design of a Simple 3-Lead ECG Acquisition System Based on
   MSP430F149 (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE ECG; Data Acquisition; Bluetooth; MSP430F149
AB Cardiovascular disease is one of the major diseases which threat human health, and ECG is the primary means of diagnosis of cardiovascular disease. This paper mainly introduces the design procedure of a simple 3-lead ECG acquisition system based on MSP430F149, introduces the structure and function of the device, finally introduces the function of each module, circuit design and the program design. The device completes the process of data acquisition using the ultra-low power microcontroller MSP430F149, and collects ECG signal to A/D sampling and conversion. It sends the ECG information to the patient phone by the Bluetooth module. This paper explains the software design process in detail, and the realization of a hardware design and optimization. The main content of software design is the data collection and the serial communication module. The software design includes the main program, timer-A interrupt, button interrupted, A/D converter, and serial communication program. This design can create a new device of 3-Lead ECG. system. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, Peng; Lv, Zhigang] Xi Technol Univ, Sch Elect & Informat Engn, Xian 710032, Peoples R China.
RP Wang, P (reprint author), Xi Technol Univ, Sch Elect & Informat Engn, Xian 710032, Peoples R China.
EM wang_peng_1@126.com
CR CHEN Jing, 2009, J WUHAN U TECHNOLOGY, V31
   Don WenQuan, 2003, MICROCONTROLLERS EMB, P1
   Hattori T., 2003, DES AUT C JAN, P390
   S Rajgopal, 1996, 9 INT C VLSI DES JAN, P329
   TI Instruments Incorporation, MSP430X13X MSP430X14
   YUAN Zheng Dao, 2008, APPL ELECT TECHNIQUE, V34
   ZHANG Shi, 2006, CHINESE MED EQUIPMEN, P26
NR 7
TC 0
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.298
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400098
DA 2018-12-27
ER

PT S
AU Wang, SS
   Chen, WB
AF Wang Shenshen
   Chen Wenbin
BE Zhou, X
TI RETRACTED: Implementation of Drill Bit Selection System Based on Offset
   Well (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE offset well; drill bit selection; algorithm
AB This paper researched the design concept of drill bit selection system based on offset well, and gave an introduction to the main function of the system and the optimization algorithm for offset well. This software was applicable and reliable for placing drill bits under the same condition. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang Shenshen] SW Petr Univ, Modern Educ Technol Ctr, Chengdu 610500, Peoples R China.
RP Wang, SS (reprint author), SW Petr Univ, Modern Educ Technol Ctr, Chengdu 610500, Peoples R China.
EM wangss@swpu.edu.cn
CR Pessier R C., 1992, SPE, V24, P584
   Spaar J R, 1995, SPE IADC, V29, P397
NR 2
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.229
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400029
DA 2018-12-27
ER

PT S
AU Wang, T
   Ma, MN
AF Wang Tao
   Ma Mingna
BE Zhou, X
TI RETRACTED: Construal-level effects on luxury brand legitimacy: using the
   Implicit Association Test (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE luxury brand legitimacy; construal -level; Implicit Association Test
ID INDIVIDUAL-DIFFERENCES; COMMUNITY; CONSUMERS; ACTOR; SELF
AB Comparing to domestic luxury brands, Chinese consumers prefer to pay a higher price premium for western luxury brand. One reason may be that the more psychological distance consumer sense, the more abstract impression they perceived which is consumer very seeking in luxury consumption. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang Tao; Ma Mingna] Wuhan Univ, Dept Mkt, Wuhan 430072, Peoples R China.
RP Ma, MN (reprint author), Wuhan Univ, Dept Mkt, Wuhan 430072, Peoples R China.
EM gressna@hotmail.com
CR Ahuvia AC, 2005, J CONSUM RES, V32, P171, DOI 10.1086/429607
   ARNOULD EJ, 1994, J MARKETING RES, V31, P484, DOI 10.2307/3151878
   Bjorkman I., 2002, MARKETS CULTURE, V5, P69
   DUBOIS B, 1995, J ADVERTISING RES, V35, P69
   Dubois Bernard, 1994, ASIA PACIFIC ADV CON, V1, P273
   Escalas JE, 2004, J CONSUM PSYCHOL, V14, P168
   FIEDLER K, 1995, PERS SOC PSYCHOL B, V21, P525, DOI 10.1177/0146167295215010
   Fournier S, 1998, J CONSUM RES, V24, P343, DOI 10.1086/209515
   Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464
   Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197
   Kates SM, 2004, J CONSUM RES, V31, P455, DOI 10.1086/422122
   Muniz AM, 2001, J CONSUM RES, V27, P412, DOI 10.1086/319618
   Robins RW, 1996, J PERS SOC PSYCHOL, V71, P375, DOI 10.1037/0022-3514.71.2.375
   SUCHMAN MC, 1995, ACAD MANAGE REV, V20, P571, DOI 10.2307/258788
   Trope Y, 2007, J CONSUM PSYCHOL, V17, P83, DOI 10.1016/S1057-7408(07)70013-X
   Vigneron F., 1999, ACAD MARKETING SCI R, V1
   WALLENDORF M, 1988, J CONSUM RES, V14, P531, DOI 10.1086/209134
NR 17
TC 0
Z9 0
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.940
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096405007
DA 2018-12-27
ER

PT S
AU Wang, TD
   Fang, TJ
   Han, JH
   Wu, J
AF Wang Tiedong
   Fang Tingjian
   Han Jianghong
   Wu Jian
BE Zhou, X
TI RETRACTED: METRASYS-Sustainable Traffic Management in Mega Cities
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Environment; Transport; Evaluation; REGOZON
AB Environmental impact evaluation is an essential component in environmental impact assessment study for any developmental project. In China, the rapid development of local and regional transportation systems has been accompanied by environmental problems, which prove to be detrimental for the economic development, social stability and public health. The project METRASYS provide a prototype for an integrated environmental monitoring and simulation system. This project deals with one of the most exigent problems of current and future mega cities and metropolitan regions. Under a scenario, various case studies of environmental impacts caused by transport in urban areas have been studied using the REGOZON model. This model includes a built-in mesoscale meteorological model that computes the local meteorological fields from synoptic fields. Since the emission model strongly depends on the other submodels, the whole system architecture for traffic flow, traffic emissions and air pollution dispersion will also be introduced. This paper describes the methodology used to evaluate these impacts. Data bases for model input and simulation results, as well as a graphic user interface for spatial data visualization. Some of the results are presented here in this paper, in particular a scenario analysis for the region Hefei. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
RP Wu, J (reprint author), Artillery Acad PLA Hefei, Hefei 230088, Peoples R China.
EM 18905607537@189.cn
CR Fedra K, 1997, NATO ASI 2, V31, P367
   Fedra K., 1996, ARCH SCI GENEVE, V39, P247
   Fedra K., 1999, ENV URBAN SYSTEMS, V23, P443
   Mieth P., 1994, P 2 INT C AIR POLL S
   Sydow A., 1994, 13 WORLD COMP C 94, V2, P605
NR 5
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.884
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404101
DA 2018-12-27
ER

PT S
AU Wang, TD
   Fang, TJ
   Han, JH
   Wu, J
AF Wang Tiedong
   Fang Tingjian
   Han Jianghong
   Wu Jian
BE Zhou, X
TI RETRACTED: Urban Transport System Evaluation Using FCD (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Floating Car Data; GPS; Traffic analysis
AB The use of FCD provides an efficient way to estimate speeds and traffic state. In Hefei this technology has been developed that provides real-time traffic information within Hefei's two ring road. It is based on the collection of localisation data, speed, direction of travel and time information from GPS in vehicles that are being driven. The scope of the project is to development and creation of a Web based data mart for the collection of FCD. The aim of this traffic management is to improve traffic flows by promoting more efficient use of the capacity of existing road infrastructure and transportation networks. For high quality traffic and safety information services, floating car data are essential to generate content. This system coverage is up to 80% and the accuracy of the information can reach more than 85%. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
RP Wu, J (reprint author), Artillery Acad PLA Hefei, Hefei 230088, Peoples R China.
EM 18905607537@189.cn
CR Greenshields B. D., 1935, NATURE, V14, P448
   Kerner B., 2005, INT TRANSP SYST 2005, P44
   Neumann T., 2009, EUR TRANSP C 5 7 OCT
   Schafer R. P., 2002, 9 ITS WORLD C 11 14
   Turksma S, 2000, IEE CONF PUBL, P51, DOI 10.1049/cp:20000103
NR 5
TC 0
Z9 0
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.882
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404099
DA 2018-12-27
ER

PT S
AU Wang, WC
AF Wang Wen-cheng
BE Zhou, X
TI RETRACTED: Design of Portable Experiment Board for SCM Teaching
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE SCM; teaching reform; experiment board; ISP
AB To the current problems in SCM experiment teaching, the necessity and principles of experiment reform are analyzed in this paper, and an experiment board is designed based on ISP download line. It presented the general structure diagram of the system, described the hard circuit and software design in details, and introduced the programming method with an example. This devices has the advantages such as low cost, easy to use and easy to carry, et al.. The practice showed that the device can greatly increase the student's interest in SCM learning, so it can provide a good solution for experiment reform. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Weifang Univ, Dept Informat & Control, Weifang 261061, Peoples R China.
RP Wang, WC (reprint author), Weifang Univ, Dept Informat & Control, Weifang 261061, Peoples R China.
EM wencheng8000@sohu.com
CR Fan YANG, 2007, J WUHAN I TECHNOLOGY, V29, P88
   Huan-ping Liu, 2009, J SHIJIAZHUANG VOCAT, V21, P48
   Jin-kui Li, 2009, J YANGZHOU COLL ED, V27, P15
   Ling LONG, 2010, J SE U NATL NATURAL, V36, P496
   Wei-peng YAO, 2009, J XIAN AERO TECHNICA, V27, P23
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.274
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400074
DA 2018-12-27
ER

PT S
AU Wang, XJ
   Li, XZ
   Lai, WD
AF Wang, Xiaojun
   Li, Xinzheng
   Lai, Weidong
BE Zhou, X
TI RETRACTED: Remote sensing image denoising based on watershed and
   Bayesian estimation threshold wavelet algorithm (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Image denoising; Bayesian estimation threshold; wavelet; watershed;
   remote sesnsing
AB Remote sensing system has been drawn extensive attentions for environment monitoring, while the quality of the remote sensed image play essential role during information interpretation. In order to enhance and improve the noised image, a combined algorithm has been established for one 256 x 256 AVIRIS detected image. The watershed filter as well as the histogram adjustment is proposed for recovering image contrast from the blurring background, while the Bayesian estimated threshold wavelet method is put forward to attenuate the Gauss noise. Simulation indicates that the combined algorithm can more effectively recover the edge of the blurred image, and the Bayesian estimation threshold is more effective than the hard or soft threshold during wavelet decompressing. The combined algorithm proposed in this article can be directly integrated in remote sensing image analyzing software to obtain higher accuracy for environmental interpretation and pattern recognition. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, Xiaojun] N China Elect Power Univ, Sci & Technol Coll, Baoding 071002, Hebei, Peoples R China.
RP Wang, XJ (reprint author), N China Elect Power Univ, Sci & Technol Coll, Baoding 071002, Hebei, Peoples R China.
EM laiwd@hbu.edu.cn
CR Carbonneau PE, 2006, EARTH SURF PROC LAND, V31, P1413, DOI 10.1002/esp.1341
   Carvalho OA, 2010, INT J REMOTE SENS, V31, P1981, DOI 10.1080/01431160902929248
   Im J, 2008, INT J REMOTE SENS, V29, P399, DOI 10.1080/01431160601075582
   Inglada J, 2007, ISPRS J PHOTOGRAMM, V62, P236, DOI 10.1016/j.isprsjprs.2007.05.011
   Nencini F, 2007, INFORM FUSION, V8, P143, DOI 10.1016/j.inffus.2006.02.001
   Zhou Y. G., 2009, PERIOD OCEAN U CHINA, V2009-s1, P77
   Zuo Z. Q., 2009, P SOC PHOTO-OPT INS, V7497, p74970V
NR 7
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.947
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096405014
DA 2018-12-27
ER

PT S
AU Wang, XJ
   Zhang, LS
   Dang, W
AF Wang, Xiaojun
   Zhang, Lianshui
   Dang, Wei
BE Zhou, X
TI RETRACTED: Generation simulating of center dot OH (A(2)Sigma(+))
   radicals in pulse streamer discharged poison gas removal system
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE center dot OH(A(2)Sigma(+)) radical; pulsed stream discharge; numerical
   stimulation; poison gas removal
ID DIELECTRIC BARRIER DISCHARGE; CORONA DISCHARGE; KINETICS; PLASMAS
AB Pulsed discharge system has been drawn extensive attentions for harmful gas removal, while the center dot OH radicals play essential role during the removal reactions. In order to clarify the center dot OH radical generation process, a zero dimensional numerical model has been established for the N-2/H2O System in negative pulsed streamer discharge instrument. The model is verified based on comparison between the simulated and the experimentally detected time-resolved fluorescence of center dot OH(A(2)Sigma(+)) radicals. The concentration variance of H2O and N-2 versus time implies that the N-2 molecules exhaust major part of the injecting energy during discharge, and the main path to produce center dot OH radicals include the excited center dot OH(A(2)Sigma(+)) formation in pulse discharge and the center dot OH((XII)-I-2) formation by energy transfer from excited N-2 to the H2O molecules after pulse discharge. The concentration of N-2 is the critical factor to manipulate the center dot OH(A(2)Sigma(+)) production dynamic, presented as the decrease of N-2 initial proportion heightening the production concentration of center dot OH(A(2)Sigma(+)), while the generation dynamic more delayed. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, Xiaojun; Zhang, Lianshui; Dang, Wei] Hebei Univ, Coll Phys Sci & Technol, Baoding 071002, Hebei, Peoples R China.
RP Zhang, LS (reprint author), Hebei Univ, Coll Phys Sci & Technol, Baoding 071002, Hebei, Peoples R China.
EM zhangls@hbu.edu.cn
CR CHANG MB, 1991, J APPL PHYS, V69, P4409, DOI 10.1063/1.348367
   Guerra V, 1997, PLASMA SOURCES SCI T, V6, P361, DOI 10.1088/0963-0252/6/3/013
   Lee YH, 2003, ENVIRON SCI TECHNOL, V37, P2563, DOI 10.1021/es0261123
   Liu ZW, 2008, EUR PHYS J D, V48, P365, DOI 10.1140/epjd/e2008-00110-7
   Magne L, 2007, J PHYS D APPL PHYS, V40, P3112, DOI 10.1088/0022-3727/40/10/015
   Mok YS, 2002, CHEM ENG J, V85, P87, DOI 10.1016/S1385-8947(01)00221-2
   Wang B., 2008, THESIS, P16
   Wang L., ACTA PHYS CHIM SIN, V24, P1400
   Wang WC, 2004, VACUUM, V73, P333, DOI 10.1016/j.vacuum.2003.12.047
   Zhang LS, 2008, ACTA PHYS-CHIM SIN, V24, P1524, DOI 10.3866/PKU.WHXB20080834
NR 10
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.849
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404066
DA 2018-12-27
ER

PT S
AU Wang, XZ
   Yin, WQ
   Zhao, HT
   Feng, K
   Zhu, JG
AF Wang, Xiaozhi
   Yin, Weiqin
   Zhao, Haitao
   Feng, Ke
   Zhu, Jianguo
BE Zhou, X
TI RETRACTED: The impact of free-air CO2 enrichment (FACE) on microelements
   concentration in soil solution in the rice season (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Elevated CO2; microelements; soil solution; rice season
AB China FACE (Free-air Carbon Dioxide Enrichment) system was used to study the effects of elevated CO2 on microelements concentration in soil solution at different depths in the rice season. The results showed that elevated atmospheric CO2 had different effects on Fe, Mn, Cu and Zn concentration in soil solution at different stages. Elevated CO2 had a trend of increasing the concentration of Fe, Mn, Cu and Zn in soil solution at different depths, although mostly had no significant difference. Elevated CO2 had the trend of increasing the average Fe concentration at all soil layers, although the effects of elevated [CO2] were not significant. Elevated CO2 significantly increased Mn concentration in soil solution at 30cm layer (P=0.020). The results indicated that the geochemistry cycle of the microelements of soils in the agricultural ecosystem could be influenced by elevated CO2 in the atmosphere. The response of microelements in soil solution in rice season to elevated atmospheric CO2 needs further study. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, Xiaozhi; Yin, Weiqin; Zhao, Haitao; Feng, Ke] Yangzhou Univ, Coll Environm Sci & Engn, Yangzhou, Jiangsu, Peoples R China.
RP Wang, XZ (reprint author), Yangzhou Univ, Coll Environm Sci & Engn, Yangzhou, Jiangsu, Peoples R China.
EM xzwang@yzu.edu.cn
CR Intergovernmental Panel on Climate Change (IPCC), 2001, 3 IPCC, P22
   Intergovernmental Panel on Climate Change (IPCC), 2009, CLIM C COP 6 18 DEC
   Liu G., 2002, CHIN J APPL ECOL, V13, P1253
   Liu HJ, 2008, FIELD CROP RES, V108, P93, DOI 10.1016/j.fcr.2008.03.007
   Okada M, 2001, NEW PHYTOL, V150, P251, DOI 10.1046/j.1469-8137.2001.00097.x
   Xu ZJ, 2006, AGR ECOSYST ENVIRON, V115, P105, DOI 10.1016/j.agee.2005.12.017
   Yang LX, 2008, GLOBAL CHANGE BIOL, V14, P1844, DOI 10.1111/j.1365-2486.2008.01624.x
NR 7
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.795
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404012
DA 2018-12-27
ER

PT S
AU Wang, X
   Zhang, CL
AF Wang, Xin
   Zhang, Chunli
BE Zhou, X
TI RETRACTED: Study on the Adsorption Performance of Furfural Residue for
   Methyl Violet (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Furfural residue; Adsorption; Methyl violet; Adsorption isotherm
ID AQUEOUS-SOLUTIONS; ACID DYE; EFFLUENT; REMOVAL; ADSORBENT
AB The adsorption performance of methyl violet from aqueous solution by furfural residue was studied. The results show that the adsorption of methyl violet on furfural residue reached equilibration by 60 minutes. The removal efficiency of methyl violet in aqueous solution on furfural residue of methyl violet achieved the 94.96% in 50mL 200mg. L-1 methyl violet aqueous solution with adding 4g/L furfural residue. The temperature had an effect on the removing of the methyl violet on furfural residue, and the adsorption of furfural residue to menthylene blue was decalescence reaction. The relationship between adsorbing capacity (qe) and equilibrium mass concentration (rho e) is in accordance with the isothermal adsorption equations of Freundlich and Langmuir. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, Xin] Shenyang Ligong Univ, Sch Environm & Chem Engn, Shenyang 110159, Liaoning, Peoples R China.
RP Wang, X (reprint author), Shenyang Ligong Univ, Sch Environm & Chem Engn, Shenyang 110159, Liaoning, Peoples R China.
EM sylgwangxin@163.com
CR Annadurai G, 2002, J HAZARD MATER, V92, P263, DOI 10.1016/S0304-3894(02)00017-1
   Bhattacharyya KG, 2003, DYES PIGMENTS, V57, P211, DOI 10.1016/S0143-7208(03)00009-3
   MEYER V, 1992, WATER SCI TECHNOL, V26, P1205
   Nassar MM, 1999, WATER SCI TECHNOL, V40, P133, DOI 10.1016/S0273-1223(99)00592-2
   POOTS VJP, 1976, WATER RES, V10, P1067, DOI 10.1016/0043-1354(76)90037-3
   Robinson T, 2002, WATER RES, V36, P2824, DOI 10.1016/S0043-1354(01)00521-8
   Sivaraj R, 2001, WASTE MANAGE, V21, P105, DOI 10.1016/S0956-053X(00)00076-3
NR 7
TC 0
Z9 0
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.858
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404075
DA 2018-12-27
ER

PT S
AU Wang, XB
   Zhou, J
AF Wang Xingbo
   Zhou Jun
BE Zhou, X
TI RETRACTED: Analytic Criterion And Algorithm For The Lowest Common
   Ancestor Of Two Neighboring Nodes In A Complete Binary Tree (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Binary tree; lowest common ancestor; Criterion
AB Finding the lowest common ancestor (LCA) of two nodes in a binary tree has been focused both in graph theory and computer science. The paper puts forward and proves an analytic criterion for the LCA of two neighboring nodes in a complete binary tree. The criterion mainly concerns addition, subtraction and bitwise operations, needs no searching procedures and thus is easy to implement in software programming as well as hardware programming. An algorithm that has logarithmic time complexity is also presented with C-language implementation in the paper. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang Xingbo] Foshan Univ, Dept Mechtron Engn, Foshan 528000, Peoples R China.
RP Wang, XB (reprint author), Foshan Univ, Dept Mechtron Engn, Foshan 528000, Peoples R China.
EM wxbstudio@gmail.com
CR [Anonymous], LOW COMM ANC
   Das V V, 2006, PRINCIPLES DATA STRU
   Graham R. L., 1994, CONCRETE MATH FDN CO
   Hauck S, 2007, RECONFIGURABLE COMPU
   Wang Xingbo, 2011, J FOSHAN U NATURAL S, V29, P54
   Wankar R, 2009, IJCSA, V6, P108
NR 6
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.233
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400033
DA 2018-12-27
ER

PT S
AU Wang, XY
   Jiang, XW
   Liu, QH
AF Wang, Xiuyu
   Jiang, Xingwu
   Liu, Qinghuai
BE Zhou, X
TI RETRACTED: Exceptional Families and Nonlinear Complementarity Problems
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE complementarity problem; quasi-P-*-mapping; P(tau, alpha, beta)
   -mapping; alternative theorem
ID PATH
AB In this paper, we study the following Linear Complementarity problem: f : R-n -> R-n, find x >= 0, such that f(x) >= 0, x(T) f(x) = 0. We use Poineare-Bohn's homotopy invariance theorem of degree to derive an alternative theorem, and give a new exceptional families. Based on this result, for the nonlinear complementarity problems with a quasi-P-*-mapping or a P(tau, alpha, beta) -mapping or a semi-monotone mapping, a sufficiently condition is established to assure the existence and boundedness of solution curve (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, Xiuyu] Changchun Univ Technol, Sch Basic Sci, Changchun 130012, Peoples R China.
RP Wang, XY (reprint author), Changchun Univ Technol, Sch Basic Sci, Changchun 130012, Peoples R China.
EM wangxiuyu.000@163.com
CR Dantzig G.B., 1963, ORC6318RR13 U BERK
   FATHI Y, 1979, MATH PROGRAM, V17, P335, DOI 10.1007/BF01588254
   ISAC G, 1992, LECT NOTES MATH, V1528, pR3
   Isac G, 2000, TOPOLOGICAL METHODS
   Li GN, 2005, APPL MATH COMPUT, V169, P657, DOI 10.1016/j.amc.2004.08.050
   PANG JS, 1979, MATH PROGRAM, V16, P325, DOI 10.1007/BF01582119
   Yu Q, 2006, APPL MATH COMPUT, V179, P696, DOI 10.1016/j.amc.2005.12.010
   Zhao YB, 2000, J OPTIMIZ THEORY APP, V105, P213, DOI 10.1023/A:1004674330768
   Zhao YB, 2004, APPL MATH COMPUT, V148, P93, DOI 10.1016/S0096-3003(02)00830-5
NR 9
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.202
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400002
DA 2018-12-27
ER

PT S
AU Wang, YL
AF Wang Yan-liang
BE Zhou, X
TI RETRACTED: Exploit on Information Retrieval based on Semantic Web
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Semantic web; Information Retriveal
AB Over the past few years, the volume of information available through the World Wide Web has been expanding exponentially. The Web has given us access to millions of resources, irrespective of their physical location and language. However, since current Web design targets human consumption, relied on textual keywords to index and retrieve documents, which may return inaccurate and incomplete results. To address this issue, in 2001, Berners-Lee proposed semantic web with the idea of adding facilities for machine-understood descriptions of metadata to current web. Semantic-based Information Retrieval (IR) represents both document and queries using semantic concepts, instead of keywords, and performs retrieval in that concept space. Its purpose is to design to improve traditional web searching and it is based on an explicit representation of semantics about web resources and real world object and aims to improve both the proportion of relevant material and the proportion of precision results. In this paper, we propose architecture of information retrieval based on semantic web. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 YanShan Univ, Sch Econ & Management, Qinhuangdao 066004, Peoples R China.
RP Wang, YL (reprint author), YanShan Univ, Sch Econ & Management, Qinhuangdao 066004, Peoples R China.
EM wyl96041@sina.com
CR Berners-Lee T., 1998, IW3C DESIGN ISSUES
   BERNERSLEE T, 2001, SCI AM           MAY
   Bighini C., INT J COMPUTATIONAL
   Broekstra, SESAME ARCHITECTURE
   Ciravegna F., 2003, FRONTIERS ARTIFICIAL
   erners-Lee T., 2002, SEMANTIC WEB ROAD MA
   Etzioni O., 2004, 3 INT WORLD WID WEB
   Fensel D., 2003, SPINNING SEMANTIC WE
   Henze N, 2004, EDUC TECHNOL SOC, V7, P82
   HP LABORATORY, 2005, INTR RDF JEN RDF APR
   Lu S., 2002, INT J INFORM RES
   Mizzaro S, 1997, J AM SOC INFORM SCI, V48, P810, DOI 10.1002/(SICI)1097-4571(199709)48:9<810::AID-ASI6>3.0.CO;2-U
NR 12
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.930
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404147
DA 2018-12-27
ER

PT S
AU Wang, YF
   Chen, MZ
   Li, SS
AF Wang Yanfen
   Chen Mengzhe
   Li Shuangshuang
BE Zhou, X
TI RETRACTED: Study on Semi-deterministic Statistical Model in Mine UWB LOS
   Environments (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE mine UWB channel; LOS Environments; double cluster; semi-deterministic
   statistical model
ID PROPAGATION
AB Based on the actual measurement environment and combined with IEEE 802.15.3a indoor model, a LOS double-cluster semi-deterministic statistical model was established to study the statistical characteristics of UWB channels, and the results obtained were consistent with the measured ones; with the help of the model established, the paper studied the impact of system resolution on the path intensity distribution, inspected and verified the measurement conclusions of actual measurement environment. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang Yanfen; Chen Mengzhe; Li Shuangshuang] China Univ Min & Technol, Sch Infor & Elect Engn, Xuzhou 221008, Jiangsu, Peoples R China.
RP Wang, YF (reprint author), China Univ Min & Technol, Sch Infor & Elect Engn, Xuzhou 221008, Jiangsu, Peoples R China.
EM lszwyf@163.com
CR Chehri, 2006, VEH TECHN C 2006 VTC
   Chehri A., 2006, GLOB TEL C NOV, P1
   Chehri A, 2006, 2006 23RD BIENNIAL SYMPOSIUM ON COMMUNICATIONS, P213, DOI 10.1109/BSC.2006.1644607
   EMSLIE AG, 1975, IEEE T ANTENN PROPAG, VAP23, P192, DOI 10.1109/TAP.1975.1141041
   FOERSTER J, 2002, P8021502368R5SG3A IE
   Wang Y, 2009, 5 INT C WIR COMM NET, P1
   Wang Yang, 2005, 6th IEE International Conference on 3G and Beyond, P413, DOI 10.1049/cp:20050256
   Zhang YP, 1998, IEEE T ANTENN PROPAG, V46, P1337, DOI 10.1109/8.719977
NR 8
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.226
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400026
DA 2018-12-27
ER

PT S
AU Wang, YT
   Shen, WL
   Feng, CP
   Li, M
AF Wang, Yuting
   Shen, Wenlong
   Feng, Chuanping
   Li, Miao
BE Zhou, X
TI RETRACTED: Removal of Sulfide Ion from Oil Wastewater Using an
   Electrochemical Method (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE electrochemical oxidation; sulfide; oil wastewater; Ti/IrO2 anode
ID HYDROGEN-SULFIDE; OXIDATION; CHEMICALS; ANODE
AB The removal of sulfide from oil wastewater containing a great number of chloride ions was studied with electrochemical oxidation technique using Ti/IrO2 anode. Electrochemical method was effective for the removal of sulfide from aquatic environment. It was found that current density can enhance the removal of sulfide. When the current density is 25 mA/cm(2), nearly 90.5% sulfide was oxidized at 10 min. To be completely oxidized, high initial concentration of sulfide required larger current density or more electrolytic time. It is generally realized that sulfide can be successfully cleaned by the electrochemical oxidation at Ti/IrO2 anode. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, Yuting; Feng, Chuanping] China Univ Geosci, Sch Water Resources & Environm, Beijing, Peoples R China.
RP Feng, CP (reprint author), China Univ Geosci, Sch Water Resources & Environm, Beijing, Peoples R China.
EM fengchuanping@.gmail.com
CR Ateya BG, 2002, ELECTROCHEM COMMUN, V4, P231, DOI 10.1016/S1388-2481(02)00254-0
   Boon A.G., 1995, WAT SCI TECH, V31
   CADENA F, 1988, J WATER POLLUT CON F, V60, P1259
   Feng YJ, 2003, WATER RES, V37, P2399, DOI 10.1016/S0043-1354(03)00026-5
   Gosselin R. E., 1984, CLIN TOXICOLOGY COMM
   Haner J, 2009, J APPL ELECTROCHEM, V39, P1733, DOI 10.1007/s10800-009-9873-7
   KOTRONAROU A, 1991, ENVIRON SCI TECHNOL, V25, P1153, DOI 10.1021/es00018a021
   Li M, 2009, ELECTROCHEM COMMUN, V11, P1853, DOI 10.1016/j.elecom.2009.08.001
   Li M, 2009, J HAZARD MATER, V171, P724, DOI 10.1016/j.jhazmat.2009.06.066
   MILLERO FJ, 1989, ENVIRON SCI TECHNOL, V23, P209, DOI 10.1021/es00179a012
   Murugananthan A, 2004, J HAZARD MATER, V109, P37, DOI 10.1016/j.jhazmat.2003.12.009
   National Research Council of Canada, 1981, 18467 NRCC NO ASS CO
   Polatides C., 2006, WATER RES, V40, P1179
   SCOTT P, 1994, OIL GAS J, V92, P72
   Selinc Jukka, 2009, ENVIRON TECHNOL, V9, P885
   State Environmental Protection Administration of China, 2002, STAND METH EX WAT WA
   TABACOVA S, 1986, NEUROTOXICOLOGY, V7, P421
   TOMAR M, 1994, WATER RES, V28, P2545, DOI 10.1016/0043-1354(94)90072-8
   Waterston K, 2007, J APPL ELECTROCHEM, V37, P367, DOI 10.1007/s10800-006-9267-z
NR 19
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.872
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404089
DA 2018-12-27
ER

PT S
AU Wang, ZJ
AF Wang Zongjiang
BE Zhou, X
TI RETRACTED: Improved Ant Colony Algorithm and Its Simulation Study
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE ant colony algorithm; pheromone; optimization; simulation; traveling
   salesman problem
AB Ant colony algorithm is development a new heuristic algorithm through simulation ant foraging. For its convergence rate slow, easy to fall into local optimal solution proposed for the adjustment of key parameters, pheromone update to improve the way and through the issue of TSP experiments, results showed that the improved algorithm has better overall search capabilities and demonstrated the feasibility and effectiveness of this method. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 WeiFang Univ, Weifang, Peoples R China.
RP Wang, ZJ (reprint author), WeiFang Univ, Weifang, Peoples R China.
EM wfwzj@163.com
CR DORIGO M, ANT COLONY OPTIMIZAT
   Duan Hai-bin, 2004, Information and Control, V33, P241
   Duan Haibin, 2005, PRINCIPLE APPL ANT C
   Jingyu Yang, 2006, WATER CONSERVANCY HY
   LI SY, 2004, ANT COLONY ALGORITHM
   Qianqian Guo, 2006, SW NATL U NATURAL SC, V32, p1123~1126
   Thomas S, 2000, FUTURE GENER COMP SY, V16, P889
   Ye Chen, 2001, COMPUTER ENG, V27, p74~76
NR 8
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.880
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404097
DA 2018-12-27
ER

PT S
AU Wei, BG
   Zhang, GZ
   Awu, FP
   Liu, JL
AF Wei Bigui
   Zhang Guozhen
   Awu Fuping
   Liu Jianlin
BE Zhou, X
TI RETRACTED: Traversal Grey Model for Water Consumption Prediction
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Grey model; Water consumption prediction; Traversal grey model; Point
   based grey model
AB Grey model (GM) method is widely used to forecast water consumption due to its strengths of little original data needed. To increase the precision of GM(1,1) and forecast urban water consumption accurately, we construct Traversal Grey Model (T-GM(1,1)) by minimum total residual sum of square. When we used the T-GM(1,1) to predict water requirement in some city, it showed that the mean absolute error, mean absolute percentage error and the maximum absolute percentage error are 0.77x10(6)m(3)/a, 3.56% and 12.58% respectively. Thus, the simulative precision of T-GM(1,1) is much better than that of GM(1,1). In conclusion, the T-GM(1,1) can predict the water consumption in the city and reduce the unstable factors that influence the forecast. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wei Bigui; Zhang Guozhen; Awu Fuping; Liu Jianlin] Lanzhou Jiaotong Univ, Engn Res Ctr Cold & Arid Reg Water Resource Compr, Minist Educ, Sch Environm & Municipal Engn, Lanzhou 730070, Gansu, Peoples R China.
RP Zhang, GZ (reprint author), Lanzhou Jiaotong Univ, Engn Res Ctr Cold & Arid Reg Water Resource Compr, Minist Educ, Sch Environm & Municipal Engn, Lanzhou 730070, Gansu, Peoples R China.
EM zhangguozhen@mail.lzjtu.cn
CR [达娃 DA Wa], 2010, [中国给水排水, China Water & Wastewater], V26, P51
   Deng J., 1992, GREY SYSTEM THEORY C
   [高传昌 GAO Chuanchang], 2005, [灌溉排水学报, Journal of Irrigation and Drainage], V24, P71
   Hansen R. D., 1996, WATER RESOW RES, V10, P321
   Molino B., 2009, WATER RESOUR MANAG, V25, P57
   [王园园 WANG Yuan-yuan], 2009, [中国给水排水, China Water & Wastewater], V25, P57
   Yuan Jiazu, 1991, GREY SYSTEM THEORY I
NR 7
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.820
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404037
DA 2018-12-27
ER

PT S
AU Wen, S
   Chen, JM
   Wu, GM
   Liu, Y
   Yi, Y
AF Wen, Si
   Chen, Jianming
   Wu, Guangmin
   Liu, Yue
   Yi, Yan
BE Zhou, X
TI RETRACTED: Land Cover Classification and Information Extraction of
   Multi-temporal High Resolution Images (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Remote sensing; object-oriented; edge effect; segmentation;
   multi-temporal data classification; Kunming Dianchi Lake Introduction
ID METROPOLITAN-AREA
AB This paper presents a technique of land cover classification of high-spatial resolution image which consists of two Quick Bird data with obvious differences to implement classification and improve classification accuracy, one of the data is covered by snow. The study area locates at the sub-watershed of Kunming Dianchi Lake watershed. There is an obvious border between two images after data fusion, which cannot be cancelled by data processing. Hence, the classification of land cover by use of a same process set in Definiens developer 7.0 becomes difficult or causes errors, that is so called edge effect. Our research develops a practical process to extract the classification information from these special regions to form thematic map for environmental and socioeconomic applications. Six classes, including forest, cultivated land, architecture, water, bare soil and shadow are classified successfully. In the class thematic map, the border effect was cancelled completely. The methodology was developed in an experimental way by suitable selection of processes, parameters and methods. Overall accuracy of classification reaches 92.32%, with Kappa statistics 0.8914. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wen, Si; Chen, Jianming; Wu, Guangmin; Liu, Yue; Yi, Yan] Kunming Univ Sci & Technol, Lab Image Proc, Basic Sci Sch, Kunming, Peoples R China.
RP Chen, JM (reprint author), Kunming Univ Sci & Technol, Lab Image Proc, Basic Sci Sch, Kunming, Peoples R China.
EM jmchen@inems.com
CR Definiens, DEF DEV 7 0 REF BOOK
   Definiens, DEF DEV 7 0 US GUID
   HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314
   Lu D, 2007, INT J REMOTE SENS, V28, P823, DOI 10.1080/01431160600746456
   Lv Peng, 2010, 3 INT C IM IN PRESS
   Yi Yan, 2009, THESIS KUNMING U SCI
   Yuan F, 2005, REMOTE SENS ENVIRON, V98, P317, DOI 10.1016/j.rse.2005.08.006
   Zhou WQ, 2008, SENSORS-BASEL, V8, P1613, DOI 10.3390/s8031613
NR 8
TC 0
Z9 0
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.953
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096405020
DA 2018-12-27
ER

PT S
AU Wu, CH
   Wang, YZ
AF Wu, Canhui
   Wang, Yanzhong
BE Zhou, X
TI RETRACTED: The Aeronautics Face-gear NC Hobbing Machining Technology
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE face-gear; hob; equation of tooth surface; simulation; hobbing machining
AB Face-gear drives become the main direction of research for aeronautical drives because of their special advantages. Face-gear machining problems have became to baffle the embedded research for face-gear. The basal coordinate systems of face-gear hobbing were setted up according to the face-gear hobbing theory. The hobbing surface equation of face-gear was established by using the equation of pinion tooth surface and matrix for coordinate transform based on the gear geometry and applied theory, then the hobbing tooth surface constrain conditions for dedendum undercutting were analyzed, at the same time, the hobbing nodal points were used to construct the three-dimensional basal worm model of face-gear hob by recurring to the three-dimensional software. Furthermore, the special hob for face-gear machining was designed and manufactured. The exact assembly and machining simulation were finished by using the program development software VC++6.0 and the UG customization function in the light of the face-gear hobbing theory. It validates the hob correctness and gets the gear hobbing program. According to the result of machining simulation, face-gear numerical control(NC) hob machining was realized in the four-axis NC machine tool. It improves the cutting efficiency and establishs the base for face-gear grinding. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wu, Canhui; Wang, Yanzhong] Beijing Univ Aeronaut & Astronaut, Sch Mech Engn & Automat, Beijing 100191, Peoples R China.
RP Wu, CH (reprint author), Beijing Univ Aeronaut & Astronaut, Sch Mech Engn & Automat, Beijing 100191, Peoples R China.
EM juleswu@126.com
CR [贺鹏 He Peng], 2008, [机械科学与技术, Mechanical Science and Technology], V27, P92
   Litvin F. L., 2005, NASACR2005213443
   Litvin FL, 2002, COMPUT METHOD APPL M, V191, P2785, DOI 10.1016/S0045-7825(02)00215-3
   Lu Y. M., 2005, J GUANGXI U, V30, P134
   Wang F., 2007, RES SIMULATION SHAPI
   Wang Y. Z., 2007, MACHINE TOOL HYDRAUL, V35, P7
   Xiong Wei, 2007, ANAL EQUATION FACE G
   Zhao N., 2007, MACHINERY DESIGN  MA, P151
NR 8
TC 1
Z9 1
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.272
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400072
DA 2018-12-27
ER

PT S
AU Wu, CH
   Jin, YX
AF Wu, Changhang
   Jin, Yunxiao
BE Zhou, X
TI RETRACTED: Performance of Nitrogen and Phosphorus Removal of Municipal
   Wastewater in Sequencing Batch Biofilm Reactor (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE SBBR; Nitrogen; Phosphorus; Municipal Wastewater
ID NITRIFICATION
AB A lab-scale innovative sequencing batch biofilm reactor (SBBR) was developed to treat municipal wastewater. At normal temperature, the operation conditions of the SBBR were 2 min inflow -> 180 min non aeration -> 300 min aeration -> 30 min sedimentation -> 10 min outflow. The SBBR system developed in this study was a high efficiency and saving energy of wastewater treatment technology. The average removal efficiencies of NH4+-N, TN, TP and COD reached 95.8%, 72.8%, 97.5%, 92.5%, respectively. The effluent concentration of NH4+-N, TN, TP and COD satisfied with the first level A criteria specified in Discharge Standard of Pollutants for Municipal Wastewater Treatment Plant (GB 18919-2002). Moreover simultaneous nitrification and denitrification(SND) was preceeded in the system. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wu, Changhang] Luoyang Inst Sci & Technol, Dept Environm & Chem Engn, Luoyang 471023, Peoples R China.
RP Wu, CH (reprint author), Luoyang Inst Sci & Technol, Dept Environm & Chem Engn, Luoyang 471023, Peoples R China.
EM ch_wu70@163.com
CR Carini D, 2003, J CHEM TECHNOL BIOT, V78, P1157, DOI 10.1002/jctb.900
   Chiou RH, 2008, BIORESOURCE TECHNOL, V99, P4408, DOI 10.1016/j.biortech.2007.08.038
   Kuba T, 1996, WATER RES, V30, P1702, DOI 10.1016/0043-1354(96)00050-4
   Mulkerrins D, 2004, ENVIRON INT, V30, P249, DOI 10.1016/S0160-4120(03)00177-6
   STALL TR, 1976, J WATER POLLUT CON F, V48, P307
   State Environmental Protection Administration, 1997, WAT WAST MON AN METH
   Wang DB, 2008, BIORESOURCE TECHNOL, V99, P5466, DOI 10.1016/j.biortech.2007.11.007
   White DM, 2000, WATER RES, V34, P2105, DOI 10.1016/S0043-1354(99)00362-0
   Wilderer PA, 2000, WATER AIR SOIL POLL, V123, P147, DOI 10.1023/A:1005237617334
   Xia S, 2008, ECOL ENG, V32, P256, DOI 10.1016/j.ecoleng.2007.11.013
   Zhang LQ, 2009, BIOPROC BIOSYST ENG, V32, P175, DOI 10.1007/s00449-008-0235-3
   Zou H, 2006, WORLD J MICROB BIOT, V22, P701, DOI 10.1007/s11274-005-9093-1
NR 12
TC 0
Z9 3
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.860
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404077
DA 2018-12-27
ER

PT S
AU Wu, JJ
   Li, DX
AF Wu Jingjing
   Li Dengxin
BE Zhou, X
TI RETRACTED: Preparation and Characterization of Magnetic Fe3O4
   Nanoparticles Coated by Oleic Acid (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Magnetic nanoparticles; co-precipitation; oleic acid; Spectrophotometric
   analysis
ID IRON-OXIDE NANOPARTICLES
AB Magnetic Fe3O4 nanoparticles were prepared by co-precipitation of catalytically oxidized liquids added with ferric and NH3 center dot H2O, and then oleic acid (OA) was coated onto the surface of it. After that, the remaining of OA in the reaction mixture was detected with the UV-visible spectrophotometer, and then calculate the coating rate of OA by subtraction. It's concluded that when the mass ratio of OA and magnetic particles is approximate to 2.69, mixing for 45minutes under temperature of 70 degrees C, pH of 7.9, the optimal coating rate added up to 75.3% through TG curve analysis. X-ray diffraction measurements showed the spinel structure for the Fe3O4 nanoparticles. Transmission electron microscopy revealed the magnetic particle size of about 25nm, and agglomerate seriously, but particles coated by OA dispersed well in the solution with an increasing size. Meanwhile, the saturation magnetization of particles decreased from 58.72emu/g to 1.42emu/g after modifying. FTIR spectra indicate that oleic acid molecules have been bound onto the surface of the magnetic nanoparticles by Fe-COOR chemical bonds. Furthermore, TG studies showed the adsorption of OA molecules on the particles by chemisorption, further verified that it's practical to calculate the coating rate of oleic acid by spectrophotometric detection method. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wu Jingjing; Li Dengxin] Donghus Univ, Sch Environm Sci & Engn, Shanghai 2016200, Peoples R China.
RP Wu, JJ (reprint author), Donghus Univ, Sch Environm Sci & Engn, Shanghai 2016200, Peoples R China.
EM wujj521@126.com
CR Chen ZP, 2008, COLLOID SURFACE A, V316, P210, DOI 10.1016/j.colsurfa.2007.09.017
   Gu HW, 2006, CHEM COMMUN, P941, DOI 10.1039/b514130c
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Jingjing Wu, 2010, INT C ENV C IN PRESS
   Lan Q, 2007, J COLLOID INTERF SCI, V310, P260, DOI 10.1016/j.jcis.2007.01.081
   Lutz HD, 1999, J MOL STRUCT, V511, P69, DOI 10.1016/S0022-2860(98)00630-9
   Ma M, 2003, COLLOID SURFACE A, V212, P219, DOI 10.1016/S0927-7757(02)00305-9
   Maity1 D., 2007, J MAGNETISM MAGNETIC, P46
   Schwertmann U., 2003, IRON OXIDE STRUCTURE
   Wunderbaldinger P, 2002, BIOCONJUGATE CHEM, V13, P264, DOI 10.1021/bc015563u
   Yang Kun, 2009, APPL SURF SCI, P3093
   Zhang L, 2006, APPL SURF SCI, V253, P2611, DOI 10.1016/j.apsusc.2006.05.023
NR 12
TC 0
Z9 0
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.911
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404128
DA 2018-12-27
ER

PT S
AU Wu, J
   He, CD
AF Wu, Jun
   He, Chengda
BE Zhou, X
TI RETRACTED: Digital Image based Fractal Dimension Analysis of Activated
   Sludge Floc from Biological Wastewater Treatment Process (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Faractal dimension; Image analysis; Biological wastewater treatment;
   Activated sludge
AB The image analysis has been used in this study to calculate the fractal dimension for activated sludge floc collected from biological wastewater treatment plant. The fractal dimension value calculated was in the range of 1.71-1.79 and was found to be inversely correlated to the activated sludge SVI value. This suggested that the fractal dimension index can be used for early warning of activated sludge settling problem during biological wastewater treatment process. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of [name organizer] (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wu, Jun; He, Chengda] Yangzhou Univ, Sch Environm Sci & Engn, Yangzhou 225000, Peoples R China.
RP Wu, J (reprint author), Yangzhou Univ, Sch Environm Sci & Engn, Yangzhou 225000, Peoples R China.
EM jun.wu08@gmail.com
CR Amaral AL, 2005, ANAL CHIM ACTA, V544, P246, DOI 10.1016/j.aca.2004.12.061
   da Motta M, 2001, BIOCHEM ENG J, V9, P165, DOI 10.1016/S1369-703X(01)00138-3
   Grijspeerdt K, 1996, WATER SCI TECHNOL, V33, P61, DOI 10.1016/0273-1223(95)00159-X
   Liwarska-Bizukojc E., 2006, TECHNOLOGY, V39, P660
   Wilen BM, 2003, WATER RES, V37, P3632, DOI 10.1016/S0043-1354(03)00291-4
NR 5
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.830
PG 4
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404047
DA 2018-12-27
ER

PT S
AU Wu, KH
   Zhou, H
   Ma, G
AF Wu Kehe
   Zhou Huan
   Ma Gang
BE Zhou, X
TI RETRACTED: Design and implementation of ARIS methodology-based process
   modeling and management platform (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE process modeling; process management; ARIS methodology; Rich client
   Application
AB With the process management of enterprise activities become mainstream. traditional process modeling and business process management exposed many shortcomings in Various aspects of business process elements of the internal relations. ARIS methodology design process management system comprehensively. And support the continuous improvement of business process management that Meeting the increasing customer quality requirements. In this paper, we use ARIS methodology as guide. using Rich client technology to create a process modeling and management platform and describing how to design and implement in detail. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wu Kehe; Zhou Huan; Ma Gang] N China Elect Power Univ, Beijing 102206, Peoples R China.
RP Zhou, H (reprint author), N China Elect Power Univ, Beijing 102206, Peoples R China.
EM shenarder@163.com
CR A Scheer W, 1998, ARIS BUSINESS PROCES
   AG IDS Scheer, 2003, ARIS METH ARIS TOOLS, P7
   Darija Ivandic Vidovic, 2003, 2 INT C INF TECHN IN
   Fei Qiao, 1999, HIGH TECHNOLOGY LETT, V2, P67
   guohua Feng, 2005, COMPUTER ENG, V14, P208
   Li Chen, 2008, IEEE INT C E BUS ENG
   Li S, 2004, BUSINESS PROCESS REE
   Parr A, 2000, J INFORM TECHNOL, V15, P289, DOI 10.1080/02683960010009051
   Scheer A. -W., 1999, ARIS BUSINESS PROCES
   Songyun HU, 2006, SCI TECHNOLOGY ENG, V1, P171
   W Scheer, 2003, BUSINESS PROCESS MOD
   Zhang Hao, 2000, INT CONTR AUT P 3 WO, V3
NR 12
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.264
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400064
DA 2018-12-27
ER

PT S
AU Wu, L
   Ji, HF
AF Wu Lan
   Ji Hui-fang
BE Zhou, X
TI RETRACTED: The Design and Implementation of IP-Camera Based On ARM
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE ARM; IP-Camera; Hardware; Linux
AB With the development of social and technology, security systems in people's lives is playing an more and more important role, and thus the clarity and intelligent video system raised higher and higher demands, in this paper a IP-Camera based on ARM was designed. We focus on the hardware system and the Linux operation system. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wu Lan] Henan Univ Technol, Coll Elect Engn, Zhengzhou 450001, Peoples R China.
RP Wu, L (reprint author), Henan Univ Technol, Coll Elect Engn, Zhengzhou 450001, Peoples R China.
EM richod@126.com
CR [Anonymous], 2001, ARM920T TECHNICAL RE
   [Anonymous], 2005, DM9000A ETHERNET CON
   [Anonymous], 2004, S3C2440A 32 BIT RISC
   Liu Miao, 2006, EMBEDDED SYSTEM INTE
NR 4
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.299
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400099
DA 2018-12-27
ER

PT S
AU Wu, MX
AF Wu Mingxin
BE Zhou, X
TI RETRACTED: An Architecture of Information Retrieval towards the Semantic
   Web (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE semantic web; information; retrieval
AB The World Wide Web plays a very important role in an integral part of most societies today. Without any doubt, the WWW has been one of the fastest growing and most pervasive phenomenons in history. Hence, it is natural to retrieve information from it and web search engines have become one of most used application in Internet. Unfortunately, the unstructured nature and huge volume of information accessible over networks have made it hard for users to sift through and find relevant in formation. In order to address this issue, the web semantic has been proposed. Research show that the semantic web will be the next generation web and the information retrieval towards at semantic web will play an important role in out's dairy life. In this paper we explore information retrieval (IR) towards the semantic web and propose a conceptual architecture for semantic web information retrieval systems. The architecture includes semantic web, agents, information retrieval engine. In addition, the key techniques of the system are discussed in details (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Beijing Univ Aeronaut & Astronaut, 37 Xueyuan Rd Haidian Distract, Beijing 100083, Peoples R China.
RP Wu, MX (reprint author), Beijing Univ Aeronaut & Astronaut, 37 Xueyuan Rd Haidian Distract, Beijing 100083, Peoples R China.
EM agogo@163.com
CR Baeza-Yates R., 2002, SIGIR WORKSH XML IR
   BERNERSLEE T, 2001, SCI AM           MAY
   FANKHAUSER P, 2003, VLDB J, V12
   FEGARAS L, 2001, VLDB J, P251
   Fensel D, 2004, ONTOLOGIES SILVER BU
   GRUBER TR, 1993, KNOWL ACQUIS, V5, P199, DOI 10.1006/knac.1993.1008
   Lassila O, 1999, RESOOURCE DESCRIPTIO
   Mizzaro S, 1997, J AM SOC INFORM SCI, V48, P810, DOI 10.1002/(SICI)1097-4571(199709)48:9<810::AID-ASI6>3.0.CO;2-U
   QUAN DA, 2004, P 13 INT C WORLD WID, P255
   SONG W, 2004, BRACHYLOGY TUTORIAL
   Yu HB, 2005, LECT NOTES COMPUT SC, V3387, P124
NR 11
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.920
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404137
DA 2018-12-27
ER

PT S
AU Wu, T
   Yan, YS
   Chen, X
AF Wu, Tao
   Yan, Yusong
   Chen, Xi
BE Zhou, X
TI RETRACTED: Reduction of Power Consumption in Wireless Sensor Networks
   for Railway Disaster Prevention and Safety Monitoring System (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Wireless Sensor Network; sensor node; energy consumption; high-speed
   railway
AB Wireless sensor network has many advantages. One of the primary benefits is their independence from the wiring costs and constraints, which makes it is suitable for monitoring the environmental conditions around the high-speed railway. However, the energy of the sensor node is limited and railways are often located in remote area. If batteries have to be replaced frequently, the initial cost savings will be lost. Therefore, power efficiency is a critical requirement for wireless sensor networks. In this paper, two algorithms have been investigated for application of wireless sensor network in Railway Disaster Prevention and Safety Monitoring System, which are Advanced Direction-aware Algorithm and Cluster Head Selection Algorithm based on the Dynamic Energy Threshold respectively. Theoretically, both algorithms can effectively extend the lifetime of the wireless sensor network. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wu, Tao; Yan, Yusong; Chen, Xi] SW Jiaotong Univ, 111 Erhuan Rd, Chengdu 610031, Peoples R China.
RP Wu, T (reprint author), SW Jiaotong Univ, 111 Erhuan Rd, Chengdu 610031, Peoples R China.
EM dorawu840720@gmail.com
OI Chen, Xi/0000-0002-3057-0309
CR Hada A., 2009, INT SENS SENS NETW I, P231
   Minming N., 2010, VEH TECHN C VTC 2010, P1
   Ni M., 2010, WIR COMM NETW MOB CO, P1
   Sha Y., 2005, RAILWAY SIGNALLING C, P33
   Shafiullah G. M., 2008, TENCON 2008, P1
   Shang Y., 2008, THESIS NANJING U AER
   Tang X., 2006, INT C POW SYST TECHN, P1
   Tilak S., 2002, ACM MOBILE COMPUTING, V6, P28, DOI DOI 10.1145/565702.565708
   Xu Y., 2010, THESIS WUHAN U TECHN
   Zhang W., 2010, RAILWAY SIGNALLING C, P80
NR 10
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.305
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400105
DA 2018-12-27
ER

PT S
AU Wu, WD
   Zhang, CK
   Liu, X
AF Wu, Weideng
   Zhang, Changkuan
   Liu, Xi
BE Zhou, X
TI RETRACTED: Fuzzy Analysis of Impact Factors on Shoal Wetland Pricing in
   Xiamen (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Resource pricing; CVM; Subordinate Function; Comprehensive Evaluation
   Matrix; Xiamen City
AB This paper focus on pricing methodology research about resources contain of non-use value. Reasonable and accurate assessment of resources plays an important role in the management of coastal zone. But valuation of resources that contain of non-use value is still unsatisfactory on its validity and reliability. This paper extends the study of pricing model, which based on Subordinate Function of resource price, to a forward step research to analyze of how the resources are priced by respondents. And there are three steps to reach this aim. A survey about shoal wetland price per year is conducted to citizens of Xiamen firstly, then the pricing results of respondent are disassembled to a series weights of factors through the resolution of fuzzy relationship equations. Finally, causality between characters of respondent and weights of factor are analyzed by means of multivariate correlation analysis. The study indicates that the "Knowledge about the resource" is the most influential character of respondent that impact on a resource pricing, while "Income" is the second of influential. And "Distance from the location of resource" has the least impact on the pricing. However, another finding is that none of the 5 characters are critical to a resource pricing. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wu, Weideng; Zhang, Changkuan] Hohai Univ, Coll Harbor Coastal & Offshore Engn, Nanjing 210098, Peoples R China.
RP Wu, WD (reprint author), Hohai Univ, Coll Harbor Coastal & Offshore Engn, Nanjing 210098, Peoples R China.
EM wuweideng@163.com
CR Gao H., 2005, APPL MULTIVARIATE ST
   Horowitz JK, 2003, J ECON BEHAV ORGAN, V51, P537, DOI 10.1016/S0167-2681(02)00216-0
   Horowitz JK, 2002, J ENVIRON ECON MANAG, V44, P426, DOI 10.1006/jeem.2001.1215
   Huang JY, 2000, FUZZY SET ITS APPL
   Li BX, 1981, FUZZY MATH       JAN, P53
   Venkatachalam L, 2004, ENVIRON IMPACT ASSES, V24, P89, DOI 10.1016/S0195-9255(03)00138-0
   WILLIG RD, 1976, AM ECON REV, V66, P589
   Wu WD, 2009, J EC WATER RESOURCES, V27, P9
   Zhao J, 2005, ENV SCI, V26, P5
   [赵军 ZHAO Jun], 2007, [环境科学学报, Acta Scientiae Circumstantiae], V27, P854
NR 10
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.804
PG 11
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404021
DA 2018-12-27
ER

PT S
AU Wu, YM
   Xu, PW
AF Wu Yanmei
   Xu Pengwen
BE Zhou, X
TI RETRACTED: Architecture of Equipment Acquisition Information System
   Based on Service oriented architecture (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE SOA (Service oriented architecture); Web Services; equipment
   acquisition; information system
AB During the process of equipment acquisition information, some relevant information systems are developed, but these systems are isolated each other, with short interoperability. Therefore, it is time to find a method to systemize the different subsystems and to achieve the interconnection, intercommunication and interoperability of heterogeneous information systems. This paper first analyzes the actualities of the equipment acquisition information management, and then puts forward an idea of the equipment acquisition information system based on service oriented architecture (SOA). After that, the conception and architecture of SOA is introduced. Based on SOA, the framework of equipment acquisition information system is proposed, and expatiates on the advantages of equipment acquisition information system based on SOA. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wu Yanmei; Xu Pengwen] Acad Equipment, Beijing, Peoples R China.
RP Wu, YM (reprint author), Acad Equipment, Beijing, Peoples R China.
EM wuyanmeiland@sina.com
CR Bass Tim, 2005, 10 ICCRTS JUN 13 16
   Electronic technology standardization institute, 2008, SOA US GUID
   LI Yinsheng, 2008, ARCHITECTURE APPL SO
   Nezhad Hamid R. Motahari, 2008, SOFTWARE ENG
   WANG Hangong, 2003, EQUIPMENT LIFE CYCLE
   ZOU Zhe, 2008, TRAINING SCI, V29, P25
NR 6
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.230
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400030
DA 2018-12-27
ER

PT S
AU Xia, H
   Ma, DD
   Wen, C
AF Xia, Hong
   Ma, Dandan
   Wen, Chen
BE Zhou, X
TI RETRACTED: Pretreatment of Concentrated and Saliferous Wastewater From
   Dye Manufacturing by Electrochemical Oxidation (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE dye wastewater; internal microelectrolysis; elcteolysis; COD removal;
   electrochemical oxidation
ID ACTIVATED CARBON-FIBER; REACTIVE DYES; ANODE; ELECTROLYSIS; DEGRADATION
AB This paper has investigated the effect of the combination of the internal microelectrolysis and the electrolysis over activated carbon cloth (ACC) electrodes on dye wastewater treatment and analyzed the efficiency of the chemical oxygen demand (COD) removal. The combined electrochemical oxidation is mainly influenced by iron chips/granular activated carbon (GAC)/wastewater volumetric ratio, current intensity, and electrode gap etc. It was found that up to 63 % COD could be removed under the conditions of iron/GAC/wastewater volumetric ratio of 30: 30: 1200, current intensity of 9.2 mA cm-2, electrode gap of 2 cm, and run time of 30 h. In addition, the current efficiency (CE) and energy consumption (EC) were also estimated under different current intensity and electrode gap. These results suggest the oxidation process is the promising, economical alternative for pretreating concentrated and saliferous wastewater from dye manufacturing. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Xia, Hong; Ma, Dandan; Wen, Chen] Tianjin Polytech Univ, Inst Environm & Chem Engn, Tianjin 300160, Peoples R China.
RP Wen, C (reprint author), Tianjin Polytech Univ, Inst Environm & Chem Engn, Tianjin 300160, Peoples R China.
EM chenwen2001@hotmail.com
CR Boonyakamol A, 2009, APPL BIOCHEM BIOTECH, V158, P180, DOI 10.1007/s12010-008-8330-0
   Cho JH, 2010, J HAZARD MATER, V180, P535, DOI 10.1016/j.jhazmat.2010.04.067
   Fernandes A, 2004, DYES PIGMENTS, V61, P287, DOI 10.1016/j.jdyepig.2003.11.008
   Gurses A, 2002, WASTE MANAGE, V22, P491, DOI 10.1016/S0956-053X(02)00015-6
   Guven G, 2008, J HAZARD MATER, V157, P69, DOI 10.1016/j.jhazmat.2007.12.082
   Guven G, 2009, CHEM ENG J, V151, P149, DOI 10.1016/j.cej.2009.02.008
   Mollah MYA, 2010, J HAZARD MATER, V174, P851, DOI 10.1016/j.jhazmat.2009.09.131
   Rajkumar D, 2006, J HAZARD MATER, V136, P203, DOI [10.1016/j.jhazmat.2005.11.096, 10.1016/j.hazement.2005.11.096]
   Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8
   Shen ZM, 2006, J HAZARD MATER, V131, P90, DOI 10.1016/j.jhazmat.2005.09.010
   Sundarapandiyan S, 2010, J HAZARD MATER, V180, P197, DOI 10.1016/j.jhazmat.2010.04.013
   Venkatesan P., 2009, J ENV SCI HLTH A, VA44, P85
   Yang XY, 2009, BIORESOURCE TECHNOL, V100, P649, DOI 10.1016/j.biortech.2008.07.035
   Yi FY, 2008, J POROUS MAT, V15, P565, DOI 10.1007/s10934-007-9134-2
   Yi FY, 2008, J HAZARD MATER, V157, P79, DOI 10.1016/j.jhazmat.2007.12.093
   Ramalho AMZ, 2010, FUEL, V89, P531, DOI 10.1016/j.fuel.2009.07.016
   Zhao X, 2010, BIORESOURCE TECHNOL, V101, P865, DOI 10.1016/j.biortech.2009.08.098
NR 17
TC 0
Z9 0
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.870
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404087
DA 2018-12-27
ER

PT S
AU Xia, J
   Bu, HL
AF Xia Jing
   Bu Hualong
BE Zhou, X
TI RETRACTED: Relief Wrapper based PLS for Gene Analysis (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Relief Wrapper; Partial Least Squares; Microarray analysis
ID PRINCIPAL COMPONENT ANALYSIS; EXPRESSION DATA; CLASSIFICATION; TUMOR
AB Partial Least Squares (PLS) is one of the widely used dimension reduction methods for analysis of gene expression microarray data, the size of the reduced space by PLS is critical to generalization performance of classifiers. Traditionally the top several components of PLS are selected for modeling according to the descending order of eigenvalues. In this paper, we prove that not all the top features are useful; features should be selected from all the components by feature selection methods. Here we demonstrate the effect of feature selection for PLS based dimension reduction. As a case study, PLS is combined with Relief Wrapper method to get more robust and efficient dimensional space, and then the constructed data from the selected components is used as input for classifiers. Experimental results on gene microarray data illustrate that not only the top features newly extracted by PLS are important; therefore, feature selection should be performed to select subsets from new features to improve generalization performance of classifiers. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Xia Jing] Chaohu Coll, Dept Math, Chaohu, Peoples R China.
RP Bu, HL (reprint author), Chaohu Coll, Dept Comp Sci, Chaohu, Peoples R China.
EM bhl@chu.edu.cn
CR Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745
   Anaparthi KK, 2005, IEEE T POWER SYST, V20, P1658, DOI 10.1109/TPWRS.2005.852092
   Chen N, 2004, SUPPORT VECTOR MACHI
   Dai JJ, 2006, STAT APPL GENET MOL, V5
   Dettling M, 2003, BIOINFORMATICS, V19, P1061, DOI 10.1093/bioinformatics/btf867
   Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248
   Ghosh D., 2002, P PAC S BIOC, P11462
   Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531
   Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616
   HEDENFALK, 2001, NEW ENGL J MED, V24, P539
   Ho PM, 2005, IEEE T CIRC SYST VID, V15, P355, DOI [10.1109/TCSVT.2004.842601, 10.1109/TCVST.2004.842601]
   Jolliffe I. T., 1986, PRINCIPAL COMPONENT
   Kira K., 1992, P 10 NAT C ART INT, P129
   Stoyanova R, 2004, BIOINFORMATICS, V20, P1772, DOI 10.1093/bioinformatics/bth170
   Sun ZH, 2004, PATTERN RECOGN, V37, P2165, DOI 10.1016/j.patcog.2004.03.013
NR 15
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.938
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096405005
DA 2018-12-27
ER

PT S
AU Xiao, R
   Wang, N
AF Xiao, Rong
   Wang, Neng
BE Zhou, X
TI RETRACTED: A Grid-based clustering Routing Protocol for Wireless Sensor
   Networks based on GROUP (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Clustering; Grid-based; WSN; Routing protocol
AB This paper proposes a modification policy on GROUP (Grid-clustering Routing Protocol for Wireless Sensor Networks). This modification aims at getting a better performance, e. g., less average energy consumption of the whole network, less average end-to-end delay of data packet, than GROUP. We call the modified protocol GROUP-M. We simulated both GROUP-M and GROUP on ns2.34 platform, and made the comparison between them. The comparison results showed that our modification on GROUP is valid and effective. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Xiao, Rong; Wang, Neng] E China Normal Univ, Dept Comp Sci & Technol, Shanghai 200241, Peoples R China.
RP Xiao, R (reprint author), E China Normal Univ, Dept Comp Sci & Technol, Shanghai 200241, Peoples R China.
EM almaxiao@yahoo.com
CR Heinzelman W. B., 2000, APPL SPECIFIC PROTOC
   Heinzelman WB, 2002, IEEE T WIREL COMMUN, V1, P660, DOI 10.1109/TWC.2002.804190
   Intanagonwiwat C., 2000, P 6 ANN INT C MOB CO, P56, DOI DOI 10.1145/345910.345920
   YE F, 2002, ACM INT C MOB COMP N, P148
   YE W, 2002, P IEEE INFOCOM, P1567, DOI DOI 10.1109/INFCOM.2002.1019408
   YOUNIS O, 2004, P IEEE INFOCOM MARCH, V1, P629
   Yu L., 2006, WIR COMM NETW MOB CO, P1, DOI [10.1109/WiCOM.2006.287, DOI 10.1109/WICOM.2006.287]
NR 7
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.289
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400089
DA 2018-12-27
ER

PT S
AU Xiao, YZ
   Huang, YN
AF Xiao, Yingzhe
   Huang, Yanan
BE Zhou, X
TI RETRACTED: Research on Statistical Process Control for Solvent Residual
   Quantity of Packaging Materials (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Packaging Quality Management; SPC; (X)over-bar-R Control Chart;
   Packaging Materials
AB Statistical Process Control (SPC) and the basic tool of its controlling - control chart - are discussed in this paper based on the development of quality management, current situation of quality management of Chinese packaging enterprises, and the necessity of applying SPC. On this basis, (X) over bar -R control chart is used to analyze and control the solvent residual in the compound process. This work may allow field personnel to find the shortcomings in the quality control by noticing the corresponding of fluctuations and slow variations in the process in time. In addition, SPC also provides objective basis for the quality management personnel to assess semi-products or products quality. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Xiao, Yingzhe] Hunan Univ Technol, Coll Packaging & Mat Engn, Zhuzhou, Peoples R China.
RP Xiao, YZ (reprint author), Hunan Univ Technol, Coll Packaging & Mat Engn, Zhuzhou, Peoples R China.
EM Xiaoyingzhe7410@126.com
CR [Anonymous], 1998, GBT100041998
   Guan Shengping, 2004, SPC STAT PROCESS CON, P124
   Pan Yuzhou, 1997, MODERN ENTERPRISE QU, P7
   Tie Jiansi, 2006, STAT METHODS QUALITY, P44
   Wang Xiaofeng, 2004, QS9000 REFERENCE MAN, P11
   Wen-ping, 2002, GUANGDONG QUALITY, P22
NR 6
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.205
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400005
DA 2018-12-27
ER

PT S
AU Xiao, Z
AF Xiao, Zhang
BE Zhou, X
TI RETRACTED: E-marketing Conditions Prediction of Enterprise by Genetic
   Support Vector Regression (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE E-marketing conditions; enterprise; genetic support vector regression;
   prediction method
ID E-COMMERCE; SYSTEM
AB E-marketing quantity prediction of enterprise has a great impotance for enterprise to make up marketing strategy and carry out E-marketing activity. Genetic support vector regression is present to E-marketing quantity prediction of enterprise in the paper. Genetic algorithm can gain the suitable parameters for the support vector regression model. A certian company is applied to perform the experimental analysis of E-marketing quantity prediction of enterprise. The comparison of prediction error between BP neural network and genetic support vector regression is performed to prove the superiority of genetic support vector regression compared with BP neural network. It is shown that genetic support vector regression has higher prediction accuracy of E-marketing quantity than BP neural network. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Rizhao Polytech, Business Management Dept, Rizhao 276826, Peoples R China.
RP Xiao, Z (reprint author), Rizhao Polytech, Business Management Dept, Rizhao 276826, Peoples R China.
EM zhangxiao67@163.com
CR Denguir-Rekik A, 2009, EUR J OPER RES, V195, P876, DOI 10.1016/j.ejor.2007.11.020
   Kannan PK, 2001, DECIS SUPPORT SYST, V32, P83, DOI 10.1016/S0167-9236(01)00103-8
   Kwong CK, 2009, EXPERT SYST APPL, V36, P3829, DOI 10.1016/j.eswa.2008.02.041
   Melkemi KE, 2006, PATTERN RECOGN LETT, V27, P1230, DOI 10.1016/j.patrec.2005.07.021
   MIAO Zhen-qin, 2007, J HENAN U TECHNONLOG, V3, P35
   Nizam M, 2010, EXPERT SYST APPL, V37, P3730, DOI 10.1016/j.eswa.2009.11.052
   Shaltoni AM, 2010, IND MARKET MANAG, V39, P1097, DOI 10.1016/j.indmarman.2009.06.011
NR 7
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.329
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400129
DA 2018-12-27
ER

PT S
AU Xie, XZ
   Zhao, RZ
   Jin, WY
   Yao, YP
AF Xie Xiaozheng
   Zhao Rongzhen
   Jin Wuyin
   Yao Yunpinga
BE Zhou, X
TI RETRACTED: Diagnosis of chatter type based on neural network (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Chatter; diagnosis; Type; BP neural network
AB By analyzing chatter dynamic model, the article studies chatter phenomenon between metal cutting tool and workpiece during the cutting. From the perspective of energy, phase position difference of chatter mark, phase position difference of vibration mode, lagging phase position angle and change rate about cutting force relative to the cutting speed are respectively determined as characteristic parameter of regenerative, coupling vibration, lagging and fricative mode of chatter. With the four input parameters, multilayer feed forward neural network learning algorithm is used to diagnose the type of cutting chatter, and experiments show that this method is effective. It is essential to take appropriate measures on vibration suppression. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Xie Xiaozheng; Zhao Rongzhen; Jin Wuyin; Yao Yunpinga] Lanzhou Univ Technol, Sch Mech & Electron Engn, Lanzhou 730050, Peoples R China.
RP Xie, XZ (reprint author), Lanzhou Univ Technol, Sch Mech & Electron Engn, Lanzhou 730050, Peoples R China.
EM x2zdavy@126.com
RI Jin, Wuyin/M-7490-2013
OI Jin, Wuyin/0000-0003-3741-3610
CR Chapman SJ, 2003, MATLAB PROGRAMMING E
   CHEN Linyun, 2008, MACHINE BUILDING AUT, V37, P48
   Erturk A, 2006, INT J MACH TOOL MANU, V46, P1901, DOI 10.1016/j.ijmachtools.2006.01.032
   Huang Yi, NONLINEAR ANAL FRICT
   Ma Hailong, 2007, TOOL ENG, V41, P32
   Shi HM, 2003, METAL CUTTING THEORY
   Solis E, 2004, INT J MACH TOOL MANU, V44, P1591, DOI 10.1016/j.ijmachtools.2004.06.011
   Sun Baoshou, 2006, Transactions of Nanjing University of Aeronautics & Astronautics, V23, P108
   Wiercigroch M, 2001, PHILOS T ROY SOC A, V359, P713, DOI 10.1098/rsta.2000.0752
   Wu B D, 1994, VIBRATION IDENTIFICA
   Wu Y, 1993, CHATTER ITS CONTROL
NR 11
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.343
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400143
DA 2018-12-27
ER

PT S
AU Xin, L
   Jia, Y
   Wu, CR
   Lu, XL
AF Xin Lu
   Jia Yue
   Wu Chunrui
   Lu Xiaolong
BE Zhou, X
TI RETRACTED: Study on Vacuum membrane distillation process for RO drained
   wastewater from iron and steel industry (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE VMD; AVMD; RO drained wastewater; Hydrophobic hollow fiber; Chemical
   hardness removal
AB Novel hydrophobic polyvinylidene fluoride (PVDF) hollow fiber membrane was used in the treatment of a reverse osmosis (RO) concentrated water from iron and steel industry via vacuum membrane distillation (VMD) method and air-blowing vacuum membrane distillation (AVMD) method. Based on the characteristic of the industrial wastewater, the hardness removal method and proportion of the hardness removal agents were studied. Waste water with hardness removal was applied in both VMD and AVMD as feed water. The results were compared with those of raw water without pretreatment. It was found that the hardness removal method of NaOH is better than that of Ca(OH)2Na2CO3 both in hardness removal rate and cost. When the RO drained wastewater was pretreated, the flux of VMD process reached nearly 18kg/(m2.h) before the water was concentrated up to 15 times, the flux of AVMD process reached nearly 20kg/(m2.h) before the water was concentrated up to 7 times. Thereafter, with the increase of the concentration fold, the flux decreased gradually. As the concentration fold arrived at 30, salt crystallization was observed. However, when the wastewater without pretreatment was taken as the feed, the flux of both VMD process and AVMD process declined drastically. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Xin Lu; Jia Yue; Wu Chunrui; Lu Xiaolong] Tianjin Polytech Univ, TJPU, State Key Lab Hollow Fiber Membrane Mat & Proc, Tianjin, Peoples R China.
RP Xin, L (reprint author), Tianjin Polytech Univ, TJPU, State Key Lab Hollow Fiber Membrane Mat & Proc, Tianjin, Peoples R China.
EM xinluhj@yahoo.com.cn
CR Chunrui Wu, 2008, J FUNCTIONAL MAT, P922
   Dong Liu, 2009, TECHNOLOGY WATER TRE, P60
   Heng Zhao, 2009, J TECHNOLOGY WATER T, P34
NR 3
TC 0
Z9 0
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.863
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404080
DA 2018-12-27
ER

PT S
AU Xiong, JL
   Yang, M
   Chen, YJ
   Fan, J
   Liu, TC
   Wang, HB
AF Xiong Jialiang
   Yang Min
   Chen Yi-jian
   Fan Jing
   Liu Tiancheng
   Wang Hongbin
BE Zhou, X
TI RETRACTED: Double-Column Capillary GC Determination of the
   Organophoshate Pesticide Residues in Tea (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Capillary gas chromatography(GC); Organophos-phorus pesticide; Residues;
   Tea
AB In this research, a determination of 6 organophosphorus pesticide residues in the tea has been established by capillary gas chromatography. After rotary steam and condensation, the sample is filtered through 0.2 mu m membrane and determined by gas chromatography FPD detector. The peak time of six pesticide ranges from 9.077min to 32.420min. The average recovery ranges between 90.5% and 110.6%, RSD, between 1.3% and 8.1%, detection limits, between 0.0066 mu g.kg-1 and 0.0085 mu g.kg-1, and the correlation coefficient of the standard curve, between 0.99848 and 0.99988 in the concentration range of 0.01-1.0mg.L-1 (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Xiong Jialiang; Yang Min; Chen Yi-jian; Fan Jing; Liu Tiancheng; Wang Hongbin] Yunnan Univ Nationalities, Sch Chem & Biotechnol, Kunming 650500, Peoples R China.
RP Wang, HB (reprint author), Yunnan Univ Nationalities, Sch Chem & Biotechnol, Kunming 650500, Peoples R China.
EM 595530820@qq.com
CR Bin Suiwu, 2008, J ANHUI AGR SCI, V36, P1942
   Fu Guang-yun, 2005, J CHEM EDUC, V2005, P9
   He Yu, 2007, ANAL TESTING, V16, P6
   [蒋永祥 JIANG Yongxiang], 2007, [分析试验室, Analytical Laboratory], V26, P97
   Liu Yuhong, 2008, CHINESE, V18, P451
   Zhao Lifeng, 2005, XIAOSHAN DISTRICT HL, V41, P26
NR 6
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.826
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404043
DA 2018-12-27
ER

PT S
AU Xu, C
AF Xu, Chen
BE Zhou, X
TI RETRACTED: The Research on Ion Exchange Resin of Cement Solidification
   Treatment (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Ion Exchange Resin; Cement Solidification; Anti-compressive Strength;
   Containing Rate
AB This paper based on the reference to domestic and foreign cement solidification formula, studys the method and principle of solidification treatment of waste resin cement blended with ultra-fine siliceous dust and zeolite, analyzes the factors of the compressive strength index affecting the solidified cement, leaching index and swelling and etc., and based on the previous studies, the optimum cement solidification formula is:
   1. Cement: resin (water content 51.7%): water: silica dust: zeolite powder: water reducing agent = 1000: 420: 395: 60: 60: 8 (sample T4)
   2. Cement: resin (water content 51.7%): water: silica dust: zeolite powder: water reducer = 1000: 416: 352: 120: 30: 8 (sample T6) (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Sichuan Inst Architectural Technol, Dept Bldg Facil, Deyang 618000, Sichuan Provinc, Peoples R China.
RP Xu, C (reprint author), Sichuan Inst Architectural Technol, Dept Bldg Facil, Deyang 618000, Sichuan Provinc, Peoples R China.
EM 45163727@qq.com
CR [Anonymous], 1997, BUILDING MAT
   [Anonymous], 2002, RAD WAST MAN DEC NUC
   Gao Liwu, HEILONGJIANG COMMUNI
   Lv Yijun, 1999, APPL DEV ION EXCHANG
   Nie Yongfeng, 2000, ENG TECHNICAL MANUAL
   Qu Naiqin, 2001, METAL B
   Tian Wenyu, 1998, RES APPL SILICA DUST
   Tian Wenyu, RES APPL SILICA POWD
   Zhang Meng, 2002, SPECIAL CEMENT SOLID, P7
NR 9
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.805
PG 4
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404022
DA 2018-12-27
ER

PT S
AU Xu, Z
   Xing, MY
   Yu, F
   Yan, Q
   Yang, J
AF Xu, Zhe
   Xing, Mei-yan
   Yu, Fen
   Yan, Qiong
   Yang, Jian
BE Zhou, X
TI RETRACTED: Investigation on Biofilm Activity in Vermifilter with Filter
   Media of Different Diameter (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Vermifilter; Biofilm biomass; Biofilm activity; VSS/SS
ID SCALE; WATER
AB Biofilm plays a crucial role on the biodegradation of organic matters in filter systems. In this study, two vermifilters (VFs, VF 1# was packed with 10 similar to 13mm and 6 similar to 9mm graded ceramic pellets, while VF 2# was packed with 6 similar to 9mm ceramic pellets entirely) were operated in parallel. The variations of biofilm biomass and biofilm activity along the depth of the reactors were investigated. The results indicated that the biofilm biomass and the biofilm activity in both vermifilters decreased first and increased subsequently. The ratio of volatile suspended solids (VSS) to suspended solids (SS) were progressively declined from 0.60 to 0.53 in VF 1#, and from 0.57 to 0.44 in VF 2#. The sludge reduction of VF 2# was 40.4%, 6.2% higher than that of VF 1#. These findings indicated that the vermifilter filled with 6 similar to 9mm ceramic pellets performed a better processing properties than the one filled with 10 similar to 13mm and 6 similar to 9mm graded ceramic pellets. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Xu, Zhe; Xing, Mei-yan; Yu, Fen; Yan, Qiong; Yang, Jian] State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China.
RP Yang, J (reprint author), State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China.
EM eyun1842@163.com
CR AMAR D, 1986, WATER RES, V20, P9, DOI 10.1016/0043-1354(86)90207-1
   [Anonymous], 2002, MON AN METH WAT WAST, P107
   EDWARDS CA, 1992, SOIL BIOL BIOCHEM, V24, P1683, DOI 10.1016/0038-0717(92)90170-3
   Elvira C, 1998, BIORESOURCE TECHNOL, V63, P205, DOI 10.1016/S0960-8524(97)00145-4
   Kwon YT, 2009, J CLEAN PROD, V17, P708, DOI 10.1016/j.jclepro.2008.11.014
   LAZAROVA V, 1995, WATER RES, V29, P2227, DOI 10.1016/0043-1354(95)00054-O
   Ragusa SR, 2004, WATER RES, V38, P2865, DOI 10.1016/j.watres.2004.03.039
   Taylor M, 2003, ECOL ENG, V21, P197, DOI 10.1016/j.ecoleng.2003.12.003
   [吴敏 Wu Min], 2003, [中国给水排水, China Water & Wastewater], V19, P59
   [吴敏 Wu Min], 2002, [中国给水排水, China Water & Wastewater], V18, P37
   [吴敏 Wu Min], 2007, [环境污染与防治, Environmental Pollution & Control], V29, P401
   Xie B. Z., 2007, J ENVIRON MANAGE, V90, P260
   Yang Jian, 2008, China Environmental Science, V28, P892
   Zhang Z. J., 2000, EFFLUENT WATER ENG R, P199
   [张增胜 Zhang Zengsheng], 2009, [水处理技术, Technology of Water Treatment], V35, P37
   Zhao LM, 2010, WATER RES, V44, P2572, DOI 10.1016/j.watres.2010.01.011
   Zhao Q. L., 2000, ENV POLLUTION CONTRO, V22, P4
   Zuo Y. S., 2003, CHINA ENV PROTECTION, V12, P31
NR 18
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.822
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404039
DA 2018-12-27
ER

PT S
AU Xu, ZO
   Tan, GJ
AF Xu Zhi-ou
   Tan Guo-jun
BE Zhou, X
TI RETRACTED: Study on Power Loss of High Power Three-Level Converter
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE three-level converter; conduction loss; switching loss; double-fed
AB Based on studying the running elements of three-level converter, the paper proposes a simple and accurate method of computing conduction and switching loss for three-level converter system. Analyses the factor of conduction and switching loss each other, also builds the experimentation of high power three-level converter and introduces a new double-fed experiment method to validating the accuracy of model. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Xu Zhi-ou; Tan Guo-jun] China Univ Min & Technol, Xuzhou, Jiangsu, Peoples R China.
RP Xu, ZO (reprint author), China Univ Min & Technol, Xuzhou, Jiangsu, Peoples R China.
EM xuzhioucumt@126.com
CR Cassimere B., 2005, P IEEE INT C EL MACH, P941
   Kim TJ, 2001, IEEE POWER ELECTRON, P1363, DOI 10.1109/PESC.2001.954310
   Maswood A.I, 2008, POW EN C 2008 PECON, P609
   S Kouro, 2008, P IEEE POW EL SPEC C, P4662
   Thammarat C, 2005, IPEC: 2005 International Power Engineering Conference, Vols 1 and 2, P836, DOI 10.1109/IPEC.2005.207024
   Weiping Zhang, 2009, 2009 IEEE 6 INT POW, P362
NR 6
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.246
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400046
DA 2018-12-27
ER

PT S
AU Xu, ZJ
   Li, Y
   Cheng, H
   Zhang, J
   Zhang, KF
AF Xu, Zhijia
   Li, Yuan
   Cheng, Hui
   Zhang, Jie
   Zhang, Kaifu
BE Zhou, X
TI RETRACTED: A Virtual Grasp Method Based on Grasp-Behavior-Model
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE virtual grasp; behavior model; overall stereotype & local modification;
   ergonomics
ID OBJECTS
AB Virtual grasp of 3D objects provides an intuitive way to interact with virtual objects. However, in current virtual grasp methods, Virtual Hand Model (VHM) has not played a role as an interactive subject, resulting into unrealistic virtual grasp. To enhance virtual grasp, a method based on Grasp Behavior Model (GBM), taking advantage of the biological phenomenon that behavior is often stereotyped, was proposed. A GBM was a medium integrating intent of human and attributes of Object Model for Grasping (OMG), giving VHM some intelligence. Accordingly, a proposed computerized Feasible Grasping Pattern Space (FGPS) of a given OMG changed the natural grasping process model and reinforced the intelligence. To make virtual grasp more realistic, a strategy of Overall Stereotype & Local Modification (OSLM) was introduced. Finally, a detailed framework of virtual grasp based on GBM, FGPS and OSLM was illustrated, including related works such as constructing GBM, OMG and VHM, defining reference frames etc. This method can make VHM understand human's order better, and let more physical sensations be provided to human. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Xu, Zhijia; Li, Yuan; Cheng, Hui; Zhang, Jie; Zhang, Kaifu] Northwestern Polytech Univ, Minist Educ, Key Lab Contemporary Design & Integrated Mfg Tech, 552 Mailbox, Xian 710072, Peoples R China.
RP Xu, ZJ (reprint author), Northwestern Polytech Univ, Minist Educ, Key Lab Contemporary Design & Integrated Mfg Tech, 552 Mailbox, Xian 710072, Peoples R China.
EM xuzhjixyz@126.com
CR Borst CW, 2005, P IEEE VIRT REAL ANN, P91
   El-Khoury S, 2010, ROBOT AUTON SYST, V58, P497, DOI 10.1016/j.robot.2010.01.008
   Johnson R., BIOLOGY, P534
   Kallmann M, 2002, J VISUAL LANG COMPUT, V13, P177, DOI 10.1006/jvlc.2001.0229
   Kyota F., 2005, P INT C CYB, P453
   Lu X. J., 2006, RES MOTION MODELING
   Luo L., 2005, COMPUTER ENG APPL, V34, P16
   Mark C. R., 1989, IEEE T ROBOTIC AUTOM, V5, P269
   Prats M, 2007, IEEE INT CONF ROBOT, P1794, DOI 10.1109/ROBOT.2007.363582
   Sun Li-bo, 2009, Computer Engineering, V35, P10
   Wan H, 2004, P 2004 ACM SIGGRAPH, P81
NR 11
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.332
PG 14
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400132
DA 2018-12-27
ER

PT S
AU Xue, YY
   Zhao, LQ
   Wu, JH
   Wang, JL
AF Xue Yaoyu
   Zhao Liqiang
   Wu Jiahuan
   Wang Jianlin
BE Zhou, X
TI RETRACTED: A Multi-objective Particle Swarm Optimization Based on Swarm
   Energy Conservation (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE multi-objective optimization; MOPSO; swarm energy conservation
ID EVOLUTIONARY ALGORITHMS
AB An improved algorithm-multi-objective particle swarm optimization based on swarm energy conservation (SEC-MOPSO) is proposed, which is aimed to solve the problem of convergence and distribution in multi-objective particle swarm optimization (MOPSO) algorithm. Swarm energy conservation mechanism is used to update the velocity and position of particles. Besides, non-dominated sorting method, adaptive grid mechanism and elitism mechanism are also incorporated into SEC-MOPSO algorithm to improve search capabilities and avoid falling into the second-best non-dominated front. The simulation results show that SEC-MOPSO has better performance than MOPSO in distribution and convergence. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Xue Yaoyu; Zhao Liqiang; Wu Jiahuan; Wang Jianlin] Beijing Univ Chem Technol, Sch Informat Sci & Technol, Beijing 100029, Peoples R China.
RP Wang, JL (reprint author), Beijing Univ Chem Technol, Sch Informat Sci & Technol, Beijing 100029, Peoples R China.
EM wangjl@mail.buct.edu.cn
CR Coello CAC, 2004, IEEE T EVOLUT COMPUT, V8, P256, DOI 10.1109/tevc.2004.826067
   Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017
   Deb K., 2000, LECT NOTES COMPUTER, P849, DOI DOI 10.1007/3-540-45356-3_83
   Hu X., 2002, P C EV COMP, P1677
   KURSAWE F, 1991, LECT NOTES COMPUT SC, V496, P193
   Parsopoulos KE, 2002, P 2002 ACM S APPL CO, P603, DOI DOI 10.1145/508791.508907
   SCHAFFER JD, 1985, P 1 INT C GEN ALG, P93
   Srinivas N., 1994, Evolutionary Computation, V2, P221, DOI 10.1162/evco.1994.2.3.221
   Wang JL, 2010, CHINESE J CHEM ENG, V18, P787, DOI 10.1016/S1004-9541(09)60130-0
   Zitzler E, 1999, IEEE T EVOLUT COMPUT, V3, P257, DOI 10.1109/4235.797969
   Zitzler E, 2000, EVOL COMPUT, V8, P173, DOI 10.1162/106365600568202
NR 11
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.337
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400137
DA 2018-12-27
ER

PT S
AU Yang, H
   Yue, ZW
   Wang, BT
AF Yang, Hao
   Yue, Zhengwen
   Wang, Baitian
BE Zhou, X
TI RETRACTED: Water-saving Effect of Superabsorbent Polymers on Ordos Sandy
   Soil (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Soil available water; Soil moisture; Soil water characteristic curve;
   Soil available water
AB Utilization of Superabsorbent Polymers in Water-saving Agriculture offers a new way to improve water resources use efficiency and sustainable development. In order to research the water-saving effect on sandy soil of Superabsorbent Polymers, four typical Superabsorbent Polymers were divided into two groups for studying. Analysis of variance, curve fitting methods was used to test and analyze the changes of soil moisture and soil available water, through which ascertained the suitable SAPs for Ordos sandy soil. Results show that :(1) Superabsorbent Polymers evidencely ameliorated soil water characteristics. Concentration of SAP from 0.5% to 1% had a typical significance to Ordos sandy soil.(2) Superabsorbent Polymers effectively improved the water holding capacity of soil, and the ameliorating effect in low Soil water suctions(<0.8MPa) obviously superior to the high Soil water suctions(>0.8MPa).(3) In terms of soil available water of Ordos sandy soil, Polymers of Polyacrylate were better performance than Polymers of polyacrylamide in lower SAP concentrations (<0.5%), while in the higher SAP concentrations (>0.5%) is the opposite.(4) The study showed that the content of available soil moisture decreased by 20%similar to 37% after stored in dry conditions for 5 years to AGROFORESTRY absorbent polymer. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yang, Hao; Yue, Zhengwen; Wang, Baitian] Beijing Forestry Univ, Minist Educ, Key Lab Soil & Water Conservat & Desertificat Com, Coll Soil & Water Conservat, Beijing 100083, Peoples R China.
RP Wang, BT (reprint author), Beijing Forestry Univ, Minist Educ, Key Lab Soil & Water Conservat & Desertificat Com, Coll Soil & Water Conservat, Beijing 100083, Peoples R China.
EM wbaitian@bjfu.edu.cn
CR Al-Omran A.M., 1997, SOIL SCI SOC AM J, V51, P1539
   Bin QUAN, 2001, SOIL ENV SCI, V10, P115
   BOWMAN DC, 1991, HORTSCIENCE, V26, P1063
   Huang Zhanbing, 2004, RES SOIL WATER CONSE, V11, P57
   Huttermann A, 1999, SOIL TILL RES, V50, P295, DOI 10.1016/S0167-1987(99)00023-9
   Jian SUN, 1985, J BEIJING FORESTRY U, P38
   Jie XiaoLei, 2000, Journal of Henan Agricultural University, V34, P22
   Jingsheng LI, 1996, J DESERT RES, V16, P86
   KHAFAGI M, 1990, Egyptian Journal of Soil Science, V30, P169
   [马爱生 MA Aisheng], 2005, [西北农林科技大学学报. 自然科学版, Journal of northwest sci-tech university of agriculture and forestry], V33, P117
   Teyel MY, 1981, ACTA HORTIC, V119, P247
   Yazdani Firouzeh, 2007, PAKISTAN J BIOL SCI, V10, P4190
NR 12
TC 0
Z9 0
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.933
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404150
DA 2018-12-27
ER

PT S
AU Yang, JH
   Dai, YH
   Peng, FQ
   Xiong, ZW
   Xu, H
AF Yang Jin-hui
   Dai Yang-hong
   Peng Fu-quan
   Xiong Zheng-wei
   Xu Hua
BE Zhou, X
TI RETRACTED: Remove as (III) from Aqueous Solution by Powder Mg(OH)(2)
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Mg(OH)(2); As(III); Adsorption; Isotherm; Wastewater treatment
AB Power Mg(OH)(2) was used to remove As(III) from arsenic-bearing wastewater. Results showed that Mg(OH)(2) had strong adsorptive property on As(III) ions with its adsorption capacity of 4.04 mg/L; Mg(OH)(2) adsorption on As(III) fit well with Langmuir Isotherm equation; As(III) removal rate increased with vibration time and input quantity of adsorbents while decreased as pH increased and effects were obvious; temperature had little affection on arsenic adsorption; As(III) removal rate can exceeded 99% when reaching equilibrium under condition As(III) concentration of 20 mg/L, Mg(OH)(2) input quantity of 2 g/L and pH of 3; Mg(OH)(2) adsorption was fast and can reach equilibrium in 60 min. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yang Jin-hui; Dai Yang-hong; Peng Fu-quan; Xiong Zheng-wei; Xu Hua] Univ S China, Sch Urban Construct, Hengyang 421001, Hunan, Peoples R China.
RP Yang, JH (reprint author), Univ S China, Sch Urban Construct, Hengyang 421001, Hunan, Peoples R China.
EM yangjinhui126@126.com
CR Allen SJ, 2004, J COLLOID INTERF SCI, V280, P322, DOI 10.1016/j.jcis.2004.08.078
   J Hingston F, SOIL SCI, V23, P177
   Jie Yang, 2003, J IND WATER TREATMEN, V23, P14
   Juang RS, 2002, WATER RES, V36, P2999, DOI 10.1016/S0043-1354(01)00537-1
   Thomas MG, 2001, ENVIRON SCI TECHNOL, V35, P3857
   Xin Huang, 2007, WATER PURIFICATION T, V26, P37
   YU Qing-yuan, 2007, SHANXI ARCH IT ECTUR, V33, P182
NR 7
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.895
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404112
DA 2018-12-27
ER

PT S
AU Yang, M
   Qian, X
AF Yang, Meng
   Qian, Xin
BE Zhou, X
TI RETRACTED: Effects of Dam Decommissioning on Flood Inundation in an
   Urban Area (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE water resource management; dam removal; flood inundation modeling
ID RIVER; MODEL
AB Flood control is the key issue when making decisions for dam decommissioning in China, especially in urban areas. The Heiwa Dam is a small aging dam that does not serve its original purpose. The dam owner proposed to decommission it. However, the local water resource managers opposed to this proposal, because they concern the potential changes to flood regime in the city. In order to identify flood inundation changes due to the dam decommissioning, 2D MIKE21 HD with 10-m spatial resolution was used to model the flood inundation for the decommissioning scenario and existing condition. The model was calibrated using the roughness coefficient. Modeling results showed that decommissioning of the Heiwa dam would neither significantly increase flood inundation area nor water depth at 50-yr flood event. Compared with existing-condition, only 1% of the whole inundation area had significant increase in inundation depth with absolute increase from 0.15 to 0.35 m and percentage changes larger than 30%. Modeling results indicated flow constriction due to the limited conveyance capacity of sewer system in the city had greater impact on flooding and flood control than the Heiwa Dam itself. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yang, Meng; Qian, Xin] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, 163 Xianlin Ave, Nanjing 210046, Jiangsu, Peoples R China.
RP Qian, X (reprint author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, 163 Xianlin Ave, Nanjing 210046, Jiangsu, Peoples R China.
EM xqian@nju.edu.cn
CR Chen AS, 2005, WATER SCI TECHNOL, V51, P221
   Chen J, 2009, J HYDROL, V373, P184, DOI 10.1016/j.jhydrol.2009.04.021
   DHI Software, 2006, MIKE21 HD HYDR MOD S
   Fewtrell TJ, 2008, HYDROL PROCESS, V22, P5107, DOI 10.1002/hyp.7148
   Gallegos HA, 2009, ADV WATER RESOUR, V32, P1323, DOI 10.1016/j.advwatres.2009.05.008
   [郭雪梅 Guo Xuemei], 2008, [灾害学, Journal of Catastrophology], V23, P46
   Horritt MS, 2002, J HYDROL, V268, P87, DOI 10.1016/S0022-1694(02)00121-X
   Liu N, 2004, CHINA WATER RESOUR, V23, P27
   Mignot E, 2006, J HYDROL, V327, P186, DOI 10.1016/j.jhydrol.2005.11.026
   Roberts SJ, 2007, ENVIRON MANAGE, V39, P113, DOI 10.1007/s00267-005-0091-8
   Schmitt TG, 2004, J HYDROL, V299, P300, DOI 10.1016/j.jhydrol.2004.08.012
   Sheng JB, 2006, CHINA WATER RESOUR, V2, P41
   Wyrick JR, 2009, J ENVIRON MANAGE, V90, pS270, DOI 10.1016/j.jenvman.2008.07.027
   Yu D, 2006, HYDROL PROCESS, V20, P1541, DOI 10.1002/hyp.5935
NR 14
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.942
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096405009
DA 2018-12-27
ER

PT S
AU Yang, TJ
   Lu, LY
AF Yang Tiejun
   Lu Liangyou
BE Zhou, X
TI RETRACTED: Performance Analysis of Clipping Noise Guided and Complex
   Base-Band Active-Set methods Based on Tone Reservation for PAPR
   Reduction in OFDM Systems (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE PAPR; CCDF; tone reservation; adaptive scale; constant scale; active-set
ID POWER RATIO REDUCTION; PAR REDUCTION; PEAK
AB Orthogonal frequency division multiplexing (OFDM) suffers from a high peak-to-average power ratio (PAPR). Tone reservation is a popular PAPR reduction technique that uses a set of reserved tones to design a peak-canceling signal. In this paper, the performance and complexity of clipping noise guided, complex base-band active-set methods based on tone reservation for PAPR reduction are analyzed and simulated. The simulation results show that the two clipping noise guided methods, the adaptive scale method and constant scale method, have better performance than complex base-band active-set methods. Furthermore, the complexity of the constant scale algorithm is lower than the adaptive scale and the complex base-band active-set algorithm. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yang Tiejun; Lu Liangyou] Henan Univ Technol, Sch Informat Sci & Engn, Zhengzhou 450001, Peoples R China.
RP Yang, TJ (reprint author), Henan Univ Technol, Sch Informat Sci & Engn, Zhengzhou 450001, Peoples R China.
EM tjyanghlyu@126.com
CR Deng SK, 2007, IEEE T COMMUN, V55, P227, DOI 10.1109/TCOMM.2006.885102
   Fischer RFH, 2009, IEEE T INFORM THEORY, V55, P1519, DOI 10.1109/TIT.2009.2013000
   Jiang T, 2008, IEEE T BROADCAST, V54, P257, DOI 10.1109/TBC.2008.915770
   Krongold BS, 2004, IEEE T SIGNAL PROCES, V52, P495, DOI 10.1109/TSP.2003.821110
   Leung SH, 2002, ELECTRON LETT, V38, P1726, DOI 10.1049/el:20021137
   Li XD, 1998, IEEE COMMUN LETT, V2, P131, DOI 10.1109/4234.673657
   Maeda N, 2003, IEICE T COMMUN, VE86B, P300
   Tellado J., 1999, THESIS STANFORD U ST
   Wang LQ, 2005, IEEE SIGNAL PROC LET, V12, P453, DOI 10.1109/LSP.2005.847886
   Wang LQ, 2008, IEEE T VEH TECHNOL, V57, P1675, DOI 10.1109/TVT.2007.907282
NR 10
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.265
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400065
DA 2018-12-27
ER

PT S
AU Yang, YX
   Ma, J
   Wang, SJ
   Zhang, J
AF Yang, Yi-xin
   Ma, Jun
   Wang, Sheng-jun
   Zhang, Jing
BE Zhou, X
TI RETRACTED: Catalytic Ozonation of Raw Water from Songhua River with Nano
   TiO2 Supported by Zeolite (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE ozone; catalyst; nano; TiO2; raw water
AB In the present paper, nanosized TiO2 supported by zeolite was used in the ozonation of Songhua River as catalyst. The catalytic activity of TiO2/Zeolite for ozonation was testified by nitrobenzene removal, which is one kind of representatively resistant organic contaminant. And the removal of some organic and inorganic compounds existing in the Songhua River by TiO2/Zeolite catalyzed ozonation was investigated. GC-MS analysis showed that the Songhua River was obviously polluted by organic contaminants. Catalytic ozonation can remove about 30 kinds of organic matters from water and reduce the total organic peak area of feed water by 62.5%. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yang, Yi-xin] Northeastern Univ, Dept Environm Sci & Engn, Qinhuangdao 066004, Peoples R China.
RP Yang, YX (reprint author), Northeastern Univ, Dept Environm Sci & Engn, Qinhuangdao 066004, Peoples R China.
EM yangyixininhit@gmail.com
CR Langlais B., 1991, OZONE WATER TREATMEN
   Yang YX, 2009, OZONE-SCI ENG, V31, P45, DOI 10.1080/01919510802584835
NR 2
TC 0
Z9 0
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.853
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404070
DA 2018-12-27
ER

PT S
AU Yang, YH
   Fang, GF
   Dutkiewicz, E
   Li, YQ
AF Yang, Yihuai
   Fang, Gengfa
   Dutkiewicz, Eryk
   Li, Yangqing
BE Zhou, X
TI RETRACTED: A new 3D statistical method for mobile channel model
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE propagation simulation; path loss; COST-Walfisch-Ikegami model; wireless
   systems
ID PROPAGATION
AB 3-dimension statistical method is used to simulate the popular micro-cell propagation model: COST231-Walfish-Ikegami model[6][7]. The extended model allows for improved path loss estimation by consideration the character of the urban environment parameters are lognormal random variables rather than deterministic. The numerical calculation results and trial measurement data is presented. Based on the measurement and modelling results, we find that the 3D COST231-WI model fits very well with the measurement result in the metropolitan scenario. The conclusion is useful and helpful to network planning in the future. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yang, Yihuai; Li, Yangqing] Kunming Univ, Sch Automat Control & Mech Engn, Kunming, Peoples R China.
RP Yang, YH (reprint author), Kunming Univ, Sch Automat Control & Mech Engn, Kunming, Peoples R China.
EM yyh_td@126.com
CR Cavdarih, 2001, IEEE VTC 53, V1, P279
   CORAZZA GE, 1994, IEEE T VEH TECHNOL, V43, P738, DOI 10.1109/25.312773
   COST 231, 1991, COST231TD90119
   Damosso Eraldo, 1999, COST ACTION 231 DIGI
   HATA M, 1980, IEEE T VEHICULAR TEC, V29
   IKEGAMI F, 1984, IEEE T ANTENN PROPAG, V32, P822, DOI 10.1109/TAP.1984.1143419
   LOO C, 1985, IEEE T VEH TECHNOL, V34, P122
   LUTZ E, 1991, IEEE T VEH TECHNOL, V40, P375, DOI 10.1109/25.289418
   Nakagami M., 1960, STAT METHODS RADIO W, V6a, P3, DOI DOI 10.1016/B978-0-08-009306-2.50005-4
   Neto Ananias Pereira, 2003, INT MICR OPT C IMOC, V2, P801
   Oestges C, 2001, ELECTRON LETT, V37, P1195, DOI 10.1049/el:20010805
   Rappaport T., 2002, WIRELESS COMMUNICATI
   ROSSI JP, 1992, RADIO SCI, V27, P971, DOI 10.1029/92RS01781
   WALFISCH J, 1988, IEEE T ANTENN PROPAG, V36, P1788, DOI 10.1109/8.14401
   Yang Yihuai, 2010, P 3 IEEE ICCSIT 2010, V2, P445
   Yang YM, 2009, PROCEEDINGS OF THE FOURTH INTERNATIONAL CONFERENCE ON AUTONOMOUS ROBOTS AND AGENTS, P284
NR 16
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.238
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400038
DA 2018-12-27
ER

PT S
AU Yang, YC
   Yi, CS
   Ye, ZX
   Yu, J
   Fu, M
AF Yang Yingchun
   Yi Chongshu
   Ye Zhixiang
   Yu Jing
   Fu Mei
BE Zhou, X
TI RETRACTED: Cloud Point Extraction and Determination of Trace 2,
   4-Dichlorophenol by High Performance Liquid Chromatography with
   Ultraviolet-Detection (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE cloud point extraction (CPE); 2,4-dichlorophenol(2,4-DCP);
   high-performance liquid chromatography(HPLC); Triton X-100;
   environmental water samples
ID SOLID-PHASE EXTRACTION; WATER SAMPLES; PRECONCENTRATION; POLLUTANTS
AB A method based on cloud point extraction(CPE) was developed for the determination of 2,4-dichlorophenol in environmental water samples using high-performance liquid chromatography separation and ultraviolet (HPLC-UV) detection. The non-ionic surfactant Triton X-100 was chosen as extraction solvent. The parameters and affecting factors of extraction efficiency, such as concentration of Triton X-100 and sodium chloride, acidity of solution, equilibrium temperature, equilibrium time and centrifugation time were evaluated and optimized. Under the optimum conditions: 0.9% (w/v) Triton X-100, 0.2 mol/L sodium chloride and 0.4% (v/v) hydrochloride, heat-assisted at 80 degrees C for 60 min, the extraction efficiencies was more than 95%. The results show that the linear dynamic ranges of detection is 0.005 similar to 0.5 mg/L for 2,4-dihlorophenol with the correlation coefficient of 0.9998, and the limit of detection is 2.0x10(-2) mu g/L (3 sigma) with relative standard deviation (RSD) of 3.51% (n = 9). The enhancement factor can achieve 33 for the determination of 2,4-dichlorophenol in environmental water samples. The recoveries range from 94.4% to 104.0% for three environmental water samples. The proposed method is simple, rapid, sensitive, accurate and friendly to environment. It is suitable to the determination of 2,4-dichlorophenol in environmental water samples. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yang Yingchun; Yi Chongshu; Ye Zhixiang; Yu Jing; Fu Mei] Chengdu Univ Informat Technol, Dept Resources & Environm, 24,Block 1,Xuefu Rd, Chengdu 610225, Sichuan, Peoples R China.
RP Yang, YC (reprint author), Chengdu Univ Informat Technol, Dept Resources & Environm, 24,Block 1,Xuefu Rd, Chengdu 610225, Sichuan, Peoples R China.
EM yangyingchun@cuit.edu.cn
CR Fan Y, 2003, ANAL CHIM ACTA, V484, P145, DOI 10.1016/S0003-2670(03)00342-8
   Fernandez AE, 1998, ANAL CHIM ACTA, V358, P145
   Ferrer R, 1996, ANAL CHIM ACTA, V330, P199, DOI 10.1016/0003-2670(96)00176-6
   Ferrera ZS, 2004, TRAC-TREND ANAL CHEM, V23, P469, DOI 10.1016/s0165-9936(04)00732-0
   FRANKEWICH RP, 1994, ANAL CHEM, V66, P944, DOI 10.1021/ac00079a005
   Liu W, 2007, ANAL CHIM ACTA, V605, P41, DOI 10.1016/j.aca.2007.10.034
   Opeolu BO, 2010, INT J PHYS SCI, V5, P576
   Pascal-Lorber S, 2004, CHEMOSPHERE, V56, P275, DOI 10.1016/j.chemosphere.2004.02.017
   Puig D, 1997, ANAL CHEM, V69, P2756, DOI 10.1021/ac961256j
   Voznakova Z., 1999, TOXICOLOGICAL ENV CH, V69, P335
   Wang Qiang, 2007, CHINESE J SPECTR SPE, V27, P560
   Yin DQ, 2003, ENVIRON POLLUT, V122, P217, DOI 10.1016/S0269-7491(02)00292-0
   Yu Yuyan, 2008, CHINESE J INSTRU ANA, V27, P607
   Yuliang SU, 2008, CHINESE J INSTRU ANA, V27, P1
NR 14
TC 0
Z9 0
U1 1
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.897
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404114
DA 2018-12-27
ER

PT S
AU Yao, L
   Wang, ZH
   Li, ZZ
   Cao, W
   Wang, YX
AF Yao, Lu
   Wang, Zhenghua
   Li, Zongzhe
   Cao, Wei
   Wang, Yongxian
BE Zhou, X
TI RETRACTED: A Hybrid Ordering Scheme for Efficient Sparse Cholesky
   Factorization (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Cholesky factorization; hybrid ordering; nested dissection;
   lexicographic ordering; symbolic factorization
ID NESTED DISSECTION
AB When applying Cholesky factorization method to solving sparse symmetric positive definite system Ax = b, two classes of ordering algorithms are widely used to reduce the amount of fill. In view of their respective advantages and disadvantages, a parallel hybrid ordering scheme is proposed, which is proved to be effective by both theoretical analysis and parallel implementation. It is noteworthy that the algorithm can not only find a good ordering efficiently, but also achieve the result of symbolic factorization simultaneously. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yao, Lu; Wang, Zhenghua; Li, Zongzhe; Cao, Wei; Wang, Yongxian] Natl Univ Def Technol, Sch Comp Sci, Changsha, Hunan, Peoples R China.
RP Yao, L (reprint author), Natl Univ Def Technol, Sch Comp Sci, Changsha, Hunan, Peoples R China.
EM shaoeq@163.com
CR FULKERSON DR, 1965, PAC J MATH, V15, P835, DOI 10.2140/pjm.1965.15.835
   Garey M.R., 1976, THEOR COMPUT SCI, P237, DOI DOI 10.1016/0304-3975(76)90059-1
   GEORGE A, 1973, SIAM J NUMER ANAL, V10, P345, DOI 10.1137/0710032
   George A., 1981, COMPUTER SOLUTION LA
   Hendrickson B, 1998, SIAM J SCI COMPUT, V20, P468, DOI 10.1137/S1064827596300656
   J Schulze, 2001, TIGHTER COUPLING BOT, P800
   R Edward M, 1977, COMBINATIONAL ALGORI
   Rose D. J., 1976, SIAM Journal on Computing, V5, P266, DOI 10.1137/0205021
   S Duff I, 2009, RR200915 LIP
NR 9
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.251
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400051
DA 2018-12-27
ER

PT S
AU Ye, KZ
   Zou, LS
AF Ye Kaizhen
   Zou Longsheng
BE Zhou, X
TI RETRACTED: Expansion of Wastewater Categories (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Mechanical vapor compression(MVC); classification of wastewater;
   viscosity; scaling
AB At present the annual amount of wastewater is a lot and how to deal with wastewater is a major problem. Wastewater is a prerequisite for the classification of water, wastewater sorting in a variety of methods. A classification based on the water sources of water, have the pollutants have nontoxicity classification, etc. This article will be on mechanical vapor compression techniques to classify wastewater and there is uncertainty indicator: viscosity, scaling, pH and boiling point. Wastewater is divided into three categories. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Ye Kaizhen] Dongguan Univ Technol, City Coll, Dongguan 523106, Guangdong, Peoples R China.
RP Ye, KZ (reprint author), Dongguan Univ Technol, City Coll, Dongguan 523106, Guangdong, Peoples R China.
EM 15573876@qq.com
CR JIANG XX, 2008, METEOROLOGICAL ENV S, V24, P54
   Johansson M, 2009, INT J HEAT MASS TRAN, V52, P2769, DOI 10.1016/j.ijheatmasstransfer.2008.09.041
   LIU QK, 2008, AS PAC C DES WAT REU, P150
   Lokiec F., 2007, IDA WORLD C MASP GRA
   OPHIR A, 2007, LATEST DEV MED MVC T
   XING YJ, 2004, LIAONING CHEM IND, V33, P665
   XU YD, 2003, CHEM PHYS COMPOSITIO
   YE Q, 2007, LIAON PROV I ENV SCI, P82
   ZHU P, 2009, XUZHOU NORMAL U NATU, V27, P17
   ZODI S, 2009, TECHNOLOGY, V69, P29
   VAPOR RECOMPRESSION, P1
NR 11
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.814
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404031
DA 2018-12-27
ER

PT S
AU Ye, Q
   Zhang, YM
   Ma, L
AF Ye Qing
   Zhang Yongmei
   Ma Li
BE Zhou, X
TI RETRACTED: Video-based Detection Method of Illegal Parking Vehicles
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE intelligent transportation system; background subtraction; morphology
   processing; detection of illegal parking
ID ALGORITHM
AB Aimed at the shortcomings of the manual detection of illegal parking vehicles, a new detection method was proposed to detect the illegal parking vehicles from real-time monitoring video sequence, which saved human and material resources. In this method, firstly, background subtraction based on adaptive threshold and binarization were used to eliminate background interference after image graying; secondly, morphology processing operations including improved erosion operation and improved dilation operation were used to extract the objects; finally, illegal parting detection was used to draw the outer rectangular frame of illegal parting cars through illegal parking judgment conditions and the camera would be controlled to capture the vehicle image which could be used to recognize the vehicle license plate. Experimental results show that this method can detect the illegal vehicles successfully and has the identification that can distinguish vehicles from non-vehicles, illegal parking from passing vehicles, and can mark and count the illegal vehicles. This method can be used for illegal parking monitoring in residential car park area to effectively control the phenomenon of illegal parking in order to reduce the waste of human and material resources and remedy the transport environment. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Ye Qing; Zhang Yongmei; Ma Li] N China Univ Technolog, Coll Informat Engn, Beijing, Peoples R China.
RP Ye, Q (reprint author), N China Univ Technolog, Coll Informat Engn, Beijing, Peoples R China.
EM yeqing_mail@163.com
CR Anagnostopoulos CNE, 2006, IEEE T INTELL TRANSP, V7, P377, DOI 10.1109/TITS.2006.880641
   Di Wei, 2009, INT C COMP INT SOFTW, P1
   [宫晓燕 Gong Xiaoyan], 2003, [中国公路学报, China Journal of Highway and Transport], V16, P82
   [Liu Bo 刘勃], 2004, [中国科学技术大学学报, Journal of University of Science and Technology of China], V34, P599
   [刘肃亮 Liu Suliang], 2004, [计算机工程, Computer Engineering], V30, P193
   Mahadevan V, 2008, IEEE C COMP VIS PATT, P1
   Regentova E, 2002, IEEE T PATTERN ANAL, V24, P1039, DOI 10.1109/TPAMI.2002.1023801
   Wheeler Matt, 2000, NAT AER EL C, P618
   Wren CR, 1997, IEEE T PATTERN ANAL, V19, P780, DOI 10.1109/34.598236
   Yiping Tang, 2009, COMPUTER MEASUREMENT, V17, P505
NR 10
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.934
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096405001
DA 2018-12-27
ER

PT S
AU Yi, LY
AF Yi Liyun
BE Zhou, X
TI RETRACTED: Slope Stability Evaluation by Cellular Ant Algorithm
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Cellular Ant Algorithm; Slope; Stability
AB There are many factors involved in slope stability evaluation and the principle ones acts differently under different slope environmental conditions. So the evaluation of slope stability demands for consideration for all kinds of factors generally with clear understanding of primary and secondary factors. Based on the theory of ant algorithms and cellular automaton, this paper puts forward a cellular ant algorithm and mathematic description with MATLAB to optimize the accuracy of slope stability evaluation and verifies the applicability of the algorithm through real project and achieves good results. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Sichuan Coll Architecture Technol, Deyang City 618000, Peoples R China.
RP Yi, LY (reprint author), Sichuan Coll Architecture Technol, Deyang City 618000, Peoples R China.
EM yiliyun126@gmail.com
CR AI-Karni Awad A., 2000, COMPUT GEOTECH, V26, P83
   Chen ZY, 2005, SOIL SLOPE STABILITY
   Donald IB, 1997, CAN GEOTECH J, V34, P853, DOI 10.1139/cgj-34-6-853
   Grnffiths D.V., 1999, GEOTECHNIQUE, V49, P387
   Ministry of Construction of Peoples of Republic of China, 2001, GB50021 2001 ROCK SO
   SAH NK, 1994, INT J ROCK MECH MIN, V31, P47, DOI 10.1016/0148-9062(94)92314-0
   Wolfram S., 1986, THEORY APPL CELLULAR
   [薛新华 XUE Xinhua], 2007, [岩土力学, Rock and Soil Mechanics], V28, P2643
   Zhu Gang, 2007, Control and Decision, V22, P1317
   [朱刚 ZHU Gang], 2007, [系统工程学报, Journal of Systems Engineering], V22, P305
NR 10
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.847
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404064
DA 2018-12-27
ER

PT S
AU Yi, LY
AF Yi Liyun
BE Zhou, X
TI RETRACTED: Research on the Contribution-Ratio Predication Method Applied
   to the Predication and Warning of the Risk of Roadbed Geological Hazards
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Contribution-ratio predication method; Evaluation factors; Roadbed
   geological hazard body; Predictable evaluation of risks
AB The predictable evaluation of the risk of roadbed geological hazards depends largely on the reliability of the fundamental information and the rationality of the mathematical model. As all the factors of the geological environment at different regions are different in the quality, the same index is likely to attach to the different fatalness grade at the different regions. Therefore, the application of the classical mathematical model to dividing the uniform standards for measuring still belongs to one of the challenging frontiers in the current international earth science field. In this paper we attempt to establish the mathematical model of contribution-ratio predication method in the predictable evaluation of the risk of roadbed geological hazards to determine the critical rainfall in which geological hazards take place, hoping to provide the theory reference for the predication and warning problems of the risk of roadbed geological hazards. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Sichuan Coll Architecture Technol, Deyang City 618000, Peoples R China.
RP Yi, LY (reprint author), Sichuan Coll Architecture Technol, Deyang City 618000, Peoples R China.
EM yiliyun126@gmail.com
CR Carrara A., 1995, GEOGRAPHICAL INFORM
   [樊晓一 Fan Xiaoyi], 2004, [山地学报, Journal of Mountain Science], V22, P730
   Li C.J., 2005, LAND RESOURCES INFOR, P32
   Qiao J.P., 2004, J LITHOLOGICAL SOFT, V23, P2920
   [乔建平 Qiao Jianping], 2006, [工程地质学报, Journal of Engineering Geology], V14, P18
   [乔建平 QIAO Jianping], 2005, [中国地质灾害与防治学报, The Chinese Journal of Geological Hazard and Control], V16, P16
   [吴彩燕 Wu Caiyan], 2005, [四川大学学报. 工程科学版, Journal of Sichuan University.Engineering Science Edition], V37, P25
   Yang X.D., 2006, SAFETY ENV ENG, V13, P9
NR 8
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.846
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404063
DA 2018-12-27
ER

PT S
AU Yi, LY
AF Yi Liyun
BE Zhou, X
TI RETRACTED: Analytic Hierarchy Process Model Evaluation on Surrounding
   Rock of Tunnel with Small Clear Spacing (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Analytic Hierarchy Process; Fuzzy Comprehensive Evaluation; tunnel with
   small clear spacing; surrounding rock; stability
AB The stability evaluation of the surrounding rock of tunnel with small clear spacing is an important step in a tunnel construction process. In this paper an indicator system was proposed to evaluate the stability state of the central rock pillar between twin tunnel with small clear spacings; then an AHP (Analytic Hierarchy Process) model was constructed to calculate the weights of indicators; and finally, with fuzzy mathematic method, a fuzzy comprehensive evaluation model was set up to evaluate the stability state of the central rock pillar between twin tunnel with small clear spacings. Project cases showed that this method is practical and effective. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Sichuan Coll Architecture Technol, Deyang City 618000, Peoples R China.
RP Yi, LY (reprint author), Sichuan Coll Architecture Technol, Deyang City 618000, Peoples R China.
EM yiliyun126@gmail.com
CR Communication Ministry of People's Republic of China, 2004, JTG D70 2004 TECHN C
   Communication Ministry of People's Republic of China, 1995, JTJ 026 94 TECHN COD
   Huang B.Z., 2003, J CHONGQING U, V44, P19
   Xiao S.X., 2004, APPL FUZZY MATH CIVI
   Zhang X.L., 2003, J CHONGQING COLL COM, V22, p[5, 27]
   ZHANG Xing-lai, 2003, J CHONGQING JIAOTONG, V22, P5
NR 6
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.845
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404062
DA 2018-12-27
ER

PT S
AU Yin, GL
AF Yin Guangli
BE Zhou, X
TI RETRACTED: The design and implementation of ducational resource
   management in colleges and universities with Active Directory (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE active directory; management; system; educational administration
   resource
AB The normal educational resources management has been a significant development and is more mature. However, the normal educational resources management still has many deficiencies, such as data mining, management forecasts, information regeneration. The paper focuses on the management of abnormal academic resources, such as resources manageability, network reliability, equipment availability. It is easy to cause resource wastage and equipment duplication without attention. Many studies in the past are lack of consideration in this regard, with the effective integration of various educational resources and classification management as the goal of this paper. The overall scheme of effective integration and classification management of the educational resources is designed based on Institute of Disaster Prevention. And with Microsoft Active Directory, a high efficient educational resources management system is implemented through LDAP and ADSI programming. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Binzhou Vocat Coll, Dept Informat Engn Binzhou, Binzhou, Shandong, Peoples R China.
RP Yin, GL (reprint author), Binzhou Vocat Coll, Dept Informat Engn Binzhou, Binzhou, Shandong, Peoples R China.
EM yin_3278051@163.com
CR [Anonymous], ACTIVE DIRECTORY DES
   [Anonymous], 2008, ACTIVE DIRECTORY PRO
   Hua Song, 2006, SHALLOW NET ACTIVE D
   Jing Chen, 2009, INFORM SYSTEMS ENG, P57
   Mei Yan Chun, 2009, INNER MONGOLIA AGR U, P126
   Qun Qiang He, 2009, MANAGEMENT, P3609
   Wen Ding, 2008, COMPUTER INFORM TECH
NR 7
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.262
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400062
DA 2018-12-27
ER

PT S
AU Yin, QZ
   Yan, XP
   Chu, XM
   Sun, X
   Chen, YQ
AF Yin, Qizhi
   Yan, Xinping
   Chu, Xiumin
   Sun, Xing
   Chen, Yiqi
BE Zhou, X
TI RETRACTED: The design of real-time oil spill monitoring system for
   inland waterway based on AIS navigation marks (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE inland waterways; ships; oil spills; monitoring; online system;
   navigation marks; automatic identification system; information fusion
AB In case of ship oil spill accidents, the oil will spread quickly if it is not detected and monitored in time. The later the oil is detected, the more harmful it will be and the more difficult to identify the accident ship. A real-time oil spill monitoring system for inland waterway is designed, which is based on navigation marks with the transponders of marine automatic identification system, and is developed by integrating the oil spill monitoring sensor ID-227, GPS and the sensors of temperature, water flow velocity, wind velocity, wind direction, and visibility. The network communications of marine automatic identification system is used to transmit data from the above sensors to marine accident control center, and information fusion technology is used to process the data. Finally, a framework for developing expert system to support decision-making during oil spill emergency is proposed based on the above oil spill on-line monitoring system. The system can be used for real-time online monitor of oil spills in inland waterways under all weather conditions. It is also helpful to search the accident ship by amalgamated the information from marine automatic identification system and oil spill monitoring system. The weather and hydrologic information at the point of accident from the system can be used to forecast the diffusion trend of the oil. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yin, Qizhi; Yan, Xinping; Chu, Xiumin; Sun, Xing; Chen, Yiqi] Wuhan Univ Technol, Minist Educ, Engn Res Ctr Transportat Safety, Y125 Mailbox,Yujiatou Campus,1040 HePing Ave, Wuhan, Peoples R China.
RP Yin, QZ (reprint author), Wuhan Univ Technol, Minist Educ, Engn Res Ctr Transportat Safety, Y125 Mailbox,Yujiatou Campus,1040 HePing Ave, Wuhan, Peoples R China.
EM qzyin@whut.edu.cn
CR Cormack Douqlas, 2005 INT OIL SPILL C, P6941
   Inbar Jacob, 1999, INT WATER POWER DAM, V51, P38
   Jha Maya Nand, 2008, P 31 AMOP TECHN SEM, V2, P741
   Li Sihai, 2004, REMOTE SENSING INFOR, V2, P53
   Shcherbak SS, 2008, INT J REMOTE SENS, V29, P6331, DOI 10.1080/01431160802175470
   Shi X., 2007, STUDY WATER POLLUTIO, P1
   Wang Likun, 2009, J TRANSPORT INFORM S, V27, P22
   Wang Shumao, 2010, CHINA MARITIME SAFET, V5, P15
   Yin Qizhi, 2010, SHIP OCEAN ENG, V39, P246
NR 9
TC 0
Z9 0
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.789
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404006
DA 2018-12-27
ER

PT S
AU You, T
   Tang, YP
   Zheng, XQ
AF You, Te
   Tang, Yunping
   Zheng, Xianqiang
BE Zhou, X
TI RETRACTED: Degradation of Chemical Industry Integrated Wastewater by
   Sequential Fenton's Pre-oxidation and Aerobic Biological Treatment
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Fenton's pre-oxidation process; Activate DEASP; COD removal;
   Biodegradability; Chemical integrated wastewater
AB A two stage sequential Fenton's Pre-oxidation followed by aerobic biological treatment train was used to achieve mineralization of refractory organics and enhance biodegradability of chemical industry integrated wastewater. In the first stage, Fenton's Pre-oxidation process was used while in the second stage activate diatomaceous earth (DE) activated sludge process (ASP) was used as biochemical treatment process. The parameters influencing the COD removal of the wastewater, reaction time, ferrous ion concentrations and molar ratio hydrogen peroxide to ferrous ion R, the initial pH have been optimized to achieve a COD reduction of 60.2% by single factor analysis method. Meanwhile the biodegradability BOD/COD (B/C) value of wastewater was studied which significant improvement was observed initial wastewater B/C value of 0.143 increased to 0.35. It was beneficial to sequential biological treatment after Fenton's Pre-oxidation. In the second stage, activate DEASP shows a mild positive effect on COD removal which further increased to 88%. Simultaneously, analysis organism from wastewater and effluent of the two stages by GC/MS. The results showed that: Fenton's reaction can be considered a suitable pre-treatment which followed by aerobic biological treatment sequence have proved to viable technique for this type of chemical integrated wastewater. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [You, Te; Zheng, Xianqiang] Univ Tianjin Polytech, Sch Environm & Chem Engn, Tianjin 300160, Peoples R China.
RP You, T (reprint author), Univ Tianjin Polytech, Sch Environm & Chem Engn, Tianjin 300160, Peoples R China.
EM tt_2004@126.com
CR Barbusinski K, 2001, POL J ENVIRON STUD, V10, P207
   BELTRAN FJ, 1998, WATER AIR SOIL POLL, V685, P105
   CAR IE, 1993, CURRENT OPINION BIOT, V331, P4
   HARITASH AK, 2009, J HAZARD MATER, V1, P169
   KANG HF, 2002, CHEMOSPHERE, V923, P46
   KANG SF, 2002, CHEMOSPHERE, V923, P26
   KITIS M, 1999, WATER RES, V2561, P33
   LODHA B, 2007, J HAZARD MATER, V459, P148
   MARTINEZ NS, 2003, HAZARDOUS MAT B, V315, P101
   MASS R, 2005, PROCESS BIOCHEM, V699, P40
   *MEPPRC, 2002, MON AN METH IN PRESS
   RIVAS FJ, 2003, J J HAZARD MAT, V259, P96
   SANZ J, 2003, ENVIRON CHEM LETT, V45, P1
   SCOTT JP, 1995, ENVIRON PROG, V88, P114
   TANTAK NP, 2006, J HAZARD MATER, V698, P136
   ZHU SG, 2010, REACTION KINETICS ME, V325, P99
NR 16
TC 1
Z9 1
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.925
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404142
DA 2018-12-27
ER

PT S
AU Yu, T
   Xu, JL
   Wei, MJ
   Song, XJ
AF Yu Tao
   Xu Jian-liang
   Wei Mo-ji
   Song Xin-jun
BE Zhou, X
TI RETRACTED: Study on the Semantic Annotation Approach for Professional
   Documents Based on Domain Ontology Partition (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE domain ontology; semantic context; syntax context; semantic annotation
AB This paper researches semantic annotation for professional documents on the web by using existed domain ontologies, and then proposes a semantic annotation approach for professional documents based on domain ontology partition. Firstly, we divide the domain ontology according to certain rules to form some domain ontology segments, and then, choose the most similar domain ontology segment(s) via calculating the semantic similarity between professional documents and domain ontology segments. Finally, professional documents are annotated by the segments. The experimental results show that the approach we have proposed improves both efficiency and accuracy. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yu Tao; Xu Jian-liang; Wei Mo-ji; Song Xin-jun] Ocean Univ China, Dept Comp Sci, OUC, Qingdao, Peoples R China.
RP Yu, T (reprint author), Ocean Univ China, Dept Comp Sci, OUC, Qingdao, Peoples R China.
EM yutao911@gmail.com
CR Berners-Lee T, 2001, SCI AM, V284, P34, DOI 10.1038/scientificamerican0501-34
   Chen Yewang, 2009, Journal of Southeast University (Natural Science Edition), V39, P1109, DOI 10.3969/j.issn.1001-0505.2009.06.005
   Kiyavitskaya N, 2009, DATA KNOWL ENG, V68, P1470, DOI 10.1016/j.datak.2009.07.012
   Macario C G N, 2009, International Journal of Metadata, Semantics and Ontologies, V4, P118, DOI 10.1504/IJMSO.2009.026260
   Macario Carla Geovana N., 2009, P 17 ACM SIGSPATIAL
   Musen MA, 1998, METHOD INFORM MED, V37, P540
   Sarin Supheakmungkol, 2008, DESIGN EXPLOITATION, V2008
   Wang Haofen, CSWS2009
   Wu Xian, 2006, P 15 INT C WORLD WID
NR 9
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.903
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404120
DA 2018-12-27
ER

PT S
AU Yuan, ZW
   Liu, Q
   Yang, FP
AF Yuan, Zheng-Wu
   Liu, Quan
   Yang, Fu-Ping
BE Zhou, X
TI RETRACTED: Research of Case Representation in Real-time Emergency Case
   Base (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Case-based reasoning; real-time emergency case base; case
   representationt
AB The concept of real-time emergency case base is proposed to solve the shortcoming of cannot automatic analysis rescue process and cannot be used real time by the emergency case. A method of emergency case representation is presented for real-time emergency case base in this paper. In order that verify the correctness and validity of the real-time emergency cases and the method of emergency case representation, a prototype system is constructed. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yuan, Zheng-Wu; Liu, Quan; Yang, Fu-Ping] Chongqing Univ Posts & Telecommun, Chongqing 400065, Peoples R China.
RP Liu, Q (reprint author), Chongqing Univ Posts & Telecommun, Chongqing 400065, Peoples R China.
EM quanshuilq2005@163.com
CR Chang N. B., 1997, ENV URBAN SYSTEMS, V21, P67
   Gheorghe AV, 1998, INT J ENVIRON POLLUT, V9, P352
   Gun H. L., 2008, KNOWL-BASED SYST, P140
   [靖可 JING Ke], 2008, [系统工程, Systems Engineering], V26, P15
   Wang HJ, 2008, EXPERT SYST APPL, V35, P1601, DOI 10.1016/j.eswa.2007.08.095
   Xia X. L., 2003, J LIAONING UNIVERCIT, V30, P55
   Zhang Ying-ju, 2009, Application Research of Computers, V26, P1412
NR 7
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.873
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404090
DA 2018-12-27
ER

PT S
AU Yun, L
   Bi, HX
   Zhu, QK
   Tian, XL
   Cui, ZW
   Zhou, HZ
   Gao, LB
AF Yun Lei
   Bi Huaxing
   Zhu Qingke
   Tian Xiaoling
   Cui Zhewei
   Zhou Huizi
   Gao Lubo
BE Zhou, X
TI RETRACTED: Water Competition and Yield of Fruit-crop Intercropping
   System in the Loess Plateau of West Shanxi (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE the Loess Plateau of west Shanxi; fruit-crop intercropping system;
   competition; soil mositure
ID HYDRAULIC LIFT; TREES; INTERFACE
AB Agroforestry is the most effective way to restore the disturbed lands on the Loess Plateau and to develop the poor local economy. Targeting four typical fruit-crop intercropping patterns, i.e. walnut-peanut, walnut-soybean, apple-peanut and apple-soybean in the Loess Plateau of west Shanxi as test objects, soil moisture, yield, land use efficiency and economic benefits of fruit-crop intercropping were studied. The results showed that: (1) Soil moisture and yield of individual peanut or soybean plants were significantly decreased, with the effects increased with decreasing distance from tree row. (2) The results of inter-effect of agroforestry system showed that there were competition for soil moisture between tree and crop in fruit-crop intercropping system. The competition was the weakest for crop and walnut, and the strongest for crop and apple. (3) Based on the comprehensive analysis and comparison, the land use efficiency and economic benefits of fruit-crop intercropping were increased by 70% and 14%, and they were more applicable for popularization in the Loess Plateau of west Shanxi. (4) In order to decrease soil moisture competition between tree and crop in fruit-crop intercropping system, the following measures should be taken: (1) Enhancing the management of irrigation and fertilization for intercropping system. (2) Increasing the distance of crop from tree row, and (3) Setting root barrier between crop and tree. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yun Lei; Bi Huaxing; Zhu Qingke; Tian Xiaoling; Cui Zhewei; Zhou Huizi; Gao Lubo] Beijing Forestry Univ, Coll Soil & Water Conservat, 35 E Qinghua Rd, Beijing 100083, Peoples R China.
RP Bi, HX (reprint author), Beijing Forestry Univ, Coll Soil & Water Conservat, 35 E Qinghua Rd, Beijing 100083, Peoples R China.
EM bhx@bjfu.edu.cn
CR CALDWELL MM, 1989, OECOLOGIA, V79, P1, DOI 10.1007/BF00378231
   Cannell MGR, 1996, AGROFOREST SYST, V34, P27, DOI 10.1007/BF00129630
   EASTHAM J, 1988, AGR FOREST METEOROL, V42, P355, DOI 10.1016/0168-1923(88)90043-3
   Hirota I, 2004, AGROFOREST SYST, V60, P181, DOI 10.1023/B:AGFO.0000013293.77907.64
   Hou QJ, 2003, AGROFOREST SYST, V57, P137, DOI 10.1023/A:1023977316170
   Jose S, 2006, FOREST ECOL MANAG, V233, P231, DOI 10.1016/j.foreco.2006.05.014
   Liu Xing-yu, 2007, Shengtaixue Zazhi, V26, P1464
   [毛瑢 MAO Rong], 2009, [中国生态农业学报, Chinese Journal of Eco-Agriculture], V17, P379
   McIntyre BD, 1997, FIELD CROP RES, V52, P151, DOI 10.1016/S0378-4290(96)01062-3
   Meng Ping, 2004, Forest Research, V17, P167
   Meng Ping, 1996, Forest Research, V9, P221
   Miller AW, 2001, AGROFOREST SYST, V53, P247, DOI 10.1023/A:1013327510748
   NAMBIAR EKS, 1993, CAN J FOREST RES, V23, P1955, DOI 10.1139/x93-247
   Rao MR, 1997, AGROFOREST SYST, V38, P3, DOI 10.1023/A:1005971525590
   Shi X. L., 2009, J BEIJING FORESTR S2, V31, P115
   Smith DM, 1998, FOREST ECOL MANAG, V105, P159, DOI 10.1016/S0378-1127(97)00292-2
   Wang D. L., 2000, CHINESE J APPL ECOLO, V11, P472
   Wanvestraut RH, 2004, AGROFOREST SYST, V60, P167, DOI 10.1023/B:AGFO.0000013292.29487.7a
   Yun Lei, 2010, Journal of Northeast Forestry University, V38, P67
   Zhang JinSong, 2003, World Forestry Research, V16, P10
   Zhang JinSong, 2002, Scientia Silvae Sinicae, V38, P30
NR 21
TC 0
Z9 0
U1 1
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.932
PG 10
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404149
DA 2018-12-27
ER

PT S
AU Zeng, P
   Fang, G
AF Zeng, Ping
   Fang, Gang
BE Zhou, X
TI RETRACTED: "An Algorithm of Complement Mining Frequent Neighboring Class
   Set" (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE complementary mining; complement set; down-up search; neighboring class
   weight; spatial data mining
AB In frequent neighboring class set mining, when generating candidate frequent itemset, present algorithms have some redundant candidate and repetitive computing, and so this paper proposes an algorithm of complementary mining frequent neighboring class set, which is suitable for mining any frequent neighboring class set. This algorithm adopts double search strategies to generate candidate frequent neighboring class set in the mining course. One is using down-up search strategy to generate candidate, namely, it connects two k-frequent neighboring class sets to generate (k+1)-candidate frequent neighboring class set. The other is computing complement set of (k+1)-candidate to generate next candidate frequent neighboring class set. By the two ways, the algorithm may delete redundant candidate and repetitive computing. The algorithm creates digital database of neighboring class set via neighboring class weight, according to character of database, it also uses digit logical operation to computes support. The result of experiment indicates that the algorithm is faster and more efficient than present algorithms when mining frequent neighboring class set in large spatial data. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zeng, Ping; Fang, Gang] Chongqing Three Gorges Univ, Chongqing 404000, Peoples R China.
RP Zeng, P (reprint author), Chongqing Three Gorges Univ, Chongqing 404000, Peoples R China.
EM zengjiping20@163.com
CR [方刚 FANG Gang], 2009, [西南大学学报. 自然科学版, Journal of Southwest University. Natural Science Edition], V31, P95
   Gang F., 2010, P 7 INT C FUZZ SYST, V3, P1442
   MA R.H., 2007, J GEOMATICS INFORM S, V32, P112
   MA R.H., 2007, GIS SPATIAL ASS PATT
   ZHANG X.W., 2007, J PROGR GEOGRAPHY, V26, P119
NR 5
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.292
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400092
DA 2018-12-27
ER

PT S
AU Zhang, C
   Zhang, YN
AF Zhang, Chao
   Zhang, Yanning
BE Zhou, X
TI RETRACTED: A Method Based on Moment Invariants and Sparse Representation
   for 3D Face Recognition (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE moment invariants; sparse representation; 3-D face recognition; NPU3D
   face database
AB This paper presents a moment invariants based three-dimensional face recognition method under sparse representation framework. An improved moment invariants descriptor is constructed and the discriminative ability in face recognition is validated on NPU3D and FRAV database. A series of partial faces are obtained by segmenting each face model according to the geodesic distance from nose middle point. Proposed moments invariants is computed and stacked as the feature of each face model. Finally, sparse representation is used in the classification step. The result on GavabDB shows that this method is very promising compared with ICP baseline. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Chao; Zhang, Yanning] Northwestern Polytech Univ, Sch Comp Sci, Shaanxi Prov Key Lab Speech & Image Informat Proc, Xian 710129, Peoples R China.
RP Zhang, YN (reprint author), Northwestern Polytech Univ, Sch Comp Sci, Shaanxi Prov Key Lab Speech & Image Informat Proc, Xian 710129, Peoples R China.
EM ynzhang@nwpu.edu.cn
CR Elad A, 2003, IEEE T PATTERN ANAL, V25, P1285, DOI 10.1109/TPAMI.2003.1233902
   HU M, 1962, IRE T INFORM THEOR, V8, P179, DOI 10.1109/TIT.1962.1057692
   Kimmel R, 1998, P NATL ACAD SCI USA, V95, P8431, DOI 10.1073/pnas.95.15.8431
   LI BC, 1993, PATTERN RECOGN, V26, P1229, DOI 10.1016/0031-3203(93)90207-D
   Li Xiaoxing, CVPR 2009, P2575
   Lo C.-H., 1990, Proceedings. 10th International Conference on Pattern Recognition (Cat. No.90CH2898-5), P540, DOI 10.1109/ICPR.1990.118161
   LO CH, 1989, IEEE T PATTERN ANAL, V11, P1053, DOI 10.1109/34.42836
   Moreno Ana Belen, 2004, WORKSH BIOM INT VIG, P77
   Pozo J. M., 2010, IEEE T PATTERN ANAL
   SADJADI FA, 1980, IEEE T PATTERN ANAL, V2, P127, DOI 10.1109/TPAMI.1980.4766990
   Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79
   Xu D, 2008, PATTERN RECOGN, V41, P240, DOI 10.1016/j.patcog.2007.05.001
NR 12
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.295
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400095
DA 2018-12-27
ER

PT S
AU Zhang, HF
   Lu, Y
   Chen, LY
AF Zhang Han-feng
   Lu Yu
   Chen Li-yun
BE Zhou, X
TI RETRACTED: Modeling Based on Colored Petri Net and Simulation of
   Equipment Battlefield Repair Supported by Space Information (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE space-based information support; battlefield repair; modeling based on
   colored Petri net; simulation
AB After groping for the process of equipment battlefield repair supported by space information, the paper establishes the model based on colored Petri net of equipment battlefield repair supported by space information. The model which can express the organization structure, function and information flow of battlefield repair system, realizes the unification of static structure and dynamic process. The simulation model based on ExSpect is constructed on the colored Petri net, as a simulation illustration, equipment battlefield repair in air defense Brigade is experimented, and some important performance indexes are gained. The conclusion is significative to optimize resource and improve the ability of battlefield repair. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang Han-feng] Air Def Forces Acad, Dept Training, Zhengzhou 450052, Peoples R China.
RP Zhang, HF (reprint author), Air Def Forces Acad, Dept Training, Zhengzhou 450052, Peoples R China.
EM air_defense@163.com
CR ASPT, 1999, EXSPECT US MAN
   van der Aals W.M.P., 1992, THESIS EINDHOVEN U T
   ZHANG Zi-qiu, 2001, EQUIPMENT TECHNOLOGY, P247
   ZHAO Hui, 2010, SPACEFLIGHT MANUFACT, P11
NR 4
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.957
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096405024
DA 2018-12-27
ER

PT S
AU Zhang, H
   Cao, XH
   Cui, GZ
   Zhang, CL
AF Zhang, Hua
   Cao, Xianghong
   Cui, Guangzhao
   Zhang, Chunlin
BE Zhou, X
TI RETRACTED: Virtual Reality System for Spine Surgery with Haptic Device
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE haptic device; virtual reality; spine surgery; simulation
ID SIMULATOR
AB Bone drilling is a fundamental skill for orthopedic surgeons, especially for spinal orthopedics. In this paper, a framework is presented for the simulation of spinal bone drilling process and a prototype simulation system for training of skull-bone drilling is introduced. In the simulation process, a user can drill a virtual spinal bone with Falcon feedback device with felling of force and vision of the virtual hole in order to improve the education effects of the residents and practical abilities. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Hua] Henan Univ Technol, Dept Elect Engn, Zhengzhou 450000, Peoples R China.
RP Zhang, H (reprint author), Henan Univ Technol, Dept Elect Engn, Zhengzhou 450000, Peoples R China.
EM ayzhanghua@126.com
CR Finley David S, 2005, Curr Surg, V62, P262, DOI 10.1016/j.cursur.2004.11.005
   Hockstein NG, 2007, J ROBOT SURG, V1, P113, DOI 10.1007/s11701-007-0021-2
   Kenney Patrick A., 2009, J UROLOGY 73, V73, P1288
   Kim Kimin, 2008, INT C CONTR AUT SYST, P255
   Sun LW, 2007, INT J MED ROBOT COMP, V3, P245, DOI 10.1002/rcs.139
   Tsai MD, 2007, COMPUT BIOL MED, V37, P1709, DOI 10.1016/j.compbiomed.2007.04.006
   Vankipuram M, 2010, J BIOMED INFORM, V43, P661, DOI 10.1016/j.jbi.2010.05.016
   von Sternberg N, 2007, INT J ORAL MAX SURG, V36, P386, DOI 10.1016/j.ijom.2006.12.016
NR 8
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.301
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400101
DA 2018-12-27
ER

PT S
AU Zhang, JM
   Feng, CP
   Hong, SQ
AF Zhang, Jianmei
   Feng, Chuanping
   Hong, Siqi
BE Zhou, X
TI RETRACTED: Performance of Solid Organic Carbon Sources for in-situ
   Biological Denitrification in Groundwater (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Groundwater; Nitrate; Sawdust; Wheatstraw; Biological denitrification
ID DRINKING-WATER; NITRATE
AB As the lack of carbon source is a key problem of in-situ denitrification in groundwater, choosing appropriate solid carbon source materials is very important. In this study, wheatstraw and sawdust were selected as potential carbon sources to evaluate the performance for in-situ biological denitrification in groundwater by three laboratory-scale column experiments operated at a flow rate of 2.0cm(3)/min for 78 d. The results showed that sawdust was a suitable carbon source with less release of nitrogen compounds and relatively stable release of organic carbon and was applicable for further use as a filling material in in-situ groundwater bioremediation. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Jianmei; Feng, Chuanping; Hong, Siqi] China Univ Geosci, Sch Water Resources & Environm, Beijing 100083, Peoples R China.
RP Zhang, JM (reprint author), China Univ Geosci, Sch Water Resources & Environm, Beijing 100083, Peoples R China.
EM wf-zjm@163.cm
CR Bedessem ME, 2005, J ENVIRON QUAL, V34, P936, DOI 10.2134/jeq2004.0024
   Gibert O, 2008, BIORESOURCE TECHNOL, V99, P7587, DOI 10.1016/j.biortech.2008.02.012
   HAMILTON PA, 1995, GROUND WATER, V33, P217, DOI 10.1111/j.1745-6584.1995.tb00276.x
   Robertson WD, 2000, GROUND WATER, V38, P689, DOI 10.1111/j.1745-6584.2000.tb02704.x
   Robinson-Lora MA, 2009, BIORESOURCE TECHNOL, V100, P534, DOI 10.1016/j.biortech.2008.06.052
   Rocca C. della, 2005, Water SA, V31, P229
   Sandor J, 2001, EUR J EPIDEMIOL, V17, P443, DOI 10.1023/A:1013765016742
   Sarina J. E., 2004, WATER RES, V38, P3225
   Schubert C, 1999, ARCH ENVIRON HEALTH, V54, P242, DOI 10.1080/00039899909602481
   Smith RL, 2001, ENVIRON SCI TECHNOL, V35, P196, DOI 10.1021/es001360p
   Su CM, 2007, CHEMOSPHERE, V66, P91, DOI 10.1016/j.chemosphere.2006.05.015
   SUPER M, 1981, WATER RES, V15, P1265, DOI 10.1016/0043-1354(81)90103-2
NR 12
TC 0
Z9 0
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.866
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404083
DA 2018-12-27
ER

PT S
AU Zhang, JH
   Peng, H
   Shao, FJ
AF Zhang, Junhu
   Peng, Hui
   Shao, Fengjing
BE Zhou, X
TI RETRACTED: How Node Mobility Impacts Reactive Ad Hoc Routing Protocols
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE ad hoc networks; reactive routing protocols; node mobility; energy
   consumption
AB To explore how the mobility of the nodes in different ad hoc network scenarios impacts the multi-hop transmission performance of some prominent on-demand pouting protocols like DSR or AODV, a static model and a mobile model for simulating different scenarios of ad hoc networks are proposed. Different criteria for assessing the multi-hop transmission performance of the protocols are also designed and evaluated in a simulation platform based on programming in NS-2. The simulation result shows that in a static ad hoc network AODV has better route discovery performance and consumes less energy for multi-hop data transmission than DSR. In a mobile ad hoc network when the nodes moves slow or when the nodes moves fast within a small network area, AODV and DSR both support a good performance of multi-hop data transmission in terms of the end to end delay, the packet delivery rate, and the energy consumption. However, when the network area becomes larger, the multi-hop transmission performance of AODV and DSR degrades greatly with the increase of the node mobility. The simulation also proves that AODV has a better data transmission performance and is more fit for the scenario with a high node mobility than DSR. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Junhu; Peng, Hui] Qingdaqo Technol Univ, Coll Comp Engn, Qingdao 266033, Peoples R China.
RP Zhang, JH (reprint author), Qingdaqo Technol Univ, Coll Comp Engn, Qingdao 266033, Peoples R China.
EM zhangjunhu@gmail.com
CR A Verma, 2011, INT J COMP TECH APPL, V2, P565
   Ciullo D., 2010, P IEEE INFOCOM, P1
   Fall Kevin, 2009, THE NS MANUAL
   I Khan, 2007, IEEE 13 INT MULT C, P159
   Jayakumar Geetha, 2008, American Journal of Applied Sciences, V5, P659, DOI 10.3844/ajassp.2008.659.664
   JOHNSON DB, 2003, DYNAMIC SOU IN PRESS
   M Pascoe-Chalke, 2007, IEEE INT C MOB ADH S, P1
   Mittal S, 2010, COMM COM INF SC, V70, P396
   MM Morshed, 2010, 4 INT C NEW TRENDS I, P399
   Perkins C., 2003, 3561 RFC
   Rahman M.A., 2010, INT C COMP COMM ENG, P1, DOI DOI 10.1109/ICCCE.2010.5556751
   Singla V., 2010, INT J COMPUTER APPL, V5, P16
   Y Chaba, 2010, P 2010 2 INT C COMP, V03, P80
NR 13
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.258
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400058
DA 2018-12-27
ER

PT S
AU Zhang, L
   Li, FL
AF Zhang, Li
   Li, Fule
BE Zhou, X
TI RETRACTED: Output-feedback Stabilization of Discrete-time Systems with
   Multiple Time-varying Delays (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE multiple delays; linear matrix inequality (LMI); out-feedback
   stabilization; Lyapunov function
ID H-INFINITY CONTROL; STABILITY-CRITERIA; STATE DELAYS
AB This paper is concerned with the problem of out-feedback stabilization for a class of discrete-time systems with multiple time-varying delays. All the time delays are assumed to be time-varying and bounded. An improved delay-dependent stability condition for the unforced system is proposed in terms of linear matrix inequality (LMI). Then, based on the obtained result, a delay-dependent result for the existence of a static output-feedback controller, which ensures the asymptotical stability of the system with controlled input and multiple delays, is derived. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Li] Qingdao Agr Univ, Coll Life Sci, Qingdao 266109, Peoples R China.
RP Zhang, L (reprint author), Qingdao Agr Univ, Coll Life Sci, Qingdao 266109, Peoples R China.
EM 0919rac@163.com
CR Esfahani SH, 2000, INT J ROBUST NONLIN, V10, P157
   Gao H, 2004, IEE P-CONTR THEOR AP, V151, P691, DOI 10.1049/ip-cta:20040822
   Ge JH, 1996, INT J CONTROL, V64, P1, DOI 10.1080/00207179608921613
   Lu CY, 2002, IEEE T CIRCUITS-I, V49, P253, DOI 10.1109/81.983874
   Palhares RM, 2001, IEEE T SIGNAL PROCES, V49, P1696, DOI 10.1109/78.934139
   Wang ZD, 1999, AUTOMATICA, V35, P1161, DOI 10.1016/S0005-1098(99)00008-4
   Yan HC, 2008, CHAOS SOLITON FRACT, V37, P157, DOI 10.1016/j.chaos.2006.08.040
   Yue D, 2003, IEE P-CONTR THEOR AP, V150, P557, DOI 10.1049/ip-cta:20030597
NR 8
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.325
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400125
DA 2018-12-27
ER

PT S
AU Zhang, LL
   Liu, SX
   Wu, JJ
AF Zhang, Lili
   Liu, Sixin
   Wu, Junjun
BE Zhou, X
TI RETRACTED: Instantaneous frequency rate estimation of multi-component
   LMF signals based on LPFT (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE multi-component linear frequency-modulated (LMF) signals; Instantaneous
   frequency rate; Local polynomial Fourier transform (LPFT)
ID TRANSFORM
AB For the problem of the instantaneous frequency rate estimation of multi-component linear frequency-modulated (LMF) signals, a new method is presented. And the local polynomial Fourier transform (LPFT) method is applied to estimate instantaneous frequency rate of multi-component LMF signals. By means of doing local polynomial Fourier transform on multi-component LMF signals, we can separate each LMF signal, and then search the value to find the corresponding frequency rate according to the local polynomial of the every LMF signal, so we accurately estimate the instantaneous frequency rate of the multi-component LMF signal. The simulation results verify the availability of the proposed method. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Lili] Shenyang Aerosp Univ, Coll Elect Informat Engn, Shenyang, Peoples R China.
RP Zhang, LL (reprint author), Shenyang Aerosp Univ, Coll Elect Informat Engn, Shenyang, Peoples R China.
EM zll08@mails.jlu.edu.cn
CR Djurovic T. Thayaparan, 2006, SIGNAL PROCESS, V1, P1
   Fabin Cheng, 2008, J ELECT INFORM TECHN, V30, P229
   Ju Y, 2007, IEEE T SIGNAL PROCES, V55, P4907, DOI 10.1109/TSP.2007.896102
   Li XW, 2009, ICIC 2009: SECOND INTERNATIONAL CONFERENCE ON INFORMATION AND COMPUTING SCIENCE, VOL 4, PROCEEDINGS, P315, DOI 10.1109/ICIC.2009.390
   M Bianu, 2003, CIRCUITS SYSTEMS DEC, P2461
   Pinnegar CR, 2003, GEOPHYSICS, V68, P381, DOI 10.1190/1.1543223
   Sejdic E, 2009, DIGIT SIGNAL PROCESS, V19, P153, DOI 10.1016/j.dsp.2007.12.004
   Stockwell R. G, 1996, SIGNAL PROCESS, V44, P98
   Xinbo Li, 2009, RES THEORIES METHODS
   Yong Wang, 2008, CHINESE J ELECTRON, P162
NR 10
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.313
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400113
DA 2018-12-27
ER

PT S
AU Zhang, QH
   Yang, LH
   Liao, DX
AF Zhang, Qianhong
   Yang, Lihui
   Liao, Daixi
BE Zhou, X
TI RETRACTED: Stability of impulsive fuzzy BAM neural networks with hybrid
   delays (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Fuzzy BAM neural networks; Equilibrium point; Globally exponential
   stability; Hybrid delays; Impulse
ID BIDIRECTIONAL ASSOCIATIVE MEMORY; TIME-VARYING DELAYS; EXPONENTIAL
   STABILITY; PERIODIC-SOLUTIONS; GLOBAL STABILITY
AB In this paper, impulsive fuzzy bi-directional associative memory (BAM) neural networks with both distributed delays and time-varying delays are considered. Constructing a vector Lyapunov function, applying M-matrix theory and differential inequality techniques, some sufficient conditions are obtained to ensure the existence, uniqueness and global exponential stability of equilibrium point for the addressed neural network. The results generalize and complete previous known results. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Qianhong] Guizhou Coll Finance & Econ, Guizhou Key Lab Econ Syst Simulat, Guiyang 550004, Guizhou, Peoples R China.
RP Zhang, QH (reprint author), Guizhou Coll Finance & Econ, Guizhou Key Lab Econ Syst Simulat, Guiyang 550004, Guizhou, Peoples R China.
EM zqianhong68@163.com
CR Cao JD, 2004, PHYS LETT A, V330, P203, DOI 10.1016/j.physleta.2004.07.064
   Cao JD, 2002, IEEE T NEURAL NETWOR, V13, P457, DOI 10.1109/72.991431
   Guo SJ, 2003, PHYS LETT A, V317, P97, DOI 10.1016/j.physleta.2003.08.019
   Huang TW, 2006, PHYS LETT A, V351, P48, DOI 10.1016/j.physleta.2005.10.060
   KOSTO B, 1987, APPL OPTICS, V26, P4947, DOI DOI 10.1364/AO.26.004947
   Kosto B., 1998, IEEE T SYST MAN CYB, V18, P49, DOI DOI 10.1109/21.87054
   Lakshmikantham V, 1989, THEORY IMPULSIVE DIF
   Li YT, 2006, J MATH ANAL APPL, V324, P1125, DOI 10.1016/j.jmaa.2006.01.016
   Liao XF, 1998, INT J CIRC THEOR APP, V26, P219, DOI 10.1002/(SICI)1097-007X(199805/06)26:3<219::AID-CTA991>3.0.CO;2-I
   Q He, 2008, APPL MATH SCI, V27, P1335
   Yang T, 1996, IEEE T CIRCUITS-I, V43, P880, DOI 10.1109/81.538999
   YANG T, 1996, P IEEE INT WORKSH CE, P181
   Yuan K, 2006, NEUROCOMPUTING, V69, P1619, DOI 10.1016/j.neucom.2005.05.011
   Zhang JY, 2001, INT J CIRC THEOR APP, V29, P185, DOI 10.1002/cta.144
   Zhang QH, 2008, PHYS LETT A, V372, P3971, DOI 10.1016/j.physleta.2008.01.063
NR 15
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.331
PG 10
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400131
DA 2018-12-27
ER

PT S
AU Zhang, QT
AF Zhang, Qitao
BE Zhou, X
TI RETRACTED: Research on Application Virtualization in Banking (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE application virtualization; delivery platform; banking
AB Combining with an actual case to give a brief introduction for application virtualization Citrix delivery platform and puts forward specific solutions, this solution can be integrated into an access platform, strides over the limitation of system application architecture mode, and connects all ends which comprising information requirement end and information supplement end to realize the end-to-end extensions. It can better satisfy the continuous development of banking business needs and adapt to the integration of the world economy and the development trend of the financial globalization. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Harbin Univ Commerce, Harbni Song Bei Xue Hai St, Harbin 150028, Peoples R China.
RP Zhang, QT (reprint author), Harbin Univ Commerce, Harbni Song Bei Xue Hai St, Harbin 150028, Peoples R China.
EM zqt_cn@126.com
CR Jiao Li, 2010, FUJIAN COMPUTER, P131
   Jiao Li, 2010, FUJIAN COMPUTER, P101
   Xuejie Li, 2007, ELECT MEASUREMENT TE, P183
   Ye Yao, 2010, COMPUTER KNOWLEDGE T, P4289
   Ye Yao, 2010, COMPUTER KNOWLEDGE T, P4299
   Zhaoying Ye, 2009, COMPUTER KNOWLEDGE T, P7810
NR 6
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.273
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400073
DA 2018-12-27
ER

PT S
AU Zhang, QT
AF Zhang, Qitao
BE Zhou, X
TI RETRACTED: SQL Optimization Based on Oracle Database (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE SQL statement; parse; optimizing performance
AB The problem of database performance has been the focus that decision makers and technicians pay attention to and an important factor that impacts database performance is the low efficiency of the SQL query statements. This paper discusses the execution, parsing procedure and the basic principle of SQL statements and the common reasons why the SQL query statements is low efficiency, and the common steps of optimizing SQL. It also analyses how to optimize the operation of database access and how to improve the query efficiency when several tables connected. Finally, it realizes the optimization of SQL based on oracle database. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Harbin Univ Commerce, Harbni Song Bei Xue Hai St, Harbin 150028, Peoples R China.
RP Zhang, QT (reprint author), Harbin Univ Commerce, Harbni Song Bei Xue Hai St, Harbin 150028, Peoples R China.
EM zqt_cn@126.com
CR Christian Antognini, 2008, TROUBLESHOOTING ORAC
   Jun Jiang, 2009, COMPUT EDUC, P184
   Niemiec RJ, 2003, ORACLE 9I DATABASE P
NR 3
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.271
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400071
DA 2018-12-27
ER

PT S
AU Zhang, XH
   Shan, XM
   Xia, ZW
AF Zhang, Xiaohui
   Shan, Xianming
   Xia, Zhongwu
BE Zhou, X
TI RETRACTED: Design and Realization of Decision Support System of
   Artillery Radar (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE decision support system; artillery radar; networking; firing calibration
AB To deal with the difficulties in the artillery shooting support by several type radar, such as low automatic transmission level, bad data precision of exploding point and deficient data fusion of exploding point coordinate, a firing calibration evaluation system of networking artillery radar was realized. Basic principle, hardware structure and software structure of the system were discussed. This system is then developed with tools of VC++6.0 and SQLServer. According the principle of Least Squares and weight value of radar precision, the data fusion algorithm of exploding point data based on several networking radar was designed. The shooting results show that the system improves the measure precision of exploding point and automatic command ability.. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Xiaohui; Shan, Xianming; Xia, Zhongwu] Shenyang Artillery Acad, Dept Elect Reconnaissance, Shenyang 110161, Peoples R China.
RP Shan, XM (reprint author), Shenyang Artillery Acad, Dept Elect Reconnaissance, Shenyang 110161, Peoples R China.
EM neusxm@139.com
CR BAI Zhen-xing, 2005, MODERN ELECT TECHNOL, V12, P71
   CHEN Wen-Qi, 2005, J XIAMEN U NATURAL S, V44, P277
   [李旭东 LI Xu-dong], 2009, [现代雷达, Modern Radar], V31, P7
   Shetty S, 1996, IEEE T AERO ELEC SYS, V32, P167, DOI 10.1109/7.481259
   YAO Ging-shun, 2008, FIRE CONTROL COMMAND, V34, P1
NR 5
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.311
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400111
DA 2018-12-27
ER

PT S
AU Zhang, XY
   Zhou, JZ
   Cao, GJ
   Wang, YH
AF Zhang, Xiaoyuan
   Zhou, Jianzhong
   Cao, Guangjing
   Wang, Yihua
BE Zhou, X
TI RETRACTED: Optimal Decision Support System Design for Mass Concrete Dam
   Construction Equipment Matching Scheme (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Decision support system; discrete event system simulation; mass concrete
   dam; construction equipment matching scheme
AB The optimal selection of construction equipment matching scheme (CEMS) is the key scientific issue in mass concrete dam construction. In conventional construction organization of water resources and hydropower projects, the CEMS selection relies on manual calculation, which is inconvenient to get the proper scheme. To overcome this problem, a decision support system (DSS) combined expert system and discrete event simulation is proposed in this paper. It can help the construction design staff to determine the proper CEMS and to obtain optimal construction parameters. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Xiaoyuan; Zhou, Jianzhong] Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, 1037 Luoyu Rd, Wuhan 430074, Peoples R China.
RP Zhou, JZ (reprint author), Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, 1037 Luoyu Rd, Wuhan 430074, Peoples R China.
EM jz.zhou@hust.edu.cn
CR L Bolc, 1988, EXPERT SYSTEM APPL
   Lixia Zheng, 2004, ARTIFICIAL INTELLIGE
   ML Sheng, 2005, CHINA RURAL WATER HY, V85-6
   [申明亮 Shen Mingliang], 2004, [中国工程科学, Engineering science], V6, P68
   SJ Wu, 2001, HONGSHUI RIVER, V20, P65
   SJ Wu, 1999, HONGSHUI RIVER, V18, P35
   Yang Xue-Hong, 2005, Journal of System Simulation, V17, P2512
   [钟登华 Zhong Denghua], 2002, [系统工程理论与实践, Systems Engineering-Theory & Practice], V22, P114
   Zhong DH, 2004, J CONSTR ENG M ASCE, V130, P742, DOI 10.1061/(ASCE)0733-9364(2004)130:5(742)
   ZP Xia, 2003, REAL TIME DYNAMIC SI
NR 10
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.241
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400041
DA 2018-12-27
ER

PT S
AU Zhang, XT
   Wang, L
   Zhang, HW
AF Zhang, Xiutao
   Wang, Liang
   Zhang, Hongwei
BE Zhou, X
TI RETRACTED: Study on fouling of nanofiltration membranes when treating
   reclaimed water (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Nanofiltration membrane; Membrane fouling; Membrane cleaning; reclaimed
ID REVERSE-OSMOSIS MEMBRANE; RO MEMBRANES; PERFORMANCE
AB According to effluent water quality character- ristics of membrane bioreactor (MBR) in the municipal sewage treatment plant, major foulants which causing fouling of nanofiltration membrane elements in subsequent nanofiltration system were analyzed. And based on finding out the major foulants, a suitable cleaning method was determined in this paper. In this paper, determining the fouling level of nanofiltration membrane fouled with the effluent of membrane bioreactor (MBR) based on the change of pressure about nanofiltration system. In order to investigate the fouling reasons and cleaning methods of nanofiltration membrane, SEM and EDX were applied to analyze the membrane fouling layer. The experimental results showed that, the pressure of nanofiltration system was increased 30% after 90 days running. And the result of SEM-EDX about membrane showed that, the major foulants of membrane include organic substances and silicon dioxide. And there may be some inorganic substances, which contained magnesium (Mg) and calcium (Ca). Thought cleaning experiments with HCl, NaOH, STPP (Sodium tripolyphosphate, Na5P3O10) +Na-DDBS (sodium dodecyl benzene sulfonate, C6H5(CH2)(12)SO3Na) about fouled membrane, it was further showed that the foulants of membrane include organic substances, silicon dioxide and some inorganic substances which contained magnesium(Mg) and calcium(Ca). (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Xiutao; Wang, Liang] Tianjin Polytech Univ, Dept Environm & Chem Engn, Tianjin 300160, Peoples R China.
RP Wang, L (reprint author), Tianjin Polytech Univ, Dept Environm & Chem Engn, Tianjin 300160, Peoples R China.
EM mashi7822@163.com
CR Beyer M, 2010, DESALINATION, V250, P977, DOI 10.1016/j.desal.2009.09.085
   Li QL, 2007, J MEMBRANE SCI, V290, P173, DOI 10.1016/j.memsci.2006.12.027
   Li SZ, 2004, SEP PURIF TECHNOL, V34, P109, DOI 10.1016/S1383-5866(03)00184-9
   Mi BX, 2010, J MEMBRANE SCI, V348, P337, DOI 10.1016/j.memsci.2009.11.021
   Mo H, 2008, J MEMBRANE SCI, V315, P28, DOI 10.1016/j.memsci.2008.02.002
   Norberg D, 2007, DESALINATION, V202, P45, DOI 10.1016/j.desa1.2005.12.037
   Park K, 2009, DESALINATION, V238, P78, DOI 10.1016/j.desal.2008.01.038
   Van Wagner EM, 2009, J MEMBRANE SCI, V345, P97, DOI 10.1016/j.memsci.2009.08.033
   Wang FL, 2007, J MEMBRANE SCI, V293, P111, DOI 10.1016/j.memsci.2007.02.003
   Wang Z, 2005, DESALINATION, V178, P171, DOI 10.1016/j.desal.2004.11.036
   Zhao Y, 2010, J MEMBRANE SCI, V349, P65, DOI 10.1016/j.memsci.2009.11.023
NR 11
TC 0
Z9 0
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.861
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404078
DA 2018-12-27
ER

PT S
AU Zhang, YF
   Ding, MH
   Yan, QS
AF Zhang Yanfei
   Ding Muhua
   Yan Qisheng
BE Zhou, X
TI RETRACTED: Study on Forecasting of Science and Technology Human
   Resources Based on SVM (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE the science and technology human resources; support vector machines
   (SVM); the prediction of human resource
AB In this paper, a new method using support vector machines (SVM) for forecasting the demand and supply of science and technology human resources is presented. The results of simulation show that the fitting precision degree of this model is higher than the traditional prediction model, including the trend fitting model, logarithm curve model and the GM(1,1) discrete grey model. The method has advantages of accuracy, convenience, reliability and rapidity. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang Yanfei; Ding Muhua; Yan Qisheng] E China Inst Technol, Fuzhou 344000, Jiangxi, Peoples R China.
RP Zhang, YF (reprint author), E China Inst Technol, Fuzhou 344000, Jiangxi, Peoples R China.
EM yfzhang0812@163.com
CR Gunn S. R., 1998, SUPPORT VECTOR MACHI
   J Smola A, 1998, NCTR9030 NEUR COLT T
   Qisheng YAN, 2007, CHINA MANAGEMENT INF, V10, P42
   Vapnik VN, 1995, NATURE SATIATICAL LE
   YIN Xun-zhen, 2007, SCI TECHNOLOGY PROGR, V24, P204
NR 5
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.894
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404111
DA 2018-12-27
ER

PT S
AU Zhang, Y
   Bai, Y
AF Zhang, Yi
   Bai, Yan
BE Zhou, X
TI RETRACTED: Reliability Analysis and Safety Evaluation of an Analog
   Output Module Based on FMEA and FTA (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE reliability; safety; SIL; FMEA; FTA
AB Based on FMEA (Failure Mode and Effects Analysis) and FTA (Fault Tree Analysis), the reliability of an analog output module is analyzed and its safety integrity level is evaluated in this paper. Firstly, two of the reliability analysis methods, FMEA and FTA, are introduced. Secondly, the two methods are employed to analyze an analog output module. The failure modes and failure data of the electronic components in the module are presented by FMEA. Then, based on the schematic diagram of the module and the information given by FMEA, the fault tree of the module is built and its PFD (Probability of Failure on Demand) is calculated, by which the SIL (Safety Integrity Level) of the module can be determined. Finally, conclusions are given and future research directions are also pointed out. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Yi; Bai, Yan] N China Elect Power Univ, Sch Control & Comp Engn, Beijing, Peoples R China.
RP Zhang, Y (reprint author), N China Elect Power Univ, Sch Control & Comp Engn, Beijing, Peoples R China.
EM evazyi@sina.com.cn
CR Cofuku Akio, 2006, P IEEE S INT JOINT C, P497, DOI [10.1109/SICE.2006.315478, DOI 10.1109/SICE.2006.315478]
   Eric W. Scharpf, 2002, SAFETY INTEGRITY LEV, P2
   Goble William M., 2005, SAFETY INSTRUMENTED, p[61, 83]
   Hsiao Tsun-Yu, 2004, P IEEE S POW SYST C, P157, DOI [10.1109/PSCE.2004.1397510, DOI 10.1109/PSCE.2004.1397510]
   Hsiao Tsun-Yu, 2007, POWER ELECT APPL, P1, DOI [10.1109/ICPS.2007.4292105, DOI 10.1109/ICPS.2007.4292105]
   Hua Song, 2005, CONTROL DECISION, V20, P854
   Jianfeng Tao, 1999, P IEEE S DIG AV SYST, p3B2, DOI [10.1109/DASC.1999.863708, DOI 10.1109/DASC.1999.863708]
   Karimi A, 2010, INT CONF COMP SCI, P130, DOI 10.1109/ICCSIT.2010.5564803
   Krasich M, 2000, P A REL MAI, P1, DOI 10.1109/RAMS.2000.816275
   Pickard K, 2005, P REL MAINT S, P457, DOI 10.1109/RAMS.2005.1408405
   Sharma Rajiv Kumar, 2010, QUALITY MAINTENANCE, V16, P64, DOI [10.1108/13552511011030336, DOI 10.1108/13552511011030336]
   Sharma SP, 2010, ENG COMPUTATION, V27, P354, DOI 10.1108/02644401011029925
   Xiangyu Peng, 2006, P IEEE S COMM CIRC S, P2791, DOI [10.1109/ICCCAS.2006.285247, DOI 10.1109/ICCCAS.2006.285247]
   Yujuan Xu, 2007, AUTOMATION PETROCHEM, V3, P1
NR 14
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.956
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096405023
DA 2018-12-27
ER

PT S
AU Zhang, ZY
   Zeng, FX
   Liu, Y
   Xuan, GX
AF Zhang, Zhenyu
   Zeng, Fanxin
   Liu, Yi
   Xuan, Guixin
BE Zhou, X
TI RETRACTED: Design of ZCZ sequences with inter-group orthogonal
   properties for CDMA communication systems (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE CDMA communication systems; sequence design; inter-group orthogonal
   ptoperties; correlation function
ID ZERO-CORRELATION ZONE; BINARY SEQUENCES; SETS
AB This paper introduces a method to generated inter-group orthogonal (IGO) zero correlation zone (ZCZ) sequences suitable for code division multiple access (CDMA) communication systems. The designed IGO ZCZ sequence set can be divided into multiple sequence groups with each sequence group including the same number of sequences and the same ZCZ width. Every sequence group in the whole IGO ZCZ sequence set can be considered as a traditional ZCZ sequence set. However, different from traditional ZCZ sequence set, these sequence groups are mutually orthogonal, that is, cross-correlation function between any two sequences from different sequence groups is equal to zero at zero shift. As a result, the number of available sequences for CDMA communication systems will be significantly enhanced. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Zhenyu; Zeng, Fanxin] Chongqing Univ, Coll Commun Engn, Chongqing 400044, Peoples R China.
RP Zhang, ZY (reprint author), Chongqing Univ, Coll Commun Engn, Chongqing 400044, Peoples R China.
EM cqzhangzy@yahoo.com.cn
RI Zhang, Zhenyu/I-5198-2012; Xuan, Guixin/G-3379-2016
OI Zhang, Zhenyu/0000-0001-8985-7083; Xuan, Guixin/0000-0001-5019-5107
CR C Zhang W, 2010, P 6 IEEE INT C WIR C
   Chen H. H., 2007, NEXT GENERATION CDMA
   Deng XM, 2000, ELECTRON LETT, V36, P993, DOI 10.1049/el:20000720
   Fan P. Z., 1996, SEQUENCE DESIGN COMM
   Fan PZ, 1999, ELECTRON LETT, V35, P777, DOI 10.1049/el:19990567
   Hayashi T, 2008, IEICE T FUND ELECTR, VE91A, P1233, DOI 10.1093/ietfec/e91-a.4.1233
   POPOVIC BP, 1995, ELECTRON LETT, V31, P944, DOI 10.1049/el:19950678
   Rathinakumar A, 2004, ELECTRON LETT, V40, P1133, DOI 10.1049/el:20045628
   Rathinakumar A., 2006, IEEE T INFORM THEORY, V52, P3817
   SUEHIRO N, 1994, IEEE J SEL AREA COMM, V12, P837, DOI 10.1109/49.298057
   Tang XH, 2000, ELECTRON LETT, V36, P551, DOI 10.1049/el:20000462
   Tang XH, 2008, IEEE T INFORM THEORY, V54, P5729, DOI 10.1109/TIT.2008.2006574
   Torii H, 2004, IEEE T INFORM THEORY, V50, P559, DOI 10.1109/TIT.2004.825399
   Zeng FX, 2009, IEICE T FUND ELECTR, VE92A, P1731, DOI 10.1587/transfun.E92.A.1731
   Zhou ZC, 2008, IEEE T INFORM THEORY, V54, P4267, DOI 10.1109/TIT.2008.928256
NR 15
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.237
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400037
DA 2018-12-27
ER

PT S
AU Zhao, GL
   Wang, JC
   Luo, J
   Long, X
   Si, XP
AF Zhao, Guanglei
   Wang, Jingcheng
   Luo, Jian
   Long, Xiao
   Si, Xianping
BE Zhou, X
TI RETRACTED: Applicability of Elliptic Curve Cryptography on Internet of
   Things (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE ECDH; ECDSA; Internet of Things
AB This paper considers the applicability of elliptic curve cryptography on Internet of Things and presents an improved Elliptic Curve Diffie-Hellman(ECDH) key agreement scheme which enhances the security of Internet of Things together with Elliptic Curve Digital Signature Algorithm(ECDSA). The implementation of the proposed procedures of ECDH and ECDSA are given explicitly. Different optimization methods are used in experimental evaluation to compare the performance difference and present the applicability of the proposed schemes on Internet of Things. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhao, Guanglei; Wang, Jingcheng; Luo, Jian; Long, Xiao] Shanghai Jiao Tong Univ, Dept Automat, Shanghai 200240, Peoples R China.
RP Zhao, GL (reprint author), Shanghai Jiao Tong Univ, Dept Automat, Shanghai 200240, Peoples R China.
EM jcwang@sjtu.edu.cn
RI Rao, Vidya/M-2590-2016
CR An L., 2008, P 7 INT C INF PROC S, P245
   Gura N., 2004, P 6 INT WORKSH CRYPT, P119
   Hankerson D, 2004, GUIDE ELLIPTIC CURVE
   Hong L., 2007, COMPUTER ENG DESIGN, V28, P3076
   Hu Yan-zhi, 2009, Computer Engineering and Design, V30, P318
   Kranenburg R.V., 2008, INTERNET THINGS CRIT
   Lopez J, 2006, J COMPUT SECUR, V14, P469, DOI 10.3233/JCS-2006-14505
   MALAN DJ, 2004, P 1 IEEE INT C SENS, P71, DOI DOI 10.1109/SAHCN.2004.1381904
   Wang H., 2006, P INT C INF COMM SEC, P519
NR 9
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.220
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400020
DA 2018-12-27
ER

PT S
AU Zhao, M
   Wu, JL
AF Zhao, Ming
   Wu, Jinlin
BE Zhou, X
TI RETRACTED: A Contrastive Study of the Environmental Education
   Development between Chinese Mainland and Taiwan (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Environmental education; Basic education; Professional education;
   Chinese Mainland and Taiwan
AB By contrastive analysis of the developmental differences of Chinese mainland and Taiwan's environmental education in the fields of basic education and professional education, the study results show that there is a large gap in Chinese Mainland's environmental education compared with Taiwan. The environmental education in Taiwan is better than that in Chinese mainland in teaching arrangement and curriculum structure. Taiwan's development patterns of environmental education can be used by Chinese mainland for reference. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhao, Ming; Wu, Jinlin] Minjiang Univ, Dept Tourism, Fuzhou 350007, Peoples R China.
RP Zhao, M (reprint author), Minjiang Univ, Dept Tourism, Fuzhou 350007, Peoples R China.
EM zhaoming1028@163.com
CR Cai bingchong, 2006, ENV ED HIGH SCH CURR
   Zhang shaoxiang, 2001, HIGHER ED RES AREAS, P53
   zheng Xiao, 2009, COMP RES PATTERN ENV
NR 3
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.823
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404040
DA 2018-12-27
ER

PT S
AU Zhao, X
   Liu, B
   Zhao, Q
AF Zhao, Xiang
   Liu, Bin
   Zhao, Qi
BE Zhou, X
TI RETRACTED: Design of the Network Learning Factor Collecting System Based
   on Mobile Agent (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Mobile Agent; Network Learning; Factor Collecting; System Design
AB According to the problems of network teaching, the paper makes a study of the network learning pattern recognition (NLPR) - the network learning factor collecting (NLFC). In this paper, mobile agent technique is used to do general design and detailed design of the NLFC system, and the design principle is expatiated. The collecting data include the multimedia on demand information collection, intercourse information collection, exercise information collection, and exam information collection. The system may collect all kinds of learning information of network learners and provide a basis for constructing NLPR system. At the same time, it is useful for solving the problems of the classification and recognition of discrete-time nonlinear learning mode in network teaching, and promote the development of network teaching evaluation, thus the system of this paper have a grater practical value. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhao, Xiang; Liu, Bin] Shijiazhuang Mech Engn Coll, Dept 6, Shijiazhuang 050003, Hebei, Peoples R China.
RP Zhao, X (reprint author), Shijiazhuang Mech Engn Coll, Dept 6, Shijiazhuang 050003, Hebei, Peoples R China.
EM zxcg2001@sina.com
CR Karjoth Gunter, 2004, SECURITY MODEL AGLET
   Lang D B, 2003, JAVA AGLET APPL PROG
   XUE Bing, 2004, J ORDNANCE ENG COLL, P54
   Zhao Qi, 2005, COLLECTING SYSTEM WE
NR 4
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.211
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400011
DA 2018-12-27
ER

PT S
AU Zhao, YT
   Wu, XJ
   Lv, HS
AF Zhao Yantao
   Wu Xijun
   Lv Hongshi
BE Zhou, X
TI RETRACTED: Reversible Data Hiding Based on Histogram Mification and
   Pediction (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Data hiding; Reversibility; Prediction; Histogram
ID DIFFERENCE EXPANSION; SCHEME
AB In this paper, a novel reversible data embedding based on histogram modification and prediction is presented. Since the data hiding scheme is reversible, the original image can be completely recovered after the secret message has been extracted from the stego-image. The predictive value is computed by using various predictors. The difference image is firstly calculated between a pixel and its predictive value, and the produce difference image will be nearly MxN pixels, while the cover image is MxN pixels. Then the secret data is embedded in the cover image by modified the histogram of the difference image. The experimental results show that the proposed method obtains high embedding capacity, and produces small bit length of keys. The multilevel embedding is also used in the scheme, and achieved a very high capacity and low distortion. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhao Yantao; Wu Xijun; Lv Hongshi] Yanshan Univ, Inst Elect Engn, Qinhuangdao, Peoples R China.
RP Zhao, YT (reprint author), Yanshan Univ, Inst Elect Engn, Qinhuangdao, Peoples R China.
EM ysuzyt@ysu.edu.cn
CR Chan YK, 2009, J SYST SOFTWARE, V82, P411, DOI 10.1016/j.jss.2008.07.008
   Fridrich J., 2011, P SPIE SECURITYAND W, V3971, P197
   Lee CC, 2008, PATTERN RECOGN, V41, P2097, DOI 10.1016/j.patcog.2007.11.018
   Lin CC, 2008, PATTERN RECOGN, V41, P3582, DOI 10.1016/j.patcog.2008.05.015
   Ni ZC, 2006, IEEE T CIRC SYST VID, V16, P354, DOI 10.1109/TCSVT.2006.869964
   Thodi DM, 2007, IEEE T IMAGE PROCESS, V16, P721, DOI 10.1109/TIP.2006.891046
   Tian J, 2003, IEEE T CIRC SYST VID, V13, P890, DOI 10.1109/TCSVT.2003.815962
   Tsai P, 2009, SIGNAL PROCESS, V89, P1129, DOI 10.1016/j.sigpro.2008.12.017
   Tseng H-W., 2009, INFORM SCI, V179, P2406
   Xuan G., 2004, IEEE WORKSH MULT SIG, P211
NR 10
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.244
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400044
DA 2018-12-27
ER

PT S
AU Zhen, CG
   Cheng, P
AF Zhen, Chenggang
   Cheng, Peng
BE Zhou, X
TI RETRACTED: Finite Automata in the Automatic Teller Machine Test Program
   Design (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE finite automaton; automatic teller machines; state transition
AB This paper introduces the concept of finite automata, formal definitions and basic composition, finally described finite automata application in the ATM by a example. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Cheng, Peng] N China Elect Power Univ, Coll Comp Sci & Technol, Baoding, Peoples R China.
RP Cheng, P (reprint author), N China Elect Power Univ, Coll Comp Sci & Technol, Baoding, Peoples R China.
EM wolfpkwolf@163.com
CR Maxwell J. Clerk, 1892, TREATISE ELECT MAGNE, V2, P68
   Qiang Huang Zhi, 2002, FINITE AUTOMATA CONT, P1
   ROSEN KH, 1998, DISCRETE MATH ITS AP
   Sethian J, 1999, LEVEL SET METHODS FA
   Ting Chan Sung, 1988, FORMAL LANGUAGES AUT, P11
NR 5
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.806
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404023
DA 2018-12-27
ER

PT S
AU Zheng, B
   Ying, GF
AF Zheng Bin
   Ying Guofu
BE Zhou, X
TI RETRACTED: The Redevelopment of Stirrer Based on ANSYS and Integration
   with VB (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE ANSYS; VB; APDL; Stirrer; Parametric Modeling
AB The stirrer is one of the key components of the mechanical mixing equipments. It is very important to establish the stirrer model in the process of designing and developing the mixing equipments. The stirrer parametric model was established by using the APDL command stream of ANSYS, and the graphical user interface was developed by using Visual Basic programming language. Thus, it has realized the parametric modeling of the stirrer. Practice proved that the system provided a friendly user interface, simplified the duplication work of modeling in the graphical user interface of ANSYS and improved work efficiency. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zheng Bin; Ying Guofu] Sichuan Univ, Sch Mfg Sci & Technol, Chengdu 610065, Peoples R China.
RP Zheng, B (reprint author), Sichuan Univ, Sch Mfg Sci & Technol, Chengdu 610065, Peoples R China.
EM 22198334@qq.com
CR ChengJin Cai, 2007, CHEM IND FLUID FLOW, P188
   Guofu Yin, 2008, COMPUT AIDED DESIGN, P101
   Gurmeet Singh, 2007, VISUAL BASIC 6, P124
   Liu G, 2003, ACT TASKS AGRIC ENG, V31, P75
   QunLin Sci, 2006, FINITE ELEMENT METHO, P1
   Ronghua Shu, 2005, STRUCTURAL SIMULATIO, P120
   Shuguang Gong, 2009, ANSYS PARAMETRIZATIO, P01
   WeiYan, 2001, VISUAL BASICAL PROGR, P86
   Xing JingZhong, 2006, ANSYS APPL EXAMPLE A, P04
   Zhipin Cheng, 2004, AGITATION MIXING DEV, P224
NR 10
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.893
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404110
DA 2018-12-27
ER

PT S
AU Zheng, GK
   Zhang, YZ
   Ding, XL
   Lin, LG
   Li, H
AF Zheng, Guikun
   Zhang, Yuzhong
   Ding, Xiaoli
   Lin, Ligang
   Li, Hong
BE Zhou, X
TI RETRACTED: Removal of Heavy Metal ions in water with resin-mixed
   PES-based membrane adsorbents (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Membrane adsorbents; Heavy metal; Cu2+; Hg2+; Pb2+; Water
AB The resin-mixed polyethersulfone (PES)-based membrane adsorbents were developed to study their adsorption behavior with heavy metal ions in water. Membrane adsorbents with an open pore surface had much better adsorption behavior with a higher adsorbing rate. The adsorption capacity of the 110 resin, 001x7 resin or D061 resin mixed PES-based membrane adsorbents with an open pore surface have the high adsorbents to Cu2+, Hg2+ and Pb2+, which was comparable with the resin static adsorption capacity. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Yuzhong] Tianjin Polytech Univ, Sch Mat Sci & Engn, Tianjin 300160, Peoples R China.
RP Zhang, YZ (reprint author), Tianjin Polytech Univ, Sch Mat Sci & Engn, Tianjin 300160, Peoples R China.
EM zhangyz2004cn@163.com
CR Boricha AG, 2009, J MEMBRANE SCI, V339, P239, DOI 10.1016/j.memsci.2009.04.057
   DIAO WP, 2004, GUANGDONG TRACE ELEM, P1
   HUANG HT, 2009, GUANGXI J LIGHT IND, P99
   Oehmen A, 2006, DESALINATION, V199, P405, DOI 10.1016/j.desal.2006.03.091
   XIONG CH, 2008, T NONFERROUS METALS, P1290
   YANG XL, 2003, GANSU SCI TECHNO JUN, P61
   YU YH, 1998, ION EXCHANGE ADSORPT, P466
   ZHANG FL, 2009, J TIANJIN POLYTE APR, P10
   Zhang YZ, 2006, DESALINATION, V192, P224, DOI 10.1016/j.desa1.2005.06.048
   ZHANG ZJ, 2005, ENV PROTECTION S AUG, P41
NR 10
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.914
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404131
DA 2018-12-27
ER

PT S
AU Zheng, X
   Li, Q
AF Zheng, Xin
   Li, Qiang
BE Zhou, X
TI RETRACTED: A new quantum-behaved particle swarm algorithm used in robust
   design method in motion mechanism (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Quantum behaved particle swarm optimization; Inverse-proportional
   inertia weight; robust design; optimum design; motion mechanism
ID EVOLUTIONARY ALGORITHM; OPTIMIZATION
AB A new quantum-behaved particle swarm optimization algorithm with inverse proportional inertia weight is presented and proved in this paper. Also a robust design method of optimization is used by optimizing the robustness of both the system objective function and constraint functions in solving the problem of breach of condition to the constraint functions. Comparing the solution of the traditional optimization and the solution of the robust optimal design, the robust design parameters display a significant stability in performance when the value of the parameters changed and all the optimizations are solved by this new efficient algorithm. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zheng, Xin] Inner Mongolia Univ Technol, Coll Mech Engn, Hohhot 010051, Peoples R China.
RP Zheng, X (reprint author), Inner Mongolia Univ Technol, Coll Mech Engn, Hohhot 010051, Peoples R China.
EM Sunday5921@yahoo.cn
CR Anlin Wang, 2008, GEN MECH OPTIMUM DES, P11
   Coelho LD, 2008, CHAOS SOLITON FRACT, V37, P1409, DOI 10.1016/j.chaos.2006.10.028
   Eberhart R, 1995, P 6 INT S MICR HUM S, P39, DOI DOI 10.1109/MHS.1995.494215
   Eberhart R. C., 2001, P IEEE C EV COMP CEC
   Greenstein G., 2005, QUANTUM CHALLENGE MO
   Guo rensheng, 2008, MECH ENG DESIGN APPL, P6
   Han KH, 2002, IEEE T EVOLUT COMPUT, V6, P580, DOI 10.1109/TEVC.2002.804320
   Jiao B, 2008, CHAOS SOLITON FRACT, V37, P698, DOI 10.1016/j.chaos.2006.09.063
   Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/ICNN.1995.488968
   Lee DS, 2008, COMPUT FLUIDS, V37, P565, DOI 10.1016/j.compfluid.2007.07.011
   Li Q, 2009, CHIN J MECH ENG, V22, P602, DOI 10.3901/CJME.2009.04.602
   Lizhou Chen, 1999, J UNIV SCI TECHNOL B, V21, P57
   Shi Y., 1999, P C EV COMP
   Shi YH, 2001, IEEE C EVOL COMPUTAT, P101, DOI 10.1109/CEC.2001.934377
   Taguchi G., ROBUST TECHNOLOGY DE
   Ueno G., 2005, P IEEE INT C SYSTEMS, V4, P3915
   Wang Y, 2007, NEUROCOMPUTING, V70, P633, DOI 10.1016/j.neucom.2006.10.001
   [于利磊 Yu Lilei], 2003, [上海交通大学学报, Journal of Shanghai Jiaotong University], V37, P1189
NR 18
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.291
PG 10
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400091
DA 2018-12-27
ER

PT S
AU Zhong, H
   Sun, BP
   Zhao, FY
   Zhang, XB
AF Zhong, Hua
   Sun, Baoping
   Zhao, Fangying
   Zhang, Xuebiao
BE Zhou, X
TI RETRACTED: Progress in Activated Sludge Model of China (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Activated Sludge; Mathematics Model; Research situation
AB Recent studies on mathematics model of activated sludge were reviewed in this paper. The current applied research of urban wastewater treatment process model and development of software were mainly introduced. And the prospect and development direction are also introduced. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhong, Hua; Sun, Baoping] Beijing Forestry Univ, State Key Lab Soil & Water Conservat & Desertific, Coll Soil & Water, Beijing, Peoples R China.
RP Zhong, H (reprint author), Beijing Forestry Univ, State Key Lab Soil & Water Conservat & Desertific, Coll Soil & Water, Beijing, Peoples R China.
EM Remyzhong@163.com
CR [Anonymous], 2000, ACT SLUDG MOD ASM1 A
   Chen Li, 1998, CHINA WATER WASTEWAT, V14, P15, DOI cnki:ISSN:1000-4602.0.1998-05-005
   Chen Xiaolong, 2003, IND WATER WASTEWATER, V34, P1, DOI cnki:ISSN:1006-4826.0.2003-01-000
   [郭亚萍 Guo Yaping], 2006, [工业水处理, Industrial Water Treatment], V26, P80
   [揭大林 Jie Dalin], 2007, [环境工程学报, Chinese Journal of Environmental Engineering], V1, P138
   [刘芳 Liu Fang], 2005, [环境工程, Environment engineering], V23, P33
   Qiao Jun-fei, 2008, Journal of System Simulation, V20, P2156
   Shang Miner, 2002, ACTIVATED SLUDGE WAS, DOI cnki:CDMD:2.2002.000271
   Shi Hanchang, 2001, CHINA WATER WASTEWAT, V17, P61, DOI cnki:ISSN:1000-4602.0.2001-10-029
   [吴凡松 Wu Fansong], 2003, [中国给水排水, China Water & Wastewater], V19, P48
   [杨青 YANG Qing], 2007, [中国给水排水, China Water & Wastewater], V23, P18
   [杨青 Yang Qing], 2002, [上海环境科学, Shanghai Environmental Science], V21, P278
   [于静洁 Yu Jingjie], 2006, [环境污染与防治, Environmental Pollution & Control], V28, P334
   [余颖 YU Ying], 2006, [计算机工程, Computer Engineering], V32, P266
   [张代钧 Zhang Daijun], 2002, [环境科学学报, Acta Scientic Circumstantance], V22, P448
   Zhang Ping, 2007, Journal of System Simulation, V19, P3188
   [周雪飞 Zhou Xuefei], 2004, [同济大学学报. 自然科学版, Journal of Tongji University], V32, P745
   Zhu Xiangdong, 2007, CHINA WATER WASTEWAT, V33, P101, DOI cnki:ISSN:1002-8471.0.2007-04-027
NR 18
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.907
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404124
DA 2018-12-27
ER

PT S
AU Zhou, D
   Liu, CH
   Guo, B
   Yue, GY
AF Zhou, Dong
   Liu, Chen-hui
   Guo, Bao
   Yue, Guan-yong
BE Zhou, X
TI RETRACTED: Experimental Study on Thermal Effect of Shear Strength of
   Cohesive Soil (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE shear strength; thermal effect; cohesive soild; time
AB The paper mainly studies the influence rules of temperature (10 degrees C similar to 60 degrees C) and curing time on shear strength indexes of cohesive soil, such as cohesion and internal friction angle, which are very significant in civil engineering works as the temperature of the earth's surface increases. Such influence plays an even more important role in the design of the ground source heat pump and the geological disposal of high-level radioactive wastes. In this paper, the triaxial unconsolidated-undrained tests on unsaturated cohesive soil samples have recently been performed. And the testing results show that the shear strength increase as temperature and curing time increase, which is a phenomenon that needs further researches. The cementation get reinforced and the change of the content of closed air caused by the temperature curing may be the key factors. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhou, Dong; Guo, Bao; Yue, Guan-yong] Guangxi Univ, Sch Civil Engn & Architecture, Nanning 530004, Peoples R China.
RP Zhou, D (reprint author), Guangxi Univ, Sch Civil Engn & Architecture, Nanning 530004, Peoples R China.
EM zhd516@163.com
CR Cekerevac C, 2004, INT J NUMER ANAL MET, V28, P209, DOI 10.1002/nag.332
   CHEN ZH, 2005, CHINESE J GEOTECHNIC, V27, P929
   DEBRUYN, 1996, ENG GEOL, V41, pL17
   [高燕希 Gao Yanxi], 2003, [力学与实践, Mechanics in Engineering], V25, P55
   LING Y, 2003, JOUTURNAL GUANGXI ME, V24, P25
   MITCHELL JK, 1969, HRB SPECIAL REPORT, V103, P9
   Ou XD, 2005, ROCK SOIL MECH, V26, P1068
   Wu H., 2000, CHINESE J ROCK MECH, V19, P199
   [谢云 Xie Yua], 2005, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V27, P1082
   Xie Y, 2007, ROCK SOIL MECH, V28, P1937
NR 10
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.918
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404135
DA 2018-12-27
ER

PT S
AU Zhou, JP
AF Zhou, Jianping
BE Zhou, X
TI RETRACTED: Detection of ECU Speed Based on Fourier Transform and Lifting
   Wavelet (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE lifting wavelet; electronic control unit (ECU); detect; speed;
   singularity
ID SCHEME
AB IPC(industrial personnel computer) emits the frequency signal to simulate the rotating speed through timer 8253. However, ECU(electronic control unit) sometimes can not recognize the discontinuous frequency signal. Lifting wavelet is widely applied to locate the abrupt signal because it can simultaneously show the local characteristic of time domain signal and frequency domain signal. Fourier transform and lifting wavelet are used to detect the rotating speed change, respectively. The simulation results show that lifting wavelet can accurately and effectively detect the singularity of vehicle speed change such as speed decreasing and speed increasing, but Fourier transform fails to detect these singularities. Accurate singularity acquisition by lifting wavelet has potential application for further improving ECU performance. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Shanghai Univ Elect Power, Chanyang Rd 2588, Shanghai 200090, Peoples R China.
RP Zhou, JP (reprint author), Shanghai Univ Elect Power, Chanyang Rd 2588, Shanghai 200090, Peoples R China.
EM zhoujianping@shiep.edu.cn
CR Chen HX, 2007, J SOUND VIB, V301, P458, DOI 10.1016/j.jsv.2006.08.041
   Fang Qiang, BIOM ENG 2003 IEEE E
   Jeffrey C, 2005, J ELECTRON TEST, V21, P405, DOI 10.1007/s10836-005-1272-3
   Mueller-Glaser Klaus D., 2006, AUTOMOTIVE SOFTWARE, V4147, P15
   Neves F., IND EL 2009 IECON 09
   Qian S., 2005, INTRO TIME FREQUENCY
   Sweldens W, 1998, SIAM J MATH ANAL, V29, P511, DOI 10.1137/S0036141095289051
   Zhou Wei, 2006, MATLAB WAVELET ANAL
NR 8
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.218
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400018
DA 2018-12-27
ER

PT S
AU Zhou, J
   Pan, JS
   Yang, SQ
AF Zhou, Jing
   Pan, Jianshou
   Yang, Shuqing
BE Zhou, X
TI RETRACTED: The Specific Moving Target Tracking in the Complex Background
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE tracking; Mean Shift; moving information
AB It mainly discusses the principles of the Mean Shift algorithm as well as its realization in the moving targets tracking; then an improved Mean Shift tracking algorithm joined in the moving information is introduced. We use the improved tracking algorithm in the complex background. The experiments prove that we can get effect tracking results. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhou, Jing; Pan, Jianshou; Yang, Shuqing] NW Univ Xian, Coll Informat Sci & Technol, Xian 710127, Peoples R China.
RP Zhou, J (reprint author), NW Univ Xian, Coll Informat Sci & Technol, Xian 710127, Peoples R China.
EM zhoujing1021@126.com
CR Comaniciu D., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1197, DOI 10.1109/ICCV.1999.790416
   COMANICIU D, 2000, P IEEE C COMP VIS PA, V2, P142, DOI DOI 10.1109/CVPR.2000.854761
   Okuma K., 2004, P EUR C COMP VIS, P1486
   Wang Bin, 2006, Mini-Micro Systems, V27, P1746
   Wang Jiang-tao, 2007, Journal of System Simulation, V19, P4216
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.319
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400119
DA 2018-12-27
ER

PT S
AU Zhou, J
   Chen, LT
   Liu, QH
   Li, YM
   Rao, YB
AF Zhou, Jun
   Chen, Lei-Ting
   Liu, Qi-He
   Li, Yan-Mei
   Rao, Yun-Bo
BE Zhou, X
TI RETRACTED: Sketch-based Simple 3d Tree Modeling (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Tree modeling; sketching; fractals; virtual reality
AB In this paper, we propose an approach for generating 3D models of trees from freehand sketches that has the benefit of offering simple and rapid user control. The system generates 3D geometry tree from a 2D sketch, which only need sketch the silhouettes of tree is quicker and more intuitive for a user than having to sketch each branch of a tree. When drawing the sketch, our system using botanical knowledge and the fractals to form trees automatically. We illustrate these ideas by presenting a sketch-based interface, used for sketching tree silhouettes, and construction visual hull using sketch, meanwhile, using botanical knowledge and the fractals to generates branches. Our system allows the user to design trees simple and interactively as compared with rule-based tree modeling systems. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhou, Jun; Chen, Lei-Ting; Liu, Qi-He; Li, Yan-Mei; Rao, Yun-Bo] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu 610054, Peoples R China.
RP Zhou, J (reprint author), Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu 610054, Peoples R China.
EM zhouj@swu.edu.cn
CR NEUBERT B, 2007, ACM T GRAPHICS SIGGR, V26
   Okabe M, 2005, COMPUT GRAPH FORUM, V24, P487, DOI 10.1111/j.1467-8659.2005.00874.x
   Oppenheimer P. E., 1986, Computer Graphics, V20, P55
   Prusinkiewicz P., 1990, ALGORITHMIC BEAUTY P
   QUAN L, 2006, ACM T GRAPHICS SIGGR, V25, P772
   Reche A, 2004, ACM T GRAPHIC, V23, P720, DOI 10.1145/1015706.1015785
   REFFYE PD, 1988, COMPUTER GRAPHICS, V22, pPP151
   Shlyakhter I, 2001, IEEE COMPUT GRAPH, V21, P53, DOI 10.1109/38.920627
   TAN P, ACM T GRAPHICS P SIG, V27
   Tan P, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1239451.1239538
   WEBER J, 1995, P 22 ANN C COMP GRAP, P119, DOI DOI 10.1145/218380.218427
NR 11
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.917
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404134
DA 2018-12-27
ER

PT S
AU Zhou, W
   Xiong, S
AF Zhou Weihong
   Xiong Shunqing
BE Zhou, X
TI RETRACTED: Optimization of BP Neural Network Classifier using Genetic
   Algorithm (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Genetic Algorithm; BP neural network; BP neural network classifier;
   Convergence; Weight
AB In this paper, a new BP neural network classifier was constructed and optimized by Genetic Algorithm, first, the BP neural network was improved by using genetic algorithm[2] to train the initial weights values of the BP neural network[3], second, a new classifier was constructed based on the new BP neural network optimized by Genetic Algorithm. Finally, data simulation experiment was taken and the result of data simulation with famous IRIS data shows that the new BP neural network classifier improved by the Genetic Algorithm has higher accuracy of classification and greater gradient of convergence than the BP Neural Network classifier which Proposed in literature [3]. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhou Weihong; Xiong Shunqing] Yunnan Nationalities Univ, Sch Math & Comp Sci, Kunming 650031, Peoples R China.
RP Zhou, W (reprint author), Yunnan Nationalities Univ, Sch Math & Comp Sci, Kunming 650031, Peoples R China.
EM ynzwh@163.com
CR CHEN Guo-liang, 2001, GENETIC ALGORITHM IT
   Chengfeng Luo, 2006, J AGR ENG, V22, P133
   Chonghui Guo, 2002, J NUMERICAL MATH, V24, P51
   Fangze Chen, 1996, J CHEM IND ENG, V47, P421
   Jiansheng Wu, 2004, J GUANGXI TEACHERS E, V21, P48
   Lei Yingjie, 2005, MATLAB GENETIC ALGOR
   Xuguang Tian, 2004, J DALIAN U TECHNOLOG, V2, P69
   Yanming Xing, 2006, JISHOU U NATURAL SCI, V27, P31
   Zhongbiao Sheng, 2008, J WEINAN TEACHERS U, V23, P65
   Zongli Jiang, 2001, INTRO ARTIFICIAL NEU, P7
NR 10
TC 0
Z9 0
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.286
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400086
DA 2018-12-27
ER

PT S
AU Zhou, WH
   Xiong, SQ
AF Zhou Weihong
   Xiong Shunqing
BE Zhou, X
TI RETRACTED: Construction of Mamdani Fuzzy Classifier Based on Genetic
   Algorithm (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE fuzzy classifier; Mamdani fuzzy logical system; fuzzy reasoning; genetic
   algorithm
AB Most of the fuzzy classifiers are created by fuzzy rules based on apriori knowledge and expert's knowledge, but in many applications, it's difficult to obtain fuzzy rules without apriori knowledge of the data. To solve this problem, a new way of creating Mamdani fuzzy classifier based on Mamdani fuzzy logical system is proposed in this paper, and the new fuzzy classifier is improved with the genetic algorithm further. The result of data simulation with Iris data shows the new Mamdani fuzzy classifier has minimum number of features, minimum number of fuzzy rules and better precision. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhou Weihong; Xiong Shunqing] Yunnan Nationalities Univ, Sch Math & Comp Sci, Kunming 650031, Peoples R China.
RP Zhou, W (reprint author), Yunnan Nationalities Univ, Sch Math & Comp Sci, Kunming 650031, Peoples R China.
EM ynzwh@163.com
CR Cordon O, 2004, FUZZY SET SYST, V141, P5, DOI 10.1016/S0165-0114(03)00111-8
   Fuller R., 2000, INTRO NEUROFUZZY SYS
   Lei Yingjie, 2005, MATLAB GENETIC ALGOR
   Wang Li-xin, 2003, COURSE FUZZY SYSTEMS
   Wang XP, 2002, GENETIC ALGORITHM TH
   Xiaoli Wu, 2002, MATLAB AUXILIARY FUZ
   Yanming Xing, 2006, JISHOU U NATURAL SCI, V27, P31
   Ying Fan, 2008, COMPUTER APPL, V28, P1024
   Zongyi Xing, 2006, SE U NATURAL SCI EDI, V36, P725
NR 9
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.260
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400060
DA 2018-12-27
ER

PT S
AU Zhu, KJ
   Ren, XL
   Wei, JL
   Duan, XF
   Yao, L
   Zhao, RZ
AF Zhu, Kaijin
   Ren, Xiaoli
   Wei, Jingli
   Duan, Xiaofang
   Yao, Ling
   Zhao, Runzhu
BE Zhou, X
TI RETRACTED: Effective Removal of Sulphide and Cyanide from Coking
   Wastewater (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Coking wastewater; Sulphide; Cyanide; Poly-alumium-ferric-silicate;
   Potassium ferrate; Effective removal
ID COAGULATING BEHAVIORS; PREFORMED POLYMERS
AB Targeted on the fact that at present the sulphide and cyanide in terminally purified coking wastewater are in excess of the state standard, a new method for effective removal of the sulphide and cyanide comes into being and reaches on ideal result, in which poly-aluminium-ferric-silicate (abbreviated PAFSi) and a little potassium ferrate (K2FeO4) are used respectively for coagulation and oxidation, and a small amount of calcium oxide(CaO) is added for precipitation. The removing rates of the sulphide and cyanide surpass 90% and 85% respectively. The high-efficient oxidation of potassium ferrate and high-efficient coagulation of poly-aluminium-ferric-silicate are analyzed in theory. The impacting factors on the removal of the sulphide and cyanide including pH, temperature and COD were studied experimentally, and therefore the conclusions are reached accordingly. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhu, Kaijin; Ren, Xiaoli; Wei, Jingli; Duan, Xiaofang; Yao, Ling; Zhao, Runzhu] Taiyuan Inst Technol, Dept Environm Engn, Taiyuan 030008, Peoples R China.
RP Zhu, KJ (reprint author), Taiyuan Inst Technol, Dept Environm Engn, Taiyuan 030008, Peoples R China.
EM zkj621104@163.com
CR Akcil A, 2003, BIOTECHNOL ADV, V21, P501, DOI 10.1016/S0734-9750(03)00099-5
   Amuda OS, 2007, J HAZARD MATER, V141, P778, DOI 10.1016/j.jhazmat.2006.07.044
   AWWA Coagulation Committee, 1989, J AM WATER WORKS ASS, V81, p72~78
   Byung RL, 2003, WATER AIR SOIL POLL, V46, p23~33
   Dong Xinjiao, 2002, ENV PROTECTION SCI, V28, p8~10
   James P.H., 1998, J APPL PHYCOL, V34, p757~763
   Jiang JQ, 1998, J CHEM TECHNOL BIOT, V73, P351, DOI 10.1002/(SICI)1097-4660(199812)73:4<351::AID-JCTB964>3.0.CO;2-S
   Junyuan Ji, 2005, IND WATER TREATMENT, V3, p5~6
   Paega JR, 2003, WASTE MANAGE, V23, p183~191
   Shigeo Ban, 1978, WATER SUPPLY IND, V232, P53
   TANG HX, 1987, WATER RES, V21, P115
   TANG HX, 1987, WATER RES, V21, P123
   Zhang J, 2006, WATER SCI TECHNOL, V53, P9, DOI [10.2166/wst.2006.274, 10.2166/wst.2006.202]
   [周静 Zhou Jing], 2008, [工业水处理, Industrial Water Treatment], V28, P35
NR 14
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.896
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404113
DA 2018-12-27
ER

PT S
AU Liang, Z
   Bing, Z
   Long, Y
   Jiang, SX
AF Zhu Liang
   Zou Bing
   Yan Long
   Jiang Suxia
BE Zhou, X
TI RETRACTED: Design of MSP430F249-based Toxic Gas Measure Terminal and
   Alarm Management System (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Toxic Gas; Leak Monitoring; Wireless Transmission; Golble Positioning
   System; SHT11
AB Because of the leak risk of toxic gas in the process of mining and using natural gas, need multi-point detection of toxic gas in a certain area to analyze problems on concentration, designed a toxic gas measure terminal and an alarm management system. The toxic gas measure terminal designed based on high performance microprocessor MSP430F249, and electrochemistry toxic gas sensor integrates temperature and humidity measurement, GPS positioning, wireless transmission into one system. Alarm management system designed based on MFC, it obtains data by transceiver command according to wireless module, and real-time monitors toxic gas concentration in a certain area. This system has small volume and portable convenient, can be used in environmental monitoring and accident emergency. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhu Liang; Zou Bing; Yan Long; Jiang Suxia] State Key Lab Chem Safety & Control, Qingdao 266071, Peoples R China.
RP Liang, Z (reprint author), State Key Lab Chem Safety & Control, Qingdao 266071, Peoples R China.
EM zhul.qday@sinopec.com
CR Barroso Luiz Augusto, 2009, IEEE T POWER SYSTEMS, V23
   Cornejo Alejandro, 2008, IEEE INT C SELF AD S, P292
   Khazini L., 2009, 2 INT C ENV COMP SCI, P309
   Liu Cong, 2009, IEEE T POWER SYSTEMS, V24
   Maleki M., 2003, P IEEE C WIR COMM NE, P16
   Narasimhan B., 2009, INT C ADV COMP CONTR, P344
   Oh I, 2007, ELECTROCHEM SOLID ST, V10, pJ19, DOI 10.1149/1.2400206
   Voiculescu I, 2006, IEEE SENS J, V6, P1094, DOI 10.1109/JSEN.2006.881431
   Zhang B, 2009, 2009 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENT TECHNOLOGY, VOL 3, PROCEEDINGS, P365, DOI 10.1109/ICEET.2009.553
   Zhang W. J., 2006, IEEE T NANOBIOSCIENC, V5
   Zhou Ji-hong, 2010, INT C CHALL ENV SCI, P315
NR 11
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.803
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404020
DA 2018-12-27
ER

PT S
AU Zhu, YC
   Wei, QJ
AF Zhu, Youchan
   Wei, Qiujuan
BE Zhou, X
TI RETRACTED: A Study of Power Marketing System Task Decomposition on Grid
   Computing (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE grid; task decomposition DAG
AB This paper using the features of grid technology, based on the analysis of power marketing system, decomposes the tasks of power marketing system. The requirements of decomposed sub-tasks for grid nodes performance will be greatly reduced, thereby enhancing processing tasks efficiency and grid performance. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhu, Youchan; Wei, Qiujuan] N China Elect Power Univ, Network Management Ctr, Baoding 071003, Hebei Province, Peoples R China.
RP Zhu, YC (reprint author), N China Elect Power Univ, Network Management Ctr, Baoding 071003, Hebei Province, Peoples R China.
EM ZYC_hd@sina.com
CR Chen Ye, 2008, SCI TECH INFORM DEV, V18, P155
   Jingwei Fu, 2002, POWER MARKETING SUPP
   Xiulan Kang, 2007, RES MIN MIN TASK SCH, P5
   Yu Li, 2008, NE DIANLI U, V28, P48
   Zhang Wei, 2004, Automation of Electric Power Systems, V28, P1
   Zhihui Du, 2002, GRID COMPUTING EB OL
   Ziying Tang, 2001, COMPUTER OPERATING S
   Zuowei Huang, 2009, TIANJIN RADIO TELEVI, V13, P62
NR 8
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.900
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096404117
DA 2018-12-27
ER

PT S
AU Zou, J
   Bei, XX
   Wu, J
AF Zou, Jiao
   Bei, Xiaoxu
   Wu, Jian
BE Zhou, X
TI RETRACTED: Urban Arterial Road Traffic Status Identification Based on
   Data Fusion (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE ITS; Camera; FCD; Decision Fusion
AB The accuracy of traffic status based on FCD (Floating Car Data) is related to taxi coverage rate and sample number. Small sample number leads to less accurate results. If no data is uploaded during some period, it will use historical archive data to infer the results which can cause error. To improve reliability of traffic information and provide accurate information to traffic management department, we carried out the traffic information fusion process which is based on camera and FCD. The two data sources can complement each other. The application scenario of this paper is based on information acquired through camera and FCD on main roads of Hefei city. We adopt decision tree methods to integrate these two data sources and get more reliable traffic status which facilitates the management and control of traffic system. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zou, Jiao; Wu, Jian] Anhui Intelligent Transportat Key Lab, Huangshan Rd 628, Hefei 230088, Peoples R China.
RP Zou, J (reprint author), Anhui Intelligent Transportat Key Lab, Huangshan Rd 628, Hefei 230088, Peoples R China.
EM xuejiao35@163.com
CR Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]
   Han J., 2006, DATA MINING CONCEPTS
   Hawas YE, 2007, TRANSPORT RES C-EMER, V15, P69, DOI 10.1016/j.trc.2007.02.001
   Jiang G. Y., 2004, TECHNOLOGIES APPL ID
   Jiang Guiyan, 2006, TRANSPORTATION ENG T, V6, P87
   Jiuh-bijing sheu S. G, 1999, TRANSPORT RES C-EMER, VC6, P315
   Xiao Yonglai, 2005, CHINA TRAFFIC INFORM, V6, P39
   Xiaoguang Yang, 2006, TRAFFIC STATE CLASSI, V1, P4
NR 8
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
DI 10.1016/j.egypro.2011.10.327
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096400127
DA 2018-12-27
ER

PT J
AU Cui, CJ
   Song, F
   Tan, Y
   Zhou, XA
   Zhao, W
   Ma, FY
   Liu, YY
   Hussain, J
   Wang, YS
   Yang, GX
   He, GY
AF Cui, Cuiju
   Song, Fei
   Tan, Yi
   Zhou, Xuan
   Zhao, Wen
   Ma, Fengyun
   Liu, Yunyi
   Hussain, Javeed
   Wang, Yuesheng
   Yang, Guangxiao
   He, Guangyuan
TI RETRACTED: Stable chloroplast transformation of immature scutella and
   inflorescences in wheat (Triticum aestivum L.) (Retracted article. See
   vol. 44, pg. 373, 2012)
SO ACTA BIOCHIMICA ET BIOPHYSICA SINICA
LA English
DT Article; Retracted Publication
DE green fluorescent protein (gfp); site-specific integration; wheat
ID GREEN FLUORESCENT PROTEIN; LACTUCA-SATIVA L.; PLASTID TRANSFORMATION;
   HOMOLOGOUS RECOMBINATION; GENETIC-TRANSFORMATION; TRANSIENT EXPRESSION;
   PLANT-REGENERATION; VISUAL MARKER; FOREIGN DNA; TOBACCO
AB Chloroplast transformation in wheat was achieved by bombardment of scutella from immature embryos and immature inflorescences, respectively. A wheat chloroplast site-specific expression vector, pBAGNRK, was constructed by placing an expression cassette containing neomycin phosphotransferase II (nptII) and green fluorescent protein (gfp) as selection and reporter genes, respectively, in the intergenic spacer between atpB and rbcL of wheat chloroplast genome. Integration of gfp gene in the plastome was identified by polymerase chain reaction (PCR) analysis and Southern blotting using gfp gene as a probe. Expression of GFP protein was examined by western blot. Three positive transformants were obtained and the Southern blot of partial fragment of atpB and rbcL (targeting site) probes verified that one of them was homoplasmic. Stable expression of GFP fluorescence was confirmed by confocal microscopy in the leaf tissues from T-1 progeny seedlings. PCR analysis of gfp gene also confirmed the inheritance of transgene in the T-1 progeny. These results strengthen the feasibility of wheat chloroplast transformation and also give a novel method for the introduction of important agronomic traits in wheat through chloroplast transformation.
C1 [Cui, Cuiju; Song, Fei; Tan, Yi; Zhou, Xuan; Zhao, Wen; Ma, Fengyun; Liu, Yunyi; Hussain, Javeed; Wang, Yuesheng; Yang, Guangxiao; He, Guangyuan] Huazhong Univ Sci & Technol, China UK HUST RRes Genet Engn & Genom Joint Lab, Genet Engn Int Cooperat Base,Key Lab Mol Biophys, Minist Sci & Technol,Minist Educ,Coll Life Sci &, Wuhan 430074, Peoples R China.
RP He, GY (reprint author), Huazhong Univ Sci & Technol, China UK HUST RRes Genet Engn & Genom Joint Lab, Genet Engn Int Cooperat Base,Key Lab Mol Biophys, Minist Sci & Technol,Minist Educ,Coll Life Sci &, Wuhan 430074, Peoples R China.
EM hegy@hust.edu.cn
FU Genetically Modified New Varieties of Major Projects of China
   [2008ZX08002-004, 2009ZX08002-013B, 2009DFB30340]; National Natural
   Science Foundation of China [30871524]
FX This work was supported by grants from the Genetically Modified New
   Varieties of Major Projects of China (2008ZX08002-004; 2009ZX08002-013B;
   2009DFB30340) and National Natural Science Foundation of China
   (30871524).
CR Barro F, 1998, THEOR APPL GENET, V97, P684, DOI 10.1007/s001220050944
   BENDICH A, 2005, BIOESSAYS, V6, P279
   Bock R, 2001, J MOL BIOL, V312, P425, DOI 10.1006/jmbi.2001.4960
   Bogorad L, 2000, TRENDS BIOTECHNOL, V18, P257, DOI 10.1016/S0167-7799(00)01444-X
   BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716
   CARRER H, 1993, MOL GEN GENET, V241, P49, DOI 10.1007/BF00280200
   Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9
   Daniell H, 2002, NAT BIOTECHNOL, V20, P581, DOI 10.1038/nbt0602-581
   Daniell H, 2002, TRENDS PLANT SCI, V7, P84, DOI 10.1016/S1360-1385(01)02193-8
   DANIELL H, 1991, PLANT CELL REP, V9, P615, DOI 10.1007/BF00231800
   Davarpanah SJ, 2009, J PLANT BIOL, V52, P244, DOI 10.1007/s12374-009-9023-0
   De Cosa B, 2001, NAT BIOTECHNOL, V19, P71, DOI 10.1038/83559
   De Marchis F, 2009, TRANSGENIC RES, V18, P17, DOI 10.1007/s11248-008-9193-4
   Dufourmantel N, 2004, PLANT MOL BIOL, V55, P479, DOI 10.1007/s11103-004-0192-4
   FROMM H, 1987, EMBO J, V6, P3233, DOI 10.1002/j.1460-2075.1987.tb02640.x
   FUJITANI Y, 1995, GENETICS, V140, P797
   Grevich JJ, 2005, CRIT REV PLANT SCI, V24, P83, DOI 10.1080/07352680590935387
   He GY, 2001, PLANT CELL REP, V20, P67, DOI 10.1007/s002990000285
   He GY, 2001, EUPHYTICA, V119, P369, DOI 10.1023/A:1017587628995
   Hibberd JM, 1998, PLANT J, V16, P627, DOI 10.1046/j.1365-313x.1998.00328.x
   HONORE N, 1995, ANTIMICROB AGENTS CH, V39, P769, DOI 10.1128/AAC.39.3.769
   Hou BK, 2003, TRANSGENIC RES, V12, P111, DOI 10.1023/A:1022180315462
   Jones HD, 2005, J CEREAL SCI, V41, P137, DOI 10.1016/j.jcs.2004.08.009
   Jordan MC, 2000, PLANT CELL REP, V19, P1069, DOI 10.1007/s002990000246
   Kanamoto H, 2006, TRANSGENIC RES, V15, P205, DOI 10.1007/s11248-005-3997-2
   Koya V, 2005, IN VITRO CELL DEV-PL, V41, P388, DOI 10.1079/IVP2005660
   Kumar S, 2004, PLANT MOL BIOL, V56, P203, DOI 10.1007/s11103-004-2907-y
   Kumar S, 2004, PLANT PHYSIOL, V136, P2843, DOI 10.1104/pp.104.045187
   Lee SM, 2006, MOL CELLS, V21, P401
   Lelivelt CLC, 2005, PLANT MOL BIOL, V58, P763, DOI 10.1007/s11103-005-7704-8
   Liu CW, 2007, PLANT CELL REP, V26, P1733, DOI 10.1007/s00299-007-0374-z
   McCormac AC, 1998, EUPHYTICA, V99, P17, DOI 10.1023/A:1018303102488
   MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x
   Nugent GD, 2006, PLANT SCI, V170, P135, DOI 10.1016/j.plantsci.2005.08.020
   Okumura S, 2006, TRANSGENIC RES, V15, P637, DOI 10.1007/s11248-006-9009-3
   Ruf S, 2001, NAT BIOTECHNOL, V19, P870, DOI 10.1038/nbt0901-870
   SAMBROOK J, 1989, MOL CLONING
   Sattarzadeh A, 2010, PLANT BIOTECHNOL J, V8, P112, DOI [10.1111/j.1467-/652.2009.00463.x, 10.1111/j.1467-7652.2009.00463.x]
   Scotti N, 2009, PLANTA, V229, P1109, DOI 10.1007/s00425-009-0898-2
   SHEN P, 1986, GENETICS, V112, P441
   Shepherd CT, 2008, CEREAL CHEM, V85, P188, DOI 10.1094/CCHEM-85-2-0188
   Sidorov VA, 1999, PLANT J, V19, P209, DOI 10.1046/j.1365-313X.1999.00508.x
   Sikdar SR, 1998, PLANT CELL REP, V18, P20, DOI 10.1007/s002990050525
   Skarjinskaia M, 2003, TRANSGENIC RES, V12, P115, DOI 10.1023/A:1022110402302
   Sparks CA, 2004, TRANSGENIC CROPS WOR
   STAUB J, 2002, PLANT J, V7, P845
   SVAB Z, 1993, P NATL ACAD SCI USA, V90, P913, DOI 10.1073/pnas.90.3.913
   Vain P, 1998, THEOR APPL GENET, V96, P164, DOI 10.1007/s001220050723
   Wang HH, 2009, J GENET GENOMICS, V36, P387, DOI 10.1016/S1673-8527(08)60128-9
   Weir B, 2001, AUST J PLANT PHYSIOL, V28, P807, DOI 10.1071/PP99211
   YE GN, 1990, PLANT MOL BIOL, V15, P809, DOI 10.1007/BF00039421
   Yu Y, 2008, PLANT BREEDING, V127, P249, DOI 10.1111/j.1439-0523.2007.01461.x
   Zubko MK, 2004, TRANSGENIC RES, V13, P523, DOI 10.1007/s11248-004-2374-x
NR 53
TC 24
Z9 31
U1 3
U2 32
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1672-9145
J9 ACTA BIOCH BIOPH SIN
JI Acta Biochim. Biophys. Sin.
PY 2011
VL 43
IS 4
BP 284
EP 291
DI 10.1093/abbs/gmr008
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 740LN
UT WOS:000288796200006
PM 21343162
OA Bronze
DA 2018-12-27
ER

PT J
AU Das, M
   Sahoo, SK
AF Das, Manasi
   Sahoo, Sanjeeb K.
TI RETRACTED: Epithelial cell adhesion molecule targeted nutlin-3a loaded
   immunonanoparticles for cancer therapy (Retracted article. See vol. 9,
   pg. 7076, 2013)
SO ACTA BIOMATERIALIA
LA English
DT Article; Retracted Publication
DE Targeted cancer therapy; Nutlin-3a; Nanoparticle; Surface
   functionalization; p53 activation
ID BIODEGRADABLE NANOPARTICLES; P53-INDUCED APOPTOSIS;
   MULTIDRUG-RESISTANCE; PLGA NANOPARTICLES; MDM2 ANTAGONISTS; GENE
   DELIVERY; P53 PATHWAY; IN-VIVO; EP-CAM; C-MYC
AB Recently much attention has been given to the anti-cancer drug nutlin-3a, an antagonist of murine double minute 2 (MDM2) that actively inhibits p53-MDM2 interaction. Reactivating p53 function by nutlin-3a thus provides a promising therapeutic strategy for the treatment of cancer. Although nutlin-3a seems a potential candidate in restoring p53 activity, it has many lacunae, toxicity, poor bioavailability, nonspecific delivery, and most importantly it is a substrate of multidrug resistance protein. The objective of the present study is to prepare and characterize nutlin-3a loaded poly(lactide-co-glycolide) (PLGA) nanoparticles (NPs), surface functionalized with epithelial cell adhesion molecule (EpCAM) antibody, with an aim to deliver encapsulated drug in a targeted manner to its site of action and to enhance its therapeutic efficacy many times over. The enhanced cellular uptake of EpCAM antibody conjugated nutlin-3a loaded NPs (EpCAM-nutlin-3a-NPs) over native nulin-3a, nutlin-3a loaded NPs (nutlin-3a-NPs) in HCT116 and A549 cells substantiate the targeting potentiality of conjugated system. IC50 values depicted superior antiproliferative activity of EpCAM-nutlin-3a-NPs over nutlin-3a-NPs and native nutlin-3a in the above studied cell lines. Cell cycle arrest, loss of mitochondrial membrane potential and apoptosis induced by above formulation were confirmed by flow cytometry. Expression of p53, p21, EpCAM, and C-myc proteins involved in cell cycle regulation and apoptosis were investigated by western blotting. The above investigation indicates the enhanced therapeutic ability of EpCAM-nutlin-3a-NPs compared to nutlin-3a or nutlin-3a-NPs. Thus, our results suggest that EpCAM-nutlin-3a-NPs could be a potentially useful drug carrier system for targeted delivery of potent anti-cancer drug nutlin-3a for cancer therapy. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Sahoo, Sanjeeb K.] Inst Life Sci, Lab Nanomed, Bhubaneswar 751023, Orissa, India.
RP Sahoo, SK (reprint author), Inst Life Sci, Lab Nanomed, Bhubaneswar 751023, Orissa, India.
EM sanjeebsahoo2005@gmail.com
FU Department of Science and Technology, Government of India
   [INT/AUS/P-8/06]
FX We are thankful for the financial support of the Department of Science
   and Technology, Government of India (Grant No. INT/AUS/P-8/06).
CR Acharya S, 2009, BIOMATERIALS, V30, P5737, DOI 10.1016/j.biomaterials.2009.07.008
   Bottger A, 1997, J MOL BIOL, V269, P744, DOI 10.1006/jmbi.1997.1078
   COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438
   Das M, 2009, EXPERT OPIN DRUG DEL, V6, P285, DOI 10.1517/17425240902780166
   Ding K, 2005, J AM CHEM SOC, V127, P10130, DOI 10.1021/ja051147z
   Fauvet R, 2005, J SURG ONCOL, V92, P337, DOI 10.1002/jso.20424
   Guillemard V, 2001, CANCER RES, V61, P694
   GUILLOUF C, 1995, BLOOD, V85, P2691
   Hainaut P, 2000, ADV CANCER RES, V77, P81
   HARPER JW, 1993, CELL, V75, P805
   Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7
   Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312
   Jain TK, 2008, BIOMATERIALS, V29, P4012, DOI 10.1016/j.biomaterials.2008.07.004
   Jinno H, 2002, BIOMED PHARMACOTHER, V56, p213S
   Kim BS, 2008, ARCH PHARM RES, V31, P1050, DOI 10.1007/s12272-001-1267-5
   Kocbek P, 2007, J CONTROL RELEASE, V120, P18, DOI 10.1016/j.jconrel.2007.03.012
   Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7
   Lee E, 2006, ARCH PHARM RES, V29, P1018, DOI 10.1007/BF02969286
   Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1
   Li XM, 2009, INT J PHARMACEUT, V373, P116, DOI 10.1016/j.ijpharm.2009.01.023
   Maaser K, 2008, BRIT J CANCER, V99, P1635, DOI 10.1038/sj.bjc.6604725
   Michaelis M, 2009, CANCER RES, V69, P416, DOI 10.1158/0008-5472.CAN-08-1856
   Misra R, 2010, EUR J PHARM SCI, V39, P152, DOI 10.1016/j.ejps.2009.11.010
   Misra R, 2009, NANOMEDICINE-UK, V4, P519, DOI 10.2217/NNM.09.28
   Miyachi M, 2009, CLIN CANCER RES, V15, P4077, DOI 10.1158/1078-0432.CCR-08-2955
   MIYASHITA T, 1995, CELL, V80, P293
   Mo Y, 2005, J CONTROL RELEASE, V108, P244, DOI 10.1016/j.jconrel.2005.08.013
   Momand J, 1997, J CELL BIOCHEM, V64, P343
   Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610
   Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3
   Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053
   Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com
   Panyam J, 2003, INT J PHARM, V262, P1, DOI 10.1016/S0378-5173(03)00295-3
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Panyam J, 2004, MOL PHARMACEUT, V1, P77, DOI 10.1021/mp034002c
   Park JS, 2006, J CONTROL RELEASE, V115, P37, DOI 10.1016/j.jconrel.2006.07.011
   Parveen S, 2008, J DRUG TARGET, V16, P108, DOI [10.1080/10611860701794353, 10.1080/10611860701794353 ]
   Reddy MK, 2008, CIRC-CARDIOVASC INTE, V1, P209, DOI 10.1161/CIRCINTERVENTIONS.108.830018
   Sahoo SK, 2005, MOL PHARMACEUT, V2, P373, DOI 10.1021/mp050032z
   Sahoo SK, 2004, INT J CANCER, V112, P335, DOI 10.1002/ijc.20405
   Sahoo SK, 2003, DRUG DISCOV TODAY, V8, P1112, DOI 10.1016/S1359-6446(03)02903-9
   Spizzo G, 2006, GYNECOL ONCOL, V103, P483, DOI 10.1016/j.ygyno.2006.03.035
   Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200
   Torchilin VP, 2003, P NATL ACAD SCI USA, V100, P6039, DOI 10.1073/pnas.0931428100
   Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103
   Tseng CL, 2007, BIOMATERIALS, V28, P3996, DOI 10.1016/j.biomaterials.2007.05.006
   Van Maerken T, 2006, CANCER RES, V66, P9646, DOI 10.1158/0008-5472.CAN-06-0792
   Vassilev LT, 2005, J MED CHEM, V48, P4491, DOI 10.1021/jm058174k
   Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472
   Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002
   Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864
   Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924
   Winkler J, 2009, MOL CANCER THER, V8, P2674, DOI 10.1158/1535-7163.MCT-09-0402
   You J, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/04/045102
   ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661
   Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883
NR 56
TC 20
Z9 21
U1 1
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2011
VL 7
IS 1
BP 355
EP 369
DI 10.1016/j.actbio.2010.08.010
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 687RJ
UT WOS:000284795300034
PM 20727991
DA 2018-12-27
ER

PT J
AU El Fadl, KA
   Ragy, N
   El Batran, M
   Kassem, N
   Nasry, SA
   Khalifa, R
   Sedrak, H
   Isenovic, ER
AF El Fadl, Khaled Abou
   Ragy, Nivine
   El Batran, Mona
   Kassem, Neemat
   Nasry, Sherine A.
   Khalifa, Rania
   Sedrak, Heba
   Isenovic, Esma R.
TI RETRACTED: Periodontitis and Cardiovascular Disease: Floss and Reduce a
   Potential Risk Factor for CVD (Retracted Article. See vol 62, pg 352,
   2011)
SO ANGIOLOGY
LA English
DT Article; Retracted Publication
DE Periodontitis; cardiovascular disease; C-reactive protein; interleukin 6
ID C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; SYSTEMIC INFLAMMATION;
   INNOCENT BYSTANDER; ATHEROSCLEROSIS; INFECTIONS; INTERLEUKIN-6; MARKERS;
   METAANALYSIS; MORTALITY
AB There is evidence supporting an association between cardiovascular disease (CVD) and periodontitis. We determined whether patients with chronic periodontitis, who are otherwise healthy individuals, have higher serum concentrations of emerging risk markers of CVD such as C-reactive protein (CRP) and interleukin 6 (IL-6) and investigated the effect of subsequent periodontal treatment on the levels of these markers. A total of 40 individuals were included in the study. Serum levels of CRP and IL-6 were estimated twice, once on the initial visits and the other 3 months after periodontal therapy. The mean CRP and IL-6 levels were significantly higher (P < .001) in the patients compared with controls and significantly decreased (P < .001) following periodontal treatment. This study suggests that periodontitis is a potential modifiable risk factor for CVD.
C1 [El Fadl, Khaled Abou; Ragy, Nivine] Cairo Univ, Dept Oral Med Periodontol & Diag, Fac Oral & Dent Med, Cairo, Egypt.
   [El Batran, Mona; Nasry, Sherine A.] Natl Res Ctr, Dept Oral & Dent Med Res, Cairo, Egypt.
   [Kassem, Neemat; Khalifa, Rania] Cairo Univ, Dept Clin Pathol, Kasr Al Aini, Egypt.
   [Sedrak, Heba] Cairo Univ, Dept Internal Med, Kasr Al Aini, Egypt.
   [Isenovic, Esma R.] Univ Belgrade, Vinca Inst, Dept Mol Genet & Radiobiol, Belgrade, Serbia.
RP Kassem, N (reprint author), 9 St,275, Cairo, Egypt.
EM nkkassem@hotmail.com
OI Nasry, Sherine/0000-0002-3764-9562
CR Athyros VG, 2008, ATHEROSCLEROSIS, V200, P1, DOI 10.1016/j.atherosclerosis.2008.02.026
   BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6
   Beck J D, 1998, Ann Periodontol, V3, P127, DOI 10.1902/annals.1998.3.1.127
   Brunetti ND, 2007, INT J CARDIOL, V120, P131, DOI 10.1016/j.ijcard.2006.08.113
   D'Aiuto F, 2005, INFLAMM RES, V54, P412, DOI 10.1007/s00011-005-1375-4
   D'Aiuto F, 2004, CYTOKINE, V28, P29, DOI 10.1016/j.cyto.2004.06.005
   D'Aiuto F, 2004, J DENT RES, V83, P156, DOI 10.1177/154405910408300214
   D'Aiuto F, 2006, AM HEART J, V151, P977, DOI 10.1016/j.ahj.2005.06.018
   Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078
   Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772
   Ebersole JL, 2000, PERIODONTOL 2000, V23, P19, DOI 10.1034/j.1600-0757.2000.2230103.x
   HAKKE SK, 2002, CLIN PERIODONTOLOGY, P132
   Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430
   Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554
   Hujoel PP, 2002, PERIODONTOL 2000, V30, P51, DOI 10.1034/j.1600-0757.2002.03005.x
   Ide M, 2003, J CLIN PERIODONTOL, V30, P334, DOI 10.1034/j.1600-051X.2003.00282.x
   Ide M, 2004, J PERIODONTOL, V75, P420, DOI 10.1902/jop.2004.75.3.420
   Ioannidou E, 2006, J PERIODONTOL, V77, P1635, DOI 10.1902/jop.2006.050443
   Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7
   Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96
   Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
   Loos BG, 2000, J PERIODONTOL, V71, P1528, DOI 10.1902/jop.2000.71.10.1528
   Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8
   Nakajima T, 2010, J PERIODONTAL RES, V45, P116, DOI 10.1111/j.1600-0765.2009.01209.x
   Nakajima T, 2009, ODONTOLOGY, V97, P84, DOI 10.1007/s10266-009-0104-9
   Noack B, 2001, J PERIODONTOL, V72, P1221, DOI 10.1902/jop.2000.72.9.1221
   OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38
   Papapanou P N, 1996, Ann Periodontol, V1, P1, DOI 10.1902/annals.1996.1.1.1
   Paraskevas KI, 2008, CURR MED RES OPIN, V24, P75, DOI 10.1185/030079908X253654
   Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x
   Rattazzi M, 2003, J HYPERTENS, V21, P1787, DOI 10.1097/01.hjh.0000084735.53355.44
   Salzberg TN, 2006, J PERIODONTOL, V77, P933, DOI 10.1902/jop.2006.050165
   Schei O, 1959, J PERIODONTOL, V30, P7
   Scirica BM, 2006, CIRCULATION, V113, P2128, DOI 10.1161/CIRCULATIONAHA.105.611350
   Slade GD, 2003, ARCH INTERN MED, V163, P1172, DOI 10.1001/archinte.163.10.1172
   Smith GD, 2006, ANN INTERN MED, V145, P70, DOI 10.7326/0003-4819-145-1-200607040-00130
   Verma S, 2006, CIRCULATION, V113, P2135
   Vita JA, 2002, CIRCULATION, V106, P164, DOI 10.1161/01.CIR.0000023452.26135.34
   Yamazaki K, 2002, INFECT IMMUN, V70, P2492, DOI 10.1128/IAI.70.5.2492-2501.2002
NR 39
TC 5
Z9 5
U1 3
U2 16
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0003-3197
EI 1940-1574
J9 ANGIOLOGY
JI Angiology
PD JAN
PY 2011
VL 62
IS 1
BP 62
EP 67
DI 10.1177/0003319710371617
PG 6
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 690KU
UT WOS:000285004500011
PM 20547538
DA 2018-12-27
ER

PT J
AU Amin, GA
   Bazaid, SA
   Youssef, NA
   Saleh, WD
AF Amin, Gamil Abd El Fattah
   Bazaid, S. Ali
   Youssef, Narmen Ahmed
   Saleh, Waleed Diaeddeen
TI RETRACTED: Assessment of insecticidal activity of red pigment produced
   by the fungus Beauveria bassiana (Retracted article. See vol. 62, pg.
   147, 2016)
SO ARCHIVES OF AGRONOMY AND SOIL SCIENCE
LA English
DT Article; Retracted Publication
ID ENTOMOPATHOGENIC FUNGUS; BIOINSECTICIDE PRODUCTION;
   BACILLUS-THURINGIENSIS; GROWTH; PATHOGENICITY; METABOLITES; METARHIZIUM;
   OOSPOREIN; MORTALITY; CORN
AB Insecticidal activity of the red pigment produced by a strain of the fungus Beauveria bassiana that was locally isolated from infected whitefly, Bemisia tabaci (Genn.) was assessed. The pigment is produced extracellularly and is water-soluble. This makes it easy and simple to be recovered from fermentation broth and used in pathogenicity experiments. When applied alone to B. tabaci nymphs, mortality percentages of 18% was recorded. For nymphs treated with B. bassiana spore suspension, mortality was 60%. The best results were obtained when red pigment was combined with fungal spores with the mortality percentage being increased to up to 92%. The highest virulence against adults emerged later on from the surviving larvae of B. tabaci and the longest days to pupation were also recorded with this treatment.
RP Amin, GA (reprint author), Taif Univ, El Hayeya, Saudi Arabia.
EM gamilamin2007@hotmail.com
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Amin G, 2008, WORLD J MICROB BIOT, V24, P2465, DOI 10.1007/s11274-008-9816-1
   Amin G., 2008, Archives of Agronomy and Soil Science, V54, P387, DOI 10.1080/03650340802158201
   BASYOUNI SH, 1966, CAN J BIOCHEM CELL B, V44, P557
   Bing L.A., 1992, Biocontrol Science and Technology, V2, P39, DOI 10.1080/09583159209355216
   Brownbridge M, 2001, J INVERTEBR PATHOL, V77, P280, DOI 10.1006/jipa.2001.5020
   Clarkson JM, 1996, TRENDS MICROBIOL, V4, P197, DOI 10.1016/0966-842X(96)10022-6
   Culliney TW, 2000, B ENTOMOL RES, V90, P9, DOI 10.1017/S0007485300000663
   EYAL J, 1994, APPL BIOCHEM BIOTECH, V44, P65, DOI 10.1007/BF02921852
   Finney D. J., 1971, PROBIT ANAL
   Grogan GJ, 2000, J MOL CATAL B-ENZYM, V9, P1, DOI 10.1016/S1381-1177(99)00080-6
   HALL RA, 1985, BIOL PEST CONTROL GL, P116
   Hamano PS, 2005, BRAZ ARCH BIOL TECHN, V48, P43, DOI 10.1590/S1516-89132005000400006
   Juzlova P, 1996, J IND MICROBIOL, V16, P163, DOI 10.1007/BF01569999
   Kirkland BH, 2004, J MED ENTOMOL, V41, P705, DOI 10.1603/0022-2585-41.4.705
   Klingen I, 2002, J APPL ENTOMOL, V126, P231, DOI 10.1046/j.1439-0418.2002.00636.x
   Leckie BM, 2008, BIOCONTROL SCI TECHN, V18, P697, DOI 10.1080/09583150802262906
   Lewis LC, 2001, CROP SCI, V41, P1395, DOI 10.2135/cropsci2001.4151395x
   NARMEN AY, 1998, THESIS FAYOUM U GIZA
   PEGRAM RA, 1982, AVIAN DIS, V26, P47, DOI 10.2307/1590024
   Quesada-Moraga E, 2004, MYCOL RES, V108, P441, DOI 10.1017/S0953756204009724
   Seger C, 2005, HELV CHIM ACTA, V88, P802, DOI 10.1002/hlca.200590057
   SNEDECTOR GW, 1956, STAT METHODS
   Strasser H, 2000, BIOCONTROL SCI TECHN, V10, P717, DOI 10.1080/09583150020011690
   Takahashi S, 1998, J ANTIBIOT, V51, P1051, DOI 10.7164/antibiotics.51.1051
   Van Driesche R., 1996, BIOL CONTROL
   Vey A., 2001, Fungi as biocontrol agents: progress, problems and potential, P311, DOI 10.1079/9780851993560.0311
NR 27
TC 1
Z9 1
U1 5
U2 19
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0365-0340
EI 1476-3567
J9 ARCH AGRON SOIL SCI
JI Arch. Agron. Soil Sci.
PY 2011
VL 57
IS 4
BP 435
EP 443
DI 10.1080/03650341003587206
PG 9
WC Agronomy; Soil Science
SC Agriculture
GA 890MM
UT WOS:000300148800008
DA 2018-12-27
ER

PT J
AU Cavus, N
AF Cavus, Nadire
TI RETRACTED: The application of a multi-attribute decision-making
   algorithm to learning management systems evaluation (Retracted article.
   See vol. 48, pg. 1512, 2017)
SO BRITISH JOURNAL OF EDUCATIONAL TECHNOLOGY
LA English
DT Article; Retracted Publication
AB Recently, because of the rapid increase in the popularity of the Internet, the delivery of learning programmes has gradually shifted from local desktop to online-based applications. As more and more technological tools become available for online education, there is an increasing interest among educators and other professionals in the application of these tools with regard to online courses. In large-scale operations, online learning management systems (LMSs) can save cost and time. LMSs are software applications that comprise a suite of tools for learning and teaching online. In conventional educational settings, online LMSs can help to improve the speed and effectiveness of the educational process, communication among learners, and also between staff and students. There are a large number of open-source and commercially available LMSs on the marketplace, and one of the problems facing an administrator or instructor is how to choose the LMS that can meet his/her needs. This paper describes a software system developed by the author to aid in the selection of a suitable LMS. The software is a web-based decision support system, titled Easy Way to Evaluate LMSs, and is based on using a multi-attribute decision-making algorithm for the effective selection of an LMS.
C1 [Cavus, Nadire] Near East Univ, Dept Comp Informat Syst, CY-98010 Nicosia, Cyprus.
RP Cavus, N (reprint author), Near East Univ, Dept Comp Informat Syst, CY-98010 Nicosia, Cyprus.
EM nadirecavus@neu.edu.tr
CR ARH T, 2007, MULTI ATTR DEC SUPP
   Arh T, 2007, J COMPUT, V2, P28, DOI 10.4304/jcp.2.10.28-37
   Bohanec M., 1999, Informatica, V23, P487
   Bohanec M., 1995, ORGANIZACIJA, V28, P427
   Cavus Nadire, 2007, Journal of Educational Computing Research, V36, P301, DOI 10.2190/T728-G676-4N18-6871
   Cavus N, 2009, PROCD SOC BEHV, V1, P426, DOI 10.1016/j.sbspro.2009.01.076
   Cavus N, 2009, BRIT J EDUC TECHNOL, V40, P78, DOI 10.1111/j.1467-8535.2007.00801.x
   CHANKONG V, 1983, MULTIOBJ DEC MAK THE
   Hanna DE, 2003, HANDBOOK OF DISTANCE EDUCATION, P67
   Johnson R, 2003, BRIT J EDUC TECHNOL, V34, P479, DOI 10.1111/1467-8535.00344
   KEENEY RL, 1976, DEC MULT OBJECT
   MITRA G, 1986, COMP ASSIST DEC MAK
   MOORE M, 2003, HDBK DIST EDU
   NAIDU S, 2006, E LEARN GDBK PRINC
   RAJKOVIC V, 1988, ACTA PSYCHOL, V68, P271, DOI 10.1016/0001-6918(88)90060-1
   Zedeh L. A., 1989, IEEE Transactions on Knowledge and Data Engineering, V1, P89, DOI 10.1109/69.43406
NR 16
TC 13
Z9 14
U1 2
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-1013
EI 1467-8535
J9 BRIT J EDUC TECHNOL
JI Br. J. Educ. Technol.
PD JAN
PY 2011
VL 42
IS 1
BP 19
EP 30
DI 10.1111/j.1467-8535.2009.01033.x
PG 12
WC Education & Educational Research
SC Education & Educational Research
GA 709IG
UT WOS:000286431100018
DA 2018-12-27
ER

PT J
AU Mehta, PP
   Kung, PP
   Yamazaki, S
   Walls, M
   Shen, A
   Nguyen, L
   Gehring, MR
   Los, G
   Smeal, T
   Yin, MJ
AF Mehta, Pramod P.
   Kung, Pei-Pei
   Yamazaki, Shinji
   Walls, Marlena
   Shen, Andrea
   Nguyen, Leslie
   Gehring, Michael R.
   Los, Gerrit
   Smeal, Tod
   Yin, Min-Jean
TI RETRACTED: A novel class of specific Hsp90 small molecule inhibitors
   demonstrate in vitro and in vivo anti-tumor activity in human melanoma
   cells (Retracted article. See vol. 422, pg. 132, 2018)
SO CANCER LETTERS
LA English
DT Article; Retracted Publication
DE Hsp90; B-Raf; Melanoma; Cancer drug
ID BREAST-CANCER CELLS; SHOCK-PROTEIN 90; B-RAF; FEEDBACK PHOSPHORYLATION;
   CHAPERONE; KINASE; BRAF; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN;
   MUTATIONS; TRANSFORMATION
AB Hsp90 is required for conformational maturation and stability of numerous key signaling proteins (clients) involved in cell proliferation and transformation Here we describe two novel Hsp90 inhibitors PF-4470296 and PF-3823863 demonstrate a differential sensitivity in B-Raf mutant (V600E) versus wild-type protein degradation These two inhibitors inhibit proliferation and anchorage-independent growth and abolish in vivo xenograft tumor growth in melanoma cells regardless of B-Raf mutation status Mutant B-Raf protein and other Hsp90 clients such as cMet ErbB2 C-Raf and ART are degraded in cells and xenograft tumors Our results indicate that Hsp90 inhibitors induce anti-tumor activity in melanoma cells and are likely to show therapeutic benefit in melanoma patients by collaboratively targeting multiple pathways (c) 2010 Elsevier Ireland Ltd All rights reserved
C1 [Mehta, Pramod P.; Kung, Pei-Pei; Yamazaki, Shinji; Walls, Marlena; Shen, Andrea; Nguyen, Leslie; Gehring, Michael R.; Los, Gerrit; Smeal, Tod; Yin, Min-Jean] Pfizer Worldwide Res & Dev, Oncol Res, San Diego, CA 92121 USA.
RP Yin, MJ (reprint author), Pfizer Worldwide Res & Dev, Oncol Res, 10724 Sci Ctr Dr, San Diego, CA 92121 USA.
CR Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245
   Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612
   Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200
   Beliakoff J, 2004, ANTI-CANCER DRUG, V15, P651, DOI 10.1097/01.cad.0000136876.11928.be
   Brummer T, 2003, ONCOGENE, V22, P8823, DOI 10.1038/sj.onc.1207185
   Burger AM, 2004, ANTI-CANCER DRUG, V15, P377, DOI 10.1097/01.cad.0000124496.74538.e4
   Connell P, 2001, NAT CELL BIOL, V3, P93
   Cox AD, 2010, CANCER CELL, V17, P221, DOI 10.1016/j.ccr.2010.02.029
   Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766
   Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632
   Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055
   Egorin MJ, 2001, CANCER CHEMOTH PHARM, V47, P291, DOI 10.1007/s002800000242
   Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313
   Friday BB, 2008, CANCER RES, V68, P6145, DOI 10.1158/0008-5472.CAN-08-1430
   Ge J, 2006, J MED CHEM, V49, P4606, DOI 10.1021/jm0603116
   Goetz MP, 2005, J CLIN ONCOL, V23, P1078, DOI 10.1200/JCO.2005.09.119
   Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103
   Guo WC, 2005, CANCER RES, V65, P10006, DOI 10.1158/0005-5472.CAN-05-2029
   Hingorani SR, 2003, CANCER RES, V63, P5198
   Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720
   Kaur G, 2004, CLIN CANCER RES, V10, P4813, DOI 10.1158/1078-0432.CCR-03-0795
   Kelland LR, 1999, J NATL CANCER I, V91, P1940, DOI 10.1093/jnci/91.22.1940
   Kung PP, 2008, BIOORG MED CHEM LETT, V18, P6273, DOI 10.1016/j.bmcl.2008.09.081
   Kung PP, 2010, J MED CHEM, V53, P499, DOI 10.1021/jm901209q
   Omholt K, 2002, CLIN CANCER RES, V8, P3468
   Osipo C, 2008, ONCOGENE, V27, P5019, DOI 10.1038/onc.2008.149
   Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902
   Reifenberger J, 2004, INT J CANCER, V109, P377, DOI 10.1002/ijc.11722
   Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09
   Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y
   Sala E, 2008, MOL CANCER RES, V6, P751, DOI 10.1158/1541-7786.MCR-07-2001
   Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543
   Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474
   Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962
   Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933
   Solit DB, 2008, CLIN CANCER RES, V14, P8302, DOI 10.1158/1078-0432.CCR-08-1002
   SUPKO JG, 1995, CANCER CHEMOTH PHARM, V36, P305, DOI 10.1007/BF00689048
   Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105
   Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1
   Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433
   WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324
   Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716
   Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012
   XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074
NR 44
TC 14
Z9 14
U1 3
U2 5
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3835
EI 1872-7980
J9 CANCER LETT
JI Cancer Lett.
PD JAN 1
PY 2011
VL 300
IS 1
BP 30
EP 39
DI 10.1016/j.canlet.2010.09.002
PG 10
WC Oncology
SC Oncology
GA 693JR
UT WOS:000285220900004
PM 20926183
DA 2018-12-27
ER

PT J
AU Singh, T
   Vaid, M
   Katiyar, N
   Sharma, S
   Katiyar, SK
AF Singh, Tripti
   Vaid, Mudit
   Katiyar, Nandan
   Sharma, Samriti
   Katiyar, Santosh K.
TI RETRACTED: Berberine, an isoquinoline alkaloid, inhibits melanoma cancer
   cell migration by reducing the expressions of cyclooxygenase-2,
   prostaglandin E-2 and prostaglandin E-2 receptors (Retracted article.
   See vol. 39, pg. 738, 2018)
SO CARCINOGENESIS
LA English
DT Article; Retracted Publication
ID GRAPE SEED PROANTHOCYANIDINS; MOUSE SKIN; INFLAMMATORY RESPONSES;
   CUTANEOUS MELANOMA; GUANYLATE-CYCLASE; CARCINOMA-CELLS; NITRIC-OXIDE;
   LUNG-CANCER; APOPTOSIS; ARREST
AB Melanoma is the leading cause of death from skin disease due, in large part, to its propensity to metastasize. We have examined the effect of berberine, an isoquinoline alkaloid, on human melanoma cancer cell migration and the molecular mechanisms underlying these effects using melanoma cell lines, A375 and Hs294. Using an in vitro cell migration assay, we show that over expression of cyclooxygenase (COX)-2, its metabolite prostaglandin E-2 (PGE(2)) and PGE(2) receptors promote the migration of cells. We found that treatment of A375 and Hs294 cells with berberine resulted in concentration-dependent inhibition of migration of these cells, which was associated with a reduction in the levels of COX-2, PGE(2) and PGE(2) receptors (EP2 and EP4). Treatment of cells with celecoxib, a COX-2 inhibitor, or transient transfection of cells with COX-2 small interfering RNA, also inhibited cell migration. Treatment of the cells with 12-O-tetradecanoylphorbol-13-acetate (TPA), an inducer of COX-2 or PGE(2), enhanced cell migration, whereas berberine inhibited TPA- or PGE(2)-promoted cell migration. Berberine reduced the basal levels as well as PGE(2)-stimulated expression levels of EP2 and EP4. Treatment of the cells with the EP4 agonist stimulated cell migration and berberine blocked EP4 agonist-induced cell migration activity. Moreover, berberine inhibited the activation of nuclear factor-kappa B (NE-kappa B), an upstream regulator of COX-2, in A375 cells, and treatment of cells with caffeic acid phenethyl ester, an inhibitor of NE-kappa B, inhibited cell migration. Together, these results indicate for the first time that berberine inhibits melanoma cell migration, an essential step in invasion and metastasis, by inhibition of COX-2, PGE(2) and PGE(2) receptors.
C1 [Singh, Tripti; Vaid, Mudit; Katiyar, Nandan; Sharma, Samriti; Katiyar, Santosh K.] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA.
   [Katiyar, Santosh K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA.
   [Katiyar, Santosh K.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA.
RP Katiyar, SK (reprint author), Univ Alabama Birmingham, Dept Dermatol, 1670 Univ Blvd,Volker Hall 557, Birmingham, AL 35294 USA.
EM skatiyar@uab.edu
FU Veterans Administration
FX Veterans Administration Merit Review Award to S.K.K.
CR *AM FAM PHYS, 2000, EARL DET TREATM SKIN
   American Cancer Society, 2007, CANC FACTS FIG
   Balch CM, 2000, CANCER-AM CANCER SOC, V88, P1484, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1484::AID-CNCR29>3.0.CO;2-D
   Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6
   Dohadwala M, 2002, J BIOL CHEM, V277, P50828, DOI 10.1074/jbc.M210707200
   Fukuda K, 1999, J ETHNOPHARMACOL, V66, P227, DOI 10.1016/S0378-8741(98)00162-7
   Fukuda K, 1999, PLANTA MED, V65, P381, DOI 10.1055/s-2006-960795
   Kim ST, 1998, JPN J APPL PHYS 2, V37, pL594, DOI 10.1143/JJAP.37.L594
   Lin JG, 1999, AM J CHINESE MED, V27, P265, DOI 10.1142/S0192415X99000306
   Lin MT, 2001, J BIOL CHEM, V276, P48997, DOI 10.1074/jbc.M107829200
   Maddodi N, 2008, PHOTOCHEM PHOTOBIOL, V84, P528, DOI 10.1111/j.1751-1097.2007.00283.x
   Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448
   Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043
   Meeran SM, 2008, J INVEST DERMATOL, V128, P2716, DOI 10.1038/jid.2008.140
   Meeran SM, 2009, NEOPLASIA, V11, P846, DOI 10.1593/neo.09528
   Meeran SM, 2009, CARCINOGENESIS, V30, P520, DOI 10.1093/carcin/bgp019
   Mukhtar H, 1996, PHOTOCHEM PHOTOBIOL, V63, P355, DOI 10.1111/j.1751-1097.1996.tb03040.x
   Punathil T, 2008, BIOCHEM BIOPH RES CO, V375, P162, DOI 10.1016/j.bbrc.2008.07.157
   Punathil T, 2009, MOL CARCINOGEN, V48, P232, DOI 10.1002/mc.20473
   Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031
   Riedl K, 2004, DRUG RESIST UPDATE, V7, P169, DOI 10.1016/j.drup.2004.04.003
   Sathyavathi G. V., 1987, MED PLANTS INDIA, V2, P230
   Sharma SD, 2010, PHARM RES-DORDR, V27, P1092, DOI 10.1007/s11095-010-0050-9
   Sharma SD, 2009, CARCINOGENESIS, V30, P1970, DOI 10.1093/carcin/bgp228
   Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200
   Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454
   Strouse JJ, 2005, J CLIN ONCOL, V23, P4735, DOI 10.1200/JCO.2005.02.899
   Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252
   TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2
NR 29
TC 97
Z9 102
U1 0
U2 16
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0143-3334
EI 1460-2180
J9 CARCINOGENESIS
JI Carcinogenesis
PD JAN
PY 2011
VL 32
IS 1
BP 86
EP 92
DI 10.1093/carcin/bgq215
PG 7
WC Oncology
SC Oncology
GA 707RF
UT WOS:000286303000014
PM 20974686
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Chiutu, C
   Stannard, A
   Sweetman, AM
   Moriarty, P
AF Chiutu, Cristina
   Stannard, Andrew
   Sweetman, Adam M.
   Moriarty, Philip
TI RETRACTED: Measuring Si-C-60 chemical forces via single molecule
   spectroscopy (Retracted article. See vol. 50, pg. 9610, 2014)
SO CHEMICAL COMMUNICATIONS
LA English
DT Article; Retracted Publication
ID C-60 MOLECULE; AB-INITIO; SURFACE; MICROSCOPY; SILICON
AB We measure the short-range chemical force between a silicon-terminated tip and individual adsorbed C-60 molecules using frequency modulation atomic force microscopy. The interaction with an adsorbed fullerene is sufficiently strong to drive significant atomic rearrangement of tip structures.
C1 [Chiutu, Cristina; Stannard, Andrew; Sweetman, Adam M.; Moriarty, Philip] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England.
RP Moriarty, P (reprint author), Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England.
EM philip.moriarty@nottingham.ac.uk
OI Stannard, Andrew/0000-0001-6283-667X
FU EPSRC [EP/G007837/1]; Leverhulme Trust [ECF/2010/0380, F00/114 BI]; EU
   Commission; Engineering and Physical Sciences Research Council
   [EP/G007837/1]
FX PM and AS thank EPSRC and the Leverhulme Trust, respectively, for
   fellowship awards [EP/G007837/1, ECF/2010/0380]. AMS acknowledges
   funding from the Leverhulme Trust [F00/114 BI]. Part of this work was
   funded by the EU Commission FET programme (via the ATMOL project). We
   also thank S. Jarvis, P. H. Beton, A. Lakin, J. Dunn, and L. Kantorovich
   for helpful discussion.
CR Abe M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2108112
   Campbellova A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295710
   Chiutu C., 2011, UNPUB
   Giessibl FJ, 2000, SCIENCE, V289, P422, DOI 10.1126/science.289.5478.422
   Giessibl FJ, 2000, APPL PHYS LETT, V76, P1470, DOI 10.1063/1.126067
   Hands ID, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.205440
   Hobbs C, 2006, SURF SCI, V600, P551, DOI 10.1016/j.susc.2005.11.009
   Hou JG, 1999, PHYS REV LETT, V83, P3001, DOI 10.1103/PhysRevLett.83.3001
   Keeling DL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.146104
   Lantz MA, 2001, SCIENCE, V291, P2580, DOI 10.1126/science.1057824
   Loske F, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3184784
   Marcos PA, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2130707
   Masenelli B, 2003, SURF SCI, V532, P875, DOI 10.1016/S0039-6028(03)00139-0
   Masenelli B, 2002, J CHEM PHYS, V117, P10627, DOI 10.1063/1.1521430
   Melinon P, 2007, NAT MATER, V6, P479, DOI 10.1038/nmat1914
   Moriarty PJ, 2010, SURF SCI REP, V65, P175, DOI 10.1016/j.surfrep.2010.08.001
   Pascual JI, 2000, CHEM PHYS LETT, V321, P78, DOI 10.1016/S0009-2614(00)00337-7
   Pellarin M, 2000, J CHEM PHYS, V112, P8436, DOI 10.1063/1.481447
   Perez R, 1998, PHYS REV B, V58, P10835, DOI 10.1103/PhysRevB.58.10835
   Rurali R, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.075419
   Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267
   Schull G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.226105
   Schull G, 2011, NAT NANOTECHNOL, V6, P23, DOI [10.1038/nnano.2010.215, 10.1038/NNANO.2010.215]
   Ternes M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.016802
   Torrente IF, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/18/184001
   Yamachika R, 2004, SCIENCE, V304, P281, DOI 10.1126/science.1095069
NR 26
TC 7
Z9 7
U1 3
U2 33
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PY 2011
VL 47
IS 38
BP 10575
EP 10577
DI 10.1039/c1cc14147c
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA 821WE
UT WOS:000295004300012
PM 21869962
DA 2018-12-27
ER

PT J
AU He, XZ
   Zhou, SH
   Wan, XH
   Wang, HY
   Zhong, QH
   Xue, JF
AF He, Xian-Zhi
   Zhou, Sheng-Hua
   Wan, Xin-Hong
   Wang, Hai-Yu
   Zhong, Qing-Hua
   Xue, Jian-Fang
TI RETRACTED: The Effect of Early and Intensive Statin Therapy on
   Ventricular Premature Beat or Nonsustained Ventricular Tachycardia in
   Patients With Acute Coronary Syndrome (Retracted article. See vol. 36,
   pg. 494, 2013)
SO CLINICAL CARDIOLOGY
LA English
DT Article; Retracted Publication
ID RANDOMIZED CONTROLLED-TRIALS; ACUTE MYOCARDIAL-INFARCTION; IMPLANTABLE
   DEFIBRILLATORS; CHANNEL FUNCTION; CA2+ CHANNELS; BINDING-SITE;
   METAANALYSIS; REGRESSION; OUTCOMES; DISEASE
AB Background: To evaluate the prognostic value of early and intensive lipid-lowering treatment on ventricular premature beat or nonsustained ventricular tachycardia (NSVT) after acute coronary syndrome (ACS) (ST-elevation myocardial infarction [STEMI], non-STEMI, and unstable angina pectoris). Hypothesis: Provided that early and intensive lipid-lowering treatment can reduce ventricular premature beat or non-sustained ventricular tachycardia after ACS.
   Methods: A total of 586 patients with ACS were randomly divided into 2 groups: group A (with conventional statin therapy, to receive 10 mg/day atorvastatin, n = 289) and group B (early and intensive statin therapy, 60 mg immediately and 40 mg/day atorvastatin, n = 297). The frequency of ventricular premature beat and NSVT was recorded with Hotter monitoring after hospitalization (24 hours and 72 hours).
   Results: Seventy-seven (11.8%) patients had NSVT. When compared to patients with no documented NSVT, patients with NSVT were older and more often had myocardial infarction, diabetes mellitus, atrial fibrillation, and an ejection fraction <40% in their history. Ventricular premature beats decreased significantly in the early and aggressive treatment group (24 hours, P < 0.01; 72 hours, P < 0.001). A significant reduction in NSVT was seen in the early and aggressive (24 hours, P < 0.01; 72 hours, P < 0.001) group. No side effects were observed in either group.
   Conclusions: Early and intensive lipid-lowering treatment can obviously decrease ventricular premature beats and NSVT.
C1 [He, Xian-Zhi; Wan, Xin-Hong; Wang, Hai-Yu; Zhong, Qing-Hua] Longgang Dist Cent Hosp Shenzhen, Dept Cardiol, Shenzhen, Guangdong, Peoples R China.
   [Zhou, Sheng-Hua] Cent S Univ, Xiangya Hosp 2, Dept Cardiol, Changsha, Hunan, Peoples R China.
RP Wan, XH (reprint author), Long Gang Dist Peoples Hosp Shenzhen, Dept Cardiol, Shenzhen 518116, Peoples R China.
EM wxinh@21cn.com
CR Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1
   Briel M, 2006, JAMA-J AM MED ASSOC, V295, P2046, DOI 10.1001/jama.295.17.2046
   Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583
   Cheung BMY, 2004, BRIT J CLIN PHARMACO, V57, P640, DOI 10.1111/j.1365-2125.2003.02060.x
   de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307
   Decher N, 2006, MOL PHARMACOL, V70, P1204, DOI 10.1124/mol.106.026203
   Drogemuller A, 2003, Z KARDIOL, V92, P164, DOI 10.1007/s00392-003-0890-y
   Ellison KE, 2002, CIRCULATION, V106, P2694, DOI 10.1161/01.CIR.0000038499.22687.39
   Gauthereau MY, 2005, EUR J PHARMACOL, V528, P17, DOI 10.1016/j.ejphar.2005.10.069
   Gingrich KJ, 2005, ANESTHESIOLOGY, V103, P1156, DOI 10.1097/00000542-200512010-00009
   Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839
   Hallstrom AP, 2001, J AM COLL CARDIOL, V37, P1093, DOI 10.1016/S0735-1097(00)01208-0
   Hulten E, 2006, ARCH INTERN MED, V166, P1814, DOI 10.1001/archinte.166.17.1814
   Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901
   Joksovic PM, 2005, BRIT J PHARMACOL, V144, P59, DOI 10.1038/sj.bjp.0706020
   Kayikcioglu M, 2003, INT J CARDIOL, V90, P63, DOI 10.1016/S0167-5273(02)00516-8
   Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013
   Mitchell LB, 2003, J AM COLL CARDIOL, V42, P81, DOI 10.1016/S0735-1097(03)00498-4
   Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005
   Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002
   Okazaki S, 2004, CIRCULATION, V110, P1061, DOI 10.1161/01.CIR.0000140261.58966.A4
   Pliquett RU, 2003, CIRCULATION, V107, P2493, DOI 10.1161/01.CIR.0000065606.63163.B9
   Priori SG, 2001, EUR HEART J, V22, P1374, DOI 10.1053/euhj.2001.2824
   Robinson JG, 2005, J AM COLL CARDIOL, V46, P1855, DOI 10.1016/j.jacc.2005.05.085
   Shafer TJ, 2005, J PHARMACOL EXP THER, V315, P1109, DOI 10.1124/jpet.105.090027
   Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516
   Starke-Peterkovic T, 2006, BIOPHYS J, V90, P4060, DOI 10.1529/biophysj.105.074666
NR 27
TC 9
Z9 11
U1 4
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-9289
EI 1932-8737
J9 CLIN CARDIOL
JI Clin. Cardiol.
PD JAN
PY 2011
VL 34
IS 1
BP 59
EP 63
DI 10.1002/clc.20818
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 716WO
UT WOS:000287004400010
PM 21259280
DA 2018-12-27
ER

PT J
AU Silva, MRE
   Gomes, A
AF Rocha e Silva, Mauricio
   Gomes, Ariane
TI RETRACTED: An overview of recently published medical papers in Brazilian
   scientific journals (Retracted article. See vol. 68, pg. 1382, 2013)
SO CLINICS
LA English
DT Review; Retracted Publication
DE Medical Headings; Brazilian Scientific Output; New Journals
ID SCHOOL-OF-MEDICINE; SAO-PAULO; BREAST-CANCER; LIVER-TRANSPLANTATION;
   URINARY-INCONTINENCE; PELVIC ENDOMETRIOSIS; STATE CAPITALS; UNIVERSITY;
   CHILDREN; WOMEN
AB A brief review intended as information to the readership of Clinics on papers recently published under various medical headings in Brazilian scientific journals recently indexed or about to be indexed in ISI-THOMSON Journal Citation Reports. Journals covered in this review are Acta Ortopedica Brasileira, Arquivos Brasileiros de Cardiologia, Jornal Brasileiro de Pneumologia, Revista Brasileira de Cirurgia Cardiovascular and Revista da Associacao Medica Brasileira.
C1 [Rocha e Silva, Mauricio; Gomes, Ariane] Univ Sao Paulo, Fac Med, Hosp Clin, BR-05508 Sao Paulo, Brazil.
RP Silva, MRE (reprint author), Univ Sao Paulo, Fac Med, Hosp Clin, BR-05508 Sao Paulo, Brazil.
EM mauricio.silva@pobox.com
CR da Silva LAA, 2010, ACTA ORTOP BRAS, V18, P162, DOI 10.1590/S1413-78522010000300009
   Ardengh JC, 2010, REV ASSOC MED BRAS, V56, P27, DOI 10.1590/S0104-42302010000100011
   Bacchi CE, 2010, REV ASSOC MED BRAS, V56, P186, DOI 10.1590/S0104-42302010000200017
   Bagnoli F, 2010, REV ASSOC MED BRAS, V56, P472, DOI 10.1590/S0104-42302010000400023
   Belangero WD, 2010, ACTA ORTOP BRAS, V18, P343, DOI 10.1590/S1413-78522010000600008
   Bellelis P, 2010, REV ASSOC MED BRAS, V56, P467, DOI 10.1590/S0104-42302010000400022
   de Matos ASB, 2010, REV ASSOC MED BRAS, V56, P318, DOI 10.1590/S0104-42302010000300017
   da Silva VMC, 2010, J BRAS PNEUMOL, V36, P190, DOI 10.1590/S1806-37132010000200014
   Salgado FXC, 2010, REV ASSOC MED BRAS, V56, P145, DOI 10.1590/S0104-42302010000200010
   Carvalho AB, 2010, REV ASSOC MED BRAS, V56, P655, DOI 10.1590/S0104-42302010000600012
   Coelho JCU, 2010, REV ASSOC MED BRAS, V56, P522, DOI 10.1590/S0104-42302010000500011
   Colicchio D, 2010, REV ASSOC MED BRAS, V56, P535, DOI 10.1590/S0104-42302010000500013
   Costa TR, 2010, REV ASSOC MED BRAS, V56, P403, DOI 10.1590/S0104-42302010000400011
   Cruz A, 2010, ACTA ORTOP BRAS, V18, P96, DOI 10.1590/S1413-78522010000200007
   Amadera JED, 2010, REV ASSOC MED BRAS, V56, P458, DOI 10.1590/S0104-42302010000400020
   de Assuncao RA, 2010, REV ASSOC MED BRAS, V56, P447, DOI 10.1590/S0104-42302010000400018
   de Carvalho AA, 2010, J BRAS PNEUMOL, V36, P339, DOI 10.1590/S1806-37132010000300012
   Fortes PAD, 2010, REV ASSOC MED BRAS, V56, P47, DOI 10.1590/S0104-42302010000100015
   de Carvalho LV, 2010, REV ASSOC MED BRAS, V56, P278, DOI 10.1590/S0104-42302010000300010
   de Souza RM, 2010, J BRAS PNEUMOL, V36, P210, DOI 10.1590/S1806-37132010000200009
   Del Giorno C, 2010, REV ASSOC MED BRAS, V56, P558
   Leme CVD, 2010, REV ASSOC MED BRAS, V56, P299, DOI 10.1590/S0104-42302010000300013
   Duque CG, 2010, REV ASSOC MED BRAS, V56, P563, DOI 10.1590/S0104-42302010000500018
   Feliciano-Alfonso JE, 2010, REV ASSOC MED BRAS, V56, P293, DOI 10.1590/S0104-42302010000300012
   Fanger PC, 2010, REV ASSOC MED BRAS, V56, P173, DOI 10.1590/S0104-42302010000200015
   Fede AB, 2010, REV ASSOC MED BRAS, V56, P313, DOI 10.1590/S0104-42302010000300016
   Fernandes FG, 2010, REV BRAS CIR CARDIOV, V25, P552, DOI 10.1590/S0102-76382010000400020
   Ferreira HD, 2010, REV ASSOC MED BRAS, V56, P74, DOI 10.1590/S0104-42302010000100020
   Ferreira MS, 2010, ACTA ORTOP BRAS, V18, P127, DOI 10.1590/S1413-78522010000300002
   Gai J, 2010, REV ASSOC MED BRAS, V56, P327, DOI 10.1590/S0104-42302010000300019
   Wolff LPG, 2010, REV ASSOC MED BRAS, V56, P711, DOI 10.1590/S0104-42302010000600023
   Gawryszewski VP, 2010, REV ASSOC MED BRAS, V56, P162, DOI 10.1590/S0104-42302010000200013
   GOMES GV, 2010, HEALTH, V56, P649, DOI DOI 10.1590/S0104-42302010000600011
   Pitanga FJG, 2010, REV ASSOC MED BRAS, V56, P697, DOI 10.1590/S0104-42302010000600021
   Grosso AF, 2010, REV ASSOC MED BRAS, V56, P157, DOI 10.1590/S0104-42302010000200012
   Junges JR, 2010, REV ASSOC MED BRAS, V56, P179, DOI 10.1590/S0104-42302010000200016
   Passos MRL, 2010, REV ASSOC MED BRAS, V56, P420, DOI 10.1590/S0104-42302010000400014
   Lourencao LG, 2010, REV ASSOC MED BRAS, V56, P81, DOI 10.1590/S0104-42302010000100021
   Macedo LG, 2010, J BRAS PNEUMOL, V36, P432, DOI 10.1590/S1806-37132010000400007
   Nardozza LMM, 2010, REV ASSOC MED BRAS, V56, P204, DOI 10.1590/S0104-42302010000200020
   Neto ADM, 2010, J BRAS PNEUMOL, V36, P674
   Rosa RFM, 2010, REV ASSOC MED BRAS, V56, P462, DOI 10.1590/S0104-42302010000400021
   Malta DC, 2010, J BRAS PNEUMOL, V36, P75, DOI 10.1590/S1806-37132010000100013
   Fonseca LAM, 2010, REV ASSOC MED BRAS, V56, P309, DOI 10.1590/S0104-42302010000300015
   de Souza DFM, 2010, ACTA ORTOP BRAS, V18, P335, DOI 10.1590/S1413-78522010000600006
   Teixeira SAM, 2010, REV ASSOC MED BRAS, V56, P440, DOI 10.1590/S0104-42302010000400017
   de Carvalho CCM, 2010, REV ASSOC MED BRAS, V56, P333, DOI 10.1590/S0104-42302010000300020
   Morelli RSES, 2010, ACTA ORTOP BRAS, V18, P79, DOI 10.1590/S1413-78522010000200004
   Nicolini AP, 2010, ACTA ORTOP BRAS, V18, P35, DOI 10.1590/S1413-78522010000100007
   Nunes MN, 2010, REV ASSOC MED BRAS, V56, P684, DOI 10.1590/S0104-42302010000600018
   Oliveira E, 2010, REV ASSOC MED BRAS, V56, P688, DOI 10.1590/S0104-42302010000600019
   de Araujo DVP, 2010, REV ASSOC MED BRAS, V56, P151, DOI 10.1590/S0104-42302010000200011
   Pannunzio E, 2010, REV ASSOC MED BRAS, V56, P32, DOI 10.1590/S0104-42302010000100012
   Parreira JG, 2010, REV ASSOC MED BRAS, V56, P660, DOI 10.1590/S0104-42302010000600013
   Parreira JG, 2010, REV ASSOC MED BRAS, V56, P541, DOI 10.1590/S0104-42302010000500014
   Pereira PB, 2010, ARQ BRAS CARDIOL, V95, P606, DOI 10.1590/S0066-782X2010005000136
   Petroianu A, 2010, REV ASSOC MED BRAS, V56, P568, DOI 10.1590/S0104-42302010000500019
   Neto PJP, 2010, ACTA ORTOP BRAS, V18, P200, DOI 10.1590/S1413-78522010000400005
   de Castro MRP, 2010, J BRAS PNEUMOL, V36, P67, DOI 10.1590/S1806-37132010000100012
   Podgaec S, 2010, REV ASSOC MED BRAS, V56, P92, DOI 10.1590/S0104-42302010000100022
   Poeta LS, 2010, REV ASSOC MED BRAS, V56, P168, DOI 10.1590/S0104-42302010000200014
   Portela MP, 2010, REV ASSOC MED BRAS, V56, P322, DOI 10.1590/S0104-42302010000300018
   Valadares ALR, 2010, REV ASSOC MED BRAS, V56, P112, DOI 10.1590/S0104-42302010000100025
   Rodrigues TC, 2010, REV ASSOC MED BRAS, V56, P67, DOI 10.1590/S0104-42302010000100019
   Rolnik DL, 2010, REV ASSOC MED BRAS, V56, P681, DOI 10.1590/S0104-42302010000600017
   Russo AC, 2010, J BRAS PNEUMOL, V36, P603, DOI 10.1590/S1806-37132010000500012
   Saad ED, 2010, REV ASSOC MED BRAS, V56, P22, DOI 10.1590/S0104-42302010000100010
   Tanuri ALS, 2010, REV ASSOC MED BRAS, V56, P348, DOI 10.1590/S0104-42302010000300022
   Santos OD, 2010, REV ASSOC MED BRAS, V56, P99, DOI 10.1590/S0104-42302010000100023
   Scheffer MC, 2010, REV ASSOC MED BRAS, V56, P691, DOI 10.1590/S0104-42302010000600020
   SOUZA FI, 2010, ACTA ORTOP BRAS, P250, DOI DOI 10.1590/S1413-78522010000500003
   Canto FRT, 2010, ACTA ORTOP BRAS, V18, P187, DOI 10.1590/S1413-78522010000400002
   Mendonca MRT, 2010, REV ASSOC MED BRAS, V56, P192, DOI 10.1590/S0104-42302010000200018
   Toledo CC, 2010, REV ASSOC MED BRAS, V56, P415, DOI 10.1590/S0104-42302010000400013
   de Souza EST, 2010, J BRAS PNEUMOL, V36, P768, DOI 10.1590/S1806-37132010000600015
   Trevisan MC, 2010, REV ASSOC MED BRAS, V56, P572, DOI 10.1590/S0104-42302010000500020
   Umeda K, 2010, ACTA ORTOP BRAS, V18, P261, DOI 10.1590/S1413-78522010000500005
   Nomura RMY, 2010, REV ASSOC MED BRAS, V56, P670, DOI 10.1590/S0104-42302010000600015
   Younes RN, 2010, REV ASSOC MED BRAS, V56, P237, DOI 10.1590/S0104-42302010000200026
   Zuliani AC, 2010, REV ASSOC MED BRAS, V56, P37, DOI 10.1590/S0104-42302010000100013
NR 80
TC 1
Z9 1
U1 2
U2 17
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PY 2011
VL 66
IS 11
BP 1975
EP 1982
DI 10.1590/S1807-59322011001100020
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA 854MK
UT WOS:000297498600020
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Patel, KK
   Caramelli, B
   Gomes, A
AF Patel, Kavita Kirankumar
   Caramelli, Bruno
   Gomes, Ariane
TI RETRACTED: A survey of recently published cardiovascular, hematological
   and pneumological original articles in the Brazilian scientific press
   (Retracted article. See vol. 68, pg. 1383, 2013)
SO CLINICS
LA English
DT Review; Retracted Publication
DE Cardiovascular; Pneumology; Clinical science; Basic research
AB Recent original scientific contributions published in selected Brazilian periodicals and classifiable under cardiovascular and pulmonary subject categories cover a wide range of sub specialties, both clinical and exprimental. Because they appear in journals with only recently enhanced visibility, we have decided to highlight a number of specific items appeared in four Brazilian journals, because we understand that this is an important subsidy to keep our readership adequately informed. These papers cover extensive sub-areas in both fields.
C1 [Patel, Kavita Kirankumar; Caramelli, Bruno; Gomes, Ariane] Univ Sao Paulo, Hosp Clin, Fac Med, BR-05508 Sao Paulo, Brazil.
RP Patel, KK (reprint author), Univ Sao Paulo, Hosp Clin, Fac Med, BR-05508 Sao Paulo, Brazil.
EM bcaramel@usp.br
RI Caramelli, Bruno/B-9916-2008
OI Caramelli, Bruno/0000-0001-6718-8456
CR AGUIAR VB, 2010, ARQUIVOS BRASILEIROS, V956, P732
   ALVES RJ, 2010, ARQUIVOS BRASILEIROS, V955, P614
   Ammirati AL, 2010, REV ASSOC MED BRAS, V56, P209, DOI 10.1590/S0104-42302010000200021
   Antunes VB, 2010, J BRAS PNEUMOL, V36, P29, DOI 10.1590/S1806-37132010000100007
   Fernandes FLA, 2010, J BRAS PNEUMOL, V36, P181, DOI 10.1590/S1806-37132010000200005
   Athanazio RA, 2010, J BRAS PNEUMOL, V36, P425, DOI 10.1590/S1806-37132010000400006
   Martinelli LMB, 2010, J BRAS PNEUMOL, V36, P51, DOI 10.1590/S1806-37132010000100010
   BARROS GF, 2010, REV BRASILEIRA CIRUR, V254, P483
   BENFATTI RA, 2010, REV BRASILEIRA CIRUR, V254, P510
   Borges MC, 2010, J BRAS PNEUMOL, V36, P8, DOI 10.1590/S1806-37132010000100004
   BOTEGA FD, 2010, REV BRASILEIRA CIRUR, V254, P527
   Brandao DS, 2010, J BRAS PNEUMOL, V36, P167, DOI 10.1590/S1806-37132010000200003
   Brandao HV, 2010, J BRAS PNEUMOL, V36, P700, DOI 10.1590/S1806-37132010000600006
   CADORE MP, 2010, REV BRASILEIRA CIRUR, V254, P447
   CAMARA LC, 2010, ARQUIVOS BRASILEIROS, V955, P571
   Carvalho AB, 2010, REV ASSOC MED BRAS, V56, P655, DOI 10.1590/S0104-42302010000600012
   Dela Bianca ACC, 2010, J BRAS PNEUMOL, V36, P402, DOI 10.1590/S1806-37132010000400003
   Lundgren FLC, 2010, J BRAS PNEUMOL, V36, P320, DOI 10.1590/S1806-37132010000300009
   Chatkin G, 2010, J BRAS PNEUMOL, V36, P332, DOI 10.1590/S1806-37132010000300011
   Coelho AC, 2010, J BRAS PNEUMOL, V36, P562, DOI 10.1590/S1806-37132010000500007
   Camargo LACD, 2010, J BRAS PNEUMOL, V36, P571, DOI 10.1590/S1806-37132010000500008
   CORONEL CC, 2010, REV BRASILEIRA CIRUR, V252, P190
   CORREIA LCL, 2010, ARQUIVOS BRASILEIROS, V955, P600
   Costa D, 2010, J BRAS PNEUMOL, V36, P306, DOI 10.1590/S1806-37132010000300007
   Santana ANC, 2010, J BRAS PNEUMOL, V36, P724, DOI 10.1590/S1806-37132010000600009
   D'Aquino LC, 2010, J BRAS PNEUMOL, V36, P460, DOI 10.1590/S1806-37132010000400011
   Melo SMD, 2010, J BRAS PNEUMOL, V36, P746, DOI 10.1590/S1806-37132010000600012
   Ferreira HPD, 2010, J BRAS PNEUMOL, V36, P175, DOI 10.1590/S1806-37132010000200004
   DAROCHA TS, 2010, REV BRASILEIRA CIRUR, V253, P350
   DASILVA CA, 2010, ARQUIVOS BRASILEIROS, V956, P720
   DASILVA RG, 2010, REV BRASILEIRA CIRUR, V252, P183
   Melo CBD, 2010, J BRAS PNEUMOL, V36, P812, DOI 10.1590/S1806-37132010000600019
   Pereira CAD, 2010, J BRAS PNEUMOL, V36, P410, DOI 10.1590/S1806-37132010000400004
   Araujo ZTD, 2010, J BRAS PNEUMOL, V36, P447, DOI 10.1590/S1806-37132010000400009
   de Souza RM, 2010, J BRAS PNEUMOL, V36, P210, DOI 10.1590/S1806-37132010000200009
   DEABREUSILVA EO, 2010, ARQUIVOS BRASILEIROS, V956, P679
   DEAGUIAR AAF, 2010, ARQUIVOS BRASILEIROS, V956, P705
   DEARRUDA ER, 2010, ARQUIVOS BRASILEIROS, V955, P640
   DECAMPOS N, 2010, REV BRASILEIRA CIRUR, V254, P457
   DECARVALHO MRM, 2010, REV BRASILEIRA CIRUR, V252, P209
   DEQUEIROZ VM, 2010, ARQUIVOS BRASILEIROS, V955, P629
   Desalu OO, 2010, J BRAS PNEUMOL, V36, P441, DOI 10.1590/S1806-37132010000400008
   Desalu OO, 2010, J BRAS PNEUMOL, V36, P325, DOI 10.1590/S1806-37132010000300010
   DESOUZA AH, 2010, REV BRASILEIRA CIRUR, V254, P506
   DIAS RR, 2010, REV BRASILEIRA CIRUR, V254, P491
   DINKHUYSEN JJ, 2010, REV BRASILEIRA CIRUR, V253, P371
   DIOGO LP, 2010, ARQUIVOS BRASILEIROS, V956, P726
   DOAMARAL JJM, 2010, REV BRASILEIRA CIRUR, V254, P543
   Almeida MLD, 2010, J BRAS PNEUMOL, V36, P293, DOI 10.1590/S1806-37132010000300005
   DUARTE JJ, 2010, REV BRASILEIRA CIRUR, V252, P160
   FAGUNDES JE, 2010, ARQUIVOS BRASILEIROS, V956, P713
   Roxo JPF, 2010, J BRAS PNEUMOL, V36, P159, DOI 10.1590/S1806-37132010000200002
   FELICIANOALFONS.JE, 2010, REV ASSOCIACAO MEDIC, V563, P293
   Felix EA, 2010, J BRAS PNEUMOL, V36, P554, DOI 10.1590/S1806-37132010000500006
   Ferrari R, 2010, J BRAS PNEUMOL, V36, P37, DOI 10.1590/S1806-37132010000100008
   Maranhao BL, 2010, J BRAS PNEUMOL, V36, P468, DOI 10.1590/S1806-37132010000400012
   FERREIRA CCD, 2010, ARQUIVOS BRASILEIROS, V955, P621
   Fonseca MD, 2010, REV ASSOC MED BRAS, V56, P642, DOI 10.1590/S0104-42302010000600010
   Forgiarini LA, 2010, J BRAS PNEUMOL, V36, P579, DOI 10.1590/S1806-37132010000500009
   Franceschini J, 2010, J BRAS PNEUMOL, V36, P595, DOI 10.1590/S1806-37132010000500011
   GABRIEL EA, 2010, REV BRASILEIRA CIRUR, V254, P516
   GAIA DF, 2010, REV BRASILEIRA CIRUR, V253, P293
   GOMES OM, 2010, REV BRASILEIRA CIRUR, V253, P388
   Goncalves BD, 2010, J BRAS PNEUMOL, V36, P347, DOI 10.1590/S1806-37132010000300013
   GUEDES MAV, 2010, REV BRASILEIRA CIRUR, V254, P534
   GUEDES MAV, 2010, REV BRASILEIRA CIRUR, V253, P322
   GUIZILINI S, 2010, ARQUIVOS BRASILEIROS, V955, P587
   Gupta S, 2010, J BRAS PNEUMOL, V36, P612, DOI 10.1590/S1806-37132010000500013
   HIJAZI EM, 2010, REV BRASILEIRA CIRUR, V252, P197
   KALIL RAK, 2010, REV BRASILEIRA CIRUR, V253, P311
   de Castro LKK, 2010, J BRAS PNEUMOL, V36, P286, DOI 10.1590/S1806-37132010000300004
   LAIZO A, 2010, REV BRASILEIRA CIRUR, V252, P166
   LAVITOLA PD, 2010, ARQUIVOS BRASILEIROS, V956, P749
   LEAL JMD, 2010, REV BRASILEIRA CIRUR, V252, P202
   Lima PB, 2010, J BRAS PNEUMOL, V36, P532, DOI 10.1590/S1806-37132010000500003
   LINS RMM, 2010, REV BRASILEIRA CIRUR, V253, P326
   Logrado VS, 2010, J BRAS PNEUMOL, V36, P205, DOI 10.1590/S1806-37132010000200008
   Macedo PG, 2010, REV ASSOC MED BRAS, V56, P56, DOI 10.1590/S0104-42302010000100017
   Machado L, 2010, J BRAS PNEUMOL, V36, P588, DOI 10.1590/S1806-37132010000500010
   Rosa RFM, 2010, REV ASSOC MED BRAS, V56, P62, DOI 10.1590/S0104-42302010000100018
   MAGEDANZ EH, 2010, REV BRASILEIRA CIRUR, V252, P154
   MALUF MA, 2010, REV BRASILEIRA CIRUR, V254, P466
   Marchi E, 2010, J BRAS PNEUMOL, V36, P759, DOI 10.1590/S1806-37132010000600014
   Marques M, 2010, J BRAS PNEUMOL, V36, P224, DOI 10.1590/S1806-37132010000200011
   MARTINI MR, 2010, REV BRASILEIRA CIRUR, V253, P359
   Mattiello R, 2010, J BRAS PNEUMOL, V36, P453, DOI 10.1590/S1806-37132010000400010
   Melo RE, 2010, J BRAS PNEUMOL, V36, P693, DOI 10.1590/S1806-37132010000600005
   MINICUCCI MF, 2010, ARQUIVOS BRASILEIROS, V955, P635
   MONTEIRO LZ, 2010, ARQUIVOS BRASILEIROS, V955, P563
   MORIEL G, 2010, ARQUIVOS BRASILEIROS, V956, P691
   NAVARRO FB, 2010, REV BRASILEIRA CIRUR, V253, P377
   Nery RM, 2010, REV ASSOC MED BRAS, V56, P547, DOI 10.1590/S0104-42302010000500015
   Maciel ELN, 2010, J BRAS PNEUMOL, V36, P232, DOI 10.1590/S1806-37132010000200012
   de Azambuja LEO, 2010, REV ASSOC MED BRAS, V56, P705, DOI 10.1590/S0104-42302010000600022
   Pedrozo C, 2010, J BRAS PNEUMOL, V36, P92, DOI 10.1590/S1806-37132010000100015
   PEGOFERNANDES PM, 2010, REV BRASILEIRA CIRUR, V254, P441
   Dantas CEP, 2010, REV BRAS CIR CARDIOV, V25, P365, DOI 10.1590/S0102-76382010000300013
   Pinheiro BD, 2010, J BRAS PNEUMOL, V36, P84, DOI 10.1590/S1806-37132010000100014
   Razi E, 2010, J BRAS PNEUMOL, V36, P23, DOI 10.1590/S1806-37132010000100006
   Reck CL, 2010, J BRAS PNEUMOL, V36, P539, DOI 10.1590/S1806-37132010000500004
   RIBEIRO RA, 2010, ARQUIVOS BRASILEIROS, V955, P577
   RIEDI C, 2010, REV BRASILEIRA CIRUR, V254, P500
   Rodrigues GD, 2010, J BRAS PNEUMOL, V36, P356, DOI 10.1590/S1806-37132010000300014
   Rodrigues MT, 2010, J BRAS PNEUMOL, V36, P44, DOI 10.1590/S1806-37132010000100009
   SA M, 2010, REV BRASILEIRA CIRUR, V254, P474
   SA M, 2010, REV BRASILEIRA CIRUR, V253, P341
   Santos DD, 2010, J BRAS PNEUMOL, V36, P14, DOI 10.1590/S1806-37132010000100005
   Sarinho E, 2010, J BRAS PNEUMOL, V36, P281, DOI 10.1590/S1806-37132010000300003
   Sarria EE, 2010, J BRAS PNEUMOL, V36, P417, DOI 10.1590/S1806-37132010000400005
   Senturk E, 2010, J BRAS PNEUMOL, V36, P753, DOI 10.1590/S1806-37132010000600013
   Silva DR, 2010, REV ASSOC MED BRAS, V56, P551, DOI 10.1590/S0104-42302010000500016
   Silveira JM, 2010, J BRAS PNEUMOL, V36, P313, DOI 10.1590/S1806-37132010000300008
   YOSHIMORI DY, 2010, REV BRASILEIRA CIRUR, V253, P333
NR 113
TC 1
Z9 1
U1 2
U2 11
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PY 2011
VL 66
IS 12
BP 2159
EP 2168
DI 10.1590/S1807-59322011001200024
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA 865SU
UT WOS:000298331400024
PM 22189744
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Iebba, V
   Aloi, M
   Civitelli, F
   Cucchiara, S
AF Iebba, Valerio
   Aloi, Marina
   Civitelli, Fortunata
   Cucchiara, Salvatore
TI RETRACTED: Gut Microbiota and Pediatric Disease (Retracted article. See
   vol. 32, pg. 313, 2014)
SO DIGESTIVE DISEASES
LA English
DT Article; Retracted Publication
DE Gut microbiota; Inflammatory bowel disease; Metagenomic studies;
   Pediatric diseases; Celiac disease; Asthma; Allergy; Autism
ID 16S RIBOSOMAL-RNA; GRADIENT GEL-ELECTROPHORESIS;
   INFLAMMATORY-BOWEL-DISEASE; IN-SITU HYBRIDIZATION; HUMAN FECAL SAMPLES;
   CROHNS-DISEASE; HUMAN FECES; INTESTINAL MICROBIOTA; BACTERIAL
   COMMUNITIES; ULCERATIVE-COLITIS
AB Background: Researchers have made every effort to assess the role of gut microbiota in pediatric diseases like inflammatory bowel disease (IBD), celiac disease, asthma, allergy, and autism. The leading hypothesis is that an altered microbial composition is present (other than the presence of a specific pathogen) and that it could be involved in the pathogenesis or progression of such disorders. Methods: Cultural, molecular, metabolomic, and metagenomic approaches are trying to define the pediatric gut microbiota imbalances in different diseases. Results and Conclusion: In pediatric IBD, a marked increase in aerobes and facultative anaerobes was found, along with an increase in Enterobacteriaceae members (Escherichia coli). In both pediatric IBD and celiac disease (Th1-mediated disorders), higher bacterial cell counts were observed, jointly with a general gain of biodiversity. A preponderance of Bacteroidetes and a parallel decrease of Firmicutes was also reported in IBD, celiac disease and autism. Contrarily, dietary changes due to Western lifestyles increase Firmicutes populations and lower short-chain fatty acids production, possibly exposing 'developed' children to the infectious challenge (Escherichia and Shigella spp.). Lactobacillus and Bifidobacterium species could be protective agents for atopic diseases, while Clostridia, Enterobacteriaceae, and staphylococci can be associated with an increased risk of such Th2-mediated disorders. In the brain-gut axis view, gut microbiota could also play a role in autism. Copyright (C) 2011 S. Karger AG, Basel
C1 [Iebba, Valerio] Univ Roma La Sapienza, Microbiol Unit, Dept Publ Hlth Sci, IT-00185 Rome, Italy.
   [Aloi, Marina; Civitelli, Fortunata; Cucchiara, Salvatore] Univ Roma La Sapienza, Dept Pediat, Pediat Gastroenterol & Liver Unit, IT-00185 Rome, Italy.
RP Iebba, V (reprint author), Univ Roma La Sapienza, Microbiol Unit, Dept Publ Hlth Sci, Piazzale Aldo Moro 5, IT-00185 Rome, Italy.
EM valerio.iebba@uniroma1.it
OI Cucchiara, Salvatore/0000-0002-2939-9698
CR Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100
   Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9
   Collado MC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-232
   CARTUN RW, 1993, MODERN PATHOL, V6, P212
   Collado MC, 2009, J CLIN PATHOL, V62, P264, DOI 10.1136/jcp.2008.061366
   Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824
   Coppa GV, 2004, J CLIN GASTROENTEROL, V38, pS80, DOI 10.1097/01.mcg.0000128926.14285.25
   Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Fanaro S, 2003, ACTA PAEDIATR, V92, P48
   Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002
   Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008
   Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8
   Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336
   Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017
   Ghose C, 2002, P NATL ACAD SCI USA, V99, P15107, DOI 10.1073/pnas.242574599
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Gore C, 2008, J ALLERGY CLIN IMMUN, V121, P135, DOI 10.1016/j.jaci.2007.07.061
   Guigoz Y, 2008, CURR OPIN CLIN NUTR, V11, P13, DOI 10.1097/MCO.0b013e3282f2bfdf
   Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019
   HARTLEY MG, 1992, J MED MICROBIOL, V36, P96, DOI 10.1099/00222615-36-2-96
   Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033
   Heavey Patricia M., 1999, Microbial Ecology in Health and Disease, V11, P75
   Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002
   KEIGHLEY MRB, 1978, GUT, V19, P1099, DOI 10.1136/gut.19.12.1099
   Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064
   Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x
   Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105
   Liu CH, 2008, P NATL ACAD SCI USA, V105, P3951, DOI 10.1073/pnas.0709266105
   Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s
   Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106
   Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x
   Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006
   Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080
   Nieuwenhuis EES, 2008, DIGEST LIVER DIS, V40, P12, DOI 10.1016/j.dld.2007.07.166
   Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008
   O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731
   Ouwehand AC, 2001, J ALLERGY CLIN IMMUN, V108, P144, DOI 10.1067/mai.2001.115754
   Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177
   PEACH S, 1978, GUT, V19, P1034, DOI 10.1136/gut.19.11.1034
   Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x
   Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001
   Peyrin-Biroulet L, 2007, GASTROENTEROLOGY, V132, P2594, DOI 10.1053/j.gastro.2007.04.027
   Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059
   Satokari RM, 2001, APPL ENVIRON MICROB, V67, P504, DOI 10.1128/AEM.67.2.504-513.2001
   Schippa S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-175
   Schippa S, 2009, INFLAMM BOWEL DIS, V15, P661, DOI 10.1002/ibd.20818
   Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004
   Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A
   Sepp E, 1997, ACTA PAEDIATR, V86, P956, DOI 10.1111/j.1651-2227.1997.tb15178.x
   Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587
   Suau A, 1999, APPL ENVIRON MICROB, V65, P4799
   Swidsinski A, 2005, WORLD J GASTROENTERO, V11, P1131, DOI 10.3748/wjg.v11.i8.1131
   Tannock GW, 2008, TRENDS MICROBIOL, V16, P488, DOI 10.1016/j.tim.2008.07.005
   Tannock GW, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P101
   Tschop MH, 2009, NAT BIOTECHNOL, V27, P344, DOI 10.1038/nbt0409-344
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136
   VANDEMERWE JP, 1988, SCAND J GASTROENTERO, V23, P1125, DOI 10.3109/00365528809090179
   Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001
   Vasquez N, 2007, INFLAMM BOWEL DIS, V13, P684, DOI 10.1002/ibd.20084
   Vaughan E E, 2000, Curr Issues Intest Microbiol, V1, P1
   Yap IKS, 2010, J PROTEOME RES, V9, P2996, DOI 10.1021/pr901188e
   Young SL, 2004, CLIN DIAGN LAB IMMUN, V11, P686, DOI 10.1128/CDLI.11.4.686-690.2004
   Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854
   Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P4225, DOI 10.1128/AEM.68.9.4225-4232.2002
NR 71
TC 29
Z9 29
U1 2
U2 35
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0257-2753
EI 1421-9875
J9 DIGEST DIS
JI Dig. Dis.
PY 2011
VL 29
IS 6
BP 531
EP 539
DI 10.1159/000332969
PG 9
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 865QJ
UT WOS:000298325100004
PM 22179208
OA Bronze
DA 2018-12-27
ER

PT J
AU Narumi, H
   Takano, H
   Shindo, S
   Fujita, M
   Mizuma, H
   Kuwabara, Y
   Komuro, I
AF Narumi, Hiroya
   Takano, Hiroyuki
   Shindo, Satoshi
   Fujita, Miwa
   Mizuma, Hiroshi
   Kuwabara, Yoichi
   Komuro, Issei
CA VART Investigators
TI RETRACTED: Effects of valsartan and amlodipine on cardiorenal protection
   in Japanese hypertensive patients: the Valsartan Amlodipine Randomized
   Trial(Retracted article. See vol. 40, pg. 103, 2017)
SO HYPERTENSION RESEARCH
LA English
DT Article; Retracted Publication
DE angiotensin II receptor blocker; calcium channel blocker; clinical
   trial; left ventricular hypertrophy
ID CHRONIC HEART-FAILURE; CONVERTING-ENZYME-INHIBITORS; LEFT-VENTRICULAR
   HYPERTROPHY; END-POINT REDUCTION; SYMPATHETIC-NERVOUS-SYSTEM; HIGH
   CARDIOVASCULAR RISKS; RANDOMIZED-TRIAL; LOSARTAN INTERVENTION;
   MICROALBUMINURIA REDUCTION; DIABETIC-NEPHROPATHY
AB The Valsartan Amlodipine Randomized Trial, a multicenter, prospective, randomized, open-labeled, blinded-end point trial, was designed to compare the beneficial effects of the angiotensin II receptor blocker valsartan and the calcium channel blocker amlodipine on cardiovascular events in Japanese essential hypertensive patients. The primary end point was a composite of all-cause death, sudden death, cerebrovascular death, cardiac events, vascular events and renal events. The secondary endpoints were effects on left ventricular hypertrophy, cardiac sympathetic nerve activity and renal function. A total of 1021 patients were enrolled in the present trial. The mean follow-up period was 3.4 years. There were no significant differences in blood pressure (BP) levels between the valsartan group and the amlodipine group throughout the trial. There was no significant difference in the primary endpoint between the two groups (hazard ratio: 1.0, P=0.843). No difference in any event category of the primary endpoint was noted for either group. However, we observed a significant reduction of left ventricular mass index, as determined by echocardiography, in the valsartan group compared with the amlodipine group. We also observed a significant decrease in cardiac sympathetic nerve activity in the valsartan group but not in the amlodipine group. Moreover, there was a significant reduction in the urinary albumin to creatinine ratio in the valsartan group but not in the amlodipine group. Therefore, although BP levels were well controlled and remained equal in the two groups, valsartan had more protective effects on the heart and kidney than amlodipine in Japanese hypertensive patients. Hypertension Research (2011) 34, 62-69; doi: 10.1038/hr.2010.186; published online 7 October 2010
C1 [Komuro, Issei] Chiba Univ, Dept Cardiovasc Sci & Med, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan.
RP Komuro, I (reprint author), Chiba Univ, Dept Cardiovasc Sci & Med, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.
EM komuro-tky@umin.ac.jp
CR Andersen S, 2000, KIDNEY INT, V58, P2129
   BIKKINA M, 1994, JAMA-J AM MED ASSOC, V272, P33, DOI 10.1001/jama.272.1.33
   Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713
   CRAWFORD MH, 1990, CIRCULATION, V81, P1173, DOI 10.1161/01.CIR.81.4.1173
   Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3
   Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778
   Gerstein HC, 2000, DIABETES CARE, V23, pB35
   Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5
   Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1
   Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81
   Ibsen H, 2005, HYPERTENSION, V45, P198, DOI 10.1161/01.HYP.0000154082.72286.2a
   Imanishi M, 1999, DIABETOLOGIA, V42, P999, DOI 10.1007/s001250051259
   Jager A, 1999, ARTERIOSCL THROM VAS, V19, P617, DOI 10.1161/01.ATV.19.3.617
   Langham RG, 2002, DIABETOLOGIA, V45, P1572, DOI 10.1007/s00125-002-0946-y
   LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203
   Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X
   McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3
   Mochizuki S, 2007, LANCET, V369, P1431, DOI 10.1016/S0140-6736(07)60669-2
   NAGANO M, 1991, J HYPERTENS, V9, P595, DOI 10.1097/00004872-199107000-00003
   Nakayama K, 2008, HYPERTENS RES, V31, P21, DOI 10.1291/hypres.31.21
   Ogihara T, 2008, HYPERTENSION, V51, P393, DOI 10.1161/HYPERTENSIONAHA.107.098475
   Okin PM, 2006, CIRCULATION, V113, P1588, DOI 10.1161/CIRCULATIONAHA.105.574822
   Palmieri V, 1999, J AM COLL CARDIOL, V34, P1625, DOI 10.1016/S0735-1097(99)00396-4
   Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1
   Roest M, 2001, CIRCULATION, V103, pE13
   Sakata K, 1999, J NUCL MED, V40, P6
   Sakata K, 1999, HYPERTENSION, V33, P1447, DOI 10.1161/01.HYP.33.6.1447
   Sawada T, 2009, EUR HEART J, V30, P2461, DOI 10.1093/eurheartj/ehp363
   Schmieder RE, 1996, CIRCULATION, V94, P1304, DOI 10.1161/01.CIR.94.6.1304
   TREVISAN R, 1995, AM J HYPERTENS, V8, P876, DOI 10.1016/0895-7061(95)00162-I
   Uzu T, 2008, HYPERTENS RES, V31, P1171, DOI 10.1291/hypres.31.1171
   Verberne HJ, 2008, EUR HEART J, V29, P1147, DOI 10.1093/eurheartj/ehn113
   Viberti G, 2002, CIRCULATION, V106, P672, DOI 10.1161/01.CIR.0000024416.33113.0A
   Wachtell K, 2003, ANN INTERN MED, V139, P901, DOI 10.7326/0003-4819-139-11-200312020-00008
   Weber MA, 2004, LANCET, V363, P2049, DOI 10.1016/S0140-6736(04)16456-8
   Yasunari K, 2004, J AM COLL CARDIOL, V43, P2116, DOI 10.1016/j.jacc.2003.12.051
   Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7
NR 37
TC 27
Z9 30
U1 1
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0916-9636
EI 1348-4214
J9 HYPERTENS RES
JI Hypertens. Res.
PD JAN
PY 2011
VL 34
IS 1
BP 62
EP 69
DI 10.1038/hr.2010.186
PG 8
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 702TP
UT WOS:000285919100014
PM 20927112
OA Bronze
DA 2018-12-27
ER

PT J
AU Lu, YB
   Li, QM
AF Lu, Y. B.
   Li, Q. M.
TI RETRACTED: Dynamic behavior of polymers at high strain-rates based on
   split Hopkinson pressure bar tests (Retracted article. See vol. 40, pg.
   68, 2012)
SO INTERNATIONAL JOURNAL OF IMPACT ENGINEERING
LA English
DT Article; Retracted Publication
DE Polymers; Strain-rate effects; Split Hopkinson pressure bar;
   Drucker-Prager model; Literal confinement
ID CONCRETE-LIKE MATERIALS; COMPRESSIVE STRENGTH ENHANCEMENT; HIGH-DENSITY
   POLYETHYLENE; FINITE-ELEMENT-ANALYSIS; AMORPHOUS POLYMERS; YIELD
   BEHAVIOR; WIDE-RANGE; GLASSY-POLYMERS; SEMICRYSTALLINE POLYMERS;
   ELEVATED-TEMPERATURES
AB Dynamic behavior of polymers at high strain rates from 10(1) to 10(4) s(-1) is frequently investigated by split Hopkinson pressure bar (SHPB) technique. It is found that the apparent strain-rate effect on the dynamic yield stress of polymers based on SHPB tests may include significant contributions from lateral confinement effects when the strain-rate is beyond a transition strain-rate. A methodology based on numerical SHPB tests and the constitutive equation without considering strain-rate effect is proposed to identify this transition strain rate. Experimentally-measured strain-rate dependence of the peak stress up to the transition strain rate is recommended for the determination of the strain-rate dependence of the polymer, which is subsequently implemented into a dynamic constitutive equation including strain-rate and temperature effects. This dynamic constitutive equation together with a kinetic friction model is used to simulate the SHPB tests in independent publications. Reasonably good agreements between numerical predictions and experimental results are observed for a range of polymers at strain rates below 10(4) s(-1). (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Lu, Y. B.; Li, Q. M.] Univ Manchester, Sch Mech Aerosp & Civil Engn, Manchester M13 9PL, Lancs, England.
RP Li, QM (reprint author), Univ Manchester, Sch Mech Aerosp & Civil Engn, Pariser Bldg,Sackville St, Manchester M13 9PL, Lancs, England.
EM qingming.li@manchester.ac.uk
FU School of Mechanical, Aerospace and Civil Engineering, The University of
   Manchester; Henry Lester Trust
FX First author acknowledges the scholarship from the School of Mechanical,
   Aerospace and Civil Engineering, The University of Manchester and the
   financial support from Henry Lester Trust.
CR Arriaga A, 2007, POLYM TEST, V26, P284, DOI 10.1016/j.polymertesting.2006.10.012
   Bardia P, 2006, STRAIN, V42, P187, DOI 10.1111/j.1475-1305.2006.00272.x
   Benaceur I, 2008, INT J MOD PHYS B, V22, P1249, DOI 10.1142/S021797920804661X
   BERTHOLF LD, 1975, J MECH PHYS SOLIDS, V23, P1, DOI 10.1016/0022-5096(75)90008-3
   Blumenthal WR, 2002, AIP CONF PROC, V620, P665
   Bowden FP, 1973, FRICTION INTRO TRIBO
   BOWDEN PB, 1972, J MATER SCI, V7, P52, DOI 10.1007/BF00549550
   BRADY TE, 1971, J APPL PHYS, V42, P4622, DOI 10.1063/1.1659831
   BRISCOE BJ, 1985, POLYM COMMUN, V26, P307
   BRISCOE BJ, 1984, WEAR, V95, P241, DOI 10.1016/0043-1648(84)90140-6
   CARAPELLUCCI LM, 1986, POLYM ENG SCI, V26, P920, DOI 10.1002/pen.760261303
   Chen W, 2004, EXP MECH, V44, P295, DOI [10.1177/001448504041544, 10.1177/0014485104041544]
   Chen W, 1997, J ENG MATER-T ASME, V119, P305, DOI 10.1115/1.2812261
   Chen W, 2002, POLYM TEST, V21, P113, DOI 10.1016/S0142-9418(01)00055-1
   CHOU SC, 1973, EXP MECH, V13, P422, DOI 10.1007/BF02324886
   Chowdhury KA, 2008, COMPUT METHOD APPL M, V197, P4485, DOI 10.1016/j.cma.2008.07.008
   Chowdhury SR, 2000, INT J SOLIDS STRUCT, V37, P3079, DOI 10.1016/S0020-7683(99)00046-3
   DAVIES EDH, 1963, J MECH PHYS SOLIDS, V11, P155, DOI 10.1016/0022-5096(63)90050-4
   DIOH NN, 1993, POLYMER, V34, P4230, DOI 10.1016/0032-3861(93)90181-9
   DION NN, 1995, P ROY SOC LOND A MAT, V499, P187
   Duan Y, 2003, POLYM ENG SCI, V43, P112, DOI 10.1002/pen.10010
   Duan Y, 2001, POLYM ENG SCI, V41, P1322, DOI 10.1002/pen.10832
   Eyring H, 1936, J CHEM PHYS, V4, P283, DOI 10.1063/1.1749836
   Field JE, 2004, INT J IMPACT ENG, V30, P725, DOI 10.1016/j.ijimpeng.2004.03.005
   Frew DJ, 2005, EXP MECH, V45, P186, DOI 10.1177/0014485105052111
   Gary G, 1998, EUR J MECH A-SOLID, V17, P403, DOI 10.1016/S0997-7538(98)80052-1
   Gavrus A, 2003, J PHYS IV, V110, P353, DOI 10.1051/jp4:20030719
   Gavrus A, 2000, ADVANCES IN MECHANICAL BEHAVIOUR, PLASTICITY AND DAMAGE, VOLS 1 AND 2, PROCEEDINGS, P535
   GORHAM DA, 1992, P R SOC-MATH PHYS SC, V438, P153, DOI 10.1098/rspa.1992.0099
   GORHAM DA, 1989, J PHYS D APPL PHYS, V22, P1888, DOI 10.1088/0022-3727/22/12/014
   GORHAM DA, 1991, J PHYS IV, V1, P411, DOI 10.1051/jp4:1991358
   GORHAM DA, 1984, I PHYS C SER, V70, P151
   Gray GT, 2000, MECH TESTING EVALUAT, V8, P462, DOI DOI 10.1361/ASMHBA0003296
   Grote DL, 2001, INT J IMPACT ENG, V25, P869, DOI 10.1016/S0734-743X(01)00020-3
   Gueguen O, 2008, ACTA MATER, V56, P1650, DOI 10.1016/j.actamat.2007.12.015
   HACDOW JB, 1965, INT J MECH SCI, V7, P657
   Hall IW, 2003, J MATER SCI LETT, V22, P1533, DOI 10.1023/A:1026167517837
   Hartley RS, 2007, INT J IMPACT ENG, V34, P1705, DOI 10.1016/j.ijimpeng.2006.09.003
   Hasegawa T, 1999, MAT SCI ENG A-STRUCT, V260, P294, DOI 10.1016/S0921-5093(98)00961-7
   HAUFE A, 2005, 5 EUR LS DYN US C
   *HIBB KARLSS SOR I, 2007, ABAQUS THEOR MAN VER
   Kolsky H., 1949, Proceedings of the Physical Society. Section B, V62, P676, DOI 10.1088/0370-1301/62/11/302
   Lee OS, 2000, J MATER SCI LETT, V19, P1805, DOI 10.1023/A:1006786122575
   Li QM, 2009, INT J IMPACT ENG, V36, P1335, DOI 10.1016/j.ijimpeng.2009.04.010
   Li QM, 2003, INT J SOLIDS STRUCT, V40, P343, DOI 10.1016/S0020-7683(02)00526-7
   Li ZH, 2001, INT J SOLIDS STRUCT, V38, P3549, DOI 10.1016/S0020-7683(00)00223-7
   *LIGO, 2005, LIGOT04010800K
   LINDHOLM US, 1964, J MECH PHYS SOLIDS, V12, P317, DOI 10.1016/0022-5096(64)90028-6
   MALINOWSKI JZ, 1986, INT J MECH SCI, V28, P381, DOI 10.1016/0020-7403(86)90057-3
   Meng H, 2003, INT J IMPACT ENG, V28, P537, DOI 10.1016/S0734-743X(02)00073-8
   MENG H, 2002, THESIS NANYANG TECHN
   Mulliken AD, 2006, INT J SOLIDS STRUCT, V43, P1331, DOI 10.1016/j.ijsolstr.2005.04.016
   PAMPILLO CA, 1971, J APPL PHYS, V42, P4674, DOI 10.1063/1.1659838
   Quinson R, 1997, J MATER SCI, V32, P1371, DOI 10.1023/A:1018525127466
   RAGHAVA R, 1973, J MATER SCI, V8, P225, DOI 10.1007/BF00550671
   Richeton J, 2007, INT J SOLIDS STRUCT, V44, P7938, DOI 10.1016/j.ijsolstr.2007.05.018
   Richeton J, 2006, INT J SOLIDS STRUCT, V43, P2318, DOI 10.1016/j.ijsolstr.2005.06.040
   Richeton J, 2005, POLYMER, V46, P6035, DOI 10.1016/j.polymer.2005.05.079
   RIETSCH F, 1990, EUR POLYM J, V26, P1071, DOI 10.1016/0014-3057(90)90005-O
   Rittel D, 2008, J MECH PHYS SOLIDS, V56, P3191, DOI 10.1016/j.jmps.2008.08.001
   Rittel D, 2008, J MECH PHYS SOLIDS, V56, P1401, DOI 10.1016/j.jmps.2007.09.003
   SAMANTA SK, 1971, J MECH PHYS SOLIDS, V19, P117, DOI 10.1016/0022-5096(71)90023-8
   Siviour CR, 2005, POLYMER, V46, P12546, DOI 10.1016/j.polymer.2005.10.109
   [宋力 Song Li], 2005, [爆炸与冲击, Explosion and Shock Waves], V25, P368
   Trautmann A, 2005, INT J IMPACT ENG, V31, P523, DOI 10.1016/j.ijimpeng.2004.02.007
   WAILEY SM, 1989, PHIL T R SOC LOND A, V328, P1
   WANG TT, 1982, POLYMER, V23, P1407, DOI 10.1016/0032-3861(82)90237-3
   Yin ZN, 2008, MAT SCI ENG A-STRUCT, V494, P304, DOI 10.1016/j.msea.2008.05.039
   YOUNG RJ, 1991, INTRO POLYM, P366
   Zencker U, 1999, EXP MECH, V39, P343, DOI 10.1007/BF02329815
   Zhang M, 2009, INT J IMPACT ENG, V36, P1327, DOI 10.1016/j.ijimpeng.2009.04.009
   Zhao H, 1998, POLYMER, V39, P1103, DOI 10.1016/S0032-3861(97)00374-1
NR 72
TC 21
Z9 24
U1 2
U2 41
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0734-743X
EI 1879-3509
J9 INT J IMPACT ENG
JI Int. J. Impact Eng.
PD JAN
PY 2011
VL 38
IS 1
BP 41
EP 50
DI 10.1016/j.ijimpeng.2010.08.001
PG 10
WC Engineering, Mechanical; Mechanics
SC Engineering; Mechanics
GA 699II
UT WOS:000285656700004
DA 2018-12-27
ER

PT J
AU Chen, KH
   Reese, EA
   Kim, HW
   Rapoport, SI
   Rao, JS
AF Chen, Kevin H.
   Reese, Edmund A.
   Kim, Hyung-Wook
   Rapoport, Stanley I.
   Rao, Jagadeesh S.
TI RETRACTED: Disturbed Neurotransmitter Transporter Expression in
   Alzheimer's Disease Brain (Retracted article. See vol. 55, pg. 445,
   2016)
SO JOURNAL OF ALZHEIMERS DISEASE
LA English
DT Article; Retracted Publication
DE Alzheimer's disease; catechol O-methyltransferase; COMT; dopamine
   transporter; excitatory amino acid; frontal cortex; serotonin; vesicular
   acetylcholine; vesicular glutamate transporter
ID VESICULAR ACETYLCHOLINE TRANSPORTER; POSITRON-EMISSION-TOMOGRAPHY; MILD
   COGNITIVE IMPAIRMENT; MESSENGER-RNA EXPRESSION; GLUTAMATE TRANSPORTERS;
   FRONTAL-CORTEX; RAT-BRAIN; NEURODEGENERATIVE DISEASES; SYNAPTIC
   PLASTICITY; ARACHIDONIC-ACID
AB Alzheimer's disease (AD) is a neurodegenerative disorder characterized by memory loss and behavioral and psychological symptoms of dementia. An imbalance of different neurotransmitters-glutamate, acetylcholine, dopamine, and serotonin-has been proposed as the neurobiological basis of behavioral symptoms in AD. The molecular changes associated with neurotransmission imbalance in AD are not clear. We hypothesized that altered reuptake of neurotransmitters by vesicular glutamate transporters (VGLUTs), excitatory amino acid transporters (EAATs), the vesicular acetylcholine transporter (VAChT), the serotonin reuptake transporter (SERT), or the dopamine reuptake transporter (DAT) are involved in the neurotransmission imbalance in AD. We tested this hypothesis by examining protein and mRNA levels of these transporters in postmortem prefrontal cortex from 10 AD patients and 10 matched non-AD controls. Compared with controls, protein and mRNA levels of VGLUTs, EAAT1-3, VAChT, and SERT were reduced significantly in AD. Expression of DAT and catechol O-methyltransferase was unchanged. Reduced VGLUTs and EAATs may contribute to an alteration in glutamatergic recycling, and reduced SERT could exacerbate depressive symptoms in AD. The reduced VAChT expression could contribute to the recognized cholinergic deficit in AD. Altered neurotransmitter transporters could contribute to the pathophysiology of AD and are potential targets for therapy.
C1 [Chen, Kevin H.; Reese, Edmund A.; Kim, Hyung-Wook; Rapoport, Stanley I.; Rao, Jagadeesh S.] NIA, Brain Physiol & Metab Sect, NIH, Bethesda, MD 20892 USA.
RP Rao, JS (reprint author), NIA, Brain Physiol & Metab Sect, NIH, 9000 Rockville Pike,Bldg 9,1S-126, Bethesda, MD 20892 USA.
EM jrao@grc.nia.nih.gov
FU Harvard Brain Bank, Boston, MA [R24MH068855]; National Institute on
   Aging, National Institutes of Health
FX We thank the Harvard Brain Bank, Boston, MA, for providing the
   postmortem brain samples under PHS grant number R24MH068855. This
   research was entirely supported by the Intramural Research Programs of
   the National Institute on Aging, National Institutes of Health.
CR Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974
   *ALZH ASS, 2010, ALZHEIMERS DEMENT, V6, P158, DOI DOI 10.1016/J.JALZ.2010.01.009
   Aoki C, 2009, J COMP NEUROL, V517, P105, DOI 10.1002/cne.22137
   Arias-Carrion O, 2007, ACTA NEUROBIOL EXP, V67, P481
   Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155
   Balschun D, 2010, CEREB CORTEX, V20, P684, DOI 10.1093/cercor/bhp133
   BarPeled O, 1997, J NEUROCHEM, V69, P2571
   Basselin M, 2009, NEUROPSYCHOPHARMACOL, V34, P1695, DOI 10.1038/npp.2008.227
   BEACH TG, 1988, BRAIN RES, V463, P357, DOI 10.1016/0006-8993(88)90410-6
   Beckstrom H, 1999, J NEUROSCI RES, V55, P218, DOI 10.1002/(SICI)1097-4547(19990115)55:2<218::AID-JNR9>3.0.CO;2-L
   BENES FM, 1989, NEUROSCIENCE, V33, P483, DOI 10.1016/0306-4522(89)90400-4
   Bowen RAR, 2002, J NEUROCHEM, V83, P764, DOI 10.1046/j.1471-4159.2002.01156.x
   Bunch L, 2009, EXPERT OPIN THER TAR, V13, P719, DOI 10.1517/14728220902926127
   Campiani G, 2003, CURR PHARM DESIGN, V9, P599, DOI 10.2174/1381612033391261
   Cannon DM, 2007, BIOL PSYCHIAT, V62, P870, DOI 10.1016/j.biopsych.2007.03.016
   CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602
   Cipriani A., 2006, COCHRANE DB SYST REV, V3
   Conductier G, 2006, EUR J NEUROSCI, V24, P1053, DOI 10.1111/j.1460-9568.2006.04943.x
   COTMAN C, 1969, BIOCHEMISTRY-US, V8, P4606, DOI 10.1021/bi00839a056
   CROSS AJ, 1984, J NEUROCHEM, V43, P1574, DOI 10.1111/j.1471-4159.1984.tb06081.x
   Dehnes Y, 1998, J NEUROSCI, V18, P3606
   DEKEYSER J, 1990, ARCH NEUROL-CHICAGO, V47, P761, DOI 10.1001/archneur.1990.00530070055011
   Dombrovski AY, 2010, INT CLIN PSYCHOPHARM, V25, P37, DOI 10.1097/YIC.0b013e328333ee10
   Drevets WC, 2007, NUCL MED BIOL, V34, P865, DOI 10.1016/j.nuemedbio.2007.06.008
   Esposito G, 2008, J NUCL MED, V49, P1414, DOI 10.2967/jnumed.107.049619
   Farlow MR, 2004, GERIATRICS, V59, P22
   Fisher A, 2008, NEUROTHERAPEUTICS, V5, P433, DOI 10.1016/j.nurt.2008.05.002
   FOX MA, 2002, PSYCHOPHARMACOLOGY B, V212, P13
   Francis PT, 2005, CNS SPECTRUMS, V10, P6, DOI 10.1017/S1092852900014164
   Frisoni GB, 1999, DEMENT GERIATR COGN, V10, P130, DOI 10.1159/000017113
   Gertz HJ, 1998, ACTA NEUROPATHOL, V95, P154, DOI 10.1007/s004010050780
   Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0
   Harrison PJ, 1995, NEUROSCI LETT, V200, P151, DOI 10.1016/0304-3940(95)12102-A
   Hatanpaa K, 1999, J NEUROPATH EXP NEUR, V58, P637, DOI 10.1097/00005072-199906000-00008
   HYMAN BT, 1989, ANNU REV PUBL HEALTH, V10, P115
   Jacob CP, 2007, J ALZHEIMERS DIS, V11, P97
   Kalueff AV, 2007, GENES BRAIN BEHAV, V6, P389, DOI 10.1111/j.1601-183X.2006.00270.x
   Karlsson RM, 2009, NEUROPSYCHOPHARMACOL, V34, P1578, DOI 10.1038/npp.2008.215
   Kirvell SL, 2006, J NEUROCHEM, V98, P939, DOI 10.1111/j.1471-4159.2006.03935.x
   Kiryk A, 2008, NEUROTOX RES, V13, P19, DOI 10.1007/BF03033364
   KUMAR A, 1991, NEUROPSYCHOPHARMACOL, V4, P35
   Lanari A, 2006, MECH AGEING DEV, V127, P158, DOI 10.1016/j.mad.2005.09.016
   LANCTOT KL, BRAIN INJ, V24, P959
   Lauriat TL, 2006, NEUROSCIENCE, V137, P843, DOI 10.1016/j.neuroscience.2005.10.003
   Leuba G, 2008, J ALZHEIMERS DIS, V15, P139
   Levey AI, 1996, P NATL ACAD SCI USA, V93, P13541, DOI 10.1073/pnas.93.24.13541
   Li S, 1997, J NEUROPATH EXP NEUR, V56, P901, DOI 10.1097/00005072-199708000-00008
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MASLIAH E, 1993, MED HYPOTHESES, V41, P334, DOI 10.1016/0306-9877(93)90078-5
   MASLIAH E, 1991, ACTA NEUROPATHOL, V81, P428, DOI 10.1007/BF00293464
   Massie A, 2001, NEUROREPORT, V12, P393, DOI 10.1097/00001756-200102120-00041
   Massie A, 2008, J COMP NEUROL, V511, P155, DOI 10.1002/cne.21823
   Masson J, 1999, EUR J NEUROSCI, V11, P1349, DOI 10.1046/j.1460-9568.1999.00540.x
   Matsumoto M, 2003, NEUROSCIENCE, V116, P127, DOI 10.1016/S0306-4522(02)00556-0
   Modrego PJ, 2010, J ALZHEIMERS DIS, V21, P1077, DOI 10.3233/JAD-2010-100153
   Moriyama Y, 2004, J BIOCHEM, V135, P155, DOI 10.1093/jb/mvh018
   Nogami M, 1998, ACTA HISTOCHEM, V100, P371, DOI 10.1016/S0065-1281(98)80034-2
   Olivier JDA, 2008, NEUROSCIENCE, V152, P573, DOI 10.1016/j.neuroscience.2007.12.032
   Pelvig DP, 2003, DEMENT GERIATR COGN, V16, P212, DOI 10.1159/000072805
   Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005
   Proitsi P, 2012, NEUROBIOL AGING, V33, P791, DOI 10.1016/j.neurobiolaging.2010.06.011
   Rao JS, 2007, MOL PSYCHIATR, V12, P151, DOI 10.1038/sj.mp.4001887
   Rao JS, 2009, INT J NEUROPSYCHOPH, V12, P851, DOI 10.1017/S146114570900025X
   Reiman EM, 2001, P NATL ACAD SCI USA, V98, P3334, DOI 10.1073/pnas.061509598
   Reisberg B, 2008, ALZHEIMERS DEMENT, V4, pS98, DOI 10.1016/j.jalz.2007.11.017
   Reisberg B, 2007, INT PSYCHOGERIATR, V19, P421, DOI 10.1017/S1041610207005261
   ROLLS ET, 1990, COGNITION EMOTION, V4, P161, DOI 10.1080/02699939008410795
   Scott HL, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0004.2002
   Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012
   Simpson JE, 2010, NEUROBIOL AGING, V31, P578, DOI 10.1016/j.neurobiolaging.2008.05.015
   Sultana R, 2008, MOL BIOSYST, V4, P36, DOI 10.1039/b715278g
   Tayebati SK, 2004, CLIN EXP HYPERTENS, V26, P363, DOI 10.1081/CEH-120034140
   Tordera RM, 2007, EUR J NEUROSCI, V25, P281, DOI 10.1111/j.1460-9568.2006.05259.x
   Vazquez-Bourgon J, 2010, PSYCHIAT RES, V175, P189, DOI 10.1016/j.psychres.2008.12.011
NR 74
TC 71
Z9 74
U1 2
U2 17
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1387-2877
EI 1875-8908
J9 J ALZHEIMERS DIS
JI J. Alzheimers Dis.
PY 2011
VL 26
IS 4
BP 755
EP 766
DI 10.3233/JAD-2011-110002
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA 832XE
UT WOS:000295843000013
PM 21743130
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Panagiotopoulou, O
   Kupczik, K
   Cobb, SN
AF Panagiotopoulou, Olga
   Kupczik, Kornelius
   Cobb, Samuel N.
TI RETRACTED: The mechanical function of the periodontal ligament in the
   macaque mandible: a validation and sensitivity study using finite
   element analysis (Retracted article. See vol. 226, pg. 498, 2015)
SO JOURNAL OF ANATOMY
LA English
DT Article; Retracted Publication
DE finite element analysis; masticatory biomechanics; periodontal ligament
ID RHYTHMIC JAW MOVEMENTS; ELEVATOR MUSCLE-ACTIVITY; ANESTHETIZED RABBIT;
   ELASTIC PROPERTIES; VISCOELASTIC PROPERTIES; SUPRAORBITAL REGION;
   FEEDFORWARD CONTROL; MOLAR TEETH; STRESS; AFFERENTS
AB Whilst the periodontal ligament (PDL) acts as an attachment tissue between bone and tooth, hypotheses regarding the role of the PDL as a hydrodynamic damping mechanism during intraoral food processing have highlighted its potential importance in finite element (FE) analysis. Although experimental and constitutive models have correlated the mechanical function of the PDL tissue with its anisotropic, heterogeneous, viscoelastic and non-linear elastic nature, in many FE simulations the PDL is either present or absent, and when present is variably modelled. In addition, the small space the PDL occupies and the inability to visualize the PDL tissue using mu CT scans poses issues during FE model construction and so protocols for the PDL thickness also vary. In this paper we initially test and validate the sensitivity of an FE model of a macaque mandible to variations in the Young's modulus and the thickness of the PDL tissue. We then tested the validity of the FE models by carrying out experimental strain measurements on the same mandible in the laboratory using laser speckle interferometry. These strain measurements matched the FE predictions very closely, providing confidence that material properties and PDL thickness were suitably defined. The FE strain results across the mandible are generally insensitive to the absence and variably modelled PDL tissue. Differences are only found in the alveolar region adjacent to the socket of the loaded tooth. The results indicate that the effect of the PDL on strain distribution and/or absorption is restricted locally to the alveolar bone surrounding the teeth and does not affect other regions of the mandible.
C1 [Panagiotopoulou, Olga] Univ London, Royal Vet Coll, Dept Vet Basic Sci, Struct & Mot Lab, Hatfield AL9 9TA, Herts, England.
   [Panagiotopoulou, Olga] Univ York, Hull York Med Sch, Funct Morphol & Evolut Unit, York YO10 5DD, N Yorkshire, England.
   [Kupczik, Kornelius] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.
   [Cobb, Samuel N.] Univ Hull, Hull York Med Sch, Funct Morphol & Evolut Unit, Kingston Upon Hull HU6 7RX, N Humberside, England.
RP Panagiotopoulou, O (reprint author), Univ London, Royal Vet Coll, Dept Vet Basic Sci, Struct & Mot Lab, Hawkshead Lane, Hatfield AL9 9TA, Herts, England.
EM opanagiotopoulou@rvc.ac.uk
RI Self, Casey/B-6871-2011; Kupczik, Kornelius/E-9788-2011
FU Marie Curie Palaeo EST Host Fellowship [MEST-CT-2005-200601]
FX Special thanks to Jia Liu and Lee Page for programming VoxFE software.
   Thanks are also due to Sue Taft for technical assistance. We are also
   grateful to J. Currey, M. Fagan, L. Fitton, P. O'Higgins, C. Ross and D.
   Strait for the useful discussions and comments. This study was funded by
   a Marie Curie Palaeo EST Host Fellowship (MEST-CT-2005-200601).
CR ANDERSEN KL, 1991, AM J ORTHOD DENTOFAC, V99, P427, DOI 10.1016/S0889-5406(05)81576-8
   ATMARAM GH, 1981, J DENT RES, V60, P873, DOI 10.1177/00220345810600050301
   BERKOVITZ BKB, 1995, PERIODONTAL LIGAMENT
   Bien S M, 1966, Adv Oral Biol, V2, P173
   BYERS MR, 1985, J COMP NEUROL, V231, P500, DOI 10.1002/cne.902310408
   CODY FWJ, 1975, J PHYSIOL-LONDON, V253, P565, DOI 10.1113/jphysiol.1975.sp011207
   COOK SD, 1982, J DENT RES, V61, P25, DOI 10.1177/00220345820610010501
   Coolidge ED, 1937, J AM DENT ASSOC, V24, P1260
   CURREY JD, 1995, BIOMATERIALS, V16, P1267, DOI 10.1016/0142-9612(95)98135-2
   CURREY JD, 2002, BONES STRUCTURE MECH, P440
   Dechow PC, 2000, AM J PHYS ANTHROPOL, V112, P553, DOI 10.1002/1096-8644(200008)112:4<553::AID-AJPA9>3.0.CO;2-R
   Dorow Christina, 2003, J Orofac Orthop, V64, P100, DOI 10.1007/s00056-003-0225-7
   Dorow Christina, 2002, J Orofac Orthop, V63, P94, DOI 10.1007/s00056-002-0107-4
   EMBERY G, 1990, EUR J ORTHODONT, V12, P77, DOI 10.1093/ejo/12.1.77
   Fagan MJ, 2007, J MORPHOL, V268, P1071
   FARAH JW, 1989, J ORAL REHABIL, V16, P603, DOI 10.1111/j.1365-2842.1989.tb01384.x
   Gathercole LJ, 1982, PERIODONTAL LIGAMENT, P103
   GOEL VK, 1992, J PROSTHET DENT, V67, P174, DOI 10.1016/0022-3913(92)90449-K
   GOODWIN GM, 1975, J NEUROPHYSIOL, V38, P560
   HANNAM AG, 1977, ARCH ORAL BIOL, V22, P181, DOI 10.1016/0003-9969(77)90152-2
   HANNAM AG, 1969, ARCH ORAL BIOL, V14, P781, DOI 10.1016/0003-9969(69)90169-1
   Hidaka O, 1999, J NEUROPHYSIOL, V82, P2633
   Hidaka O, 1997, J NEUROPHYSIOL, V77, P3168
   HYLANDER WL, 1984, AM J PHYS ANTHROPOL, V64, P1, DOI 10.1002/ajpa.1330640102
   HYLANDER WL, 1991, AM J PHYS ANTHROPOL, V86, P1, DOI 10.1002/ajpa.1330860102
   HYLANDER WL, 1991, ARCH ORAL BIOL, V36, P273, DOI 10.1016/0003-9969(91)90097-E
   HYLANDER WL, 1985, AM ZOOL, V25, P315
   Johnsen SE, 2005, J NEUROPHYSIOL, V93, P1889, DOI 10.1152/jn.00664.2004
   Johnsen SE, 2003, J NEUROPHYSIOL, V89, P1478, DOI 10.1152/jn.00537.2002
   KAPUR SP, 1991, ORBANS ORAL HISTOLOG, P435
   Kessler O, 2006, CLIN BIOMECH, V21, P603, DOI 10.1016/j.clinbiomech.2006.01.011
   KO CC, 1992, J PROSTHET DENT, V68, P421, DOI 10.1016/0022-3913(92)90404-X
   Kober C, 2008, Int J Comput Dent, V11, P169
   Komuro A, 2001, NEUROSCI RES, V39, P21, DOI 10.1016/S0168-0102(00)00192-9
   Komuro A, 2001, J NEUROPHYSIOL, V86, P2834
   KORIOTH TWP, 1994, J DENT RES, V73, P56, DOI 10.1177/00220345940730010801
   Kupczik K, 2007, J ANAT, V210, P41, DOI 10.1111/j.1469-7580.2006.00662.x
   Kupczik K, 2009, AM J PHYS ANTHROPOL, V139, P193, DOI 10.1002/ajpa.20972
   LARSON CR, 1981, J NEUROPHYSIOL, V46, P130
   Linden R.W.A., 1990, NEUROPHYSIOLOGY JAWS, P52
   LINDEN RWA, 1990, EUR J ORTHODONT, V12, P91, DOI 10.1093/ejo/12.1.91
   LOESCHER AR, 1989, J NEUROPHYSIOL, V62, P971
   LUKE D, 1998, CLIN ORAL SCI, P134
   LUND JP, 1979, J NEUROPHYSIOL, V42, P710
   MELCHER AH, 1976, ERUPTION OCCLUSION T, P183
   Moroi H H, 1993, Int J Prosthodont, V6, P564
   MOW VC, 1984, J BIOMECH, V17, P325, DOI 10.1016/0021-9290(84)90027-7
   MOXHAM BJ, 1987, RES VET SCI, V42, P61, DOI 10.1016/S0034-5288(18)30656-8
   Natali AN, 2004, CONNECT TISSUE RES, V45, P222, DOI 10.1080/03008200490885742
   NIKISHIHIRA M, 1996, INFORM COMMUN ENG, V6, P45
   NOKUBI T, 1977, J OSAKA U DENT SOC, V17, P9
   OTTENHOFF FAM, 1992, J NEUROPHYSIOL, V67, P75
   OTTENHOFF FAM, 1992, J NEUROPHYSIOL, V68, P933
   Panagiotopoulou O, 2010, J BIOMECH, V43, P1603, DOI 10.1016/j.jbiomech.2009.12.027
   Panagiotopoulou O, 2009, ANN HUM BIOL, V36, P609, DOI 10.1080/03014460903019879
   Panagiotopoulou O, 2009, AM J PHYS ANTHROPOL, P205
   PICTON DCA, 1978, J PROSTHET DENT, V40, P263, DOI 10.1016/0022-3913(78)90031-8
   Pini M, 2002, J PERIODONTAL RES, V37, P237, DOI 10.1034/j.1600-0765.2002.00344.x
   Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104
   Rees JS, 1997, BIOMATERIALS, V18, P995, DOI 10.1016/S0142-9612(97)00021-5
   Richmond BG, 2005, ANAT REC PART A, V283A, P259, DOI 10.1002/ar.a.20169
   Ross CF, 2007, INTEGR COMP BIOL, V47, P118, DOI 10.1093/icb/icm044
   Ross CF, 2007, J EXP BIOL, V210, P1046, DOI 10.1242/jeb.02733
   ROSS GG, 1976, J BIOMECH, V9, P723, DOI 10.1016/0021-9290(76)90174-3
   Sato Y, 2003, DENT BIOMECHANICS, P20
   Schwartz GT, 1998, J HUM EVOL, V35, P523, DOI 10.1006/jhev.1998.0239
   SELF CJ, 2008, 86 GEN SESS INT ASS
   SHADWICK RE, 1992, BIOMECHANICS STRUCTU, P234
   Shibata T, 2006, EUR J ORAL SCI, V114, P74, DOI 10.1111/j.1600-0722.2006.00269.x
   SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405
   SPOOR F, 1995, J ANAT, V186, P271
   Strait DS, 2007, J HUM EVOL, V52, P585, DOI 10.1016/j.jhevol.2006.11.019
   Strait DS, 2009, P NATL ACAD SCI USA, V106, P2124, DOI 10.1073/pnas.0808730106
   Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172
   SU M, 2005, J HOLOGR SPECKLE, V2, P34
   TAKAHASHI N, 1980, J ORAL REHABIL, V7, P453, DOI 10.1111/j.1365-2842.1980.tb00464.x
   TANNE K, 1987, AM J ORTHOD DENTOFAC, V92, P499, DOI 10.1016/0889-5406(87)90232-0
   Tanne K, 1983, J Osaka Univ Dent Sch, V23, P143
   TAYLOR A, 1974, BRAIN RES, V71, P523, DOI 10.1016/0006-8993(74)90996-2
   TAYLOR A, 1968, NATURE, V220, P301, DOI 10.1038/220301a0
   TENCATE AR, 1998, ORAL HISTOLOGY DEV S, P259
   THRESHER RW, 1973, J BIOMECH, V6, P443, DOI 10.1016/0021-9290(73)90003-1
   TYRER JR, 1995, OPT LASER ENG, V23, P291, DOI 10.1016/0143-8166(95)00035-M
   van Driel WD, 2000, P I MECH ENG H, V214, P497, DOI 10.1243/0954411001535525
   VanRietbergen B, 1996, INT J NUMER METH ENG, V39, P2743
   VANRIETBERGEN B, 1994, P ASME CED HIGH PERF, V6, P47
   Vollmer D, 1999, EUR J ORTHODONT, V21, P633, DOI 10.1093/ejo/21.6.633
   Wang Q, 2006, AM J PHYS ANTHROPOL, V131, P402, DOI 10.1002/ajpa.20438
   WILLIAMS KR, 1984, BIOMATERIALS, V5, P347, DOI 10.1016/0142-9612(84)90033-4
   WILLS DJ, 1976, ARCH ORAL BIOL, V21, P175, DOI 10.1016/0003-9969(76)90127-8
   WILSON A, 1991, THESIS U WALES SWANS
   Wilson A N, 1994, Br J Orthod, V21, P161
   Wroe S, 2007, ANAT REC, V290, P1248, DOI 10.1002/ar.20594
   YANG L, 2007, EXPT ANAL NANO ENG M, P581
   Yanga L, 2007, OPT LASER ENG, V45, P843, DOI 10.1016/j.optlaseng.2007.02.004
   YETTRAM AL, 1976, J DENT RES, V55, P1004, DOI 10.1177/00220345760550060201
NR 96
TC 39
Z9 40
U1 7
U2 29
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8782
EI 1469-7580
J9 J ANAT
JI J. Anat.
PD JAN
PY 2011
VL 218
IS 1
BP 75
EP 86
DI 10.1111/j.1469-7580.2010.01257.x
PG 12
WC Anatomy & Morphology
SC Anatomy & Morphology
GA 695GJ
UT WOS:000285358300008
PM 20584094
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Cobb, SN
   Panagiotopoulou, O
AF Cobb, Samuel N.
   Panagiotopoulou, Olga
TI RETRACTED: Balancing the spatial demands of the developing dentition
   with the mechanical demands of the catarrhine mandibular symphysis
   (Retracted article. See vol. 226, pg. 499, 2015)
SO JOURNAL OF ANATOMY
LA English
DT Article; Retracted Publication
DE biomechanics; feeding; finite elements analysis; function; Macaca;
   ontogeny; strain
ID FINITE-ELEMENT-ANALYSIS; ADDUCTOR MUSCLE FORCE; ELASTIC PROPERTIES;
   MORPHOLOGICAL INTEGRATION; DEVELOPMENTAL MODULARITY;
   FUNCTIONAL-MORPHOLOGY; SUPRAGINGIVAL PLAQUE; MACACA-FASCICULARIS;
   SUPRAORBITAL REGION; MASTICATORY-STRESS
AB The superior transverse torus of the catarrhine mandible has been shown to effectively reduce bending at the symphysis during unilateral postcanine biting. While the adult superior transverse torus contains trabecular bone, the juvenile one is almost entirely filled by developing permanent incisors until their eruption. This study uses finite elements analysis (FEA) to investigate whether the presence of developing incisors in the juvenile symphysis increases strains on the superior transverse torus. Two FE models of a juvenile Macaca fascicularis mandible were created: one included all the developing teeth; the second was modified to remove the incisor tooth crypts by filling them with trabecular bone. The models were loaded identically to simulate static physiological unilateral biting on dp(4) and strain magnitudes, patterns and distributions of the two FE models were compared. The FEA results show a notable increase in strain magnitudes by up to 40% when the developing incisors are present. The results indicate that, in order to maintain the same symphyseal strain magnitudes during chewing, the presence of the incisors in the symphysis necessitates a larger superior transverse torus in the juvenile than would be required if the superior transverse torus did not house the developing incisors. These results highlight the adaptational balance of the symphyseal morphology throughout ontogeny between biomechanics and the spatial demands of the developing dentition. Based on the findings we therefore propose that the spatial requirements of the developing incisors during ontogeny can act as a constraint on the functional adaptation and subsequent adult morphology observed in the catarrhine mandibular symphysis.
C1 [Cobb, Samuel N.] Univ Hull, Hull York Med Sch, Funct Morphol & Evolut Unit, Kingston Upon Hull HU6 7RX, N Humberside, England.
   [Panagiotopoulou, Olga] Univ London, Royal Vet Coll, Dept Vet Basic Sci, Struct & Mot Lab, London, England.
   [Panagiotopoulou, Olga] Univ York, Hull York Med Sch, Funct Morphol & Evolut Unit, York YO10 5DD, N Yorkshire, England.
RP Cobb, SN (reprint author), Univ Hull, Hull York Med Sch, Funct Morphol & Evolut Unit, Kingston Upon Hull HU6 7RX, N Humberside, England.
EM sam.cobb@hyms.ac.uk
FU Marie Curie Palaeo EST [MEST-CT-2005-200601]
FX The authors thank P. Dechow, K. Kupczik and C. Ross for their comments,
   help and useful discussions. Special thanks to P. O'Higgins and M. Fagan
   for generously providing access to VoxFE software, to J. Liu and L. Page
   for programming VoxFE software, and to S. Taft for technical assistance.
   This study was funded by the Marie Curie Palaeo EST
   (MEST-CT-2005-200601).
CR ANDERSEN KL, 1991, AM J ORTHOD DENTOFAC, V99, P427, DOI 10.1016/S0889-5406(05)81576-8
   Arthur W, 2002, NATURE, V415, P757
   Badyaev AV, 2010, PHILOS T R SOC B, V365, P1111, DOI 10.1098/rstb.2009.0285
   Bartholomew G.A., 1987, P11
   Bastir M, 2004, J HUM EVOL, V47, P359, DOI 10.1016/j.jhevol.2004.08.009
   Boughner JC, 2004, J HUM EVOL, V46, P255, DOI 10.1016/j.jhevol.2003.11.007
   Boughner JC, 2008, DEV DYNAM, V237, P1, DOI 10.1002/dvdy.21383
   Brown Barbara, 1997, P153
   CHAMBERLAIN AT, 1985, AM J PHYS ANTHROPOL, V66, P399, DOI 10.1002/ajpa.1330660408
   Cobb SN, 2008, AM J PHYS ANTHROPOL, P79
   Cobb SN, 2009, AM J PHYS ANTHROPOL, P107
   Cobb S, 2009, J VERTEBR PALEONTOL, V29, p80A
   Cobb SN, 2009, FRONT ORAL BIOL, V13, P121, DOI 10.1159/000242403
   Daegling DJ, 2009, AM J PHYS ANTHROPOL, V138, P306, DOI 10.1002/ajpa.20929
   DAEGLING DJ, 1991, AM J PHYS ANTHROPOL, V86, P321, DOI 10.1002/ajpa.1330860302
   Daegling DJ, 2001, J MORPHOL, V250, P12, DOI 10.1002/jmor.1055
   DAEGLING DJ, 1993, J HUM EVOL, V25, P247, DOI 10.1006/jhev.1993.1048
   DEAN M C, 1991, Zeitschrift fuer Morphologie und Anthropologie, V78, P425
   Dechow PC, 2000, AM J PHYS ANTHROPOL, V112, P553, DOI 10.1002/1096-8644(200008)112:4<553::AID-AJPA9>3.0.CO;2-R
   Fagan MJ, 2007, J MORPHOL, V268, P1071
   Garland T, 2003, EXPTL BIOL REV, P23
   Guy F, 2008, J HUM EVOL, V55, P37, DOI 10.1016/j.jhevol.2007.12.003
   Hofer H., 1952, VERHANDLUNGEN ANATOM, V50, P102
   Hylander WL, 1998, AM J PHYS ANTHROPOL, V107, P257, DOI 10.1002/(SICI)1096-8644(199811)107:3<257::AID-AJPA3>3.0.CO;2-6
   HYLANDER WL, 1984, AM J PHYS ANTHROPOL, V64, P1, DOI 10.1002/ajpa.1330640102
   HYLANDER WL, 1994, AM J PHYS ANTHROPOL, V94, P523, DOI 10.1002/ajpa.1330940407
   Hylander WL, 2000, AM J PHYS ANTHROPOL, V112, P469, DOI 10.1002/1096-8644(200008)112:4<469::AID-AJPA5>3.0.CO;2-V
   HYLANDER WL, 1991, AM J PHYS ANTHROPOL, V86, P1, DOI 10.1002/ajpa.1330860102
   HYLANDER WL, 1991, ARCH ORAL BIOL, V36, P273, DOI 10.1016/0003-9969(91)90097-E
   HYLANDER WL, 1985, AM ZOOL, V25, P315
   Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927
   Kimbel W.H., 1988, P175
   Kimbel W. H., 2004, SKULL AUSTRALOPITHEC
   Klingenberg Christian Peter, 2005, P219, DOI 10.1016/B978-012088777-4/50013-2
   Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054
   Kupczik K, 2009, AM J PHYS ANTHROPOL, V139, P193, DOI 10.1002/ajpa.20972
   McCollum MA, 1999, SCIENCE, V284, P301, DOI 10.1126/science.284.5412.301
   Panagiotopoulou O, 2010, J BIOMECH, V43, P1603, DOI 10.1016/j.jbiomech.2009.12.027
   Panagiotopoulou O, 2009, ANN HUM BIOL, V36, P609, DOI 10.1080/03014460903019879
   Panagiotopoulou O, 2009, AM J PHYS ANTHROPOL, P205
   Panagiotopoulou O, 2011, J ANAT, V218, P75, DOI 10.1111/j.1469-7580.2010.01257.x
   Plavcan JM, 2006, J HUM EVOL, V51, P171, DOI 10.1016/j.jhevol.2006.02.005
   RAVOSA MJ, 1991, J HUM EVOL, V20, P3, DOI 10.1016/0047-2484(91)90042-T
   Ravosa MJ, 2000, FOLIA PRIMATOL, V71, P305, DOI 10.1159/000021754
   Ravosa MJ, 1999, FOLIA PRIMATOL, V70, P65, DOI 10.1159/000021678
   Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104
   Richmond BG, 2005, ANAT REC PART A, V283A, P259, DOI 10.1002/ar.a.20169
   RIESENFE.A, 1970, AM J PHYS ANTHROPOL, V33, P429, DOI 10.1002/ajpa.1330330317
   RIESENFELD A, 1970, ACTA ANAT, V77, P188
   Schwartz GT, 1998, J HUM EVOL, V35, P523, DOI 10.1006/jhev.1998.0239
   SHEA BT, 1985, AM J PHYS ANTHROPOL, V68, P329, DOI 10.1002/ajpa.1330680304
   SHEA BT, 1987, ORANGUTAN BIOL, P233
   SIEGEL MI, 1972, ACTA ANAT, V83, P17
   SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425
   SMITH K, 1986, J DENT RES, V65, P1349, DOI 10.1177/00220345860650111401
   SMITH K, 1987, ARCH ORAL BIOL, V32, P473, DOI 10.1016/S0003-9969(87)80007-9
   SMITH RJ, 1983, AM J PHYS ANTHROPOL, V61, P315, DOI 10.1002/ajpa.1330610306
   Sonntag C. F., 1924, MORPHOLOGY EVOLUTION
   SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405
   Strait DS, 2007, J HUM EVOL, V52, P585, DOI 10.1016/j.jhevol.2006.11.019
   Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172
   Taylor AB, 2002, AM J PHYS ANTHROPOL, V117, P133, DOI 10.1002/ajpa.10013
   Taylor AB, 2003, CAM S BIO EVOL ANTHR, V35, P132
   VanRietbergen B, 1996, INT J NUMER METH ENG, V39, P2743
   VANRIETBERGEN B, 1994, ASME CED, V6, P47
   Vinyard CJ, 1998, J MORPHOL, V235, P157, DOI 10.1002/(SICI)1097-4687(199802)235:2<157::AID-JMOR5>3.0.CO;2-6
   Wagner GP, 1996, EVOLUTION, V50, P967, DOI 10.1111/j.1558-5646.1996.tb02339.x
   Wang Q, 2006, AM J PHYS ANTHROPOL, V131, P402, DOI 10.1002/ajpa.20438
   Williams Susan H., 2008, P39, DOI 10.1007/978-0-387-76585-3_3
   Winther RG, 2001, J EXP ZOOL, V291, P116, DOI 10.1002/jez.1064
   WOLPOFF MH, 1975, CRANIOFACIAL GROWTH, V4, P1
   Wood B.A., 1978, P125
NR 72
TC 15
Z9 15
U1 2
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8782
EI 1469-7580
J9 J ANAT
JI J. Anat.
PD JAN
PY 2011
VL 218
IS 1
BP 96
EP 111
DI 10.1111/j.1469-7580.2010.01321.x
PG 16
WC Anatomy & Morphology
SC Anatomy & Morphology
GA 695GJ
UT WOS:000285358300010
PM 21158857
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Luo, XJ
   Jian, DL
   Lv, ZJ
AF Luo, Xingjun
   Jian, Daolin
   Lv, Zuojun
TI RETRACTED: The Beneficial Effect of Direct Peritoneal Resuscitation on
   Septic Shock in Rats (Retracted article. See 457504, 2015)
SO JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
LA English
DT Article; Retracted Publication
ID MULTIPLE ORGAN FAILURE; BLOOD-FLOW; HEMORRHAGIC-SHOCK; ABDOMINAL-MUSCLE;
   OXYGEN-TRANSPORT; ENDOTOXIN-SHOCK; SMALL-INTESTINE; TISSUE WATER;
   SEPSIS; PERFUSION
AB The high mortality associated with conventionally resuscitated septic shock and the subsequent multiple-organ failure remain a very significant and costly clinical problem. Conventional simple intravenous resuscitation (CR) from septic shock often fails to restore the progressive splanchnic vasoconstriction and hypoperfusion, and fails to reverse gut-derived systemic inflammatory response and fluid sequestration. Numerous interventions have been used to protect organ systems and cellular viability from the lethal injury accompanying hypoperfusion and ischemia but none of these efforts have been sufficient to halt or reverse the main course of the pathophysiology noted with conventional resuscitated shock. Recently, some studies have found that in hemorrhagic shock, direct peritoneal resuscitation (DPR) not only produces sustained hyperperfusion in viscera but also has immunomodulatory and anti-fluid sequestration effects. Although the etiology and pathogenesis of septic shock and hemorrhagic shock differ, both kinds of shock result in hypoperfusion of the intestines and other internal organs. In this paper, we seek to determine whether DPR has a similar therapeutic effect on septic shock/resuscitation.
C1 [Luo, Xingjun; Jian, Daolin; Lv, Zuojun] Three Gorge Univ, Renhe Hosp, Dept Anesthesiol, Yichang 443001, Peoples R China.
RP Jian, DL (reprint author), Three Gorge Univ, Renhe Hosp, Dept Anesthesiol, Yichang 443001, Peoples R China.
EM rhjdl@ctgu.edu.cn
CR Breborowicz A, 1999, PERITON DIALYSIS INT, V19, P119
   Dahlback B, 2004, INT J HEMATOL, V79, P109, DOI 10.1532/IJH97.03149
   Deitch EA, 1998, SHOCK, V9, P1, DOI 10.1097/00024382-199801000-00001
   Demissachew H, 1999, J AM SOC NEPHROL, V10, P347
   Farquhar I, 1996, J SURG RES, V61, P190, DOI 10.1006/jsre.1996.0103
   Fitch SJ, 2002, POSTGRAD MED, V111, P53, DOI 10.3810/pgm.2002.03.1133
   Freeman BD, 2000, EXPERT OPIN INV DRUG, V9, P1651, DOI 10.1517/13543784.9.7.1651
   Fruchterman TM, 1998, SHOCK, V10, P417, DOI 10.1097/00024382-199812000-00007
   Garrison RN, 2004, SURGERY, V136, P900, DOI 10.1016/j.surg.2004.06.027
   Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001
   Hiltebrand LB, 2000, CRIT CARE MED, V28, P3233, DOI 10.1097/00003246-200009000-00019
   Holmes CL, 2001, CHEST, V120, P989, DOI 10.1378/chest.120.3.989
   Hopkins JW, 2011, J PEDIATR SURG, V46, P237, DOI 10.1016/j.jpedsurg.2010.09.054
   Hui Y, 2003, J INFECTION, V47, P155, DOI 10.1016/S0163-4453(03)00043-4
   Ivatury RR, 1996, J AM COLL SURGEONS, V183, P145
   Koike Kaoru, 2004, Nihon Rinsho, V62, P2262
   LeDoux D, 2000, CRIT CARE MED, V28, P2729, DOI 10.1097/00003246-200008000-00007
   Lee DW, 1996, EUR J CANCER, V32A, P945, DOI 10.1016/0959-8049(96)00046-9
   Meier-Hellmann A, 2000, SCHWEIZ MED WSCHR, V130, P1942
   Miyata Y, 2000, AM J PHYSIOL-CELL PH, V278, pC1218
   MOON PF, 1994, SHOCK, V2, P355, DOI 10.1097/00024382-199411000-00010
   MOORE EE, 1994, J TRAUMA, V37, P881, DOI 10.1097/00005373-199412000-00002
   Parker SJ, 2001, BRIT J SURG, V88, P22, DOI 10.1046/j.1365-2168.2001.01632.x
   Reilly PM, 2001, SHOCK, V15, P329, DOI 10.1097/00024382-200115050-00001
   Revelly JP, 1996, CRIT CARE MED, V24, P1345, DOI 10.1097/00003246-199608000-00013
   Rhee P, 2000, CRIT CARE MED, V28, P74, DOI 10.1097/00003246-200001000-00012
   RIPPE B, 1989, KIDNEY INT, V35, P1234, DOI 10.1038/ki.1989.115
   RUOKONEN E, 1993, CRIT CARE MED, V21, P1296
   Secchi A, 1997, J CRIT CARE, V12, P137, DOI 10.1016/S0883-9441(97)90043-5
   Spittler A, 2000, CLIN INFECT DIS, V31, P1338, DOI 10.1086/317499
   THEUER CJ, 1993, CIRC SHOCK, V40, P61
   TUCHSCHMIDT J, 1992, CHEST, V102, P216, DOI 10.1378/chest.102.1.216
   VALLET B, 1994, J APPL PHYSIOL, V76, P793
   van Haren FMP, 2007, ANAESTH INTENS CARE, V35, P679
   Venkataraman R, 2002, SHOCK, V18, P507, DOI 10.1097/01.shk.0000043617.39685.b4
   Waxman K, 1996, New Horiz, V4, P153
   Waxman K, 1996, New Horiz, V4, P151
   Werdan K, 2001, THER APHER, V5, P115, DOI 10.1046/j.1526-0968.2001.005002115.x
   Wischmeyer PE, 2001, J APPL PHYSIOL, V90, P2403
   Zakaria E, 1999, PERITON DIALYSIS INT, V19, pS208
   ZAKARIA ER, 1993, ACTA PHYSIOL SCAND, V149, P355, DOI 10.1111/j.1748-1716.1993.tb09631.x
   Zakaria ER, 2000, AM J PHYSIOL-RENAL, V278, pF875
   Zakaria ER, 2005, J TRAUMA, V58, P499, DOI 10.1097/01.TA.0000152892.24841.54
   Zakaria ER, 2003, AM J SURG, V186, P443, DOI 10.1016/j.amjsurg.2003.07.006
   Zakaria ER, 2003, ANN SURG, V237, P704, DOI 10.1097/00000658-200305000-00013
NR 45
TC 4
Z9 4
U1 2
U2 6
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1110-7243
EI 1110-7251
J9 J BIOMED BIOTECHNOL
JI J. Biomed. Biotechnol.
PY 2011
AR 743763
DI 10.1155/2011/743763
PG 7
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 868ZK
UT WOS:000298565200001
PM 22190858
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Wang, ZW
   Li, YW
   Ahmad, A
   Banerjee, S
   Azmi, AS
   Kong, DJ
   Wojewoda, C
   Miele, L
   Sarkar, FH
AF Wang, Zhiwei
   Li, Yiwei
   Ahmad, Aamir
   Banerjee, Sanjeev
   Azmi, Asfar S.
   Kong, Dejuan
   Wojewoda, Christine
   Miele, Lucio
   Sarkar, Fazlul H.
TI RETRACTED: Down-Regulation of Notch-1 Is Associated With Akt and FoxM1
   in Inducing Cell Growth Inhibition and Apoptosis in Prostate Cancer
   Cells (Retracted article. See vol. 117, pg. 1962, 2016)
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article; Retracted Publication
DE NOTCH-1; PROSTATE CANCER; CELL GROWTH; APOPTOSIS; Akt; FoxM1
ID FORKHEAD BOX M1; FACTOR-KAPPA-B; VIVO MOLECULAR EVIDENCE;
   PANCREATIC-CANCER; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; IN-VITRO;
   THERAPEUTIC TARGET; GENISTEIN; INACTIVATION
AB Although many studies have been done to uncover the mechanisms by which down-regulation of Notch-1 exerts its anti-tumor activity against a variety of human malignancies, the precise molecular mechanisms remain unclear. In the present study, we investigated the cellular consequence of Notch-1 down-regulation and also assessed the molecular consequence of Notch-1-mediated alterations of its downstream targets on cell viability and apoptosis in prostate cancer (PCa) cells. We found that the down-regulation of Notch-1 led to the inhibition of cell growth and induction of apoptosis, which was mechanistically linked with down-regulation of Akt and FoxM1, suggesting for the first time that Akt and FoxM1 are downstream targets of Notch-1 signaling. Moreover, we found that a "natural agent" (genistein) originally discovered from soybean could cause significant reduction in cell viability and induced apoptosis of PCa cells, which was consistent with down-regulation of Notch-1, Akt, and FoxM1. These results suggest that down-regulation of Notch-1 by novel agents could become a newer approach for the prevention of tumor progression and/or treatment, which is likely to be mediated via inactivation of Akt and FoxM1 signaling pathways in PCa. J. Cell. Biochem. 112: 78-88, 2011. (C) 2010 Wiley-Liss, Inc.
C1 [Wang, Zhiwei; Sarkar, Fazlul H.] Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA.
   [Miele, Lucio] Univ Mississippi, Inst Canc, Jackson, MS 39216 USA.
RP Wang, ZW (reprint author), Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, 740 HWCRC,4100 John R St, Detroit, MI 48201 USA.
EM zhiweiwang@med.wayne.edu; fsarkar@med.wayne.edu
OI AZMI, ASFAR/0000-0003-1178-9505; Miele, Lucio/0000-0002-5853-7287
FU Department of Defense [W81XWH-08-1-0196]; National Cancer Institute, NIH
   [5R01CA083695, 1R01CA101870]
FX Grant sponsor: Department of Defense Postdoctoral Training Award; Grant
   number: W81XWH-08-1-0196; Grant sponsor: National Cancer Institute, NIH;
   Grant numbers: 5R01CA083695, 1R01CA101870.
CR Banerjee S, 2005, CANCER RES, V65, P9064, DOI 10.1158/0008-5472.CAN-05-1330
   Banerjee S, 2008, CANCER LETT, V269, P226, DOI 10.1016/j.canlet.2008.03.052
   Banerjee S, 2007, CANCER RES, V67, P3818, DOI 10.1158/0008-5472.CAN-06-3879
   Banerjee S, 2007, INT J CANCER, V120, P906, DOI 10.1002/ijc.22332
   Bektas N, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-42
   Bin Hafeez B, 2009, CLIN CANCER RES, V15, P452, DOI 10.1158/1078-0432.CCR-08-1631
   Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64
   Chiuri VE, 2009, CURR DRUG TARGETS, V10, P982, DOI 10.2174/138945009789578007
   Falci C, 2009, CANCER TREAT REV, V35, P522, DOI 10.1016/j.ctrv.2009.04.014
   Gartel AL, 2008, EXPERT OPIN THER TAR, V12, P663, DOI [10.1517/14728222.12.6.663, 10.1517/14728222.12.6.663 ]
   Gartel AL, 2010, EXPERT OPIN INV DRUG, V19, P235, DOI 10.1517/13543780903563364
   Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006
   Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138
   Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045
   Leong KG, 2008, DIFFERENTIATION, V76, P699, DOI 10.1111/j.1432-0436.2008.00288.x
   Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045
   Li Y., 2005, BMC CANCER, V5, P1
   Li YW, 2006, CANCER RES, V66, P4816, DOI 10.1158/0008-5472.CAN-05-3752
   Li YW, 2005, MOL CANCER THER, V4, P389
   Li YW, 2005, CANCER RES, V65, P6934, DOI 10.1158/0008-5472.CAN-04-4604
   Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589
   Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004
   Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771
   Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570
   Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700
   Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753
   Pandit B, 2010, PROSTATE, V70, P825, DOI 10.1002/pros.21116
   Park HJ, 2009, EMBO J, V28, P2908, DOI 10.1038/emboj.2009.239
   Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576
   Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226
   Shou JY, 2001, CANCER RES, V61, P7291
   Villaronga MA, 2008, CURR CANCER DRUG TAR, V8, P566, DOI 10.2174/156800908786241096
   Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265
   Wang ZW, 2010, CANCER TREAT REV, V36, P151, DOI 10.1016/j.ctrv.2009.11.006
   Wang ZW, 2010, J CELL BIOCHEM, V109, P726, DOI 10.1002/jcb.22451
   Wang ZW, 2009, CANCER RES, V69, P2757, DOI 10.1158/0008-5472.CAN-08-3060
   Wang ZW, 2008, ANTICANCER RES, V28, P3621
   Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281
   Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299
   Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754
   Zhang YX, 2006, INT J CANCER, V119, P2071, DOI 10.1002/ijc.22077
NR 41
TC 64
Z9 67
U1 2
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD JAN
PY 2011
VL 112
IS 1
BP 78
EP 88
DI 10.1002/jcb.22770
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 719PE
UT WOS:000287216200008
PM 20658545
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Deng, TZ
   Wang, L
   Lv, J
   Pang, JL
   Liu, B
   Du, Y
   Ke, J
AF Deng, Tianzheng
   Wang, Lin
   Lv, Jing
   Pang, Jianliang
   Liu, Bing
   Du, Yan
   Ke, Jie
TI RETRACTED: Association of Three Bacterial Species and Periodontal Status
   in Chinese Adults: an Epidemiological Approach (Retracted article. See
   vol. 49, pg. 2082, 2011)
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article; Retracted Publication
ID PORPHYROMONAS-GINGIVALIS; BACTEROIDES-FORSYTHUS;
   ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; SUBGINGIVAL PLAQUE; RISK
   INDICATORS; AGGREGATIBACTER-ACTINOMYCETEMCOMITANS; DISEASE SEVERITY;
   PATHOGENS; MICROBIOTA; PREVALENCE
AB Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythia are oral pathogens associated with periodontitis. The association between these three bacteria and periodontal disease has been reported in populations of many countries. However, corresponding data in Chinese populations are still lacking. The aim of this study was to detect these pathogens in subgingival plaque collected from 468 subjects with chronic periodontitis in a group of Chinese adults by using a PCR method and to determine the degree of association between the target bacteria and periodontal status based on logistic regression analysis. A. actinomycetemcomitans, P. gingivalis, and T. forsythia were found in 20.5%, 70.7%, and 77.1% of the subjects, respectively. About one-third (36.1%) of subjects had chronic periodontitis. Upon univariate analysis, age, male gender, current smoking status, diabetes, and the presence of A. actinomycetemcomitans or P. gingivalis were positively associated with chronic periodontitis, whereas education and income exhibited inverse associations with chronic periodontitis. Upon multivariate analysis, education, current smoking status, diabetes, and the presence of A. actinomycetemcomitans and P. gingivalis remained significant. The adjusted odds ratios for having chronic periodontitis were 2.5 and 3.4 in subjects positive for A. actinomycetemcomitans and P. gingivalis, respectively. However, no significant association was observed between the presence of T. forsythia and periodontal status. This study assesses the prevalence of periodontal pathogens and chronic periodontitis and the associations with sociodemographic characteristics among this group of Chinese adults. These findings also suggest that PCR should be considered for field oral epidemiologic studies and may be necessary in investigations presenting major logistic challenges.
C1 [Deng, Tianzheng; Lv, Jing; Pang, Jianliang; Liu, Bing; Ke, Jie] Gen Hosp Air Force Chinese Peoples Liberat Army, Dept Stomatol, Beijing 100142, Peoples R China.
   [Wang, Lin] Peoples Liberat Army Gen Hosp, Inst Geriatr Cardiol, Beijing 100853, Peoples R China.
   [Du, Yan] Peoples Liberat Army Gen Hosp, Dept Periodontol & Oral Med, Stomatol Ctr, Beijing 100853, Peoples R China.
RP Ke, J (reprint author), Gen Hosp Air Force Chinese Peoples Liberat Army, Dept Stomatol, 30 Fucheng Rd, Beijing 100142, Peoples R China.
EM jieke630331@163.com
FU National Natural Science Foundation of China [30900314]; China
   Postdoctoral Science Foundation [20090451541]
FX This study was supported by the National Natural Science Foundation of
   China (30900314) and the China Postdoctoral Science Foundation
   (20090451541).
CR Amano A, 2004, J PERIODONTAL RES, V39, P136, DOI 10.1111/j.1600-0765.2004.00719.x
   American Academy of Periodontology, 1996, ANN PERIODONTOL, V1, P216
   Ashimoto A, 1996, ORAL MICROBIOL IMMUN, V11, P266, DOI 10.1111/j.1399-302X.1996.tb00180.x
   BECK JD, 1992, J PERIODONTOL, V63, P93, DOI 10.1902/jop.1992.63.2.93
   CHRISTERSSON LA, 1992, J PERIODONTOL, V63, P418, DOI 10.1902/jop.1992.63.5.418
   Cortelli JR, 2005, J CLIN PERIODONTOL, V32, P860, DOI 10.1111/j.1600-051X.2005.00777.x
   GROSSI SG, 1994, J PERIODONTOL, V65, P260, DOI 10.1902/jop.1994.65.3.260
   Haffajee AD, 2006, ORAL MICROBIOL IMMUN, V21, P269, DOI 10.1111/j.1399-302X.2006.00287.x
   Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x
   Huang Y, 2003, ORAL MICROBIOL IMMUN, V18, P208, DOI 10.1034/j.1399-302X.2003.00060.x
   Kim TS, 2009, J PERIODONTOL, V80, P2020, DOI 10.1902/jop.2009.090241
   Lafaurie GI, 2007, J PERIODONTOL, V78, P629, DOI 10.1902/jop.2007.060187
   Lamell CW, 2000, J CLIN MICROBIOL, V38, P1196
   Leys EJ, 2002, J CLIN MICROBIOL, V40, P821, DOI 10.1128/JCM.40.3.821-825.2002
   Marsh P D, 1994, Adv Dent Res, V8, P263
   Mayorga-Fayad I, 2007, BIOMEDICA, V27, P21, DOI 10.7705/biomedica.v27i1.230
   McClellan DL, 1996, J CLIN MICROBIOL, V34, P2017
   Meng S, 2009, QUINTESSENCE INT, V40, P53
   Naka Shuhei, 2009, BMC Oral Health, V9, P24, DOI 10.1186/1472-6831-9-24
   Okada M, 2001, J CLIN PERIODONTOL, V28, P576, DOI 10.1034/j.1600-051x.2001.028006576.x
   Papapanou Panos N, 2002, Ann Periodontol, V7, P54, DOI 10.1902/annals.2002.7.1.54
   Papapanou PN, 2002, EUR J ORAL SCI, V110, P345, DOI 10.1034/j.1600-0722.2002.21361.x
   PREUS HR, 1995, J CLIN PERIODONTOL, V22, P674, DOI 10.1111/j.1600-051X.1995.tb00825.x
   Ready D, 2008, J CLIN MICROBIOL, V46, P3380, DOI 10.1128/JCM.01007-08
   Sanz M, 2000, EUR J ORAL SCI, V108, P383, DOI 10.1034/j.1600-0722.2000.108005383.x
   Tan KS, 2001, J PERIODONTAL RES, V36, P398, DOI 10.1034/j.1600-0765.2001.360608.x
   Umeda M, 1998, J PERIODONTOL, V69, P1111, DOI 10.1902/jop.1998.69.10.1111
   van Winkelhoff A J, 2003, Int J Dent Hyg, V1, P131
   van Winkelhoff AJ, 2002, J CLIN PERIODONTOL, V29, P1023, DOI 10.1034/j.1600-051X.2002.291107.x
   Wara-aswapati N, 2009, ORAL DIS, V15, P354, DOI 10.1111/j.1601-0825.2009.01562.x
   WOLFF LF, 1993, J CLIN PERIODONTOL, V20, P699, DOI 10.1111/j.1600-051X.1993.tb00694.x
   Wu Yan-min, 2007, Journal of Zhejiang University-Science B, V8, P121, DOI 10.1631/jzus.2007.B0121
   Ximenez-Fyvie LA, 2006, J PERIODONTOL, V77, P460, DOI 10.1902/jop.2006.050177
NR 33
TC 6
Z9 6
U1 2
U2 13
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD JAN
PY 2011
VL 49
IS 1
BP 184
EP 188
DI 10.1128/JCM.01819-10
PG 5
WC Microbiology
SC Microbiology
GA 701AQ
UT WOS:000285787100025
PM 21106792
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Shin, DH
   Hwang, Y
AF Shin, Dong-Hee
   Hwang, Yongsuk
TI RETRACTED: Examining the Factors Affecting the Rate of IPTV Diffusion:
   Empirical Study on Korean IPTV (Retracted article. See vol. 26, pg. 162,
   2013)
SO JOURNAL OF MEDIA ECONOMICS
LA English
DT Article; Retracted Publication
ID MODEL; TECHNOLOGY; SUBSTITUTION; ACCEPTANCE; GROWTH
AB Recently, the Internet Protocol Television (IPTV) market has shown rapid development in terms of new services offered and an impressive increase in the number of subscribers. This study examines the diffusion of IPTV by focusing on socio-technical components and consumer-economic factors. This study combines the socio-technical theory and diffusion theory to investigate the technological, economic, and consumer factors contributing to the diffusion. The results help to gain a better understanding of how IPTV will evolve and stabilize in the next generation of convergence environments. The study uses Korea as an example of a technologically advanced and economically complex market with proactive consumers. The findings show the different factors that affect the diffusion process and how these factors are interrelated and interplay in the process of IPTV diffusion. The results offer useful insights on IPTV market development in other countries.
C1 [Hwang, Yongsuk] KonKuk Univ, Dept Journalism & Media Studies, Seoul, South Korea.
   [Shin, Dong-Hee] Sungkyunkwan Univ, Dept Interact Sci, Seoul, South Korea.
RP Hwang, Y (reprint author), KonKuk Univ, Grad Sch Mass Commun & Publ Relat, Seoul, South Korea.
EM prohys@kku.ac.kr
CR BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215
   BEWLEY R, 1988, INT J FORECASTING, V4, P177, DOI 10.1016/0169-2070(88)90076-3
   Bijker W. E., 1995, BICYCLES BAKELITES B
   Boyatzis R., 1998, TRANSFORMING QUALITA
   DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008
   FISHER JC, 1971, TECHNOL FORECAST SOC, V3, P75, DOI 10.1016/S0040-1625(71)80005-7
   Ha I, 2009, 11TH INTERNATIONAL CONFERENCE ON ADVANCED COMMUNICATION TECHNOLOGY, VOLS I-III, PROCEEDINGS,, P1123
   Huh D. H., 2009, KISDI REPORT, V21, P66
   JORESKOG KG, 1996, LISREL, V8
   MacKenzie Donald, 1999, SOCIAL SHAPING TECHN
   Michalakelis C, 2008, TELECOMMUN POLICY, V32, P234, DOI 10.1016/j.telpol.2008.01.004
   Oksman V., 2010, EUROITV EUR INT TV 2
   Orlikowski WJ, 2002, ORGAN SCI, V13, P249, DOI 10.1287/orsc.13.3.249.2776
   Ovum, 2010, IPTV VEND ANT
   Pawitan Y, 2001, ALL LIKELIHOOD
   Rai LP, 1999, J SCI IND RES INDIA, V58, P14
   Rogers E. M., 1995, DIFFUSION INNOVATION
   Sawyer S, 2003, J INFORM TECHNOL, V18, P121, DOI 10.1080/0268396032000101171
   Shin DH, 2009, BEHAV INFORM TECHNOL, V28, P361, DOI 10.1080/01449290701814232
   Vishwanath A, 2003, NEW MEDIA SOC, V5, P547, DOI 10.1177/146144480354005
   Wang YS, 2008, CYBERPSYCHOL BEHAV, V11, P603, DOI 10.1089/cpb.2007.0203
   Weniger S., 2010, ETRUST IMPLICATIONS, P154
NR 22
TC 5
Z9 5
U1 4
U2 22
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0899-7764
EI 1532-7736
J9 J MEDIA ECON
JI J. Media Econ.
PY 2011
VL 24
IS 3
BP 174
EP 200
DI 10.1080/08997764.2011.601980
PG 27
WC Communication; Economics
SC Communication; Business & Economics
GA 885JG
UT WOS:000299774600004
DA 2018-12-27
ER

PT J
AU Walumbwa, FO
   Luthans, F
   Avey, JB
   Oke, A
AF Walumbwa, Fred O.
   Luthans, Fred
   Avey, James B.
   Oke, Adegoke
TI RETRACTED: Authentically leading groups: The mediating role of
   collective psychological capital and trust (Retracted article. See vol.
   35, pg. 746, 2014)
SO JOURNAL OF ORGANIZATIONAL BEHAVIOR
LA English
DT Article; Retracted Publication
ID POSITIVE ORGANIZATIONAL-BEHAVIOR; SELF-EFFICACY; LEADERSHIP;
   PERFORMANCE; OPTIMISM; VALIDATION; MANAGEMENT; LEVEL; WORK; INTERVENTION
AB Although there have been recent theoretical advances in what is increasingly being recognized as authentic leadership, research testing possible mediating processes and the impact on group-level outcomes has not received attention. To help address this need, this study examined at the group level of analysis the role that collective psychological capital and trust may play in the relationship between authentic leadership and work groups' desired outcomes. Utilizing 146 intact groups from a large financial institution, the results indicated a significant relationship between both their collective psychological capital and trust with their group-level performance and citizenship behavior. These two variables were also found to mediate the relationship between authentic leadership and the desired group outcomes, even when controlling for transformational leadership. Implications for future research and practice conclude the paper. Copyright (C) 2009 John Wiley & Sons, Ltd.
C1 [Walumbwa, Fred O.; Oke, Adegoke] Arizona State Univ, WP Carey Sch Business, Tempe, AZ 85287 USA.
   [Luthans, Fred] Univ Nebraska, Lincoln, NE USA.
   [Avey, James B.] Cent Washington Univ, Coll Business, Ellensburg, WA USA.
RP Walumbwa, FO (reprint author), Arizona State Univ, WP Carey Sch Business, Tempe, AZ 85287 USA.
EM Fred.Walumbwa@asu.edu
CR Argote L., 1999, ORG LEARNING CREATIN
   Avolio B. J., 2006, HIGH IMPACT LEADER M
   Avolio BJ, 2004, LEADERSHIP QUART, V15, P801, DOI 10.1016/j.leaqua.2004.09.003
   Avolio BJ, 2006, RES PERS H, V25, P273, DOI 10.1016/S0742-7301(06)25007-2
   Bandura A, 1977, SOCIAL LEARNING THEO
   Bandura A., 2008, POSITIVE PSYCHOL, V1, P167
   Bandura A., 1997, SELF EFFICACY EXERCI
   Bandura A, 2006, PERSPECT PSYCHOL SCI, V1, P164, DOI 10.1111/j.1745-6916.2006.00011.x
   Bass BM, 2004, MULTIFACTOR LEADERSH
   Blau P. M., 1964, EXCHANGE POWER SOCIA
   Bono JE, 2003, ACAD MANAGE J, V46, P554, DOI 10.2307/30040649
   Brissette I, 2002, J PERS SOC PSYCHOL, V82, P102, DOI 10.1037//0022-3514.82.1.102
   Byrne D., 1971, ATTRACTION PARADIGM
   CAMPION MA, 1993, PERS PSYCHOL, V46, P823, DOI 10.1111/j.1744-6570.1993.tb01571.x
   Chan D, 1998, J APPL PSYCHOL, V83, P234, DOI 10.1037/0021-9010.83.2.234
   Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01
   Dirks KT, 2002, J APPL PSYCHOL, V87, P611, DOI 10.1037/0021-9010.87.4.611
   Dirks KT, 1999, J APPL PSYCHOL, V84, P445, DOI 10.1037//0021-9010.84.3.445
   Gardner WL, 2005, LEADERSHIP QUART, V16, P343, DOI 10.1016/j.leaqua.2005.03.003
   George B., 2003, AUTHENTIC LEADERSHIP
   Gully SM, 2002, J APPL PSYCHOL, V87, P819, DOI 10.1037/0021-9010.87.5.819
   Ilies R, 2005, LEADERSHIP QUART, V16, P373, DOI 10.1016/j.leaqua.2005.03.002
   Isenberg D. J., 1988, DECISION MAKING DESC
   James L. R, 1988, APPL INTERACTIONIST, P253
   JAMES LR, 1984, J APPL PSYCHOL, V69, P85, DOI 10.1037/0021-9010.69.1.85
   Jones GR, 1998, ACAD MANAGE REV, V23, P531, DOI 10.5465/AMR.1998.926625
   Judge TA, 2001, J APPL PSYCHOL, V86, P80, DOI 10.1037/0021-9010.86.1.80
   Kark R, 2007, ACAD MANAGE REV, V32, P500, DOI 10.5465/AMR.2007.24351846
   KATZENBACK JR, 1993, WISDOM TEAMS
   Kenny D. A., 1998, HDB SOCIAL PSYCHOL, P233, DOI DOI 10.1177/0146167208331253
   Kernis M. H., 2005, BUILDING DEFENDING R, P31
   Kirkman BL, 1999, ACAD MANAGE J, V42, P58, DOI 10.2307/256874
   Kirkman BL, 2002, ACAD MANAGE EXEC, V16, P67, DOI 10.5465/AME.2002.8540322
   Lee K, 2002, J APPL PSYCHOL, V87, P131, DOI 10.1037/0021-9010.87.1.131
   Lewis K., 1999, THESIS U MARYLAND CO
   Luthans F, 2006, J ORGAN BEHAV, V27, P387, DOI 10.1002/job.373
   Luthans F, 2004, ORGAN DYN, V33, P143, DOI 10.1016/j.orgdyn.2004.01.003
   Luthans F, 2002, J ORGAN BEHAV, V23, P695, DOI 10.1002/job.165
   Luthans F., 2007, PSYCHOL CAPITAL
   Luthans F, 2005, MANAG ORGAN REV, V1, P249, DOI DOI 10.1111/J.1740-8784.2005.00011.X
   Luthans F, 2003, POSITIVE ORG SCHOLAR, P241
   Luthans F, 2008, INT J HUM RESOUR MAN, V19, P818, DOI 10.1080/09585190801991194
   Luthans F, 2008, ACAD MANAG LEARN EDU, V7, P209, DOI 10.5465/AMLE.2008.32712618
   Luthans F, 2008, J ORGAN BEHAV, V29, P219, DOI 10.1002/job.507
   Luthans F, 2007, PERS PSYCHOL, V60, P541, DOI 10.1111/j.1744-6570.2007.00083.x
   Luthans F, 2007, J MANAGE, V33, P321, DOI 10.1177/0149206307300814
   MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037//1082-989X.7.1.83
   MADDI SR, 1987, HLTH PROMOTION EVALU, P101
   Masten A., 2002, HDB POSITIVE PSYCHOL, P74, DOI DOI 10.1093/OXFORDHB/9780195187243.013.0012
   MAYER RC, 1995, ACAD MANAGE REV, V20, P709, DOI 10.2307/258792
   Norman S. M., LEADERSHIP IN PRESS
   Organ D. W., 2006, ORG CITIZENSHIP BEHA
   Parker SK, 1998, J APPL PSYCHOL, V83, P835, DOI 10.1037/0021-9010.83.6.835
   Peterson C, 2000, AM PSYCHOL, V55, P44, DOI 10.1037/0003-066X.55.1.44
   Podsakoff P., 1990, LEADERSHIP QUART, V1, P107, DOI DOI 10.1016/1048-9843(90)90009-7
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9101.88.5.879
   Podsakoff PM, 2000, J MANAGE, V26, P513, DOI 10.1177/014920630002600306
   Rousseau DM, 2006, ACAD MANAGE REV, V31, P256, DOI 10.5465/AMR.2006.20208679
   SALANCIK GR, 1978, ADMIN SCI QUART, V23, P224, DOI 10.2307/2392563
   SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219
   Seligman M., 2002, AUTHENTIC HAPPINESS
   Seligman M. E. P., 1998, LEARNED OPTIMISM
   Snyder C. R, 1994, PSYCHOL HOPE
   SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570
   Snyder CR, 1996, J PERS SOC PSYCHOL, V70, P321, DOI 10.1037//0022-3514.70.2.321
   Sparrowe RT, 2006, ACAD MANAGE J, V49, P1194
   Srivastava S, 2006, J PERS SOC PSYCHOL, V91, P143, DOI 10.1037/0022-3514.91.1.143
   Stajkovic AD, 2006, J APPL PSYCHOL, V91, P1208, DOI 10.1037/0021-9010.91.6.1208
   Tiger L, 1979, OPTIMISM BIOL HOPE
   Tyler R. T., 2000, COOPERATION GROUPS P
   WAGNILD GM, 1993, J NURSING MEASUREMEN, V1, P165
   Walumbwa F. O., LEADERSHIP IN PRESS
   Walumbwa FO, 2008, J MANAGE, V34, P89, DOI 10.1177/0149206307308913
   West BJ, 2009, J ORGAN BEHAV, V30, P249, DOI 10.1002/job.593
   Yammarino FJ, 2008, LEADERSHIP QUART, V19, P693, DOI 10.1016/j.leaqua.2008.09.004
NR 75
TC 126
Z9 134
U1 9
U2 118
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0894-3796
EI 1099-1379
J9 J ORGAN BEHAV
JI J. Organ. Behav.
PD JAN
PY 2011
VL 32
IS 1
BP 4
EP 24
DI 10.1002/job.653
PG 21
WC Business; Psychology, Applied; Management
SC Business & Economics; Psychology
GA 707MK
UT WOS:000286290500002
OA Bronze
DA 2018-12-27
ER

PT J
AU Tang, K
   Robinson, DA
   Harvey, M
AF Tang, Kevin
   Robinson, David A.
   Harvey, Michael
TI RETRACTED: Sustainability managers or rogue mid-managers? A typology of
   corporate sustainability managers (Retracted article. See vol. 49, pg.
   1598, 2011)
SO MANAGEMENT DECISION
LA English
DT Article; Retracted Publication
DE Corporate social responsibility; Corporate sustainability; Change
   agents; Environmental champions; Meaning in life; Psychology;
   Sustainability managers; Values; Scientist; Messenger; Storyteller;
   Artisan
ID SOCIAL-RESPONSIBILITY; BUSINESS SCHOOL; PERFORMANCE; CITIZENSHIP;
   AGENCY; VALUES; LIFE; ORGANIZATIONS; PERSPECTIVES; KNOWLEDGE
AB Purpose - This paper aims to look into the motivations of managers to commit their time and energies to look at environmental, social, and ethical issues. In short, this research set out to answer the following research questions: What are the different types of change agents for sustainability, in terms of their existential needs? What are the motivations and frustrations faced by sustainability managers as change agents? and How are the motivations and frustrations of sustainability managers framed by the sources of meaning in their life and work?
   Design/methodology/approach - As the research is still at an exploratory stage, a qualitative methodology was adopted. This methodology was also appropriate for the purpose of this research, which was focused on studying how meaning emerges and changes in situated organizational settings. The authors were engaged in 27 value-laden semi-structured interviews where they were looking to build a close relationship between the researcher and what was studied. The interview process was divided into three phases to ensure the planning and validity of the process.
   Findings - It identifies four such categories of sustainability managers, those being Scientist, Messenger, Artist and Storyteller. The findings suggest the key role of expertise, empowerment, values, inspiration, strategic thinking and social contribution as key meaning for these managers. The empirical findings help build on understanding of the different psychological dimensions of corporate sustainability management, and provides a useful tool for developing effective organizational leadership, enhancing recruitment and retention of sustainability talent, and improving individual and team performance for key sustainability growth.
   Originality/value - This research has helped to deal application of existential psychology theories to complement corporate sustainability. The findings more or less confirm the usability of major existential psychology theories to find sources of motivations of sustainability managers.
C1 [Tang, Kevin; Harvey, Michael] Bond Univ, Gold Coast, Australia.
   [Robinson, David A.] Cent Queensland Univ, Rockhampton, Qld 4702, Australia.
   [Harvey, Michael] Univ Mississippi, Oxford, MS USA.
RP Tang, K (reprint author), Bond Univ, Gold Coast, Australia.
EM KTang@bond.edu.au
CR Alexander J, 2007, J BUS ETHICS, V76, P155, DOI 10.1007/s10551-006-9264-5
   Andersson LM, 2000, ACAD MANAGE J, V43, P548, DOI 10.2307/1556355
   Annandale D., 2004, BUSINESS STRATEGY EN, V13, P1, DOI DOI 10.1002/BSE.390
   ANTONOVSKY A, 1979, TYPOLOGIES TAXONOMIE
   Balkundi P, 2006, ACAD MANAGE J, V49, P49, DOI 10.5465/AMJ.2006.20785500
   BANSAL P, 2000, ACAD MANAGE J, V41, P556
   BATTISTA J, 1973, PSYCHIATRY, V36, P409, DOI 10.1080/00332747.1973.11023774
   Benn S., 2006, AUSTRALAS J ENV MAN, V13, P156, DOI DOI 10.1080/14486563.2006.10648683
   Bird F, 2007, J BUS ETHICS, V73, P1, DOI 10.1007/s10551-006-9192-4
   Cohen BN, 2003, J CAREER DEV, V29, P195, DOI 10.1023/A:1021470230341
   COLLE S, 2008, J BUS ETHICS, V81, P751
   Crane A, 2005, ACAD MANAGE REV, V30, P681
   Crane A, 2000, ORGAN STUD, V21, P673, DOI 10.1177/0170840600214001
   CRUMBAUGH JC, 1964, J CLIN PSYCHOL, V20, P200, DOI 10.1002/1097-4679(196404)20:2<200::AID-JCLP2270200203>3.0.CO;2-U
   DENZIN N, 1998, INTERPRETIVE ETHNOGR
   Denzin N. K., 2005, SAGE HDB QUALITATIVE
   DIAMANTIS D, 1999, TRAVEL TOURISM ANAL, V4, P89
   Dunphy D., 2003, ORG CHANGE CORPORATE
   EHRENFELD J, 2000, FORUM APPL RES P WIN, P35
   EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P57, DOI 10.5465/AMR.1989.4279003
   ELKINGTON J, 2001, TRIPLE BOTTOM LINE 2
   Esterberg Kristin G., 2002, QUALITATIVE METHODS
   Fineman S, 1996, ORGAN STUD, V17, P479, DOI 10.1177/017084069601700306
   Fineman S, 2006, ACAD MANAGE REV, V31, P270
   Fineman S., 1997, BRIT J MANAGE, V8, P31
   Fontana A, 1994, INTERVIEWING ART SCI
   Frankl V., 1965, DOCTOR SOUL PSYCHOTH
   Frankl V. E., 1964, MANS SEARCH MEANING
   FRANKL VE, 1966, J HUMANIST PSYCHOL, V6, P97, DOI 10.1177/002216786600600201
   FRENCH PA, 1979, AM PHILOS QUART, V16, P207
   Fryxell GE, 2003, J BUS ETHICS, V46, P45, DOI 10.1023/A:1024773012398
   Gardberg NA, 2006, ACAD MANAGE REV, V31, P329, DOI 10.5465/AMR.2006.20208684
   Georg S., 2000, BUSINESS STRATEGY EN, V9, P175
   Gibbons M., 1994, NEW PRODUCTION KNOWL
   GILLENTINE A, 2006, COLORADO SPRINGS BUS
   Glaser B. G., 1967, DISCOVERY GROUNDED T
   Godfrey PC, 2007, J BUS ETHICS, V70, P87, DOI 10.1007/s10551-006-9080-y
   Gopinath C, 2005, BUS SOC REV, V110, P331, DOI 10.1111/j.0045-3609.2005.00019.x
   Grayson D, 2004, CORPORATE SOCIAL OPP
   Guba E. G., 1994, COMPETING PARADIGMS
   Gummesson E, 1991, QUALITATIVE METHODS
   Hall M. R., 2006, J PUBLIC RELAT RES, V18, P1, DOI DOI 10.1207/S1532754XJPRR1801_1
   HANSON D, 2005, STRATEGIC MANAGEMENT
   Hemingway CA, 2004, J BUS ETHICS, V50, P33, DOI 10.1023/B:BUSI.0000020964.80208.c9
   Henriques I, 1996, J ENVIRON ECON MANAG, V30, P381, DOI 10.1006/jeem.1996.0026
   HOPKINS M, 2006, J PUBLIC AFFAIRS, V6, P298, DOI DOI 10.1002/PA.238
   Hostager TJ, 1998, J ORGAN CHANGE MANAG, V11, P11, DOI 10.1108/09534819810369536
   Howard-Grenville JA, 2003, ACAD MANAGE EXEC, V17, P70, DOI 10.5465/AME.2003.10025199
   IRWIN D, 2002, ENCOURAGING RESPONSI
   JANESICK VJ, 1998, DANCE QUALITATIVE RE
   JENSEN MC, 1976, J FINANC ECON, V3, P305, DOI 10.1016/0304-405X(76)90026-X
   Keogh PD, 1998, J ORGAN CHANGE MANAG, V11, P38, DOI 10.1108/09534819810369563
   KIRK D, 1998, HOSPITALITY MANAGEME, V17, P33
   KOHLI AK, 1990, J MARKETING, V54, P1, DOI 10.2307/1251866
   LEISS W, 1976, LIMITS SATISFACTION
   Maignan I, 2003, J BUS RES, V56, P55, DOI 10.1016/S0148-2963(01)00222-3
   Mathieu JE, 2006, ACAD MANAGE J, V49, P605, DOI 10.5465/AMJ.2006.21794678
   Menon A, 1997, J MARKETING, V61, P51, DOI 10.2307/1252189
   MILLER J, 1997, QUALITATIVE RES
   Moon J, 2005, BUS ETHICS Q, V15, P429, DOI 10.5840/beq200515329
   Moore G, 1999, J BUS ETHICS, V21, P329, DOI 10.1023/A:1006020214228
   PATTERSON CH, 1996, THEORIES PSYCHOTHERA
   Pfeffer J, 2004, J MANAGE STUD, V41, P1501, DOI 10.1111/j.1467-6486.2004.00484.x
   PORTER ME, 1995, HARVARD BUS REV, V73, P120
   POSNER BZ, 1993, J BUS ETHICS, V12, P341, DOI 10.1007/BF00882023
   Post J. E., 1994, J ORGAN CHANGE MANAG, V7, P64
   Prahalad CK, 2000, HARVARD BUS REV, V78, P79
   PRAKASH A, 2001, BUSINESS STRATEGY EN, V10, P286, DOI DOI 10.1002/BSE.305
   Reker G. T., 1988, EMERGENT THEORIES AG, P214
   ROOME C, 1999, BETTER ENV DECISIONS
   RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069
   Saiia David H., 2003, BUS SOC, V42, P169, DOI DOI 10.1177/0007650303042002002
   Schaper M., 2004, J DEV ENTREPRENEURSH, V9, P239
   Schmidt VA, 2004, WEST EUR POLIT, V27, P183, DOI 10.1080/0140238042000214874
   Seifert B., 2004, BUSINESS SOC, V43, P135, DOI DOI 10.1177/0007650304263919
   Sharma S, 2000, ACAD MANAGE J, V43, P681, DOI 10.2307/1556361
   Sharma S, 2002, RES CORPORATE SUSTAI, P1
   SHRIVASTAVA P, 1995, ACAD MANAGE REV, V20, P936, DOI 10.2307/258961
   SMITH C, 1994, HARVARD BUS REV, V72, P105
   Stake RE, 1998, CASE STUDIES STRATEG
   STARIK M, 1995, ACAD MANAGE REV, V20, P908, DOI 10.2307/258960
   Starkey K, 2004, J MANAGE STUD, V41, P1521, DOI 10.1111/j.1467-6486.2004.00485.x
   Starkey K, 2003, ACAD MANAGE REV, V28, P220
   STERN PC, 1992, ANNU REV PSYCHOL, V43, P269, DOI 10.1146/annurev.ps.43.020192.001413
   STRAUSS A, 1998, GROUNDED THEORY METH
   SWANSON DL, 1995, ACAD MANAGE REV, V20, P43, DOI 10.5465/AMR.1995.9503271990
   TAIT M, 1989, J APPL PSYCHOL, V74, P502, DOI 10.1037//0021-9010.74.3.502
   TANG K, 2010, AS AC MAN
   TAYLOR S, 1984, IN DEPTH INTERVIEWIN
   Tsang E. W. K., 1998, ACAD MANAGEMENT EXEC, V12, P64
   TU WM, 1995, MORAL BUSINESS GRAND, P409
   van Marrewijk M, 2003, J BUS ETHICS, V44, P89
   VISSER W, 2008, MAKING DIFFERENCE PU
   Walley L. E., 1999, ECOMANAGEMENT AUDITI, V6, P26, DOI DOI 10.1002/(SICI)1099-0925(199903)6:1<26::AID-EMA94>3.0.C0;2-T
   Weiss J., 2003, BUSINESS ETHICS STAK
   Welford R., 2007, Corporate Social Responsibility and Environmental Management, V14, P42, DOI 10.1002/csr.139
   Welford R, 2004, J CORPORATE CITIZENS, V13, P31, DOI DOI 10.9774/GLEAF.4700.2004.SP.00007
   Wheeler D., 2003, Journal of General Management, V28, P1
   WINN M, 1995, CORPORATE LEADERSHIP
   Wolff R., 1998, BUSINESS STRATEGY EN, V7, P297
   Wong P.T.P., 1998, HUMAN QUEST MEANING
   WOOD DJ, 1991, ACAD MANAGE REV, V16, P691, DOI 10.5465/AMR.1991.4279616
   Yalom I. D., 1980, EXISTENTIAL PSYCHOTH
   ZIKA S, 1992, BRIT J PSYCHOL, V83, P133, DOI 10.1111/j.2044-8295.1992.tb02429.x
NR 104
TC 7
Z9 7
U1 1
U2 45
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0025-1747
EI 1758-6070
J9 MANAGE DECIS
JI Manag. Decis.
PY 2011
VL 49
IS 7-8
BP 1371
EP 1394
DI 10.1108/00251741111163179
PG 24
WC Business; Management
SC Business & Economics
GA 838RO
UT WOS:000296310100019
DA 2018-12-27
ER

PT J
AU Wang, M
   Hu, YJ
   Amatangelo, MD
   Stearns, ME
AF Wang, Min
   Hu, Youji
   Amatangelo, Michael D.
   Stearns, Mark E.
TI RETRACTED: Role of Ribosomal Protein RPS2 in Controlling let-7a
   Expression in Human Prostate Cancer (Retracted article. See vol. 10, pg.
   570, 2012)
SO MOLECULAR CANCER RESEARCH
LA English
DT Article; Retracted Publication
ID ELEVATED EXPRESSION; BINDING PROTEIN; MICRORNA FAMILY; MESSENGER-RNAS;
   CELLS; LIN28; GENE; DIFFERENTIATION; SURVIVAL; GROWTH
AB We discovered that an inverse relationship exists in the expression of ras/c-myc and ribosomal protein RPS2 with pre-let-7a-1/let-7a/let-7f miRNA and prostate tumor cell malignancy. Nonmalignant IBC-10a cells expressed low levels of ras/RPS2 and elevated pre-let-7a-1/let-7a/let-7f miRNA, whereas the reverse occurred in malignant PCa-20a and PC-3ML cells. Stable transfection of IBC-10a cells with pBABE.ras and pBABE. RPS2 induced ras, c-myc, and RPS2 expression, whereas the levels of let-7a/let-7f miRNA dropped to near zero. Conversely, in pBABE. pre-let-7a-1 transfected PCa-20a and PC-3ML clones, let-7a/let-7f increased whereas ras, RPS2, and c-myc dropped greater than 5-fold. Electrophoretic mobility shift assays, antibody "supershift" assays and immunoprecipitation assays revealed that RPS2 specifically binds pre-let-7a-1 to block RNA processing. Immunoflourescent studies and Northern blots confirmed that RPS2 complexes with pre-let-7a-1 (i.e., in episomal structures) to block processing to let-7a/let-7f, indicating RPS2 may prevent let-7a miRNA expression to indirectly promote oncogene expression. Functional studies further showed that the colony-forming ability (CFA) and invasive activities of IBC-10a cells were significantly enhanced in pBABE-ras.IBC-10a and pBABE-RPS2-IBC-10a clones. Conversely, with the "knockdown" of ras and RPS2 in malignant PC-3ML cells (i.e., in pLKO. TRC.shRNA.ras.PC3-ML, pLKO.TRC.shRNA.RPS2.PC-3ML transfected cells), there was both a loss of these functions and a loss of tumorigenesis in SCID mice. Likewise, with the overexpression of let-7a/let-7f in pBABE. pre-let-7a-1. PC-3ML clones (and PCa-20a clones), CFAs, invasive activities in vitro, and tumorigenesis in vivo were significantly reduced. These results show for the first time that RPS2 blocks pre-let-7a-1 processing to enable ras and c-myc expression and the transformation of primary tumor cells. Mol Cancer Res; 9(1); 36-50. (C) 2011 AACR.
C1 [Wang, Min; Hu, Youji; Amatangelo, Michael D.; Stearns, Mark E.] Drexel Univ, Coll Med, Dept Pathol, Philadelphia, PA 19102 USA.
RP Stearns, ME (reprint author), Drexel Univ, Coll Med, Dept Pathol, MS 435,15th & Vine St, Philadelphia, PA 19102 USA.
EM stearnsm1@aol.com
FU  [NIH-NCI-CA076639-8]
FX NIH-NCI-CA076639-8 (M. E. Stearns).
CR AGNANTIS NJ, 1994, ANTICANCER RES, V14, P2135
   Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903
   Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000
   Blevins T, 2010, METHODS MOL BIOL, V631, P87, DOI 10.1007/978-1-60761-646-7_9
   Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184
   Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001
   BUSHMAN EC, 1995, J UROLOGY, V153, P233, DOI 10.1097/00005392-199501000-00083
   Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995
   Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997
   CHIAO PJ, 1992, MOL CARCINOGEN, V5, P219, DOI 10.1002/mc.2940050309
   Croce CM, 1999, CANCER RES, V59, p1778S
   Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294
   Forooghian F, 2008, AM J OPHTHALMOL, V146, P489, DOI 10.1016/j.ajo.2008.05.046
   Goodyear SM, 2009, PROSTATE, V69, P689, DOI 10.1002/pros.20918
   Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5
   Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014
   Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083
   Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014
   KONDOH N, 1992, CANCER RES, V52, P791
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003
   Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407
   Loging WT, 1999, CANCER EPIDEM BIOMAR, V8, P1011
   Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702
   Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999
   Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a
   Motoyama K, 2008, CLIN CANCER RES, V14, P2334, DOI 10.1158/1078-0432.CCR-07-4667
   Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731
   Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108
   NYGARD O, 1990, EUR J BIOCHEM, V191, P1, DOI 10.1111/j.1432-1033.1990.tb19087.x
   Ohkia A, 2004, CLIN CANCER RES, V10, P2452, DOI 10.1158/1078-0432.CCR-03-0170
   Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200
   SAMBROOK J, 2003, MOL CLONING LAB MANU, V108, P82
   Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462
   Schulman BRM, 2008, CELL CYCLE, V7, P3935
   SCOTT MRD, 1983, CELL, V34, P557, DOI 10.1016/0092-8674(83)90388-4
   Shama Silvian, 1995, Gene Expression, V4, P241
   Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104
   SHIN DM, 1993, CARCINOGENESIS, V14, P163, DOI 10.1093/carcin/14.1.163
   SLYNN G, 1990, NUCLEIC ACIDS RES, V18, P681, DOI 10.1093/nar/18.3.681
   Stearns M, 2005, CANCER RES, V65, P2085, DOI 10.1158/0008-5472.CAN-04-4100
   Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637
   Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200
   Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040
   WANG M, 1991, DIFFERENTIATION, V48, P115, DOI 10.1111/j.1432-0436.1991.tb00250.x
   WANG M, 2004, J EXP CLIN CANC RES, V28, P6
   Watanabe S, 2009, AM J PATHOL, V174, P854, DOI 10.2353/ajpath.2009.080523
   Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8
   Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488
   Yasunaga Y, 2001, ONCOGENE, V20, P8036, DOI 10.1038/sj.onc.1205002
   Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054
NR 51
TC 8
Z9 8
U1 2
U2 12
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1541-7786
EI 1557-3125
J9 MOL CANCER RES
JI Mol. Cancer Res.
PD JAN
PY 2011
VL 9
IS 1
BP 36
EP 50
DI 10.1158/1541-7786.MCR-10-0158
PG 15
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA 706LU
UT WOS:000286220700004
PM 21148031
OA Bronze
DA 2018-12-27
ER

PT J
AU Basselin, M
   Ramadan, E
   Chen, M
   Rapoport, SI
AF Basselin, Mireille
   Ramadan, Epolia
   Chen, Mei
   Rapoport, Stanley I.
TI RETRACTED: Anti-Inflammatory Effects of Chronic Aspirin on Brain
   Arachidonic Acid Metabolites (Retracted article. See vol. 40, pg. 1094,
   2015)
SO NEUROCHEMICAL RESEARCH
LA English
DT Article; Retracted Publication
DE Aspirin; Neuroinflammation; Eicosanoids; Arachidonic acid; Lipoxin A(4);
   15-epi-lipoxin A(4)
ID LOW-DOSE ASPIRIN; FACTOR-KAPPA-B; LIPOXIN A(4); RAT-BRAIN; TRIGGERED
   15-EPI-LIPOXINS; CYCLOOXYGENASE ISOZYMES; ALZHEIMERS-DISEASE;
   GENE-EXPRESSION; LEUKOTRIENE B-4; EICOSANOIDS
AB Pro-inflammatory and anti-inflammatory mediators derived from arachidonic acid (AA) modulate peripheral inflammation and its resolution. Aspirin (ASA) is a unique non-steroidal anti-inflammatory drug, which switches AA metabolism from prostaglandin E-2 (PGE(2)) and thromboxane B-2 (TXB2) to lipoxin A(4) (LXA(4)) and 15-epi-LXA(4). However, it is unknown whether chronic therapeutic doses of ASA are anti-inflammatory in the brain. We hypothesized that ASA would dampen increases in brain concentrations of AA metabolites in a rat model of neuroinflammation, produced by a 6-day intracerebroventricular infusion of bacterial lipopolysaccharide (LPS). In rats infused with LPS (0.5 ng/h) and given ASA-free water to drink, concentrations in high-energy microwaved brain of PGE(2), TXB2 and leukotriene B-4 (LTB4) were elevated. In rats infused with artificial cerebrospinal fluid, 6 weeks of treatment with a low (10 mg/kg/day) or high (100 mg/kg/day) ASA dose in drinking water decreased brain PGE(2), but increased LTB4, LXA(4) and 15-epi-LXA(4) concentrations. Both doses attenuated the LPS effects on PGE(2), and TXB2. The increments in LXA(4) and 15-epi-LXA(4) caused by high-dose ASA were significantly greater in LPS-infused rats. The ability of ASA to increase anti-inflammatory LXA(4) and 15-epi-LXA(4) and reduce pro-inflammatory PGE(2) and TXB2 suggests considering aspirin further for treating clinical neuroinflammation.
C1 [Basselin, Mireille; Ramadan, Epolia; Chen, Mei; Rapoport, Stanley I.] NIA, Brain Physiol & Metab Sect, NIH, Bethesda, MD 20892 USA.
RP Ramadan, E (reprint author), NIA, Brain Physiol & Metab Sect, NIH, Bldg 9,Room 1S126,9000 Rockville Pike, Bethesda, MD 20892 USA.
EM ramadanir@mail.nih.gov
FU National Institute on Aging, NIH
FX This work was supported entirely by the Intramural Research Program of
   the National Institute on Aging, NIH. None of the authors has a
   financial or other conflict of interest related to this work.
CR Antonio V, 2002, BIOCHEM J, V368, P415, DOI 10.1042/BJ20020658
   Arbibe L, 1997, J IMMUNOL, V159, P391
   Basselin M, 2007, J NEUROCHEM, V102, P761, DOI 10.1111/j.1471-4159.2007.04593.x
   Basselin M, 2011, J CEREBR BLOOD F MET, V31, P486, DOI 10.1038/jcbfm.2010.111
   Basselin M, 2010, J LIPID RES, V51, P1049, DOI 10.1194/jlr.M002469
   Bauer MKA, 1997, EUR J BIOCHEM, V243, P726, DOI 10.1111/j.1432-1033.1997.00726.x
   Bosetti F, 2003, J NEUROCHEM, V85, P690, DOI 10.1046/j.1471-4159.2003.01701.x
   BOSISIO E, 1976, PROSTAGLANDINS, V11, P773, DOI 10.1016/0090-6980(76)90186-6
   Chiang N, 2004, P NATL ACAD SCI USA, V101, P15178, DOI 10.1073/pnas.0405445101
   Chiang N, 2005, PROSTAG LEUKOTR ESS, V73, P163, DOI 10.1016/j.plefa.2005.05.003
   CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475
   Decker Y, 2009, AM J PHYSIOL-CELL PH, V296, pC1420, DOI 10.1152/ajpcell.00380.2008
   DeMar JC, 2006, BBA-MOL CELL BIOL L, V1761, P1050, DOI 10.1016/j.bbalip.2006.06.006
   Deutsch J, 1997, NEUROCHEM RES, V22, P759, DOI 10.1023/A:1022030306359
   Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0
   Doorduin J, 2009, J NUCL MED, V50, P1801, DOI 10.2967/jnumed.109.066647
   Engstrom K, 2001, PROSTAG LEUKOTR ESS, V64, P291, DOI 10.1054/plef.2001.0275
   Esposito G, 2008, J NUCL MED, V49, P1414, DOI 10.2967/jnumed.107.049619
   Farias SE, 2008, J LIPID RES, V49, P1990, DOI 10.1194/jlr.M800200-JLR200
   Fiorucci S, 2003, BRIT J PHARMACOL, V139, P1351, DOI 10.1038/sj.bjp.0705356
   Fiorucci S, 2002, GASTROENTEROLOGY, V123, P1598, DOI 10.1053/gast.2002.36558
   Ghelardoni S, 2004, BIOL PSYCHIAT, V56, P248, DOI 10.1016/j.biophysc.2004.05.012
   Golovko MY, 2008, J LIPID RES, V49, P893, DOI 10.1194/jlr.D700030-JLR200
   Hauss-Wegrzyniak B, 1999, BRAIN RES, V815, P36, DOI 10.1016/S0006-8993(98)01081-6
   Hauss-Wegrzyniak B, 1998, BRAIN RES, V780, P294, DOI 10.1016/S0006-8993(97)01215-8
   HOECK WG, 1993, P NATL ACAD SCI USA, V90, P4475, DOI 10.1073/pnas.90.10.4475
   Ishizuka T, 2008, LIFE SCI, V82, P806, DOI 10.1016/j.lfs.2008.01.017
   Ketterer MW, 1996, J PSYCHOSOM RES, V40, P53, DOI 10.1016/0022-3999(95)00524-2
   KIM SJ, 1989, ANN NY ACAD SCI, V559, P461
   Kure I, 2010, J PHARMACOL EXP THER, V332, P541, DOI 10.1124/jpet.109.159046
   Laan W, 2010, J CLIN PSYCHIAT, V71, P520, DOI 10.4088/JCP.09m05117yel
   Lee H, 2004, J NEUROCHEM, V91, P936, DOI 10.1111/j.1471-4159.2004.02786.x
   Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200
   MEADE EA, 1993, J BIOL CHEM, V268, P6610
   Minghetti L, 2005, CURR OPIN NEUROL, V18, P315, DOI 10.1097/01.wco.0000169752.54191.97
   MORII H, 1994, BIOCHEM BIOPH RES CO, V205, P6, DOI 10.1006/bbrc.1994.2621
   Morris T, 2009, J IMMUNOL, V183, P2089, DOI 10.4049/jimmunol.0900477
   Planaguma A, 2002, FASEB J, V16, P1937, DOI 10.1096/fj.02-0224fje
   Rao JS, 2010, MOL PSYCHIATR, V15, P384, DOI 10.1038/mp.2009.47
   Renna NF, 2009, CLIN EXP PHARMACOL P, V36, P162, DOI 10.1111/j.1440-1681.2008.05042.x
   Richardson RL, 2005, BEHAV PHARMACOL, V16, P531, DOI 10.1097/01.fbp.0000179278.03868.96
   ROMANO M, 1993, BIOCHEM J, V296, P127, DOI 10.1042/bj2960127
   Rosenberger TA, 2004, J NEUROCHEM, V88, P1168, DOI 10.1046/j.1471-4159.2003.02246.x
   SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055
   Serhan CN, 2005, PROSTAG LEUKOTR ESS, V73, P141, DOI 10.1016/j.plefa.2005.05.002
   Serhan CN, 1997, PROSTAG OTH LIPID M, V53, P107, DOI 10.1016/S0090-6980(97)00001-4
   SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x
   Sobrado M, 2009, J NEUROSCI, V29, P3875, DOI 10.1523/JNEUROSCI.5529-08.2009
   Stolk P, 2010, PROSTAG LEUKOTR ESS, V82, P9, DOI 10.1016/j.plefa.2009.10.007
   Striggow F, 1997, BIOCHEM BIOPH RES CO, V237, P413, DOI 10.1006/bbrc.1997.7152
   TABACHNICK BG, 2001, COMPUTER ASSISTED RE, P184
   Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2
   Tanne D, 2008, NEUROBIOL DIS, V30, P56, DOI 10.1016/j.nbd.2007.12.004
   Titos E, 1999, AM J PHYSIOL-CELL PH, V277, pC870, DOI 10.1152/ajpcell.1999.277.5.C870
   VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0
   VOISIN EM, 1990, REGUL TOXICOL PHARM, V12, P107, DOI 10.1016/S0273-2300(05)80052-2
   Wada K, 2006, FASEB J, V20, P1785, DOI 10.1096/fj.06-5809com
   Wahner AD, 2007, NEUROLOGY, V69, P1836, DOI 10.1212/01.wnl.0000279519.99344.ad
   WEISSMANN G, 1991, SCI AM, V264, P84, DOI 10.1038/scientificamerican0191-84
   Whitehead SN, 2007, STROKE, V38, P381, DOI 10.1161/01.STR.0000254464.05561.72
   WIENTJES MG, 1988, J PHARMACOL EXP THER, V245, P809
   Xiao LH, 1999, AM J TROP MED HYG, V60, P668, DOI 10.4269/ajtmh.1999.60.668
   YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T
NR 63
TC 19
Z9 20
U1 4
U2 13
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0364-3190
EI 1573-6903
J9 NEUROCHEM RES
JI Neurochem. Res.
PD JAN
PY 2011
VL 36
IS 1
BP 139
EP 145
DI 10.1007/s11064-010-0282-4
PG 7
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 711KA
UT WOS:000286589000017
PM 20981485
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Takayasu, K
AF Takayasu, Kenichi
TI RETRACTED: Superselective Transarterial Chemoembolization for
   Hepatocellular Carcinoma: Recent Progression and Perspective (Retracted
   article. See vol. 82, pg. 188, 2012)
SO ONCOLOGY
LA English
DT Article; Retracted Publication
DE Hepatocellular carcinoma; Transcatheter arterial chemoembolization;
   Treatment algorithm; Japanese guidelines; BCLC staging system
ID TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; RANDOMIZED CONTROLLED TRIAL;
   ENDOTHELIAL GROWTH-FACTOR; IODIZED OIL; PORTAL-VEIN; EMBOLIZATION;
   SURVIVAL; EXPRESSION; THERAPY; COHORT
AB Transcatheter arterial chemoembolization (TACE) is widely performed in 32% of the patients with unresectable hepatocellular carcinoma (HCC) at initial diagnosis and in 58% of those with recurrent HCC in Japan. However, the patient population which undergoes TACE is heterogeneous, and thus the 3-year survival rate varies from 26 to 47%. The selection criteria for TACE is 2-3 tumors 1 3 cm or 4 or more tumors in patients with liver damage A/B (corresponding well to Child-Pugh class A/B) and absence of vascular invasion and extrahepatic spread, as proposed by Japanese guidelines. The 3-year survival rate of TACE for patients with 2-3 tumors 1 3 cm or 4 or more tumors was 55 and 46%, respectively, in Child-Pugh A and 30 and 22%, respectively, in class B. These outcomes could help to understand the various results of TACE in different backgrounds in the East and West. Recently, TACE with calibrated drug-eluting beads loaded with doxorubicin showed a similar tumor response and radioembolization with yttrium-90 microspheres demonstrated a similar median survival compared with conventional TACE. Based on these results, the combination of TACE and novel molecular targeted agents can be used to elucidate the synergic effect on survival. Copyright (C) 2011 S. Karger AG, Basel
C1 Natl Canc Ctr, Dept Diagnost Radiol, Chuo Ku, Tokyo 1040045, Japan.
RP Takayasu, K (reprint author), Natl Canc Ctr, Dept Diagnost Radiol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.
EM ktakayas@ncc.go.jp
CR Arai Y, 2010, ASCO M CHIC, V28, P4030
   Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933
   Carlomagno F, 2006, J NATL CANCER I, V98, P326, DOI 10.1093/jnci/djj069
   Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7
   Chung Y, 2010, J CLIN ONC S, V28, P4026
   El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013
   Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gast.2004.09.014
   Ikai I, 2010, HEPATOL RES, V40, P1043, DOI 10.1111/j.1872-034X.2010.00731.x
   Iwazawa J, 2009, AM J ROENTGENOL, V192, P1057, DOI 10.2214/AJR.08.1285
   Kudo M, 2011, 2 AS PAC PRIM LIV CA, P198
   Kudo M, 2007, ONCOLOGY-BASEL, V72, P2, DOI 10.1159/000111702
   Kudo M, 2011, EUR J CANCER, V47, P2117, DOI 10.1016/j.ejca.2011.05.007
   Kulik LM, 2008, HEPATOLOGY, V47, P71, DOI 10.1002/hep.21980
   Lammer J, 2010, CARDIOVASC INTER RAD, V33, P41, DOI 10.1007/s00270-009-9711-7
   Lencioni R, 2010, ASCO M CHIC
   Lewandowski RJ, 2010, RADIOLOGY, V255, P955, DOI 10.1148/radiol.10091473
   Li X, 2004, WORLD J GASTROENTERO, V10, P2878
   Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122
   Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047
   Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X
   Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857
   Llovet JM, 2008, J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134
   Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156
   Makuuchi M, 2008, HEPATOL RES, V38, P37, DOI 10.1111/j.1872-034X.2007.00216.x
   Malagari K, 2010, CARDIOVASC INTER RAD, V33, P541, DOI 10.1007/s00270-009-9750-0
   Marelli L, 2007, CARDIOVASC INTER RAD, V30, P6, DOI 10.1007/s00270-006-0062-3
   MATSUI O, 1993, RADIOLOGY, V188, P79, DOI 10.1148/radiology.188.1.8390073
   Miyayama S, 2007, J VASC INTERV RADIOL, V18, P365, DOI 10.1016/j.jvir.2006.12.004
   Okusaka T, 2004, INVEST NEW DRUG, V22, P169, DOI 10.1023/B:DRUG.0000011793.72775.d1
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   Raoul JL, 2011, CANCER TREAT REV, V37, P212, DOI 10.1016/j.ctrv.2010.07.006
   Salem R, 2011, GASTROENTEROLOGY, V140, P497, DOI 10.1053/j.gastro.2010.10.049
   Salem R, 2010, GASTROENTEROLOGY, V138, P52, DOI 10.1053/j.gastro.2009.09.006
   Santi V, 2010, J HEPATOL, V53, P291, DOI 10.1016/j.jhep.2010.03.010
   Sun HC, 2004, J CANCER RES CLIN, V130, P307, DOI 10.1007/s00432-003-0530-y
   Takayama T., 2010, MALIGNANT LIVER TUMO, P317
   Takayasu K, 2001, AM J ROENTGENOL, V176, P681, DOI 10.2214/ajr.176.3.1760681
   Takayasu K, J HEPATOL IN PRESS
   Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021
   Terayama N, 2001, CARDIOVASC INTER RAD, V24, P383, DOI 10.1007/s00270-001-0070-2
   UCHIDA H, 1990, CARDIOVASC INTER RAD, V13, P140, DOI 10.1007/BF02575465
   Ueno K, 2000, CANCER, V88, P1574, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1574::AID-CNCR11>3.0.CO;2-8
   Varela M, 2007, J HEPATOL, V46, P474, DOI 10.1016/j.jhep.2006.10.020
   Virmani S, 2008, J VASC INTERV RADIOL, V19, P1483, DOI 10.1016/j.jvir.2008.06.017
   Wang B, 2008, ACTA RADIOL, V49, P523, DOI 10.1080/02841850801958890
   Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443
NR 46
TC 6
Z9 6
U1 3
U2 11
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0030-2414
EI 1423-0232
J9 ONCOLOGY-BASEL
JI Oncology
PY 2011
VL 81
SU 1
BP 105
EP 110
DI 10.1159/000333269
PG 6
WC Oncology
SC Oncology
GA 870IX
UT WOS:000298663700015
PM 22212943
DA 2018-12-27
ER

PT J
AU Liedl, A
   Muller, J
   Morina, N
   Karl, A
   Denke, C
   Knaevelsrud, C
AF Liedl, Alexandra
   Mueller, Julia
   Morina, Naser
   Karl, Anke
   Denke, Claudia
   Knaevelsrud, Christine
TI RETRACTED: Physical Activity within a CBT Intervention Improves Coping
   with Pain in Traumatized Refugees: Results of a Randomized Controlled
   Design (Retracted article. See vol. 12, pg. 234, 2011)
SO PAIN MEDICINE
LA English
DT Article; Retracted Publication
DE Posttraumatic Stress Disorder; Chronic Pain; Cognitive Behavioral
   Therapy; Biofeedback; Pain Management
ID POSTTRAUMATIC-STRESS-DISORDER; LOW-BACK-PAIN; COMORBID CHRONIC PAIN;
   IRAQI ASYLUM SEEKERS; PSYCHIATRIC-DISORDERS; MUTUAL MAINTENANCE;
   SYMPTOMS; EXERCISE; VETERANS; THERAPY
AB Objective.
   Many traumatized refugees experience both posttraumatic stress disorder and chronic pain. Based on Mutual Maintenance Theory and the Perpetual Avoidance Model, this study examined the additional effect of physical activity within a biofeedback-based cognitive behavioral therapy (CBT-BF) for traumatized refugees.
   Design.
   In a controlled design, 36 patients were randomized into one of three conditions (CBT-BF, CBT-BF with physical activity [CBT-BF+active], and a waiting list control group [WL]). Thirty patients (n = 10 in each group) completed the treatment and a follow-up assessment 3 months later. Participants' coping strategies, pain and mental health status, and physiological reactivity were assessed before and after the intervention and at 3-month follow-up. Treatment effects were analyzed using analyses of variance with baseline scores as covariates (ANCOVAs) and the Reliable Change Index.
   Results.
   The CBT-BF and CBT-BF+active groups showed improvements in all outcome measures relative to the WL group. The effect sizes for the main outcome measures were higher in the CBT-BF+active group than in the CBT-BF group. Repeated measures analyses of covariance showed significant group effects for coping strategies-in particular, for the "cognitive restructuring" and "counter-activities" subscales as well as a marginally significant group effect for "perceived self-competence"-with the CBT-BF+active group showing more favorable outcomes than the CBT-BF group. Moreover, 60% of participants in the CBT-BF+active group showed clinically reliable intraindividual change in at least one subscale of the pain coping strategies questionnaire, compared with just 30% of participants in the CBT-BF group.
   Conclusion.
   Findings of improved coping strategies, larger effect sizes, and higher rates of clinical improvement in the CBT-BF+active group suggest that physical activity adds value to pain management interventions for traumatized refugees. Given the small sample size, however, these preliminary results need replication in a larger trial.
C1 [Liedl, Alexandra; Knaevelsrud, Christine] Treatment Ctr Torture Victims Berlin, Berlin, Germany.
   [Denke, Claudia] Charite, Dept Anaesthesiol & Crit Care Med, Berlin, Germany.
   [Liedl, Alexandra; Knaevelsrud, Christine] Free Univ Berlin, Dept Clin Psychol, D-1000 Berlin, Germany.
   [Liedl, Alexandra] Tech Univ Dresden, Dept Clin Psychol & Psychotherapy, Dresden, Germany.
   [Mueller, Julia; Morina, Naser] Univ Zurich Hosp, Dept Psychiat, Zurich, Switzerland.
   [Karl, Anke] Univ Southampton, Sch Psychol, Southampton SO9 5NH, Hants, England.
RP Liedl, A (reprint author), Treatment Ctr Torture Victims Berlin Bzfo, Res Dept, Turmstra 21, D-10559 Berlin, Germany.
EM a.liedl@bzfo.de
OI Karl, Anke/0000-0002-6472-2876
CR American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Basoglu M, 2005, JAMA-J AM MED ASSOC, V294, P580, DOI 10.1001/jama.294.5.580
   Beckham JC, 1997, J CLIN PSYCHOL, V53, P847, DOI 10.1002/(SICI)1097-4679(199712)53:8<847::AID-JCLP9>3.0.CO;2-C
   BRIERE J, 1997, PSYCHOL ASS ADULT PO
   Campello M, 1996, SCAND J MED SCI SPOR, V6, P63, DOI 10.1111/j.1600-0838.1996.tb00073.x
   Cohen J., 1988, STAT POWER ANAL BEHA, Vxxi
   Dahl Solveig, 2006, Tidsskr Nor Laegeforen, V126, P608
   Daniel M, 1992, Br J Sports Med, V26, P111
   DENKE C, 2006, BIOFEEDBACK MA UNPUB
   DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102
   Diaz Ann B, 2008, Int J Emerg Ment Health, V10, P49
   FOA EB, 1995, PDS POSTTRAUMATIC ST
   Geissner E, 2001, FRAGEBOGEN ERFASSUNG
   Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530
   Guy W, 1976, ECDEU ASSESSMENT PSY
   Hayden JA, 2005, ANN INTERN MED, V142, P765, DOI 10.7326/0003-4819-142-9-200505030-00013
   Haythornthwaite JA, 1998, PAIN, V77, P33, DOI 10.1016/S0304-3959(98)00078-5
   Heneweer H, 2009, PAIN, V143, P21, DOI 10.1016/j.pain.2008.12.033
   Hurwitz EL, 2005, AM J PUBLIC HEALTH, V95, P1817, DOI 10.2105/AJPH.2004.052993
   *INS INSTR, 1999, SOFTM COMF 7 O
   JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12
   Jenewein J, 2009, J TRAUMA STRESS, V22, P540, DOI 10.1002/jts.20453
   Johnson H, 2008, CLIN PSYCHOL REV, V28, P36, DOI 10.1016/j.cpr.2007.01.017
   Kleijn WC, 2001, PSYCHOL REP, V88, P527, DOI 10.2466/PR0.88.2.527-532
   KNAEVELSRUD C, VALIDATION ACC UNPUB
   Knaevelsrud C., 2008, MULTICASI MULTILINGU
   KronerHerwig B, 1996, SCHMERZ, V10, P47, DOI 10.1007/s004820050021
   Laban CJ, 2005, J NERV MENT DIS, V193, P825, DOI 10.1097/01.nmd.0000188977.44657.1d
   Laban CJ, 2004, J NERV MENT DIS, V192, P843, DOI 10.1097/01.nmd.0000146739.26187.15
   Liddle SD, 2004, PAIN, V107, P176, DOI 10.1016/j.pain.2003.10.017
   Liedl A, 2010, PSYCHOL MED, V40, P1215, DOI 10.1017/S0033291709991310
   Liedl Alexandra, 2008, Torture, V18, P69
   Maher CG, 2004, ORTHOP CLIN N AM, V35, P57, DOI 10.1016/S0030-5898(03)00088-9
   Manger Theresa A, 2005, Int J Emerg Ment Health, V7, P49
   MARTINSEN EW, 1994, ACTA PSYCHIAT SCAND, V89, P23, DOI 10.1111/j.1600-0447.1994.tb05797.x
   McCracken LM, 2007, PAIN, V130, P119, DOI 10.1016/j.pain.2006.11.016
   MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008
   Muller Julia, 2009, Cognitive Behaviour Therapy, V38, P184, DOI 10.1080/16506070902815024
   Otis JD, 2009, PAIN MED, V10, P1300, DOI 10.1111/j.1526-4637.2009.00715.x
   Payne JK, 2008, ONCOL NURS FORUM, V35, P635, DOI 10.1188/08.ONF.635-642
   Robjant K, 2009, BRIT J PSYCHIAT, V194, P306, DOI 10.1192/bjp.bp.108.053223
   Rudy TE, 2003, CLIN J PAIN, V19, P18, DOI 10.1097/00002508-200301000-00003
   SACKS MH, 1993, MIND BODY MED, P315
   Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi
   Shipherd JC, 2007, J REHABIL RES DEV, V44, P153, DOI 10.1682/JRRD.2006.06.0065
   Tang MF, 2010, SUPPORT CARE CANCER, V18, P1329, DOI 10.1007/s00520-009-0757-5
   Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0
NR 48
TC 18
Z9 18
U1 3
U2 24
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1526-2375
EI 1526-4637
J9 PAIN MED
JI Pain Med.
PY 2011
VL 12
IS 2
BP 234
EP 245
DI 10.1111/j.1526-4637.2010.01040.x
PG 12
WC Anesthesiology; Medicine, General & Internal
SC Anesthesiology; General & Internal Medicine
GA 719JC
UT WOS:000287200000008
PM 21223501
OA Bronze
DA 2018-12-27
ER

PT J
AU Taylor, J
AF Taylor, Jeannette
TI RETRACTED: STRENGTHENING THE LINK BETWEEN PERFORMANCE MEASUREMENT AND
   DECISION MAKING (Retracted article. See vol. 89, pg. 1701, 2011)
SO PUBLIC ADMINISTRATION
LA English
DT Article; Retracted Publication
ID PUBLIC-SECTOR; MUNICIPAL-GOVERNMENT; MANAGEMENT; ACCOUNTABILITY;
   ORGANIZATIONS; INDICATORS; SYSTEMS; MODELS; STATE
AB Many public agencies now face dual pressures to meet external accountability demands on one hand, and improve their internal performance on the other. This begs the question whether the demands that are made on public agencies to externally report on their performance have a limited or wide ranging impact on the utilization of performance indicators (PIs) for internal improvements. This article addresses this question via a small group of public agencies and public accountability authorities in Australia. It also examines the main factors that affect the use of PIs for decision making. The evidence suggests that the agencies use PIs more for meeting external reporting requirements than for achieving internal improvements. Various constraints on the use of PIs were identified, mainly technical problems, and to a lesser extent, political and organizational issues.
C1 Univ Western Australia, Sch Social & Cultural Studies, Crawley, WA, Australia.
RP Taylor, J (reprint author), Univ Western Australia, Sch Social & Cultural Studies, Crawley, WA, Australia.
OI Taylor, Jeannette/0000-0003-0001-0586
CR ALLISON GT, 1969, AM POLIT SCI REV, V63, P689, DOI 10.2307/1954423
   Ashworth R., 2001, NEW GOVERNANCE NEW D
   Audit Office of New South Wales, 2006, AUD GEN REP PERF AUD
   Behn RD, 2003, PUBLIC ADMIN REV, V63, P586, DOI 10.1111/1540-6210.00322
   Berman E, 2000, PUBLIC ADMIN REV, V60, P409, DOI 10.1111/0033-3352.00104
   Bohte J, 2000, PUBLIC ADMIN REV, V60, P173, DOI 10.1111/0033-3352.00075
   Bouckaert G, 1993, PUBLIC PRODUCTIVITY, V17, P31, DOI DOI 10.2307/3381047
   Boyne G, 2002, PUBLIC ADMIN, V80, P691, DOI 10.1111/1467-9299.00324
   Boyne GA, 2004, PUBLIC ADMIN REV, V64, P463, DOI 10.1111/j.1540-6210.2004.00392.x
   Boyne GA, 2004, ADMIN SOC, V36, P328, DOI 10.1177/0095399704265294
   Boyne GA, 2007, J PUBL ADM RES THEOR, V17, P455, DOI 10.1093/jopart/mul007
   Cavalluzzo KS, 2004, ACCOUNT ORG SOC, V29, P243, DOI 10.1016/S0361-3682(03)00013-8
   Chaffee E.E., 1980, THESIS STANFORD U PA
   Coplin WD, 2002, PUBLIC ADMIN REV, V62, P699, DOI 10.1111/1540-6210.00252
   COVALESKI MA, 1991, J ACCOUNT PUBLIC POL, V10, P135, DOI 10.1016/0278-4254(91)90009-9
   Cyert R. M., 1963, BEHAV THEORY FIRM
   Day P, 1987, ACCOUNTABILITIES 5 P
   de Kool D., 2004, C EUR GROUP ADM LJUB
   de Lancer Julnes P., 2006, ASPA EGPA PERFORMING
   Feldman MS, 1989, ORDER DESIGN INFORM
   Gregory R., 2006, ASPA EGPA PERFORMING
   GUPTA PP, 1994, ADMIN SCI QUART, V39, P264, DOI 10.2307/2393236
   Halachmi A, 2005, INT REV ADM SCI, V71, P255, DOI 10.1177/0020852305053884
   Halachmi A, 2004, INT REV ADM SCI, V70, P5, DOI 10.1177/0020852304041227
   Heald D, 2003, PUBLIC ADMIN, V81, P723, DOI 10.1111/j.0033-3298.2003.00369.x
   Heinrich CJ, 2002, PUBLIC ADMIN REV, V62, P712, DOI 10.1111/1540-6210.00253
   Henri JF, 2006, ACCOUNT ORG SOC, V31, P77, DOI 10.1016/j.aos.2004.10.003
   Ho ATK, 2006, J PUBL ADM RES THEOR, V16, P217, DOI 10.1093/jopart/mui046
   Holzer M, 2004, INT REV ADM SCI, V70, P15, DOI 10.1177/0020852304041228
   Ingraham PW, 2005, PUBLIC ADMIN REV, V65, P390, DOI 10.1111/j.1540-6210.2005.00466.x
   Julnes G., 2006, ASPA EGPA PERFORMING
   Julnes PD, 2001, PUBLIC ADMIN REV, V61, P693, DOI 10.1111/0033-3352.00140
   Kim P.S., 2006, ASPA EGPA PERFORMING
   Marnoch G., 2006, ASPA EGPA PERFORMING
   Martin S, 2005, J PUBL ADM RES THEOR, V15, P599, DOI 10.1093/jopart/mui036
   Melkers J, 2005, PUBLIC ADMIN REV, V65, P180, DOI 10.1111/j.1540-6210.2005.00443.x
   MEYER JW, 1977, AM J SOCIOL, V83, P340, DOI 10.1086/226550
   MOYNIHAN D, 2001, DOES PERFORMANCE INF
   Moynihan DP, 2006, J PUBL ADM RES THEOR, V16, P151, DOI 10.1093/jopart/muj003
   Murphy Kevin E., 1995, UNDERSTANDING PERFOR
   Norman R, 2002, INT REV ADM SCI, V68, P619, DOI 10.1177/0020852302684007
   Nutt PC, 2006, J PUBL ADM RES THEOR, V16, P289, DOI 10.1093/jopart/mui041
   Office of Auditor General for Western Australia, 2006, AUD GEN REP AUD RES
   Office of Auditor General for Western Australia, 2005, AUD GEN REP AUD RES
   Osborne S. P., 1995, FINANCIAL ACCOUNTABI, V11, P19, DOI [10.1111/j.1468-0408.1995.tb00394.x, DOI 10.1111/J.1468-0408.1995.TB00159.X]
   Pfeffer J., 1992, MANAGING POWER POLIT
   Pfeffer J, 1981, POWER ORG
   Poister TH, 1999, PUBLIC ADMIN REV, V59, P325, DOI 10.2307/3110115
   Poister TH, 2005, PUBLIC ADMIN REV, V65, P45, DOI 10.1111/j.1540-6210.2005.00429.x
   Pollitt C, 2006, J PUBL ADM RES THEOR, V16, P25, DOI 10.1093/jopart/mui045
   Power M., 1997, AUDIT SOC RITUALS VE
   Queensland Audit Office, 2005, RES MAN SYST AUD OUT
   RICH RF, 1991, KNOWLEDGE, V12, P319, DOI 10.1177/107554709101200308
   Rubenstein R, 2003, PUBLIC ADMIN REV, V63, P607, DOI 10.1111/1540-6210.00323
   SCOTT WR, 1987, ADMIN SCI QUART, V32, P493, DOI 10.2307/2392880
   SIMON H, 1992, CLASSICS PUBLIC ADM
   Taylor J., 2001, HIGHER ED Q, V55, P42, DOI DOI 10.1111/HEQU.2001.55.ISSUE-1
   Taylor J., 2001, J FURTHER HIGHER ED, V25, P379
   Taylor J, 2007, PUBLIC ADMIN DEVELOP, V27, P341, DOI 10.1002/pad.460
   Tillema S., 2006, ASPA EGPA PERFORMING
   Vakkuri J, 2006, FINANC ACCOUNT MANAG, V22, P235, DOI 10.1111/j.0267-4424.2006.00401.x
   Wholey J.S., 1999, PUBLIC PRODUCTIVITY, V22, P288, DOI DOI 10.2307/3380705
   WHOLEY JS, 1992, PUBLIC ADMIN REV, V52, P604, DOI 10.2307/977173
NR 63
TC 9
Z9 10
U1 3
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0033-3298
EI 1467-9299
J9 PUBLIC ADMIN
JI Public Adm.
PY 2011
VL 89
IS 3
BP 860
EP 878
DI 10.1111/j.1467-9299.2009.01802.x
PG 19
WC Political Science; Public Administration
SC Government & Law; Public Administration
GA 823AD
UT WOS:000295092200009
DA 2018-12-27
ER

PT J
AU Ateya, SF
   Ahmad, AA
AF Ateya, Saieed F.
   Ahmad, Abd El-Baset A.
TI RETRACTED: Inferences based on generalized order statistics under
   truncated Type I generalized logistic distribution (Retracted article.
   See vol. 46, pg. 563, 2012)
SO STATISTICS
LA English
DT Article; Retracted Publication
DE logistic distribution; maximum-likelihood estimation; Bayes estimation;
   Bayesian prediction intervals; one-sample scheme; generalized order
   statistics; MCMC technique; Monte Carlo integration
ID EXPONENTIAL-DISTRIBUTION; RECURRENCE RELATIONS; PRODUCT MOMENTS; SINGLE;
   PREDICTION; PARETO
AB In this paper, estimation of the parameters of a truncated Type I generalized logistic distribution TTIGL(beta, alpha, tau), when beta = 0, is obtained based on a doubly truncated sample of generalized order statistics. This model is introduced by [AL-Angary, Truncated logistic distributions as lifetime models, M.Sc. thesis, Department of Statistics, Faculty of Science, King Abdulaziz University, Jeddah, Kindom of Saudi Arabia, 1997] and the finite mixture of TTIGL(beta, alpha, tau) component model studied by [Ateya, Mixtures of logistic distributions as life-time models. M.Sc. thesis, Department of Mathematics, Faculty of Science, Assiut University, Assiut, Egypt, 2001] and [AL-Hussaini and Ateya, Maximum likelihood estimations under a mixture of truncated type I generalized logistic components model, J. Stat. Theory Appl. 2(1) (2003), pp. 47-60; AL-Hussaini and Ateya, Bayes estimations under a mixture of truncated type I generalized logistic components model, J. Stat. Theory Appl. 4(2) (2005), pp. 183-208]. The maximum-likelihood and Bayes methods are used in the estimation and then we compare these methods by computing the mean squared errors of the estimates in both cases considering order statistics and upper record values cases. Also, the Bayesian prediction intervals for the future generalized order statistics are computed based on a one-sample scheme.
C1 [Ateya, Saieed F.; Ahmad, Abd El-Baset A.] Assiut Univ, Dept Math, Assiut, Egypt.
RP Ahmad, AA (reprint author), Assiut Univ, Dept Math, Assiut, Egypt.
EM abahmad2002@yahoo.com
CR Ahmad A, 2003, J STAT PLAN INFER, V117, P241, DOI 10.1016/S0378-3758(02)00385-3
   Ahmad A.A., 2010, STATISTICS IN PRESS
   Ahmad A.A., 2008, J PROBAB STAT SCI, V6, P243
   Ahmad A.A., 2007, J EGYPT MATH SOC, V15, P117
   Ahmad AEBA, 2008, COMMUN STAT-THEOR M, V37, P1162, DOI 10.1080/03610920701713344
   Ahsanullah M, 2000, J STAT PLAN INFER, V85, P85, DOI 10.1016/S0378-3758(99)00068-3
   AL-Angary A., 1997, THESIS KING ABDULAZI
   AL-Hussaini E.K., 2006, J EGYP MATH SOC, V14, P55
   AL-Hussaini E.K., 2004, J APPL STAT SCI, V13, P59
   AL-Hussaini E.K., 2003, J STAT THEORY APPL, V2, P47
   Al-Hussaini EK, 2003, TEST, V12, P79, DOI 10.1007/BF02595812
   Al-Hussaini EK, 2003, METRIKA, V57, P165, DOI 10.1007/s001840200207
   Al-Hussaini EK, 2005, J STAT THEORY APPL, V4, P183
   BALAKRISHNAN N, 1985, J STAT COMPUT SIM, V20, P287, DOI 10.1080/00949658508810784
   Balakrishnan N., 1992, HDB LOGISTIC DISTRIB
   Bernardo J. M, 1994, BAYESIAN THEORY
   Cramer E, 2000, J STAT PLAN INFER, V89, P79, DOI 10.1016/S0378-3758(00)00074-4
   Geisser S., 1993, PREDICTIVE INFERENCE
   Habibullah M, 2000, COMMUN STAT-THEOR M, V29, P1597, DOI 10.1080/03610920008832567
   Jaheen Z. F., 2002, J STAT THEOR APPL, V1, P191
   Jaheen ZF, 2005, COMMUN STAT-THEOR M, V34, P785, DOI 10.1081/STA-200054408
   Kamps U., 1995, CONCEPT GEN ORDER ST
   Kamps U., 1997, APPL MATH, V24, P383
   Keseling C, 1999, METRIKA, V49, P27, DOI 10.1007/s001840050023
   Kjelsberg M.O., 1962, THESIS U MINNESOTA M
   Maritz J. S., 1989, EMPIRICAL BAYES METH
   Mousa MAMA, 2003, STATISTICS, V37, P65, DOI 10.1080/0233188021000004639
   Pawlas P, 2001, COMMUN STAT-THEOR M, V30, P739, DOI 10.1081/STA-100002148
   Press S. J., 2003, SUBJECTIVE OBJECTIVE
   Raqab MZ, 2001, IEEE T RELIAB, V50, P112, DOI 10.1109/24.935025
   Reed LJ, 1929, J PHYS CHEM-US, V33, P760, DOI 10.1021/j150299a014
   Verhulst P.-F, 1838, CORRES MATH PHYSIQUE, V10, P113
   Verhulst Pierre F., 1845, NOUVEAUX MEMOIRES AC, V20, P1
NR 33
TC 4
Z9 4
U1 2
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0233-1888
EI 1029-4910
J9 STATISTICS-ABINGDON
JI Statistics
PY 2011
VL 45
IS 4
BP 389
EP 402
DI 10.1080/02331881003650149
PG 14
WC Statistics & Probability
SC Mathematics
GA 884UB
UT WOS:000299733200007
DA 2018-12-27
ER

PT J
AU Lukianova-Hleb, EY
   Oginsky, AO
   Samaniego, AP
   Shenefelt, DL
   Wagner, DS
   Hafner, JH
   Farach-Carson, MC
   Lapotko, DO
AF Lukianova-Hleb, Ekaterina Y.
   Oginsky, Alexander O.
   Samaniego, Adam P.
   Shenefelt, Derek L.
   Wagner, Daniel S.
   Hafner, Jason H.
   Farach-Carson, Mary C.
   Lapotko, Dmitri O.
TI RETRACTED: Tunable Plasmonic Nanoprobes for Theranostics of Prostate
   Cancer(Retracted article. See vol. 7, pg. 561, 2017)
SO THERANOSTICS
LA English
DT Article; Retracted Publication
DE Plasmonic nanobubble; gold nanoparticle; laser; photothermal; prostate
   cancer; theranostics
ID GOLD NANOPARTICLES; BIOMEDICAL APPLICATIONS; PHOTOTHERMAL BUBBLES; LASER
   VAPORIZATION; CELLULAR UPTAKE; LIVING CELLS; LIVE CELLS; CANCER;
   THERAPY; PROSTATE
AB Theranostic applications require coupling of diagnosis and therapy, a high degree of specificity and adaptability to delivery methods compatible with clinical practice. The tunable physical and biological effects of selective targeting and activation of plasmonic nanobubbles (PNB) were studied in a heterogeneous biological microenvironment of prostate cancer and stromal cells. All cells were targeted with conjugates of gold nanoparticles (NPs) through an anti-body-receptor-endocytosis-nanocluster mechanism that produced NP clusters. The simultaneous pulsed optical activation of intracellular NP clusters at several wavelengths resulted in higher optical contrast and therapeutic selectivity of PNBs compared with those of gold NPs alone. The developed mechanism was termed "rainbow plasmonic nanobubbles." The cellular effect of rainbow PNBs was tuned in situ in target cells, thus supporting a theranostic algorithm of prostate cancer cell detection and follow-up guided destruction without damage to collateral cells. The specificity and tunability of PNBs is promising for theranostic applications and we discuss a fiber optic platform that will capitalize on these features to bring theranostic tools to the clinic.
C1 [Lukianova-Hleb, Ekaterina Y.; Oginsky, Alexander O.; Samaniego, Adam P.; Lapotko, Dmitri O.] Rice Univ, Joint Amer Belarusian Lab Fundamental & Biomed Na, Houston, TX 77005 USA.
   [Oginsky, Alexander O.] Belarusian State Univ Informat & Radioelect, Minsk 220013, BELARUS.
   [Shenefelt, Derek L.; Wagner, Daniel S.; Farach-Carson, Mary C.; Lapotko, Dmitri O.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA.
   [Hafner, Jason H.; Lapotko, Dmitri O.] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA.
RP Lapotko, DO (reprint author), Rice Univ, Joint Amer Belarusian Lab Fundamental & Biomed Na, MS 61,6100 Main St, Houston, TX 77005 USA.
EM dl5@rice.edu
RI Wagner, Daniel/C-9379-2009; Hafner, Jason/A-7959-2008
OI Wagner, Daniel/0000-0002-0595-2436; Hafner, Jason/0000-0002-6943-4232
FU National Institute of Health [1R21CA133641, R01GM094816, P01CA098912,
   S10RR026399-01]
FX This work was supported by the National Institute of Health, grants
   1R21CA133641 and R01GM094816 and Hamill Innovation Award to D.O.L.,
   P01CA098912 to M.C.F.C. Authors thank Professor S. Link (Rice
   University) for providing gold nanorods, Professor R.A. Drezek for
   providing silica-gold shells and the members of the Carson laboratory,
   especially Drs. Brian Danysh and Pam Constantinou, for many helpful
   discussions. Ms. S. Parminter has kindly copy-edited the manuscript.
   Confocal microscopy was performed on equipment obtained through a Shared
   Instrumentation Grant from the National Institutes of Health
   (S10RR026399-01).
CR ANDERSON RR, 1983, SCIENCE, V220, P524, DOI 10.1126/science.6836297
   Arnida, 2010, J APPL TOXICOL, V30, P212, DOI 10.1002/jat.1486
   Bhojani MS, 2010, MOL PHARMACEUT, V7, P1921, DOI 10.1021/mp100298r
   Brandenberger C, 2010, SMALL, V6, P1669, DOI 10.1002/smll.201000528
   Chanda N, 2009, NANO LETT, V9, P1798, DOI 10.1021/nl8037147
   Chen JY, 2010, SMALL, V6, P811, DOI 10.1002/smll.200902216
   Chen WX, 2010, MOL CANCER THER, V9, P1028, DOI 10.1158/1535-7163.MCT-09-0829
   Cherukuri P, 2010, ADV DRUG DELIVER REV, V62, P339, DOI 10.1016/j.addr.2009.11.006
   Daou TJ, 2009, LANGMUIR, V25, P3040, DOI 10.1021/la8035083
   Day ES, 2010, J NEUROONCOL
   Farny CH, 2005, ACOUST RES LETT ONL, V6, P138, DOI 10.1121/1.1897823
   Govorov AO, 2007, NANO TODAY, V2, P30, DOI 10.1016/S1748-0132(07)70017-8
   Green DE, 2009, ACS NANO, V3, P2065, DOI 10.1021/nn900434p
   Gu YJ, 2009, TOXICOL APPL PHARM, V237, P196, DOI 10.1016/j.taap.2009.03.009
   Hirsch LR, 2006, ANN BIOMED ENG, V34, P15, DOI 10.1007/s10439-005-9001-8
   Hleb EY, 2008, NANOMEDICINE-UK, V3, P647, DOI 10.2217/17435889.3.5.647
   Hleb EY, 2008, NANOMEDICINE-UK, V3, P797, DOI 10.2217/17435889.3.6.797
   Hmelar M, 1998, Patent No. 5772657
   Hooper John W, 2006, MLO Med Lab Obs, V38, P22
   Hu M, 2006, CHEM SOC REV, V35, P1084, DOI 10.1039/b517615h
   Huang HC, 2010, ACS NANO, V4, P2892, DOI 10.1021/nn901884d
   Huang XH, 2008, LASER MED SCI, V23, P217, DOI 10.1007/s10103-007-0470-x
   Huang X, 2007, LASER SURG MED, V39, P747, DOI 10.1002/lsm.20577
   Huang XH, 2010, METHODS MOL BIOL, V624, P343, DOI 10.1007/978-1-60761-609-2_23
   Javier DJ, 2008, J NANOPHOTONICS, V2, DOI 10.1117/1.2927370
   Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30
   Kim C, 2010, CHEM REV, V110, P2756, DOI 10.1021/cr900266s
   Kogan MJ, 2007, NANOMEDICINE-UK, V2, P287, DOI 10.2217/17435889.2.3.287
   Kotaidis V, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2187476
   Lapotko D, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1854685
   Lapotko D, 2002, PHOTOCHEM PHOTOBIOL, V75, P519, DOI 10.1562/0031-8655(2002)075<0519:PMORSO>2.0.CO;2
   Lapotko D, 2009, NANOMEDICINE-UK, V4, P813, DOI [10.2217/nnm.09.59, 10.2217/NNM.09.59]
   Lapotko D, 2009, OPT EXPRESS, V17, P2538, DOI 10.1364/OE.17.002538
   Lapotko DO, 2007, NANOMEDICINE-UK, V2, P241, DOI 10.2217/17435889.2.2.241
   Lapotko DO, 2006, LASER SURG MED, V38, P631, DOI 10.1002/lsm.20359
   *LAS I AM, 2000, Z13612000 ANSI LAS I
   Lasagna-Reeves C, 2010, BIOCHEM BIOPH RES CO, V393, P649, DOI 10.1016/j.bbrc.2010.02.046
   Li JL, 2009, CANCER LETT, V274, P319, DOI 10.1016/j.canlet.2008.09.024
   Liu ZW, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/10/105304
   Lukianova-Hleb EY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/22/225102
   Lukianova-Hleb EY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/8/085102
   Lukianova-Hleb E, 2010, ACS NANO, V4, P2109, DOI 10.1021/nn1000222
   Lukianova-Hleb EY, 2009, NANO LETT, V9, P2160, DOI 10.1021/nl9007425
   Mailander V, 2009, BIOMACROMOLECULES, V10, P2379, DOI 10.1021/bm900266r
   McLaughlan JR, 2010, OPT LETT, V35, P2127, DOI 10.1364/OL.35.002127
   Mueller H, 2004, J BIOMOL SCREEN, V9, P506, DOI 10.1177/1087057104265386
   Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u
   O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004
   Oberdorster G, 2009, J NANOSCI NANOTECHNO, V9, P4996, DOI 10.1166/jnn.2009.GR02
   Olafsson R, 2010, OPT EXPRESS, V18, P18625, DOI 10.1364/OE.18.018625
   Patra CR, 2010, ADV DRUG DELIVER REV, V62, P346, DOI 10.1016/j.addr.2009.11.007
   Picard FJ, 2002, DRUG DISCOV TODAY, V7, P1092, DOI 10.1016/S1359-6446(02)02497-2
   Pitsillides CM, 2003, BIOPHYS J, V84, P4023, DOI 10.1016/S0006-3495(03)75128-5
   Podder Tarun K, 2010, 2010 International Conference on BioInformatics and BioEngineering (BIBE), P209, DOI 10.1109/BIBE.2010.41
   Prasad V, 2005, LANGMUIR, V21, P7528, DOI 10.1021/la051036d
   Rosi NL, 2006, SCIENCE, V312, P1027, DOI 10.1126/science.1125559
   Shah J, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940362
   Sountoulides P, 2008, YONSEI MED J, V49, P189, DOI 10.3349/ymj.2008.49.2.189
   Stern JM, 2008, J UROLOGY, V179, P748, DOI 10.1016/j.juro.2007.09.018
   Svaasand LO, 1989, LASER MED SCI, V4, P309
   Taylor U, 2010, CYTOM PART A, V77A, P439, DOI 10.1002/cyto.a.20846
   Terentyuk GS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3122371
   Tong L, 2007, ADV MATER, V19, P3136, DOI 10.1002/adma.200701974
   Tong L, 2009, PHOTOCHEM PHOTOBIOL, V85, P21, DOI 10.1111/j.1751-1097.2008.00507.x
   VANGEMERT MJC, 1989, IEEE ENG MED BIOL, V8, P10, DOI 10.1109/51.45950
   VANSWOL CFP, 1995, WORLD J UROL, V13, P88, DOI 10.1007/BF00183620
   Volkov AN, 2007, APPL SURF SCI, V253, P6394, DOI 10.1016/j.apsusc.2007.01.112
   Wagner DS, 2010, BIOMATERIALS, V31, P7567, DOI 10.1016/j.biomaterials.2010.06.031
   Wang ST, 2010, ANGEW CHEM INT EDIT, V49, P3777, DOI 10.1002/anie.201000062
   Wang YW, 2004, NANO LETT, V4, P1689, DOI 10.1021/nl049126a
   Wosnitzer MS, 2009, UROL CLIN N AM, V36, P471, DOI 10.1016/j.ucl.2009.08.004
   Wu TH, 2010, OPT EXPRESS, V18, P938, DOI 10.1364/OE.18.000938
NR 72
TC 51
Z9 51
U1 3
U2 35
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1838-7640
J9 THERANOSTICS
JI Theranostics
PY 2011
VL 1
BP 3
EP 17
DI 10.7150/thno/v01p0003
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 876PX
UT WOS:000299121000002
PM 21547151
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Yong, GC
AF Yong, Gao-Chan
TI RETRACTED: Effects of elastic and inelastic NN scattering cross sections
   on pi(-)/pi(+) ratios in heavy-ion collisions at intermediate energies
   (Retracted article. See vol. 84, art no 029904, 2011)
SO PHYSICAL REVIEW C
LA English
DT Article; Retracted Publication
ID NUCLEAR SYMMETRY ENERGY; EQUATION-OF-STATE; NEUTRON-STARS;
   PARTICLE-PRODUCTION; DENSE MATTER; PHYSICS
AB Based on the isospin-dependent Boltzmann-Uehling-Uhlenbeck transport model and the scaling model according to nucleon effective mass, effects of elastic and inelastic NN scattering cross sections on pi(-)/pi(+) in the neutron-rich reaction of Ca-48 + Ca-48 at a beam energy of 400 MeV/nucleon are studied. It is found that cross-section effects of both NN elastic and inelastic scatterings affect Delta(1232), pi(-) and pi(+) production, as well as the value of pi(-)/pi(+).
C1 Chinese Acad Sci, Inst Modern Phys, Lanzhou 730000, Peoples R China.
RP Yong, GC (reprint author), Chinese Acad Sci, Inst Modern Phys, Lanzhou 730000, Peoples R China.
FU National Natural Science Foundation of China [10740420550, 10875151]
FX This work is supported in part by the National Natural Science
   Foundation of China under Grants No. 10740420550 and No. 10875151.
CR Banik S, 2000, J PHYS G NUCL PARTIC, V26, P1495, DOI 10.1088/0954-3899/26/10/305
   Baran V, 2005, PHYS REP, V410, P335, DOI 10.1016/j.physrep.2004.12.004
   Basu DN, 2007, ACTA PHYS POL B, V38, P169
   Chabanat E, 1998, NUCL PHYS A, V635, P231, DOI 10.1016/S0375-9474(98)00180-8
   Chen LW, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.054316
   Chen LW, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.064309
   Das CB, 2003, PHYS REV C, V67, DOI 10.1103/PhysRevC.67.034611
   DECHARGE J, 1980, PHYS REV C, V21, P1568, DOI 10.1103/PhysRevC.21.1568
   Di Toro M, 2010, J PHYS G NUCL PARTIC, V37, DOI 10.1088/0954-3899/37/8/083101
   Famiano MA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.052701
   FRIEDMAN B, 1981, NUCL PHYS A, V361, P502, DOI 10.1016/0375-9474(81)90649-7
   Gaitanos T, 2004, NUCL PHYS A, V732, P24, DOI 10.1016/j.nuclphysa.2003.12.001
   Khoa DT, 1996, NUCL PHYS A, V602, P98, DOI 10.1016/0375-9474(96)00091-7
   Krastev PG, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.025808
   KUTSCHERA M, 1994, PHYS LETT B, V340, P1, DOI 10.1016/0370-2693(94)91288-2
   Larionov AB, 2003, NUCL PHYS A, V728, P135, DOI 10.1016/j.nuclphysa.2003.08.005
   Larionov AB, 2001, NUCL PHYS A, V696, P747, DOI 10.1016/S0375-9474(01)01216-7
   Lattimer JM, 2004, SCIENCE, V304, P536, DOI 10.1126/science.1090720
   Li BA, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.064611
   Li BA, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.014608
   Li BA, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.011603
   Li BA, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.192701
   Li BA, 2008, PHYS REP, V464, P113, DOI 10.1016/j.physrep.2008.04.005
   Li QF, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.034613
   Li ZH, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.047304
   Mao GJ, 1997, PHYS REV C, V55, P792, DOI 10.1103/PhysRevC.55.792
   Nagle JL, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.024901
   NEGELE JW, 1981, PHYS REV LETT, V47, P71, DOI 10.1103/PhysRevLett.47.71
   PANDHARIPANDE VR, 1972, PHYS LETT B, VB 39, P608, DOI 10.1016/0370-2693(72)90009-3
   Persram D, 2002, PHYS REV C, V65, DOI 10.1103/PhysRevC.65.064611
   Prassa V, 2007, NUCL PHYS A, V789, P311, DOI 10.1016/j.nuclphysa.2007.02.014
   Reisdorf W, 2007, NUCL PHYS A, V781, P459, DOI 10.1016/j.nuclphysa.2006.10.085
   Shetty DV, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.024606
   Steiner AW, 2005, PHYS REP, V411, P325, DOI 10.1016/j.physrep.2005.02.004
   STOCK R, 1986, PHYS REP, V135, P259, DOI 10.1016/0370-1573(86)90134-1
   Stone JR, 2003, PHYS REV C, V68, DOI 10.1103/PhysRevC.68.034324
   SUMIYOSHI K, 1994, ASTROPHYS J, V422, P700, DOI 10.1086/173763
   Szmaglinski A, 2006, ACTA PHYS POL B, V37, P277
   Tsang MB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.122701
   WIRINGA RB, 1988, PHYS REV C, V38, P1010, DOI 10.1103/PhysRevC.38.1010
   Xiao ZG, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.062502
NR 41
TC 4
Z9 4
U1 2
U2 11
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 2469-9985
EI 2469-9993
J9 PHYS REV C
JI Phys. Rev. C
PD DEC 15
PY 2010
VL 82
IS 6
AR 064604
DI 10.1103/PhysRevC.82.064604
PG 5
WC Physics, Nuclear
SC Physics
GA 713LH
UT WOS:000286739000002
DA 2018-12-27
ER

PT J
AU Barre, B
   Perkins, ND
AF Barre, Benjamin
   Perkins, Neil D.
TI RETRACTED: Phosphorylation of the p52 NF-kappa B subunit (Retracted
   article. See vol. 14, pg. 784, 2015)
SO CELL CYCLE
LA English
DT Editorial Material; Retracted Publication
ID PATHWAYS
C1 [Perkins, Neil D.] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Barre, Benjamin] INSERM, U892, F-75654 Paris 13, France.
RP Perkins, ND (reprint author), Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM n.d.perkins@ncl.ac.uk
CR Barre B, 2007, EMBO J, V26, P4841, DOI 10.1038/sj.emboj.7601899
   Barre B, 2010, CELL CYCLE, V9, P4795, DOI 10.4161/cc.9.24.14245
   Barre B, 2010, MOL CELL, V38, P524, DOI 10.1016/j.molcel.2010.03.018
   Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008
   Cramer P, 1997, EMBO J, V16, P7078, DOI 10.1093/emboj/16.23.7078
   Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105
   Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001
   Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475
   Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937
   Viatour P, 2004, MOL CELL, V16, P35, DOI 10.1016/j.molcel.2004.09.004
   Weintz G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.29
NR 11
TC 4
Z9 5
U1 3
U2 8
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1538-4101
EI 1551-4005
J9 CELL CYCLE
JI Cell Cycle
PD DEC 15
PY 2010
VL 9
IS 24
BP 4774
EP 4775
DI 10.4161/cc.9.24.14246
PG 2
WC Cell Biology
SC Cell Biology
GA 695AQ
UT WOS:000285343400003
PM 21150331
DA 2018-12-27
ER

PT J
AU Kono, S
   Miyajima, H
AF Kono, Satoshi
   Miyajima, Hiroaki
TI RETRACTED: DOMINANT-NEGATIVE EFFECTS OF A NOVEL MUTATION IN THE FILAMIN
   MYOPATHY (Retracted article. See vol. 76, pg. 202, 2011)
SO NEUROLOGY
LA English
DT Letter; Retracted Publication
CR Kono S, 2010, NEUROLOGY, V75, P547, DOI 10.1212/WNL.0b013e3181ec7fbd
   Odgerel Z, 2010, CLIN CHEM LAB MED, V48, P1409, DOI 10.1515/CCLM.2010.272
NR 2
TC 2
Z9 2
U1 3
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD DEC 7
PY 2010
VL 75
IS 23
BP 2137
EP 2138
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA 690XV
UT WOS:000285044300028
DA 2018-12-27
ER

PT J
AU Calisto, KL
   Carvalho, BD
   Ropelle, ER
   Mittestainer, FC
   Camacho, ACA
   Guadagnini, D
   Carvalheira, JBC
   Saad, MJA
AF Calisto, Kelly Lima
   Carvalho, Bruno de Melo
   Ropelle, Eduardo Rochete
   Mittestainer, Francine Cappa
   Aranha Camacho, Angelica Costa
   Guadagnini, Dioze
   Campelo Carvalheira, Jose Barreto
   Abdalla Saad, Mario Jose
TI RETRACTED: Atorvastatin Improves Survival in Septic Rats: Effect on
   Tissue Inflammatory Pathway and on Insulin Signaling (Retracted article.
   See vol. 11, e0159283, 2016)
SO PLOS ONE
LA English
DT Article; Retracted Publication
ID ENDOPLASMIC-RETICULUM STRESS; COA REDUCTASE INHIBITOR; NF-KAPPA-B;
   HOMEOSTASIS MODEL ASSESSMENT; MULTIPLE SERINE KINASES; POPULATION-BASED
   COHORT; CRITICALLY-ILL PATIENTS; HUMAN MONOCYTIC CELLS; STATIN THERAPY;
   IN-VIVO
AB The aim of the present study was to investigate whether the survival-improving effect of atorvastatin in sepsis is accompanied by a reduction in tissue activation of inflammatory pathways and, in parallel, an improvement in tissue insulin signaling in rats. Diffuse sepsis was induced by cecal ligation and puncture surgery ( CLP) in male Wistar rats. Serum glucose and inflammatory cytokines levels were assessed 24 h after CLP. The effect of atorvastatin on survival of septic animals was investigated in parallel with insulin signaling and its modulators in liver, muscle and adipose tissue. Atorvastatin improves survival in septic rats and this improvement is accompanied by a marked improvement in insulin sensitivity, characterized by an increase in glucose disappearance rate during the insulin tolerance test. Sepsis induced an increase in the expression/activation of TLR4 and its downstream signaling JNK and IKK/NF-kappa B activation, and blunted insulin-induced insulin signaling in liver, muscle and adipose tissue; atorvastatin reversed all these alterations in parallel with a decrease in circulating levels of TNF-alpha and IL-6. In summary, this study demonstrates that atorvastatin treatment increased survival, with a significant effect upon insulin sensitivity, improving insulin signaling in peripheral tissues of rats during peritoneal-induced sepsis. The effect of atorvastatin on the suppression of the TLR-dependent inflammatory pathway may play a central role in regulation of insulin signaling and survival in sepsis insult.
C1 [Calisto, Kelly Lima; Carvalho, Bruno de Melo; Ropelle, Eduardo Rochete; Mittestainer, Francine Cappa; Aranha Camacho, Angelica Costa; Guadagnini, Dioze; Campelo Carvalheira, Jose Barreto; Abdalla Saad, Mario Jose] Univ Estadual Campinas, UNICAMP, Dept Internal Med, FCM, Sao Paulo, Brazil.
RP Calisto, KL (reprint author), Univ Estadual Campinas, UNICAMP, Dept Internal Med, FCM, Sao Paulo, Brazil.
EM msaad@fcm.unicamp.br
RI Carvalheira, Jose/H-8405-2012; 5, INCT/H-4505-2013; Diabetes,
   Inct/I-2186-2013; Ropelle, Eduardo/C-3977-2012; Calisto,
   Kelly/J-9681-2016
OI Ropelle, Eduardo/0000-0003-1655-9557; Carvalheira,
   Jose/0000-0002-0136-0943
FU CAPES
FX K.L.C. holds a graduate fellowship from CAPES, www.capes.gov.br. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391
   Almog Y, 2003, CHEST, V124, P740, DOI 10.1378/chest.124.2.740
   Ando H, 2000, J PHARMACOL EXP THER, V294, P1043
   Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5
   Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649
   Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604
   Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57
   Breder I, 2010, ATHEROSCLEROSIS, V212, P30, DOI 10.1016/j.atherosclerosis.2010.04.036
   Brix-Christensen V, 2004, ANESTHESIOLOGY, V100, P861, DOI 10.1097/00000542-200404000-00016
   BRIXCHRISTENSEN V, 2005, INFLAMMATORY RESPONS, P991
   Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716
   Bultinck J, 2006, CYTOKINE, V36, P160, DOI 10.1016/j.cyto.2006.11.010
   Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959
   Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029
   Clarke RM, 2007, NEUROPHARMACOLOGY, V52, P136, DOI 10.1016/j.neuropharm.2006.07.031
   Coleman CI, 2007, CURR MED RES OPIN, V23, P1783, DOI 10.1185/030079907X210570
   Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003
   Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013
   Davis RJ, 1999, BIOCHEM SOC SYMP, P1
   Dostal LA, 1996, FUND APPL TOXICOL, V32, P285, DOI 10.1006/faat.1996.0132
   Fernandez R, 2006, INTENS CARE MED, V32, P160, DOI 10.1007/s00134-005-2743-9
   Frost FJ, 2007, CHEST, V131, P1006, DOI 10.1378/chest.06-1997
   Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383
   Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200
   Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2
   Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200
   Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429
   Gupta R, 2007, JAMA-J AM MED ASSOC, V297, P1455, DOI 10.1001/jama.297.13.1455
   Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0
   Hatherill M, 2000, CRIT CARE MED, V28, P2591, DOI 10.1097/00003246-200007000-00068
   He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833
   Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9
   Jeschke MG, 2004, ENDOCRINOLOGY, V145, P4084, DOI 10.1210/en.2004-0592
   Jeschke MG, 2005, J HEPATOL, V42, P870, DOI 10.1016/j.jhep.2004.12.036
   Kidd LB, 2008, J PHARMACOL EXP THER, V326, P348, DOI 10.1124/jpet.108.138891
   Kruger P, 2006, INTENS CARE MED, V32, P75, DOI 10.1007/s00134-005-2859-y
   Kyle UG, 2010, INTENS CARE MED, V36, P312, DOI 10.1007/s00134-009-1703-1
   Langouche L, 2005, J CLIN INVEST, V115, P2277, DOI 10.1172/JCI25385
   Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200
   Li CF, 1999, AM J PHYSIOL-HEART C, V276, pH543, DOI 10.1152/ajpheart.1999.276.2.H543
   Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334
   Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630
   Maitra SR, 2000, SHOCK, V13, P379, DOI 10.1097/00024382-200005000-00006
   Major CD, 2001, DIABETES, V50, P2721, DOI 10.2337/diabetes.50.12.2721
   Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C
   Marik PE, 2004, INTENS CARE MED, V30, P748, DOI 10.1007/s00134-004-2167-y
   Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McGown CC, 2007, BRIT J ANAESTH, V98, P163, DOI 10.1093/bja/ael358
   Merx MW, 2005, CIRCULATION, V112, P117, DOI 10.1161/CIRCULATIONAHA.104.502195
   Merx MW, 2004, CIRCULATION, V109, P2560, DOI 10.1161/01.CIR.0000129774.09737.5B
   Mortensen EM, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-82
   Mortensen EM, 2007, PHARMACOTHERAPY, V27, P1619, DOI 10.1592/phco.27.12.1619
   Niessner A, 2006, ATHEROSCLEROSIS, V189, P408, DOI 10.1016/j.atherosclerosis.2005.12.022
   Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Prada PO, 2005, ENDOCRINOLOGY, V146, P1576, DOI 10.1210/en.2004-0767
   Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214
   Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632
   Schabbauer G, 2004, ARTERIOSCL THROM VAS, V24, pE3
   Schlienger RG, 2007, PHARMACOTHERAPY, V27, P325, DOI 10.1592/phco.27.3.325
   Schmidt H, 2006, INTENS CARE MED, V32, P1248, DOI 10.1007/s00134-006-0246-y
   Shapiro NI, 2006, CRIT CARE MED, V34, P1025, DOI 10.1097/01.CCM.0000206104.18647.A8
   Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898
   Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069
   Spitzer AL, 2006, SURGERY, V139, P283, DOI 10.1016/j.surg.2005.08.029
   Terblanche M, 2006, LANCET INFECT DIS, V6, P242, DOI 10.1016/S1473-3099(06)70439-X
   Thirone ACP, 2004, ENDOCRINOLOGY, V145, P281, DOI 10.1210/en.2003-0575
   Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4
   Tian B, 2003, RECENT PROG HORM RES, V58, P95, DOI 10.1210/rp.58.1.95
   Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286
   Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595
   Van den Berghe G, 2004, J CLIN INVEST, V114, P1187, DOI 10.1172/JCI200423506
   Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521
   Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300
   Williams DL, 2004, J IMMUNOL, V172, P449, DOI 10.4049/jimmunol.172.1.449
NR 79
TC 24
Z9 25
U1 1
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 6
PY 2010
VL 5
IS 12
AR e14232
DI 10.1371/journal.pone.0014232
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 690IB
UT WOS:000284995300004
PM 21151908
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Barnett, RLE
AF Barnett, R. -L. Etienne
TI RETRACTED: Autopsies of the center (Retracted article. See vol. 42, pg.
   359, 2015)
SO NEOHELICON
LA French
DT Article; Retracted Publication
C1 [Barnett, R. -L. Etienne] Off Univ Provost, Atlanta, GA 30360 USA.
   [Barnett, R. -L. Etienne] Univ Atlanta, Atlanta, GA 30360 USA.
RP Barnett, RLE (reprint author), Off Univ Provost, Atlanta, GA 30360 USA.
EM RL_Barnett@msn.com
CR ALAIN M, 2007, AUTRES FRONTIERES
   [Anonymous], 1975, BARTHES ROLAND BARTH
   BAETENS J, 1997, FORMULES, V1, P71
   BAETENS J, 1993, MESURES EXCES
   BAETENS Jan, 1995, ETHIQUE CONTRAINTE
   BARNETT RLE, 2007, EXEGESES NOUVELLES, V2
   BARNETT RLE, 1998, ESPRIT CREATEUR, P27
   BARNETT RLE, 2004, TRAVAUX LIT, P81
   BARNETT RLE, 1995, REPRISES CONT C LAUS
   BARNETT RLE, POETIQUE MARGES
   BARNETT RLE, 2006, DEGRES REV SYNTHESE, P213
   BARNETT RLE, 1998, DEGRE 2, P171
   Barthes Roland, 1972, DEGRE ZERO ECRITURE
   BORGES, 1977, PERSPECTIVAS MODERNA
   Camus Renaud, 1980, BUENA VISTA PARK
   COMPAGNON Antoine, 1990, CINQ PARADOXES MODER
   COSTE D, 1997, FORMULES, V1, P7
   DEBRAY R, 1994, VIE MORT IMAGE HIST
   EIZENSWEIG U, 1983, NECROLOGIE ROMAN POL
   FALEMPIN M, 1995, APPARENCE VIE
   Fish S, 1997, CRIT INQUIRY, V23, P378, DOI 10.1086/448833
   HARRON JM, 2007, LIMITES NOUVELLES
   PEETERS B, 1983, BIJOUX RAVIS
   PEREC G, 1969, DISPARITION
   PRIGENT C, 1994, ANTHOLOGIE TXT
   PRIGENT C, 1991, CEUX QUI MEREDRENT
   Prigent Christian, 1996, ERREUR NATURE
   PUECH JB, 1990, VIVANT AUTEUR
   RICARDOU J, 1996, CONSEQUENCES, P224
   ROUBAUD J, 1996, MATHEMATIQUE
   ROUBAUD J, 1993, BOUCLE
   Roubaud Jacques, 1989, GRAND INCENDIE LONDR
   Roubaud Jacques, 1978, VIEILLESSE ALEXANDRE
NR 33
TC 1
Z9 1
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0324-4652
EI 1588-2810
J9 NEOHELICON
JI Neohelicon
PD DEC
PY 2010
VL 37
IS 2
BP 479
EP 487
PG 9
WC Literature
SC Literature
GA 763LC
UT WOS:000290557100015
DA 2018-12-27
ER

PT J
AU Khan, GM
   Al Moharby, D
   Al Busaidi, Y
AF Khan, Golam Mostafa
   Al Moharby, Darwish
   Al Busaidi, Yousef
TI RETRACTED: Oman National Dairy Products: The Rise and Fall of a
   Well-known Company from the Arabian Gulf (Retracted Article)
SO ASIAN CASE RESEARCH JOURNAL
LA English
DT Article; Retracted Publication
C1 [Khan, Golam Mostafa] Sultan Qaboos Univ, Coll Commerce & Econ, Al Khoud 123, Oman.
RP Khan, GM (reprint author), Sultan Qaboos Univ, Coll Commerce & Econ, POB 20, Al Khoud 123, Oman.
EM mostafa.khan@hotmail.com
CR BHATNAGAR A, 2007, OMAN EC REV      FEB, P34
   Buchholtz A. K., 2009, BUSINESS SOC
   HYMOWITZ C, 2003, WALL STREET J   1027
   KAMOONPURI H, 2005, TOP BRANDS OMAN, P184
   *WJ TOW GROUP CO, 2010, CORP PROF
   2006, OMAN DAILY OBSE 0710
   2007, TIMES OMAN      0522
NR 7
TC 0
Z9 0
U1 2
U2 7
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0218-9275
EI 1793-6772
J9 ASIAN CASE RES J
JI Asian Case Res. J.
PD DEC
PY 2010
VL 14
IS 2
BP 245
EP 263
DI 10.1142/S0218927510001404
PG 19
WC Business
SC Business & Economics
GA 725SD
UT WOS:000287665500004
DA 2018-12-27
ER

PT J
AU Isacsson, G
   Reutfors, J
   Papadopoulos, FC
   Osby, U
   Ahlner, J
AF Isacsson, G.
   Reutfors, J.
   Papadopoulos, F. C.
   Osby, U.
   Ahlner, J.
TI RETRACTED: Antidepressant medication prevents suicide in depression
   (Retracted article. See vol. 125, pg. 419, 2012)
SO ACTA PSYCHIATRICA SCANDINAVICA
LA English
DT Article; Retracted Publication
DE suicide; prevention; depression; antidepressants
ID SWEDEN; RISK; INDIVIDUALS; MORTALITY; DISORDER; BEHAVIOR; BIPOLAR; RATES
AB Objective: Ecological studies have demonstrated a substantial decrease in suicide in parallel with an increasing use of antidepressants. To investigate on the individual level the hypothesis that antidepressant medication was a causal factor.
   Method: Data on the toxicological detection of antidepressants in 18 922 suicides in Sweden 1992-2003 were linked to registers of psychiatric hospitalization as well as registers with sociodemographic data.
   Results: The probability for the toxicological detection of an antidepressant was lowest in the non-suicide controls, higher in suicides, and even higher in suicides that had been psychiatric inpatients but excluding those who had been in-patients for the treatment of depression.
   Conclusion: The finding that in-patient care for depression did not increase the probability of the detection of antidepressants in suicides is difficult to explain other than by the assumption that a substantial number of depressed individuals were saved from suicide by postdischarge treatment with antidepressant medication.
C1 [Isacsson, G.] Karolinska Univ Hosp Huddinge, Dept Clin Neurosci, Div Psychiat, Karolinska Inst, S-14186 Stockholm, Sweden.
   [Reutfors, J.] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden.
   [Papadopoulos, F. C.] Univ Uppsala Hosp, Dept Neurosci, Uppsala, Sweden.
   [Ahlner, J.] Natl Board Forens Med, Dept Forens Toxicol & Forens Genet, Linkoping, Sweden.
RP Isacsson, G (reprint author), Karolinska Univ Hosp Huddinge, Dept Clin Neurosci, Div Psychiat, Karolinska Inst, M59, S-14186 Stockholm, Sweden.
EM goran.isacsson@ki.se
OI Reutfors, Johan/0000-0003-1372-4262
FU Karolinska Institute; Stockholm County Council; Psychiatry South-West
   (ALF); National Board of Forensic Medicine; H. Lundbeck; Eli Lilly; GSK
FX Financial support from the Karolinska Institute and the Stockholm County
   Council, Psychiatry South-West (ALF); the National Board of Forensic
   Medicine.; Goran Isacsson has received fees for being a speaker at
   symposiums arranged by pharmaceutical companies like H. Lundbeck, Eli
   Lilly, GSK, and has attended an Astra Zeneca advisory board meeting.
   Johan Ahlner has been involved in a research project funded by H.
   Lundbeck. Urban Osby has been involved in advisory boards for BMS and
   Pfizer, received fees as a consultant from Eli Lilly, Astra Zeneca and
   BMS, and has received research grants from BMS and Jansen-Cilag. Fotios
   C. Papadopoulos and Johan Reutfors declare no conflicts of interest.
CR Angst Jules, 2005, Arch Suicide Res, V9, P279, DOI 10.1080/13811110590929488
   Donaldson AE, 2006, INJURY PREV, V12, P338, DOI 10.1136/ip.2005.011171
   Erlangsen A, 2008, J EPIDEMIOL COMMUN H, V62, P448, DOI 10.1136/jech.2007.061580
   Gibbons RD, 2007, AM J PSYCHIAT, V164, P1356, DOI 10.1176/j.appi.apj.2007.07030454
   Helgason T, 2004, BRIT J PSYCHIAT, V184, P157, DOI 10.1192/bjp.184.2.157
   Henriksson S, 2006, EUR PSYCHIAT, V21, P355, DOI 10.1016/j.eurpsy.2006.04.003
   ISACSSON G, 1994, J AFFECT DISORDERS, V32, P277, DOI 10.1016/0165-0327(94)90092-2
   Isacsson G, 2000, ACTA PSYCHIAT SCAND, V102, P113, DOI 10.1034/j.1600-0447.2000.102002113.x
   ISACSSON G, 1994, BRIT MED J, V308, P506, DOI 10.1136/bmj.308.6927.506
   Isacsson G, 2009, ACTA PSYCHIAT SCAND, V120, P37, DOI 10.1111/j.1600-0447.2009.01344.x
   Isacsson G, 1997, ACTA PSYCHIAT SCAND, V96, P94, DOI 10.1111/j.1600-0447.1997.tb09912.x
   ISACSSON G, 2009, J EPIDEMIOL COMMUNIT
   Isacsson G, 2008, EUR PSYCHIAT REV, V1, P24
   ISACSSON GG, 1994, THESIS KAROLINSKA I
   Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338
   Lauterbach E, 2008, ACTA PSYCHIAT SCAND, V118, P469, DOI 10.1111/j.1600-0447.2008.01266.x
   Ludwig J, 2009, J HEALTH ECON, V28, P659, DOI 10.1016/j.jhealeco.2009.02.002
   Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389
   Osby U, 2001, ARCH GEN PSYCHIAT, V58, P844, DOI 10.1001/archpsyc.58.9.844
   RIHMER Z, 1990, J AFFECT DISORDERS, V20, P87, DOI 10.1016/0165-0327(90)90121-N
   RUTZ W, 1989, ACTA PSYCHIAT SCAND, V80, P151, DOI 10.1111/j.1600-0447.1989.tb01318.x
   SPSS Inc, 2009, SPSS 17 0
   Tiihonen J, 2006, ARCH GEN PSYCHIAT, V63, P1358, DOI 10.1001/archpsyc.63.12.1358
   Tondo L, 2003, CNS DRUGS, V17, P491, DOI 10.2165/00023210-200317070-00003
NR 24
TC 11
Z9 12
U1 4
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-690X
EI 1600-0447
J9 ACTA PSYCHIAT SCAND
JI Acta Psychiatr. Scand.
PD DEC
PY 2010
VL 122
IS 6
BP 454
EP 460
DI 10.1111/j.1600-0447.2010.01561.x
PG 7
WC Psychiatry
SC Psychiatry
GA 685ZD
UT WOS:000284665700006
PM 20384599
DA 2018-12-27
ER

PT J
AU Tokuyama, Y
   Takahashi, T
   Okumura, N
   Nonaka, K
   Kawaguchi, Y
   Yamaguchi, K
   Osada, S
   Gazdar, A
   Yoshida, K
AF Tokuyama, Yasuharu
   Takahashi, Takao
   Okumura, Naoki
   Nonaka, Kenichi
   Kawaguchi, Yoshihiro
   Yamaguchi, Kazuya
   Osada, Shinji
   Gazdar, Adi
   Yoshida, Kazuhiro
TI RETRACTED: Aberrant Methylation of Heparan Sulfate Glucosamine
   3-O-Sulfotransferase 2 Genes as a Biomarker in Colorectal Cancer
   (Retracted article. See vol. 32, pg. 5138, 2012)
SO ANTICANCER RESEARCH
LA English
DT Article; Retracted Publication
DE 3OST2; early detection; bowel lavage; blood of main drainage vein
ID NORMAL COLONIC-MUCOSA; FECAL DNA; PROMOTER METHYLATION; GASTRIC-CANCER;
   STOOL DNA; EXPRESSION; HYPERMETHYLATION; MUTATIONS; LUNG; PCR
AB Aim: The first aim was to determine whether hypermethylation of certain tumor related genes, including 3OST2, CHFR, RUNX3, and p16, could be detected in Japanese colorectal cancer (CRC) patients. The second was to utilize the most frequently hypermethylated genes as biomarkers for early detection of CRC. Materials and Methods: We investigated the aberrant promoter methylation profile of 4 genes in 129 colorectal tumors and corresponding normal mucosa. For the second step, bowel lavage and blood of the main tumor drainage vein from 21 CRC patients were analyzed. Results: The 3OST2 gene was the most frequently methylated (57%) and was methylated frequently (9/21, 43%) in bowel lavage but rarely (1/21; 4.7%) in the venous drainage. The concordance between 3OST2 methylation in bowel lavage and corresponding tumor samples was 71.4%. Conclusion: These results may show the possibility of early detection for CRC by examining 3OST2 gene methylation status in DNA extracted from stool.
C1 [Tokuyama, Yasuharu; Takahashi, Takao; Okumura, Naoki; Nonaka, Kenichi; Kawaguchi, Yoshihiro; Yamaguchi, Kazuya; Osada, Shinji; Yoshida, Kazuhiro] Gifu Univ, Dept Surg Oncol, Grad Sch Med, Gifu 5008705, Japan.
   [Gazdar, Adi] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA.
   [Gazdar, Adi] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA.
RP Takahashi, T (reprint author), Gifu Univ, Dept Surg Oncol, Grad Sch Med, Yanagido 1-1, Gifu 5008705, Japan.
EM takaota@gifu-u.ac.jp
FU Ministry of Education, Culture, Sports, Science, and Technology of Japan
   [18591460]
FX Grant support: Grant-in-Aid (no.18591460) for Scientific Research on
   Priority Areas from the Ministry of Education, Culture, Sports, Science,
   and Technology of Japan.
CR Ahlquist T, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-94
   Ausch C, 2009, CLIN CHEM, V55, P1559, DOI 10.1373/clinchem.2008.122937
   Berginc G, 2010, CANCER INVEST, V28, P94, DOI 10.3109/07357900902849673
   Bernal C, 2008, CLIN CANCER RES, V14, P6264, DOI 10.1158/1078-0432.CCR-07-4522
   Bo BL, 2009, CLIN CANCER RES, V15, P6185
   Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229
   Diehl F, 2008, GASTROENTEROLOGY, V135, P489, DOI 10.1053/j.gastro.2008.05.039
   Esteller M, 2001, HUM MOL GENET, V10, P3001, DOI 10.1093/hmg/10.26.3001
   Glockner SC, 2009, CANCER RES, V69, P4691, DOI 10.1158/0008-5472.CAN-08-0142
   Gotze S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-447
   Gonzalez-Quevedo R, 2004, INT J ONCOL, V24, P349
   Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759
   Grunau C, 2008, CANCER EPIDEM BIOMAR, V17, P1374, DOI 10.1158/1055-9965.EPI-07-2656
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821
   Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403
   Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816
   Kawakami K, 2006, BRIT J CANCER, V94, P593, DOI 10.1038/sj.bjc.6602940
   Ku JL, 2004, ONCOGENE, V23, P6736, DOI 10.1038/sj.onc.1207731
   Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6
   Markowitz SD, 2002, CANCER CELL, V1, P233, DOI 10.1016/S1535-6108(02)00053-3
   Mixich F, 2007, J GASTROINTEST LIVER, V16, P5
   Miyamoto K, 2003, ONCOGENE, V22, P274, DOI 10.1038/sj.onc.1206146
   Mizuno K, 2002, ONCOGENE, V21, P2328, DOI 10.1038/sj/onc/1205402
   Nagasaka T, 2009, J NATL CANCER I, V101, P1244, DOI 10.1093/jnci/djp265
   Nakagawa H, 2001, CANCER RES, V61, P6991
   Osborn NK, 2005, GASTROENTEROLOGY, V128, P192, DOI 10.1053/j.gastro.2004.10.041
   Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000
   Petko Z, 2005, CLIN CANCER RES, V11, P1203
   Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157
   Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108
   Shames DS, 2007, CURR MOL MED, V7, P85, DOI 10.2174/156652407779940413
   Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021
   Shworak NW, 1999, J BIOL CHEM, V274, P5170, DOI 10.1074/jbc.274.8.5170
   Taback B, 2006, ANN NY ACAD SCI, V1075, P197, DOI 10.1196/annals.1368.027
   Takahashi T, 2006, INT J CANCER, V118, P924, DOI 10.1002/ijc.21453
   Takahashi T, 2005, INT J CANCER, V115, P503, DOI 10.1002/ijc.20910
   Trzeciak L, 2001, CANCER LETT, V163, P17, DOI 10.1016/S0304-3835(00)00652-2
   [Vital and Health Statistics Division Statistics and Information Department Minister's Secretariat Ministry of Health Labour and Welfare], 2006, DEATH TABL 15 VIT ST
   Yoshida K, 1996, J CLIN PATHOL, V49, P300, DOI 10.1136/jcp.49.4.300
   Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/ng0501-29
NR 41
TC 10
Z9 11
U1 3
U2 14
PU INT INST ANTICANCER RESEARCH
PI ATHENS
PA EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22,
   ATHENS 19014, GREECE
SN 0250-7005
EI 1791-7530
J9 ANTICANCER RES
JI Anticancer Res.
PD DEC
PY 2010
VL 30
IS 12
BP 4811
EP 4818
PG 8
WC Oncology
SC Oncology
GA 717BV
UT WOS:000287018100004
PM 21187457
DA 2018-12-27
ER

PT J
AU Boraiah, S
   Paul, O
   Gardner, MJ
   Parker, RJ
   Barker, JU
   Helfet, D
   Lorich, D
AF Boraiah, Sreevathsa
   Paul, Omesh
   Gardner, Michael J.
   Parker, Robert J.
   Barker, Joseph U.
   Helfet, David
   Lorich, Dean
TI RETRACTED: Outcomes of length-stable fixation of femoral neck fractures
   (Retracted article. See vol. 132, pg. 739, 2012)
SO ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
LA English
DT Article; Retracted Publication
DE Femoral neck fractures; Length-stable fixation; Functional outcome after
   fixation; Gait analysis
ID TOTAL HIP-ARTHROPLASTY; QUALITY-OF-LIFE; INTERNAL-FIXATION; DISPLACED
   FRACTURES; COMPONENT OFFSET; GARDEN SCREWS; METAANALYSIS; PARALLEL
AB The most common implants for treating unstable femoral neck fractures are sliding constructs, which allow postoperative collapse. Successful healing, typically, is a malunion with a shortened femoral neck. Functional sequelae resulting from altered femoral neck biomechanics have been increasingly reported. Re-operation rate due to nonunion, avascular necrosis, hardware cut-out and prominence is high with this treatment modality. We evaluated the outcomes of patients with femoral neck fractures treated with stable calcar pivot reduction, intraoperative compression across the fracture, and stabilization with length-stable implants.
   Fifty-four patients with femoral neck fractures underwent open reduction and internal fixation. Average follow up duration was 23.6 months (range: 15-36 months). There were 23 Garden I, 2 Garden II, 14 Garden III and 15 Garden IV fractures. Reduction was achieved through a modified Smith-Petersen approach. Fractures were compressed initially, and subsequently stabilized with a length-stable device. Post-operative radiographs were assessed for change in fracture alignment. Variation in the femoral neck offset and abductor lever arm measurements was performed using the contralateral hip as control. Functional outcome was assessed using SF-36, Harris Hip Score (HHS) and a gait analysis device. The average patient age was 78 years. Fifty-one (94%) healed without complications. Surgical fixation failed in two patients and one patient developed avascular necrosis. The average femoral neck shortening was 1.7 mm.
   The average difference in femoral neck offset and the abductor lever arm measurement at the latest follow up was 3.5 and 1.5 mm respectively. The average score on physical, mental components of SF-36 and HHS was 42 and 47 and 87 respectively. By 6 months, patients on average recovered 94% of the single limb stance time, 98% of cadence, 90% of cycle duration, 96% in stride length compared to the uninjured side.
   Reduction with a stable calcar pivot, intraoperative compression and length-stable fixation can achieve high union rates with minimal femoral neck shortening and improved functional outcomes.
   IV, retrospective with historical controls.
C1 [Boraiah, Sreevathsa; Paul, Omesh; Gardner, Michael J.; Parker, Robert J.; Barker, Joseph U.; Helfet, David; Lorich, Dean] Orthopaed Trauma Serv, New York, NY 10021 USA.
RP Boraiah, S (reprint author), Orthopaed Trauma Serv, 520 E 70th St, New York, NY 10021 USA.
EM bsreevathsa@rediffmail.com
OI Boraiah, Sreevathsa/0000-0002-1921-117X
CR ALHO A, 1992, ACTA ORTHOP SCAND, V63, P639
   Bhandari M, 2003, J BONE JOINT SURG AM, V85A, P1673, DOI 10.2106/00004623-200309000-00004
   Bjorgul K, 2007, ACTA ORTHOP, V78, P498, DOI 10.1080/17453670710014149
   Bray TJ, 1997, CLIN ORTHOP RELAT R, P20
   Charles Mark N, 2005, Instr Course Lect, V54, P131
   Davey J R, 1993, J Arthroplasty, V8, P23
   DeFrances Carol J, 2007, Vital Health Stat 13, P1
   Deneka DA, 1997, J ORTHOP TRAUMA, V11, P337, DOI 10.1097/00005131-199707000-00007
   Gardner MJ, 2007, ARCH ORTHOP TRAUM SU, V127, P223, DOI 10.1007/s00402-006-0279-2
   HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012
   Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089
   Ito K, 2001, J BONE JOINT SURG BR, V83B, P171, DOI 10.1302/0301-620X.83B2.11092
   Liporace F, 2008, J BONE JOINT SURG AM, V90A, P1654, DOI 10.2106/JBJS.G.01353
   LUYAO GL, 1994, J BONE JOINT SURG AM, V76A, P15, DOI 10.2106/00004623-199401000-00003
   MATHIESEN T, 1989, ACTA RADIOL, V30, P639
   MCGRORY BJ, 1995, J BONE JOINT SURG BR, V77B, P865
   Molnar RB, 2007, J ORTHOP TRAUMA, V21, P490, DOI 10.1097/BOT.0b013e31804a7f7f
   Parker MJ, 1998, ACTA ORTHOP SCAND, V69, P138, DOI 10.3109/17453679809117614
   PARKER MJ, 1994, INJURY, V25, P383, DOI 10.1016/0020-1383(94)90131-7
   PARKER MJ, 1991, J BONE JOINT SURG BR, V73, P826
   SAITO N, 1995, ARCH ORTHOP TRAUM SU, V114, P183, DOI 10.1007/BF00444259
   Sakalkale DP, 2001, CLIN ORTHOP RELAT R, P125
   SWIONTKOWSKI MF, 1984, J BONE JOINT SURG AM, V66A, P837, DOI 10.2106/00004623-198466060-00003
   Tidermark J, 2003, J BONE JOINT SURG BR, V85B, P380, DOI 10.1302/0301-620X.85B3.13609
   Tidermark J, 2002, J ORTHOP TRAUMA, V16, P34, DOI 10.1097/00005131-200201000-00008
   Zhang K, 2003, OBES RES, V11, P33, DOI 10.1038/oby.2003.7
   Zlowodzki M, 2008, J TRAUMA, V64, P163, DOI 10.1097/01.ta.0000241143.71274.63
   Zlowodzki M, 2007, CLIN ORTHOP RELAT R, P213, DOI 10.1097/BLO.0b013e31805b7ec4
NR 28
TC 8
Z9 11
U1 2
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0936-8051
EI 1434-3916
J9 ARCH ORTHOP TRAUM SU
JI Arch. Orthop. Trauma Surg.
PD DEC
PY 2010
VL 130
IS 12
BP 1523
EP 1531
DI 10.1007/s00402-010-1103-6
PG 9
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 684ZM
UT WOS:000284593800017
PM 20414782
DA 2018-12-27
ER

PT J
AU Johnson, CS
   Stapel, DA
AF Johnson, Camille S.
   Stapel, Diederik A.
TI RETRACTED: It depends on how you look at it: Being versus becoming
   mindsets determine responses to social comparisons (Retracted article.
   See vol. 51, pg. 497, 2012)
SO BRITISH JOURNAL OF SOCIAL PSYCHOLOGY
LA English
DT Article; Retracted Publication
ID SELF-AFFIRMATION; CONTRAST; ACCESSIBILITY; ASSIMILATION; PERSONALITY;
   PERFORMANCE; INFORMATION; JUDGMENT; DISTANCE; IMPLICIT
AB The current studies examine how focusing on evaluation of the current self (a 'being' mindset) or focusing on the projection of future selves (a 'becoming mindset') influences responses to social comparison information. The studies show that the mindset of individuals, independent of other situational variables, determines whether individuals regard targets as threatening, how targets influence self-evaluations, and how targets affect performance on relevant tasks. The studies also show that mindsets determine what kinds of social comparison information are influential. In a becoming mindset, people are influenced mainly by information from domains that are considered mutable, whereas in a being mindset, people are influenced by information from both immutable and mutable domains.
C1 [Johnson, Camille S.] San Jose State Univ, San Jose, CA 95192 USA.
   [Stapel, Diederik A.] Tilburg Univ, NL-5000 LE Tilburg, Netherlands.
RP Johnson, CS (reprint author), San Jose State Univ, 1 Washington Sq, San Jose, CA 95192 USA.
EM johnson.1967@osu.edu
CR ASPINWALL LG, 1993, J PERS SOC PSYCHOL, V64, P708, DOI 10.1037/0022-3514.64.5.708
   Blanton H, 2001, COGNITIVE SOCIAL PSYCHOLOGY, P75
   Blanton H, 2008, J PERS SOC PSYCHOL, V94, P1018, DOI 10.1037/0022-3514.94.6.1018
   Chiu CY, 1997, J PERS SOC PSYCHOL, V73, P19, DOI 10.1037/0022-3514.73.1.19
   Dijksterhuis A, 1998, J PERS SOC PSYCHOL, V75, P862, DOI 10.1037//0022-3514.75.4.862
   DWECK CS, 1988, PSYCHOL REV, V95, P256, DOI 10.1037//0033-295X.95.2.256
   Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202
   Forster J, 2008, J PERS SOC PSYCHOL, V94, P579, DOI 10.1037/0022-3514.94.4.579
   Fujita K, 2006, PSYCHOL SCI, V17, P278, DOI 10.1111/j.1467-9280.2006.01698.x
   GILBERT DT, 1995, J PERS SOC PSYCHOL, V69, P227, DOI 10.1037/0022-3514.69.2.227
   Hart W, 2009, PSYCHOL SCI, V20, P238, DOI 10.1111/j.1467-9280.2009.02277.x
   HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037/0033-295X.94.3.319
   Johnson CS, 2007, EUR J SOC PSYCHOL, V37, P258, DOI 10.1002/ejsp.361
   Johnson CS, 2008, SELF IDENTITY, V7, P262, DOI 10.1080/15298860701438414
   Lockwood P, 1997, J PERS SOC PSYCHOL, V73, P91, DOI 10.1037//0022-3514.73.1.91
   LOEWENSTEIN G, 1987, ECON J, V97, P666, DOI 10.2307/2232929
   Markman KD, 2003, PERS SOC PSYCHOL REV, V7, P244, DOI 10.1207/S15327957PSPR0703_04
   Markus H., 1989, GOAL CONCEPTS PERSON, P211
   Martens A, 2006, J EXP SOC PSYCHOL, V42, P236, DOI 10.1016/j.jesp.2005.04.010
   Mussweiler T, 2003, PSYCHOL REV, V110, P472, DOI 10.1037/0033-295X.110.3.472
   Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879
   Sherman DK, 2006, ADV EXP SOC PSYCHOL, V38, P183, DOI 10.1016/S0065-2601(06)38004-5
   Sherman DK, 2002, CURR DIR PSYCHOL SCI, V11, P119, DOI 10.1111/1467-8721.00182
   SRULL TK, 1979, J PERS SOC PSYCHOL, V37, P1660, DOI 10.1037//0022-3514.37.10.1660
   Stapel DA, 2004, J PERS SOC PSYCHOL, V87, P468, DOI 10.1037/0022-3514.87.4.468
   Stapel DA, 2002, J PERS SOC PSYCHOL, V83, P60, DOI 10.1037//0022-3514.83.1.60
   Stapel DA, 2001, PERS SOC PSYCHOL B, V27, P915, DOI 10.1177/0146167201278001
   Stapel DA, 2000, J PERS SOC PSYCHOL, V79, P1068, DOI 10.1037//0022-3514.79.6.1068
   STAPEL DA, 2006, ATTRACTIVENES UN PUB
   Tesser A., 1988, ADV EXPT SOCIAL PSYC, P181, DOI DOI 10.1016/S0065-2601(08)60227-0
   Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403
   Trope Y, 2007, J CONSUM PSYCHOL, V17, P83, DOI 10.1016/S1057-7408(07)70013-X
   WOOD JV, 1989, J PERS SOC PSYCHOL, V106, P231
NR 33
TC 3
Z9 3
U1 0
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0144-6665
EI 2044-8309
J9 BRIT J SOC PSYCHOL
JI Br. J. Soc. Psychol.
PD DEC
PY 2010
VL 49
IS 4
BP 703
EP 723
DI 10.1348/014466609X476827
PG 21
WC Psychology, Social
SC Psychology
GA 705XK
UT WOS:000286173800005
PM 19948082
DA 2018-12-27
ER

PT J
AU Negorev, DG
   Vladimirova, OV
   Kossenkov, AV
   Nikonova, EV
   Demarest, RM
   Capobianco, AJ
   Showe, MK
   Rauscher, FJ
   Showe, LC
   Maul, GG
AF Negorev, Dmitri G.
   Vladimirova, Olga V.
   Kossenkov, Andrew V.
   Nikonova, Elena V.
   Demarest, Renee M.
   Capobianco, Anthony J.
   Showe, Michael K.
   Rauscher, Frank J., III
   Showe, Louise C.
   Maul, Gerd G.
TI RETRACTED: Sp100 as a Potent Tumor Suppressor: Accelerated Senescence
   and Rapid Malignant Transformation of Human Fibroblasts through
   Modulation of an Embryonic Stem Cell Program (Retracted article. See
   vol. 73, pg. 4960, 2013)
SO CANCER RESEARCH
LA English
DT Article; Retracted Publication
ID SIMPLEX-VIRUS TYPE-1; SAND DOMAIN; PML; PROTEIN; REPRESSION; TARGET;
   ND10; RAS; PHOSPHORYLATION; ISOFORMS
AB Identifying the functions of proteins, which associate with specific subnuclear structures, is critical to understanding eukaryotic nuclear dynamics. Sp100 is a prototypical protein of ND10/PML nuclear bodies, which colocalizes with Daxx and the proto-oncogenic PML. Sp100 isoforms contain SAND, PHD, Bromo, and HMG domains and are highly sumoylated, all characteristics suggestive of a role in chromatin-mediated gene regulation. A role for Sp100 in oncogenesis has not been defined previously. Using selective Sp100 isoform-knockdown approaches, we show that normal human diploid fibroblasts with reduced Sp100 levels rapidly senesce. Subsequently, small rapidly dividing Sp100 minus cells emerge from the senescing fibroblasts and are found to be highly tumorigenic in nude mice. The derivation of these tumorigenic cells from the parental fibroblasts is confirmed by microsatellite analysis. The small rapidly dividing Sp100 minus cells now also lack ND10/PML bodies, and exhibit genomic instability and p53 cytoplasmic sequestration. They have also activated MYC, RAS, and TERT pathways and express mesenchymal to epithelial transdifferentiation ( MET) markers. Reintroduction of expression of only the Sp100A isoform is sufficient to maintain senescence and to inhibit emergence of the highly tumorigenic cells. Global transcriptome studies, quantitative PCR, and protein studies, as well as immunolocalization studies during the course of the transformation, reveal that a transient expression of stem cell markers precedes the malignant transformation. These results identify a role for Sp100 as a tumor suppressor in addition to its role in maintaining ND10/PML bodies and in the epigenetic regulation of gene expression. Cancer Res; 70( 23); 9991-10001. (C)2010 AACR.
C1 [Negorev, Dmitri G.; Vladimirova, Olga V.; Kossenkov, Andrew V.; Nikonova, Elena V.; Demarest, Renee M.; Showe, Michael K.; Rauscher, Frank J., III; Showe, Louise C.; Maul, Gerd G.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA.
   [Capobianco, Anthony J.] Univ Miami, Miami, FL USA.
RP Showe, LC (reprint author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.
EM negorev@wistar.org; lshowe@wistar.org
FU NIH [AI 41136, GM 57599, HD 34612]; NCI [CA 132098, S10 RR024693];
   Mathers Foundation; PA DOH Commonwealth Universal Research Enhancement
   Program; NIHCore [CA 010815]; Pennsylvania Department of Health;  [T32
   CA009171]
FX This study was supported by funds from NIH AI 41136, NIH GM 57599, NIH
   HD 34612, NCI CA 132098, S10 RR024693, the Mathers Foundation, and the
   PA DOH Commonwealth Universal Research Enhancement Program. A.V.
   Kossenkov was supported by T32 CA009171. NIHCore grant CA 010815 is
   acknowledged for the support of the microscopy, genomics, and sequencing
   facilities. This project is funded in part under a grant with the
   Pennsylvania Department of Health.
CR ASCOLI CA, 1991, J CELL BIOL, V112, P785, DOI 10.1083/jcb.112.5.785
   Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716
   Bea S, 2009, BLOOD, V113, P3059, DOI 10.1182/blood-2008-07-170183
   Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341
   Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675
   BOYER B, 1989, J MEMBRANE BIOL, V112, P97, DOI 10.1007/BF01871271
   Chandriani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006693
   Chang JT, 2009, MOL CELL, V34, P104, DOI 10.1016/j.molcel.2009.02.030
   Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106
   Cohen N, 2001, EMBO J, V20, P4547, DOI 10.1093/emboj/20.16.4547
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0
   DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9
   Esteller M, 2000, CANCER RES, V60, P2368
   Everett RD, 2008, J VIROL, V82, P2661, DOI 10.1128/JVI.02308-07
   Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06
   Ferbeyre G, 2000, GENE DEV, V14, P2015
   Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251
   Gibson TJ, 1998, TRENDS BIOCHEM SCI, V23, P242, DOI 10.1016/S0968-0004(98)01231-6
   Guldner HH, 1999, J CELL SCI, V112, P733
   Hahn WC, 1999, NATURE, V400, P464
   Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902
   Ishov AM, 2004, J CELL SCI, V117, P3807, DOI 10.1242/jcs.01230
   Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221
   Jeong SH, 2009, EXP MOL MED, V41, P912, DOI 10.3858/emm.2009.41.12.097
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Lehming N, 1998, P NATL ACAD SCI USA, V95, P7322, DOI 10.1073/pnas.95.13.7322
   Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lloyd AC, 2002, NAT CELL BIOL, V4, pE25, DOI 10.1038/ncb0202-e25
   Mathon NE, 2001, NAT REV CANCER, V1, P203, DOI 10.1038/35106045
   MU ZM, 1994, MOL CELL BIOL, V14, P6858, DOI 10.1128/MCB.14.10.6858
   Nasr R, 2009, CLIN CANCER RES, V15, P6321, DOI 10.1158/1078-0432.CCR-09-0209
   Negorev DG, 2006, J VIROL, V80, P8019, DOI 10.1128/JVI.02164-05
   Negorev DG, 2009, J VIROL, V83, P5168, DOI 10.1128/JVI.02083-08
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   Park MS, 2003, J VIROL, V77, P9522, DOI 10.1128/JVI.77.17.9522-9532.2003
   Pearson M, 2000, NATURE, V406, P207
   Rego EM, 2001, J EXP MED, V193, P521, DOI 10.1084/jem.193.4.521
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015
   Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tavalai N, 2006, J VIROL, V80, P8006, DOI 10.1128/JVI.00743-06
   Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392
   Weichenhan D, 1998, CYTOGENET CELL GENET, V80, P226, DOI 10.1159/000014985
   Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944
   Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1172482
   Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888
NR 53
TC 11
Z9 13
U1 1
U2 15
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD DEC 1
PY 2010
VL 70
IS 23
BP 9991
EP 10001
DI 10.1158/0008-5472.CAN-10-1483
PG 11
WC Oncology
SC Oncology
GA 690YJ
UT WOS:000285045900048
PM 21118961
OA Green Accepted, Bronze
DA 2018-12-27
ER

PT J
AU Quintavalle, C
   Incoronato, M
   Puca, L
   Acunzo, M
   Zanca, C
   Romano, G
   Garofalo, M
   Iaboni, M
   Croce, CM
   Condorelli, G
AF Quintavalle, C.
   Incoronato, M.
   Puca, L.
   Acunzo, M.
   Zanca, C.
   Romano, G.
   Garofalo, M.
   Iaboni, M.
   Croce, C. M.
   Condorelli, G.
TI RETRACTED: c-FLIPL enhances anti-apoptotic Akt functions by modulation
   of Gsk3 beta activity(Retracted article. See vol. 24, pg. 1134, 2017)
SO CELL DEATH AND DIFFERENTIATION
LA English
DT Article; Retracted Publication
DE apoptosis; AKT; Bcl-2 family
ID GLYCOGEN-SYNTHASE KINASE-3-BETA; NF-KAPPA-B; SIGNALING PATHWAYS;
   CANCER-THERAPY; CELL-SURVIVAL; LUNG-CANCER; DEATH; ACTIVATION;
   INHIBITOR; PHOSPHORYLATION
AB Akt is a serine-threonine kinase that has an important role in transducing survival signals. Akt also regulates a number of proteins involved in the apoptotic process. To find new Akt interactors, we performed a two-hybrid screening in yeast using full-length Akt cDNA as bait and a human cDNA heart library as prey. Among 200 clones obtained, two of them were identified as coding for the c-FLIPL protein. c-FLIPL is an endogenous inhibitor of death receptor-induced apoptosis through the caspase-8 pathway. Using co-immunoprecipitation experiments of either transfected or endogenous proteins, we confirmed the interaction between Akt and c-FLIPL. Furthermore, we observed that c-FLIPL overexpression interferes with Gsk3-beta phosphorylation levels. Moreover, through its effects on Gsk3 beta, c-FLIPL overexpression in cancer cells induced resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). This effect was mediated by the regulation of p27(Kip1) and caspase-3 expression. These results indicate the existence of a new mechanism of resistance to TRAIL in cancer cells, and unexpected functions of c-FLIPL. Cell Death and Differentiation (2010) 17, 1908-1916; doi:10.1038/cdd.2010.65; published online 28 May 2010
C1 [Quintavalle, C.; Puca, L.; Acunzo, M.; Zanca, C.; Garofalo, M.; Iaboni, M.; Condorelli, G.] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, I-80131 Naples, Italy.
   [Incoronato, M.; Romano, G.] Fdn SDN, Naples, Italy.
   [Garofalo, M.; Croce, C. M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA.
   [Condorelli, G.] CNR, IEOS, I-80125 Naples, Italy.
   [Condorelli, G.] Univ Naples Federico II, Fac Sci Biotechnol, I-80131 Naples, Italy.
RP Condorelli, G (reprint author), Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Via Pansini 5, I-80131 Naples, Italy.
EM gecondor@unina.it
OI Incoronato, Mariarosaria/0000-0001-7019-0581; condorelli,
   gerolama/0000-0003-0177-8829
FU Associazione Italiana Ricerca sul Cancro (AIRC); MIUR-FIRB [RBIN04J4J7];
   EU EMIL (European Molecular Imaging Laboratories Network) [503569]
FX We thank Dr. V de Franciscis and M Latronico for paper revision; and LR
   Vitiani for preparation of c-FLIP-overexpressing cells. This study was
   partially supported by funds from: Associazione Italiana Ricerca sul
   Cancro (AIRC) (to GC), MIUR-FIRB (RBIN04J4J7) and EU grant EMIL
   (European Molecular Imaging Laboratories Network) contract number
   503569.
CR Belanger C, 2001, J HUMAN VIROL, V4, P62
   Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006
   Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8
   Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4
   Cardone M, 1998, MOL BIOL CELL, V9, p246A
   Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075
   Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5
   Djerbi M, 1999, J EXP MED, V190, P1025, DOI 10.1084/jem.190.7.1025
   Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384
   Fang LW, 2004, J BIOL CHEM, V279, P13, DOI 10.1074/jbc.M303860200
   Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115
   Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6
   Garofalo M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004070
   Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178
   Giampietri C, 2008, J HYPERTENS, V26, P1008, DOI 10.1097/HJH.0b013e3282f6a179
   Hauck L, 2008, NAT MED, V14, P315, DOI 10.1038/nm1729
   Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710
   Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574
   Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657
   Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2
   Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1
   Lens SMA, 2002, MOL CELL BIOL, V22, P5419, DOI 10.1128/MCB.22.15.5419-5433.2002
   Liao XB, 2003, MOL CANCER THER, V2, P1215
   Lin YD, 2008, MOL CANCER THER, V7, P3556, DOI 10.1158/1535-7163.MCT-08-0648
   Maedler K, 2002, P NATL ACAD SCI USA, V99, P8236, DOI 10.1073/pnas.122686299
   Markou T, 2008, CELL SIGNAL, V20, P206, DOI 10.1016/j.cellsig.2007.10.004
   Missero C, 2001, J BIOL CHEM, V276, P33569, DOI 10.1074/jbc.M104963200
   Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412
   Peter Marcus E, 2004, Biochem J, V382, pe1
   Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102
   Safa AR, 2008, CURR CANCER DRUG TAR, V8, P37, DOI 10.2174/156800908783497087
   Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541
   Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124
   Todaro M, 2006, CANCER RES, V66, P1491, DOI 10.1158/0008-5472.CAN-05-2514
   Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284
   Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9
   Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954
NR 37
TC 18
Z9 19
U1 1
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1350-9047
EI 1476-5403
J9 CELL DEATH DIFFER
JI Cell Death Differ.
PD DEC
PY 2010
VL 17
IS 12
BP 1908
EP 1916
DI 10.1038/cdd.2010.65
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 680CI
UT WOS:000284209600010
PM 20508645
OA Bronze
DA 2018-12-27
ER

PT J
AU Bernardino, S
AF Bernardino, Saccomanni
TI RETRACTED: Vertebroplasty: a point of view on this surgical treatment
   (Retracted Article. See vol 30, pg 151, 2011)
SO CLINICAL RHEUMATOLOGY
LA English
DT Editorial Material; Retracted Publication
ID OSTEOPOROTIC VERTEBRAL FRACTURES; PERCUTANEOUS VERTEBROPLASTY;
   RANDOMIZED-TRIAL
C1 Univ G dAnnunzio, Dept Orthopaed & Trauma Surg, I-66013 Chieti, Italy.
RP Bernardino, S (reprint author), Univ G dAnnunzio, Dept Orthopaed & Trauma Surg, Via Vestini, I-66013 Chieti, Italy.
EM bernasacco@yahoo.it
CR Alvarez L, 2006, SPINE, V31, P1113
   Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429
   Diamond TH, 2003, AM J MED, V114, P257, DOI 10.1016/S0002-9343(02)01524-3
   Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563
   Rousing Rikke, 2009, Spine (Phila Pa 1976), V34, P1349, DOI 10.1097/BRS.0b013e3181a4e628
   Wardlaw D, 2009, LANCET, V373, P1016, DOI 10.1016/S0140-6736(09)60010-6
   Weinstein JN, 2009, NEW ENGL J MED, V361, P619, DOI 10.1056/NEJMe0905889
NR 7
TC 2
Z9 2
U1 3
U2 8
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0770-3198
EI 1434-9949
J9 CLIN RHEUMATOL
JI Clin. Rheumatol.
PD DEC
PY 2010
VL 29
IS 12
BP 1341
EP 1343
DI 10.1007/s10067-010-1565-5
PG 3
WC Rheumatology
SC Rheumatology
GA 684KA
UT WOS:000284547600001
PM 20842514
OA Bronze
DA 2018-12-27
ER

PT J
AU Marrouchi, M
AF Marrouchi, Mustapha
TI RETRACTED: Introduction: Embargoed Literature: Arabic (Retracted
   article. See vol. 42, pg. 536, 2015)
SO COLLEGE LITERATURE
LA English
DT Editorial Material; Retracted Publication
CR AHMED AA, 2008, ECHO TUNBUIKIGUE OCT, P74
   DARWISH M, 2002, MONDE DIPLOMATI 0409
   KHATIBI A, 1976, SPLENDOUR ISLAMIC CA
   Mearsheimer John, 2007, ISRAEL LOBBY US FORE
   Meyer Stefan G., 2001, EXPT ARABIC NOVEL PO
   SAID E, 2004, MONDE DIPLOMATI 0805
   SAID E, 1990, NATION          0917, P34
   SAID E, 2002, HARPERS MAGAZINE JUL
   SHATZ A, 2008, LRB             1009
   STETKEVYCH J, 2006, MODERN ARABIC LIT LA
   Woolf Virginia, 1985, MOMENTS BEING
NR 11
TC 1
Z9 1
U1 2
U2 4
PU WEST CHESTER UNIV
PI W CHESTER
PA SPECIAL FUNDS OFFICE, W CHESTER, PA 19383 USA
SN 0093-3139
EI 1542-4286
J9 COLL LITERATURE
JI Coll. Lit.
PD WIN
PY 2010
VL 37
IS 1
SI SI
BP 1
EP 10
PG 10
WC Literature
SC Literature
GA 550XH
UT WOS:000274166500001
DA 2018-12-27
ER

PT J
AU Hunton, J
   Arnold, V
   Reck, JL
AF Hunton, James
   Arnold, Vicky
   Reck, Jacqueline L.
TI RETRACTED: Decision Aid Reliance: A Longitudinal Field Study Involving
   Professional Buy-Side Financial Analysts (Retracted article. See vol.
   32, 2015)
SO CONTEMPORARY ACCOUNTING RESEARCH
LA English
DT Article; Retracted Publication
DE Decision aid reliance; Financial analysts; Forecast accuracy
ID JUDGMENT PERFORMANCE; INCENTIVES; JUSTIFICATION; INFORMATION;
   MOTIVATION; KNOWLEDGE; SETTINGS; PRESSURE; AUDITOR; TRUST
AB This study complements and extends prior decision aid (DA) research by examining the DA reliance behavior of professional buy-side financial analysts in the context of their actual work environment. A large mutual fund company provided data on buy-side analysts' earnings forecasts over the course of one year, during which forecasts were made at the end of each quarter for the following four consecutive quarters. As part of the decision process, all analysts could voluntarily access a DA to assist them in forecasting earnings. Consistent with extant DA theory, the results indicate that analysts with greater performance-contingent incentives were less likely to rely on the DA and analysts with more complex portfolios were more likely to rely on the DA. Contrary to the results of most DA research and inconsistent with extant DA theory, analysts with greater task ability relied more on the DA than analysts with lesser ability. Finally, when DA reliance was high, analysts' forecast accuracy was also high, regardless of DA accuracy. The results provide valuable insight into the use of DAs by professional decision makers and the influence of DA reliance on their judgments in light of real-world pressures and performance consequences. The theoretical and practical implications of this study call for more research into why, how, and under what conditions highly skilled knowledge workers rely on the advice of DAs.
C1 [Hunton, James] Bentley Univ, Bentley, WA, Australia.
   [Arnold, Vicky] Univ Cent Florida, Orlando, FL 32816 USA.
   [Reck, Jacqueline L.] Univ S Florida, Tampa, FL 33620 USA.
RP Hunton, J (reprint author), Bentley Univ, Bentley, WA, Australia.
CR Al-Natour S, 2008, DECISION SCI, V39, P175, DOI 10.1111/j.1540-5915.2008.00189.x
   ARKES HR, 1986, ORGAN BEHAV HUM DEC, V37, P93, DOI 10.1016/0749-5978(86)90046-4
   Arnold V, 2006, MIS QUART, V30, P79
   Arnold V., 2004, ACCOUNT FINANC, V44, P1, DOI DOI 10.1111/J.1467-629X.2004.00099.X
   Arnold V, 1998, ADV ACCOUNTING BEHAV, V1, P175
   ASHTON RH, 1992, ORGAN BEHAV HUM DEC, V52, P292, DOI 10.1016/0749-5978(92)90040-E
   ASHTON RH, 1990, J ACCOUNTING RES, V28, P148, DOI 10.2307/2491253
   BAUMEISTER RF, 1984, J PERS SOC PSYCHOL, V46, P610, DOI 10.1037/0022-3514.46.3.610
   Benbasat I., 1990, Decision Support Systems, V6, P203, DOI 10.1016/0167-9236(90)90015-J
   Boatsman JR, 1997, ORGAN BEHAV HUM DEC, V71, P211, DOI 10.1006/obhd.1997.2720
   Bonner S. E., 2008, JUDGMENT DECISION MA
   Bonner SE, 1996, ACCOUNT REV, V71, P221
   BROWN DL, 1998, J INFORMATION SYSTEM, V12, P75
   BUTLER SA, 1985, J ACCOUNTING RES, V23, P513, DOI 10.2307/2490824
   DAVIS EB, 1998, ADV ACCOUNTING BEHAV, V1, P33
   DAVIS FD, 1994, DECISION SCI, V25, P57, DOI 10.1111/j.1540-5915.1994.tb00516.x
   Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627
   DILLON WR, 1984, WILEY SERIES PROBABI
   Dowling C, 2007, International Journal of Accounting Information Systems, V8, P92, DOI 10.1016/j.accinf.2007.04.001
   Dowling C, 2009, ACCOUNT REV, V84, P771, DOI 10.2308/accr.2009.84.3.771
   Echambadi R, 2007, MARKET SCI, V26, P438, DOI 10.1287/mksc.1060.0263
   EINHORN HJ, 1972, ORGAN BEHAV HUM PERF, V7, P86, DOI 10.1016/0030-5073(72)90009-8
   Eining MM, 1997, AUDITING-J PRACT TH, V16, P1
   Hampton C., 2005, International Journal of Accounting Information Systems, V6, P217, DOI 10.1016/j.accinf.2005.10.001
   Hunton JE, 1997, ACCOUNT REV, V72, P497
   Jaccard J., 2003, INTERACTION EFFECTS
   JOYCE EJ, 1981, J ACCOUNTING RES, V19, P323, DOI 10.2307/2490868
   JOYCE EJ, 1981, J ACCOUNTING RES, V19, P120, DOI 10.2307/2490965
   KACHELMEIER SJ, 1990, ACCOUNT REV, V65, P209
   KLEINMUNTZ B, 1990, PSYCHOL BULL, V107, P296, DOI 10.1037//0033-2909.107.3.296
   KMENTA J., 1997, ELEMENTS ECONOMETRIC
   Lee JD, 2004, HUM FACTORS, V46, P50, DOI 10.1518/hfes.46.1.50.30392
   LIBBY R, 1993, ACCOUNT ORG SOC, V18, P425, DOI 10.1016/0361-3682(93)90040-D
   MASSELLI J, 2002, J AM TAX ASS, V24, P260
   Mauldin E. G., 2003, Journal of Information Systems, V17, P19, DOI 10.2308/jis.2003.17.1.19
   McGraw K. O., 1978, HIDDEN COSTS REWARD, P33
   MUIR BM, 1987, INT J MAN MACH STUD, V27, P527, DOI 10.1016/S0020-7373(87)80013-5
   Neter J, 1990, APPL LINEAR STAT MOD
   PETERSON DK, 1986, J APPL PSYCHOL, V71, P163, DOI 10.1037/0021-9010.71.1.163
   Rose J, 2002, RES ACCOUNTING INFOR, P111
   Shepherd DA, 2003, J BUS VENTURING, V18, P381, DOI 10.1016/S0883-9026(02)00099-X
   Sieck WR, 2005, J BEHAV DECIS MAKING, V18, P29, DOI 10.1002/bdm.486
   TODD P, 1992, MIS QUART, V16, P373, DOI 10.2307/249534
   Whitecotton S., 1996, BEHAV RES ACCOUNTING, V8, P194
   WILLINGHAM JJ, 1987, 1987 P ARTH YOUNG PR, P171
NR 45
TC 5
Z9 5
U1 2
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0823-9150
EI 1911-3846
J9 CONTEMP ACCOUNT RES
JI Contemp. Account. Res.
PD WIN
PY 2010
VL 27
IS 4
BP 997
EP +
DI 10.1111/j.1911-3846.2010.01034.x
PG 28
WC Business, Finance
SC Business & Economics
GA 690LR
UT WOS:000285006800001
DA 2018-12-27
ER

PT J
AU Ochmann, C
   Tuschy, B
   Beschmann, R
   Hamm, F
   Rohm, KD
   Piper, SN
AF Ochmann, Carsten
   Tuschy, Benjamin
   Beschmann, Ralf
   Hamm, Florian
   Roehm, Kerstin D.
   Piper, Swen N.
TI RETRACTED: Supplemental oxygen reduces serotonin levels in plasma and
   platelets during colorectal surgery and reduces postoperative nausea and
   vomiting (Retracted article. See vol. 29, pg. 164, 2012)
SO EUROPEAN JOURNAL OF ANAESTHESIOLOGY
LA English
DT Article; Retracted Publication
DE colon surgery; nausea; oxygen; postoperative nausea and vomiting;
   serotonin; vomiting
ID RANDOMIZED CONTROLLED-TRIAL; SURGICAL SITE INFECTION; PERIOPERATIVE
   OXYGEN; NITROUS-OXIDE; BLOOD-FLOW; ANESTHESIA; PREVENTION; FRACTION;
   LAPAROSCOPY; PRESSURE
AB Background and objective It has been shown that supplemental oxygen reduces the incidence of postoperative nausea and vomiting (PONV) in patients undergoing colon surgery. Serotonin is a potent trigger of PONV. Theoretically, supplemental oxygen decreases gut ischaemia during surgery and in this way minimizes the release of serotonin. We investigated the release of serotonin during and after colorectal surgery with normal and supplemental oxygen administration.
   Methods Patients (n=53) undergoing colon surgery were randomly assigned to one of two intraoperative ventilation regimens: group A (n=30) received 80% oxygen and 20% nitrogen mixed with desflurane and group B (n=23) received 30% oxygen and 70% nitrogen mixed with desflurane. To verify oxygenation status, we measured the arterial oxygen partial pressure (pO(2)) by blood gas analysis and the intramuscular tissue oxygenation using a polarographic microoxygen sensor (Licox, GMS, Mielkendorf, Germany). Serotonin levels in plasma and in platelets were measured using high-performance liquid chromatography (HPLC) before the beginning of surgery (T-0), at the end of surgery (T-1), and 2 h (T-2), 8 h (T-3) and 24 h (T-4) postoperatively. PONV was assessed in the early (0-4 h) and overall (0-24 h) postoperative period by an anaesthesiologist unaware of patients' treatment regime.
   Results At T-1, T-2 and T-3, serotonin levels were significantly (T-1 '80% group' 80 +/- 68.2 vs. '30% group' 147 +/- 130.5; T-2 '80% group' 78.4 +/- 61 vs. '30% group' 139 +/- 103; T-3 '80% group' 76.2 +/- 49.5 vs. '30% group' 124 +/- 73.7; P<0.05) reduced in the '80% oxygen group'. Patients in the '80% group' showed a significantly higher pO(2) and subcutaneous tissue oxygenation (ptO(2)). The overall incidence of PONV was significantly reduced in the '80% oxygen group' ('80% group' 7% vs. '30% group' 35%).
   Conclusion An inspired oxygen fraction of 0.8 reduces serotonin levels significantly and decreases PONV significantly in patients undergoing colon surgery. Eur J Anaesthesiol 2010;27:1036-1043
C1 [Ochmann, Carsten; Tuschy, Benjamin; Hamm, Florian; Roehm, Kerstin D.] Klinikum Stadt Ludwigshafen, Dept Anaesthesiol & Intens Care Med, D-67063 Ludwigshafen, Germany.
   [Beschmann, Ralf; Piper, Swen N.] Stadtklin Frankenthal, Dept Anaesthesiol & Intens Care Med, Frankenthal, Germany.
RP Ochmann, C (reprint author), Klinikum Stadt Ludwigshafen, Dept Anaesthesiol & Intens Care Med, Bremserstr 79, D-67063 Ludwigshafen, Germany.
EM carstenochmann@hotmail.com
CR Akca O, 1999, ANESTHESIOLOGY, V91, P991, DOI 10.1097/00000542-199910000-00019
   Apfel CC, 2002, BRIT J ANAESTH, V88, P234, DOI 10.1093/bja/88.2.234
   Apfel CC, 2004, NEW ENGL J MED, V350, P2441, DOI 10.1056/NEJMoa032196
   Apfel CC, 2002, BRIT J ANAESTH, V88, P659, DOI 10.1093/bja/88.5.659
   Brar MS, 2009, J SURG RES
   CAMPELL MJ, 1996, BMJ-BRIT MED J, V13, P96
   CAMPELL MJ, 1995, BMJ-BRIT MED J, V28, P1145
   DIEBEL LN, 1992, J TRAUMA, V33, P45, DOI 10.1097/00005373-199207000-00010
   Donaldson ABP, 2005, ANAESTH INTENS CARE, V33, P744
   Gan TJ, 2003, ANESTH ANALG, V97, P62, DOI 10.1213/01.ANE.0000068580.00245.95
   GELMAN S, 1987, ANESTH ANALG, V66, P936
   Ghods Ali Asghar, 2005, J Perianesth Nurs, V20, P200
   Goll V, 2001, ANESTH ANALG, V92, P112, DOI 10.1097/00000539-200101000-00022
   GRANGER DN, 1980, GASTROENTEROLOGY, V78, P837
   Greif R, 1999, ANESTHESIOLOGY, V91, P1246, DOI 10.1097/00000542-199911000-00014
   Greif R, 2000, NEW ENGL J MED, V342, P161, DOI 10.1056/NEJM200001203420303
   Hartung J, 1996, ANESTH ANALG, V83, P114, DOI 10.1097/00000539-199607000-00020
   HEYSSEL RM, 1961, J CLIN INVEST, V40, P2134, DOI 10.1172/JCI104439
   Joris JL, 2003, BRIT J ANAESTH, V91, P857, DOI 10.1093/bja/aeg267
   Kober A, 2002, MAYO CLIN PROC, V77, P35, DOI 10.4065/77.1.35
   Koivuranta M, 1997, ANAESTHESIA, V52, P443, DOI 10.1111/j.1365-2044.1997.117-az0113.x
   Macario A, 1999, ANESTH ANALG, V89, P652, DOI 10.1097/00000539-199909000-00022
   Marston A, 1977, J Clin Pathol Suppl (R Coll Pathol), V11, P59
   Mayzler O, 2005, Minerva Anestesiol, V71, P21
   MCNEILL JR, 1982, CAN J PHYSIOL PHARM, V60, P363, DOI 10.1139/y82-052
   Meyhoff CS, 2009, JAMA-J AM MED ASSOC, V302, P1543, DOI 10.1001/jama.2009.1452
   Moher D, 2001, ANN INTERN MED, V134, P657, DOI 10.7326/0003-4819-134-8-200104170-00011
   Nicole PC, 2002, CAN J ANAESTH, V49, P453, DOI 10.1007/BF03017919
   Orhan-Sungur M, 2008, ANESTH ANALG, V106, P1733, DOI 10.1213/ane.0b013e3181731c5a
   Overdyk FJ, 1997, ANESTH ANALG, V84, P231, DOI 10.1097/00000539-199701000-00055
   Piper SN, 2006, BRIT J ANAESTH, V97, P647, DOI 10.1093/bja/ael242
   Pryor KO, 2004, JAMA-J AM MED ASSOC, V291, P79, DOI 10.1001/jama.291.1.79
   Purhonen S, 2003, BRIT J ANAESTH, V91, P284, DOI 10.1093/bja/aeg162
   Purhonen S, 2003, ANESTH ANALG, V96, P91, DOI 10.1213/01.ANE.0000040007.58378.29
   Rincon DA, 2008, REV ESP ANEST REANIM, V55, P101, DOI 10.1016/S0034-9356(08)70517-6
   Rusch D, 2004, ANAESTHESIST, V53, P228, DOI 10.1007/s00101-003-0636-2
   Sadrolsadat SH, 2008, HERNIA, V12, P167, DOI 10.1007/s10029-007-0303-7
   Treschan TA, 2005, ANESTHESIOLOGY, V103, P6, DOI 10.1097/00000542-200507000-00005
   Turan A, 2006, ANAESTHESIA, V61, P628, DOI 10.1111/j.1365-2044.2006.04703.x
   WATCHA MF, 1992, ANESTHESIOLOGY, V77, P162, DOI 10.1097/00000542-199207000-00023
   WEISS H, 1926, MUENCHENER MED WOCHE, V73, P658
NR 41
TC 8
Z9 11
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0265-0215
EI 1365-2346
J9 EUR J ANAESTH
JI Eur. J. Anaesth.
PD DEC
PY 2010
VL 27
IS 12
BP 1036
EP 1043
DI 10.1097/EJA.0b013e32833b04e4
PG 8
WC Anesthesiology
SC Anesthesiology
GA 678TT
UT WOS:000284104500004
PM 20613542
DA 2018-12-27
ER

PT J
AU Bianchini, D
   Zivi, A
   Sandhu, S
   de Bono, JS
AF Bianchini, Diletta
   Zivi, Andrea
   Sandhu, Shahneen
   de Bono, Johann S.
TI RETRACTED: Horizon scanning for novel therapeutics for the treatment of
   prostate cancer (Retracted article. See vol. 21, pg. 1591, 2012)
SO EXPERT OPINION ON INVESTIGATIONAL DRUGS
LA English
DT Review; Retracted Publication
DE drug development; metastatic castration-resistant prostate cancer;
   molecular target; targeted therapy
ID PHASE-II TRIAL; ENDOTHELIAL GROWTH-FACTOR; CIRCULATING TUMOR-CELLS;
   HISTONE DEACETYLASE INHIBITORS; MONOCLONAL-ANTIBODY CP-751,871;
   NONRECEPTOR TYROSINE KINASES; RANDOMIZED CONTROLLED-TRIAL; REMAINS
   HORMONE DRIVEN; ADVANCED SOLID TUMORS; HEAT-SHOCK PROTEINS
AB Importance of the field: Treatment options for patients with advanced prostate cancer (PCa) remain limited. Improved understanding of the underlying molecular drivers of prostate cancer pathogenesis, progression and resistance development has provided the fundamental basis for rational targeted drug design.
   Areas covered in this review: This review will discuss the most recent developments in the field of prostate cancer therapies including key findings such as the identification of ETS gene rearrangements, the dissection of prostate cancer molecular heterogeneity and the discovery that castration-resistant prostate cancer (CRPC) remains androgen-driven despite the androgen-depleted milieu, thus making androgen receptor signaling a continued focus of molecularly targeted treatments. A multitude of new molecularly targeted agents are in clinical development and are highly likely to change the current treatment paradigm.
   What the reader will gain: This review will outline the current clinical development of molecular targeted treatments in CRPC.
   Take home message: Unraveling the complex molecular biology that underpins this heterogeneous disease may pave the way to personalized therapy with a wide range of rationally targeted agents and combination treatments. In conclusion, we can predict that the rational clinical development of new targeted drugs will improve the outcome of men with prostate cancer in the years ahead.
C1 [Bianchini, Diletta; Zivi, Andrea; Sandhu, Shahneen; de Bono, Johann S.] Royal Marsden NHS Fdn Trust, Inst Canc Res, Med Sect, Drug Dev Unit, Sutton SM2 5PT, Surrey, England.
RP de Bono, JS (reprint author), Royal Marsden NHS Fdn Trust, Inst Canc Res, Med Sect, Drug Dev Unit, Downs Rd, Sutton SM2 5PT, Surrey, England.
EM johann.de-bono@icr.ac.uk
CR *AM CANC SOC, 2009, CANC FACTS FIG
   ARAUJO J, 2009, J CLIN ONCOL S, V27, pNI394
   Arnott JA, 2008, BONE, V42, P871, DOI 10.1016/j.bone.2008.01.006
   Assinder SJ, 2009, BIOCHEM J, V417, P411, DOI 10.1042/BJ20081610
   Attard G, 2008, J CLIN PATHOL, V61, P891, DOI 10.1136/jcp.2008.056341
   Attard G, 2008, BRIT J CANCER, V99, P314, DOI 10.1038/sj.bjc.6604472
   Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749
   Attard G, 2009, J CLIN ONCOL, V27, P3742, DOI 10.1200/JCO.2008.20.0642
   Attard G, 2009, CANCER RES, V69, P4937, DOI 10.1158/0008-5472.CAN-08-4531
   Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477
   Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132
   Bjorkman M, 2008, INT J CANCER, V123, P2774, DOI 10.1002/ijc.23885
   Bok Robert A, 2008, Ther Clin Risk Manag, V4, P79
   Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133
   Bradley D, 2009, CANCER-AM CANCER SOC, V115, P5541, DOI 10.1002/cncr.24597
   BRISTOW RG, 2009, GENT CANC S 26 28 FE
   Carducci MA, 2007, CANCER, V110, P1959, DOI 10.1002/cncr.22996
   Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037
   CETNAR JP, 2009, J CLIN ONCOL S, V27
   Chang YM, 2007, NEOPLASIA, V9, P90, DOI 10.1593/neo.06694
   Chee KG, 2007, CLIN GENITOURIN CANC, V5, P433, DOI 10.3816/CGC.2007.n.031
   Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972
   Chen Y, 2009, LANCET ONCOL, V10, P981, DOI 10.1016/S1470-2045(09)70229-3
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Chi KN, 2008, ANN ONCOL, V19, P746, DOI 10.1093/annonc/mdm554
   Chi KN, 2009, EUR UROL, V56, P594, DOI 10.1016/j.eururo.2009.06.027
   CHI KN, 2009, J CLIN ONCOL S, V27, pNI347
   Chu QSC, 2009, EXPERT OPIN BIOL TH, V9, P263, DOI [10.1517/14712590802666397, 10.1517/14712590802666397 ]
   Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070
   Cooperberg MR, 2004, J UROLOGY, V171, P1393, DOI 10.1097/01.ju.0000107247.81471.06
   Dahut WL, 2004, J CLIN ONCOL, V22, P2532, DOI 10.1200/JCO.2004.05.074
   DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082
   Danila DC, 2010, J CLIN ONCOL, V28, P1496, DOI 10.1200/JCO.2009.25.9259
   DANILA DC, 2010, GEN CANC S 5 7 MARCH
   de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872
   de Bono JS, 2007, CLIN CANCER RES, V13, P3611, DOI 10.1158/1078-0432.CCR-07-0268
   DECOSTER R, 1986, CLIN ENDOCRINOL, V24, P657
   Demers Laurence M., 2000, Cancer, V88, P2919, DOI 10.1002/1097-0142(20000615)88:12+<2919::AID-CNCR7>3.0.CO;2-Z
   Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122
   Di Lorenzo G, 2008, EUR UROL, V54, P1089, DOI 10.1016/j.eururo.2008.01.082
   DiPaola RS, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-1
   Dougall WC, 2006, CANCER METAST REV, V25, P541, DOI 10.1007/s10555-006-9021-3
   Dreicer R, 2010, J CLIN ONCOL, V28, P3084
   Duque JLF, 1999, UROLOGY, V54, P523, DOI 10.1016/S0090-4295(99)00167-3
   Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504
   Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009
   Ferrer FA, 1999, UROLOGY, V54, P567, DOI 10.1016/S0090-4295(99)00156-9
   Figg WD, 2005, J UROLOGY, V173, P790, DOI 10.1097/01.ju.0000147013.09157.8e
   Figg WD, 2001, CLIN CANCER RES, V7, P1888
   FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
   Fox WD, 2002, CLIN CANCER RES, V8, P3226
   Gan L, 2009, CANCER RES, V69, P8386, DOI 10.1158/0008-5472.CAN-09-1504
   GEORGE DJ, 2008, GEN CANC S 14 16 FEB
   Gibbons NB, 2000, PROSTATE, V45, P58
   Ginn-Pease ME, 2003, CANCER RES, V63, P282
   Gray IC, 1998, BRIT J CANCER, V78, P1296, DOI 10.1038/bjc.1998.674
   Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   Guise Theresa A, 2004, Cancer Treat Res, V118, P197
   Haluska P, 2007, CLIN CANCER RES, V13, P5834, DOI 10.1158/1078-0432.CCR-07-1118
   Heath EI, 2008, CLIN CANCER RES, V14, P7940, DOI 10.1158/1078-0432.CCR-08-0221
   HIGANO C, 2009, J CLIN ONCOL S, V27
   Higano C, 2009, GEN CANC S 26 28 FEB
   Higano CS, 2008, CANCER, V113, P975, DOI 10.1002/cncr.23669
   Howard CS, 2009, CANCER CELL, V15, P461
   Huggins C, 1941, CANCER RES, V1, P293
   Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875
   Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691
   Hussain M, 2005, J CLIN ONCOL, V23, P8724, DOI 10.1200/JCO.2005.02.4448
   Isambert N, 2008, J CLIN ONCOL, V26
   James ND, 2009, EUR UROL, V55, P1112, DOI 10.1016/j.eururo.2008.11.002
   KANTOFF P, 2010, GEN CANC S 5 7 MARCH
   Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597
   KANTOFF PW, 2009, J CLIN ONCOL S, V27
   KARP DD, 2009, J CLIN ONCOL S, V27, pNI248
   Keller ET, 2001, CANCER METAST REV, V20, P333, DOI 10.1023/A:1015599831232
   Kelly WK, 2010, J CLIN ONCOL, V28
   KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820
   Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272
   Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402
   Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X
   Lara PN, 2009, ANTI-CANCER DRUG, V20, P179, DOI 10.1097/CAD.0b013e328325a867
   Lee JJ, 2009, NAT CLIN PRACT ONCOL, V6, P85, DOI 10.1038/ncponc1281
   Lee LF, 2001, MOL CELL BIOL, V21, P8385, DOI 10.1128/MCB.21.24.8385-8397.2001
   Liu G, 2009, CLIN CANCER RES, V15, P3172, DOI 10.1158/1078-0432.CCR-08-2985
   Liu JL, 2005, MOL CELL BIOL, V25, P6211, DOI 10.1128/MCB.25.14.6211-6224.2005
   Ma WW, 2007, DRUG TODAY, V43, P659, DOI 10.1358/dot.2007.43.10.1148059
   Ma WW, 2009, CA-CANCER J CLIN, V59, P111, DOI 10.3322/caac.20003
   MACVICAR GR, 2009, J CLIN ONCOL S, V27, pNI395
   Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375
   Miayake H, 2000, J NATL CANCER I, V92, P34, DOI 10.1093/jnci/92.1.34
   Mita AC, 2009, CLIN CANCER RES, V15, P723, DOI 10.1158/1078-0432.CCR-08-0596
   MITSIADES N, 2009, J CLIN ONCOL S, V27, pNI340
   Miyake H, 2000, CLIN CANCER RES, V6, P1655
   Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03
   Molife LR, 2010, ANN ONCOL, V21, P109, DOI 10.1093/annonc/mdp270
   Morris PG, 2008, CLIN CANCER RES, V14, P7167, DOI 10.1158/1078-0432.CCR-08-0169
   Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867
   Nelson J, 2003, NAT REV CANCER, V3, P110, DOI 10.1038/nrc990
   Nelson JB, 2008, CANCER, V113, P2478, DOI 10.1002/cncr.23864
   O'Donnell A, 2004, BRIT J CANCER, V90, P2317, DOI 10.1038/sj.bjc.6601879
   O'Donnell A, 2008, J CLIN ONCOL, V26, P1588, DOI 10.1200/JCO.2007.14.0988
   Olmos D, 2009, ANN ONCOL, V20, P27, DOI 10.1093/annonc/mdn544
   OLMOS D, 2008, J CLIN ONCOL, V26
   PACEY SC, 2009, J CLIN ONCOL S, V27
   Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318
   Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097
   POLLAK MN, 1987, CANCER LETT, V38, P223, DOI 10.1016/0304-3835(87)90218-7
   Powers MV, 2006, ENDOCR-RELAT CANCER, V13, pS125, DOI 10.1677/erc.1.01324
   RAFFO AJ, 1995, CANCER RES, V55, P4438
   Rauhala HE, 2008, INT J CANCER, V123, P1601, DOI [10.1002/ijc.23658, 10.1002/ijc.23659]
   Raymond E, 2004, J CLIN ONCOL, V22, P2336, DOI 10.1200/JCO.2004.08.116
   Redondo M, 2000, AM J PATHOL, V157, P393, DOI 10.1016/S0002-9440(10)64552-X
   Reid AHM, 2010, J CLIN ONCOL, V28, P1489, DOI 10.1200/JCO.2009.24.6819
   Rizzi F, 2009, J CELL PHYSIOL, V219, P314, DOI 10.1002/jcp.21671
   Rosenberg JE, 2007, CANCER, V110, P556, DOI 10.1002/cncr.22811
   Ross R.W., 2008, J CLIN ONCOL, V26
   Ryan CJ, 2010, J CLIN ONCOL, V28, P1481, DOI 10.1200/JCO.2009.24.1281
   Saad F, 2002, J NATL CANCER I, V94, P1458, DOI 10.1093/jnci/94.19.1458
   Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013
   SANDA MG, 1994, J UROLOGY, V151, P622, DOI 10.1016/S0022-5347(17)35032-2
   Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181
   Saporita AJ, 2007, PROSTATE, V67, P509, DOI 10.1002/pros.20541
   Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125
   SARTOR AO, 2010, GEN CANC S 5 7 MARCH
   Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487
   Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9
   Scher HI, 2009, LANCET ONCOL, V10, P233, DOI 10.1016/S1470-2045(08)70340-1
   Shariat SF, 2004, CANCER, V100, P751, DOI 10.1002/cncr.20039
   Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042
   Simons JW, 2006, UROL ONCOL-SEMIN ORI, V24, P419, DOI 10.1016/j.urolonc.2005.08.021
   SLOVIN SF, 2009, J CLIN ONCOL S, V27
   SMALL E, 2009, GEN CANC S 26 28 FEB
   Small EJ, 2007, CLIN CANCER RES, V13, P3883, DOI 10.1158/1078-0432.CCR-06-2937
   Small EJ, 2006, J CLIN ONCOL, V24, P3089, DOI 10.1200/JCO.2005.04.5252
   Smith MR, 2009, NEW ENGL J MED, V361, P745, DOI 10.1056/NEJMoa0809003
   Snyder DS, 2009, EXPERT REV ANTICANC, V9, P285, DOI 10.1586/14737140.9.3.285
   Solit DB, 2004, J CLIN ONCOL, V22, p203S
   SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O
   Steinberg J, 1997, CLIN CANCER RES, V3, P1707
   Sternberg CN, 2009, ANN ONCOL, V20, P1264, DOI 10.1093/annonc/mdn784
   Sternberg CN, 2009, J CLIN ONCOL, V27, P5431, DOI 10.1200/JCO.2008.20.1228
   Sznol M, 2010, J CLIN ONCOL, V28
   Tabernero J, 2007, J CLIN ONCOL, V25
   Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720
   Tarassoff CP, 2006, ONCOLOGIST, V11, P451, DOI 10.1634/theoncologist.11-5-451
   Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525
   TOLCHER AW, 2009, GEN CANC S 26 28 FEB
   Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168
   Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931
   Wang XR, 2008, CANCER RES, V68, P7409, DOI 10.1158/0008-5472.CAN-08-1522
   Welsbie DS, 2009, CANCER RES, V69, P958, DOI 10.1158/0008-5472.CAN-08-2216
   YU E, 2009, J CLIN ONCOL S, V27, pNIL22
   Yu EY, 2009, CLIN CANCER RES, V15, P7421, DOI 10.1158/1078-0432.CCR-09-1691
   Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291
   Zhang J, 2003, CANCER RES, V63, P7883
   Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685
NR 157
TC 6
Z9 6
U1 1
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1354-3784
EI 1744-7658
J9 EXPERT OPIN INV DRUG
JI Expert Opin. Investig. Drugs
PD DEC
PY 2010
VL 19
IS 12
BP 1487
EP 1502
DI 10.1517/13543784.2010.514261
PG 16
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 685ES
UT WOS:000284612200003
PM 20868208
DA 2018-12-27
ER

PT J
AU Beeregowda, YC
   Kiran, B
   Gowda, NY
AF Beeregowda, Y. C.
   Kiran, B.
   Gowda, N. Yellappa
TI RETRACTED: Neonatal Umbilical Myiasis with Sepsis (Retracted article.
   See vol. 79, pg. 964, 2012)
SO INDIAN JOURNAL OF PEDIATRICS
LA English
DT Article; Retracted Publication
DE Neonate; Myiasis; Cochliomyia hominivorax
ID COCHLIOMYIA-HOMINIVORAX DIPTERA; DOMESTIC-ANIMALS; SCREWWORM FLIES;
   CALLIPHORIDAE; OVIPOSITION; ATTRACTANT; RESPONSES; FLY
AB The authors report a 9-day old neonate from a rural area with umbilical myiasis caused by fly larvae of Cochliomyia hominivorax. The blowfly causing this infestation belongs to the family Calliphoridae (Diptera) and the genus Cochliomyia that usually infests only open wounds of animals. The new-world screw-worm fly Cochliomyia hominivorax, is an obligate ectoparasite of domestic and wild animals, and in some cases may affect humans. This is the rare reported case of neonatal umbilical myiasis with sepsis in the world literature.
C1 [Beeregowda, Y. C.; Kiran, B.; Gowda, N. Yellappa] Sri Devaraj URS Med Coll, Dept Paediat, Kolar 563101, Karnataka, India.
RP Beeregowda, YC (reprint author), Sri Devaraj URS Med Coll, Dept Paediat, Kolar 563101, Karnataka, India.
EM rljhunit8@gmail.com
CR Bowry R, 1997, J ACCID EMERG MED, V14, P177
   HALL M, 1995, ADV PARASIT, V35, P257, DOI 10.1016/S0065-308X(08)60073-1
   HAMMACK L, 1991, J ECON ENTOMOL, V84, P185, DOI 10.1093/jee/84.1.185
   HAMMACK L, 1987, ANN ENTOMOL SOC AM, V80, P775, DOI 10.1093/aesa/80.6.775
   HAMMACK L, 1983, J CHEM ECOL, V9, P913, DOI 10.1007/BF00987814
   James M. T., 1947, USDA MISCELLANEOUS P, V631, P1
   MARILUIS JC, 1994, MEM I OSWALDO CRUZ, V89, P139, DOI 10.1590/S0074-02761994000200003
   Szekely R., 1975, Boletin Chil Parasit, V30, P25
   THOMAS DB, 1989, ANN ENTOMOL SOC AM, V82, P526, DOI 10.1093/aesa/82.4.526
   Zupan J, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001057.PUB2
NR 10
TC 6
Z9 6
U1 2
U2 8
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0019-5456
EI 0973-7693
J9 INDIAN J PEDIATR
JI Indian J. Pediatr.
PD DEC
PY 2010
VL 77
IS 12
BP 1443
EP 1445
DI 10.1007/s12098-010-0236-5
PG 3
WC Pediatrics
SC Pediatrics
GA 693EI
UT WOS:000285207000015
PM 20882424
DA 2018-12-27
ER

PT J
AU Lichtenthaler, U
AF Lichtenthaler, Ulrich
TI RETRACTED: Outward knowledge transfer: the impact of project-based
   organization on performance (Retracted article. See vol. 22, pg. 849,
   2013)
SO INDUSTRIAL AND CORPORATE CHANGE
LA English
DT Article; Retracted Publication
ID ABSORPTIVE-CAPACITY; PRODUCT DEVELOPMENT; STRATEGIC ALLIANCES;
   TECHNOLOGY-TRANSFER; MARKET INTELLIGENCE; MANAGING KNOWLEDGE; CAPTURING
   VALUE; FIRMS; INNOVATION; INDUSTRY
AB Recently, interfirm knowledge transactions have increased although many firms experience major managerial difficulties in outward knowledge transfer, e.g. technology licensing. To reduce the traditional underemphasis on empirical research into corporate outward knowledge transfer, we use data from 152 firms to test four hypotheses relating firms' outward knowledge transfer performance to two types of project-based organization, which complement formal and informal organizational structures: projects that are directed at identifying knowledge transfer opportunities and projects that are directed at implementing outward knowledge transfer. The results underscore the benefits from both types of projects, and their positive interaction further contributes to explaining the discrepancies between some successful firms in managing outward knowledge transfer and many others.
C1 WHU Otto Beisheim Sch Management Technol & Innova, D-56179 Vallendar, Germany.
RP Lichtenthaler, U (reprint author), WHU Otto Beisheim Sch Management Technol & Innova, Burgpl 2, D-56179 Vallendar, Germany.
EM lichtenthaler@whu.edu
CR Agrawal A, 2001, INT J MANAG REV, V3, P285, DOI 10.1111/1468-2370.00069
   Amesse F, 2001, RES POLICY, V30, P1459, DOI 10.1016/S0048-7333(01)00162-7
   Argote L, 2003, MANAGE SCI, V49, pV
   Arora A, 2004, IND CORP CHANGE, V13, P451, DOI 10.1093/icc/dth018
   Artto K, 2009, INT J PROJ MANAG, V27, P1, DOI 10.1016/j.ijproman.2007.10.007
   Bartlett C.A., 1998, MANAGING BORDERS TRA
   Bozeman B, 2000, RES POLICY, V29, P627, DOI 10.1016/S0048-7333(99)00093-1
   BROCKHOFF K, 1991, IND MARKET MANAG, V20, P91, DOI 10.1016/0019-8501(91)90027-D
   BROWN SL, 1995, ACAD MANAGE REV, V20, P343, DOI 10.2307/258850
   Cameron A.C., 1998, REGRESSION ANAL COUN
   Carlile PR, 2004, ORGAN SCI, V15, P555, DOI 10.1287/orcs.1040.0094
   Chesbrough H, 2003, CALIF MANAGE REV, V45, P33, DOI 10.2307/41166175
   Chesbrough H, 2002, IND CORP CHANGE, V11, P529, DOI 10.1093/icc/11.3.529
   Chesbrough H., 2006, OPEN BUSINESS MODELS
   Cohen J., 2003, APPL MULTIPLE REGRES
   COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553
   COOPER RG, 1995, J PROD INNOVAT MANAG, V12, P374, DOI 10.1016/0737-6782(95)00059-3
   Cummings JL, 2003, J ENG TECHNOL MANAGE, V20, P39, DOI 10.1016/S0923-4748(03)00004-3
   DAVIS JL, 2001, EDISON BOARDROOM LEA
   Debackere K, 2005, RES POLICY, V34, P321, DOI 10.1016/j.respol.2004.12.003
   Edmondson AC, 2007, ACAD MANAGE REV, V32, P1155
   EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557
   Ernst H, 1998, J ENG TECHNOL MANAGE, V15, P279, DOI 10.1016/S0923-4748(98)00018-6
   FAHEY L, 1986, MACROENVIRONMENTAL A
   Fosfuri A, 2006, STRATEGIC MANAGE J, V27, P1141, DOI 10.1002/smj.562
   Frishammar J, 2005, J PROD INNOVAT MANAG, V22, P251, DOI 10.1111/j.0737-6782.2005.00121.x
   Galbraith J.R, 1993, COMPETING FLEXIBLE L
   Gambardella A, 2001, MARKETS TECHNOLOGY E
   Gans JS, 2003, RES POLICY, V32, P333, DOI 10.1016/S0048-7333(02)00103-8
   George G, 2005, IND CORP CHANGE, V14, P119, DOI 10.1093/icc/dth046
   GERBING DW, 1988, J MARKETING RES, V25, P186, DOI 10.2307/3172650
   GERYBADZE A, 1994, R&D MANAGE, V24, P131, DOI 10.1111/j.1467-9310.1994.tb00865.x
   Geyskens I, 2006, ACAD MANAGE J, V49, P519, DOI 10.5465/AMJ.2006.21794670
   GHOSHAL S, 1986, SLOAN MANAGE REV, V28, P49
   Granstrand O, 2000, EC MANAGEMENT INTELL
   Grant RM, 2004, J MANAGE STUD, V41, P61, DOI 10.1111/j.1467-6486.2004.00421.x
   Grindley PC, 1997, CALIF MANAGE REV, V39, P8, DOI 10.2307/41165885
   Hair J., 2006, MULTIVARIATE DATA AN
   Henderson R., 1994, IND CORP CHANGE, V3, P607
   HILBE JM, 2007, NEGATIVE BINOMIAL RE
   HINKIN TR, 1995, J MANAGE, V21, P967, DOI 10.1016/0149-2063(95)90050-0
   Hoang H, 2005, ACAD MANAGE J, V48, P332, DOI 10.5465/AMJ.2005.16928417
   Hoegl M, 2005, J MANAGE, V31, P530, DOI 10.1177/0149206304272291
   Jansen JJP, 2005, ACAD MANAGE J, V48, P999, DOI 10.5465/AMJ.2005.19573106
   Kale P, 2000, STRATEGIC MANAGE J, V21, P217, DOI 10.1002/(SICI)1097-0266(200003)21:3<217::AID-SMJ95>3.3.CO;2-P
   Kale P, 2002, STRATEGIC MANAGE J, V23, P747, DOI 10.1002/smj.248
   King N., 1994, QUALITATIVE METHODS
   Kline D, 2003, MIT SLOAN MANAGE REV, V44, P89
   Kostoff RN, 2001, IEEE T ENG MANAGE, V48, P132, DOI 10.1109/17.922473
   Lane PJ, 2006, ACAD MANAGE REV, V31, P833, DOI 10.5465/AMR.2006.22527456
   Lane PJ, 2001, STRATEGIC MANAGE J, V22, P1139, DOI 10.1006/smj.206
   Lee T. W., 1999, USING QUALITATIVE ME
   Levinthal Daniel A., 1998, IND CORP CHANGE, V7, P217, DOI DOI 10.1093/ICC/7.2.217
   Lichtenthaler E, 2004, R&D MANAGE, V34, P121, DOI 10.1111/j.1467-9310.2004.00328.x
   Lichtenthaler U, 2007, CALIF MANAGE REV, V49, P67, DOI 10.2307/41166406
   Lichtenthaler U, 2009, STRATEG ORGAN, V7, P183, DOI 10.1177/1476127009102672
   Lindell MK, 2001, J APPL PSYCHOL, V86, P114, DOI 10.1037//0021-9010.86.1.114
   Linden G, 2003, IND CORP CHANGE, V12, P545, DOI 10.1093/icc/12.3.545
   LONG JS, 2002, REGRESSION MODELS CA
   Maddala G. S, 1983, LTD DEPENDENT QUALIT
   Makadok R, 2001, MANAGE SCI, V47, P1621, DOI 10.1287/mnsc.47.12.1621.10245
   Malerba F., 2000, IND CORP CHANGE, V9, P289, DOI DOI 10.1093/ICC/9.2.289
   Maltz E, 1996, J MARKETING RES, V33, P47, DOI 10.2307/3152012
   March JG, 1991, ORGAN SCI, V2, P71, DOI 10.1287/orsc.2.1.71
   Martin X, 2003, J INT BUS STUD, V34, P356, DOI 10.1057/palgrave.jibs.8400037
   MARTINEZ JI, 1989, J INT BUS STUD, V20, P489, DOI 10.1057/palgrave.jibs.8490370
   MARTINEZ JI, 1991, J INT BUS STUD, V22, P429, DOI 10.1057/palgrave.jibs.8490309
   Mathews JA, 2003, IND CORP CHANGE, V12, P1157, DOI 10.1093/icc/12.6.1157
   Miles M B., 1994, QUALITATIVE DATA ANA
   Mitchell W, 1992, IND CORP CHANGE, V1, P327
   Mowery DC, 2009, IND CORP CHANGE, V18, P1, DOI 10.1093/icc/dtn049
   Mowery David C., 2001, IND CORP CHANGE, V10, P317, DOI [10.1093/icc/10.2.317, DOI 10.1093/ICC/10.2.317]
   Mowery DC, 1996, STRATEGIC MANAGE J, V17, P77, DOI 10.1002/smj.4250171108
   Nagaoka S, 2006, RES POLICY, V35, P1347, DOI 10.1016/j.respol.2006.05.007
   Nonaka I., 2000, IND CORP CHANGE, V9, P1, DOI DOI 10.1093/ICC/9.1.1
   Platje A., 1994, INT J PROJ MANAG, V12, P100
   Project Management Institute, 2008, GUID PROJ MAN BOD KN
   Rivette K, 2000, REMBRANDTS ATTIC UNL
   Rolander D., 1990, MANAGING GLOBAL FIRM
   Rothaermel FT, 2004, STRATEGIC MANAGE J, V25, P201, DOI 10.1002/smj.376
   Shane S, 2000, ORGAN SCI, V11, P448, DOI 10.1287/orsc.11.4.448.14602
   Sherman JD, 2005, J PROD INNOVAT MANAG, V22, P399
   Szulanski G, 1996, STRATEGIC MANAGE J, V17, P27, DOI 10.1002/smj.4250171105
   Tanriverdi H, 2005, STRATEGIC MANAGE J, V26, P97, DOI 10.1002/smj.435
   Teece D., 1994, IND CORP CHANGE, V3, P537, DOI DOI 10.1093/ICC/3.3.537-A
   Teece DJ, 1998, CALIF MANAGE REV, V40, P55, DOI 10.2307/41165943
   TRAJTENBERG M, 1990, RAND J ECON, V21, P172, DOI 10.2307/2555502
   TSABBAR D, 2008, STRATEG ORGAN, V6, P375
   Tsoukas H, 1996, STRATEGIC MANAGE J, V17, P11, DOI 10.1002/smj.4250171104
   Tushman ML, 1996, CALIF MANAGE REV, V38, P8, DOI 10.2307/41165852
   van Wijk R., 2008, J MANAGE STUD, V45, P831
   WINKELMANN R, 2003, ECONOMETRIC ANAL COU
   Yin R. K., 2003, CASE STUDY RES DESIG
   Zahra SA, 2002, ACAD MANAGE REV, V27, P185, DOI 10.5465/AMR.2002.6587995
NR 94
TC 5
Z9 6
U1 3
U2 47
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0960-6491
J9 IND CORP CHANGE
JI Ind. Corp. Change
PD DEC
PY 2010
VL 19
IS 6
BP 1705
EP 1739
DI 10.1093/icc/dtq041
PG 35
WC Business; Economics; Management
SC Business & Economics
GA 685OR
UT WOS:000284638500002
DA 2018-12-27
ER

PT J
AU Zhang, KJ
   Jiao, XL
   Liu, XY
   Zhang, BY
   Wang, JG
   Wang, QA
   Tao, Y
   Zhang, DAL
AF Zhang, Kejun
   Jiao, Xuelong
   Liu, Xiaoyi
   Zhang, Bingyuan
   Wang, Jigang
   Wang, Quan
   Tao, Yan
   Zhang, Dianliang
TI RETRACTED: Knockdown of Snail Sensitizes Pancreatic Cancer Cells to
   Chemotherapeutic Agents and Irradiation (Retracted article. See vol. 18,
   2017)
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article; Retracted Publication
DE pancreatic cancer; Snail; sensitization; chemotherapeutics; irradiation
ID EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTORS SNAIL; HUMAN
   BREAST-CANCER; EXPRESSION; CARCINOMA; SLUG; PROGRESSION; APOPTOSIS;
   PATHWAYS; THERAPY
AB The prognosis of patients with pancreatic cancer remains poor; only patients with small tumors and complete resection have a chance of a complete cure. Pancreatic cancer responds poorly to conventional therapies, including chemotherapy and irradiation. Snail is a transcription factor that has been associated with anti-apoptotic and chemoresistant properties in pancreatic cancer cells. In this study, we investigated whether knockdown of Snail suppresses growth of and/or sensitizes pancreatic cancer cells to chemotherapeutic agents and irradiation through induction of apoptosis. An adeno-associated virus vector was used to deliver Snail siRNA and knockdown Snail expression in untreated pancreatic cancer cells and in pancreatic cancer cells treated with chemotherapeutic agents or.-irradiation. Our data indicate that our adeno-associated virus vector can efficiently deliver Snail siRNA into PANC-1 cells both in vitro and in vivo, resulting in the knockdown of Snail expression at the mRNA and protein levels. We further show that knockdown of Snail expression results in potent growth suppression of pancreatic cancer cells and suppresses xenograft tumor growth in vivo through induction of apoptosis. Finally, knockdown of Snail expression significantly sensitizes pancreatic cancer cells to chemotherapeutic agents and gamma-irradiation through induction of apoptosis. In conclusion, our findings indicate that Snail is an important modulator of therapeutic responses of pancreatic cancer cells and is potentially useful as a sensitizer in pancreatic cancer therapy.
C1 [Zhang, Kejun; Jiao, Xuelong; Liu, Xiaoyi; Zhang, Bingyuan; Zhang, Dianliang] QingDao Univ, Affiliated Hosp, Dept Gen Surg, Coll Med, Qing Dao 266003, Shan Dong Prov, Peoples R China.
   [Wang, Jigang] QingDao Univ, Affiliated Hosp, Dept Pathol, Coll Med, Qing Dao 266003, Shan Dong Prov, Peoples R China.
   [Wang, Quan] QingDao Univ, Affiliated Hosp, Dept Mol Biol, Coll Med, Qing Dao 266003, Shan Dong Prov, Peoples R China.
   [Tao, Yan] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Gen Surg, Pancreat Ctr, Wuhan 430000, Hubei Province, Peoples R China.
RP Zhang, KJ (reprint author), QingDao Univ, Affiliated Hosp, Dept Gen Surg, Coll Med, Qing Dao 266003, Shan Dong Prov, Peoples R China.
EM kjzhang2009@163.com; jiaoxuelong@163.com; zhangzemi@126.com;
   love5028@sohu.com; zlfzyj2009@163.com; wlsdermyy@163.com
OI Jiao, Xuelong/0000-0002-0348-9732
CR Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907
   Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001
   Coultas L, 2000, APOPTOSIS, V5, P491, DOI 10.1023/A:1009617727938
   Diamantidis M, 2008, CURR MOL MED, V8, P12
   Dubois JB, 2009, CANCER RADIOTHER, V13, P423, DOI 10.1016/j.canrad.2009.05.013
   Hamacher R., 2008, MOL CANCER, V24, P64
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926
   Ikeda Masafumi, 2010, Gan To Kagaku Ryoho, V37, P408
   Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6
   Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004
   Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320
   Koliopanos A, 2008, HEPATOB PANCREAT DIS, V7, P345
   Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010
   Masamune Atsushi, 2009, Nihon Shokakibyo Gakkai Zasshi, V106, P1147
   Nieto J, 2008, ONCOLOGIST, V13, P562, DOI 10.1634/theoncologist.2007-0181
   Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757
   Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131
   Plentz RR, 2010, MINERVA ENDOCRINOL, V35, P27
   Pliarchopoulou K, 2009, CANCER TREAT REV, V35, P431, DOI 10.1016/j.ctrv.2009.02.005
   Schuller HM, 2008, ANTI-CANCER DRUG, V19, P655, DOI 10.1097/CAD.0b013e3283025b58
   Sugimachi K, 2003, CLIN CANCER RES, V9, P2657
   Takkunen M, 2006, J HISTOCHEM CYTOCHEM, V54, P1263, DOI 10.1369/jhc.6A6958.2006
   Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058
   Turrini O, 2009, GASTROEN CLIN BIOL, V33, P1028, DOI 10.1016/j.gcb.2009.08.007
   Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104
   Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087
   Yin T, 2007, J SURG RES, V141, P196, DOI 10.1016/j.jss.2006.09.027
   Yu J, 2004, CURR OPIN ONCOL, V16, P19, DOI 10.1097/00001622-200401000-00005
   Zhuo WL, 2008, LUNG CANCER, V62, P8, DOI 10.1016/j.lungcan.2008.02.007
NR 30
TC 19
Z9 20
U1 4
U2 13
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD DEC
PY 2010
VL 11
IS 12
BP 4891
EP 4904
DI 10.3390/ijms11124891
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 700BV
UT WOS:000285708000008
PM 21614180
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Saitoh, Y
   Oshima, T
   Nakata, Y
AF Saitoh, Yuhji
   Oshima, Tsutomu
   Nakata, Yoshinori
TI RETRACTED: Monitoring of vecuronium-induced neuromuscular block at the
   sternocleidomastoid muscle in anesthetized patients (Retracted article.
   See vol. 32, pg. 654, 2018)
SO JOURNAL OF ANESTHESIA
LA English
DT Article; Retracted Publication
DE Sternocleidomastoid muscle; Adductor pollicis muscle; Vecuronium
ID CORRUGATOR SUPERCILII MUSCLE; ADDUCTOR POLLICIS MUSCLES; VASTUS MEDIALIS
   MUSCLE; ORBICULARIS OCULI; TRAIN-OF-4 RESPONSES; STIMULATION; DIAPHRAGM;
   AUTOPSY; HUMANS; LARYNX
AB To assess the degree of neuromuscular block acceleromyographically at the sternocleidomastoid muscle.
   Eighteen adult patients scheduled for air-oxygen-sevoflurane-fentanyl and epidural anesthesia were studied. In the patients, the right accessory nerve and the sternocleidomastoid muscle were stimulated and the contraction of the sternocleidomastoid muscle was evaluated acceleromyographically. Simultaneously, the response of the adductor pollicis muscle was measured electromyographically. Supramaximal stimulating current, degree of maximum neuromuscular block after vecuronium 0.1 mg/kg, and onset of or recovery from vecuronium-induced neuromuscular block were compared between the two muscles.
   The supramaximal stimulating current at the sternocleidomastoid muscle was significantly higher than that at the adductor pollicis muscle (54.8 +/- A 7.1 vs. 33.7 +/- A 10.3 mA, mean +/- A SD, P < 0.001). The onset of neuromuscular block at the sternocleidomastoid muscle did not significantly differ from that at the adductor pollicis muscle (214 +/- A 117 vs. 161 +/- A 87 s, P = 0.131). The degree of maximum neuromuscular block at the sternocleidomastoid muscle was significantly less than that at the adductor pollicis muscle (93.6 +/- A 3.1 vs. 99.2 +/- A 2.5%, P < 0.001). During recovery from neuromuscular block, T1/control and train-of-four ratio measured at the sternocleidomastoid muscle were significantly higher than those at the adductor pollicis muscle 10-30 and 40-120 min after vecuronium, respectively (P < 0.05).
   The sternocleidomastoid muscle is more resistant to vecuronium than the adductor pollicis muscle. Recovery from neuromuscular block is faster at the sternocleidomastoid muscle than at the adductor pollicis muscle.
C1 [Saitoh, Yuhji] Tsujinaka Hosp Kashiwanoha, Dept Anesthesiol, Chiba 2770871, Japan.
   [Oshima, Tsutomu] Canc Inst Hosp, Japanese Fdn Canc Res, Dept Anesthesia, Tokyo, Japan.
   [Nakata, Yoshinori] Teikyo Univ, Sch Med, Dept Anesthesia & Crit Care, Tokyo 173, Japan.
RP Saitoh, Y (reprint author), Tsujinaka Hosp Kashiwanoha, Dept Anesthesiol, 148-6 Kashiwanoha Campus,178-2 Wakashiba, Chiba 2770871, Japan.
EM ysr311@auone.jp
CR Abdulatif M, 1997, BRIT J ANAESTH, V79, P24
   ALTOSE MD, 1976, J APPL PHYSIOL, V40, P345
   Browner W. S., 2001, DESIGNING CLIN RES E, P65
   BRULL SJ, 1990, ANESTHESIOLOGY, V72, P629, DOI 10.1097/00000542-199004000-00009
   Goodmurphy CW, 1999, CLIN ANAT, V12, P1, DOI 10.1002/(SICI)1098-2353(1999)12:1<1::AID-CA1>3.0.CO;2-J
   Hemmerling TM, 2000, BRIT J ANAESTH, V85, P856, DOI 10.1093/bja/85.6.856
   Hemmerling TM, 2003, CAN J ANAESTH, V50, P779, DOI 10.1007/BF03019373
   Hemmerling TM, 2002, BRIT J ANAESTH, V88, P389, DOI 10.1093/bja/88.3.389
   IBEBUNJO C, 1993, BRIT J ANAESTH, V71, P732, DOI 10.1093/bja/71.5.732
   JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3
   KOPMAN AF, 1984, ANESTHESIOLOGY, V61, P83, DOI 10.1097/00000542-198461010-00015
   KOPMAN AF, 1985, ANESTHESIOLOGY, V63, P208, DOI 10.1097/00000542-198508000-00020
   Larsen PB, 2002, ACTA ANAESTH SCAND, V46, P1131, DOI 10.1034/j.1399-6576.2002.460912.x
   Michaud G, 2005, CAN J ANAESTH, V52, P795, DOI 10.1007/BF03021772
   OSHIMA T, 1992, BRIT J ANAESTH, V69, P236, DOI 10.1093/bja/69.3.236
   Plaud B, 2001, ANESTHESIOLOGY, V95, P96, DOI 10.1097/00000542-200107000-00019
   POLGAR J, 1973, J NEUROL SCI, V19, P307, DOI 10.1016/0022-510X(73)90094-4
   Saitoh Y, 1998, EUR J ANAESTH, V15, P649, DOI 10.1097/00003643-199811000-00005
   SAITOH Y, 1995, CAN J ANAESTH, V42, P992, DOI 10.1007/BF03011071
   Saitoh Y, 2003, CAN J ANAESTH, V50, P342, DOI 10.1007/BF03021030
   SAITOH Y, 1993, BRIT J ANAESTH, V70, P402, DOI 10.1093/bja/70.4.402
   Saitoh Y, 1998, ANAESTHESIA, V53, P244, DOI 10.1046/j.1365-2044.1998.00336.x
   Saitoh Y, 1999, BRIT J ANAESTH, V82, P329, DOI 10.1093/bja/82.3.329
   Saitoh Y, 2010, J CLIN ANESTH, V22, P318, DOI 10.1016/j.jclinane.2009.09.004
   SKARVAN K, 1970, RESPIRATION, V27, P480, DOI 10.1159/000192703
   VIBYMOGENSEN J, 1988, ACTA ANAESTH SCAND, V32, P45
   VibyMogensen J, 1996, ACTA ANAESTH SCAND, V40, P59, DOI 10.1111/j.1399-6576.1996.tb04389.x
   VIBYMOGENSEN J, 2000, ANESTHESIA, P1363
   WILSON SH, 1984, AM REV RESPIR DIS, V129, P460
NR 29
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 0913-8668
EI 1438-8359
J9 J ANESTH
JI J. Anesth.
PD DEC
PY 2010
VL 24
IS 6
BP 838
EP 844
DI 10.1007/s00540-010-1012-4
PG 7
WC Anesthesiology
SC Anesthesiology
GA 692LD
UT WOS:000285153400003
PM 20725751
DA 2018-12-27
ER

PT J
AU Chanimov, M
   Evron, S
   Haitov, Z
   Stolero, S
   Cohen, ML
   Friedland, M
   Shul, I
   Bahar, M
AF Chanimov, Michael
   Evron, Shmuel
   Haitov, Zoya
   Stolero, Sorin
   Cohen, Mathias L.
   Friedland, Mark
   Shul, Ina
   Bahar, Murat
TI RETRACTED: Accidental venous and dural puncture during epidural
   analgesia in obese parturients (BMI > 40 kg/m(2)): three different body
   positions during insertion (Retracted article. See vol. 23, pg. 601,
   2011)
SO JOURNAL OF CLINICAL ANESTHESIA
LA English
DT Article; Retracted Publication
DE Anesthesia, Complications; Obesity; Patient position; Venous puncture
ID VENA-CAVAL PRESSURE; CATHETER INSERTION; MORBIDLY OBESE; INTRAVASCULAR
   INJECTION; CESAREAN-SECTION; LABORING WOMEN; SPACE; PLACEMENT;
   ANESTHESIA; AIR
AB Study Objective: To assess the frequency of blood vessel punctures in morbidly obese parturients [body mass index (BMI) > 40 kg/m(2)] during epidural catheterization, in three different body positions.
   Design: Prospective, randomized study.
   Setting: Delivery room of a university-affiliated hospital.
   Patients: 347 obese parturients (BMI > 40 kg/m(2)) undergoing continuous epidural analgesia during labor.
   Interventions: Patients were randomized to undergo epidural catheterization in the sitting, lateral recumbent horizontal, or lateral recumbent head-down positions.
   Measurements and Main Results: A lower frequency of epidural venous cannulation was noted when this procedure was performed in the lateral recumbent head-down position (4.8%) than in the lateral recumbent horizontal (11.6%) or sitting position (18.3%) (P = 0.001). Frequency of accidental subarachnoid puncture did not differ significantly (2.5%, 2.6%, and 3.7%), respectively.
   Conclusion: Adoption of the lateral recumbent head-down position for the performance of lumbar epidural blockade in labor at term reduces the frequency of lumbar epidural venous puncture in obese parturients (BMI > 40 kg/m(2)). (C) 2010 Elsevier Inc. All rights reserved.
C1 [Chanimov, Michael; Haitov, Zoya; Stolero, Sorin; Cohen, Mathias L.; Friedland, Mark; Shul, Ina; Bahar, Murat] Assaf Harofeh Med Ctr, Dept Anesthesiol, IL-70300 Zerifin, Israel.
   [Chanimov, Michael; Haitov, Zoya; Stolero, Sorin; Cohen, Mathias L.; Friedland, Mark; Shul, Ina; Bahar, Murat] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel.
   [Evron, Shmuel] Edith Wolfson Med Ctr, Obstet Anesthesia Unit, IL-58100 Holon, Israel.
   [Evron, Shmuel] Cleveland Clin Fdn, Outcomes Res Grp, Cleveland, OH 44195 USA.
RP Bahar, M (reprint author), Assaf Harofeh Med Ctr, Dept Anesthesiol, IL-70300 Zerifin, Israel.
EM fredricag@asaf.health.gov.il
CR Bahar M, 2004, CAN J ANAESTH, V51, P577, DOI 10.1007/BF03018401
   Bahar M, 2001, CAN J ANAESTH, V48, P48, DOI 10.1007/BF03019814
   Banwell BR, 1998, CAN J ANAESTH, V45, P370, DOI 10.1007/BF03012031
   Bell DN, 2007, ANAESTH INTENS CARE, V35, P335
   Bonica JJ, 1995, PRINCIPLES PRACTICE, P427
   BUCKLEY FP, 1983, ANAESTHESIA, V38, P840, DOI 10.1111/j.1365-2044.1983.tb12249.x
   Colonna-Romano P, 1998, ANESTH ANALG, V86, P985
   Crawford JS, 1984, PRINCIPLES PRACTICE, P181
   Evron S, 2004, ANESTH ANALG, V99, P245, DOI 10.1213/01.ane.0000120084.56136.15
   Evron S, 2007, ANESTH ANALG, V105, P460, DOI 10.1213/01.ane.0000267543.39388.3e
   Gadalla F, 2003, CAN J ANAESTH, V50, P382, DOI 10.1007/BF03021036
   Guay J, 2006, ANESTH ANALG, V102, P921, DOI 10.1213/01.ane.0000196687.88590.6b
   Harney D, 2005, EUR J ANAESTH, V22, P103, DOI 10.1017/S0265021505000190
   HOOD DD, 1993, ANESTHESIOLOGY, V79, P1210, DOI 10.1097/00000542-199312000-00011
   LEIGHTON BL, 1987, ANESTHESIOLOGY, V66, P688, DOI 10.1097/00000542-198705000-00017
   MAITRA AM, 1979, ANESTH ANALG, V58, P348
   MICHAEL S, 1989, ANAESTHESIA, V44, P578, DOI 10.1111/j.1365-2044.1989.tb11446.x
   Mulroy MF, 2002, REGION ANESTH PAIN M, V27, P556, DOI 10.1053/rapm.2002.37127
   Paech M, 1999, ANESTH ANALG, V89, P1590, DOI 10.1097/00000539-199912000-00066
   PERLOW JH, 1994, AM J OBSTET GYNECOL, V170, P560, DOI 10.1016/S0002-9378(94)70227-6
   POULSEN H, 1995, HYPERTENSION, V25, P1161, DOI 10.1161/01.HYP.25.6.1161
   SANTOS A, 1984, ANESTH ANALG, V63, P1009
   Schier R, 2009, ANESTH ANALG, V109, P2012, DOI 10.1213/ANE.0b013e3181bc113a
   SCOTT DB, 1963, J OBSTET GYN BR COMM, V70, P1044
   SCOTT DB, 1963, ANAESTHESIA, V18, P135, DOI 10.1111/j.1365-2044.1963.tb13526.x
   Segal S, 2010, ANESTH ANALG, V110, P558, DOI 10.1213/ANE.0b013e3181c84e4e
   SHAH JL, 1982, ANAESTHESIA, V37, P426, DOI 10.1111/j.1365-2044.1982.tb01153.x
   Soens MA, 2008, ACTA ANAESTH SCAND, V52, P6, DOI 10.1111/j.1399-6576.2007.01483.x
   STONE PA, 1990, ANAESTHESIA, V45, P920, DOI 10.1111/j.1365-2044.1990.tb14619.x
   VALENTINE SJ, 1991, BRIT J ANAESTH, V66, P224, DOI 10.1093/bja/66.2.224
   Vincent R D, 1991, Int J Obstet Anesth, V1, P9, DOI 10.1016/0959-289X(91)90023-J
   WATTS RW, 1993, ANAESTH INTENS CARE, V21, P309
NR 32
TC 2
Z9 2
U1 5
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0952-8180
EI 1873-4529
J9 J CLIN ANESTH
JI J. Clin. Anesth.
PD DEC
PY 2010
VL 22
IS 8
BP 614
EP 618
DI 10.1016/j.jclinane.2010.06.004
PG 5
WC Anesthesiology
SC Anesthesiology
GA 695WY
UT WOS:000285404500008
PM 21109134
DA 2018-12-27
ER

PT J
AU Zhou, HF
   Chen, XL
   Fang, LA
   Liu, XB
   Wang, YL
AF Zhou, Huanfu
   Chen, Xiuli
   Fang, Liang
   Liu, Xiaobin
   Wang, Yiliang
TI RETRACTED: Microwave Dielectric Properties of LiBiW2O8 Ceramics with Low
   Sintering Temperature (Retracted article. See vol. 94, pg. 291, 2011)
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article; Retracted Publication
ID SYSTEM; MICROSTRUCTURE
AB Preparation, phase structure, sintering behavior, and microwave dielectric properties of LiBiW2O8 ceramic have been investigated. The LiBiW2O8 ceramic can be well densified in the temperature range from 650 degrees to 750 degrees C for 2-8 h. X-ray diffraction data show that LiBiW2O8 ceramic has a monoclinic structure coupled with a second unknown phase. The LiBiW2O8 ceramic, sintered at 700 degrees C for 2 h, exhibit microwave dielectric properties with permittivity of 26.5, Qxf of 16400 GHz, and temperature coefficient of resonant frequency (tau(f)) of 70 ppm/degrees C. The addition of 30 mol% TiO2 to LiBiW2O8 also results in a ceramic composite exhibiting epsilon(r)similar to 30.2, Q x f similar to 13 000 GHz and tau(f)similar to-9 ppm/oC. However, the reaction between LiBiW2O8 and Ag will affect its further application in low-temperature cofired ceramic.
C1 [Zhou, Huanfu; Chen, Xiuli; Fang, Liang; Liu, Xiaobin; Wang, Yiliang] Guilin Univ Technol, Key Lab Nonferrous Mat & New Proc Technol, Minist Educ, State Key Lab Breeding Base Nonferrous Met & Spec, Guilin 541004, Peoples R China.
RP Zhou, HF (reprint author), Guilin Univ Technol, Key Lab Nonferrous Mat & New Proc Technol, Minist Educ, State Key Lab Breeding Base Nonferrous Met & Spec, Guilin 541004, Peoples R China.
EM zhouhuanfu@163.com
RI Fang, Liang/B-7081-2012
FU Natural Science Foundation of China [50962004, 50762002]; Natural
   Science Foundation of Guangxi [0832003Z, 0832001]; MOE, China
   [NCET-06-0656]
FX This work was supported by Natural Science Foundation of China (No.
   50962004, and No. 50762002), Natural Science Foundation of Guangxi (No.
   0832003Z and No. 0832001), and Program for NCET-06-0656, MOE, China.
CR Borisevich AY, 2002, J AM CERAM SOC, V85, P573
   Borisov S.V., 1968, Kristallografiya, V13, P517
   Chen XM, 2004, J AM CERAM SOC, V87, P2208, DOI 10.1111/j.1151-2916.2004.tb07492.x
   Cho IS, 2007, J EUR CERAM SOC, V27, P3081, DOI 10.1016/j.jeurceramsoc.2006.11.030
   Feteira A, 2008, J AM CERAM SOC, V91, P1338, DOI 10.1111/j.1551-2916.2008.02272.x
   Fu MS, 2008, J AM CERAM SOC, V91, P1163, DOI 10.1111/j.1551-2916.2007.02243.x
   HANUZA J, 1995, J SOLID STATE CHEM, V117, P177, DOI 10.1006/jssc.1995.1261
   Huang CL, 2002, JPN J APPL PHYS 1, V41, P758, DOI [10.1143/JJAP.41.758, 10.1143/JJAP.41.7581]
   Huang CL, 2001, MATER RES BULL, V36, P1985, DOI 10.1016/S0025-5408(01)00677-8
   Kim HJ, 1997, J AM CERAM SOC, V80, P1316
   Kwon DK, 2005, J AM CERAM SOC, V88, P3419, DOI 10.1111/j.1551-2916.2005.00613.x
   Kwon DK, 2005, J CERAM SOC JPN, V113, P216, DOI 10.2109/jcersj.113.216
   Kwon DK, 2007, MATER LETT, V61, P1827, DOI 10.1016/j.matlet.2006.07.141
   Ratheesh R, 1998, J MATER SCI-MATER EL, V9, P291, DOI 10.1023/A:1008828807015
   Shlyakhtin OA, 2006, J AM CERAM SOC, V89, P3366, DOI 10.1111/j.1551-2916.2006.01246.x
   Subodh G, 2007, J AM CERAM SOC, V90, P2266, DOI 10.1111/j.1551-2916.2007.01673.x
   Udovic M, 2004, J AM CERAM SOC, V87, P591, DOI 10.1111/j.1551-2916.2004.00591.x
   Udovic M, 2001, J EUR CERAM SOC, V21, P1735, DOI 10.1016/S0955-2219(01)00105-4
   Valant M, 2004, J EUR CERAM SOC, V24, P1715, DOI 10.1016/S0955-2219(03)00483-7
   Zhang SX, 2001, J MATER SCI LETT, V20, P1409, DOI 10.1023/A:1011647611924
   Zhou D, 2008, J AM CERAM SOC, V91, P3419, DOI 10.1111/j.1551-2916.2008.02596.x
   Zhou HF, 2008, J MATER SCI, V43, P3725, DOI 10.1007/s10853-008-2572-7
NR 22
TC 17
Z9 18
U1 2
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-7820
EI 1551-2916
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD DEC
PY 2010
VL 93
IS 12
BP 3976
EP 3979
DI 10.1111/j.1551-2916.2010.04162.x
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 688KX
UT WOS:000284849300003
DA 2018-12-27
ER

PT J
AU Romero-Vargas, S
   Ruiz-Sandoval, JL
   Sotomayor-Gonzalez, A
   Revuelta-Gutierrez, R
   Celis-Lopez, MA
   Gomez-Amador, JL
   Garcia-Gonzalez, U
   Lopez-Serna, R
   Garcia-Navarro, V
   Mendez-Rosito, D
   Correa-Correa, V
   Gomez-Llata, S
AF Romero-Vargas, Samuel
   Luis Ruiz-Sandoval, Jose
   Sotomayor-Gonzalez, Arturo
   Revuelta-Gutierrez, Rogelio
   Angel Celis-Lopez, Miguel
   Luis Gomez-Amador, Juan
   Garcia-Gonzalez, Ulises
   Lopez-Serna, Raul
   Garcia-Navarro, Victor
   Mendez-Rosito, Diego
   Correa-Correa, Victor
   Gomez-Llata, Sergio
TI RETRACTED: A look at Mayan artificial cranial deformation practices:
   morphological and cultural aspects (Retracted article. See vol.45, artn
   no.E2, 2010)
SO NEUROSURGICAL FOCUS
LA English
DT Article; Retracted Publication
DE Mayan culture; artificial cranial deformation; archaeology
AB Induced deformation of the cranial vault is one form of permanent alteration of the body that has been performed by human beings from the beginning of history as a way of differentiating from others. These procedures have been observed in different cultures, but were particularly widespread in Mesoamerica. The authors examined and reviewed the historical and anthropological literature of intentional deformation practices in Mayan culture. The Mayans performed different types of cranial deformations and used different techniques and instruments to deform children's heads. The most remarkable morphological alteration is seen in the flattening of the frontal bone. Some archeological investigations link deformation types with specific periods. This article provides a glance at the cultural environment of the Mayans and demonstrates the heterogeneity of this interesting cultural phenomenon, which has changed over time. (DOI: 10.3171/2010.9.FOCUS10200)
C1 [Romero-Vargas, Samuel; Sotomayor-Gonzalez, Arturo; Revuelta-Gutierrez, Rogelio; Angel Celis-Lopez, Miguel; Luis Gomez-Amador, Juan; Garcia-Gonzalez, Ulises; Lopez-Serna, Raul; Garcia-Navarro, Victor; Mendez-Rosito, Diego; Correa-Correa, Victor; Gomez-Llata, Sergio] Inst Nacl Neurol & Neurocirugia Manuel Velazco Su, Dept Neurosurg, Mexico City 14269, DF, Mexico.
   [Luis Ruiz-Sandoval, Jose] Univ Guadalajara, Dept Neurol & Neurosurg, Hosp Civil Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.
RP Sotomayor-Gonzalez, A (reprint author), Inst Nacl Neurol & Neurocirugia Manuel Velazco Su, Dept Neurosurg, Insurgentes 3877 Co Fama, Mexico City 14269, DF, Mexico.
EM arturo_sotomayor@hotmail.com
OI Garcia Gonzalez, Ulises/0000-0002-6661-5409; Garcia Navarro,
   Victor/0000-0002-5451-8265
CR ANTON SC, 1989, AM J PHYS ANTHROPOL, V79, P253, DOI 10.1002/ajpa.1330790213
   COE MD, 2002, MEXICO OLMECS AZTECS, P89
   COMAS J, 1957, MANUAL ANTR FISICA, P698
   Dembo A, 1938, DEFORMACIONES INTENC, P329
   DINGWALL EJ, 1931, ARTIFICIAL CRANIAL D, P151
   GERSZTEN PC, 1995, NEUROSURGERY, V37, P374, DOI 10.1227/00006123-199509000-00002
   Joyce R. A., 1998, RES ANTHR AESTHETICS, V33, P147
   Lekovic GP, 2007, NEUROSURGERY, V60, P1137, DOI 10.1227/01.NEU.0000255462.99516.B0
   MARQUEZ L, 1982, COLECCION CIENTIFICA, V119
   OVIEDO GF, 1959, HISTORIA, V4, P71
   ROMANO A, 1987, 1 C INT MAYIST MEX U, P25
   Sotelo Laura, 1992, ESTUDIOS CULTURA MAY, V19, P187
   STEPHENS JL, 1963, INCIDENTS TRAVEL YUC, V1, P161
   STEWART TD, 1949, ANTROPOLOGIA HIST GU, V1, P23
   Taube Karl A., 1992, MAJOR GODS ANCIENT Y
   TIESLER V, 1998, COSTUMBRE DEFORMACIO, P42
   TIESLER V, 1994, DEFORMACION CEFALICA
   Weidenreich F., 1939, Peking Natural History Bulletin, V13, P161
NR 18
TC 8
Z9 9
U1 1
U2 12
PU AMER ASSOC NEUROLOGICAL SURGEONS
PI ROLLING MEADOWS
PA 5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA
SN 1092-0684
J9 NEUROSURG FOCUS
JI Neurosurg. Focus
PD DEC
PY 2010
VL 29
IS 6
AR E2
DI 10.3171/2010.9.FOCUS10200
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 699FI
UT WOS:000285648900003
PM 21121716
OA Bronze
DA 2018-12-27
ER

PT J
AU Chen, T
   Wu, LL
   Yang, XD
   Chen, G
AF Chen, Ting
   Wu, Lili
   Yang, Xudong
   Chen, Ge
TI RETRACTED: Impact Force of Water Jets in the Hydroentanglement Nonwoven
   Process: Numerical Simulation and Experimental Verification (Retracted
   article. See vol. 51, pg. 1906, 2011)
SO POLYMER ENGINEERING AND SCIENCE
LA English
DT Article; Retracted Publication
ID NOZZLE GEOMETRY; FLOW
AB The water jet flow model in the hydroentanglement nonwoven process is established and solved numerically. The impact force of water jets is calculated with aid of the model and verified with the experimental data. The numerical simulation results of the impact force coincide with the experimental data, which confirms the effectiveness of the two-dimensional model established. Computer simulations and experiments show that higher water jet pressure, smaller water jet inclination angle, and smaller standoff distance will yield larger impact force. The results show that there is great potential for this research in field of computer-assisted design in hydroentanglement technology and equipment. POLYM. ENG. SCI., 50:2425-2430, 2010. (C) 2010 Society of Plastics Engineers
C1 [Chen, Ting; Wu, Lili] Soochow Univ, Natl Engn Lab Modern Silk, Coll Text & Clothing Engn, Suzhou 215021, Peoples R China.
   [Yang, Xudong] Donghua Univ, Coll Text, Shanghai 201620, Peoples R China.
   [Chen, Ge] Donghua Univ, Coll Mech Engn, Shanghai 201620, Peoples R China.
RP Chen, T (reprint author), Soochow Univ, Natl Engn Lab Modern Silk, Coll Text & Clothing Engn, Suzhou 215021, Peoples R China.
EM tingchen@suda.edu.cn
FU Foundation for the Author of National Excellent Doctoral Dissertation of
   China [200761]; Fok Ying Tune Education Foundation [111076]; National
   Natural Science Foundation of China [50506007]; Natural Science
   Foundation of Jiangsu Province [BK2009123]; National Engineering
   Laboratory for Modem Silk, Soochow University
FX Contract grant sponsor: Foundation for the Author of National Excellent
   Doctoral Dissertation of China; contract grant number: 200761; contract
   grant sponsor: Fok Ying Tune Education Foundation; contract grant
   number: 111076; contract grant sponsor: National Natural Science
   Foundation of China; contract grant number: 50506007; contract grant
   sponsor: Natural Science Foundation of Jiangsu Province; contract grant
   number: BK2009123; contract grant sponsor: National Engineering
   Laboratory for Modem Silk, Soochow University.
CR Begenir A, 2004, TEXT RES J, V74, P178, DOI 10.1177/004051750407400215
   Ghassemieh E, 2003, TEXT RES J, V73, P444, DOI 10.1177/004051750307300512
   HONG CP, 2004, SER MAT SCI ENGN, pR11
   SHEN Z, 1998, THEORY TECHNOLOGY WA, P125
   Tafreshi HV, 2004, TEXT RES J, V74, P359
   Tafreshi HV, 2003, TEXT RES J, V73, P700, DOI 10.1177/004051750307300807
   Tafreshi HV, 2003, TEXT RES J, V73, P256, DOI 10.1177/004051750307300310
   WILCOX DC, 1994, TURBULENCE MODELING, P89
NR 8
TC 1
Z9 1
U1 2
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0032-3888
EI 1548-2634
J9 POLYM ENG SCI
JI Polym. Eng. Sci.
PD DEC
PY 2010
VL 50
IS 12
BP 2425
EP 2430
DI 10.1002/pen.21775
PG 6
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 686UU
UT WOS:000284722600017
DA 2018-12-27
ER

PT J
AU Trampe, D
   Stapel, DA
   Siero, FW
   Mulder, H
AF Trampe, Debra
   Stapel, Diederik A.
   Siero, Frans W.
   Mulder, Henriette
TI RETRACTED: Beauty as a Tool: The Effect of Model Attractiveness, Product
   Relevance, and Elaboration Likelihood on Advertising Effectiveness
   (Retracted article. See vol. 29, pg. 805, 2012)
SO PSYCHOLOGY & MARKETING
LA English
DT Article; Retracted Publication
ID MATCH-UP HYPOTHESIS; THIN MEDIA IMAGES; PHYSICAL ATTRACTIVENESS;
   MODERATING ROLE; INFORMATION; INVOLVEMENT; PERSUASION; ATTITUDE;
   SPOKESPERSON; PERSPECTIVE
AB Although it seems intuitively appealing that physically attractive models constitute useful advertising tools, the existing literature on the topic has yielded inconsistent findings with regard to the conditions under which physically attractive models affect product attitudes favorably. The current research aimed to examine the role of elaboration likelihood and product relevance in predicting the advertising effectiveness of physically attractive models. Two experiments are reported that suggest that when elaboration likelihood is high, product relevance is consequential: An attractive model that advertises a product that is relevant for physical attractiveness affects product attitudes more favorably than does an attractive model that advertises a product that is less relevant for attractiveness. In contrast, when elaboration likelihood is low, relevance of the model for the product was observed to be inconsequential for product attitudes. (C) 2010 Wiley Periodicals, Inc.
C1 [Trampe, Debra] Univ Groningen, Dept Mkt, NL-9700 AV Groningen, Netherlands.
   [Stapel, Diederik A.] Tilburg Univ, Tilburg, Netherlands.
RP Trampe, D (reprint author), Univ Groningen, Dept Mkt, POB 800, NL-9700 AV Groningen, Netherlands.
EM D.Trampe@rug.nl
CR Bower AB, 2001, J ADVERTISING, V30, P1
   Bower AB, 2001, J ADVERTISING, V30, P51, DOI 10.1080/00913367.2001.10673645
   CABALLERO MJ, 1984, J ADVERTISING, V13, P17, DOI 10.1080/00913367.1984.10672870
   CABALLERO MJ, 1984, J MARKETING, V48, P94, DOI 10.2307/1251315
   CABALLERO MJ, 1989, J ADVERTISING RES, V29, P16
   CHAIKEN S, 1980, J PERS SOC PSYCHOL, V39, P752, DOI 10.1037/0022-3514.39.5.752
   CHAIKEN S, 1994, J PERS SOC PSYCHOL, V66, P460, DOI 10.1037//0022-3514.66.3.460
   Chaiken S., 1987, SOCIAL INFLUENCE ONT, V5, P3
   CHAIKEN S, 1979, J PERS SOC PSYCHOL, V39, P1387
   Cialdini R. B., 1987, SOCIAL INFLUENCE ONT, V5, P165
   DION K, 1972, J PERS SOC PSYCHOL, V24, P285, DOI 10.1037/h0033731
   Garner D. M., 1997, PSYCHOL TODAY, V30, P30
   Groesz LM, 2002, INT J EAT DISORDER, V31, P1, DOI 10.1002/eat.10005
   Hafner M, 2009, J CONSUM PSYCHOL, V19, P619, DOI 10.1016/j.jcps.2009.06.004
   Higgins ET, 1996, SOCIAL PSYCHOL HDB B, P133
   JOHNSON BT, 1989, PSYCHOL BULL, V106, P290, DOI 10.1037//0033-2909.106.2.290
   KAHLE LR, 1985, J CONSUM RES, V11, P954, DOI 10.1086/209029
   KAMINS MA, 1990, J ADVERTISING, V19, P4, DOI 10.1080/00913367.1990.10673175
   KAMINS MA, 1994, PSYCHOL MARKET, V11, P569, DOI 10.1002/mar.4220110605
   Kang YS, 2006, J CONSUM RES, V33, P123, DOI 10.1086/504143
   Kirmani Amna, 1998, J CONSUM PSYCHOL, V7, P25, DOI DOI 10.1207/S15327663JCP0701_02
   Koernig SK, 2002, PSYCHOL MARKET, V19, P91, DOI 10.1002/mar.1003
   MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19
   MAHESWARAN D, 1991, J PERS SOC PSYCHOL, V61, P13, DOI 10.1037//0022-3514.61.1.13
   Mills JS, 2002, PERS SOC PSYCHOL B, V28, P1687, DOI 10.1177/014616702237650
   MINIARD PW, 1991, J CONSUM RES, V18, P92, DOI 10.1086/209244
   Petty R, 1999, DUAL PROCESS THEORIE, P37
   Petty R. E., 1998, HDB SOCIAL PSYCHOL, V2, P323
   PETTY RE, 1983, J CONSUM RES, V10, P135, DOI 10.1086/208954
   PETTY RE, 1980, J PERS SOC PSYCHOL, V38, P81, DOI 10.1037//0022-3514.38.1.81
   Petty RE, 1998, SOC COGNITION, V16, P93, DOI 10.1521/soco.1998.16.1.93
   Petty Richard E, 1986, ADV EXPT SOCIAL PSYC, V19, P123, DOI DOI 10.1016/S0065-2601(08)60214-2
   Reingen P. H., 1993, J CONSUM PSYCHOL, V2, P25, DOI DOI 10.1016/S1057-7408(08)80073-3
   Schwarz N, 2006, J CONSUM RES, V33, P19, DOI 10.1086/504124
   SCOTT LM, 1994, J CONSUM RES, V21, P252, DOI 10.1086/209396
   Sheeran Paschal, 2002, J CONSUM PSYCHOL, V12, P1, DOI DOI 10.1016/S1057-7408(08)80002-2
   Smeesters D, 2006, J CONSUM RES, V32, P576, DOI 10.1086/500489
   STAATS AW, 1958, J ABNORM SOC PSYCH, V57, P37, DOI 10.1037/h0042782
   Till BD, 2000, J ADVERTISING, V29, P1
   Trampe D, 2007, J PERS SOC PSYCHOL, V92, P106, DOI 10.1037/0022-3514.92.1.106
NR 40
TC 24
Z9 26
U1 4
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-6046
EI 1520-6793
J9 PSYCHOL MARKET
JI Psychol. Mark.
PD DEC
PY 2010
VL 27
IS 12
BP 1101
EP 1121
DI 10.1002/mar.20375
PG 21
WC Business; Psychology, Applied
SC Business & Economics; Psychology
GA 678BO
UT WOS:000284043300002
DA 2018-12-27
ER

PT J
AU Sternberg, RJ
AF Sternberg, Robert J.
TI RETRACTED: WICS: A new model for school psychology (Retracted article.
   See vol. 39, pg. 329, 2018)
SO SCHOOL PSYCHOLOGY INTERNATIONAL
LA English
DT Article; Retracted Publication
DE creativity; intelligence; wisdom; admissions; identification;
   instruction
ID SUCCESSFUL INTELLIGENCE; ARCHITECTURE; ASSESSMENTS; ADMISSIONS;
   SETTINGS; RAINBOW
AB This article presents a unified model for cognitive processing, WICS, which is an acronym for wisdom, intelligence, and creativity, synthesized. The model can be applied to identification/admissions, diagnosis, instruction, and assessment. I discuss why there is a need for such a model. Then I describe traditional models, after which I describe the WICS model. The article attempts to show how the WICS model can be applied to admissions/identification as well as to instruction and assessment.
C1 Oklahoma State Univ, Stillwater, OK 74078 USA.
RP Sternberg, RJ (reprint author), Oklahoma State Univ, Whitehurst 101, Stillwater, OK 74078 USA.
EM robert.sternberg@gmx.com
CR Anderson J. R., 1983, ARCHITECTURE COGNITI
   Anderson J. R., 1993, RULES MIND
   ANDERSON JR, 1991, PSYCHOL REV, V98, P409, DOI 10.1037/0033-295X.98.3.409
   Baltes PB, 1997, AM PSYCHOL, V52, P366, DOI 10.1037/0003-066X.52.4.366
   Binet A., 1916, DEV INTELLIGENCE CHI
   BORKOWSKI JG, 1979, HDB MENTAL DEFICIENC, P569
   Bouchard TJ, 1998, HUM BIOL, V70, P257
   BUTTERFIELD EC, 1977, PSYCHOL DEV DISABILI
   CAMPIONE JC, 1982, HDB HUMAN INTELLIGEN, P392
   Carroll J. B, 1993, HUMAN COGNITIVE ABIL
   Cattell J. M., 1890, MIND, V15, P373, DOI DOI 10.1093/MIND/OS-XV.59.373
   Cattell RB., 1971, ABILITIES THEIR STRU
   Chart H., 2008, CRITICAL ISSUES PRAC, P281
   Deary I. J., 2000, HDB INTELLIGENCE, P267, DOI DOI 10.1017/CB09780511807947.014
   DEMETRIOU A, 1993, MONOGR SOC RES CHILD, V58, pR5
   Dewey J, 1997, EXPERIENCE ED
   Dickens C., 1854, HARD TIMES THESE TIM
   DUNLOSKI J, 2008, METACOGNITION TXB CO
   FEUERSTEIN R, 1980, INSTRUMENTAL ENRICHM
   Feuerstein R, 1979, DYNAMIC ASSESSMENT R
   FLAVELL JH, 1992, DEV PSYCHOL, V28, P998, DOI 10.1037/0012-1649.28.6.998
   Galton F, 1883, INQUIRY HUMAN FACULT
   Gardner H., 1993, MULTIPLE INTELLIGENC
   Gardner H., 1983, FRAMES MIND THEORY M
   Gardner H, 1999, ED INFORMATION TRANS, P111
   Gopnik A, 1997, WORDS THOUGHTS THEOR
   GOSWAMI U, 1996, ADV CHILD DEV BEHAV, V26
   Grigorenko E., 2008, PSYCHOL SCI Q, V50, P295
   Grigorenko EL, 2002, CONTEMP EDUC PSYCHOL, V27, P167, DOI 10.1006/ceps.2001.1087
   GUILFORD JP, 1982, PSYCHOL REV, V89, P48, DOI 10.1037//0033-295X.89.1.48
   Gustafsson J. E., 1988, ADV PSYCHOL HUMAN IN, V4, P35
   Hedlund J, 2006, LEARN INDIVID DIFFER, V16, P101, DOI 10.1016/j.lindif.2005.07.005
   Herrnstein Richard, 1994, BELL CURVE
   HEZLETT S, 2001, EFFECTIVENESS SAT PR
   Horn J. L., 1994, ENCY HUMAN INTELLIGE, V1, P443
   HUNT EG, 1973, PSYCHOL LEARN MOTIV, V87, P87
   Jensen AR, 1998, G FACTOR SCI MENTAL
   McNeil NM, 2009, LEARN INSTR, V19, P171, DOI 10.1016/j.learninstruc.2008.03.005
   Ravitch D., 2009, BOSTON GLOBE, V276, pA15
   ROID G, 2006, STANFORD BINET INTEL
   SCHAIE KW, 1986, DEV PSYCHOL, V22, P223, DOI 10.1037//0012-1649.22.2.223
   Siegler R., 1989, CHILDREN DISCOVER NE
   Siegler R. S., 1996, EMERGING MINDS PROCE
   Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107
   Spearman C., 1927, ABILITIES MAN
   Stemler SE, 2006, CONTEMP EDUC PSYCHOL, V31, P344, DOI 10.1016/j.cedpsych.2005.11.001
   Stemler SE, 2009, CONTEMP EDUC PSYCHOL, V34, P195, DOI 10.1016/j.cedpsych.2009.04.001
   Sternberg R., 2010, COLL ADMISSIONS 21 C
   Sternberg R, 1997, SUCCESSFUL INTELLIGE
   Sternberg R. J, 1995, DEFYING CROWD CULTIV
   Sternberg R. J., 2000, PRACTICAL INTELLIGEN
   Sternberg R. J., 2007, CHRON HIGHER EDUC, V53, pB11
   Sternberg R. J., 2003, WISDOM INTELLIGENCE
   Sternberg R. J., 2006, COLL U, V81, P17
   Sternberg R. J., 1996, DEV STUDENT CREATIVI
   Sternberg R. J., 2007, TEACHING SUCCESSFUL
   Sternberg RJ, 1998, J EDUC PSYCHOL, V90, P374, DOI 10.1037//0022-0663.90.3.374
   Sternberg RJ, 2001, EDUC PSYCHOL, V36, P227, DOI 10.1207/S15326985EP3604_2
   Sternberg RJ, 1999, EUR J PSYCHOL ASSESS, V15, P3, DOI 10.1027//1015-5759.15.1.3
   STERNBERG RJ, 2005, HDB WISDOM PSYCHOL P, P331
   Sternberg RJ, 2002, GEN FACTOR INTELLIGE
   Sternberg RJ, 2006, INTELLIGENCE, V34, P321, DOI 10.1016/j.intell.2006.01.002
   Sternberg RJ, 2009, TEACHING FOR WISDOM: CROSS-CULTURAL PERSPECTIVES ON FOSTERING WISDOM, P37, DOI 10.1007/978-1-4020-6532-3_3
   Sternberg RJ, 2009, EUR PSYCHOL, V14, P279, DOI 10.1027/1016-9040.14.4.279
   Sternberg RJ, 2008, PERSPECT PSYCHOL SCI, V3, P486, DOI 10.1111/j.1745-6924.2008.00095.x
   Thurstone L. L., 1938, PRIMARY MENTAL ABILI
   Vernon P. E, 1971, STRUCTURE HUMAN ABIL
   Wechsler D., 2003, MANUAL WECHSLER INTE
   WISSLER C, 2001, PSYCHOL REV MONOGR S, V3
NR 69
TC 12
Z9 12
U1 0
U2 8
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0143-0343
EI 1461-7374
J9 SCHOOL PSYCHOL INT
JI Sch. Psychol. Int.
PD DEC
PY 2010
VL 31
IS 6
SI SI
BP 599
EP 616
DI 10.1177/0143034310386534
PG 18
WC Psychology, Educational
SC Psychology
GA 696PW
UT WOS:000285454900004
DA 2018-12-27
ER

PT J
AU Li, HL
   Takai, N
   Yuge, A
   Furukawa, Y
   Tsuno, A
   Tsukamoto, Y
   Kong, S
   Moriyama, M
   Narahara, H
AF Li, Haili
   Takai, Noriyuki
   Yuge, Akitoshi
   Furukawa, Yuichi
   Tsuno, Akitoshi
   Tsukamoto, Yoshiyuki
   Kong, Shigi
   Moriyama, Masatsugu
   Narahara, Hisashi
TI RETRACTED: Novel target genes responsive to the anti-growth activity of
   triptolide in endometrial and ovarian cancer cells (Retracted article.
   See vol. 338, pg. 331, 2013)
SO CANCER LETTERS
LA English
DT Article; Retracted Publication
DE Triptolide; Cell cycle; Apoptosis; Microarray; Gynecologic cancer
ID GASTRIC-CANCER; R-CADHERIN; EXPRESSION; METASTASIS; INHIBITORS;
   AMINOPEPTIDASES; TRANSFORMATION; APOPTOSIS; PATHWAY; TUMORS
AB Triptolide (TPL), a bioactive component of the Chinese medicinal herb Tripterygium wilfordii Hook F, induces apoptosis in some lines of human tumor cells. However, the effect of TPL on gynecologic cancer cells has not yet been well-described. We investigated the effects of TPL on cell growth, cell cycle, and apoptosis in endometrial and ovarian cancer cell lines. Furthermore, we examined global changes in gene expression after treatment with TPL. By using a list of 20 differentially expressed genes, Western blot analyses were performed on five endometrial and ovarian cancer cell lines. All cell lines were sensitive to the growth-inhibitory effect of TPL. TPL increased the proportion of cells in the S-phase of the cell cycle and induced apoptosis. cDNA microarray assay demonstrated that the treatment with TPL changed the expression of cell cycle regulators, apoptosis-related factors and cell proliferation markers. Of the gene expression changes induced by TPL treatment, up-regulation of LRAP, CDH4, and SFRP1 and down-regulation of cystatin, TNNT 1, and L1-CAM were confirmed using Western blot analysis in all the cell lines examined. We found a strong anticancer activity of TPL and identified some potential target genes of this drug, raising hopes that TPL may become a useful therapy for endometrial and ovarian cancers. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
C1 [Li, Haili; Takai, Noriyuki; Yuge, Akitoshi; Furukawa, Yuichi; Tsuno, Akitoshi; Narahara, Hisashi] Oita Univ, Fac Med, Dept Obstet & Gynecol, Yufu, Oita 8795593, Japan.
   [Li, Haili] Hebei Med Univ, Hosp 4, Dept Obstet & Gynecol, Shijiazhuang, Peoples R China.
   [Tsukamoto, Yoshiyuki; Moriyama, Masatsugu] Oita Univ, Fac Med, Dept Mol Pathol, Yufu, Oita 8795593, Japan.
   [Kong, Shigi] Oita Univ, Fac Med, Dept Neurosurg, Yufu, Oita 8795593, Japan.
RP Takai, N (reprint author), Oita Univ, Fac Med, Dept Obstet & Gynecol, 1-1 Idaigaoka,Hasama Machi, Yufu, Oita 8795593, Japan.
EM takai@med.oita-u.ac.jp
FU Japan Society of Gynecologic Oncology [FK344]; Ministry of Education,
   Culture, Sports, Science, and Technology, Japan [21592139]; Oita
   University
FX The study was supported by a Grant (Project code FK344 to NT) from the
   Japan Society of Gynecologic Oncology, a Grant-in-Aid (No. 21592139 to
   NT) for Scientific Research from the Ministry of Education, Culture,
   Sports, Science, and Technology, Japan and a Research Fund at the
   Discretion of the President, Oita University.
CR Agiostratidou G, 2009, CANCER RES, V69, P5030, DOI 10.1158/0008-5472.CAN-08-4007
   Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020
   Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180
   BARRETT AJ, 1986, BIOMED BIOCHIM ACTA, V45, P1363
   Basso D, 2004, GUT, V53, P1159, DOI 10.1136/gut.2003.024471
   Carter BZ, 2006, BLOOD, V108, P630, DOI 10.1182/blood-2005-09-3898
   Chen Y, 2001, CANCER RES, V61, P6437
   Choi EH, 2009, CLIN CHIM ACTA, V406, P45, DOI 10.1016/j.cca.2009.05.008
   Chung MT, 2009, GYNECOL ONCOL, V112, P646, DOI 10.1016/j.ygyno.2008.10.026
   Fruci D, 2006, J IMMUNOL, V176, P4869, DOI 10.4049/jimmunol.176.8.4869
   Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051
   Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760
   Kiviharju TM, 2002, CLIN CANCER RES, V8, P2666
   Kucharczak J, 2008, CANCER RES, V68, P6559, DOI 10.1158/0008-5472.CAN-08-0196
   KUPCHAN SM, 1972, J AM CHEM SOC, V94, P7194, DOI 10.1021/ja00775a078
   LIM SS, 1986, J CELL SCI, V85, P1
   Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099
   Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636
   Miotto E, 2004, CANCER RES, V64, P8156, DOI 10.1158/0008-5472.CAN-04-3000
   Obel Jennifer C, 2006, Clin Adv Hematol Oncol, V4, P459
   Qin W Z, 1983, J Tradit Chin Med, V3, P131
   Qiu Daoming, 2003, Drugs R D, V4, P1, DOI 10.2165/00126839-200304010-00001
   Qiu DM, 1999, J BIOL CHEM, V274, P13443, DOI 10.1074/jbc.274.19.13443
   Reinhardt M. J., 2008, V170, P141
   Rimon G, 1997, J NEUROSCI RES, V48, P563, DOI 10.1002/(SICI)1097-4547(19970615)48:6<563::AID-JNR9>3.0.CO;2-8
   SJODIN A, 1995, EXP CELL RES, V221, P413, DOI 10.1006/excr.1995.1392
   Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330
   Takai N, 2004, CLIN CANCER RES, V10, P1141, DOI 10.1158/1078-0432.CCR-03-0100
   Takai N, 2008, GYNECOL ONCOL, V109, P107, DOI 10.1016/j.ygyno.2007.12.020
   Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200
   TAO XL, 1989, CHINESE MED J-PEKING, V102, P327
   Wang Q, 2001, ANAT REC, V263, P72, DOI 10.1002/ar.1078
   Westfall SD, 2008, CHEMOTHERAPY, V54, P67, DOI 10.1159/000112419
   Winter WE, 2008, J CLIN ONCOL, V26, P83, DOI 10.1200/JCO.2007.13.1953
   Xu B, 2010, CANCER LETT, V291, P200, DOI 10.1016/j.canlet.2009.10.013
   Yang SM, 2003, MOL CANCER THER, V2, P65
NR 36
TC 19
Z9 26
U1 4
U2 15
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3835
EI 1872-7980
J9 CANCER LETT
JI Cancer Lett.
PD NOV 28
PY 2010
VL 297
IS 2
BP 198
EP 206
DI 10.1016/j.canlet.2010.05.012
PG 9
WC Oncology
SC Oncology
GA 661IX
UT WOS:000282720900008
PM 20547442
DA 2018-12-27
ER

PT J
AU Bokhan, D
   Ten-no, S
AF Bokhan, Denis
   Ten-no, Seiichiro
TI RETRACTED: Explicitly correlated equation-of-motion coupled-cluster
   methods for excited and electron-attached states (Retracted Article. See
   vol 134, ARTN 109901, 2011)
SO JOURNAL OF CHEMICAL PHYSICS
LA English
DT Article; Retracted Publication
ID CONNECTED TRIPLE EXCITATIONS; BASIS-SETS; NUMERICAL QUADRATURES;
   PERTURBATION-THEORY; CORRELATION CUSP; FULL INCLUSION; IONIZED STATES;
   WAVE-FUNCTIONS; EOM-CCSDT; ENERGIES
AB Based on the linearly approximated F12 coupled cluster singles and doubles [CCSD(F12)] model, equation-of-motion [EOM-CCSD(F12)] methods for electron affinities (EAs) and excitation energies (EEs) have been formulated and implemented. Extended electron-attachment and excitation operators are introduced for balanced descriptions of both neutral and electron-attached (or excited) states. In our implementation the cusp conditions are used for the definition of extended electron-attachment (excitation) operators. It is shown that EA-EOM-CCSD(F12) provides vertical electron affinities accurate to 0.1 eV compared to those in the complete basis set limit. Numerical tests conducted on a selection of small molecules have also shown notable improvement in Rydberg excitation energies compared to valence ones by the use of correlation factors. (C) 2010 American Institute of Physics. [doi:10.1063/1.3505637]
C1 [Bokhan, Denis; Ten-no, Seiichiro] Kobe Univ, Grad Sch Engn, Nada Ku, Kobe, Hyogo 6578501, Japan.
   [Ten-no, Seiichiro] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan.
RP Bokhan, D (reprint author), Kobe Univ, Grad Sch Engn, Nada Ku, Kobe, Hyogo 6578501, Japan.
EM denisbokhan@mail.ru
FU Japan Society for the Promotion of Science (JSPS) [P08348]
FX This work was funded by the Japan Society for the Promotion of Science
   (JSPS) under the Grant No. P08348.
CR Alder TB, 2007, J CHEM PHYS, V127
   Bak KL, 2001, J CHEM PHYS, V114, P6548, DOI 10.1063/1.1357225
   BARTLETT RJ, 1994, REV COMP CH, V5, P65, DOI 10.1002/9780470125823.ch2
   Bokhan D, 2008, PHYS CHEM CHEM PHYS, V10, P3320, DOI 10.1039/b803426p
   Bokhan D, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3291042
   Bokhan D, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3212884
   Bokhan D, 2009, CHEM PHYS LETT, V469, P214, DOI 10.1016/j.cplett.2008.12.054
   DelBene JE, 1997, J CHEM PHYS, V106, P6051, DOI 10.1063/1.473245
   Hattig C, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3442368
   Helgaker T, 1997, J CHEM PHYS, V106, P9639, DOI 10.1063/1.473863
   Helgaker T, 2008, MOL PHYS, V106, P2107, DOI 10.1080/00268970802258591
   KATO T, 1957, COMMUN PUR APPL MATH, V10, P151, DOI 10.1002/cpa.3160100201
   KLOPPER W, 1991, CHEM PHYS LETT, V186, P583, DOI 10.1016/0009-2614(91)90471-K
   Klopper W, 2002, J CHEM PHYS, V116, P6397, DOI 10.1063/1.1461814
   Klopper W, 2006, INT REV PHYS CHEM, V25, P427, DOI 10.1080/01442350600799921
   Knizia G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3054300
   KOCH H, 1990, J CHEM PHYS, V93, P3333, DOI 10.1063/1.458814
   Kohn A, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3116792
   Kohn A, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3079543
   Kohn A, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3028546
   KUTZELNIGG W, 1991, J CHEM PHYS, V94, P1985, DOI 10.1063/1.459921
   MONKHORST HJ, 1977, INT J QUANTUM CHEM, P421
   MUKHERJEE D, 1979, CHEM PHYS, V39, P325, DOI 10.1016/0301-0104(79)80153-6
   MUKHOPADHYAY D, 1991, THEOR CHIM ACTA, V80, P483
   Musial M, 2003, J CHEM PHYS, V119, P1901, DOI 10.1063/1.1584657
   Musial M, 2003, J CHEM PHYS, V118, P1128, DOI 10.1063/1.1527013
   NAKATSUJI H, 1978, CHEM PHYS LETT, V59, P362
   NAKATSUJI H, 1978, J CHEM PHYS, V68, P2053, DOI 10.1063/1.436028
   Neiss C, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2335443
   NOGA J, 1994, J CHEM PHYS, V101, P7738, DOI 10.1063/1.468266
   Noga J, 2001, J CHEM PHYS, V115, P2022, DOI 10.1063/1.1384011
   Noga J, 2000, CHEM PHYS LETT, V324, P166, DOI 10.1016/S0009-2614(00)00600-X
   NOGA J, 1997, RECENT ADV COUPLED C
   Noga J, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2907741
   NOOIJEN M, 1995, J CHEM PHYS, V102, P6735, DOI 10.1063/1.469147
   Nooijen M, 1997, J CHEM PHYS, V107, P6812, DOI 10.1063/1.474922
   NOOIJEN M, 1993, INT J QUANTUM CHEM, V48, P15, DOI 10.1002/qua.560480103
   NOOIJEN M, 1995, J CHEM PHYS, V102, P3629, DOI 10.1063/1.468592
   PACK RT, 1966, J CHEM PHYS, V45, P556, DOI 10.1063/1.1727605
   Shiozaki T, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2967181
   SINHA D, 1989, CHEM PHYS LETT, V154, P544, DOI 10.1016/0009-2614(89)87149-0
   STANTON JF, 1993, J CHEM PHYS, V98, P7029, DOI 10.1063/1.464746
   STANTON JF, 1994, J CHEM PHYS, V101, P8938, DOI 10.1063/1.468022
   Ten-No S, 2004, CHEM PHYS LETT, V398, P56, DOI 10.1016/j.cplett.2004.09.041
   Ten-no S, 2004, J CHEM PHYS, V121, P117, DOI 10.1063/1.1757439
   Ten-No S, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2403853
   Ten-no S, 2007, CHEM PHYS LETT, V447, P175, DOI 10.1016/j.cplett.2007.09.006
   Tew DP, 2008, CHEM PHYS LETT, V452, P326, DOI 10.1016/j.cplett.2007.12.070
   Tew DP, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2338037
   Tew DP, 2007, PHYS CHEM CHEM PHYS, V9, P1921, DOI 10.1039/b617230j
   Tew DP, 2010, MOL PHYS, V108, P315, DOI 10.1080/00268970903449388
   Tew DP, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1999632
   Torheyden M, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3254836
   Valeev EF, 2008, PHYS CHEM CHEM PHYS, V10, P106, DOI 10.1039/b713938a
   Valeev EF, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2403852
   Valeev EF, 2004, CHEM PHYS LETT, V395, P190, DOI 10.1016/j.cplett.2004.07.061
   Valiron P, 2003, CHEM PHYS LETT, V367, P723, DOI 10.1016/S0009-2614(02)01788-8
   Wilke JJ, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3269031
   WOON DE, 1995, J CHEM PHYS, V103, P4572, DOI 10.1063/1.470645
   Yang J, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3093947
NR 60
TC 5
Z9 5
U1 3
U2 17
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0021-9606
J9 J CHEM PHYS
JI J. Chem. Phys.
PD NOV 28
PY 2010
VL 133
IS 20
AR 204103
DI 10.1063/1.3505637
PG 7
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 690LB
UT WOS:000285005200004
PM 21133437
DA 2018-12-27
ER

PT J
AU Taylor, AW
   Price, K
   Gill, TK
   Adams, R
   Pilkington, R
   Carrangis, N
   Shi, ZM
   Wilson, D
AF Taylor, Anne W.
   Price, Kay
   Gill, Tiffany K.
   Adams, Robert
   Pilkington, Rhiannon
   Carrangis, Natalie
   Shi, Zumin
   Wilson, David
TI RETRACTED: Multimorbidity - not just an older person's issue. Results
   from an Australian biomedical study (Retracted article. See vol. 46, pg.
   351, 2011)
SO BMC PUBLIC HEALTH
LA English
DT Article; Retracted Publication
ID MULTIPLE CHRONIC CONDITIONS; MEASURE COMORBIDITY; ELDERLY POPULATION;
   CHRONIC DISEASES; PREVALENCE; PATTERNS; QUALITY; CONSEQUENCES; ADULTS;
   COSTS
AB Background: Multimorbidity, the simultaneous occurrence of two or more chronic conditions, is usually associated with older persons. This research assessed multimorbidity across a range of ages so that planners are informed and appropriate prevention programs, management strategies and health service/health care planning can be implemented.
   Methods: Multimorbidity was assessed across three age groups from data collected in a major biomedical cohort study (North West Adelaide Health Study). Using randomly selected adults, diabetes, asthma, and chronic obstructive pulmonary disease were determined clinically and cardio-vascular disease, osteoporosis, arthritis and mental health by self-report (ever been told by a doctor). A range of demographic, social, risk and protective factors including high blood pressure and high cholesterol (assessed bio-medically), health service use, quality of life and medication use (linked to government records) were included in the multivariate modelling.
   Results: Overall 4.4% of the 20-39 year age group, 15.0% of the 40-59 age group and 39.2% of those aged 60 years of age or older had multimorbidity (17.1% of the total). Of those with multimorbidity, 42.1% were aged less than 60 years of age. A variety of variables were included in the final logistic regression models for the three age groups including family structure, marital status, education attainment, country of birth, smoking status, obesity measurements, medication use, health service utilisation and overall health status.
   Conclusions: Multimorbidity is not just associated with older persons and flexible care management support systems, appropriate guidelines and care-coordination programs are required across a broader age range. Issues such as health literacy and polypharamacy are also important considerations. Future research is required into assessing multimorbidity across the life course, prevention of complications and assessment of appropriate self-care strategies.
C1 [Taylor, Anne W.; Gill, Tiffany K.; Pilkington, Rhiannon; Carrangis, Natalie; Shi, Zumin] S Australian Dept Hlth, Adelaide, SA, Australia.
   [Taylor, Anne W.; Gill, Tiffany K.; Shi, Zumin] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia.
   [Price, Kay] Univ S Australia, Sch Nursing & Midwifery, Adelaide, SA 5001, Australia.
   [Adams, Robert; Wilson, David] Univ Adelaide, Queen Elizabeth Hosp, Hlth Observ, Adelaide, SA, Australia.
RP Taylor, AW (reprint author), S Australian Dept Hlth, Adelaide, SA, Australia.
EM anne.taylor@health.sa.gov.au
RI Taylor, Anne/F-5708-2010; Gill, Tiffany/F-9042-2010; Shi,
   Zumin/A-1093-2009; Price, Kay/B-1755-2009
OI Taylor, Anne/0000-0002-4422-7974; Gill, Tiffany/0000-0002-2822-2436;
   Shi, Zumin/0000-0002-3099-3299; Price, Kay/0000-0002-3161-422X
CR Appleton SL, 2005, J ALLERGY CLIN IMMUN, V116, P976, DOI 10.1016/j.jaci.2005.08.034
   Bayliss EA, 2008, FAM PRACT, V25, P287, DOI 10.1093/fampra/cmn040
   Bayliss Elizabeth A, 2003, Ann Fam Med, V1, P15, DOI 10.1370/afm.4
   Bodenheimer T, 2005, ANN INTERN MED, V143, P26, DOI 10.7326/0003-4819-143-1-200507050-00007
   Britt HC, 2008, MED J AUSTRALIA, V189, P72
   Chittleborough CR, 2006, QUAL LIFE RES, V15, P687, DOI 10.1007/s11136-005-3570-8
   CORDELIUS A, 2008, ARCH GERONTOL GERIAT, V46, P41
   de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1
   Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272
   Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2
   Gill T, 2003, SOZ PRAVENTIV MED, V48, P191, DOI 10.1007/s00038-003-2055-1
   Grant Janet F, 2006, Epidemiol Perspect Innov, V3, P4, DOI 10.1186/1742-5573-3-4
   GRANT JF, 2008, INT J EPIDEMIOL, P1
   HOSMER DW, 2000, APPL LOGISTIC REGRES, P2
   Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337
   Keizer I, 2009, ADDICT BEHAV, V34, P815, DOI 10.1016/j.addbeh.2009.03.018
   Loeb SJ, 2003, WESTERN J NURS RES, V25, P8, DOI 10.1177/0193945902238830
   Marengoni A, 2008, AM J PUBLIC HEALTH, V98, P1198, DOI 10.2105/AJPH.2007.121137
   Marengoni A, 2009, J AM GERIATR SOC, V57, P225, DOI 10.1111/j.1532-5415.2008.02109.x
   McCormick WC, 2005, J AM GERIATR SOC, V53, P2227, DOI 10.1111/j.1532-5415.2005.00504.x
   Mercer SW, 2009, FAM PRACT, V26, P79, DOI 10.1093/fampra/cmp020
   Nagel G, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-384
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rozzini R, 2004, J CLIN EPIDEMIOL, V57, P321, DOI 10.1016/j.jclinepi.2003.08.001
   Schram MT, 2008, J CLIN EPIDEMIOL, V61, P1104, DOI 10.1016/j.jclinepi.2007.11.021
   Smith SM, 2007, BRIT J GEN PRACT, V57, P268
   Starfield Barbara, 2003, Ann Fam Med, V1, P8, DOI 10.1370/afm.1
   Taylor AW, 2006, AUST NZ J PUBL HEAL, V30, P238, DOI 10.1111/j.1467-842X.2006.tb00864.x
   Taylor AW, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-11
   TAYLOR AW, 2010, AUSTR NZ J PUBLIC HE
   Tooth L, 2008, J CLIN EPIDEMIOL, V61, P151, DOI 10.1016/j.jclinepi.2007.05.015
   Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1
   Wehling M, 2009, J AM GERIATR SOC, V57, P560, DOI 10.1111/j.1532-5415.2009.02131.x
   Wilon D, 2005, CHEST, V128, P2035, DOI 10.1378/chest.128.4.2035
NR 34
TC 102
Z9 102
U1 2
U2 27
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD NOV 22
PY 2010
VL 10
AR 718
DI 10.1186/1471-2458-10-718
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 693YC
UT WOS:000285260300001
PM 21092218
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Niture, SK
   Jaiswal, AK
AF Niture, Suryakant K.
   Jaiswal, Anil K.
TI RETRACTED: Hsp90 Interaction with INrf2(Keap1) Mediates Stress-induced
   Nrf2 Activation (Retracted article. See vol. 289, pg. 11568, 2014)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID CUL3-BASED E3 LIGASE; HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE; OXIDATIVE
   STRESS; GENE-EXPRESSION; BINDING SITE; LUNG-CANCER; KINASE-C; KEAP1;
   COMPLEX
AB INrf2(Keap1) functions as an adapter for Cul3/Rbx1-mediated degradation of Nrf2. In response to stress, Nrf2 is released from INrf2 and translocates inside the nucleus leading to activation of cytoprotective proteins critical in protection against adverse effects including cancer. We demonstrate here a novel role of heat shock protein 90 (Hsp90) in control of the INrf2 and Nrf2 activation. Hsp90 interacted with INrf2 that leds to stabilization of INrf2 during heat shock stress. Domain mapping showed the requirement of INrf2-NTR and the Hsp90-CLD region for interaction of Hsp90 with INrf2. Heat shock and antioxidants induced Hsp90, and casein kinase 2 (CK2) phosphorylated INrf2Thr55. This led to increased Hsp90-INrf2 interaction, dissociation of the Rbx1/Cul3 center dot INrf2 center dot Nrf2 complex, and activation of Nrf2. Inhibitors of CK2 and Hsp90, and mutation of INrf2Thr55 abolished the Hsp90-INrf2 interaction and downstream signaling. INrf2 is released from Hsp90 once the heat shock or antioxidant stress subsidized, thereby allowing INrf2 to interact with Nrf2 and facilitate Nrf2 ubiquitination and degradation. The results together demonstrate a novel role for the stress-induced Hsp90-INrf2 interaction in regulation of Nrf2 activation and induction of cytoprotective proteins.
C1 [Niture, Suryakant K.; Jaiswal, Anil K.] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA.
RP Jaiswal, AK (reprint author), 655 W Baltimore St, Baltimore, MD 21201 USA.
EM ajaiswal@som.umaryland.edu
FU National Institutes of Health [RO1 ES012265]
FX This work was supported, in whole or in part, by National Institutes of
   Health Grant RO1 ES012265.
CR Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200
   Brown MA, 2007, BIOCHEM BIOPH RES CO, V363, P241, DOI 10.1016/j.bbrc.2007.08.054
   Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0
   Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006
   Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501
   Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8
   Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004
   Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0
   Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102
   Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05
   Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200
   JAISWAL AK, 2004, Biol Med, V36, P1199
   Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035
   Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004
   Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200
   Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200
   Lee OH, 2007, J BIOL CHEM, V282, P36412, DOI 10.1074/jbc.M706517200
   Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200
   MINAMI Y, 1991, J BIOL CHEM, V266, P10099
   MIYATA Y, 1992, J BIOL CHEM, V267, P7042
   Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009
   Niture SK, 2009, J CELL SCI, V122, P4452, DOI 10.1242/jcs.058537
   Niture SK, 2009, J BIOL CHEM, V284, P13856, DOI 10.1074/jbc.M808084200
   Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013
   Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640
   Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1
   Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420
   Soti C, 2003, EUR J BIOCHEM, V270, P2421, DOI 10.1046/j.1432-1033.2003.03610.x
   Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2
   Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/vmvi056
   Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101
   Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248
   Wang W, 2006, FREE RADICAL BIO MED, V40, P1119, DOI 10.1016/j.freeradbiomed.2005.10.063
   WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0
   Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004
   Zhang R, 2005, ONCOGENE, V24, P3954, DOI 10.1038/sj.onc.1208548
NR 36
TC 28
Z9 29
U1 2
U2 10
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 19
PY 2010
VL 285
IS 47
BP 36865
EP 36875
DI 10.1074/jbc.M110.175802
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 679FE
UT WOS:000284146100087
PM 20864537
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Akimoto, C
   Ueda, T
   Inoue, K
   Yamaoka, I
   Sakari, M
   Obara, W
   Fujioka, T
   Nagahara, A
   Nonomura, N
   Tsutsumi, S
   Aburatani, H
   Miki, T
   Matsumoto, T
   Kitagawa, H
   Kato, S
AF Akimoto, Chihiro
   Ueda, Takashi
   Inoue, Kazuki
   Yamaoka, Ikuko
   Sakari, Matomo
   Obara, Wataru
   Fujioka, Tomoaki
   Nagahara, Akira
   Nonomura, Norio
   Tsutsumi, Syuichi
   Aburatani, Hiroyuki
   Miki, Tsuneharu
   Matsumoto, Takahiro
   Kitagawa, Hirochika
   Kato, Shigeaki
TI RETRACTED: Testis-specific protein on Y chromosome (TSPY) represses the
   activity of the androgen receptor in androgen-dependent testicular
   germ-cell tumors (Retracted article. See vol. 111, pg. 2398, 2014)
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article; Retracted Publication
DE gonadoblastoma; repressor; NEC8; seminoma; nonseminoma
ID PROSTATE-CANCER; NUCLEAR RECEPTOR; GENE; TRANSCRIPTION; EXPRESSION;
   COREGULATORS; SPERMATOGENESIS; GONADOBLASTOMA; SEQUENCE; REQUIRES
AB Testis-specific protein on Y chromosome (TSPY) is an ampliconic gene on the Y chromosome, and genetic interaction with gonadoblastoma has been clinically established. However, the function of the TSPY protein remains to be characterized in physiological and pathological settings. In the present study, we observed coexpression of TSPY and the androgen receptor (AR) in testicular germ-cell tumors (TGCTs) in patients as well as in model cell lines, but such coexpression was not seen in normal testis of humans or mice. TSPY was a repressor for androgen signaling because of its trapping of cytosolic AR even in the presence of androgen. Androgen treatment stimulated cell proliferation of a TGCT model cell line, and TSPY potently attenuated androgen-dependent cell growth. Together with the finding that TSPY expression is reduced in more malignant TGCTs in vivo, the present study suggests that TSPY serves as a repressor in androgen-induced tumor development in TGCTs and raises the possibility that TSPY could be used as a clinical marker to assess the malignancy of TGCTs.
C1 [Akimoto, Chihiro; Ueda, Takashi; Inoue, Kazuki; Yamaoka, Ikuko; Sakari, Matomo; Matsumoto, Takahiro; Kitagawa, Hirochika; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.
   [Ueda, Takashi; Miki, Tsuneharu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Urol, Kyoto 6028566, Japan.
   [Yamaoka, Ikuko; Matsumoto, Takahiro; Kato, Shigeaki] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan.
   [Obara, Wataru; Fujioka, Tomoaki] Iwate Med Univ, Sch Med, Dept Urol, Morioka, Iwate 0205111, Japan.
   [Nagahara, Akira; Nonomura, Norio] Osaka Univ, Grad Sch Med, Dept Urol, Suita, Osaka 5650871, Japan.
   [Tsutsumi, Syuichi; Aburatani, Hiroyuki] Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Div, Meguro Ku, Tokyo 1538904, Japan.
   [Kitagawa, Hirochika] Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gumma 3718512, Japan.
RP Kato, S (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.
EM uskato@mail.ecc.u-tokyo.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology; Japan
   Society for the Promotion of Science
FX We thank all the members of our laboratory for their help and
   discussion. We also thank Mai Yamaki for manuscript handling. This work
   was supported in part by grants from the Ministry of Education, Culture,
   Sports, Science and Technology (to H. K., and S. K.). This work also was
   supported in part by Japan Society for the Promotion of Science Research
   Fellowships for Young Scientists (to C. A.).
CR Akimoto C, 2008, GENES CELLS, V13, P623, DOI 10.1111/j.1365-2443.2008.01193.x
   Bartkova J, 2003, APMIS, V111, P252, DOI 10.1034/j.1600-0463.2003.1110129.x
   BARZELL WE, 1979, SEMIN ONCOL, V6, P48
   Chmelar R, 2007, INT J CANCER, V120, P719, DOI 10.1002/ijc.22365
   de Wit R, 2006, J CLIN ONCOL, V24, P5482, DOI 10.1200/JCO.2006.07.9434
   HALL RE, 1994, EUR J CANCER, V30A, P484, DOI 10.1016/0959-8049(94)90424-3
   Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019
   Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750
   Hildenbrand R, 1999, J PATHOL, V189, P623, DOI 10.1002/(SICI)1096-9896(199912)189:4<623::AID-PATH475>3.0.CO;2-#
   Jiang M, 2009, MOL ENDOCRINOL, V23, P1927, DOI 10.1210/me.2009-0103
   Kato S, 2004, J STEROID BIOCHEM, V89-90, P627, DOI 10.1016/j.jsbmb.2004.03.099
   Kim HS, 1996, AM J PHYS ANTHROPOL, V100, P301
   Kim J, 2004, J CELL BIOCHEM, V93, P233, DOI 10.1002/jcb.20228
   Lau YFC, 1999, AM J HUM GENET, V64, P921, DOI 10.1086/302353
   Looijenga LHJ, 2007, ANN NY ACAD SCI, V1120, P187, DOI 10.1196/annals.1411.000
   Lupien M, 2009, ENDOCR-RELAT CANCER, V16, P381, DOI 10.1677/ERC-09-0038
   MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X
   Mazeyrat S, 1998, HUM MOL GENET, V7, P557, DOI 10.1093/hmg/7.3.557
   Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626
   Miyamoto J, 2007, MOL CELL BIOL, V27, P4807, DOI 10.1128/MCB.02039-06
   Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025
   Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568
   Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680
   Rahman M, 2004, CLIN CANCER RES, V10, P2208, DOI 10.1158/1078-0432.CCR-0746-3
   Rao MK, 2003, MOL ENDOCRINOL, V17, P223, DOI 10.1210/me.2002-0232
   Rapley E, 2007, INT J ANDROL, V30, P242, DOI 10.1111/j.1365-2605.2007.00778.x
   Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754
   Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806
   Sato T, 2004, P NATL ACAD SCI USA, V101, P1673, DOI 10.1073/pnas.0305303101
   Sato T, 2003, BIOCHEM BIOPH RES CO, V300, P167, DOI 10.1016/S0006-291X(02)02774-2
   Schnieders F, 1996, HUM MOL GENET, V5, P1801, DOI 10.1093/hmg/5.11.1801
   Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722
   Takayama K, 2007, ONCOGENE, V26, P4453, DOI 10.1038/sj.onc.1210229
   Vijayakumar S, 2006, CANCER RES, V66, P4055, DOI 10.1158/0008-5472.CAN-05-3822
   Vogt PH, 2004, MOL CELL ENDOCRINOL, V224, P1, DOI 10.1016/j.mce.2004.06.008
   Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041
   Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056
   Wang RS, 2009, ENDOCR REV, V30, P119, DOI 10.1210/er.2008-0025
   Yanagisawa J, 2002, MOL CELL, V9, P553, DOI 10.1016/S1097-2765(02)00478-1
NR 39
TC 18
Z9 19
U1 1
U2 18
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 16
PY 2010
VL 107
IS 46
BP 19891
EP 19896
DI 10.1073/pnas.1010307107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 680UT
UT WOS:000284261800054
PM 21041627
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Wu, YQ
   Huang, FL
AF Wu, Y. Q.
   Huang, F. L.
TI RETRACTED: Frictional properties of single crystals HMX, RDX and PETN
   explosives (Retracted article. See vol. 194, pg. 447, 2011)
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article; Retracted Publication
DE Secondary explosive crystals; Coefficient of friction; Environmental
   scanning electron; microscopy
AB The frictional properties of single crystals of cyclotetramethylene tetranitramine (HMX), cyclotrimethylene trinitramine (RDX) and pentaerythritol tetranitrate (PETN) secondary explosives are examined using a sensitive friction machine. The explosive crystals used for the measurements are at least 3.5 mm wide. The friction coefficients between crystals of the same explosive (i.e., HMX on HMX, etc.), crystals of different explosives (i.e., HMX on RDX, etc.), and each explosive and a well-polished gauge steel surface are determined. The frictional surfaces are also studied under an environmental scanning electron microscope (ESEM) to analyze surface microstructural changes under increasing loading forces. The friction coefficients vary considerably with increasing normal loading forces and are particularly sensitive to slider shapes, crystal roughness and the mechanical properties of both the slider and the sample. With increasing loading forces, most friction experiments show surface damage, consisting of grooves, debris, and nano-particles, on both the slider and sample. In some cases, a strong evidence of a localized molten state is found in the central region of the friction track. Possible mechanisms that affect the friction coefficient are discussed based on microscopic observations. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Wu, Y. Q.; Huang, F. L.] Beijing Inst Technol, State Key Lab Explos Sci & Technol, Beijing 100081, Peoples R China.
RP Wu, YQ (reprint author), Beijing Inst Technol, State Key Lab Explos Sci & Technol, Beijing 100081, Peoples R China.
EM wuyqing@bit.edu.cn
FU Cavendish Laboratory, University of Cambridge; Chinese National Nature
   Science Foundation [10832003, 10902016]; State Key Laboratory of Science
   and Technology in Beijing Institute of Technology [ZDKT10-03A]
FX The authors would like to thank Dr. M.M. Chaudhri of the Cavendish
   Laboratory, University of Cambridge, the Chinese National Nature Science
   Foundation (Grant No. 10832003 and No. 10902016), and the State Key
   Laboratory of Science and Technology in Beijing Institute of Technology
   (Project No. ZDKT10-03A)
CR AMUZU JKA, 1976, J PHYS D APPL PHYS, V9, P133, DOI 10.1088/0022-3727/9/1/019
   DICKSON PM, 2005, P AIP C P SHOCK COMP, P1057
   Dienes JK, 2006, J MECH PHYS SOLIDS, V54, P1237, DOI 10.1016/j.jmps.2005.12.001
   Dienes JK, 2004, AIP CONF PROC, V706, P447
   Molinari A, 1999, J TRIBOL-T ASME, V121, P35, DOI 10.1115/1.2833808
   PETERSON PD, 2007, AIP C P SHOCK COMPRE, P983
   Thimoshenko S, 1951, THEORY ELASTICITY
   WIEGAND DA, 2009, AIP C P SHOCK COMPRE, P349
   Zuo QH, 2005, INT J SOLIDS STRUCT, V42, P1309, DOI 10.1016/j.ijsolstr.2004.08.003
NR 9
TC 13
Z9 15
U1 3
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
EI 1873-3336
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD NOV 15
PY 2010
VL 183
IS 1-3
BP 324
EP 333
DI 10.1016/j.jhazmat.2010.07.027
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 659ZY
UT WOS:000282607600041
PM 20688432
DA 2018-12-27
ER

PT J
AU Sung, BK
   Ravindran, J
   Prasad, S
   Pandey, MK
   Aggarwal, BB
AF Sung, Bokyung
   Ravindran, Jayaraj
   Prasad, Sahdeo
   Pandey, Manoj K.
   Aggarwal, Bharat B.
TI RETRACTED: Gossypol Induces Death Receptor-5 through Activation of the
   ROS-ERK-CHOP Pathway and Sensitizes Colon Cancer Cells to TRAIL
   (Retracted article. See vol. 291, pg. 16923, 2016)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID NF-KAPPA-B; INDUCED APOPTOSIS; MEDIATED APOPTOSIS; UP-REGULATION;
   CARCINOMA-CELLS; LIGAND TRAIL; APO-2 LIGAND; EXPRESSION; MITOCHONDRIA;
   APO2L/TRAIL
AB Development of resistance to TRAIL, an apoptosis-inducing cytokine, is one of the major problems in its development for cancer treatment. Thus, pharmacological agents that are safe and can sensitize the tumor cells to TRAIL are urgently needed. We investigated whether gossypol, a BH3 mimetic that is currently in the clinic, can potentiate TRAIL-induced apoptosis. Intracellular esterase activity, sub-G(1) cell cycle arrest, and caspase-8, -9, and -3 activity assays revealed that gossypol potentiated TRAIL-induced apoptosis in human colon cancer cells. Gossypol also down-regulated cell survival proteins (BclxL, Bcl-2, survivin, XIAP, and cFLIP) and dramatically up-regulated TRAIL death receptor (DR)-5 expression but had no effect on DR4 and decoy receptors. Gossypol-induced receptor induction was not cell type-specific, as DR5 induction was observed in other cell types. Deletion of DR5 by siRNA significantly reduced the apoptosis induced by TRAIL and gossypol. Gossypol induction of the death receptor required the induction of CHOP, and thus, gene silencing of CHOP abolished gossypol-induced DR5 expression and associated potentiation of apoptosis. ERK1/2 (but not p38 MAPK or JNK) activation was also required for gossypol-induced TRAIL receptor induction; gene silencing of ERK abolished both DR5 induction and potentiation of apoptosis by TRAIL. We also found that reactive oxygen species produced by gossypol treatment was critical for TRAIL receptor induction and apoptosis potentiation. Overall, our results show that gossypol enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and the up-regulation of TRAIL death receptors through the ROS-ERK-CHOP-DR5 pathway.
C1 [Sung, Bokyung; Ravindran, Jayaraj; Prasad, Sahdeo; Pandey, Manoj K.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA.
RP Aggarwal, BB (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, 1515 Holcombe Blvd, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI Aggarwal, Bharat/G-3388-2013; Pandey, Manoj/K-9706-2015
OI Pandey, Manoj/0000-0002-2767-2929
FU National Institutes of Health [CA-16672]; M.D. Anderson Center for
   Targeted Therapy;  [CA-124787-01A2]
FX This work was supported, in whole or in part, by National Institutes of
   Health Core Grant CA-16672 and Program Project Grant CA-124787-01A2.
   This work was also supported by a grant from the M.D. Anderson Center
   for Targeted Therapy.
CR Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270
   Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184
   Aggarwal BB, 2004, VITAM HORM, V67, P453
   Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198
   Azuhata T, 2006, J PEDIATR SURG, V41, P1431, DOI 10.1016/j.jpedsurg.2006.04.020
   Balakrishnan K, 2009, BLOOD, V113, P149, DOI 10.1182/blood-2008-02-138560
   Bhardwaj A, 2003, J CLIN IMMUNOL, V23, P317, DOI 10.1023/A:1025319031417
   Bodmer JL, 2000, NAT CELL BIOL, V2, P241
   Cheson BD, 2009, CURR OPIN HEMATOL, V16, P299, DOI 10.1097/MOH.0b013e32832ad69a
   Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4
   DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165
   El-Deiry WS, 2001, CELL DEATH DIFFER, V8, P1066, DOI 10.1038/sj.cdd.4400943
   Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363
   Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj/onc/1205258
   Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936
   Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129
   Inoue S, 2004, CELL DEATH DIFFER, V11, pS193, DOI 10.1038/sj.cdd.4401535
   Kim H, 2006, CANCER RES, V66, P1740, DOI 10.1158/0008-5472.CAN-05-1568
   Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z
   Kroemer G, 1998, CELL DEATH DIFFER, V5, P547, DOI 10.1038/sj.cdd.4400387
   LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187
   Lu M, 2008, CANCER RES, V68, P1180, DOI 10.1158/0008-5472.CAN-07-2978
   Marsters SA, 1996, CURR BIOL, V6, P750, DOI 10.1016/S0960-9822(09)00456-4
   Moon DO, 2008, CANCER LETT, V264, P192, DOI 10.1016/j.canlet.2008.01.030
   Nguyen DM, 2006, CANCER J, V12, P257, DOI 10.1097/00130404-200607000-00004
   Oliver CL, 2005, MOL CANCER THER, V4, P23
   Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815
   Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687
   Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096
   Reed JC, 2005, BLOOD, V106, P408, DOI 10.1182/blood-2004-07-2761
   Sandur SK, 2007, CARCINOGENESIS, V28, P1765, DOI 10.1093/carcin/bgm123
   Sarker M, 2001, CELL DEATH DIFFER, V8, P172, DOI 10.1038/sj.cdd.4400791
   Seol DW, 2001, CANCER RES, V61, P1138
   Shenoy K, 2009, CANCER RES, V69, P1941, DOI 10.1158/0008-5472.CAN-08-1996
   Siegelin MD, 2009, NEUROCHEM INT, V55, P423, DOI 10.1016/j.neuint.2009.04.011
   Siegelin MD, 2008, MOL CANCER THER, V7, P3566, DOI 10.1158/1535-7163.MCT-08-0236
   Song JJ, 2007, J BIOL CHEM, V282, P319, DOI 10.1074/jbc.M608065200
   STEIN RC, 1992, CANCER CHEMOTH PHARM, V30, P480, DOI 10.1007/BF00685601
   Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209
   Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386
   Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141
   WU YW, 1989, CANCER RES, V49, P3754
   Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200
   Yeow WS, 2006, J THORAC CARDIOV SUR, V132, P1356, DOI 10.1016/j.jtcvs.2006.07.025
   Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161
   Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693
   Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792
   Zhang MC, 2003, BIOCHEM PHARMACOL, V66, P93, DOI 10.1016/S0006-2952(03)00248-X
   Zhang XC, 2003, J BIOL CHEM, V278, P22061, DOI 10.1074/jbc.M301858200
   Zhu HB, 2005, CANCER BIOL THER, V4, P393
   Ziauddin MF, 2006, NEOPLASIA, V8, P446, DOI 10.1593/neo.05823
NR 51
TC 74
Z9 74
U1 2
U2 11
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 12
PY 2010
VL 285
IS 46
BP 35418
EP 35427
DI 10.1074/jbc.M110.172767
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 675QK
UT WOS:000283845300019
PM 20837473
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Alberts, B
AF Alberts, Bruce
TI RETRACTED: Editorial Expression of Concern (Retracted article. See vol.
   333, pg. 404, 2011)
SO SCIENCE
LA English
DT Letter; Retracted Publication
CR Sebastiani Paola, 2010, Science, V2010, DOI 10.1126/science.1190532
NR 1
TC 8
Z9 9
U1 0
U2 20
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD NOV 12
PY 2010
VL 330
IS 6006
BP 912
EP 912
DI 10.1126/science.330.6006.912-b
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 678XY
UT WOS:000284118000014
PM 21071647
OA Bronze
DA 2018-12-27
ER

PT J
AU Harland, CW
   Bradley, MJ
   Parthasarathy, R
AF Harland, Christopher W.
   Bradley, Miranda J.
   Parthasarathy, Raghuveer
TI RETRACTED: Phospholipid bilayers are viscoelastic (Retracted article.
   See vol. 108, pg. 14705, 2011)
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article; Retracted Publication
DE complex fluids; biomaterials; soft condensed matter
ID COMPLEX FLUIDS; 2-POINT MICRORHEOLOGY; PARTICLE TRACKING;
   LIPID-MEMBRANES; DIFFUSION; MICROSCOPY; PROTEINS; MOBILITY; DOMAINS;
   MODULI
AB Lipid bilayers provide the structural framework for cellular membranes, and their character as two-dimensional fluids enables the mobility of membrane macromolecules. Though the existence of membrane fluidity is well established, the nature of this fluidity remains poorly characterized. Three-dimensional fluids as diverse as chocolates and cytoskeletal networks show a rich variety of Newtonian and non-Newtonian dynamics that have been illuminated by contemporary rheological techniques. Applying particle-tracking microrheology to freestanding phospholipid bilayers, we find that the membranes are not simply viscous but rather exhibit viscoelasticity, with an elastic modulus that dominates the response above a characteristic frequency that diverges at the fluid-gel (L(alpha) - L(beta)) phase-transition temperature. These findings fundamentally alter our picture of the nature of lipid bilayers and the mechanics of membrane environments.
C1 [Parthasarathy, Raghuveer] Univ Oregon, Dept Phys, Inst Mat Sci, Eugene, OR 97403 USA.
   Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.
RP Parthasarathy, R (reprint author), Univ Oregon, Dept Phys, Inst Mat Sci, Eugene, OR 97403 USA.
EM raghu@uoregon.edu
RI Parthasarathy, Raghuveer/A-5958-2008
OI Parthasarathy, Raghuveer/0000-0002-6006-4749
FU Alfred P. Sloan Foundation; Office of Naval Research through the Oregon
   Nanoscience and Microtechnologies Institute; National Science Foundation
   [1006171, 0742540, 0622620]
FX We thank Jennifer Curtis, John Toner, and Eric Weeks for useful
   discussions. This work was supported by the Alfred P. Sloan Foundation
   (R.P.), the Office of Naval Research through the Oregon Nanoscience and
   Microtechnologies Institute (R.P. and C.W.H.), and the National Science
   Foundation via Awards 1006171 (to R.P.), 0742540 (to C.W.H.), and
   0622620 (to M.J.B.).
CR BARNES GT, 2005, INTERFACIAL SCI INTR
   Caggioni M, 2007, J RHEOL, V51, P851, DOI 10.1122/1.2751385
   Cicuta P, 2007, J PHYS CHEM B, V111, P3328, DOI 10.1021/jp0702088
   CLEGG RM, 1985, PROGR PROTEIN LIPID, P344
   Collins MD, 2008, P NATL ACAD SCI USA, V105, P124, DOI 10.1073/pnas.0702970105
   CRAWFORD GE, 1987, BIOPHYS J, V52, P87, DOI 10.1016/S0006-3495(87)83191-0
   Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217
   Crocker JC, 2000, PHYS REV LETT, V85, P888, DOI 10.1103/PhysRevLett.85.888
   Crocker JC, 2007, METHOD CELL BIOL, V83, P141, DOI 10.1016/S0091-679X(07)83007-X
   Edidin M, 2003, NAT REV MOL CELL BIO, V4, P414, DOI 10.1038/nrm1102
   Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103
   Gardel M. L, 2005, MICROSCALE DIAGNOSTI, P1, DOI DOI 10.1007/3-540-26449-3_1
   Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844
   HUGHES BD, 1981, J FLUID MECH, V110, P349, DOI 10.1017/S0022112081000785
   Kandar AK, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041504
   Levine AJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.061606
   Marsh D, 1990, CRC HDB LIPID BILAYE
   Mason TG, 2000, RHEOL ACTA, V39, P371, DOI 10.1007/s003970000094
   Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282
   MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250
   Naji A, 2007, BIOPHYS J, V93, pL49, DOI [10.1529/biophysj.107.119222, 10.1529/biophysj.l07.119222]
   Owen DM, 2009, TRAFFIC, V10, P962, DOI 10.1111/j.1600-0854.2009.00908.x
   PETERS R, 1982, P NATL ACAD SCI-BIOL, V79, P4317, DOI 10.1073/pnas.79.14.4317
   Petrov EP, 2008, BIOPHYS J, V94, pL41, DOI 10.1529/biophysj.107.126565
   Prasad V, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.176001
   SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111
   Schnurr B, 1997, MACROMOLECULES, V30, P7781, DOI 10.1021/ma970555n
   SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720
   Ursell TS, 2009, P NATL ACAD SCI USA, V106, P13301, DOI 10.1073/pnas.0903825106
   Waigh TA, 2005, REP PROG PHYS, V68, P685, DOI 10.1088/0034-4885/68/3/R04
   WHITE SH, 1978, BIOPHYS J, V23, P337, DOI 10.1016/S0006-3495(78)85453-8
NR 31
TC 28
Z9 28
U1 2
U2 28
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 9
PY 2010
VL 107
IS 45
BP 19146
EP 19150
DI 10.1073/pnas.1010700107
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 677MZ
UT WOS:000283997800006
PM 20974934
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Wu, XB
   Xu, TQ
   Atkinson, JP
AF Wu, Xiaobo
   Xu, Thomas Q.
   Atkinson, John P.
TI RETRACTED: Properdin homeostasis requires turnover of the alternative
   complement pathway (Retracted article. See vol. 108, pg. 10372, 2011)
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article; Retracted Publication
DE innate immunity; C3; neutrophil; regulators of complement activation
ID FACTOR-H; MICE DEFICIENT; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS;
   POSITIVE REGULATOR; T-CELLS; ACTIVATION; C3B; PROTEIN; EXPRESSION;
   SYSTEM
AB Properdin is a plasma protein and is also released from neutrophil granules following stimulation. At inflammatory sites it can bind bacteria and apoptotic bodies to trigger alternative pathway (AP) activation. Principles governing properdin homeostasis are unknown. We monitored properdin during AP activation and in complement-deficient mice. There was a > 90% reduction of properdin in the Crry single-knockout mice (Crry SKO). These membrane complement regulatory protein-deficient mice feature accelerated AP turnover, leading to reduced C3 and fB. Injecting cobra venom factor into wild-type mice activated the AP and led to the consumption of C3, fB, and properdin. However, and unexpectedly, properdin was also deficient in C3(-/-), fB(-/-), and fD(-/-) mice. It was present in C1q(-/-), C4(-/-), and C5(-/-) mice. These findings implicate AP turnover in the maintenance of basal levels of properdin in the blood. To explore the mechanism, classical pathway-activating immune complexes were infused. Within 10 min, properdin was partially restored in fB(-/-) but not in C3(-/-) mice. Markedly reduced properdin in mice deficient in an AP component and its partial restoration by activating C3 suggest a requirement for continuous C3 activation via AP tickover to maintain properdin homeostasis. The mechanism underlying this C3-dependent process was not identified. Engagement of C3a and C5a receptors was ruled out. These findings represent an instructive example of how a positive regulator of an innate immune recognition and effector pathway is controlled. A rationale for such a means to supply properdin for immune reactions is proposed.
C1 [Wu, Xiaobo; Xu, Thomas Q.; Atkinson, John P.] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA.
RP Atkinson, JP (reprint author), Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA.
EM jatkinso@dom.wustl.edu
FU National Institutes of Health [AI037618, AI041592]
FX We thank Kathy Liszewski and Dennis Hourcade for a critical review of
   the report; Lorraine Schwartz and Madonna Bogacki for assistance with
   manuscript preparation; Scott Drouin (University of Texas, Houston) for
   the C3aR<SUP>-/-</SUP> sera; Bao Lu and Craig Gerard (Children's
   Hospital, Boston) for the C3aR<SUP>-/-</SUP> C5aR<SUP>-/-</SUP> sera;
   and Jessie Zhang for assistance with irradiation. This work was
   supported by National Institutes of Health Grants AI037618 and AI041592.
CR ALPER CA, 1970, J CLIN INVEST, V49, pA3
   ATKINSON JP, 1978, CLIN IMMUNOL IMMUNOP, V9, P350, DOI 10.1016/0090-1229(78)90106-X
   Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56
   Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1
   Drouin SM, 2001, J IMMUNOL, V166, P2025, DOI 10.4049/jimmunol.166.3.2025
   FARRIES TC, 1989, J IMMUNOL, V142, P842
   FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856
   Ferreira VP, 2010, IMMUNOBIOLOGY, V215, P932, DOI 10.1016/j.imbio.2010.02.002
   GANU VS, 1989, MOL IMMUNOL, V26, P939, DOI 10.1016/0161-5890(89)90112-0
   GOUNDIS D, 1989, GENOMICS, V5, P56, DOI 10.1016/0888-7543(89)90085-2
   Haas PJ, 2007, IMMUNOL RES, V37, P161, DOI 10.1007/BF02697367
   HOGASEN K, 1995, J CLIN INVEST, V95, P1054, DOI 10.1172/JCI117751
   Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105
   Kemper C, 2010, ANNU REV IMMUNOL, V28, P131, DOI 10.1146/annurev-immunol-030409-101250
   KIM YU, 1995, J EXP MED, V181, P151, DOI 10.1084/jem.181.1.151
   Kimura Y, 2008, BLOOD, V111, P732, DOI 10.1182/blood-2007-05-089821
   KOHLER PF, 1972, J CLIN INVEST, V51, P868, DOI 10.1172/JCI106881
   KOHLER PF, 1969, SCIENCE, V163, P474, DOI 10.1126/science.163.3866.474
   Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2
   LEVY M, 1986, KIDNEY INT, V30, P949, DOI 10.1038/ki.1986.278
   Liszewski MK, 1996, ADV IMMUNOL, V61, P201
   LOPEZLARREA C, 1987, BIOCHEM SOC T, V15, P648, DOI 10.1042/bst0150648
   Mao DL, 2003, IMMUNITY, V19, P813, DOI 10.1016/S1074-7613(03)00321-2
   Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720
   Miwa T, 2007, MOL IMMUNOL, V44, P139, DOI 10.1016/j.molimm.2006.06.023
   Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357
   MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321
   Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912
   PILLEMER L, 1954, SCIENCE, V120, P279, DOI 10.1126/science.120.3112.279
   Riley-Vargas RC, 2005, J CLIN INVEST, V115, P1241, DOI 10.1172/JCI200523213
   Ruseva MM, 2009, MOL IMMUNOL, V46, P803, DOI 10.1016/j.molimm.2008.09.003
   SCHWAEBLE W, 1993, J IMMUNOL, V151, P2521
   SCHWAEBLE W, 1994, EUR J BIOCHEM, V219, P759, DOI 10.1111/j.1432-1033.1994.tb18555.x
   Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600
   Suny XJ, 1999, P NATL ACAD SCI USA, V96, P628, DOI 10.1073/pnas.96.2.628
   THOMPSON RA, 1981, CLIN EXP IMMUNOL, V46, P110
   WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490
   Wirthmueller U, 1997, J IMMUNOL, V158, P4444
   WONG WW, 1985, J IMMUNOL, V134, P4048
   Wu XB, 2000, J IMMUNOL, V165, P3119, DOI 10.4049/jimmunol.165.6.3119
   Wu XB, 2008, J IMMUNOL, V181, P2732, DOI 10.4049/jimmunol.181.4.2732
   Xiang Y, 2007, ARTHRITIS RHEUM-US, V56, P2018, DOI 10.1002/art.22645
   Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498
   Xu W, 2008, J IMMUNOL, V180, P7613, DOI 10.4049/jimmunol.180.11.7613
   Xu YY, 2001, P NATL ACAD SCI USA, V98, P14577, DOI 10.1073/pnas.261428398
   ZIEGLER JB, 1975, J CLIN INVEST, V55, P668, DOI 10.1172/JCI107975
NR 46
TC 3
Z9 3
U1 1
U2 13
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 9
PY 2010
VL 107
IS 45
BP 19444
EP 19448
DI 10.1073/pnas.1006608107
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 677MZ
UT WOS:000283997800058
PM 20974943
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Yu, JH
   Hua, YE
AF Yu, Jia Huan
   Hua, Yang En
TI RETRACTED: The Application of ISMD in Development of White ECC
   (Retracted article. See vol. 10, pg. 279, 2011)
SO JOURNAL OF ASIAN ARCHITECTURE AND BUILDING ENGINEERING
LA English
DT Article; Retracted Publication
DE engineered cementitious composites; panel; ISMD; mechanical properties;
   micromechanics
ID CEMENTITIOUS COMPOSITES; PERFORMANCE
AB Integrated structural and materials design (ISMD) represents a new design approach that combines materials and structural engineering for the purpose of more effectively achieving targeted structural performance. Performance based design of structures provides flexibility and incentive to select composite materials with properties that efficiently meet the structural performance target. Currently, modern materials engineering provides tools for tailoring material ingredients for desired composite properties. Thus, the integration of structural and materials design is a natural joining of these technical fields. In this paper, the ISMD concept is applied to develop white Engineered Cementitious Composites (White ECC) thin panels for architectural applications. Finite Element Analysis (FEA) is carried out in order to transfer targeted structural performance to required material properties. Based on the simulation results, White ECC is developed to meet the desired mechanical properties.
C1 [Yu, Jia Huan] Shenyang Jianzhu Univ, Shenyang 110168, Liaoning Prov, Peoples R China.
   [Hua, Yang En] Univ Michigan, Dept Civil & Environm Engn, Ann Arbor, MI 48109 USA.
RP Yu, JH (reprint author), Shenyang Jianzhu Univ, Shenyang Hunnan E Rd 911, Shenyang 110168, Liaoning Prov, Peoples R China.
EM jiahuan@umich.edu
CR Kang THK, 2009, J STRUCT ENG-ASCE, V135, P147, DOI 10.1061/(ASCE)0733-9445(2009)135:2(147)
   Li V.C., 2006, RILEM, V15, P1
   LI VC, 2003, ADV CONCRETE TECHNOL, V1, P215, DOI DOI 10.3151/JACT.1.215
   Li VC, 2006, PROBABILIST ENG MECH, V21, P201, DOI 10.1016/j.probengmech.2005.10.008
   Li Victor C, 2007, Journal of the Chinese Ceramic Society, V35, P531
   Schlangen E, 2007, SIMULATION PHYS MECH, P45
   Yang EH, 2008, J ADV CONCR TECHNOL, V6, P181, DOI 10.3151/jact.6.181
   Yu JH, 2009, J STRAIN ANAL ENG, V44, P417, DOI 10.1243/03093247JSA513
   Yu JH, 2009, MATER SCI TECH-LOND, V25, P651, DOI 10.1179/174328408X327731
   Zhou J, 2008, THEOR APPL FRACT MEC, V49, P199, DOI 10.1016/j.tafmec.2007.11.006
NR 10
TC 1
Z9 1
U1 4
U2 22
PU ARCHITECTURAL INST JAPAN
PI TOKYO
PA 5-26-20 SHIBA, MINATO-KU, TOKYO, 108-8414, JAPAN
SN 1346-7581
EI 1347-2852
J9 J ASIAN ARCHIT BUILD
JI J. Asian Archit. Build. Eng.
PD NOV
PY 2010
VL 9
IS 2
BP 487
EP 493
DI 10.3130/jaabe.9.487
PG 7
WC Architecture; Construction & Building Technology
SC Architecture; Construction & Building Technology
GA 738IZ
UT WOS:000288634800029
OA Bronze
DA 2018-12-27
ER

PT J
AU Aboul-Soud, MAM
AF Aboul-Soud, Mourad A. M.
TI RETRACTED: Exogenous nitric oxide has negative impacts on ethylene
   emissions from intact and fresh-cut tomato fruit (Retracted article. See
   vol. 88, pg. 368, 2013)
SO JOURNAL OF HORTICULTURAL SCIENCE & BIOTECHNOLOGY
LA English
DT Article; Retracted Publication
ID BIOLOGICAL-ACTIVITY; POSTHARVEST LIFE; RELAXING FACTOR; SENESCENCE;
   PLANTS; GENE; ARABIDOPSIS; FUMIGATION; INHIBITION; VEGETABLES
AB The objective of this study was to investigate the effect of nitric oxide (NO) on the production of basal and wound-associated stress ethylene (C2H4) emissions from intact and fresh-cut tomato fruit, respectively. For this purpose, a non-invasive, on-line sampling technique based on laser photo-acoustic spectroscopy (LPAS) was employed. Pre-treatment of intact mature green (MG) tomato fruit with a low concentration (0.2 mu l l(-1)) of NO resulted in a significant and steady average reduction of 33% in the basal level of C2H4 production, to 6.0 +/- 0.44 pmol h(-1) g(-1) FW compared to 9.0 +/- 0.18 pmol h(-1) g(-1) FW in non-treated MG control fruit. Moreover, fumigation of fresh-cut MG tomato fruit slices with NO caused a 60% reduction in the peak of wound-induced C2H4 emissions compared to untreated, fresh-cut MG control fruit. These results clearly indicate that pre-treatment with NO has negative a impact on basal and wound-associated stress levels of C2H4 emissions in intact and fresh-cut tomato fruit, respectively. These results are discussed in the context of possible mechanisms for interference by NO in the biosynthesis of C2H4. Moreover, the potential use and utility of NO to control undesirable stress-induced, biochemical changes, which are known to occur in fresh-cut fruit, are highlighted.
C1 King Saud Univ, Coll Sci, Ctr Excellence Biotechnol Res, Riyadh 11451, Saudi Arabia.
RP Aboul-Soud, MAM (reprint author), King Saud Univ, Coll Sci, Ctr Excellence Biotechnol Res, POB 2455, Riyadh 11451, Saudi Arabia.
EM maboulsoud@ksu.edu.sa
FU European Union (EU) [FP6-026183]
FX This work was supported by the European Union (EU) through the
   EU-FP6-Infrastructures-5 Programme, Project FP6-026183 'Life Science
   Trace Gas Facility'. Thanks are due to Lucas Laarhoven and Simona
   Cristescu for technical training with the LPAS system, its set-up, and
   data collection.
CR Aboul-Soud MAM, 2009, PLANT SIGNAL BEHAV, V4, P191, DOI 10.4161/psb.4.3.8256
   Aboul-Soud MAM, 2009, PLANT SCI, V176, P241, DOI 10.1016/j.plantsci.2008.10.010
   AHVENAINEN R, 1994, VTT SYMP, V142, P17
   Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072
   BRECHT JK, 1995, HORTSCIENCE, V30, P18
   BREWER RJ, 1982, APPL OPTICS, V21, P4092, DOI 10.1364/AO.21.004092
   CANTWELL M, 2002, POSTHARVEST TECHNOLO, V3311, P445
   Clarke A, 2000, PLANT J, V24, P667, DOI 10.1046/j.1365-313x.2000.00911.x
   Cristescu SM, 2002, APPL ENVIRON MICROB, V68, P5342, DOI 10.1128/AEM.68.11.5340-5350.2002
   Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087
   Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328
   Ferrer MA, 1999, PLANT CELL ENVIRON, V22, P891, DOI 10.1046/j.1365-3040.1999.00459.x
   FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0
   Gil MI, 2006, J AGR FOOD CHEM, V54, P4284, DOI 10.1021/jf060303y
   HAMILTON AJ, 1990, NATURE, V346, P284, DOI 10.1038/346284a0
   IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265
   KOSHLAND DE, 1992, SCIENCE, V258, P1861, DOI 10.1126/science.1470903
   Lanciotti R, 1999, J AGR FOOD CHEM, V47, P4769, DOI 10.1021/jf990611e
   Leshem YY, 1998, BIOL PLANTARUM, V41, P1, DOI 10.1023/A:1001779227767
   Leshem YY, 2000, J EXP BOT, V51, P1471, DOI 10.1093/jexbot/51.349.1471
   Leshem YY, 1998, PLANT PHYSIOL BIOCH, V36, P825, DOI 10.1016/S0981-9428(99)80020-5
   Leshem YY, 1996, J PLANT PHYSIOL, V148, P258, DOI 10.1016/S0176-1617(96)80251-3
   Lester GE, 2003, POSTHARVEST OXIDATIVE STRESS IN HORTICULTURAL CROPS, P113
   Levitt J, 1972, RESPONSES PLANTS ENV
   Lindermayr C, 2006, J BIOL CHEM, V281, P4285, DOI 10.1074/jbc.M511635200
   OELLER PW, 1991, SCIENCE, V254, P437, DOI 10.1126/science.1925603
   Orozco-Cardenas ML, 2002, PLANT PHYSIOL, V130, P487, DOI 10.1104/pp.008375
   PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0
   PICTON S, 1993, PLANT J, V3, P469, DOI 10.1111/j.1365-313X.1993.tb00167.x
   Reid MS, 2008, HORTSCIENCE, V43, P83
   Soegiarto L, 2004, HORTTECHNOLOGY, V14, P538
   Sozzi GO, 2003, J HORTIC SCI BIOTECH, V78, P899, DOI 10.1080/14620316.2003.11511716
   Toivonen PMA, 2002, FRESH-CUT FRUITS AND VEGETABLES: SCIENCE, TECHNOLOGY, AND MARKET, P91
   Wang XD, 2004, P NATL ACAD SCI USA, V101, P11477, DOI 10.1073/pnas.0402201101
   Wendehenne D, 2001, TRENDS PLANT SCI, V6, P177, DOI 10.1016/S1360-1385(01)01893-3
   Wills RBH, 2000, POSTHARVEST BIOL TEC, V18, P75, DOI 10.1016/S0925-5214(99)00061-7
   Zhu SH, 2007, FOOD CHEM, V100, P1517, DOI 10.1016/j.foodchem.2005.12.022
   Zhu SH, 2006, POSTHARVEST BIOL TEC, V42, P41, DOI 10.1016/j.postharvbio.2006.05.004
NR 38
TC 2
Z9 2
U1 2
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1462-0316
EI 2380-4084
J9 J HORTIC SCI BIOTECH
JI J. Horticult. Sci. Biotechnol.
PD NOV
PY 2010
VL 85
IS 6
BP 516
EP 520
PG 5
WC Horticulture
SC Agriculture
GA 699NT
UT WOS:000285670800010
DA 2018-12-27
ER

PT J
AU Duan, F
   Jin, BS
   Huang, YJ
   Li, B
   Sun, Y
   Wu, YM
   Zhang, MY
AF Duan Feng
   Jin Bao-Sheng
   Huang Ya-Ji
   Li Bin
   Sun Yu
   Wu Yiming
   Zhang Ming-Yao
TI RETRACTED: Reasearch on the main factors for changes in pressure based
   on turbulent circulating fluidized bed coal gasification technology
   (Retracted article. See vol. 28, pg. 314, 2011)
SO KOREAN JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article; Retracted Publication
DE Circulating Fluidized Bed; Gasification; Pressurized; Bituminous
ID BLOWN GASIFICATION; AIR GASIFICATION; GASIFIER; REACTOR
AB High temperature preheated air and steam as gasifying agent and coal gasification was performed in a pressurized turbulent circulating fluidized bed (CFB) gasification pilot plant to investigate the pressurized gasification process and estimate its potential. Within the scope of this paper this test facility as well as its operation behavior was described. Furthermore, the parameter pressure has been investigated regarding its influence on the syngas composition and was presented and discussed in the following. The results show that the gasification quality is improved at higher pressure because of the better fluidization in the reactor. Coal gasification at a higher pressure shows advantages in lower heat value and carbon conversion. With the gasifier pressure increased from 0.1 MPa to 0.3 MPa, the gas heating value is increased by 15%. Increasing the gasifier pressure would increase the carbon conversion from 57.52% to 76.76%. Also, the dry gas yield and efficiency of cold gas increase little with the increase of the gasifier pressure. The operating parameter of pressure exists at optimum operating range for this specific CFB coal gasification process.
C1 [Duan Feng; Jin Bao-Sheng; Huang Ya-Ji; Li Bin; Sun Yu; Wu Yiming; Zhang Ming-Yao] Southeast Univ, Thermoenergy Engn Res Inst, Nanjing 210096, Jiangsu Prov, Peoples R China.
   [Duan Feng] Anhui Univ Technol, Sch Met & Resource, Maanshan 243002, Anhui Prov, Peoples R China.
RP Duan, F (reprint author), Southeast Univ, Thermoenergy Engn Res Inst, Nanjing 210096, Jiangsu Prov, Peoples R China.
EM ddffeng@126.com
RI Lv, Henry/C-9692-2011
FU National Basic Research Program of China [2007CB210208]; Southeast
   university [4003001012]; "Qing-lan Project" of Jiangsu province
   [JS0801]; Excellent youth talented fund of Anhui province [2009SQRZ073]
FX Financial support of this work by National Basic Research Program of
   China (2007CB210208); Foundation for Excellent Youth teacher fund of
   Southeast university (4003001012) and "Qing-lan Project" of Jiangsu
   province (JS0801) and Excellent youth talented fund of Anhui province
   (2009SQRZ073) is gratefully acknowledged.
CR APNOLD MSJ, 1992, CAN J CHEM ENG, V70, P991
   Bai D., 1993, CHEM ENG TECHNOL, V16, P307
   Bi HT, 2000, CHEM ENG SCI, V55, P4789, DOI 10.1016/S0009-2509(00)00107-X
   CAI P, 1990, CIESC J, V2, P18
   Choi YC, 2006, KOREAN J CHEM ENG, V23, P380, DOI 10.1007/BF02706738
   Fang YT, 2001, FUEL PROCESS TECHNOL, V69, P29, DOI 10.1016/S0378-3820(00)00131-4
   HIRSCHFELDER H, 1999, P 6 INT C CIRC FLUID
   Kim YJ, 2000, FUEL, V79, P69, DOI 10.1016/S0016-2361(99)00128-3
   KURKELA E, 1992, FUEL PROCESS TECHNOL, V31, P1, DOI 10.1016/0378-3820(92)90038-R
   Lee JM, 1998, ENERGY, V23, P475, DOI 10.1016/S0360-5442(98)00011-5
   Li Bin, 2009, Journal of Southeast University (Natural Science Edition), V39, P998, DOI 10.3969/j.issn.1001-0505.2009.05.026
   Niksa S, 2003, PROG ENERG COMBUST, V29, P425, DOI 10.1016/S0360-1285(03)00033-9
   Ocampo A, 2003, FUEL, V82, P161, DOI 10.1016/S0016-2361(02)00253-3
   RCH L, 1995, CHEM ENG TECHNOL, V18, P75
   Sugiyama S, 2005, ENERGY, V30, P399, DOI 10.1016/j.energy.2004.06.001
   VARADI T, 1978, HIGH PRESSURE FLUIDI
   Xiao R, 2006, ENERG FUEL, V20, P715, DOI 10.1021/ef050233h
   Xiao R, 2007, FUEL, V86, P1631, DOI 10.1016/j.fuel.2006.11.014
   Xiao R, 2007, ENERG CONVERS MANAGE, V48, P778, DOI 10.1016/j.enconman.2006.09.004
   ZHANG RG, 2005, CHIN SOC ELEC ENG, V25, P103
   ZHOU HC, 2007, CHEM ENG, V24, P489
NR 21
TC 1
Z9 1
U1 7
U2 35
PU KOREAN INSTITUTE CHEMICAL  ENGINEERS
PI SEOUL
PA F.5, 119, ANAM-RO, SEONGBUK-GU, SEOUL 136-075, SOUTH KOREA
SN 0256-1115
EI 1975-7220
J9 KOREAN J CHEM ENG
JI Korean J. Chem. Eng.
PD NOV
PY 2010
VL 27
IS 6
BP 1707
EP 1714
DI 10.1007/s11814-010-0266-8
PG 8
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 675NJ
UT WOS:000283837100011
DA 2018-12-27
ER

PT J
AU Kurita, A
   Taniguchi, T
   Yamamoto, K
AF Kurita, Akihide
   Taniguchi, Takumi
   Yamamoto, Ken
TI RETRACTED: The Effects of Carvedilol Administration on Cardiopulmonary
   Resuscitation in a Rat Model of Cardiac Arrest Induced by Airway
   Obstruction (Retracted article. See vol. 122, pg. 2067, 2016)
SO ANESTHESIA AND ANALGESIA
LA English
DT Article; Retracted Publication
ID CONGESTIVE-HEART-FAILURE; INFLAMMATORY RESPONSES; MYOCARDIAL-INFARCTION;
   MORTALITY; MORBIDITY; SURVIVAL; DYSFUNCTION; METOPROLOL; PROPOFOL;
   BLOCKADE
AB BACKGROUND: Carvedilol is a nonselective beta-adrenoceptor and selective alpha(1)-adrenoceptor blocker and is widely used in the treatment of patients with hypertensive and/or chronic heart failure because, unlike classic beta-blockers, this drug has additional endothelium-dependent vasodilatory effects. We evaluated the effects of oral administration of carvedilol on cardiopulmonary resuscitation (CPR) in a rat model of cardiac arrest (CA) induced by airway obstruction.
   METHODS: Twenty-four rats were randomly assigned to 2 groups: control group (no medication) and treatment group (oral administration of carvedilol [10 mg/kg/d] for 5 days) (n = 12 per group). All the animals were anesthetized, and CA was induced by obstructing the airway. Three minutes after CA, the animals were revived by administering CPR. The rate of chest compressions (CCs) was 240 to 260 CCs/min and the depth of CCs was adjusted to maintain the diastolic arterial blood pressure between 25 to 30 mm Hg in both groups. Epinephrine (0.02 mg/kg) was administered after 5 minutes of CPR. No other therapy was administered before, during, or after CA.
   RESULTS: The time interval between airway obstruction and CA in the treatment group was significantly longer than in the control group (230 +/- 27 vs 203 +/- 24 seconds; P < 0.05). The rate of return of spontaneous circulation in the treatment group was significantly higher than in the control group (92% vs 50%; P < 0.05). Acidosis and increased glucose and tumor necrosis factor-a concentrations in the treatment group were significantly lower than in the control group.
   CONCLUSIONS: The results of our study showed that rats that had been administered oral carvedilol for several days were more resistant to CA induced by airway obstruction, and when CA did occur, were more likely to be resuscitated. These findings suggest that carvedilol may prolong the safe ischemic time induced by respiratory failure. (Anesth Analg 2010;111:1207-10)
C1 [Taniguchi, Takumi] Kanazawa Univ Hosp, Intens Care Unit, Kanazawa, Ishikawa 9208641, Japan.
   [Kurita, Akihide; Yamamoto, Ken] Kanazawa Univ, Grad Sch Med Sci, Dept Anesthesiol & Intens Care Med, Kanazawa, Ishikawa, Japan.
RP Taniguchi, T (reprint author), Kanazawa Univ Hosp, Intens Care Unit, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.
EM takutaniyan@yahoo.co.jp
CR Azevedo ER, 2001, CIRCULATION, V104, P2194, DOI 10.1161/hc4301.098282
   Cleland JGF, 2006, J AM COLL CARDIOL, V47, P1603, DOI 10.1016/j.jacc.2005.11.069
   Fonarow GC, 2007, AM HEART J, V154, P637, DOI 10.1016/j.ahj.2007.06.002
   Kasama S, 2007, EUR HEART J, V28, P989, DOI 10.1093/eurheartj/ehm048
   Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301
   Mizuochi Y, 2007, TRANSL RES, V149, P223, DOI 10.1016/j.trsl.2006.11.008
   Noguchi N, 2000, BIOCHEM PHARMACOL, V59, P1069, DOI 10.1016/S0006-2952(99)00417-7
   Oliveira PJ, 2000, BIOCHEM BIOPH RES CO, V276, P82, DOI 10.1006/bbrc.2000.3374
   Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201
   Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101
   Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402
   Remme WJ, 2007, J AM COLL CARDIOL, V49, P963, DOI 10.1016/j.jacc.2006.10.059
   Schmitz D, 2007, RESUSCITATION, V72, P286, DOI 10.1016/j.resuscitation.2006.07.001
   Suzuki T, 2005, CRIT CARE MED, V33, P2294, DOI 10.1097/01.CCM.0000182796.11329.3B
   Taniguchi T, 2000, CRIT CARE MED, V28, P1101, DOI 10.1097/00003246-200004000-00032
   Taniguchi T, 2002, CRIT CARE MED, V30, P904, DOI 10.1097/00003246-200204000-00032
   Taniguchi T, 2009, SHOCK, V32, P272, DOI 10.1097/SHK.0b013e3181a24cb3
   Wallhaus TR, 2001, CIRCULATION, V103, P2441
NR 18
TC 3
Z9 3
U1 2
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0003-2999
J9 ANESTH ANALG
JI Anesth. Analg.
PD NOV
PY 2010
VL 111
IS 5
BP 1207
EP 1210
DI 10.1213/ANE.0b013e3181f1bd55
PG 4
WC Anesthesiology
SC Anesthesiology
GA 673PI
UT WOS:000283675000020
PM 20705786
DA 2018-12-27
ER

PT J
AU Lee, PHU
   Shulman, MS
   Vellayappan, U
   Symes, JF
   Olenchock, SA
AF Lee, Peter H. U.
   Shulman, Mark S.
   Vellayappan, Usha
   Symes, James F.
   Olenchock, Stephen A., Jr.
TI RETRACTED: Surgical Treatment of an Amniotic Fluid Embolism With
   Cardiopulmonary Collapse (Retracted article. See vol. 95, pg. 776, 2013)
SO ANNALS OF THORACIC SURGERY
LA English
DT Editorial Material; Retracted Publication
ID PULMONARY-ARTERY THROMBOEMBOLECTOMY; BYPASS
AB Afluid embolism is a rare but devastating condition associated with a very high rate of morbidity and mortality. The treatment has traditionally been aggressive supportive care. We report a case of a term pregnant woman with complete cardiovascular collapse secondary to a paradoxical amniotic fluid embolism. The embolism was seen on transesophageal echocardiogram during an emergency Cesarean section as a free-floating interatrial clot through a patent foramen ovale. She was subsequently and successfully treated with immediate cardiopulmonary bypass, thromboembolectomy, and closure of the patent foramen ovale. (Ann Thorac Surg 2010;90:1694-6) (C) 2010 by The Society of Thoracic Surgeons
C1 [Olenchock, Stephen A., Jr.] St Lukes Hosp & Hlth Network, Bethlehem, PA 18015 USA.
   Tufts Univ, Sch Med, St Elizabeths Med Ctr, Dept Surg & Anesthesia, Boston, MA 02111 USA.
   Univ Miami, Miller Sch Med, Miami VA Med Ctr, Dept Surg, Miami, FL 33136 USA.
RP Olenchock, SA (reprint author), St Lukes Hosp & Hlth Network, 701 Ostrum St,Ste 603, Bethlehem, PA 18015 USA.
EM olenchs@slhn.org
CR Aurangzeb M, 2004, CRIT CARE CLIN, V20, P643, DOI 10.1016/j.ccc.2004.06.002
   CLARK SL, 1995, AM J OBSTET GYNECOL, V172, P1158, DOI 10.1016/0002-9378(95)91474-9
   Corbett SM, 2005, CRIT CARE MED, V33, pA128, DOI 10.1097/00003246-200512002-00452
   ESPOSITO RA, 1990, AM J OBSTET GYNECOL, V163, P572, DOI 10.1016/0002-9378(90)91200-V
   Harnett MJP, 2005, ANAESTHESIA, V60, P1068, DOI 10.1111/j.1365-2044.2005.04373.x
   KOOL MJ, 1991, AM J OBSTET GYNECOL, V164, P701, DOI 10.1016/S0002-9378(11)80054-2
   Stanten RD, 2003, OBSTET GYNECOL, V102, P496, DOI 10.1016/S0029-7844(03)00161-3
   Tuffnell DJ, 2003, CURR OPIN OBSTET GYN, V15, P119, DOI 10.1097/01.gco.0000063546.93768.ba
NR 8
TC 7
Z9 7
U1 3
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
EI 1552-6259
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD NOV
PY 2010
VL 90
IS 5
BP 1694
EP 1696
DI 10.1016/j.athoracsur.2010.05.017
PG 4
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 669LO
UT WOS:000283352200064
PM 20971295
DA 2018-12-27
ER

PT J
AU Samariya, A
   Singhal, RK
   Kumar, S
   Xing, YT
   Sharma, SC
   Kumari, P
   Jain, DC
   Dolia, SN
   Deshpande, UP
   Shripathi, T
   Saitovitch, E
AF Samariya, A.
   Singhal, R. K.
   Kumar, Sudhish
   Xing, Y. T.
   Sharma, S. C.
   Kumari, P.
   Jain, D. C.
   Dolia, S. N.
   Deshpande, U. P.
   Shripathi, T.
   Saitovitch, E.
TI RETRACTED: Effect of hydrogenation vs. re-heating on intrinsic
   magnetization of Co doped In2O3 (Retracted article. See vol. 300, pg.
   213, 2014)
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Retracted Publication
DE Magnetic semiconductors; X-ray photoelectron spectroscopy
ID THIN-FILMS; OXIDE; SEMICONDUCTORS; FERROMAGNETISM; MAGNETISM;
   SPINTRONICS
AB Influence of Co doping for In in In2O3 matrix has been investigated to study the effect on magnetic vs. electronic properties. Rietveld refinement of X-ray diffraction patterns confirmed formation of single phase cubic bixbyite structure without any parasitic phase. Photoelectron spectroscopy and refinement results further revealed that dopant Co2+ ions are well incorporated at the In3+ sites in In2O3 lattice and also ruled out formation of cluster in the doped samples. Magnetization measurements infer that pure In2O3 is diamagnetic and turns to weak ferromagnetic upon Co doping. Hydrogenation further induces a huge ferromagnetism at 300 K that vanishes upon re-heating. Experimental findings confirm the induced ferromagnetism to be intrinsic, and the magnetic moments to be associated with the point defects (oxygen vacancies V-o) or bound magnetic polarons around the dopant ions. (C) 2010 Elsevier B. V. All rights reserved.
C1 [Samariya, A.; Singhal, R. K.; Sharma, S. C.; Kumari, P.; Jain, D. C.; Dolia, S. N.] Univ Rajasthan, Dept Phys, Jaipur 302004, Rajasthan, India.
   [Kumar, Sudhish] ML Sukhadia Univ, Dept Phys, Udaipur 313002, India.
   [Singhal, R. K.; Xing, Y. T.; Saitovitch, E.] CBPF, Rio De Janeiro, Brazil.
   [Deshpande, U. P.; Shripathi, T.] UGC DAE CSR, Indore 452001, Madhya Pradesh, India.
RP Singhal, RK (reprint author), Univ Rajasthan, Dept Phys, JLN Marg, Jaipur 302004, Rajasthan, India.
EM singhal46@yahoo.co.in
CR Berciu M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.107203
   Bibes M, 2007, IEEE T ELECTRON DEV, V54, P1003, DOI 10.1109/TED.2007.894366
   Chambers SA, 2006, SURF SCI REP, V61, P345, DOI 10.1016/j.surfrep.2006.05.001
   Coey JMD, 2006, CURR OPIN SOLID ST M, V10, P83, DOI 10.1016/j.cossms.2006.12.002
   Coey JMD, 2005, NAT MATER, V4, P173, DOI 10.1038/nmat1310
   Hong NH, 2007, J MAGN MAGN MATER, V316, P214, DOI 10.1016/j.jmmm.2007.02.081
   Hong NH, 2006, J MAGN MAGN MATER, V302, P228, DOI 10.1016/j.jmmm.2005.09.010
   HSU HS, 2006, APPL PHYS LETT, V88
   Huang CM, 2006, CHEM PHYS LETT, V432, P468, DOI 10.1016/j.cplett.2006.10.010
   Jeong BS, 2004, APPL PHYS LETT, V84, P2608, DOI 10.1063/1.1691499
   LEE HJ, 2006, APPL PHYS LETT, V88, P3
   Manivannan A, 2003, APPL PHYS LETT, V83, P111, DOI 10.1063/1.1590744
   Pan F, 2008, MAT SCI ENG R, V62, P1, DOI 10.1016/j.mser.2008.04.002
   Pearton SJ, 2003, J APPL PHYS, V93, P1, DOI 10.1063/1.1517164
   Philip J, 2006, NAT MATER, V5, P298, DOI 10.1038/nmat1613
   Ramachandran S, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2213930
   Rodriguez-Carvajal J., 2003, FULLPROF VERSION 3 0
   SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551
   Singhal RK, 2010, J ALLOY COMPD, V496, P324, DOI 10.1016/j.jallcom.2010.02.005
   Singhal RK, 2010, J MAGN MAGN MATER, V322, P2187, DOI 10.1016/j.jmmm.2010.02.007
   Song C, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.024405
   Song YQ, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/25/255210
   Sundaresan A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.161306
   TAN BJ, 1991, J AM CHEM SOC, V113, P855, DOI 10.1021/ja00003a019
   Van de Walle CG, 2000, PHYS REV LETT, V85, P1012, DOI 10.1103/PhysRevLett.85.1012
   Venkatesan M, 2004, NATURE, V430, P630, DOI 10.1038/430630a
   VODUNGBO B, 2007, APPL PHYS LETT, V90
NR 27
TC 30
Z9 30
U1 5
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD NOV 1
PY 2010
VL 257
IS 2
BP 585
EP 590
DI 10.1016/j.apsusc.2010.07.037
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 648EW
UT WOS:000281674200040
DA 2018-12-27
ER

PT J
AU Abe, Y
   Kawakami, A
   Osaka, M
   Uematsu, S
   Akira, S
   Shimokado, K
   Sacks, FM
   Yoshida, M
AF Abe, Yasuko
   Kawakami, Akio
   Osaka, Mizuko
   Uematsu, Satoshi
   Akira, Shizuo
   Shimokado, Kentaro
   Sacks, Frank M.
   Yoshida, Masayuki
TI RETRACTED: Apolipoprotein CIII Induces Monocyte Chemoattractant
   Protein-1 and Interleukin 6 Expression Via Toll-Like Receptor 2 Pathway
   in Mouse Adipocytes (Retracted article. See vol. 32, pg. E22, 2012)
SO ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
LA English
DT Article; Retracted Publication
DE apolipoproteins; atherosclerosis; cytokines; immune system; signal
   transduction
ID TRIGLYCERIDE-RICH LIPOPROTEINS; C-III; INSULIN-RESISTANCE;
   ENDOTHELIAL-CELLS; ADIPOSE-TISSUE; METABOLIC SYNDROME; TRANSGENIC MICE;
   APOC-III; A-I; OBESITY
AB Objective-To examine the direct effect of apolipoprotein CIII (apoCIII) on adipokine expressions that are involved in obesity, insulin resistance, or metabolic syndrome.
   Methods and Results-ApoCIII in triglyceride-rich lipoproteins is elevated in patients with obesity, insulin resistance, or metabolic syndrome. Its level is also associated with proinflammatory adipokines. Fully differentiated mouse 3T3L1 adipocytes were incubated with apoCIII. ApoCIII activated nuclear factor kappa B of 3T3L1 adipocytes and induced the expression of monocyte chemoattractant protein (MCP) 1 and interleukin (IL) 6. ApoCIII also activated extracellular signal-regulated kinase and p38. Mitogen-activated protein kinase kinase (MEK)-1 inhibitor PD98059, but not p38 inhibitor SB203580, inhibited apoCIII-induced upregulation of MCP-1 and IL-6. Previously, it was shown that apoCIII activates proinflammatory signals through toll-like receptor (TLR) 2. TLR2-blocking antibody abolished activation of nuclear factor kappa B and extracellular signal-regulated kinase induced by apoCIII and inhibited apoCIII-induced upregulation of MCP-1 and IL-6. ApoCIII also reduced adiponectin expression of 3T3L1 adipocytes, which was recovered by TLR2-blocking antibody. ApoCIII induced the expression of MCP-1 and IL-6 in TLR2-overexpressed human embryonic kidney 293 cells but not wild-type human embryonic kidney 293 cells without TLR2. ApoCIII induced the expression of MCP-1 and IL-6 and decreased adiponectin expression in white adipose tissue of wild-type mice but not of TLR2-deficient mice in vivo.
   Conclusion-ApoCIII may activate extracellular signal-regulated kinase and nuclear factor kB through TLR2 and induce proinflammatory adipokine expression in vitro and in vivo. Thus, apoCIII links dyslipidemia to inflammation in adipocytes, which, in turn, may contribute to atherosclerosis. (Arterioscler Thromb Vasc Biol. 2010;30:2242-2248.)
C1 [Kawakami, Akio] Tokyo Med & Dent Univ, Dept Geriatr & Vasc Med, Bunkyo Ku, Tokyo 1138519, Japan.
   [Kawakami, Akio; Osaka, Mizuko; Yoshida, Masayuki] Tokyo Med & Dent Univ, Life Sci & Bioeth Res Ctr, Tokyo 1138519, Japan.
   [Uematsu, Satoshi; Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Osaka, Japan.
   [Sacks, Frank M.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
RP Kawakami, A (reprint author), Tokyo Med & Dent Univ, Dept Geriatr & Vasc Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.
EM kawakami.vasc@tmd.ac.jp
RI Akira, Shizuo/C-3134-2009; 王, 强/F-4212-2011
FU ONO Medical Research Foundation; Takeda Science Foundation; Mitsukoshi
   Health and Welfare Foundation; Uehara Memorial Foundation; Ministry of
   Education, Science, Sports and Culture of Japan [18590805]; Japan
   Research Promotion Society for Cardiovascular Diseases; ONO Research
   Foundation
FX This study was supported by a grant from the ONO Medical Research
   Foundation; a grant from the Takeda Science Foundation; a grant from the
   Mitsukoshi Health and Welfare Foundation; a grant from the Uehara
   Memorial Foundation; grant 18590805 from the Ministry of Education,
   Science, Sports and Culture of Japan; a Sakakibara Memorial Research
   Grant from the Japan Research Promotion Society for Cardiovascular
   Diseases (Dr Kawakami); and a grant from the ONO Research Foundation (Dr
   Yoshida).
CR AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066
   Alaupovic P, 1997, ARTERIOSCL THROM VAS, V17, P715, DOI 10.1161/01.ATV.17.4.715
   Altomonte J, 2004, J CLIN INVEST, V114, P1493, DOI 10.1172/JCI200419992
   Bes-Houtmann S, 2007, HISTOCHEM CELL BIOL, V127, P131, DOI 10.1007/s00418-006-0230-1
   Campos H, 2001, J LIPID RES, V42, P1239
   Chan DC, 2008, EUR J CLIN INVEST, V38, P743, DOI 10.1111/j.1365-2362.2008.02019.x
   Chan DC, 2006, ARTERIOSCL THROM VAS, V26, P590, DOI 10.1161/01.ATV.0000203519.25116.54
   Chan DC, 2005, CLIN CHEM, V51, P578, DOI 10.1373/clinchem.2004.045120
   Chan DC, 2008, J CLIN ENDOCR METAB, V93, P557, DOI 10.1210/jc.2006-2676
   Chung S, 2006, ENDOCRINOLOGY, V147, P5340, DOI 10.1210/en.2006-0536
   Cohn JS, 2004, J CLIN ENDOCR METAB, V89, P3949, DOI 10.1210/jc.2003-032056
   Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050
   Feve B, 2009, NAT REV ENDOCRINOL, V5, P305, DOI 10.1038/nrendo.2009.62
   Fruchart JC, 2008, AM J CARDIOL, V102, p1K, DOI [10.1016/j.amjcard.2008.10.002, 10.1016/S0002-9149(08)01833-X]
   GINSBERG HN, 1986, J CLIN INVEST, V78, P1287, DOI 10.1172/JCI112713
   Hiukka A, 2009, DIABETES, V58, P2018, DOI 10.2337/db09-0206
   Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JC126498
   Kawakami A, 2006, CIRCULATION, V113, P691, DOI 10.1161/CIRCULATIONAHA.105.591743
   Kawakami A, 2008, CIRCULATION, V118, P731, DOI 10.1161/CIRCULATIONAHA.108.784785
   Kawakami A, 2007, ARTERIOSCL THROM VAS, V27, P219, DOI 10.1161/01.ATV.0000249620.68705.0d
   Kawakami A, 2006, CIRCULATION, V114, P681, DOI 10.1161/CIRCULATIONAHA.106.622514
   Kawakami A, 2008, CIRC RES, V103, P1402, DOI 10.1161/CIRCRESAHA.108.178426
   Marra F, 2009, HEPATOLOGY, V50, P957, DOI 10.1002/hep.23046
   Mendivil C.O., 2009, ARTERIOSCLER THROMB, V30, P239
   Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482
   Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964
   Olivieri O, 2003, J LIPID RES, V44, P2374, DOI 10.1194/jlr.M300253-JLR200
   Sacks FM, 2000, CIRCULATION, V102, P1886, DOI 10.1161/01.CIR.102.16.1886
   Salerno AG, 2007, INT J OBESITY, V31, P1586, DOI 10.1038/sj.ijo.0803646
   Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069
   Sol ERM, 2008, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-3
   Steffens S, 2008, CIRC RES, V102, P140, DOI 10.1161/CIRCRESAHA.107.170274
   Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942
   Takahashi Y, 2009, FEBS LETT, V583, P493, DOI 10.1016/j.febslet.2008.12.050
   Tschop M, 2006, NAT MED, V12, P1359, DOI 10.1038/nm1206-1359
   Vitseva OI, 2008, OBESITY, V16, P932, DOI 10.1038/oby.2008.25
   Yamashita A, 2007, OBESITY, V15, P2549, DOI 10.1038/oby.2007.305
   Zheng CY, 2007, J LIPID RES, V48, P1190, DOI 10.1194/jlr.P600011-JLR200
   Zheng CY, 2010, CIRCULATION, V121, P1722, DOI 10.1161/CIRCULATIONAHA.109.875807
NR 39
TC 13
Z9 18
U1 2
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1079-5642
J9 ARTERIOSCL THROM VAS
JI Arterioscler. Thromb. Vasc. Biol.
PD NOV
PY 2010
VL 30
IS 11
BP 2242
EP U501
DI 10.1161/ATVBAHA.110.210427
PG 14
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 667YS
UT WOS:000283234800651
PM 20829510
OA Bronze, Green Accepted
DA 2018-12-27
ER

PT J
AU Bernardino, S
AF Bernardino, Saccomanni
TI RETRACTED: Total elbow arthroplasty: history, current concepts, and
   future (Retracted Article. See vol 30, pg 155, 2011)
SO CLINICAL RHEUMATOLOGY
LA English
DT Review; Retracted Publication
DE Current concepts; Future; History; Total elbow arthroplasty
ID RHEUMATOID-ARTHRITIS; FOLLOW-UP; PROSTHESIS; REPLACEMENT; FRACTURES;
   HUMERUS
AB Total elbow arthroplasty (TEA) has proven to be a reliable joint replacement procedure that has a high degree of patient satisfaction. The long-term functional and implant survival scores rival those of total knee arthroplasty. Despite these favorable outcomes, few patients with disabling elbow degenerative conditions have TEA recommended to them as an alternative procedure by rheumatologists, physiatrists, or orthopedists. This article reviews the history, current concepts, and future of TEA.
C1 Univ Chieti Italy, I-66013 Chieti, Italy.
RP Bernardino, S (reprint author), Univ Chieti Italy, Via Vestini, I-66013 Chieti, Italy.
EM bernasacco@yahoo.it
CR Angst F, 2005, ARTHRIT RHEUM-ARTHR, V53, P73, DOI 10.1002/art.20911
   Armstrong AD, 2004, HAND CLIN, V20, P475, DOI 10.1016/j.hcl.2004.06.006
   BARR JS, 1965, J BONE JOINT SURG AM, VA 47, P1408, DOI 10.2106/00004623-196547070-00019
   BRYAN RS, 1982, CLIN ORTHOP RELAT R, V166, P188
   Chafik Dara, 2004, Am J Orthop (Belle Mead NJ), V33, P496
   Cobb TK, 1997, J BONE JOINT SURG AM, V79A, P826, DOI 10.2106/00004623-199706000-00004
   COONRAD RW, 1982, S TOT JOINT REPL UPP, P75
   DEE R, 1972, Journal of Bone and Joint Surgery British Volume, V54, P88
   EWALD FC, 1993, J BONE JOINT SURG AM, V75A, P498, DOI 10.2106/00004623-199304000-00004
   Gill DR, 2000, ELBOW ITS DISORDERS, P631
   Gill DRJ, 1998, J BONE JOINT SURG AM, V80A, P1327, DOI 10.2106/00004623-199809000-00012
   GOLDBERG VM, 1988, J BONE JOINT SURG AM, V70A, P778, DOI 10.2106/00004623-198870050-00022
   Gschwend N, 1999, J BONE JOINT SURG BR, V81B, P1005, DOI 10.1302/0301-620X.81B6.9495
   Hastings Hill 2nd, 2003, Am J Orthop (Belle Mead NJ), V32, P20
   Hildebrand KA, 2000, J BONE JOINT SURG AM, V82A, P1379, DOI 10.2106/00004623-200010000-00003
   HURRI L, 1964, Acta Chir Scand, V127, P459
   Jensen CH, 2006, ACTA ORTHOP, V77, P143, DOI 10.1080/17453670610045830
   Kamineni S, 2005, J Bone Joint Surg Am, V87 Suppl 1, P41, DOI 10.2106/JBJS.D.02871
   King Graham J W, 2002, Instr Course Lect, V51, P43
   KRAAY MJ, 1994, J BONE JOINT SURG BR, V76B, P636
   Lee BP, 2005, J BONE JOINT SURG AM, V87A, P1080, DOI 10.2106/JBJS.D.02163
   Little CP, 2005, J BONE JOINT SURG AM, V87A, P2439, DOI 10.2106/JBJS.D.02927
   Little CP, 2005, J BONE JOINT SURG BR, V87B, P437, DOI 10.1302/0301-620X.87B4
   LONDON JT, 1993, ELBOW ITS DISORDERS, P626
   MADSEN F, 1989, ACTA ORTHOP SCAND, V60, P249, DOI 10.3109/17453678909149269
   Mansat P, 2001, JOINT BONE SPINE, V68, P198, DOI 10.1016/S1297-319X(01)00273-1
   McKee MD, 2003, J BONE JOINT SURG AM, V85A, P802, DOI 10.2106/00004623-200305000-00005
   MELLEN RH, 1947, J BONE JOINT SURG, V29, P348
   Moro JK, 2000, CLIN ORTHOP RELAT R, P102
   MORREY BF, 1981, J BONE JOINT SURG AM, V63, P872, DOI 10.2106/00004623-198163060-00002
   MORREY BF, 1992, J BONE JOINT SURG AM, V74A, P479, DOI 10.2106/00004623-199274040-00003
   MORREY BF, 1991, SEMICONSTRAINED TOTA
   MORRIS RA, 1981, AM J AGR ECON, V63, P1050
   Rahme H, 2001, ACTA ORTHOP SCAND, V72, P107, DOI 10.1080/000164701317323336
   Rauhaniemi J, 2006, J HAND SURG-BRIT EUR, V31B, P162, DOI 10.1016/j.jhsh.2005.07.010
   van der Lugt JCT, 2006, J SHOULDER ELB SURG, V15, P208, DOI 10.1016/j.jse.2005.07.009
   van der Lugt JCT, 2005, ACTA ORTHOP, V76, P654, DOI 10.1080/17453670510041736
   van der Lugt JCT, 2004, CLIN RHEUMATOL, V23, P291, DOI 10.1007/s10067-004-0884-9
   van der Lugt JCT, 2004, J BONE JOINT SURG AM, V86A, P465, DOI 10.2106/00004623-200403000-00002
   Wright TW, 2000, J SHOULDER ELB SURG, V9, P524, DOI 10.1067/mse.2000.109408
   Yamaguchi K, 1998, J BONE JOINT SURG AM, V80A, P481, DOI 10.2106/00004623-199804000-00004
NR 41
TC 13
Z9 14
U1 3
U2 11
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0770-3198
EI 1434-9949
J9 CLIN RHEUMATOL
JI Clin. Rheumatol.
PD NOV
PY 2010
VL 29
IS 11
BP 1217
EP 1221
DI 10.1007/s10067-010-1539-7
PG 5
WC Rheumatology
SC Rheumatology
GA 652XO
UT WOS:000282046000002
PM 20683741
DA 2018-12-27
ER

PT J
AU Horton-Salway, M
   Locke, A
AF Horton-Salway, Mary
   Locke, Abigail
TI RETRACTED: 'But you might be damaging your baby': Constructing choice
   and risk in labour and childbirth (Retracted article. See vol. 21, pg.
   295, 2011)
SO FEMINISM & PSYCHOLOGY
LA English
DT Article; Retracted Publication
DE cautionary tales; ante-natal classes; 'coercive choice'; discursive
   psychology; medicalization; risk
ID INFORMED CHOICE; MATERNITY CARE; HOME BIRTH; PERCEPTIONS; MOTHERHOOD;
   PREGNANCY; MEDICINE; DELIVERY; TALK
AB This article examines how choice is constructed in relation to risk in a UK ante-natal class. Discursive psychology was applied to transcripts of 50 hours of audio recordings collected from local UK National Childbirth Trust classes. We found that consent to medical control of the birth environment is positively encouraged through Class Leaders' persuasive advice-giving and the delivery of cautionary (moral) tales in the form of extreme horror stories. Whilst parental agency is embedded in a 'rhetoric of choice', regulatory mechanisms of 'coercive choice' operate in tandem through a rhetoric of risk that positions medical intervention as the safer option. The right to choose seems to take on the status of a 'required element', which is both observed and resisted in discourse but, as previous research has suggested, may not necessarily be sustainable in practice. Our analysis suggests that the normativity of medical interventions in labour and childbirth is discursively reproduced in ante-natal classes whilst parental choice is limited by a powerful 'rhetoric of risk'.
C1 [Locke, Abigail] Univ Huddersfield, Sch Human & Hlth Sci, Huddersfield HD1 3DH, W Yorkshire, England.
   [Horton-Salway, Mary] Open Univ, Fac Social Sci, Milton Keynes MK7 6AA, Bucks, England.
RP Horton-Salway, M (reprint author), Open Univ, Fac Social Sci, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.
EM m.k.horton-salway@open.ac.uk
CR Baker SR, 2005, FEM PSYCHOL, V15, P315, DOI 10.1177/0959-353505054718
   Beck U., 1994, RISK SOC NEW MODERNI
   Beckett K, 2005, LAW SOC REV, V39, P125, DOI 10.1111/j.0023-9216.2005.00079.x
   Benwell B., 1999, PRAGMATICS, V9, P535
   Billig M., 1988, IDEOLOGICAL DILEMMAS
   Cahill M., 2000, J ADV NURS, V33, P334
   Crossley ML, 2007, FEM PSYCHOL, V17, P543, DOI 10.1177/0959353507083103
   Crossley ML, 2009, FEM PSYCHOL, V19, P71, DOI 10.1177/0959353508098620
   DANZIGER SK, 1979, AM J PUBLIC HEALTH, V69, P895, DOI 10.2105/AJPH.69.9.895
   DAVISFLOYD RE, 1994, SOC SCI MED, V38, P1125, DOI 10.1016/0277-9536(94)90228-3
   *DEP HLTH, 2004, MAT STAND NAT FRAM C
   *DEP HLTH, 1993, CHANG CHILDB
   Department of Health, 2006, OUR HLTH OUR CAR OUR
   Edwards D., 1992, DISCURSIVE PSYCHOL
   Foucault M., 1973, BIRTH CLIN
   Gill R, 2008, FEM PSYCHOL, V18, P35, DOI 10.1177/0959353507084950
   GREGG R, 1993, WOMEN HLTH, V20, P55
   Hamlyn B., 2002, INFANT FEEDING 2000
   Heritage J, 1998, RES LANG SOC INTERAC, V31, P397, DOI 10.1207/s15327973rlsi3103&4_5
   Horton-Salway M., 2001, DISCOURSE DATA GUIDE, P147
   Horton-Salway M, 2008, DISCOURSE STUD, V10, P737, DOI 10.1177/1461445608096571
   HUTCHBY I, 1992, SOCIOLOGY, V26, P673, DOI 10.1177/0038038592026004008
   Jefferson G., 1990, INTERACTION COMPETEN, P63
   Kitzinger J., 1990, POLITICS MATERNITY C, P92
   KITZINGER S, 1984, EXPERIENCE CHILDBIRT
   KITZINGER S, 2002, BIRTH YOUR WAY CHOOS
   Kringeland T, 2006, J PSYCHOSOM OBST GYN, V27, P185, DOI 10.1080/01674820600707594
   Lawrence SG, 1996, RES LANG SOC INTERAC, V29, P181, DOI 10.1207/s15327973rlsi2903_1
   Locke A, 2003, BRIT J SOC PSYCHOL, V42, P239, DOI 10.1348/014466603322127238
   Locke A, 2009, J HEALTH PSYCHOL, V14, P435, DOI 10.1177/1359105309102200
   LOTHIAN L, 2006, J GYNECOLOGY OBSTET, V35, P295
   LUPTON D, 1993, INT J HEALTH SERV, V23, P425, DOI 10.2190/16AY-E2GC-DFLD-51X2
   Maclean LI, 2000, J REPROD INFANT PSYC, V18, P153, DOI 10.1080/02646830050008396
   Marshall H, 2000, FEM PSYCHOL, V10, P351, DOI 10.1177/0959353500010003005
   *NAT CHILDB TRUST, 2007, ANT POSTN MENT HLTH
   National Institute of Clinical Excellence, 2007, INTR CAR
   O'Cathain A, 2002, MIDWIFERY, V18, P136, DOI 10.1054/midw.0301
   Pilnick A, 2008, SOCIOL HEALTH ILL, V30, P511, DOI 10.1111/j.1467-9566.2007.01071.x
   Pomerantz A., 1984, STRUCTURES SOCIAL AC, P57, DOI DOI 10.1017/CBO9780511665868
   Potter J, 1996, REPRESENTING REALITY
   Rex LA, 2002, AM EDUC RES J, V39, P765, DOI 10.3102/00028312039003765
   RICHARDS MPM, 1982, BIRTH-ISS PERINAT C, V9, P253, DOI 10.1111/j.1523-536X.1982.tb01672.x
   ROTHMAN BK, 1998, TENTATIVE PREGNANCY
   Rudolfsdottir AG, 2000, FEM PSYCHOL, V10, P337, DOI 10.1177/0959353500010003004
   Sachs L, 1996, SOCIOL HEALTH ILL, V18, P632, DOI 10.1111/1467-9566.ep10934515
   Sevon E, 2005, FEM PSYCHOL, V15, P461, DOI 10.1177/0959-353505057619
   Shaw R, 2007, FEM PSYCHOL, V17, P203, DOI 10.1177/0959353507076553
   Simkin P. P., 1980, PLANNING YOUR BABYS
   SIMKIN PP, 2007, BIRTH-ISS PERINAT C, V34, P1
   Stockill C, 2007, FEM PSYCHOL, V17, P571, DOI 10.1177/0959353507083093
   Stokoe E. H., 2000, LANGUAGE ED, V14, P184, DOI DOI 10.1080/09500780008666789
   Stokoe E. H., 2002, DISCOURSE STUDIES, V4, P429, DOI DOI 10.1177/1461445602004004023
   TANNEN D, 1987, POWER DISCOURSE, P3
   Thachuk A, 2007, FEM PSYCHOL, V17, P39, DOI 10.1177/0959353507072911
   Tiefer L, 2008, FEM PSYCHOL, V18, P466, DOI 10.1177/0959353508095529
   Viisainen K, 2000, SOCIOL HEALTH ILL, V22, P792, DOI 10.1111/1467-9566.00231
   Wooffitt R., 1992, TELLING TALES UNEXPE
   WOOFFITT RC, 1998, CONVERSATION ANAL PR
NR 58
TC 5
Z9 5
U1 3
U2 22
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0959-3535
J9 FEM PSYCHOL
JI Feminism Psychol.
PD NOV
PY 2010
VL 20
IS 4
BP 435
EP 453
DI 10.1177/0959353510375415
PG 19
WC Psychology, Multidisciplinary; Women's Studies
SC Psychology; Women's Studies
GA 684UQ
UT WOS:000284577000001
DA 2018-12-27
ER

PT J
AU Ma, XH
   Guo, W
   Liu, XP
   Yin, T
   Jia, X
   Xiong, JA
   Zhang, HP
   Wang, LJ
AF Ma, Xiaohui
   Guo, Wei
   Liu, Xiaoping
   Yin, Tai
   Jia, Xin
   Xiong, Jiang
   Zhang, Hongpeng
   Wang, Lijun
TI RETRACTED: Hybrid Endovascular Repair in Aortic Arch Pathologies: A
   Retrospective Study (Retracted article. See vol. 16, pg. 30342, 2015)
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article; Retracted Publication
DE aortic arch; endovascular repair; aneurysm; dissection
ID DESCENDING THORACIC AORTA; BRANCHED STENT-GRAFT; ANEURYSM; DISSECTION;
   RECONSTRUCTION; EXPERIENCE; BYPASS
AB The aortic arch presents specific challenges to endovascular repair. Hybrid repair is increasingly evolving as an alternative option for selected patients, and promising initial results have been reported. The aim of this study was to introduce our experiences and evaluate mid-term results of supra aortic transpositions for extended endovascular repair of aortic arch pathologies. From December 2002 to January 2008, 25 patients with thoracic aortic aneurysms and dissections involving the aortic arch were treated with hybrid endovascular treatment in our center. Of the 25 cases, 14 were atherosclerotic thoracic aortic aneurysms and 11 were thoracic aortic dissection. The hybrid repair method included total-arch transpositions (15 cases) or hemi-arch transpositions (10 cases), and endovascular procedures. All hybrid endovascular procedures were completed successfully. Three early residual type-I endoleaks and one type-II endoleak were observed. Stroke occurred in three patients (8%) during the in-hospital stage. The perioperative mortality rate was 4%; one patients died post-operatively from catheter related complications. The average follow-up period was 15 +/- 5.8 months (range, 1-41 months). The overall crude survival rate at 15 months was 92% (23/25). During follow-up, new late endoleaks and stent-raft related complications were not observed. One case (4%) developed a unilateral lower limb deficit at 17 days and was readmitted to hospital. In conclusion, the results are encouraging for endovascular aortic arch repair in combination with supra-aortic transposition in high risk cases. Aortic endografting offers good mid-term results. Mid-term results of the hybrid approach in elderly patients with aortic arch pathologies are satisfying.
C1 [Ma, Xiaohui; Guo, Wei; Liu, Xiaoping; Yin, Tai; Jia, Xin; Xiong, Jiang; Zhang, Hongpeng; Wang, Lijun] Gen Hosp & Postgrad Med Sch, Dept Vasc Surg, Clin Div Surg, Chinese People Liberat Army PLA, Beijing 100853, Peoples R China.
RP Guo, W (reprint author), Gen Hosp & Postgrad Med Sch, Dept Vasc Surg, Clin Div Surg, Chinese People Liberat Army PLA, 28 Fuxing Rd, Beijing 100853, Peoples R China.
EM maxhtiger@yahoo.cn; guowei3842@yahoo.com.cn; xiaopingliubj@163.com;
   taiyinbj@163.com; xinjiabjj@163.com; jiangxiongbj@163.com;
   hongpengzhangbj@163.com; lijunwangbj@163.com
OI xiong, jiang/0000-0002-9884-1267
CR Bergeron P, 2006, EUR J VASC ENDOVASC, V32, P38, DOI 10.1016/j.ejvs.2005.12.023
   Bergeron P, 2003, J CARDIOVASC SURG, V44, P349
   Brinkman WT, 2007, CURR OPIN CARDIOL, V22, P510, DOI 10.1097/HCO.0b013e3282f04273
   Buth J, 1998, J ENDOVASC SURG, V5, P329, DOI 10.1583/1074-6218(1998)005<0329:CATSGT>2.0.CO;2
   Chuter TAM, 2003, J ENDOVASC THER, V10, P940, DOI 10.1583/1545-1550(2003)010<0940:DOABSF>2.0.CO;2
   Chuter TAM, 2003, J VASC SURG, V38, P859, DOI 10.1016/S0741-5214(03)01023-1
   Conrad MF, 2009, ANN SURG, V250, P383, DOI 10.1097/SLA.0b013e3181b365bd
   Criado FJ, 2002, J VASC SURG, V36, P1121, DOI 10.1067/mva.2002.129649
   Criado FJ, 2002, J ENDOVASC THER, V9, P32, DOI 10.1583/1545-1550-9.sp3.32
   Czerny M, 2007, EUR J CARDIO-THORAC, V31, P623, DOI 10.1016/j.ejcts.2006.12.030
   Drenth DJ, 2003, J THORAC CARDIOV SUR, V126, P1184, DOI 10.1016/S0022-5223(03)00804-3
   Inoue K, 1999, CIRCULATION, V100, P316
   Jacobs MJ, 2001, CARDIOVASC SURG, V9, P396, DOI 10.1016/S0967-2109(01)00009-6
   JEX RK, 1986, J VASC SURG, V3, P226
   Kato N, 2002, CARDIOVASC INTER RAD, V25, P419, DOI 10.1007/s00270-002-0466-7
   Kikuchi Y, 2002, Kyobu Geka, V55, P309
   Kochi K, 2002, J THORAC CARDIOV SUR, V123, P363, DOI 10.1067/mtc.2002.119061
   Kpodonu Jacques, 2007, Perspect Vasc Surg Endovasc Ther, V19, P174, DOI 10.1177/1531003507303427
   Matalanis George, 2003, Ann Thorac Cardiovasc Surg, V9, P174
   Matsuda H, 2002, Kyobu Geka, V55, P340
   Melissano G, 2004, J VASC SURG, V39, P124, DOI 10.1016/S0741-5214(03)01034-6
   Mitchell RS, 2002, J ENDOVASC THER, V9, P98
   Moon MC, 2007, SEMIN VASC SURG, V20, P97, DOI 10.1053/j.semvascsurg.2007.04.007
   Nakai M, 2002, Kyobu Geka, V55, P280
   Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7
   Niinami H, 2003, J CARDIOVASC SURG, V44, P243
   Nitta Y, 2003, J THORAC CARDIOV SUR, V126, P1186, DOI 10.1016/S0022-5223(03)00934-6
   Okita Y, 1999, ANN THORAC SURG, V67, P72, DOI 10.1016/S0003-4975(98)01043-1
   Schoder M, 2009, EUR J VASC ENDOVASC, V38, P255, DOI 10.1016/j.ejvs.2009.06.007
   Schumacher H, 2003, J ENDOVASC THER, V10, P1066, DOI 10.1583/1545-1550(2003)010<1066:EAARWS>2.0.CO;2
   TABAYASHI K, 1993, ANN THORAC SURG, V55, P864, DOI 10.1016/0003-4975(93)90107-S
   WANG WG, 2010, PHYS REV E 2, V81, pNIL24
NR 32
TC 5
Z9 8
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD NOV
PY 2010
VL 11
IS 11
BP 4687
EP 4696
DI 10.3390/ijms11114687
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 684UB
UT WOS:000284575100032
PM 21151464
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Wang, F
   Okamoto, Y
   Inoki, I
   Yoshioka, K
   Du, W
   Qi, X
   Takuwa, N
   Gonda, K
   Yamamoto, Y
   Ohkawa, R
   Nishiuchi, T
   Sugimoto, N
   Yatomi, Y
   Mitsumori, K
   Asano, M
   Kinoshita, M
   Takuwa, Y
AF Wang, Fei
   Okamoto, Yasuo
   Inoki, Isao
   Yoshioka, Kazuaki
   Du, Wa
   Qi, Xun
   Takuwa, Noriko
   Gonda, Koichi
   Yamamoto, Yasuhiko
   Ohkawa, Ryunosuke
   Nishiuchi, Takumi
   Sugimoto, Naotoshi
   Yatomi, Yutaka
   Mitsumori, Kunitoshi
   Asano, Masahide
   Kinoshita, Makoto
   Takuwa, Yoh
TI RETRACTED: Sphingosine-1-phosphate receptor-2 deficiency leads to
   inhibition of macrophage proinflammatory activities and atherosclerosis
   in apoE-deficient mice (Retracted article. See vol. 122, pg. 1131, 2012)
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article; Retracted Publication
ID PROTEIN-COUPLED RECEPTOR; NITRIC-OXIDE SYNTHASE; SPHINGOSINE
   1-PHOSPHATE; REDUCES ATHEROSCLEROSIS; CHOLESTEROL EFFLUX;
   ENDOTHELIAL-CELLS; LESION FORMATION; KINASE PATHWAY; TUMOR-GROWTH;
   RHO-KINASE
AB Sphingosine-1-phosphate (S1P) is a biologically active sphingolipid that has pleiotropic effects in a variety of cell types including ECs, SMCs, and macrophages, all of which are central to the development of atherosclerosis. It may therefore exert stimulatory and inhibitory effects on atherosclerosis. Here, we investigated the role of the S1P receptor S1PR2 in atherosclerosis by analyzing S1pr2(-/-) mice with an Apoe(-/-) background. S1PR2 was expressed in macrophages, ECs, and SMCs in atherosclerotic aortas. In S1pr2(-/-)Apoe(-/-) mice fed a high-cholesterol diet for 4 months, the area of the atherosclerotic plaque was markedly decreased, with reduced macrophage density, increased SMC density, increased eNOS phosphorylation, and downregulation of proinflammatory cytokines compared with S1pr2(+/+)Apoe(-/-) mice. Bone marrow chimera experiments indicated a major role for macrophage S1PR2 in atherogenesis. S1pr2(-/-)Apoe(-/-) macrophages showed diminished Rho/Rho kinase/NF-kappa B (ROCK/NE-kappa B) activity. Consequently, they also displayed reduced cytokine expression, reduced oxidized LDL uptake, and stimulated cholesterol efflux associated with decreased scavenger receptor expression and increased cholesterol efflux transporter expression. S1pr2(-/-)Apoe(-/-) ECs also showed reduced ROCK and NF-kappa B activities, with decreased MCP-1 expression and elevated eNOS phosphorylation. Pharmacologic S1PR2 blockade in S1pr2(+/+)Apoe(-/-) mice diminished the atherosclerotic plaque area in aortas and modified LDL accumulation in macrophages. We conclude therefore that S1PR2 plays a critical role in atherogenesis and may serve as a novel therapeutic target for atherosclerosis.
C1 [Wang, Fei; Okamoto, Yasuo; Inoki, Isao; Yoshioka, Kazuaki; Du, Wa; Qi, Xun; Takuwa, Noriko; Sugimoto, Naotoshi; Takuwa, Yoh] Kanazawa Univ, Dept Physiol, Grad Sch Med, Kanazawa, Ishikawa 9208640, Japan.
   [Inoki, Isao] Kanazawa Univ, Dept Dis Control & Homeostasis, Grad Sch Med, Kanazawa, Ishikawa 9208640, Japan.
   [Takuwa, Noriko] Ishikawa Prefectural Nursing Univ, Dept Hlth Sci & Med, Kahoku, Ishikawa, Japan.
   [Gonda, Koichi] Univ Tokyo, Dept Plast Surg, Grad Sch Med, Tokyo, Japan.
   [Yamamoto, Yasuhiko] Kanazawa Univ, Dept Vasc Biol, Grad Sch Med, Kanazawa, Ishikawa 9208640, Japan.
   [Ohkawa, Ryunosuke; Yatomi, Yutaka] Univ Tokyo, Dept Clin Lab Med, Grad Sch Med, Tokyo, Japan.
   [Nishiuchi, Takumi] Kanazawa Univ, Div Life Sci, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9208640, Japan.
   [Nishiuchi, Takumi] Kanazawa Univ, Div Funct Genom, Adv Sci Res Ctr, Kanazawa, Ishikawa 9208640, Japan.
   [Mitsumori, Kunitoshi] Tokyo Univ Agr Technol, Dept Vet Med, Fuchu, Tokyo, Japan.
   [Asano, Masahide] Kanazawa Univ, Div Transgen Anim Sci, Adv Sci Res Ctr, Kanazawa, Ishikawa 9208640, Japan.
   [Kinoshita, Makoto] Teikyo Univ, Sch Med, Dept Med, Tokyo 173, Japan.
RP Takuwa, Y (reprint author), Kanazawa Univ, Dept Physiol, Grad Sch Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.
EM linakura@med.kanazawa-u.ac.jp; ytakuwa@med.kanazawa-u.ac.jp
RI Ohkawa, Ryunosuke/C-5402-2017; Yoshioka, Kazuaki/G-1038-2013
OI Ohkawa, Ryunosuke/0000-0002-8584-133X; Yoshioka,
   Kazuaki/0000-0002-8631-3846; Nishiuchi, Takumi/0000-0001-9429-5396; Du,
   Wa/0000-0002-1518-7301; TAKUWA, Noriko/0000-0002-4278-2704
FU Ministry of Education, Science, Sports, and Culture of Japan; Japan
   Society for the Promotion of Science; AstraZeneca
FX We thank M. Sasaki for helpful comments on histological analysis. We
   thank M.Okabe for the generous gift of GFP mice and S. Kaneko for the
   use of a cell sorter. We also thank C. Hirose and Y. Mishima for
   secretarial and technical assistance. This work was supported by grants
   from the Ministry of Education, Science, Sports, and Culture of Japan,
   and the Japan Society for the Promotion of Science, and a research grant
   from AstraZeneca.
CR Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593
   Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965
   Argmann CA, 2005, J BIOL CHEM, V280, P22212, DOI 10.1074/jbc.M502761200
   Benitah SA, 2003, MOL BIOL CELL, V14, P3041, DOI 10.1091/mbc.E03-01-0016
   Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788
   Bot I, 2007, CIRCULATION, V115, P2516, DOI 10.1161/CIRCULATIONAHA.106.660472
   Bradley MN, 2007, J CLIN INVEST, V117, P2337, DOI 10.1172/JCI31909
   Du W, 2010, CANCER RES, V70, P772, DOI 10.1158/0008-5472.CAN-09-2722
   Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007
   Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016
   Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2
   Hahn CG, 2005, J COMP NEUROL, V483, P154, DOI 10.1002/cne.20424
   Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008
   Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779
   Inoki I, 2006, BIOCHEM BIOPH RES CO, V346, P293, DOI 10.1016/j.bbrc.2006.05.119
   Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731
   Keul P, 2007, ARTERIOSCL THROM VAS, V27, P607, DOI 10.1161/01.ATV.0000254679.42583.88
   Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399
   Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200
   Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129
   Lepley D, 2005, CANCER RES, V65, P3788, DOI 10.1158/0008-5472.CAN-04-2311
   Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236
   Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257
   Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323
   Lin CI, 2007, BIOCHEM BIOPH RES CO, V355, P895, DOI 10.1016/j.bbrc.2007.02.043
   MacLennan AJ, 2001, EUR J NEUROSCI, V14, P203, DOI 10.1046/j.0953-816x.2001.01634.x
   Mallat Z, 2003, CIRC RES, V93, P884, DOI 10.1161/01.RES.0000099062.55042.9A
   Nofer JR, 2007, CIRCULATION, V115, P501, DOI 10.1161/CIRCULATIONAHA.106.641407
   Nofer JR, 2005, TRENDS CARDIOVAS MED, V15, P265, DOI 10.1016/j.tcm.2005.08.005
   Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004
   Ohkawa R, 2008, ANN CLIN BIOCHEM, V45, P356, DOI 10.1258/acb.2007.007189
   OZAWA K, 2003, Patent No. 2003051876
   Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221
   Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535
   Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796
   Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Ryu Y, 2002, CIRC RES, V90, P325, DOI 10.1161/hh0302.104455
   Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640
   Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103
   Sugimoto N, 2003, MOL CELL BIOL, V23, P1534, DOI 10.1128/MCB.23.5.1534-1545.2003
   Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950
   Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f
   Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452
   Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001
   Tsukamoto Kayo, 2002, J Atheroscler Thromb, V9, P57
   Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E
   Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845
   Wang HW, 2008, FASEB J, V22, P3561, DOI 10.1096/fj.08-108829
   Whetzel AM, 2006, CIRC RES, V99, P731, DOI 10.1161/01.RES.0000244088.33375.52
   Wolfrum S, 2004, ARTERIOSCL THROM VAS, V24, P1842, DOI 10.1161/01.ATV.0000142813.33538.82
   Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372
   Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883
   Zhou Q, 2009, CURR PHARM DESIGN, V15, P3108, DOI 10.2174/138161209789057986
   Zhu SN, 2009, J EXP MED, V206, P2141, DOI 10.1084/jem.20090866
NR 55
TC 48
Z9 50
U1 2
U2 17
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA
SN 0021-9738
J9 J CLIN INVEST
JI J. Clin. Invest.
PD NOV
PY 2010
VL 120
IS 11
BP 3979
EP 3995
DI 10.1172/JCI42315
PG 17
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 672XU
UT WOS:000283621800031
PM 20978351
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Cisterna, R
   Ezpeleta, G
   Telleria, O
   Guinea, J
   Regueiro, B
   Garcia-Rodriguez, J
   Esperalba, J
AF Cisterna, R.
   Ezpeleta, G.
   Telleria, O.
   Guinea, J.
   Regueiro, B.
   Garcia-Rodriguez, J.
   Esperalba, J.
CA Spanish Candidemia Surveillance Gr
TI RETRACTED: Nationwide Sentinel Surveillance of Bloodstream Candida
   Infections in 40 Tertiary Care Hospitals in Spain (Retracted Article.
   See vol 49, pg 1193, 2011)
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article; Retracted Publication
ID SECULAR TRENDS; UNITED-STATES; RISK-FACTORS; ANTIFUNGAL SUSCEPTIBILITY;
   EUROPEAN CONFEDERATION; NOSOCOMIAL CANDIDEMIA; TRANSPLANT RECIPIENTS;
   FUNGAL-INFECTIONS; EPIDEMIOLOGY; MORTALITY
AB Candidemia studies have documented geographic differences in rates and epidemiology, underscoring the need for surveillance to monitor trends. We conducted prospective candidemia surveillance in Spain to assess the incidence, species distribution, frequency of antifungal resistance, and risk factors for acquiring a Candida infection. Prospective laboratory-based surveillance was conducted from June 2008 to June 2009 in 40 medical centers located around the country. A case of candidemia was defined as the isolation of a Candida species from a blood culture. Incidence rates were calculated per 1,000 admissions. Antifungal susceptibility tests were performed by using broth microdilution assay according to the guidelines of the Clinical and Laboratory Standards Institute. We detected 984 cases, for an overall incidence of 1.09 cases per 1,000 admissions. The crude mortality was 20.20%. Candida albicans was the most common species (49.08%), followed by C. parapsilosis (20.73%), C. glabrata (13.61%), and C. tropicalis (10.77%). Overall, decreased susceptibility to fluconazole occurred in 69 (7.01%) incident isolates. Antifungal resistance was rare, and a moderate linear correlation between fluconazole and voriconazole MICs was observed. This is the largest multicenter candidemia study conducted to date and shows the substantial morbidity and mortality of candidemia in Spain.
C1 [Cisterna, R.; Ezpeleta, G.; Telleria, O.] Basurto Hosp, Clin Microbiol & Infect Control Dept, Bilbao 48013, Spain.
   [Guinea, J.] Hosp Univ Gregorio Maranon, Dept Clin Microbiol, Madrid, Spain.
   [Regueiro, B.] Complejo Hosp Univ Santiago, Dept Clin Microbiol, Santiago De Compostela, Spain.
   [Garcia-Rodriguez, J.] Hosp Univ La Paz, Dept Clin Microbiol, Madrid, Spain.
   [Esperalba, J.] Hosp Univ Puerta Hierro, Dept Clin Microbiol, Madrid, Spain.
RP Cisterna, R (reprint author), Basurto Hosp, Clin Microbiol & Infect Control Dept, Ave Montevideo 18, Bilbao 48013, Spain.
EM ramon.cisternacancer@osakidetza.net
RI IBIS, TUBERCULOSIS/O-9334-2015; Camarena Minana, Juan/H-6130-2015;
   Fernandez Natal, Isabel/C-9328-2015
OI Camarena Minana, Juan/0000-0002-9863-6319; Fernandez Natal,
   Isabel/0000-0002-2701-9815; Esperalba, Juliana/0000-0003-1326-1341;
   Regueiro, Benito/0000-0002-4009-7922; Rezusta Lopez,
   Antonio/0000-0001-7294-245X; Peman, Javier/0000-0003-3222-5653
FU Pfizer, Inc.; Basque Foundation for Health Innovation and Research
   (BIOEF)
FX This paper was partially supported by an independent medical grant
   provided by Pfizer, Inc., and The Basque Foundation for Health
   Innovation and Research (BIOEF).
CR Al-Jasser AM, 2004, SAUDI MED J, V25, P566
   Almirante B, 2005, J CLIN MICROBIOL, V43, P1829, DOI 10.1128/JCM.43.4.1829-1835.2005
   Alonso-Valle H, 2003, EUR J CLIN MICROBIOL, V22, P254, DOI 10.1007/s10096-003-0890-x
   Antunes Ana Graciela Ventura, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P239, DOI 10.1590/S0036-46652004000500001
   Asmundsdottir LR, 2002, J CLIN MICROBIOL, V40, P3489, DOI 10.1128/JCM.40.9.3489-3492.2002
   BANERJEE SN, 1991, AM J MED, V91, pS86, DOI 10.1016/0002-9343(91)90349-3
   Blumberg HM, 2001, CLIN INFECT DIS, V33, P177, DOI 10.1086/321811
   Clark TA, 2004, J CLIN MICROBIOL, V42, P4468, DOI 10.1128/JCM.42.10.4468-4472.2004
   Colombo AL, 1999, DIAGN MICR INFEC DIS, V34, P281
   Costa SF, 2000, J HOSP INFECT, V45, P69, DOI 10.1053/jhin.1999.0670
   Diekema DJ, 2002, J CLIN MICROBIOL, V40, P1298, DOI 10.1128/JCM.40.4.1298-1302.2002
   Doczi I, 2002, J MED MICROBIOL, V51, P677, DOI 10.1099/0022-1317-51-8-677
   FRASER VJ, 1992, CLIN INFECT DIS, V15, P414, DOI 10.1093/clind/15.3.414
   Garbino J, 2002, MEDICINE, V81, P425, DOI 10.1097/00005792-200211000-00003
   Girmenia C, 1996, CLIN INFECT DIS, V23, P506, DOI 10.1093/clinids/23.3.506
   Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745
   Imhof A, 2004, CLIN INFECT DIS, V39, P743, DOI 10.1086/423274
   Kao AS, 1999, CLIN INFECT DIS, V29, P1164, DOI 10.1086/313450
   KOMSHIAN SV, 1989, REV INFECT DIS, V11, P379
   Levy I, 1998, CLIN INFECT DIS, V26, P1086, DOI 10.1086/520277
   Lin MY, 2005, ANTIMICROB AGENTS CH, V49, P4555, DOI 10.1128/AAC.49.11.4555-4560.2005
   Luzzati R, 2000, EUR J CLIN MICROBIOL, V19, P602, DOI 10.1007/s100960000325
   Macphail GLP, 2002, MYCOSES, V45, P141, DOI 10.1046/j.1439-0507.2002.00741.x
   Marchetti O, 2004, CLIN INFECT DIS, V38, P311, DOI 10.1086/380637
   Marr KA, 2000, J INFECT DIS, V181, P309, DOI 10.1086/315193
   Messer SA, 2009, J CLIN MICROBIOL, V47, P1942, DOI 10.1128/JCM.02434-08
   Morgan J, 2005, INFECT CONT HOSP EP, V26, P540, DOI 10.1086/502581
   *NAT COMM CLIN LAB, 2002, M27A2 NAT COMM CLIN
   Nguyen MH, 1998, J INFECT DIS, V177, P425, DOI 10.1086/514193
   Nucci M, 1998, INFECT CONT HOSP EP, V19, P846
   Ostrosky-Zeichner L, 2003, ANTIMICROB AGENTS CH, V47, P3149, DOI 10.1128/AAC.47.10.3149-3154.2003
   Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906
   Pasqualotto AC, 2005, INFECT CONT HOSP EP, V26, P553, DOI 10.1086/502583
   Pfaller MA, 2004, J CLIN MICROBIOL, V42, P3142, DOI 10.1128/JCM.42.7.3142-3146.2004
   Pfaller MA, 1998, J CLIN MICROBIOL, V36, P1886
   PITTET D, 1995, ARCH INTERN MED, V155, P1177, DOI 10.1001/archinte.155.11.1177
   Richet H, 2002, CLIN MICROBIOL INFEC, V8, P405, DOI 10.1046/j.1469-0691.2002.00446.x
   San Miguel LG, 2005, INFECT CONT HOSP EP, V26, P548, DOI 10.1086/502582
   Sandven P, 1998, J CLIN MICROBIOL, V36, P3455
   Silva V, 2004, MED MYCOL, V42, P333, DOI 10.1080/13693780410001657153
   Tortorano AM, 2004, EUR J CLIN MICROBIOL, V23, P317, DOI 10.1007/s10096-004-1103-y
   Tortorano AM, 2002, J HOSP INFECT, V51, P297, DOI 10.1053/jhin.2002.1261
   Trick WE, 2002, CLIN INFECT DIS, V35, P627, DOI 10.1086/342300
   Viudes A, 2002, EUR J CLIN MICROBIOL, V21, P767, DOI 10.1007/s10096-002-0822-1
   WEEMS JJ, 1992, CLIN INFECT DIS, V14, P756, DOI 10.1093/clinids/14.3.756
NR 45
TC 60
Z9 62
U1 2
U2 15
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD NOV
PY 2010
VL 48
IS 11
BP 4200
EP 4206
DI 10.1128/JCM.00920-10
PG 7
WC Microbiology
SC Microbiology
GA 672MK
UT WOS:000283588500053
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Dubey, RB
   Hanmandlu, M
   Gupta, SK
AF Dubey, Rash Bihari
   Hanmandlu, Madasu
   Gupta, Suresh Kumar
TI RETRACTED: Risk of Brain Tumors From Wireless Phone Use (Retracted
   article. See vol. 37, pg. 123, 2013)
SO JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
LA English
DT Review; Retracted Publication
DE brain tumors; cell phones; wireless phones; electromagnetic radiations;
   glioma; meningioma; acoustic neuroma
ID CELLULAR-TELEPHONE USE; ORNITHINE DECARBOXYLASE ACTIVITY; NORTH EUROPEAN
   COUNTRIES; INTERPHONE-STUDY-GROUP; ACOUSTIC NEUROMA; MOBILE PHONES;
   CORDLESS TELEPHONES; POOLED ANALYSIS; ELECTROMAGNETIC-FIELDS; TESTICULAR
   CANCER
AB The debate regarding the health effects of low-intensity electromagnetic radiation from sources such as power lines, base stations, and cell phones has recently been reignited. Wireless communication has dramatically influenced our lifestyle; its impact on human health has not been completely assessed. Widespread concern continues in the community about the deleterious effects of radiofrequency radiations on human tissues and the subsequent potential threat of carcinogenesis. Exposure to low-frequency electromagnetic field has been linked to a variety of adverse health outcomes. This article surveys the results of early cell phone studies, where exposure duration was too short to expect tumor genesis, and 2 sets of more recent studies with longer exposure duration: the Interphone studies and the Swedish studies led by Hardell.
C1 [Dubey, Rash Bihari] Apeejay Coll Engn, ICE Dept, Sohna, Gurgaon, India.
   [Hanmandlu, Madasu] IIT, Dept Elect Engn, New Delhi, India.
   [Gupta, Suresh Kumar] Vaish Coll Engn, Rohtak, Haryana, India.
RP Dubey, RB (reprint author), Apeejay Coll Engn, ICE Dept, Sohna, Gurgaon, India.
EM rbdubeyster@gmail.com
CR Agarwal A, 2008, FERTIL STERIL, V89, P124, DOI 10.1016/j.fertnstert.2007.01.166
   Auvinen A, 2002, EPIDEMIOLOGY, V13, P356, DOI 10.1097/00001648-200205000-00018
   AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0
   Baste V, 2008, EUR J EPIDEMIOL, V23, P369, DOI 10.1007/s10654-008-9236-4
   Berg G, 2005, J EXPO ANAL ENV EPID, V15, P217, DOI 10.1038/sj.jea.7500390
   *BTRUS, STAT REP 2002 3 2004
   Cardis E, 2008, PHYS MED BIOL, V53, P2771, DOI 10.1088/0031-9155/53/11/001
   Cardis E, 2007, EUR J EPIDEMIOL, V22, P647, DOI 10.1007/s10654-007-9152-z
   CARLO G, 2000, CELL PHONES INVISIBL
   Christensen HC, 2004, AM J EPIDEMIOL, V159, P277, DOI 10.1093/aje/kwh032
   Christensen HC, 2005, NEUROLOGY, V64, P1189, DOI 10.1212/01.WNL.0000156351.72313.D3
   Croft RJ, 2008, AUSTRALAS PHYS ENG S, V31, P255, DOI 10.1007/BF03178595
   Fejes I, 2005, ARCH ANDROLOGY, V51, P385, DOI 10.1080/014850190924520
   Foster KR, 2000, IEEE T PLASMA SCI, V28, P15, DOI 10.1109/27.842819
   HALMEKYTO M, 1992, BIOCHEM BIOPH RES CO, V187, P493, DOI 10.1016/S0006-291X(05)81521-9
   Han YY, 2009, SURG NEUROL, V72, P216, DOI 10.1016/j.surneu.2009.01.010
   Hardell L, 2006, INT J ONCOL, V28, P509
   Hardell L, 2004, OCCUP ENVIRON MED, V61, P675, DOI 10.1136/oem.2003.011262
   Hardell L, 2007, INT J ANDROL, V30, P115, DOI 10.1111/j.1365-2605.2006.00721.x
   Hardell L, 2006, INT J ANDROL, V29, P228, DOI 10.1111/j.1365-2605.2005.00622.x
   Hardell L, 2006, BRIT MED J, V332, P1035, DOI 10.1136/bmj.332.7548.1035-a
   Hardell L, 2005, OCCUP ENVIRON MED, V62, P390, DOI 10.1136/oem.2004.017434
   Hardell L, 2000, MedGenMed, V2, pE2
   Hardell L, 2003, ENVIRON HEALTH PERSP, V111, P930, DOI 10.1289/ehp.5816
   Hardell L, 2003, INT J ONCOL, V22, P399
   Hardell L., 2008, Open Environmental Journal, V2, P54, DOI 10.2174/1874233500802010054
   Hardell L, 2006, INT ARCH OCC ENV HEA, V79, P630, DOI 10.1007/s00420-006-0088-5
   Hardell L, 2008, INT J ONCOL, V32, P1097
   Hardell Lennart, 2006, World J Surg Oncol, V4, P74, DOI 10.1186/1477-7819-4-74
   Hardell L, 2008, BIOMED PHARMACOTHER, V62, P104, DOI 10.1016/j.biopha.2007.12.004
   Hardell Lennart, 2009, Pathophysiology, V16, P113, DOI 10.1016/j.pathophys.2009.01.003
   Hardell L, 2009, INT J ONCOL, V35, P5, DOI 10.3892/ijo_00000307
   Hepworth SJ, 2006, BRIT MED J, V332, P883, DOI 10.1136/bmj.38720.687975.55
   HERBERMAN R, 2008, INT HERALD TRIB 0724
   HIBSHOOSH H, 1991, ONCOGENE, V6, P739
   Hoffman S, 2006, NEURO-ONCOLOGY, V8, P27, DOI 10.1215/S1522851705000323
   Hours M, 2007, REV EPIDEMIOL SANTE, V55, P321, DOI 10.1016/j.respe.2007.06.002
   Huss A, 2007, ENVIRON HEALTH PERSP, V115, P1
   *IEGMP, OP M THURSD 11 NOV 1
   Inskip PD, 2001, NEW ENGL J MED, V344, P79, DOI 10.1056/NEJM200101113440201
   Kheifets L, 2005, PEDIATRICS, V116, pE303, DOI 10.1542/peds.2004-2541
   Khurana VG, 2009, SURG NEUROL, V72, P205, DOI 10.1016/j.surneu.2009.01.019
   Klaeboe L, 2007, EUR J CANCER PREV, V16, P158, DOI 10.1097/01.cej.0000203616.77183.4c
   Kohli D. R., 2009, Indian Journal of Cancer, V46, P5, DOI 10.4103/0019-509X.48589
   Lahkola A, 2008, INT J EPIDEMIOL, V37, P1304, DOI 10.1093/ije/dyn155
   Lahkola A, 2007, INT J CANCER, V120, P1769, DOI 10.1002/ijc.22503
   LEAN G, 2008, SUNDAY, V30
   LEWI R, 2006, APPL NEUROLOGY
   LIN JC, 2009, IEEE MICROW MAG, P138
   LIN JC, 2005, IEEE MICROW MAG, P28
   LITOVITZ TA, 1991, BIOCHEM BIOPH RES CO, V178, P862, DOI 10.1016/0006-291X(91)90970-I
   Lonn S, 2005, AM J EPIDEMIOL, V161, P526, DOI 10.1093/aje/kwi091
   Lonn S, 2004, EPIDEMIOLOGY, V15, P653, DOI 10.1097/01.ede.0000142519.00772.bf
   Lonn S, 2004, OCCUP ENVIRON MED, V61, P769, DOI 10.1136/oem.2003.012567
   Mild KH, 2007, INT J OCCUP SAF ERGO, V13, P63
   Milham S, 2006, BRIT J CANCER, V94, P1351, DOI 10.1038/sj.bjc.6603068
   Morgan LL, 2006, AM J EPIDEMIOL, V164, P294, DOI 10.1093/aje/kwj229
   Morgan L Lloyd, 2009, Pathophysiology, V16, P137, DOI 10.1016/j.pathophys.2009.01.009
   Morgan LL, 2006, BRIT MED J, V332, P1035, DOI 10.1136/bmj.332.7548.1035-b
   MOSHIER JA, 1993, CANCER RES, V53, P2618
   Muscat JE, 2000, JAMA-J AM MED ASSOC, V284, P3001, DOI 10.1001/jama.284.23.3001
   Newey RJ, 2009, PLOS ONE, V4, pe6446
   *NIH, 2005, STUD RAD FREQ RAD EM
   Phillips J L, 2009, Pathophysiology, V16, P79, DOI 10.1016/j.pathophys.2008.11.005
   Sadetzki S, 2008, AM J EPIDEMIOL, V167, P457, DOI 10.1093/aje/kwm325
   Salford LG, 2003, ENVIRON HEALTH PERSP, V111, P881, DOI 10.1289/ehp.6039
   Schlehofer B, 2007, EUR J CANCER, V43, P1741, DOI 10.1016/j.ejca.2007.05.008
   Schoemaker MJ, 2005, BRIT J CANCER, V93, P842, DOI 10.1038/sj.bjc.6602764
   Schuz J, 2006, AM J EPIDEMIOL, V163, P512, DOI 10.1093/aje/kwj068
   Schuz J, 2006, J NATL CANCER I, V98, P1707, DOI 10.1093/jnci/djj464
   Stang A, 2001, EPIDEMIOLOGY, V12, P7, DOI 10.1097/00001648-200101000-00003
   Takebayashi T, 2008, BRIT J CANCER, V98, P652, DOI 10.1038/sj.bjc.6604214
   Takebayashi T, 2006, OCCUP ENVIRON MED, V63, P802, DOI 10.1136/oem.2006.028308
   Vrijheid M, 2009, J EXPO SCI ENV EPID, V19, P369, DOI 10.1038/jes.2008.27
   Warren HG, 2003, LARYNGOSCOPE, V113, P663, DOI 10.1097/00005537-200304000-00015
   *WHO, 2000, 193 WHO
   Wiart J, 2008, PHYS MED BIOL, V53, P3681, DOI 10.1088/0031-9155/53/13/019
   World Health Organization, 2005, WHAT AR HLTH RISKS A
NR 78
TC 13
Z9 13
U1 5
U2 43
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0363-8715
EI 1532-3145
J9 J COMPUT ASSIST TOMO
JI J. Comput. Assist. Tomogr.
PD NOV-DEC
PY 2010
VL 34
IS 6
BP 799
EP 807
DI 10.1097/RCT.0b013e3181ed9b54
PG 9
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 681WA
UT WOS:000284352800001
PM 21084892
DA 2018-12-27
ER

PT J
AU Jinnin, M
   Ishihara, T
   Boye, E
   Olsen, BR
AF Jinnin, Masatoshi
   Ishihara, Tsuyoshi
   Boye, Eileen
   Olsen, Bjorn R.
TI RETRACTED: Recent progress in studies of infantile hemangioma (Retracted
   Article. See vol 38, pg 107, 2011)
SO JOURNAL OF DERMATOLOGY
LA English
DT Review; Retracted Publication
DE cytokines; endothelial cells; vascular anomalies
ID ENDOTHELIAL GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; BLOOD-VESSEL
   FORMATION; VASCULAR MALFORMATIONS; TRANSCRIPTIONAL REGULATION;
   SIGNAL-TRANSDUCTION; CELL-ADHESION; PATHOLOGICAL ANGIOGENESIS; CLINICAL
   CHARACTERISTICS; CONGENITAL HEMANGIOMAS
AB A hallmark of infantile hemangioma, the most common tumor of infancy, is its dramatic growth after birth, by diffuse proliferation of immature endothelial cells, followed by spontaneous regression. The growth and involution of infantile hemangioma is quite different from other vascular anomalies, which do not regress and can occur at any time during life. Some hemangioma lesions can be extremely disfiguring and destructive to normal tissue and may even be life-threatening. Unfortunately, existing therapeutic approaches have limited success and significant adverse effects of some treatment modalities limit their use. Better understanding of the pathogenesis of hemangioma will enable the development of better therapeutic strategies. Herein, we review recent studies and new hypotheses on the pathogenesis of the tumor. Detailed mechanisms of activated vascular endothelial growth factor (VEGF) signaling in tumor cells, identification of their origin and characterization of multipotent stem cells that can give rise to infantile hemangioma are shedding new light on this intriguing vascular tumor.
C1 [Jinnin, Masatoshi] Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, Grad Sch Med & Pharmaceut Sci, Kumamoto 8608556, Japan.
   [Boye, Eileen; Olsen, Bjorn R.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA.
RP Jinnin, M (reprint author), Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, Grad Sch Med & Pharmaceut Sci, 1-1-1 Honjo, Kumamoto 8608556, Japan.
EM mjin@kumamoto-u.ac.jp
CR Amir J, 1986, Pediatr Dermatol, V3, P331, DOI 10.1111/j.1525-1470.1986.tb00535.x
   Aplin AE, 1998, PHARMACOL REV, V50, P197
   Bakaris S, 2004, PEDIATR DEVEL PATHOL, V7, P258, DOI 10.1007/s10024-003-4042-1
   Barnes CM, 2005, P NATL ACAD SCI USA, V102, P19097, DOI 10.1073/pnas.0509579102
   Barry SM, 2003, BLOOD, V102, P1771, DOI 10.1182/blood-2002-11-3551
   Berard M, 1997, AM J PATHOL, V150, P1315
   Berenguer B, 2003, PEDIATR DEVEL PATHOL, V6, P495, DOI 10.1017/s10024-003-2134-6
   Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232
   Bischoff J, 2002, TRENDS CARDIOVAS MED, V12, P220, DOI 10.1016/S1050-1738(02)00165-2
   Blei F, 1998, ARCH DERMATOL, V134, P718, DOI 10.1001/archderm.134.6.718
   Boscolo E, 2009, ANGIOGENESIS, V12, P197, DOI 10.1007/s10456-009-9148-2
   Boye E, 2001, J CLIN INVEST, V107, P745, DOI 10.1172/JCI11432
   Boye E, 2009, J CRANIOFAC SURG, V20, P678, DOI 10.1097/SCS.0b013e318193d6c1
   Brouillard P, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.024174
   BURROWS PE, 1983, AM J ROENTGENOL, V141, P483, DOI 10.2214/ajr.141.3.483
   BURTON BK, 1995, PRENATAL DIAG, V15, P209, DOI 10.1002/pd.1970150302
   Calicchio ML, 2009, AM J PATHOL, V174, P1638, DOI 10.2353/ajpath.2009.080517
   Carson-Walter EB, 2001, CANCER RES, V61, P6649
   Chang J, 1999, PLAST RECONSTR SURG, V103, P1, DOI 10.1097/00006534-199901000-00001
   Chang LC, 2008, PEDIATRICS, V122, P360, DOI 10.1542/peds.2007-2767
   Cheung DSM, 1997, ANN PLAS SURG, V38, P269, DOI 10.1097/00000637-199703000-00014
   Chiller Katarina G, 2003, Lymphat Res Biol, V1, P267, DOI 10.1089/153968503322758076
   Chiller KG, 2002, ARCH DERMATOL, V138, P1567, DOI 10.1001/archderm.138.12.1567
   Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661
   Dadras SS, 2004, MODERN PATHOL, V17, P1068, DOI 10.1038/modpathol.3800153
   Dosanjh A, 2000, J CUTAN PATHOL, V27, P441, DOI 10.1034/j.1600-0560.2000.027009441.x
   Drolet BA, 1999, NEW ENGL J MED, V341, P173, DOI 10.1056/NEJM199907153410307
   Drolet BA, 2008, J PEDIATR, V153, P712, DOI 10.1016/j.jpeds.2008.05.043
   Dubois J, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781541
   Dubois J, 1998, AM J ROENTGENOL, V171, P247, DOI 10.2214/ajr.171.1.9648798
   Dudziak D, 2003, J VIROL, V77, P8290, DOI 10.1128/JVI.77.15.8290-8298.2003
   Enis DR, 2005, P NATL ACAD SCI USA, V102, P425, DOI 10.1073/pnas.0408357102
   Enjoras O, 2004, ARCH PEDIATRIE, V11, P99, DOI 10.1016/j.arcped.2003.10.014
   Esterly N B, 1996, Curr Probl Pediatr, V26, P3, DOI 10.1016/S0045-9380(96)80023-5
   ESTERLY NB, 1995, CURR PROBL DERMATOL, V7, P65, DOI DOI 10.1016/S1040-0486(09)80020-3
   EZEKOWITZ RAB, 1992, NEW ENGL J MED, V326, P1456, DOI 10.1056/NEJM199205283262203
   Ferrara N, 2005, EXP SUPPL, V94, P209
   Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C
   FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0
   Garzon MC, 2008, ARCH DERMATOL, V144, P1231, DOI 10.1001/archderm.144.9.1231
   Garzon MC, 2005, J AM ACAD DERMATOL, V52, P281, DOI 10.1016/j.jaad.2004.09.004
   Girard C, 2006, ARCH DERMATOL, V142, P884, DOI 10.1001/archderm.142.7.884
   Gorincour G, 2005, PEDIATR RADIOL, V35, P1178, DOI 10.1007/s00247-005-1557-9
   Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8
   Haggstrom AN, 2006, PEDIATRICS, V117, P698, DOI 10.1542/peds.2005-1092
   Haggstrom AN, 2007, J PEDIATR-US, V150, P291, DOI 10.1016/j.jpeds.2006.12.003
   Haggstrom AN, 2006, PEDIATRICS, V118, P882, DOI 10.1542/peds.2006-0413
   Hidano A, 1986, Pediatr Dermatol, V3, P140
   Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703
   HOLMDAHL K, 1955, Acta Paediatr, V44, P370, DOI 10.1111/j.1651-2227.1955.tb04151.x
   Hotchkiss KA, 2005, EXP CELL RES, V305, P133, DOI 10.1016/j.yexcr.2004.12.025
   Huang SA, 2000, NEW ENGL J MED, V343, P185, DOI 10.1056/NEJM200007203430305
   Isik FF, 1996, J SURG RES, V61, P71, DOI 10.1006/jsre.1996.0083
   JACOBS ALVIN H., 1957, CALIFORNIA MED, V86, P8
   Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685
   Jang YC, 2000, J SURG RES, V93, P144, DOI 10.1006/jsre.2000.5973
   Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877
   Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374
   Khan ZA, 2008, J CLIN INVEST, V118, P2592, DOI 10.1172/JCI33493
   Khan ZA, 2006, BLOOD, V108, P915, DOI 10.1182/blood-2006-03-006478
   Kleinman Mark E, 2003, Lymphat Res Biol, V1, P301, DOI 10.1089/153968503322758102
   KONEZ O, 2008, CT MR ANGIOGRAPHY CO, P1118
   Kraling BM, 1996, AM J PATHOL, V148, P1181
   Leaute-Labreze C, 2008, NEW ENGL J MED, V358, P2649, DOI 10.1056/NEJMc0708819
   LEAVESLEY DI, 1993, J CELL BIOL, V121, P163, DOI 10.1083/jcb.121.1.163
   Lei L, 2008, MOL CELL BIOL, V28, P794, DOI 10.1128/MCB.00443-07
   Leon-Villapalos J, 2005, BRIT J PLAST SURG, V58, P348, DOI 10.1016/j.bjps.2004.05.029
   Li Q, 2003, J PATHOL, V201, P296, DOI 10.1002/path.1443
   Mancini AJ, 1996, AM J DERMATOPATH, V18, P505, DOI 10.1097/00000372-199610000-00009
   McCuaig CC, 2009, PEDIATR DERMATOL, V26, P203, DOI 10.1111/j.1525-1470.2008.00857.x
   McKinsey TA, 2000, MOL IMMUNOL, V37, P783, DOI 10.1016/S0161-5890(00)00099-7
   Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590
   Metry DW, 2000, ARCH DERMATOL, V136, P905, DOI 10.1001/archderm.136.7.905
   Metry DW, 2006, AM J MED GENET A, V140A, P975, DOI 10.1002/ajmg.a.31189
   Metz BJ, 2004, ARCH DERMATOL, V140, P867, DOI 10.1001/archderm.140.7.867
   MEYER JS, 1991, AM J ROENTGENOL, V157, P559, DOI 10.2214/ajr.157.3.1872245
   Moroz B, 1982, S VASC MALF MEL LES, P27
   Moukaddam H, 2009, SKELETAL RADIOL, V38, P535, DOI 10.1007/s00256-008-0609-2
   Mulligan-Kehoe MJ, 2008, RHEUM DIS CLIN N AM, V34, P73, DOI 10.1016/j.rdc.2007.12.006
   Mulliken J B, 1993, Semin Vasc Surg, V6, P204
   Mulliken JB, 2004, J AM ACAD DERMATOL, V50, P875, DOI 10.1016/j.jaad.2003.10.670
   MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002
   MULLIKEN JB, 1982, SURGERY, V92, P348
   Mulliken JB, 1999, PEDIATR INT, V14, P132
   MULLIKEN JB, 2000, VASCULAR ANOMALIES, P517
   MULLIKEN JB, 1988, VASCULAR BIRTHMARKS, P64
   Nguyen J, 2009, SEMIN OPHTHALMOL, V24, P178, DOI 10.1080/08820530902805602
   Nguyen VA, 2004, HUM PATHOL, V35, P739, DOI 10.1016/j.humpath.2004.02.005
   North PE, 2006, CARDIOVASC PATHOL, V15, P303, DOI 10.1016/j.carpath.2006.03.001
   North PE, 2000, HUM PATHOL, V31, P11, DOI 10.1016/S0046-8177(00)80192-6
   North PE, 2001, ARCH DERMATOL, V137, P559
   Olferiev M, 2007, J BIOL CHEM, V282, P1738, DOI 10.1074/jbc.M605808200
   PACK G T, 1950, Angiology, V1, P405, DOI 10.1177/000331975000100504
   Pandey A, 2008, OSTOMY WOUND MANAG, V54, P16
   Pandey A, 2009, J PEDIATR SURG, V44, P688, DOI 10.1016/j.jpedsurg.2008.10.038
   PASYK KA, 1984, PLAST RECONSTR SURG, V73, P69, DOI 10.1097/00006534-198401000-00015
   Perry BN, 2006, J INVEST DERMATOL, V126, P2316, DOI 10.1038/sj.jid.5700413
   Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003
   Picard A, 2008, PEDIATR RES, V63, P263, DOI 10.1203/PDR.0b013e318163a243
   Pittman KM, 2006, J INVEST DERMATOL, V126, P2533, DOI 10.1038/sj.jid.5700516
   Pramanik K, 2009, BLOOD, V113, P1184, DOI 10.1182/blood-2008-06-162180
   Przewratil P, 2009, PEDIATR DERMATOL, V26, P399, DOI 10.1111/j.1525-1470.2009.00910.x
   Qian F, 2005, DEV DYNAM, V233, P1163, DOI 10.1002/dvdy.20444
   Regnier S, 2007, BRIT J DERMATOL, V157, P158, DOI 10.1111/j.1365-2133.2007.07922.x
   Ritter Matthew R, 2003, Lymphat Res Biol, V1, P291, DOI 10.1089/153968503322758094
   Ritter MR, 2002, P NATL ACAD SCI USA, V99, P7455, DOI 10.1073/pnas.102185799
   Ritter MR, 2006, AM J PATHOL, V168, P621, DOI 10.2353/ajpath.2006.050618
   Roberts DM, 2004, AM J PATHOL, V164, P1531, DOI 10.1016/S0002-9440(10)63711-X
   Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003
   SANGUEZA OP, 2003, CURRENT CLIN PATHOLO, P136
   Sato Y, 2000, ANN NY ACAD SCI, V902, P201
   SCHWARTZ MA, 1993, J CELL BIOL, V120, P1003, DOI 10.1083/jcb.120.4.1003
   Shan SG, 2009, J HUAZHONG U SCI-MED, V29, P335, DOI 10.1007/s11596-009-0314-y
   SHAW WC, 1981, BRIT J PLAST SURG, V34, P237, DOI 10.1016/0007-1226(81)90001-1
   Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012
   Shibuya M, 2001, INT J BIOCHEM CELL B, V33, P409, DOI 10.1016/S1357-2725(01)00026-7
   Shih I-Hsin, 2007, Chang Gung Med J, V30, P220
   Sjaastad MD, 1997, BIOESSAYS, V19, P47, DOI 10.1002/bies.950190109
   SLOAN GM, 1989, PLAST RECONSTR SURG, V83, P459, DOI 10.1097/00006534-198903000-00009
   SMOLLER BR, 1993, J CUTAN PATHOL, V20, P330, DOI 10.1111/j.1600-0560.1993.tb01271.x
   St Croix B, 2000, SCIENCE, V289, P1197
   Stockman A, 2007, DERMATOLOGY, V214, P40, DOI 10.1159/000096911
   TAKAHASHI K, 1994, J CLIN INVEST, V93, P2357, DOI 10.1172/JCI117241
   Tan ST, 2004, PLAST RECONSTR SURG, V113, P999, DOI 10.1097/01.PRS.0000105683.10752.A6
   Timur AA, 2005, CELL MOL LIFE SCI, V62, P1434, DOI 10.1007/s00018-005-4523-7
   Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0
   Wakiya K, 1996, J BIOL CHEM, V271, P30823, DOI 10.1074/jbc.271.48.30823
   Walter JW, 2002, GENE CHROMOSOME CANC, V33, P295, DOI 10.1002/gcc.10028
   Walter JW, 1999, AM J MED GENET, V82, P77, DOI 10.1002/(SICI)1096-8628(19990101)82:1<77::AID-AJMG15>3.0.CO;2-A
   Waner M, 2003, ARCH DERMATOL, V139, P869, DOI 10.1001/archderm.139.7.869
   Yu HJ, 2009, MED HYPOTHESES, V73, P495, DOI 10.1016/j.mehy.2009.06.015
   Yu Y, 2001, AM J PATHOL, V159, P2271, DOI 10.1016/S0002-9440(10)63077-5
   Yu Y, 2006, STEM CELLS, V24, P1605, DOI 10.1634/stemcells.2005-0298
   Zhang L, 2005, PLAST RECONSTR SURG, V116, P200, DOI 10.1097/01.PRS.0000170804.80834.5F
   Zhang Li, 2006, Zhonghua Wai Ke Za Zhi, V44, P186
   Zvulunov A, 2002, CLIN DERMATOL, V20, P660, DOI 10.1016/S0738-081X(02)00287-0
NR 136
TC 14
Z9 19
U1 3
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0385-2407
EI 1346-8138
J9 J DERMATOL
JI J. Dermatol.
PD NOV
PY 2010
VL 37
IS 11
BP 939
EP 955
DI 10.1111/j.1346-8138.2010.00927.x
PG 17
WC Dermatology
SC Dermatology
GA 674CK
UT WOS:000283711100001
PM 21039783
DA 2018-12-27
ER

PT J
AU Sanna, LJ
   Lundberg, KB
   Parks, CD
   Chang, EC
AF Sanna, Lawrence J.
   Lundberg, Kristjen B.
   Parks, Craig D.
   Chang, Edward C.
TI RETRACTED: Think and act globally, think and act locally: Cooperation
   depends on matching construal to action levels in social dilemmas
   (Retracted article. See vol. 49, pg. 317, 2013)
SO JOURNAL OF EXPERIMENTAL SOCIAL PSYCHOLOGY
LA English
DT Article; Retracted Publication
DE Social dilemmas; Cooperation; Construal level; Construal Level Theory
   (CLT)
ID TEMPORAL DISTANCE; CONCRETE MINDSETS; EVENTS; VALUES; GOALS
AB The authors proposed and tested hypotheses that cooperation in social dilemmas depends on matching construal to action levels. Using a computerized resource dilemma that modeled fishing the oceans, when motives were framed at abstract levels, in terms of values (e.g., cooperation vs. competition), high construal levels produced more cooperativeness and competitiveness, respectively. Conversely, when motives were framed at concrete levels, in terms of actions (e.g., returning vs. taking), low construal levels produced more cooperativeness and competitiveness, respectively. Implications for integrating and extending research on construal levels in social dilemmas and increasing cooperation are discussed. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Sanna, Lawrence J.; Lundberg, Kristjen B.] Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA.
   [Sanna, Lawrence J.] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA.
   [Parks, Craig D.] Washington State Univ, Dept Psychol, Pullman, WA 99164 USA.
   [Chang, Edward C.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.
RP Sanna, LJ (reprint author), Univ N Carolina, Dept Psychol, CB 3270 Davie Hall, Chapel Hill, NC 27599 USA.
EM sanna@unc.edu
OI Parks, Craig/0000-0001-5299-093X
CR Agerstrom J, 2009, SOC COGNITION, V27, P261, DOI 10.1521/soco.2009.27.2.261
   Bargh JA, 2001, J PERS SOC PSYCHOL, V81, P1014, DOI 10.1037//0022-3514.81.6.1014
   Carter SE, 2008, J EXP SOC PSYCHOL, V44, P1339, DOI 10.1016/j.jesp.2008.03.017
   Eyal T, 2008, J EXP SOC PSYCHOL, V44, P1204, DOI 10.1016/j.jesp.2008.03.012
   Eyal T, 2009, J EXP SOC PSYCHOL, V45, P35, DOI 10.1016/j.jesp.2008.07.023
   Freitas AL, 2004, J EXP SOC PSYCHOL, V40, P739, DOI 10.1016/j.jesp.2004.04.003
   Freitas AL, 2009, J RES PERS, V43, P938, DOI 10.1016/j.jrp.2009.05.006
   Fujita K, 2006, J PERS SOC PSYCHOL, V90, P351, DOI 10.1037/0022-3514.90.3.351
   Fujita K, 2006, PSYCHOL SCI, V17, P278, DOI 10.1111/j.1467-9280.2006.01698.x
   Fujita K, 2008, J EXP SOC PSYCHOL, V44, P562, DOI 10.1016/j.jesp.2007.10.005
   Fujita K, 2008, SOC PERSONAL PSYCHOL, V2, P1475, DOI 10.1111/j.1751-9004.2008.00118.x
   GIACOMANTONIO M, J EXPT SOCI IN PRESS
   HARDIN G, 1968, SCIENCE, V162, P1243
   Henderson MD, 2006, J PERS SOC PSYCHOL, V91, P712, DOI 10.1037/0022-3514.91.4.712
   KELLEY HH, 2003, ATLAS INTERPERSONAL
   Komorita S.S, 1996, SOCIAL DILEMMAS
   Liberman N, 2002, J EXP SOC PSYCHOL, V38, P523, DOI 10.1016/S0022-1031(02)00535-8
   Liberman N, 2007, J EXP SOC PSYCHOL, V43, P143, DOI 10.1016/j.jesp.2005.12.009
   Messick D. M., 1983, REV PERSONALITY SOCI, V4, P11
   Nussbaum S, 2003, J PERS SOC PSYCHOL, V84, P485, DOI 10.1037/0022-3514.84.3.485
   Parks C. D., 1999, GROUP PERFORMANCE IN
   Rosenthal R., 2000, CONTRASTS EFFECT SIZ
   Sanna LJ, 2009, PSYCHOL SCI, V20, P1319, DOI 10.1111/j.1467-9280.2009.02458.x
   Sanna LJ, 2003, GROUP DYN-THEOR RES, V7, P26, DOI 10.1037/1089-2699.7.1.26
   Schroeder D. A, 1995, SOCIAL DILEMMAS
   Torelli CJ, 2009, J PERS SOC PSYCHOL, V96, P231, DOI 10.1037/a0013836
   Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403
NR 27
TC 11
Z9 11
U1 1
U2 33
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-1031
EI 1096-0465
J9 J EXP SOC PSYCHOL
JI J. Exp. Soc. Psychol.
PD NOV
PY 2010
VL 46
IS 6
BP 1126
EP 1129
DI 10.1016/j.jesp.2010.05.018
PG 4
WC Psychology, Social
SC Psychology
GA 682YZ
UT WOS:000284440200040
DA 2018-12-27
ER

PT J
AU Caramia, F
   Tinelli, E
   Francia, A
   Pozzilli, C
AF Caramia, Francesca
   Tinelli, E.
   Francia, A.
   Pozzilli, C.
TI RETRACTED: Cognitive deficits in multiple sclerosis: a review of
   functional MRI studies (Retracted article. See vol. 33, pg. 483, 2012)
SO NEUROLOGICAL SCIENCES
LA English
DT Article; Retracted Publication
DE Multiple sclerosis; Functional MRI; Cognition
ID RELAPSING-REMITTING MS; WORKING-MEMORY; BRAIN REORGANIZATION; ACTIVATION
   PATTERNS; FMRI; ATTENTION; PERFORMANCE; TASKS; DYSFUNCTION; IMPAIRMENT
AB Cognitive dysfunction frequently occurs during the course of multiple sclerosis (MS). In patients with MS the severity of cognitive manifestations is not closely related to indices of structural brain damage. Neuroplasticity may contribute to the maintenance of normal performance despite scattered brain lesions. Changes in functional organization of the cerebral cortex have been reported by functional magnetic resonance imaging (fMRI) studies in MS. fMRI studies provide an interesting way of understanding how the brain changes its functional organization in response to MS, and might be useful in the study of the effects of rehabilitative or pharmacological therapy on brain plasticity. The purpose of this review is to examine major fMRI studies focusing on cognitive dysfunction in MS.
C1 [Caramia, Francesca; Tinelli, E.; Francia, A.; Pozzilli, C.] Univ Roma La Sapienza, Dept Neurol Sci, I-00185 Rome, Italy.
RP Caramia, F (reprint author), Univ Roma La Sapienza, Dept Neurol Sci, Viale Univ 30, I-00185 Rome, Italy.
EM francesca.caramia@uniroma1.it
FU Sanofi Aventis; Merck Serono; Bayer Schering
FX C. Pozzilli received honoraria for consultancy or speaking from Sanofi
   Aventis, Biogen, Bayer schering, Merck Serono and Novartis and received
   research grants from Sanofi Aventis, Merck Serono and Bayer Schering. E.
   Tinelli, F. Caramia and A. Francia declare that they have no conflict of
   interest related to the publication of this article.
CR Bobholz JA, 2006, NEUROLOGY, V67, P1640, DOI 10.1212/01.wnl.0000242885.71725.76
   Chiaravalloti ND, 2005, J CLIN EXP NEUROPSYC, V27, P33, DOI 10.1080/138033990513609
   DeLuca J, 2008, J NEUROL SCI, V270, P28, DOI 10.1016/j.jns.2008.01.018
   Forn C, 2007, HUM BRAIN MAPP, V28, P424, DOI 10.1002/hbm.20284
   Genova HM, 2009, J INT NEUROPSYCH SOC, V15, P383, DOI 10.1017/S1355617709090535
   Hillary FG, 2003, J CLIN EXP NEUROPSYC, V25, P965, DOI 10.1076/jcen.25.7.965.16490
   Lazeron RHC, 2004, MULT SCLER, V10, P549, DOI 10.1191/1352458504ms1072oa
   Mainero C, 2006, J NEUROL SCI, V245, P93, DOI 10.1016/j.jns.2005.08.024
   Mainero C, 2004, NEUROIMAGE, V21, P858, DOI 10.1016/j.neuroimage.2003.10.004
   Nebel K, 2007, BRAIN RES, V1151, P150, DOI 10.1016/j.brainres.2007.03.007
   Penner IK, 2003, J NEUROL, V250, P461, DOI 10.1007/s00415-003-1025-0
   POZZILLI C, 1993, J NEUROL SCI, V115, pS55, DOI 10.1016/0022-510X(93)90210-P
   RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685
   Rocca MA, 2010, NEUROLOGY, V74, P1252, DOI 10.1212/WNL.0b013e3181d9ed91
   Staffen W, 2002, BRAIN, V125, P1275, DOI 10.1093/brain/awf125
   Sumowski JF, 2010, BRAIN, V133, P362, DOI 10.1093/brain/awp307
   Sweet LH, 2004, J NEUROIMAGING, V14, P150, DOI 10.1177/1051228403262695
   Tiemann L, 2009, MULT SCLER J, V15, P1164, DOI 10.1177/1352458509106853
   Tinelli E, 2009, MULT SCLER, V15, pS211
   Wishart HA, 2004, NEUROLOGY, V62, P234, DOI 10.1212/01.WNL.0000103238.91536.5F
NR 20
TC 7
Z9 7
U1 3
U2 17
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD NOV
PY 2010
VL 31
SU 2
BP 239
EP 243
DI 10.1007/s10072-010-0379-1
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 687LA
UT WOS:000284778800008
DA 2018-12-27
ER

PT J
AU Smiri, M
   Chaoui, A
   Rouhier, N
   Gelhaye, E
   Jacquot, JP
   El Ferjani, E
AF Smiri, Moez
   Chaoui, Abdelilah
   Rouhier, Nicolas
   Gelhaye, Eric
   Jacquot, Jean-Pierre
   El Ferjani, Ezzedine
TI RETRACTED: Redox regulation of the glutathione
   reductase/iso-glutaredoxin system in germinating pea seed exposed to
   cadmium (Retracted article. See vol. 188, pg. 111, 2012)
SO PLANT SCIENCE
LA English
DT Article; Retracted Publication
DE Cadmium; Germination; Glutaredoxin; Pisum sativum
ID PISUM-SATIVUM L.; ANTIOXIDATIVE ENZYMES; COPPER STRESS; NITRIC-OXIDE;
   VICIA-FABA; PLANTS; METABOLISM; MITOCHONDRIA; LEAVES; ACID
AB The present work aims at understanding the regulation of the glutathione/glutathione reductase/glutaredoxin system (GSH/GR/GRX) in plant, namely the transition from heterotrophic growth to photoautotrophic metabolism in seedlings. Pea seeds were analyzed between 0 and 5 days. This study compares seedlings grown in the presence or absence of external cadmium. GSH/GR/GRX system was studied separately in cotyledons that mainly serve to reserve breakdown and in embryonic axes that prepare for cell elongation and cell division associated with radicle emergence. We made extracts of the proteins at various stages of the development, quantify their protein content and use them for activity measurements and estimation of specific protein levels. Cadmium caused a reduction of the total glutathione content. The levels of glutaredoxin C4 (GRX C4) and glutaredoxin 512 (GRX S12) showed a Cd-dependent increase, although GRX activity was depressed. Glutathione reductase activity was significantly reduced by cadmium. However, Cd treatment provoked a strong induction in protein level and activity of glutathione peroxidase (GPX). The disturbances in the resumption of redox metabolism may be a contributory cause of deleterious effect of cadmium on pea seed germination. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
C1 [Smiri, Moez; Rouhier, Nicolas; Gelhaye, Eric; Jacquot, Jean-Pierre] INRA Univ Henri Poincare, IFR110, Fac Sci, Unite Mixte Rech, F-54506 Vandoeuvre Les Nancy, France.
   [Smiri, Moez; Chaoui, Abdelilah; El Ferjani, Ezzedine] Fac Sci Bizerte, Zarzouna 7021, Tunisia.
RP Smiri, M (reprint author), INRA Univ Henri Poincare, IFR110, Fac Sci, Unite Mixte Rech, 1136 Interact Arbres Microorganismes,BP 239, F-54506 Vandoeuvre Les Nancy, France.
EM moez.smiri@scbiol.uhp-nancy.fr
RI gelhaye, eric/K-7390-2013
OI gelhaye, eric/0000-0002-0699-9113; Jacquot,
   Jean-Pierre/0000-0003-4975-8587
FU Tunisian Ministry of Higher Education, Scientific Research, and
   Technology; INRA-Henri Poincare University
FX The authors would like to thank all colleagues who have made this
   contribution possible. We are also thankful to two anonymous reviewers
   for helpful comments on the manuscript. Financial support for this work
   was received from the Tunisian Ministry of Higher Education, Scientific
   Research, and Technology and INRA-Henri Poincare University (French).
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Aina R, 2007, ENVIRON EXP BOT, V59, P381, DOI 10.1016/j.envexpbot.2006.04.010
   ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548
   Bansal P, 2002, BIOL PLANTARUM, V45, P125, DOI 10.1023/A:1015173112842
   BANSAL P., 2000, INDIAN J ENV ECOPLAN, V3, P249
   Barroso JB, 2006, J EXP BOT, V57, P1785, DOI 10.1093/jxb/erj175
   Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055
   BITTELL JE, 1974, PHYSIOL PLANTARUM, V30, P226, DOI 10.1111/j.1399-3054.1974.tb03648.x
   CARLSON CL, 1991, WATER AIR SOIL POLL, V59, P231, DOI 10.1007/BF00211832
   Chaoui A, 2005, CR BIOL, V328, P23, DOI 10.1016/j.crvi.2004.10.001
   Chaoui A, 2004, J PLANT PHYSIOL, V161, P1225, DOI 10.1016/j.jplph.2004.02.002
   Chaoui A, 1997, PLANT SCI, V126, P21, DOI 10.1016/S0168-9452(97)00090-3
   Chugh LK, 1996, ENVIRON POLLUT, V92, P1, DOI 10.1016/0269-7491(95)00093-3
   Corpas FJ, 1998, BIOCHEM J, V330, P777
   Corpas FJ, 2008, J PLANT PHYSIOL, V165, P1319, DOI 10.1016/j.jplph.2008.04.004
   EDWARDS EA, 1994, PLANTA, V192, P137
   Ernst W. H. O., 1998, BIOACCUMULATION BIOL, P587
   FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001
   KESSELER A, 1994, EUR J BIOCHEM, V225, P897, DOI 10.1111/j.1432-1033.1994.0897b.x
   Lemaire S, 1999, PLANT PHYSIOL, V120, P773, DOI 10.1104/pp.120.3.773
   Leon AM, 2002, PLANT PHYSIOL BIOCH, V40, P813, DOI 10.1016/S0981-9428(02)01444-4
   Mihoub A, 2005, CR BIOL, V328, P33, DOI 10.1016/j.crvi.2004.10.003
   Munzuroglu O, 2002, ARCH ENVIRON CON TOX, V43, P203, DOI 10.1007/s00244-002-1116-4
   MURRAY DR, 1979, PLANTA, V147, P111, DOI 10.1007/BF00389509
   Nagalakshmi N, 2001, PLANT SCI, V160, P291, DOI 10.1016/S0168-9452(00)00392-7
   Navrot N, 2006, PLANT PHYSIOL, V142, P1364, DOI 10.1104/pp.106.089458
   NAWA Y, 1971, PLANT PHYSIOL, V48, P671, DOI 10.1104/pp.48.6.671
   Noriega GO, 2007, BIOMETALS, V20, P841, DOI 10.1007/s10534-006-9077-0
   Posmyk MM, 2009, ECOTOX ENVIRON SAFE, V72, P596, DOI 10.1016/j.ecoenv.2008.04.024
   Rahoui S, 2008, ACTA PHYSIOL PLANT, V30, P451, DOI 10.1007/s11738-008-0142-x
   Rodriguez-Serrano M, 2006, PLANT CELL ENVIRON, V29, P1532, DOI 10.1111/j.1365-3040.2006.01531.x
   Rodriguez-Serrano M, 2009, PLANT PHYSIOL, V150, P229, DOI 10.1104/pp.108.131524
   Romanowska E, 2002, PHYSIOL PLANTARUM, V116, P148, DOI 10.1034/j.1399-3054.2002.1160203.x
   Romero-Puertas MC, 2007, J PLANT PHYSIOL, V164, P1346, DOI 10.1016/j.jplph.2006.06.018
   Romero-Puertas MC, 1999, FREE RADICAL RES, V31, P25
   Rouhier N, 2004, CELL MOL LIFE SCI, V61, P1266, DOI 10.1007/s00018-004-3410-y
   Rouhier N, 2002, FEBS LETT, V511, P145, DOI 10.1016/S0014-5793(01)03302-6
   Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811
   Saher S, 2005, PLANT PHYSIOL BIOCH, V43, P573, DOI 10.1016/j.plaphy.2005.05.006
   Shetty P, 2002, PROCESS BIOCHEM, V37, P1285, DOI 10.1016/S0032-9592(02)00013-4
   Smiri M, 2009, J PLANT PHYSIOL, V166, P259, DOI 10.1016/j.jplph.2008.05.006
   STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053
   Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI [10.1089/ars.2008.2331, 10.1089/ARS.2008.2331]
   Vazquez S, 2009, PLANT PHYSIOL BIOCH, V47, P63, DOI 10.1016/j.plaphy.2008.09.010
   WAGNER GJ, 1993, ADV AGRON, V51, P173, DOI 10.1016/S0065-2113(08)60593-3
   WALK RA, 1977, PLANTA, V134, P277, DOI 10.1007/BF00384194
   Wojtyla L, 2006, J PLANT PHYSIOL, V163, P1207, DOI 10.1016/j.jplph.2006.06.014
   Yamamoto Y, 2002, PLANT PHYSIOL, V128, P63, DOI 10.1104/pp.128.1.63
   Yannarelli GG, 2007, PHYTOCHEMISTRY, V68, P505, DOI 10.1016/j.phytochem.2006.11.016
   Yano H, 2001, PLANT CELL PHYSIOL, V42, P879, DOI 10.1093/pcp/pce119
   ZHAO ZF, 1987, PLANT PHYSIOL, V84, P987, DOI 10.1104/pp.84.4.987
NR 51
TC 4
Z9 4
U1 2
U2 33
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-9452
J9 PLANT SCI
JI Plant Sci.
PD NOV
PY 2010
VL 179
IS 5
BP 423
EP 436
DI 10.1016/j.plantsci.2010.06.015
PG 14
WC Biochemistry & Molecular Biology; Plant Sciences
SC Biochemistry & Molecular Biology; Plant Sciences
GA 664XM
UT WOS:000282997300002
PM 21802601
DA 2018-12-27
ER

PT J
AU Nasiri, S
   Karimifar, M
   Bonakdar, ZS
   Salesi, M
AF Nasiri, Siavash
   Karimifar, Mansoor
   Bonakdar, Zahra Sayed
   Salesi, Mansour
TI RETRACTED: Correlation of ESR, C3, C4, anti-DNA and lupus activity based
   on British Isles Lupus Assessment Group Index in patients of
   rheumatology clinic (Retracted article. See vol. 36, pg. 749, 2016)
SO RHEUMATOLOGY INTERNATIONAL
LA English
DT Article; Retracted Publication
DE Systemic lupus erythematosus; ESR; C3; C4; Anti-dsDNA; BILAG index;
   SLEDAI-2K
ID DISEASE-ACTIVITY INDEXES; ERYTHEMATOSUS ACTIVITY; REVISED CRITERIA;
   GENETIC-BASIS; VALIDATION; CLASSIFICATION; DR3
AB This study aimed to determine the correlation between of ESR, C3, C4, anti-DNA, and lupus activity and also the construct and criterion validity of the British Isles Lupus Assessment Group (BILAG) index for assessing disease activity in systemic lupus erythematosus (SLE). Patients with SLE were recruited into a cross-sectional study. Data were analyzed for estimating of SLE disease activity [scores on the BILAG index and Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K)]. Overall BILAG scores were determined by the highest score achieved in any of the individual systems in the respective index. Erythrocyte sedimentation rates (ESRs), C3 levels, C4 levels, anti-double-stranded DNA (anti-dsDNA) levels, and SLEDAI-2K scores were used in the analysis of construct validity. Statistical analyses were performed using ordinal logistic regression for construct validity. Of the 100 patients with SLE, 90% were women. Their mean +/- A SD age was 31.1 +/- A 9.8 years. Increasing overall scores on the BILAG index were associated with increasing ESRs, decreasing C3 levels, decreasing C4 levels, elevated anti-dsDNA levels, and increasing SLEDAI-2K scores (all P < 0.01). These findings show that the ESR, C3, C4, and anti-DNA should be used in the evaluation and management of patients with SLE. Also the results show that the BILAG index has construct validity.
C1 [Nasiri, Siavash; Karimifar, Mansoor; Bonakdar, Zahra Sayed; Salesi, Mansour] Isfahan Univ Med Sci, Dept Rheumatol, Alzahra Hosp, Esfahan, Iran.
RP Karimifar, M (reprint author), Isfahan Univ Med Sci, Dept Rheumatol, Alzahra Hosp, Soffe Ave, Esfahan, Iran.
EM Drnasiri1352@yahoo.com; Mansoor_karimifar@yahoo.com;
   bonakdar@med.mui.ac.ir; mansour1380@yahoo.com
RI Karimifar, Mansoor/D-2074-2018
OI Karimifar, Mansoor/0000-0003-4688-991X; Sayedbonakdar,
   Zahra/0000-0003-1814-921X
CR BATCHELOR JR, 1987, CLIN EXP IMMUNOL, V70, P364
   Davas EM, 1999, CLIN RHEUMATOL, V18, P17, DOI 10.1007/s100670050045
   DAVIES EJ, 1993, BRIT J RHEUMATOL, V32, P870
   Gladman DD, 2002, J RHEUMATOL, V29, P288
   GLADMAN DD, 1992, J RHEUMATOL, V19, P608
   GLADMAN DD, 1994, J RHEUMATOL, V21, P1468
   GUZMAN J, 1992, J RHEUMATOL, V19, P1551
   HARTUNG K, 1992, RHEUMATOL INT, V11, P243, DOI 10.1007/BF00301501
   HAY EM, 1993, Q J MED, V86, P447
   Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
   Illei GG, 2002, ARTHRITIS RHEUM, V46, P995, DOI 10.1002/art.10142
   Isenberg DA, 2005, RHEUMATOLOGY, V44, P902, DOI 10.1093/rheumatology/keh624
   LIANG MH, 1988, ARTHRITIS RHEUM, V31, P817, DOI 10.1002/art.1780310701
   Price P, 1999, IMMUNOL REV, V167, P257, DOI 10.1111/j.1600-065X.1999.tb01398.x
   PROVOST TT, 1988, J INVEST DERMATOL, V914, P369
   Schoof RA, 2005, J ENVIRON QUAL, V34, P114, DOI 10.2134/jeq2005.0114
   TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101
   Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x
   Wollaston SJ, 2004, J RHEUMATOL, V31, P2390
   Yee CS, 2006, ARTHRITIS RHEUM-US, V54, P3300, DOI 10.1002/art.22162
NR 20
TC 16
Z9 16
U1 3
U2 6
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0172-8172
EI 1437-160X
J9 RHEUMATOL INT
JI Rheumatol. Int.
PD NOV
PY 2010
VL 30
IS 12
BP 1605
EP 1609
DI 10.1007/s00296-009-1201-3
PG 5
WC Rheumatology
SC Rheumatology
GA 671KK
UT WOS:000283503200009
PM 19809816
DA 2018-12-27
ER

PT J
AU Li, W
   Kong, XH
   Ruan, M
   Ma, FM
   Jiang, YF
   Liu, MZ
   Chen, Y
   Zuo, XH
AF Li, W.
   Kong, X. H.
   Ruan, M.
   Ma, F. M.
   Jiang, Y. F.
   Liu, M. Z.
   Chen, Y.
   Zuo, X. H.
TI RETRACTED: Green waxes, adhesives and lubricants (Retracted article. See
   vol. 370, pg. 3269, 2012)
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Review; Retracted Publication
DE waxes; adhesives; lubricants; green materials
ID OIL-BASED POLYURETHANE; LOW-TEMPERATURE PROPERTIES; EPOXIDIZED SOYBEAN
   OIL; MODIFIED VEGETABLE-OILS; FISCHER-TROPSCH WAXES; ALPHA-HYDROXY
   ETHERS; PHYSICAL-PROPERTIES; OXIDATIVE STABILITY; BASE-STOCKS; CANOLA
   OIL
AB General characteristics of waxes, adhesives and lubricants as well as the recent fundamental investigations on their physical and mechanical behaviour are introduced. The current R&D status for new type/generation of waxes, adhesives and lubricants from natural products is reviewed, with an emphasis on their tribological applications. In particular, some crucial issues and challenges relating to technological improvement and materials development are discussed. Based on the current predicted shortage of energy resources and environmental concerns, prospective research on the development of green waxes, adhesives and lubricants is suggested.
C1 [Kong, X. H.] Huangshi Inst Technol, Sch Chem & Mat Engn, Huangshi 435003, Peoples R China.
   Huangshi Inst Technol, Hubei Key Lab Environm Pollut Control & Resources, Huangshi 435003, Peoples R China.
RP Kong, XH (reprint author), Huangshi Inst Technol, Sch Chem & Mat Engn, Huangshi 435003, Peoples R China.
EM xkong@ualberta.ca
FU Science Foundation of HuBei Provincial Department of Education
   [Z20104401]
FX The authors would like to acknowledge the financial support from the
   Science Foundation of HuBei Provincial Department of Education
   (Z20104401).
CR Adamczewska J. Z., 1997, J SYNTH LUBR, V14, P129, DOI DOI 10.1002/JSL.3000140203
   Adhvaryu A, 2006, IND ENG CHEM RES, V45, P928, DOI 10.1021/ie0509185
   Adhvaryu A, 2004, WEAR, V257, P359, DOI 10.1016/j.wear.2004.01.005
   Aluyor EO, 2009, SCI RES ESSAYS, V4, P543
   Anand O, 1998, J SYNTH LUBR, V15, P97, DOI DOI 10.1002/JSL.3000150203
   Anwar M, 1999, PET SCI TECHNOL, V17, P491, DOI 10.1080/10916469908949730
   Arnsek A, 2001, LUBR ENG, V57, P17
   Arnsek A, 1999, LUBR ENG, V55, P11
   ARNSEK A., 1999, J SYNTH LUBR, V16, P281, DOI DOI 10.1002/JSL.3000160402
   Asadauskas S, 1996, LUBR ENG, V52, P877
   Badri KH, 2006, J APPL POLYM SCI, V100, P1759, DOI 10.1002/app.23015
   BASSON I, 1988, J PHYS D APPL PHYS, V21, P1429, DOI 10.1088/0022-3727/21/9/017
   BASSON I, 1992, CHEM PHYS LETT, V198, P367, DOI 10.1016/0009-2614(92)85066-J
   Birova A, 2002, J SYNTH LUBR, V18, P291, DOI DOI 10.1002/JSL.3000180405
   Bokade VV, 2007, PROCESS SAF ENVIRON, V85, P372, DOI 10.1205/psep06073
   BORSINGER GG, 2007, Patent No. 7267743
   BORSINGER GG, 2005, Patent No. 6890982
   Cappillino P, 2003, IND CROP PROD, V17, P177, DOI 10.1016/S0926-6690(02)00096-1
   Carelli AA, 2002, J AM OIL CHEM SOC, V79, P763, DOI 10.1007/s11746-002-0556-9
   Castro W, 2006, J AM OIL CHEM SOC, V83, P47, DOI 10.1007/s11746-006-1174-2
   CHALLINOR CJ, 1969, CHEM PHYS LIPIDS, V3, P145, DOI 10.1016/0009-3084(69)90005-X
   COFFEY GL, 1997, Patent No. 5691285
   Coscione AR, 2005, J AGR FOOD CHEM, V53, P2088, DOI 10.1021/jf040341m
   De Gray D, 1998, ADHES AGE, V41, P23
   DEHAULT ED, 1984, J AM OIL CHEM SOC, V61, P195
   Desai SD, 2003, J POLYM RES-TAIWAN, V10, P275, DOI 10.1023/B:JPOL.0000004630.77120.bb
   Desai SD, 2003, INT J ADHES ADHES, V23, P393, DOI 10.1016/S0143-7496(03)00070-8
   Dirand M, 1998, FUEL, V77, P1253, DOI 10.1016/S0016-2361(98)00032-5
   Doll KM, 2007, IND ENG CHEM RES, V46, P3513, DOI 10.1021/ie070127y
   Dorset DL, 1997, J PHYS D APPL PHYS, V30, P451, DOI 10.1088/0022-3727/30/3/018
   DOWNING DT, 1974, J INVEST DERMATOL, V62, P228, DOI 10.1111/1523-1747.ep12676793
   Driver PJ, 1996, SURV OPHTHALMOL, V40, P343, DOI 10.1016/S0039-6257(96)80064-6
   Dunn RO, 2005, FUEL PROCESS TECHNOL, V86, P1071, DOI 10.1016/j.fuproc.2004.11.003
   Erhan S. Z., 2006, SYNTHETICS MINERAL O, P361
   Erhan SZ, 2006, IND CROP PROD, V24, P292, DOI 10.1016/j.indcrop.2006.06.008
   Erhan SZ, 1997, J AM OIL CHEM SOC, V74, P703, DOI 10.1007/s11746-997-0204-z
   ETHAN SZ, 2008, J AGR FOOD CHEM, V56, P8919, DOI DOI 10.1021/JF801463D
   Fasano A, 2004, MECCANICA, V39, P441, DOI 10.1023/B:MECC.0000046444.98941.3c
   Fox NJ, 2007, TRIBOL INT, V40, P1035, DOI 10.1016/j.triboint.2006.10.001
   FRANKEL EN, 1967, J ORG CHEM, V32, P1447, DOI 10.1021/jo01280a602
   GIBBS A, 1995, COMP BIOCHEM PHYS B, V112, P243, DOI 10.1016/0305-0491(95)00081-X
   Gu GT, 2009, TRIBOL INT, V42, P397, DOI 10.1016/j.triboint.2008.07.012
   HASSAN A, 2004, Patent No. 6811824
   Holloway P. J., 1984, HDB CHROMATOGRAPHY, P347
   Holser RA, 2006, FUEL, V85, P393, DOI 10.1016/j.fuel.2005.07.018
   Honary LAT, 1996, BIORESOURCE TECHNOL, V56, P41, DOI 10.1016/0960-8524(95)00184-0
   Horner D., 2002, J SYNTH LUBR, V18, P327, DOI DOI 10.1002/JSL.3000180407
   HU XJ, 1993, J AM OIL CHEM SOC, V70, P535, DOI 10.1007/BF02542589
   Hwang HS, 2001, J AM OIL CHEM SOC, V78, P1179, DOI 10.1007/s11745-001-0410-0
   Hwang HS, 2003, J AM OIL CHEM SOC, V80, P811, DOI 10.1007/s11746-003-0777-y
   Hwang HS, 2006, IND CROP PROD, V23, P311, DOI 10.1016/j.indcrop.2005.09.002
   Imai T, 2001, COLLOID SURFACE A, V194, P233, DOI 10.1016/S0927-7757(01)00799-3
   Jetter R, 2008, PLANT J, V54, P670, DOI 10.1111/j.1365-313X.2008.03467.x
   John N, 1998, J APPL POLYM SCI, V68, P1185, DOI 10.1002/(SICI)1097-4628(19980516)68:7<1185::AID-APP15>3.0.CO;2-X
   KIM ES, 1995, AM J BOT, V82, P1207, DOI 10.2307/2446242
   King JW, 2001, J AM OIL CHEM SOC, V78, P107, DOI 10.1007/s11746-001-0229-8
   Kobayashi M, 2005, J JPN PETROL INST, V48, P365, DOI 10.1627/jpi.48.365
   Kodali DR, 2002, IND LUBR TRIBOL, V54, P165, DOI 10.1108/00368790210431718
   Kong XH, 2008, BIOMACROMOLECULES, V9, P2221, DOI 10.1021/bm800335x
   Kong X, 2008, BIOMACROMOLECULES, V9, P1424, DOI 10.1021/bm8001478
   Kong XH, 2007, BIOMACROMOLECULES, V8, P3584, DOI 10.1021/bm0704018
   Kong X, 2007, BIOMACROMOLECULES, V8, P2203, DOI 10.1021/bm070016i
   Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0
   Lathi PS, 2007, APPL CATAL B-ENVIRON, V69, P207, DOI 10.1016/j.apcatb.2006.06.016
   LI S, 2004, LUBR SCI, V16, P127
   Maciejewski H, 2006, J MOL CATAL A-CHEM, V257, P141, DOI 10.1016/j.molcata.2006.04.039
   MCCULLEY JP, 2002, LACRIMAL GLAND TEAR, V3, P373
   Meier MAR, 2007, CHEM SOC REV, V36, P1788, DOI 10.1039/b703294c
   Mezouari S, 2006, EUR J LIPID SCI TECH, V108, P679, DOI 10.1002/ejlt.200600066
   Mitchell RD, 1999, ADHES AGE, V42, P24
   Mittal K.L., 2003, HDB ADHESIVE TECHNOL
   MIWA TK, 1984, J AM OIL CHEM SOC, V61, P407, DOI 10.1007/BF02678804
   MIWA TK, 1972, J AM OIL CHEM SOC, V49, P673, DOI 10.1007/BF02609387
   Moser BR, 2008, FUEL, V87, P2253, DOI 10.1016/j.fuel.2008.01.005
   Moser BR, 2007, J AM OIL CHEM SOC, V84, P675, DOI 10.1007/s11746-007-1083-z
   Moser BR, 2007, EUR J LIPID SCI TECH, V109, P206, DOI 10.1002/ejlt.200600257
   Moser BR, 2006, J AM OIL CHEM SOC, V83, P959, DOI 10.1007/s11746-006-5053-7
   Murphy T, 2004, US Patent, Patent No. [6,824,572, 6824572]
   Narine SS, 2007, J AM OIL CHEM SOC, V84, P55, DOI 10.1007/s11746-006-1006-4
   Narine SS, 2007, J AM OIL CHEM SOC, V84, P65, DOI 10.1007/s11746-006-1008-2
   NASH JE, 2000, Patent No. 6063114
   NICOLAIDES N, 1981, INVEST OPHTH VIS SCI, V20, P522
   NIESCHLAG HJ, 1977, IND ENG CHEM PROD RD, V16, P202, DOI 10.1021/i360063a003
   NIKKARI T, 1974, J INVEST DERMATOL, V62, P257, DOI 10.1111/1523-1747.ep12676800
   Ogunniyi DS, 2006, BIORESOURCE TECHNOL, V97, P1086, DOI 10.1016/j.biortech.2005.03.028
   Paul CW, 1999, ADHES AGE, V42, P34
   Petitjean D, 2008, ENERG FUEL, V22, P697, DOI 10.1021/ef700423g
   Pizzi A, 2006, J ADHES SCI TECHNOL, V20, P829, DOI 10.1163/156856106777638635
   Pizzi A., 1983, WOOD ADHESIVES CHEM
   PIZZI A., 1994, ADV WOOD ADHESIVES T
   Regert M, 2005, J CHROMATOGR A, V1091, P124, DOI 10.1016/j.chroma.2005.07.039
   RETAMAR JA, 1995, ESSENZEE DERIVATI AG, V65, P523
   Rezaei K, 2002, J AM OIL CHEM SOC, V79, P1241, DOI 10.1007/s11746-002-0634-z
   Rissmann R, 2008, BBA-BIOMEMBRANES, V1778, P2350, DOI 10.1016/j.bbamem.2008.06.017
   Saliba R, 2009, IMMUNOPHARM IMMUNOT, V31, P583, DOI 10.3109/08923970902838672
   Salimon J, 2009, EUR J SCI RES, V32, P216
   SCHMIDT MA, 2006, SYNTHETICS MINERAL O, P389
   Schulz H, 1999, APPL CATAL A-GEN, V186, P3, DOI 10.1016/S0926-860X(99)00160-X
   Sharma BK, 2008, J AGR FOOD CHEM, V56, P3049, DOI 10.1021/jf073070z
   Sharma BK, 2007, ENERG FUEL, V21, P2408, DOI 10.1021/ef0605854
   Sharma BK, 2007, GREEN CHEM, V9, P469, DOI 10.1039/b614100e
   Somani KP, 2003, INT J ADHES ADHES, V23, P269, DOI 10.1016/S0143-7496(03)00044-7
   SPENCER GF, 1973, J AM OIL CHEM SOC, V50, P202, DOI 10.1007/BF02640490
   SPERLING LH, 1981, INTERPENETRATING POL, pCH8
   TAO BY, 2001, Patent No. 6284007
   TULLOCH AP, 1971, CHEM PHYS LIPIDS, V6, P235, DOI 10.1016/0009-3084(71)90063-6
   Uosukainen E, 1998, J AM OIL CHEM SOC, V75, P1557, DOI 10.1007/s11746-998-0094-8
   Vallat MF, 2000, J APPL POLYM SCI, V76, P665, DOI 10.1002/(SICI)1097-4628(20000502)76:5<665::AID-APP8>3.0.CO;2-A
   VERKUIJLEN E, 1977, J CHEM SOC CHEM COMM, P198, DOI 10.1039/c39770000198
   Wang LP, 2007, J AM OIL CHEM SOC, V84, P1149, DOI 10.1007/s11746-007-1147-0
   Wisniak J., 1987, CHEM TECHNOLOGY JOJO
   Yunus R, 2004, EUR J LIPID SCI TECH, V106, P52, DOI 10.1002/ejlt.200300862
   ZAJCEW M, 1958, J AM OIL CHEM SOC, V35, P475, DOI 10.1007/BF02539920
NR 113
TC 14
Z9 15
U1 3
U2 31
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
EI 1471-2962
J9 PHILOS T R SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD OCT 28
PY 2010
VL 368
IS 1929
BP 4869
EP 4890
DI 10.1098/rsta.2010.0197
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 651MX
UT WOS:000281932900011
PM 20855324
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Sixt, SU
   Jennissen, HP
   Winterhalter, M
   Laub, M
AF Sixt, S. U.
   Jennissen, H. P.
   Winterhalter, M.
   Laub, M.
TI RETRACTED: DETECTION OF UBIQUITYL-CALMODULIN CONJUGATES WITH A NOVEL
   HIGH-MOLECULAR WEIGHT UBIQUITYLPROTEIN-ISOPEPTIDASE IN RABBIT TISSUES
   (Retracted article. See vol. 16, pg. R2, 2011)
SO EUROPEAN JOURNAL OF MEDICAL RESEARCH
LA English
DT Article; Retracted Publication
DE ubiquitin; ubiquitylprotein-isopeptidase; protein degradation;
   ubiquitin-conjugates; western-blot
ID CARBOXYL-TERMINAL HYDROLASE; INTRACELLULAR PROTEIN-DEGRADATION;
   DEPENDENT PROTEOLYTIC SYSTEM; CELL-CYCLE PROGRESSION; HUMAN
   SKELETAL-MUSCLE; PROTEASOME SYSTEM; MULTIPLE UBIQUITINATION;
   POLYUBIQUITIN CHAIN; SYNTHETASE SYSTEM; ACTIVATING ENZYME
AB The selective degradation of many proteins in eukaryotic cells is carried out by the ubiquitin system. In this pathway, proteins are targeted for degradation by covalent ligation to ubiquitin, a highly conserved protein [1]. Ubiquitylated proteins were degraded by the 26S proteasome in an ATP-depended manner. The degradation of ubiquitylated proteins were controlled by isopeptidase cleavage. A well characterised system of ubiquitylation and deubiquitylation is the calmodulin system in vitro [2]. Detection of ubiquityl-calmodulin conjugtates in vivo have not been shown so far. In this article we discuss the detection of ubiquitin calmodulin conjugates in vivo by incubation with a novel high-molecular weight ubiquitylprotein-isopeptidase in rabbit tissues. Proteins with a molecular weight of ubiquityl-calmodulin conjugates could be detected in all organs tested. Incubation with ubiquitylprotein-isopeptidase showed clearly a decrease of ubiquitin calmodulin conjugates in vivo with an origination of unbounded ubiquitin. These results suggest that only few ubiquitin calmodulin conjugates exist in rabbit tissues.
C1 [Sixt, S. U.; Winterhalter, M.] Univ Klinikum Dusseldorf, Anasthesiol Klin, D-40225 Dusseldorf, Germany.
   [Jennissen, H. P.; Laub, M.] Univ Duisburg Essen, AG Biochem Endokrinol, Inst Physiol Chem, Duisburg, Germany.
RP Sixt, SU (reprint author), Univ Klinikum Dusseldorf, Anasthesiol Klin, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM StephanUrs.Sixt@med.uni-duesseldorf.de
FU Deutsche Forschungsgemeinschaft [Je 84/8-1, Je 84/9-1]
FX This work was supported by grants (Je 84/8-1, Je 84/9-1) from the
   Deutsche Forschungsgemeinschaft. The authors appreciate the excellent
   technical assistance of G. Botzet dagger.
CR ANDERSEN MW, 1981, BIOCHEMISTRY-US, V20, P1100, DOI 10.1021/bi00508a009
   ANDERSEN MW, 1981, FEBS LETT, V132, P210, DOI 10.1016/0014-5793(81)81162-3
   Armbruster FP, 2001, EUR J MED RES, V6, P1
   Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173
   AUTRIC F, 1980, BIOCHIM BIOPHYS ACTA, V631, P139, DOI 10.1016/0304-4165(80)90062-8
   Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200
   BAMEZAI S, 1989, BIOCHEM BIOPH RES CO, V162, P89, DOI 10.1016/0006-291X(89)91966-9
   Boddy MN, 1996, ONCOGENE, V13, P971
   BOND U, 1985, MOL CELL BIOL, V5, P949, DOI 10.1128/MCB.5.5.949
   Browatzki M, 2007, EUR J MED RES, V12, P129
   Browatzki M, 2005, EUR J MED RES, V10, P197
   BUSCH H, 1981, MOL CELL BIOCHEM, V40, P173
   CHEN ZJ, 1990, J BIOL CHEM, V265, P21835
   Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200
   CIECHANOVER A, 1991, P NATL ACAD SCI USA, V88, P139, DOI 10.1073/pnas.88.1.139
   CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365
   CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537
   Ciechanover A, 2006, EXP BIOL MED, V231, P1197
   DORAN JF, 1983, J NEUROCHEM, V40, P1542, DOI 10.1111/j.1471-4159.1983.tb08124.x
   Dubiel W, 1999, CURR BIOL, V9, pR554, DOI 10.1016/S0960-9822(99)80353-4
   EYTAN E, 1993, J BIOL CHEM, V268, P4668
   FALQUET L, 1995, FEBS LETT, V359, P73, DOI 10.1016/0014-5793(94)01451-6
   FANG CH, 1995, J AM COLL SURGEONS, V180, P161
   FERBER S, 1986, J BIOL CHEM, V261, P3128
   FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501
   Fitzgerald J, 1999, J BIOL CHEM, V274, P27392, DOI 10.1074/jbc.274.39.27392
   FURUNO K, 1990, J BIOL CHEM, V265, P8550
   GEHRKE PP, 1987, BIOL CHEM H-S, V368, P691, DOI 10.1515/bchm3.1987.368.1.691
   GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0
   GOLDKNOPF IL, 1981, BIOCHEM BIOPH RES CO, V100, P1464, DOI 10.1016/0006-291X(81)90683-5
   HAAS AL, 1985, J BIOL CHEM, V260, P4694
   HAAS AL, 1987, J BIOL CHEM, V262, P11315
   HAAS AL, 1991, J BIOL CHEM, V266, P5104
   HEMDAN ES, 1989, P NATL ACAD SCI USA, V86, P1811, DOI 10.1073/pnas.86.6.1811
   Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004
   Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200
   Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425
   Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656
   JENNISSEN HP, 1988, BIOL CHEM H-S, V369, P1325, DOI 10.1515/bchm3.1988.369.2.1325
   JENNISSEN HP, 1992, FEBS LETT, V296, P51, DOI 10.1016/0014-5793(92)80401-2
   JENNISSEN HP, 1995, EUR J BIOCHEM, V231, P1
   JENNISSEN HP, 1976, BIOCHEMISTRY-US, V15, P5683, DOI 10.1021/bi00671a001
   Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557
   Kamitani T, 1998, J BIOL CHEM, V273, P11349, DOI 10.1074/jbc.273.18.11349
   Kamitani T, 1997, J BIOL CHEM, V272, P14001, DOI 10.1074/jbc.272.22.14001
   Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7
   Urso M, 2006, J APPL PHYSIOL, V101, P1136, DOI 10.1152/japplphysiol.00180.2006
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lapenta V, 1997, GENOMICS, V40, P362, DOI 10.1006/geno.1996.4556
   LAUB M, 1991, FEBS LETT, V294, P229, DOI 10.1016/0014-5793(91)81436-C
   Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083
   Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S
   LEW VL, 1989, METHOD ENZYMOL, V173, P100
   Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457
   Lincoln S, 1999, NEUROREPORT, V10, P427, DOI 10.1097/00001756-199902050-00040
   LLOVERA M, 1994, FEBS LETT, V338, P311, DOI 10.1016/0014-5793(94)80290-4
   LOWE J, 1995, J PATHOL, V177, P163, DOI 10.1002/path.1711770210
   MADURA K, 1990, NUCLEIC ACIDS RES, V18, P771, DOI 10.1093/nar/18.4.771
   MAHAFFEY D, 1993, J BIOL CHEM, V268, P21205
   MAJETSCHAK M, 1993, FEBS LETT, V315, P347, DOI 10.1016/0014-5793(93)81192-3
   Majetschak M, 1998, EUR J BIOCHEM, V255, P482, DOI 10.1046/j.1432-1327.1998.2550482.x
   Majetschak M, 1998, EUR J BIOCHEM, V255, P492, DOI 10.1046/j.1432-1327.1998.2550492.x
   Mannen H, 1996, BIOCHEM BIOPH RES CO, V222, P178, DOI 10.1006/bbrc.1996.0717
   MATSUI SI, 1982, P NATL ACAD SCI-BIOL, V79, P1535, DOI 10.1073/pnas.79.5.1535
   Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457
   May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3
   MAYER AN, 1989, BIOCHEMISTRY-US, V28, P166, DOI 10.1021/bi00427a024
   MAYER RJ, 1991, BIOCHIM BIOPHYS ACTA, V1089, P141, DOI 10.1016/0167-4781(91)90002-4
   Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002
   MITCH WE, 1994, J CLIN INVEST, V93, P2127, DOI 10.1172/JCI117208
   Mizushima N, 1998, NATURE, V395, P395
   MORI S, 1993, J BIOL CHEM, V268, P577
   MOSKOVITZ J, 1994, BIOCHEM BIOPH RES CO, V205, P354, DOI 10.1006/bbrc.1994.2672
   Naze P, 2002, NEUROSCI LETT, V328, P1, DOI 10.1016/S0304-3940(02)00231-8
   Okura T, 1996, J IMMUNOL, V157, P4277
   Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x
   PICKART CM, 1985, J BIOL CHEM, V260, P7903
   RABINOVITZ M, 1964, BIOCHIM BIOPHYS ACTA, V91, P313, DOI 10.1016/0926-6550(64)90255-5
   ROSE IA, 1983, BIOCHEMISTRY-US, V22, P4234, DOI 10.1021/bi00287a012
   SAIRAM MR, 1976, BIOCHEM BIOPH RES CO, V69, P190, DOI 10.1016/S0006-291X(76)80290-2
   Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252
   SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8
   Seiffert M, 2007, PHYSIOL RES, V56, P227
   Shen ZY, 1996, GENOMICS, V36, P271, DOI 10.1006/geno.1996.0462
   SPENCE J, 1995, MOL CELL BIOL, V15, P1265
   Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325
   Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x
   SUDAKIN V, 1995, MOL BIOL CELL, V6, P185
   SUNG P, 1990, P NATL ACAD SCI USA, V87, P2695, DOI 10.1073/pnas.87.7.2695
   TIAO G, 1995, SHOCK, V4, P403
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Tsytsykova AV, 1998, MOL IMMUNOL, V35, P1057, DOI 10.1016/S0161-5890(98)00094-7
   UGAI S, 1993, J BIOCHEM, V113, P754, DOI 10.1093/oxfordjournals.jbchem.a124116
   Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5
   WILKINSON DA, 1986, BIOCHEMISTRY-US, V25, P295, DOI 10.1021/bi00350a002
   WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630
   WILKINSON KD, 1986, BIOCHEMISTRY-US, V25, P6644, DOI 10.1021/bi00369a047
   WING SS, 1993, AM J PHYSIOL, V264, pE668
   Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6
   ZIEGENHAGEN R, 1988, FEBS LETT, V237, P103, DOI 10.1016/0014-5793(88)80180-7
   ZIEGENHAGEN R, 1988, BIOL CHEM H-S, V369, P1317, DOI 10.1515/bchm3.1988.369.2.1317
   ZIEGENHAGEN R, 1990, FEBS LETT, V273, P253, DOI 10.1016/0014-5793(90)81097-8
   ZIEGENHAGEN R, 1990, FEBS LETT, V271, P71, DOI 10.1016/0014-5793(90)80374-R
NR 103
TC 1
Z9 1
U1 1
U2 12
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 0949-2321
EI 2047-783X
J9 EUR J MED RES
JI Eur. J. Med. Res.
PD OCT 25
PY 2010
VL 15
IS 10
BP 428
EP 447
DI 10.1186/2047-783X-15-10-428
PG 20
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 676FN
UT WOS:000283895800003
PM 21156402
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Kannappan, R
   Yadav, VR
   Aggarwal, BB
AF Kannappan, Ramaswamy
   Yadav, Vivek R.
   Aggarwal, Bharat B.
TI RETRACTED: gamma-Tocotrienol but Not gamma-Tocopherol Blocks STAT3 Cell
   Signaling Pathway through Induction of Protein-tyrosine Phosphatase
   SHP-1 and Sensitizes Tumor Cells to Chemotherapeutic Agents (Retracted
   article. See vol. 291, pg. 16922, 2016)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID FACTOR-KAPPA-B; NATURAL VITAMIN-E; INDUCED APOPTOSIS; MULTIPLE-MYELOMA;
   GENE-PRODUCTS; CANCER CELLS; ACTIVATION; INHIBITION; TRANSCRIPTION; SRC
AB Although gamma-tocotrienol (T3), a vitamin E isolated primarily from palm and rice bran oil, has been linked with anticancer activities, the mechanism of this action is poorly understood. In this study, we investigated whether gamma-T3 can modulate the STAT3 cell signaling pathway, closely linked to inflammation and tumorigenesis. We found that gamma-T3 but not gamma-tocopherol, the most common saturated form of vitamin E, inhibited constitutive activation of STAT3 in a dose-and time-dependent manner, and this inhibition was not cell type-specific. gamma-T3 also inhibited STAT3 DNA binding. This correlated with inhibition of Src kinase and JAK1 and JAK2 kinases. Pervanadate reversed the gamma-T3-induced down-regulation of STAT3 activation, suggesting the involvement of a protein-tyrosine phosphatase. When examined further, we found that gamma-T3 induced the expression of the tyrosine phosphatase SHP-1, and gene silencing of the SHP-1 by small interfering RNA abolished the ability of gamma-T3 to inhibit STAT3 activation, suggesting a vital role for SHP-1 in the action of gamma-T3. Also gamma-T3 down-modulated activation of STAT3 and induced SHP-1 in vivo. Eventually, gamma-T3 down-regulated the expression of STAT3-regulated antiapoptotic (Bcl-2, Bcl-xL, and Mcl-1), proliferative (cyclin D1), and angiogenic (VEGF) gene products; and this correlated with suppression of proliferation, the accumulation of cells in sub-G(1) phase of the cell cycle, and induction of apoptosis. This vitamin also sensitized the tumor cells to the apoptotic effects of thalidomide and bortezomib. Overall, our results suggest that gamma-T3 is a novel blocker of STAT3 activation pathway both in vitro and in vivo and thus may have potential in prevention and treatment of cancers.
C1 [Kannappan, Ramaswamy; Yadav, Vivek R.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA.
RP Aggarwal, BB (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, 1515 Holcombe Blvd,Box 143, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI Aggarwal, Bharat/G-3388-2013
FU National Institutes of Health [CA-16 672, CA-124787-01A2]; Malaysian
   Palm Oil Board, Kuala Lumpur, Malaysia; Center for Targeted Therapy of
   M. D. Anderson Cancer Center
FX This work was supported, in whole or in part, by National Institutes of
   Health Grant CA-16 672 and Program Project Grant CA-124787-01A2. This
   work was also supported by Malaysian Palm Oil Board, Kuala Lumpur,
   Malaysia, and in part by a grant from the Center for Targeted Therapy of
   M. D. Anderson Cancer Center.
CR AGGARWAL BB, 2010, BIOCH PHARM IN PRESS
   Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063
   Ahmad NS, 2005, CLIN EXP PHARMACOL P, V32, P761, DOI 10.1111/j.1440-1681.2005.04264.x
   Ahn KS, 2007, J BIOL CHEM, V282, P809, DOI 10.1074/jbc.M610028200
   Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130
   Bachawal SV, 2010, ANTICANCER RES, V30, P429
   Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465
   Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527
   Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733
   Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553
   Cavo M, 2006, LEUKEMIA, V20, P1341, DOI 10.1038/sj.leu.2404278
   Das S, 2005, AM J PHYSIOL-HEART C, V289, pH361, DOI 10.1152/ajpheart.01285.2004
   Gunaje JJ, 2001, BIOCHEM BIOPH RES CO, V288, P252, DOI 10.1006/bbrc.2001.5759
   Han YJ, 2006, BLOOD, V108, P2796, DOI 10.1182/blood-2006-04-017434
   Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5
   Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086
   Kannappan R, 2010, MOL CANCER THER, V9, P2196, DOI 10.1158/1535-7163.MCT-10-0277
   Kashiwagi K, 2009, LIFE SCI, V84, P650, DOI 10.1016/j.lfs.2009.02.007
   KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0
   Kim H, 1999, MOL CELL BIOL, V19, P5326
   KLEIN B, 1995, BLOOD, V85, P863
   Kuhad A, 2009, PHARMACOL BIOCHEM BE, V92, P251, DOI 10.1016/j.pbb.2008.12.012
   Kunnumakkara AB, 2007, CANCER RES, V67, P3853, DOI 10.1158/0008-5472.CAN-06-4257
   MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4
   Oka T, 2002, CANCER RES, V62, P6390
   QURESHI AA, 1991, AM J CLIN NUTR, V53, pS1021, DOI 10.1093/ajcn/53.4.1021S
   Saito Y, 2004, ANN NY ACAD SCI, V1031, P368, DOI 10.1196/annals.1331.047
   Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200
   Sen CK, 2007, VITAM HORM, V76, P203, DOI 10.1016/S0083-6729(07)76008-9
   Sen CK, 2007, MOL ASPECTS MED, V28, P692, DOI 10.1016/j.mam.2007.03.001
   Sen CK, 2000, J BIOL CHEM, V275, P13049, DOI 10.1074/jbc.275.17.13049
   Sen CK, 2004, ANN NY ACAD SCI, V1031, P127, DOI 10.1196/annals.1331.013
   SERBINOVA EA, 1994, METHOD ENZYMOL, V234, P354
   Shen YH, 2001, P NATL ACAD SCI USA, V98, P1543, DOI 10.1073/pnas.041588198
   Sun S, 2002, J GEN VIROL, V83, P1651, DOI 10.1099/0022-1317-83-7-1651
   Sylvester PW, 2005, FRONT BIOSCI, V10, P699, DOI 10.2741/1565
   Takada Y, 2006, J BIOL CHEM, V281, P5612, DOI 10.1074/jbc.M507213200
   Tanuma N, 2000, J BIOL CHEM, V275, P28216
   Tenev T, 2000, EUR J CELL BIOL, V79, P261, DOI 10.1078/S0171-9335(04)70029-1
   Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545
   Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X
   YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555
   Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275
   Yu WP, 1999, NUTR CANCER, V33, P26, DOI 10.1080/01635589909514744
   Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588
   Zushi SI, 1998, INT J CANCER, V78, P326, DOI 10.1002/(SICI)1097-0215(19981029)78:3<326::AID-IJC12>3.0.CO;2-4
NR 46
TC 44
Z9 44
U1 1
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 22
PY 2010
VL 285
IS 43
BP 33520
EP 33528
DI 10.1074/jbc.M110.158378
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 665PP
UT WOS:000283048200086
PM 20720018
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Panagiotopoulou, O
   Curtis, N
   O'Higgins, P
   Cobb, SN
AF Panagiotopoulou, O.
   Curtis, N.
   O'Higgins, P.
   Cobb, S. N.
TI RETRACTED: Modelling subcortical bone in finite element analyses: A
   validation and sensitivity study in the macaque mandible (vol 43, pg
   1603, 2010) (Retracted article. See vol. 48, pg. 1234, 2015)
SO JOURNAL OF BIOMECHANICS
LA English
DT Correction; Retracted Publication
C1 [Panagiotopoulou, O.] Univ London, Dept Vet Basic Sci, Struct & Mot Lab, Royal Vet Coll, Hatfield AL9 9TA, Herts, England.
   [Curtis, N.] Univ Hull, Ctr Med Engn & Technol, Kingston Upon Hull HU6 7RX, N Humberside, England.
   [Cobb, S. N.] Univ Hull, Hull York Med Sch, Funct Morphol & Evolut Unit, Kingston Upon Hull HU6 7RX, N Humberside, England.
   [Panagiotopoulou, O.; O'Higgins, P.] Univ York, Hull York Med Sch, Funct Morphol & Evolut Unit, York YO10 5DD, N Yorkshire, England.
RP Panagiotopoulou, O (reprint author), Univ London, Dept Vet Basic Sci, Struct & Mot Lab, Royal Vet Coll, Room 21,Hawkshead Lane, Hatfield AL9 9TA, Herts, England.
EM opanagiotopoulou@rvc.ac.uk
CR Panagiotopoulou O, 2010, J BIOMECH, V43, P1603, DOI 10.1016/j.jbiomech.2009.12.027
NR 1
TC 1
Z9 1
U1 3
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PD OCT 19
PY 2010
VL 43
IS 14
BP 2867
EP 2867
DI 10.1016/j.jbiomech.2010.06.001
PG 1
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 681TW
UT WOS:000284343700037
DA 2018-12-27
ER

PT J
AU Bharathi, KK
   Kalidindi, NR
   Ramana, CV
AF Bharathi, K. Kamala
   Kalidindi, N. R.
   Ramana, C. V.
TI RETRACTED: Grain size and strain effects on the optical and electrical
   properties of hafnium oxide nanocrystalline thin films (Retracted
   article. See vol. 109, artn no. 109903, 2011)
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article; Retracted Publication
ID SPECTROSCOPIC ELLIPSOMETRY; HFO2; RESISTIVITY; DIELECTRICS; SURFACE;
   LAYERS
AB Nanocrystalline hafnium oxide (HfO2) thin films with an average crystal size similar to 5-50 nm have been produced under controlled temperature and pressure and their structural, optical and electrical properties have been evaluated. Structural investigations indicate that the monoclinic HfO2 nanocrystals are highly oriented along the ((1) over bar 11) direction. The lattice expansion increases with a reduction in size while minimum strain energy occurs at maximum lattice expansion. The strain factor increases linearly from 2.4% to 4% with increasing HfO2 crystal dimensions from 10 to 40 nm. The optical absorption measurements indicate that the band gap (E-g) changes are not very significant with size reduction. The interband absorption corresponding to O 2p -> Hf 5d transitions dominate the optical absorption edge at E similar to 6.25 eV; E-g varied in the range 5.42-5.60 eV for a variation in crystal dimension in the range 10-40 nm. Room temperature electrical conductivity increases from 1.08 X 10(-3) to 1.7 X 10(-3) (Omega cm)(-1) with increasing size from 10 to 40 nm. The frequency dispersion of the electrical resistivity reveals the hopping conduction mechanism. The functional relationship derived between geometric and electronic structure for HfO2 suggest that tuning properties for desired applications can be achieved by controlling the grain size and, hence, the strain at the nanoscale dimensions. (C) 2010 American Institute of Physics. [doi:10.1063/1.3499325]
C1 [Bharathi, K. Kamala; Kalidindi, N. R.; Ramana, C. V.] Univ Texas El Paso, Dept Mech Engn, El Paso, TX 79968 USA.
RP Bharathi, KK (reprint author), Univ Texas El Paso, Dept Mech Engn, El Paso, TX 79968 USA.
EM rvchintalapalle@utep.edu
FU U.S. Department of Energy; Department of Energy [DE-FE0000765]
FX The authors thank with pleasure the funding from the U.S. Department of
   Energy. This material is based upon work supported by the Department of
   Energy under Award No. DE-FE0000765.
CR Armelao L, 2007, ADV FUNCT MATER, V17, P1671, DOI 10.1002/adfm.200600458
   AZAROFF LV, 1968, ELEMENTS XRAY CRYSTA, P193
   BAKONYI I, 1993, NANOSTRUCT MATER, V3, P155, DOI 10.1016/0965-9773(93)90073-K
   Boher P, 2004, MAT SCI ENG B-SOLID, V109, P64, DOI 10.1016/j.mseb.2003.10.117
   BRUS LE, 1984, J CHEM PHYS, V80, P4403, DOI 10.1063/1.447218
   Cao Q, 2006, ADV FUNCT MATER, V16, P2355, DOI 10.1002/adfm.200600539
   Cisneros-Morales MC, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3428965
   Cullity B.D., 2001, ELEMENTS X RAY DIFFR
   Ferrari S, 2004, THIN SOLID FILMS, V450, P124, DOI 10.1016/j.tsf.2003.10.051
   Filatova EO, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/18/185012
   Gruger H, 2004, THIN SOLID FILMS, V447, P509, DOI 10.1016/j.tsf.2003.07.013
   Gullapalli SK, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3421540
   He G, 2004, J CRYST GROWTH, V268, P155, DOI 10.1016/j.jcrysgro.2004.05.038
   Kingon AI, 2000, NATURE, V406, P1032, DOI 10.1038/35023243
   Lee BH, 2000, APPL PHYS LETT, V76, P1926, DOI 10.1063/1.126214
   Nguyen NV, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2126136
   Nishide T, 2000, THIN SOLID FILMS, V371, P61, DOI 10.1016/S0040-6090(00)01010-5
   Pereira L, 2004, MAT SCI ENG B-SOLID, V109, P89, DOI 10.1016/j.mseb.2003.10.053
   Ramana CV, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2430933
   Ramana CV, 2004, J VAC SCI TECHNOL A, V22, P2453, DOI 10.1116/1.1809123
   Ramo DM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.155504
   Ran Jiang, 2009, J SEMICOND, V30
   SMITH J, 1965, FERRITES
   Tang J, 2005, ADV FUNCT MATER, V15, P1595, DOI 10.1002/adfm.200500050
   Villanueva-Ibanez M, 2003, REV ADV MATER SCI, V5, P296
   WANG YZ, 1993, MATER LETT, V17, P152, DOI 10.1016/0167-577X(93)90075-9
   Washizu E, 2003, SOLID STATE IONICS, V165, P175, DOI 10.1016/j.ssi.2003.08.030
   Wilk GD, 2001, J APPL PHYS, V89, P5243, DOI 10.1063/1.1361065
   WU L, 1980, J PHYS D APPL PHYS, V13, P259, DOI 10.1088/0022-3727/13/2/023
   YOFFE AD, 1993, ADV PHYS, V42, P173, DOI 10.1080/00018739300101484
   Yu JJ, 2003, APPL SURF SCI, V208, P676, DOI 10.1016/S0169-4332(02)01424-1
NR 31
TC 20
Z9 20
U1 2
U2 25
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0021-8979
EI 1089-7550
J9 J APPL PHYS
JI J. Appl. Phys.
PD OCT 15
PY 2010
VL 108
IS 8
AR 083529
DI 10.1063/1.3499325
PG 5
WC Physics, Applied
SC Physics
GA 674LJ
UT WOS:000283745100046
DA 2018-12-27
ER

PT J
AU Bill, A
   Schmitz, A
   Albertoni, B
   Song, JN
   Heukamp, LC
   Walrafen, D
   Thorwirth, F
   Verveer, PJ
   Zimmer, S
   Meffert, L
   Schreiber, A
   Chatterjee, S
   Thomas, RK
   Ullrich, RT
   Lang, T
   Famulok, M
AF Bill, Anke
   Schmitz, Anton
   Albertoni, Barbara
   Song, Jin-Na
   Heukamp, Lukas C.
   Walrafen, David
   Thorwirth, Franziska
   Verveer, Peter J.
   Zimmer, Sebastian
   Meffert, Lisa
   Schreiber, Arne
   Chatterjee, Sampurna
   Thomas, Roman K.
   Ullrich, Roland T.
   Lang, Thorsten
   Famulok, Michael
TI RETRACTED: Cytohesins Are Cytoplasmic ErbB Receptor Activators
   (Retracted article. See vol. 165, pg. 1293, 2016)
SO CELL
LA English
DT Article; Retracted Publication
ID GROWTH-FACTOR RECEPTOR; NUCLEOTIDE EXCHANGE FACTORS; CELL LUNG-CANCER;
   EGF RECEPTOR; KINASE ACTIVATION; CLINICAL-RESPONSE; DOMAIN; MUTATIONS;
   DIMERIZATION; INHIBITION
AB Signaling by ErbB receptors requires the activation of their cytoplasmic kinase domains, which is initiated by ligand binding to the receptor ectodomains. Cytoplasmic factors contributing to the activation are unknown. Here we identify members of the cytohesin protein family as such factors. Cytohesin inhibition decreased ErbB receptor autophosphorylation and signaling, whereas cytohesin overexpression stimulated receptor activation. Monitoring epidermal growth factor receptor (EGFR) conformation by anisotropy microscopy together with cell-free reconstitution of cytohesin-dependent receptor autophosphorylation indicate that cytohesins facilitate conformational rearrangements in the intracellular domains of dimerized receptors. Consistent with cytohesins playing a prominent role in ErbB receptor signaling, we found that cytohesin overexpression correlated with EGF signaling pathway activation in human lung adenocarcinomas. Chemical inhibition of cytohesins resulted in reduced proliferation of EGFR-dependent lung cancer cells in vitro and in vivo. Our results establish cytohesins as cytoplasmic conformational activators of ErbB receptors that are of pathophysiological relevance.
C1 [Bill, Anke; Schmitz, Anton; Albertoni, Barbara; Song, Jin-Na; Famulok, Michael] Univ Bonn, Program Unit Chem Biol & Med Chem, LIMES Inst, Biol Chem Lab, D-53121 Bonn, Germany.
   [Heukamp, Lukas C.; Zimmer, Sebastian; Meffert, Lisa] Univ Bonn, Inst Pathol, Univ Klinikum, D-53123 Bonn, Germany.
   [Walrafen, David; Schreiber, Arne; Lang, Thorsten] Univ Bonn, Program Unit Membrane Biol & Lipid Biochem, LIMES Inst, Lab Membrane Biochem, D-53121 Bonn, Germany.
   [Thorwirth, Franziska; Verveer, Peter J.] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany.
   [Chatterjee, Sampurna; Thomas, Roman K.; Ullrich, Roland T.] Univ Cologne, Max Planck Inst Neurol Res, Klaus Joachim Zulich Labs, Max Planck Soc, D-50931 Cologne, Germany.
   [Chatterjee, Sampurna; Thomas, Roman K.; Ullrich, Roland T.] Univ Cologne, Fac Med, D-50931 Cologne, Germany.
   [Thomas, Roman K.] Max Planck Gesell, Chem Genom Ctr, D-44227 Dortmund, Germany.
   [Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol, D-50937 Cologne, Germany.
   [Thomas, Roman K.] Univ Cologne, Dept Internal Med 1, D-50937 Cologne, Germany.
RP Famulok, M (reprint author), Univ Bonn, Program Unit Chem Biol & Med Chem, LIMES Inst, Biol Chem Lab, Gerhard Domagk Str 1, D-53121 Bonn, Germany.
EM m.famulok@uni-bonn.de
RI Heukamp, Lukas/A-8338-2013
FU Deutsche Krebshilfe; BMBF; DFG [SFB 645, SFB 704, SFB 832, GRK804];
   Fritz-Thyssen-Stiftung; Fonds der Chemischen Industrie; Roche Research
   Foundation
FX We thank S. Rose-John for plasmid pMWOS-L-gp130, K. Nishio for PC9
   cells, the Department of Nanobiophotonics, MPI Gottingen for Atto647N
   coupled secondary antibodies and access to STED microscopy, Silvio
   Rizzoli for providing MatLab routines for image analysis, Philippe I. H.
   Bastiaens for advice on the anisotropy measurements, V. Fieberg and Y.
   Aschenbach-Paul for technical assistance, J. Hannam, A. M. Hayallah, and
   X.-H. Bi for the synthesis of SecinH3 and XH1009, B. Neumaier for the
   synthesis of [<SUP>18</SUP>F]FLT, and the members of the Famulok
   laboratory for helpful discussions. This work was supported by grants
   from the DFG, the SFBs 645, 704, and 832, and the GRK804. The CIO
   Biobank is supported by the Deutsche Krebshilfe. A. B. and B. A. thank
   the Fonds der Chemischen Industrie and the Roche Research Foundation for
   scholarships. R. K. T. is supported by the Deutsche Krebshilfe,
   Fritz-Thyssen-Stiftung, and the BMBF NGFNplus-program. A. S. and M. F.
   are co-owners of a patent application for SecinH3.
CR Abulrob A, 2010, J BIOL CHEM, V285, P3145, DOI 10.1074/jbc.M109.073338
   Anastasi S, 2007, ONCOGENE, V26, P7833, DOI 10.1038/sj.onc.1210590
   Bergamin E, 2010, MOL CELL, V39, P100, DOI 10.1016/j.molcel.2010.06.007
   Bi XH, 2008, ANGEW CHEM INT EDIT, V47, P9565, DOI 10.1002/anie.200803962
   Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018
   Bose R, 2009, EXP CELL RES, V315, P649, DOI 10.1016/j.yexcr.2008.07.031
   Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301
   Brew C, 2009, ASSESS EVAL HIGH EDU, V34, P641, DOI 10.1080/02602930802468567
   Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008
   Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x
   Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210
   Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827
   Cui TX, 2002, MOL ENDOCRINOL, V16, P2113, DOI 10.1210/me.2001-0284
   D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910
   Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401
   Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829
   Fischer OM, 2003, BIOCHEM SOC T, V31, P1203
   Friedrichs N, 2007, HISTOPATHOLOGY, V51, P814, DOI 10.1111/j.1365-2559.2007.02887.x
   GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543
   Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198
   GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104
   Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415
   HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780
   Heukamp LC, 2006, HISTOPATHOLOGY, V49, P242, DOI 10.1111/j.1365-2559.2006.02489.x
   Inoue A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000113
   Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025
   Kolanus W, 2007, IMMUNOL REV, V218, P102, DOI 10.1111/j.1600-065X.2007.00542.x
   Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202
   Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610
   Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938
   Mayer G, 2001, P NATL ACAD SCI USA, V98, P4961, DOI 10.1073/pnas.091100698
   Mi LZ, 2008, BIOCHEMISTRY-US, V47, P10314, DOI 10.1021/bi801006s
   Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923
   Nagy P, 1999, J CELL SCI, V112, P1733
   Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314
   Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101
   Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016
   Qiu C, 2009, BIOCHEMISTRY-US, V48, P6624, DOI 10.1021/bi900755n
   Reschke M, 2010, HEPATOLOGY, V51, P1383, DOI 10.1002/hep.23428
   Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088
   Sharma SV, 2009, EXP CELL RES, V315, P557, DOI 10.1016/j.yexcr.2008.07.026
   Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337
   Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]
   Squire A, 2004, J STRUCT BIOL, V147, P62, DOI 10.1016/j.jsb.2003.10.013
   Stuhlmann-Laeisz C, 2006, MOL BIOL CELL, V17, P2986, DOI 10.1091/mbc.E05-12-1129
   Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020
   Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491
   Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096
   YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034
   Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013
   Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998
   Zhu HJ, 2003, GROWTH FACTORS, V21, P15, DOI 10.1080/0897719031000096424
   Zimmer S, 2009, J CANCER RES CLIN, V135, P723, DOI 10.1007/s00432-008-0509-9
NR 53
TC 57
Z9 58
U1 1
U2 11
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD OCT 15
PY 2010
VL 143
IS 2
BP 201
EP 211
DI 10.1016/j.cell.2010.09.011
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 665RC
UT WOS:000283052200010
PM 20946980
OA Bronze
DA 2018-12-27
ER

PT J
AU Patra, S
   Sarkar, S
   Bera, SK
   Paul, GK
   Ghosh, R
AF Patra, S.
   Sarkar, S.
   Bera, S. K.
   Paul, G. K.
   Ghosh, R.
TI RETRACTED: Influence of surface topography and chemical structure on
   wettability of electrodeposited ZnO thin films (Retracted article. See
   vol. 110, pg. 033901, 2011)
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article; Retracted Publication
ID ZINC-OXIDE FILMS; SELF-ASSEMBLED MONOLAYERS; CLEANING PROPERTIES; CARBON
   NANOTUBES; WATER; BEHAVIOR
AB The wettability of electrodeposited zinc oxide (ZnO) thin films has been rationally controlled by individually engineering surface topography and surface chemical structure. We have studied the wettability of hydrophobic ZnO thin films that were rendered ultrahydrophobic by coating with low surface-energy self-assembled monolayer of octadecyltrichlorosilane and also hydrophilized by annealing at elevated temperature in air ambient. The as deposited ZnO film was hydrophobic with contact angle of around 105 degrees +/- 3 degrees against water, while the annealed films were distinctly hydrophilic. The silanized films were ultrahydrophobic with a contact angle of 143 degrees +/- 3 degrees. The films could be successfully tailored to obtain hydrophilic, hydrophobic as well as ultrahydrophobic behavior. It is likely that similar tunable wetting behavior may be observed in other oxide materials also. (C) 2010 American Institute of Physics. [doi: 10.1063/1.3493735]
C1 [Patra, S.; Sarkar, S.] Haldia Inst Technol, Dept Elect & Commun Engn, Purba Medinipur 721657, W Bengal, India.
   [Bera, S. K.] Tamralipta Mahavidyalaya, Dept Phys, Purba Medinipur 721636, W Bengal, India.
   [Paul, G. K.] Aliah Univ, Dept Phys, Kolkata 700016, India.
   [Ghosh, R.] Haldia Inst Technol, Sch Appl Sci, Purba Medinipur 721657, W Bengal, India.
RP Patra, S (reprint author), Haldia Inst Technol, Dept Elect & Commun Engn, HIT Campus, Purba Medinipur 721657, W Bengal, India.
EM ghosh.ranajit@gmail.com
FU DST, West Bengal [939/(Sanc.)/ST/P/ST/3 G-19/2008,
   184/1(100)(Sanc.)/ST/P/ST/Misc-1/2008]; DST, New Delhi
   [SR/S2/CMP-0023/2008]; Haldia Institute of Technology (HIT), Haldia
FX The authors acknowledge DST, West Bengal [Sanction Letter No.
   939/(Sanc.)/ST/P/S&T/3 G-19/2008, dated 30.03.2009, Sanction Letter No.
   184/1(100)(Sanc.)/ST/P/S&T/Misc-1/2008, dated 02.07.2008], and DST, New
   Delhi (Sanction Letter No. SR/S2/CMP-0023/2008, dated: 15.04.2009) for
   providing the financial support to carry out this research work. The
   authors also gratefully acknowledge the supports from Haldia Institute
   of Technology (HIT), Haldia, in carrying out this work.
CR Alivov YI, 2003, APPL PHYS LETT, V83, P2943, DOI 10.1063/1.1615308
   Ashurst WR, 2001, SENSOR ACTUAT A-PHYS, V91, P239, DOI 10.1016/S0924-4247(01)00593-3
   Badre C, 2008, PHYSICA E, V40, P2454, DOI 10.1016/j.physe.2007.10.016
   Badre C, 2007, SUPERLATTICE MICROST, V42, P99, DOI 10.1016/j.spmi.2007.04.018
   Bico J, 1999, EUROPHYS LETT, V47, P220, DOI 10.1209/epl/i1999-00548-y
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Chen W, 1999, LANGMUIR, V15, P3395, DOI 10.1021/la990074s
   Furstner R, 2005, LANGMUIR, V21, P956, DOI 10.1021/la0401011
   GINGLEY DS, 2000, MRS BULL, V25, P15
   Guo M, 2007, THIN SOLID FILMS, V515, P7162, DOI 10.1016/j.tsf.2007.03.038
   Huang L, 2005, J PHYS CHEM B, V109, P7746, DOI 10.1021/jp046549s
   Izaki M, 1996, APPL PHYS LETT, V68, P2439, DOI 10.1063/1.116160
   Jin BJ, 2000, THIN SOLID FILMS, V366, P107, DOI 10.1016/S0040-6090(00)00746-X
   JIWEI Z, 2000, CERAM INT, V26, P883, DOI DOI 10.1016/S0272-8842(00)00031-6
   Kind H, 1999, ADV MATER, V11, P1285, DOI 10.1002/(SICI)1521-4095(199910)11:15<1285::AID-ADMA1285>3.0.CO;2-J
   Kojio K, 2000, COLLOID SURFACE A, V169, P295, DOI 10.1016/S0927-7757(00)00444-1
   Kong XY, 2003, NANO LETT, V3, P1625, DOI 10.1021/nl034463p
   Lin LY, 2008, APPL SURF SCI, V254, P7370, DOI 10.1016/j.apsusc.2008.05.337
   Majumder M, 2005, NATURE, V438, P44, DOI 10.1038/43844a
   Marotti RE, 2004, SOL ENERG MAT SOL C, V82, P85, DOI [10.1016/j.solmat.2004.01.008, 10.1016/j.solnat.2004.01.008]
   MCCARTHY TJ, 2001, Patent No. 00069572
   Nakajima A, 2000, LANGMUIR, V16, P7044, DOI 10.1021/la000155k
   Nakajima A, 1999, ADV MATER, V11, P1365, DOI 10.1002/(SICI)1521-4095(199911)11:16<1365::AID-ADMA1365>3.3.CO;2-6
   Natsume Y, 2000, THIN SOLID FILMS, V372, P30, DOI 10.1016/S0040-6090(00)01056-7
   Oner D, 2000, LANGMUIR, V16, P7777, DOI 10.1021/la000598o
   PALASANTZAS G, 1993, PHYS REV B, V48, P2873, DOI 10.1103/PhysRevB.48.2873
   Patra S, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/7/075301
   Paul GK, 2008, CHEM PHYS LETT, V463, P117, DOI 10.1016/j.cplett.2008.08.065
   Pesika NS, 2002, J PHYS CHEM B, V106, P6985, DOI 10.1021/jp0144606
   PIZZINI S, 1989, J ELECTROCHEM SOC, V136, P1945, DOI 10.1149/1.2097092
   Shibuichi S, 1996, J PHYS CHEM-US, V100, P19512, DOI 10.1021/jp9616728
   Tadanaga K, 1997, J AM CERAM SOC, V80, P3213
   Wang MJ, 2005, LANGMUIR, V21, P1848, DOI 10.1021/la048483y
   Wang WJ, 2005, ACTA CRYSTALLOGR E, V61, pM813, DOI 10.1107/S1600536805009748
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   Yang C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.116103
   Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
   Zhang JL, 2006, LANGMUIR, V22, P2946, DOI 10.1021/la053428q
NR 38
TC 9
Z9 10
U1 2
U2 20
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0021-8979
EI 1089-7550
J9 J APPL PHYS
JI J. Appl. Phys.
PD OCT 15
PY 2010
VL 108
IS 8
AR 083507
DI 10.1063/1.3493735
PG 6
WC Physics, Applied
SC Physics
GA 674LJ
UT WOS:000283745100024
DA 2018-12-27
ER

PT J
AU Eftekhari-Sis, B
   Akbari, A
   Harms, K
AF Eftekhari-Sis, Bagher
   Akbari, Ali
   Harms, Klaus
TI RETRACTED: Highly Chemoselective Baylis-Hillman and Aldol Reactions of
   2H-Thiopyran-4(3H)-one Using Tertiary Amine Catalysts in Aqueous Media
   (Retracted Article. See vol 12, pg 5600, 2010)
SO ORGANIC LETTERS
LA English
DT Article; Retracted Publication
ID LIGAND-ACCELERATED CATALYSIS; ORGANIC-REACTIONS; FACILE SYNTHESIS;
   MANNICH REACTION; CARBON-CARBON; SOLVENT-FREE; WATER; DERIVATIVES;
   ALDEHYDES; LIQUID
AB For the first time the Baylis-Hillman (BH) reaction of 2H-thiopyran-4(3H)-one is investigated, and surprisingly, the reaction of 2H-thiopyran-4(3H)-one with aldehydes in the presence of different tertiary amines shows excellent chemo- and regioselectivity in water. At room temperature. DBU affords BH adducts, but with DABCO, aldol products were obtained. In the case of DABCO, Et3N, or DMAP, domino aldol-rearrangement reactions occurred at 45-50 degrees C
C1 [Eftekhari-Sis, Bagher; Akbari, Ali] Univ Maragheh, Dept Chem, Fac Sci, Golshar, Maragheh, Iran.
   [Harms, Klaus] Univ Marburg, Fachbereich Chem, D-35032 Marburg, Germany.
RP Eftekhari-Sis, B (reprint author), Univ Maragheh, Dept Chem, Fac Sci, POB 55181-83111, Golshar, Maragheh, Iran.
CR Abaee MS, 2007, SYNTHESIS-STUTTGART, P3339, DOI 10.1055/s-2007-990806
   Aggarwal VK, 1999, CHEM COMMUN, P2311, DOI 10.1039/a907754e
   Aggarwal VK, 1996, CHEM COMMUN, P2713, DOI 10.1039/cc9960002713
   Aggarwal VK, 1998, J ORG CHEM, V63, P7183, DOI 10.1021/jo980421n
   Anastas P. T., 1998, FRONTIERS BENIGN CHE
   Azizi N, 2006, ORG LETT, V8, P2079, DOI 10.1021/ol060498v
   Basavaiah D, 1996, TETRAHEDRON, V52, P8001, DOI 10.1016/0040-4020(96)00154-8
   Basavaiah D, 2002, SYNTHETIC COMMUN, V32, P689, DOI 10.1081/SCC-120002506
   Basavaiah D, 2003, CHEM REV, V103, P811, DOI 10.1021/cr010043d
   Basavaiah D, 2010, EUR J ORG CHEM, P1843, DOI 10.1002/ejoc.200901483
   Basavaiah D, 2010, CHEM-EUR J, V16, P2031, DOI 10.1002/chem.200902887
   BAYLIS AB, 1972, Patent No. 2155113
   Boersma AJ, 2007, ORG LETT, V9, P3647, DOI 10.1021/ol7015274
   Boersma AJ, 2009, ANGEW CHEM INT EDIT, V48, P3346, DOI 10.1002/anie.200900371
   CIGANEK I, 1997, ORG REACTIONS, V51, P201
   Font D, 2006, ORG LETT, V8, P4653, DOI 10.1021/ol061964j
   Franck X, 2002, TETRAHEDRON LETT, V43, P1449, DOI 10.1016/S0040-4039(02)00058-8
   Garnier JM, 2009, ADV SYNTH CATAL, V351, P331, DOI 10.1002/adsc.200800679
   Gu YL, 2006, ANGEW CHEM INT EDIT, V45, P7217, DOI 10.1002/anie.200603070
   Han J, 2009, J AM CHEM SOC, V131, P2060, DOI 10.1021/ja808935n
   Hayashi Y, 2008, ORG LETT, V10, P21, DOI 10.1021/ol702489k
   Huang JW, 2003, ADV SYNTH CATAL, V345, P953, DOI 10.1002/adsc.200303072
   Kaye PT, 2002, J CHEM SOC PERK T 1, P1318, DOI 10.1039/b201827f
   Kobayashi S, 2002, ACCOUNTS CHEM RES, V35, P209, DOI 10.1021/ar000145a
   Langer P, 2000, ANGEW CHEM INT EDIT, V39, P3049, DOI 10.1002/1521-3773(20000901)39:17<3049::AID-ANIE3049>3.0.CO;2-5
   Li CJ, 2002, ACCOUNTS CHEM RES, V35, P533, DOI 10.1021/ar0100125
   Li CJ, 2002, CHEM COMMUN, P268, DOI 10.1039/b108851n
   Liu LF, 2005, J ORG CHEM, V70, P9666, DOI 10.1021/jo0520821
   Miyabe H, 2000, J ORG CHEM, V65, P5043, DOI 10.1021/jo000318+
   Myers E. L., 2007, ANGEW CHEM, V119, P1925
   Paradowska J, 2009, ANGEW CHEM INT EDIT, V48, P4288, DOI 10.1002/anie.200802038
   PARASARAN T, 1964, J ORG CHEM, V29, P946, DOI 10.1021/jo01027a507
   Ramachandran PV, 2001, CHEM COMMUN, P757, DOI 10.1039/b009177b
   Reddy MVR, 2002, J ORG CHEM, V67, P5382, DOI 10.1021/jo025591l
   Redondo MC, 2010, ORG LETT, V12, P568, DOI 10.1021/ol902763g
   Roy D, 2007, ORG LETT, V9, P4873, DOI 10.1021/oI702211d
   Roy D, 2008, CHEM-EUR J, V14, P10530, DOI 10.1002/chem.200801822
   Shapiro N, 2008, ANGEW CHEM INT EDIT, V47, P2849, DOI 10.1002/anie.200705347
   Shen ZL, 2008, J ORG CHEM, V73, P3922, DOI 10.1021/jo8000589
   Shi M, 2001, CHEM COMMUN, P833, DOI 10.1039/b101019k
   SHI M, 2002, LIN J ORG CHEM, P696
   SINGH V, 2010, J ORG CHEM, P3684
   SRINAM D, 2007, ORG LETT, V9, P3639
   Takeda Y, 2008, ORG LETT, V10, P1013, DOI 10.1021/ol8000377
   Tan B, 2010, CHEM-EUR J, V16, P3842, DOI 10.1002/chem.200902932
   Vilaro M, 2008, ORG LETT, V10, P3243, DOI 10.1021/ol801009z
   Wang J, 2008, ORG LETT, V10, P2561, DOI 10.1021/ol800835m
   Wu YY, 2006, ORG LETT, V8, P4417, DOI 10.1021/ol061418q
   Wu ZQ, 2010, EUR J ORG CHEM, P1854, DOI 10.1002/ejoc.201000060
   Yang XF, 2003, ORG LETT, V5, P657, DOI 10.1021/ol0273102
   Yao XQ, 2005, ORG LETT, V7, P4395, DOI 10.1021/ol051575+
   Younkin TR, 2000, SCIENCE, V287, P460, DOI 10.1126/science.287.5452.460
   Yu CZ, 2002, J ORG CHEM, V67, P219, DOI 10.1021/jo016004j
   Yu CZ, 2001, J ORG CHEM, V66, P5413, DOI 10.1021/jo01568m
NR 54
TC 1
Z9 1
U1 3
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1523-7060
EI 1523-7052
J9 ORG LETT
JI Org. Lett.
PD OCT 15
PY 2010
VL 12
IS 20
BP 4568
EP 4571
DI 10.1021/ol101883g
PG 4
WC Chemistry, Organic
SC Chemistry
GA 659YX
UT WOS:000282604700035
PM 20845913
DA 2018-12-27
ER

PT J
AU Klimczuk, T
   Gofryk, K
   Wang, CH
   Allred, JM
   Ronning, F
   Sadowski, W
   Griveau, JC
   Colineau, E
   Safarik, D
   Thompson, JD
   Cava, RJ
AF Klimczuk, T.
   Gofryk, K.
   Wang, C. H.
   Allred, J. M.
   Ronning, F.
   Sadowski, W.
   Griveau, J. -C.
   Colineau, E.
   Safarik, D.
   Thompson, J. D.
   Cava, R. J.
TI RETRACTED: Superconductivity in the Rh-based Heusler family MRh2Sn
   (Retracted article. See vol. 83, artn no. 19901, 2011)
SO PHYSICAL REVIEW B
LA English
DT Article; Retracted Publication
ID TRANSITION-TEMPERATURE; EARTH; ALLOYS; MGB2
AB Superconductivity and structural characterization is reported for the Heusler structure compounds ScRh2Sn, LuRh2Sn, and YRh2Sn. The superconducting T-c's are 2.0 K, 2.9 K, and 4.1 K, respectively. The electronic contributions to the specific heat and the Debye temperatures are reported, and suggest that the observed trend in T-c is governed primarily by an increase in electron-phonon coupling on going from ScRh2Sn to YRh2Sn. The electron-phonon coupling constant lambda(ep) and the normalized specific-heat jump Delta C/gamma T-c suggest that the MRh2Sn system evolves from weak coupling to moderate coupling superconductivity.
C1 [Klimczuk, T.; Gofryk, K.; Wang, C. H.; Ronning, F.; Safarik, D.; Thompson, J. D.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA.
   [Klimczuk, T.; Griveau, J. -C.; Colineau, E.] European Commiss, Joint Res Ctr, Inst Transuranium Elements, D-76125 Karlsruhe, Germany.
   [Klimczuk, T.; Sadowski, W.] Gdansk Univ Technol, Fac Appl Phys & Math, PL-80952 Gdansk, Poland.
   [Wang, C. H.] Univ Calif Irvine, Irvine, CA 92697 USA.
   [Allred, J. M.; Cava, R. J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.
RP Klimczuk, T (reprint author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.
RI Klimczuk, Tomasz/M-1716-2013; Gofryk, Krzysztof/F-8755-2014; Gofryk,
   Krzysztof/M-3225-2018
OI Klimczuk, Tomasz/0000-0003-2602-5049; Gofryk,
   Krzysztof/0000-0002-8681-6857; Klimczuk, Tomasz/0000-0002-7089-4631;
   Safarik, Douglas/0000-0001-8648-9377; Ronning, Filip/0000-0002-2679-7957
FU U.S. Department of Energy, Office of Science; U.S. Department of Energy
   [DE-FG02-98ER45706]; European Commission
FX Work at Los Alamos National Laboratory was performed under the auspices
   of the U.S. Department of Energy, Office of Science. The work at
   Princeton University was supported by the U.S. Department of Energy,
   Grant No. DE-FG02-98ER45706. T.K. acknowledges the European Commission
   for financial support.
CR An JM, 2001, PHYS REV LETT, V86, P4366, DOI 10.1103/PhysRevLett.86.4366
   Chadov S, 2010, NAT MATER, V9, P541, DOI [10.1038/NMAT2770, 10.1038/nmat2770]
   Gofryk K, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.094409
   Guritanu V, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.184526
   Hamaya K, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.137204
   Heusler F., 1903, Verhandlungen der Deutschen Physikalischen Gesellschaft, V5
   Hohl H, 1999, J PHYS-CONDENS MAT, V11, P1697, DOI 10.1088/0953-8984/11/7/004
   Ishikawa M., 1982, SUPERCONDUCTIVITY D
   JOHNSON MJ, 1984, SOLID STATE COMMUN, V52, P839, DOI 10.1016/0038-1098(84)90252-7
   JORDA JL, 1985, J LESS-COMMON MET, V107, P321, DOI 10.1016/0022-5088(85)90091-8
   KLIMCZUK T, UNPUB
   Larson A., 2000, 86 LAUR LOS AL NAT L
   Lin H, 2010, NAT MATER, V9, P546, DOI [10.1038/NMAT2771, 10.1038/nmat2771]
   MALIK SK, 1985, PHYS REV B, V32, P4426, DOI 10.1103/PhysRevB.32.4426
   MCMILLAN WL, 1968, PHYS REV, V167, P331, DOI 10.1103/PhysRev.167.331
   MUHLSCHLEGEL B, 1959, Z PHYS, V155, P313, DOI 10.1007/BF01332932
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   Seaman CL, 1996, PHYS REV B, V53, P2651, DOI 10.1103/PhysRevB.53.2651
   Shan R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.246601
   Teyssier J, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.134504
   Toby BH, 2001, J APPL CRYSTALLOGR, V34, P210, DOI 10.1107/S0021889801002242
   Uher C, 1999, PHYS REV B, V59, P8615, DOI 10.1103/PhysRevB.59.8615
   WAKI S, 1985, J PHYS SOC JPN, V54, P1673, DOI 10.1143/JPSJ.54.1673
   Wang YX, 2001, PHYSICA C, V355, P179, DOI 10.1016/S0921-4534(01)00617-7
   WERTHAME.NR, 1966, PHYS REV, V147, P295, DOI 10.1103/PhysRev.147.295
   Winterlik J, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.184506
   Winterlik J, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.064508
NR 27
TC 1
Z9 1
U1 1
U2 14
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 2469-9950
EI 2469-9969
J9 PHYS REV B
JI Phys. Rev. B
PD OCT 14
PY 2010
VL 82
IS 13
AR 134520
DI 10.1103/PhysRevB.82.134520
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 664CX
UT WOS:000282937600006
DA 2018-12-27
ER

PT J
AU Oh, MH
   Wang, XF
   Wu, X
   Zhao, YF
   Clouse, SD
   Huber, SC
AF Oh, Man-Ho
   Wang, Xiaofeng
   Wu, Xia
   Zhao, Youfu
   Clouse, Steven D.
   Huber, Steven C.
TI RETRACTED: Autophosphorylation of Tyr-610 in the receptor kinase BAK1
   plays a role in brassinosteroid signaling and basal defense gene
   expression (Retracted article. See vol. 113, pg. E3987, 2016)
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article; Retracted Publication
DE basal immunity; flagellin signaling; receptor-like kinase; tyrosine
   phosphorylation; phosphospecific antibodies
ID PHOSPHORYLATION SITES; ARABIDOPSIS-THALIANA; INNATE IMMUNITY; IN-VITRO;
   FLAGELLIN; PERCEPTION; COMPLEX; PLANTS; BRI1; IDENTIFICATION
AB BAK1 is a leucine-rich repeat receptor-like kinase that functions as a coreceptor with the brassinosteroid (BR) receptor BRI1 and the flagellin receptor FLS2, and as a negative regulator of programmed cell death. BAK1 has been shown to autophosphorylate on numerous serine/threonine sites in vitro as well as to transphosphorylate associated receptor kinases both in vitro and in planta. In the present study we identify Tyr-610 in the carboxyl-terminal domain of BAK1 as a major site of autophosphorylation that is brassinolide-induced in vivo and requires a kinase-active BAK1. Expression of BAK1(Y610F)-Flag in transgenic plants lacking the endogenous bak1 and its functional paralogue, bkk1, produced plants that were viable but extremely small and generally resembled BR signaling mutants, whereas an acidic substitution for Tyr-610 to mimic phosphorylation restored normal growth. Several lines of evidence support the notion that BR signaling is impaired in the BAK1(Y610F)-Flag plants, and are consistent with the recently proposed sequential transphosphorylation model for BRI1/BAK1 interaction and activation. In contrast, the FLS2-mediated inhibition of seedling growth by the flg22 elicitor occurred normally in the Y610F-directed mutant. However, expression of many defense genes was dramatically reduced in BAK1(Y610F) plants and the nonpathogenic hrpA mutant of Pseudomonas syringae was able to grow rapidly in the mutant. These results indicate that phosphorylation of Tyr-610 is required for some but not all functions of BAK1, and adds significantly to the emerging notion that tyrosine phosphorylation could play an important role in plant receptor kinase signaling.
C1 [Oh, Man-Ho; Huber, Steven C.] ARS, USDA, Urbana, IL 61801 USA.
   [Wang, Xiaofeng; Clouse, Steven D.] N Carolina State Univ, Dept Hort Sci, Raleigh, NC 27695 USA.
   [Zhao, Youfu] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.
   [Wu, Xia] Univ Illinois, Dept Plant Biol, Physiol & Mol Plant Biol Program, Urbana, IL 61801 USA.
RP Huber, SC (reprint author), ARS, USDA, Urbana, IL 61801 USA.
EM schuber1@uiuc.edu
RI Wu, Xia/J-8690-2014
OI Wu, Xia/0000-0002-0024-4481; Oh, Man-Ho/0000-0002-6524-3252
FU US Department of Agriculture/National Institute of Food and Agriculture
   [2007-35318-17801, 2004-35304-14930]; National Science Foundation
   [MCB-0419819, MCB-0740211, IOS-1022177]; US Department of Agriculture
   Agricultural Research Service
FX The authors thank Yanhai Yin (Iowa State University, Ames, IA) for
   providing anti-BES1 antibody. This work was supported by National
   Research Initiative Competitive Grants 2007-35318-17801 and
   2004-35304-14930 from the US Department of Agriculture/National
   Institute of Food and Agriculture; National Science Foundation Grants
   MCB-0419819, MCB-0740211, and IOS-1022177; and the US Department of
   Agriculture Agricultural Research Service.
CR Chae L, 2009, MOL PLANT, V2, P84, DOI 10.1093/mp/ssn083
   Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x
   Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8
   He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036
   Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.127.3.803
   Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104
   Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412
   Karlova R, 2009, PROTEOMICS, V9, P368, DOI 10.1002/pmic.200701059
   Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046
   Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353
   Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7
   Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398
   Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743
   Nurnberger T, 2006, TRENDS PLANT SCI, V11, P519, DOI 10.1016/j.tplants.2006.09.005
   Oh MH, 2009, PLANT SIGNAL BEHAV, V4, P1182, DOI 10.4161/psb.4.12.10046
   Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106
   Oh MH, 2000, PLANT PHYSIOL, V124, P751, DOI 10.1104/pp.124.2.751
   Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598
   Underwood W, 2007, PLANT J, V52, P658, DOI 10.1111/j.1365-313X.2007.03262.x
   Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241
   Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393
   Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011
   Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001
   Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3
   Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616
   Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485
NR 28
TC 88
Z9 96
U1 2
U2 28
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT 12
PY 2010
VL 107
IS 41
BP 17827
EP 17832
DI 10.1073/pnas.0915064107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 662LV
UT WOS:000282809700069
PM 20876109
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Li, LW
   Zhang, CP
   Li, XY
   Lu, SH
   Zhou, Y
AF Li, Linwei
   Zhang, Chunpeng
   Li, Xiaoyan
   Lu, ShihHsin
   Zhou, Yun
TI RETRACTED: The candidate tumor suppressor gene ECRG4 inhibits cancer
   cells migration and invasion in esophageal carcinoma (Retracted article.
   See vol. 30, artn no. 19, 2011)
SO JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
LA English
DT Article; Retracted Publication
ID NF-KAPPA-B; EXPRESSION; GROWTH; ACTIVATION; GLIOMA; CDNA
AB Background: The esophageal cancer related gene 4 (ECRG4) was initially identified and cloned in our laboratory from human normal esophageal epithelium (GenBank accession no.AF325503). ECRG4 was a new tumor suppressor gene in esophageal squamous cell carcinoma (ESCC) associated with prognosis. In this study, we investigated the novel tumor-suppressing function of ECRG4 in cancer cell migration, invasion, adhesion and cell cycle regulation in ESCC.
   Methods: Transwell and Boyden chamber experiments were utilized to examined the effects of ECRG4 expression on ESCC cells migration, invasion and adhesion. And flow cytometric analysis was used to observe the impact of ECRG4 expression on cell cycle regulation. Finally, the expression levels of cell cycle regulating proteins p53 and p21 in human ESCC cells transfected with ECRG4 gene were evaluated by Western blotting.
   Results: The restoration of ECRG4 expression in ESCC cells inhibited cancer cells migration and invasion (P < 0.05), which did not affect cell adhesion capacity (P > 0.05). Furthermore, ECRG4 could cause cell cycle G1 phase arrest in ESCC (P < 0.05), through inducing the increased expression of p53 and p21 proteins.
   Conclusion: ECRG4 is a candidate tumor suppressor gene which suppressed tumor cells migration and invasion without affecting cell adhesion ability in ESCC. Furthermore, ECRG4 might cause cell cycle G1 phase block possibly through inducing the increased expression of p53 and p21 proteins in ESCC.
C1 [Li, Linwei; Li, Xiaoyan; Zhou, Yun] Henan Prov Peoples Hosp, Dept Oncol, Zhengzhou 450003, Peoples R China.
   [Zhang, Chunpeng; Lu, ShihHsin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.
   [Zhang, Chunpeng; Lu, ShihHsin] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100021, Peoples R China.
   [Zhang, Chunpeng; Lu, ShihHsin] Peking Union Med Coll, Beijing 100021, Peoples R China.
RP Zhou, Y (reprint author), Henan Prov Peoples Hosp, Dept Oncol, Zhengzhou 450003, Peoples R China.
EM lilinweillw@yahoo.com.cn
FU Chinese State Key Projects for Basic Research [2002CB513101,
   2004CB518701]; Henan Province Science Research Key Project [0624410058]
FX This work was supported by the Chinese State Key Projects for Basic
   Research (2002CB513101 and 2004CB518701) and the Henan Province Science
   Research Key Project (0624410058). We thank professor Wei Jing of
   Burnham Institute Cancer Center (La Jolla, CA92037, USA) for helpful
   comments on this manuscript. We also thank Dr Xiao-chun Wang and Dr
   Hong-yan Chen for the technical assistance.
CR Bi MX, 2001, ACTA BIOCH BIOPH SIN, V33, P257
   Gotze S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-447
   Han Yaling, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P455
   Ho YT, 2009, CANCER LETT, V279, P155, DOI 10.1016/j.canlet.2009.01.033
   Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003
   Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780
   Li LW, 2009, INT J CANCER, V125, P1505, DOI 10.1002/ijc.24513
   Li W, 2010, J EXP CLIN CANC RES, V29, P1, DOI 10.1186/1756-9966-29-89
   Liu FN, 2009, INT J CANCER, V125, P2511, DOI 10.1002/ijc.24588
   Liu QY, 2007, MOL IMMUNOL, V44, P2686, DOI 10.1016/j.molimm.2006.12.003
   Lu SH, 2000, MUTAT RES-REV MUTAT, V462, P343, DOI 10.1016/S1383-5742(00)00023-5
   Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218
   Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003
   Mori Y, 2007, ONCOL REP, V18, P981
   Niu JG, 2007, J BIOL CHEM, V282, P6001, DOI 10.1074/jbc.M606878200
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924
   Steck E, 2002, BIOCHEM BIOPH RES CO, V299, P109, DOI 10.1016/S0006-291X(02)02585-8
   SU T, 1998, CHINESE J ONCOL, V20, P254
   Takaoka K, 2006, INT J ONCOL, V29, P1095
   Whitson JM, 2009, INT J CANCER, V125, P446, DOI 10.1002/ijc.24370
   Wu CY, 2005, WORLD J GASTROENTERO, V11, P3197, DOI 10.3748/wjg.v11.i21.3197
   Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530
   Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016
   Yang ZQ, 2000, CANCER RES, V60, P4735
   Yue CM, 2003, WORLD J GASTROENTERO, V9, P1174, DOI 10.3748/wjg.v9.i6.1174
NR 26
TC 18
Z9 22
U1 2
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-9966
J9 J EXP CLIN CANC RES
JI J. Exp. Clin. Cancer Res.
PD OCT 11
PY 2010
VL 29
AR 133
DI 10.1186/1756-9966-29-133
PG 6
WC Oncology
SC Oncology
GA 668SZ
UT WOS:000283291600001
PM 20937111
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Naskar, S
   Sood, SK
   Goyal, V
   Dhara, M
AF Naskar, Shovan
   Sood, Sanjay Kumar
   Goyal, Vinay
   Dhara, Madhurima
TI RETRACTED: Mechanism(s) of deep brain stimulation and insights into
   cognitive outcomes in Parkinson's disease (Retracted article. See vol.
   1419, pg. 117, 2011)
SO BRAIN RESEARCH REVIEWS
LA English
DT Review; Retracted Publication
DE Deep brain stimulation; Parkinsonism; Basal ganglia; Cognition
ID HIGH-FREQUENCY STIMULATION; SUBTHALAMIC NUCLEUS STIMULATION; BILATERAL
   PALLIDAL STIMULATION; OBSESSIVE-COMPULSIVE DISORDER; STRIATAL DOPAMINE
   RELEASE; NIGRA PARS RETICULATA; MPTP-TREATED MONKEYS; GLOBUS-PALLIDUS;
   SUBSTANTIA-NIGRA; ELECTRICAL-STIMULATION
AB Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor, cognitive, neuropsychiatric, autonomic, and other nonmotor symptoms. Deep brain stimulation (DBS) at high frequency is now considered the most effective neurosurgical therapy for movement disorders, especially PD. An electrode is chronically implanted in a particular area of the brain and, when continuously stimulated, it significantly alleviates motor symptoms. In Parkinson's disease, the common target nuclei of high frequency stimulation (HFS) are the basal ganglia nuclei, such as the internal segment of the pallidum and the subthalamic nucleus (STN), with a preference for the STN in recent years. Two fundamental mechanisms have been proposed to underlie the beneficial effects of HFS: either silencing or excitation of STN neurons. This article highlights the recent views concerned with the mechanisms of DBS. Although the efficacy of DBS for the motor symptoms of advanced PD is well established, the effects of DBS on the cognitive and neuropsychiatric symptoms are less clear. The cognitive aspects of DBS for PD have recently been of considerable clinical and pathophysiological interest. This article also reviews the published literature on the cognitive aspects of DBS for PD. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Sood, Sanjay Kumar] All India Inst Med Sci, Dept Physiol, Cognit Neurophysiol Lab, New Delhi 29, India.
   [Goyal, Vinay] All India Inst Med Sci, Dept Neurol, New Delhi 29, India.
RP Sood, SK (reprint author), All India Inst Med Sci, Dept Physiol, Cognit Neurophysiol Lab, New Delhi 29, India.
EM sksaiims@yahoo.com
CR Abosch A, 2003, NEUROSURGERY, V53, P1095, DOI 10.1227/01.NEU.0000088662.69419.1B
   Alegret M, 2001, ARCH NEUROL-CHICAGO, V58, P1223, DOI 10.1001/archneur.58.8.1223
   Anderson ME, 2003, J NEUROPHYSIOL, V89, P1150, DOI 10.1152/jn.00475.2002
   Aouizerate B, 2004, J NEUROSURG, V101, P682, DOI 10.3171/jns.2004.101.4.0682
   Ardouin C, 1999, ANN NEUROL, V46, P217, DOI 10.1002/1531-8249(199908)46:2<217::AID-ANA11>3.0.CO;2-Z
   AZIZ TZ, 1991, MOVEMENT DISORD, V6, P288, DOI 10.1002/mds.870060404
   Benabid AL, 2006, MOVEMENT DISORD, V21, pS168, DOI 10.1002/mds.20954
   BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T
   Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001
   Benazzouz A, 2000, NEUROREPORT, V11, P1593, DOI 10.1097/00001756-200005150-00043
   BENAZZOUZ A, 1993, EUR J NEUROSCI, V5, P382, DOI 10.1111/j.1460-9568.1993.tb00505.x
   BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638
   Berney A, 2002, NEUROLOGY, V59, P1427, DOI 10.1212/01.WNL.0000032756.14298.18
   Beurrier C, 2001, J NEUROPHYSIOL, V85, P1351
   Beurrier C, 1999, J NEUROSCI, V19, P599
   Bevan MD, 1999, J NEUROSCI, V19, P7617, DOI 10.1523/JNEUROSCI.19-17-07617.1999
   Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x
   Brown P, 2004, EXP NEUROL, V188, P480, DOI 10.1016/j.expneurol.2004.05.009
   BURBAUD P, 1994, J PHYSIOLOGY-PARIS, V88, P359, DOI 10.1016/0928-4257(94)90029-9
   Burchiel KJ, 1999, NEUROSURGERY, V45, P1375, DOI 10.1097/00006123-199912000-00024
   Carlson JD, 2010, J NEUROPHYSIOL, V103, P962, DOI 10.1152/jn.00363.2009
   Ceballos-Baumann AO, 1999, ARCH NEUROL-CHICAGO, V56, P997, DOI 10.1001/archneur.56.8.997
   Coubes P, 2004, J NEUROSURG, V101, P189, DOI 10.3171/jns.2004.101.2.0189
   Daniele A, 2003, J NEUROL NEUROSUR PS, V74, P175, DOI 10.1136/jnnp.74.2.175
   Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570
   Dujardin K, 2000, NEUROPSYCHOLOGIA, V38, P1305, DOI 10.1016/S0028-3932(00)00027-0
   Dujardin K, 2001, J NEUROL, V248, P603, DOI 10.1007/s004150170139
   Fields JA, 1999, CLIN NEUROL NEUROSUR, V101, P182, DOI 10.1016/S0303-8467(99)00044-X
   Filali M, 2004, EXP BRAIN RES, V156, P274, DOI 10.1007/s00221-003-1784-y
   Funkiewiez A, 2004, J NEUROL NEUROSUR PS, V75, P834, DOI 10.1136/jnnp.2002.009803
   Garcia L, 2005, TRENDS NEUROSCI, V28, P209, DOI 10.1016/j.tins.2005.02.005
   Garcia L, 2003, J NEUROSCI, V23, P8743
   Gerschlager W, 2001, J NEUROL, V248, P285, DOI 10.1007/s004150170202
   Gironell A, 2003, J NEUROL, V250, P917, DOI 10.1007/s00415-003-1109-x
   Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093
   GROENEWEGEN HJ, 1990, J COMP NEUROL, V294, P607, DOI 10.1002/cne.902940408
   Haberler C, 2000, ANN NEUROL, V48, P372, DOI 10.1002/1531-8249(200009)48:3<372::AID-ANA12>3.3.CO;2-S
   HAMMOND C, 1978, BRAIN RES, V151, P235, DOI 10.1016/0006-8993(78)90881-8
   Hariz MI, 2000, MOVEMENT DISORD, V15, P136, DOI 10.1002/1531-8257(200001)15:1<136::AID-MDS1021>3.0.CO;2-5
   Hassani OK, 1996, NEUROSCIENCE, V72, P105, DOI 10.1016/0306-4522(95)00535-8
   Hershey T, 2004, NEUROLOGY, V62, P1110, DOI 10.1212/01.WNL.0000118202.19098.10
   Hershey T, 2003, NEUROLOGY, V61, P816, DOI 10.1212/01.WNL.0000083991.81859.73
   Hilker R, 2003, MOVEMENT DISORD, V18, P41, DOI 10.1002/mds.10297
   Hirsch EC, 2000, TRENDS NEUROSCI, V23, pS78, DOI 10.1016/S1471-1931(00)00021-5
   Holsheimer J, 2000, EUR J NEUROSCI, V12, P4573, DOI 10.1046/j.1460-9568.2000.01306.x
   Houeto JL, 2005, J NEUROL NEUROSUR PS, V76, P992, DOI 10.1136/jnnp.2004.043273
   Houeto JL, 2002, J NEUROL NEUROSUR PS, V72, P701, DOI 10.1136/jnnp.72.6.701
   Jahanshahi M, 2000, BRAIN, V123, P1142, DOI 10.1093/brain/123.6.1142
   Kiss ZHT, 2002, NEUROSCIENCE, V113, P137, DOI 10.1016/S0306-4522(02)00122-7
   Kovacs N, 2008, PARKINSONISM RELAT D, V14, P476, DOI 10.1016/j.parkreldis.2008.01.002
   Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275
   Kumar R, 1999, NEUROLOGY, V53, P871, DOI 10.1212/WNL.53.4.871
   Lang AE, 2000, ARCH NEUROL-CHICAGO, V57, P1118, DOI 10.1001/archneur.57.8.1118
   Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001
   Lee KH, 2004, J NEUROSURG, V101, P511, DOI 10.3171/jns.2004.101.3.0511
   Levy R, 2001, BRAIN, V124, P2105, DOI 10.1093/brain/124.10.2105
   LIMOUSIN P, 1995, LANCET, V345, P91, DOI 10.1016/S0140-6736(95)90062-4
   Lipsman N, 2007, NEUROSURGERY, V61, P1, DOI 10.1227/01.NEU.0000255498.64557.6C
   Lozano AM, 2002, LANCET NEUROL, V1, P225, DOI 10.1016/S1474-4422(02)00101-1
   Magarinos-Ascone C, 2002, NEUROSCIENCE, V115, P1109, DOI 10.1016/S0306-4522(02)00538-9
   Maurice N, 2003, J NEUROSCI, V23, P9929
   Meissner W, 2004, NEUROCHEM INT, V44, P281, DOI 10.1016/S0197-0186(03)00138-4
   Meissner W, 2003, J NEUROCHEM, V85, P601, DOI 10.1046/j.1471-4159.2003.01665.x
   Moretti R, 2003, PARKINSONISM RELAT D, V10, P73, DOI 10.1016/S1353-8020(03)00073-7
   Moro E, 1999, NEUROLOGY, V53, P85, DOI 10.1212/WNL.53.1.85
   Morrison CE, 2004, ARCH CLIN NEUROPSYCH, V19, P165, DOI 10.1016/S0887-6177(03)00004-0
   Nakajima T, 2003, J NEUROSURG, V98, P57, DOI 10.3171/jns.2003.98.1.0057
   NAKANISHI H, 1991, BRAIN RES, V549, P285, DOI 10.1016/0006-8993(91)90469-C
   NASKAR S, 2010, PARKINSONISM RELAT D, V30, P1
   Neimat Joseph S, 2006, Expert Rev Neurother, V6, P101, DOI 10.1586/14737175.6.1.101
   Nowak LG, 1998, EXP BRAIN RES, V118, P477, DOI 10.1007/s002210050304
   Perozzo P, 2001, J NEUROL SCI, V192, P9, DOI 10.1016/S0022-510X(01)00575-5
   Pillon B, 2000, NEUROLOGY, V55, P411, DOI 10.1212/WNL.55.3.411
   RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9
   Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944
   Rezai AR, 2006, MOVEMENT DISORD, V21, pS197, DOI 10.1002/mds.20956
   RINVIK E, 1993, J CHEM NEUROANAT, V6, P19, DOI 10.1016/0891-0618(93)90004-N
   Rosales MG, 1997, NEUROSCIENCE, V80, P803, DOI 10.1016/S0306-4522(97)00160-7
   Saint-Cyr JA, 2000, BRAIN, V123, P2091, DOI 10.1093/brain/123.10.2091
   Salin P, 2002, J NEUROSCI, V22, P5137, DOI 10.1523/JNEUROSCI.22-12-05137.2002
   SORIN B, 2004, CELL TISSUE RES, V318, P275
   Strafella AP, 2003, NEUROREPORT, V14, P1287, DOI 10.1097/01.wnr.0000081873.45938.56
   Tai CH, 2003, FASEB J, V17, P1820, DOI 10.1096/fj.03-0163com
   Thobois S, 2003, J NEUROL, V250, P1219, DOI 10.1007/s00415-003-0188-z
   THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P501
   Trepanier LL, 2000, BRAIN COGNITION, V42, P324, DOI 10.1006/brcg.1999.1108
   Troster AI, 1997, NEUROLOGY, V49, P1078, DOI 10.1212/WNL.49.4.1078
   Troster AI, 2002, BRAIN COGNITION, V50, P207, DOI 10.1016/S0278-2626(02)00504-3
   Vingerhoets G, 1999, J NEUROL NEUROSUR PS, V66, P297, DOI 10.1136/jnnp.66.3.297
   Visser-Vandewalle V, 2007, ACTA NEUROCHIR SUPPL, V97, P215
   Vitek JL, 2002, MOVEMENT DISORD, V17, pS69, DOI 10.1002/mds.10144
   Volkmann J, 2004, ANN NEUROL, V55, P871, DOI 10.1002/ana.20091
   Wallace BA, 2007, BRAIN, V130, P2129, DOI 10.1093/brain/awm137
   Welter ML, 2004, ARCH NEUROL-CHICAGO, V61, P89, DOI 10.1001/archneur.61.1.89
   Windels F, 2000, EUR J NEUROSCI, V12, P4141, DOI 10.1046/j.1460-9568.2000.00296.x
   Witt K, 2004, ARCH NEUROL-CHICAGO, V61, P697, DOI 10.1001/archneur.61.5.697
NR 96
TC 10
Z9 11
U1 4
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0173
EI 1872-6321
J9 BRAIN RES REV
JI Brain Res. Rev.
PD OCT 5
PY 2010
VL 65
IS 1
BP 1
EP 13
DI 10.1016/j.brainresrev.2010.04.010
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA 663ZZ
UT WOS:000282930000001
PM 20457181
DA 2018-12-27
ER

PT J
AU Yu, JH
   Yang, EH
AF Yu, J. H.
   Yang, E. H.
TI RETRACTED: Microstructure of self-healed PVA engineered cementitious
   composites under wet-dry cycles (Retracted article. See vol. 110, pg.
   250, 2011)
SO ADVANCES IN APPLIED CERAMICS
LA English
DT Article; Retracted Publication
DE ECC; Self-healing; Microstructure; Fly ash; Crack width
ID PERFORMANCE; CONCRETE
AB Self-healing of engineered cementitious composites (ECCs) subjected to cyclic wetting and drying regimes is investigated in this paper. Structures of ECCs subjected to outdoor environmental conditions such as wind and rain runoff can be simulated by accelerated test method of wetting and drying cycles. Uniaxial tensile tests of ECC M45 and ECC 2.8FA specimens are conducted respectively. It is found that the crack width of ECC 2.8FA is similar to 10 mu m with increased amount of fly ash, while that of ECC M45 is similar to 100 mu m. New insights about the microstructure and chemical composition analysis of ECC specimens initially cracked to 2% strain and then self-healed under wet-dry cycles are presented. The type of self-healing for ECC 2.8FA is more effective for the recovery of tensile strength over ECC M45.
C1 [Yu, J. H.] Shenyang Jianzhu Univ, Sch Civil Engn, Shenyang 110168, Peoples R China.
   [Yang, E. H.] Univ Michigan, Dept Civil & Environm Engn, Ann Arbor, MI 48105 USA.
RP Yu, JH (reprint author), Shenyang Jianzhu Univ, Sch Civil Engn, Shenyang 110168, Peoples R China.
EM jiahuan@umich.edu
FU China Scholarship Council
FX Financial supports China Scholarship Council are gratefully
   acknowledged. This work was completed while the author J. H. Yu was a
   visiting professor at ACE-MRL Laboratory under Professor V. C. Li's
   supervision at the University of Michigan.
CR Black L, 2007, ADV APPL CERAM, V106, P327, DOI 10.1179/174367607X228052
   Black L, 2007, J AM CERAM SOC, V90, P908, DOI 10.1111/j.1551-2916.2006.01429.x
   Edvardsen C, 1999, ACI MATER J, V96, P448
   Edwards DD, 2007, ADV APPL CERAM, V106, P309, DOI 10.1179/174367607X228061
   Li VC, 2006, PROBABILIST ENG MECH, V21, P201, DOI 10.1016/j.probengmech.2005.10.008
   Li VC, 2007, SPRINGER SER MATER S, V100, P161, DOI 10.1007/978-1-4020-6250-6_8
   Martinez-Ramirez S, 2003, CEMENT CONCRETE RES, V33, P2063, DOI 10.1016/s0008-8846(03)00227-8
   Yang EH, 2008, J ADV CONCR TECHNOL, V6, P181, DOI 10.3151/jact.6.181
   Yang YZ, 2009, CEMENT CONCRETE RES, V39, P382, DOI 10.1016/j.cemconres.2009.01.013
   Yu JH, 2009, J STRAIN ANAL ENG, V44, P417, DOI 10.1243/03093247JSA513
   Yu JH, 2009, MATER SCI TECH-LOND, V25, P651, DOI 10.1179/174328408X327731
NR 11
TC 1
Z9 1
U1 9
U2 31
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1743-6753
EI 1743-6761
J9 ADV APPL CERAM
JI Adv. Appl. Ceram.
PD OCT
PY 2010
VL 109
IS 7
BP 399
EP 404
DI 10.1179/174367510X12677121374582
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 654AR
UT WOS:000282141000006
DA 2018-12-27
ER

PT J
AU Sur, S
   Ozturk, Z
   Oztas, M
   Bedir, M
AF Sur, Serap
   Ozturk, Zihni
   Oztas, Mustafa
   Bedir, Metin
TI RETRACTED: Deposition and characterization of polycrystalline ZnS films
   prepared using a chemical bath deposition technique in an
   aqueous/ethanolic solution (Retracted article. See vol. 83, artn no.
   069802, 2011)
SO PHYSICA SCRIPTA
LA English
DT Article; Retracted Publication
ID THIN-FILMS; OPTICAL-PROPERTIES; ELECTRICAL-PROPERTIES; GROWTH;
   MICROSTRUCTURE; TEMPERATURE
AB Polycrystalline zinc sulfide (ZnS) films were prepared on glass substrates using a chemical bath deposition (CBD) technique in an aqueous/ethanolic solution. The films were characterized by x-ray diffraction (XRD), scanning electron microscopy (SEM) and electrical conductivity measurement. The XRD studies revealed that the deposited films have a polycrystalline structure, which correlated with SEM results. The films have the hexagonal structure of ZnS as determined by XRD. The electrical measurements of the samples are performed using a dc four-probe technique on rectangular-shaped samples. The influences of various parameters such as temperature and solvent polarity (ethanol/water volume ratio) on the properties of the films were studied in detail.
C1 [Sur, Serap; Ozturk, Zihni; Oztas, Mustafa; Bedir, Metin] Gaziantep Univ, Dept Engn Phys, TR-27310 Gaziantep, Turkey.
RP Sur, S (reprint author), Gaziantep Univ, Dept Engn Phys, TR-27310 Gaziantep, Turkey.
EM oztas@gantep.edu.tr
OI Celik, Serap/0000-0002-5223-025X
CR Arenas OL, 1997, SEMICOND SCI TECH, V12, P1323, DOI 10.1088/0268-1242/12/10/022
   BRIEN PO, 1998, J MATER CHEM, V8, P2309
   BRIOT O, 1994, SEMICOND SCI TECH, V9, P207, DOI 10.1088/0268-1242/9/2/013
   Cheng A, 2003, SEMICOND SCI TECH, V18, P676
   Chourashiya MG, 2008, MATER CHEM PHYS, V109, P39, DOI 10.1016/j.matchemphys.2007.10.028
   DEAN PJ, 1982, J CRYST GROWTH, V59, P301, DOI 10.1016/0022-0248(82)90341-4
   DONA JM, 1994, J ELECTROCHEM SOC, V141, P205, DOI 10.1149/1.2054685
   El Hichou A, 2004, SEMICOND SCI TECH, V19, P230, DOI 10.1088/0268-1242/19/2/018
   HARBEKE G, 1985, POLYCRYSTALLINE SEMI
   Johnston DA, 2002, THIN SOLID FILMS, V403, P102, DOI 10.1016/S0040-6090(01)01536-X
   Kazmerski L. L., 1980, POLYCRYSTALLINE AMOR
   LEDGER AM, 1979, APPL OPTICS, V18, P2979, DOI 10.1364/AO.18.002979
   Lee EYM, 2005, APPL SURF SCI, V241, P493, DOI 10.1016/j.apsusc.2004.07.003
   Liu YH, 2005, THIN SOLID FILMS, V479, P83, DOI 10.1016/j.tsf.2004.11.147
   Maity R, 2006, SOL ENERG MAT SOL C, V90, P597, DOI 10.1016/j.solmat.2005.05.001
   Mane RS, 2000, MATER CHEM PHYS, V65, P1, DOI 10.1016/S0254-0584(00)00217-0
   McKeever S W S, 1995, THERMOLUMINESCENCE D
   McKeever S. W. S., 1985, THERMOLUMINESCENCE S
   NICOLAU YF, 1990, J ELECTROCHEM SOC, V137, P2915, DOI 10.1149/1.2087099
   Oztas M, 2007, J MATER SCI-MATER EL, V18, P505, DOI 10.1007/s10854-006-9065-8
   Oztas M, 2006, PHYSICA B, V381, P40, DOI 10.1016/j.physb.2005.12.248
   Prathap P, 2007, J PHYS D APPL PHYS, V40, P5275, DOI 10.1088/0022-3727/40/17/039
   RUFFNER JA, 1989, APPL OPTICS, V28, P5209, DOI 10.1364/AO.28.005209
   TOMOMURA Y, 1990, J CRYST GROWTH, V99, P451, DOI 10.1016/0022-0248(90)90562-Y
   TONOUCHI M, 1990, JPN J APPL PHYS 2, V29, pL2453, DOI 10.1143/JJAP.29.L2453
   Vidal J, 1999, MATER CHEM PHYS, V61, P139, DOI 10.1016/S0254-0584(99)00130-3
   Vij D. J., 1998, LUMINESCENCE SOLIDS
   Wahi RK, 2006, J COLLOID INTERF SCI, V302, P530, DOI 10.1016/j.jcis.2006.07.003
   YAMAGA S, 1988, J CRYST GROWTH, V86, P252, DOI 10.1016/0022-0248(90)90725-Z
NR 29
TC 4
Z9 4
U1 3
U2 23
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0031-8949
EI 1402-4896
J9 PHYS SCRIPTA
JI Phys. Scr.
PD OCT
PY 2010
VL 82
IS 4
AR 045604
DI 10.1088/0031-8949/82/04/045604
PG 6
WC Physics, Multidisciplinary
SC Physics
GA 672IW
UT WOS:000283577500030
DA 2018-12-27
ER

PT J
AU Wee, DW
   Mullany, LC
   Katz, J
   Khatry, SK
   LeClerq, SC
   Tielsch, JM
AF Wee, David W.
   Mullany, Luke C.
   Katz, Joanne
   Khatry, Subarna K.
   LeClerq, Steven C.
   Tielsch, James M.
TI RETRACTED: Pregnancy-related Mortality in Southern Nepal Between 2001
   and 2006: Independent Estimates From a Prospective, Population-based
   Cohort and a Direct Sisterhood Survey (Retracted article. See vol. 175,
   pg. 478, 2012)
SO AMERICAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Article; Retracted Publication
DE demography; health surveys; maternal mortality; Nepal
ID CLUSTER-RANDOMIZED TRIAL; PLACEBO-CONTROLLED TRIAL; MATERNAL MORTALITY;
   NEONATAL-MORTALITY; CHILD-MORTALITY; SUPPLEMENTATION; CHLORHEXIDINE;
   HEALTH; IMPACT; DEATH
AB Demographic household surveys in Nepal between 1996 and 2006 indicate potentially large decreases in the pregnancy-related mortality ratio and raise hopes that Nepal may be on track to meet Millennium Development Goal 5. Between 2002 and 2006, 23,478 pregnant women in Sarlahi District, Nepal, were followed through pregnancy to 42 days postpartum. The pregnancy-related mortality ratio (PRMR) was estimated directly, comparing deaths among women during pregnancy or within 42 days of pregnancy termination to livebirths. In a separate household survey, 13,319 married females reported on the pregnancy history of 28,829 sisters, allowing for a concurrent comparison of estimation methodologies. In the prospective study, there were 121 pregnancy-related deaths and 23,662 livebirths (PRMR = 511, 95% confidence interval: 425, 611). In the household survey, participants reported 396 deaths among sisters, 87 (22.0%) of which were pregnancy related, and 116,491 person-years of exposure (PRMR = 529, 95% confidence interval: 419, 638). Two independent estimates collected with different methods in the same geographic area over similar time periods resulted in similarly high estimates of mortality that are approximately twice the current national estimate. Access to life-saving maternal health interventions remains low in rural Nepal, and continued efforts are necessary to ensure equitable and country-wide progress toward Millennium Development Goal 5.
C1 [Wee, David W.; Mullany, Luke C.; Katz, Joanne; Khatry, Subarna K.; LeClerq, Steven C.; Tielsch, James M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.
   [Khatry, Subarna K.; LeClerq, Steven C.] Nepal Nutr Intervent Project Sarlahi, Kathmandu, Nepal.
RP Mullany, LC (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.
EM lmullany@jhsph.edu
FU National Institutes of Health, Bethesda, Maryland [HD 553466, HD 44004,
   HD 38753]; Bill and Melinda Gates Foundation, Seattle, Washington
   [810-2054]; Johns Hopkins University; Office of Health and Nutrition, US
   Agency for International Development, Washington, DC
   [HRN-A-00-97-00015-00, GHS-A-00-03-000019-00]
FX This work was supported by the National Institutes of Health, Bethesda,
   Maryland (grants HD 553466, HD 44004, and HD 38753); the Bill and
   Melinda Gates Foundation, Seattle, Washington (grant 810-2054); and
   Cooperative Agreements between Johns Hopkins University and the Office
   of Health and Nutrition, US Agency for International Development,
   Washington, DC (HRN-A-00-97-00015-00 and GHS-A-00-03-000019-00).
CR AbouZahr C, 2001, B WORLD HEALTH ORGAN, V79, P561
   Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1
   Christian P, 2008, PUBLIC HEALTH, V122, P161, DOI 10.1016/j.puhe.2007.06.003
   Dhakal S, 2007, LANCET, V370, P1301, DOI 10.1016/S0140-6736(07)61560-8
   Hanley JA, 1996, STUD FAMILY PLANN, V27, P220, DOI 10.2307/2137955
   Hill K, 2006, B WORLD HEALTH ORGAN, V84, P173, DOI 10.2471/BLT.05.027714
   Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4
   Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1
   *MIN HLTH FAM HLTH, 2002, NEP DEM HLTH SURV 20
   *MIN HLTH POP MACR, 2007, NEP DEM HLTH SURV 20
   Mullany LC, 2006, LANCET, V367, P910, DOI 10.1016/S0140-6736(06)68381-5
   PANT PD, 2008, INVESTIGATING RECENT
   Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026
   PRADHAN A, 1997, NEPAL FAMILY HLTH SU
   Rojas G, 2006, GUIDE DHS STAT
   RUTENBERG N, 1991, P DHS WORLD C WASH D, V3, P1669
   SHAHIDULLAH M, 1995, INT J EPIDEMIOL, V24, P937, DOI 10.1093/ije/24.5.937
   Sharma GK, 2002, LANCET, V359, P1519, DOI 10.1016/S0140-6736(02)08422-2
   Singh S, 2004, CAN MED ASSOC J, V171, P1499, DOI 10.1503/cmaj.1040777
   Singh S, 2006, PLOS MED, V3, P948, DOI 10.1371/journal.pmed.0030203
   Stanton C, 2000, STUD FAMILY PLANN, V31, P111, DOI 10.1111/j.1728-4465.2000.00111.x
   Stanton C, 2001, B WORLD HEALTH ORGAN, V79, P657
   Stanton C., 1997, DHS MATERNAL MORTALI
   Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9
   Tielsch JM, 2007, LANCET, V370, P1230, DOI 10.1016/S0140-6736(07)61539-6
   Tielsch JM, 2007, PEDIATRICS, V119, pE330, DOI 10.1542/peds.2006-1192
   Tielsch JM, 2006, LANCET, V367, P144, DOI 10.1016/S0140-6736(06)67963-4
   *WHO, 2005, HLTH MILL DEV GOALS
   Wilmoth J, 2009, B WORLD HEALTH ORGAN, V87, P256, DOI 10.2471/BLT.07.048280
   World Health Organisation UNFPA UNDP The World Bank UNICEF, 2007, MAT MORT 2005 EST DE
NR 30
TC 4
Z9 4
U1 2
U2 13
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9262
EI 1476-6256
J9 AM J EPIDEMIOL
JI Am. J. Epidemiol.
PD OCT 1
PY 2010
VL 172
IS 7
BP 855
EP 860
DI 10.1093/aje/kwq207
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 654KJ
UT WOS:000282166900015
PM 20696651
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Berglund, ED
   Kang, L
   Lee-Young, RS
   Hasenour, CM
   Lustig, DG
   Lynes, SE
   Donahue, EP
   Swift, LL
   Charron, MJ
   Wasserman, DH
AF Berglund, Eric D.
   Kang, Li
   Lee-Young, Robert S.
   Hasenour, Clinton M.
   Lustig, Daniel G.
   Lynes, Sara E.
   Donahue, E. Patrick
   Swift, Larry L.
   Charron, Maureen J.
   Wasserman, David H.
TI RETRACTED: Glucagon and lipid interactions in the regulation of hepatic
   AMPK signaling and expression of PPAR alpha and FGF21 transcripts in
   vivo(Retracted article. See vol.311,pg.E850,2016)
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article; Retracted Publication
DE adenosine 5 '-monophosphate-activated protein kinase; peroxisome
   proliferator-activated receptor-alpha; fibroblast growth factor 21
ID ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE; GLUCOSE-METABOLISM;
   FATTY-ACIDS; INSULIN SENSITIVITY; PROLONGED EXERCISE; ENERGY-STATE;
   SHORT-TERM; RAT-LIVER; MICE
AB Berglund ED, Kang L, Lee-Young RS, Hasenour CM, Lustig DG, Lynes SE, Donahue EP, Swift LL, Charron MJ, Wasserman DH. Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPAR alpha and FGF21 transcripts in vivo. Am J Physiol Endocrinol Metab 299: E607-E614, 2010. First published July 27, 2010; doi: 10.1152/ajpendo.00263.2010.-Hepatic glucagon action increases in response to accelerated metabolic demands and is associated with increased whole body substrate availability, including circulating lipids. The hypothesis that increases in hepatic glucagon action stimulate AMP-activated protein kinase (AMPK) signaling and peroxisome proliferator-activated receptor-alpha (PPAR alpha) and fibroblast growth factor 21 (FGF21) expression in a manner modulated by fatty acids was tested in vivo. Wild-type (gcgr(+/+)) and glucagon receptor-null (gcgr(-/-)) littermate mice were studied using an 18-h fast, exercise, and hyperglucagonemic-euglycemic clamps plus or minus increased circulating lipids. Fasting and exercise in gcgr(+/+), but not gcgr(-/-) mice, increased hepatic phosphorylated AMPK alpha at threonine 172 (p-AMPK(Thr172)) and PPAR alpha and FGF21 mRNA. Clamp results in gcgr(+/+) mice demonstrate that hyperlipidemia does not independently impact or modify glucagon-stimulated increases in hepatic AMP/ATP, p-AMPK(Thr172), or PPAR alpha and FGF21 mRNA. It blunted glucagon-stimulated acetyl-CoA carboxylase phosphorylation, a downstream target of AMPK, and accentuated PPAR alpha and FGF21 expression. All effects were absent in gcgr(-/-) mice. These findings demonstrate that glucagon exerts a critical regulatory role in liver to stimulate pathways linked to lipid metabolism in vivo and shows for the first time that effects of glucagon on PPAR alpha and FGF21 expression are amplified by a physiological increase in circulating lipids.
C1 [Berglund, Eric D.; Kang, Li; Lee-Young, Robert S.; Hasenour, Clinton M.; Lustig, Daniel G.; Lynes, Sara E.; Donahue, E. Patrick; Wasserman, David H.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.
   [Swift, Larry L.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA.
   [Wasserman, David H.] Vanderbilt Univ, Sch Med, NIH, Mouse Metab Phenotyping Ctr, Nashville, TN 37212 USA.
   [Charron, Maureen J.] Albert Einstein Coll Med, Dept Biochem, Brooklyn, NY USA.
RP Wasserman, DH (reprint author), 823 Light Hall, Nashville, TN 37232 USA.
EM david.wasserman@vanderbilt.edu
FU National Institute of Diabetes and Digestive and Kidney Diseases
   [DK-50277, DK-59637]; National Institutes of Health [DK-07563]
FX This work was supported by National Institute of Diabetes and Digestive
   and Kidney Diseases Grants DK-50277 and DK-59637 to D. H. Wasserman. E.
   D. Berglund was supported by an National Institutes of Health T32
   Molecular Endocrinology Training Program Grant (DK-07563 awarded to R.
   O'Brien).
CR Anavi S, 2010, OBESITY, V18, P1108, DOI 10.1038/oby.2009.489
   Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686
   Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Basu A, 2004, J INVEST MED, V52, P366, DOI 10.1136/jim-52-06-30
   Basu R, 2004, AM J PHYSIOL-ENDOC M, V287, pE55, DOI 10.1152/ajpendo.00549.2003
   Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615
   Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221
   Berglund ED, 2009, J CLIN INVEST, V119, P2412, DOI 10.1172/JCI38650
   Bunger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006
   Camacho RC, 2006, AM J PHYSIOL-ENDOC M, V290, pE405, DOI 10.1152/ajpendo.00385.2005
   Carlson CL, 1999, J APPL PHYSIOL, V86, P669
   CHAN T M, 1976, Analytical Biochemistry, V71, P96
   Chen WW, 2008, EXP CLIN ENDOCR DIAB, V116, P65, DOI 10.1055/s-2007-985148
   Dzamko N, 2008, J PHYSIOL-LONDON, V586, P5819, DOI 10.1113/jphysiol.2008.159814
   Forman BM, 1996, ANN NY ACAD SCI, V804, P266, DOI 10.1111/j.1749-6632.1996.tb18621.x
   Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200
   Fueger PT, 2007, J PHYSIOL-LONDON, V582, P801, DOI 10.1113/jphysiol.2007.132902
   GALBO H, 1975, J APPL PHYSIOL, V38, P70
   Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100
   Gomez-Valades AG, 2008, DIABETES, V57, P2199, DOI 10.2337/db07-1087
   Griffiths MA, 1996, J NUTR, V126, P1959
   Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002
   Kharitonenkov A, 2008, BIODRUGS, V22, P37, DOI 10.2165/00063030-200822010-00004
   Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200
   Krishna MG, 2000, AM J PHYSIOL-ENDOC M, V279, pE638
   Lavoie JM, 2005, CAN J APPL PHYSIOL, V30, P282, DOI 10.1139/h05-121
   Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008
   Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068
   MACDONALD IA, 1985, J NEUROSCI METH, V13, P239, DOI 10.1016/0165-0270(85)90072-X
   MARLISS EB, 1970, J CLIN INVEST, V49, pA61
   MORGAN CR, 1962, P SOC EXP BIOL MED, V110, P29
   Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051
   Sindelar DK, 1997, DIABETES, V46, P187, DOI 10.2337/diabetes.46.2.187
   Suchankova G, 2005, BIOCHEM BIOPH RES CO, V326, P851, DOI 10.1016/j.bbrc.2004.11.114
   SVEDBERG J, 1991, J CLIN INVEST, V88, P2054, DOI 10.1172/JCI115534
   Uebanso T, 2009, AM J PHYSIOL-ENDOC M, V297, pE76, DOI 10.1152/ajpendo.00014.2009
   UNGER RH, 1963, J CLIN INVEST, V42, P1031, DOI 10.1172/JCI104788
   van Raalte DH, 2004, PHARM RES-DORDR, V21, P1531, DOI 10.1023/B:PHAM.0000041444.06122.8d
   Wasserman DH, 2009, AM J PHYSIOL-ENDOC M, V296, pE11, DOI 10.1152/ajpendo.90563.2008
   WASSERMAN DH, 1989, AM J PHYSIOL, V257, pE108
   WASSERMAN DH, 1995, ANNU REV PHYSIOL, V57, P191
   WASSERMAN DH, 1984, J CLIN INVEST, V74, P1404, DOI 10.1172/JCI111551
   Williams EL, 2006, J DAIRY SCI, V89, P693, DOI 10.3168/jds.S0022-0302(06)72132-4
   WINDER WW, 1979, J APPL PHYSIOL, V46, P766
   WITTERS LA, 1994, ARCH BIOCHEM BIOPHYS, V308, P413, DOI 10.1006/abbi.1994.1058
   Wojtaszewski JFP, 2002, BIOCHEM BIOPH RES CO, V298, P309, DOI 10.1016/S0006-291X(02)02465-8
   Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200
   Za'tara G, 2008, BIOCHEM PHARMACOL, V76, P1263, DOI 10.1016/j.bcp.2008.08.028
   Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476
NR 51
TC 69
Z9 71
U1 2
U2 10
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD OCT
PY 2010
VL 299
IS 4
BP E607
EP E614
DI 10.1152/ajpendo.00263.2010
PG 8
WC Endocrinology & Metabolism; Physiology
SC Endocrinology & Metabolism; Physiology
GA 673MF
UT WOS:000283666700011
PM 20663988
OA Green Published
DA 2018-12-27
ER

PT J
AU Sakao, S
   Tanabe, N
   Tatsumi, K
AF Sakao, Seiichiro
   Tanabe, Nobuhiro
   Tatsumi, Koichiro
TI RETRACTED: The estrogen paradox in pulmonary arterial hypertension
   (Retracted article. See vol. 300, pg. L508, 2011)
SO AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
LA English
DT Article; Retracted Publication
DE vasoconstriction; remodeling
ID ESTRADIOL-INDUCED ATTENUATION; HORMONE REPLACEMENT THERAPY; ENDOTHELIAL
   GROWTH-FACTOR; ISOLATED SHEEP LUNGS; CHRONIC HYPOXIA;
   SYSTEMIC-SCLEROSIS; GENDER DIFFERENCES; GENE-EXPRESSION; RAT PULMONARY;
   RISK-FACTOR
AB Sakao S, Tanabe N, Tatsumi K. The estrogen paradox in pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 299: L435-L438, 2010. First published July 23, 2010; doi:10.1152/ajplung.00057.2010.-Idiopathic pulmonary arterial hypertension (PAH) is a disabling condition characterized by PA vasoconstriction and remodeling as well as in situ thrombosis and eventual right heart failure. Idiopathic PAH occurs more frequently in females than in males. The female: male ratio is 1.64 similar to 3.88:1. Although endogenous sex hormones including estrogen have been suggested to account for the observed gender differences in PAH, a precise pathobiology for the gender differences remains uncertain. Recent studies demonstrated that estrogen exerts beneficial effects on the pulmonary vasculature. However, it seems to contradict the female predominance that is observed in idiopathic PAH. Moreover, Sweeney and Voelkel (Sweeney L and Voelkel NF. Eur J Med Res 14: 433-442, 2009) showed that early and long-term estrogen exposure might be correlated with an increased risk of the development of PAH. Here we ask the question: Is estrogen a friend or a foe? According to accumulating evidence, we postulate that the different effects of estrogens on different target cells could account for this paradox, i.e., estrogens may exert beneficial effects only on the increased muscularization of vessel walls, but not on phenotypically altered endothelial cells. The effects of estrogens on the pulmonary vasculature are potent and complex, yet not fully understood. A better mechanistic understanding may allow for future therapeutic interventions in patients with PAH.
C1 [Sakao, Seiichiro; Tanabe, Nobuhiro; Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol, Chuo Ku, Chiba 2608670, Japan.
RP Sakao, S (reprint author), Chiba Univ, Grad Sch Med, Dept Respirol B2, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.
EM sakaos@faculty.chiba-u.jp
FU Ministry of Health, Labor, and Welfare, Japan [19-9, 22-33]; Japanese
   Ministry of Education and Science [C 22590851]; Chiba Foundation for
   Health Promotion and Disease Prevention
FX This study was supported by Research Grants for the Respiratory Failure
   Research Group and Cardiovascular Diseases (19-9, 22-33) from the
   Ministry of Health, Labor, and Welfare, Japan, the Grant-in-Aid for
   Scientific Research (Category C 22590851) from the Japanese Ministry of
   Education and Science, and Chiba Foundation for Health Promotion and
   Disease Prevention.
CR Agrawal R, 2000, FERTIL STERIL, V73, P56, DOI 10.1016/S0015-0282(99)00476-8
   Badesch DB, 2010, CHEST, V137, P376, DOI 10.1378/chest.09-1140
   Bauer NR, 2007, AM J PHYSIOL-LUNG C, V293, pL580, DOI 10.1152/ajplung.00281.2007
   Beretta L, 2006, SCAND J RHEUMATOL, V35, P468, DOI 10.1080/03009740600844498
   BURTON RR, 1968, AM J PHYSIOL, V214, P1438
   COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801
   Earley S, 2002, AM J PHYSIOL-LUNG C, V283, pL86, DOI 10.1152/ajplung.00476.2001
   English KM, 2001, HORM METAB RES, V33, P645, DOI 10.1055/s-2001-18689
   FUCHS KI, 1982, J APPL PHYSIOL, V53, P703
   Gaine SP, 1998, LANCET, V352, P719, DOI 10.1016/S0140-6736(98)02111-4
   Gargett CE, 2002, J CLIN ENDOCR METAB, V87, P4341, DOI 10.1210/jc.2001-010588
   Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336
   Gierach GL, 2006, J AM COLL CARDIOL, V47, p50S, DOI 10.1016/j.jacc.2005.02.099
   Gonzales, 1999, J Cardiovasc Pharmacol Ther, V4, P227, DOI 10.1177/107424849900400404
   Gonzales RJ, 2001, AM J PHYSIOL-LUNG C, V280, pL555
   GORDON JB, 1986, J APPL PHYSIOL, V61, P2116
   Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC
   Hyder SM, 2000, CANCER RES, V60, P3183
   Jeffery TK, 2001, PHARMACOL THERAPEUT, V92, P1, DOI 10.1016/S0163-7258(01)00157-7
   Jing ZC, 2007, CHEST, V132, P373, DOI 10.1378/chest.06-2913
   Jones PL, 1997, AM J PATHOL, V150, P1349
   Kakusaka I, 1989, Nihon Kyobu Shikkan Gakkai Zasshi, V27, P51
   KANNEL WB, 1976, ANN INTERN MED, V85, P447, DOI 10.7326/0003-4819-85-4-447
   Kauser K, 1997, J VASC RES, V34, P229, DOI 10.1159/000159227
   LantinHermoso RL, 1997, AM J PHYSIOL-LUNG C, V273, pL119
   Levy M, 2007, J AM COLL CARDIOL, V49, P803, DOI 10.1016/j.jacc.2006.09.049
   Li SH, 2001, CIRC RES, V89, P517, DOI 10.1161/hh1801.097165
   MacRitchie AN, 1997, CIRC RES, V81, P355, DOI 10.1161/01.RES.81.3.355
   MASI AT, 1976, CHEST, V69, P451
   McLaughlin VV, 2006, CIRCULATION, V114, P1417, DOI 10.1161/CIRCULATIONAHA.104.503540
   MCMURTRY IF, 1973, J APPL PHYSIOL, V35, P459
   MEYRICK B, 1980, AM J PATHOL, V100, P151
   MOORE LC, 1980, AM J PHYSIOL, V239, pF57
   Morse JH, 1999, CHEST, V116, P847, DOI 10.1378/chest.116.3.847
   Peacock AJ, 2007, EUR RESPIR J, V30, P104, DOI 10.1183/09031936.00092306
   RABINOVITCH M, 1981, AM J PHYSIOL, V240, pH62
   REID LM, 1989, PULMONARY PHYSL PATH
   Resta TC, 2001, AM J PHYSIOL-LUNG C, V280, pL88
   SAKAO S, AM J RESP C IN PRESS
   Scorza R, 2002, ANN NY ACAD SCI, V966, P238, DOI 10.1111/j.1749-6632.2002.tb04221.x
   Sherman TS, 2002, AM J RESP CELL MOL, V26, P610, DOI 10.1165/ajrcmb.26.5.4528
   Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8
   Smadja DM, 2009, CIRCULATION, V119, P374, DOI 10.1161/CIRCULATIONAHA.108.808246
   Spyridopoulos I, 1997, CIRCULATION, V95, P1505
   Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009
   STUPFEL M, 1984, AVIAT SPACE ENVIR MD, V55, P136
   Sweeney L, 2009, EUR J MED RES, V14, P433, DOI 10.1186/2047-783X-14-10-433
   SYLVESTER JT, 1985, CHEST, V88, pS252, DOI 10.1378/chest.88.4.252S
   Taraseviciute A, 2006, EUR J MED RES, V11, P198
   Thenappan T, 2007, EUR RESPIR J, V30, P1103, DOI 10.1183/09031936.00042107
   Tofovic SP, 2006, VASC PHARMACOL, V45, P358, DOI 10.1016/j.vph.2006.05.007
   Tuder RM, 2001, CLIN CHEST MED, V22, P405, DOI 10.1016/S0272-5231(05)70280-X
   Tuder RM, 2009, J AM COLL CARDIOL, V54, pS3, DOI 10.1016/j.jacc.2009.04.009
   vanderSchouw YT, 1996, LANCET, V347, P714, DOI 10.1016/S0140-6736(96)90075-6
   WETZEL RC, 1983, J APPL PHYSIOL, V55, P100
   WETZEL RC, 1984, J APPL PHYSIOL, V56, P1199
   Zhang XC, 2005, CIRCULATION, V112, pU152
   2004, J AM COLL CARDIO S12, V43, pS1
NR 58
TC 7
Z9 7
U1 2
U2 11
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1040-0605
EI 1522-1504
J9 AM J PHYSIOL-LUNG C
JI Am. J. Physiol.-Lung Cell. Mol. Physiol.
PD OCT
PY 2010
VL 299
IS 4
BP L435
EP L438
DI 10.1152/ajplung.00057.2010
PG 4
WC Physiology; Respiratory System
SC Physiology; Respiratory System
GA 673NB
UT WOS:000283669100001
PM 20656892
DA 2018-12-27
ER

PT J
AU Tudisco, R
   Mastellone, V
   Cutrignelli, MI
   Lombardi, P
   Bovera, F
   Mirabella, N
   Piccolo, G
   Calabro, S
   Avallone, L
   Infascelli, F
AF Tudisco, R.
   Mastellone, V.
   Cutrignelli, M. I.
   Lombardi, P.
   Bovera, F.
   Mirabella, N.
   Piccolo, G.
   Calabro, S.
   Avallone, L.
   Infascelli, F.
TI RETRACTED: Fate of transgenic DNA and evaluation of metabolic effects in
   goats fed genetically modified soybean and in their offsprings
   (Retracted article. See vol. 10, pg. 1076, 2016)
SO ANIMAL
LA English
DT Article; Retracted Publication
DE genetically modified soybean meal; goat; kid; DNA passage
ID POLYMERASE-CHAIN-REACTION; ENDOGENOUS PLANT DNA; MODIFIED MAIZE DNA;
   ANIMAL-TISSUES; FEED; FRAGMENTS; NUTRITION; RUMEN; MILK; IDENTIFICATION
AB The presence of DNA fragments in blood and milk from goats fed conventional (control) or Roundup Ready (R) soybean meal solvent extracted (s.e.; treated) was investigated by using a polymerase chain reaction approach. The same investigation was carried out on blood, skeletal muscle and organs from kids of both groups fed only dams' milk until weaning. Moreover, the possible effects on cell metabolism were evaluated by determination of several specific enzymes in serum, heart, skeletal muscle, liver and kidney. Fragments of the multicopy chloroplast (trnL) gene were found in blood and milk samples from goats of both groups. In kids, the chloroplast fragments were found in samples of both groups. In samples, which proved positive for the presence of chloroplast DNA, fragments of the specific soybean single copy gene (lectin) were detected in several blood and milk samples. The same fragment was also found in control and treated groups of kids. Transgenic fragments were not found in those samples, which were found positive for chloroplast fragments of control groups of either goats or kids. On the contrary, in blood and milk of treated goats, fragments both of the 35S promoter and the CP4 EPSPS gene were detected. These fragments were also found in treated kids with a significant detection of the 35S promoter in liver, kidney and blood, and of the CP4 EPSPS gene fragment in liver, kidney, heart and muscle. A significant increase in lactic dehydrogenase, mainly concerning the lactic dehydrogenase-1 isoenzyme was found in heart, skeletal muscle and kidney of treated kids, thus suggesting a change in the local production of the enzyme. Finally, no significant differences were detected concerning kid body and organ weight.
C1 [Tudisco, R.; Cutrignelli, M. I.; Bovera, F.; Piccolo, G.; Calabro, S.; Infascelli, F.] Univ Naples Federico II, Sez B Ferrara, Dipartimento Sci Zootecn & Lspez Alimenti, I-80137 Naples, Italy.
   [Mastellone, V.] Univ Catanzaro Magna Graecia, Dipartimento Med Sperimentale & Clin Gaetano Salv, I-11588100 Catanzaro, Italy.
   [Lombardi, P.; Mirabella, N.] Univ Naples Federico II, Dipartimento Strutture Funzioni & Tecnol Biol, I-80137 Naples, Italy.
RP Lombardi, P (reprint author), Univ Naples Federico II, Sez B Ferrara, Dipartimento Sci Zootecn & Lspez Alimenti, Via F Delpino 1, I-80137 Naples, Italy.
EM pilombar@unina.it
OI MASTELLONE, Vincenzo/0000-0001-6173-708X; Cutrignelli, Monica
   Isabella/0000-0002-2493-9317; LOMBARDI, Pietro/0000-0001-7876-8800
CR Association of Official Analytical Chemists (AOAC), 2000, OFF METH AN
   Aumaitre A, 2002, LIVEST PROD SCI, V74, P223, DOI 10.1016/S0301-6226(02)00016-7
   Bottero MT, 2003, INT DAIRY J, V13, P277, DOI 10.1016/S0958-6946(02)00170-X
   Cardarelli P, 2005, FOOD CONTROL, V16, P859, DOI 10.1016/j.foodcont.2004.07.010
   Chowdhury EH, 2003, VET HUM TOXICOL, V45, P95
   Chowdhury EH, 2003, J ANIM SCI, V81, P2546
   Duggan PS, 2003, BRIT J NUTR, V89, P159, DOI 10.1079/BJN2002764
   *EFSA, 2007, STAT FAT REC DNA PRO
   EFSA, 2008, FOOD CHEM TOXICOL, V46, P52, DOI DOI 10.1016/J.FCT.2008.02.008
   Einspanier R, 2004, EUR FOOD RES TECHNOL, V218, P269, DOI 10.1007/s00217-003-0842-9
   Hernandez M, 2003, ANAL BIOCHEM, V323, P164, DOI 10.1016/j.ab.2003.07.015
   *INRA, 1978, AL RUM
   Jennings JC, 2003, J ANIM SCI, V81, P1447
   Klaften M, 2004, ACS SYM SER, V866, P83
   Klotz A., 1998, MAIS, V3, P109
   Kuribara H, 2002, J AOAC INT, V85, P1077
   LAUDADIO V, 2006, P 12 AAAP ANIM SCI C, P3
   Lipp M, 1999, J AOAC INT, V82, P923
   Malatesta M, 2002, CELL STRUCT FUNCT, V27, P173, DOI 10.1247/csf.27.173
   Malatesta M, 2008, HISTOCHEM CELL BIOL, V130, P967, DOI 10.1007/s00418-008-0476-x
   Mazza R, 2005, TRANSGENIC RES, V14, P775, DOI 10.1007/s11248-005-0009-5
   Nemeth A, 2004, J AGR FOOD CHEM, V52, P6129, DOI 10.1021/jf049567f
   PADGETTE SR, 1995, CROP SCI, V35, P1451, DOI 10.2135/cropsci1995.0011183X003500050032x
   Phipps RH, 2003, J DAIRY SCI, V86, P4070, DOI 10.3168/jds.S0022-0302(03)74019-3
   Reuter T, 2003, EUR FOOD RES TECHNOL, V216, P185, DOI [10.1007/s00217-002-0642-7, 10.1007/s00217-003-0753-9]
   Rizzi A, 2008, EUR FOOD RES TECHNOL, V227, P1699, DOI 10.1007/s00217-008-0896-9
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sharma R, 2006, J AGR FOOD CHEM, V54, P1699, DOI 10.1021/jf052459o
   Singh M, 2003, ASIAN AUSTRAL J ANIM, V16, P1732, DOI 10.5713/ajas.2003.1732
   *SPSS INC, 1999, SPSS WIND VER 12 0
   Terzi V, 2004, LEBENSM-WISS TECHNOL, V37, P239, DOI 10.1016/j.lwt.2003.08.005
   Tony MA, 2003, ARCH ANIM NUTR, V57, P235, DOI 10.1080/00039420310001594397
   Tudisco R, 2006, ANIM SCI, V82, P193, DOI 10.1079/ASC200530
   Tudisco R, 2006, LIVEST SCI, V105, P12, DOI 10.1016/j.livsci.2006.04.036
   VANHAL, 2000, ACTA PHYSIOL SCAND, V168, P643
   VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2
   Yonemochi Chisato, 2003, Animal Science Journal, V74, P81, DOI 10.1046/j.1344-3941.2003.00090.x
NR 37
TC 27
Z9 30
U1 3
U2 40
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1751-7311
EI 1751-732X
J9 ANIMAL
JI Animal
PD OCT
PY 2010
VL 4
IS 10
BP 1662
EP 1671
DI 10.1017/S1751731110000728
PG 10
WC Agriculture, Dairy & Animal Science; Veterinary Sciences
SC Agriculture; Veterinary Sciences
GA 654TO
UT WOS:000282193500007
PM 22445119
OA Bronze
DA 2018-12-27
ER

PT J
AU Jin, YC
   Zou, XH
   Feng, XL
AF Jin, Yucui
   Zou, Xianghong
   Feng, Xiaoling
TI RETRACTED: 3,3 '-Diindolylmethane negatively regulates Cdc25A and
   induces a G2/M arrest by modulation of microRNA 21 in human breast
   cancer cells (Retracted article. See vol. 22, pg. 303, 2011)
SO ANTI-CANCER DRUGS
LA English
DT Article; Retracted Publication
DE 3,3 '-Diindolylmethane; breast cancer; cell cycle arrest; Cdc25A;
   microRNA 21
ID INDOLE-3-CARBINOL; EXPRESSION; GROWTH; PHOSPHATASES; RISK;
   PHOSPHORYLATION; DEGRADATION; INHIBITION; TRANSITION; CHECKPOINT
AB 3,3'-Diindolylmethane (DIM) is a potential chemopreventive phytochemical derived from Brassica vegetables. In this study, we assessed the effects of DIM on cell cycle regulation in both estrogen-dependent MCF-7 and estrogen receptor negative p53 mutant MDA-MB-468 human breast cancer cells. In-vitro culture studies showed that DIM dose dependently inhibited the proliferation of both cells. In addition, in-vivo xenograft model showed that DIM strongly inhibited the development of human breast tumors. Fluorescence activated cell sorter analysis showed a DIM-mediated G2/M cell cycle arrest in MCF-7 and MDA-MB-468 cells. Western blot analysis showed that DIM downregulated the expression of cyclin-dependent kinases 2 and 4 and Cdc25A, which plays an important role in G2/M phase. Furthermore, treatment of MCF-7 cells with DIM, which increased microRNA 21 expression, caused a downregulation of Cdc25A, resulting in an inhibition of breast cancer cell proliferation. Taken together, our data show that DIM is able to stop the cell cycle progression of human breast cancer cells regardless of their estrogen-dependence and p53 status, by differentially modulating cell cycle regulatory pathways. The modulation of microRNA 21 mediates the DIM cell cycle regulator effect in MCF-7 cells. Anti-Cancer Drugs 21:814-822 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
C1 [Jin, Yucui; Zou, Xianghong] Capital Normal Univ, Coll Life Sci, Lab Cell Cycle & Canc, Beijing 100048, Peoples R China.
   [Jin, Yucui; Zou, Xianghong; Feng, Xiaoling] Ohio State Univ, Dept Pathol, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA.
RP Jin, YC (reprint author), Capital Normal Univ, Coll Life Sci, Lab Cell Cycle & Canc, Beijing 100048, Peoples R China.
EM lantianmeiyu1985@gmail.com
FU National Natural Science Foundation of China [30571006]; National
   Institutes of Health [CA113579]
FX The authors thank Carolyn Paisie (Ohio State University) for modifying
   this manuscript. Financial support for this study was provided by the
   National Natural Science Foundation of China funds (30571006) and Grants
   CA113579 from the National Institutes of Health.
CR Aggarwal BB, 2005, CELL CYCLE, V4, P1201, DOI 10.4161/cc.4.9.1993
   Ali SM, 2003, CLIN ORTHOP RELAT R, pS132, DOI 10.1097/01.blo.0000092981.12414.7b
   Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8
   Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368
   Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003
   Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169
   Cangi MG, 2000, J CLIN INVEST, V106, P753, DOI 10.1172/JCI9174
   Chang XF, 2005, CARCINOGENESIS, V26, P771, DOI 10.1093/carcin/bgi018
   Chen I, 1998, CARCINOGENESIS, V19, P1631, DOI 10.1093/carcin/19.9.1631
   EVANS KL, 2000, MOL MED TODAY, V6, P459
   Fung TT, 2005, INT J CANCER, V116, P116, DOI 10.1002/ijc.20999
   GALAKTIONOV K, 1991, CELL, V67, P1181, DOI 10.1016/0092-8674(91)90294-9
   Gandini S, 2000, EUR J CANCER, V36, P636, DOI 10.1016/S0959-8049(00)00022-8
   Goloudina A, 2003, CELL CYCLE, V2, P473, DOI 10.4161/cc.2.5.482
   Hayes JD, 2008, EUR J NUTR, V47, P73, DOI 10.1007/s00394-008-2009-8
   Hermann S, 2002, NUTR CANCER, V44, P23, DOI 10.1207/S15327914NC441_4
   Hillman GG, 2004, MOL CANCER THER, V3, P1271
   Holst B, 2004, NAT PROD REP, V21, P425, DOI 10.1039/b204039p
   Hong C, 2002, BIOCHEM PHARMACOL, V63, P1085, DOI 10.1016/S0006-2952(02)00856-0
   Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200
   Li M, 2008, CELL CYCLE, V7, P1301, DOI 10.4161/cc.7.9.5958
   Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298
   Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567
   Melixetian M, 2009, NAT CELL BIOL, V11, P1247, DOI 10.1038/ncb1969
   Melkamu T, 2010, CARCINOGENESIS, V31, P252, DOI 10.1093/carcin/bgp208
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156
   Rahman KMW, 2007, MOL CANCER THER, V6, P2757, DOI 10.1158/1535-7163.MCT-07-0336
   Rahman KMW, 2006, MOL CANCER THER, V5, P2747, DOI 10.1158/1535-7163.MCT-06-0221
   Rahman KMW, 2006, CANCER RES, V66, P4952, DOI 10.1158/0008-5472.CAN-05-3918
   Rossi L, 2007, PHARMACOL RES, V56, P248, DOI 10.1016/j.phrs.2007.07.001
   SADHU K, 1990, P NATL ACAD SCI USA, V87, P5139, DOI 10.1073/pnas.87.13.5139
   Sarkar FH, 2004, J NUTR, V134, p3493S, DOI 10.1093/jn/134.12.3493S
   Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200
   Sherr CJ, 2000, CANCER RES, V60, P3689
   SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149
   Strickley RG, 2004, PHARM RES, V21, P201, DOI 10.1023/B:PHAM.0000016235.32639.23
   Sun M, 2008, MOL CANCER THER, V7, P464, DOI 10.1158/1535-7163.MCT-07-2272
   Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996
   Wu YS, 2010, CANCER PREV RES, V3, P818, DOI 10.1158/1940-6207.CAPR-09-0213
NR 40
TC 22
Z9 25
U1 5
U2 16
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0959-4973
EI 1473-5741
J9 ANTI-CANCER DRUG
JI Anti-Cancer Drugs
PD OCT
PY 2010
VL 21
IS 9
BP 814
EP 822
DI 10.1097/CAD.0b013e32833e53ea
PG 9
WC Oncology; Pharmacology & Pharmacy
SC Oncology; Pharmacology & Pharmacy
GA 647LY
UT WOS:000281621200003
PM 20724916
DA 2018-12-27
ER

PT J
AU Yadav, VR
   Prasad, S
   Kannappan, R
   Ravindran, J
   Chaturvedi, MM
   Vaahtera, L
   Parkkinen, J
   Aggarwal, BB
AF Yadav, Vivek R.
   Prasad, Sandeo
   Kannappan, Ramaswamy
   Ravindran, Jayaraj
   Chaturvedi, Madan M.
   Vaahtera, Lauri
   Parkkinen, Jaakko
   Aggarwal, Bharat B.
TI RETRACTED: Cyclodextrin-complexed curcumin exhibits anti-inflammatory
   and antiproliferative activities superior to those of curcumin through
   higher cellular uptake (Retracted article. See vol. 102, pg. 142, 2016)
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article; Retracted Publication
DE Cyclodextrin complex of curcumin; Solubility; Apoptosis; NF-kappa B;
   Cancer
ID B-ALPHA-KINASE; NF-KAPPA-B; METASTATIC GENE-PRODUCTS; COLORECTAL-CANCER;
   DOWN-REGULATION; IN-VITRO; ACTIVATION; APOPTOSIS; CELLS; SUPPRESSION
AB Curcumin, a yellow pigment present in the spice turmeric (Curcuma longa), has been linked with multiple beneficial activities, but its optimum potential is limited by poor bioavailability, in part due to the lack of solubility in aqueous solvents. To overcome the solubility problem, we have recently developed a novel cyclodextrin complex of curcumin (CDC) and examined here this compound for anti-inflammatory and antiproliferative effects. Using the electrophoretic mobility shift assay, we found that CDC was more active than free curcumin in inhibiting TNF-induced activation of the inflammatory transcription factor NF-kappa B and in suppressing gene products regulated by NF-kappa B, including those involved in cell proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF). CDC was also more active than free curcumin in inducing the death receptors DR4 and DR5. Annexin V staining, cleavage of caspase-3 and PARP, and DNA fragmentation showed that CDC was more potent than free curcumin in inducing apoptosis of leukemic cells. Antiproliferative assays also demonstrated that CDC was more active than free curcumin in suppressing proliferation of various cancer cell lines. The cyclodextrin vehicle had no effect in these assays. Compared with free curcumin, CDC had a greater cellular uptake and longer half-life in the cells. Overall we demonstrated that CDC had superior attributes compared with free curcumin for cellular uptake and for antiproliferative and anti-inflammatory activities. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Yadav, Vivek R.; Prasad, Sandeo; Kannappan, Ramaswamy; Ravindran, Jayaraj; Chaturvedi, Madan M.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, 1515 Holcombe Blvd,Unit 143, Houston, TX 77030 USA.
   [Vaahtera, Lauri; Parkkinen, Jaakko] Univ Helsinki, Dept Biomed Biochem, Helsinki, Finland.
RP Aggarwal, BB (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, 1515 Holcombe Blvd,Unit 143, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI Aggarwal, Bharat/G-3388-2013
FU National Institutes of Health (NIH) [CA-1247870-1A2]; Clayton Foundation
   for Research, USA; Academy of Finland
FX Dr. Aggarwal is the Ransom Horne, Jr., Professor of Cancer Research.
   This work was supported by a grant from a program project grant from
   National Institutes of Health (NIH CA-1247870-1A2), and a grant from
   Clayton Foundation for Research, USA. Dr. Parkkinen was supported by the
   Academy of Finland.
CR Aggarwal S, 2006, MOL PHARMACOL, V69, P195, DOI 10.1124/mol.105.017400
   ANAND P, 2009, BIOCHEM PHARMACOL, V79, P330
   Bae MK, 2006, ONCOL REP, V15, P1557
   BERTONCELLO I, 1991, EXP HEMATOL, V19, P95
   Bharti AC, 2004, BLOOD, V103, P3175, DOI 10.1182/blood-2003-06-2151
   Brewster ME, 2007, ADV DRUG DELIVER REV, V59, P645, DOI 10.1016/j.addr.2007.05.012
   CHATURVEDI MM, 1994, J BIOL CHEM, V269, P14575
   CHIGNELL CF, 1994, PHOTOCHEM PHOTOBIOL, V59, P295, DOI 10.1111/j.1751-1097.1994.tb05037.x
   Dahan A, 2010, J PHARM SCI-US, V99, P2739, DOI 10.1002/jps.22033
   Datta R, 1996, BLOOD, V88, P1936
   Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024
   Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016
   Groll AH, 2002, ANTIMICROB AGENTS CH, V46, P2554, DOI 10.1128/AAC.46.8.2554-2563.2002
   HOLDER GM, 1978, XENOBIOTICA, V8, P761, DOI 10.3109/00498257809069589
   HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292
   Jaiswal AS, 2002, ONCOGENE, V21, P8414, DOI 10.1038/sj.onc.1205947
   Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009
   Kunnumakkara AB, 2009, INT J CANCER, V125, P2187, DOI 10.1002/ijc.24593
   Kunwar A, 2008, BBA-GEN SUBJECTS, V1780, P673, DOI 10.1016/j.bbagen.2007.11.016
   Kunwar A, 2006, BBA-GEN SUBJECTS, V1760, P1513, DOI 10.1016/j.bbagen.2006.06.012
   LEROYLECHAT F, 1994, INT J PHARM, V101, P97, DOI 10.1016/0378-5173(94)90080-9
   Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300
   Loftsson T, 2004, J PHARM SCI-US, V93, P1091, DOI 10.1002/jps.20047
   Monnaert V, 2004, J PHARMACOL EXP THER, V311, P1115, DOI 10.1124/jpet.104.071845
   Pan MH, 1999, DRUG METAB DISPOS, V27, P486
   Piel G, 2007, INT J PHARM, V338, P35, DOI 10.1016/j.ijpharm.2007.01.015
   Ralhan Ranju, 2009, Front Biosci (Schol Ed), V1, P45
   Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x
   Salmaso S, 2007, J DRUG TARGET, V15, P379, DOI 10.1080/10611860701349752
   Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200
   Sharma RA, 2001, CLIN CANCER RES, V7, P1894
   Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744
   SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457
   SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995
   Sou K, 2008, INT J PHARM, V352, P287, DOI 10.1016/j.ijpharm.2007.10.033
   Sung B, 2007, MOL PHARMACOL, V71, P1703, DOI 10.1124/mol.107.034512
   Takada Y, 2005, ONCOGENE, V24, P6957, DOI 10.1038/sj.onc.1208845
   Takahashi M, 2008, BIOSCI BIOTECH BIOCH, V72, P1199, DOI 10.1271/bbb.706591
   THARAKAN ST, 2009, BIOCH PHARM
   Tomren MA, 2007, INT J PHARM, V338, P27, DOI 10.1016/j.ijpharm.2007.01.013
   Tonnesen HH, 2002, INT J PHARM, V244, P127, DOI 10.1016/S0378-5173(02)00323-X
   WAHLSTROM B, 1978, ACTA PHARMACOL TOX, V43, P86
   Yadav VR, 2009, AAPS PHARMSCITECH, V10, P752, DOI 10.1208/s12249-009-9264-8
NR 43
TC 108
Z9 111
U1 1
U2 41
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0006-2952
EI 1873-2968
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD OCT 1
PY 2010
VL 80
IS 7
BP 1021
EP 1032
DI 10.1016/j.bcp.2010.06.022
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 645CP
UT WOS:000281428800010
PM 20599780
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Garedew, A
   Henderson, SO
   Moncada, S
AF Garedew, A.
   Henderson, S. O.
   Moncada, S.
TI RETRACTED: Activated macrophages utilize glycolytic ATP to maintain
   mitochondrial membrane potential and prevent apoptotic cell
   death(Retracted article. See vol. 24, pg. 1132, 2017)
SO CELL DEATH AND DIFFERENTIATION
LA English
DT Article; Retracted Publication
DE macrophage activation; Delta Psi(m); glycolysis; oxidative
   phosphorylation; apoptosis; caspase activation
ID NECROSIS-FACTOR-ALPHA; CYTOCHROME-C RELEASE; T-CELL-ACTIVATION;
   INTRACELLULAR PH; NITRIC-OXIDE; INNER MEMBRANE; EARLY EVENTS; DEATH;
   HYPERPOLARIZATION; STAUROSPORINE
AB We have previously analysed the bioenergetic consequences of activating J774.A1 macrophages (MU) with interferon-gamma (IFN-gamma) and lipopolysaccharide (LPS) and found that there is a nitric oxide (NO)-dependent mitochondrial impairment and stabilization of hypoxia-inducible factor (HIF)-1 alpha, which synergize to activate glycolysis and generate large quantities of ATP. We now show, using tetramethylrhodamine methyl ester (TMRM) fluorescence and time-lapse confocal microscopy, that these cells maintain a high mitochondrial membrane potential (Delta Psi m) despite the complete inhibition of respiration. The maintenance of high Delta Psi m is due to the use of a significant proportion of glycolytically generated ATP as a defence mechanism against cell death. This is achieved by the reverse functioning of FoF1-ATP synthase and adenine nucleotide translocase (ANT). Treatment of activated MU with inhibitors of either of these enzymes, but not with inhibitors of the respiratory chain complexes I to IV, led to a collapse in Delta Psi m and to an immediate increase in intracellular [ATP], due to the prevention of ATP hydrolysis by the FoF1-ATP synthase. This collapse in Delta Psi m was followed by translocation of Bax from cytosol to the mitochondria, release of cytochrome c into the cytosol, activation of caspases 3 and 9 and subsequent apoptotic cell death. Our results indicate that during inflammatory activation 'glycolytically competent cells' such as MU use significant amounts of the glycolytically generated ATP to maintain Delta Psi m and thereby prevent apoptosis. Cell Death and Differentiation (2010) 17, 1540-1550; doi:10.1038/cdd.2010.27; published online 26 March 2010
C1 [Garedew, A.; Henderson, S. O.; Moncada, S.] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England.
RP Moncada, S (reprint author), UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England.
EM s.moncada@ucl.ac.uk
CR Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998
   Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370
   Banki K, 1999, J IMMUNOL, V162, P1466
   Belaud-Rotureau MA, 2000, APOPTOSIS, V5, P551, DOI 10.1023/A:1009693630664
   Beltran B, 2000, P NATL ACAD SCI USA, V97, P14602, DOI 10.1073/pnas.97.26.14602
   Beltran B, 2002, P NATL ACAD SCI USA, V99, P8892, DOI 10.1073/pnas.092259799
   Cartron PF, 2004, FEBS LETT, V578, P41, DOI 10.1016/j.febslet.2004.10.080
   Cartron PF, 2008, FEBS LETT, V582, P3045, DOI 10.1016/j.febslet.2008.07.047
   Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]
   Fernandez D, 2009, AUTOIMMUN REV, V8, P184, DOI 10.1016/j.autrev.2008.07.041
   Gao Q, 2008, AM J PHYSIOL-HEART C, V295, pH978, DOI 10.1152/ajpheart.00316.2008
   Garedew A, 2008, J CELL SCI, V121, P3468, DOI 10.1242/jcs.034660
   Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231
   Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000
   Khaled AR, 2001, J BIOL CHEM, V276, P6453, DOI 10.1074/jbc.M006391200
   Khaled AR, 1999, P NATL ACAD SCI USA, V96, P14476, DOI 10.1073/pnas.96.25.14476
   Kinnally KW, 2007, APOPTOSIS, V12, P857, DOI 10.1007/s10495-007-0722-z
   Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716
   Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011
   Koya RC, 2000, J BIOL CHEM, V275, P15343, DOI 10.1074/jbc.275.20.15343
   Krayl M, 2007, MOL CELL BIOL, V27, P411, DOI 10.1128/MCB.01391-06
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155
   MARTIN J, 1991, J BIOL CHEM, V266, P18051
   Nagy G, 2007, FREE RADICAL BIO MED, V42, P1625, DOI 10.1016/j.freeradbiomed.2007.02.026
   Perl A, 2004, TRENDS IMMUNOL, V25, P360, DOI 10.1016/j.it.2004.05.001
   PETIT PX, 1995, J CELL BIOL, V130, P157, DOI 10.1083/jcb.130.1.157
   Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675
   Scarlett JL, 2000, FEBS LETT, V475, P267, DOI 10.1016/S0014-5793(00)01681-1
   Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2
   Sionov RV, 2006, J EXP MED, V203, P189, DOI 10.1084/jem.20050433
   Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105
   Tafani M, 2002, J BIOL CHEM, V277, P49569, DOI 10.1074/jbc.M208915200
   Talanian RV, 1997, J BIOL CHEM, V272, P9677
   ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367
   ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661
NR 36
TC 68
Z9 69
U1 1
U2 16
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1350-9047
EI 1476-5403
J9 CELL DEATH DIFFER
JI Cell Death Differ.
PD OCT
PY 2010
VL 17
IS 10
BP 1540
EP 1550
DI 10.1038/cdd.2010.27
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 649CQ
UT WOS:000281745200003
PM 20339378
OA Bronze
DA 2018-12-27
ER

PT J
AU Mandal, D
   Fu, PF
   Levine, AD
AF Mandal, Debasmita
   Fu, Pingfu
   Levine, Alan D.
TI RETRACTED: REDOX regulation of IL-13 signaling in intestinal epithelial
   cells: Usage of alternate pathways mediates distinct gene expression
   patterns (Retracted article. See vol. 28, pg. 1440, 2016)
SO CELLULAR SIGNALLING
LA English
DT Article; Retracted Publication
DE Reactive oxygen species; NADPH oxidase; STAT6; MAPK; TFF3; Bcl-xl
ID NADPH OXIDASES; ULCERATIVE-COLITIS; MESSENGER-RNA; COLON-CANCER;
   NOX-FAMILY; BCL-XL; APOPTOSIS; CYCLOOXYGENASE-2; INTERLEUKIN-13;
   PATHOPHYSIOLOGY
AB In the classic view interleukin-13 (IL-13) binds to a heterodimer protein complex of the IL-13R alpha 1 and IL-4R alpha chains and signals through a Janus kinase 1 (JAK1)-signal transducer and activator of transcription 6 (STAT6) mechanism. We recently reported that IL-13 also signals through the IL-13R alpha 2 chain initiating all three mitogen activated protein kinase (MAPK) pathways, and the relative expression of IL-13R alpha 1 and IL-13R alpha 2 modulates one another's transduction pathway. Therefore we investigated whether generation of reactive oxygen species (ROS) as second messengers may serve as a common nexus between these two pathways emanating from the individual IL-13 receptor chains in intestinal epithelial cells (IEC). IL-13 stimulates intracellular ROS synthesis within 5 min via IL-13R alpha 1-JAK1-STAT6- and IL-13R alpha 2-MEK1/2-ERK1/2-dependent activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-1 (NOX-1). IL-13-induced ROS generation in turn positively regulates phosphorylation of ERK1/2 and STAT6, yielding a feed forward amplification loop. IL-13 also stimulates the stable, long-term gene expression of two other NADPH oxidases, NOX-4 and DUOX-2, which along with constitutive NOX-1, might facilitate elevated, continuous production of ROS in IL-13-activated IEC. The contribution of each signal transduction pathway initiated by IL-13 engagement to such biological functions as wound healing, inflammation, and apoptosis was mapped for representative, responsive genes. Distinct usage patterns were observed, demonstrating not only that IL-13 signal transduction through STAT6, MAPK, and ROS is regulated in both an antagonistic and cyclic fashion, but also that each pathway plays a specific role in modulating the wound healing and antiapoptotic capabilities of the intestinal epithelium. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Levine, Alan D.] Case Western Reserve Univ, Dept Med, Sch Med, Cleveland, OH 44106 USA.
   [Mandal, Debasmita; Levine, Alan D.] Case Western Reserve Univ, Dept Pathol, Sch Med, Cleveland, OH 44106 USA.
   [Fu, Pingfu] Case Western Reserve Univ, Dept Epidemiol & Biostat, Sch Med, Cleveland, OH 44106 USA.
   [Levine, Alan D.] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA.
   [Fu, Pingfu; Levine, Alan D.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Sch Med, Cleveland, OH 44106 USA.
RP Levine, AD (reprint author), Case Western Reserve Univ, Dept Med, Sch Med, BRB426,10900 Euclid Ave, Cleveland, OH 44106 USA.
EM alan.levine@case.edu
FU National Institute of Health [DK-54213, AI-53188]; American Cancer
   Society, Ohio Division, Inc.; University Hospitals Case Medical Center
   [NIH/NCI P30 CA43703]
FX We thank R. M. Sramkoski for training in the use of the Coulter XLMCL
   Flow Cytometer, the laboratory of A Weinberg in the School of Dental
   Medicine for guidance with the iCycler iQ thermocycler, and D.
   Danielpour for providing us with LY294002. This research was supported
   by funds from the National Institute of Health (DK-54213 and AI-53188)
   and the American Cancer Society, Ohio Division, Inc. to A.D.L, and the
   Tissue Procurement and Histology Core Facility of the Comprehensive
   Cancer Center of Case Western Reserve University and University
   Hospitals Case Medical Center (NIH/NCI P30 CA43703).
CR Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701
   Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005
   Blanchard C, 2004, J IMMUNOL, V172, P3775, DOI 10.4049/jimmunol.172.6.3775
   Byrd JC, 2004, CANCER METAST REV, V23, P77, DOI 10.1023/A:1025815113599
   Durual S, 2005, DIFFERENTIATION, V73, P36, DOI 10.1111/j.1432-0436.2005.07301006.x
   Eisenmesser EZ, 2001, J MOL BIOL, V310, P231, DOI 10.1006/jmbi.2001.4765
   Emami S, 2004, PEPTIDES, V25, P885, DOI 10.1016/j.peptides.2003.10.019
   Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332
   Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]
   Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836
   Garg Tarun K, 2003, BMC Ophthalmol, V3, P5, DOI 10.1186/1471-2415-3-5
   Geiszt M, 2006, CARDIOVASC RES, V71, P289, DOI 10.1016/j.cardiores.2006.05.004
   HALL PA, 1994, J CELL SCI, V107, P3569
   Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002
   Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333
   Inaba T, 2004, INT J HEMATOL, V80, P210, DOI 10.1532/IJH97.04093
   Iwashita J, 2003, IMMUNOL CELL BIOL, V81, P275, DOI 10.1046/j.1440-1711.2003.t01-1-01163.x
   Kim R, 2005, BIOCHEM BIOPH RES CO, V333, P336, DOI 10.1016/j.bbrc.2005.04.161
   Kundu JK, 2008, MUTAT RES-REV MUTAT, V659, P15, DOI 10.1016/j.mrrev.2008.03.002
   Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028
   Masuda A, 2001, J BIOL CHEM, V276, P26107, DOI 10.1074/jbc.M011475200
   May FEB, 1997, J PATHOL, V183, P4
   Misra S, 2008, CONNECT TISSUE RES, V49, P219, DOI 10.1080/03008200802143356
   Monick MM, 2002, J BIOL CHEM, V277, P32992, DOI 10.1074/jbc.M203218200
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   Sharma P, 2008, IMMUNITY, V29, P551, DOI 10.1016/j.immuni.2008.07.019
   SHIBAHARA T, 1995, ARCH HISTOL CYTOL, V58, P205, DOI 10.1679/aohc.58.205
   Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x
   Tan XD, 2000, J CELL SCI, V113, P2149
   Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203
   Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005
   Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015
   Waris Gulam, 2006, J Carcinog, V5, P14, DOI 10.1186/1477-3163-5-14
   Wurster AL, 2002, J BIOL CHEM, V277, P27169, DOI 10.1074/jbc.M201207200
   Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142
   Yang D, 2007, EXP EYE RES, V85, P462, DOI 10.1016/j.exer.2007.06.013
   Yu CL, 1998, INFLAMM RES, V47, P167, DOI 10.1007/s000110050312
NR 37
TC 36
Z9 37
U1 2
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0898-6568
EI 1873-3913
J9 CELL SIGNAL
JI Cell. Signal.
PD OCT
PY 2010
VL 22
IS 10
BP 1485
EP 1494
DI 10.1016/j.cellsig.2010.05.017
PG 10
WC Cell Biology
SC Cell Biology
GA 634ZK
UT WOS:000280625000011
PM 20570727
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Hasheminejad, SM
   Abbasion, S
   Bahari, A
AF Hasheminejad, Seyyed M.
   Abbasion, Saeed
   Bahari, Ako
TI RETRACTED: Time domain computation and visualization of shock induced
   sound fields for a doubly fluid-loaded hollow cylinder (Retracted
   article. See vol. 92, pg. 349, 2012)
SO COMPUTERS & STRUCTURES
LA English
DT Article; Retracted Publication
DE Thick-walled cylindrical shell; Transient acoustic scattering;
   Elasticity solution; Cesaro summation; Lamb waves; Franz's creeping
   waves
ID FINITE-ELEMENT METHODS; EVACUATED CYLINDRICAL-SHELL; TRANSIENT
   ACOUSTIC-WAVE; SPHERICAL-SHELL; A(0) WAVE; SCATTERING; RADIATION;
   EQUATION
AB The linear theory of elasticity in conjunction with the Laplace transform technique is used to present theoretical analysis and numerical simulations for two-dimensional transient fluid-structure interaction of plane acoustic shock waves with a fluid-filled and submerged elastic hollow cylinder of arbitrary wall thickness. The inversion of Laplace transforms have been carried out numerically using Durbin's approach, while special convergence enhancement techniques are invoked to completely eradicate spurious oscillations and obtain uniformly convergent solutions. Detailed numerical results for the transient and vibratory responses of water-submerged steel cylinders of selected wall thickness parameters with various internal fluid loadings under an exponential pulse excitation are presented. Many of the interesting dynamic features in the transient cylinder-shock interaction are examined using appropriate images of the internal pressure field. Limiting cases are considered and good agreements with solutions in the existing literature are established. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Hasheminejad, Seyyed M.; Abbasion, Saeed; Bahari, Ako] Iran Univ Sci & Technol, Dept Mech Engn, Acoust Res Lab, Tehran 16844, Iran.
RP Hasheminejad, SM (reprint author), Iran Univ Sci & Technol, Dept Mech Engn, Acoust Res Lab, Tehran 16844, Iran.
EM hashemi@iust.ac.ir
RI Hasheminejad, Seyyed Mohammad/S-9355-2018
CR Abramowitz M., 1964, HDB MATH FUNCTIONS
   Ahyi AC, 2005, J ACOUST SOC AM, V118, P124, DOI 10.1121/1.1852548
   Ahyi AC, 1998, J ACOUST SOC AM, V104, P2727, DOI 10.1121/1.423856
   Antoine X, 2009, J COMPUT PHYS, V228, P3114, DOI 10.1016/j.jcp.2009.01.008
   BATHE K J., 2004, ADINA USERS MANUAL V
   Carrier G E., 1951, 4 BROWN U
   DEBILLY M, 1994, J ACOUST SOC AM, V95, P1143, DOI 10.1121/1.408462
   DURBIN F, 1974, COMPUT J, V17, P371, DOI 10.1093/comjnl/17.4.371
   GAUNAURD GC, 1997, APPL MECH REV, V50, P131
   GEERS TL, 1972, J ACOUST SOC AM, V51, P1640, DOI 10.1121/1.1913010
   Harari I, 2006, COMPUT METHOD APPL M, V195, P1594, DOI 10.1016/j.cma.2005.05.030
   Hasheminejad SM, 2006, ULTRASONICS, V45, P165, DOI 10.1016/j.ultras.2006.08.009
   Hildebrand F.B., 1976, ADV CALCULUS APPL
   HUANG H, 1979, J APPL MECH-T ASME, V46, P513, DOI 10.1115/1.3424598
   HUANG H, 1970, J APPL MECH, V37, P1091
   Iakovlev S, 2008, J FLUID STRUCT, V24, P1077, DOI 10.1016/j.jfluidstructs.2008.01.004
   Iakovlev S, 2008, J FLUID STRUCT, V24, P1098, DOI 10.1016/j.jfluidstructs.2008.01.005
   Iakovlev S, 2007, J FLUID STRUCT, V23, P117, DOI 10.1016/j.jfluidstructs.2006.07.004
   Iakovlev S, 2006, J FLUID STRUCT, V22, P997, DOI 10.1016/j.jfluidstructs.2006.03.006
   Iakovlev S, 2009, J SOUND VIB, V322, P401, DOI 10.1016/j.jsv.2008.11.037
   Ianculescu C, 2006, COMPUT METHOD APPL M, V195, P3709, DOI 10.1016/j.cma.2005.02.030
   Kechroud R, 2009, ADV ENG SOFTW, V40, P738, DOI 10.1016/j.advengsoft.2008.12.016
   Mair HU, 1999, SHOCK VIB, V6, P169, DOI 10.1155/1999/743708
   Manoj KG, 2000, INT J NUMER METH ENG, V48, P925, DOI 10.1002/(SICI)1097-0207(20000630)48:6<925::AID-NME915>3.0.CO;2-0
   NEUBAUER WG, 1969, J ACOUST SOC AM, V45, P1134, DOI 10.1121/1.1911584
   Pao Y. H., 1973, DIFFRACTION ELASTIC
   PIERCE A, 1991, ACOUSTICS INTRO ITS
   Sun M, 1996, SHOCK WAVES, V6, P323
   TANG SC, 1970, J ACOUST SOC AM, V47, P1325, DOI 10.1121/1.1912038
   Thompson LL, 2005, COMPUT METHOD APPL M, V194, P1947, DOI 10.1016/j.cma.2004.07.019
   Zakout U, 1997, INT J ENG SCI, V35, P1203, DOI 10.1016/S0020-7225(97)00011-6
   ZHANG P, 1993, J ACOUST SOC AM, V93, P696, DOI 10.1121/1.405433
NR 32
TC 4
Z9 4
U1 3
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0045-7949
EI 1879-2243
J9 COMPUT STRUCT
JI Comput. Struct.
PD OCT
PY 2010
VL 88
IS 19-20
BP 1077
EP 1091
DI 10.1016/j.compstruc.2010.06.007
PG 15
WC Computer Science, Interdisciplinary Applications; Engineering, Civil
SC Computer Science; Engineering
GA 653IE
UT WOS:000282081900003
DA 2018-12-27
ER

PT J
AU Zhao, YF
   He, TH
   Wang, PB
AF Zhao, Yu-Feng
   He, Tian-Hu
   Wang, Ping-Bo
TI RETRACTED: Effect of flux jump on temperature distributions in high
   temperature superconductors (Retracted article. See vol. 51, pg. 614,
   2011)
SO CRYOGENICS
LA English
DT Article; Retracted Publication
DE Flux jump; Temperature distributions; Thermomagnetic diffusion equations
ID MAGNETIC INSTABILITIES; YBA2CU3O7
AB The influence of flux jump on the temperature distributions is studied in high temperature superconducting slab. The thermomagnetic diffusion equations based on the dynamic process of thermomagnetic interaction are presented in this paper to estimate the effect of flux jump on the temperature inside the slab and the changes of the surface temperature in the flux jump process. Numerical results obtained show that the temperature distributions are significantly affected by flux jump. It is intended that flux jump analysis presented here be useful to researchers interested in thermomagnetic characteristics. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Zhao, Yu-Feng; He, Tian-Hu] Lanzhou Univ Technol, Sch Sci, Lanzhou 730050, Peoples R China.
   [Wang, Ping-Bo] Lanzhou Univ Technol, State Key Lab Gansu Adv Nonferrous Met Mat, Lanzhou 730050, Peoples R China.
RP Zhao, YF (reprint author), Lanzhou Univ Technol, Sch Sci, Lanzhou 730050, Peoples R China.
EM zhaoyf04@lzu.cn
FU Natural Science Foundation of China [10872083]; China Postdoctoral
   Science Foundation [200902310]
FX This research was supported by a grant of the Fund of Natural Science
   Foundation of China (No. 10872083) and China Postdoctoral Science
   Foundation funded project (No. 200902310). The authors gratefully
   acknowledge the support.
CR Chabanenko V, 2003, J LOW TEMP PHYS, V130, P175, DOI 10.1023/A:1022236117354
   CHEN K, 1991, PHYSICA C, V173, P227, DOI 10.1016/0921-4534(91)90373-7
   GERBER A, 1993, PHYSICA C, V209, P147, DOI 10.1016/0921-4534(93)90892-T
   Han GC, 1997, PHYSICA C, V274, P33, DOI 10.1016/S0921-4534(96)00653-3
   IGOR A, 2001, PHYS REV LETT, V87
   Mints RG, 1996, PHYS REV B, V53, P12311, DOI 10.1103/PhysRevB.53.12311
   MONLER D, 1998, EUR PHYS J B, V3, P143
   MULLER KH, 1994, PHYS REV B, V49, P1294, DOI 10.1103/PhysRevB.49.1294
   Nabialek A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.024518
   SWARTZ ET, 1989, REV MOD PHYS, V61, P605, DOI 10.1103/RevModPhys.61.605
   SWARTZ PS, 1968, J APPL PHYS, V39, P4991, DOI 10.1063/1.1655898
   THOLENCE JL, 1988, SOLID STATE COMMUN, V65, P1131, DOI 10.1016/0038-1098(88)90907-6
   WIPF SL, 1991, CRYOGENICS, V31, P936, DOI 10.1016/0011-2275(91)90217-K
   Zhao YF, 2008, EUR PHYS J B, V61, P391, DOI 10.1140/epjb/e2008-00090-4
   Zhou YH, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.054507
NR 15
TC 1
Z9 1
U1 4
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0011-2275
EI 1879-2235
J9 CRYOGENICS
JI Cryogenics
PD OCT
PY 2010
VL 50
IS 10
BP 670
EP 673
DI 10.1016/j.cryogenics.2010.06.014
PG 4
WC Thermodynamics; Physics, Applied
SC Thermodynamics; Physics
GA 657MZ
UT WOS:000282418100004
DA 2018-12-27
ER

PT J
AU Hattori, Y
   Jojima, T
   Tomizawa, A
   Satoh, H
   Hattori, S
   Kasai, K
   Hayashi, T
AF Hattori, Y.
   Jojima, T.
   Tomizawa, A.
   Satoh, H.
   Hattori, S.
   Kasai, K.
   Hayashi, T.
TI RETRACTED: A glucagon-like peptide-1 (GLP-1) analogue, liraglutide,
   upregulates nitric oxide production and exerts anti-inflammatory action
   in endothelial cells (Retracted article. See vol. 55, pg. 533, 2012)
SO DIABETOLOGIA
LA English
DT Article; Retracted Publication
DE Endothelial cells; GLP-1; NF-kappa B; Nitric oxide
ID ACTIVATED PROTEIN-KINASE; IN-VIVO; RECEPTOR; EXPRESSION; INCRETIN;
   ALBUMIN; PHARMACOKINETICS; EXENDIN-4; PATHWAYS; ADHESION
AB Glucagon-like peptide-1 (GLP-1), a member of the proglucagon-derived peptide family, was seen to exert favourable actions on cardiovascular function in preclinical and clinical studies. The mechanisms through which GLP-1 modulates cardiovascular function are complex and incompletely understood. We thus investigated whether the GLP-1 analogue, liraglutide, which is an acylated GLP-1, has protective effects on vascular endothelial cells.
   Nitrite and nitrate were measured in medium with an automated nitric oxide detector. Endothelial nitric oxide synthase (eNOS) activation was assessed by evaluating the phosphorylation status of the enzyme and evaluating eNOS activity by citrulline synthesis. Nuclear factor kappa B (NF-kappa B) activation was assessed by reporter gene assay.
   Liraglutide dose-dependently increased nitric oxide production in HUVECs. It also caused eNOS phosphorylation, potentiated eNOS activity and restored the cytokine-induced downregulation of eNOS (also known as NOS3) mRNA levels, which is dependent on NF-kappa B activation. We therefore examined the effect of liraglutide on TNF alpha-induced NF-kappa B activation and NF-kappa B-dependent expression of proinflammatory genes. Liraglutide dose-dependently inhibited NF-kappa B activation and TNF alpha-induced I kappa B degradation. It also reduced TNF alpha-induced MCP-1 (also known as CCL2), VCAM1, ICAM1 and E-selectin mRNA expression. Liraglutide-induced enhancement of nitric oxide production and suppression of NF-kappa B activation were attenuated by the AMP-activated protein kinase (AMPK) inhibitor compound C or AMPK (also known as PRKAA1) small interfering RNA. Indeed, liraglutide induced phosphorylation of AMPK, which occurs through a signalling pathway independent of cyclic AMP.
   Liraglutide exerts an anti-inflammatory effect on vascular endothelial cells by increasing nitric oxide production and suppressing NF-kappa B activation, partly at least through AMPK activation. These effects may explain some of the observed vasoprotective properties of liraglutide, as well as its beneficial effects on the cardiovascular system.
C1 [Hattori, Y.; Jojima, T.; Tomizawa, A.; Satoh, H.; Hattori, S.; Kasai, K.] Dokkyo Univ, Sch Med, Dept Endocrinol & Metab, Mibu, Tochigi 3210293, Japan.
   [Hayashi, T.] Nagoya Univ, Grad Sch Med, Dept Geriatr, Nagoya, Aichi 4648601, Japan.
RP Hattori, Y (reprint author), Dokkyo Univ, Sch Med, Dept Endocrinol & Metab, Mibu, Tochigi 3210293, Japan.
EM yhattori@dokkyomed.ac.jp
FU Japan Private School Promotion Foundation
FX This study was supported in part by a grant from the Japan Private
   School Promotion Foundation. The authors are grateful to K. Manaka and
   K. Akimoto (Institute for Medical Science, Dokkyo University School of
   Medicine) for technical assistance.
CR Arakawa M, 2010, DIABETES, V59, P1030, DOI 10.2337/db09-1694
   Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938
   Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124
   Damholt B, 2006, J CLIN PHARMACOL, V46, P635, DOI 10.1177/0091270006288215
   Daniel EE, 2002, AM J PHYSIOL-GASTR L, V283, pG595, DOI 10.1152/ajpgi.00110.2002
   Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004
   Elbrond B, 2002, DIABETES CARE, V25, P1398, DOI 10.2337/diacare.25.8.1398
   Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004
   Hattori Y, 2002, HYPERTENSION, V39, P22, DOI 10.1161/hy1201.097300
   Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72
   Herman GA, 2006, J CLIN ENDOCR METAB, V91, P4612, DOI 10.1210/jc.2006-1009
   Irwin DM, 2001, REGUL PEPTIDES, V98, P1, DOI 10.1016/S0167-0115(00)00232-9
   Ishibashi Y, 2010, BIOCHEM BIOPH RES CO, V391, P1405, DOI 10.1016/j.bbrc.2009.12.075
   Kang JH, 2009, J ENDOCRINOL, V202, P65, DOI 10.1677/JOE-08-0507
   Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876
   Kurtzhals P, 1995, BIOCHEM J, V312, P725, DOI 10.1042/bj3120725
   Madsen K, 2007, J MED CHEM, V50, P6126, DOI 10.1021/jm070861j
   Markussen J, 1996, DIABETOLOGIA, V39, P281
   Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6
   Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193
   Nystrom T, 2004, AM J PHYSIOL-ENDOC M, V287, pE1209, DOI 10.1152/ajpendo.00237.2004
   OCONNELL KA, 1990, J IMMUNOL, V144, P521
   Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096
   THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641
NR 24
TC 115
Z9 135
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD OCT
PY 2010
VL 53
IS 10
BP 2256
EP 2263
DI 10.1007/s00125-010-1831-8
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 647IT
UT WOS:000281612600025
PM 20593161
OA Bronze
DA 2018-12-27
ER

PT J
AU Duan, SG
   Cheng, L
   Li, DJ
   Zhu, J
   Xiong, Y
   Li, XW
   Wang, SG
AF Duan, Shi-Gang
   Cheng, Long
   Li, Da-Jiang
   Zhu, Jin
   Xiong, Yan
   Li, Xiao-Wu
   Wang, Shu-Guang
TI RETRACTED: The Role of MAPK-ERK Pathway in 67-kDa Laminin
   Receptor-Induced FasL Expression in Human Cholangiocarcinoma Cells
   (Retracted article. See vol. 137, pg. 391, 2010)
SO DIGESTIVE DISEASES AND SCIENCES
LA English
DT Article; Retracted Publication
DE Cholangiocarcinoma; Laminin receptor; MAPK-ERK kinases; Fas ligand
   (FasL)
ID COLON-CANCER CELLS; C-MYC EXPRESSION; LIGAND EXPRESSION; TUMOR-CELLS;
   IN-VIVO; BINDING PROTEIN; GLIOMA-CELLS; PROGRESSION; ACTIVATION;
   CARCINOMA
AB Cancer cells are thought to possess immune evasion properties due to FasL overexpression in many types of human tumors. In the present study, we set out to investigate the role of MAPK-ERK pathway in 67-kDa laminin receptor induced FasL expression and FasL-mediated apoptosis in human cholangiocarcinoma cells.
   The expression of FasL and its promoter activity in cultured cholangiocarcinoma cells were examined after treatment with laminin or transfection with plasmids containing siRNA targeted to 67-kDa laminin receptor. The effects of MAPK-ERK cascade inhibitor and c-Myc inhibition by siRNA on 67-kDa laminin receptor-induced FasL expression were determined. Apoptosis assay was performed to analyze the apoptosis of lymphocytes cocultured with cholangiocarcinoma cells treated with or without MAPK-ERK cascade inhibitor.
   Our results revealed that the specific MAPK-ERK cascade inhibitor, PD98059, significantly attenuated phosphorylation of c-Myc on Ser-62 and FasL upregulation in QBC-939 cells and these cells showed decreased cytotoxicity against Fas-sensitive Jurkat T cells. A luciferase reporter assay revealed that FasL promoter activity was significantly reduced in cells treated with PD98059 or transfected with c-Myc siRNA.
   Based on these results, we conclude that 67LR induces FasL expression and cytotoxicity against Fas-sensitive Jurkat T cells in human cholangiocarcinoma cells through the phosphorylation of c-Myc on Ser-62 and the subsequent activation of the FasL promoter through the ERK pathway.
C1 [Duan, Shi-Gang; Cheng, Long; Li, Da-Jiang; Zhu, Jin; Xiong, Yan; Li, Xiao-Wu; Wang, Shu-Guang] Third Mil Med Univ, Southwest Hosp, Hepatobiliary Surg Hosp & Inst, Chongqing 400038, Peoples R China.
RP Wang, SG (reprint author), Third Mil Med Univ, Southwest Hosp, Hepatobiliary Surg Hosp & Inst, Chongqing 400038, Peoples R China.
EM sgwang90@yahoo.com
FU National Natural Science Foundation [30772109]
FX This work was supported by the National Natural Science Foundation (No.
   30772109). The authors declare that they have no competing interests.
CR Adachi K, 2006, TRANSPL P, V38, P2710, DOI 10.1016/j.transproceed.2006.08-011
   Asanuma K, 2004, J IMMUNOL, V172, P3922, DOI 10.4049/jimmunol.172.6.3922
   Bennett MW, 1998, J IMMUNOL, V160, P5669
   Bermudez Y, 2008, GROWTH FACTORS, V26, P1, DOI 10.1080/08977190802001389
   Berno V, 2005, ENDOCR-RELAT CANCER, V12, P393, DOI 10.1677/erc.1.00870
   Brunner T, 2000, J BIOL CHEM, V275, P9767, DOI 10.1074/jbc.275.13.9767
   Chanprasert S, 2006, CELL SIGNAL, V18, P1212, DOI 10.1016/j.cellsig.2005.09.010
   Choi C, 2001, CANCER RES, V61, P3084
   Eberle J, 2003, ONCOGENE, V22, P9131, DOI 10.1038/sj.onc.1207228
   Gao CF, 2005, P NATL ACAD SCI USA, V102, P10528, DOI 10.1073/pnas.0504367102
   GAO ZF, 2008, CHIN J DIG SURG, V6, P53
   Ghosh S, 2000, MICROSC RES TECHNIQ, V51, P238, DOI 10.1002/1097-0029(20001101)51:3<238::AID-JEMT4>3.0.CO;2-3
   Givant-Horwitz V, 2005, CANCER LETT, V223, P1, DOI 10.1016/j.canlet.2004.08.030
   Givant-Horwitz V, 2004, CANCER RES, V64, P3572, DOI 10.1158/0008-5472.CAN-03-3424
   Gloe T, 1999, J BIOL CHEM, V274, P15996, DOI 10.1074/jbc.274.23.15996
   Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489
   Kasibhatla S, 2000, CURR BIOL, V10, P1205, DOI 10.1016/S0960-9822(00)00727-2
   Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4
   Kavurma MM, 2003, CELL DEATH DIFFER, V10, P36, DOI 10.1038/sj.cdd.4401179
   Kohno Michiaki, 2003, Prog Cell Cycle Res, V5, P219
   Li D, 2009, EUR SURG RES, V42, P168, DOI 10.1159/000198234
   Li Ziyu, 2002, Zhonghua Yi Xue Za Zhi, V82, P606
   Menard S, 1998, BREAST CANCER RES TR, V52, P137, DOI 10.1023/A:1006171403765
   Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010
   NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326
   O'Callaghan G, 2008, BRIT J CANCER, V99, P502, DOI 10.1038/sj.bjc.6604490
   OConnell J, 1996, J EXP MED, V184, P1075, DOI 10.1084/jem.184.3.1075
   Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8
   Pereira DB, 2002, NEUROPHARMACOLOGY, V42, P9, DOI 10.1016/S0028-3908(01)00162-9
   Ryan AE, 2005, CANCER RES, V65, P9817, DOI 10.1158/0008-5472.CAN-05-1462
   Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V
   Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674
   Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058
   Satoh K, 1999, BRIT J CANCER, V80, P1115, DOI 10.1038/sj.bjc.6690474
   Schenk S, 2003, TRENDS CELL BIOL, V13, P366, DOI 10.1016/S0962-8924(03)00129-6
   Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800
   Shinohara H, 2000, CANCER RES, V60, P1766
   Taj MM, 2001, PROSTATE, V47, P194, DOI 10.1002/pros.1063
   VACCA A, 1993, CANCER, V72, P455, DOI 10.1002/1097-0142(19930715)72:2<455::AID-CNCR2820720222>3.0.CO;2-8
   Walker PR, 1998, CURR OPIN IMMUNOL, V10, P564, DOI 10.1016/S0952-7915(98)80225-2
   Wang CL, 2009, CANCER LETT, V276, P221, DOI 10.1016/j.canlet.2008.11.007
   Wang Shu-guang, 2004, Zhonghua Yi Xue Za Zhi, V84, P1642
   Wang YH, 2005, BREAST CANCER RES, V7, pR220, DOI 10.1186/bcr975
   Wehrle-Haller B, 2003, J PATHOL, V200, P481, DOI 10.1002/path.1399
   Whiteside TL, 2007, IMMUNOL INVEST, V36, P25, DOI 10.1080/08820130600991893
NR 45
TC 10
Z9 12
U1 4
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0163-2116
EI 1573-2568
J9 DIGEST DIS SCI
JI Dig. Dis. Sci.
PD OCT
PY 2010
VL 55
IS 10
BP 2844
EP 2852
DI 10.1007/s10620-009-1121-9
PG 9
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 653LU
UT WOS:000282093700038
PM 20101459
DA 2018-12-27
ER

PT J
AU Portin, P
AF Portin, Petter
TI RETRACTED: Evidence based on studies of the mus309 mutant, deficient in
   DNA double-strand break repair, that meiotic crossing over in Drosophila
   melanogaster is a two-phase process (Retracted Article. See vol 138, pg
   1309, 2010)
SO GENETICA
LA English
DT Article; Retracted Publication
DE Chiasma localization; Crossing-over; Crossover interference; DNA
   double-strand break repair; Meiosis
ID SYNDROME GENE-PRODUCT; CROSSOVER FORMATION; X-CHROMOSOME; BLM HELICASE;
   RECOMBINATION; MEIOSIS; YEAST; FEMALES; CHECKPOINT; INITIATION
AB The mus309 gene in Drosophila melanogaster encodes a RecQ helicase which is involved in DNA double-strand break (DSB) repair and specifically in the choice between the different pathways of the repair. In a brood pattern analysis of mus309 and wild type females which either had or had not experienced a temperature shock, different parameters of meiotic crossing over including map distances and crossover interference in the X chromosome were measured. The results suggest that, like in other eukaryotes studied, the control of meiotic crossover formation also in D. melanogaster is a two-phase process. The first phase seems to be temperature shock sensitive, independent of the mus309 gene and coincidental with the premeiotic DNA synthesis, thus most likely representing the formation of DSBs. The second phase seems to be temperature shock tolerant, dependent on the mus309 gene, occurring during the meiotic prophase and most likely representing the choice made by the oocyte between the different pathways of the DSB repair. A hypothesis of the localization of chiasmata is also presented, combining the mechanisms of interference and the so-called centromere effect, and based on the balance between the SDSA and DSBR pathways of DSB repair.
C1 Univ Turku, Dept Biol, Genet Lab, Turku 20014, Finland.
RP Portin, P (reprint author), Univ Turku, Dept Biol, Genet Lab, Turku 20014, Finland.
EM petter.portin@utu.fi
CR Abdu U, 2003, GENETICS, V165, P197
   Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198
   Baker B. S., 1976, GENETICS BIOL DROS B, V1, P351
   BAKER BS, 1972, GENETICS, V71, P255
   Beadle GW, 1932, P NATL ACAD SCI USA, V18, P160, DOI 10.1073/pnas.18.2.160
   Beall EL, 1996, GENE DEV, V10, P921, DOI 10.1101/gad.10.8.921
   BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J
   BOYD JB, 1981, GENETICS, V97, P607
   BOYD JB, 1987, J CELL SCI, P39
   BRIDGES CB, 1915, J EXP ZOOL, V16, P1
   BRIDGES CB, 1927, J GEN PHYSIOL, V8, P687
   CARPENTER ATC, 1981, CHROMOSOMA, V83, P59, DOI 10.1007/BF00286016
   Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006
   DEMUYT A, 2009, PLOS GENET, V5, P1
   ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1
   Ghabrial A, 1999, NAT CELL BIOL, V1, P354
   Ghabrial A, 1998, GENE DEV, V12, P2711, DOI 10.1101/gad.12.17.2711
   GRELL RF, 1973, GENETICS, V73, P87
   GRELL RF, 1965, P NATL ACAD SCI USA, V53, P1340, DOI 10.1073/pnas.53.6.1340
   HAWLEY RS, 1993, ANNU REV GENET, V27, P281
   HERTWIG O, 2002, LEHRBUCH ENTWICKLUNG
   Heyer WD, 2003, TRENDS BIOCHEM SCI, V28, P548, DOI 10.1016/j.tibs.2003.08.011
   Heyer WD, 2004, CURR BIOL, V14, pR56, DOI 10.1016/j.cub.2003.12.043
   Jones GH, 2006, CELL, V126, P246, DOI 10.1016/j.cell.2006.07.010
   Joyce EF, 2009, GENETICS, V181, P335, DOI 10.1534/genetics.108.093104
   Joyce EF, 2009, GENETICS, V181, P39, DOI 10.1534/genetics.108.093112
   Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611
   Keeney S, 2006, BIOCHEM SOC T, V34, P523, DOI 10.1042/BST0340523
   Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6
   Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0
   Kusano K, 2001, SCIENCE, V291, P2600, DOI 10.1126/science.291.5513.2600
   LAKE S, 1984, HEREDITAS, V100, P121, DOI 10.1111/j.1601-5223.1984.tb00113.x
   Laurencon A, 2004, GENETICS, V167, P217, DOI 10.1534/genetics.167.1.217
   Longhese MP, 2008, DNA REPAIR, V7, P545, DOI 10.1016/j.dnarep.2007.09.006
   Longhese MP, 2009, DNA REPAIR, V8, P1127, DOI 10.1016/j.dnarep.2009.04.005
   Lorenz A, 2006, BIOCHEM SOC T, V34, P537, DOI 10.1042/BST0340537
   LUNING KG, 1983, HEREDITAS, V99, P57, DOI 10.1111/j.1601-5223.1983.tb00732.x
   Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135
   Martinez-Perez E, 2009, CURR OPIN GENET DEV, V19, P105, DOI 10.1016/j.gde.2009.02.005
   Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044
   Mather K, 1939, GENETICS, V24, P413
   McKim KS, 1998, GENE DEV, V12, P2932, DOI 10.1101/gad.12.18.2932
   McKim KS, 2002, ANNU REV GENET, V36, P205, DOI 10.1146/annurev.genet.36.041102.113929
   Mcvey M, 2007, GENETICS, V176, P1979, DOI 10.1534/genetics.106.070052
   Mehrotra S, 2006, PLOS GENET, V2, P1883, DOI 10.1371/journal.pgen.0020200
   Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035
   Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843
   Murakami H, 2008, GENE DEV, V22, P286, DOI 10.1101/gad.1642308
   OLSENKROGH B, 2004, ANNU REV GENET, V38, P233
   Portin P, 2005, GENET RES, V86, P185, DOI 10.1017/S0016672305007883
   PORTIN P, 1973, HEREDITAS, V75, P267
   Portin P, 2010, GENETICA, V138, P333, DOI 10.1007/s10709-009-9422-7
   Rockmill B, 2003, CURR BIOL, V13, P1954, DOI 10.1016/j.cub.2003.10.059
   Roig I, 2008, DEV CELL, V15, P331, DOI 10.1016/j.devcel.2008.08.009
   SANDLER L, 1968, GENETICS, V60, P525
   Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608
   Staeva-Vieira E, 2003, EMBO J, V22, P5863, DOI 10.1093/emboj/cdg564
   Stevens WL, 1936, J GENET, V32, P51, DOI 10.1007/BF02982501
   van Brabant AJ, 2000, ANNU REV GENOM HUM G, V1, P409, DOI 10.1146/annurev.genom.1.1.409
   Wan L, 2008, GENE DEV, V22, P386, DOI 10.1101/gad.1626408
   Weinert BT, 2007, NUCLEIC ACIDS RES, V35, P1367, DOI 10.1093/nar/gkl831
   Weinstein A, 1936, GENETICS, V21, P155
   Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200
NR 63
TC 2
Z9 2
U1 2
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0016-6707
J9 GENETICA
JI Genetica
PD OCT
PY 2010
VL 138
IS 9-10
BP 1033
EP 1045
DI 10.1007/s10709-010-9489-1
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA 657SG
UT WOS:000282432000012
PM 20803348
DA 2018-12-27
ER

PT J
AU Dhingra, KK
   Gupta, P
   Saroha, V
   Roy, S
   Khurana, N
AF Dhingra, Kajal Kiran
   Gupta, Parul
   Saroha, Vijay
   Roy, Somak
   Khurana, Nita
TI RETRACTED: Primary primitive neuroectodermal tumor of the breast: A rare
   entity (Retracted article. See vol. 54, pg. 406, 2011)
SO INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY
LA English
DT Letter; Retracted Publication
C1 [Khurana, Nita] Dept Pathol, New Delhi 110002, India.
   [Dhingra, Kajal Kiran; Gupta, Parul; Saroha, Vijay; Roy, Somak] Maulana Azad Med Coll, New Delhi 110002, India.
   [Dhingra, Kajal Kiran; Gupta, Parul; Saroha, Vijay; Roy, Somak] Lok Nayak Hosp, New Delhi 110002, India.
RP Dhingra, KK (reprint author), D-3-3099 Vasant Kunj, New Delhi 110070, India.
EM kajaldhingra@yahoo.com
CR da Silva BB, 2008, EUR J OBSTET GYN R B, V137, P248, DOI 10.1016/j.ejogrb.2006.11.013
   Friedrichs N, 2002, PATHOL RES PRACT, V198, P563, DOI 10.1078/0344-0338-00303
   JAYAKUMAR S, 2006, INTERNET J ORTHOPEDI
   Kwak JY, 2002, J CLIN ULTRASOUND, V30, P374, DOI 10.1002/jcu.10076
   Maxwell RW, 2006, J ULTRAS MED, V25, P1331, DOI 10.7863/jum.2006.25.10.1331
   Tamura G, 2007, PATHOL INT, V57, P509, DOI 10.1111/j.1440-1827.2007.02132.x
NR 6
TC 4
Z9 4
U1 2
U2 8
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0377-4929
EI 0974-5130
J9 INDIAN J PATHOL MICR
JI Indian J. Pathol. Microbiol.
PD OCT-DEC
PY 2010
VL 53
IS 4
BP 880
EP U324
DI 10.4103/0377-4929.72033
PG 3
WC Pathology
SC Pathology
GA 676ON
UT WOS:000283921900089
PM 21045465
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Stanghellini, V
   Barbara, G
   Cremon, C
   Cogliandro, R
   Antonucci, A
   Gabusi, V
   Frisoni, C
   De Giorgio, R
   Grasso, V
   Serra, M
   Corinaldesi, R
AF Stanghellini, Vincenzo
   Barbara, Giovanni
   Cremon, Cesare
   Cogliandro, Rosanna
   Antonucci, Alexandra
   Gabusi, Veronica
   Frisoni, Chiara
   De Giorgio, Roberto
   Grasso, Valentina
   Serra, Mauro
   Corinaldesi, Roberto
TI RETRACTED: Gut microbiota and related diseases: clinical features
   (Retracted article. See vol. 10, pg. 259, 2015)
SO INTERNAL AND EMERGENCY MEDICINE
LA English
DT Article; Retracted Publication
DE Gut microbiota; Irritable bowel syndrome; Inflammatory bowel disease;
   Colon cancer
ID IRRITABLE-BOWEL-SYNDROME; INTESTINAL BACTERIAL OVERGROWTH; FECAL
   MICROFLORA; HEALTHY-SUBJECTS; CROHNS-DISEASE; MUCOSAL FLORA; INNATE;
   CELLS; COLON; PATHOGENESIS
AB Intestinal microbiota is essential for gut homeostasis. Specifically, the microorganisms inhabiting the gut lumen interact with the intestinal immune system, supply key nutrients for the major components of the gut wall, and modulate energy metabolism. Host-microbiome interactions can be either beneficial or deleterious, driving gastrointestinal lymphoid tissue activities and shaping gut wall structures. This overview briefly focuses on the potential role played by abnormalities in gut microbiota and relative responses of the gastrointestinal tract in the determination of important pathological conditions such as the irritable bowel syndrome, inflammatory bowel diseases and colorectal cancer.
C1 [Stanghellini, Vincenzo; Barbara, Giovanni; Cremon, Cesare; Cogliandro, Rosanna; Antonucci, Alexandra; Gabusi, Veronica; Frisoni, Chiara; De Giorgio, Roberto; Grasso, Valentina; Serra, Mauro; Corinaldesi, Roberto] Univ Bologna, Dept Clin Med, St Orsola Malpighi Hosp, I-40138 Bologna, Italy.
RP Stanghellini, V (reprint author), Univ Bologna, Dept Clin Med, St Orsola Malpighi Hosp, Bldg 5,Via Massarenti 9, I-40138 Bologna, Italy.
EM v.stanghellini@unibo.it
OI De Giorgio, Roberto/0000-0003-0867-5873
CR BALSARI A, 1982, MICROBIOLOGICA, V5, P185
   Barbara G, 2004, GASTROENTEROLOGY, V126, P693, DOI 10.1053/j.gastro.2003.11.055
   Barbara G, 2005, AM J GASTROENTEROL, V100, P2560, DOI 10.1111/j.1572-0241.2005.00230.x
   Barbara G, 2007, GASTROENTEROLOGY, V132, P26, DOI 10.1053/j.gastro.2006.11.039
   Barbara G, 2009, DIGEST DIS, V27, P115, DOI 10.1159/000268131
   Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504
   Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175
   BURKITT DP, 1971, CANCER, V28, P3, DOI 10.1002/1097-0142(197107)28:1<3::AID-CNCR2820280104>3.0.CO;2-N
   Cenac N, 2007, J CLIN INVEST, V117, P636, DOI 10.1172/JCI29255
   de Giorgio R, 2010, GASTROENTEROLOGY, V138, P1663, DOI 10.1053/j.gastro.2010.03.022
   DLUGOSZ A, 2010, GASTROENTEROLOGY S1, V138, pS626
   Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x
   Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x
   Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104
   Gasbarrini A, 2009, ALIMENT PHARM THER, V29, P1, DOI 10.1111/j.1365-2036.2009.03951.x
   Gewirtz AT, 2006, CURR OPIN GASTROEN, V22, P8, DOI 10.1097/01.mog.0000194791.59337.28
   GIBSON GR, 1990, GUT, V31, P679, DOI 10.1136/gut.31.6.679
   Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104
   Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JC134610, 10.1172/JCI34610]
   Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005
   Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500
   Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432
   Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061
   Lyra A, 2009, WORLD J GASTROENTERO, V15, P5936, DOI 10.3748/wjg.15.5936
   Madden JAJ, 2001, GUT, V48, pA58
   Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x
   Maukonen J, 2006, J MED MICROBIOL, V55, P625, DOI 10.1099/jmm.046134-0
   MCCALLUM R, 2005, GASTROENTEROLOGY, V128, pT1118
   MCKERNAN DP, 2010, GASTROENTEROLOGY S1, V138, pS628
   Moayyedi P, 2010, GUT, V59, P325, DOI 10.1136/gut.2008.167270
   Nucera G, 2005, ALIMENT PHARM THERAP, V21, P1391, DOI 10.1111/j.1365-2036.2005.02493.x
   Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851
   Piche T, 2009, GUT, V58, P196, DOI 10.1136/gut.2007.140806
   Pimentel M, 2004, ANN RHEUM DIS, V63, P450, DOI 10.1136/ard.2003.011502
   Pimentel M, 2003, AM J GASTROENTEROL, V98, P412, DOI 10.1016/S0002-9270(02)05902-6
   Pimentel M, 2000, AM J GASTROENTEROL, V95, P3503
   PIMENTEL M, 2010, GASTROENTEROLOGY S1, V138, pS64
   Pimentel M, 2006, ANN INTERN MED, V145, P557, DOI 10.7326/0003-4819-145-8-200610170-00004
   Posserud I, 2007, GUT, V56, P802, DOI 10.1136/gut.2006.108712
   Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072
   REDDY BS, 1975, J NUTR, V105, P878
   Roediger WEW, 1997, DIGEST DIS SCI, V42, P1571, DOI 10.1023/A:1018851723920
   Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059
   Schoepfer AM, 2008, NEUROGASTROENT MOTIL, V20, P1110, DOI 10.1111/j.1365-2982.2008.01166.x
   Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229
   Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074
   Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005
   Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294
   Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186
   Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681
   Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653
   Vernier Gwenola, 2004, Curr Gastroenterol Rep, V6, P482, DOI 10.1007/s11894-004-0070-x
   WYATT GM, 1988, J MED MICROBIOL, V26, P295, DOI 10.1099/00222615-26-4-295
NR 53
TC 14
Z9 16
U1 2
U2 22
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1828-0447
EI 1970-9366
J9 INTERN EMERG MED
JI Intern. Emerg. Med.
PD OCT
PY 2010
VL 5
SU 1
BP S57
EP S63
DI 10.1007/s11739-010-0451-0
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA 654PS
UT WOS:000282181100010
PM 20865476
DA 2018-12-27
ER

PT J
AU Tomita, M
   Tanaka, Y
   Mori, N
AF Tomita, Mariko
   Tanaka, Yuetsu
   Mori, Naoki
TI RETRACTED: Aurora kinase inhibitor AZD1152 negatively affects the growth
   and survival of HTLV-1-infected T lymphocytes in vitro (Retracted
   article. See vol. 129, pg. 2763, 2011)
SO INTERNATIONAL JOURNAL OF CANCER
LA English
DT Article; Retracted Publication
DE HTLV-1; ATL; AZD1152; Aurora B; cell cycle; apoptosis
ID NF-KAPPA-B; ANTICANCER AGENTS; LEUKEMIA-CELLS; CANCER-CELLS; CHECKPOINT;
   APOPTOSIS; VIVO; EXPRESSION; DISCOVERY; TARGETS
AB Aurora kinases play an essential role in regulating mitosis and cell division. Inhibition of Aurora kinases results in suppression of cell division, phosphorylation of histone H3 and induction of apoptosis in many cell types. These characteristics have prompted the testing of Aurora kinase inhibitors as chemotherapeutic agents. In our study, we report the in vitro activities of AZD1152, a selective inhibitor of Aurora B kinase in human T-cell leukemia virus type 1 (HTLV-1), the causative agent of adult T-cell leukemia (ATL), -infected T-cell lines. Overexpression of Aurora B was noted in HTLV-1-infected T-cell lines compared to HTLV-1-uninfected T-cell lines. AZD1152 reduced the viability of HTLV-1-infected T-cell lines within 24 hr but did not affect that of -uninfected T-cell lines. Although AZD1152 inhibited phosphorylation of histone H3 on Ser10 in both HTLV-1-infected and -uninfected T-cell lines, it induced polyploidy only in HTLV-1-uninfected T-cell lines. AZD1152 induced early apoptosis of HTLV-1-infected T-cells without induction of polyploidy. We have reported previously that a pan-Aurora kinase inhibitor induced apoptosis through inhibition of NF-kappa B signaling activity in HTLV-1-infected T-cell lines. In contrast, AZD1152 did not affect NF-kappa B activity in these cells. It induced p53 and p21 expression in HTLV-1-infected but not in HTLV-1-uninfected T-cell lines, suggesting that activation of p53-dependent postmitotic checkpoint might prevent polyploidy in HTLV-1-infected T-cells. Our results suggest that specific inhibition of Aurora B kinase is a potentially useful therapeutic strategy in the treatment of All and that further in vivo exploration is warranted.
C1 [Tomita, Mariko; Mori, Naoki] Univ Ryukyus, Div Mol Virol & Oncol, Grad Sch Med, Okinawa 9030215, Japan.
   [Tanaka, Yuetsu] Univ Ryukyus, Div Immunol, Fac Med, Okinawa 9030215, Japan.
RP Mori, N (reprint author), Univ Ryukyus, Div Mol Virol & Oncol, Grad Sch Med, 207 Uehara, Okinawa 9030215, Japan.
EM n-mori@med.u-ryukyu.ac.jp
FU Japan Society for the Promotion of Science [JSPS KAKENHI 21591212];
   Princes Takamatsu Cancer Research Fund [07-23905]; Ichiro Kanehara
   Foundation; Mitsubishi Pharma Research Foundation; Yasuda Medical
   Foundation
FX Grant sponsor: Japan Society for the Promotion of Science; Grant number:
   JSPS KAKENHI 21591212; Grant sponsor: Princes Takamatsu Cancer Research
   Fund; Grant number: 07-23905; Grant sponsors: Ichiro Kanehara
   Foundation, Mitsubishi Pharma Research Foundation, Yasuda Medical
   Foundation
CR Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052
   Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245
   Carvajal RD, 2006, CLIN CANCER RES, V12, P6869, DOI 10.1158/1078-0432.CCR-06-1405
   Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018
   Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091
   Evans RP, 2008, BRIT J HAEMATOL, V140, P295, DOI 10.1111/j.1365-2141.2007.06913.x
   Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179
   Gizatullin F, 2006, CANCER RES, V66, P7668, DOI 10.1158/0008-5472.CAN-05-3353
   Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003
   Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092
   Ikezoe T, 2009, LAB INVEST, V89, P1364, DOI 10.1038/labinvest.2009.106
   Ishiyama M, 1996, BIOL PHARM BULL, V19, P1518
   Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502
   Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054
   Margolis RL, 2003, J CELL BIOCHEM, V88, P673, DOI 10.1002/jcb.10411
   Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526
   Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111
   Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006\
   Mori N, 1999, BLOOD, V93, P2360
   Mortlock AA, 2007, J MED CHEM, V50, P2213, DOI 10.1021/jm061335f
   Oke A, 2009, CANCER RES, V69, P4150, DOI 10.1158/0008-5472.CAN-08-3203
   Park HU, 2004, ONCOGENE, V23, P4966, DOI 10.1038/sj.onc.1207644
   Pollard JR, 2009, J MED CHEM, V52, P2629, DOI 10.1021/jm8012129
   Schellens JH, 2006, J CLIN ONCOL, V24, p122S
   Soncini C, 2006, CLIN CANCER RES, V12, P4080, DOI 10.1158/1078-0432.CCR-05-1964
   TANAKA Y, 1990, JPN J CANCER RES, V81, P225, DOI 10.1111/j.1349-7006.1990.tb02554.x
   Tang CJC, 2006, DEV BIOL, V290, P398, DOI 10.1016/j.ydbio.2005.11.036
   Tao Y, 2008, ONCOGENE, V27, P3244, DOI 10.1038/sj.onc.1210990
   Tao YG, 2009, CELL CYCLE, V8, P3172, DOI 10.4161/cc.8.19.9729
   Tomita M, 2004, ONCOGENE, V23, P8272, DOI 10.1038/sj.onc.1208059
   Tomita M, 2009, INT J CANCER, V124, P2607, DOI 10.1002/ijc.24257
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   Vitale I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001337
   Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979
NR 34
TC 7
Z9 8
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7136
EI 1097-0215
J9 INT J CANCER
JI Int. J. Cancer
PD OCT 1
PY 2010
VL 127
IS 7
BP 1584
EP 1594
DI 10.1002/ijc.25178
PG 11
WC Oncology
SC Oncology
GA 643ZM
UT WOS:000281340200009
PM 20091867
DA 2018-12-27
ER

PT J
AU Fujii, Y
AF Fujii, Yoshitaka
TI RETRACTED: Prevention of nausea and vomiting during termination of
   pregnancy (Retracted article. See vol. 120, pg. 109, 2013)
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Review; Retracted Publication
DE Antiemetics; Complications; Curettage; Dilatation; Pregnancy; Vomiting
ID MINOR GYNECOLOGICAL SURGERY; POSTOPERATIVE NAUSEA; NITROUS-OXIDE;
   AMBULATORY ANESTHESIA; CONTROLLED TRIAL; DOUBLE-BLIND; CLINICAL USE;
   RISK SCORE; PROPOFOL; DROPERIDOL
AB Background: Postoperative nausea and vomiting (PONV) is common in women undergoing dilatation and curettage under general anesthesia for pregnancy termination, and many studies suggest treating these women prophylactically for PONV. Objectives: Reviewing the antiemetics used over the past 20 years for this indication and comparing their efficacy. Search strategy: We performed MEDLINE and EMBASE searches for articles published from January 1980 through June 2009. The search terms were complications, nausea, vomiting, antiemetics, anesthetics, surgery, dilatation, curettage, pregnancy, and women. Selection criteria: We selected the studies of the antiemetics droperidol, metoclopramide, hydroxyzine, propofol, dexamethasone, ondansetron, and ramosetron when used for the stated indication. When assessing drug efficacy, we compared the antiemetics used at the time the article was written. Data collection and analysis: We reviewed the selected studies, presented the reported incidence rates of PONV for each drug, and presented and interpreted the P values reported for the different comparisons. Main results: Although all antiemetics assessed decreased the incidence of PONV, the combination of dexamethasone and droperidol seems to be the most effective in preventing PONV. Conclusions: All antiemetics used in the last 20 years to prevent PONV are effective (some more than others) in women undergoing dilatation and curettage for pregnancy termination. However, there is a need for benefit and risk analyses of the different treatments. (C) 2010 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
C1 Toho Univ, Sch Med, Dept Anesthesiol 1, Ohta Ku, Tokyo 1438541, Japan.
RP Fujii, Y (reprint author), Toho Univ, Sch Med, Dept Anesthesiol 1, Ohta Ku, 6-11-1 Ohmori Nishi, Tokyo 1438541, Japan.
EM yfujii@med.toho-u.ac.jp
CR ALON E, 1992, ANESTH ANALG, V75, P561
   Apfel CC, 1999, ANESTHESIOLOGY, V91, P693, DOI 10.1097/00000542-199909000-00022
   Apfel CC, 1998, ACTA ANAESTH SCAND, V42, P495, DOI 10.1111/j.1399-6576.1998.tb05157.x
   BONICA JJ, 1958, ANESTHESIOLOGY, V19, P532, DOI 10.1097/00000542-195807000-00010
   BORGEAT A, 1992, ANESTH ANALG, V74, P539
   BUNCE KT, 1992, BRIT J ANAESTH, V69, pS60, DOI 10.1093/bja/69.supplement_1.60S
   Cechetto DF, 2001, ANESTH ANALG, V92, P934
   Fujii Y, 2004, INT J OBSTET ANESTH, V13, P15, DOI 10.1016/S0959-289X(03)00101-8
   Fujii Y, 2002, OBSTET GYNECOL, V99, P58, DOI 10.1016/S0029-7844(01)01650-7
   Gan TJ, 2003, ANESTH ANALG, V97, P62, DOI 10.1213/01.ANE.0000068580.00245.95
   Gan TJ, 2007, ANESTH ANALG, V105, P1615, DOI 10.1213/01.ane.0000295230.55439.f4
   Habib AS, 2003, ANESTH ANALG, V96, P1377
   HARRINGTON RA, 1983, DRUGS, V25, P451, DOI 10.2165/00003495-198325050-00002
   Hartung J, 1996, ANESTH ANALG, V83, P114, DOI 10.1097/00000539-199607000-00020
   HEATH PJ, 1990, ANAESTHESIA, V45, P911, DOI 10.1111/j.1365-2044.1990.tb14617.x
   Henzi I, 2000, CAN J ANAESTH, V47, P537, DOI 10.1007/BF03018945
   Henzi I, 2000, ANESTH ANALG, V90, P186, DOI 10.1097/00000539-200001000-00038
   Hough M, 1998, ANAESTHESIA, V53, P932, DOI 10.1046/j.1365-2044.1998.0617p.x
   JOSHI R, 1993, EUR J ANAESTH, V10, P109
   Kasinath NS, 2003, CAN J ANAESTH, V50, P229, DOI 10.1007/BF03017789
   LOESER EA, 1979, CAN ANAESTH SOC J, V26, P125, DOI 10.1007/BF03013781
   MADEJ TH, 1986, BRIT J ANAESTH, V58, P879, DOI 10.1093/bja/58.8.879
   McCormick C., 2002, ASA NEWSL, V66, P19
   MCKENZIE R, 1981, ANESTH ANALG, V60, P783
   Monagle J, 1997, EUR J ANAESTH, V14, P604, DOI 10.1046/j.1365-2346.1994.00184.x
   Nathan N, 1998, CAN J ANAESTH, V45, P1148, DOI 10.1007/BF03012454
   Nelskyla K, 1999, BRIT J ANAESTH, V83, P576
   OSTMAN PL, 1990, ANESTH ANALG, V71, P536
   PERREAULT L, 1982, CAN ANAESTH SOC J, V29, P428, DOI 10.1007/BF03009404
   RAEDER JC, 1988, ACTA ANAESTH SCAND, V32, P607, DOI 10.1111/j.1399-6576.1988.tb02796.x
   SAMPSON IH, 1988, BRIT J ANAESTH, V61, P707, DOI 10.1093/bja/61.6.707
   SANCHEZ LA, 1995, J RES PHARM EC, V6, P35
   Sandhya, 1994, Singapore Medical Journal, V35, P271
   Sinclair DR, 1999, ANESTHESIOLOGY, V91, P109, DOI 10.1097/00000542-199907000-00018
   SMITH I, 1994, ANESTHESIOLOGY, V81, P1005
   Sotiriadis A, 2005, OBSTET GYNECOL, V105, P1104, DOI 10.1097/01.AOG.0000158857.44046.a4
   Tolan MM, 1999, ANESTHESIOLOGY, V90, P340, DOI 10.1097/00000542-199901000-00073
   Tzeng J I, 2000, Acta Anaesthesiol Sin, V38, P137
   Uerpairojkit K, 2003, J OBSTET GYNAECOL RE, V29, P79, DOI 10.1046/j.1341-8076.2003.00083.x
   WATCHA MF, 1992, ANESTHESIOLOGY, V77, P162, DOI 10.1097/00000542-199207000-00023
NR 40
TC 3
Z9 3
U1 2
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD OCT
PY 2010
VL 111
IS 1
BP 3
EP 7
DI 10.1016/j.ijgo.2010.05.007
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 661NN
UT WOS:000282735100002
PM 20598689
DA 2018-12-27
ER

PT J
AU Chen, WK
   Ko, JW
   Chang, CMJ
AF Chen, Wei-Kuan
   Ko, Jing-Wei
   Chang, Chieh-Ming J.
TI RETRACTED: Vapor-Liquid Equilibria and Density Measurement for Binary
   Mixtures of Benzene plus Nonane, Methylbenzene plus 1,2-Dimethylbenzene,
   1,3-Dimethylbenzene plus 2,3,4,5-Tetrahydrothiophene-1,1-dioxide
   (Sulfolane), 1,2-Dimethylbenzene plus Sulfolane, 1,2-Dimethylbenzene
   plus N-Methylformamide (NMF), 1,3-Dimethylbenzene plus NMF, and
   1,4-Dimethylbenzene plus NMF from (333.15 to 353.15) K at Vacuum
   Conditions (Retracted article. See vol. 56, pg. 3714, 2011)
SO JOURNAL OF CHEMICAL AND ENGINEERING DATA
LA English
DT Article; Retracted Publication
ID AROMATIC-HYDROCARBONS; M-XYLENE; SYSTEMS; TOLUENE; WATER; EXPRESSION;
   VOLUMES; ENERGY; HEXANE
AB Vapor-liquid equilibria at (333.15, 343.15, and 353.15) K for seven binary mixtures of benzene + nonane, methylbenzene + 1,2-dimethylbenzene, 1,3-dimethylbenzene + 2,3,4,5-tetrahydrothiophene-1, 1-dioxide, 1,2-dimethylbenzene + 2,3,4,5-tetrahydrothiophene-1,1-dioxide, 1,2-dimethylbenzene + N-methylformamide (NMF), 1,3-dimethylbenzene + NMF. and 1,4-dimethylbenzene + NMF have been obtained at pressures ranging from (0.01 to 101.3) kPa. The Wilson, nonrandom two-liquid (NRTL), and universal quasichemical (UNIQUAC) activity coefficient models have been employed to correlate experimental data to find intermolecular parameters. The nonideal behavior of the vapor phase has been considered by using the Peng-Robinson equation of state in calculating the vapor mole fraction. Liquid and vapor densities were measured by using two vibrating tube densitometers to determine liquid excess molar volumes. Six systems of benzene + nonane. 1,3-dimethylbenzene + 2,3,4,5-tetrahydrothiophene-1, 1-dioxide, 1,2-dimethylbenzene + 2,3,4,5-tetrahydrothiophene-1,1-dioxide. 1,2-dimethylbenzene + NMF, 1,3-dimethylbenzene + NMF, and 1,4-dimethylbenzene + NMF mixtures present large positive deviations from the ideal solution and belong to endothermic mixtures because their excess Gibbs energies are positive. Only one system of the methylbenzene + 1,2-dimethylbenzene mixture may present a slight exothermic mixing deviation from the ideal solution. Temperature-dependent intermolecular parameters in the three models were obtained in this study.
C1 [Chen, Wei-Kuan; Chang, Chieh-Ming J.] Natl Chung Hsing Univ, Dept Chem Engn, Taichung 402, Taiwan.
   [Ko, Jing-Wei] Res Inst, Proc Res Dept Refining & Manufacturing, Chiayi 600, Taiwan.
RP Chang, CMJ (reprint author), Natl Chung Hsing Univ, Dept Chem Engn, 250 Kuokuang Rd, Taichung 402, Taiwan.
EM cmchang@dragon.nuchu.edu.tw
FU National Science Council of the Republic of China, Taiwan
   [NSC98-2221-E005-053-MY3]; Ministry of Education, Taiwan
FX Received for review May 17, 2010. Accepted June 17. 2010. Thc authors
   would like to thank the National Science Council of the Republic of
   China, Taiwan for financially supporting this research
   (NSC98-2221-E005-053-MY3). This work is also supported in part by the
   Ministry of Education, Taiwan, ROC under the ATU plan and China
   Petroleum Company and National Chung Hsing University project
   (EEA9715003)
CR ABRAMS DS, 1975, AICHE J, V21, P116, DOI 10.1002/aic.690210115
   Calvar N, 2009, J CHEM THERMODYN, V41, P939, DOI 10.1016/j.jct.2009.03.009
   Chang CMJ, 1999, FLUID PHASE EQUILIBR, V163, P119, DOI 10.1016/S0378-3812(99)00213-7
   Chang CMJ, 2005, FLUID PHASE EQUILIBR, V233, P56, DOI 10.1016/j.fluid.2005.04.008
   Chen WK, 2010, FLUID PHASE EQUILIBR, V291, P40, DOI 10.1016/j.fluid.2009.12.002
   Chen WK, 2010, FLUID PHASE EQUILIBR, V287, P126, DOI 10.1016/j.fluid.2009.09.024
   Domanska U, 1996, J CHEM ENG DATA, V41, P624, DOI 10.1021/je950227n
   Harris RA, 2003, J CHEM ENG DATA, V48, P341, DOI 10.1021/je020130i
   *INV PROC SYST INC, 2006, SIM4ME PRO 2 PROVISI
   Jang S, 2009, J CHEM THERMODYN, V41, P51, DOI 10.1016/j.jct.2008.07.024
   KARVO M, 1980, J CHEM THERMODYN, V12, P1175, DOI 10.1016/S0021-9614(80)80011-5
   KLARA SM, 1987, J CHEM ENG DATA, V32, P143, DOI 10.1021/je00048a004
   Lee KJ, 2009, J TAIWAN INST CHEM E, V40, P573, DOI 10.1016/j.jtice.2009.03.002
   Lee KJ, 2009, FLUID PHASE EQUILIBR, V280, P42, DOI 10.1016/j.fluid.2009.03.012
   LUCKENBACH R, 1987, BEILSTEIN HDB ORGA S, V18
   LUCKENBACH R, 1984, BEILSTEIN HDB ORGANI, V17
   PENG D, 1976, IND ENG CHEM FUND, V15, P59, DOI 10.1021/i160057a011
   RAAL JD, 1998, PHASE EQUILIBRIA MEA
   Reid R. C., 1987, PROPERTIES GASES LIQ
   RENON H, 1968, AICHE J, V14, P135, DOI 10.1002/aic.690140124
   WILSON GM, 1964, J AM CHEM SOC, V86, P127, DOI 10.1021/ja01056a002
   Yu YX, 2001, FLUID PHASE EQUILIBR, V190, P61, DOI 10.1016/S0378-3812(01)00589-1
   Yu YX, 1998, FLUID PHASE EQUILIBR, V147, P207, DOI 10.1016/S0378-3812(98)00243-X
   Zhou L, 2008, THERMOCHIM ACTA, V468, P116, DOI 10.1016/j.tca.2007.11.003
   ZIELKIEWICZ J, 1995, J CHEM THERMODYN, V27, P1275, DOI 10.1006/jcht.1995.0134
   Zielkiewicz J, 1996, J CHEM THERMODYN, V28, P887, DOI 10.1006/jcht.1996.0078
NR 26
TC 6
Z9 6
U1 3
U2 24
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-9568
J9 J CHEM ENG DATA
JI J. Chem. Eng. Data
PD OCT
PY 2010
VL 55
IS 10
BP 4352
EP 4361
DI 10.1021/je100517z
PG 10
WC Thermodynamics; Chemistry, Multidisciplinary; Engineering, Chemical
SC Thermodynamics; Chemistry; Engineering
GA 662XU
UT WOS:000282848400035
DA 2018-12-27
ER

PT J
AU Sababeh, J
   Mohammadi, K
AF Sababeh, Javad
   Mohammadi, Karim
TI RETRACTED: AUTONOMOUS GROUP TESTING BASED FAULT TOLERANCE IN
   RECONFIGURABLE LOGIC DEVICES (RETRACTED ARTICLE) (Retracted article. See
   vol. 22, 1393001, 2013)
SO JOURNAL OF CIRCUITS SYSTEMS AND COMPUTERS
LA English
DT Article; Retracted Publication
DE Autonomous systems; fault tolerance; group testing; reconfigurable
   hardware; reliable systems
ID CONCURRENT ERROR-DETECTION
AB A fault tolerance technique for reconfigurable logic devices in self-organized systems is developed by using the Combinatorial Group Testing (CGT) principles. It employs adaptive combinatorial group testing techniques to autonomously maintain resource viability information as an organic means of transient and permanent fault resolution. By minimizing the repair time due to using CGT algorithm addressed in this paper, the online availability of the device progressively increases. The approach of CGT proposes a novel method for isolating faults at progressively increasing granularity using only functional testing. Dedicated test vectors are unnecessary as the algorithm operates on the output response produced for real-time operational FPGA's throughput. The information about the resource performance obtained using CGT techniques is utilized to identify the faulty resource on the FPGA by using alternate configurations which lead to exclude the faulty resource. However, after the algorithm locates the fault, a cell swapping operator is used to isolate the defective resource and realizes the fault tolerance. Simulation is done on two different combinatorial circuits from LGSynth93 Benchmarks. Results show that the algorithm would be able to successively isolate a stuck-at fault at the input of a logic resource for proposed benchmark circuits at most in 27 stages.
C1 [Sababeh, Javad; Mohammadi, Karim] Iran Univ Sci & Technol, Coll Elect Engn, Tehran, Iran.
RP Sababeh, J (reprint author), Iran Univ Sci & Technol, Coll Elect Engn, Tehran, Iran.
EM jsababeh@ee.iust.ac.ir; mohammadi@iust.ac.ir
RI Mohammadi, Karim/T-5571-2018
FU Iran Telecommunication Research Center
FX This research was supported by Iran Telecommunication Research Center.
CR Abramovici M, 2001, THIRD NASA/DOD WORKSHOP ON EVOLVABLE HARDWARE, PROCEEDINGS, P73, DOI 10.1109/EH.2001.937949
   BARSEVER Y, JPL TECHNICAL REPORT
   Cheatham JA, 2006, ACM T DES AUTOMAT EL, V11, P501, DOI 10.1145/1142155.1142167
   DEMARA RF, 2005, P 2005 INT C PAR DIS
   DEMARA RF, 2005, P NASA DOD C 29 MAY
   Dorfman R, 1943, ANN MATH STAT, V14, P436, DOI 10.1214/aoms/1177731363
   Doumar A, 2003, IEEE T VLSI SYST, V11, P386, DOI 10.1109/TVLSI.2002.801609
   Du D., 2000, COMBINATORIAL GROUP
   Emmert JM, 2007, IEEE T VLSI SYST, V15, P216, DOI 10.1109/TVLSI.2007.891102
   FISCHMAN MA, 2004, P 2004 IEEE RAD C PH
   Garvie M, 2004, 10TH IEEE INTERNATIONAL ON-LINE TESTING SYMPOSIUM, PROCEEDINGS, P155, DOI 10.1109/OLT.2004.1319674
   GREENWOOD GW, 2007, INTRO EVOLVABLE HARD
   Huang W., 2001, P 9 ANN IEEE S FIELD, P137
   KEYMEULEN D, 2000, IEEE T RELIABILITY, V49
   KHANG AB, 2004, IEEE T COMPUT AID D, V25, P533
   KHANG AB, 2006, IEEE T COMPUT AID D, V25, P533
   Lach J, 1998, IEEE T VLSI SYST, V6, P212, DOI 10.1109/92.678870
   Li YM, 2000, PROCEEDINGS OF THE IEEE 2000 NATIONAL AEROSPACE AND ELECTRONICS CONFERENCE, P588, DOI 10.1109/NAECON.2000.894965
   Mitra S, 2000, INT TEST CONF P, P985, DOI 10.1109/TEST.2000.894311
   Mohanram K, 2003, 9TH IEEE INTERNATIONAL ON-LINE TESTING SYMPOSIUM, PROCEEDINGS, P35, DOI 10.1109/OLT.2003.1214364
   OREIFEJ RS, 2006, P IEEE INT C REC COM, P1
   Shanthi AP, 2005, APPL SOFT COMPUT, V5, P357, DOI 10.1016/j.asoc.2004.08.006
   SHARMA CA, 2006, P INT C ADV COMP SCI
   Touba NA, 1997, IEEE T COMPUT AID D, V16, P783, DOI 10.1109/43.644041
   VIGANDER S, 2001, THESIS NORWEGIAN U S
   YUI CC, 2003, P 2003 IEEE NUCL SPA
NR 26
TC 1
Z9 1
U1 3
U2 17
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0218-1266
EI 1793-6454
J9 J CIRCUIT SYST COMP
JI J. Circuits Syst. Comput.
PD OCT
PY 2010
VL 19
IS 6
BP 1199
EP 1215
DI 10.1142/S0218126610006827
PG 17
WC Computer Science, Hardware & Architecture; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA 671KA
UT WOS:000283501400004
DA 2018-12-27
ER

PT J
AU Asgary, S
   Eghbal, MJ
AF Asgary, S.
   Eghbal, M. J.
TI RETRACTED: A Clinical Trial of Pulpotomy vs. Root Canal Therapy of
   Mature Molars (Retracted article. See vol. 90, pg. 1145, 2011)
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article; Retracted Publication
DE human; molar; NEC; CEM cement; pulpitis; pulpotomy
ID ENDODONTIC TREATMENT; IRREVERSIBLE PULPITIS; POSTOPERATIVE PAIN; TEETH;
   CEMENT; MEDICATIONS; SUCCESS; PULPS
AB Root canal therapy (RCT) and tooth extraction are the main treatment options for irreversible pulpitis or its sequelae. Pulpotomy is an alternative treatment; however, more evidence is required. If outcomes of pulpotomy with a calcium-enriched mixture (PCEM) are non-inferior for mature molars with irreversible pulpitis compared with those from one-visit RCT (ORCT), this may be a beneficial treatment option. Four hundred seven individuals met the inclusion criteria and were randomly allocated [ PCEM (n = 205), ORCT (n = 202)]. We used NRS questionnaires to record pain intensity. Six-month clinical and radiographic successes were assessed. Individuals in the ORCT arm reported significantly more postoperative pain than those in the PCEM arm (P < 0.001). Clinical success rates in the two arms showed no statistically significant difference; however, the radiographic success rates were significantly greater in the PCEM arm (P < 0.001). This trial suggests PCEM as an alternative for treatment of irreversible pulpitis. If long-term results confirm initial ones, PCEM may revolutionize oral health worldwide.
C1 [Asgary, S.; Eghbal, M. J.] Shahid Beheshti Univ MC, Sch Dent, Dent Res Ctr, Iranian Ctr Endodont Res, Tehran 1983963113, Iran.
RP Asgary, S (reprint author), Shahid Beheshti Univ MC, Sch Dent, Dent Res Ctr, Iranian Ctr Endodont Res, Tehran 1983963113, Iran.
EM saasgary@yahoo.com
FU Iranian Ministry of Health and Medical Education; ICER, Shahid Beheshti
   Medical University, Tehran, Iran
FX This study was supported by the Iranian Ministry of Health and Medical
   Education (Health Deputy, Oral Health Office) and by ICER, Shahid
   Beheshti Medical University, Tehran, Iran. The authors thank the study
   participants and dentists (Drs. S. Niknam, H. Abdolmaleki, M. Shahriari,
   B. Sepehri, M. Zarei, H. Mohadesi, L. Kochmeshki, N. Shirzaei, S.H.
   Hoseini, M.R. Naderi, A.R. Torkamanzadeh, N. Sahranavard, J. Mohebi, A.
   Naseri, M. Forozanfar, A. Razavi, A. Izadi, H. Fadaei, K. Khorshidian,
   H.A. Taheri, M.H. Bagheri-Atabak, M. Zareshahi, and M. Pahlevan-Shamsi)
   for their enthusiastic contributions; as well as Drs. K.
   Bagheri-lankarani, S.H. Emami-Razavi, S.M. Alavian, M.H. Khoshnevisan,
   H. Hesary, M.M. Vardi, M. Sourosh, and Prof. J. Ghoddusi, who provided
   the national supervision of and support for this trial; Dr S. M.R.
   Safavi for critical review; Drs. A.R. Zali, S. Mohamad-Sadeghi, M.
   Piriaei, and S. Kheirieh for administrative help; Drs. A. Akbarzadeh and
   M.J. Kharazi-Fard, who helped to develop the original statistical design
   and analysis; Drs. R.A. Taheri, F. Rahnama, A. Heravi, G.A. Dehghani,
   and H. Fotohi, who monitored the trial in different states; Dr. E.
   Soheilipour, M. Ghorbanpour, B. Shadman, O. Hosseini, and Z. Khademi,
   who entered and checked the data; Drs. H. Nazarinia and S. Goorang, who
   interpreted the x-rays; and Dr. L. Alim Marvasti for the English editing
   of the manuscript.
CR Aida J, 2006, J EPIDEMIOL, V16, P214, DOI 10.2188/jea.16.214
   Albashaireh ZSM, 1998, J DENT, V26, P227, DOI 10.1016/S0300-5712(97)00006-7
   Asgary S, 2008, J BIOMED MATER RES A, V87A, P706, DOI 10.1002/jbm.a.31678
   Asgary S, 2008, ORAL SURG ORAL MED O, V106, P609, DOI 10.1016/j.tripleo.2008.06.006
   Asgary S, 2008, J ENDODONT, V34, P990, DOI 10.1016/j.joen.2008.05.006
   Asgary Saeed, 2006, Iran Endod J, V1, P117
   Asgary Saeed, 2009, J Conserv Dent, V12, P31, DOI 10.4103/0972-0707.53340
   Asgary Saeed, 2006, Iran Endod J, V1, P101
   Asgary S, 2010, J ENDODONT, V36, P837, DOI 10.1016/j.joen.2010.03.005
   Asgary S, 2009, AUST ENDOD J, V35, P147, DOI 10.1111/j.1747-4477.2008.00137.x
   Asgary Saeed, 2008, J Oral Sci, V50, P469
   Asgary S, 2009, J ENDODONT, V35, P243, DOI 10.1016/j.joen.2008.10.026
   Averbuch M, 2000, J CLIN PHARMACOL, V40, P133, DOI 10.1177/00912700022008775
   Bakland LK, 2002, ENDODONTICS, P795
   Bender I B, 2000, Aust Endod J, V26, P10
   Boykin MJ, 2003, J ENDODONT, V29, P806, DOI 10.1097/00004770-200312000-00005
   CALISKAN MK, 1994, INT ENDOD J, V27, P52, DOI 10.1111/j.1365-2591.1994.tb00230.x
   DiRenzo A, 2002, ORAL SURG ORAL MED O, V93, P605, DOI 10.1067/moe.2002.121900
   Eghbal MJ, 2009, AUST ENDOD J, V35, P4, DOI 10.1111/j.1747-4477.2009.00166.x
   Ghoddusi Jamileh, 2008, Iran Endod J, V3, P17
   HASSELGREN G, 1989, J ENDODONT, V15, P254, DOI 10.1016/S0099-2399(89)80219-5
   Kojima K, 2004, ORAL SURG ORAL MED O, V97, P95, DOI 10.1016/j.tripleo.2003.07.006
   Matsuo T, 1996, J ENDODONT, V22, P551, DOI 10.1016/S0099-2399(96)80017-3
   McDonald R, 2004, DENT CHILD ADOLESCEN, P389
   McDougal RA, 2004, J AM DENT ASSOC, V135, P1707, DOI 10.14219/jada.archive.2004.0123
   MEJARE I, 1993, ENDOD DENT TRAUMATOL, V9, P238
   Menhinick KA, 2004, INT ENDOD J, V37, P531, DOI 10.1111/j.1365-2591.2004.00836.x
   Nosrat A, 2010, J ENDODONT, V36, P912, DOI 10.1016/j.joen.2009.11.025
   O'Keefe E M, 1976, J Endod, V2, P315
   Peters LB, 2002, INT ENDOD J, V35, P660, DOI 10.1046/j.1365-2591.2002.00541.x
   SAMIEE M, 2009, CLIN ORAL INVES 1104
   Strindberg LZ, 1956, ACTA ODONTOL SCA S21, V14, P1
   Sundqvist G, 1998, ORAL SURG ORAL MED O, V85, P86, DOI 10.1016/S1079-2104(98)90404-8
   TABARCI B, 2010, INT ENDOD J     0423
   TORABINEJAD M, 1994, J ENDODONT, V20, P345, DOI 10.1016/S0099-2399(06)80098-1
   WAYMAN BE, 1994, J ENDODONT, V20, P399, DOI 10.1016/S0099-2399(06)80299-2
   Witherspoon DE, 2006, J AM DENT ASSOC, V137, P610, DOI 10.14219/jada.archive.2006.0256
   Zilberman U, 1989, Am J Dent, V2, P147
NR 38
TC 8
Z9 9
U1 3
U2 18
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD OCT
PY 2010
VL 89
IS 10
BP 1080
EP 1085
DI 10.1177/0022034510374057
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 671TY
UT WOS:000283535100011
PM 20562409
DA 2018-12-27
ER

PT J
AU Xu, HZ
   Zeng, GS
AF Xu Hongzhen
   Zeng Guosun
TI RETRACTED: Specification and verification of dynamic evolution of
   software architectures (Retracted article. See vol. 58, pg. 338, 2012)
SO JOURNAL OF SYSTEMS ARCHITECTURE
LA English
DT Article; Retracted Publication
DE Software architecture; Dynamic evolution; Evolution rule; Verification;
   Liveness
AB With software systems being more and more open and complex, a major challenge for those systems is to evolve themselves gradually, especially during their runtime, where software architectures can provide a foundation for dynamic software evolution. In this paper, we propose a specifying and verifying method for dynamic evolution of software architectures using hypergraph grammars. We propose two general atomic evolution rules and three general composite evolution rules of software architectures based on hypergraphs, and specify dynamic evolution of software architectures according to those rules and a pre-defined architecture style through a case study. At last we verify the liveness property of dynamic evolution of software architectures using model checking, and give out corresponding verification algorithms. Our approach provides both a user-friendly graphical representation and formal models based on grammars. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Xu Hongzhen; Zeng Guosun] Tongji Univ, Dept Comp Sci & Technol, Shanghai 201804, Peoples R China.
   [Xu Hongzhen] E China Inst Technol, Dept Comp Sci & Technol, Fuzhou 344000, Jiangxi, Peoples R China.
   [Xu Hongzhen] Minist Educ, Applicat Nucl Technol Engn Ctr, Nanchang 330013, Jiangxi, Peoples R China.
   [Zeng Guosun] Minist Educ, Embedded Syst & Serv Comp Key Lab, Shanghai 201804, Peoples R China.
RP Xu, HZ (reprint author), Tongji Univ, Dept Comp Sci & Technol, Shanghai 201804, Peoples R China.
EM xhz_97@163.com
FU National High-Tech Research and Development Plan of China (863 Program)
   [2007AA01Z425, 2009AA012201]; National Grand Fundamental Research
   Program of China (973 Program) [2007CB316502]; National Natural Science
   Foundation of China [90718015]; NSFC [60970155]; Ph.D. Programs
   Foundation of Ministry of Education [20090072110035]; Program of
   Shanghai Subject Chief Scientist [10XD1404400]; State Key Laboratory of
   High-end Server & Storage Technology [2009HSSA06]; Education Department
   of Jiangxi province of China [GJJ09263]
FX The authors would like to thank the editor and the anonymous reviewers
   for their insightful and constructive comments that have helped us to
   significantly improve the presentation. This work was supported by the
   National High-Tech Research and Development Plan of China (863 Program)
   under Grant No. 2007AA01Z425 and No. 2009AA012201, the National Grand
   Fundamental Research Program of China (973 Program) under Grant No.
   2007CB316502, the National Natural Science Foundation Major Research
   Project of China under Grant No. 90718015, the Joint of NSFC and
   Microsoft Asia Research under Grant No. 60970155, the Ph.D. Programs
   Foundation of Ministry of Education under Grant No. 20090072110035, the
   Program of Shanghai Subject Chief Scientist under Grant No. 10XD1404400,
   the State Key Laboratory of High-end Server & Storage Technology under
   Grant No. 2009HSSA06, the Scientific Research Plan Projects of Education
   Department of Jiangxi province of China under Grant No. GJJ09263.
CR Aguirre N, 2002, ASE 2002: 17TH IEEE INTERNATIONAL CONFERENCE ON AUTOMATED SOFTWARE ENGINEERING, P271, DOI 10.1109/ASE.2002.1115028
   Allen R, 1998, LECT NOTES COMPUT SC, V1382, P21
   ALLEN RJ, 1997, THESIS CARNEGIE MELL
   Bradbury J. S., 2004, 2004477 QUEENS U
   Bruni R, 2008, ELECTRON NOTES THEOR, V213, P39, DOI 10.1016/j.entcs.2008.04.073
   BUCCHIARONE A, 2008, THESIS IMT I ADV STU
   Bucchiarone A, 2009, 2009 JOINT WORKING IEEE/IFIP CONFERENCE ON SOFTWARE ARCHITECTURE AND EUROPEAN CONFERENCE ON SOFTWARE ARCHITECTURE, P181, DOI 10.1109/WICSA.2009.5290804
   CANAL C, 1999, P TC2 1 WORK IFIP C, P107
   Clarke E. M., 2000, MODEL CHECKING
   CORTELLESSA V, 2004, WORKSH SOFTW ARCH DE
   DAVID PC, 2006, OBJET, V12, P113
   EHRIG H, 2010, LNCS, P139
   ENDLER M, 1994, P 12 BRAZ S COMP NET, P175
   GANG H, 2004, SCI CHINA SER F, V47, P555
   Gomaa H, 2004, FOURTH WORKING IEEE/IFIP CONFERENCE ON SOFTWARE ARCHITECTURE (WICSA 2004), PROCEEDINGS, P79, DOI 10.1109/WICSA.2004.1310692
   Grunske L., 2003, P 7 INT C SOFTW ENG, P613
   HIRSCH D, 2004, ELECT NOTES THEORETI, V109, P97
   KACEM MH, 2006, P S APPL COMP, P1245
   KACEM MH, 2005, COEA 2005, P25
   Magee J., 1996, P 4 ACM SIGSOFT S FD, P3, DOI DOI 10.1145/239098.239104
   Medvidovic N, 2002, ACM T SOFTW ENG METH, V11, P2, DOI 10.1145/504087.504088
   METAYER DL, 1998, IEEE T SOFTWARE ENG, V24, P521
   Oquendo F., 2004, ACM SIGSOFT SOFTWARE, V29, P1, DOI DOI 10.1145/986710.986728
   Oreizy P, 1998, PROC INT CONF SOFTW, P177, DOI 10.1109/ICSE.1998.671114
   Perry DE, 1992, ACM SIGSOFT SOFTWARE, V17, P40, DOI DOI 10.1145/141874.141884
   Riemenschneider RA, 2004, IEEE INTELL SYST, V19, P62, DOI 10.1109/MIS.2004.54
   Shaw M, 1996, SOFTWARE ARCHITECTUR
   Vergnaud T, 2005, LECT NOTES COMPUT SC, V3555, P67
   Wang QX, 2003, 27TH ANNUAL INTERNATIONAL COMPUTER SOFTWARE AND APPLICATIONS CONFERENCE, PROCEEDINGS, P230, DOI 10.1109/CMPSAC.2003.1245346
   Wang Ying-hui, 2005, Acta Electronica Sinica, V33, P1381
   WILE D, 2001, P WORK C COMPL DYN S
NR 31
TC 2
Z9 4
U1 2
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1383-7621
EI 1873-6165
J9 J SYST ARCHITECT
JI J. Syst. Architect.
PD OCT
PY 2010
VL 56
IS 10
BP 523
EP 533
DI 10.1016/j.sysarc.2010.08.005
PG 11
WC Computer Science, Hardware & Architecture; Computer Science, Software
   Engineering
SC Computer Science
GA 684SW
UT WOS:000284570600004
DA 2018-12-27
ER

PT J
AU Walumbwa, FO
   Wang, P
   Wang, H
   Schaubroeck, J
   Avolio, BJ
AF Walumbwa, Fred O.
   Wang, Peng
   Wang, Hui
   Schaubroeck, John
   Avolio, Bruce J.
TI RETRACTED: Psychological processes linking authentic leadership to
   follower behaviors (Retracted article. See vol. 25, pg. 1071, 2014)
SO LEADERSHIP QUARTERLY
LA English
DT Article; Retracted Publication
DE Authentic leadership; Empowerment; Identification; Engagement;
   Organizational citizenship behavior
ID ORGANIZATIONAL CITIZENSHIP BEHAVIORS; SOCIAL IDENTITY THEORY; EMPLOYEE
   ENGAGEMENT; TRANSFORMATIONAL LEADERSHIP; MEMBER EXCHANGE; ETHICAL
   LEADERSHIP; MEDIATING ROLE; EMPOWERMENT; PERFORMANCE; SELF
AB We examined the direct and indirect effect of authentic leadership behavior on the organizational citizenship behavior and work engagement of followers. With 387 employees and their 129 immediate supervisors, hierarchical linear modeling (HLM) results revealed that authentic leadership behavior was positively related to supervisor-rated organizational citizenship behavior and work engagement, controlling for ideal power distance, company type, and followers' demographics such as age and sex. These relationships were mediated by the followers' level of identification with the supervisor and their feelings of empowerment. We discuss the implications of these findings for theory, research and practice. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Walumbwa, Fred O.] Arizona State Univ, WP Carey Sch Business, Dept Management, Tempe, AZ 85287 USA.
   [Wang, Peng] Miami Univ, Oxford, OH 45056 USA.
   [Wang, Hui] Peking Univ, Beijing 100871, Peoples R China.
   [Schaubroeck, John] Michigan State Univ, E Lansing, MI 48824 USA.
   [Avolio, Bruce J.] Univ Washington, Seattle, WA 98195 USA.
RP Walumbwa, FO (reprint author), Arizona State Univ, WP Carey Sch Business, Dept Management, Tempe, AZ 85287 USA.
EM Fred.Walumbwa@asu.edu
RI Schaubroeck, John/L-3255-2013
OI Schaubroeck, John/0000-0001-9204-3603
CR Aditya R. N., 1997, NEW PERSPECTIVES INT, P535
   Alge BJ, 2006, J APPL PSYCHOL, V91, P221, DOI 10.1037/0021-9010.91.1.221
   Aryee S, 2006, J BUS RES, V59, P793, DOI 10.1016/j.jbusres.2005.03.003
   ASHFORTH BE, 1989, ACAD MANAGE REV, V14, P20, DOI 10.2307/258189
   Avery DR, 2007, J APPL PSYCHOL, V92, P1542, DOI 10.1037/0021-9010.92.6.1542
   Avolio BJ, 2005, LEADERSHIP QUART, V16, P315, DOI 10.1016/j.leaqua.2005.03.001
   Avolio BJ, 2004, LEADERSHIP QUART, V15, P801, DOI 10.1016/j.leaqua.2004.09.003
   Bandura A, 1977, SOCIAL LEARNING THEO
   Bliese P. D, 2000, MULTILEVEL THEORY RE, P349
   Bliese PD, 1998, ORGAN RES METHODS, V1, P355, DOI 10.1177/109442819814001
   Bono JE, 2003, ACAD MANAGE J, V46, P554, DOI 10.2307/30040649
   Brislin R., 1980, HDB CROSS CULTURAL P, P389
   Brockner J, 2001, J EXP SOC PSYCHOL, V37, P300, DOI 10.1006/jesp.2000.1451
   Brown ME, 2005, ORGAN BEHAV HUM DEC, V97, P117, DOI 10.1016/j.obhdp.2005.03.002
   Chen G, 2003, ACAD MANAGE J, V46, P591, DOI 10.2307/30040651
   Chen G, 2007, J APPL PSYCHOL, V92, P331, DOI 10.1037/0021-9010.92.2.331
   Chen GL, 2002, J APPL PSYCHOL, V87, P549, DOI 10.1037//0021-9010.87.3.549
   CONGER JA, 1988, ACAD MANAGE REV, V13, P471, DOI 10.2307/258093
   Dalal RS, 2008, IND ORGAN PSYCHOL-US, V1, P52, DOI 10.1111/j.1754-9434.2007.00008.x
   DAWIS RV, 1992, J COUNS PSYCHOL, V39, P7, DOI 10.1037/0022-0167.39.1.7
   De Cremer David, 2005, LEADERSHIP ORG DEV J, V26, P355, DOI DOI 10.1108/01437730510607853
   Dorfman P., 2004, HDB INT MANAGEMENT R, P265
   Gardner WL, 2005, LEADERSHIP QUART, V16, P343, DOI 10.1016/j.leaqua.2005.03.003
   George W, 2003, AUTHENTIC LEADERSHIP
   Harter JK, 2008, IND ORGAN PSYCHOL-US, V1, P36, DOI 10.1111/j.1754-9434.2007.00004.x
   Harter JK, 2002, J APPL PSYCHOL, V87, P268, DOI 10.1037/0021-9010.87.2.268
   Harter S., 2002, HDB POSITIVE PSYCHOL, P382
   Hofmann DA, 1998, J MANAGE, V24, P623, DOI 10.1177/014920639802400504
   Hofstede G. H., 2005, CULTURES ORG SOFTWAR
   Hogg MA, 2005, PERS SOC PSYCHOL B, V31, P991, DOI 10.1177/0146167204273098
   Ilies R, 2005, LEADERSHIP QUART, V16, P373, DOI 10.1016/j.leaqua.2005.03.002
   Ilies R, 2007, J APPL PSYCHOL, V92, P269, DOI 10.1037/0021-9010.92.1.269
   JAMES LR, 1982, J APPL PSYCHOL, V67, P219, DOI 10.1037//0021-9010.67.2.219
   JAMES LR, 1984, J APPL PSYCHOL, V69, P85, DOI 10.1037/0021-9010.69.1.85
   Judge TA, 1997, RES ORGAN BEHAV, V19, P151
   KAHN WA, 1990, ACAD MANAGE J, V33, P692, DOI 10.2307/256287
   Kark R, 2003, J APPL PSYCHOL, V88, P246, DOI 10.1037/0021-9010.88.2.246
   Kelman H. C, 1958, J CONFLICT RESOLUT, V2, P51, DOI [10.1177/002200275800200106, DOI 10.1177/002200275800200106]
   Kenny D. A., 1998, HDB SOCIAL PSYCHOL, P233, DOI DOI 10.1177/0146167208331253
   Kernis M. H., 2005, BUILDING DEFENDING R, P31
   Kernis MH, 2003, PSYCHOL INQ, V14, P1, DOI 10.1207/S15327965PLI1401_01
   Kirkman BL, 1999, ACAD MANAGE J, V42, P58, DOI 10.2307/256874
   Kozlowski S. W. J., 2000, MULTILEVEL THEORY RE, P3
   KOZLOWSKI SWJ, 1992, J APPL PSYCHOL, V77, P161, DOI 10.1037/0021-9010.77.2.161
   Kreiner GE, 2006, ACAD MANAGE J, V49, P1031, DOI 10.5465/AMJ.2006.22798186
   Lam SSK, 1999, J APPL PSYCHOL, V84, P594, DOI 10.1037//0021-9010.84.4.594
   Luthans F., 2006, HIGH IMPACT LEADER A
   Luthans F, 2005, MANAG ORGAN REV, V1, P249, DOI DOI 10.1111/J.1740-8784.2005.00011.X
   Luthans F, 2003, POSITIVE ORG SCHOLAR, P241
   Macey WH, 2008, IND ORGAN PSYCHOL-US, V1, P3, DOI 10.1111/j.1754-9434.2007.0002.x
   Masson RC, 2008, IND ORGAN PSYCHOL-US, V1, P56, DOI 10.1111/j.1754-9434.2007.00009.x
   Mayer DM, 2009, ORGAN BEHAV HUM DEC, V108, P1, DOI 10.1016/j.obhdp.2008.04.002
   Mayer RC, 2005, ACAD MANAGE J, V48, P874
   Organ D. W., 2006, ORG CITIZENSHIP BEHA
   Podsakoff P., 1990, LEADERSHIP QUART, V1, P107, DOI DOI 10.1016/1048-9843(90)90009-7
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9101.88.5.879
   Podsakoff PM, 2000, J MANAGE, V26, P513, DOI 10.1177/014920630002600306
   Pratt M.G, 1998, IDENTITY ORG BUILDIN, P171, DOI DOI 10.4135/9781452231495.N6
   Ralston DA, 1999, J INT BUS STUD, V30, P415, DOI 10.1057/palgrave.jibs.8490077
   Raudenbush S. W., 2002, HIERARCHICAL LINEAR
   Saks AM, 2008, IND ORGAN PSYCHOL-US, V1, P40, DOI 10.1111/j.1754-9434.2007.00005.x
   Schaubroeck J, 2007, J APPL PSYCHOL, V92, P1020, DOI 10.1037/0021-9010.92.4.1020
   Schaufeli WB, 2004, J ORGAN BEHAV, V25, P293, DOI 10.1002/job.248
   Schneider B, 2005, ACAD MANAGE J, V48, P1017, DOI 10.5465/AMJ.2005.19573107
   Seibert SE, 2004, ACAD MANAGE J, V47, P332, DOI 10.2307/20159585
   SIROTNIK KA, 1980, J EDUC MEAS, V17, P245, DOI 10.1111/j.1745-3984.1980.tb00831.x
   Sluss DM, 2007, ACAD MANAGE REV, V32, P9
   Sparrowe RT, 2005, LEADERSHIP QUART, V16, P419, DOI 10.1016/j.leaqua.2005.03.004
   Spreitzer GM, 1996, ACAD MANAGE J, V39, P483, DOI 10.2307/256789
   Spreitzer GM, 1997, J MANAGE, V23, P679, DOI 10.1177/014920639702300504
   SPREITZER GM, 1995, ACAD MANAGE J, V38, P1442, DOI 10.2307/256865
   THOMAS KW, 1990, ACAD MANAGE REV, V15, P666, DOI 10.2307/258687
   Tsui A.S., 2002, MANAGEMENT ENTERPRIS
   Van Dyne L, 1998, ACAD MANAGE J, V41, P108, DOI 10.2307/256902
   van Knippenberg D, 2004, LEADERSHIP QUART, V15, P825, DOI 10.1016/j.leaqua.2004.09.002
   Walumbwa FO, 2008, J MANAGE, V34, P89, DOI 10.1177/0149206307308913
   Wang H, 2005, ACAD MANAGE J, V48, P420
   Wat D, 2005, PERS REV, V34, P406, DOI 10.1108/00483480510599752
   Zhu WC, 2009, GROUP ORGAN MANAGE, V34, P590, DOI 10.1177/1059601108331242
NR 79
TC 158
Z9 162
U1 9
U2 210
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1048-9843
EI 1873-3409
J9 LEADERSHIP QUART
JI Leadersh. Q.
PD OCT
PY 2010
VL 21
IS 5
BP 901
EP 914
DI 10.1016/j.leaqua.2010.07.015
PG 14
WC Psychology, Applied; Management
SC Psychology; Business & Economics
GA 677UY
UT WOS:000284018600015
DA 2018-12-27
ER

PT J
AU Daghighi, Y
   Li, DQ
AF Daghighi, Yasaman
   Li, Dongqing
TI RETRACTED: Induced-charge electrokinetic phenomena (Retracted article.
   See vol. 13, pg. 695, 2012)
SO MICROFLUIDICS AND NANOFLUIDICS
LA English
DT Review; Retracted Publication
DE Induced-charge electrokinetic phenomena; Polarisable surfaces/particles;
   Conductive surfaces/particles; Heterogeneous (Janus) particles;
   Electro-osmotic; Electrophoresis
ID IDEALLY POLARIZABLE PARTICLES; AC ELECTRIC-FIELDS; ELECTROPHORETIC
   MOTION; HYDRODYNAMIC INTERACTION; PAIR INTERACTION; DOUBLE-LAYER;
   FLUID-FLOW; DISPERSE PARTICLES; ELCTROOSMOSIS; MICROCHANNEL
AB The induced-charge electrokinetic (ICEK) phenomena are relatively new area of research in microfluidics and nanofluidics. Different from the traditional electrokinetic phenomena which are based on the interactions between applied electric field and the electrostatic charge, the ICEK phenomena result from the interaction of the applied electric field and the induced charge on polarisable surfaces. Because of the different underline physics, ICEK phenomena have many unique characteristics that may lead to new applications in microfluidics and nanofluidics. In this paper, we review the major advancement of research in the field of ICEK phenomena, discuss the applications and the limitations, and suggest some future research directions.
C1 [Daghighi, Yasaman; Li, Dongqing] Univ Waterloo, Dept Mech & Mechatron Engn, Waterloo, ON N2L 3G1, Canada.
RP Li, DQ (reprint author), Univ Waterloo, Dept Mech & Mechatron Engn, Waterloo, ON N2L 3G1, Canada.
EM dongqing@mme.uwaterloo.ca
FU Natural Sciences and Engineering Research Council (NSERC) of Canada
FX The authors wish to thank the financial support of the Natural Sciences
   and Engineering Research Council (NSERC) of Canada through a research
   grant to D. Li.
CR Ajdari A., 2000, PHYS REV E, V61, P45
   ANDERSON JL, 1989, ANNU REV FLUID MECH, V21, P61
   Bard A.J., 2001, ELECTROCHEMICAL METH
   Bazant MZ, 2006, LAB CHIP, V6, P1455, DOI 10.1039/b608092h
   Bazant MZ, 2009, ADV COLLOID INTERFAC, V152, P48, DOI 10.1016/j.cis.2009.10.001
   Bazant MZ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.066101
   BAZANT MZ, 2010, CURR OPIN C IN PRESS
   BAZANT MZ, 2008, ENCY MICROFLUIDICS N, V14, P1461
   Ben Y, 2002, J FLUID MECH, V461, P229, DOI 10.1017/S0022112002008662
   BIKERMAN JJ, 1940, T FARADAY SOC, V36, P154
   Brown ABD, 2001, PHYS REV E, V63
   Burch D, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.055303
   Chu KT, 2007, J COLLOID INTERF SCI, V315, P319, DOI 10.1016/j.jcis.2007.06.024
   Chu KT, 2005, SIAM J APPL MATH, V65, P1485, DOI 10.1137/040609926
   DUKHIN AS, 1986, COLLOID J USSR+, V48, P203
   DUKHIN AS, 1986, COLLOID J USSR+, V48, P376
   DUKHIN AS, 1993, COLLOID SURFACE A, V73, P29, DOI 10.1016/0927-7757(93)80005-Y
   Dukhin S. S., 1974, SURF COLLOID SCI, V7
   Gamayunov N.I., 1992, J COLLOID, V54, P26
   GAMAYUNOV NI, 1986, COLLOID J USSR+, V48, P197
   Gangwal S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.058302
   Gonzalez A, 2000, PHYS REV E, V61, P4019, DOI 10.1103/PhysRevE.61.4019
   GONZALEZ A, 2008, IEEE INT C DIEL LIQ, P1, DOI DOI 10.1109/ICDL2008.4622452
   Green NG, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026305
   Green NG, 2000, PHYS REV E, V61, P4011, DOI 10.1103/PhysRevE.61.4011
   Gregersen M. M., 2009, NEW J PHYS, V11
   Harnett CK, 2008, LAB CHIP, V8, P565, DOI 10.1039/b717416k
   Hoffman BD, 2009, J FLUID MECH, V624, P361, DOI 10.1017/S0022112008005405
   Hunter R. J., 2001, FDN COLLOID SCI
   Hunter R. J. R. J, 1981, ZETA POTENTIAL COLLO
   Khair AS, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2963507
   KILIC MS, 2007, ARXIV07120453
   Laser D. J., 2004, J MICROMECH MICROENG, V14, P35
   Levich V. G, 1962, PHYSICOCHEMICAL HYDR
   Levitan JA, 2005, COLLOID SURFACE A, V267, P122, DOI 10.1016/j.colsurfa.2005.06.050
   Li D., 2008, ENCY MICROFLUIDICS N
   LID, 2004, ELECTROKINETICS MICR
   Long D, 1998, PHYS REV LETT, V81, P1529, DOI 10.1103/PhysRevLett.81.1529
   Lyklema J. J., 1995, FUNDAMENTALS INTERFA, V2
   Mansuripur TS, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/7/075030
   MISHCHUK NA, 1995, COLLOID SURFACE A, V95, P119, DOI 10.1016/0927-7757(94)02988-5
   Murtsovkin VA, 1996, COLLOID J+, V58, P341
   Olesen LH, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.056313
   OLESEN LH, 2006, THESIS DANISH TU
   OLESEN LH, 2009, PHYS FLUID DYN
   Pascall AJ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.088301
   Ramos A, 1999, J COLLOID INTERF SCI, V217, P420, DOI 10.1006/jcis.1999.6346
   ROSE KA, 1967, PHYS REV E, V75
   RUBINSTEIN I, 1979, J CHEM SOC FARAD T 2, V75, P231, DOI 10.1039/f29797500231
   Saintillan D, 2006, J FLUID MECH, V563, P223, DOI 10.1017/S0022112006001376
   Saintillan D, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2931689
   Saintillan D, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2396913
   SAVILLE DA, 1977, ANNU REV FLUID MECH, V9, P321, DOI 10.1146/annurev.fl.09.010177.001541
   Schoch RB, 2008, REV MOD PHYS, V80, P839, DOI 10.1103/RevModPhys.80.839
   SIMONOV IN, 1973, COLLOID J USSR+, V35, P191
   SONI G, 2007, MICROTOTAL ANAL SYST, V1, P291
   Squires TM, 2004, J FLUID MECH, V509, P217, DOI 10.1017/S0022112004009309
   Squires TM, 2006, J FLUID MECH, V560, P65, DOI 10.1017/S0022112006000371
   Squires TM, 2009, LAB CHIP, V9, P2477, DOI 10.1039/b906909g
   Stone H. A., 2004, ANNU REV FLUID MECH, V36
   Studer V, 2004, ANALYST, V129, P944, DOI 10.1039/b408382m
   Suh Y. K., 2008, PHYS REV E, V77
   Thamida SK, 2002, PHYS FLUIDS, V14, P4315, DOI 10.1063/1.1519530
   Urbanski JP, 2007, J COLLOID INTERF SCI, V309, P332, DOI 10.1016/j.jcis.2007.01.095
   URBANSKI JP, 2006, APPL PHYS LETT, V89
   Wang SC, 2006, BIOSENS BIOELECTRON, V22, P563, DOI 10.1016/j.bios.2006.05.032
   Wu J, 2008, IET NANOBIOTECHNOL, V2, P14, DOI 10.1049/iet-nbt:20070023
   Wu J, 2006, IEEE T NANOTECHNOL, V5, P84, DOI 10.1109/TNANO.2006.869645
   Wu ZM, 2008, ELECTROCHIM ACTA, V53, P5827, DOI 10.1016/j.electacta.2008.03.039
   Wu ZM, 2008, MICROFLUID NANOFLUID, V5, P65, DOI 10.1007/s10404-007-0227-7
   Wu ZM, 2009, ELECTROCHIM ACTA, V54, P3960, DOI 10.1016/j.electacta.2009.02.016
   Wu Z, 2009, ELECTROPHORESIS, V30, P773, DOI 10.1002/elps.200800381
   Yariv E, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1900823
   Yariv E, 2008, J FLUID MECH, V613, P85, DOI 10.1017/S0022112008003327
   Yariv E, 2009, P R SOC A, V465, P709, DOI 10.1098/rspa.2008.0322
   Ye CZ, 2004, J COLLOID INTERF SCI, V272, P480, DOI 10.1016/j.jcis.2003.11.014
   Yossifon G, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2746847
   Yossifon G, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2391701
   Zaltzman B, 2007, J FLUID MECH, V579, P173, DOI 10.1017/S0022112007004880
   Zhao H, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.066217
   Zhao H, 2007, LANGMUIR, V23, P4053, DOI 10.1021/la063224p
NR 81
TC 13
Z9 14
U1 4
U2 43
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1613-4982
J9 MICROFLUID NANOFLUID
JI Microfluid. Nanofluid.
PD OCT
PY 2010
VL 9
IS 4-5
BP 593
EP 611
DI 10.1007/s10404-010-0607-2
PG 19
WC Nanoscience & Nanotechnology; Instruments & Instrumentation; Physics,
   Fluids & Plasmas
SC Science & Technology - Other Topics; Instruments & Instrumentation;
   Physics
GA 645RW
UT WOS:000281483400001
DA 2018-12-27
ER

PT J
AU Reuter, S
   Prasad, S
   Phromnoi, K
   Kannappan, R
   Yadav, VR
   Aggarwal, BB
AF Reuter, Simone
   Prasad, Sahdeo
   Phromnoi, Kanokkarn
   Kannappan, Ramaswamy
   Yadav, Vivek R.
   Aggarwal, Bharat B.
TI RETRACTED: Embelin Suppresses Osteoclastogenesis Induced by Receptor
   Activator of NF-KB Ligand and Tumor Cells In vitro through Inhibition of
   the NF-KB Cell Signaling Pathway (Retracted article. See vol. 16, pg.
   1443, 2018)
SO MOLECULAR CANCER RESEARCH
LA English
DT Article; Retracted Publication
ID FACTOR-KAPPA-B; OSTEOLYTIC BONE METASTASIS; MULTIPLE-MYELOMA;
   BREAST-CANCER; BLOCKS OSTEOCLASTOGENESIS; INFLAMMATORY ARTHRITIS;
   GENE-PRODUCTS; EXPRESSION; APOPTOSIS; DISEASE
AB Most patients with cancer die not because of the tumor in the primary site, but because it has spread to other sites. Common tumors, such as breast, multiple myeloma, and prostate tumors, frequently metastasize to the bone. It is now well recognized that osteoclasts are responsible for the osteolysis observed in bone metastases of the tumor. Receptor activator of NF-kappa B ligand (RANKL), a member of the tumor necrosis factor superfamily and an activator of the NF-kappa B signaling pathway, has emerged as a major mediator of bone loss, commonly associated with cancer and other chronic inflammatory diseases. Embelin (2,5-dihydroxy-3-undecyl-1,4-benzoquinone), derived from the Ayurvedic medicinal plant Embelia ribes, has been shown to bind and inhibit X-linked inhibitor of apoptosis protein and inhibit inflammatory pathways. We investigated whether embelin could inhibit osteoclastogenesis-associated bone loss induced by RANKL and by tumor cells in vitro. We found that embelin suppressed the RANKL-induced differentiation of monocytes into osteoclasts. This benzoquinone also suppressed the osteoclastogenesis induced by multiple myeloma and by breast cancer cells. This effect of embelin correlated with the suppression of NF-kappa B activation and inhibition of I kappa B alpha phosphorylation and I kappa B alpha degradation. Inhibition of I kappa B alpha phosphorylation was due to the inhibition of I kappa B alpha kinase (IKK) activation. Furthermore, by using an inhibitor of the IKK gamma or NF-kappa B essential modulator (NEMO), the regulatory component of the IKK complex, we showed that the NF-kappa B signaling pathway is mandatory for RAW 264.7 cell differentiation into osteoclasts. Thus, embelin, an inhibitor of RANKL-induced NF-kappa B activation has great potential as a therapeutic agent for osteoporosis and cancer-linked bone loss. Mol Cancer Res; 8(10); 1425-36. (C) 2010 AACR.
C1 [Reuter, Simone; Prasad, Sahdeo; Phromnoi, Kanokkarn; Kannappan, Ramaswamy; Yadav, Vivek R.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, Houston, TX 77030 USA.
RP Aggarwal, BB (reprint author), Univ Texas MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, 1515 Holcombe Blvd,Box 143, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI Aggarwal, Bharat/G-3388-2013
FU NIH [CA-16 672, CA-124787-01A2]; Center for Targeted Therapy at The
   University of Texas MD Anderson Cancer Center; Fonds National de la
   Recherche Luxembourg [PDR-08-017]
FX M.D. Anderson Cancer Center Support Grant from the NIH (CA-16 672), a
   program project grant from the NIH (CA-124787-01A2), and a grant from
   the Center for Targeted Therapy at The University of Texas MD Anderson
   Cancer Center, where Dr. Aggarwal is the Ransom Horne, Jr., Professor of
   Cancer Research. Dr Simone Reuter was supported by a grant from the
   Fonds National de la Recherche Luxembourg (PDR-08-017).
CR Abu-Amer Y, 2001, J BIOL CHEM, V276, P30499, DOI 10.1074/jbc.M104725200
   Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003
   Ahn KS, 2007, MOL PHARMACOL, V71, P209, DOI 10.1124/mol.106.028787
   Bharti AC, 2004, BLOOD, V103, P3175, DOI 10.1182/blood-2003-06-2151
   Bharti AC, 2004, APOPTOSIS, V9, P677, DOI 10.1023/B:APPT.0000045780.10463.c6
   Bhatia P, 2005, CLIN CANCER RES, V11, P162
   Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101
   Body JJ, 2006, CLIN CANCER RES, V12, P1221, DOI 10.1158/1078-0432.CCR-05-1933
   Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658
   Canon JR, 2008, CLIN EXP METASTAS, V25, P119, DOI 10.1007/s10585-007-9127-1
   Carlin Bruce I., 2000, Cancer, V88, P2989, DOI 10.1002/1097-0142(20000615)88:12+<2989::AID-CNCR14>3.3.CO;2-H
   Cartsos VM, 2008, J AM DENT ASSOC, V139, P23, DOI 10.14219/jada.archive.2008.0016
   Chaisson ML, 2004, J BIOL CHEM, V279, P54841, DOI 10.1074/jbc.M406392200
   Chappard D., 2008, Morphologie, V92, P162, DOI 10.1016/j.morpho.2008.10.003
   CHITRA M, 1994, CHEMOTHERAPY, V40, P109, DOI 10.1159/000239181
   Clohisy JC, 2003, J IMMUNOL, V171, P5547, DOI 10.4049/jimmunol.171.10.5547
   Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2001.0210
   Dai S, 2004, J BIOL CHEM, V279, P37219, DOI 10.1074/jbc.C400258200
   DALLACKER F, 1972, CHEM BER-RECL, V105, P614, DOI 10.1002/cber.19721050227
   DU Y C, 1963, Yao Xue Xue Bao, V10, P578
   Farrugia AN, 2003, CANCER RES, V63, P5438
   Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482
   Gevorgyan A, 2008, CURR OPIN OTOLARYNGO, V16, P325, DOI 10.1097/MOO.0b013e328304b445
   Giuliani N, 2001, BLOOD, V98, P3527, DOI 10.1182/blood.V98.13.3527
   Giuliani N, 2002, BLOOD, V100, P4615, DOI 10.1182/blood-2002-04-1121
   GUPTA O P, 1977, Indian Journal of Physiology and Pharmacology, V21, P31
   Heider U, 2003, CLIN CANCER RES, V9, P1436
   Hoff AO, 2008, J BONE MINER RES, V23, P826, DOI [10.1359/jbmr.080205, 10.1359/JBMR.080205]
   Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540
   Hughes DE, 1997, J CLIN PATHOL-MOL PA, V50, P132, DOI 10.1136/mp.50.3.132
   Hunt NCA, 2001, BRIT J CANCER, V85, P78, DOI 10.1054/bjoc.2001.1856
   Idris AI, 2009, MOL CANCER THER, V8, P2339, DOI 10.1158/1535-7163.MCT-09-0133
   Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054
   Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8
   Lai FPL, 2004, BRIT J HAEMATOL, V126, P192, DOI 10.1111/j.1365-2141.2004.05018.x
   Mariotti A, 2008, J DENT EDUC, V72, P919
   Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333
   Pandey MK, 2007, J BIOL CHEM, V282, P17340, DOI 10.1074/jbc.C700890200
   Parfitt AM, 1996, J BONE MINER RES, V11, P150
   Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519
   Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498
   Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831
   Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081
   Sung B, 2007, MOL PHARMACOL, V71, P1703, DOI 10.1124/mol.107.034512
   Tada T, 2005, INT J CANCER, V116, P253, DOI 10.1002/ijc.21008
   Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x
   Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122
   Wei S, 2001, ENDOCRINOLOGY, V142, P1290, DOI 10.1210/en.142.3.1290
   Yavropoulou M. P., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P204
   Zheng H, 2006, J BIOL CHEM, V281, P15809, DOI 10.1074/jbc.M513225200
NR 50
TC 29
Z9 36
U1 1
U2 3
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1541-7786
EI 1557-3125
J9 MOL CANCER RES
JI Mol. Cancer Res.
PD OCT
PY 2010
VL 8
IS 10
BP 1425
EP 1436
DI 10.1158/1541-7786.MCR-10-0141
PG 12
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA 665SK
UT WOS:000283055600011
PM 20826545
OA Green Accepted, Bronze
DA 2018-12-27
ER

PT J
AU Xiao, HY
   Zhang, QB
   Shen, JK
   Bindokas, V
   Xing, HR
AF Xiao, Hongyan
   Zhang, Qingbei
   Shen, Jikun
   Bindokas, Vytas
   Xing, H. Rosie
TI RETRACTED: Pharmacologic Inactivation of Kinase Suppressor of Ras1
   Sensitizes Epidermal Growth Factor Receptor and Oncogenic Ras-Dependent
   Tumors to Ionizing Radiation Treatment (Retracted article. See vol. 15,
   pg. 343, 2016)
SO MOLECULAR CANCER THERAPEUTICS
LA English
DT Article; Retracted Publication
ID ACTIVATED PROTEIN-KINASE; HISTONE H2AX PHOSPHORYLATION; KSR-1 GENE
   ENCODES; CARCINOMA-CELLS; SIGNAL-TRANSDUCTION; MISMATCH-REPAIR;
   C-ELEGANS; DNA; EXPRESSION; PATHWAY
AB Selective enhancement of tumor response to radiation therapy is a highly attractive objective, but it has not been met clinically. Gain-of-function Ras (gf) signaling via hyperactivation of receptor tyrosine kinases, such as the epidermal growth factor receptor (EGFR), or via oncogenic mutation of Ras is shown to confer radioresistance and requires the engagement of the Raf/MEK/ERK pathway. However, upstream mediators of such interaction in cancer cells that could be targeted for radiosensitization have not been identified and characterized. Here, we provide original observations both in vitro and in vivo that kinase suppressor of Ras1 (KSR1) is a new target for reversing gf Ras-mediated radioresistance. We employed EGFR-dependent A431 squamous cell carcinoma (SCC) and genetically defined the molecular function of KSR1 in irradiation-induced Raf/MEK/ERK activation. In vitro KSR1 inactivation via genetic inhibition of its expression or kinase function abrogated ionizing radiation-induced activation of the Raf/MEK/ERK2 cascade, enhanced the cytotoxic effect of radiation, and achieved radiosensitization associated with inhibition of DNA damage repair and enhancement of clonogenic death. In vivo pharmacologic inactivation of KSR1 by KSR1 AS-ODN infusion leads to radiosensitization in EGFR-dependent A431 SCC and in oncogenic K-Ras-driven A549 human non-small cell lung carcinoma. These observations collectively establish KSR1 as a novel target for radiosensitization and show the feasibility of using KSR1 AS-ODN as a radiosensitizer for treating gf Ras-dependent human malignancies. Identification of such mediators of gf Ras signaling in response to irradiation holds promises for improving the therapeutic efficacy of radiation therapy and our ability to eradicate tumor. Mol Cancer Ther; 9(10); 2724-36. (C) 2010 AACR.
C1 [Xiao, Hongyan; Zhang, Qingbei; Shen, Jikun; Xing, H. Rosie] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA.
   [Xiao, Hongyan; Zhang, Qingbei; Shen, Jikun; Xing, H. Rosie] Univ Chicago, Radiat Dept, Chicago, IL 60637 USA.
   [Xiao, Hongyan; Zhang, Qingbei; Shen, Jikun; Xing, H. Rosie] Univ Chicago, Dept Cellular Oncol, Chicago, IL 60637 USA.
   [Xing, H. Rosie] Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA.
   [Xing, H. Rosie] Univ Chicago, Univ Chicago Canc Ctr, Chicago, IL 60637 USA.
   [Bindokas, Vytas] Univ Chicago, Integrated Microscopy Core, Chicago, IL 60637 USA.
RP Xing, HR (reprint author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave,N339,MC1089, Chicago, IL 60637 USA.
EM hxing@bsd.uchicago.edu
FU  [CA089022]
FX CA089022 (H. R. Xing).
CR Bernhard EJ, 2000, CANCER RES, V60, P6597
   Camp ER, 2005, CLIN CANCER RES, V11, P397
   Camphausen K, 2004, CANCER RES, V64, P316, DOI 10.1158/0008-5472.CAN-03-2630
   Chinnaiyan P, 2005, CANCER RES, V65, P3328, DOI 10.1158/0008-5472.CAN-04-3547
   Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012
   Contessa JN, 2002, ONCOGENE, V21, P4032, DOI 10.1038/sj.onc.1205500
   Dent Paul, 2003, Methods Mol Biol, V222, P269
   Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200
   French AJ, 2008, CLIN CANCER RES, V14, P3408, DOI 10.1158/1078-0432.CCR-07-1489
   Friedmann BJ, 2006, MOL CANCER THER, V5, P209, DOI 10.1158/1535-7163.MCT-05-0239
   Golding SE, 2007, CANCER RES, V67, P1046, DOI 10.1158/0008-5472.CAN-06-2371
   Gupta AK, 2000, RADIAT RES, V154, P64, DOI 10.1667/0033-7587(2000)154[0064:RMRRIN]2.0.CO;2
   KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6
   Lammering G, 2003, ONCOGENE, V22, P5545, DOI 10.1038/sj.onc.1206788
   Lee M, 2007, J CELL BIOCHEM, V101, P488, DOI 10.1002/jcb.21199
   LIN CR, 1984, SCIENCE, V224, P843, DOI 10.1126/science.6326261
   Lozano J, 2003, CANCER RES, V63, P4232
   MERLINO GT, 1984, SCIENCE, V224, P417, DOI 10.1126/science.6200934
   Michaud NR, 1997, P NATL ACAD SCI USA, V94, P12792, DOI 10.1073/pnas.94.24.12792
   Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853
   Munshi A, 2005, CLIN CANCER RES, V11, P4912, DOI 10.1158/1078-0432.CCR-04-2088
   Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002
   Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a
   Ritt DA, 2006, METHOD ENZYMOL, V407, P224, DOI 10.1016/S0076-6879(05)07019-9
   Rodemann HP, 2007, INT J RADIAT BIOL, V83, P781, DOI 10.1080/09553000701769970
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   SchmidtUllrich RK, 1997, ONCOGENE, V15, P1191, DOI 10.1038/sj.onc.1201275
   Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2
   Stewart S, 1999, MOL CELL BIOL, V19, P5523
   SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8
   Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200
   THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X
   Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684
   Tong T, 2001, EXP CELL RES, V269, P64, DOI 10.1006/excr.2001.5312
   ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0
   Wang XN, 2001, EXP CELL RES, V268, P294, DOI 10.1006/excr.2001.5292
   Weidhaas JB, 2006, CANCER RES, V66, P10434, DOI 10.1158/0008-5472.CAN-06-2182
   Xing HR, 2000, J BIOL CHEM, V275, P17276, DOI 10.1074/jbc.C900989199
   Xing HR, 2003, NAT MED, V9, P1266
   Xing HR, 2001, J BIOL CHEM, V276, P9733, DOI 10.1074/jbc.M008096200
   Xing RH, 1997, CANCER RES, V57, P3585
   Yacoub A, 2003, RADIAT RES, V159, P439, DOI 10.1667/0033-7587(2003)159[0439:EGFAIR]2.0.CO;2
   Yan F, 2004, J CLIN INVEST, V114, P1272, DOI 10.1172/JCI200421022
   Yan F, 2001, CANCER RES, V61, P8668
   Yin XL, 2009, CELL PHYSIOL BIOCHEM, V24, P219, DOI 10.1159/000233248
   Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X
   Zafrullah M, 2009, BIOCHEM BIOPH RES CO, V390, P434, DOI 10.1016/j.bbrc.2009.09.048
   Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X
NR 48
TC 8
Z9 9
U1 2
U2 6
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1535-7163
EI 1538-8514
J9 MOL CANCER THER
JI Mol. Cancer Ther.
PD OCT
PY 2010
VL 9
IS 10
BP 2724
EP 2736
DI 10.1158/1535-7163.MCT-10-0124
PG 13
WC Oncology
SC Oncology
GA 661JS
UT WOS:000282724600008
PM 20876746
OA Bronze
DA 2018-12-27
ER

PT J
AU Aziz, EF
   Rittmann-Frank, MH
   Lange, KM
   Bonhommeau, S
   Chergui, M
AF Aziz, Emad F.
   Rittmann-Frank, M. Hannelore
   Lange, Kathrin M.
   Bonhommeau, Sebastien
   Chergui, Majed
TI RETRACTED: Charge transfer to solvent identified using dark channel
   fluorescence-yield L-edge spectroscopy (Retracted article. See vol. 9,
   pg. 828, 2017)
SO NATURE CHEMISTRY
LA English
DT Article; Retracted Publication
ID X-RAY-ABSORPTION; EXCITED OPTICAL LUMINESCENCE; ELECTRON-YIELD; SPECTRA;
   WATER; CRYSTALS; XAS; FE
AB Aqueous ions are central to catalysis and biological function and play an important role in radiation biology as sources of damage-inducing electrons. Detailed knowledge of solute-solvent interactions is therefore crucial. For transition-metal ions, soft X-ray L-edge spectroscopy allows access to d orbitals, which are involved in chemical bonding. Using this technique, we show that the fluorescence-yield spectra of aqueous ionic species exhibit additional features compared with those of non-aqueous solvents. Some features dip below the fluorescence background of the solvent and this is rationalized by the competition between the fluorescence yields of the solute and solvent species, and between the solute radiative (fluorescence) and non-radiative channels; in particular, electron transfer to the water molecules. This method allows us to determine the nature, directionality and timescale of the electron transfer. Remarkably, we observe such features even for fully ligated metal atoms, which indicates a direct interaction with the water molecules.
C1 [Aziz, Emad F.; Rittmann-Frank, M. Hannelore; Lange, Kathrin M.] BESSY, Helmholtz Zentrum Berlin Mat & Energie, D-12489 Berlin, Germany.
   [Aziz, Emad F.; Rittmann-Frank, M. Hannelore; Chergui, Majed] Ecole Polytech Fed Lausanne, Lab Spect Ultrarapide, Fac Sci Base, ISC, CH-1015 Lausanne, Switzerland.
   [Bonhommeau, Sebastien] Univ Bordeaux 1, Inst Mol Sci, CNRS, UMR 5255, F-33405 Talence, France.
RP Aziz, EF (reprint author), BESSY, Helmholtz Zentrum Berlin Mat & Energie, Albert Einstein Str 15, D-12489 Berlin, Germany.
EM Aziz@helmholtz-berlin.de; Majed.Chergui@epfl.ch
RI Aziz, Emad/A-4463-2017
OI Aziz, Emad/0000-0003-1794-4350
FU Helmholtz-Gemeinschaft [VH-NG-635]; Swiss National Science Foundation
   [200021-116533/1, IZK0Z2-126024]; Swiss State Secretariat for Education
   and Research [COST CM0702]; Alexander von Humboldt Foundation
FX We thank F. de Groot for discussions. This work was supported by the
   Helmholtz-Gemeinschaft (the young investigator fund VH-NG-635), the
   Swiss National Science Foundation (grants 200021-116533/1 and
   IZK0Z2-126024) and the Swiss State Secretariat for Education and
   Research (COST CM0702). M.C. is grateful to the Alexander von Humboldt
   Foundation for support.
CR Aziz EF, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.075120
   Aziz EF, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2176616
   Aziz EF, 2008, NATURE, V455, P89, DOI 10.1038/nature07252
   Aziz EF, 2007, J PHYS CHEM B, V111, P4440, DOI 10.1021/jp070085r
   Aziz EF, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.068103
   Bergmann N, 2010, PHYS CHEM CHEM PHYS, V12, P4827, DOI 10.1039/b924245g
   Bonhommeau S, 2008, J PHYS CHEM B, V112, P12571, DOI 10.1021/jp8071266
   Cannizzo A, 2006, ANGEW CHEM INT EDIT, V45, P3174, DOI 10.1002/anie.200600125
   de Groot F, 2008, ADV CONDENS MAT SCI, V6, P1
   DEGROOT FMF, 1994, SOLID STATE COMMUN, V92, P991, DOI 10.1016/0038-1098(94)90027-2
   Eggleston CM, 1996, AM MINERAL, V81, P1036
   EISEBITT S, 1993, PHYS REV B, V47, P14103, DOI 10.1103/PhysRevB.47.14103
   Fontana I, 2007, PHYS STATUS SOLIDI B, V244, P4669, DOI 10.1002/pssb.200743103
   Frausto da Silva J.J.R., 1991, BIOL CHEM ELEMENTS I
   Heigl F, 2006, J AM CHEM SOC, V128, P3906, DOI 10.1021/ja060243c
   Hocking RK, 2006, J AM CHEM SOC, V128, P10442, DOI 10.1021/ja061802i
   Kim PS, 2001, J AM CHEM SOC, V123, P8870, DOI 10.1021/ja015619v
   KRAUSE MO, 1979, J PHYS CHEM REF DATA, V8, P329, DOI 10.1063/1.555595
   Lehnert S, 2008, SER MED PHYS BIOMED, P1
   Moret ME, 2009, J PHYS CHEM B, V113, P7737, DOI 10.1021/jp900147r
   Nakajima R, 1999, PHYS REV B, V59, P6421, DOI 10.1103/PhysRevB.59.6421
   Naslund LA, 2003, J PHYS CHEM A, V107, P6869, DOI 10.1021/jp034296h
   Nesbitt HW, 2004, AM MINERAL, V89, P382, DOI 10.2138/am-2004-2-319
   Ohno M, 2003, J ELECTRON SPECTROSC, V128, P1, DOI 10.1016/S0368-2048(02)00210-4
   Pompa M, 1997, PHYS REV B, V56, P2267, DOI 10.1103/PhysRevB.56.2267
   Schnadt J, 2002, NATURE, V418, P620, DOI 10.1038/nature00952
   Stohr J, 1992, NEXAFS SPECTROSCOPY
   Tarnovsky AN, 2006, J PHYS CHEM B, V110, P26497, DOI 10.1021/jp064696f
   VANELP J, 1994, J AM CHEM SOC, V116, P1918, DOI 10.1021/ja00084a036
   Vigliotti F, 1997, FARADAY DISCUSS, V108, P139, DOI 10.1039/a705434c
   Vinogradov AS, 2001, J ELECTRON SPECTROSC, V114, P813, DOI 10.1016/S0368-2048(00)00272-3
   WOHRLE D, 2003, METAL COMPLEXES META
NR 32
TC 57
Z9 57
U1 5
U2 143
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1755-4330
EI 1755-4349
J9 NAT CHEM
JI Nat. Chem.
PD OCT
PY 2010
VL 2
IS 10
BP 853
EP 857
DI 10.1038/NCHEM.768
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 653KX
UT WOS:000282091300018
PM 20861901
DA 2018-12-27
ER

PT J
AU Avramova, YR
   Stapel, DA
   Lerouge, D
AF Avramova, Yana R.
   Stapel, Diederik A.
   Lerouge, Davy
TI RETRACTED: The Influence of Mood on Attribution (Retracted article. See
   vol. 38, pg. 1378, 2012)
SO PERSONALITY AND SOCIAL PSYCHOLOGY BULLETIN
LA English
DT Article; Retracted Publication
DE mood; attribution; social perception; salience; attention
ID SPONTANEOUS TRAIT INFERENCES; POSITIVE AFFECT; SITUATIONAL INFERENCES;
   SOCIAL INFERENCE; OF-VIEW; ACCESSIBILITY; JUDGMENTS; FLEXIBILITY;
   PERCEIVERS; ATTENTION
AB Four studies show that mood systematically affects attributions of observed behavior by altering relative attention to actor and context. When the actor is more salient, sad people are more inclined to perceive an actor in stable trait terms and favor dispositional over situational explanations, whereas the opposite is true for happy people (Studies 1-3). However, when the context is made more salient, this pattern reverses, such that those in a negative mood make more situational attributions than those in a positive mood (Study 4). Taken together, these findings provide strong support for our hypothesis that mood and salience interact to affect attributions.
C1 [Avramova, Yana R.] Tilburg Univ, Social Psychol Dept, Tilburg Inst Behav Econ Res, NL-5000 LE Tilburg, Netherlands.
RP Avramova, YR (reprint author), Tilburg Univ, Social Psychol Dept, Tilburg Inst Behav Econ Res, POB 90153, NL-5000 LE Tilburg, Netherlands.
EM y.r.avramova@uvt.nl
CR Avramova YR, 2008, J PERS SOC PSYCHOL, V95, P542, DOI 10.1037/a0012560
   AVRAMOVA YR, J PERSONALI IN PRESS
   Bargh J. A, 2000, HDB RES METHODS SOCI, P253
   BARGH JA, 1997, ADV SOC COG, V10, P1
   BASSILI JN, 1990, J PERS SOC PSYCHOL, V59, P881
   DERRYBERRY D, 1993, MOTIV EMOTION, V17, P65, DOI 10.1007/BF00995186
   ERBER R, 1991, J EXP SOC PSYCHOL, V27, P480, DOI 10.1016/0022-1031(91)90005-Q
   ESTRADA CA, 1994, MOTIV EMOTION, V18, P285, DOI 10.1007/BF02856470
   Fiedler K., 2001, THEORIES MOOD COGNIT, P85
   Forgas Joseph, 2006, AFFECT SOCIAL THINKI
   Forgas JP, 1998, J PERS SOC PSYCHOL, V75, P318, DOI 10.1037/0022-3514.75.2.318
   Forster J, 2006, J EXP SOC PSYCHOL, V42, P133, DOI 10.1016/j.jesp.2005.02.004
   Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238
   FRIJDA NH, 1988, AM PSYCHOL, V43, P349, DOI 10.1037/0003-066X.43.5.349
   Gasper K, 2002, PSYCHOL SCI, V13, P34, DOI 10.1111/1467-9280.00406
   GAWRONSKI B, 2004, EUROPEAN REV SOCIAL, V15, P183, DOI DOI 10.1080/10463280440000026
   GILBERT DT, 1995, PSYCHOL BULL, V117, P21, DOI 10.1037/0033-2909.117.1.21
   GILBERT DT, 1988, J PERS SOC PSYCHOL, V54, P733, DOI 10.1037/0022-3514.54.5.733
   Gilbert F, 1998, GENET TEST, V2, P89
   Ham J, 2003, J EXP SOC PSYCHOL, V39, P434, DOI 10.1016/S0022-1031(03)00033-7
   Heider F., 1958, PSYCHOL INTERPERSONA
   Ichheiser G, 1949, AM J SOCIOL, V55, P110, DOI 10.1086/220465
   Isen A. M., 2000, HDB EMOTIONS
   ISEN AM, 1987, J PERS SOC PSYCHOL, V52, P1122, DOI 10.1037/0022-3514.52.6.1122
   Jones E. E., 1990, INTERPERSONAL PERCEP
   JONES EE, 1967, J EXP SOC PSYCHOL, V3, P1, DOI 10.1016/0022-1031(67)90034-0
   Krull DS, 1996, PERS SOC PSYCHOL B, V22, P949, DOI 10.1177/0146167296229008
   KRULL DS, 1993, PERS SOC PSYCHOL B, V19, P340, DOI 10.1177/0146167293193011
   Krull DS, 2001, COGNITIVE SOCIAL PSYCHOLOGY, P211
   Lee F, 2001, J PERS SOC PSYCHOL, V80, P545, DOI 10.1037//0022-3514.80.4.545
   MACKIE DM, 1989, J PERS SOC PSYCHOL, V57, P27, DOI 10.1037/0022-3514.57.1.27
   Martin LL, 1998, MOTIV EMOTION, V22, P33, DOI 10.1023/A:1023092508471
   MARTIN LL, 2001, THEORIES MOOD COGNIT, P137
   MOSKOWITZ GB, 1992, J PERS SOC PSYCHOL, V62, P728, DOI 10.1037/0022-3514.62.5.728
   Nisbett R. E., 1991, PERSON SITUATION PER
   QUATTRONE GA, 1982, J PERS SOC PSYCHOL, V42, P593, DOI 10.1037//0022-3514.42.4.593
   REGAN DT, 1975, J PERS SOC PSYCHOL, V32, P850, DOI 10.1037//0022-3514.32.5.850
   RHOLES WS, 1982, PERS SOC PSYCHOL B, V8, P719, DOI 10.1177/0146167282084019
   Ross L, 1977, ADV EXPT SOCIAL PSYC, V10, P173, DOI [DOI 10.1016/S0065-2601(08)60357-3, 10.1016/S0065-2601(08)60357-3]
   Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104
   Ruys KI, 2008, PSYCHOL SCI, V19, P593, DOI 10.1111/j.1467-9280.2008.02128.x
   Ruys KI, 2008, PSYCHOL SCI, V19, P385, DOI 10.1111/j.1467-9280.2008.02097.x
   Schmitz TW, 2009, J NEUROSCI, V29, P7199, DOI 10.1523/JNEUROSCI.5387-08.2009
   SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513
   SCHWARZ N, 1996, HDB BASIC PRINCIPLES, P433
   Schwarz N., 1990, HDB MOTIVATION COGNI, V2, P527, DOI DOI 10.1016/J.NEUBIOREV.2008.01.001
   SMITH ER, 1979, J PERS SOC PSYCHOL, V48, P813, DOI DOI 10.1037/0022-3514.48.4.813
   Stapel DA, 1996, J PERS SOC PSYCHOL, V70, P437, DOI 10.1037/0022-3514.70.3.437
   Stapel DA, 2002, J PERS SOC PSYCHOL, V83, P60, DOI 10.1037//0022-3514.83.1.60
   Storbeck J, 2005, PSYCHOL SCI, V16, P785, DOI 10.1111/j.1467-9280.2005.01615.x
   STORMS MD, 1973, J PERS SOC PSYCHOL, V27, P165, DOI 10.1037/h0034782
   Taylor S. E., 1978, ADV EXPT SOCIAL PSYC, V11, P249, DOI [DOI 10.1016/S0065-2601(08)60009-X, 10.1016/S0065-2601(08)60009-X]
   TAYLOR SE, 1975, J PERS SOC PSYCHOL, V32, P439, DOI 10.1037/h0077095
   Tesser A., 1978, ADV EXPT SOCIAL PSYC, V11, P289, DOI DOI 10.1016/S0065-2601(08)60010-6
   TROPE Y, 1986, PSYCHOL REV, V93, P239, DOI 10.1037/0033-295X.93.3.239
   Trope Y, 1997, J PERS SOC PSYCHOL, V73, P662
   Tucker D. M., 1994, HEARTS EYE EMOTIONAL, P167, DOI [10.1016/B978-0-12-410560-7.50014-4, DOI 10.1016/B978-0-12-410560-7.50014-4]
   Uleman JS, 1996, ADV EXP SOC PSYCHOL, V28, P211, DOI 10.1016/S0065-2601(08)60239-7
NR 58
TC 1
Z9 2
U1 1
U2 13
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0146-1672
EI 1552-7433
J9 PERS SOC PSYCHOL B
JI Pers. Soc. Psychol. Bull.
PD OCT
PY 2010
VL 36
IS 10
BP 1360
EP 1371
DI 10.1177/0146167210381083
PG 12
WC Psychology, Social
SC Psychology
GA 654LK
UT WOS:000282169600007
PM 20716636
DA 2018-12-27
ER

PT J
AU Badr, MOT
   Hashem, MA
   Gado, NN
AF Badr, Mohamed O. T.
   Hashem, Mohamed A.
   Gado, Nissreen N.
TI RETRACTED: Comparative biochemical studies on steroidogenic compounds in
   chickens (Retracted article. See vol. 91, pg. 498, 2011)
SO RESEARCH IN VETERINARY SCIENCE
LA English
DT Article; Retracted Publication
DE Estrogen; Nordette; Lutofolone; Serum enzymes; Chickens
ID SERUM; PROGESTERONE; ESTRADIOL; PROTEIN; ACID
AB Comparative studies of the effects of Nordette and Lutofolone on 15 days old chicken were carried out to determine their effects on growth performance, biochemical parameters and an analysis of hormonal residues in the liver and muscle. Sixty chickens were equally divided into three groups. Group 1 was served as a control. Groups 2 and 3 were treated daily with Nordette (1 mg/kg B.W.) mixed in the ration and Lutofolone (0.5 mg/kg B.W.) orally via a bent stainless steel feeding tube, respectively, for 30 days (from the 15th till the 45th day old). Then these treated groups were left for another 15 days without any treatment. Blood samples were collected at 45 and 60 days old and used for biochemical studies, while liver and muscles were excised from each chicken and used to prepare tissue homogenate for estimation of hormonal residues (estrogen and progesterone).
   Both drugs caused a gain in body weight. They also increased several serum variables, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), cholesterol, creatine kinase (CK), creatinine and uric acid, and reduced total proteins, albumin and globulin levels at 30 days post-administration. Moreover, this study exhibited a significant increase in the levels of estrogen residues in the liver and muscle. Estrogen level was much higher in the liver than muscles. However, some of these findings were insignificant changed at 15 days post-stopping of the hormones. Data on the biochemical parameters and residue levels obtained from these results clearly indicate that anabolic agents may entail a special risk to the chickens and probably to the consumer. (C) 2010 Published by Elsevier Ltd.
C1 [Badr, Mohamed O. T.; Hashem, Mohamed A.] Zagazig Univ, Fac Vet Med, Dept Clin Pathol, Zagazig, Egypt.
RP Hashem, MA (reprint author), Zagazig Univ, Fac Vet Med, Dept Clin Pathol, Zagazig, Egypt.
EM mhashem.vet@gmail.com
CR ABDELKADER MM, 1979, EGYPT J VET SCI, V16, P151
   ALRAWI MM, 2002, J KING SAUD U, V15, P59
   BENJAMIN MM, 1961, OUTLINE VET CLIN PAT
   BRODY S, 1968, BIOENERGESTICS GROWT
   CHANDRA M, 1984, AVIAN DIS, V28, P1, DOI 10.2307/1590124
   COLES BH, 1997, AVIAN MED SURG
   Coles E. H., 1986, VET CLIN PATHOLOGY
   DOUMAS BT, 1981, CLIN CHEM, V27, P1642
   Drupt F., 1974, PHARM BIOL, V9, P777
   DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478
   ELALLAWY RM, 1984, J DRUG RES, V15, P74
   GANONG WF, 1995, REV MED PHYSL, P459
   GARY GP, 2002, INT J POULT SCI, V5, P662
   GERHARDT W, 1979, CLIN CHEM, V25, P1274
   GHOUNIEM MH, 1987, THESIS ZAGAZIG U
   GIAMBRONE JJ, 1986, AVIAN DIS, V30, P557, DOI 10.2307/1590421
   GILBERT AB, 1962, POULTRY SCI, V41, P784, DOI 10.3382/ps.0410784
   GUILLAUME J, 1987, SURG GYNECOL OBSTET, V165, P9
   HAGAN RC, 1984, TOXICOL APPL PHARM, V76, P483, DOI 10.1016/0041-008X(84)90352-1
   HARCOURT BF, 2002, TXB RABBIT MED, P89
   HARRISON GJ, 1986, CLIN AVIAN MED SURG, P203
   HENDERSON BE, 1983, BRIT J CANCER, V48, P437, DOI 10.1038/bjc.1983.210
   Hermier D, 1996, COMP BIOCHEM PHYS A, V115, P259, DOI 10.1016/0300-9629(96)00057-6
   HILL FW, 1958, AM J PHYSIOL, V195, P654
   HOFFMANN B, 1983, J STEROID BIOCHEM, V19, P947, DOI 10.1016/0022-4731(83)90038-9
   Hoffmann B., 1986, Drug residues in animals, P111
   HOUSTON DC, 1995, J EXP BIOL, V211, P400
   KETTERSON ED, 1999, AM NAT, V140, P533
   Khan T. A., 2005, International Journal of Poultry Science, V4, P748
   KOVANEN PT, 1981, P NATL ACAD SCI-BIOL, V78, P1396, DOI 10.1073/pnas.78.3.1396
   LICHTENBERG V, 1992, LAB MED, V16, P412
   Lone KP, 1997, CRIT REV FOOD SCI, V37, P93, DOI 10.1080/10408399709527771
   MA YT, 1986, MED SCI, V83, P792
   MAHMOUD AZ, 1998, ASSIUT J VET SCI, V2, P95
   MORGAN EH, 1975, Q J EXP PHYSIOL CMS, V60, P233, DOI 10.1113/expphysiol.1975.sp002314
   NESHEIM MC, 1976, ENV QUAL SAF S, V5, P110
   RANNEY RE, 1951, AM J PHYSIOL, V165, P600
   Rath NC, 1996, POULTRY SCI, V75, P556, DOI 10.3382/ps.0750556
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56
   Sadek I. A., 1998, Eastern Mediterranean Health Journal, V4, P239
   SADEK IA, 1986, J NUTR GROWTH CANCER, V3, P239
   Sadex I. A., 1995, Eastern Mediterranean Health Journal, V1, P241
   SANDERS GTB, 1980, CLIN CHIM ACTA, V101, P299, DOI 10.1016/0009-8981(80)90257-0
   SLOT C, 1965, SCAND J CLIN LAB INV, V17, P381, DOI 10.3109/00365516509077065
   STAKE PE, 1981, AVIAN DIS, V25, P410, DOI 10.2307/1589933
   STURKIE PD, 1965, AVIAN PHYSL, V2, P853
   TAMHANE AC, 2000, STAT DATA ANAL ELEME, P85
   THAYER RH, 1945, POULTRY SCI, V24, P483, DOI 10.3382/ps.0240483
   Tietz NW, 1995, CLIN GUIDE LAB TESTS, P610
   Tully TN, 2000, AVIAN MED
   Varley H., 1980, PRACTICAL CLIN BIOCH, V5th
   Wagner EC, 2008, J EXP BIOL, V211, P400, DOI 10.1242/jeb.011205
   WILLIAMS DL, 1978, P NATL ACAD SCI USA, V75, P5974, DOI 10.1073/pnas.75.12.5974
   Zilva JF, 1988, CLIN CHEM DIAGNOSIS
NR 54
TC 1
Z9 1
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0034-5288
EI 1532-2661
J9 RES VET SCI
JI Res. Vet. Sci.
PD OCT
PY 2010
VL 89
IS 2
BP 168
EP 173
DI 10.1016/j.rvsc.2010.03.010
PG 6
WC Veterinary Sciences
SC Veterinary Sciences
GA 653TS
UT WOS:000282120400006
PM 20542304
DA 2018-12-27
ER

PT J
AU Han, XU
   Zou, JH
   Wang, XF
   Guo, W
   Huo, GC
   Shen, RX
   Xiang, WH
AF Han, Xiue
   Zou, Jianhua
   Wang, Xuefeng
   Guo, Wei
   Huo, Guicheng
   Shen, Rongxian
   Xiang, Wenhua
TI RETRACTED: Amino Acid Mutations in the env gp90 Protein That Modify
   N-Linked Glycosylation of the Chinese EIAV Vaccine Strain Enhance
   Resistance to Neutralizing Antibodies (Retracted article. See vol. 24,
   pg. 65, 2011)
SO VIRAL IMMUNOLOGY
LA English
DT Article; Retracted Publication
ID INFECTIOUS-ANEMIA VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; CYTOTOXIC
   T-LYMPHOCYTE; PERSISTENT INFECTION; IMMUNE-RESPONSES; ENVELOPE GENE;
   PROVIRAL DNA; IN-VIVO; GLYCOPROTEIN; DISEASE
AB The Chinese EIAV vaccine is an attenuated live-virus vaccine obtained by serial passage of a virulent horse isolate (EIAV(L)) in donkeys (EIAV(D)), and subsequently in donkey cells in vitro. In this study, we compare the env gene of the original horse virulent virus (EIAV(L)) with attenuated strains serially passaged in donkey MDM (EIAV(DLV)), and donkey dermal cells (EIAV(FDDV)). Genetic comparisons among parental and attenuated strains found that vaccine strains contained amino acid substitutions/deletions in gp90 that resulted in a loss of three potential N-linked glycosylation sites, designated g5, g9, and g10. To investigate the biological significance of these changes, reverse-mutated viruses were constructed in the backbone of the EIAV(FDDV) infectious molecular clone (pLGFD3). The resulting virus stocks were characterized for replication efficiency in donkey dermal cells and donkey MDM, and were tested for sensitivity to neutralization using sera from two ponies experimentally-infected with EIAV(FDDV). The results clearly show that these mutations generated by site-directed mutagenesis resulted in cloned viruses with enhanced resistance to serum-neutralizing antibodies that were also able to recognize parental viruses. The results of this study indicate that these mutations play an important role in the attenuation of the EIAV vaccine strains.
C1 [Han, Xiue] NE Agr Univ, Heilongjiang Dairy Ind Tech Dev Ctr, Harbin 150030, Peoples R China.
   [Han, Xiue; Zou, Jianhua; Wang, Xuefeng; Guo, Wei; Shen, Rongxian; Xiang, Wenhua] Chinese Acad Agr Sci, Natl Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Peoples R China.
   [Han, Xiue; Huo, Guicheng] NE Agr Univ, Key Lab Dairy Sci, Minist Educ, Coll Food Sci & Engn, Harbin 150030, Peoples R China.
RP Han, XU (reprint author), NE Agr Univ, Heilongjiang Dairy Ind Tech Dev Ctr, Harbin 150030, Peoples R China.
EM xiangwenhua1@yahoo.com
FU National Natural Science Foundation of China [30771994]; Helongjiang
   Provincial Foundation for New Technology [FW05B007]; Harbin City
   Foundation for Science and Technology [2006AA3AS040]
FX This work was supported in part by funding from National Natural Science
   Foundation of China grant 30771994, Helongjiang Provincial Foundation
   for New Technology grant FW05B007, and Harbin City Foundation for
   Science and Technology grant 2006AA3AS040.
CR Abel K, 2003, J VIROL, V77, P3099, DOI 10.1128/JVI.77.5.3099-3118.2003
   Amara RR, 2005, J VIROL, V79, P15356, DOI 10.1128/JVI.79.24.15356-15367.2005
   BACK NKT, 1994, VIROLOGY, V199, P431, DOI 10.1006/viro.1994.1141
   BALL JM, 1992, J VIROL, V66, P732
   Bogers WMJM, 2000, AIDS, V14, pS141
   BOLMSTEDT A, 1992, J GEN VIROL, V73, P3099, DOI 10.1099/0022-1317-73-12-3099
   Bolmstedt A, 1996, J ACQ IMMUN DEF SYND, V12, P213, DOI 10.1097/00042560-199607000-00001
   Busch M, 2005, VACCINE, V23, P4036, DOI 10.1016/j.vaccine.2005.03.013
   Chackerian B, 1997, J VIROL, V71, P7719
   Cook RF, 1998, J VIROL, V72, P1383
   Cook RF, 2003, VIROLOGY, V313, P588, DOI 10.1016/S0042-6822(03)00351-9
   Craigo JK, 2007, P NATL ACAD SCI USA, V104, P15105, DOI 10.1073/pnas.0706449104
   Dacheux L, 2004, J VIROL, V78, P12625, DOI 10.1128/JVI.78.22.12625-12637.2004
   Grund CH, 1996, J GEN VIROL, V77, P435, DOI 10.1099/0022-1317-77-3-435
   Hammond SA, 2000, J VIROL, V74, P5968, DOI 10.1128/JVI.74.13.5968-5981.2000
   Hammond SA, 1997, J VIROL, V71, P3840
   Harrold SM, 2000, J VIROL, V74, P3112, DOI 10.1128/JVI.74.7.3112-3121.2000
   He Xiang, 2003, Chinese Journal of Virology, V19, P128
   Howe L, 2002, J VIROL, V76, P10588, DOI 10.1128/JVI.76.21.10588-10597.2002
   HUSSAIN KA, 1987, J VIROL, V61, P2956
   Johnson WE, 2003, J VIROL, V77, P9993, DOI 10.1128/JVI.77.18.9993-10003.2003
   Johnson WE, 2003, J VIROL, V77, P375, DOI 10.1128/JVI.77.1..375-381.2003
   Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115
   Leroux C, 1997, J VIROL, V71, P9627
   Leroux C, 2001, J VIROL, V75, P4570, DOI 10.1128/JVI.75.10.4570-4583.2001
   Li F, 2003, J VIROL, V77, P7244, DOI 10.1128/JVI.77.13.7244-7253.2003
   Liang H, 2006, ARCH VIROL, V151, P1387, DOI 10.1007/s00705-005-0718-3
   Lichtenstein DL, 1996, J VIROL, V70, P3346
   MARTHAS ML, 1993, J VIROL, V67, P6047
   Mills J, 2000, AIDS RES HUM RETROV, V16, P1453, DOI 10.1089/088922200750005976
   Ohgimoto S, 1998, J VIROL, V72, P8365
   Pang H, 1997, J VET MED SCI, V59, P1089, DOI 10.1292/jvms.59.1089
   PAYNE SL, 1987, VIROLOGY, V161, P321, DOI 10.1016/0042-6822(87)90124-3
   Pikora CA, 2004, CURR HIV RES, V2, P243, DOI 10.2174/1570162043351264
   Raabe MR, 1998, J VIROL METHODS, V71, P87, DOI 10.1016/S0166-0934(97)00204-8
   Reitter JN, 1998, J VIROL, V72, P5399
   RWAMBO PM, 1990, ARCH VIROL, V111, P275, DOI 10.1007/BF01311062
   SHEN RX, 1979, CHINA AGR SCI, P41
   SHEN RX, DEV USE EQUINE INFEC
   SHINJI O, 1998, J VIROL, V72, P8365
   Spyrou V, 2005, VIRUS RES, V107, P63, DOI 10.1016/j.virusres.2004.06.016
   Tagmyer TL, 2007, J GEN VIROL, V88, P1324, DOI 10.1099/vir.0.82391-0
   Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470
   Zheng YH, 2000, VIRUS RES, V68, P93, DOI 10.1016/S0168-1702(00)00147-7
NR 44
TC 0
Z9 0
U1 4
U2 13
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0882-8245
J9 VIRAL IMMUNOL
JI Viral Immunol.
PD OCT
PY 2010
VL 23
IS 5
BP 531
EP 539
DI 10.1089/vim.2009.0006
PG 9
WC Immunology; Virology
SC Immunology; Virology
GA 656UD
UT WOS:000282362300009
PM 20883167
DA 2018-12-27
ER

PT J
AU Venkataraman, S
   Dirks, RM
   Ueda, CT
   Pierce, NA
AF Venkataraman, Suvir
   Dirks, Robert M.
   Ueda, Christine T.
   Pierce, Niles A.
TI RETRACTED: Selective cell death mediated by small conditional RNAs
   (Retracted article. See vol. 110, pg. 384, 2013)
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article; Retracted Publication
DE hybridization chain reaction; selective PKR activation; nucleic acid
   nanotechnology; chemical biology
ID DOUBLE-STRANDED-RNA; DEPENDENT PROTEIN-KINASE; CONFERS ENHANCED
   TUMORIGENICITY; TRANSFECTED CELLS; CHROMOSOME-TRANSLOCATION;
   MESSENGER-RNA; PKR; DNA; ACTIVATION; GROWTH
AB Cancer cells are characterized by genetic mutations that deregulate cell proliferation and suppress cell death. To arrest the uncontrolled replication of malignant cells, conventional chemotherapies systemically disrupt cell division, causing diverse and often severe side effects as a result of collateral damage to normal cells. Seeking to address this shortcoming, we pursue therapeutic regulation that is conditional, activating selectively in cancer cells. This functionality is achieved using small conditional RNAs that interact and change conformation to mechanically transduce between detection of a cancer mutation and activation of a therapeutic pathway. Here, we describe small conditional RNAs that undergo hybridization chain reactions (HCR) to induce cell death via an innate immune response if and only if a cognate mRNA cancer marker is detected within a cell. The sequences of the small conditional RNAs can be designed to accept different mRNA markers as inputs to HCR transduction, providing a programmable framework for selective killing of diverse cancer cells. In cultured human cancer cells (glioblastoma, prostate carcinoma, Ewing's sarcoma), HCR transduction mediates cell death with striking efficacy and selectivity, yielding a 20- to 100-fold reduction in population for cells containing a cognate marker, and no measurable reduction otherwise. Our results indicate that programmable mechanical transduction with small conditional RNAs represents a fundamental principle for exploring therapeutic conditional regulation in living cells.
C1 [Venkataraman, Suvir; Dirks, Robert M.; Pierce, Niles A.] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA.
   [Dirks, Robert M.; Ueda, Christine T.] CALTECH, Dept Chem, Pasadena, CA 91125 USA.
   [Pierce, Niles A.] CALTECH, Dept Appl & Computat Math, Pasadena, CA 91125 USA.
RP Pierce, NA (reprint author), CALTECH, Dept Bioengn, Pasadena, CA 91125 USA.
EM niles@caltech.edu
FU National Institutes of Health (NIH) National Cancer Institute [R01
   CA140759]; Pardee Foundation; National Science Foundation (NSF) [CCF
   0832824]; Caltech Center for Biological Circuit Design; Beckman
   Institute at Caltech; Caltech Innovation Initiative; Caltech grubstake
   fund
FX We thank S. Mukhurjee, D.K. Newman, and M.E. Davis for discussions. We
   thank C.R. Calvert for performing blind trials on selective cell death.
   We thank P.C. Bevilacqua for providing a PKR plasmid, F. Furnari for
   providing U87MG-Delta EGFR and U87MG-wtEGFR cells, and M.E. Davis for
   providing TC71 cells. This work was funded by the National Institutes of
   Health (NIH) National Cancer Institute (R01 CA140759), the Pardee
   Foundation, the National Science Foundation (NSF) Molecular Programming
   Project (CCF 0832824), the Caltech Center for Biological Circuit Design,
   the Beckman Institute at Caltech, the Caltech Innovation Initiative, and
   a Caltech grubstake fund. The authors declare competing financial
   interests.
CR Aagaard L, 2007, ADV DRUG DELIVER REV, V59, P75, DOI 10.1016/j.addr.2007.03.005
   Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598
   Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104
   Brunel C, 2002, BIOCHIMIE, V84, P925, DOI 10.1016/S0300-9084(02)01401-3
   Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758
   Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595
   Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956
   Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041
   Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070
   DiazGuerra M, 1997, VIROLOGY, V236, P354, DOI 10.1006/viro.1997.8719
   Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Friedrich I, 2005, MOL THER, V12, P969, DOI 10.1016/j.ymthe.2005.06.442
   Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299
   Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44
   Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001
   HERRMANN M, 1994, NUCLEIC ACIDS RES, V22, P5506, DOI 10.1093/nar/22.24.5506
   HU YH, 1993, J INTERFERON RES, V13, P323, DOI 10.1089/jir.1993.13.323
   Hu-Lieskovan S, 2005, CANCER RES, V65, P8984, DOI 10.1158/0008-5472.CAN-05-0565
   Huang S, 2003, ONCOGENE, V22, P3721, DOI 10.1038/sj.onc.1206490
   KAUFMAN RJ, 1987, MOL CELL BIOL, V7, P1568, DOI 10.1128/MCB.7.4.1568
   Kuan CT, 2001, ENDOCR-RELAT CANCER, V8, P83, DOI 10.1677/erc.0.0080083
   MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238
   Nagane M, 1996, CANCER RES, V56, P5079
   NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727
   Osman F, 1999, GENE DEV, V13, P3280, DOI 10.1101/gad.13.24.3280
   SAMUEL CE, 1990, VIROLOGY, V176, P106, DOI 10.1016/0042-6822(90)90235-J
   SAMUEL CE, 1992, PHARMACOL THERAPEUT, V54, P307, DOI 10.1016/0163-7258(92)90005-K
   Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200
   Shir A, 2002, NAT BIOTECHNOL, V20, P895, DOI 10.1038/nbt730
   Simmel FC, 2005, SMALL, V1, P284, DOI 10.1002/smll.200400111
   Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754
   THOMIS DC, 1993, J VIROL, V67, P7695
   Venkataraman S, 2007, NAT NANOTECHNOL, V2, P490, DOI 10.1038/nnano.2007.225
   Veronese ML, 1996, CANCER RES, V56, P728
   WHANGPENG J, 1984, NEW ENGL J MED, V311, P584, DOI 10.1056/NEJM198408303110907
   Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524
   Zhang F, 2001, J BIOL CHEM, V276, P24946, DOI 10.1074/jbc.M102108200
   ZINN K, 1988, SCIENCE, V240, P210, DOI 10.1126/science.3281258
NR 39
TC 57
Z9 58
U1 4
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 28
PY 2010
VL 107
IS 39
BP 16777
EP 16782
DI 10.1073/pnas.1006377107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 655AA
UT WOS:000282211700011
PM 20823260
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Norman, LL
   Bruges, J
   Sengupta, K
   Sens, P
   Aranda-Espinoza, H
AF Norman, Leann L.
   Bruges, Jan
   Sengupta, Kheya
   Sens, Pierre
   Aranda-Espinoza, Helim
TI RETRACTED: Cell Blebbing and Membrane Area Homeostasis in Spreading and
   Retracting Cells (Retracted article. See vol. 99, pg. 2715, 2010)
SO BIOPHYSICAL JOURNAL
LA English
DT Article; Retracted Publication
ID PLASMA-MEMBRANE; TRYPSINIZED CELLS; MODES; MIGRATION; TENSION; MITOSIS;
   BLEBS; INTERNALIZATION; DICTYOSTELIUM; REQUIREMENTS
AB Cells remodel their plasma membrane and cytoskeleton during numerous physiological processes, including spreading and motility. Morphological changes require the cell to adjust its membrane tension on different timescales. While it is known that endo- and exocytosis regulate the cell membrane area in a timescale of 1 h, faster processes, such as abrupt cell detachment, require faster regulation of the plasma membrane tension. In this article, we demonstrate that cell blebbing plays a critical role in the global mechanical homeostasis of the cell through regulation of membrane tension. Abrupt cell detachment leads to pronounced blebbing (which slow detachment does not), and blebbing decreases with time in a dynamin-dependent fashion. Cells only start spreading after a lag period whose duration depends on the cell's blebbing activity. Our model quantitatively reproduces the monotonic decay of the blebbing activity and accounts for the lag phase in the spreading of blebbing cells.
C1 [Norman, Leann L.; Aranda-Espinoza, Helim] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Bruges, Jan; Sens, Pierre] Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR 7083, Paris, France.
   [Sengupta, Kheya] Aix Marseille Univ, Ctr Interdisciplinaire Nanosci Marseille, CNRS, UPR 3118, Marseille, France.
RP Aranda-Espinoza, H (reprint author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
EM helim@umd.edu
RI Brugues, Jan/C-7727-2017; Sengupta, Kheya/E-8629-2011; sens,
   pierre/C-3537-2011
OI Brugues, Jan/0000-0002-6731-4130; Sengupta, Kheya/0000-0002-1060-2713;
   sens, pierre/0000-0003-4523-3791
FU Maryland Higher Education Commission under National Science Foundation
   [CMMI-0643783]; U.S. Army; French Agence Nationale pour la Recherche
FX H.A.-E. was supported by the Maryland Higher Education Commission under
   National Science Foundation grant No. CMMI-0643783, and L.L.N. was
   supported by a U.S. Army CREST fellowship. J.B. and P.S. acknowledge
   support from the French Agence Nationale pour la Recherche.
CR Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657
   BEREITERHAHN J, 1990, J CELL SCI, V96, P171
   Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023
   Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104
   Chamaraux F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.158102
   Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550
   Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453
   Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605
   Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085
   CUNNINGHAM CC, 1995, J CELL BIOL, V129, P1589, DOI 10.1083/jcb.129.6.1589
   Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058
   Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7
   del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293
   del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571
   DEMAN JJ, 1977, J CELL SCI, V27, P167
   Dobereiner HG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108105
   Dubin-Thaler BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003735
   ERICKSON CA, 1976, EXP CELL RES, V99, P375, DOI 10.1016/0014-4827(76)90595-4
   EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094
   Gauthier NC, 2009, MOL BIOL CELL, V20, P3261, DOI 10.1091/mbc.E09-01-0071
   Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755
   HASTON WS, 1984, J CELL SCI, V68, P227
   HOGLUND AS, 1985, TISSUE CELL, V17, P649, DOI 10.1016/0040-8166(85)90002-3
   KOLODNY GM, 1972, EXP CELL RES, V70, P196, DOI 10.1016/0014-4827(72)90197-8
   KUPFER A, 1987, CELL MOTIL CYTOSKEL, V8, P182, DOI 10.1002/cm.970080210
   Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003
   Langridye PD, 2006, EXP CELL RES, V312, P2009, DOI 10.1016/j.yexcr.2006.03.007
   Laster SM, 1996, MICROSC RES TECHNIQ, V34, P272, DOI 10.1002/(SICI)1097-0029(19960615)34:3<272::AID-JEMT10>3.0.CO;2-J
   Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002
   Merkel R, 2000, BIOPHYS J, V79, P707, DOI 10.1016/S0006-3495(00)76329-6
   Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040
   NORMAN LL, CELL MOL BIOL, V3, P151
   Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590
   Paluch E, 2006, TRENDS CELL BIOL, V16, P5, DOI 10.1016/j.tcb.2005.11.003
   Paluch E, 2006, J CELL BIOL, V175, P687, DOI 10.1083/jcb.200607159
   Raucher D, 1999, J CELL BIOL, V144, P497, DOI 10.1083/jcb.144.3.497
   Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019
   Sengupta K, 2006, BIOPHYS J, V91, P4638, DOI [10.1529/biophysj.105.080382, 10.1529/biophysj.106.080382]
   Sens P, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031918
   STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1
   Upadhyaya A, 2004, BIOPHYS J, V86, P2923, DOI 10.1016/S0006-3495(04)74343-X
   Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152
   Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925
NR 43
TC 51
Z9 52
U1 3
U2 25
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD SEP 22
PY 2010
VL 99
IS 6
BP 1726
EP 1733
DI 10.1016/j.bpj.2010.07.031
PG 8
WC Biophysics
SC Biophysics
GA 654UY
UT WOS:000282197500008
PM 20858416
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Gualberto, A
   Dolled-Filhart, M
   Gustavson, M
   Christiansen, J
   Wang, YF
   Hixon, ML
   Reynolds, J
   McDonald, S
   Ang, A
   Rimm, DL
   Langer, CJ
   Blakely, J
   Garland, L
   Paz-Ares, LG
   Karp, DD
   Lee, AV
AF Gualberto, Antonio
   Dolled-Filhart, Marisa
   Gustavson, Mark
   Christiansen, Jason
   Wang, Yu-Fen
   Hixon, Mary L.
   Reynolds, Jennifer
   McDonald, Sandra
   Ang, Agnes
   Rimm, David L.
   Langer, Corey J.
   Blakely, Johnetta
   Garland, Linda
   Paz-Ares, Luis G.
   Karp, Daniel D.
   Lee, Adrian V.
TI RETRACTED: Molecular Analysis of Non-Small Cell Lung Cancer Identifies
   Subsets with Different Sensitivity to Insulin-like Growth Factor I
   Receptor Inhibition (Retracted article. See vol. 20, pg. 3358, 2014)
SO CLINICAL CANCER RESEARCH
LA English
DT Article; Retracted Publication
ID MAMMARY EPITHELIAL-CELLS; BETA-CATENIN; E-CADHERIN; EXPRESSION; IGF;
   TRANSFORMATION; SUBSTRATE-1; BMS-536924; TRANSITION; GEFITINIB
AB Purpose: This study aimed to identify molecular determinants of sensitivity of non-small cell lung cancer (NSCLC) to anti-insulin-like growth factor receptor (IGF-IR) therapy.
   Experimental Design: A total of 216 tumor samples were investigated, of which 165 consisted of retrospective analyses of banked tissue and an additional 51 were from patients enrolled in a phase II study of figitumumab, a monoclonal antibody against IGF-IR, in stage IIIb/IV NSCLC. Biomarkers assessed included IGF-IR, epidermal growth factor receptor, IGF-II, IGF-IIR, insulin receptor substrate 1 (IRS-1), IRS-2, vimentin, and E-cadherin. Subcellular localization of IRS-1 and phosphorylation levels of mitogen-activated protein kinase and Akt1 were also analyzed.
   Results: IGF-IR was differentially expressed across histologic subtypes (P = 0.04), with highest levels observed in squamous cell tumors. Elevated IGF-IR expression was also observed in a small number of squamous cell tumors responding to chemotherapy combined with figitumumab (P = 0.008). Because no other biomarker/response interaction was observed using classical histologic subtyping, a molecular approach was undertaken to segment NSCLC into mechanism-based subpopulations. Principal component analysis and unsupervised Bayesian clustering identified three NSCLC subsets that resembled the steps of the epithelial to mesenchymal transition: E-cadherin high/IRS-1 low (epithelial-like), E-cadherin intermediate/IRS-1 high (transitional), and E-cadherin low/IRS-1 low (mesenchymal-like). Several markers of the IGF-IR pathway were overexpressed in the transitional subset. Furthermore, a higher response rate to the combination of chemotherapy and figitumumab was observed in transitional tumors (71%) compared with those in themesenchymal-like subset (32%; P = 0.03). Only one epithelial-like tumor was identified in the phase II study, suggesting that advanced NSCLC has undergone significant dedifferentiation at diagnosis.
   Conclusion: NSCLC comprises molecular subsets with differential sensitivity to IGF-IR inhibition. Clin Cancer Res; 16(18); 4654-65. (c) 2010 AACR.
C1 [Gualberto, Antonio] Dept Clin Dev & Med Affairs, New London, CT USA.
   [Gualberto, Antonio; Hixon, Mary L.] Brown Univ, Dept Pathol & Lab Med, Warren Alpert Med Sch, Providence, RI 02912 USA.
   [Dolled-Filhart, Marisa; Gustavson, Mark; Christiansen, Jason; Ang, Agnes] HistoRx Inc, New Haven, CT USA.
   [Rimm, David L.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.
   [Wang, Yu-Fen; Lee, Adrian V.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Dept Med, Translat Biol & Mol Med Program, Houston, TX 77030 USA.
   [Wang, Yu-Fen; Lee, Adrian V.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Dept Mol & Cellular Biol, Translat Biol & Mol Med Program, Houston, TX 77030 USA.
   [Karp, Daniel D.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac Oncol, Houston, TX 77030 USA.
   [Reynolds, Jennifer] Pfizer Global Res & Dev, Dept Mol Med, Groton, CT USA.
   [McDonald, Sandra] Pfizer Res & Dev, Dept Early Res & Target Safety, St Louis, MO USA.
   [Langer, Corey J.] Abramson Canc Ctr, Div Hematol Oncol, Philadelphia, PA USA.
   [Blakely, Johnetta] West Clin, Dept Med Oncol, Memphis, TN USA.
   [Garland, Linda] Univ Arizona, Arizona Canc Ctr, Dept Med Oncol, Tucson, AZ USA.
   [Paz-Ares, Luis G.] Virgen del Rocio Univ Hosp, Dept Med Oncol, Seville, Spain.
RP Gualberto, A (reprint author), 50 Pequot Ave MS6025-A3266, New London, CT 06320 USA.
EM antonio_gualberto@brown.edu
RI IBIS, NUEVAS TERAPIA/P-3415-2015
FU NIH PHS [P50CA58183, ES015704]; US DOD [DAMD-W81XWH-08-1-0220]; Pfizer
   Inc.
FX NIH PHS grants P50CA58183 (A.V. Lee) and ES015704 (M.L. Hixon), and by
   Pfizer Inc. Y-F. Wang is a recipient of a US DOD Predoctoral Traineeship
   Award (DAMD-W81XWH-08-1-0220).
CR Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159
   Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791
   Canonici A, 2008, INT J CANCER, V122, P572, DOI 10.1002/ijc.23164
   Cappuzzo F, 2006, ANN ONCOL, V17, P1120, DOI 10.1093/annonc/mdl077
   Chan B, 2008, J MAMMARY GLAND BIOL, V13, P415, DOI 10.1007/s10911-008-9101-9
   Chang Q, 2002, CANCER RES, V62, P6035
   Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070
   Dziadziuszko R, 2010, J CLIN ONCOL, V28, P2174, DOI 10.1200/JCO.2009.24.6611
   FAVONI RE, 1994, INT J CANCER, V56, P858, DOI 10.1002/ijc.2910560618
   Gong YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007273
   GUALBERTO A, 2009, J CLIN ONCOL, V27, pS15
   Hixon ML, 2009, J CLIN ONCOL S, V27, p15s
   Huang F, 2009, CANCER RES, V69, P161, DOI 10.1158/0008-5472.CAN-08-0835
   JULIENGRILLE S, 2005, RISE FALL EPITHELIAL, P215
   Kim HJ, 2007, MOL CELL BIOL, V27, P3165, DOI 10.1128/MCB.01315-06
   Knowlden JM, 2008, BREAST CANCER RES TR, V111, P79, DOI 10.1007/s10549-007-9763-9
   Litzenburger BC, 2009, CLIN CANCER RES, V15, P226, DOI 10.1158/1078-0432.CCR-08-0801
   MERRICK DT, 2007, J CLIN ONCOL, V25
   Morali OG, 2001, ONCOGENE, V20, P4942, DOI 10.1038/sj.onc.1204660
   Playford MP, 2000, P NATL ACAD SCI USA, V97, P12103, DOI 10.1073/pnas.210394297
   Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536
   REYNOLDS JM, 2009, AACR MOL TARGETS CAN
   Spitz MR, 2002, CANCER EPIDEM BIOMAR, V11, P1413
NR 23
TC 52
Z9 52
U1 2
U2 19
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1078-0432
EI 1557-3265
J9 CLIN CANCER RES
JI Clin. Cancer Res.
PD SEP 15
PY 2010
VL 16
IS 18
BP 4654
EP 4665
DI 10.1158/1078-0432.CCR-10-0089
PG 12
WC Oncology
SC Oncology
GA 651FF
UT WOS:000281910400020
PM 20670944
OA Green Accepted, Bronze
DA 2018-12-27
ER

PT J
AU Bhui, K
   Warfa, N
AF Bhui, Kamaldeep
   Warfa, Nasir
TI RETRACTED: Trauma, khat and common psychotic symptoms: A quantitative
   study (Retracted article. See vol. 134, pg. 202, 2011)
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article; Retracted Publication
DE Khat; Common psychoses; Trauma; Migrant
ID SOMALI REFUGEES; METAANALYSIS; DISORDERS; MIGRATION; SCHIZOPHRENIA
AB Aim To investigate the relationship between (i) khat use and (ii) traumatic events, with measures of common psychotic symptoms and symptoms of anxiety and depression To undertake this work in a Somali population of emigrants who have sought asylum in a non-conflict zone country
   Materials & Methods: A secondary analysis of data on a population sample of 180 Somali men and women
   Results: Frequency of khat use was not associated with common psychotic symptoms or with symptoms of anxiety and depression, nor with traumatic events in this population Traumatic events were related to low levels of psychotic symptoms and high levels of symptoms of anxiety and depression.
   Conclusions: Khat use is not inevitably linked to psychotic symptoms in population samples of Somali men and women. The contrasts between these findings and those from studies in conflict zones and studies of people with mental health problems using khat suggest further investigations are necessary. These should take account environmental and physiological interactions. (C) 2010 Elsevier Ireland Ltd All rights reserved
C1 [Bhui, Kamaldeep; Warfa, Nasir] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Psychiat, Wolfson Inst Prevent Med, London EC1M 6BQ, England.
RP Bhui, K (reprint author), Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Psychiat, Wolfson Inst Prevent Med, Old Anat Bldg,Charterhouse Sq, London EC1M 6BQ, England.
CR Bhui K, 2006, SOC PSYCH PSYCH EPID, V41, P400, DOI 10.1007/s00127-006-0043-5
   Bhui K, 2003, SOC PSYCH PSYCH EPID, V38, P35, DOI 10.1007/s00127-003-0596-5
   Breslau N, 2009, TRAUMA VIOLENCE ABUS, V10, P198, DOI 10.1177/1524838009334448
   Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12
   DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017
   Dominguez MD, 2009, SCHIZOPHRENIA B
   Fitzgerald J, 2009, KHAT LIT REV
   GLASER JP, 2009, ACTA PSYCHIAT S 0625
   MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008
   Odenwald M, 2007, PLOS MED, V4, P1959, DOI 10.1371/journal.pmed.0040341
   Odenwald M, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-5
   Odenwald M, 2009, SOC SCI MED, V69, P1040, DOI 10.1016/j.socscimed.2009.07.020
   OVERALL JE, 1962, PSYCHOL REP, V10, P799
   Swinnen SGHA, 2007, BRIT J PSYCHIAT, V190, P6, DOI 10.1192/bip.bp.105.020800
   Toennes SW, 2003, BRIT J CLIN PHARMACO, V56, P125, DOI 10.1046/j.1365-2125.2003.01834.x
   van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814
   van Os J, 2009, LANCET, V374, P635, DOI 10.1016/S0140-6736(09)60995-8
   WARFA N, 2006, DIVERSITY HLTH SOCIA, V3, P111
   Warfa N, 2007, SOC SCI MED, V65, P309, DOI 10.1016/j.socscimed.2007.04.038
NR 19
TC 3
Z9 3
U1 2
U2 14
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD SEP 15
PY 2010
VL 131
IS 2
BP 459
EP 463
DI 10.1016/j.jep.2010.06.045
PG 5
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 661FD
UT WOS:000282709100028
PM 20633622
DA 2018-12-27
ER

PT J
AU Lo, SC
   Pripuzova, N
   Li, BJ
   Komaroff, AL
   Hung, GC
   Wang, R
   Alter, HJ
AF Lo, Shyh-Ching
   Pripuzova, Natalia
   Li, Bingjie
   Komaroff, Anthony L.
   Hung, Guo-Chiuan
   Wang, Richard
   Alter, Harvey J.
TI RETRACTED: Detection of MLV-related virus gene sequences in blood of
   patients with chronic fatigue syndrome and healthy blood donors
   (Retracted article. See vol. 109, pg. 346, 2012)
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article; Retracted Publication
DE xenotropic murine leukemia virus-related virus; murine leukemia
   virus-like virus; viral gag gene sequence; polytropic; mouse
   mitochondria DNA PCR
ID MURINE LEUKEMIA-VIRUS; PROSTATE-CANCER; RETROVIRUS XMRV; PATHOGENESIS;
   PREVALENCE; RELEASE; ABSENCE; RNA
AB Chronic fatigue syndrome (CFS) is a serious systemic illness of unknown cause. A recent study identified DNA from a xenotropic murine leukemia virus-related virus (XMRV) in peripheral blood mononuclear cells (PBMCs) from 68 of 101 patients (67%) by nested PCR, as compared with 8 of 218 (3.7%) healthy controls. However, four subsequent reports failed to detect any murine leukemia virus (MLV)-related virus gene sequences in blood of CFS patients. We examined 41 PBMC-derived DNA samples from 37 patients meeting accepted diagnostic criteria for CFS and found MLV-like virus gag gene sequences in 32 of 37 (86.5%) compared with only 3 of 44 (6.8%) healthy volunteer blood donors. No evidence of mouse DNA contamination was detected in the PCR assay system or the clinical samples. Seven of 8 gag-positive patients tested again positive in a sample obtained nearly 15 y later. In contrast to the reported findings of near-genetic identity of all XMRVs, we identified a genetically diverse group of MLV-related viruses. The gag and env sequences from CFS patients were more closely related to those of polytropic mouse endogenous retroviruses than to those of XMRVs and were even less closely related to those of ecotropic MLVs. Further studies are needed to determine whether the same strong association with MLV-related viruses is found in other groups of patients with CFS, whether these viruses play a causative role in the development of CFS, and whether they represent a threat to the blood supply.
C1 [Lo, Shyh-Ching; Pripuzova, Natalia; Li, Bingjie; Hung, Guo-Chiuan] US FDA, Tissue Microbiol Lab, Div Cellular & Gene Therapies, Bethesda, MD 20892 USA.
   [Lo, Shyh-Ching; Pripuzova, Natalia; Li, Bingjie; Hung, Guo-Chiuan] US FDA, Off Cellular Tissue & Gene Therapy, Div Human Tissues, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA.
   [Komaroff, Anthony L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA.
   [Wang, Richard; Alter, Harvey J.] NIH, Dept Transfus Med, Warren Grant Magnuson Clin Ctr, Bethesda, MD 20892 USA.
RP Lo, SC (reprint author), US FDA, Tissue Microbiol Lab, Div Cellular & Gene Therapies, Bethesda, MD 20892 USA.
EM shyhching.lo@FDA.hhs.gov; halter@mail.nih.gov
FU National Institute of Allergy and Infectious Diseases [R01-A127314,
   U01-A132246]; De Young Foundation
FX We thank Richard Schacterle, Ph.D., and Jennifer Redd, who helped
   collect the specimens and clinical data. Drs. Jakob Reiser and Paolo
   Lusso kindly helped to review the manuscript. Support for this work was
   provided in part by National Institute of Allergy and Infectious
   Diseases Grants R01-A127314 and U01-A132246 and by a gift from the De
   Young Foundation to A.L.K.
CR Coffin JM, 2009, SCIENCE, V326, P530, DOI 10.1126/science.1181349
   CORBIN A, 1994, J VIROL, V68, P3857
   Corbin A, 1996, BIOCHIMIE, V78, P632, DOI 10.1016/S0300-9084(96)80009-5
   Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519
   Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016
   FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009
   Groom HC, 2010, RETROVIROLOGY, V7, pe10
   HERR W, 1984, J VIROL, V49, P471
   Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92
   Kim S, 2008, J VIROL, V82, P9964, DOI 10.1128/JVI.01299-08
   KOMAROFF AL, 1993, CLIN INFECT DIS, V17, P1074, DOI 10.1093/clinids/17.6.1074
   Komaroff AL, 2006, J CLIN VIROL, V37, pS39, DOI 10.1016/S1386-6532(06)70010-5
   Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052
   Low A, 2007, J VIROL, V81, P3685, DOI 10.1128/JVI.01538-06
   Nitta T, 2010, P NATL ACAD SCI USA, V107, P1190, DOI 10.1073/pnas.0908660107
   Raisch KP, 2003, VIROLOGY, V308, P83, DOI 10.1016/S0042-6822(02)00074-0
   Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106
   Silverman RH, 2010, NAT REV UROL, V7, P392, DOI 10.1038/nrurol.2010.77
   Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57
   Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025
   van Kuppeveld FJM, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1018
   Voisset C, 2008, MICROBIOL MOL BIOL R, V72, P157, DOI 10.1128/MMBR.00033-07
NR 22
TC 151
Z9 153
U1 3
U2 34
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 7
PY 2010
VL 107
IS 36
BP 15874
EP 15879
DI 10.1073/pnas.1006901107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 647RY
UT WOS:000281637800046
PM 20798047
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Foster, WM
   Adler, KB
   Crews, AL
   Potts, EN
   Fischer, BM
   Voynow, JA
AF Foster, W. Michael
   Adler, Kenneth B.
   Crews, Anne L.
   Potts, Erin N.
   Fischer, Bernard M.
   Voynow, Judith A.
TI RETRACTED: MARCKS-related peptide modulates in vivo the secretion of
   airway Muc5ac (Retracted article. See vol. 309, pg. L 750, 2015)
SO AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
LA English
DT Article; Retracted Publication
DE myristoylated alanine-rich C kinase substrate; airway
   hyperresponsiveness; elastase; serotonin
ID MUCIN GENE-EXPRESSION; EPITHELIAL-CELLS; MOUSE MODEL; PROTEIN; ASTHMA;
   MUCUS; INHIBITION; METAPLASIA; RESPONSES; VITRO
AB Foster WM, Adler KB, Crews AL, Potts EN, Fischer BM, Voynow JA. MARCKS-related peptide modulates in vivo the secretion of airway Muc5ac. Am J Physiol Lung Cell Mol Physiol 299: L345-L352, 2010. First published June 11, 2010; doi:10.1152/ajplung.00067.2010.-In a mouse model of neutrophil elastase-induced bronchitis that exhibits goblet cell metaplasia and inflammation, we investigated the effects of intratracheal instillation of the MANS peptide, a peptide identical to the NH2 terminus of the myristoylated alanine-rich C kinase substrate (MARCKS) on mucin protein airway secretion, inflammation, and airway reactivity. To induce mucus cell metaplasia in the airways, male BALB/c mice were treated repetitively with the serine protease, neutrophil elastase, on days 1, 4, and 7. On day 11, when goblet cell metaplasia was fully developed and profiles of proinflammatory cytokines were maximal, the animals were exposed to aerosolized methacholine after intratracheal instillation of MANS or a missense control peptide (RNS). MANS, but not RNS, attenuated the methacholine-stimulated secretion of the major respiratory mucin protein, Muc5ac (50% reduction). Concurrently, elastase-induced proinflammatory cytokines typically recovered in bronchoalveolar lavage (BAL), including KC, IL-1 beta, IL-6, MCP-1, and TNF alpha, were reduced by the MANS peptide (mean levels decreased 50-60%). Secondary to the effects of MANS on mucin secretion and inflammation, mechanical lung function by forced oscillation technique was characterized with respect to airway reactivity in response to cumulative aerosol stimulation with serotonin. The MANS peptide was also found to effectively attenuate airway hyperresponsiveness to serotonin in this airway hypersecretory model. Collectively, these findings support the concept that even in airway epithelia remodeled with goblet cell metaplasia and in a state of mucin hypersecretion, exogenous attenuation of function of MARCKS protein via the MANS peptide decreases airway mucin secretion, inflammation, and hyperreactivity.
C1 [Foster, W. Michael; Potts, Erin N.] Duke Univ, Med Ctr, Dept Med, Div Pulm Allergy & Crit Care Med, Durham, NC 27710 USA.
   [Adler, Kenneth B.; Crews, Anne L.] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC USA.
   [Foster, W. Michael; Fischer, Bernard M.; Voynow, Judith A.] Duke Univ, Med Ctr, Div Pulm, Dept Pediat, Durham, NC 27710 USA.
RP Foster, WM (reprint author), Duke Univ, Med Ctr, Div Pulm, Dept Pediat, Box 2643, Durham, NC 27710 USA.
EM foste028@mc.duke.edu
FU National Institutes of Health [HL-82504, HL-81763, HL-36982, ES-16347,
   AI-81672]
FX Research was supported by National Institutes of Health Grants HL-82504
   (J. A. Voynow), HL-81763 (B. M. Fischer), HL-36982 (K. B. Adler),
   ES-16347 (W. M. Foster), and AI-81672 (W. M. Foster).
CR Agrawal A, 2007, J APPL PHYSIOL, V102, P399, DOI 10.1152/japplphysiol.00630.2006
   Alimam MZ, 2000, AM J RESP CELL MOL, V22, P253, DOI 10.1165/ajrcmb.22.3.3768
   Auten RL, 2009, AM J RESP CRIT CARE, V180, P1218, DOI 10.1164/rccm.200901-0116OC
   Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638
   ECKERT BS, 2009, AM J RESP CELL MOL B, V42, P586
   Fahy JV, 2002, CHEST, V122, p320S, DOI 10.1378/chest.122.6_suppl.320S
   Fernandez VE, 1999, LUNG, V177, P355, DOI 10.1007/PL00007653
   Jester WF, 2007, CHEST, V132, p522S
   KING M, 1985, RESP PHYSIOL, V62, P47, DOI 10.1016/0034-5687(85)90049-0
   Li YH, 2001, J BIOL CHEM, V276, P40982, DOI 10.1074/jbc.M105614200
   Lidell ME, 2008, FEBS J, V275, P481, DOI 10.1111/j.1742-4658.2007.06215.x
   MARTIN TR, 1988, J APPL PHYSIOL, V64, P2318
   Newman TM, 1996, AM J RESP CELL MOL, V15, P529, DOI 10.1165/ajrcmb.15.4.8879187
   Ordonez CL, 2001, AM J RESP CRIT CARE, V163, P517, DOI 10.1164/ajrccm.163.2.2004039
   Phillips Jonathan E., 2006, Journal of Pharmacological and Toxicological Methods, V53, P160, DOI 10.1016/j.vasen.2005.03.001
   Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005
   Singer M, 2004, NAT MED, V10, P193, DOI 10.1038/nm983
   STEVENS WH, 1990, J APPL PHYSIOL, V69, P875
   Takashi S, 2006, AM J RESP CELL MOL, V34, P647, DOI 10.1165/rcmb.2006-0030RC
   Thornton DJ, 2000, AM J PHYSIOL-LUNG C, V278, pL1118
   Voynow JA, 2004, AM J PHYSIOL-LUNG C, V287, pL1293, DOI 10.1152/ajplung.00140.2004
   Voynow JA, 1998, LUNG, V176, P345, DOI 10.1007/PL00007616
   Voynow JA, 2009, AM J RESP CELL MOL, V41, P107, DOI 10.1165/rcmb.2008-0381OC
NR 23
TC 20
Z9 20
U1 2
U2 7
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1040-0605
EI 1522-1504
J9 AM J PHYSIOL-LUNG C
JI Am. J. Physiol.-Lung Cell. Mol. Physiol.
PD SEP
PY 2010
VL 299
IS 3
BP L345
EP L352
DI 10.1152/ajplung.00067.2010
PG 8
WC Physiology; Respiratory System
SC Physiology; Respiratory System
GA 645IZ
UT WOS:000281449500006
PM 20543006
OA Green Published
DA 2018-12-27
ER

PT J
AU Sivasubramanian, M
AF Sivasubramanian, M.
TI RETRACTED: New parallel theory (Retracted article. See vol. 24, pg. 406,
   2011)
SO APPLIED MATHEMATICS LETTERS
LA English
DT Article; Retracted Publication
DE Euclidean theory of parallel; Spherical geometry; New parallel theory
AB It is well known that for a given line, there is only one parallel line through a point in Euclidean space, there are many parallel lines through a point in Lobachevskian space and there are no parallel through a point in spherical space. But in this work, the author has attempted and showed that there is a set of parallel segment spheres. (C) 2010 Elsevier Ltd. All rights reserved.
C1 Dr Mahalingam Coll Engn & Technol, Dept Math, Pollachi 642003, Tamil Nadu, India.
RP Sivasubramanian, M (reprint author), Dr Mahalingam Coll Engn & Technol, Dept Math, Pollachi 642003, Tamil Nadu, India.
EM profpk49@yahoo.com
CR Sivasubramanian M, 2009, Journal of Mathematics and Statistics, V5, P88
   Sivasubramanian M, 2009, Journal of Mathematics and Statistics, V5, P90
   Sivasubramanian M, 2008, Journal of Mathematics and Statistics, V4, P148
   Sivasubramanian M, 2009, SCI RES ESSAYS, V4, P1408
   SIVASUBRAMANIAN M, 2009, EUROPEAN J SCI RES, V38, P157
   SIVASUBRAMANIAN M, 2009, INDIAN J SCI TECHNOL, V2, P23
   SIVASUBRAMANIAN M, 2009, NATURE SCI, V7, P31
   SIVASUBRAMANIAN M, 2009, RESEARCHER, V1, P44
   SIVASUBRAMANIAN M, COMPUTERS MATH APPL
   SIVASUBRAMANIAN M, 2009, RESEARCHER, V1, P58
   SIVASUBRAMANIAN M, 2009, ADV ALGEBRA, V2, P43
   SIVASUBRAMANIAN M, 2008, J MATH STAT, V4, P122
NR 12
TC 0
Z9 0
U1 2
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0893-9659
J9 APPL MATH LETT
JI Appl. Math. Lett.
PD SEP
PY 2010
VL 23
IS 9
BP 1137
EP 1139
DI 10.1016/j.aml.2010.05.003
PG 3
WC Mathematics, Applied
SC Mathematics
GA 627BO
UT WOS:000280013200037
OA Bronze
DA 2018-12-27
ER

PT J
AU Zhang, W
   Liu, W
AF Zhang, Wen
   Liu, Wei
TI RETRACTED: Evidence for recombination between vaccine and wild-type
   mumps virus strains (Retracted Article. See vol 156, pg 929, 2011)
SO ARCHIVES OF VIROLOGY
LA English
DT Article; Retracted Publication
ID L-ZAGREB; SEQUENCES; EVOLUTION; HANTAVIRUS; POLIOVIRUS; GENES
AB Recombination of mumps virus (MuV) has rarely been reported. In this study, phylogenetic and recombination analyses were performed on 30 complete MuV genomes, including 17 vaccine and 13 wild-type strains. One potentially significant recombination event was found to have occurred between the lineage represented by the vaccine strain L3/Russia/Vector (AY508995) as the minor parent and wild MuV strain Drag94 (AY669145) as the major parent, and this led to a recombinant, 9218/Zg98 (EU370206), a wild-type MuV strain isolated from a 3-year-old boy with parotitis. In summary, we found a recombinant of MuV derived from vaccine and wild-type MuV strains.
C1 [Zhang, Wen] Jiangsu Univ, Sch Med Sci & Lab Med, Jiangsu 212013, Peoples R China.
   [Liu, Wei] Fudan Univ, Shanghai Med Coll, Inst Med Microbiol, Key Lab Med Mol Virol, Shanghai 200032, Peoples R China.
   [Liu, Wei] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China.
RP Zhang, W (reprint author), Jiangsu Univ, Sch Med Sci & Lab Med, 301 Xuefu Rd, Jiangsu 212013, Peoples R China.
EM z0216wen@yahoo.com
FU Professional Research Foundation for Advanced Talents of Jiangsu
   University [10JDG059]
FX This work was supported by the Professional Research Foundation for
   Advanced Talents of Jiangsu University under Grant No. 10JDG059.
CR Atrasheuskaya AV, 2006, VACCINE, V24, P1530, DOI 10.1016/j.vaccine.2005.10.009
   BECK M, 1989, J BIOL STAND, V17, P85, DOI 10.1016/0092-1157(89)90031-0
   ELANGO N, 1988, J GEN VIROL, V69, P2893, DOI 10.1099/0022-1317-69-11-2893
   Galazka AM, 1999, B WORLD HEALTH ORGAN, V77, P3
   Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573
   Hviid A, 2008, LANCET, V371, P932, DOI 10.1016/S0140-6736(08)60419-5
   Ivancic J, 2005, VIRUS RES, V109, P95, DOI 10.1016/j.virusres.2004.11.013
   Ivancic-Jelecki J, 2008, INFECT GENET EVOL, V8, P603, DOI 10.1016/j.meegid.2008.04.007
   Karakasiliotis I, 2005, J GEN VIROL, V86, P3137, DOI 10.1099/vir.0.80823-0
   Kosutic-Gulija T, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-79
   Liu HM, 2003, J VIROL, V77, P10994, DOI 10.1128/JVI.77.20.10994-11005.2003
   Malim MH, 2001, CELL, V104, P469, DOI 10.1016/S0092-8674(01)00234-3
   Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562
   Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490
   Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98
   Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056
   Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698
   Riquet FB, 2008, J VIROL, V82, P8927, DOI 10.1128/JVI.00239-08
   Santak M, 2006, J MED VIROL, V78, P638, DOI 10.1002/jmv.20587
   Sibold C, 1999, J VIROL, V73, P667
   Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06
   Sironen T, 2001, J VIROL, V75, P11803, DOI 10.1128/JVI.75.23.11803-11810.2001
   SMITH JM, 1992, J MOL EVOL, V34, P126
   Tanabayashi K, 1990, Virus Genes, V3, P361, DOI 10.1007/BF00569042
   Worobey M, 1999, P NATL ACAD SCI USA, V96, P7352, DOI 10.1073/pnas.96.13.7352
NR 25
TC 1
Z9 2
U1 3
U2 13
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD SEP
PY 2010
VL 155
IS 9
BP 1493
EP 1496
DI 10.1007/s00705-010-0733-x
PG 4
WC Virology
SC Virology
GA 653KT
UT WOS:000282090900015
PM 20574642
DA 2018-12-27
ER

PT J
AU Safarinejad, MR
AF Safarinejad, Mohammad Reza
TI RETRACTED: The effects of the adjunctive bupropion on male sexual
   dysfunction induced by a selective serotonin reuptake inhibitor: a
   double-blind placebo-controlled and randomized study (Retracted article.
   See vol. 115, pg. E11, 2015)
SO BJU INTERNATIONAL
LA English
DT Article; Retracted Publication
DE bupropion; SSRI; sexual dysfunction; treatment; male
ID MAJOR DEPRESSIVE DISORDER; ERECTILE DYSFUNCTION; SUSTAINED-RELEASE;
   CONTROLLED TRIAL; SCALE; ANTIDEPRESSANTS; PREVALENCE; SILDENAFIL; WOMEN
AB OBJECTIVE
   To determine the safety and efficacy of adjunctive bupropion sustained-release (SR) on male sexual dysfunction (SD) induced by a selective serotonin reuptake inhibitor (SSRI), as SD is a common side-effect of SSRIs and the most effective treatments have yet to be determined.
   PATIENTS AND METHODS
   The randomized sample consisted of 234 euthymic men who were receiving some type of SSRI. The men were randomly assigned to bupropion SR (150 mg twice daily, 117) or placebo (twice daily, 117) for 12 weeks. Efficacy was evaluated using the Clinical Global Impression-Sexual Function (CGI-SF; the primary outcome measure), the International Index of Erectile Function (IIEF), Arizona Sexual Experience Scale (ASEX), and Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) (secondary outcome measures). Participants were followed biweekly during study period.
   RESULTS
   After 12 weeks of treatment, the mean (sd) scores for CGI-SF were significantly lower, i.e. better, in patients on bupropion SR, at 2.4 (1.2), than in the placebo group, at 3.9 (1.1) (P = 0.01). Men who received bupropion had a significant increase in the total IIEF score (54.4% vs 1.2%; P = 0.003), and in the five different domains of the IIEF. Total ASEX scores were significantly lower, i.e. better, among men who received bupropion than placebo, at 15.5 (4.3) vs 21.5 (4.7) (P = 0.002). The EDITS scores were 67.4 (10.2) for the bupropion and 36.3 (11.7) for the placebo group (P = 0.001). The ASEX score and CGI-SF score were correlated (P = 0.003). In linear regression analyses the CGI-SF score was not affected significantly by the duration of SD, type of SSRI used and age.
   CONCLUSIONS
   Bupropion is an effective treatment for male SD induced by SSRIs. These results provide empirical support for conducting a further study of bupropion.
C1 Shahid Beheshti Univ MC, Urol & Nephrol Res Ctr, Tehran, Iran.
RP Safarinejad, MR (reprint author), Shahid Beheshti Univ MC, Urol & Nephrol Res Ctr, POB 19395-1849, Tehran, Iran.
EM safarinejad@unrc.ir
OI Safarinejad, Mohammad Reza/0000-0003-3055-5915
CR Althof SE, 1999, UROLOGY, V53, P793, DOI 10.1016/S0090-4295(98)00582-2
   Atkinson JH, 1999, PAIN, V83, P137, DOI 10.1016/S0304-3959(99)00082-2
   Aukst-Margetic B, 2005, PROG NEURO-PSYCHOPH, V29, P754, DOI 10.1016/j.pnpbp.2005.04.007
   BALON R, 1993, J CLIN PSYCHIAT, V54, P209
   Balon R, 2006, AM J PSYCHIAT, V163, P1504, DOI 10.1176/appi.ajp.163.9.1504
   Clayton A, 2006, J AFFECT DISORDERS, V91, P27, DOI 10.1016/j.jad.2005.12.007
   Clayton AH, 2004, J CLIN PSYCHIAT, V65, P62
   Clayton Anita H, 2002, Curr Womens Health Rep, V2, P182
   DeBattista C, 2005, J CLIN PSYCHIAT, V66, P844, DOI 10.4088/JCP.v66n0706
   FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011
   Guy W., 1976, ECDEU ASSESSMENT MAN
   HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56
   HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x
   Herrera-Guzman I, 2008, PSYCHIAT RES, V160, P72, DOI 10.1016/j.psychres.2007.04.012
   Jespersen S, 2004, INT CLIN PSYCHOPHARM, V19, P161, DOI 10.1097/01.yic.0000122863.35081.84
   Landen M, 1999, J CLIN PSYCHOPHARM, V19, P268, DOI 10.1097/00004714-199906000-00012
   Lane RM, 1997, J PSYCHOPHARMACOL, V11, P72, DOI 10.1177/026988119701100117
   Masand PS, 2001, AM J PSYCHIAT, V158, P805, DOI 10.1176/appi.ajp.158.5.805
   McGahuey CA, 2000, J SEX MARITAL THER, V26, P25, DOI 10.1080/009262300278623
   Meston CM, 2004, J SEX MARITAL THER, V30, P57, DOI 10.1080/00926230490247093
   Michelson D, 2000, AM J PSYCHIAT, V157, P239, DOI 10.1176/appi.ajp.157.2.239
   Mitamaa T, 2006, PHARMACOL BIOCHEM BE, V83, P360, DOI 10.1016/j.pbb.2006.02.015
   MontejoGonzalez AL, 1997, J SEX MARITAL THER, V23, P176
   Montgomery SA, 2002, J AFFECT DISORDERS, V69, P119, DOI 10.1016/S0165-0327(01)00313-5
   Murray JB, 1998, J PSYCHOL, V132, P407, DOI 10.1080/00223989809599275
   *NAT AMB CAR MED S, 1999, ADV DATA, V305, P1
   Numberg HG, 2008, DRUG TODAY, V44, P147, DOI 10.1358/dot.2008.44.2.1191059
   Nurnberg HG, 2003, JAMA-J AM MED ASSOC, V289, P56, DOI 10.1001/jama.289.1.56
   Paredes RG, 2004, PROG NEUROBIOL, V73, P179, DOI 10.1016/j.pneurobio.2004.05.001
   Ramasubbu R, 1999, J PSYCHIATR NEUROSCI, V24, P45
   Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0
   Safarinejad MR, 2008, J CLIN PSYCHOPHARM, V28, P418, DOI 10.1097/JCP.0b013e31817e6f80
   Safarinejad MR, 2008, J UROLOGY, V179, P1066, DOI 10.1016/j.juro.2007.10.063
   Safarinejad MR, 2003, INT J IMPOT RES, V15, P246, DOI 10.1038/sj.ijir.3901024
   Segraves RT, 2007, J CLIN PSYCHOPHARM, V27, P62, DOI 10.1097/JCP.0b013e31802e2d60
   Segraves RT, 2004, J CLIN PSYCHOPHARM, V24, P339, DOI 10.1097/01.jcp.0000125686.20338.cl
   Stahl SM, 2004, PRIM CARE COMPANION, V6, P159, DOI DOI 10.4088/PCC.V06N0403
   Wilens TE, 2005, BIOL PSYCHIAT, V57, P793, DOI 10.1016/j.biopsych.2005.01.027
   Williams VSL, 2006, J CLIN PSYCHIAT, V67, P204, DOI 10.4088/JCP.v67n0205
NR 39
TC 28
Z9 28
U1 2
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1464-4096
EI 1464-410X
J9 BJU INT
JI BJU Int.
PD SEP
PY 2010
VL 106
IS 6
BP 840
EP 847
DI 10.1111/j.1464-410X.2009.09154.x
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA 643HK
UT WOS:000281286000019
PM 20067456
OA Bronze
DA 2018-12-27
ER

PT J
AU Wang, SD
   Zhou, YW
AF Wang, Sheng-Dong
   Zhou, Yong-Wu
TI RETRACTED: Supply chain coordination models for newsvendor-type
   products: Considering advertising effect and two production modes
   (Retracted article. See vol. 61, pg. 904, 2011)
SO COMPUTERS & INDUSTRIAL ENGINEERING
LA English
DT Article; Retracted Publication
DE Supply chain coordination; Newsvendor-type products; Advertising
   expenditure; Two production modes; Partial backlogging; Improved
   revenue-sharing contract
ID ORDERING OPPORTUNITIES; QUANTITY DECISIONS; NEWSBOY PROBLEM; DEMAND;
   MANUFACTURER; POLICIES; GOODS; CONSTRAINT; CONTRACTS; BUYER
AB This paper discusses production and order as well as advertising coordination issues in a single-manufacturer single-buyer supply chain, where the manufacturer sells a newsvendor-type product through the buyer who faces a random demand depending on advertising expenditure. Before the start of the selling period, the buyer needs to determine how much she should invest in advertising and how many units of products she should order from the manufacturer. By the end of the season, if the revealed demand exceeds stock on hand, the buyer has an opportunity to place a second order from manufacturer to meet part of the unfilled demand. The ordered items are produced by the manufacturer in two production modes for different requirements. Under such a setting, the centralized and decentralized decision models are developed respectively, and the closed form solution to each model is provided as well. An improved revenue-sharing contract is proposed to achieve the supply chain coordination. (c) 2010 Elsevier Ltd. All rights reserved.
C1 [Wang, Sheng-Dong] Hefei Elect Engn Inst, Dept Math, Hefei 230037, Peoples R China.
   [Wang, Sheng-Dong] Hefei Univ Technol, Sch Management, Hefei 230009, Peoples R China.
   [Zhou, Yong-Wu] S China Univ Technol, Sch Business Adm, Guangzhou 510641, Peoples R China.
RP Wang, SD (reprint author), Hefei Elect Engn Inst, Dept Math, Hefei 230037, Peoples R China.
EM mswangsd@sina.com.cn; zyw_666@hotmail.com
FU National Natural Science Foundation of China [70771034, 70772029,
   70971041]; Foundation for the Author of National Excellent Doctoral
   Dissertation of PR China [200565]; Project for Social Science Study of
   Guangdong [08JDXM63003]
FX We thank the Editor and the anonymous referees for their kindness and
   constructive comments on the earlier version of this paper. This
   research was supported in part by National Natural Science Foundation of
   China under Grant No. 70771034, 70772029 and 70971041, a Foundation for
   the Author of National Excellent Doctoral Dissertation of PR China under
   Grant No. 200565, and Project for Social Science Study of Guangdong
   under Grant No. 08JDXM63003.
CR Agrawal V., 2000, Manufacturing & Service Operations Management, V2, P410, DOI 10.1287/msom.2.4.410.12339
   Atkinson A. A., 1979, Decision Sciences, V10, P341, DOI 10.1111/j.1540-5915.1979.tb00030.x
   Bronnenberg BJ, 1998, J MARKETING RES, V35, P399, DOI 10.2307/3152037
   CACHON G, 1999, CONTRACTING ASSURE S
   Cachon G. P., 2003, HDB OPERATIONS RES M, V11
   Cachon GP, 2005, MANAGE SCI, V51, P30, DOI 10.1287/mnsc.1040.0215
   Chen HY, 2006, INT J PROD ECON, V103, P347, DOI 10.1016/j.ijpe.2005.09.002
   Choi TM, 2003, J OPER RES SOC, V54, P846, DOI 10.1057/palgrave.jors.2601584
   Donohue KL, 2000, MANAGE SCI, V46, P1397, DOI 10.1287/mnsc.46.11.1397.12088
   Emmons H, 1998, MANAGE SCI, V44, P276, DOI 10.1287/mnsc.44.2.276
   Eppen GD, 1997, OPER RES, V45, P805, DOI 10.1287/opre.45.6.805
   Eppen GD, 1997, MANAGE SCI, V43, P1469, DOI 10.1287/mnsc.43.11.1469
   Feinberg FM, 2001, MANAGE SCI, V47, P1476, DOI 10.1287/mnsc.47.11.1476.10246
   GERCHAK Y, 1987, COMPUT OPER RES, V14, P1, DOI 10.1016/0305-0548(87)90052-9
   GOODMAN DA, 1970, J MARKETING, V34, P31, DOI 10.2307/1250709
   GOYAL SK, 1995, COMPUT IND ENG, V28, P755, DOI 10.1016/0360-8352(95)00016-T
   Gurnani H, 1999, MANAGE SCI, V45, P1456, DOI 10.1287/mnsc.45.10.1456
   Ismail B. E., 1979, Decision Sciences, V10, P205, DOI 10.1111/j.1540-5915.1979.tb00019.x
   Iyer AV, 1997, MANAGE SCI, V43, P559, DOI 10.1287/mnsc.43.4.559
   Jones John Philip, 1995, ADS WORK NEW PROOF A
   Kabak I, 1978, SLOAN MANAGE REV, V10, P53
   Khouja M, 2003, INT J PROD ECON, V86, P93, DOI 10.1016/S0925-5273(03)00008-2
   Khouja M, 1999, OMEGA-INT J MANAGE S, V27, P537, DOI 10.1016/S0305-0483(99)00017-1
   Lau AHL, 1998, INT J PROD ECON, V55, P57, DOI 10.1016/S0925-5273(98)00040-1
   LAU HS, 1980, J OPER RES SOC, V31, P525, DOI 10.1057/jors.1980.96
   Lau HS, 1997, EUR J OPER RES, V103, P557, DOI 10.1016/S0377-2217(96)00117-8
   Lee CH, 2007, INT J PROD ECON, V106, P307, DOI 10.1016/j.ijpe.2006.06.019
   Luo WH, 1998, COMPUT IND ENG, V34, P685, DOI 10.1016/S0360-8352(97)00327-6
   Mantrala M, 2002, HDB MARKETING, P409
   NAHMIAS S, 1984, NAV RES LOG, V31, P463, DOI 10.1002/nav.3800310311
   Pasternack B. A., 1985, MARKET SCI, V4, P166, DOI DOI 10.1287/MKSC.4.2.166
   SHIMP TA, 1997, ADVERTISING PROMOTIO
   SUBRAMANYAM ES, 1981, AIIE T, V13, P312, DOI 10.1080/05695558108974567
   Taylor TA, 2002, MANAGE SCI, V48, P992, DOI 10.1287/mnsc.48.8.992.168
   Weng ZK, 2003, EUR J OPER RES, V151, P12, DOI 10.1016/S0377-2217(02)00577-5
   Weng ZK, 2004, EUR J OPER RES, V156, P148, DOI 10.1016/S0377-2217(03)00003-1
   Whitin T. M., 1955, MANAGE SCI, V2, P61
   Zhou Y, 2007, APPL MATH MODEL, V31, P1029, DOI 10.1016/j.apm.2006.02.011
   Zhou YW, 2009, EUR J OPER RES, V198, P958, DOI 10.1016/j.ejor.2008.10.026
NR 39
TC 8
Z9 13
U1 3
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-8352
J9 COMPUT IND ENG
JI Comput. Ind. Eng.
PD SEP
PY 2010
VL 59
IS 2
BP 220
EP 231
DI 10.1016/j.cie.2010.04.003
PG 12
WC Computer Science, Interdisciplinary Applications; Engineering,
   Industrial
SC Computer Science; Engineering
GA 635LF
UT WOS:000280656300005
DA 2018-12-27
ER

PT J
AU Smiri, M
   Chaoui, A
   Rouhier, N
   Gelhaye, E
   Jacquot, JP
   El Ferjani, E
AF Smiri, Moez
   Chaoui, Abdelilah
   Rouhier, Nicolas
   Gelhaye, Eric
   Jacquot, Jean-Pierre
   El Ferjani, Ezzedine
TI RETRACTED: Effect of cadmium on resumption of respiration in cotyledons
   of germinating pea seeds (Retracted article. See vol. 84, pg. 360, 2012)
SO ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
LA English
DT Article; Retracted Publication
DE Cadmium; Fermentation; Germination; Pentose phosphate; Pea; Respiration
ID PISUM-SATIVUM L.; ALCOHOL-DEHYDROGENASE; OXIDATIVE STRESS; ANTIOXIDATIVE
   ENZYMES; ELECTRON-TRANSPORT; PLANT-MITOCHONDRIA; SOYBEAN LEAVES; RICE
   SEEDLINGS; VICIA-FABA; IN-VIVO
AB Pea seeds (Pisum sativum L) were germinated by soaking in H2O or 5 mM CdCl2 during a 5-day period. Enzyme activities involved in respiratory metabolism were studied in cotyledons. Mitochondrial cytochrome c oxidase and NADH- and succinate-cytochrome c reductase activities were inhibited by cadmium treatment. The effects of Cd were performed in vivo and in vitro allowing to distinguish between the direct inhibition of the enzyme activities and the influence on the same enzymes into the cell environment. However, Cd exposure stimulated an enzyme activity of fermentation and inhibited the capacity of the enzyme inactivator (alcohol dehydrogenase inactivator). Moreover, the enzyme activities of NAD(P)H-recycling dehydrogenases via secondary pentose phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases, were enhanced in Cd-stressed seeds. These disturbances suggest that cadmium may inflict a serious injury on renewal of respiration. The findings will help clarify the overall mechanisms that underlie cadmium-mediated toxicity in germinating seeds. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Smiri, Moez; Chaoui, Abdelilah; El Ferjani, Ezzedine] Fac Sci Bizerte, Zarzouna 7021, Tunisia.
   [Smiri, Moez; Rouhier, Nicolas; Gelhaye, Eric; Jacquot, Jean-Pierre] Univ Henri Poincare, INRA, Fac Sci, IFR110,UMR Interact Arbres Microorganismes 1136, F-54506 Vandoeuvre Les Nancy, France.
RP Smiri, M (reprint author), Fac Sci Bizerte, Zarzouna 7021, Tunisia.
EM moez.smiri@scbiol.uhp-nancy.fr
RI gelhaye, eric/K-7390-2013
OI gelhaye, eric/0000-0002-0699-9113; Jacquot,
   Jean-Pierre/0000-0003-4975-8587
FU Tunisian High Ministry Education Scientific Research and Technology
   [99/UR/09-18]; INRA-Henri Poincare University, French
FX Scientific work financed by the Tunisian High Ministry Education
   Scientific Research and Technology (99/UR/09-18) and INRA-Henri Poincare
   University, French.
CR Amor Y, 1998, FEBS LETT, V440, P1, DOI 10.1016/S0014-5793(98)01408-2
   [Anonymous], 1983, ENCY PLANT PHYSL C
   Balestrasse KB, 2006, PLANT SCI, V170, P339, DOI 10.1016/j.plantsci.2005.09.001
   BANSAL P, 2000, J ENV ECOPLANT, V3, P249
   BENAVIDES MP, 2005, J PLANT PHYSL, V17, P21, DOI DOI 10.1590/S1677-04202005000100003
   Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055
   BITTELL JE, 1974, PHYSIOL PLANTARUM, V30, P226, DOI 10.1111/j.1399-3054.1974.tb03648.x
   BOUSBIHSFAXI A, 2010, ECOTOX ENV IN PRESS, DOI DOI 10.1016/J.ECOENV.2010.01.005
   Cannino G, 2009, MITOCHONDRION, V9, P377, DOI 10.1016/j.mito.2009.08.009
   CARLSON CL, 1991, WATER AIR SOIL POLL, V59, P231, DOI 10.1007/BF00211832
   Chai WX, 2006, HYPERTENSION, V47, P665, DOI 10.1161/01.HYP.0000205831.39339.a5
   Chaoui A, 2005, CR BIOL, V328, P23, DOI 10.1016/j.crvi.2004.10.001
   Chaoui A, 2004, J PLANT PHYSIOL, V161, P1225, DOI 10.1016/j.jplph.2004.02.002
   Chaoui A, 1997, PLANT SCI, V126, P21, DOI 10.1016/S0168-9452(97)00090-3
   Chugh LK, 1996, ENVIRON POLLUT, V92, P1, DOI 10.1016/0269-7491(95)00093-3
   Conley TR, 1999, PLANT PHYSIOL, V119, P599, DOI 10.1104/pp.119.2.599
   Dixit V, 2002, PLANT CELL ENVIRON, V25, P687, DOI 10.1046/j.1365-3040.2002.00843.x
   DOUCE R, 1972, BIOCHIM BIOPHYS ACTA, V275, P148, DOI 10.1016/0005-2728(72)90035-7
   Ernst W. H. O., 1998, BIOACCUMULATION BIOL, P587
   Garnier L, 2006, PLANT CELL ENVIRON, V29, P1956, DOI 10.1111/j.1365-3040.2006.01571.x
   Gratao PL, 2005, FUNCT PLANT BIOL, V32, P481, DOI 10.1071/FP05016
   GREGER M, 1987, PHYSIOL PLANTARUM, V69, P81, DOI 10.1111/j.1399-3054.1987.tb01948.x
   HERNANDEZ LE, 1996, FERTILIZERS ENV, P503
   Hodges T K, 1974, Methods Enzymol, V32, P392
   Kasimova MR, 2006, PLANT CELL, V18, P688, DOI 10.1105/tpc.105.039354
   Kato-Noguchi H, 2002, J PLANT PHYSIOL, V159, P751, DOI 10.1078/0176-1617-0757
   KESSELER A, 1994, EUR J BIOCHEM, V225, P897, DOI 10.1111/j.1432-1033.1994.0897b.x
   KLEINER D, 1974, ARCH BIOCHEM BIOPHYS, V165, P121, DOI 10.1016/0003-9861(74)90148-9
   KOLLOFFEL C, 1970, ACTA BOT NEERL, V19, P539, DOI 10.1111/j.1438-8677.1970.tb00683.x
   Leon AM, 2002, PLANT PHYSIOL BIOCH, V40, P813, DOI 10.1016/S0981-9428(02)01444-4
   Lozano RM, 1996, PLANTA, V200, P100
   Matsumura H., 1980, METHOD ENZYMOL, V69, P465
   Mattioni C, 1997, J PLANT PHYSIOL, V150, P173, DOI 10.1016/S0176-1617(97)80198-8
   Mihoub A, 2005, CR BIOL, V328, P33, DOI 10.1016/j.crvi.2004.10.003
   Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009
   NAWA Y, 1971, PLANT PHYSIOL, V48, P671, DOI 10.1104/pp.48.6.671
   Noriega GO, 2004, BIOCHEM BIOPH RES CO, V323, P1003, DOI 10.1016/j.bbrc.2004.08.199
   Rahoui S, 2008, ACTA PHYSIOL PLANT, V30, P451, DOI 10.1007/s11738-008-0142-x
   RAUSER WE, 1995, PLANT PHYSIOL, V109, P195, DOI 10.1104/pp.109.1.195
   Rodriguez-Serrano M, 2006, PLANT CELL ENVIRON, V29, P1532, DOI 10.1111/j.1365-3040.2006.01531.x
   Romero-Puertas MC, 2007, J PLANT PHYSIOL, V164, P1346, DOI 10.1016/j.jplph.2006.06.018
   Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x
   Rouhier N, 2001, PLANT PHYSIOL, V127, P1299, DOI 10.1104/pp.127.3.1299
   Sandalio LM, 2001, J EXP BOT, V52, P2115, DOI 10.1093/jexbot/52.364.2115
   Shetty P, 2002, PROCESS BIOCHEM, V37, P1285, DOI 10.1016/S0032-9592(02)00013-4
   SHIMOMURA S, 1983, PLANT PHYSIOL, V71, P736, DOI 10.1104/pp.71.4.736
   SHIMOMURA S, 1983, PLANT PHYSIOL, V71, P742, DOI 10.1104/pp.71.4.742
   Smiri M, 2009, J PLANT PHYSIOL, V166, P259, DOI 10.1016/j.jplph.2008.05.006
   STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H
   SUZUKI Y, 1972, PHYSIOL PLANTARUM, V27, P121, DOI 10.1111/j.1399-3054.1972.tb03587.x
   VAN AF, 1990, PLANT CELL ENVIRON, V13, P195
   WAGNER GJ, 1993, ADV AGRON, V51, P173, DOI 10.1016/S0065-2113(08)60593-3
   Wang LY, 1999, J BACTERIOL, V181, P1211
   WEI Y, 1991, J INORG BIOCHEM, V44, P155, DOI 10.1016/0162-0134(91)80052-J
   Yoshihara T, 2006, PLANT CELL REP, V25, P365, DOI 10.1007/s00299-005-0092-3
   ZHAO ZF, 1987, PLANT PHYSIOL, V84, P987, DOI 10.1104/pp.84.4.987
NR 56
TC 7
Z9 8
U1 3
U2 26
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-6513
EI 1090-2414
J9 ECOTOX ENVIRON SAFE
JI Ecotox. Environ. Safe.
PD SEP
PY 2010
VL 73
IS 6
BP 1246
EP 1254
DI 10.1016/j.ecoenv.2010.05.015
PG 9
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA 650BL
UT WOS:000281822200020
PM 20570353
DA 2018-12-27
ER

PT J
AU Rao, PS
   Mhaisalkar, VA
   Shrivastava, A
   Kumar, A
   Chakrabarti, T
   Devotta, S
AF Rao, Padma S.
   Mhaisalkar, Vasant A.
   Shrivastava, A.
   Kumar, Animesh
   Chakrabarti, T.
   Devotta, S.
TI RETRACTED: Environmental impact of plantations in and around the
   petroleum refinery: a case study (Retracted article. See vol. 191, 2019)
SO ENVIRONMENTAL MONITORING AND ASSESSMENT
LA English
DT Article; Retracted Publication
DE Plantation; Green belt; Petroleum industry
AB Plantation or green belt (GB) grown around the factories and industrial premises improves the condition of land, mitigates air pollution (as the plants serve as a sink for pollutants and check the flow of dust, etc.), and reduces the level of noise pollution. The software developed by NEERI for the determination of the optimal width of GB in and around an industry is based on the pollution attenuation coefficient of selected plant species of deciduous trees existing in the region. The assessment of the impact of these plantations/green belts of 500-m width in and around a petroleum refinery in the west coast of India is evaluated for reducing/managing various waste generated, and it is observed that the overall efficiency is more than 60%.
C1 [Rao, Padma S.; Shrivastava, A.] NEERI KoZL, Kolkata Zonal Lab, Kolkata 700107, India.
   [Mhaisalkar, Vasant A.] VNIT, Environm Engn Div, Nagpur, Maharashtra, India.
   [Kumar, Animesh; Chakrabarti, T.; Devotta, S.] Natl Environm Engn Res Inst, Nagpur 440020, Maharashtra, India.
RP Rao, PS (reprint author), NEERI KoZL, Kolkata Zonal Lab, Kolkata 700107, India.
EM ps_rao@neeri.res.in
OI Devotta, Sukumar/0000-0002-1148-2418
CR BACHE DH, 1979, ATMOS ENVIRON, V13, P1681, DOI 10.1016/0004-6981(79)90327-5
   *CENTR POLL CONTR, 1995, EMISSION REGULATION, V54, P770
   *IND STAND I, 1981, COD PRACT AIR POLL C
   *NEERI, 1993, RAP ENV IMP ASS STUD
   *NEERI, 2001, ENV AUD GUJ REF
   *NEERI, 2002, ENV AUD GUJ REF
   *NEERI, 1995, NEERI GREEN MOD
   *NEERI, 2000, ENV AUD GUJ REF
   WAHI SK, 1992, ENV MANAGEMENT PETRO
NR 9
TC 1
Z9 1
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0167-6369
EI 1573-2959
J9 ENVIRON MONIT ASSESS
JI Environ. Monit. Assess.
PD SEP
PY 2010
VL 168
IS 1-4
BP 55
EP 61
DI 10.1007/s10661-009-1091-6
PG 7
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 635FH
UT WOS:000280640500006
PM 19626446
DA 2018-12-27
ER

PT J
AU Chu, ZKH
AF Chu, Z. Kwang-Hua
TI RETRACTED: Can we tell students where the Higgs boson lies? (Retracted
   article. See vol. 32, pg. 1441, 2011)
SO EUROPEAN JOURNAL OF PHYSICS
LA English
DT Article; Retracted Publication
ID BROKEN SYMMETRIES; STANDARD MODEL; PARTICLES; BREAKING; MASS
AB We pedagogically introduce the search for the Higgs boson and the measurement of its properties which will be one of the primary goals of the Large Hadron Collider. Our presentation will be useful to the relevant graduate and senior undergraduate students studying physics, as well as researchers in this field.
C1 [Chu, Z. Kwang-Hua] Inner Mongolia Univ Sci & Technol, Sch Math Phys & Biol Engn, Baotou 014010, Peoples R China.
   [Chu, Z. Kwang-Hua] Distribut Ctr, Urumqi 830000, Peoples R China.
RP Chu, ZKH (reprint author), Inner Mongolia Univ Sci & Technol, Sch Math Phys & Biol Engn, Baotou 014010, Peoples R China.
EM xjwipmqin@gmail.com
CR Aitchison I. J. R., 2003, GAUGE THEORIES PARTI, V2
   BARDEEN WA, 1990, PHYS REV D, V41, P1647, DOI 10.1103/PhysRevD.41.1647
   Brout R, 2007, CR PHYS, V8, P973, DOI 10.1016/j.crhy.2006.12.004
   CAHN RN, 1989, REP PROG PHYS, V52, P389, DOI 10.1088/0034-4885/52/4/001
   DJOUADI A, 2005, ARXIVHEPPH0503172
   Einstein A, 1905, ANN PHYS-BERLIN, V18, P639
   ENGLERT F, 1964, PHYS REV LETT, V13, P321, DOI 10.1103/PhysRevLett.13.321
   Espinosa JR, 2008, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2008/05/002
   Higgs P, 2007, CR PHYS, V8, P970, DOI 10.1016/j.crhy.2006.12.006
   HIGGS PW, 1964, PHYS REV LETT, V13, P508, DOI 10.1103/PhysRevLett.13.508
   HIGGS PW, 1964, PHYS LETT, V12, P132, DOI 10.1016/0031-9163(64)91136-9
   Jackson CB, 2010, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2010/04/004
   KLEIN O, 1986, SURVEYS HIGH ENERG P, V5, P269
   Plehn T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.111801
   POLYAKOV AM, 1974, JETP LETT+, V20, P194
   QUIGG C, 2006, NEW PHYS 21 CENTURY, P86
   Quigg C, 2007, REP PROG PHYS, V70, P1019, DOI 10.1088/0034-4885/70/7/R01
   Renton PB, 2002, REP PROG PHYS, V65, P1271, DOI 10.1088/0034-4885/65/9/202
   't Hooft G, 2000, REV MOD PHYS, V72, P333, DOI 10.1103/RevModPhys.72.333
   TREILLE D, 1994, REP PROG PHYS, V57, P1137, DOI 10.1088/0034-4885/57/11/002
NR 20
TC 1
Z9 1
U1 4
U2 11
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0143-0807
EI 1361-6404
J9 EUR J PHYS
JI Eur. J. Phys.
PD SEP
PY 2010
VL 31
IS 5
BP 1149
EP 1158
DI 10.1088/0143-0807/31/5/016
PG 10
WC Education, Scientific Disciplines; Physics, Multidisciplinary
SC Education & Educational Research; Physics
GA 644WY
UT WOS:000281414000016
DA 2018-12-27
ER

PT J
AU Gine, E
   Martinez, A
   Villamor, N
   Lopez-Guillermo, A
   Camos, M
   Martinez, D
   Esteve, J
   Calvo, X
   Muntanola, A
   Abrisqueta, P
   Rozman, M
   Rozman, C
   Bosch, F
   Campo, E
   Montserrat, E
AF Gine, Eva
   Martinez, Antoni
   Villamor, Neus
   Lopez-Guillermo, Armando
   Camos, Mireia
   Martinez, Daniel
   Esteve, Jordi
   Calvo, Xavier
   Muntanola, Ana
   Abrisqueta, Pau
   Rozman, Maria
   Rozman, Ciril
   Bosch, Francesc
   Campo, Elias
   Montserrat, Emili
TI RETRACTED: Expanded and highly active proliferation centers identify a
   histological subtype of chronic lymphocytic leukemia ("accelerated"
   chronic lymphocytic leukemia) with aggressive clinical behavior
   (Retracted Article. See vol 95, pg 1620, 2010)
SO HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
LA English
DT Article; Retracted Publication
DE accelerated chronic lymphocytic leukemia; lymph node biopsy; ZAP-70
ID LYMPH-NODE HISTOLOGY; ZAP-70 EXPRESSION; RICHTERS-SYNDROME; DISEASE;
   GUIDELINES; DIAGNOSIS; SURVIVAL
AB Background The concept of "accelerated" chronic lymphocytic leukemia is frequently used by both pathologists and clinicians. However, neither histological criteria to define this form of chronic lymphocytic leukemia nor its clinical correlates and prognostic impact have been formally defined in large series of patients.
   Design and Methods Tissue biopsies from 100 patients with chronic lymphocytic leukemia were analyzed for the size of proliferation centers and their proliferation rate as assessed by mitosis count and Ki-67 immunostaining. Histological patterns were correlated with main clinico-biological features and outcome.
   Results A suspicion of disease transformation was the main reason for carrying out tissue biopsy, which was performed at a median time of 14 months (range, 0 to 204 months) after the diagnosis of chronic lymphocytic leukemia. The biopsy showed histological transformation to diffuse large B-cell lymphoma in 22 cases. In the remaining 78 patients, the presence of expanded proliferation centers (broader than a 20x field) and high proliferation rate (either >2.4 mitoses/proliferation center or Ki-67 >40%/proliferation center) predicted a poor outcome and were selected to define a highly proliferative group. Thus, 23 patients with either expanded proliferation centers or high proliferation rate were considered as having "accelerated" chronic lymphocytic leukemia. These patients displayed particular features, including higher serum lactate dehydrogenase levels and more frequently elevated ZAP-70 than "non-accelerated" cases. The median survival from biopsy of patients with "non-accelerated" chronic lymphocytic leukemia, "accelerated" chronic lymphocytic leukemia and transformation to diffuse large B-cell leukemia was 76, 34, and 4.3 months, respectively (P<0.001).
   Conclusions The presence of expanded and/or highly active proliferation centers identifies a group of patients with "accelerated" chronic lymphocytic leukemia characterized by an aggressive clinical behavior.
C1 [Gine, Eva; Lopez-Guillermo, Armando; Esteve, Jordi; Calvo, Xavier; Muntanola, Ana; Abrisqueta, Pau; Rozman, Ciril; Bosch, Francesc; Montserrat, Emili] Hosp Clin Barcelona, Dept Hematol, Inst Hematol & Oncol, E-08036 Barcelona, Spain.
   [Martinez, Antoni; Villamor, Neus; Camos, Mireia; Martinez, Daniel; Rozman, Maria; Campo, Elias] Hosp Clin Barcelona, Hematopathol Unit, E-08036 Barcelona, Spain.
RP Bosch, F (reprint author), Hosp Clin Barcelona, Dept Hematol, Inst Hematol & Oncol, Hosp Clin Villarroel 170, E-08036 Barcelona, Spain.
EM fbosch@clinic.ub.es
RI Martinez, Antonio/D-8188-2012
OI Martinez, Antonio/0000-0003-0790-9017; Calvo,
   Xavier/0000-0001-7934-9130; Martinez, Daniel/0000-0001-7492-5311; Camos,
   Mireia/0000-0003-3658-7942; Campo, elias/0000-0001-9850-9793; Bosch,
   Francesc/0000-0001-9241-2886
FU Spanish Ministry of Health [FIS- PI07/0409, PI08/0095, Pi08/0304,
   RT06/0020/002051, 2009-SGR-1008, CICYT SAF 2008-03630]; RTICC (Red
   Tematica de Investigacion Cooperativa en Cancer) [RD06/0020/0051]
FX Funding: this work was supported by grants from the Spanish Ministry of
   Health, FIS- PI07/0409, PI08/0095, Pi08/0304, RT06/0020/002051,
   2009-SGR-1008, CICYT SAF 2008-03630 and by the RTICC (Red Tematica de
   Investigacion Cooperativa en Cancer, RD06/0020/0051).
CR Asplund SL, 2002, AM J SURG PATHOL, V26, P624, DOI 10.1097/00000478-200205000-00008
   Bea S, 2002, AM J PATHOL, V161, P957, DOI 10.1016/S0002-9440(10)64256-3
   BENEZRA J, 1989, BLOOD, V73, P579
   Bonato M, 1998, AM J SURG PATHOL, V22, P49, DOI 10.1097/00000478-199801000-00006
   Caligaris-Cappio F, 2008, J CLIN ONCOL, V26, P4497, DOI 10.1200/JCO.2007.15.4393
   Carreras J, 2005, J PATHOL, V205, P507, DOI 10.1002/path.1727
   Cheson BD, 1996, BLOOD, V87, P4990
   Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720
   Cobo F, 2002, LEUKEMIA, V16, P1028, DOI 10.1038/sj/leu/2402529
   COX DR, 1972, J R STAT SOC B, V34, P187
   Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143
   Damle RN, 2002, BLOOD, V99, P4087, DOI 10.1182/blood.V99.11.4087
   DICK FR, 1978, CANCER, V41, P283, DOI 10.1002/1097-0142(197801)41:1<283::AID-CNCR2820410140>3.0.CO;2-H
   Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602
   Ginaldi L, 1998, J CLIN PATHOL, V51, P364, DOI 10.1136/jcp.51.5.364
   Granziero L, 2001, BLOOD, V97, P2777, DOI 10.1182/blood.V97.9.2777
   Halldorsdottir AM, 2007, LEUKEMIA LYMPHOMA, V48, P1338, DOI 10.1080/10428190701377022
   Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906
   Hamblin TJ, 1999, BLOOD, V94, P1848
   Herreros B, 2010, LEUKEMIA, V24, P872, DOI 10.1038/leu.2009.285
   Hothorn T, 2003, COMPUT STAT DATA AN, V43, P121
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   Lampert IA, 1999, HUM PATHOL, V30, P648, DOI 10.1016/S0046-8177(99)90089-8
   Lennert K., 1978, MALIGNANT LYMPHOMAS
   LENNERT K, 1990, HISTOPATHOLOGY NONHO
   MORRISON WH, 1989, J CLIN ONCOL, V7, P598, DOI 10.1200/JCO.1989.7.5.598
   PETO R, 1973, BIOMETRICS, V29, P579, DOI 10.2307/2529177
   ROZMAN C, 1995, NEW ENGL J MED, V333, P1052, DOI 10.1056/NEJM199510193331606
   SanchezBeato M, 1997, AM J PATHOL, V151, P151
   SCHMID C, 1994, HISTOPATHOLOGY, V24, P445, DOI 10.1111/j.1365-2559.1994.tb00553.x
   Schroers R, 2005, LEUKEMIA, V19, P750, DOI 10.1038/sj.leu.2403707
   Soma LA, 2006, HUM PATHOL, V37, P152, DOI 10.1016/j.humpath.2005.09.029
   STILGENBAUER S, 2005, BLOOD, V106, P715
   SWERDLOW SH, 1984, BRIT J CANCER, V50, P587, DOI 10.1038/bjc.1984.225
   Swerdlow SH, 2008, WHO CLASSIFICATION T
   Tsimberidou AM, 2006, J CLIN ONCOL, V24, P2343, DOI 10.1200/JCO.2005.05.0187
NR 36
TC 69
Z9 71
U1 4
U2 4
PU FERRATA STORTI FOUNDATION
PI PAVIA
PA VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY
SN 0390-6078
EI 1592-8721
J9 HAEMATOL-HEMATOL J
JI Haematol-Hematol. J.
PD SEP
PY 2010
VL 95
IS 9
BP 1526
EP 1533
DI 10.3324/haematol.2010.022277
PG 8
WC Hematology
SC Hematology
GA 651NA
UT WOS:000281933200015
PM 20421272
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Chang, H
   Jiang, N
   Jiang, H
   Saha, MN
   Qi, CI
   Xu, W
   Reece, D
AF Chang, Hong
   Jiang, Nan
   Jiang, Hua
   Saha, Manujendra N.
   Qi, Connie
   Xu, Wei
   Reece, Donna
TI RETRACTED: CKS1B nuclear expression is inversely correlated with
   p27(Kip1) expression and is predictive of an adverse survival in
   patients with multiple myeloma (Retracted Article. See vol 95, pg 1620,
   2010)
SO HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
LA English
DT Article; Retracted Publication
DE multiple myeloma; 1q21; cyclin kinase subunit 1B; immunohistochemistry;
   fluorescence in situ hybridization
ID COMPARATIVE GENOMIC HYBRIDIZATION; IN-SITU HYBRIDIZATION; STEM-CELL
   TRANSPLANTATION; CHROMOSOME BAND 1Q21; AMPLIFICATION; GENE;
   IMMUNOHISTOCHEMISTRY; LEUKEMIA; INCREASE; DISEASE
AB Background CKS1B is a member of the highly conserved cyclin kinase subunit 1 (CKS1) family that interacts with cyclin-dependent kinases and plays an important role in cell cycle progression. We and others have shown that CKS1B amplification located on chromosome 1q21 is an adverse prognostic factor in multiple myeloma, but its relationship with CKS1B nuclear protein expression, is unclear. The aim of this study was to correlate nuclear CKS1B protein immunoreactivity, 1q21 amplification status, p27(Kip1) expression and survival in patients with newly-diagnosed multiple myeloma.
   Design and Methods Nuclear expression of CKS1B and p27(Kip1) was evaluated by immunohistochemistry in decalcified, paraffin-embedded bone marrow biopsies from 94 patients with newly diagnosed multiple myeloma. Clonal plasma cells of the bone marrow aspirates from the same cohort were examined for CKS1B gene status by interphase cytoplasmic fluorescence in situ hybridization.
   Results Fluorescence in situ hybridization detected the 1q21 amplification in 36(38%) of the 94 patients and immunohistochemistry showed CKS1B protein expression in 37 (39%). Thirty-two (86%) of the 36 amplified (1q21) cases expressed CKS1B and 31(84%) of the 37 CKS1B immunoreactive cases had amplified 1q21. 1q21 amplification and CKS1B protein expression were strongly correlated (P<0.0001). CKS1B protein expression was inversely correlated with p27(Kip1) immunostaining (P<0.0001) and was associated with a shorter overall survival (median 44.5 versus 89.3 months, P<0.0001).
   Conclusions Immunohistochemistry for CKS1B is a simple, rapid method that appears to predict 1q21 amplification and adverse outcome for risk stratification of patients with multiple myeloma.
C1 [Chang, Hong; Reece, Donna] Univ Hlth Network, Dept Lab Hematol & Med Oncol, Toronto, ON M5G 2C4, Canada.
   [Chang, Hong; Jiang, Nan; Saha, Manujendra N.; Qi, Connie] Univ Toronto, Toronto Gen Hosp, Res Inst, Div Cellular & Mol Biol, Toronto, ON M5G 1L7, Canada.
   [Jiang, Hua] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Hematol & Oncol, Shanghai 200030, Peoples R China.
   [Xu, Wei] Univ Hlth Network, Dept Biostat, Toronto, ON M5G 2C4, Canada.
RP Chang, H (reprint author), Univ Hlth Network, Dept Lab Hematol, 200 Elizabeth St,11E-413, Toronto, ON M5G 2C4, Canada.
EM hong.chang@uhn.on.ca
FU Canadian Institute of Research (CIHR); Leukemia & Lymphoma Society of
   Canada (LLSC)
FX Funding: this study was supported in part by operating grants from the
   Canadian Institute of Research (CIHR) and the Leukemia & Lymphoma
   Society of Canada (LLSC).
CR AvetLoiseau H, 1997, GENE CHROMOSOME CANC, V19, P124, DOI 10.1002/(SICI)1098-2264(199706)19:2<124::AID-GCC8>3.0.CO;2-0
   Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6
   Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471
   Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019
   Chang H, 2005, BLOOD, V106, P353, DOI 10.1182/blood-2005-01-0033
   Chang H, 2007, BRIT J HAEMATOL, V138, P324, DOI 10.1111/j.1365-2141.2007.06649.x
   Chang H, 2006, BRIT J HAEMATOL, V135, P486, DOI 10.1111/j.1365-2141.2006.06325.x
   Chang H, 2006, BRIT J HAEMATOL, V134, P613, DOI 10.1111/j.1365-2141.2006.06237.x
   Cigudosa JC, 1998, BLOOD, V91, P3007
   Filipits M, 2003, CLIN CANCER RES, V9, P820
   Fonseca R, 2006, LEUKEMIA, V20, P2034, DOI 10.1038/sj.leu.2404403
   Fonseca R, 2009, LEUKEMIA, V23, P2210, DOI 10.1038/leu.2009.174
   Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126
   Gutierrez NC, 2004, BLOOD, V104, P2661, DOI 10.1182/blood-2004-04-1319
   HADWIGER JA, 1989, MOL CELL BIOL, V9, P2034, DOI 10.1128/MCB.9.5.2034
   Hanamura I, 2006, BLOOD, V108, P1724, DOI 10.1182/blood-2006-03-009910
   Pruneri G, 2003, HUM PATHOL, V34, P41, DOI 10.1053/hupa.2003.6
   Sawyer JR, 2005, GENE CHROMOSOME CANC, V42, P95, DOI 10.1002/gcc.20109
   Sawyer JR, 1998, BLOOD, V91, P1732
   SAWYER JR, 1995, CANCER GENET CYTOGEN, V82, P41, DOI 10.1016/0165-4608(94)00284-I
   Shaughnessy J, 2005, HEMATOLOGY, V10, P117, DOI 10.1080/10245330512331390140
   Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430
   Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672
   Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6
   Yamamoto S, 2009, VIRCHOWS ARCH, V455, P413, DOI 10.1007/s00428-009-0844-5
   Zhan FH, 2007, BLOOD, V109, P4995, DOI 10.1182/blood-2006-07-038703
   ZHAN FH, 2009, BLOOD, V114
NR 27
TC 19
Z9 19
U1 5
U2 17
PU FERRATA STORTI FOUNDATION
PI PAVIA
PA VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY
SN 0390-6078
EI 1592-8721
J9 HAEMATOL-HEMATOL J
JI Haematol-Hematol. J.
PD SEP
PY 2010
VL 95
IS 9
BP 1542
EP 1547
DI 10.3324/haematol.2010.022210
PG 6
WC Hematology
SC Hematology
GA 651NA
UT WOS:000281933200017
PM 20421271
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Safarinejad, MR
   Taghva, A
   Shekarchi, B
   Safarinejad, S
AF Safarinejad, M. R.
   Taghva, A.
   Shekarchi, B.
   Safarinejad, Sh
TI RETRACTED: Safety and efficacy of sildenafil citrate in the treatment of
   Parkinson-emergent erectile dysfunction: a double-blind,
   placebo-controlled, randomized study (Retracted article. See vol. 23,
   pg. 94, 2011)
SO INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH
LA English
DT Article; Retracted Publication
DE sildenafil; erectile dysfunction; treatment; Parkinson; sexual
   dysfunction
ID SEXUAL DYSFUNCTION; ORAL SILDENAFIL; DISEASE; MEN; SATISFACTION; VIAGRA;
   DOPAMINE; LEVODOPA; BEHAVIOR; LIFE
AB Parkinson's disease (PD) is one of the most commonly occurring neurodegenerative disorders, with lifetime incidence between 1 and 2% among people older than 65 years. ED is one of the more disabling and poorly addressed aspects of PD. The purpose of this study was to assess the efficacy and safety of sildenafil citrate in Parkinson-emergent ED. Sexual function of participants was assessed using responses to the 15-question International Index of Erectile Function (IIEF), Sexual Encounter Profile (SEP) diary questions 2 and 3, Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) questionnaire and a Global Efficacy Question 'Has the treatment you have been taking over the study period improved your erections?' This randomized, double-blind, placebo-controlled study, comprised a screening period of at least 1 month, a placebo-lead in period of 1 week and treatment period. Two hundred thirty-six patients entered the trial. These patients had mild-to-moderate PD (stages I-III Hoehn-Yahr) and were experiencing Parkinson-emergent neurogenic ED. They were randomized to receive 100 mg sildenafil on demand 1 h before sexual activity (group 1, n = 118), or similar regimen of placebo (group 2, n = 118). Patients were instructed to use at least 24 doses/attempts at home. At the end of the trial, differences between sildenafil and placebo groups were significant for the IIEF erectile function (EF) score (22.6 +/- 4.6 vs 14.8 +/- 4.2, P = 0.01), for percent Global Efficacy Question 'Yes' responses (68.1 +/- 4.6 vs 12.2 +/- 3.2, P = 0.001), for SEP2 'Yes' responses (68.1 +/- 4.2 vs 32.5 +/- 2.2, P = 0.003), for SEP3 'Yes' responses (75.9 +/- 5.4 vs 33.5 +/- 4.4, P = 0.004) and for mean EDITS score (69.8 +/- 4.2 vs 13.0 +/- 2.7, P = 0.004). A normal EF domain score (>= 26) at end point was achieved by 56.9 and 8.7% of the patients in the sildenafil and placebo groups, respectively (P = 0.001). Sildenafil can be considered as an effective treatment in patients with Parkinson-emergent ED. International Journal of Impotence Research (2010) 22, 325-335; doi: 10.1038/ijir.2010.23; published online 23 September 2010
C1 [Taghva, A.] Aja Univ Med Sci, Dept Psychiat, Tehran, Iran.
   [Shekarchi, B.] Aja Univ Med Sci, Dept Radiol, Tehran, Iran.
RP Safarinejad, MR (reprint author), POB 19395-1849, Tehran, Iran.
EM safarinejad@urologist.md
OI Safarinejad, Mohammad Reza/0000-0003-3055-5915
CR Althof SE, 1999, UROLOGY, V53, P793, DOI 10.1016/S0090-4295(98)00582-2
   American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Benito-Leon J, 2003, MOVEMENT DISORD, V18, P267, DOI 10.1002/mds.10362
   Bronner G, 2004, J SEX MARITAL THER, V30, P95, DOI 10.1080/00926230490258893
   BROWN RG, 1990, J NEUROL NEUROSUR PS, V53, P480, DOI 10.1136/jnnp.53.6.480
   Fleiss JL, 1986, DESIGN ANAL CLIN EXP, P49
   FuglMeyer AR, 1997, INT J IMPOT RES, V9, P141, DOI 10.1038/sj.ijir.3900269
   GOODWIN FK, 1971, CLIN PHARMACOL THER, V12, P383
   Hamani C, 2003, ANN NY ACAD SCI, V991, P15
   HAND A, 2009, PARKINSONISM RELAT D, V16, P172
   HARVEY NS, 1988, BRIT J PSYCHIAT, V153, P833, DOI 10.1192/bjp.153.6.833
   Hobson P, 2003, PARKINSONISM RELAT D, V10, P67, DOI 10.1016/j.parkreldis.2003.07.001
   HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427
   HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181
   Hussain IF, 2001, J NEUROL NEUROSUR PS, V71, P371, DOI 10.1136/jnnp.71.3.371
   Jarow JP, 1999, J UROLOGY, V162, P722, DOI 10.1097/00005392-199909010-00024
   Levinson I.P., 2005, J SEX MED S1, V2, P36
   Lewis R, 2001, UROLOGY, V57, P960, DOI 10.1016/S0090-4295(01)00945-1
   Mattis S., 1976, GERIATRIC PSYCHIAT, P77
   Meco G, 2008, PARKINSONISM RELAT D, V14, P451, DOI 10.1016/j.parkreldis.2007.10.008
   MELIS MR, 1995, NEUROSCI BIOBEHAV R, V19, P19, DOI 10.1016/0149-7634(94)00020-2
   MONTORSI F, 1994, J UROLOGY, V151, P373, DOI 10.1016/S0022-5347(17)34952-2
   Moore O, 2002, PARKINSONISM RELAT D, V8, P243, DOI 10.1016/S1353-8020(01)00042-6
   MOSTILEA G, 2009, PARKINSONISM RELAT D, pS224
   Padma-Nathan H, 1998, INT J CLIN PRACT, V52, P375
   Papatsoris AG, 2006, UROLOGY, V67, P447, DOI 10.1016/j.urology.2005.10.017
   Raffaele R, 2002, EUR UROL, V41, P382, DOI 10.1016/S0302-2838(02)00054-4
   Rendell MS, 1999, JAMA-J AM MED ASSOC, V281, P421, DOI 10.1001/jama.281.5.421
   Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0
   Safarinejad MR, 2009, BJU INT, V104, P376, DOI 10.1111/j.1464-410X.2009.08560.x
   Safarinejad MR, 2009, J UROLOGY, V181, P252, DOI 10.1016/j.juro.2008.09.003
   Safarinejad MR, 2004, J DIABETES COMPLICAT, V18, P205, DOI 10.1016/S1056-8727(03)00056-4
   Singer C, 1989, J NEURO REHAB, V3, P199
   Weintraub D, 2006, ARCH NEUROL-CHICAGO, V63, P969, DOI 10.1001/archneur.63.7.969
   Wilkins CJ, 2003, CLIN RADIOL, V58, P514, DOI 10.1016/S0009-9260(03)00112-0
   Zesiewicz TA, 2000, MOVEMENT DISORD, V15, P305, DOI 10.1002/1531-8257(200003)15:2<305::AID-MDS1015>3.0.CO;2-W
   INT C HARM TECHN REQ
NR 37
TC 10
Z9 10
U1 2
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0955-9930
J9 INT J IMPOT RES
JI Int. J. Impot. Res.
PD SEP-OCT
PY 2010
VL 22
IS 5
BP 325
EP 335
DI 10.1038/ijir.2010.23
PG 11
WC Urology & Nephrology
SC Urology & Nephrology
GA 667AN
UT WOS:000283165100005
PM 20861846
OA Bronze
DA 2018-12-27
ER

PT J
AU Al-Daraji, WI
AF Al-Daraji, Wael I.
TI RETRACTED: A preliminary examination of the role of NFAT 3 in human
   skin, cultured keratocytes and dermal fibroblasts (Retracted article.
   See vol. 38, pg. 600, 2011)
SO JOURNAL OF CUTANEOUS PATHOLOGY
LA English
DT Article; Retracted Publication
ID PROTEIN-KINASE-C; GLYCOGEN-SYNTHASE KINASE-3; T-CELLS FAMILY;
   CYCLOSPORINE-A; HUMAN KERATINOCYTES; NUCLEAR FACTOR; PHORBOL ESTER;
   TRANSCRIPTIONAL ACTIVITY; MOUSE EPIDERMIS; TRANSGENIC MICE
AB Background: Ciclosporin A (CsA) is widely utilized for the treatment of inflammatory skin diseases such as psoriasis. The therapeutic effects of CsA are thought to be mediated via its immunosuppressive action on infiltrating lymphocytes in skin lesions. CsA and tacrolimus block T cell activation by inhibiting the phosphatase calcineurin and preventing translocation from the cytoplasm to the nucleus of the transcription factor Nuclear Factor of Activated T cells ( NFAT).
   Methods: RT-PCR and Western Analysis were used to investigate the presence of NFAT-3 mRNA and protein in human keratocytes. Tissue culture of human keratocytes and immunostaining of cells on coverslips and confocal microscopy were used to assess the degree of nuclear localisation of NFAT-3 in cultured cells. Keratome biopsies were taken from patients with psoriasis (lesional and non-lesional skin) and normal skin and immunohistochemistry was used to assess the NFAT-3 localisation in these biopsies using a well characterized anti-NFAT-3 antibody.
   Results: The NFAT-3 mRNA and protein expression was demonstrated using RT-PCR and Western blotting. The expression of NFAT-3 in human keratocytes and response to different agonists provides perhaps a unique opportunity to examine the regulation, subcellular localization and kinetics of translocation of different NFATs in primary cultured human cells. As with NFAT 1, NFAT 2 and recently NFAT 5, differentiation-promoting agents that increase intracellular calcium concentration induced nuclear translocation of NFAT- 3 in cultured keratocytes but with different kinetics.
   Conclusion: These data provide the first evidence of that NFAT- 3 is expressed in normal skin, psoriasis and that NFAT- 3 functionally active in human keratocytes and that nuclear translocation of NFAT- 3 in human skin cells has different kinetics than NFAT 1 suggesting that NFAT- 3 may play an important role in regulation of keratocytes proliferation and differentiation at a different stage. Inhibition of this pathway in human epidermal keratocytes many account, in part for the therapeutic effects of CsA and tacrolimus in skin disorders such as psoriasis.
C1 [Al-Daraji, Wael I.] Ain Shams Univ, Dept Clin Dermatol, Cairo, Egypt.
   [Al-Daraji, Wael I.] Ain Shams Univ, Dept Mol Dermatol, Cairo, Egypt.
   [Al-Daraji, Wael I.] Ain Shams Univ, Dept Skin, Cairo, Egypt.
   [Al-Daraji, Wael I.] Ain Shams Univ, Dept Soft Tissue Tumour Pathol, Cairo, Egypt.
RP Al-Daraji, WI (reprint author), Ain Shams Univ, Dept Clin Dermatol, Cairo, Egypt.
EM waldaraji@aol.com
CR Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905
   Al-Daraji WI, 2002, J INVEST DERMATOL, V118, P779, DOI 10.1046/j.1523-1747.2002.01709.x
   ALDARAJI WI, 2005, CLIN EXP DE IN PRESS
   ALDARAJI WI, 2004, CLIN EXP DE IN PRESS
   Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5
   Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129
   BOUROUIS M, 1990, EMBO J, V9, P2877, DOI 10.1002/j.1460-2075.1990.tb07477.x
   CASTOR CW, 1985, SEMIN ARTHRITIS RHEU, V15, P33, DOI 10.1016/0049-0172(85)90008-3
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0
   Cook D, 1996, EMBO J, V15, P4526, DOI 10.1002/j.1460-2075.1996.tb00830.x
   COOPER KD, 1992, J INVEST DERMATOL, V98, P259, DOI 10.1111/1523-1747.ep12556095
   DEUEL TF, 1987, NEW ENGL J MED, V317, P236, DOI 10.1056/NEJM198707233170409
   DEVENTE J, 1987, BRAIN RES, V411, P120, DOI 10.1016/0006-8993(87)90688-3
   FISHER GJ, 1988, J INVEST DERMATOL, V91, P142, DOI 10.1111/1523-1747.ep12464387
   Freshney RI, 2000, CULTURE ANIMAL CELLS
   FURUE M, 1988, J INVEST DERMATOL, V90, P796, DOI 10.1111/1523-1747.ep12462009
   FURUE M, 1988, J IMMUNOL, V140, P4139
   GOTTLIEB AB, 1992, J INVEST DERMATOL, V98, P302, DOI 10.1111/1523-1747.ep12499782
   Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8
   Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378
   GSCHWENDT M, 1985, BIOCHEM BIOPH RES CO, V126, P327, DOI 10.1016/0006-291X(85)90609-6
   GSCHWENDT M, 1987, CARCINOGENESIS, V8, P203, DOI 10.1093/carcin/8.2.203
   GSCHWENDT M, 1986, CARCINOGENESIS, V7, P449, DOI 10.1093/carcin/7.3.449
   GUPTA AK, 1989, J INVEST DERMATOL, V93, P379, DOI 10.1111/1523-1747.ep12280279
   HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0
   Ho IC, 1998, P NATL ACAD SCI USA, V95, P15537, DOI 10.1073/pnas.95.26.15537
   HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6
   Huang CS, 2000, J BIOL CHEM, V275, P9143, DOI 10.1074/jbc.275.13.9143
   JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0
   KATO N, 1987, J INVEST DERMATOL, V88, P52, DOI 10.1111/1523-1747.ep12465001
   Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0
   KRUEGER GG, 1990, J INVEST DERMATOL, V95, pS56, DOI 10.1111/1523-1747.ep12505791
   Loh C, 1996, MOL CELL BIOL, V16, P3945
   Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475
   MELAN MA, 1992, J CELL SCI, V101, P731
   NICKOLOFF BJ, 1988, AM J PATHOL, V131, P12
   Nishio H, 2000, HISTOCHEM CELL BIOL, V114, P9
   NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0
   PIGATTO PD, 1990, J INVEST DERMATOL, V94, P372, DOI 10.1111/1523-1747.ep12874494
   RAMIREZBOSCA A, 1990, ACTA DERM-VENEREOL, V70, P6
   Reynolds NJ, 1997, BRIT J DERMATOL, V136, P666, DOI 10.1111/j.1365-2133.1997.tb03649.x
   Reynolds NJ, 2002, CLIN EXP DERMATOL, V27, P555, DOI 10.1046/j.1365-2230.2002.01148.x
   REYNOLDS NJ, 1995, BRIT J DERMATOL, V133, P157, DOI 10.1111/j.1365-2133.1995.tb02611.x
   Reynolds NJ, 1998, BRIT J DERMATOL, V139, P16
   SAIAG P, 1985, SCIENCE, V230, P669, DOI 10.1126/science.2413549
   Sambrook J, 2000, MOL CLONING LAB MANU
   Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698
   SHARPE GR, 1990, BRIT J DERMATOL, V123, P207, DOI 10.1111/j.1365-2133.1990.tb01848.x
   TAYLOR M, 1993, J INVEST DERMATOL, V100, P237, DOI 10.1111/1523-1747.ep12468979
   Timmerman LA, 1997, J IMMUNOL, V159, P2735
   Todd C, 1998, AM J PATHOL, V153, P39, DOI 10.1016/S0002-9440(10)65543-5
   Turner H, 1997, J EXP MED, V185, P43, DOI 10.1084/jem.185.1.43
   URABE A, 1989, J INVEST DERMATOL, V92, P755, DOI 10.1111/1523-1747.ep12722454
   VERWEIJ CL, 1990, J BIOL CHEM, V265, P15788
   WATANABE S, 1991, Journal of Dermatology (Tokyo), V18, P714
   WATT FM, 1988, J CELL SCI, V90, P525
   Yamamoto S, 1994, J Dermatol Sci, V7 Suppl, pS47, DOI 10.1016/0923-1811(94)90035-3
   ZHOU FC, 1995, NEUROCHEM INT, V26, P135, DOI 10.1016/0197-0186(94)00108-7
NR 60
TC 7
Z9 7
U1 2
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-6987
EI 1600-0560
J9 J CUTAN PATHOL
JI J. Cutan. Pathol.
PD SEP
PY 2010
VL 37
IS 9
BP E21
EP E36
DI 10.1111/j.1600-0560.2009.01313.x
PG 16
WC Dermatology; Pathology
SC Dermatology; Pathology
GA 630VX
UT WOS:000280304100002
PM 20653821
DA 2018-12-27
ER

PT J
AU Okamura, C
   Ueda, T
   Hasezaki, K
AF Okamura, Chinatsu
   Ueda, Takashi
   Hasezaki, Kazuhiro
TI RETRACTED: Single-Phase beta-Zn4Sb3 Prepared by a Mechanical Grinding
   Method (Retracted article. See vol. 41, pg. 2659, 2012)
SO JOURNAL OF ELECTRONIC MATERIALS
LA English
DT Article; Proceedings Paper; Retracted Publication
CT 28th International Conference on Thermoelectrics/7th European Conference
   on Thermoelectrics
CY JUL 26-30, 2009
CL Freiburg, GERMANY
DE Thermoelectric material; beta-Zn4Sb3; mechanical grinding; figure of
   merit; zinc; antimony
ID THERMOELECTRIC PROPERTIES; ZN4SB3
AB Single-phase beta-Zn4Sb3 materials were prepared by mechanical grinding (MG). Source materials for the Zn4Sb3 ingots were prepared using three different processes after the direct melting of constituent elements. In process 1, the ingot was obtained by quenching the melt in water within an evacuated quartz ampoule. In process 2, the ingot was heat-treated for 100 h at 723 K after process 1. In process 3, the ingot was heat-treated for a total of 200 h in two stages at 723 K and 673 K after process 1. The resultant ingots were mechanically ground and sintered at 623 K by hot pressing. The sintered materials were characterized by x-ray diffraction, differential thermal analysis (DTA), and thermoelectric property measurements. The thermal conductivity of the sintered materials was 0.88 W m(-1) K-1 at room temperature, being slightly lower than that reported for the materials prepared by a conventional method. Results indicate that the dimensionless figure of merit of the single-phase beta-Zn4Sb3 ranged from 1.06 to 1.31 at 573 K.
C1 [Okamura, Chinatsu; Ueda, Takashi; Hasezaki, Kazuhiro] Shimane Univ, Dept Mat Sci, Matsue, Shimane 6908504, Japan.
RP Okamura, C (reprint author), Shimane Univ, Dept Mat Sci, 1060 Nishikawatsu Cho, Matsue, Shimane 6908504, Japan.
EM s099109@matsu.shimane-u.ac.jp
CR Caillat T, 1997, J PHYS CHEM SOLIDS, V58, P1119, DOI 10.1016/S0022-3697(96)00228-4
   Hamachiyo T, 2009, MATER TRANS, V50, P167, DOI 10.2320/matertrans.MRA2008241
   Ignatev N. A., 1971, J STRUCT CHEM, V12, P665
   Itoh T, 2008, J PROPUL POWER, V24, P353, DOI 10.2514/1.20944
   Itoh T, 2009, J ELECTRON MATER, V38, P925, DOI 10.1007/s11664-009-0697-3
   Izard V, 2002, J ALLOY COMPD, V345, P257, DOI 10.1016/S0925-8388(02)00398-5
   MAYER HW, 1978, J LESS-COMMON MET, V59, P43, DOI 10.1016/0022-5088(78)90109-1
   Nakamoto G, 2007, J ALLOY COMPD, V432, P116, DOI 10.1016/j.jallcom.2006.05.118
   Pedersen BL, 2007, CHEM MATER, V19, P6304, DOI 10.1021/cm702247b
   Pedersen BL, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2404612
   Pedersen BL, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2916705
   Souma T, 2002, J ALLOY COMPD, V340, P275, DOI 10.1016/S0925-8388(02)00113-5
   TAPIERO M, 1985, SOL ENERG MATER, V12, P257, DOI 10.1016/0165-1633(85)90051-6
   UEDA T, 2008, MAT T, V49, P1894
   Ur SC, 2003, J MATER SCI, V38, P3553, DOI 10.1023/A:1025608926808
   Zhu TJ, 2000, MATER LETT, V46, P44, DOI 10.1016/S0167-577X(00)00140-3
NR 16
TC 3
Z9 3
U1 3
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0361-5235
EI 1543-186X
J9 J ELECTRON MATER
JI J. Electron. Mater.
PD SEP
PY 2010
VL 39
IS 9
BP 2172
EP 2175
DI 10.1007/s11664-009-0979-9
PG 4
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Physics, Applied
SC Engineering; Materials Science; Physics
GA 644PW
UT WOS:000281393000146
DA 2018-12-27
ER

PT J
AU Nikisch, G
   Baumann, P
   Kiessling, B
   Reinert, M
   Wiedemann, G
   Kehr, J
   Mathe, AA
   Piel, M
   Roesch, F
   Weisser, H
   Schneider, P
   Hertel, A
AF Nikisch, Georg
   Baumann, Pierre
   Kiessling, Bernhard
   Reinert, Michael
   Wiedemann, Georg
   Kehr, Jan
   Mathe, Aleksander A.
   Piel, Markus
   Roesch, Frank
   Weisser, Heike
   Schneider, Peter
   Hertel, Andreas
TI RETRACTED: Relationship between dopamine D-2 receptor occupancy,
   clinical response, and drug and monoamine metabolites levels in plasma
   and cerebrospinal fluid. A pilot study in patients suffering from
   first-episode schizophrenia treated with quetiapine (Retracted article.
   See vol. 46, pg. 1108, 2012)
SO JOURNAL OF PSYCHIATRIC RESEARCH
LA English
DT Article; Retracted Publication
DE Schizophrenia; Quetiapine; Norquetiapine; CSF; Monoamine metabolites;
   Neuroimaging
ID IN-VIVO; 5-HYDROXYINDOLEACETIC ACID; PSYCHOTIC DISORDERS; HUMAN BRAIN;
   CLOZAPINE; HALOPERIDOL; RISPERIDONE; BLOCKADE; PET; PHARMACOKINETICS
AB Combining measurements of the monoamine metabolites in the cerebrospinal fluid (CSF) and neuroimaging can increase efficiency of drug discovery for treatment of brain disorders. To address this question, we examined five drug-naive patients suffering from schizophrenic disorder. Patients were assessed clinically, using the Positive and Negative Syndrome Scale (PANSS): at baseline and then at weekly intervals. Plasma and CSF levels of quetiapine and norquetiapine as well CSF 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), 5-hydroxyindole-acetic acid (5-HIAA) and 3-methoxy-4-hydroxyphenylglycol (MHPG) were obtained at baseline and again after at least a 4 week medication trail with 600 mg/day quetiapine. CSF monoamine metabolites levels were compared with dopamine D-2 receptor occupancy (DA-D-2) using [F-18]fallypride and positron emission tomography (PET). Quetiapine produced preferential occupancy of parietal cortex vs. putamenal DA-D-2, 41.4% (p < 0.05, corrected for multiple comparisons). DA-D-2 receptor occupancies in the occipital and parietal cortex were correlated with CSF quetiapine and norquetiapine levels (p < 0.01 and p < 0.05, respectively). CSF monoamine metabolites were significantly increased after treatment and correlated with regional receptor occupancies in the putamen [DOPAC: (p <0.01) and HVA: (p < 0.05)], caudate nucleus [HVA: (p <0.01)], thalamus [MHPG: (p < 0.05)1 and in the temporal cortex [HVA: (p < 0.05) and 5-HIAA: (p < 0.05)]. This suggests that CSF monoamine metabolites levels reflect the effects of quetiapine treatment on neurotransmitters in vivo and indicates that monitoring plasma and CSF quetiapine and norquetiapine levels may be of clinical relevance. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Nikisch, Georg; Kiessling, Bernhard; Wiedemann, Georg] Klinikum Fulda gAG, Dept Psychiat & Psychotherapy, D-36043 Fulda, Germany.
   [Hertel, Andreas] Klinikum Fulda gAG, Dept Nucl Med, D-36043 Fulda, Germany.
   [Weisser, Heike] Klinikum Fulda gAG, Dept Lab Med, D-36043 Fulda, Germany.
   [Reinert, Michael; Schneider, Peter] Klinikum Fulda gAG, Dept Med Phys & Radiat Protect, D-36043 Fulda, Germany.
   [Piel, Markus; Roesch, Frank] Johannes Gutenberg Univ Mainz, Inst Nucl Chem, D-55128 Mainz, Germany.
   [Mathe, Aleksander A.] Karolinska Univ Hosp Huddinge, Karolinska Inst, S-14186 Stockholm, Sweden.
   [Baumann, Pierre] CHUV, Hosp Cery, Dept Psychiat, CH-1008 Prilly, Switzerland.
   [Kehr, Jan] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.
RP Nikisch, G (reprint author), Klinikum Fulda gAG, Dept Psychiat & Psychotherapy, Pacelliallee 4, D-36043 Fulda, Germany.
EM georg.nikisch@klinikum-fulda.de; pierre.baumann@chuv.ch;
   kiessling.bernhard@klinikum-fulda.de;
   Michael.-Reinert.Radiologie@klinikum-fulda.de;
   psychiatrie@klinikum-fulda.de; jan.kehr@ki.se; aleksander.mathe@ki.se;
   piel@uni-mainz.de; frank.roesch@uni-mainz.de;
   heike.weisser@klinikum-fulda.de; p.schneider@klinikum-fulda.de;
   AHertel.RAZ@kli-nikum-fulda.de
RI Piel, Markus/L-8787-2016
FU AstraZeneca GmbH, Germany [D1449L00033]; Swedish Medical Research
   Council [10414]
FX This project was supported by a grant from AstraZeneca GmbH, Germany
   (Study Code: D1449L00033) and the Swedish Medical Research Council grant
   10414 (A.A.M and J.K). We thank Dr. Takahashi Yoshitake for measurements
   of monoamine metabolites in CSF.
CR AGNATI LF, 1995, NEUROSCIENCE, V69, P711, DOI 10.1016/0306-4522(95)00308-6
   BIANCHINE J, 1994, CEREBROSPINAL FLUID, P35
   Bigliani V, 2000, PSYCHOPHARMACOLOGY, V150, P132, DOI 10.1007/s002130000435
   Bressan RA, 2003, J CLIN PSYCHOPHARM, V23, P5, DOI 10.1097/00004714-200302000-00002
   Charney DS, 2004, AM J PSYCHIAT, V161, P1, DOI 10.1176/appi.ajp.161.1.1
   CHIODO LA, 1983, NEUROSCIENCE, V21, P1607
   Davis PC, 2010, J PHARMACEUT BIOMED, V51, P1113, DOI 10.1016/j.jpba.2009.11.018
   de Lange ECM, 2002, CLIN PHARMACOKINET, V41, P691, DOI 10.2165/00003088-200241100-00001
   DeVane CL, 2001, CLIN PHARMACOKINET, V40, P509, DOI 10.2165/00003088-200140070-00003
   FARDE L, 1994, J CLIN PSYCHIAT, V55, P67
   GARELIS E, 1973, J NEUROL NEUROSUR PS, V36, P625, DOI 10.1136/jnnp.36.4.625
   Gefvert O, 1998, PSYCHOPHARMACOLOGY, V135, P119, DOI 10.1007/s002130050492
   Gerlach M, 2007, PHARMACOPSYCHIATRY, V40, P72, DOI 10.1055/s-2007-972573
   GOLDSTEIN JM, 1993, PSYCHOPHARMACOLOGY, V112, P293, DOI 10.1007/BF02244924
   GOLDSTEIN JM, 1995, EXPERT OPINION INVES, V4, P291
   Grunder G, 2003, J NUCL MED, V44, P109
   HAMACHER K, 1986, J NUCL MED, V27, P235
   Hasselstrom J, 2004, THER DRUG MONIT, V26, P486, DOI 10.1097/00007691-200410000-00005
   Jensen NH, 2008, NEUROPSYCHOPHARMACOL, V33, P2303, DOI 10.1038/sj.npp.1301646
   Kapur S, 2000, NEUROPSYCHOPHARMACOL, V23, P595, DOI 10.1016/S0893-133X(00)00139-1
   Kapur S, 1996, AM J PSYCHIAT, V153, P948
   KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261
   Kessler R.M., 2000, NEUROIMAGE, V11, pS32
   Kessler RM, 2006, NEUROPSYCHOPHARMACOL, V31, P1991, DOI 10.1038/sj.npp.1301108
   Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066
   Little JT, 1999, BIOL PSYCHIAT, V45, P285, DOI 10.1016/S0006-3223(98)00078-X
   MELTZER HY, 1992, BRIT J PSYCHIAT, V160, P22, DOI 10.1192/S0007125000296876
   Mukherjee J, 2002, SYNAPSE, V46, P170, DOI 10.1002/syn.10128
   Mukherjee J, 2001, NEUROPSYCHOPHARMACOL, V25, P476, DOI 10.1016/S0893-133X(01)00251-2
   NORDSTROM AL, 1993, BIOL PSYCHIAT, V33, P227, DOI 10.1016/0006-3223(93)90288-O
   Pilowsky LS, 1997, LANCET, V350, P490, DOI 10.1016/S0140-6736(05)63079-6
   POTTER WZ, 1993, ARCH GEN PSYCHIAT, V50, P653
   SCHEEPERS FE, 2004, NEUROPSYCHOPHARMACOL, V4, P468
   Schotte A, 1996, PSYCHOPHARMACOLOGY, V124, P57, DOI 10.1007/BF02245606
   Shayegan DK, 2004, CNS SPECTRUMS, V9, P6, DOI 10.1017/S1092852900025086
   Siessmeier T, 2005, J NUCL MED, V46, P964
   Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0
   STARK D, 2007, BIOORGAN MED CHEM, V15, P19
   STENFORS C, 1995, BRAIN RES, V698, P39, DOI 10.1016/0006-8993(95)00784-N
   Tauscher-Wisniewski S, 2002, J CLIN PSYCHIAT, V63, P992, DOI 10.4088/JCP.v63n1106
   Weikop P, 2007, EUR NEUROPSYCHOPHARM, V17, P658, DOI 10.1016/j.euroneuro.2007.02.014
   WEIR RL, 1973, BRAIN RES, V52, P409, DOI 10.1016/0006-8993(73)90682-3
   Winter HR, 2008, J CHILD ADOL PSYCHOP, V18, P81, DOI 10.1089/cap.2007.0084
NR 43
TC 13
Z9 13
U1 2
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3956
J9 J PSYCHIATR RES
JI J. Psychiatr. Res.
PD SEP
PY 2010
VL 44
IS 12
BP 754
EP 759
DI 10.1016/j.jpsychires.2010.02.004
PG 6
WC Psychiatry
SC Psychiatry
GA 643WI
UT WOS:000281330100003
PM 20176367
DA 2018-12-27
ER

PT J
AU Baek, JI
   Park, ST
AF Baek, Jong-Il
   Park, Sung-Tae
TI RETRACTED: Convergence of weighted sums for arrays of negatively
   dependent random variables and its applications (Retracted article. See
   vol. 143, pg. 1619, 2013)
SO JOURNAL OF STATISTICAL PLANNING AND INFERENCE
LA English
DT Article; Retracted Publication
DE Complete convergence; Negatively dependent random variables; Linear
   processes
ID MOVING AVERAGE PROCESSES; DISTRIBUTED RANDOM-VARIABLES;
   CENTRAL-LIMIT-THEOREM; LARGE NUMBERS; STRONG LAW; SUMMABILITY METHODS;
   SURE CONVERGENCE; LARGE DEVIATIONS; RANDOM ELEMENTS; INEQUALITIES
AB We discuss discuss the complete convergence of weighted sums for arrays of rowwise negatively dependent random variables (ND r.v.'s) to linear processes. As an application, we obtain the complete convergence of linear processes based on a ND r.v.'s which extends the result of Li et al. (1992), including the results of Baum and Katz (1965), from the i.i.d. case to a negatively dependent (ND) setting. We complement the results of Ahmed et al. (2002) and confirm their conjecture on linear processes in the ND case. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Baek, Jong-Il] Wonkwang Univ, Inst Basic Nat Sci, Div Math & Informat Stat, Iksan 570749, South Korea.
   [Park, Sung-Tae] Wonkwang Univ, Div Business, Iksan 570749, South Korea.
   [Park, Sung-Tae] Wonkwang Univ, Business & Econ Res Inst, Iksan 570749, South Korea.
RP Baek, JI (reprint author), Wonkwang Univ, Inst Basic Nat Sci, Div Math & Informat Stat, Iksan 570749, South Korea.
EM jibaek@wonkwang.ac.kr; pst@wonkwang.ac.kr
FU Wonkwang University
FX This paper was supported by a Wonkwang University Grant in 2008.
CR Ahmed SE, 2002, STAT PROBABIL LETT, V58, P185, DOI 10.1016/S0167-7152(02)00126-8
   Amini M., 2004, WSEAS T MATH, V3, P637
   Baek JI, 2003, AUST NZ J STAT, V45, P331, DOI 10.1111/1467-842X.00287
   BAUM LE, 1965, T AM MATH SOC, V120, P108, DOI 10.2307/1994170
   Bingham NH, 2004, J APPL PROBAB, V41A, P231, DOI 10.1239/jap/1082552201
   BINGHAM NH, 1991, ALMOST EVERYWHERE CO, V2, P69
   BINGHAM NH, 1985, DEP PROBAB STAT, P291
   BLOCK HW, 1981, COMMUN STAT A-THEOR, V10, P749, DOI 10.1080/03610928108828072
   BOZORGNIA A, 1996, WORLD C NONLINEAR AN, V92, P1639
   BRINDLEY EC, 1972, J AM STAT ASSOC, V67, P822, DOI 10.2307/2284644
   Brockwell PJ, 1990, TIME SERIES THEORY M
   BURTON RM, 1990, STAT PROBABIL LETT, V9, P397, DOI 10.1016/0167-7152(90)90031-2
   Chandra TK, 1996, J THEOR PROBAB, V9, P797, DOI 10.1007/BF02214087
   Chandra TK, 1996, ACTA MATH HUNG, V71, P327, DOI 10.1007/BF00114421
   Chen Y, 2007, STAT PROBABIL LETT, V77, P530, DOI 10.1016/j.spl.2006.08.021
   CHOW Y. S., 1973, B I MATH ACAD SINICA, V1, P207
   CHOW YS, 1971, ANN MATH STAT, V42, P401, DOI 10.1214/aoms/1177693533
   EBRAHIMI N, 1981, COMMUN STAT-THEOR M, V89, P625
   ESARY JD, 1972, ANN MATH STAT, V43, P651, DOI 10.1214/aoms/1177692646
   ESARY JD, 1967, ANN MATH STAT, V38, P1466, DOI 10.1214/aoms/1177698701
   FakhreZakeri I, 1997, STAT PROBABIL LETT, V35, P417, DOI 10.1016/S0167-7152(97)00040-0
   Ghosal S, 1998, J THEOR PROBAB, V11, P621, DOI 10.1023/A:1022646429754
   GUT A, 1993, PROBAB THEORY REL, V97, P169, DOI 10.1007/BF01199318
   Gut A, 2000, J MATH ANAL APPL, V248, P233, DOI 10.1006/jmaa.2000.6892
   Gut A, 1992, PERIOD MATH HUNG, V25, P51, DOI DOI 10.1007/BF02454383
   Hannan EJ, 1970, MULTIVARIATE TIME SE
   HARRIS R, 1970, ANN MATH STAT, V41, P713, DOI 10.1214/aoms/1177697121
   HSU PL, 1947, P NATL ACAD SCI USA, V33, P25, DOI 10.1073/pnas.33.2.25
   Hu TC, 2002, THEOR PROBAB APPL+, V47, P455, DOI 10.1137/S0040585X97979858
   Hu TC, 1999, STOCH ANAL APPL, V17, P963, DOI 10.1080/07362999908809645
   Ibragimov I.A, 1962, THEOR PROBAB APPL, V7, P349, DOI DOI 10.1137/1107036
   JOAGDEV K, 1983, ANN STAT, V11, P286, DOI 10.1214/aos/1176346079
   JOGDEO K, 1975, SANKHYA B, V37, P158
   KARLIN S, 1980, J MULTIVARIATE ANAL, V10, P499, DOI 10.1016/0047-259X(80)90066-4
   Kim TS, 2001, STAT PROBABIL LETT, V51, P299, DOI 10.1016/S0167-7152(00)00168-1
   KUCZMASZEWSKA A, 1994, INT J MATH MATH SCI, V17, P1
   LAI TL, 1974, P AM MATH SOC, V45, P253, DOI 10.2307/2040073
   LEHMANN EL, 1966, ANN MATH STAT, V37, P1137, DOI 10.1214/aoms/1177699260
   LI DL, 1992, STAT PROBABIL LETT, V14, P111, DOI 10.1016/0167-7152(92)90073-E
   LI DL, 1995, J THEOR PROBAB, V8, P49, DOI 10.1007/BF02213454
   MATULA P, 1992, STAT PROBABIL LETT, V15, P209, DOI 10.1016/0167-7152(92)90191-7
   Matula P, 2003, PUBL MATH-DEBRECEN, V63, P511
   Taylor RL, 2002, STOCH ANAL APPL, V20, P643
   Wang JF, 2006, ACTA MATH HUNG, V110, P293, DOI 10.1007/s10474-006-0024-x
   WANG XC, 1993, STOCH ANAL APPL, V11, P115, DOI 10.1080/07362999308809305
   Zhang LX, 1996, STAT PROBABIL LETT, V30, P165, DOI 10.1016/0167-7152(95)00215-4
NR 46
TC 13
Z9 15
U1 1
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-3758
EI 1873-1171
J9 J STAT PLAN INFER
JI J. Stat. Plan. Infer.
PD SEP
PY 2010
VL 140
IS 9
BP 2461
EP 2469
DI 10.1016/j.jspi.2010.02.021
PG 9
WC Statistics & Probability
SC Mathematics
GA 606CJ
UT WOS:000278398300011
DA 2018-12-27
ER

PT J
AU Chong, B
AF Chong, Billy
TI RETRACTED: Simulation of crack growth using cohesive crack method
   (Retracted article. See vol. 18, pg. 1205, 2014)
SO KSCE JOURNAL OF CIVIL ENGINEERING
LA English
DT Article; Retracted Publication
DE applied mechanics; fracture mechanics; damage; concrete
ID REINFORCED-CONCRETE STRUCTURES; ARBITRARY EVOLVING CRACKS; MESHFREE THIN
   SHELL; PARTICLE METHODS; DYNAMIC FRACTURE; SHEAR BANDS; PROPAGATION;
   ENRICHMENT; MODEL; APPROXIMATIONS
AB We study non-linear fracture of concrete by discrete cohesive crack model in the context of the Element-Free Galerkin (EFG) method. The crack surface is represented by several straight-line interface elements. The constitutive law of cohesive cracks is considered through the use of these interface elements. The stiffness equation of the domain is constructed by directly including a term in the weak form of the global system equation that is related to the energy dissipation along the interface elements. The constitutive law of cohesive cracks can then be considered directly and efficiently by using this energy term. The validity and efficiency of the proposed method are discussed by using several problems.
C1 Wuhan Univ Technol, Fac Engn, Wuhan 430072, Peoples R China.
RP Chong, B (reprint author), Wuhan Univ Technol, Fac Engn, Luojia Hill, Wuhan 430072, Peoples R China.
EM raydin@ogu.edu.tr
CR Alfaiate J, 1997, COMPUT STRUCT, V63, P17, DOI 10.1016/S0045-7949(97)85247-9
   Arrea M, 1982, 8113 CORN U DEP STRU
   Baant Z. P., 1983, MATERIALS STRUCTURES, V16, P155, DOI DOI 10.1007/BF02486267
   Belytschko T, 1999, COMPUT STRUCT, V71, P173, DOI 10.1016/S0045-7949(98)00205-3
   BELYTSCHKO T, 1994, INT J NUMER METH ENG, V37, P229, DOI 10.1002/nme.1620370205
   BELYTSCHKO T, 2003, COMPUTER METHODS IN, V139, P3
   BOCCA P, 1991, INT J SOLIDS STRUCT, V27, P1139, DOI 10.1016/0020-7683(91)90115-V
   Bordas S, 2008, ENG FRACT MECH, V75, P943, DOI 10.1016/j.engfracmech.2007.05.010
   Danielson KT, 2008, J COMPUT CIVIL ENG, V22, P140, DOI 10.1061/(ASCE)0887-3801(2008)22:2(140)
   Hillerborg A., 1976, CEMENT CONCRETE RES, V6, P773, DOI [10.1016/0008-8846(76)90007-7, DOI 10.1016/0008-8846(76)90007-7]
   Jirasek M, 1998, J ENG MECH-ASCE, V124, P842, DOI 10.1061/(ASCE)0733-9399(1998)124:8(842)
   Kunigahalli R, 1997, J COMPUT CIVIL ENG, V11, P92, DOI 10.1061/(ASCE)0887-3801(1997)11:2(92)
   LANCASTER P, 1981, MATH COMPUT, V37, P141, DOI 10.2307/2007507
   LIU WK, 1995, INT J NUMER METH FL, V20, P1081, DOI 10.1002/fld.1650200824
   MONAGHAN JJ, 1994, J COMPUT PHYS, V110, P399, DOI 10.1006/jcph.1994.1034
   Nguyen VP, 2008, MATH COMPUT SIMULAT, V79, P763, DOI 10.1016/j.matcom.2008.01.003
   Organ D, 1996, COMPUT MECH, V18, P225
   Prasad MVKV, 2002, COMPUT METHOD APPL M, V191, P2699, DOI 10.1016/S0045-7825(02)00210-4
   Rabczuk T, 2007, INT J NUMER METH ENG, V72, P524, DOI 10.1002/nme.2013
   Rabczuk T, 2007, COMPUT METHOD APPL M, V196, P2777, DOI 10.1016/j.cma.2006.06.020
   Rabczuk T, 2007, INT J NUMER METH ENG, V69, P993, DOI 10.1002/nme.1797
   Rabczuk T, 2006, COMMUN NUMER METH EN, V22, P1031, DOI 10.1002/cnm.871
   Rabczuk T, 2006, INT J NUMER ANAL MET, V30, P1159, DOI 10.1002/nag.522
   Rabczuk T, 2006, INT J IMPACT ENG, V32, P1878, DOI 10.1016/j.ijimpeng.2005.02.008
   Rabczuk T, 2006, INT J FRACTURE, V137, P19, DOI 10.1007/s10704-005-3075-z
   Rabczuk T, 2005, INT J NUMER METH ENG, V63, P1559, DOI 10.1002/nme.1326
   Rabczuk T, 2005, INT J SOLIDS STRUCT, V42, P1327, DOI 10.1016/j.ijsolstr.2004.07.019
   Rabczuk T, 2004, INT J NUMER METH ENG, V61, P2316, DOI 10.1002/nme.1151
   Rabczuk T, 2004, COMPUT METHOD APPL M, V193, P1035, DOI 10.1016/j.cma.2003.12.005
   Rabczuk T, 2004, INT J SOLIDS STRUCT, V41, P1061, DOI 10.1016/j.ijsolstr.2003.09.040
   Rabczuk T, 2003, INT J NUMER METH ENG, V56, P1421, DOI 10.1002/nme.617
   Rabczuk T, 2008, COMPUT METHOD APPL M, V197, P641, DOI 10.1016/j.cma.2007.08.027
   Rabczuk T, 2008, ENG FRACT MECH, V75, P4740, DOI 10.1016/j.engfracmech.2008.06.019
   Rabczuk T, 2007, COMPUT MECH, V40, P473, DOI 10.1007/s00466-006-0122-1
   Rabczuk T, 2007, COMPUT MECH, V39, P743, DOI 10.1007/s00466-006-0067-4
   Rabczuk T, 2006, CMES-COMP MODEL ENG, V16, P115
   Rabczuk T, 2010, INT J NUMER METH ENG, V81, P48, DOI 10.1002/nme.2670
   Rabczuk T, 2009, ENG FRACT MECH, V76, P730, DOI 10.1016/j.engfracmech.2008.06.002
   Randles P. W., 1997, INT J IMPACT ENG, V20, P525
   Randles PW, 2000, INT J NUMER METH ENG, V48, P1445, DOI 10.1002/1097-0207(20000810)48:10<1445::AID-NME831>3.0.CO;2-9
   SWEGLE JW, 1995, J COMPUT PHYS, V116, P123, DOI 10.1006/jcph.1995.1010
   Ventura G, 2002, INT J NUMER METH ENG, V54, P923, DOI 10.1002/nme.471
   Zi G, 2007, COMPUT MECH, V40, P367, DOI 10.1007/s00466-006-0115-0
NR 43
TC 2
Z9 2
U1 2
U2 10
PU KOREAN SOCIETY OF CIVIL ENGINEERS-KSCE
PI SEOUL
PA 50-7 OGUM-DONG, SONGPA-KU, SEOUL, 138-857, SOUTH KOREA
SN 1226-7988
EI 1976-3808
J9 KSCE J CIV ENG
JI KSCE J. Civ. Eng.
PD SEP
PY 2010
VL 14
IS 5
BP 765
EP 772
DI 10.1007/s12205-010-1050-3
PG 8
WC Engineering, Civil
SC Engineering
GA 637UZ
UT WOS:000280845500015
DA 2018-12-27
ER

PT J
AU Okell, TW
   Chappell, MA
   Woolrich, MW
   Gunther, M
   Feinberg, DA
   Jezzard, P
AF Okell, Thomas W.
   Chappell, Michael A.
   Woolrich, Mark W.
   Guenther, Matthias
   Feinberg, David A.
   Jezzard, Peter
TI RETRACTED: Vessel-Encoded Dynamic Magnetic Resonance Angiography Using
   Arterial Spin Labeling (Retracted article. See vol. 65, pg. 900, 2011)
SO MAGNETIC RESONANCE IN MEDICINE
LA English
DT Article; Retracted Publication
DE magnetic resonance angiography; pseudo-continuous arterial spin
   labeling; vessel selective; cerebral arteries; cerebrovascular disease
ID DIAGNOSTIC CEREBRAL-ANGIOGRAPHY; SELECTIVE INVERSION-RECOVERY;
   MR-ANGIOGRAPHY; COLLATERAL CIRCULATION; FLOW; WILLIS; CIRCLE
AB A new noninvasive MRI method for vessel selective angiography is presented. The technique combines vessel-encoded pseudocontinuous arterial spin labeling with a two-dimensional dynamic angiographic readout and was used to image the cerebral arteries in healthy volunteers. Time-of-flight angiograms were also acquired prior to vessel-selective dynamic angiography acquisitions in axial, coronal, and/or sagittal planes, using a 3-T MRI scanner. The latter consisted of a vessel-encoded pseudocontinuous arterial spin labeling pulse train of 300 or 1000 ms followed by a two-dimensional thick-slab flow-compensated fast low angle shot readout combined with a segmented Look-Locker sampling strategy (temporal resolution = 55 ms). Selective labeling was performed at the level of the neck to generate individual angiograms for both right and left internal carotid and vertebral arteries. Individual vessel angiograms were reconstructed using a bayesian inference method. The vessel-selective dynamic angiograms obtained were consistent with the time-of-flight images, and the longer of the two vessel-encoded pseudocontinuous arterial spin labeling pulse train durations tested (1000 ms) was found to give better distal vessel visibility. This technique provides highly selective angiograms quickly and noninvasively that could potentially be used in place of intra-arterial x-ray angiography for larger vessels. Magn Reson Med 64:698-706, 2010. (C) 2010 Wiley-Liss, Inc.
C1 [Okell, Thomas W.; Chappell, Michael A.; Woolrich, Mark W.; Jezzard, Peter] Univ Oxford, Ctr Funct Magnet Resonance Imaging Brain, Dept Clin Neurol, Oxford OX3 9DU, England.
   [Okell, Thomas W.] Churchill Hosp, Dept Med Phys & Clin Engn, Oxford OX3 7LJ, England.
   [Guenther, Matthias] Heidelberg Univ, Univ Klinikum Mannheim, Dept Neurol, D-6800 Mannheim, Germany.
   [Guenther, Matthias] Mediri GmbH, Heidelberg, Germany.
   [Feinberg, David A.] Adv MRI Technol, Sebastapol, CA USA.
RP Jezzard, P (reprint author), Univ Oxford, John Radcliffe Hosp, FMRIB Ctr, Dept Clin Neurol, Oxford OX3 9DU, England.
EM peterj@fmrib.ox.ac.uk
OI Jezzard, Peter/0000-0001-7912-2251; Okell, Thomas/0000-0001-8258-0659;
   Chappell, Michael/0000-0003-1802-4214
FU Engineering and Physical Sciences Research Council [EP/C539788/1];
   Medical Research Council [G0802179]
CR Bendszus M, 1999, LANCET, V354, P1594, DOI 10.1016/S0140-6736(99)07083-X
   CHAPPELL MA, 2009, MED IMAGE COMPUT COM, V5762, P514
   Charara J, 1999, J MED ENG TECHNOL, V23, P83, DOI 10.1080/030919099294221
   DAI W, 2009, P 17 ANN M ISMRM HON, P275
   DAI W, 2008, P 16 ANN M ISMRM TOR, P184
   Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790
   DIXON WT, 1986, MAGN RESON MED, V3, P454, DOI 10.1002/mrm.1910030311
   EDELMAN RR, 1994, MAGNET RESON MED, V31, P233, DOI 10.1002/mrm.1910310219
   Gunther M, 2001, MAGNET RESON MED, V46, P974
   Gunther M, 2002, P 10 ANN M ISMRM HON, P1100
   Hoksbergen AWJ, 2000, STROKE, V31, P1346, DOI 10.1161/01.STR.31.6.1346
   Kansagra AP, 2008, J MAGN RESON IMAGING, V28, P762, DOI 10.1002/jmri.21462
   Kaufmann TJ, 2007, RADIOLOGY, V243, P812, DOI 10.1148/radiol.2433060536
   Lee P. M., 1997, BAYESIAN STAT
   Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06
   Look D. C., 1970, Review of Scientific Instruments, V41, P250, DOI 10.1063/1.1684482
   MACKAY DJC, 1995, NETWORK-COMP NEURAL, V6, P469, DOI 10.1088/0954-898X/6/3/011
   MASARYK TJ, 1989, RADIOLOGY, V171, P793, DOI 10.1148/radiology.171.3.2717754
   MORAN P R, 1982, Magnetic Resonance Imaging, V1, P197
   NISHIMURA DG, 1987, MAGNET RESON MED, V4, P193, DOI 10.1002/mrm.1910040214
   Sallustio F, 2008, STROKE, V39, P1894, DOI 10.1161/STROKEAHA.107.503482
   van Osch MJP, 2006, MED IMAGE ANAL, V10, P59, DOI 10.1016/j.media.2005.04.010
   Walsh DO, 2000, MAGNET RESON MED, V43, P682, DOI 10.1002/(SICI)1522-2594(200005)43:5<682::AID-MRM10>3.0.CO;2-G
   WANG SJ, 1991, MAGNET RESON MED, V17, P244, DOI 10.1002/mrm.1910170127
   Warmuth C, 2005, AM J NEURORADIOL, V26, P1035
   WONG E, 2008, P 16 ANN M ISMRM TOR, P182
   Wong EC, 2007, MAGN RESON MED, V58, P1086, DOI 10.1002/mrm.21293
   Wu B, 2008, AM J NEURORADIOL, V29, P1855, DOI 10.3174/ajnr.A1259
NR 28
TC 21
Z9 21
U1 1
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0740-3194
EI 1522-2594
J9 MAGN RESON MED
JI Magn. Reson. Med.
PD SEP
PY 2010
VL 64
IS 3
BP 698
EP 706
DI 10.1002/mrm.22458
PG 9
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 644BV
UT WOS:000281346300010
PM 20535814
OA Bronze
DA 2018-12-27
ER

PT J
AU Jiang, YR
   Yin, ZG
   Yi, YL
   Zhou, XH
AF Jiang Yu-ren
   Yin Zhi-gang
   Yi Yun-lai
   Zhou Xiao-hong
TI RETRACTED: Synthesis and collecting properties of novel carboxyl
   hydroxamic acids for diaspore and aluminosilicate minerals (Retracted
   article. See vol. 39, 2018)
SO MINERALS ENGINEERING
LA English
DT Article; Retracted Publication
DE Collector; Flotation behavior; Adsorption mechanism; Diaspore;
   Aluminosilicate mineral
AB Novel carboxyl hydroxamic acids compounds, including 2-carboxyl-6-methylcyclohexane carboxamic acid (CMCA), 2-carboxymethyl-decylen-4-yl hydroxamic acid (CDHA), and 2-carboxymethyl-tetradecen-4-yl hydroxamic acid (CTHA) were synthesized, and the flotation behaviors of diaspore, kaolinite and illite were investigated by using these compounds as collectors. The adsorption mechanism of CTHA on the surface of diaspore, kaolinite and illite was conducted by zeta-potential, adsorption amount and FTIR spectra measurement. The interaction of CTHA on the diaspore surface may be mainly dominated by the chemical adsorption; however, the adsorption of CTHA on kaolinite or illite is mainly dominated by the physical one. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Jiang Yu-ren; Yin Zhi-gang; Yi Yun-lai; Zhou Xiao-hong] Cent S Univ, Coll Chem & Chem Engn, Changsha 410083, Peoples R China.
RP Jiang, YR (reprint author), Cent S Univ, Coll Chem & Chem Engn, Changsha 410083, Peoples R China.
EM jiangyr@mail.csu.edu.cn
FU National Natural Science Foundation of China [20876180]
FX The research is supported by the National Natural Science Foundation of
   China (20876180), the authors express their great appreciations. We also
   thank Jiang Hao for her assistance in the part of flotation tests and
   Mrs. Rosemary Graham for her timely help in refining the language of
   this manuscript.
NR 0
TC 13
Z9 16
U1 3
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0892-6875
J9 MINER ENG
JI Miner. Eng.
PD SEP
PY 2010
VL 23
IS 10
BP 830
EP 832
DI 10.1016/j.mineng.2010.05.016
PG 3
WC Engineering, Chemical; Mineralogy; Mining & Mineral Processing
SC Engineering; Mineralogy; Mining & Mineral Processing
GA 643JR
UT WOS:000281292900011
DA 2018-12-27
ER

PT J
AU Kaynar, AM
   Shapiro, SD
AF Kaynar, A. Murat
   Shapiro, Steven D.
TI RETRACTED: NET loss of air in cystic fibrosis (Retracted article. See
   vol. 17, pg. 899, 2011)
SO NATURE MEDICINE
LA English
DT Editorial Material; Retracted Publication
ID NEUTROPHILS; DNA
C1 [Kaynar, A. Murat] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.
   [Shapiro, Steven D.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA.
RP Kaynar, AM (reprint author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.
EM sds33@pitt.edu
OI Kaynar, Ata Murat/0000-0001-8847-0450
CR Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385
   Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710
   Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565
   Downey DG, 2009, THORAX, V64, P81, DOI 10.1136/thx.2007.082388
   Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003
   Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959
   Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028
   Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209
   WALTERS S, 2007, CYSTIC FIBROSIS, P21
   Yost CC, 2009, BLOOD, V113, P6419, DOI 10.1182/blood-2008-07-171629
   Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855
NR 11
TC 2
Z9 2
U1 3
U2 10
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
J9 NAT MED
JI Nat. Med.
PD SEP
PY 2010
VL 16
IS 9
BP 967
EP 969
DI 10.1038/nm0910-967
PG 4
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA 647MP
UT WOS:000281622900020
PM 20823877
DA 2018-12-27
ER

PT J
AU Marcos, V
   Zhou, Z
   Yildirim, AO
   Bohla, A
   Hector, A
   Vitkov, L
   Wiedenbauer, EM
   Krautgartner, WD
   Stoiber, W
   Belohradsky, BH
   Rieber, N
   Kormann, M
   Koller, B
   Roscher, A
   Roos, D
   Griese, M
   Eickelberg, O
   Doring, G
   Mall, MA
   Hartl, D
AF Marcos, Veronica
   Zhou, Zhe
   Yildirim, Ali Oender
   Bohla, Alexander
   Hector, Andreas
   Vitkov, Ljubomir
   Wiedenbauer, Eva-Maria
   Krautgartner, Wolf Dietrich
   Stoiber, Walter
   Belohradsky, Bernd H.
   Rieber, Nikolaus
   Kormann, Michael
   Koller, Barbara
   Roscher, Adelbert
   Roos, Dirk
   Griese, Matthias
   Eickelberg, Oliver
   Doering, Gerd
   Mall, Marcus A.
   Hartl, Dominik
TI RETRACTED: CXCR2 mediates NADPH oxidase-independent neutrophil
   extracellular trap formation in cystic fibrosis airway inflammation
   (Retracted article. See vol. 17, pg. 899, 2011)
SO NATURE MEDICINE
LA English
DT Article; Retracted Publication
ID CF LUNG-DISEASE; MITOCHONDRIAL-DNA; INTERLEUKIN-8; RELEASE; DEFENSE;
   MICE; INDUCTION; BACTERIA; IMMUNITY; LIGANDS
AB Upon activation, neutrophils release DNA fibers decorated with antimicrobial proteins, forming neutrophil extracellular traps (NETs)(1-3). Although NETs are bactericidal and contribute to innate host defense, excessive NET formation has been linked to the pathogenesis of autoinflammatory diseases(4,5). However, the mechanisms regulating NET formation, particularly during chronic inflammation, are poorly understood. Here we show that the G protein-coupled receptor (GPCR) CXCR2 mediates NET formation. Downstream analyses showed that CXCR2-mediated NET formation was independent of NADPH oxidase and involved Src family kinases. We show the pathophysiological relevance of this mechanism in cystic fibrosis lung disease, characterized by chronic neutrophilic inflammation(6,7). We found abundant NETs in airway fluids of individuals with cystic fibrosis and mouse cystic fibrosis lung disease, and NET amounts correlated with impaired obstructive lung function. Pulmonary blockade of CXCR2 by intra-airway delivery of small-molecule antagonists inhibited NET formation and improved lung function in vivo without affecting neutrophil recruitment, proteolytic activity or antibacterial host defense. These studies establish CXCR2 as a receptor mediating NADPH oxidase-independent NET formation and provide evidence that this GPCR pathway is operative and druggable in cystic fibrosis lung disease.
C1 [Marcos, Veronica; Hector, Andreas; Wiedenbauer, Eva-Maria; Belohradsky, Bernd H.; Rieber, Nikolaus; Kormann, Michael; Roscher, Adelbert; Griese, Matthias; Hartl, Dominik] Univ Munich, Childrens Hosp, Res Ctr, D-8000 Munich, Germany.
   [Zhou, Zhe; Mall, Marcus A.] Univ Heidelberg, Dept Pediat 3, Div Pediat Pulmonol, Heidelberg, Germany.
   [Zhou, Zhe; Mall, Marcus A.] Univ Heidelberg, Dept Pediat 3, Cyst Fibrosis Ctr, Heidelberg, Germany.
   [Yildirim, Ali Oender; Bohla, Alexander; Eickelberg, Oliver] Univ Munich, Univ Hosp, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, D-8000 Munich, Germany.
   [Hector, Andreas; Kormann, Michael; Hartl, Dominik] Univ Tubingen, Childrens Hosp, Tubingen, Germany.
   [Hector, Andreas; Kormann, Michael; Hartl, Dominik] Univ Tubingen, Interdisciplinary Ctr Infect Dis, Tubingen, Germany.
   [Vitkov, Ljubomir] Univ Saarland, Dept Operat Dent & Periodontol, D-6650 Homburg, Germany.
   [Vitkov, Ljubomir; Krautgartner, Wolf Dietrich; Stoiber, Walter] Salzburg Univ, Dept Organism Biol, Div Light & Electron Microscopy, A-5020 Salzburg, Austria.
   [Koller, Barbara] Univ Munich, Dept Dermatol & Allergy, D-8000 Munich, Germany.
   [Roos, Dirk] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands.
   [Doering, Gerd] Univ Tubingen, Inst Med Microbiol & Hyg, Tubingen, Germany.
RP Hartl, D (reprint author), Univ Munich, Childrens Hosp, Res Ctr, D-8000 Munich, Germany.
EM dominik.hartl@med.uni-tuebingen.de
RI Bohla, Alexander/J-1537-2012; Eickelberg, Oliver/A-5461-2013
OI Bohla, Alexander/0000-0001-9610-5138; Eickelberg,
   Oliver/0000-0001-7170-0360; Yildirim, Ali Onder/0000-0003-1969-480X;
   Vitkov, Ljubomir/0000-0002-1249-0161
FU German Research Foundation; Alexander von Humboldt Foundation; German
   Society of Pediatric Pneumology; PINAe.V.; Novartis Foundation;
   Ernest-Solvay-Foundation;  [HA 5274/3-1];  [2081/3-3];  [MA 2081/4-1]
FX We thank B. Lange-Sperandio and F. Beitinger for lung sample
   preparations. We thank O. Gires and L. Mays for manuscript discussions.
   We thank M. Klappacher, A. Obermayer, T. Stoger, B. Ritter, S. Stritzke
   and M. Franz for assistance in experimental workup and S. Hirtz for
   breeding and genotyping of experimental mice. Supported by the German
   Research Foundation (Deutsche Forschungsgemeinschaft, Emmy Noether
   Programme HA 5274/3-1 to D. H., MA 2081/3-3 and MA 2081/4-1 to M. A.
   M.), the Alexander von Humboldt Foundation (B. K.), the German Society
   of Pediatric Pneumology (D. H.), PINAe.V. (D. H.), the Novartis
   Foundation (D. H.) and the Ernest-Solvay-Foundation (D. H.).
CR BAGGIOLINI M, 1995, INT J IMMUNOPHARMACO, V17, P103, DOI 10.1016/0192-0561(94)00088-6
   Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x
   Barnes PJ, 2008, CURR OPIN PHARMACOL, V8, P300, DOI 10.1016/j.coph.2008.03.001
   Belperio JA, 2005, J CLIN INVEST, V115, P1150, DOI 10.1172/JCI200524233
   Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385
   Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710
   Chakrabarti S, 2005, J LEUKOCYTE BIOL, V78, P279, DOI 10.1189/jlb.1004612
   Chapman RW, 2009, PHARMACOL THERAPEUT, V121, P55, DOI 10.1016/j.pharmthera.2008.10.005
   Chmiel JF, 2002, CLIN REV ALLERG IMMU, V23, P5, DOI 10.1385/CRIAI:23:1:005
   Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565
   Davis P B, 2001, Pediatr Rev, V22, P257, DOI 10.1542/pir.22-8-257
   Frizzell RA, 2004, NAT MED, V10, P452, DOI 10.1038/nm0504-452
   Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027
   Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003
   Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690
   Herbold W, 2010, INFECT IMMUN, V78, P2620, DOI 10.1128/IAI.01169-09
   Jones SA, 1996, P NATL ACAD SCI USA, V93, P6682, DOI 10.1073/pnas.93.13.6682
   Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959
   Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028
   Martinelli S, 2004, J BIOL CHEM, V279, P44123, DOI 10.1074/jbc.M405883200
   MCELVANEY NG, 1992, J CLIN INVEST, V90, P1296, DOI 10.1172/JCI115994
   Mehrad B, 1999, J IMMUNOL, V163, P6086
   Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785
   Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895
   Ness TL, 2003, J IMMUNOL, V171, P3775, DOI 10.4049/jimmunol.171.7.3775
   OLSON TS, 2002, AM J PHYSIOL-REG I, V283, P7
   Pease James E, 2002, Am J Respir Med, V1, P19
   Richardson RM, 1998, J BIOL CHEM, V273, P23830, DOI 10.1074/jbc.273.37.23830
   Sai JQ, 2008, J BIOL CHEM, V283, P26538, DOI 10.1074/jbc.M805611200
   Sue RD, 2004, J IMMUNOL, V172, P3860, DOI 10.4049/jimmunol.172.6.3860
   Tsai WC, 2000, INFECT IMMUN, V68, P4289, DOI 10.1128/IAI.68.7.4289-4296.2000
   Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x
   Urban C, 2007, NAT MED, V13, P403, DOI 10.1038/nm0407-403
   Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841
   von Kockritz-Blickwede M, 2009, J MOL MED, V87, P775, DOI 10.1007/s00109-009-0481-0
   Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072
   Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96
   Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855
   Zarbock A, 2008, BRIT J PHARMACOL, V155, P357, DOI 10.1038/bjp.2008.270
NR 39
TC 128
Z9 136
U1 2
U2 22
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
J9 NAT MED
JI Nat. Med.
PD SEP
PY 2010
VL 16
IS 9
BP 1018
EP U114
DI 10.1038/nm.2209
PG 7
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA 647MP
UT WOS:000281622900031
PM 20818377
DA 2018-12-27
ER

PT J
AU Wan, LD
   Xia, R
   Ding, WL
AF Wan, L. D.
   Xia, R.
   Ding, W. L.
TI RETRACTED: ELECTRICAL STIMULATION ENHANCED REMYELINATION OF INJURED
   SCIATIC NERVES BY INCREASING NEUROTROPHINS (Retracted article. See vol.
   182, pg. 248, 2011)
SO NEUROSCIENCE
LA English
DT Article; Retracted Publication
DE electrical stimulation; myelination; BDNF; Schwann cell; Par-3
ID PROMOTE FUNCTIONAL RECOVERY; PERIPHERAL NERVOUS-SYSTEM; REGULATE
   MYELINATION; AXON REGENERATION; ACTION-POTENTIALS; GENE-EXPRESSION;
   SENSORY AXONS; REPAIR; MOTONEURONS; BDNF
AB Previous studies have demonstrated that electrical stimulation (ES) enhances axonal regeneration following central and peripheral nerve injury. However, the effect of ES on peripheral remyelination after nerve damage has been investigated less, and the mechanism underlying its action remains unclear. In the present study, neuron/Schwann cell (SC) co-cultures in vitro and crush-injured sciatic nerves in rats were subjected to 1 h of continuous ES (20 Hz, 100 mu s, 3 V). Electron microscopy and nerve morphometry were performed to investigate the extent of regenerated nerve myelination. The expression profiles of PO, Par-3 and brain-derived neurotrophic factor (BDNF) in vitro and in vivo were examined by western blotting. We reported that 20 Hz ES increased the number of regenerated and myelinated axons at 4 and 8 weeks after injury. PO level in the ES-treated groups, as well as myelin sheath thickness, were enhanced compared with the controls. The earlier peak Par-3 in the ES-treated groups indicated earlier initiation of SC myelination. Moreover, the similar results were achieved in the cell co-culture. Additionally, brief ES significantly elevated BDNF expression in co-cultured cells and nerve tissues. In conclusion, ES of the site of nerve injury potentiates axonal regrowth and myelin maturation during peripheral nerve regeneration. Further, the therapeutic actions of ES on myelination that is mediated via enhanced BDNF signals, which driving the promyelination effect on SCs at the onset of myelination. (C) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.
C1 [Wan, L. D.; Xia, R.; Ding, W. L.] Shanghai Jiao Tong Univ, Sch Med, Dept Anat, Shanghai 200025, Peoples R China.
   [Wan, L. D.] Nanchang Univ, Sch Med, Dept Anat, Nanchang 330006, Jiangxi, Peoples R China.
RP Ding, WL (reprint author), Shanghai Jiao Tong Univ, Sch Med, Dept Anat, 227 S Chongqing Rd, Shanghai 200025, Peoples R China.
EM dingwL500@sina.com.cn
FU Shanghai Leading Academic Discipline Project [S30201, S30205]; Shanghai
   Science and Technology Committee [09410706200]
FX Research was supported by Shanghai Leading Academic Discipline Project,
   Project Number: S30201, S30205 and The International Cooperation
   Projects of Shanghai Science and Technology Committee, Project number:
   09410706200.
CR Ahlborn P, 2007, EXP NEUROL, V208, P137, DOI 10.1016/j.expneurol.2007.08.005
   Al-Majed AA, 2004, CELL MOL NEUROBIOL, V24, P379, DOI 10.1023/B:CEMN.0000022770.66463.f7
   Al-Majed AA, 2000, EUR J NEUROSCI, V12, P4381, DOI 10.1046/j.1460-9568.2000.01341.x
   Brushart TM, 2005, EXP NEUROL, V194, P221, DOI 10.1016/j.expneuro.2005.02.007
   Chan JR, 2006, SCIENCE, V314, P832, DOI 10.1126/science.1134069
   Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024
   Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398
   Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595
   De Groot DM, 2006, MOL ENDOCRINOL, V20, P2987, DOI 10.1210/me.2006-0168
   Eberhardt KA, 2006, EXP NEUROL, V198, P500, DOI 10.1016/j.expneurol.2005.12.018
   English AW, 2007, DEV NEUROBIOL, V67, P158, DOI 10.1002/neu.20339
   Fields RD, 2005, CELL CALCIUM, V37, P433, DOI 10.1016/j.ceca.2005.01.011
   Franz CK, 2008, BRAIN, V131, P1492, DOI 10.1093/brain/awn039
   Geremia NM, 2007, EXP NEUROL, V205, P347, DOI 10.1016/j.expneurol.2007.01.040
   Gordon T, 2007, ACTA NEUROCHIR SUPPL, V100, P3
   Gordon T, 2003, J PERIPHER NERV SYST, V8, P236, DOI 10.1111/j.1085-9489.2003.03029.x
   Gordon T, 2008, NEUROL RES, V30, P1012, DOI 10.1179/174313208X362488
   Lang EM, 2008, J NEUROTRAUM, V25, P384, DOI 10.1089/neu.2007.0396
   Ng BK, 2007, J NEUROSCI, V27, P7597, DOI 10.1523/JNEUROSCI.0563-07.2007
   Rosenberg SS, 2006, BRAIN PATHOL, V16, P288, DOI 10.1111/j.1750-3639.2006.00035.x
   Stevens B, 1998, J NEUROSCI, V18, P9303
   Tolwani RJ, 2004, J NEUROSCI RES, V77, P662, DOI 10.1002/jnr.20181
   Udina E, 2008, EXP NEUROL, V210, P238, DOI 10.1016/j.expneurol.2007.11.007
   Vivo M, 2008, EXP NEUROL, V211, P180, DOI 10.1016/j.expneurol.2008.01.020
   Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511
   Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209
   Xia R, 2007, ACTA NEUROCHIR, V149, P67, DOI 10.1007/s00701-006-1058-0
   Zalc B, 2000, NEUROSCIENTIST, V6, P5, DOI 10.1177/107385840000600109
   Zealear DL, 2002, J NEUROPHYSIOL, V87, P2195, DOI 10.1152/jn.00451.2001
NR 29
TC 21
Z9 26
U1 5
U2 20
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4522
EI 1873-7544
J9 NEUROSCIENCE
JI Neuroscience
PD SEP 1
PY 2010
VL 169
IS 3
BP 1029
EP 1038
DI 10.1016/j.neuroscience.2010.05.051
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA 641FC
UT WOS:000281109200008
PM 20553821
DA 2018-12-27
ER

PT J
AU Lichtenthaler, U
   Ernst, H
   Hoegl, M
AF Lichtenthaler, Ulrich
   Ernst, Holger
   Hoegl, Martin
TI RETRACTED: Not-Sold-Here: How Attitudes Influence External Knowledge
   Exploitation (Retracted article. See vol. 23, pg. 1781, 2012)
SO ORGANIZATION SCIENCE
LA English
DT Article; Retracted Publication
DE employee attitudes; dynamic capabilities; external knowledge
   exploitation; microfoundations; not-invented-here; technology licensing
ID RESEARCH-AND-DEVELOPMENT; GROUP DECISION-MAKING; RESOURCE-BASED VIEW;
   DYNAMIC CAPABILITIES; FIRM-LEVEL; TECHNOLOGICAL RESOURCES; INTEGRATIVE
   FRAMEWORK; STRATEGIC MANAGEMENT; COMPETITIVE ACTIVITY;
   CONSTRUCT-VALIDITY
AB Employee attitudes with regard to the usefulness of external knowledge may influence a firm's extent of inter-organizational knowledge transactions. Prior research has focused on "not-invented-here (NIH)" tendencies, which refer to negative attitudes in organizations toward the acquisition of knowledge from external sources. In this research, we develop the concept of "not-sold-here (NSH)" tendencies, which result from protective attitudes in firms toward the external exploitation of knowledge, for example, technology licensing. We show conceptually how NSH tendencies develop and how they can influence the extent of outward knowledge transfer. We test five hypotheses regarding antecedents and consequences of NSH tendencies with data from 152 firms spanning multiple industries. The empirical findings show that NSH tendencies exist in organizations and that they constitute a major barrier to the implementation of external knowledge commercialization strategies. The concept of NSH therefore helps explain the varying degrees of activity in external knowledge exploitation, and it contributes to understanding particular microfoundations of dynamic capabilities.
C1 [Lichtenthaler, Ulrich; Ernst, Holger; Hoegl, Martin] WHU Otto Beisheim Sch Management, Chair Technol & Innovat Management, D-56179 Vallendar, Germany.
RP Lichtenthaler, U (reprint author), WHU Otto Beisheim Sch Management, Chair Technol & Innovat Management, D-56179 Vallendar, Germany.
EM lichtenthaler@whu.edu; hernst@whu.edu; hoegl@whu.edu
CR ADAM Y, 1988, J PROD INNOVAT MANAG, V5, P32, DOI 10.1111/1540-5885.510032
   AJZEN I, 1970, J EXP SOC PSYCHOL, V6, P466, DOI 10.1016/0022-1031(70)90057-0
   Anand BN, 2000, J IND ECON, V48, P103
   Argote L, 2003, MANAGE SCI, V49, P571, DOI 10.1287/mnsc.49.4.571.14424
   Argote L, 2007, ORGAN SCI, V18, P337, DOI 10.1287/orsc.1070.0280
   Arora A, 2006, MANAGE SCI, V52, P293, DOI 10.1287/mnsc.1050.0437
   ASHFORTH BE, 1989, ACAD MANAGE REV, V14, P20, DOI 10.2307/258189
   BAGOZZI RP, 1991, ADMIN SCI QUART, V36, P421, DOI 10.2307/2393203
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
   Brodbeck FC, 2007, ACAD MANAGE REV, V32, P459
   Carlile PR, 2004, ORGAN SCI, V15, P555, DOI 10.1287/orcs.1040.0094
   CAVES RE, 1983, OXFORD B ECON STAT, V45, P249
   Chesbrough H, 2003, OPEN INNOVATION NEW
   Chesbrough H, 2006, OPEN INNOVATION RES
   Chesbrough H., 2006, OPEN BUSINESS MODELS
   Chesbrough H, 2007, CALIF MANAGE REV, V49, P45, DOI 10.2307/41166394
   Coase RH, 1937, ECONOMICA-NEW SER, V4, P386, DOI 10.1111/j.1468-0335.1937.tb00002.x
   Cohen J., 2003, APPL MULTIPLE REGRES
   Cohen W. M., 2000, 7552 NAT BUR EC RES
   COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553
   Cyert R. M., 1963, BEHAV THEORY FIRM
   DAVIS JL, 2001, EDISON BOARDROOM LEA
   de Jong A, 2005, J MANAGE STUD, V42, P1593, DOI 10.1111/j.1467-6486.2005.00558.x
   Debackere K, 2005, RES POLICY, V34, P321, DOI 10.1016/j.respol.2004.12.003
   DESHPANDE R, 1993, J MARKETING, V57, P23, DOI 10.2307/1252055
   DUCKITT J., 1992, SOCIAL PSYCHOL PREJU
   Eisenhardt KM, 2000, STRATEGIC MANAGE J, V21, P1105, DOI 10.1002/1097-0266(200010/11)21:10/11<1105::AID-SMJ133>3.0.CO;2-E
   Ernst H, 2001, RES POLICY, V30, P143, DOI 10.1016/S0048-7333(99)00098-0
   Escher JP, 2003, TECHNOLOGY INNOVATIO, P215
   Fosfuri A, 2006, STRATEGIC MANAGE J, V27, P1141, DOI 10.1002/smj.562
   Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115
   Gambardella A, 2001, MARKETS TECHNOLOGY E
   Gambardella A, 2007, RES POLICY, V36, P1163, DOI 10.1016/j.respol.2007.07.006
   Gans JS, 2003, RES POLICY, V32, P333, DOI 10.1016/S0048-7333(02)00103-8
   Gavetti G, 2005, ORGAN SCI, V16, P599, DOI 10.1287/orsc.1050.0140
   George E, 2003, ORGAN SCI, V14, P386, DOI 10.1287/orsc.14.4.386.17488
   Gibson D. V., 1994, R D COLLABORATION TR
   Gilkey R, 2007, HARVARD BUS REV, V85, P53
   GODFREY PC, 1995, STRATEGIC MANAGE J, V16, P519, DOI 10.1002/smj.4250160703
   GOODING RZ, 1995, J MANAGE STUD, V32, P1, DOI 10.1111/j.1467-6486.1995.tb00643.x
   Griffith J, 2006, J APPL SOC PSYCHOL, V36, P1848, DOI 10.1111/j.0021-9029.2006.00085.x
   Grindley PC, 1997, CALIF MANAGE REV, V39, P8, DOI 10.2307/41165885
   Hair J., 2006, MULTIVARIATE DATA AN
   Hayward MLA, 2006, STRATEGIC MANAGE J, V27, P541, DOI 10.1002/smj.526
   Helfat C. E., 2007, DYNAMIC CAPABILITIES
   HILL CWL, 1992, ORGAN SCI, V3, P428, DOI 10.1287/orsc.3.3.428
   Hoegl M, 2004, ORGAN SCI, V15, P38, DOI 10.1287/orsc.1030.0053
   Hollingshead AB, 1996, ORGAN BEHAV HUM DEC, V68, P181, DOI 10.1006/obhd.1996.0098
   HOSKISSON RE, 1993, ORGAN SCI, V4, P325, DOI 10.1287/orsc.4.2.325
   Huston L, 2006, HARVARD BUS REV, V84, P58
   Janssen O, 2001, ACAD MANAGE J, V44, P1039, DOI 10.2307/3069447
   JAWORSKI BJ, 1993, J MARKETING, V57, P53, DOI 10.2307/1251854
   Kale P, 2007, STRATEG MANAGE J, V28, P981, DOI 10.1002/smj.616
   KATZ R, 1982, R&D MANAGE, V12, P7, DOI 10.1111/j.1467-9310.1982.tb00478.x
   KELLEY HH, 1980, ANNU REV PSYCHOL, V31, P457, DOI 10.1146/annurev.ps.31.020180.002325
   KIESLER S, 1982, ADMIN SCI QUART, V27, P548, DOI 10.2307/2392530
   King MF, 2000, PSYCHOL MARKET, V17, P79, DOI 10.1002/(SICI)1520-6793(200002)17:2<79::AID-MAR2>3.0.CO;2-0
   Kline D, 2003, MIT SLOAN MANAGE REV, V44, P89
   KOGUT B, 1992, ORGAN SCI, V3, P383, DOI 10.1287/orsc.3.3.383
   KUMAR N, 1993, ACAD MANAGE J, V36, P1633, DOI 10.2307/256824
   LEVIN R. C., 1987, BROOKINGS PAPERS EC, V3, P783, DOI DOI 10.2307/2534454
   LICHTENTHALER U, 2005, AC MAN C HON AUG 10
   Lichtenthaler U, 2007, RES POLICY, V36, P37, DOI 10.1016/j.respol.2006.08.005
   Lichtenthaler U, 2006, R&D MANAGE, V36, P367, DOI 10.1111/j.1467-9310.2006.00443.x
   Lindell MK, 2001, J APPL PSYCHOL, V86, P114, DOI 10.1037//0021-9010.86.1.114
   LONG JS, 2002, REGRESSION MODELS CA
   Menon T, 2003, MANAGE SCI, V49, P497, DOI 10.1287/mnsc.49.4.497.14422
   Menon T, 2006, MANAGE SCI, V52, P1129, DOI 10.1287/mnsc.1060.0525
   Miller DJ, 2004, STRATEGIC MANAGE J, V25, P1097, DOI 10.1002/smj.411
   Motohashi K, 2008, RES POLICY, V37, P1548, DOI 10.1016/j.respol.2007.12.014
   Pennings JME, 2000, MANAGE SCI, V46, P1337, DOI 10.1287/mnsc.46.10.1337.12275
   Pitelis CN, 2007, ORGAN SCI, V18, P478, DOI 10.1287/orsc.1060.0244
   RAVLIN E. C., 2006, J MANAGERIAL ISSUES, V18, P175
   Rindova VP, 2004, ACAD MANAGE REV, V29, P670
   Rivette K, 2000, REMBRANDTS ATTIC UNL
   Rothaermel FT, 2006, J BUS VENTURING, V21, P429, DOI 10.1016/j.jbusvent.2005.02.006
   SAGIE A, 1994, J ORGAN BEHAV, V15, P37, DOI 10.1002/job.4030150105
   Sakkab NY, 2002, RES TECHNOL MANAGE, V45, P38
   Santos FA, 2005, ORGAN SCI, V16, P491, DOI 10.1287/orsc.1050.0152
   Schein EH, 1996, ADMIN SCI QUART, V41, P229, DOI 10.2307/2393715
   Schneider B, 1996, PERS PSYCHOL, V49, P695, DOI 10.1111/j.1744-6570.1996.tb01591.x
   Scott SG, 1997, J ENG TECHNOL MANAGE, V14, P97, DOI 10.1016/S0923-4748(97)00007-6
   Shamir B, 1998, ACAD MANAGE J, V41, P387, DOI 10.2307/257080
   Shane S, 2001, MANAGE SCI, V47, P1173, DOI 10.1287/mnsc.47.9.1173.9785
   Shane S., 1992, MANAGE INT REV, V32, P295
   Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422
   Silverman BS, 1999, MANAGE SCI, V45, P1109, DOI 10.1287/mnsc.45.8.1109
   Tang JM, 2006, RES POLICY, V35, P68, DOI 10.1016/j.respol.2005.08.004
   Teece DJ, 2007, STRATEG MANAGE J, V28, P1319, DOI 10.1002/smj.640
   Teece DJ, 2006, RES POLICY, V35, P1131, DOI 10.1016/j.respol.2006.09.009
   Teece DJ, 1998, CALIF MANAGE REV, V40, P55, DOI 10.2307/41165943
   Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z
   Tripsas M, 2000, STRATEGIC MANAGE J, V21, P1147, DOI 10.1002/1097-0266(200010/11)21:10/11<1147::AID-SMJ128>3.3.CO;2-I
   TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124
   Van Dyne L, 2004, J ORGAN BEHAV, V25, P439, DOI 10.1002/job.249
   Wagner JA, 1997, STRATEGIC MANAGE J, V18, P275, DOI 10.1002/(SICI)1097-0266(199704)18:4<275::AID-SMJ880>3.3.CO;2-M
   Williamson O. E., 1975, MARKETS HIERARCHIES
   Wood RE, 2008, ORGAN RES METHODS, V11, P270, DOI 10.1177/1094428106297811
   Young G, 1996, ORGAN SCI, V7, P243, DOI 10.1287/orsc.7.3.243
   Zahra SA, 2006, J MANAGE STUD, V43, P917, DOI 10.1111/j.1467-6486.2006.00616.x
NR 100
TC 30
Z9 32
U1 5
U2 71
PU INFORMS
PI HANOVER
PA 7240 PARKWAY DR, STE 310, HANOVER, MD 21076-1344 USA
SN 1047-7039
J9 ORGAN SCI
JI Organ Sci.
PD SEP-OCT
PY 2010
VL 21
IS 5
BP 1054
EP 1071
DI 10.1287/orsc.1090.0499
PG 18
WC Management
SC Business & Economics
GA 651SW
UT WOS:000281948400006
DA 2018-12-27
ER

PT J
AU Cai, WH
   Ma, JF
   Chi, W
   Zou, MJ
   Guo, JK
   Lu, CM
   Zhang, LX
AF Cai, Wenhe
   Ma, Jinfang
   Chi, Wei
   Zou, Meijuan
   Guo, Jinkui
   Lu, Congming
   Zhang, Lixin
TI RETRACTED: Cooperation of LPA3 and LPA2 Is Essential for Photosystem II
   Assembly in Arabidopsis(Retracted article. See vol. 173, pg. 1526,2017)
SO PLANT PHYSIOLOGY
LA English
DT Article; Retracted Publication
ID MEMBRANE-PROTEIN COMPLEXES; PSBA MESSENGER-RNA;
   CHLAMYDOMONAS-REINHARDTII; D1 PROTEIN; THYLAKOID MEMBRANES; BINDING
   PROTEIN; SPLIT-UBIQUITIN; THALIANA; ACCUMULATION; LIGHT
AB Photosystem II (PSII) is a multisubunit membrane protein complex that is assembled in a sequence of steps. However, the molecular mechanisms responsible for the assembly of the individual subunits into functional PSII complexes are still largely unknown. Here, we report the identification of a chloroplast protein, Low PSII Accumulation3 (LPA3), which is required for the assembly of the CP43 subunit in PSII complexes in Arabidopsis (Arabidopsis thaliana). LPA3 interacts with LPA2, a previously identified PSII CP43 assembly factor, and a double mutation of LPA2 and LPA3 is more deleterious for assembly than either single mutation, resulting in a seedling-lethal phenotype. Our results indicate that LPA3 and LPA2 have overlapping functions in assisting CP43 assembly and that cooperation between LPA2 and LPA3 is essential for PSII assembly. In addition, we provide evidence that LPA2 and LPA3 interact with Albino3 (Alb3), which is essential for thylakoid protein biogenesis. Thus, the function of Alb3 in some PSII assembly processes is probably mediated through interactions with LPA2 and LPA3.
C1 [Cai, Wenhe; Ma, Jinfang; Chi, Wei; Zou, Meijuan; Guo, Jinkui; Lu, Congming; Zhang, Lixin] Chinese Acad Sci, Photosynth Res Ctr, Key Lab Photobiol, Inst Bot, Beijing 100093, Peoples R China.
RP Zhang, LX (reprint author), Chinese Acad Sci, Photosynth Res Ctr, Key Lab Photobiol, Inst Bot, Beijing 100093, Peoples R China.
EM zhanglixin@ibcas.ac.cn
FU National Natural Science Foundation of China [30630007, 30725003]; Major
   State Basic Research Development Program [2006CB910300]; Knowledge
   Innovation Engineering of the Chinese Academy of Sciences [KJCX2-SW-w29]
FX This work was supported by the National Natural Science Foundation of
   China (grant nos. 30630007 and 30725003), the Major State Basic Research
   Development Program (grant no. 2006CB910300), and the Frontier Project
   of Knowledge Innovation Engineering of the Chinese Academy of Sciences
   (grant no. KJCX2-SW-w29).
CR ADIR N, 1990, J BIOL CHEM, V265, P12563
   Amann K, 2004, PLANT CELL, V16, P3084, DOI 10.1105/tpc.104.024935
   ANDERSON JM, 1986, ANNU REV PLANT PHYS, V37, P93, DOI 10.1146/annurev.pp.37.060186.000521
   ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2
   Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a
   Bailey S, 2001, PLANTA, V213, P794, DOI 10.1007/s004250100556
   Barkan A, 2000, BIOCHIMIE, V82, P559, DOI 10.1016/S0300-9084(00)00602-7
   BARKAN A, 1988, EMBO J, V7, P2637, DOI 10.1002/j.1460-2075.1988.tb03116.x
   Bellafiore S, 2002, PLANT CELL, V14, P2303, DOI 10.1105/tpc.003442
   Boudreau E, 1997, EMBO J, V16, P6095, DOI 10.1093/emboj/16.20.6095
   Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017
   Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x
   DEVITRY C, 1989, J CELL BIOL, V109, P991, DOI 10.1083/jcb.109.3.991
   Dobakova M, 2007, PLANT PHYSIOL, V145, P1681, DOI 10.1104/pp.107.107805
   Fu A, 2007, P NATL ACAD SCI USA, V104, P15947, DOI 10.1073/pnas.0707851104
   Gohre V, 2006, PLANT CELL, V18, P1454, DOI 10.1105/tpc.105.038695
   Hager M, 2002, J BIOL CHEM, V277, P14031, DOI 10.1074/jbc.M112053200
   Hankamer B, 1999, NAT STRUCT BIOL, V6, P560, DOI 10.1038/9341
   Iwata S, 2004, CURR OPIN STRUC BIOL, V14, P447, DOI 10.1016/j.sbi.2004.07.002
   JENSEN KH, 1986, J CELL BIOL, V103, P1315, DOI 10.1083/jcb.103.4.1315
   Kiefer D, 2007, INT REV CYTOL, V259, P113, DOI 10.1016/S0074-7969(06)59003-5
   Kuhn A, 2003, TRENDS CELL BIOL, V13, P510, DOI 10.1016/j.tcb.2003.08.005
   Lezhneva L, 2004, PLANT J, V38, P740, DOI 10.1111/j.1365-313X.2004.02081.x
   Lima A, 2006, P NATL ACAD SCI USA, V103, P12631, DOI 10.1073/pnas.0605452103
   Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795
   Ma JF, 2007, PLANT CELL, V19, P1980, DOI 10.1105/tpc.107.050526
   Meurer J, 1998, EMBO J, V17, P5286, DOI 10.1093/emboj/17.18.5286
   Minai L, 2006, PLANT CELL, V18, P159, DOI 10.1105/tpc.105.037705
   Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529
   Muller B, 1999, PLANT CELL, V11, P2365, DOI 10.1105/tpc.11.12.2365
   Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X
   NANBA O, 1987, P NATL ACAD SCI USA, V84, P109, DOI 10.1073/pnas.84.1.109
   Naver H, 2001, PLANT CELL, V13, P2731
   Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350
   Ossenbuhl F, 2004, PLANT CELL, V16, P1790, DOI 10.1105/tpc.023226
   Ossenbuhl F, 2002, EUR J BIOCHEM, V269, P3912, DOI 10.1046/j.1432-1033.2002.03057.x
   Pasch JC, 2005, APPL MICROBIOL BIOT, V69, P440, DOI 10.1007/s00253-005-0029-3
   Peng LW, 2006, PLANT CELL, V18, P955, DOI 10.1105/tpc.105.037689
   Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7
   Rochaix JD, 2001, PLANT PHYSIOL, V127, P1394, DOI 10.1104/pp.127.4.1394
   Rokka A, 2005, BIOCHEM J, V388, P159, DOI 10.1042/BJ20042098
   SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112
   Schult K, 2007, PLANT CELL, V19, P1329, DOI 10.1105/tpc.106.042895
   Sirpio S, 2008, PLANT J, V55, P639, DOI 10.1111/j.1365-313X.2008.03532.x
   Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187
   Sun XW, 2007, PLANT CELL, V19, P1347, DOI 10.1105/tpc.106.049510
   Sundberg E, 1997, PLANT CELL, V9, P717, DOI 10.1105/tpc.9.5.717
   Suorsa M, 2004, EUR J BIOCHEM, V271, P96, DOI 10.1046/j.1432-1033.2003.03906.x
   Trebitsh T, 2001, J BIOL CHEM, V276, P4564, DOI 10.1074/jbc.M005950200
   van der Laan M, 2005, CURR OPIN MICROBIOL, V8, P182, DOI 10.1016/j.mib.2005.02.004
   vanWijk KJ, 1997, BIOCHEMISTRY-US, V36, P6178, DOI 10.1021/bi962921l
   Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003
   Wollman FA, 1999, BBA-BIOENERGETICS, V1411, P21, DOI 10.1016/S0005-2728(99)00043-2
   YU JJ, 1990, PLANT CELL, V2, P315
   YU JJ, 1993, J BIOL CHEM, V268, P7407
   Zhang LX, 1999, J BIOL CHEM, V274, P16062, DOI 10.1074/jbc.274.23.16062
   Zhang LX, 2000, PLANT CELL, V12, P1769, DOI 10.1105/tpc.12.9.1769
NR 57
TC 29
Z9 35
U1 7
U2 19
PU AMER SOC PLANT BIOLOGISTS
PI ROCKVILLE
PA 15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA
SN 0032-0889
EI 1532-2548
J9 PLANT PHYSIOL
JI Plant Physiol.
PD SEP
PY 2010
VL 154
IS 1
BP 109
EP 120
DI 10.1104/pp.110.159558
PG 12
WC Plant Sciences
SC Plant Sciences
GA 646VA
UT WOS:000281570000009
PM 20605914
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Chen, FL
   Lu, SM
   Wang, E
   Tseng, KT
AF Chen, Falin
   Lu, Shyi-Min
   Wang, Eric
   Tseng, Kuo-Tung
TI RETRACTED: Renewable energy in Taiwan (Retracted article. See vol. 51,
   pg. 1797, 2015)
SO RENEWABLE & SUSTAINABLE ENERGY REVIEWS
LA English
DT Review; Retracted Publication
DE Renewable energy; Taiwan; Development status; Development strategy
ID POLICIES
AB With limited indigenous conventional energy resources. Taiwan imports over 99% of its energy supply from foreign countries, mostly from the Middle East. Developing independent renewable energy resources is thus of priority concern for the Taiwanese government. A medium subtropical island surrounded by the Pacific Ocean, Taiwan has enormous potential to develop various renewable energies, such as solar energy, biomass energy, wind power, geothermal energy, hydropower, etc. However, owing to the importance of conventional fossil energy in generating exceptionally cheap electricity, renewable energy has not yet fully developed in Taiwan, resulting from a lack of market competition. Consequently, numerous promotional and subsidy programs have recently been proclaimed by the Taiwanese government, focused on the development of various renewables. This study reviews the achievements, polices and future plans in this area. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Chen, Falin; Lu, Shyi-Min; Wang, Eric; Tseng, Kuo-Tung] Natl Taiwan Univ, Inst Appl Mech, Taipei 10617, Taiwan.
RP Lu, SM (reprint author), Natl Taiwan Univ, Inst Appl Mech, Taipei 10617, Taiwan.
EM accklk@yahoo.com.tw
FU National Science Council of the Republic of China, Taiwan
FX The authors thank the National Science Council of the Republic of China,
   Taiwan, for sponsoring this work.
CR Boyle G., 2004, RENEWABLE ENERGY POW
   *BP, 2000, BP STAT REV WORLD EN
   Chang K, 2006, RENEW ENERG, V31, P1299, DOI 10.1016/j.renene.2005.07.003
   CHIANG W, 2005, ENGINEERING, V78, P97
   *ECMOEC, 1999, GEN PLANN REP RES DE, P13
   *EUR REN EN COUNC, 2004, REN EN EUR BUILD MAR
   *NCKU RES DEV FDN, 701 NCKU RES DEV FDN
   *PV TECHN CTR IND, 310 PV TECHN CTR IND
   Tsai WT, 2006, RENEW SUST ENERG REV, V10, P491, DOI 10.1016/j.rser.2004.09.006
   Tsai WT, 2005, RENEW SUST ENERG REV, V9, P237, DOI 10.1016/j.rser.2004.03.003
   Tsai WT, 2005, RENEW SUST ENERG REV, V9, P119, DOI 10.1016/j.rser.2004.01.014
   Tsai WT, 2004, RENEW SUST ENERG REV, V8, P461, DOI 10.1016/j.rser.2003.12.008
   Wu JH, 2006, RENEW ENERG, V31, P1718, DOI 10.1016/j.renene.2005.09.007
   YAN W, 310 ROC WIND SOL EN
   Yue CD, 2006, ENERG POLICY, V34, P730, DOI 10.1016/j.enpol.2004.07.003
   Yue CD, 2001, ENERG POLICY, V29, P951, DOI 10.1016/S0301-4215(01)00025-8
NR 16
TC 25
Z9 25
U1 3
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1364-0321
J9 RENEW SUST ENERG REV
JI Renew. Sust. Energ. Rev.
PD SEP
PY 2010
VL 14
IS 7
BP 2029
EP 2038
DI 10.1016/j.rser.2010.03.009
PG 10
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA 617CI
UT WOS:000279258000026
DA 2018-12-27
ER

PT J
AU Prasad, S
   Yadav, VR
   Sundaram, C
   Reuter, S
   Hema, PS
   Nair, MS
   Chaturvedi, MM
   Aggarwal, BB
AF Prasad, Sahdeo
   Yadav, Vivek R.
   Sundaram, Chitra
   Reuter, Simone
   Hema, Padmanabhan S.
   Nair, Mangalam S.
   Chaturvedi, Madan M.
   Aggarwal, Bharat B.
TI RETRACTED: Crotepoxide Chemosensitizes Tumor Cells through Inhibition of
   Expression of Proliferation, Invasion, and Angiogenic Proteins Linked to
   Proinflammatory Pathway (Retracted article. See vol. 291, pg. 16921,
   2016)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID NF-KAPPA-B; ALPHA KINASE ACTIVATION; NECROSIS-FACTOR; CYCLOHEXANE
   DIEPOXIDE; TRANSCRIPTION FACTOR; KAEMPFERIA-ROTUNDA; GENE-PRODUCTS;
   CROTON MACROSTACHYS; PROSTATE-CANCER; TYROSINE KINASE
AB Crotepoxide (a substituted cyclohexane diepoxide), isolated from Kaempferia pulchra (peacock ginger), although linked to antitumor and anti-inflammatory activities, the mechanism by which it exhibits these activities, is not yet understood. Because nuclear factor kappa B (NF-kappa B) plays a critical role in these signaling pathways, we investigated the effects of crotepoxide on NF-kappa B-mediated cellular responses in human cancer cells. We found that crotepoxide potentiated tumor necrosis factor (TNF), and chemotherapeutic agents induced apoptosis and inhibited the expression of NF-kappa B-regulated gene products involved in anti-apoptosis (Bcl-2, Bcl-xL, IAP1,(2) MCl-1, survivin, and TRAF1), apoptosis (Bax, Bid), inflammation (COX-2), proliferation (cyclin D1 and c-myc), invasion (ICAM-1 and MMP-9), and angiogenesis (VEGF). We also found that crotepoxide inhibited both inducible and constitutive NF-kappa B activation. Crotepoxide inhibition of NF-kappa B was not inducer-specific; it inhibited NF-kappa B activation induced by TNF, phorbol 12-myristate 13-acetate, lipopolysaccharide, and cigarette smoke. Crotepoxide suppression of NF-kappa B was not cell type-specific because NF-kappa B activation was inhibited in myeloid, leukemia, and epithelial cells. Furthermore, we found that crotepoxide inhibited TAK1 activation, which led to suppression of I kappa B alpha kinase, abrogation of I kappa B alpha phosphorylation and degradation, nuclear translocation of p65, and suppression of NF-kappa B-dependent reporter gene expression. Overall, our results indicate that crotepoxide sensitizes tumor cells to cytokines and chemotherapeutic agents through inhibition of NF-kappa B and NF-kappa B-regulated gene products, and this may provide the molecular basis for crotepoxide ability to suppress inflammation and carcinogenesis.
C1 [Prasad, Sahdeo; Yadav, Vivek R.; Sundaram, Chitra; Reuter, Simone; Chaturvedi, Madan M.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA.
   [Hema, Padmanabhan S.; Nair, Mangalam S.] Natl Inst Interdisciplinary Sci & Technol CSIR, Organ Chem Sect, Trivandrum 695019, Kerala, India.
RP Aggarwal, BB (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, 1515 Holcombe Blvd,Box 143, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI MSN, Nair/F-9473-2013; TVM, NIIST/E-5132-2012; Aggarwal,
   Bharat/G-3388-2013
OI TVM, NIIST/0000-0002-5814-466X; 
FU National Institutes of Health [CA-124787-01A2, CA-16 672]; Clayton
   Foundation for Research; Center for Targeted Therapy of the MD Anderson
   Cancer Center
FX This work was supported, in whole or in part, by National Institutes of
   Health Grants CA-124787-01A2 (a program project grant) and CA-16 672 (a
   core grant). This work was also supported by grants from the Clayton
   Foundation for Research (to B. B. A.) and the Center for Targeted
   Therapy of the MD Anderson Cancer Center.
CR Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x
   Anto RJ, 2002, CARCINOGENESIS, V23, P1511, DOI 10.1093/carcin/23.9.1511
   Bharti AC, 2004, BLOOD, V103, P3175, DOI 10.1182/blood-2003-06-2151
   Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1
   Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959
   Blonska M, 2005, J BIOL CHEM, V280, P43056, DOI 10.1074/jbc.M507807200
   Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926
   CHATURVEDI MM, 1994, J BIOL CHEM, V269, P14575
   Chilov D, 1997, J BIOL CHEM, V272, P25176, DOI 10.1074/jbc.272.40.25176
   Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724
   DEMUTH MR, 1976, J AM CHEM SOC, V98, P634, DOI 10.1021/ja00418a065
   DUYAO MP, 1992, J BIOL CHEM, V267, P16288
   Esteve PO, 2002, J BIOL CHEM, V277, P35150, DOI 10.1074/jbc.M108600200
   FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884
   Guttridge DC, 1999, MOL CELL BIOL, V19, P5785
   Han G. Q., 1989, Acta Pharmaceutica Sinica, V24, P438
   Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8
   Joseph CC, 2007, NAT PROD RES, V21, P1009, DOI 10.1080/14786410701194310
   Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621
   KUPCHAN SM, 1968, J AM CHEM SOC, V90, P2982, DOI 10.1021/ja01013a056
   KUPCHAN SM, 1969, J ORG CHEM, V34, P3898, DOI 10.1021/jo01264a033
   Lin LC, 2006, J NAT PROD, V69, P842, DOI 10.1021/np0505521
   Lotulung Puspa D N, 2008, Pak J Biol Sci, V11, P2447
   MAHON TM, 1995, J BIOL CHEM, V270, P28557, DOI 10.1074/jbc.270.48.28557
   Mulholland D, 2000, BIOCHEM SYST ECOL, V28, P595, DOI 10.1016/S0305-1978(99)00099-X
   Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090
   NELSEN B, 1988, MOL CELL BIOL, V8, P3526, DOI 10.1128/MCB.8.8.3526
   PAI BR, 1970, INDIAN J CHEM, V8, P468
   PANCHAROEN O, 1989, PHYTOCHEMISTRY, V28, P1143, DOI 10.1016/0031-9422(89)80198-0
   Pancharoen O, 1996, PHYTOCHEMISTRY, V43, P305, DOI 10.1016/0031-9422(96)00218-X
   Pandey MK, 2007, J BIOL CHEM, V282, P17340, DOI 10.1074/jbc.C700890200
   Partha P, 2007, BANGL J PLANT TAXON, V14, P129
   Politi C, 2008, NEUROPATH APPL NEURO, V34, P357, DOI 10.1111/j.1365-2990.2007.00901.x
   Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2
   Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641
   Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   Schwenzer R, 1999, J BIOL CHEM, V274, P19368, DOI 10.1074/jbc.274.27.19368
   SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X
   Shishodia S, 2004, J BIOL CHEM, V279, P47148, DOI 10.1074/jbc.M408093200
   Shishodia Shishir, 2004, Cancer Treat Res, V119, P139
   Simeonidis S, 1999, P NATL ACAD SCI USA, V96, P49, DOI 10.1073/pnas.96.1.49
   Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200
   Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848
   Stevenson PC, 2007, PHYTOCHEMISTRY, V68, P1579, DOI 10.1016/j.phytochem.2007.03.015
   Sung B, 2007, MOL PHARMACOL, V71, P1703, DOI 10.1124/mol.107.034512
   Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200
   Takada Y, 2003, J BIOL CHEM, V278, P23390, DOI 10.1074/jbc.M213237200
   Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531
   TANEJA SC, 1991, PHYTOCHEMISTRY, V30, P871, DOI 10.1016/0031-9422(91)85269-6
   THEVENIN C, 1990, New Biologist, V2, P793
   VANDESTOLPE A, 1994, J BIOL CHEM, V269, P6185
   Yore MM, 2006, MOL CANCER THER, V5, P3232, DOI 10.1158/1535-7163.MCT-06-0444
   You MJ, 1997, MOL CELL BIOL, V17, P7328, DOI 10.1128/MCB.17.12.7328
   Zerbini LF, 2003, CANCER RES, V63, P2206
NR 55
TC 13
Z9 15
U1 1
U2 11
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD AUG 27
PY 2010
VL 285
IS 35
BP 26987
EP 26997
DI 10.1074/jbc.M110.121061
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 641ZQ
UT WOS:000281172700030
PM 20576605
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Gan, L
   Zhu, DX
   Ding, ZH
AF Gan, Lu
   Zhu, Dongxing
   Ding, Zhenhua
TI RETRACTED: Transcription factor activator protein-2 beta accelerates
   lipid accumulation in macrophages via enhancing the transcription of
   CD36 (Retracted article. See vol. 585, pg. 267, 2011)
SO FEBS LETTERS
LA English
DT Article; Retracted Publication
DE Activator protein-2; Atherosclerosis; Foam cell; CD36; Lipid uptake;
   Transcription factor
ID CASSETTE TRANSPORTER A1; MONOCYTE-DERIVED MACROPHAGES;
   LOW-DENSITY-LIPOPROTEIN; GENE-EXPRESSION; GENOMIC ORGANIZATION;
   DNA-BINDING; FACTOR AP-2; ATHEROSCLEROSIS; ADIPONECTIN; INVOLVEMENT
AB The role of transcription factor activator protein-2 beta (AP-2 beta) in foam cell formation was investigated. Uptake assay of DiI-labeled oxidized low density lipoprotein and the lipid quantitative analysis by high performance liquid chromatography showed AP-2 beta promoted the lipid accumulation. The quantitative real-time RT-PCR and Western blot indicated that AP-2 beta upregulated the expression of CD36. Luciferase assay, electrophoretic mobility shift assay and chromatin immunoprecipitation confirmed that AP-2 beta bound to AP-2 binding sites in CD36 promoter region and enhanced the promoter activity of CD36 gene. We conclude that AP-2 beta may function in foam cell formation through enhancing the transcription and expression of CD36 followed by increased lipid uptake. (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
C1 [Gan, Lu; Ding, Zhenhua] So Med Univ, Dept Radiat Med, Sch Publ Hlth & Trop Med, Guangzhou 510515, Guangdong, Peoples R China.
   [Zhu, Dongxing] Univ Edinburgh, Roslin Inst, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland.
RP Gan, L (reprint author), So Med Univ, Dept Radiat Med, Sch Publ Hlth & Trop Med, Guangzhou 510515, Guangdong, Peoples R China.
EM gan_lu@yahoo.com.cn
FU Natural Science Foundation of Guangdong Province [9451051501002535];
   School of Public Health and Tropical Medicine, Southern Medical
   University [GW200806]
FX This work was supported by the Natural Science Foundation of Guangdong
   Province (No. 9451051501002535), the Dean fund of School of Public
   Health and Tropical Medicine, Southern Medical University (No.
   GW200806).
CR Chilov D, 1997, J BIOL CHEM, V272, P25176, DOI 10.1074/jbc.272.40.25176
   Collot-Teixeira S, 2007, CARDIOVASC RES, V75, P468, DOI 10.1016/j.cardiores.2007.03.010
   Cullen P, 1997, J LIPID RES, V38, P401
   Ding XF, 2009, J CELL BIOCHEM, V106, P285, DOI 10.1002/jcb.22002
   Ditiatkovski M, 2006, ARTERIOSCL THROM VAS, V26, P2337, DOI 10.1161/01.ATV.0000238357.60338.90
   Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246
   Ferreira V, 2007, ATHEROSCLEROSIS, V192, P283, DOI 10.1016/j.atherosclerosis.2006.07.018
   Gan L, 2008, ACTA PHARMACOL SIN, V29, P465, DOI 10.1111/j.1745-7254.2008.00780.x
   Garcia MA, 1996, J NEUROSCI, V16, P7550
   Ikeda K, 2006, J BIOL CHEM, V281, P31245, DOI 10.1074/jbc.M605132200
   Itabe H, 2000, BBA-MOL CELL BIOL L, V1487, P233, DOI 10.1016/S1388-1981(00)00098-6
   Itabe H, 1996, J LIPID RES, V37, P45
   Iwamoto N, 2008, ARTERIOSCL THROM VAS, V28, P2282, DOI 10.1161/ATVBAHA.108.174714
   Iwamoto N, 2007, CIRC RES, V101, P156, DOI 10.1161/CIRCRESAHA.107.151746
   Joyce CW, 2002, P NATL ACAD SCI USA, V99, P407, DOI 10.1073/pnas.012587699
   Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057
   Silverstein Roy L, 2009, Cleve Clin J Med, V76 Suppl 2, pS27, DOI 10.3949/ccjm.76.s2.06
   Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748
   Tao Y, 2006, ENDOCRINOLOGY, V147, P1685, DOI 10.1210/en.2005-1304
   Welker P, 2005, ALLERGY, V60, P1046, DOI 10.1111/j.1398-9995.2005.00811.x
   WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670
   Zhou JL, 2005, FEBS LETT, V579, P1715, DOI 10.1016/j.febslet.2005.02.027
NR 22
TC 3
Z9 3
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD AUG 20
PY 2010
VL 584
IS 16
BP 3615
EP 3619
DI 10.1016/j.febslet.2010.07.034
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 638KW
UT WOS:000280894800018
PM 20659467
OA Bronze
DA 2018-12-27
ER

PT J
AU Chau, YF
   Yeh, HH
   Liu, CY
   Tsai, DP
AF Chau, Yuan-Fong
   Yeh, Han-Hsuan
   Liu, Chi-Yu
   Tsai, Din Ping
TI RETRACTED: The optical properties in a chain waveguide of an array of
   silver nanoshell with dielectric holes (Retracted article. See vol. 309,
   pg. 358, 2013)
SO OPTICS COMMUNICATIONS
LA English
DT Article; Retracted Publication
DE Plasmonic chain waveguide; Finite element method; Nanoshell
ID ELECTROMAGNETIC ENERGY-TRANSPORT; PLASMON
AB Plasmonic chain waveguide by employing an array of silver nanoshell with dielectric holes that interact with incident plane wave of transverse magnetic polarization are simulated by use of the finite element method. Results show that the working wavelength of the system is highly tunable by using the nanoshell instead of solid particles and by varying the dielectric constant of the core. Besides, chain waveguides that are operated on resonant multipolar modes can provide longer propagation lengths, which is beyond what is maximally achieved by conventional solid particle chains. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Chau, Yuan-Fong; Yeh, Han-Hsuan; Liu, Chi-Yu] Ching Yun Univ, Dept Elect Engn, Jhongli 320, Taiwan.
   [Tsai, Din Ping] Natl Taiwan Univ, Dept Phys, Taipei 10617, Taiwan.
RP Chau, YF (reprint author), Ching Yun Univ, Dept Elect Engn, Jhongli 320, Taiwan.
EM yfc01@cyu.edu.tw
FU National Science Council, Taiwan, ROC [SC 96-2112-M-231-001-MY3,
   NSC-98-2120-M-002-004-]
FX The authors are thankful for the financial support from the National
   Science Council, Taiwan, ROC, under Grant numbers NSC
   96-2112-M-231-001-MY3 and NSC-98-2120-M-002-004-.
CR Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927
   [Anonymous], COMSOL MULT
   Baer R, 2004, NANO LETT, V4, P85, DOI 10.1021/nl034902k
   BAER R, 2003, NANO LETT, V3, P1411
   Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937
   Brongersma ML, 2000, PHYS REV B, V62, P16356, DOI 10.1103/PhysRevB.62.R16356
   Chau YF, 2008, APPL OPTICS, V47, P5557, DOI 10.1364/AO.47.005557
   Chau YF, 2009, PLASMONICS, V4, P253, DOI 10.1007/s11468-009-9100-8
   Chau YF, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3068469
   Chen YG, 2007, OPT COMMUN, V274, P236, DOI 10.1016/j.optcom.2007.02.001
   Citrin DS, 2004, NANO LETT, V4, P1561, DOI [10.1021/nl049679l, 10.1021/nl0496791]
   Cui XD, 2008, J OPT SOC AM A, V25, P1783, DOI 10.1364/JOSAA.25.001783
   Ditlbacher H, 2002, APPL PHYS LETT, V81, P1762, DOI 10.1063/1.1506018
   Engheta N, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.095504
   Gresho P.M., 2000, INCOMPRESSIBLE FLOW, V2
   Gresho PM, 2000, INCOMPRESSIBLE FLOW, V1
   Hernandez JV, 2005, J PHYS CHEM B, V109, P15808, DOI 10.1021/jp0527352
   JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370
   Koenderink AF, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.033402
   Kreibig U., 1995, OPTICAL PROPERTIES M
   Maier SA, 2003, NAT MATER, V2, P229, DOI 10.1038/nmat852
   Okamoto T., 2001, NEAR FIELD OPTICS SU, P99
   Oldenburg SJ, 1999, APPL PHYS LETT, V75, P1063, DOI 10.1063/1.124597
   Quinten M, 1998, OPT LETT, V23, P1331, DOI 10.1364/OL.23.001331
   WADE RD, 2007, NANO LETT, V7, P2004
   WEBER WH, 2004, PHYS REV B, V40
   West JL, 2003, ANNU REV BIOMED ENG, V5, P285, DOI 10.1146/annurev.bioeng.5.011303.120723
NR 27
TC 11
Z9 11
U1 3
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0030-4018
EI 1873-0310
J9 OPT COMMUN
JI Opt. Commun.
PD AUG 15
PY 2010
VL 283
IS 16
BP 3189
EP 3193
DI 10.1016/j.optcom.2010.04.028
PG 5
WC Optics
SC Optics
GA 621QN
UT WOS:000279597000016
DA 2018-12-27
ER

PT J
AU Sheu, MJ
   Cheng, HC
   Chien, YC
   Chou, PY
   Huang, GJ
   Chen, JS
   Lin, SY
   Wu, CH
AF Sheu, Ming-Jyh
   Cheng, Hsu-Chen
   Chien, Yi-Chung
   Chou, Pei-Yu
   Huang, Guang-Jhong
   Chen, Jwo-Sheng
   Lin, Sung-Yuan
   Wu, Chieh-Hsi
TI RETRACTED: Molecular mechanism of green microalgae, Dunaliella sauna,
   involved in attenuating balloon injury-induced neointimal formation
   (Retracted article. See vol. 109, pg. 2113, 2013)
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article; Retracted Publication
DE Human aortic smooth muscle cells; Angioplasty; Neointima formation;
   Restenosis; Dunaliella saline
ID MUSCLE-CELL PROLIFERATION; CORONARY ANGIOPLASTY; NUCLEAR ANTIGEN;
   IN-VIVO; RESTENOSIS; EXPRESSION; SALINA; CYCLE; APOPTOSIS; ARTERIES
AB The pathological mechanism of restenosis is primarily attributed to excessive proliferation of vascular smooth muscle cells (VSMC). The preventive effects of ethanol extract of Dunaliella salina (EDS) on balloon injury-induced neointimal formation were investigated. To explore its molecular mechanism in regulating cell proliferation, we first showed that EDS markedly reduced the human aortic smooth muscle cell proliferation via the inhibition of 5'-bromo-2'-deoxyuridine (BrdU) incorporation at 40 and 801 mu g/ml. This was further supported by the G(0)/G(1)-phase arrest using a flow cytometric analysis. In an in vivo study, EDS at 40 and 80 mu g/ml was previously administered to the Sprague Dawley rats and found that the thickness of neointima, and the ratio of neointima:media were also reduced. EDS inhibited VSMC proliferation in a dose-dependent manner following stimulation of VSMC cultures with 15% fetal bovine serum (FBS). Suppressed by EDS were 15% FBS-stimulated intracellular Rat, phosphorylated extracellular signal-regulated kinases (p-Erk) involved in cell-cycle arrest and proliferating cell nuclear antigen. Phosphorylated focal adhesion kinase (p-FAK) was also suppressed by EDS. Also active caspase-9, caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) protein expression levels were increased by administration with EDS; the apoptotic pathway may play an important role in the regulatory effects of EDS on cell growth. These observations provide a mechanism of EDS in attenuating cell proliferation, thus as a potential intervention for restenosis.
C1 [Sheu, Ming-Jyh; Wu, Chieh-Hsi] China Med Univ, Sch Pharm, Taichung 404, Taiwan.
   [Cheng, Hsu-Chen; Chien, Yi-Chung; Chou, Pei-Yu] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan.
   [Huang, Guang-Jhong] Grad Inst Chinese Pharmaceut Sci, Taichung 404, Taiwan.
   [Chen, Jwo-Sheng] China Med Univ, Dept Sports Med, Taichung 404, Taiwan.
   [Lin, Sung-Yuan] China Med Univ, Grad Inst Basic Med, Taichung 404, Taiwan.
RP Sheu, MJ (reprint author), China Med Univ, Sch Pharm, 91 Hsueh Shih Rd, Taichung 404, Taiwan.
EM soybean13mtdtw@gmail.com
RI Guan-Jhong, Huang/G-6657-2011; Sheu, Ming-Jyh/C-6013-2012
FU China Medical University, Taichung, Taiwan [CMU95-247, CMU97-141,
   CMU98-S-08]
FX We are grateful to Gong Bih Enterprise Co., Ltd for providing dry D.
   sauna powder. We also appreciate the technical support from Ms Shih
   Chen-I. We are also grateful to Jeffery Conrad for English writing
   assistance. The present study was partially supported by CMU95-247,
   CMU97-141 and CMU98-S-08 from China Medical University, Taichung,
   Taiwan.
CR Bult H, 2000, TRENDS PHARMACOL SCI, V21, P274, DOI 10.1016/S0165-6147(00)01505-4
   BURR ML, 1989, LANCET, V2, P757
   Cohen GM, 1997, BIOCHEM J, V326, P1
   Degertekin M, 2003, AM J CARDIOL, V91, P1046, DOI 10.1016/S0002-9149(03)00146-2
   Dorafshar AH, 2003, J SURG RES, V114, P179, DOI 10.1016/S0022-4804(03)00254-3
   FAIRMAN MP, 1990, J CELL SCI, V95, P1
   Ghiselli G, 2003, ARTERIOSCL THROM VAS, V23, P1808, DOI 10.1161/01.ATV.0000090140.20291.CE
   Grube E., 2002, Zeitschrift fuer Kardiologie, V91, P44, DOI 10.1007/s00392-002-1309-x
   Herrero M, 2006, J AGR FOOD CHEM, V54, P5597, DOI 10.1021/jf060546q
   Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412
   KARIM MA, 1995, CIRCULATION, V91, P2049, DOI 10.1161/01.CIR.91.7.2049
   Kibbe MR, 2000, CIRC RES, V86, P829, DOI 10.1161/01.RES.86.8.829
   Labinaz M, 1999, CARDIOVASC RES, V41, P255, DOI 10.1016/S0008-6363(98)00203-X
   LANDAU C, 1994, NEW ENGL J MED, V330, P981, DOI 10.1056/NEJM199404073301407
   Levy Y, 2000, ANN NUTR METAB, V44, P54, DOI 10.1159/000012821
   Mazure NM, 1996, CANCER RES, V56, P3436
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murthy KNC, 2005, LIFE SCI, V76, P1381, DOI 10.1016/j.lfs.2004.10.015
   Raja R, 2007, MICROBIOL RES, V162, P177, DOI 10.1016/j.micres.2006.03.009
   Ranganna K, 2000, MOL CELL BIOCHEM, V205, P149, DOI 10.1023/A:1007078200482
   Roig EG, 2003, J PLANT PHYSIOL, V160, P983, DOI 10.1078/0176-1617-01088
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   SERRUYS PW, 1988, CIRCULATION, V77, P361, DOI 10.1161/01.CIR.77.2.361
   Shaish A, 2006, ATHEROSCLEROSIS, V189, P215, DOI 10.1016/j.atherosclerosis.2005.12.004
   Sheu MJ, 2008, IN VIVO, V22, P369
   STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1
   Sturek M, 2002, CARDIOVASC RES, V53, P292, DOI 10.1016/S0008-6363(01)00567-3
   Szocs K, 2002, ARTERIOSCL THROM VAS, V22, P21, DOI 10.1161/hq0102.102189
   Wei GL, 1997, CIRC RES, V80, P418, DOI 10.1161/01.res.0000435858.35902.ea
   Wu CH, 2005, J BIOMED SCI, V12, P503, DOI 10.1007/s11373-005-6900-5
   Wu CH, 2004, J PHARMACOL SCI, V94, P252, DOI 10.1254/jphs.94.252
   Wu CH, 2001, J SURG RES, V99, P100, DOI 10.1006/jsre.2001.6159
   Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997
NR 33
TC 3
Z9 3
U1 4
U2 18
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD AUG 14
PY 2010
VL 104
IS 3
BP 326
EP 335
DI 10.1017/S0007114510000693
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 638NC
UT WOS:000280900600004
PM 20370940
OA Bronze
DA 2018-12-27
ER

PT J
AU Kono, S
   Nishio, T
   Takahashi, Y
   Goto-Inoue, N
   Kinoshita, M
   Zaima, N
   Suzuki, H
   Fukutoku-Otsuji, A
   Setou, M
   Miyajima, H
AF Kono, S.
   Nishio, T.
   Takahashi, Y.
   Goto-Inoue, N.
   Kinoshita, M.
   Zaima, N.
   Suzuki, H.
   Fukutoku-Otsuji, A.
   Setou, M.
   Miyajima, H.
TI RETRACTED: Dominant-negative effects of a novel mutation in the filamin
   myopathy (Retracted article. See vol. 75, pg. 2138, 2010)
SO NEUROLOGY
LA English
DT Article; Retracted Publication
ID MYOFIBRILLAR MYOPATHY; BINDING PROTEIN; MUSCULAR-DYSTROPHY;
   SKELETAL-MUSCLE; ACTININ-BINDING; GAMMA-FILAMIN; GENE; DIMERIZATION;
   MYOGENESIS; PHENOTYPE
AB Background: Filamin myopathy is associated with mutations in the filamin C gene ( FLNC) and is a myofibrillar myopathy characterized by focal myofibrillar destruction and cytoplasmic aggregates containing several Z-disk-related proteins.
   Methods: This study investigated 6 Japanese patients with dominantly inherited myofibrillar myopathy manifested by adult-onset, slow and progressive muscle weakness and atrophy in the distal extremities.
   Results: The abundantly expressed proteins in the affected muscles were identified as filamin C by nano liquid chromatography-tandem mass spectrometry. A genetic analysis of FLNC identified a heterozygous c.8107delG mutation that was localized to the dimerization domain of filamin C. A biochemical crosslinking analysis of bacterially expressed recombinant wild-type and mutant filamin C fragments demonstrated that the mutant monomer disturbed the proper dimerization of the wild-type filamin dimer, resulting in formation of a heterotrimer with the wild-type filamin dimer. The expression study in C2C12 myoblasts showed that the mutant filamin fragments formed cytoplasmic aggregates with endogenous wild-type filamin C.
   Conclusions: This study provides evidence for the dominant-negative effects of the FLNC mutation. These effects may be mutation-specific and likely result in the variation in the clinical phenotypes seen in patients with filamin myopathy. Neurology (R) 2010; 75: 547-554
C1 [Kono, S.; Takahashi, Y.; Suzuki, H.; Fukutoku-Otsuji, A.; Miyajima, H.] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka 4313192, Japan.
   [Nishio, T.] Hamamatsu Univ Sch Med, Dept Lab Med, Hamamatsu, Shizuoka 4313192, Japan.
   [Goto-Inoue, N.; Zaima, N.; Setou, M.] Hamamatsu Univ Sch Med, Dept Mol Anat, Hamamatsu, Shizuoka 4313192, Japan.
   [Kinoshita, M.] Hamamatsu Univ Sch Med, Dept Pathol, Hamamatsu, Shizuoka 4313192, Japan.
   [Takahashi, Y.] Enshu Hosp, Dept Internal Med, Hamamatsu, Shizuoka, Japan.
   [Fukutoku-Otsuji, A.] Natl Hosp Org, Dept Neurol, Tenryu Hosp, Hamamatsu, Shizuoka, Japan.
RP Kono, S (reprint author), Hamamatsu Univ Sch Med, Dept Med 1, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.
EM satokono@hama-med.ac.jp
CR ASKANAS V, 1993, NEUROLOGY, V43, P1265, DOI 10.1212/WNL.43.6.1265-a
   Chiang W, 2000, DEV DYNAM, V217, P99, DOI 10.1002/(SICI)1097-0177(200001)217:1<99::AID-DVDY9>3.3.CO;2-X
   Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104
   Dalkilic I, 2006, MOL CELL BIOL, V26, P6522, DOI 10.1128/MCB.00243-06
   Engel AG, 1999, ANN NEUROL, V46, P681, DOI 10.1002/1531-8249(199911)46:5<681::AID-ANA1>3.0.CO;2-B
   Faulkner G, 2000, J BIOL CHEM, V275, P41234, DOI 10.1074/jbc.M007493200
   Goetsch SC, 2005, STEM CELLS DEV, V14, P181, DOI 10.1089/scd.2005.14.181
   Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300
   Himmel M, 2003, BIOCHEMISTRY-US, V42, P430, DOI 10.1021/bi026501+
   Kley RA, 2007, BRAIN, V130, P3250, DOI 10.1093/brain/awm271
   Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319
   Lowe T, 2007, HUM MOL GENET, V16, P1351, DOI 10.1093/hmg/ddm085
   MAESTRINI E, 1993, HUM MOL GENET, V2, P761, DOI 10.1093/hmg/2.6.761
   Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006
   Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014
   Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119
   Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376
   Selcen D, 2004, NEUROLOGY, V62, P1363, DOI 10.1212/01.WNL.0000123576.74801.75
   Selcen D, 2004, BRAIN, V127, P439, DOI 10.1093/brain/awh052
   Selcen D, 2008, CURR OPIN NEUROL, V21, P585, DOI 10.1097/WCO.0b013e32830a752b
   Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553
   Shatunov A, 2009, EUR J HUM GENET, V17, P656, DOI 10.1038/ejhg.2008.226
   Sjekloca L, 2007, J MOL BIOL, V368, P1011, DOI 10.1016/j.jmb.2007.02.018
   Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082
   Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698
   Thompson TG, 2000, J CELL BIOL, V148, P115, DOI 10.1083/jcb.148.1.115
   van der Ven PFM, 2000, J CELL BIOL, V151, P235, DOI 10.1083/jcb.151.2.235
   Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765
   Vorgerd M, 2005, AM J HUM GENET, V77, P297, DOI 10.1086/431959
   Walter MC, 2007, BRAIN, V130, P1485, DOI 10.1093/brian/awm039
   Xie ZW, 1998, BIOCHEM BIOPH RES CO, V251, P914, DOI 10.1006/bbrc.1998.9506
NR 31
TC 6
Z9 6
U1 1
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0028-3878
J9 NEUROLOGY
JI Neurology
PD AUG 10
PY 2010
VL 75
IS 6
BP 547
EP 554
DI 10.1212/WNL.0b013e3181ec7fbd
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA 636SE
UT WOS:000280759600012
PM 20697107
DA 2018-12-27
ER

PT J
AU Vetter, G
   Saumet, A
   Moes, M
   Vallar, L
   Le Bechec, A
   Laurini, C
   Sabbah, M
   Arar, K
   Theillet, C
   Lecellier, CH
   Friederich, E
AF Vetter, G.
   Saumet, A.
   Moes, M.
   Vallar, L.
   Le Bechec, A.
   Laurini, C.
   Sabbah, M.
   Arar, K.
   Theillet, C.
   Lecellier, C-H
   Friederich, E.
TI RETRACTED: miR-661 expression in SNAI1-induced epithelial to mesenchymal
   transition contributes to breast cancer cell invasion by targeting
   Nectin-1 and StarD10 messengers (Retracted article. See vol. 35, pg.
   670, 2016)
SO ONCOGENE
LA English
DT Article; Retracted Publication
DE EMT; miR-661; SNAI1; StarD10; Nectin-1; breast cancer cell invasion
ID TRANSCRIPTION FACTOR SNAIL; E-CADHERIN; GENE-EXPRESSION; MIR-200 FAMILY;
   REPRESSORS ZEB1; METASTASIS; PHENOTYPE; MICRORNA; RECEPTORS; SIGNATURE
AB Epithelial to mesenchymal transition (EMT) is a key step toward metastasis. MCF7 breast cancer cells conditionally expressing the EMT master regulator SNAI1 were used to identify early expressed microRNAs (miRNAs) and their targets that may contribute to the EMT process. Potential targets of miRNAs were identified by matching lists of in silico predicted targets and of inversely expressed mRNAs. MiRNAs were ranked based on the number of predicted hits, highlighting miR-661, a miRNA with so far no reported role in EMT. MiR-661 was found required for efficient invasion of breast cancer cells by destabilizing two of its predicted mRNA targets, the cell-cell adhesion protein Nectin-1 and the lipid transferase StarD10, resulting, in turn, in the downregulation of epithelial markers. Reexpression of Nectin-1 or StarD10 lacking the 3'-untranslated region counteracted SNAI1-induced invasion. Importantly, analysis of public transcriptomic data from a cohort of 295 well-characterized breast tumor specimen revealed that expression of StarD10 is highly associated with markers of luminal subtypes whereas its loss negatively correlated with the EMT-related, basal-like subtype. Collectively, our non-a priori approach revealed a nonpredicted link between SNAI1-triggered EMT and the down-regulation of Nectin-1 and StarD10 through the up-regulation of miR-661, which may contribute to the invasion of breast cancer cells and poor disease outcome. Oncogene (2010) 29, 4436-4448; doi: 10.1038/onc.2010.181; published online 14 June 2010
C1 [Vetter, G.; Moes, M.; Le Bechec, A.; Laurini, C.; Friederich, E.] Univ Luxembourg, FSTC, Life Sci Res Unit, Cytoskeleton & Cell Plast Lab, L-1511 Luxembourg, Luxembourg.
   [Saumet, A.; Theillet, C.] INSERM, Inst Rech Cancerol Montpellier, U896, Montpellier, France.
   [Vallar, L.] Ctr Rech Publ Sante, Microarray Ctr, Luxembourg, Luxembourg.
   [Sabbah, M.] Hop Saint Antoine, INSERM, U938, Paris, France.
   [Arar, K.] Sigma Aldrich, Evry, France.
   [Lecellier, C-H] CNRS, Inst Genet Mol Montpellier, UMR 5535, IFR 122, Montpellier, France.
RP Friederich, E (reprint author), Univ Luxembourg, FSTC, Life Sci Res Unit, Cytoskeleton & Cell Plast Lab, L-1511 Luxembourg, Luxembourg.
EM evelyne.friederich@uni.lu
RI Theillet, Charles/O-7634-2018
OI Theillet, Charles/0000-0001-5555-2759
FU Fond National de la Recherche (FNR) du Luxembourg (BIOSAN); Fondation
   Luxembourgeoise Contre le Cancer; Human Frontier Science Program
   [RGP0058/2005]; INSERM; CNRS, France; Ministere de la Culture, de
   l'Enseignement Superieur et de la Recherche, Luxembourg [BFR 08/046];
   Fond National de la Recherche, Luxembourg
FX We thank M Yatskou, P Nazarov and A Muller (CRP-Sante, Luxembourg) for
   their help with the microarray data analysis. We thank C
   Hoffmann-Laporte (CRP-Sante, Luxembourg) for her help with confocal
   microscopy observations. We especially thank E Schaffner-Reckinger for
   critical reading of the article and P Savagner for helpful discussions.
   This work was supported by grants from the Fond National de la Recherche
   (FNR) du Luxembourg (BIOSAN), the Fondation Luxembourgeoise Contre le
   Cancer, Human Frontier Science Program (RGP0058/2005), INSERM and CNRS,
   France. A Saumet is a recipient of a fellowship from the Ministere de la
   Culture, de l'Enseignement Superieur et de la Recherche, Luxembourg (BFR
   08/046). M Moes and A Le Bechec are supported by AFR grants from the
   Fond National de la Recherche, Luxembourg.
CR Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034
   Brakeman PR, 2009, AM J PHYSIOL-RENAL, V296, pF564, DOI 10.1152/ajprenal.90328.2008
   Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025
   Cano A, 2008, TRENDS CELL BIOL, V18, P357, DOI 10.1016/j.tcb.2008.05.005
   De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545
   De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1
   Divijendra S, 2009, CANCER RES, V69, P5639, DOI 10.1158/0008-5472.CAN-09-0898
   Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933
   Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9
   Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851
   Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722
   Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058
   Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104
   Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632
   Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08
   Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200
   Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001
   Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784
   Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024
   Murphy NC, 2010, INT J CANCER, V126, P1445, DOI 10.1002/ijc.24826
   Olayioye MA, 2005, J BIOL CHEM, V280, P27436, DOI 10.1074/jbc.M413330200
   Olayioye MA, 2004, CANCER RES, V64, P3538, DOI 10.1158/0008-5472.CAN-03-3731
   Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938
   Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608
   Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131
   Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001
   Sakisaka T, 2007, CURR OPIN CELL BIOL, V19, P593, DOI 10.1016/j.ceb.2007.09.007
   Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017
   Saumet A, 2009, BLOOD, V113, P412, DOI 10.1182/blood-2008-05-158139
   Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457
   Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835
   van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967
   Vetter G, 2009, BIOCHEM BIOPH RES CO, V385, P485, DOI 10.1016/j.bbrc.2009.05.025
NR 34
TC 88
Z9 96
U1 3
U2 15
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-9232
EI 1476-5594
J9 ONCOGENE
JI Oncogene
PD AUG 5
PY 2010
VL 29
IS 31
BP 4436
EP 4448
DI 10.1038/onc.2010.181
PG 13
WC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
GA 634DG
UT WOS:000280559100007
PM 20543867
OA Green Published, Green Accepted, Bronze
DA 2018-12-27
ER

PT J
AU Savine, AC
   Braver, TS
AF Savine, Adam C.
   Braver, Todd S.
TI RETRACTED: Motivated Cognitive Control: Reward Incentives Modulate
   Preparatory Neural Activity during Task-Switching (Retracted article.
   See vol. 33, pg. 8922, 2013)
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article; Retracted Publication
ID WORKING-MEMORY TASK; PRIMATE PREFRONTAL CORTEX; EVENT-RELATED FMRI;
   TOP-DOWN CONTROL; DOPAMINE NEURONS; ORBITOFRONTAL CORTEX; ANTERIOR
   CINGULATE; ACTIVITY DYNAMICS; PARIETAL CORTEX; BRAIN
AB It is increasingly appreciated that executive control processes need to be understood in terms of motivational as well as cognitive mechanisms. The current study examined the impact of performance-contingent reward incentives (monetary bonuses) on neural activity dynamics during cued task-switching performance. Behavioral measures indicated that performance was improved and task-switch costs selectively reduced on incentive trials. Trial-by-trial fluctuations in incentive value were associated with activation in reward-related brain regions (dopaminergic midbrain, paracingulate cortex) and also modulated the dynamics of switch-selective activation in the brain cognitive control network. Within lateral prefrontal cortex (PFC), both additive (inferior frontal junction) and interactive [dorsolateral PFC (DLPFC)] incentive effects were observed. In DLPFC, incentive modulation of activation predicted task-switching behavioral performance, but with hemispherically dissociable effects. Furthermore, in left DLPFC, incentive modulation specifically enhanced task-cue-related activation, and this activation in turn predicted that the trial would be subsequently rewarded (because of optimal performance). The results suggest that motivational incentives have a selective effect on brain regions that subserve cognitive control processes during task-switching and, moreover, that one mechanism of effect might be the enhancement of cue-related task preparation within left DLPFC.
C1 [Savine, Adam C.; Braver, Todd S.] Washington Univ, Dept Psychol, St Louis, MO 63139 USA.
RP Savine, AC (reprint author), Washington Univ, Dept Psychol, Campus Box 1125, St Louis, MO 63139 USA.
EM acsavine@artsci.wustl.edu
OI Braver, Todd/0000-0002-2631-3393
FU National Institutes of Health [2R01MH066078]
FX This work has been supported by National Institutes of Health R01 Grant
   2R01MH066078 (T. S. B.).
CR Ahsan RL, 2007, NEUROIMAGE, V38, P261, DOI 10.1016/j.neuroimage.2007.06.004
   Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884
   Badre D, 2006, P NATL ACAD SCI USA, V103, P7186, DOI 10.1073/pnas.0509550103
   Beck SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009251
   Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001
   Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x
   Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624
   Boucher L, 2007, PSYCHOL REV, V114, P376, DOI 10.1037/0033-295X.114.2.376
   Brass M, 2004, J COGNITIVE NEUROSCI, V16, P609, DOI 10.1162/089892904323057335
   Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001
   Braver T., 2007, NEUROSCIENCE RULE GU, P255, DOI DOI 10.3758/S13415-012-0117-7
   Braver T S, 1999, Prog Brain Res, V121, P327
   Braver T. S., 2006, FUNCTIONAL NEUROIMAG, P307
   Braver T. S., 2007, VARIATION WORKING ME, P76, DOI [DOI 10.1093/ACPROF:OSO/9780195168648.003.0004, 10.1093/acprof:oso/9780195168648.003.0004]
   Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106
   Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5
   Braver TS, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P713
   Bunge SA, 2005, J NEUROSCI, V25, P10347, DOI 10.1523/JNEUROSCI.2937-05.2005
   COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507
   Cohen J, 2002, CURR OPIN NEUROBIOL, V12, P223, DOI 10.1016/S0959-4388(02)00314-8
   Conturo T. E., 1996, Society for Neuroscience Abstracts, V22, P7
   Cools R, 2008, NEUROSCIENTIST, V14, P381, DOI 10.1177/1073858408317009
   Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127
   DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193
   Driver J., 2000, CONTROL COGNITIVE PR
   Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460
   Emery L, 2008, NEUROIMAGE, V42, P1577, DOI 10.1016/j.neuroimage.2008.06.021
   Engelmann JB, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.004.2009
   Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160
   Fales CL, 2008, COGN AFFECT BEHAV NE, V8, P239, DOI 10.3758/CABN.8.3.239
   Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312
   FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019
   Gilbert Alison M., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P540, DOI 10.3758/CABN.4.4.540
   Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129
   Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008
   Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450
   Jensen J, 2007, HUM BRAIN MAPP, V28, P294, DOI 10.1002/hbm.20274
   Jimura K, 2010, CEREB CORTEX, V20, P1420, DOI 10.1093/cercor/bhp206
   Jimura K, 2010, P NATL ACAD SCI USA, V107, P8871, DOI 10.1073/pnas.1002007107
   Johnston K, 2007, NEURON, V53, P453, DOI 10.1016/j.neuron.2006.12.023
   Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007
   Kamigaki T, 2009, NEURON, V61, P941, DOI 10.1016/j.neuron.2009.01.028
   Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5
   Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001
   Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321
   Krawczyk DC, 2007, BRAIN RES, V1141, P168, DOI 10.1016/j.brainres.2007.01.052
   Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303
   Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006
   Kruglanski AW, 2002, ADV EXP SOC PSYCHOL, V34, P331, DOI 10.1016/S0065-2601(02)80008-9
   Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5
   LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145
   Locke HS, 2008, COGN AFFECT BEHAV NE, V8, P99, DOI 10.3758/CABN.8.1.99
   Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210
   Mayr U, 2006, PSYCHON B REV, V13, P794, DOI 10.3758/BF03193999
   Mcclure SM, 2004, NEUROSCIENTIST, V10, P260, DOI 10.1177/1073858404263526
   Meiran N, 2000, PSYCHOL RES-PSYCH FO, V63, P234, DOI 10.1007/s004269900004
   Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167
   MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024
   Monsell S, 2006, J EXP PSYCHOL HUMAN, V32, P493, DOI 10.1037/0096-1523.32.3.493
   Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903
   Mueller J, 2007, EUR J NEUROSCI, V26, P3661, DOI 10.1111/j.1460-9568.2007.05949.x
   Nitschke JB, 2006, NAT NEUROSCI, V9, P435, DOI 10.1038/nn1645
   Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4
   O'Doherty J, 2003, J NEUROSCI, V23, P7931
   O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285
   O'Reilly RC, 2006, SCIENCE, V314, P91, DOI 10.1126/science.1127242
   Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711
   Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131
   Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317
   Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006
   Pochon JB, 2002, P NATL ACAD SCI USA, V99, P5669, DOI 10.1073/pnas.082111099
   ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037//0096-3445.124.2.207
   Rowe J, 2008, CEREB CORTEX, V18, P2275, DOI 10.1093/cercor/bhm249
   Ruge H, 2009, NEUROPSYCHOLOGIA, V47, P1670, DOI 10.1016/j.neuropsychologia.2009.02.004
   Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642
   Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9
   Satoh T, 2003, J NEUROSCI, V23, P9913
   Savine AC, 2010, COGNITION EMOTION, V24, P338, DOI 10.1080/02699930903381564
   SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731
   Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593
   Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4
   Schultz W, 1998, J NEUROPHYSIOL, V80, P1
   Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563
   Small DM, 2005, CEREB CORTEX, V15, P1855, DOI 10.1093/cercor/bhi063
   Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657
   Snyder AZ, 1996, QUANTIFICATION BRAIN
   Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497
   Stoet G, 2007, J COGNITIVE NEUROSCI, V19, P194, DOI 10.1162/jocn.2007.19.2.194
   Talairach J., 1988, COPLANAR STEREOTAXIC
   Taylor SF, 2004, NEUROIMAGE, V21, P1045, DOI 10.1016/j.neuroimage.2003.10.032
   van den Bos W, 2007, COGN AFFECT BEHAV NE, V7, P337, DOI 10.3758/CABN.7.4.337
   Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2
   Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052
   Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255
   Watanabe J, 2002, NEUROIMAGE, V17, P1207, DOI 10.1006/nimg.2002.1198
   Watanabe M, 1997, J NEUROPHYSIOL, V78, P2795
   Watanabe M, 2002, J NEUROSCI, V22, P2391, DOI 10.1523/JNEUROSCI.22-06-02391.2002
   Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0
   WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0
   Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028
   WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024
   Yeung N, 2006, J NEUROSCI, V26, P1429, DOI 10.1523/JNEUROSCI.3109-05.2006
NR 102
TC 72
Z9 77
U1 2
U2 29
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD AUG 4
PY 2010
VL 30
IS 31
BP 10294
EP 10305
DI 10.1523/JNEUROSCI.2052-10.2010
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA 637BP
UT WOS:000280789600005
PM 20685974
OA Green Accepted, Bronze
DA 2018-12-27
ER

PT J
AU Parveen, S
   Mitra, M
   Krishnakumar, S
   Sahoo, SK
AF Parveen, Suphiya
   Mitra, Moutushy
   Krishnakumar, S.
   Sahoo, Sanjeeb K.
TI RETRACTED: Enhanced antiproliferative activity of carboplatin-loaded
   chitosan-alginate nanoparticles in a retinoblastoma cell line (Retracted
   article. See vol. 9, pg. 7075, 2013)
SO ACTA BIOMATERIALIA
LA English
DT Article; Retracted Publication
DE Carboplatin; Chitosan; Nanoparticles; Ocular drug delivery;
   Retinoblastoma
ID OCULAR DRUG-DELIVERY; IN-VITRO; OXIDE NANOPARTICLES; GENE DELIVERY;
   PACLITAXEL; APOPTOSIS; PROTEIN; TOXICITY; CARRIERS; RELEASE
AB In the present study the potential of carboplatin-loaded chitosan-alginate nanoparticles (CANPs) for the treatment of retinoblastoma was investigated The carboplatin-loaded CANPs were similar to 300 nm in size. exhibited a high zeta potential of similar to 36 mV and drug encapsulation of similar to 20 wt % The CANPs were further characterized by Fourier transform infrared spectroscopy, differential scanning calorimetry and transmission electron microscopy In vitro release studies revealed fast release of similar to 25% of the drug during the first 24 h, followed by sustained release. CANPs demonstrated greater and sustained antiproliferative activity of the drug in a dose- and time-dependent manner (carboplann IC50 = 056 mu g ml(-1), carboplatin-loaded CANPs IC50 = 0.004 mu g ml(-1)), as well as an enhanced apoptotic effect as compared with the drug in solution in a retinoblastoma cell line (Y79) The higher cytotoxic effect of CANPs may be due to their greater cellular uptake as compared with native carboplatin It was also demonstrated that clathrin-mediated endocytosis plays a key role in the internalization of CANPs in the Y79 cell line. In conclusion, biodegradable chitosan nanoparticles could be used as an effective ocular drug delivery system for sustained intracellular delivery of carboplatin for the treatment of retinoblastoma (C) 2010 Acts Materialla Inc Published by Elsevier Ltd. All rights reserved
C1 [Parveen, Suphiya; Sahoo, Sanjeeb K.] Inst Life Sci, Lab Nanomed, Bhubaneswar 751023, Orissa, India.
   [Mitra, Moutushy; Krishnakumar, S.] Sankara Nethralaya, Vis Res Fdn, Dept Ocular Pathol, Madras 600006, Tamil Nadu, India.
RP Sahoo, SK (reprint author), Inst Life Sci, Lab Nanomed, Nalco Sq, Bhubaneswar 751023, Orissa, India.
FU Department of Biotechnology, Government of India
   [BT/04(SBIRI)/48/2006-PID, BT/PR7968/MED/14/1206/2006]
FX S.K.S thanks the Department of Biotechnology, Government of India, for
   providing Grants No BT/04(SBIRI)/48/2006-PID and
   BT/PR7968/MED/14/1206/2006. S P thanks the Department of Biotechnology,
   Government of India, for a Senior Research Fellowship.
CR Abramson DH, 1998, OPHTHALMOLOGY, V105, P573, DOI 10.1016/S0161-6420(98)94006-4
   Al-Joudi FS, 2005, ACTA HISTOCHEM CYTOC, V38, P323, DOI 10.1267/ahc.38.323
   ALONSO MJ, 2004, ACS SYM SER, V879, pCH20
   AMENDOLA BE, 1989, INT J RADIAT ONCOL, V17, P63, DOI 10.1016/0360-3016(89)90371-4
   Cafaggi S, 2007, J CONTROL RELEASE, V121, P110, DOI 10.1016/j.jconrel.2007.05.037
   Calvo P, 1997, INT J PHARM, V153, P41, DOI 10.1016/S0378-5173(97)00083-5
   Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
   CHAN HSL, 1989, ANTICANCER RES, V9, P469
   Chavanpatil MD, 2006, INT J PHARMACEUT, V320, P150, DOI 10.1016/j.ijpharm.2006.03.045
   Choi EK, 2003, INT J HYPERTHER, V19, P431, DOI 10.1080/0265673021000017118
   de Campos AM, 2004, PHARM RES, V21, P803, DOI 10.1023/B:PHAM.0000026432.75781.cb
   De Campos AM, 2001, INT J PHARM, V224, P159, DOI 10.1016/S0378-5173(01)00760-8
   de Salamanca AE, 2006, INVEST OPHTH VIS SCI, V47, P1416, DOI 10.1167/iovs.05-0495
   De SJ, 2003, J CONTROL RELEASE, V89, P101, DOI 10.1016/S0168-3659(03)00098-1
   Di Felice V, 1998, INT J ONCOL, V13, P225
   Dodane V, 1998, PHARM SCI TECHNOL TO, V1, P246, DOI 10.1016/S1461-5347(98)00059-5
   Dodane V, 1999, INT J PHARM, V182, P21, DOI 10.1016/S0378-5173(99)00030-7
   Douglas KL, 2008, EUR J PHARM BIOPHARM, V68, P676, DOI 10.1016/j.ejpb.2007.09.002
   Ellsworth R M, 1977, Mod Probl Ophthalmol, V18, P94
   Fizet J, 2009, J NANOSCI NANOTECHNO, V9, P5717, DOI 10.1166/jnn.2009.1237
   Gallie B. L., 1995, OPHTHALMOLOGY S, V102, P109
   Genta I, 1997, J PHARM PHARMACOL, V49, P737, DOI 10.1111/j.2042-7158.1997.tb06103.x
   Griesinger F, 2004, LUNG CANCER-J IASLC, V44, P261, DOI 10.1016/j.lungcan.2003.11.015
   Hamelers IHL, 2006, MOL CANCER THER, V5, P2007, DOI 10.1158/1535-7163.MCT-06-0089
   Hay RW, 1998, POLYHEDRON, V17, P2337, DOI 10.1016/S0277-5387(97)00477-4
   Huang M, 2002, PHARM RES-DORDR, V19, P1488, DOI 10.1023/A:1020404615898
   Ioannou YA, 1996, NUCLEIC ACIDS RES, V24, P992
   Jabr-Milane LS, 2008, CANCER TREAT REV, V34, P592, DOI 10.1016/j.ctrv.2008.04.003
   Jain D, 2008, J BIOMED MATER RES B, V86B, P105, DOI 10.1002/jbm.b.30994
   Janes KA, 2001, J CONTROL RELEASE, V73, P255, DOI 10.1016/S0168-3659(01)00294-2
   KOOPMAN G, 1994, BLOOD, V84, P1415
   Koping-Hoggard M, 2004, GENE THER, V11, P1441, DOI 10.1038/sj.gt.3302312
   Li T, 2007, J BIOMED MATER RES A, V83A, P383, DOI 10.1002/jbm.a.31322
   Mittal A, 2007, J CHROMATOGR B, V855, P211, DOI 10.1016/j.jchromb.2007.05.005
   Mo Y, 2007, MOL VIS, V13, P746
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Motwani SK, 2008, EUR J PHARM BIOPHARM, V68, P513, DOI 10.1016/j.ejpb.2007.09.009
   Mu L, 2002, J CONTROL RELEASE, V80, P129, DOI 10.1016/S0168-3659(02)00025-1
   Myles ME, 2005, ADV DRUG DELIVER REV, V57, P2063, DOI 10.1016/j.addr.2005.08.006d
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Parveen S, 2008, J DRUG TARGET, V16, P108, DOI [10.1080/10611860701794353, 10.1080/10611860701794353 ]
   Rodriguez-Galindo C, 2008, PEDIATRICS, V122, pE763, DOI 10.1542/peds.2008-0518
   ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z
   Sabah J, 2004, MOL VIS, V10, P254
   Sahoo SK, 2007, NANOMED-NANOTECHNOL, V3, P20, DOI 10.1016/j.nano.2006.11.008
   Sahoo SK, 2005, MOL PHARMACEUT, V2, P373, DOI 10.1021/mp050032z
   Schipper NGM, 1997, PHARMACEUT RES, V14, P923, DOI 10.1023/A:1012160102740
   SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217
   Shields CL, 1996, ARCH OPHTHALMOL-CHIC, V114, P1330, DOI 10.1001/archopht.1996.01100140530002
   Short BG, 2008, TOXICOL PATHOL, V36, P49, DOI 10.1177/0192623307310955
   SOFER A, 1995, J BIOL CHEM, V270, P12117, DOI 10.1074/jbc.270.20.12117
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Van Quill KR, 2005, OPHTHALMOLOGY, V112, P1151, DOI 10.1016/j.ophtha.2004.11.060
   WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107
   Wu Y, 2005, INT J PHARM, V295, P235, DOI 10.1016/j.ijpharm.2005.01.042
   Yang H, 2009, J NANOSCI NANOTECHNO, V9, P282, DOI [10.1166/jnn.2009.J065, 10.1166/jnn.2009J065]
   Zheng YL, 2006, J PHARM SCI-US, V95, P181, DOI 10.1002/jps.20399
NR 57
TC 46
Z9 46
U1 6
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD AUG
PY 2010
VL 6
IS 8
BP 3120
EP 3131
DI 10.1016/j.actbio.2010.02.010
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 621MQ
UT WOS:000279583400029
PM 20149903
DA 2018-12-27
ER

PT J
AU Bayazit, V
   Bayram, B
   Pala, Z
   Atan, O
AF Bayazit, Vahdettin
   Bayram, Banu
   Pala, Zeydin
   Atan, Ozkan
TI RETRACTED: EVALUATION OF CARCINOGENIC EFFECTS OF ELECTROMAGNETIC FIELDS
   (EMF) (Retracted article. See vol. 10, pg. 331, 2010)
SO BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES
LA English
DT Article; Retracted Publication
DE electromagnetic field; cancer
ID SPRAGUE-DAWLEY RATS; MOBILE PHONE USE; CELLULAR-TELEPHONE USE;
   BREAST-CANCER MODEL; HZ MAGNETIC-FIELDS; BRAIN-TUMORS; MAMMARY-GLAND;
   ACOUSTIC NEUROMA; CORDLESS TELEPHONES; GSM-900 MICROWAVES
AB The purpose of this study was to investigate the carcinogenic effects of electromagnetic fields on human. There are many effects of electromagnetic fields on human such as cancer, epidemiology, acute and chronic effects. These effects vary according to the field strength and environmental conditions. There have been many instances of harmful effects of electromagnetic fields from such seemingly innocuous devices as mobile phones, computers, power lines and domestic wiring. The balance of epidemiologic evidence indicates that mobile phone use of less than 10 years does not pose any increased risk of brain tumour or acoustic neuroma. For long-term use, data are sparse, and the following conclusions are therefore uncertain and tentative.
C1 [Bayazit, Vahdettin; Bayram, Banu] Mus Alparslan Univ, Fac Arts & Sci, Dept Biol, TR-49100 Mus, Turkey.
   [Pala, Zeydin] Mus Alparslan Univ, Dept Elect & Automat, Vocat Sch, TR-49100 Mus, Turkey.
   [Atan, Ozkan] Yuzuncu Yil Univ, Vocat Sch, Dept Tech Programs, TR-65080 Van, Turkey.
RP Bayazit, V (reprint author), Mus Alparslan Univ, Fac Arts & Sci, Dept Biol, TR-49100 Mus, Turkey.
CR Ahlbom A, 2000, BRIT J CANCER, V83, P692, DOI 10.1054/bjoc.2000.1376
   Anane R, 2003, RADIAT RES, V160, P492, DOI 10.1667/RR3052
   Anane R, 2003, BIOELECTROMAGNETICS, V24, P211, DOI 10.1002/bem.10093
   Anderson LE, 1999, CARCINOGENESIS, V20, P1615, DOI 10.1093/carcin/20.8.1615
   Auvinen A, 2002, EPIDEMIOLOGY, V13, P356, DOI 10.1097/00001648-200205000-00018
   BAUM A, 1995, CARCINOGENESIS, V16, P119, DOI 10.1093/carcin/16.1.119
   Berg G, 2005, J EXPO ANAL ENV EPID, V15, P217, DOI 10.1038/sj.jea.7500390
   Besset A, 2005, BIOELECTROMAGNETICS, V26, P102, DOI 10.1002/bem.20053
   Blackman CF, 2001, BIOELECTROMAGNETICS, V22, P122, DOI 10.1002/1521-186X(200102)22:2<122::AID-BEM1015>3.0.CO;2-V
   Boorman GA, 1999, CARCINOGENESIS, V20, P899, DOI 10.1093/carcin/20.5.899
   Christensen HC, 2004, AM J EPIDEMIOL, V159, P277, DOI 10.1093/aje/kwh032
   Christensen HC, 2005, NEUROLOGY, V64, P1189, DOI 10.1212/01.WNL.0000156351.72313.D3
   Diem E, 2005, MUTAT RES-GEN TOX EN, V583, P178, DOI 10.1016/j.mrgentox.2005.03.006
   Fedrowitz M, 2004, CANCER RES, V64, P243, DOI 10.1158/0008-5472.CAN-03-2808
   Fedrowitz M, 2002, CANCER RES, V62, P1356
   Foliart DE, 2006, BRIT J CANCER, V94, P161, DOI 10.1038/sj.bjc.6602916
   Forssen UM, 2005, AM J EPIDEMIOL, V161, P250, DOI 10.1093/aje/kwi041
   French PW, 2001, DIFFERENTIATION, V67, P93, DOI 10.1046/j.1432-0436.2001.670401.x
   Girgert R, 2005, BIOCHEM BIOPH RES CO, V336, P1144, DOI 10.1016/j.bbrc.2005.08.243
   Hardell L, 2006, ENVIRON RES, V100, P232, DOI 10.1016/j.envres.2005.04.006
   Hardell L, 2005, NEUROEPIDEMIOLOGY, V25, P120, DOI 10.1159/000086354
   Hardell L, 2002, EUR J CANCER PREV, V11, P377, DOI 10.1097/00008469-200208000-00010
   HEPWORTH SJ, 2006, BMJ-BRIT MED J, V1332, P883
   Imaida K, 2001, CARCINOGENESIS, V22, P1837, DOI 10.1093/carcin/22.11.1837
   Inoue Y, 1999, ANTICANCER RES, V19, P3989
   Inskip PD, 2001, NEW ENGL J MED, V344, P79, DOI 10.1056/NEJM200101113440201
   Ishido M, 2001, CARCINOGENESIS, V22, P1043, DOI 10.1093/carcin/22.7.1043
   Ivancsits S, 2003, INT ARCH OCC ENV HEA, V76, P431, DOI 10.1007/s00420-003-0446-5
   Johansen C, 2001, J NATL CANCER I, V93, P203, DOI 10.1093/jnci/93.3.203
   Kheifets L, 2005, PEDIATRICS, V116, pE303, DOI 10.1542/peds.2004-2541
   Koivisto M, 2000, NEUROREPORT, V11, P413, DOI 10.1097/00001756-200002070-00038
   Kumlin T, 1998, INT J RADIAT BIOL, V73, P113, DOI 10.1080/095530098142761
   Lonn S, 2005, AM J EPIDEMIOL, V161, P526, DOI 10.1093/aje/kwi091
   LOSCHER W, 1993, CANCER LETT, V71, P75, DOI 10.1016/0304-3835(93)90100-N
   Loscher W, 2001, BIOELECTROMAGNETICS, V22, P603, DOI 10.1002/bem.90
   Mevissen M, 1996, CARCINOGENESIS, V17, P903, DOI 10.1093/carcin/17.5.903
   Miyakoshi J, 2005, BIOELECTROMAGNETICS, V26, P251, DOI 10.1002/bem.20077
   Nikolova T, 2005, FASEB J, V19, P1686, DOI 10.1096/jf.04-3549fje
   Pacini S, 2001, ONCOL RES, V13, P19
   Rollwitz J, 2004, BBA-GEN SUBJECTS, V1674, P231, DOI 10.1016/j.bbagen.2004.06.024
   Roschke J, 1997, BIOELECTROMAGNETICS, V18, P172
   ROTI JL, 2004, RADIAT RES, V161, P193
   Schoemaker MJ, 2005, BRIT J CANCER, V93, P842, DOI 10.1038/sj.bjc.6602764
   Schuz J, 2006, AM J EPIDEMIOL, V163, P512, DOI 10.1093/aje/kwj068
   Simko A, 2006, TOXICOL LETT, V161, P73, DOI 10.1016/j.toxlet.2005.08.005
   Wolf FI, 2005, BBA-MOL CELL RES, V1743, P120, DOI 10.1016/j.bbamer.2004.09.005
   Zook BC, 2001, RADIAT RES, V155, P572, DOI 10.1667/0033-7587(2001)155[0572:TEOMRR]2.0.CO;2
NR 47
TC 5
Z9 5
U1 0
U2 8
PU ASSOC BASIC MEDICAL SCI FEDERATION BOSNIA & HERZEGOVINA SARAJEVO
PI CEKALUSA
PA UNIV SARAJEVO, MEDICAL FAC, CEKALUSA, SARAJEVO 90, BOSNIA & HERCEG
SN 1512-8601
EI 1840-4812
J9 BOSNIAN J BASIC MED
JI Bosnian J. Basic Med. Sci.
PD AUG
PY 2010
VL 10
IS 3
BP 245
EP 250
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 654IY
UT WOS:000282162900011
PM 20846133
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Reed, SD
   Fulmer, A
   Buckholz, J
   Zhang, B
   Cutrera, J
   Shiomitsu, K
   Li, S
AF Reed, S. D.
   Fulmer, A.
   Buckholz, J.
   Zhang, B.
   Cutrera, J.
   Shiomitsu, K.
   Li, S.
TI RETRACTED: Bleomycin/interleukin-12 electrochemogenetherapy for treating
   naturally occurring spontaneous neoplasms in dogs (Retracted article.
   See vol. 17, pg. 826, 2010)
SO CANCER GENE THERAPY
LA English
DT Article; Retracted Publication
DE electroporation; BLM; interleukin-12; canine; neoplasia
ID GENE-THERAPY; INTERLEUKIN-12 GENE; ENHANCED DELIVERY; DRUG-DELIVERY;
   CANCER; ELECTROPORATION; BLEOMYCIN; ELECTROCHEMOTHERAPY; FUTURE; CELLS
AB On the basis of superior outcomes from electrochemogenetherapy (ECGT) compared with electrochemotherapy in mice, we determined the efficacy of ECGT applied to spontaneous canine neoplasms. Intralesional bleomycin (BLM) and feline interleukin-12 DNA injection combined with translesional electroporation resulted in complete cure of two recurrent World Health Organization stage T2bN0M0 oral squamous cell carcinomas (SCCs) and one T2N0M0 acanthomatous ameloblastoma. Three remaining dogs, which had no other treatment options, had partial responses to ECGT; one had mandibular T3bN2bM1 melanoma with pulmonary and lymph node metastases; one had cubital T3N0M1 histiocytic sarcoma with spleen metastases; and one had soft palate T3N0M0 fibrosarcoma. The melanoma dog had decrease in the size of the primary tumor before recrudescence and euthanasia. The histiocytic sarcoma dog had resolution of the primary tumor, but was euthanized because of metastases 4 months after the only treatment. The dog with T3N0M0 fibrosarcoma had tumor regression with recrudescence. Treatment was associated with minimal side effects and was easy to perform, was associated with repair of bone lysis in cured dogs, improved quality of life for dogs with partial responses and extended overall survival time. ECGT seems to be a safe and resulted in complete responses in SCC and acanthomatous ameloblastoma. Cancer Gene Therapy (2010) 17, 571-578; doi:10.1038/cgt.2010.13; published online 23 April 2010
C1 [Reed, S. D.; Zhang, B.; Cutrera, J.; Li, S.] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Lab Mol Therapy, Baton Rouge, LA 70803 USA.
   [Fulmer, A.; Buckholz, J.; Shiomitsu, K.] Louisiana State Univ, Sch Vet Med, Dept Vet Clin Sci, Oncol Unit, Baton Rouge, LA 70803 USA.
RP Li, S (reprint author), Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Lab Mol Therapy, Skip Bertman Dr, Baton Rouge, LA 70803 USA.
EM sli@vetmed.lsu.edu
RI Li, Shulin/D-6478-2011
FU NCI NIH HHS [R01 CA142855, 5R01CA120895, R01 CA098928]; PHS HHS [T-32]
CR Barbul Alexander, 2009, V480, P141, DOI 10.1007/978-1-59745-429-2_10
   Buttner M, 1998, CYTOKINE, V10, P241, DOI 10.1006/cyto.1997.0284
   Campana LG, 2009, ANN SURG ONCOL, V16, P191, DOI 10.1245/s10434-008-0204-8
   Cemazar M, 2008, J VET INTERN MED, V22, P826, DOI 10.1111/j.1939-1676.2008.0117.x
   Cutrera Jeffry, 2008, V423, P319, DOI 10.1007/978-1-59745-194-9_24
   Daud AI, 2008, J CLIN ONCOL, V26, P3235, DOI 10.1200/JCO.2007.13.9048
   Ehrhart N, 2005, J AM ANIM HOSP ASSOC, V41, P241, DOI 10.5326/0410241
   Gehl J, 2003, ACTA PHYSIOL SCAND, V177, P437, DOI 10.1046/j.1365-201X.2003.01093.x
   Gothelf A, 2003, CANCER TREAT REV, V29, P371, DOI 10.1016/S0305-7372(03)00073-2
   Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b
   Kishida T, 2003, MOL THER, V8, P738, DOI 10.1016/S1525-0016(03)00279-X
   Lollini Pier-Luigi, 2005, Future Oncol, V1, P57, DOI 10.1517/14796694.1.1.57
   Mazzolini G, 2003, CURR PHARM DESIGN, V9, P1981, DOI 10.2174/1381612033454261
   Mir Lluis M., 2008, V423, P3, DOI 10.1007/978-1-59745-194-9_1
   Miyazaki M, 2006, PERITON DIALYSIS INT, V26, P633
   Mortara L, 2007, SURG ONCOL, V16, pS33, DOI 10.1016/j.suronc.2007.10.045
   Persano L, 2007, MOL ASPECTS MED, V28, P87, DOI 10.1016/j.mam.2006.12.005
   Qian C, 2006, CELL RES, V16, P182, DOI 10.1038/sj.cr.7310025
   Reed SD, 2009, CURR GENE THER, V9, P316, DOI 10.2174/156652309788921062
   Sammeta SM, 2009, PHARM DEV TECHNOL, V14, P159, DOI 10.1080/10837450802471180
   Spugnini EP, 2009, VET J, V179, P117, DOI 10.1016/j.tvjl.2007.08.011
   Takimoto CH, 2008, CANC MANAGEMENT MULT
   Teissie J, 2005, BBA-GEN SUBJECTS, V1724, P270, DOI 10.1016/j.bbagen.2005.05.006
   Torrero MN, 2006, CLIN CANCER RES, V12, P257, DOI 10.1158/1078-0432.CCR-05-1514
   Weiss JM, 2007, EXPERT OPIN BIOL TH, V7, P1705, DOI 10.1517/14712598.7.11.1705
NR 25
TC 11
Z9 11
U1 2
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0929-1903
EI 1476-5500
J9 CANCER GENE THER
JI Cancer Gene Ther.
PD AUG
PY 2010
VL 17
IS 8
BP 571
EP 578
DI 10.1038/cgt.2010.13
PG 8
WC Biotechnology & Applied Microbiology; Oncology; Genetics & Heredity;
   Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Oncology; Genetics & Heredity;
   Research & Experimental Medicine
GA 628FI
UT WOS:000280099600006
PM 20414325
OA Bronze
DA 2018-12-27
ER

PT J
AU Nabae, Y
   Moriya, S
   Matsubayashi, K
   Lyth, SM
   Malon, M
   Wu, LB
   Islam, NM
   Koshigoe, Y
   Kuroki, S
   Kakimoto, MA
   Miyata, S
   Ozaki, J
AF Nabae, Yuta
   Moriya, Shogo
   Matsubayashi, Katsuyuki
   Lyth, Stephen M.
   Malon, Michal
   Wu, Libin
   Islam, Nazrul M.
   Koshigoe, Yuka
   Kuroki, Shigeki
   Kakimoto, Masa-aki
   Miyata, Seizo
   Ozaki, Jun-ichi
TI RETRACTED: The role of Fe species in the pyrolysis of Fe phthalocyanine
   and phenolic resin for preparation of carbon-based cathode catalysts
   (Retracted article. See vol. 55, pg. 379, 2013)
SO CARBON
LA English
DT Article; Retracted Publication
ID OXYGEN-REDUCTION ACTIVITY; ELECTROLYTE FUEL-CELLS; NITROGEN-CONTAINING
   CARBON; HEAT-TREATED IRON; ACTIVE-SITES; STRUCTURAL-CHARACTERIZATION;
   ELECTROCATALYSTS; SURFACE; BLACK; CARBONIZATION
AB Pyrolysis of a mixture of Fe phthalocyanine and phenolic resin (FePc/PhRs) was studied to clarify the details of the preparation protocol of nitrogen-doped carbon-based materials for cathode catalysts in polymer electrolyte membrane fuel cells. TEM images show that nanoshell carbon is formed by the pyrolysis of FePc/PhRs in the temperature range of 600-800 degrees C. The optimum pyrolysis temperature for the FePc/PhRs mixture was 600 degrees C, where moderate conductivity and high nitrogen content of the prepared carbon were both satisfied. This catalyst showed a promising fuel cell performance with 1.01 V open-circuit voltage and 0.33 W cm(-2) maximum output, at 0.2 MPa absolute pressure and 80 degrees C. A detailed study of the carbonization process suggests that the presence of Fe species during carbonization process contributes to higher nitrogen content and growth of nanoshell structure of the resulting carbon. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Nabae, Yuta; Moriya, Shogo; Matsubayashi, Katsuyuki; Lyth, Stephen M.; Malon, Michal; Wu, Libin; Islam, Nazrul M.; Kuroki, Shigeki; Kakimoto, Masa-aki; Miyata, Seizo; Ozaki, Jun-ichi] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan.
   [Koshigoe, Yuka; Ozaki, Jun-ichi] Gunma Univ, Grad Sch Engn, Dept Environm & Chem Engn, Gunma 3768515, Japan.
   [Miyata, Seizo] New Energy & Ind Technol Dev Org, Saiwai Ku, Kanagawa 2128554, Japan.
RP Nabae, Y (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Organ & Polymer Mat, Meguro Ku, 2-12-1 S8-26 Ookayama, Tokyo 1528552, Japan.
EM nabae.y.aa@m.titech.ac.jp
RI dong, guofa/D-5248-2011
OI Lyth, Stephen/0000-0001-9563-867X
FU New Energy and Industrial Technology Development Organization (NEDO)
FX This study was financially supported by the New Energy and Industrial
   Technology Development Organization (NEDO). CHN elemental analysis was
   carried out in the Center for Advanced Materials Analysis in Tokyo
   Institute of Technology. The authors thank Mr. Kazuaki Sato, Mr. Yo
   Hosaka and Ms. Mayu Sonoda for technical assistance.
CR ALVES MCM, 1992, J PHYS CHEM-US, V96, P10898, DOI 10.1021/j100205a054
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   BOCK C, 2008, PEM FUEL CELL ELECTR, P447
   Bron M, 2002, J ELECTROANAL CHEM, V535, P113, DOI 10.1016/S0022-0728(02)01189-0
   Chokai M, 2010, J POWER SOURCES, V195, P5947, DOI 10.1016/j.jpowsour.2010.01.012
   Datta SS, 2008, NANO LETT, V8, P1912, DOI 10.1021/nl080583r
   Enoki T, 2007, INT REV PHYS CHEM, V26, P609, DOI 10.1080/01442350701611991
   Entani S, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2194867
   Faubert G, 1996, ELECTROCHIM ACTA, V41, P1689, DOI 10.1016/0013-4686(95)00423-8
   Garcia MH, 2009, J ORGANOMET CHEM, V694, P433, DOI 10.1016/j.jorganchem.2008.11.019
   Gasteiger HA, 2005, APPL CATAL B-ENVIRON, V56, P9, DOI 10.1016/j.apcatb.2004.06.021
   Gong KP, 2009, SCIENCE, V323, P760, DOI 10.1126/science.1168049
   Huang SF, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.235410
   Ikeda T, 2008, J PHYS CHEM C, V112, P14706, DOI 10.1021/jp806084d
   Iwazaki T, 2009, ELECTROCHEM COMMUN, V11, P376, DOI 10.1016/j.elecom.2008.11.045
   Jahnke H, 1976, Top Curr Chem, V61, P133
   Jiang DE, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2715558
   Konishi S, 2006, CARBON, V44, P2338, DOI 10.1016/j.carbon.2006.05.003
   Lalande G, 1996, J POWER SOURCES, V61, P227, DOI 10.1016/S0378-7753(96)02356-7
   Lefevre M, 2002, J PHYS CHEM B, V106, P8705, DOI 10.1021/jp020267f
   Lefevre M, 2009, SCIENCE, V324, P71, DOI 10.1126/science.1170051
   Liu G, 2009, ECS TRANSACTIONS, V25, P1251, DOI 10.1149/1.3210680
   Lyth SM, 2009, J PHYS CHEM C, V113, P20148, DOI 10.1021/jp907928j
   Maldonado S, 2004, J PHYS CHEM B, V108, P11375, DOI 10.1021/jp0496553
   Matter PH, 2007, J MOL CATAL A-CHEM, V264, P73, DOI 10.1016/j.molcata.2006.09.008
   Matter PH, 2006, J CATAL, V239, P83, DOI 10.1016/j.jcat.2006.01.022
   Milev AS, 2008, J PHYS CHEM C, V112, P5339, DOI 10.1021/jp710923f
   Miura K, 2001, ENERG FUEL, V15, P599, DOI 10.1021/ef0001787
   Nallathambi V, 2008, J POWER SOURCES, V183, P34, DOI 10.1016/j.jpowsour.2008.05.020
   NIWA H, 2009, 216 ECS M AUSTR CTR, P990
   Niwa H, 2009, J POWER SOURCES, V187, P93, DOI 10.1016/j.jpowsour.2008.10.064
   OZAKI A, 2007, CARBON, V228, P153
   Ozaki J, 1998, CARBON, V36, P131, DOI 10.1016/S0008-6223(97)00165-6
   Ozaki J, 1998, CHEM MATER, V10, P3386, DOI 10.1021/cm980081m
   Ozaki JI, 2006, CARBON, V44, P1324, DOI 10.1016/j.carbon.2005.12.026
   Ozaki JI, 2006, J APPL ELECTROCHEM, V36, P239, DOI 10.1007/s10800-005-9054-2
   Ozaki J, 2007, CARBON, V45, P1847, DOI 10.1016/j.carbon.2007.04.031
   Ozaki J, 2006, CARBON, V44, P3358, DOI 10.1016/j.carbon.2006.08.022
   Ozaki J, 2010, ELECTROCHIM ACTA, V55, P1864, DOI 10.1016/j.electacta.2009.10.037
   Pylypenko S, 2008, ELECTROCHIM ACTA, V53, P7875, DOI 10.1016/j.electacta.2008.05.047
   Raymundo-Pinero E, 2002, CARBON, V40, P597, DOI 10.1016/S0008-6223(01)00155-5
   SAITO M, 2009, 215 ECS M HILT SAN F, P265
   Schulenburg H, 2003, J PHYS CHEM B, V107, P9034, DOI 10.1021/jp030349j
   VANVEEN JAR, 1988, ELECTROCHIM ACTA, V33, P801, DOI 10.1016/S0013-4686(98)80010-8
   WATANABE T, 1994, CARBON, V32, P329, DOI 10.1016/0008-6223(94)90196-1
   WIDELOV A, 1993, ELECTROCHIM ACTA, V38, P2493, DOI 10.1016/0013-4686(93)80144-O
   WILSON MS, 1992, J APPL ELECTROCHEM, V22, P1, DOI 10.1007/BF01093004
   Wood TE, 2008, J POWER SOURCES, V178, P510, DOI 10.1016/j.jpowsour.2007.10.093
   Wu G, 2008, ECS TRANSACTIONS, V16, P159, DOI 10.1149/1.2981852
   Yang RZ, 2007, J ELECTROCHEM SOC, V154, pB893, DOI 10.1149/1.2750444
   YEAGER E, 1984, ELECTROCHIM ACTA, V29, P1527, DOI 10.1016/0013-4686(84)85006-9
   Zhang L, 2006, J POWER SOURCES, V156, P171, DOI 10.1016/j.jpowsour.2005.05.069
NR 52
TC 101
Z9 101
U1 4
U2 92
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0008-6223
EI 1873-3891
J9 CARBON
JI Carbon
PD AUG
PY 2010
VL 48
IS 9
BP 2613
EP 2624
DI 10.1016/j.carbon.2010.03.066
PG 12
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 608LK
UT WOS:000278585400029
DA 2018-12-27
ER

PT J
AU Kwon, E
   Kim, S
AF Kwon, Eilhan
   Kim, Sungpyo
TI RETRACTED: An investigation into the impact of CO2 co-feed on pyrolysis
   and gasification (Retracted Article. See vol 83, pg 83, 2011)
SO CHEMOSPHERE
LA English
DT Article; Retracted Publication
DE Pyrolysis/gasification; Biomass; Sub-bituminous coal; Municipal solid
   waste; Syngas; Biofuel
ID MSW GASIFICATION; BIOMASS; REACTOR; ENERGY; ATMOSPHERE; CONVERSION;
   HYDROGEN; STEAM; MODEL; CHAR
AB This paper presents experimental results of the impact of CO2 co-feed on a gasification/pyrolysis process for various feedstocks (biomass, coal, and municipal solid waste (MSW)). Various feedstocks were thermo-gravimetrically characterized under various atmospheric conditions and heating rates. A substantial amount of char burn out was identified in the presence of CO2 via a series of thermo-gravimetric analysis tests, which enabled high conversion of final mass (similar to 99%) to be achieved. The impact of CO2 co-feed on the volatilization regime during the pyrolysis/gasification process was not apparent at a heating rate of 10-40 degrees C min(-1). However, the impact of CO2 on the volatilization regime at a fast heating rate (950 degrees C min(-1)) was substantial. For example, significant enhancement in the generation of CO, by a factor of similar to 2, was observed in the presence of CO2. The generation of major chemical species, such as CH4 and C2H4, were enhanced, but this was not as apparent as in the case with CO. In addition, introducing CO2 to the pyrolysis/gasification process enabled the amount of condensable liquid hydrocarbons, such as tar (similar to 30-40%) to be significantly reduced in the presence of CO2, in that injecting CO2 into the pyrolysis/gasification process expedites cracking the volatilized chemical species. Experimental work confirmed that biomass and MSW could be feasible and desirable feedstocks for the pyrolysis/gasification process as these feedstocks can be easily treated compared to coal. To extend this understanding to a more practical level, various feedstocks were tested in a tubular reactor and drop tube reactor under various experimental conditions. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Kim, Sungpyo] Korea Univ, Dept Environm Engn, Coll Sci & Technol, Jochiwon Eup 339700, South Korea.
   [Kwon, Eilhan] Columbia Univ, Dept Earth & Environm Engn, New York, NY 10027 USA.
RP Kim, S (reprint author), Korea Univ, Dept Environm Engn, Coll Sci & Technol, Sejong Campus, Jochiwon Eup 339700, South Korea.
EM ub1905ub@korea.ac.kr
OI Kim, Sungpyo/0000-0002-6648-2984
CR Adanez J, 1997, FUEL, V76, P257, DOI 10.1016/S0016-2361(96)00204-9
   Agnew J, 2000, FUEL, V79, P1515, DOI 10.1016/S0016-2361(99)00287-2
   Authier O, 2009, IND ENG CHEM RES, V48, P4796, DOI 10.1021/ie801854c
   Boateng AA, 2007, IND ENG CHEM RES, V46, P1891, DOI 10.1021/ie0614529
   Branca C, 2003, IND ENG CHEM RES, V42, P3190, DOI 10.1021/ie030066d
   Butterman HC, 2009, ENVIRON ENG SCI, V26, P703, DOI 10.1089/ees.2008.0209
   CHEN G, 2003, TAIYANGNENG XUEBAO, V24, P380
   Choy KKH, 2004, CHEM ENG J, V105, P31, DOI 10.1016/j.cej.2004.07.012
   Czernik S, 2002, IND ENG CHEM RES, V41, P4209, DOI 10.1021/ie020107q
   DENT CG, 1990, BIOMASS, V22, P307, DOI 10.1016/0144-4565(90)90025-F
   Dietenberger MA, 2007, IND ENG CHEM RES, V46, P8863, DOI 10.1021/ie071158w
   Encinar JM, 1997, IND ENG CHEM RES, V36, P4176, DOI 10.1021/ie960795b
   *EPA, 2006, EPA530F07030
   Gale TK, 1996, ENERG FUEL, V10, P766, DOI 10.1021/ef950217s
   Garcia L, 1998, IND ENG CHEM RES, V37, P3812, DOI 10.1021/ie9801960
   Gonzalez JF, 2005, IND ENG CHEM RES, V44, P3003, DOI 10.1021/ie0490942
   Hayashi J, 2000, FUEL, V79, P439, DOI 10.1016/S0016-2361(99)00179-9
   Jung CH, 2005, WASTE MANAGE, V25, P301, DOI 10.1016/j.wasman.2004.08.012
   Kwon E, 2009, ENVIRON SCI TECHNOL, V43, P5996, DOI 10.1021/es900564b
   Lanza R, 2009, IND ENG CHEM RES, V48, P1391, DOI 10.1021/ie801280g
   Li HY, 2009, RENEW ENERG, V34, P2872, DOI 10.1016/j.renene.2009.04.007
   Lo Mastro F, 2004, WASTE MANAGE, V24, P309, DOI 10.1016/j.wasman.2003.10.007
   Malkow T, 2004, WASTE MANAGE, V24, P53, DOI 10.1016/S0956-053X(03)00038-2
   Naredi P, 2008, ENERG FUEL, V22, P317, DOI 10.1021/ef7004157
   Ranzi E, 2008, ENERG FUEL, V22, P4292, DOI 10.1021/ef800551t
   SJOSTROM K, 1990, IND ENG CHEM RES, V29, P892
   Tan LL, 2000, FUEL, V79, P1883, DOI 10.1016/S0016-2361(00)00078-8
   Thamavithya M, 2008, FUEL PROCESS TECHNOL, V89, P949, DOI 10.1016/j.fuproc.2008.03.003
   Wang Y, 2007, FUEL PROCESS TECHNOL, V88, P243, DOI 10.1016/j.fuproc.2006.10.002
   Xiao G, 2009, WASTE MANAGE, V29, P240, DOI 10.1016/j.wasman.2008.02.022
   Zubtsov VM, 2005, ENERGY, V30, P2229, DOI 10.1016/j.energy.2003.10.018
NR 31
TC 0
Z9 0
U1 2
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0045-6535
EI 1879-1298
J9 CHEMOSPHERE
JI Chemosphere
PD AUG
PY 2010
VL 80
IS 8
BP 957
EP 963
DI 10.1016/j.chemosphere.2010.04.068
PG 7
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 638DV
UT WOS:000280873200021
PM 20546843
DA 2018-12-27
ER

PT J
AU Fujii, Y
   Itakura, M
AF Fujii, Yoshitaka
   Itakura, Michiyo
TI RETRACTED: A Prospective, Randomized, Double-Blind, Placebo-Controlled
   Study to Assess the Antiemetic Effects of Midazolam on Postoperative
   Nausea and Vomiting in Women Undergoing Laparoscopic Gynecologic Surgery
   (Retracted article. See vol. 40, pg. 1048, 2018)
SO CLINICAL THERAPEUTICS
LA English
DT Article; Retracted Publication
DE complications; nausea; vomiting; antiemetics; midazolam; gynecologic
   laparoscopic surgery
ID PREVENTION; METOCLOPRAMIDE; PROPHYLAXIS; CHILDREN
AB Background: Postoperative nausea and vomiting (PONV) are distressing and frequent adverse effects (AEs) in women undergoing laparoscopic gynecologic surgery. Midazolam has been reported to be effective for preventing PONV in adults undergoing middle ear surgery and children undergoing strabismus surgery or tonsillectomy.
   Objective: The aim of this study was to assess the antiemetic effects of midazolam on PONV in women undergoing laparoscopic gynecologic surgery.
   Methods: This prospective, randomized, double-blind, placebo-controlled study was conducted (January December 2009) at the Department of Anesthesiology, Ushiku Aiwa General Hospital (Ibaraki, Japan). Nonpregnant Japanese women (aged 22-54 years) undergoing myomectomy, hysterectomy, salpingo-oophorectomy, or oophorectomy were randomized to receive 1 of 2 different midazolam doses (50 or 75 mu g/kg IV) or placebo immediately after induction of anesthesia. Anesthesia was induced with propofol 2 mg/kg IV, and vecuronium 0.1 mg/kg IV was used to facilitate tracheal intubation. After tracheal intubation, anesthesia was maintained with sevoflurane 1.0% to 3.0% (inspired concentration) and air in oxygen. All episodes of PONY during the first 24 hours after anesthesia were assessed by an investigator 24 hours postoperatively; the investigator was blinded as to which treatment each patient had received. The patients were asked if nausea, vomiting, or retching had occurred. Details were recorded of any other AEs, as well as any spontaneous complaints.
   Results: A total of 90 nonpregnant Japanese women were enrolled (mean [SD] age, 35 [6] years; mean height, 159 [6] cm; mean weight, 53 [8] kg). Each study group comprised 30 patients and was comparable with regard to patient demographic characteristics and types of surgery. The rate of patients experiencing PONY during the first 24 hours after anesthesia with midazolam 50 mu g/kg was 30% (P = 0.004 vs placebo) compared with 27% with midazolam 75 mu g/kg (P = 0.002 vs placebo) and 67% with placebo. The difference in the incidence of PONV between patients receiving midazolam 75 mu g/kg and those receiving midazolam 50 mu g/kg was not statistically significant. No clinically important AEs due to the study drug were observed in any of the groups.
   Conclusion: Midazolam 50 mu g/kg was not significantly different from midazolam 75 mu g/kg in the incidence of PONY, and both doses were associated with significantly less PONY compared with placebo during the first 24 hours after anesthesia in these Japanese women undergoing laparoscopic gynecologic surgery. (Clin Ther. 2010;32:1633-1637) (C) 2010 Excerpta Medica Inc.
C1 [Fujii, Yoshitaka] Toho Univ, Sch Med, Dept Anesthesiol 1, Ohta Ku, Tokyo 1438541, Japan.
   [Itakura, Michiyo] Ushiku Aiwa Gen Hosp, Dept Anesthesiol, Ibaraki, Japan.
RP Fujii, Y (reprint author), Toho Univ, Sch Med, Dept Anesthesiol 1, Ohta Ku, 6-11-1 Ohmori Nishi, Tokyo 1438541, Japan.
EM yfujii@med.toho-u.ac.jp
CR DIFLORIO T, 1992, ANAESTH INTENS CARE, V20, P383
   Fujii Y, 2009, INT J GYNECOL OBSTET, V106, P50, DOI 10.1016/j.ijgo.2009.03.008
   Gonzalez R, 2004, AM SURGEON, V70, P668
   Habib AS, 2002, ANAESTHESIA, V57, P725, DOI 10.1046/j.1365-2044.2002.270923.x
   *JAP PHARM INF CTR, 2009, DRUGS JAP
   Jung JS, 2007, OTOLARYNG HEAD NECK, V137, P753, DOI 10.1016/j.otohns.2007.07.024
   Kovac AL, 2000, DRUGS, V59, P213, DOI 10.2165/00003495-200059020-00005
   LERMAN J, 1995, CAN J ANAESTH, V42, P263, DOI 10.1007/BF03010699
   Mais V, 1996, AM J OBSTET GYNECOL, V174, P654, DOI 10.1016/S0002-9378(96)70445-3
   Papadimitriou L, 2001, EUR J ANAESTH, V18, P615, DOI 10.1046/j.1365-2346.2001.00894.x
   Parlow JL, 1999, CAN J ANAESTH, V46, P719, DOI 10.1007/BF03013905
   PHILLIS JW, 1980, BRAIN RES, V195, P494, DOI 10.1016/0006-8993(80)90087-6
   RAMSAY TM, 1994, CAN J ANAESTH, V41, P798, DOI 10.1007/BF03011586
   RAPHAEL JH, 1993, BRIT J ANAESTH, V71, P845, DOI 10.1093/bja/71.6.845
   REVES JG, 1985, ANESTHESIOLOGY, V62, P310, DOI 10.1097/00000542-198503000-00017
   SPLINTER W, 1994, CAN J OPHTHALMOL, V29, P224
   SPLINTER WM, 1995, CAN J ANAESTH, V42, P201, DOI 10.1007/BF03010676
   TAKADA K, 1993, BRIT J ANAESTH, V70, P181, DOI 10.1093/bja/70.2.181
   Wang JJ, 2000, BRIT J ANAESTH, V84, P459
   WATCHA MF, 1992, ANESTHESIOLOGY, V77, P162, DOI 10.1097/00000542-199207000-00023
   WHITE PF, 1993, ANESTHESIOLOGY, V78, P2, DOI 10.1097/00000542-199301000-00002
NR 21
TC 4
Z9 5
U1 1
U2 9
PU ELSEVIER
PI BRIDGEWATER
PA 685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA
SN 0149-2918
EI 1879-114X
J9 CLIN THER
JI Clin. Ther.
PD AUG
PY 2010
VL 32
IS 9
BP 1633
EP 1637
DI 10.1016/j.clinthera.2010.08.005
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 648JH
UT WOS:000281688800006
PM 20974320
DA 2018-12-27
ER

PT J
AU Bostrom, P
   Andersson, L
   Vind, B
   Haversen, L
   Rutberg, M
   Wickstrom, Y
   Larsson, E
   Jansson, PA
   Svensson, MK
   Branemark, R
   Ling, C
   Beck-Nielsen, H
   Boren, J
   Hojlund, K
   Olofsson, SO
AF Bostrom, Pontus
   Andersson, Linda
   Vind, Birgitte
   Haversen, Liliana
   Rutberg, Mikael
   Wickstrom, Ylva
   Larsson, Erik
   Jansson, Per-Anders
   Svensson, Maria K.
   Branemark, Richard
   Ling, Charlotte
   Beck-Nielsen, Henning
   Boren, Jan
   Hojlund, Kurt
   Olofsson, Sven-Olof
TI RETRACTED: The SNARE Protein SNAP23 and the SNARE-Interacting Protein
   Munc18c in Human Skeletal Muscle Are Implicated in Insulin
   Resistance/Type 2 Diabetes(Retracted article. See vol. 66, pg.1426,
   2017)
SO DIABETES
LA English
DT Article; Retracted Publication
ID LIPID DROPLETS; GLUT4 TRANSLOCATION; 3T3-L1 ADIPOCYTES; TRAFFICKING;
   SENSITIVITY; SYNTAXIN-4; GLYCOGEN; OBESITY; FUSION; MICE
AB OBJECTIVE-Our previous studies suggest that the SNARE protein synaptosomal-associated protein of 23 kDa (SNAP23) is involved in the link between increased lipid levels and insulin resistance in cardiomyocytes. The objective was to determine whether SNAP23 may also be involved in the known association between lipid accumulation in skeletal muscle and insulin resistance/type 2 diabetes in humans, as well as to identify a potential regulator of SNAP23.
   RESEARCH DESIGN AND METHODS-We analyzed skeletal muscle biopsies from patients with type 2 diabetes and healthy, insulin-sensitive control subjects for expression (mRNA and protein) and intracellular localization (subcellular fractionation and immunohistochemistry) of SNAP23, and for expression of proteins known to interact with SNARE proteins. Insulin resistance was determined by a euglycemic hyperinsulinemic clamp Potential mechanisms for regulation of SNAP23 were also investigated in the skeletal muscle cell line L6.
   RESULTS-We showed increased SNAP23 levels in skeletal muscle from patients with type 2 diabetes compared with that from lean control subjects Moreover, SNAP23 was redistributed from the plasma membrane to the microsomal/cytosolic compartment in the patients with the type 2 diabetes Expression of the SNARE-interacting protein Munc18c was higher in skeletal muscle from patients with type 2 diabetes Studies in L6 cells showed that Munc18c promoted the expression of SNAP23.
   CONCLUSIONS-We have translated our previous in vitro results into humans by showing that there is a change in the distribution of SNAP23 to the interior of the cell in skeletal muscle from patients with type 2 diabetes. We also showed that Munc18c is a potential regulator of SNAP23. Diabetes 59: 1870-1878, 2010
C1 [Bostrom, Pontus; Andersson, Linda; Haversen, Liliana; Rutberg, Mikael; Wickstrom, Ylva; Larsson, Erik; Jansson, Per-Anders; Svensson, Maria K.; Boren, Jan; Olofsson, Sven-Olof] Sahlgrens Univ Hosp, Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, Gothenburg, Sweden.
   [Vind, Birgitte; Beck-Nielsen, Henning; Hojlund, Kurt] Odense Univ Hosp, Diabet Res Ctr, Dept Endocrinol, DK-5000 Odense, Denmark.
   [Branemark, Richard] Sahlgrens Univ Hosp, Dept Orthoped Surg, Gothenburg, Sweden.
   [Ling, Charlotte] Lund Univ, Dept Clin Sci CRC, Malmo Univ Hosp, S-22100 Lund, Sweden.
RP Olofsson, SO (reprint author), Sahlgrens Univ Hosp, Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, Gothenburg, Sweden.
RI Ling, Charlotte/Q-2432-2015
OI Ling, Charlotte/0000-0003-0587-7154
FU Swedish Research Council; Swedish Foundation for Strategic Research;
   Swedish Heart and Lung Foundation; NovoNordic Foundation; Swedish
   Diabetes Association; Soderberg foundation; EU; Swedish Department of
   Higher Education
FX This work was supported by grants from the Swedish Research Council, the
   Swedish Foundation for Strategic Research, the Swedish Heart and Lung
   Foundation, the NovoNordic Foundation, the Swedish Diabetes Association,
   the Soderberg foundation, and the EU projects NACARDIO and LipidomicNet.
   The group of Swedish twins was recruited from The Swedish Twin Registry,
   which is supported by grants from the Swedish Department of Higher
   Education and the Swedish Research Council. No other potential conflicts
   of interest relevant to this article were reported.
CR Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941
   Aran V, 2009, BIOCHEM J, V419, P655, DOI 10.1042/BJ20082293
   Bergman BC, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-21
   Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648
   Brandie FM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004074
   Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200
   Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200
   Buxton P, 2003, BIOCHEM J, V375, P433, DOI 10.1042/BJ20030427
   Coen PM, 2010, DIABETES, V59, P80, DOI 10.2337/db09-0988
   D'Andrea-Merrins M, 2007, J BIOL CHEM, V282, P16553, DOI 10.1074/jbc.M610818200
   Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584
   Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628
   Foster LJ, 1999, AM J PHYSIOL-CELL PH, V276, pC1108, DOI 10.1152/ajpcell.1999.276.5.C1108
   Hojlund K, 2006, DIABETOLOGIA, V49, P1283, DOI 10.1007/s00125-006-0240-5
   Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681
   Kawanishi M, 2000, J BIOL CHEM, V275, P8240, DOI 10.1074/jbc.275.11.8240
   Kraegen EW, 2008, CURR OPIN LIPIDOL, V19, P235, DOI 10.1097/01.mol.0000319118.44995.9a
   Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x
   Levin K, 2001, DIABETOLOGIA, V44, P824
   Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912
   Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1
   Olofsson SO, 2008, CURR OPIN LIPIDOL, V19, P441, DOI 10.1097/MOL.0b013e32830dd09b
   Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001
   Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009
   Schlaepfer IR, 2003, J LIPID RES, V44, P1174, DOI 10.1194/jlr.M300003-JLR200
   Spurlin BA, 2003, DIABETES, V52, P1910, DOI 10.2337/diabetes.52.8.1910
   Szendroedi J, 2009, CURR OPIN LIPIDOL, V20, P50, DOI 10.1097/MOL.0b013e328321b3a8
   Tamori Y, 1998, J BIOL CHEM, V273, P19740, DOI 10.1074/jbc.273.31.19740
   Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876
   Veit M, 1996, BIOCHEM J, V318, P163, DOI 10.1042/bj3180163
   Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007
NR 31
TC 22
Z9 24
U1 2
U2 8
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD AUG
PY 2010
VL 59
IS 8
BP 1870
EP 1878
DI 10.2337/db09-1503
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 636PA
UT WOS:000280749100005
PM 20460426
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Du, WQ
   Ji, HZ
   Cao, SS
   Wang, L
   Bai, FH
   Liu, J
   Fan, DM
AF Du, Wenqi
   Ji, Hongzan
   Cao, Shanshan
   Wang, Li
   Bai, Feihu
   Liu, Jie
   Fan, Daiming
TI RETRACTED: EpCAM: A Potential Antimetastatic Target for Gastric Cancer
   (Retracted article. See vol. 58, pg. 1811, 2013)
SO DIGESTIVE DISEASES AND SCIENCES
LA English
DT Article; Retracted Publication
DE EpCAM (epithelial cellular adhesion molecule); Gastric cancer;
   Metastasis; Small interfering RNA (siRNA)
ID JUNCTION PROTEIN CLAUDIN-7; CELL ADHESION MOLECULE; MONOCLONAL-ANTIBODY;
   COLON-CANCER; IN-SITU; EP-CAM; EXPRESSION; METASTASIS; INVASION;
   CARCINOMA
AB Epithelial cellular adhesion molecule (EpCAM) is an attractive immunotherapeutic target to overcome metastasis of a variety of epithelium-oriented cancers. Edrecolomab, one kind of EpCAM monoclonal antibody (Panorex(A (R))), has been approved for clinical application as postoperative adjuvant therapy in breast and colorectal cancer. However, the role of EpCAM in gastric cancer metastasis remains unclear.
   EpCAM was found to be more highly overexpressed in metastatic gastric cancer than in nonmetastatic samples by immunohistochemistry staining. The expression level of EpCAM in gastric cancer cell lines was determined by reverse-transcription polymerase chain reaction (RT-PCR) and Western blotting, respectively. Downregulation of EpCAM by small interfering RNA (siRNA) significantly suppressed in vitro adhesive, invasive, and migratory and in vivo metastatic abilities of gastric cancer cells.
   We provide first evidence that EpCAM contributes to the migration of gastric cancer, suggesting that EpCAM-targeted therapy might be a promising strategy in metastatic gastric cancer.
C1 [Du, Wenqi; Cao, Shanshan; Wang, Li; Bai, Feihu; Liu, Jie; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian 710032, Shaanxi Prov, Peoples R China.
   [Ji, Hongzan] Nanjing Mil Command, PLA, Nanjing Gen Hosp, Dept Digest Dis, Nanjing 210002, Jiangsu Prov, Peoples R China.
   [Liu, Jie] Fudan Univ, Huashan Hosp, Dept Digest Dis, Shanghai 200040, Peoples R China.
RP Liu, J (reprint author), Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, 15 Changle Western Rd, Xian 710032, Shaanxi Prov, Peoples R China.
EM dwq0307@fmmu.edu.cn; Jieliu@fmmu.edu.cn; fandaim@fmmu.edu.cn
FU National Natural Science Foundation of China [30670969]
FX This work was supported by grants from the National Natural Science
   Foundation of China (No. 30670969).
CR Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494
   Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038
   Calabrese G, 2001, CYTOGENET CELL GENET, V92, P164, DOI 10.1159/000056891
   Chaudry MA, 2007, BRIT J CANCER, V96, P1013, DOI 10.1038/sj.bjc.6603505
   Chen JL, 2003, WORLD J GASTROENTERO, V9, P1607, DOI 10.3748/wjg.v9.i7.1607
   Gulubova MV, 2002, HISTOCHEM J, V34, P67
   Hippo Y, 2001, CANCER RES, V61, P889
   Hsieh HF, 1999, J CLIN PATHOL-MOL PA, V52, P25, DOI 10.1136/mp.52.1.25
   Huntsman DG, 2001, NEW ENGL J MED, V344, P1904, DOI 10.1056/NEJM200106213442504
   Ito R, 2003, VIRCHOWS ARCH, V442, P118, DOI 10.1007/s00428-002-0718-6
   Jin HF, 2007, MOL CANCER RES, V5, P423, DOI 10.1158/1541-7786.MCR-06-0407
   Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199
   Ladwein M, 2005, EXP CELL RES, V309, P345, DOI 10.1016/j.yexcr.2005.06.013
   Liu N, 2004, CLIN CANCER RES, V10, P6239, DOI 10.1158/1078-0432.CCR-04-0242
   Pan YL, 2006, FASEB J, V20, P1886, DOI 10.1096/fj.06-6138fje
   Polverini PJ, 1996, AM J PATHOL, V148, P1023
   Punt CJA, 2002, LANCET, V360, P671, DOI 10.1016/S0140-6736(02)09836-7
   RIETHMULLER G, 1994, LANCET, V343, P1177, DOI 10.1016/S0140-6736(94)92398-1
   Schmidt DS, 2004, EXP CELL RES, V297, P329, DOI 10.1016/j.yexcr.2004.02.023
   Thamilselvan V, 2004, GASTROENTEROLOGY, V126, P8, DOI 10.1053/j.gastro.2003.10.078
   VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M
   Winter MJ, 2003, EXP CELL RES, V285, P50, DOI 10.1016/S0014-4827(02)00045-9
   Xie X, 2005, WORLD J GASTROENTERO, V11, P344, DOI 10.3748/wjg.v11.i3.344
NR 23
TC 14
Z9 18
U1 3
U2 17
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0163-2116
EI 1573-2568
J9 DIGEST DIS SCI
JI Dig. Dis. Sci.
PD AUG
PY 2010
VL 55
IS 8
BP 2165
EP 2171
DI 10.1007/s10620-009-1033-8
PG 7
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 617PV
UT WOS:000279294200007
PM 19941073
DA 2018-12-27
ER

PT J
AU Cuoghi, OA
   Sella, RC
   de Mendonca, MR
AF Cuoghi, Osmar Aparecido
   Sella, Rodrigo Castellazzi
   de Mendonca, Marcos Rogerio
TI RETRACTED: Mesiodistal angulations of the mandibular canines, premolars
   and molars with or without the presence of third molars (Retracted
   article. See vol. 38, pg. 225, 2016)
SO EUROPEAN JOURNAL OF ORTHODONTICS
LA English
DT Article; Retracted Publication
ID 3RD MOLAR; PANORAMIC RADIOGRAPHS; SYSTEM; ARCH
AB The results show that, in both groups, the mandibular premolars and molars had enhanced angulation in the mesial direction, when compared with a control group of 42 Caucasians ranging in age from 12 to 17 years with a 'normal' occlusion (P < 0.05), while the mesiodistal axial angulation of the mandibular canines was similar to the control group (P < 0.05). The two groups, when compared, exhibited similar angular values for the canines, premolars and mandibular molars (P < 0.05), indicating no influence of the third molars.
C1 [Cuoghi, Osmar Aparecido; Sella, Rodrigo Castellazzi; de Mendonca, Marcos Rogerio] Sao Paulo State Univ, UNESP, Sch Dent, Dept Pediat & Social Dent,Discipline Orthodont, Sao Paulo, Brazil.
RP Cuoghi, OA (reprint author), Rua Jose Bonifacio 1193, BR-16015050 Aracatuba, SP, Brazil.
EM osmar@foa.unesp.br
CR ADES AG, 1990, AM J ORTHOD DENTOFAC, V97, P323, DOI 10.1016/0889-5406(90)70105-L
   Akcam MO, 2003, AM J ORTHOD DENTOFAC, V123, P175, DOI 10.1067/mod.2003.3
   Andrews L F, 1976, J Clin Orthod, V10, P174
   Andrews L F, 1976, J Clin Orthod, V10, P99
   ANDREWS LF, 1976, DENT CLIN N AM, V20, P671
   Artun J, 2005, EUR J ORTHODONT, V27, P590, DOI 10.1093/ejo/cji049
   BERGSTROM K, 1961, SVENSK TANDLAK TSKR, V54, P111
   Dahlberg G., 1940, STAT METHODS MED BIO
   de Almeida-Pedrin RR, 2006, AM J ORTHOD DENTOFAC, V130, P56, DOI 10.1016/j.ajodo.2006.03.001
   DEMIRJIAN A, 1973, HUM BIOL, V45, P211
   DEWEL BF, 1949, AM J ORTHOD DENTOFAC, V35, P98, DOI 10.1016/0002-9416(49)90111-6
   Frykholm A, 1977, Dentomaxillofac Radiol, V6, P77
   GRABER TM, 1966, ANGLE ORTHOD, V36, P293
   Holdaway RA, 1952, ANGLE ORTHOD, V22, P227
   HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6
   Ishii N, 2002, EUR J ORTHODONT, V24, P493, DOI 10.1093/ejo/24.5.493
   Langland OE, 2002, PRINCIPLES DENT IMAG
   Liu Y T, 1991, Br J Orthod, V18, P21
   OPPENHEIM A, 1911, T EUROPEAN ORTHODONS, P303
   PHILIPP RG, 1978, ANGLE ORTHOD, V48, P317
   PHILLIPS JE, 1967, ORAL SURG ORAL MED O, V24, P41, DOI 10.1016/0030-4220(67)90287-3
   Richardson M E, 1979, Eur J Orthod, V1, P219
   RICHARDSON ME, 1989, AM J ORTHOD DENTOFAC, V95, P79, DOI 10.1016/0889-5406(89)90139-X
   Roth R H, 1987, J Clin Orthod, V21, P632
   Roth R H, 1981, J Clin Orthod, V15, P174
   Samawi S S, 1984, Br J Orthod, V11, P100
   Sandler P J, 1988, Br J Orthod, V15, P105
   Stramotas S, 2002, EUR J ORTHODONT, V24, P43, DOI 10.1093/ejo/24.1.43
   Swessi D M, 1993, Eur J Orthod, V15, P503
   TAVANO O, 1989, ODONT MOD, V16, P22
   Ursi W J, 1990, J Clin Orthod, V24, P166
   Vego L., 1962, ANGLE ORTHOD, V32, P187, DOI DOI 10.1043/0003-3219(1962)032<0187:ALSOMA>2.0.CO;2
   WEINSTEIN S, 1971, J AM DENT ASSOC, V82, P819, DOI 10.14219/jada.archive.1971.0156
NR 33
TC 4
Z9 6
U1 2
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0141-5387
EI 1460-2210
J9 EUR J ORTHODONT
JI Eur. J. Orthodont.
PD AUG
PY 2010
VL 32
IS 4
BP 472
EP 476
DI 10.1093/ejo/cjp138
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 630JI
UT WOS:000280268800019
PM 20133513
OA Bronze
DA 2018-12-27
ER

PT J
AU Samrot, AV
   Senthilkumar, P
   Pavankumar, K
   Akilandeswari, GC
   Rajalakshmi, N
   Dhathathreyan, KS
AF Samrot, Antony V.
   Senthilkumar, P.
   Pavankumar, K.
   Akilandeswari, G. C.
   Rajalakshmi, N.
   Dhathathreyan, K. S.
TI RETRACTED: Electricity generation by Enterobacter cloacae SU-1 in
   mediator less microbial fuel cell (Retracted article. See vol. 37, pg.
   728, 2012)
SO INTERNATIONAL JOURNAL OF HYDROGEN ENERGY
LA English
DT Article; Retracted Publication
DE Fuel cells; Microbial fuel cells; Mediator less; Enterobacter cloacae
ID ELECTRON-TRANSFER; CATHODE; POWER
AB We have investigated a Enterobacter cloacae SU-1, bacteria for mediator less microbial fuel cell with different carbon sources and is found to be more effective as the microorganism is able to transfer electrons directly (exo-electrogenic organism) via the cytochromes or the ubiquinone. These carriers of electrons are in form of stable reversible redox couples, not biologically degraded and not toxic to cell. The major advantage of mediator less microbial fuel cells emphasize that additives in the anolyte is not compatible with the purpose of water purification. The anode chamber with the bacteria is maintained under anaerobic conditions so that the bacteria will undergo anaerobic biochemical pathways like Glycolysis, TCA cycle, Electron Transport Chain (ETC) where electrons and protons are released. Here protons are released in TCA cycle and whereas electrons are released from ETC. The mediator less microbial fuel cell delivered an open circuit potential (OCP) of 0.93 V and power of 3 mW/sq cm. During power generation from the microbes, there was a drop in coulombic efficiency in terms of fluctuations during drawing power, as the carbon source is being utilized for the cell growth. (C) 2010 Professor T. Nejat Veziroglu. Published by Elsevier Ltd. All rights reserved.
C1 [Rajalakshmi, N.; Dhathathreyan, K. S.] Ctr Fuel Cell Technol ARCI, Chennai 600113, Tamil Nadu, India.
   [Samrot, Antony V.; Senthilkumar, P.; Pavankumar, K.; Akilandeswari, G. C.] Sathyabama Univ, Dept Biotechnol, Madras, Tamil Nadu, India.
RP Rajalakshmi, N (reprint author), Ctr Fuel Cell Technol ARCI, IITM Res Pk,Phase 1,2nd Floor,6 Kanagam Rd, Chennai 600113, Tamil Nadu, India.
EM lakshmiraja2003@yahoo.com
RI Hyderabad, ARCI/F-8552-2013
OI Dhathathreyan, K.S./0000-0002-6595-5962; P,
   Senthilkumar/0000-0002-1839-8809; Natarajan,
   Rajalakshmi/0000-0001-7926-8111
FU Department of Science and Technology, Govt of India
FX The authors would like to acknowledge Dr. G. Sundararajan, Director
   ARCI, for his constant support and encouragement and Department of
   Science and Technology, Govt of India for financial support.
CR Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003
   Chaudhuri SK, 2003, NAT BIOTECHNOL, V21, P1229, DOI 10.1038/nbt867
   DAVID KD, 2009, INT J HYDROGEN ENERG, V34, P7555
   DELANEY GM, 1984, J CHEM TECH BIOT B, V34, P13
   Gil GC, 2003, BIOSENS BIOELECTRON, V18, P327, DOI 10.1016/S0956-5663(02)00110-0
   HABERMANN W, 1991, APPL MICROBIOL BIOT, V35, P128
   He Z, 2006, ENVIRON SCI TECHNOL, V40, P5212, DOI 10.1021/es060394f
   Holzman DC, 2005, ENVIRON HEALTH PERSP, V113, pA754, DOI 10.1289/ehp.113-a754
   Kim BH, 2004, APPL MICROBIOL BIOT, V63, P672, DOI 10.1007/s00253-003-1412-6
   Liu H, 2004, ENVIRON SCI TECHNOL, V38, P2281, DOI 10.1021/es034923g
   Liu H, 2004, ENVIRON SCI TECHNOL, V38, P4040, DOI 10.1021/es0499344
   Mohan Y, 2008, INT J HYDROGEN ENERG, V33, P423, DOI 10.1016/j.ijhydene.2007.07.027
   Park DH, 2003, BIOTECHNOL BIOENG, V81, P348, DOI 10.1002/bit.10501
   PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x
   Rabaey K, 2004, APPL ENVIRON MICROB, V70, P5373, DOI 10.1128/AEM.70.9.5373-5382.2004
   Rabaey K, 2006, ENVIRON SCI TECHNOL, V40, P5218, DOI 10.1021/es060382u
   Schaetzle O, 2008, ENERG ENVIRON SCI, V1, P607, DOI 10.1039/b810642h
   SHARMA VN, 2009, J BIOCH TECH, V1, P4
   Tender LM, 2002, NAT BIOTECHNOL, V20, P821, DOI 10.1038/nbt716
   Wang C. -T., 2010, INT J HYDROGEN ENERG, V36, P1
   WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/jb.173.2.697-703.1991
   Willner I, 1998, J CHEM SOC PERK T 2, P1817, DOI 10.1039/a801487f
   YAMA M, 2009, INT J HYDROGEN ENERG, V34, P7542
   Yi HN, 2009, BIOSENS BIOELECTRON, V24, P3498, DOI 10.1016/j.bios.2009.05.004
   YOGESH S, 2010, INT J HYDROGEN ENERG, V35, P3789
   Zou YJ, 2008, INT J HYDROGEN ENERG, V33, P4856, DOI 10.1016/j.ijhydene.2008.06.061
NR 26
TC 27
Z9 28
U1 2
U2 28
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3199
EI 1879-3487
J9 INT J HYDROGEN ENERG
JI Int. J. Hydrog. Energy
PD AUG
PY 2010
VL 35
IS 15
SI SI
BP 7723
EP 7729
DI 10.1016/j.ijhydene.2010.05.047
PG 7
WC Chemistry, Physical; Electrochemistry; Energy & Fuels
SC Chemistry; Electrochemistry; Energy & Fuels
GA 644NH
UT WOS:000281383900008
DA 2018-12-27
ER

PT J
AU Wang, SD
   Zhou, YW
   Wang, JP
AF Wang, Sheng-Dong
   Zhou, Yong-Wu
   Wang, Jun-Ping
TI RETRACTED: Coordinating ordering, pricing and advertising policies for a
   supply chain with random demand and two production modes (Retracted
   article. See vol. 133, pg. 776, 2011)
SO INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS
LA English
DT Article; Retracted Publication
DE Supply chain management; Random demand; Advertising expenditure; Two
   production modes; Return policy; Sales rebate/penalty policy
ID QUANTITY DECISIONS; INVENTORY; MANUFACTURER; CHANNEL; RETAILER; GOODS;
   TIME; OPPORTUNITIES; STRATEGIES; CONTRACT
AB This paper discusses production and order as well as advertising coordination issues for a single-manufacturer single-buyer supply chain. In the two-echelon system, the manufacturer sells a newsvendor-type product through the buyer who faces a random demand depending on advertising expenditure and selling price. Before the start of the selling period, the buyer needs to determine how much she should invest in advertising, how many units of products she should order from the manufacturer and at what price she should sell the ordered products. At the end of the selling period, when the revealed demand exceeds stock on hand, all the superfluous demand is met by a second order from the manufacturer, if unfilled customers are offered a discount in selling price. Based on the buyer's first order, the manufacturer needs to select his initial production quantity under a relatively cheap but long lead-time production mode, and responds to the buyer's second order with an expensive but quick-response production mode (if necessary). Under both the centralized and decentralized setting, we formulate mathematical models of how two members make their decisions, respectively, and provide the closed-form solution to each model. In order to achieve perfect coordination of the supply chain, we propose an improved sales rebate contract, which can arbitrarily allocate the profit between two parties. Finally, we implement a numerical study to illustrate the models. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Wang, Sheng-Dong] Hefei Elect Engn Inst, Dept Math, Hefei 230037, Peoples R China.
   [Zhou, Yong-Wu] S China Univ Technol, Sch Business Adm, Guangzhou 510641, Peoples R China.
   [Wang, Sheng-Dong; Wang, Jun-Ping] Hefei Univ Technol, Sch Management, Hefei 230009, Peoples R China.
RP Wang, SD (reprint author), Hefei Elect Engn Inst, Dept Math, Hefei 230037, Peoples R China.
EM mswangsd@sina.com.cn; zyw_666@hotmail.com
FU National Natural Science Foundation of China [70771034, 70772029,
   70971041, 70631003]; National Excellent Doctoral Dissertation of PR
   China [200565]; Project for Social Science Study of Guangdong
   [08JDXM63003]
FX We thank the Editor and two anonymous referees for their kindness and
   constructive comments on the earlier version of this paper. This
   research was supported in part by National Natural Science Foundation of
   China under Grant nos. 70771034, 70772029, 70971041 and 70631003, a
   Foundation for the Author of National Excellent Doctoral Dissertation of
   PR China under Grant no. 200565, and Project for Social Science Study of
   Guangdong under Grant no. 08JDXM63003.
CR Agrawal V., 2000, Manufacturing & Service Operations Management, V2, P410, DOI 10.1287/msom.2.4.410.12339
   Arcelus FJ, 2008, OMEGA-INT J MANAGE S, V36, P808, DOI 10.1016/j.omega.2006.04.002
   CACHON G, 1999, CONTRACTING ASSURE S
   Cachon GP, 2003, HDB OPERATIONS RES M
   Chen HY, 2006, INT J PROD ECON, V103, P347, DOI 10.1016/j.ijpe.2005.09.002
   Choi TM, 2003, J OPER RES SOC, V54, P846, DOI 10.1057/palgrave.jors.2601584
   Donohue KL, 2000, MANAGE SCI, V46, P1397, DOI 10.1287/mnsc.46.11.1397.12088
   Emmons H, 1998, MANAGE SCI, V44, P276, DOI 10.1287/mnsc.44.2.276
   Eppen GD, 1997, OPER RES, V45, P805, DOI 10.1287/opre.45.6.805
   Eppen GD, 1997, MANAGE SCI, V43, P1469, DOI 10.1287/mnsc.43.11.1469
   Feinberg FM, 2001, MANAGE SCI, V47, P1476, DOI 10.1287/mnsc.47.11.1476.10246
   GERCHAK Y, 1987, COMPUT OPER RES, V14, P1, DOI 10.1016/0305-0548(87)90052-9
   GOYAL SK, 1995, COMPUT IND ENG, V28, P755, DOI 10.1016/0360-8352(95)00016-T
   Gurnani H, 1999, MANAGE SCI, V45, P1456, DOI 10.1287/mnsc.45.10.1456
   Iyer AV, 1997, MANAGE SCI, V43, P559, DOI 10.1287/mnsc.43.4.559
   Jorgensen S, 2003, J ECON DYN CONTROL, V27, P801, DOI 10.1016/S0165-1889(01)00072-0
   Jorgensen S, 1999, J OPTIMIZ THEORY APP, V102, P111, DOI 10.1023/A:1021894529093
   Khouja M, 2003, INT J PROD ECON, V86, P93, DOI 10.1016/S0925-5273(03)00008-2
   Khouja M, 1999, OMEGA-INT J MANAGE S, V27, P537, DOI 10.1016/S0305-0483(99)00017-1
   Khouja MJ, 2000, INT J PROD ECON, V65, P201, DOI 10.1016/S0925-5273(99)00027-4
   Lau AHL, 1998, INT J PROD ECON, V55, P57, DOI 10.1016/S0925-5273(98)00040-1
   LAU AHL, 1988, IIE TRANS, V20, P168, DOI 10.1080/07408178808966166
   Lau HS, 1997, EUR J OPER RES, V103, P557, DOI 10.1016/S0377-2217(96)00117-8
   Lee CH, 2007, INT J PROD ECON, V106, P307, DOI 10.1016/j.ijpe.2006.06.019
   Li SJ, 2009, INT J PROD ECON, V120, P88, DOI 10.1016/j.ijpe.2008.07.015
   Luo WH, 1998, COMPUT IND ENG, V34, P685, DOI 10.1016/S0360-8352(97)00327-6
   Mantrala M, 2002, HDB MARKETING, P409
   Petruzzi NC, 1999, OPER RES, V47, P183, DOI 10.1287/opre.47.2.183
   POLATOGLU LH, 1991, INT J PROD ECON, V23, P175, DOI 10.1016/0925-5273(91)90060-7
   Szmerekovsky JG, 2009, EUR J OPER RES, V192, P904, DOI 10.1016/j.ejor.2007.10.005
   Taylor TA, 2002, MANAGE SCI, V48, P992, DOI 10.1287/mnsc.48.8.992.168
   Webster S, 2008, INT J PROD ECON, V114, P476, DOI 10.1016/j.ijpe.2007.06.010
   Weng ZK, 2003, EUR J OPER RES, V151, P12, DOI 10.1016/S0377-2217(02)00577-5
   Weng ZK, 2004, EUR J OPER RES, V156, P148, DOI 10.1016/S0377-2217(03)00003-1
   Whitin T. M., 1955, MANAGE SCI, V2, P61
   Xie JX, 2009, EUR J OPER RES, V197, P785, DOI 10.1016/j.ejor.2008.07.014
   You PS, 2003, J OPER RES SOC, V54, P1093, DOI 10.1057/palgrave.jors.2601619
   Yue JF, 2006, EUR J OPER RES, V168, P65, DOI 10.1016/j.ejor.2004.05.005
   Zhou Y, 2007, APPL MATH MODEL, V31, P1029, DOI 10.1016/j.apm.2006.02.011
   Zhou YW, 2009, EUR J OPER RES, V198, P958, DOI 10.1016/j.ejor.2008.10.026
NR 40
TC 12
Z9 15
U1 4
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-5273
J9 INT J PROD ECON
JI Int. J. Prod. Econ.
PD AUG
PY 2010
VL 126
IS 2
BP 168
EP 180
DI 10.1016/j.ijpe.2010.03.004
PG 13
WC Engineering, Industrial; Engineering, Manufacturing; Operations Research
   & Management Science
SC Engineering; Operations Research & Management Science
GA 629QI
UT WOS:000280214400003
DA 2018-12-27
ER

PT J
AU He, XL
   H'ng, SC
   Leong, DT
   Hutmacher, DW
   Melendez, AJ
AF He, Xiaoli
   H'ng, Shiau-Chen
   Leong, David T.
   Hutmacher, Dietmar W.
   Melendez, Alirio J.
TI RETRACTED: Sphingosine-1-Phosphate Mediates Proliferation Maintaining
   the Multipotency of Human Adult Bone Marrow and Adipose Tissue-derived
   Stem Cells (Retracted article. See vol. 3, pg. 382, 2011)
SO JOURNAL OF MOLECULAR CELL BIOLOGY
LA English
DT Article; Retracted Publication
DE bone-marrow and adipose tissue; sphingolipids; mesenchymal stem cells
ID UMBILICAL-CORD BLOOD; SPHINGOSINE 1-PHOSPHATE; LYSOPHOSPHOLIPIDS;
   THERAPIES
AB High renewal and maintenance of multipotency of human adult stem cells (hSCs), are a prerequisite for experimental analysis as well as for potential clinical usages. The most widely used strategy for hSC culture and proliferation is using serum. However, serum is poorly defined and has a considerable degree of inter-batch variation, which makes it difficult for large-scale mesenchymal stem cells (MSCs) expansion in homogeneous culture conditions. Moreover, it is often observed that cells grown in serum-containing media spontaneously differentiate into unknown and/or undesired phenotypes. Another way of maintaining hSC development is using cytokines and/or tissue-specific growth factors; this is a very expensive approach and can lead to early unwanted differentiation. In order to circumvent these issues, we investigated the role of sphingosine-1-phosphate (S1P), in the growth and multipotency maintenance of human bone marrow and adipose tissue-derived MSCs. We show that S1P induces growth, and in combination with reduced serum, or with the growth factors FGF and platelet-derived growth factor-AB, S1P has an enhancing effect on growth. We also show that the MSCs cultured in S1P-supplemented media are able to maintain their differentiation potential for at least as long as that for cells grown in the usual serum-containing media. This is shown by the ability of cells grown in S1P-containing media to be able to undergo osteogenic as well as adipogenic differentiation. This is of interest, since S1P is a relatively inexpensive natural product, which can be obtained in homogeneous high-purity batches: this will minimize costs and potentially reduce the unwanted side effects observed with serum. Taken together, S1P is able to induce proliferation while maintaining the multipotency of different human stem cells, suggesting a potential for S1P in developing serum-free or serum-reduced defined medium for adult stem cell cultures.
C1 [He, Xiaoli; H'ng, Shiau-Chen; Melendez, Alirio J.] Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117548, Singapore.
   [Leong, David T.; Hutmacher, Dietmar W.] Natl Univ Singapore, Div Bioengn, Fac Engn, Singapore 117548, Singapore.
   [Melendez, Alirio J.] Univ Glasgow, Div Immunol Infect & Inflammat, Fac Med, Glasgow Biomed Res Ctr, Glasgow G12 8TA, Lanark, Scotland.
RP Melendez, AJ (reprint author), Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117548, Singapore.
EM a.melendez-romero@clinmed.gla.ac.uk
OI Hutmacher, Dietmar Werner/0000-0001-5678-2134
FU National University of Singapore; University of Glasgow; Medical
   Research Council [G0700794]
FX X. H. was funded by a scholarship from the National University of
   Singapore Bioengineering Program. This study was supported by an
   Academic Research Grant from the National University of Singapore, and a
   start-up grant from the University of Glasgow. We are grateful to Dr.
   Michael Raghunath for his kind advice during the study. We thank A-K
   Fraser-Andrews for proofreading the manuscript.
CR Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001
   Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029
   Donati C, 2007, STEM CELLS, V25, P1713, DOI 10.1634/stemcells.2006-0725
   Harada J, 2004, J NEUROCHEM, V88, P1026, DOI 10.1046/j.1471-4159.2003.02219.x
   Hayashi O, 2008, CALCIFIED TISSUE INT, V82, P238, DOI 10.1007/s00223-008-9112-y
   Karliner JS, 2002, BBA-MOL CELL BIOL L, V1582, P216, DOI 10.1016/S1388-1981(02)00174-9
   Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Landeen LK, 2008, AM J PHYSIOL-HEART C, V294, pH736, DOI 10.1152/ajpheart.00316.2007
   Le Blanc K, 2006, CURR OPIN IMMUNOL, V18, P586, DOI 10.1016/j.coi.2006.07.004
   Leong DT, 2007, BIOMATERIALS, V28, P203, DOI 10.1016/j.biomaterials.2006.09.011
   Malek RL, 2001, J BIOL CHEM, V276, P5692, DOI 10.1074/jbc.M003964200
   Nincheri P, 2009, CELL MOL LIFE SCI, V66, P1741, DOI 10.1007/s00018-009-9181-8
   Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338
   Pebay A, 2007, PROSTAG OTH LIPID M, V84, P83, DOI 10.1016/j.prostaglandins.2007.08.004
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rodriguez AM, 2005, BIOCHIMIE, V87, P125, DOI 10.1016/j.biochi.2004.11.007
   Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589
   Schneidereit J, 2005, CELL COMMUN SIGNAL, V3, P5, DOI DOI 10.1186/1478-811X-3-5
   Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200
   Tsukada YT, 2007, J CARDIOVASC PHARM, V50, P660, DOI 10.1097/FJC.0b013e318157a5fe
   Vilquin JT, 2006, REGEN MED, V1, P589, DOI 10.2217/17460751.1.4.589
   Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 25
TC 25
Z9 26
U1 2
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1674-2788
EI 1759-4685
J9 J MOL CELL BIOL
JI J. Mol. Cell Biol.
PD AUG
PY 2010
VL 2
IS 4
BP 199
EP 208
DI 10.1093/jmcb/mjq011
PG 10
WC Cell Biology
SC Cell Biology
GA 709HC
UT WOS:000286428100007
PM 20584786
OA Bronze
DA 2018-12-27
ER

PT J
AU Avramova, YR
   Stapel, DA
   Lerouge, D
AF Avramova, Yana R.
   Stapel, Diederik A.
   Lerouge, Davy
TI RETRACTED: Mood and Context-Dependence: Positive Mood Increases and
   Negative Mood Decreases the Effects of Context on Perception (Retracted
   article. See vol. 103, pg. 488, 2012)
SO JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY
LA English
DT Article; Retracted Publication
DE mood; context dependence; perceptual context effects; target judgment
ID FACIAL EXPRESSIONS; SIZE CONTRAST; EMOTION; CATEGORIZATION; JUDGMENT;
   BEHAVIOR; FACE; ACCESSIBILITY; CONSEQUENCES; PERSUASION
AB Five studies show that mood affects context-dependence, such that negative mood promotes attention to a salient target. whereas positive mood enhances attention to both target and context Judgments of temperature (Study 1), weight (Study 2), and size (Studies 3 and 4) were more strongly affected by the context in a positive than in a negative mood Moreover, these effects extend to the social domain When perceiving a target person's emotions, happy people were more influenced by the context than were sad people (Study 5) Thus, positive mood enhanced, and negative mood reduced, the magnitude of perceptual context effects The results suggest that this pattern is not easily explained in terms of effort or depth of processing differences
C1 [Avramova, Yana R.; Stapel, Diederik A.; Lerouge, Davy] Tilburg Univ, Social Psychol Dept, TIBER, NL-5000 LE Tilburg, Netherlands.
RP Avramova, YR (reprint author), Tilburg Univ, Social Psychol Dept, TIBER, Warandelaan 2,POB 90153, NL-5000 LE Tilburg, Netherlands.
CR Aviezer H, 2008, PSYCHOL SCI, V19, P724, DOI 10.1111/j.1467-9280.2008.02148.x
   Avramova YR, 2008, J PERS SOC PSYCHOL, V95, P542, DOI 10.1037/a0012560
   Balcetis E, 2007, PSYCHOL SCI, V18, P917, DOI 10.1111/j.1467-9280.2007.02000.x
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
   Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003
   Biernat M., 2005, STANDARDS EXPECTANCI
   BLESS H, 1990, PERS SOC PSYCHOL B, V16, P331, DOI 10.1177/0146167290162013
   BROWN DR, 1953, AM J PSYCHOL, V66, P199, DOI 10.2307/1418726
   Bruner JS, 1948, J SOC PSYCHOL, V27, P203, DOI 10.1080/00224545.1948.9918925
   BRUNER JS, 1947, J ABNORM SOC PSYCH, V42, P33, DOI 10.1037/h0058484
   Carroll JM, 1996, J PERS SOC PSYCHOL, V70, P205, DOI 10.1037/0022-3514.70.2.205
   COREN S, 1993, PERCEPT PSYCHOPHYS, V54, P579, DOI 10.3758/BF03211782
   COREN S, 1978, SEEING IS DECEIVING
   Dijksterhuis A, 2001, J EXP SOC PSYCHOL, V37, P286, DOI 10.1006/jesp.2000.1449
   Duffy S, 2009, J EXP CHILD PSYCHOL, V102, P351, DOI 10.1016/j.jecp.2008.06.006
   Dunning D, 1999, PSYCHOL INQ, V10, P1, DOI 10.1207/s15327965pli1001_1
   Eiser J, 1990, SOCIAL JUDGMENT
   Ekman P, 1999, HDB COGNITION EMOTIO, P301, DOI DOI 10.1002/0470013494.CH16
   ERBER R, 1991, J EXP SOC PSYCHOL, V27, P480, DOI 10.1016/0022-1031(91)90005-Q
   FERNANDEZDOLS JM, 1997, PSYCHOL FACIAL EXPRE, P275
   Forgas Joseph, 2006, AFFECT SOCIAL THINKI
   Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238
   Fridlund A. J., 1994, HUMAN FACIAL EXPRESS
   FRIJDA NH, 1988, AM PSYCHOL, V43, P349, DOI 10.1037/0003-066X.43.5.349
   Gasper K, 2002, PSYCHOL SCI, V13, P34, DOI 10.1111/1467-9280.00406
   GOLDSTONE RL, 1995, PSYCHOL SCI, V6, P298, DOI 10.1111/j.1467-9280.1995.tb00514.x
   Helson H., 1964, ADAPTATION LEVEL THE
   HERR PM, 1986, J PERS SOC PSYCHOL, V51, P1106, DOI 10.1037//0022-3514.51.6.1106
   Hovland CI, 1961, SOCIAL JUDGEMENT ASS
   ISEN AM, 1984, J PERS SOC PSYCHOL, V47, P1206, DOI 10.1037//0022-3514.47.6.1206
   Kitayama S, 2003, PSYCHOL SCI, V14, P201, DOI 10.1111/1467-9280.02432
   MACKIE DM, 1989, J PERS SOC PSYCHOL, V57, P27, DOI 10.1037/0022-3514.57.1.27
   Martin L. L., 2001, THEORIES MOOD COGNIT
   Masuda T, 2008, J PERS SOC PSYCHOL, V94, P365, DOI 10.1037/0022-3514.94.3.365
   Muller D, 2005, J PERS SOC PSYCHOL, V89, P852, DOI 10.1037/0022-3514.89.6.852
   NIEDENTHAL PM, 1994, HEARTS EYE EMOTIONAL
   Nisbett R. E., 2003, GEOGRAPHY THOUGHT AS
   Parducci A., 1995, HAPPINESS PLEASURE J
   Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x
   Righart R, 2008, COGN AFFECT BEHAV NE, V8, P264, DOI 10.3758/CABN.8.3.264
   Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104
   RUSSELL JA, 1991, PSYCHOL BULL, V110, P426, DOI 10.1037/0033-2909.110.3.426
   SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513
   SCHWARZ N, 1992, CONSTRUCTION OF SOCIAL JUDGMENTS, P217
   SHULMAN GL, 1992, Q J EXP PSYCHOL-A, V45, P529, DOI 10.1080/14640749208401332
   Stapel DA, 2006, J PERS SOC PSYCHOL, V90, P258, DOI 10.1037/0022-3514.90.2.258
   Stapel DA, 2007, ASSIMILATION AND CONTRAST IN SOCIAL PSYCHOLOGY, P1
   Stapel DA, 1997, J PERS SOC PSYCHOL, V73, P1177, DOI 10.1037//0022-3514.73.6.1177
   Stapel DA, 2007, ASSIMILATION AND CONTRAST IN SOCIAL PSYCHOLOGY, P143
   Stapel DA, 2007, J PERS SOC PSYCHOL, V93, P23, DOI 10.1037/0022-3514.93.1.23
   Stefanucci JK, 2008, PERCEPTION, V37, P321, DOI 10.1068/p5796
   TANAKAMATSUMI J, 1995, MOTIV EMOTION, V19, P139, DOI 10.1007/BF02250567
   Tucker D. M., 1994, HEARTS EYE EMOTIONAL, P167, DOI [10.1016/B978-0-12-410560-7.50014-4, DOI 10.1016/B978-0-12-410560-7.50014-4]
   van Baaren RB, 2006, SOC COGNITION, V24, P426, DOI 10.1521/soco.2006.24.4.426
   Wedell DH, 2007, ASSIMILATION AND CONTRAST IN SOCIAL PSYCHOLOGY, P45
   WITKIN HA, 1977, PSYCHOL BULL, V84, P661, DOI 10.1037//0033-2909.84.4.661
   WITKIN HA, 1949, PSYCHOL MONOGR, V63, P46
NR 57
TC 14
Z9 16
U1 2
U2 20
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0022-3514
EI 1939-1315
J9 J PERS SOC PSYCHOL
JI J. Pers. Soc. Psychol.
PD AUG
PY 2010
VL 99
IS 2
BP 203
EP 214
DI 10.1037/a0020216
PG 12
WC Psychology, Social
SC Psychology
GA 631ZK
UT WOS:000280389200001
PM 20658839
DA 2018-12-27
ER

PT J
AU Li, J
AF Li, J.
TI RETRACTED: Effect of PA6 Content on the Mechanical and Tribological
   Properties of Blending PA6 with PP (Retracted article. See vol. 29, pg.
   3297, 2010)
SO JOURNAL OF REINFORCED PLASTICS AND COMPOSITES
LA English
DT Article; Retracted Publication
DE compositions; friction and wear; wear mechanisms
ID COMPATIBILIZING AGENT; CRYSTALLIZATION; POLYPROPYLENE; NANOCOMPOSITES;
   POLYAMIDE-6; BEHAVIOR
AB Blending polypropylene (PP) with recycled polyamide-6 (PA6) industrial wastes at different compositions was produced in a corotating twin-screw extruder, where PP acts as the polymer matrix and polyamide as the dispersed phase. The mechanical and tribological properties of these blends were investigated. Results show that with the increasing filler content, the flexural strength and compressive strength of composites increase to the maximum and then decreases. When the filler mass fraction reaches 15%, the flexural strength and compressive strength of samples reach the maximum. The wear rate and the friction coefficient of PP decreased with the addition of PA6. The friction coefficients of PA6/PP composites are lower than those of PP. The main wear mechanisms are the plastic deformation and mechanical microploughing.
C1 Shanghai Second Polytech Univ, Sch Mech & Elect Engn, Shanghai 201209, Peoples R China.
RP Li, J (reprint author), Shanghai Second Polytech Univ, Sch Mech & Elect Engn, Shanghai 201209, Peoples R China.
EM ben2008d@gmail.com
FU Shanghai Education Commission [egd08003]
FX The authors would like to thank Shanghai Education Commission (Project
   No.egd08003) for their help.
CR Adem E, 2005, NUCL INSTRUM METH B, V236, P295, DOI 10.1016/j.nimb.2005.03.260
   Chow WS, 2003, POLYMER, V44, P7427, DOI 10.1016/j.polymer.2003.09.006
   Chow WS, 2005, EUR POLYM J, V41, P687, DOI 10.1016/j.eurpolymj.2004.10.041
   Fu SY, 2005, COMPOS B, V37, P182
   Meng H, 2008, POLYMER, V49, P610, DOI 10.1016/j.polymer.2007.12.001
   Menyhard A, 2006, EUR POLYM J, V42, P3257, DOI 10.1016/j.eurpolymj.2006.09.003
   Roeder J, 2002, POLYM TEST, V21, P815, DOI 10.1016/S0142-9418(02)00016-8
   Yang ZG, 2008, EUR POLYM J, V44, P3754, DOI 10.1016/j.eurpolymj.2008.08.010
NR 8
TC 1
Z9 1
U1 3
U2 16
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0731-6844
EI 1530-7964
J9 J REINF PLAST COMP
JI J. Reinf. Plast. Compos.
PD AUG
PY 2010
VL 29
IS 16
BP 2413
EP 2421
DI 10.1177/0731684409352257
PG 9
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA 638WN
UT WOS:000280929000003
DA 2018-12-27
ER

PT J
AU Ozaki, H
   Miyachi, M
   Nakajima, T
   Abe, T
AF Ozaki, Hayao
   Miyachi, Motohiko
   Nakajima, Toshiaki
   Abe, Takashi
TI RETRACTED: MUSCLE VOLUME AND STRENGTH AND ARTERIAL COMPLIANCE AFTER WALK
   TRAINING WITH BLOOD FLOW REDUCTION IN ELDERLY WOMEN (Retracted article.
   See vol. 59, pg. 380, 2011)
SO JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
LA English
DT Letter; Retracted Publication
ID RESISTANCE EXERCISE; PROTEIN-SYNTHESIS; RESTRICTION
C1 [Ozaki, Hayao; Abe, Takashi] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan.
   [Miyachi, Motohiko] Natl Inst Hlth & Nutr, Tokyo 162, Japan.
   [Nakajima, Toshiaki] Univ Tokyo, Grad Sch Med, Tokyo, Japan.
RP Ozaki, H (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan.
OI Miyachi, Motohiko/0000-0002-1146-0905
CR Abe T, 2006, J APPL PHYSIOL, V100, P1460, DOI 10.1152/japplphysiol.01267.2005
   Abe T, 2010, J GERIATR PHYS THER, V33, P34, DOI 10.1097/JPT.0b013e3181d07a73
   Bogaard HJ, 1997, EUR J APPL PHYSIOL, V75, P435, DOI 10.1007/s004210050185
   Fry CS, 2010, J APPL PHYSIOL, V108, P1199, DOI 10.1152/japplphysiol.01266.2009
   Fujita S, 2007, J APPL PHYSIOL, V103, P903, DOI 10.1152/japplphysiol.00195.2007
   MACDOUGALL JD, 1985, J APPL PHYSIOL, V58, P785
   MATSUDA M, 1993, EUR J APPL PHYSIOL O, V66, P122, DOI 10.1007/BF01427052
   Miyachi M, 2004, CIRCULATION, V110, P2858, DOI 10.1161/01.CIR.0000146380.08401.99
   Sakamaki M, 2008, INT J KAATSU TRAININ, V4, P17, DOI DOI 10.3806/IJKTR.4.17
   Takarada Y, 2002, EUR J APPL PHYSIOL, V86, P308, DOI 10.1007/s00421-001-0561-5
NR 10
TC 2
Z9 2
U1 3
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-8614
EI 1532-5415
J9 J AM GERIATR SOC
JI J. Am. Geriatr. Soc.
PD AUG
PY 2010
VL 58
IS 8
BP 1597
EP 1598
DI 10.1111/j.1532-5415.2010.02989.x
PG 2
WC Geriatrics & Gerontology; Gerontology
SC Geriatrics & Gerontology
GA 635GN
UT WOS:000280643700028
PM 20942877
DA 2018-12-27
ER

PT J
AU Xie, S
   Hua, BZ
AF Xie, Sha
   Hua, Baozhen
TI RETRACTED: Sperm ultrastructure in two species of Panorpa and one
   Bittacus (Mecoptera) (Retracted article. See vol. 61, pg. 70, 2014)
SO MICRON
LA English
DT Review; Retracted Publication
DE Insecta; Mecoptera; Spermatozoa; Structure; Panorpidae; Bittacidae
ID GENUS; SIPHONAPTERA; INSECTS; BIOLOGY; CHINA
AB The sperm ultrastructure of the scorpionflies Panorpa liui and P. longihypovalva in Panorpidae and the hangingfly Bittacus planus in Bittacidae were investigated using transmission electron microscopy. The common features of the spermatozoa shared by all the mecopterans examined include a bilayered acrosome with a central perforatorium, an elongated homogeneously condensed nucleus, and a long flagellum with a 9 + 2 axoneme pattern and two mitochondrial derivatives. The two species of Panorpa possess a fossa at the posterior end of the nucleus, and differ from B. planus by lacking both the globular units running laterally from the head to the flagellum and the Golgi complex-derived membrane present in the flagellum. P. liui has pear-shaped mitochondrial derivatives and two small accessory bodies, while P. longihypovalva has elliptical mitochondrial derivatives and only one accessory body. The marked differences of the sperm structure among the Panorpa examined further confirm the paraphyly of this genus. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Hua, Baozhen] NW A&F Univ, Entomol Museum, Minist Educ, Key Lab Plant Protect Resources & Pest Management, Yangling 712100, Shaanxi, Peoples R China.
RP Hua, BZ (reprint author), NW A&F Univ, Entomol Museum, Minist Educ, Key Lab Plant Protect Resources & Pest Management, Yangling 712100, Shaanxi, Peoples R China.
EM shasha7728@163.com; huabzh@nwsuaf.edu.cn
FU National Natural Science Foundation of China [30670255, 30970386];
   Doctoral Program of Higher Education [20090204110004]
FX We thank Dr. Yankai Li for providing the spermatid light micrograph of
   P. liui. Our thanks are also due to Guoyun Zhang and Qingmei Han for
   their technical assistance in transmission electron microscopy
   observation. Special thanks are due to two anonymous reviewers for their
   helpful and valuable comments on the revision of our manuscript. This
   research was financially supported by the National Natural Science
   Foundation of China (grant nos. 30670255 and 309703863) and the Research
   Fund for the Doctoral Program of Higher Education (grant no.
   20090204110004).
CR ANDRE J, 1962, J Ultrastruct Res, VSuppl 3, P1
   Baccetti B., 1972, Advances Insect Physiol, V9, P315, DOI 10.1016/S0065-2806(08)60279-9
   BACCETTI B, 1969, J MICROSC-PARIS, V8, P233
   BACCETTI B, 1998, MICROSCOPIC ANATOM C, V11, P843
   BRELAND OP, 1966, CAN J GENET CYTOL, V8, P759, DOI 10.1139/g66-091
   BYERS G W, 1979, Journal of the Kansas Entomological Society, V52, P402
   BYERS GW, 1983, ANNU REV ENTOMOL, V28, P203, DOI 10.1146/annurev.en.28.010183.001223
   Cai LJ, 2008, ZOOTAXA, P43
   CHENG FUNG YING, 1949, PSYCHE, V56, P139, DOI 10.1155/1949/36572
   Dallai R, 2003, ZOOMORPHOLOGY, V122, P211, DOI 10.1007/s00435-003-0087-y
   GASSNER G, 1972, ANN ENTOMOL SOC AM, V65, P1302, DOI 10.1093/aesa/65.6.1302
   Hou Xiao-Yan, 2008, Acta Zootaxonomica Sinica, V33, P427
   Hua BZ, 2009, J NAT HIST, V43, P545, DOI 10.1080/00222930802610519
   Hua Baozheng, 1997, Entomotaxonomia, V19, P213
   Jamieson Barrie G., 1995, Memoires du Museum National d'Histoire Naturelle, V166, P1
   JAMIESON BGM, 1987, ULTRASTRUCTURE PHYLO, P205
   JAMIESON BGM, 1999, INSECTS THEIR SPERMA, P313
   KALTENBACH A., 1978, HDB ZOOLOGIE, V4, P1
   LAMBKIN K J, 1988, Memoirs of the Queensland Museum, V25, P439
   Ma N, 2009, SYST BIODIVERS, V7, P403, DOI 10.1017/S1477200009990107
   Misof B, 2000, MOL PHYLOGENET EVOL, V17, P76, DOI 10.1006/mpev.2000.0817
   PENNY N D, 1979, Acta Amazonica, V9, P365
   Tan JL, 2009, ZOOTAXA, P27
   Tan JL, 2009, J NAT HIST, V43, P2937, DOI 10.1080/00222930903359628
   Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x
   Willmann R., 1989, ABH SENCKENB NAT, V544, P1
NR 26
TC 9
Z9 9
U1 3
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD AUG
PY 2010
VL 41
IS 6
BP 622
EP 632
DI 10.1016/j.micron.2010.03.007
PG 11
WC Microscopy
SC Microscopy
GA 620UZ
UT WOS:000279527300013
PM 20399105
DA 2018-12-27
ER

PT J
AU Kannappan, R
   Ravindran, J
   Prasad, S
   Sung, BK
   Yadav, VR
   Reuter, S
   Chaturvedi, MM
   Aggarwal, BB
AF Kannappan, Ramaswamy
   Ravindran, Jayaraj
   Prasad, Sahdeo
   Sung, Bokyung
   Yadav, Vivek R.
   Reuter, Simone
   Chaturvedi, Madan M.
   Aggarwal, Bharat B.
TI RETRACTED: gamma-Tocotrienol Promotes TRAIL-Induced Apoptosis through
   Reactive Oxygen Species/Extracellular Signal-Regulated
   Kinase/p53-Mediated Upregulation of Death Receptors (Retracted article.
   See vol. 17, pg. 2072, 2018)
SO MOLECULAR CANCER THERAPEUTICS
LA English
DT Article; Retracted Publication
ID MAMMARY EPITHELIAL-CELLS; BREAST-CANCER CELLS; NATURAL VITAMIN-E;
   IN-VIVO; MEDIATED APOPTOSIS; MULTIPLE-MYELOMA; SGC-7901 CELLS; RICH
   FRACTION; C-FLIP; DR5
AB Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a member of the tumor necrosis factor superfamily, is in clinical trials for cancer therapy, but its anticancer potential is limited by the development of resistance. We investigated the ability of tocotrienol (T3), an unsaturated vitamin E present in palm oil, rice bran, barley, oats, and wheat germ, to sensitize tumor cells to TRAIL. Results from esterase staining, colony formation, caspase activation, and sub-G1 cell cycle arrest revealed that gamma-T3 can sensitize human colon cancer cells to TRAIL. When examined for the mechanism, we found that gamma-T3 significantly downregulated the expression of antiapoptotic proteins (c-IAP2 and Bcl-xL). We also found that gamma-T3, but not tocopherol, induced the expression of the TRAIL receptors death receptor (DR)-4 and DR5. This induction was not cell type specific, as upregulation was also found in pancreatic, kidney, and leukemic cells. Upregulation of DRs by gamma-T3 required the production of reactive oxygen species (ROS), and sequestering of ROS abolished both upregulation of the receptors and potentiation of TRAIL-induced apoptosis. Induction of DRs by gamma-T3 also required activation of extracellular signal-regulated kinase 1 (ERK1), as silencing of ERK1 by specific siRNA abrogated the upregulation of TRAIL receptors. Further, induction of DRs by gamma-T3 required the expression of p53 and Bax, as no induction of the receptors was found in colon cancer cells with deletion of these genes. Overall, our results show that gamma-T3 sensitizes tumor cells to TRAIL by upregulating DRs through the ROS/ERK/p53 pathway and by downregulating cell survival proteins. Mol Cancer Ther; 9(8); 2196-207. (C) 2010 AACR.
C1 [Kannappan, Ramaswamy; Ravindran, Jayaraj; Prasad, Sahdeo; Sung, Bokyung; Yadav, Vivek R.; Reuter, Simone; Chaturvedi, Madan M.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA.
RP Aggarwal, BB (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, 1515 Holcombe Blvd,Box 143, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI Aggarwal, Bharat/G-3388-2013
FU Malaysian Palm Oil Board (MPOB), Kuala Lumpur, Malaysia
FX The Malaysian Palm Oil Board (MPOB), Kuala Lumpur, Malaysia. B. B.
   Aggarwal is the Ransom Horne, Jr., Professor of Cancer Research.
CR Agarwal MK, 2004, CELL CYCLE, V3, P205
   Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184
   Ahmad NS, 2005, CLIN EXP PHARMACOL P, V32, P761, DOI 10.1111/j.1440-1681.2005.04264.x
   Ahn KS, 2007, J BIOL CHEM, V282, P809, DOI 10.1074/jbc.M610028200
   Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198
   Baritaki S, 2007, MOL CANCER THER, V6, P1387, DOI 10.1158/1535-7163.MCT-06-0521
   Chang PN, 2009, NUTR CANCER, V61, P357, DOI 10.1080/01635580802567166
   Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8
   Chen JJ, 2008, J IMMUNOL, V180, P8030, DOI 10.4049/jimmunol.180.12.8030
   Chin SF, 2008, NUTRITION, V24, P1, DOI 10.1016/j.nut.2007.08.006
   Comitato R, 2009, AM J PHYSIOL-ENDOC M, V297, pE427, DOI 10.1152/ajpendo.00187.2009
   Das S, 2005, AM J PHYSIOL-HEART C, V289, pH361, DOI 10.1152/ajpheart.01285.2004
   GOULD MN, 1991, AM J CLIN NUTR, V53, pS1068
   Hiura Y, 2009, J NUTR BIOCHEM, V20, P607, DOI 10.1016/j.jnutbio.2008.06.004
   Jiang JF, 2008, BIOCHEM BIOPH RES CO, V368, P145, DOI 10.1016/j.bbrc.2008.01.055
   Jung EM, 2005, CARCINOGENESIS, V26, P1905, DOI 10.1093/carcin/bgi167
   Kamat AM, 2009, CANCER RES, V69, P8958, DOI 10.1158/0008-5472.CAN-09-2045
   Kim H, 2006, CANCER RES, V66, P1740, DOI 10.1158/0008-5472.CAN-05-1568
   Kim YH, 2008, FREE RADICAL BIO MED, V44, P1055, DOI 10.1016/j.freeradbiomed.2007.12.001
   Kuhad A, 2009, PHARMACOL BIOCHEM BE, V92, P251, DOI 10.1016/j.pbb.2008.12.012
   Kumar SS, 2004, BBA-GEN SUBJECTS, V1672, P100, DOI 10.1016/j.bbagen.2004.03.002
   Nakagawa K, 2007, J NUTR, V137, P1938
   Ndozangue-Touriguine O, 2008, ONCOGENE, V27, P6012, DOI 10.1038/onc.2008.197
   Ohtsuka T, 2002, J BIOL CHEM, V277, P29294, DOI 10.1074/jbc.M203342200
   Pathak AK, 2007, MOL CANCER RES, V5, P943, DOI 10.1158/1541-7786.MCR-06-0348
   Perez LE, 2008, J IMMUNOL, V180, P1545, DOI 10.4049/jimmunol.180.3.1545
   QURESHI AA, 1991, AM J CLIN NUTR, V53, pS1021, DOI 10.1093/ajcn/53.4.1021S
   Qureshi AA, 1996, J NUTR, V126, P389
   Sakai M, 2004, ANTICANCER RES, V24, P1683
   Samant GV, 2006, CELL PROLIFERAT, V39, P563, DOI 10.1111/j.1365-2184.2006.00412.x
   Schaffer S, 2005, J NUTR, V135, P151
   Sen CK, 2004, ANN NY ACAD SCI, V1031, P127, DOI 10.1196/annals.1331.013
   Shah SJ, 2005, EXP BIOL MED, V230, P235
   Shenoy K, 2009, CANCER RES, V69, P1941, DOI 10.1158/0008-5472.CAN-08-1996
   Shetty S, 2005, MOL CELL BIOL, V25, P5404, DOI 10.1128/MCB25.135404-5416.2005
   Srivastava JK, 2006, BIOCHEM BIOPH RES CO, V346, P447, DOI 10.1016/j.bbrc.2006.05.147
   Sun WG, 2008, BRIT J NUTR, V99, P1247, DOI 10.1017/S0007114507879128
   Sun WG, 2009, J NUTR BIOCHEM, V20, P276, DOI 10.1016/j.jnutbio.2008.03.003
   Sylvester PW, 2005, J PLANT PHYSIOL, V162, P803, DOI 10.1016/j.jplph.2005.04.014
   Szliszka E, 2008, INT J MOL SCI, V9, P56, DOI 10.3390/ijms9010056
   Takahashi K, 2004, BIOCHEM PHARMACOL, V67, P315, DOI 10.1016/j.bcp.2003.07.015
   Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489
   Taniguchi H, 2008, CANCER RES, V68, P8918, DOI 10.1158/0008-5472.CAN-08-1120
   Tomasetti M, 2006, FEBS LETT, V580, P1925, DOI 10.1016/j.febslet.2006.02.054
   Wada S, 2005, CANCER LETT, V229, P181, DOI 10.1016/j.canlet.2005.06.036
   Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8
   Xu WL, 2009, NUTRITION, V25, P555, DOI 10.1016/j.nut.2008.10.019
   Yamada Y, 2008, J NUTR SCI VITAMINOL, V54, P117, DOI 10.3177/jnsv.54.117
   Yoshida T, 2007, CANCER SCI, V98, P1417, DOI 10.1111/j.1349-7006.2007.00559.x
   Yu WP, 2008, CANCER LETT, V259, P165, DOI 10.1016/j.canlet.2007.10.008
NR 50
TC 46
Z9 48
U1 0
U2 9
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1535-7163
EI 1538-8514
J9 MOL CANCER THER
JI Mol. Cancer Ther.
PD AUG
PY 2010
VL 9
IS 8
BP 2196
EP 2207
DI 10.1158/1535-7163.MCT-10-0277
PG 12
WC Oncology
SC Oncology
GA 636KU
UT WOS:000280734200005
PM 20682650
OA Bronze
DA 2018-12-27
ER

PT J
AU Sud, N
   Wiseman, DA
   Black, SM
AF Sud, Neetu
   Wiseman, Dean A.
   Black, Stephen M.
TI RETRACTED: Caveolin 1 Is Required for the Activation of Endothelial
   Nitric Oxide Synthase in Response to 17 beta-Estradiol (Retracted
   Article. See vol 25, pg 375, 2011)
SO MOLECULAR ENDOCRINOLOGY
LA English
DT Article; Retracted Publication
ID ESTROGEN-RECEPTOR-ALPHA; TYROSINE PHOSPHORYLATION; MEMBRANE SUPPORTS;
   PEPTIDE ARRAYS; NO SYNTHASE; BINDING; CELLS; DYSFUNCTION; MECHANISMS;
   EXPRESSION
AB Evidence suggests that estrogen mediates rapid endothelial nitric oxide synthase (eNOS) activation via estrogen receptor-a (ER alpha) within the plasma membrane of endothelial cells (EC). ER alpha is known to colocalize with caveolin 1, the major structural protein of caveolae, and caveolin 1 stimulates the translocation of ER alpha to the plasma membrane. However, the role played by caveolin 1 in regulating 17 beta-estradiol-mediated NO signaling in EC has not been adequately resolved. Thus, the purpose of this study was to explore how 17 beta-estradiol stimulates eNOS activity and the role of caveolin 1 in this process. Our data demonstrate that modulation of caveolin 1 expression using small interfering RNA or adenoviral gene delivery alters ER alpha localization to the plasma membrane in EC. Further, before estrogen stimulation ER alpha associates with caveolin 1, whereas stimulation promotes a pp60(Src)-mediated phosphorylation of caveolin 1 at tyrosine 14, increasing ER alpha-PI3 kinase interactions and disrupting caveolin 1-ER alpha interactions. Adenoviral mediated overexpression of a phosphorylation-deficient mutant of caveolin (Y14FCav) attenuated the ER alpha/PI3 kinase interaction and prevented Akt-mediated eNOS activation. Furthermore, Y14FCav overexpression reduced eNOS phosphorylation at serine1177 and decreased NO generation after estrogen exposure. Using a library of overlapping peptides we identified residues 62-73 of caveolin 1 as the ER alpha-binding site. Delivery of a synthetic peptide based on this sequence decreased ER alpha plasma membrane translocation and reduced estrogen-mediated activation of eNOS. In conclusion, caveolin 1 stimulates 17 beta-estradiol-induced NO production by promoting ER alpha to the plasma membrane, which facilitates the activation of the PI3 kinase pathway, leading to eNOS activation and NO generation. (Molecular Endocrinology 24: 1637-1649, 2010)
C1 [Sud, Neetu; Wiseman, Dean A.; Black, Stephen M.] Med Coll Georgia, Vasc Biol Ctr, Pulm Vasc Dis Program, Augusta, GA 30912 USA.
RP Black, SM (reprint author), Med Coll Georgia, Vasc Biol Ctr, Pulm Vasc Dis Program, 1459 Laney Walker Blvd CB 3210B, Augusta, GA 30912 USA.
EM sblack@mcg.edu
FU National Institutes of Health (NIH) [HL60190, HL67841, HL084739,
   HD057406, F32HL090198, HL097153]; American Heart Association [0550133Z];
   Pacific Mountain Affiliates; Fondation LeDucq
FX This work was supported by National Institutes of Health (NIH) Grants
   HL60190, HL67841, HL084739, and HD057406 (all to S. M. B.); Grant
   0550133Z from the American Heart Association, Pacific Mountain
   Affiliates (to S.M.B.); and by a grant from the Fondation LeDucq (to
   S.M.B.). D.W. was supported in part by NIH Grant F32HL090198. N.S. was
   supported in part by an American Heart Association postdoctoral
   fellowship from the American Heart Association Southeast affiliates and
   by NIH Grant HL097153.
CR Baillie GS, 2007, BIOCHEM J, V404, P71, DOI 10.1042/BJ20070005
   Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x
   Chambliss KL, 2002, MOL ENDOCRINOL, V16, P938, DOI 10.1210/me.16.5.938
   Chen DB, 2004, ENDOCRINOLOGY, V145, P113, DOI 10.1210/en.2003-0547
   Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688
   Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125
   Feron O, 2001, CIRC RES, V88, P129
   Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0
   GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237
   GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448
   Geary GG, 2000, AM J PHYSIOL-HEART C, V279, pH511
   Gong M, 2003, J CLIN INVEST, V111, P1579, DOI 10.1172/JCI200316777
   Hisamoto K, 2001, J BIOL CHEM, V276, P3459, DOI 10.1074/jbc.M005036200
   Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522
   Kiss AL, 2005, MOL CELL ENDOCRINOL, V245, P128, DOI 10.1016/j.mce.2005.11.005
   Kramer A, 1998, METH MOL B, V87, P25
   Li H, 2001, AM J PHYSIOL-ENDOC M, V280, pE75
   Lin MC, 1997, J CLIN INVEST, V99, P737, DOI 10.1172/JCI119219
   Machleidt T, 2000, J CELL BIOL, V148, P17, DOI 10.1083/jcb.148.1.17
   MANDERS EMM, 1992, J CELL SCI, V103, P857
   McNeill AM, 1999, STROKE, V30, P2186, DOI 10.1161/01.STR.30.10.2186
   Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583
   Nilsson S, 2001, PHYSIOL REV, V81, P1535
   Razani B, 2001, J BIOL CHEM, V276, P38121
   Reineke U, 2002, J IMMUNOL METHODS, V267, P37, DOI 10.1016/S0022-1759(02)00139-4
   Sbaa E, 2005, TRENDS CARDIOVAS MED, V15, P157, DOI 10.1016/j.tcm.2005.05.006
   Schlegel A, 1999, J BIOL CHEM, V274, P33551, DOI 10.1074/jbc.274.47.33551
   Schlegel A, 2001, BIOCHEM J, V359, P203, DOI 10.1042/0264-6021:3590203
   SEVERS NJ, 1988, J CELL SCI, V90, P341
   Stirone C, 2003, EUR J PHARMACOL, V478, P35, DOI 10.1016/j.ejphar.2003.08.037
   Sud N, 2008, AM J PHYSIOL-CELL PH, V294, pC1407, DOI 10.1152/ajpcell.00384.2007
   Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007
   Sun XT, 2009, ENDOCRINOLOGY, V150, P3742, DOI 10.1210/en.2008-1464
   Wedgwood S, 2003, AM J PHYSIOL-LUNG C, V284, pL650, DOI 10.1152/ajplung.00252.2002
   Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986
NR 35
TC 16
Z9 18
U1 2
U2 12
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0888-8809
EI 1944-9917
J9 MOL ENDOCRINOL
JI Mol. Endocrinol.
PD AUG
PY 2010
VL 24
IS 8
BP 1637
EP 1649
DI 10.1210/me.2010-0043
PG 13
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 631YU
UT WOS:000280387500012
PM 20610538
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Li, Q
   Ke, F
   Zhang, WW
   Laumonnier, Y
   Syrovets, T
   Simmet, T
   Wang, HL
AF Li, Qun
   Ke, Fang
   Zhang, Weiwei
   Laumonnier, Yves
   Syrovets, Tatiana
   Simmet, Thomas
   Wang, Honglin
TI RETRACTED: A role for the annexin A2 amino-terminal peptide in the
   plasmin-induced activation of human peripheral monocytes (Retracted
   article. See vol. 49, pg. 566, 2011)
SO MOLECULAR IMMUNOLOGY
LA English
DT Article; Retracted Publication
DE Plasmin; Monocytes; Annexin A2 heterotetramer complex; Amino terminal
   annexin A2 (A2NP); JAK/STAT3; MCP 1
ID SERINE-PROTEASE PLASMIN; CYTOKINE RECEPTOR; INDUCED MIGRATION;
   EXPRESSION; PATHWAY; INTERLEUKIN-31; CELLS; THROMBIN; PATTERNS; FAMILY
AB Plasmin is recognized as a potent signaling molecule in particular human monocytes inducing a pro-inflammatory response Recently the annexin A2 heterotetramer a plasmin receptor was described at the surface of the human monocytes Plasmin is initiating a signaling in monocytes by cleavage of the annexin A2 subunit of the receptor and the apparent dissociation of the heterotetramer at the surface of cell However the exact mechanism linking this dissociation and the activation of the intracellular pathway remains undefined Here we report that the molecular mechanism of monocyte activation may rely on a new molecule containing the amino-terminal end of annexin A2 (A2NP) generated by plasmin cleavage of its receptor - the annexin A2 heterotetramer - as in vitro A2NP is able to mimic plasmin activation of the tyrosine kinase JAK1 and STAT3 and the subsequent increase in expression and release of monocyte/macrophage chemoattractant protein (MCP)-1 which is a major chemokine released by monocytes/macrophages Additionally we show that plasmin-induced the phosphorylation of STAT3 is similar to that of IL-6 and IL-31 and protease-activated receptor 1 does not affect plasmin-induced cytokine MCP-1 release in human monocytes Finally our data demonstrate that plasmin triggers the production of MCP-1 in macrophages in vivo Thus A2NP generated by plasmin cleavage of the annexin A2 heterotetramer could serve as a new proteolytically generated signaling molecule activating an associated transmembrane co-receptor such as type I cytokine receptors (C) 2010 Elsevier Ltd All rights reserved
C1 [Li, Qun; Ke, Fang; Zhang, Weiwei; Wang, Honglin] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200025, Peoples R China.
   [Li, Qun] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Shanghai Inst Hypertens, Ruijin Hosp,Sch Med,Shanghai Key Lab Vasc Biol, Shanghai 200025, Peoples R China.
   [Laumonnier, Yves; Syrovets, Tatiana; Simmet, Thomas] Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, Ulm, Germany.
   [Li, Qun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci Ctr, Lab Vasc Biol, Shanghai, Peoples R China.
RP Wang, HL (reprint author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200025, Peoples R China.
FU National Natural Science Foundation of China [30972787]; Shanghai
   Institutions of Higher Learning; Shanghai Municipal Education Commission
   [J50208, J50207]
FX This research is supported by grant from National Natural Science
   Foundation of China (No 30972787) supported by the Program for Professor
   of Special Appointment (Eastern Scholar) at Shanghai Institutions of
   Higher Learning and supported by Leading Academic Discipline Project of
   Shanghai Municipal Education Commission (Nos J50208 and J50207)
CR Bando T, 2006, NEUROSCIENCE, V142, P1263, DOI 10.1016/j.neuroscience.2006.07.009
   Burysek L, 2002, J BIOL CHEM, V277, P33509, DOI 10.1074/jbc.M201941200
   Chattopadhyay S, 2007, J BIOL CHEM, V282, P3014, DOI 10.1074/jbc.M609655200
   Colognato R, 2003, BLOOD, V102, P2645, DOI 10.1182/blood-2002-08-2497
   Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084
   Diveu C, 2003, J BIOL CHEM, V278, P49850, DOI 10.1074/jbc.M307286200
   Diveu C, 2004, EUR CYTOKINE NETW, V15, P291
   Dreuw A, 2004, J BIOL CHEM, V279, P36112, DOI 10.1074/jbc.M401122200
   Ernst S, 2004, J IMMUNOL, V172, P7669, DOI 10.4049/jimmunol.172.12.7669
   Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001
   Ghilardi N, 2002, J BIOL CHEM, V277, P16831, DOI 10.1074/jbc.M201140200
   GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x
   HAJJAR KA, 1994, J BIOL CHEM, V269, P21191
   Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20020407
   Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0
   KUBE E, 1992, J BIOL CHEM, V267, P14175
   Laumonnier Y, 2006, BLOOD, V107, P3342, DOI 10.1182/blood-2005-07-2840
   Majumdar M, 2004, J BIOL CHEM, V279, P37528, DOI 10.1074/jbc.M401372200
   Mitani Y, 2001, GENES CELLS, V6, P631, DOI 10.1046/j.1365-2443.2001.00448.x
   Nagai T, 2006, J NEUROSCI, V26, P12374, DOI 10.1523/JNEUROSCI.3139-06.2006
   Naldini A, 2004, PEPTIDES, V25, P1917, DOI 10.1016/j.peptides.2004.05.017
   Nieman MT, 2007, BIOCHEMISTRY-US, V46, P8603, DOI 10.1021/bi700597p
   Pendurthi UR, 2002, ARTERIOSCL THROM VAS, V22, P1421, DOI 10.1161/01.ATV.0000030200.59331.3F
   Spah F, 2008, BRIT J DERMATOL, V159, P10, DOI 10.1111/j.1365-2133.2008.08780.x
   Strande JL, 2007, BASIC RES CARDIOL, V102, P350, DOI 10.1007/s00395-007-0653-4
   Swisher JFA, 2007, J LEUKOCYTE BIOL, V82, P1174, DOI 10.1189/jlb.0307154
   Syrovets T, 1997, BLOOD, V89, P4574
   Syrovets T, 2004, CELL MOL LIFE SCI, V61, P873, DOI 10.1007/s00018-003-3348-5
   Syrovets T, 2001, BLOOD, V97, P3941, DOI 10.1182/blood.V97.12.3941
   Tarui T, 2002, J BIOL CHEM, V277, P33564, DOI 10.1074/jbc.M205514200
   WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592
   Weide I, 1996, THROMB HAEMOSTASIS, V76, P561
NR 32
TC 4
Z9 4
U1 3
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0161-5890
J9 MOL IMMUNOL
JI Mol. Immunol.
PD AUG
PY 2010
VL 47
IS 14
BP 2405
EP 2410
DI 10.1016/j.molimm.2010.03.015
PG 6
WC Biochemistry & Molecular Biology; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA 681IN
UT WOS:000284304700013
PM 20627396
DA 2018-12-27
ER

PT J
AU Baird, LC
   Newman, CB
   Volk, H
   Svinth, JR
   Conklin, J
   Levy, ML
AF Baird, Lissa C.
   Newman, C. Benjamin
   Volk, Hunter
   Svinth, Joseph R.
   Conklin, Jordan
   Levy, Michael L.
TI RETRACTED: Mortality Resulting From Head Injury in Professional Boxing:
   Case Report (Retracted article. See vol. 67, pg. E1475, 2010)
SO NEUROSURGERY
LA English
DT Article; Retracted Publication
DE Boxing; Head trauma; Mortality
ID MEDICAL ASPECTS; BRAIN-INJURY; BIOMECHANICS; CONCUSSION; FATALITIES;
   FOOTBALL; PUNCH
AB BACKGROUND: The majority of boxing-related fatalities result from traumatic brain injury. Biomechanical forces in boxing result in rotational acceleration with resultant subdural hematoma and diffuse axonal injury.
   OBJECTIVE: Given the inherent risk and the ongoing criticism boxing has received, we evaluated mortalities associated with professional boxing.
   METHODS: We used the Velazquez Fatality Collection of boxing injuries and supplementary sources to analyze mortality from 1950 to 2007. Variables evaluated included age at time of death, association with knockout or other outcome of match, rounds fought, weight class, location of fight, and location of preterminal event.
   RESULTS: There were 339 mortalities between 1950 and 2007 (mean age, 24 +/- 3.8 years); 64% were associated with knockout and 15% with technical knockout. A higher percentage occurred in the lower weight classes. The preterminal event occurred in the ring (61%), in the locker room (17%), and outside the arena (22%). We evaluated for significant changes after 1983 when championship bouts were reduced from 15 to 12 rounds.
   CONCLUSION: There was a significant decline in mortality after 1983. We found no significant variables to support that this decline is related to a reduction in rounds. Rather, we hypothesize the decline to be the result of a reduction in exposure to repetitive head trauma (shorter careers and fewer fights), along with increased medical oversight and stricter safety regulations. Increased efforts should be made to improve medical supervision of boxers. Mandatory central nervous system imaging after a knockout could lead to a significant reduction in associated mortality.
C1 [Baird, Lissa C.; Newman, C. Benjamin; Volk, Hunter; Levy, Michael L.] Univ Calif San Diego, Dept Neurosurg, San Diego, CA 92103 USA.
   [Svinth, Joseph R.; Conklin, Jordan] Rady Childrens Hosp San Diego, San Diego, CA USA.
RP Levy, ML (reprint author), 8010 Frost St,Ste 502, San Diego, CA 92123 USA.
EM mlevy@chsd.org
CR ATHA J, 1985, BRIT MED J, V291, P1756, DOI 10.1136/bmj.291.6511.1756
   Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005
   BORGES R, 25 YEARS IS LONG TIM
   Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4
   Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4
   Castro FP, 2003, CLIN SPORT MED, V22, P483, DOI 10.1016/S0278-5919(02)00094-7
   Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046
   COHEN L, 1984, CAN MED ASSOC J, V130, P767
   CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357
   Ghiselli G, 2003, CLIN SPORT MED, V22, P445, DOI 10.1016/S0278-5919(02)00109-6
   GONZALES TA, 1951, JAMA-J AM MED ASSOC, V146, P1506, DOI 10.1001/jama.1951.03670160048012
   HODGSON VR, 1972, P 16 STAPP CAR CRASH
   JOCH W, 1981, BIOMECHANICS A, V7, P343
   JORDAN BD, 1990, PHYSICIAN SPORTSMED, V18, P81, DOI 10.1080/00913847.1990.11709974
   JORDAN BD, 1987, ARCH NEUROL-CHICAGO, V44, P453, DOI 10.1001/archneur.1987.00520160083020
   Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575
   KING AI, 1995, BIOMEDICAL ENG HDB, P357
   LUNDBERG GD, 1983, JAMA-J AM MED ASSOC, V249, P250, DOI 10.1001/jama.1983.03330260068037
   MCCOWN IA, 1959, AM J SURG, V98, P509, DOI 10.1016/0002-9610(59)90545-8
   Miele VJ, 2007, NEUROSURGERY, V60, P307, DOI 10.1227/01.NEU.0000249247.48299.5B
   Miele Vincent J, 2006, Neurosurg Focus, V21, pE8
   Moore M, 1980, Phys Sportsmed, V8, P101, DOI 10.1080/00913847.1980.11710972
   MORRISON RG, 1986, JAMA-J AM MED ASSOC, V255, P2475, DOI 10.1001/jama.255.18.2475
   Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824
   PINCEMAILLE YTX, 1989, P 33 STAPP CAR CRASH
   POLIN AW, 1996, NEUROLOGY TRAUMA, P166
   REFSHAUGE JG, 1963, MED J AUSTRALIA, V1, P611
   Roberts AH, 1969, BRAIN DAMAGE BOXERS
   ROSS RJ, 1983, JAMA-J AM MED ASSOC, V249, P211, DOI 10.1001/jama.249.2.211
   SERCL M., 1962, WORLD NEUROL, V3, P351
   Smith MS, 2000, J SPORT SCI, V18, P445, DOI 10.1080/02640410050074377
   SUGAR BR, 1981, RING RECORD BOOK BOX
   SVINTH J, 2007, J COMBATIVE SPORT
   UNTERHARNSCHEIDT F, 1970, TEX REP BIOL MED, V28, P421
   Unterharnscheidt F J, 1972, Scand J Rehabil Med, V4, P77
   VIANO D, 1988, P 32 STAPP CAR CRASH
   Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9
   VIANO DC, 1999, CRASH PREV INJ CONTR, V1, P35
   Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126
   WHITING WC, 1988, AM J SPORT MED, V16, P130, DOI 10.1177/036354658801600207
NR 40
TC 4
Z9 5
U1 3
U2 12
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0148-396X
EI 1524-4040
J9 NEUROSURGERY
JI Neurosurgery
PD AUG
PY 2010
VL 67
IS 2
BP E519
EP U378
DI 10.1227/01.NEU.0000373207.04297.13
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 628HI
UT WOS:000280105800080
PM 20644386
DA 2018-12-27
ER

PT J
AU Younis, A
   Seher, S
AF Younis, Adnan
   Seher, Shama
TI RETRACTED: Response of Cu-0.5(Tl0.5-yHgy)Ba2Ca3 Zn2Cu2O12-delta (y=0,
   0.15, 0.25 and 0.35) superconductors in electric and magnetic fields
   (Retracted article. See vol. 84, artn no. 019801, 2011)
SO PHYSICA SCRIPTA
LA English
DT Article; Retracted Publication
ID SUSCEPTIBILITY MEASUREMENTS; CUPRATE SUPERCONDUCTORS; AC SUSCEPTIBILITY;
   PRESSURE; TEMPERATURE; TRANSITION
AB The superconducting properties of the Cu-0.5(Tl0.5-yHgy)Ba2Ca3Zn2Cu2O12-delta compound have been studied by resistivity and ac magnetic susceptibility measurements. Mercury substitution has been found to improve the superconductivity of the Cu0.5Tl0.5Ba2Ca3Zn2Cu2O12-delta (CuTl-1234) compound, which is evidenced by the improvement of physical properties such as zero resistivity critical temperature, critical current density and flux pinning. The main objective of the present study was to examine the possible role of Hg in enhancing the superconducting properties of CuTl-1234. Post-annealing of the samples was also carried out at 550 degrees C in an oxygen atmosphere. The oxygen post-annealing enhanced the intergranular coupling and the superconducting properties of Cu1-xTlx-1234 samples. But ac susceptibility measurements under different magnetic fields show that CuTlHg-1234 has superior flux pinning characteristics as compared to Cu1-xTlx-1234, which make them useful for applications in external magnetic fields.
C1 [Younis, Adnan; Seher, Shama] Quaid I Azam Univ, Mat Sci Lab, Dept Phys, Islamabad 45320, Pakistan.
RP Younis, A (reprint author), Quaid I Azam Univ, Mat Sci Lab, Dept Phys, Islamabad 45320, Pakistan.
CR Abd-Shukor R, 1998, J MATER SCI LETT, V17, P103
   Abou-Aly AI, 2001, J MAGN MAGN MATER, V226, P328, DOI 10.1016/S0304-8853(00)01368-8
   Agarwal SK, 1998, PHYS REV B, V58, P9504, DOI 10.1103/PhysRevB.58.9504
   Badica P, 2002, SUPERCOND SCI TECH, V15, P975, DOI 10.1088/0953-2048/15/6/324
   Chen XJ, 1999, PHYS REV B, V59, P4513, DOI 10.1103/PhysRevB.59.4513
   Gomory F, 1997, SUPERCOND SCI TECH, V10, P523, DOI 10.1088/0953-2048/10/8/001
   Gonzalez JL, 2003, PHYSICA C, V384, P102, DOI 10.1016/S0921-4534(02)01805-1
   IHARA H, 1994, JPN J APPL PHYS 2, V33, pL503, DOI 10.1143/JJAP.33.L503
   Ihara H, 1997, PHYSICA C, V282, P957, DOI 10.1016/S0921-4534(97)00592-3
   Karppinen M, 2004, J SOLID STATE CHEM, V177, P1037, DOI 10.1016/j.jssc.2003.10.011
   KASOWSKI RV, 1988, PHYS REV B, V38, P6470, DOI 10.1103/PhysRevB.38.6470
   Khan NA, 2005, PHYSICA C, V422, P9, DOI 10.1016/j.physc.2005.02.013
   Khurram AA, 2006, SUPERCOND SCI TECH, V19, P679, DOI 10.1088/0953-2048/19/6/043
   Kim MS, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.134513
   Kito H, 2002, PHYSICA C, V378, P329, DOI 10.1016/S0921-4534(02)01437-5
   Kunold A, 2002, PHYSICA C, V370, P63, DOI 10.1016/S0921-4534(01)00945-5
   LAIC C, 1991, CHINESE J PHYS, V29, P57
   MATTHEISS LF, 1990, PHYS REV B, V42, P10108, DOI 10.1103/PhysRevB.42.10108
   Sarmago RV, 2001, PHYSICA C, V364, P239, DOI 10.1016/S0921-4534(01)00762-6
   Shibata T, 2001, PHYSICA C, V353, P200, DOI 10.1016/S0921-4534(00)01745-7
   Tokiwa K, 1999, J LOW TEMP PHYS, V117, P903, DOI 10.1023/A:1022502908121
   YANG IS, 1993, PHYS REV B, V48, P7570, DOI 10.1103/PhysRevB.48.7570
NR 22
TC 1
Z9 1
U1 3
U2 11
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0031-8949
EI 1402-4896
J9 PHYS SCRIPTA
JI Phys. Scr.
PD AUG
PY 2010
VL 82
IS 2
AR 025701
DI 10.1088/0031-8949/82/02/025701
PG 6
WC Physics, Multidisciplinary
SC Physics
GA 635IO
UT WOS:000280649000015
DA 2018-12-27
ER

PT J
AU Kang, SK
   Kang, KS
   Jee, MK
   Kim, BS
AF Kang, Soo Kyung
   Kang, Kyung Sun
   Jee, Min Ki
   Kim, Bong Sun
TI RETRACTED: Vascular Endothelial Growth Factor/Kinase Insult Domain
   Receptor (KDR)/Fetal Liver Kinase 1 (FLK1)-Mediated Skin-Epithelial
   Progenitor Cells Reprogramming (Retracted article. See vol. 20, pg.
   2806, 2014)
SO TISSUE ENGINEERING PART A
LA English
DT Article; Retracted Publication
ID ADULT HIPPOCAMPAL NEUROGENESIS; STIMULATES AXONAL OUTGROWTH; ACTIVATED
   PROTEIN-KINASES; CEREBRAL-ISCHEMIA; NERVOUS-SYSTEM; MITOGEN; VEGF;
   ANGIOGENESIS; BRAIN
AB Vascular endothelial growth factor (VEGF) is an angiogenic protein that has effects on damaged neurons. We investigated VEGF function and found that it effectively induces the transition of skin-derived epithelial progenitor cells (EPCs) to more primitive stem cells. This change was accompanied by the epigenetic reprogramming of many genes. Among these genes are several stem-cell-associated transcription factors, such as Rex1, Oct4, Nanog, and Sox2. The VEGF-induced reprogramming of EPCs occurred through the FLK1 receptor and Janus kinase (JAK)/signal transducer-and activator of transcription 3 (STAT3) phosphorylation. When we engrafted VEGF-sensitized EPCs into sites of brain trauma, both engrafted VEGF/EPCs and endogenous cells showed functionally active neurogenesis and potent immunomodulatory function. These results indicate that VEGF actively induces the reprogramming of EPCs to become more primitive stem cells that display active cell growth, neurogenesis, migration, and survival behaviors, which may lead to a novel therapeutic strategy for central nervous system disorders.
C1 [Kang, Soo Kyung; Jee, Min Ki; Kim, Bong Sun] Seoul Natl Univ, Coll Vet Med, Dept Vet Biotechnol, Seoul, South Korea.
   [Kang, Kyung Sun] Seoul Natl Univ, Coll Vet Med, Dept Vet Publ Hlth, Seoul, South Korea.
RP Kang, SK (reprint author), Seoul Natl Univ, Coll Vet Med, Dept Vet Biotechnol, Seoul, South Korea.
EM kangsookyung@hanmail.net
FU 21st Century Frontier/Stem Cell Research Committee in South Korea
   [SC5110]; Korean government (Ministry of Education, Science and
   Technology [MEST]) [M10841000109-08N4100-10910]
FX This work was supported by the 21st Century Frontier/Stem Cell Research
   Committee (SC5110) in South Korea, and was also supported by a Korea
   Science and Engineering Foundation (KOSEF) grant funded by the Korean
   government (Ministry of Education, Science and Technology [MEST], No.
   M10841000109-08N4100-10910).
CR Avivi Y, 2004, DEV DYNAM, V230, P12, DOI 10.1002/dvdy.20006
   Bao WL, 1999, ACTA PHARMACOL SIN, V20, P313
   Carmeliet P, 2002, SEMIN CELL DEV BIOL, V13, P39, DOI 10.1006/scdb.2001.0290
   Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1046/j.1460-9568.2003.03041.x
   Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029
   Grafi G, 2007, DEV BIOL, V306, P838, DOI 10.1016/j.ydbio.2007.03.023
   Hayashi T, 1998, J CEREBR BLOOD F MET, V18, P887, DOI 10.1097/00004647-199808000-00009
   Jin KL, 2000, J MOL NEUROSCI, V14, P197, DOI 10.1385/JMN:14:3:197
   KANG SK, 2007, TISSUE ENG, V13, P1247
   KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987
   Kim JH, 2008, STEM CELLS, V26, P2724, DOI 10.1634/stemcells.2008-0184
   Lennmyr F, 2002, ACTA NEUROL SCAND, V106, P333, DOI 10.1034/j.1600-0404.2002.01313.x
   LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
   Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709
   Matsuzaki H, 2001, FASEB J, V15, P1218
   Melder RJ, 1996, NAT MED, V2, P992, DOI 10.1038/nm0996-992
   Ng DCH, 2000, J BIOL CHEM, V275, P40856, DOI 10.1074/jbc.M004639200
   Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3
   Rosenstein Kenneth, 2003, Health Law Can, V24, P18
   Silverman WF, 1999, NEUROSCIENCE, V90, P1529, DOI 10.1016/S0306-4522(98)00540-5
   Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999
   Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x
   Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977
   Yang XH, 2004, SEMIN CELL DEV BIOL, V15, P91, DOI 10.1016/j.semcdb.2003.09.004
   Yeo JE, 2007, BBA-MOL BASIS DIS, V1772, P1199, DOI 10.1016/j.bbadis.2007.09.004
NR 25
TC 6
Z9 6
U1 2
U2 9
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD AUG
PY 2010
VL 16
IS 8
BP 2687
EP 2697
DI 10.1089/ten.tea.2010.0010
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 635IL
UT WOS:000280648700025
PM 20367253
DA 2018-12-27
ER

PT J
AU Donmez, G
   Wang, D
   Cohen, DE
   Guarente, L
AF Donmez, Gizem
   Wang, Diana
   Cohen, Dena E.
   Guarente, Leonard
TI RETRACTED: SIRT1 Suppresses beta-Amyloid Production by Activating the
   alpha-Secretase Gene ADAM10 (Retracted article. See vol. 158, pg. 959,
   2014)
SO CELL
LA English
DT Article; Retracted Publication
ID ONSET ALZHEIMERS-DISEASE; RETINOIC ACID RECEPTORS; CALORIE RESTRICTION;
   TRANSGENIC MICE; MOUSE MODEL; IN-VIVO; PROTEIN; NOTCH; PATHWAY; BRAIN
AB A hallmark of Alzheimer's disease (AD) is the accumulation of plaques of A beta 1-40 and 1-42 peptides, which result from the sequential cleavage of APP by the beta and gamma-secretases. The production of A beta peptides is avoided by alternate cleavage of APP by the alpha and gamma-secretases. Here we show that production of beta-amyloid and plaques in a mouse model of AD are reduced by overexpressing the NAD-dependent deacetylase SIRT1 in brain, and are increased by knocking out SIRT1 in brain. SIRT1 directly activates the transcription of the gene encoding the alpha-secretase, ADAM10. SIRT1 deacetylates and coactivates the retinoic acid receptor beta, a known regulator of ADAM10 transcription. ADAM10 activation by SIRT1 also induces the Notch pathway, which is known to repair neuronal damage in the brain. Our findings indicate SIRT1 activation is a viable strategy to combat AD and perhaps other neurodegenerative diseases.
C1 [Donmez, Gizem; Wang, Diana; Cohen, Dena E.; Guarente, Leonard] MIT, Paul F Glenn Lab, Cambridge, MA 02139 USA.
   [Donmez, Gizem; Wang, Diana; Cohen, Dena E.; Guarente, Leonard] MIT, Dept Biol, Cambridge, MA 02139 USA.
RP Guarente, L (reprint author), MIT, Paul F Glenn Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM leng@mit.edu
FU American Parkinson Disease Association; NIH
FX We are grateful to Hyo-Jin Park and Seong Hun Kim for N2A
   APPswe/PSEN1dE9 cells. We thank Dennis Selkoe for helpful discussions.
   We also thank Takashi Nakagawa, Hung Chun Chang, and Petra Simic for
   comments on the manuscript. This work is supported by an American
   Parkinson Disease Association post-doctoral fellowship to G.D. and
   grants from the NIH and a gift from the Paul F. Glenn Foundation to L.G.
CR Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014
   Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5
   Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x
   Bryan KJ, 2009, FRONT NEUROSCI, P1
   Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200
   Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100
   Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209
   Corcoran JPT, 2004, EUR J NEUROSCI, V20, P896, DOI 10.1111/j.1460-9568.2004.03563.x
   Costa RM, 2005, TRENDS NEUROSCI, V28, P429, DOI 10.1016/j.tins.2005.05.003
   De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897
   DOLLE P, 1990, DEVELOPMENT, V110, P1133
   Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x
   Fahrenholz F, 2008, ADV BEHAV BIOL, V57, P369, DOI 10.1007/978-0-387-72076-0_38
   Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020
   Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8
   Goodman AB, 2003, P NATL ACAD SCI USA, V100, P2901, DOI 10.1073/pnas.0437937100
   Goodman AB, 2006, J CELL PHYSIOL, V209, P598, DOI 10.1002/jcp.20784
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   Hartmann D, 2001, J MOL NEUROSCI, V17, P171, DOI 10.1385/JMN:17:2:171
   Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019
   Johansson S, 2006, NEUROREPORT, V17, P907, DOI 10.1097/01.wnr.0000221844.35502.29
   Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758
   Kim M, 2009, HUM MOL GENET, V18, P3987, DOI 10.1093/hmg/ddp323
   Kojro E, 2005, SUB CELL BIOCHEM, V38, P105
   Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045
   Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533
   Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360
   MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7
   MANGELSDORF DJ, 1992, RETINOID RECEPTORS T
   Mattson MP, 1997, PHYSIOL REV, V77, P1081
   McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003
   Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261
   PANTER SS, 1985, NEUROCHEM RES, V10, P1567, DOI 10.1007/BF00988599
   Patel NV, 2005, NEUROBIOL AGING, V26, P995, DOI 10.1016/j.neurobiolaging.2004.09.014
   POSTINA R, 2004, J CLIN INVEST, V113, P1384
   Pozniak CD, 2002, J NEUROSCI, V22, P9800
   Prinzen C, 2005, FASEB J, V19, P1522, DOI 10.1096/fj.04-3619fje
   Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200
   Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x
   Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200
   SAFTIG P, 2005, ADAM FAMILY PROTEASE, P85
   Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630
   Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019
   Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008
   Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392
   van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775
   Vieira SI, 2009, MOL CELL BIOCHEM, V328, P145, DOI 10.1007/s11010-009-0084-7
   Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475
NR 49
TC 315
Z9 340
U1 2
U2 43
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD JUL 23
PY 2010
VL 142
IS 2
BP 320
EP 332
DI 10.1016/j.cell.2010.06.020
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 629MT
UT WOS:000280204300022
PM 20655472
OA Bronze, Green Accepted
DA 2018-12-27
ER

PT J
AU Hon, KLE
   Ng, PC
   Leung, TF
AF Hon, Kam L. E.
   Ng, Pak C.
   Leung, Ting F.
TI RETRACTED: Influenza or not influenza: Analysis of a case of high fever
   that happened 2000 years ago in Biblical time (Retracted article. See
   vol. 7, art no. 190, 2010)
SO VIROLOGY JOURNAL
LA English
DT Article; Retracted Publication
ID ACUTE RESPIRATORY SYNDROME; SARS
AB The Bible describes the case of a woman with high fever cured by our Lord Jesus Christ. Based on the information provided by the gospels of Mark, Matthew and Luke, the diagnosis and the possible etiology of the febrile illness is discussed. Infectious diseases continue to be a threat to humanity, and influenza has been with us since the dawn of human history. If the postulation is indeed correct, the woman with fever in the Bible is among one of the very early description of human influenza disease. Infectious diseases continue to be a threat to humanity, and influenza has been with us since the dawn of human history. We analysed a case of high fever that happened 2000 years ago in Biblical time and discussed possible etiologies.
C1 [Hon, Kam L. E.; Ng, Pak C.; Leung, Ting F.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Paediat, Shatin, Hong Kong, Peoples R China.
RP Hon, KLE (reprint author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Paediat, Shatin, Hong Kong, Peoples R China.
EM ehon@hotmail.com
CR Hon KL, 2009, PEDIATR PULM, V44, P1048, DOI 10.1002/ppul.21085
   Hon KL, 2008, PEDIATR PULM, V43, P275, DOI 10.1002/ppul.20768
   Hon Kam-Lun, 2009, Adv Pediatr, V56, P47, DOI 10.1016/j.yapd.2009.08.019
   Hon KLE, 2003, LANCET, V361, P1984, DOI 10.1016/S0140-6736(03)13556-8
   Hon KLE, 2003, LANCET, V361, P1701, DOI 10.1016/S0140-6736(03)13364-8
   Leung T F, 2003, Paediatr Respir Rev, V4, P334, DOI 10.1016/S1526-0542(03)00088-5
   Li AM, 2004, J PAEDIATR CHILD H, V40, P63, DOI 10.1111/j.1440-1754.2004.00294.x
   *SIZ INC, 2006, FAHR TEMP SCAL
   1982, HOLY BIBLE NEW KING
NR 9
TC 1
Z9 1
U1 1
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD JUL 21
PY 2010
VL 7
AR 169
DI 10.1186/1743-422X-7-169
PG 2
WC Virology
SC Virology
GA 659YB
UT WOS:000282602300004
PM 20663162
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Prasad, AS
   Dolia, SN
   Reddy, VR
   Predeep, P
AF Prasad, Arun S.
   Dolia, S. N.
   Reddy, V. R.
   Predeep, P.
TI RETRACTED: MAGNETIC BEHAVIOR OF FUNCTIONALLY COATED SUPER-PARAMAGNETIC
   Ni0.5Cu0.5Fe2O4-POLYPYRROLE NANO-COMPOSITES (Retracted article. See vol.
   28, 1493001, 2014)
SO MODERN PHYSICS LETTERS B
LA English
DT Article; Retracted Publication
DE Nano-particles; spinel ferrites; nano-composites; super-paramagnetism;
   Mossbauer
ID SPINEL FERRITE; NANOCOMPOSITES; NANOPARTICLES; RELAXATION; PARTICLES
AB The magnetic behavior of nano-crystalline Ni0.5Cu0.5Fe2O4, synthesized by the co-precipitation method and their functionally coated nano-composites with polypyrrole has been studied. The nano-composite samples have been prepared by chemical oxidative polymerization of the monomer, pyrrole in presence of Ni0.5Cu0.5Fe2O4 nanoparticles using ammonium peroxodisulphate as oxidant as well as initiator. The X-ray diffraction patterns confirm the formation of cubic spinel structure. The Mossbauer measurements reveal the quadrupole splitting as well as the magnetic hyperfine behavior of both the samples respectively at 300 K and 20 K. The DC magnetization measurements show that the samples are super-paramagnetic above the blocking temperature and the blocking temperature increases on polymerization. The increase in saturation magnetization and the blocking temperature in the case of polypyrrole coated nano-composites compared to the pristine nano-particle has been attributed to the surface spin ordering of nano-particles due to the crystal growth, ionic site exchange and the molecular level interactions at the surface.
C1 [Predeep, P.] Natl Inst Technol, Dept Phys, Lab Unconvent Elect & Photon, Calicut 673601, Kerala, India.
   [Prasad, Arun S.; Dolia, S. N.] Univ Rajasthan, Dept Phys, Mossbauer & Magnetism Lab, Jaipur 302004, Rajasthan, India.
   [Reddy, V. R.] UGC DAE Consortium Sci Res, Indore 452017, Madhya Pradesh, India.
RP Predeep, P (reprint author), Natl Inst Technol, Dept Phys, Lab Unconvent Elect & Photon, Calicut 673601, Kerala, India.
EM predeep@nitc.ac.in
CR Chander S, 2003, PRAMANA-J PHYS, V61, P617, DOI 10.1007/BF02705484
   Dey A, 2005, J PHYS-CONDENS MAT, V17, P5895, DOI 10.1088/0953-8984/17/37/025
   Dolia SN, 2008, HYPERFINE INTERACT, V184, P75, DOI 10.1007/s10751-008-9769-7
   Dolia SN, 2005, HYPERFINE INTERACT, V160, P219, DOI 10.1007/s1075I-005-9167-3
   Hoque SM, 2002, J MAGN MAGN MATER, V251, P292, DOI 10.1016/S0304-8853(02)00700-X
   JERNBERG P, 1983, UUIP1090
   Jiao QG, 2008, MOD PHYS LETT B, V22, P1497, DOI 10.1142/S0217984908016212
   Murillo N, 2004, NANOTECHNOLOGY, V15, pS322, DOI 10.1088/0957-4484/15/4/037
   NANBA N, 1978, JPN J APPL PHYS, V17, P1819, DOI 10.1143/JJAP.17.1819
   Park IW, 2003, SOLID STATE COMMUN, V126, P385, DOI 10.1016/S0038-1098(03)00189-3
   Rondinone AJ, 1999, J PHYS CHEM B, V103, P6876, DOI 10.1021/jp9912307
   SAWANT SR, 1981, SOLID STATE COMMUN, V40, P391, DOI 10.1016/0038-1098(81)90845-0
   Sharma V, 2009, INT J MOD PHYS B, V23, P125, DOI 10.1142/S0217979209049528
   Zhang Y, 2009, MOD PHYS LETT B, V23, P633, DOI 10.1142/S0217984909018035
   Zhang ZM, 2005, NANOTECHNOLOGY, V16, P2827, DOI 10.1088/0957-4484/16/12/016
NR 15
TC 10
Z9 10
U1 3
U2 14
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0217-9849
EI 1793-6640
J9 MOD PHYS LETT B
JI Mod. Phys. Lett. B
PD JUL 20
PY 2010
VL 24
IS 18
BP 1987
EP 1995
DI 10.1142/S0217984910024389
PG 9
WC Physics, Applied; Physics, Condensed Matter; Physics, Mathematical
SC Physics
GA 628ZP
UT WOS:000280164000008
DA 2018-12-27
ER

PT J
AU Harada, N
   Zhao, JA
   Kurihara, H
   Nakagata, N
   Okajima, K
AF Harada, Naoaki
   Zhao, Juan
   Kurihara, Hiroki
   Nakagata, Naomi
   Okajima, Kenji
TI RETRACTED: Stimulation of Fc gamma RI on Primary Sensory Neurons
   Increases Insulin-Like Growth Factor-I Production, Thereby Reducing
   Reperfusion-Induced Renal Injury in Mice (Retracted article. See vol.
   187, pg. 3448, 2011)
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article; Retracted Publication
ID ACTIVATION; RATS; ISCHEMIA/REPERFUSION; APOPTOSIS; CAPSAICIN; TRPV1;
   MODULATION; ANANDAMIDE; ELASTASE; CURRENTS
AB Biological role(s) of Fc gamma RI on mouse primary sensory neurons are not fully understood. Sensory neuron stimulation increases insulin-like growth factor-I (IGF-I) production, thereby reducing ischemia/reperfusion (I/R)-induced tissue injury in mice. In this study, we examined whether the Fc fragment of IgG (IgGFc) increases IGF-I production through sensory neuron stimulation, thereby reducing I/R-induced renal injury in mice. IgGFc increased the calcitonin-gene-related peptide (CGRP) release and cellular cAMP levels in dorsal root ganglion neurons isolated from wild-type (WT) mice, whereas, native IgG did not. Pretreatment with anti-Fc gamma RI Ab, a protein kinase A inhibitor KT5710, and a phospholipase A(2) inhibitor 4-bromophenylacyl bromide inhibited these effects induced by IgGFc. Administration of IgGFc enhanced increases of renal tissue levels of CGRP and IGF-I and reduced I/R-induced renal injury in WT mice. Increases of renal tissue level of caspase-3, renal accumulation of neutorphils, and renal tubular apoptosis were inhibited by administration of IgGFc in WT mice subjected to renal I/R. Pretreatment with anti-IGF-I Ab completely reversed these effects induced by IgGFc in WT mice. Administration of native IgG did not show any effects in WT mice subjected to renal I/R. None of the effects observed in WT mice was seen after IgGFc administration in CGRP-knockout mice and denervated WT mice. These observations suggest that activation of Fc gamma RI by IgGFc may stimulate sensory neurons, thereby promoting IGF-I production, contributing to reduction of the reperfusion-induced renal injury via attenuation of inflammatory responses in mice. The Journal of Immunology, 2010, 185: 1303-1310.
C1 [Harada, Naoaki; Zhao, Juan; Okajima, Kenji] Nagoya City Univ, Dept Translat Med Sci Res, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi 4678601, Japan.
   [Kurihara, Hiroki] Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metab, Tokyo, Japan.
   [Nakagata, Naomi] Kumamoto Univ, Div Reprod Engn, Ctr Anim Resources & Dev, Kumamoto, Japan.
RP Okajima, K (reprint author), Nagoya City Univ, Dept Translat Med Sci Res, Grad Sch Med Sci, Mizuho Ku, Kawasumi 1,Mizuho Cho, Nagoya, Aichi 4678601, Japan.
EM whynot@med.nagoya-cu.ac.jp
OI Nakagata, Naomi/0000-0002-5737-9993
CR BUCK SH, 1986, PHARMACOL REV, V38, P179
   Carroll PV, 2001, BEST PRACT RES CL EN, V15, P435, DOI 10.1053/beem.2001.0162
   Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974
   DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68
   De Vries B, 2003, TRANSPLANTATION, V75, P375, DOI 10.1097/01.TP.0000044455.05584.2A
   EVANS RJ, 1993, BRIT J PHARMACOL, V110, P591, DOI 10.1111/j.1476-5381.1993.tb13851.x
   Harada N, 2008, SHOCK, V30, P379, DOI 10.1097/SHK.0b013e3181673e2c
   Harada N, 2008, CRIT CARE MED, V36, P971, DOI [10.1097/CCM.0B613IE3181653642, 10.1097/CCM.0B013E3181653642]
   Harada N, 2007, NEUROPHARMACOLOGY, V52, P1303, DOI 10.1016/j.neuropharm.2007.01.016
   Harada N, 2006, THROMB HAEMOSTASIS, V95, P788, DOI 10.1160/TH05-09-0636
   Hou LF, 2001, J NEUROSCI RES, V66, P592, DOI 10.1002/jnr.1249
   Kunduzova OR, 2003, FASEB J, V17, P872, DOI 10.1096/fj.02-0504fje
   Kushimoto S, 1996, CRIT CARE MED, V24, P1041, DOI 10.1097/00003246-199606000-00026
   Mejia-Vilet JM, 2007, AM J PHYSIOL-RENAL, V293, pF78, DOI 10.1152/ajprenal.00077.2007
   Mizutani A, 2003, BLOOD, V101, P3029, DOI 10.1182/blood-2002-08-2406
   Mohapatra DP, 2003, J BIOL CHEM, V278, P50080, DOI 10.1074/jbc.M306619200
   Nakayama T, 2007, J PHARMACOL EXP THER, V322, P582, DOI 10.1124/jpet.107.120725
   Narimatsu N, 2009, J PHARMACOL EXP THER, V330, P2, DOI 10.1124/jpet.108.147280
   Oh-hashi Y, 2001, CIRC RES, V89, P983, DOI 10.1161/hh2301.100812
   OKAJIMA K, 2004, AM J PHYSIOL-GASTR L, V287, P1116
   Park KA, 2005, TRENDS PHARMACOL SCI, V26, P571, DOI 10.1016/j.tips.2005.09.010
   Price TJ, 2004, BRIT J PHARMACOL, V141, P1118, DOI 10.1038/sj.bjp.0705711
   Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872
   Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008
   Suh YG, 2005, CURR PHARM DESIGN, V11, P2687, DOI 10.2174/1381612054546789
   Tognetto M, 2001, J NEUROSCI, V21, P1104
   VAN RD, 1997, NEUROSCI BIOBEHAV R, V21, P649
   Zhao J, 2009, GROWTH HORM IGF RES, V19, P136, DOI 10.1016/j.ghir.2008.08.003
   Zheng L, 1999, IMMUNOLOGY, V96, P90
NR 29
TC 9
Z9 9
U1 2
U2 14
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD JUL 15
PY 2010
VL 185
IS 2
BP 1303
EP 1310
DI 10.4049/jimmunol.0902051
PG 8
WC Immunology
SC Immunology
GA 622PH
UT WOS:000279675200060
PM 20548031
OA Bronze
DA 2018-12-27
ER

PT J
AU Wei, B
   Cao, HL
   Song, SH
AF Wei, Bin
   Cao, Hailin
   Song, Shenhua
TI RETRACTED: Environmental resistance and mechanical performance of basalt
   and glass fibers (Retracted article. See vol. 640, pg. 481, 2015)
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Retracted Publication
DE Glass fibers; Basalt fibers; Weight loss; Corrosion; Microstructure
ID STRESS-CORROSION CRACKING; COMPOSITES; FAILURE; FATIGUE; WATER
AB The treated basalt and glass fibers with sodium hydroxide and hydrochloric acid solutions for different times were analyzed, respectively. This paper summarized the mass loss ratio and the strength maintenance ratios of the fibers after treatment. The fibers' surface corrosion morphologies were characterized using scanning electron microscopy and their compositions were detected using energy dispersive X-ray spectroscopy. The acid resistance was much better than the alkali resistance for the basalt fibers. Nevertheless, for the glass fibers the situation is different: the acid resistance was almost the same as the alkali resistance. Among the two types of aqueous environments evaluated, the alkali solution is the most aggressive to the fibers' surface. The possible corrosion mechanisms are revealed. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Cao, Hailin] Shenzhen Aerosp Tech Innovat Inst, Shenzhen Key Lab Composite Mat, Shenzhen 518057, Peoples R China.
   [Cao, Hailin] Harbin Inst Technol, Harbin 150001, Peoples R China.
   [Wei, Bin; Song, Shenhua] Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen 518055, Peoples R China.
RP Cao, HL (reprint author), Shenzhen Aerosp Tech Innovat Inst, Shenzhen Key Lab Composite Mat, Shenzhen 518057, Peoples R China.
EM caohl@hit.edu.cn
FU National Nature Science Foundation of China [50503007]
FX The authors would like to thank the National Nature Science Foundation
   of China (Grant No. 50503007) for financial support.
CR ABLESIMOV NE, 1983, TIKHOOKEAN GEOL, P55
   Akdemir A, 2001, COMPOS PART B-ENG, V32, P123, DOI 10.1016/S1359-8368(00)00036-6
   Arniruddin AK, 2008, MATER DESIGN, V29, P1453, DOI 10.1016/j.matdes.2007.07.006
   BAUER HW, 1979, THESIS U ERLANGEN NU
   Belarbi A, 2007, COMPOS PART B-ENG, V38, P674, DOI 10.1016/j.compositesb.2006.09.004
   Berozashvili M., 2001, ADV MAT COM NEWS COM, V6, P5
   Brik VB, 1999, ADV CONCEPT CO UNPUB
   BRIK VB, 1999, PERFORMANCE EV UNPUB
   Deak T, 2009, TEXT RES J, V79, P645, DOI 10.1177/0040517508095597
   DEWIMILLE B, 1983, COMPOSITES, V14, P35, DOI 10.1016/0010-4361(83)90141-6
   EDGE EC, 1980, COMPOSITES, V11, P101, DOI 10.1016/0010-4361(80)90378-X
   GU H, 2008, MATER DESIGN, V30, P867
   Gu H, 2008, MATER DESIGN, V29, P1893, DOI 10.1016/j.matdes.2008.04.025
   Gutnikov SI, 2009, RUSS J INORG CHEM+, V54, P191, DOI 10.1134/S0036023609020041
   IWAMOTO N, 1978, J NON-CRYST SOLIDS, V29, P347, DOI 10.1016/0022-3093(78)90155-2
   Kumosa L, 2001, COMPOS SCI TECHNOL, V61, P615, DOI 10.1016/S0266-3538(00)00244-X
   Lubas M, 2005, J MOL STRUCT, V744, P615, DOI 10.1016/j.molstruc.2004.12.011
   Mertiny P, 2007, POLYM TEST, V26, P751, DOI 10.1016/j.polymertesting.2007.03.006
   Militky J, 2002, ENG FRACT MECH, V69, P1025, DOI 10.1016/S0013-7944(01)00119-9
   Myers TJ, 2007, J HAZARD MATER, V142, P695, DOI 10.1016/j.jhazmat.2006.06.132
   OKA Y, 1979, J AM CERAM SOC, V62, P11
   OZDEN OO, 2001, ICCM13
   Ozturk B, 2007, TRIBOL INT, V40, P37, DOI 10.1016/j.triboint.2006.01.027
   PRICE JN, 1987, COMPOS SCI TECHNOL, V28, P193, DOI 10.1016/0266-3538(87)90002-9
   RABINOVICH FN, 2001, STEKLO KERAM, P29
   RODRIGUEZ EL, 1987, J MATER SCI LETT, V6, P718, DOI 10.1007/BF01770937
   Scheffler C, 2009, J NON-CRYST SOLIDS, V355, P2588, DOI 10.1016/j.jnoncrysol.2009.09.018
   Shan Y, 2001, COMPOS PART B-ENG, V32, P355, DOI 10.1016/S1359-8368(01)00014-2
   SHI QH, 2003, FIBER GLASS, V4, P27
   SHULTZ JM, 1984, POLYM COMPOSITE, V7, P208
   Sim J, 2005, COMPOS PART B-ENG, V36, P504, DOI 10.1016/j.compositesb.2005.02.002
   SOULIER JP, 1988, POLYM COMMUN, V29, P243
   Wang Lan, 2000, FIBER REINFORCED PLA, V6, P22
   Wang X, 2008, COMPOS SCI TECHNOL, V68, P444, DOI 10.1016/j.compscitech.2007.06.016
   Xiong S. L., 2005, FIBER GLASS, V6, P5
NR 35
TC 108
Z9 120
U1 6
U2 67
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JUL 15
PY 2010
VL 527
IS 18-19
BP 4708
EP 4715
DI 10.1016/j.msea.2010.04.021
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 617SG
UT WOS:000279300900026
DA 2018-12-27
ER

PT J
AU Spohn, G
   Jennings, GT
   Martina, BEE
   Keller, I
   Beck, M
   Pumpens, P
   Osterhaus, ADME
   Bachmann, MF
AF Spohn, Gunther
   Jennings, Gary T.
   Martina, Byron E. E.
   Keller, Iris
   Beck, Markus
   Pumpens, Paul
   Osterhaus, Albert D. M. E.
   Bachmann, Martin F.
TI RETRACTED: A VLP-based vaccine targeting domain III of the West Nile
   virus E protein protects from lethal infection in mice (Retracted
   article. See vol. 232, pg. 266, 2016)
SO VIROLOGY JOURNAL
LA English
DT Article; Retracted Publication
ID RECOMBINANT ENVELOPE PROTEIN; AUTOIMMUNE ARTHRITIS; ACTIVE IMMUNIZATION;
   ANTIBODY; PARTICLES; NEUTRALIZATION; DEFICIENCY; EPIDEMIC; BINDING;
   PHAGE
AB Background: Since its first appearance in the USA in 1999, West Nile virus (WNV) has spread in the Western hemisphere and continues to represent an important public health concern. In the absence of effective treatment, there is a medical need for the development of a safe and efficient vaccine. Live attenuated WNV vaccines have shown promise in preclinical and clinical studies but might carry inherent risks due to the possibility of reversion to more virulent forms. Subunit vaccines based on the large envelope (E) glycoprotein of WNV have therefore been explored as an alternative approach. Although these vaccines were shown to protect from disease in animal models, multiple injections and/or strong adjuvants were required to reach efficacy, underscoring the need for more immunogenic, yet safe DIII-based vaccines.
   Results: We produced a conjugate vaccine against WNV consisting of recombinantly expressed domain III (DIII) of the E glycoprotein chemically cross-linked to virus-like particles derived from the recently discovered bacteriophage AP205. In contrast to isolated DIII protein, which required three administrations to induce detectable antibody titers in mice, high titers of DIII-specific antibodies were induced after a single injection of the conjugate vaccine. These antibodies were able to neutralize the virus in vitro and provided partial protection from a challenge with a lethal dose of WNV. Three injections of the vaccine induced high titers of virus-neutralizing antibodies, and completely protected mice from WNV infection.
   Conclusions: The immunogenicity of DIII can be strongly enhanced by conjugation to virus-like particles of the bacteriophage AP205. The superior immunogenicity of the conjugate vaccine with respect to other DIII-based subunit vaccines, its anticipated favourable safety profile and low production costs highlight its potential as an efficacious and cost-effective prophylaxis against WNV.
C1 [Spohn, Gunther; Jennings, Gary T.; Keller, Iris; Beck, Markus; Bachmann, Martin F.] Cytos Biotechnol, CH-8952 Schlieren, Switzerland.
   [Martina, Byron E. E.; Osterhaus, Albert D. M. E.] Erasmus MC, Dept Virol, NL-3000 CA Rotterdam, Netherlands.
   [Pumpens, Paul] Latvian Biomed Res & Study Ctr, LV-1067 Riga, Latvia.
   [Keller, Iris] AO Fdn, CH-7270 Davos, Switzerland.
   [Beck, Markus] Swiss Fed Inst Technol, Inst Integrat Biol, CH-8092 Zurich, Switzerland.
RP Spohn, G (reprint author), Cytos Biotechnol, Wagistr 25, CH-8952 Schlieren, Switzerland.
EM gunther.spohn@cytos.com
RI Pumpens, Paul/A-2163-2008
OI Osterhaus, Albert/0000-0002-6074-1172
FU European Community [LSHB-CT-2004-005246]
FX Part of this work has been supported by a grant of the European
   Community (contract LSHB-CT-2004-005246 "COMPUVAC").
CR Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004
   BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784
   BACHMANN MF, 2007, Patent No. 2007039552
   Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002
   Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7
   Choi KS, 2007, VIRUS RES, V123, P216, DOI 10.1016/j.virusres.2006.09.002
   Chu JHJ, 2007, J IMMUNOL, V178, P2699, DOI 10.4049/jimmunol.178.5.2699
   Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x
   Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970
   Gubler DJ, 2007, CLIN INFECT DIS, V45, P1039, DOI 10.1086/521911
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1174, DOI 10.3201/eid1108.050289b
   Huang CYH, 2005, J VIROL, V79, P7300, DOI 10.1128/JVI.79.12.7300-7310.2005
   Jennings GT, 2008, BIOL CHEM, V389, P521, DOI 10.1515/BC.2008.064
   Kaptoul D, 2007, SCAND J INFECT DIS, V39, P70, DOI 10.1080/00365540600740553
   Klovins J, 2002, J GEN VIROL, V83, P1523, DOI 10.1099/0022-1317-83-6-1523
   KOZLOVSKA TM, 1993, GENE, V137, P133, DOI 10.1016/0378-1119(93)90261-Z
   Ledizet M, 2005, VACCINE, V23, P3915, DOI 10.1016/j.vaccine.2005.03.006
   Lee JWM, 2006, J BIOL CHEM, V281, P1352, DOI 10.1074/jbc.M506614200
   Lim JK, 2008, J INFECT DIS, V197, P262, DOI 10.1086/524691
   MARTINA BEE, PLOS ONE IN PRESS
   Martina BE, 2008, VACCINE, V26, P153, DOI 10.1016/j.vaccine.2007.10.055
   McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613
   Monath TP, 2006, P NATL ACAD SCI USA, V103, P6694, DOI 10.1073/pnas.0601932103
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   O'Leary DR, 2004, VECTOR-BORNE ZOONOT, V4, P61, DOI 10.1089/153036604773083004
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   PEABODY DS, 1990, J BIOL CHEM, V265, P5684
   Rohn TA, 2006, EUR J IMMUNOL, V36, P2857, DOI 10.1002/eji.200636658
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   ROSSINI G, 2008, EURO SURVEILL, V13
   Sanchez MD, 2005, VIROLOGY, V336, P70, DOI 10.1016/j.virol.2005.02.020
   Spohn G, 2005, J IMMUNOL, V175, P6211, DOI 10.4049/jimmunol.175.9.6211
   Spohn G, 2008, EXPERT REV VACCINES, V7, P43, DOI 10.1586/14760584.7.1.43
   Spohn G, 2008, EUR J IMMUNOL, V38, P877, DOI 10.1002/eji.200737989
   Spohn G, 2007, J IMMUNOL, V178, P7450, DOI 10.4049/jimmunol.178.11.7450
   Tissot AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009809
   van den Worm SHE, 2006, J MOL BIOL, V363, P558, DOI 10.1016/j.jmb.2006.08.053
   Volk DE, 2004, J BIOL CHEM, V279, P38755, DOI 10.1074/jbc.M402385200
   Wang T, 2001, J IMMUNOL, V167, P5273, DOI 10.4049/jimmunol.167.9.5273
NR 40
TC 53
Z9 54
U1 3
U2 13
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD JUL 6
PY 2010
VL 7
AR 146
DI 10.1186/1743-422X-7-146
PG 9
WC Virology
SC Virology
GA 659XQ
UT WOS:000282601200001
PM 20604940
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Chatterji, BP
   Banerjee, M
   Singh, P
   Panda, D
AF Chatterji, Biswa Prasun
   Banerjee, Mithu
   Singh, Parminder
   Panda, Dulal
TI RETRACTED: HMBA depolymerizes microtubules, activates mitotic
   checkpoints and induces mitotic block in MCF-7 cells by binding at the
   colchicine site in tubulin (Retracted Article. See vol 80, pg 1113,
   2010)
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article; Retracted Publication
DE Microtubule; HMBA; Apoptosis; Anticancer drugs; Spindle assembly
   checkpoint proteins; p53
ID HEXAMETHYLENE BISACETAMIDE NSC-95580; PHASE-I TRIAL; ANTIPROLIFERATIVE
   ACTIVITY; INDUCED-DIFFERENTIATION; ANTIMICROTUBULE AGENTS; KINETIC
   STABILIZATION; DYNAMIC INSTABILITY; KINETOCHORE PAIRS; ASSEMBLY
   DYNAMICS; ANTICANCER DRUGS
AB 10-[(3-Hydroxy-4-methoxybenzylidene)]-9(10H)-anthracenone (HMBA), a synthetic compound, has been reported to have a potent antitumor activity. In this study, we found that HMBA depolymerized microtubules in MCF-7 cells and produced aberrant spindles in the MCF-7 cells. It also reduced the distance between the centrosomes and activated the mitotic checkpoint proteins BubR1 and Mad2. Further, HMBA inhibited the progression of MCF-7 cells in mitosis and induced apoptotic cell death involving p53 pathway. In vitro, HMBA bound to purified brain tubulin with a dissociation constant of 4.1 +/- 0.9 mu M. It inhibited microtubule assembly and increased the GTP hydrolysis rate of microtubule assembly. The compound did not alter the binding of 2'(or 3')-O-(trinitrophenyl)guanosine 5'-triphosphate (TNP-GTP), a fluorescent analogue of GTP, to tubulin suggesting that it did not inhibit the binding of GTP to tubulin. However, we obtained evidence indicating that HMBA perturbed the conformation of the GTP binding site in tubulin. In addition, an analysis of the modified Dixon plot suggested that HMBA competitively inhibited the binding of colchicine to tubulin. A computational analysis of the binding of HMBA to tubulin supported the finding that HMBA shared its binding site with colchicine in tubulin and indicated that the binding of HMBA to tubulin was primarily stabilized through hydrogen bonding. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Chatterji, Biswa Prasun; Banerjee, Mithu; Singh, Parminder; Panda, Dulal] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.
RP Panda, D (reprint author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.
EM panda@iitb.ac.in
FU Council of Scientific and Industrial Research, Government of India
FX This work is supported by a grant from the Council of Scientific and
   Industrial Research, Government of India to DP. DP is a Swarnajayanti
   fellow. We thank Centre for Research in Nanotechnology and Science of
   Indian Institute of Technology Bombay for FACS facility. We thank Sonia
   Kapoor and Bhavya Jindal for critically reading the manuscript.
CR Acharya BR, 2008, BIOCHEMISTRY-US, V47, P7838, DOI 10.1021/bi800730q
   Alvarez R, 2009, BIOORGAN MED CHEM, V17, P6422, DOI 10.1016/j.bmc.2009.07.012
   ANDREEFF M, 1992, BLOOD, V80, P2604
   Aneja R, 2006, BIOCHEM PHARMACOL, V72, P415, DOI 10.1016/j.bcp.2006.05.004
   BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Carlson RO, 2008, EXPERT OPIN INV DRUG, V17, P707, DOI [10.1517/13543784.17.5.707 , 10.1517/13543780802065552]
   Chiang YK, 2009, J MED CHEM, V52, P4221, DOI 10.1021/jm801649y
   Choudhary SK, 2008, J INFECT DIS, V197, P1162, DOI 10.1086/529525
   Clement MJ, 2008, BIOCHEMISTRY-US, V47, P13016, DOI 10.1021/bi801136q
   CONLEY BA, 1989, CANCER RES, V49, P3436
   DETRICH HW, 1981, BIOCHEMISTRY-US, V20, P5999, DOI 10.1021/bi00524a012
   Dey A, 2008, CELL CYCLE, V7, P3759, DOI 10.4161/cc.7.23.7213
   DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170
   EGORIN MJ, 1987, CANCER RES, V47, P617
   Giannakakou P, 2002, P NATL ACAD SCI USA, V99, P10855, DOI 10.1073/pnas.132275599
   Gupta K, 2002, BIOCHEMISTRY-US, V41, P13029, DOI 10.1021/bi025952r
   Gupta KK, 2006, FEBS J, V273, P5320, DOI 10.1111/j.1742-4658.2006.05525.x
   HAMEL E, 1981, ARCH BIOCHEM BIOPHYS, V209, P29, DOI 10.1016/0003-9861(81)90253-8
   Han Y, 1998, BIOCHEMISTRY-US, V37, P6636, DOI 10.1021/bi9719760
   Jaiswal R, 2007, BIOCHEMISTRY-US, V46, P4211, DOI 10.1021/bi602573e
   Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nr1317
   KIYOKAWA H, 1994, MOL CELL BIOL, V14, P7195, DOI 10.1128/MCB.14.11.7195
   Kovacs P, 2008, COMP BIOCHEM PHYS B, V149, P259, DOI 10.1016/j.cbpb.2007.09.014
   LEE JC, 1975, J BIOL CHEM, V250, P9276
   LENG L, 1993, CANCER RES, V53, P5554
   MARKS PA, 1994, P NATL ACAD SCI USA, V91, P10251, DOI 10.1073/pnas.91.22.10251
   Mohan R, 2008, CANCER RES, V68, P6181, DOI 10.1158/0008-5472.CAN-08-0584
   Montes M, 2008, J CHEM INF MODEL, V48, P157, DOI 10.1021/ci700313e
   Montes M, 2007, PROTEINS, V68, P712, DOI 10.1002/prot.21405
   Ouyang GL, 2004, WORLD J GASTROENTERO, V10, P954, DOI 10.3748/wjg.v10.i7.945
   Palumbo C, 2004, CANCER CHEMOTH PHARM, V54, P398, DOI 10.1007/s00280-004-0838-6
   PANDA D, 1992, BIOCHEMISTRY-US, V31, P9709, DOI 10.1021/bi00155a026
   Panda D, 2005, P NATL ACAD SCI USA, V102, P9878, DOI 10.1073/pnas.0501821102
   Panda D, 1997, P NATL ACAD SCI USA, V94, P10560, DOI 10.1073/pnas.94.20.10560
   Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366
   Prinz H, 2003, J MED CHEM, V46, P3382, DOI 10.1021/jm0307685
   Putey A, 2009, J MED CHEM, V52, P5916, DOI 10.1021/jm900476c
   Rathinasamy K, 2006, FEBS J, V273, P4114, DOI 10.1111/j.1742-4658.2006.05413.x
   Rathinasamy K, 2008, BIOCHEM PHARMACOL, V76, P1669, DOI 10.1016/j.bcp.2008.09.001
   Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393
   Romagnoli R, 2009, BIOORGAN MED CHEM, V17, P6862, DOI 10.1016/j.bmc.2009.08.027
   Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679
   SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765
   Siegel DS, 1998, P NATL ACAD SCI USA, V95, P162, DOI 10.1073/pnas.95.1.162
   Singh P, 2008, IUBMB LIFE, V60, P368, DOI 10.1002/iub.42
   Srivastava P, 2007, FEBS J, V274, P4788, DOI 10.1111/j.1742-4658.2007.06004.x
   vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047
   Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X
   Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783
   WARD LD, 1988, BIOCHEMISTRY-US, V27, P1508, DOI 10.1021/bi00405a017
   YOUNG CW, 1988, CANCER RES, V48, P7304
   Zhou J, 2002, J BIOL CHEM, V277, P17200, DOI 10.1074/jbc.M110369200
   Zuse A, 2007, J MED CHEM, V50, P6059, DOI 10.1021/jm0708984
   Zuse A, 2007, EUR J PHARMACOL, V575, P34, DOI 10.1016/j.ejphar.2007.07.050
NR 55
TC 7
Z9 8
U1 1
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0006-2952
EI 1873-2968
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD JUL 1
PY 2010
VL 80
IS 1
BP 50
EP 61
DI 10.1016/j.bcp.2010.03.016
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 593XW
UT WOS:000277497600006
PM 20302847
DA 2018-12-27
ER

PT J
AU Safarinejad, MR
   Asgari, MA
   Hosseini, SY
   Dadkhah, F
AF Safarinejad, Mohammad Reza
   Asgari, Majid Ali
   Hosseini, Seyyed Yousof
   Dadkhah, Farid
TI RETRACTED: A double-blind placebo-controlled study of the efficacy and
   safety of pentoxifylline in early chronic Peyronie's disease (Retracted
   article. See vol. 115, pg. E10, 2015)
SO BJU INTERNATIONAL
LA English
DT Article; Retracted Publication
DE pentoxifylline; Peyronie's disease; treatment; erectile dysfunction
ID NONSURGICAL TREATMENT; ERECTILE DYSFUNCTION; INTERNATIONAL INDEX;
   NATURAL-HISTORY; L-CARNITINE; COMBINATION; SUPPRESSION; FIBROSIS;
   THERAPY; PLAQUE
AB OBJECTIVE
   To analyse the safety and efficacy of pentoxifylline sustained-release (PTX-SR) treatment in patients with early chronic Peyronie's disease (PD).
   PATIENTS AND METHODS
   In all, 228 patients with a mean (sd) age of 51 (9) years who had early chronic PD were randomized to receive 400 mg PTX-SR (Apo-Pentoxifylline, Apotex Inc., Toronto, Canada) twice daily (group 1, 114) or similar regimen of placebo (group 2, 114) for 6 months. A medical history was taken and the men had a complete physical examination. The following variables were assessed before and after therapy: penile curvature and penile artery spectral traces (end-diastolic velocity, EDV, peak systolic velocity, PSV, and resistivity index, RI, of the right and left cavernous arteries assessed with dynamic penile duplex ultrasonography), plaque characteristics (assessed by penile X-ray and penile ultrasonography), pain (assessed by visual analogue scale), erectile function (assessed by the International Index of Erectile Function, IIEF questionnaire), treatment satisfaction (assessed by Erectile Dysfunction Inventory of Treatment Satisfaction questionnaire), and side-effects. Patient perception of penile curvature and plaque size, and mean weekly intercourse attempts were also assessed.
   RESULTS
   Overall, 36.9% of patients who received PTX-SR reported a positive response, vs only 4.5% in the placebo group. Of patients in PTX-SR group, 12 (11%) had disease progression, vs 46 (42%) in placebo group (P = 0.01). Improvement in penile curvature (P = 0.01), and plaque volume (P = 0.001) was significantly greater in patients treated with PTX-SR than placebo. The increase in IIEF total score was significantly higher in the PTX-SR group (P = 0.02). Mean PSV changes after therapy compared to baseline were statistically significant between PTX-SR (right, +11.4%, left, +11.7%) and placebo-treated (+0.2% and -4.2%, respectively) patients (both P = 0.04).
   CONCLUSIONS
   PTX-R was moderately effective in reducing penile curvature and plaque volume in patients with early chronic PD. Further studies with different treatment regimens are needed to better elucidate the beneficial effects of PTX-SR in PD.
C1 Shahid Beheshti Univ MC, Urol & Nephrol Res Ctr, Tehran, Iran.
   Shahid Beheshti Univ MC, Shaheed Modarress Hosp, Dept Urol, Tehran, Iran.
RP Safarinejad, MR (reprint author), POB 19395-1849, Tehran, Iran.
EM safarinejad@unrc.ir
RI Hosseini, Seyed Yousef/K-5189-2018
OI Hosseini, Seyed Yousef/0000-0001-5069-8548
CR Biagiotti G, 2001, BJU INT, V88, P63, DOI 10.1046/j.1464-410x.2001.02241.x
   Cappelleri JC, 1999, UROLOGY, V54, P346, DOI 10.1016/S0090-4295(99)00099-0
   Cormio L, 2009, EUR UROL, V55, P1469, DOI 10.1016/j.eururo.2008.11.041
   Fernandes JL, 2008, ATHEROSCLEROSIS, V196, P434, DOI 10.1016/j.atherosclerosis.2006.11.032
   GELBARD MK, 1990, J UROLOGY, V144, P1376, DOI 10.1016/S0022-5347(17)39746-X
   Gholami SS, 2003, J UROLOGY, V169, P1234, DOI 10.1097/01.ju.0000053800.62741.fe
   Haag SM, 2008, EUR UROL, V53, P425, DOI 10.1016/j.eururo.2007.06.036
   Haag SM, 2007, EUR UROL, V51, P255, DOI 10.1016/j.eururo.2006.05.002
   Hauck EW, 2006, EUR UROL, V49, P987, DOI 10.1016/j.eururo.2006.02.059
   Jarow JP, 1997, J UROLOGY, V158, P1388, DOI 10.1016/S0022-5347(01)64222-8
   Kadioglu A, 2002, J UROLOGY, V168, P1075, DOI 10.1097/01.ju.0000024040.55662.36
   Kapetanos D, 2007, GASTROINTEST ENDOSC, V66, P513, DOI 10.1016/j.gie.2007.03.1045
   KELAMI A, 1983, UROL INT, V38, P229, DOI 10.1159/000280897
   Levine LA, 2007, EUR UROL, V51, P601, DOI 10.1016/j.eururo.2006.10.048
   Lischer G H, 2001, Curr Opin Urol, V11, P631, DOI 10.1097/00042307-200111000-00012
   Louvet A, 2008, J HEPATOL, V48, P465, DOI 10.1016/j.jhep.2007.10.010
   Maiti R, 2007, VASC PHARMACOL, V47, P118, DOI 10.1016/j.vph.2007.05.004
   Menon RTR, 2008, J NEUROIMMUNOL, V201, P128, DOI 10.1016/j.jneuroim.2008.05.023
   MONTORSI F, 1994, J UROLOGY, V151, P373, DOI 10.1016/S0022-5347(17)34952-2
   Prasad K, 2007, ATHEROSCLEROSIS, V192, P313, DOI 10.1016/j.atherosclerosis.2006.07.034
   Raetsch C, 2002, GUT, V50, P241, DOI 10.1136/gut.50.2.241
   Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0
   Safarinejad MR, 2007, J UROLOGY, V178, P1398, DOI 10.1016/j.juro.2007.05.162
   Safarinejad MR, 2009, J SEX MED, V6, P1743, DOI 10.1111/j.1743-6109.2009.01235.x
   Safarinejad MR, 2004, INT J IMPOT RES, V16, P238, DOI 10.1038/sj.ijir.3901185
   SCHANDENE L, 1992, IMMUNOLOGY, V76, P30
   Valente EGA, 2003, NITRIC OXIDE-BIOL CH, V9, P229, DOI 10.1016/j.niox.2003.12.002
   Venkitaraman R, 2008, CLIN ONCOL-UK, V20, P288, DOI 10.1016/j.clon.2008.01.012
   Wilkins CJ, 2003, CLIN RADIOL, V58, P514, DOI 10.1016/S0009-9260(03)00112-0
   WILLIAMS JL, 1970, J UROLOGY, V103, P75, DOI 10.1016/S0022-5347(17)61894-9
   Windmeier C, 1997, GEN PHARMACOL-VASC S, V29, P181, DOI 10.1016/S0306-3623(96)00314-X
NR 31
TC 36
Z9 39
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1464-4096
EI 1464-410X
J9 BJU INT
JI BJU Int.
PD JUL
PY 2010
VL 106
IS 2
BP 240
EP 248
DI 10.1111/j.1464-410X.2009.09041.x
PG 9
WC Urology & Nephrology
SC Urology & Nephrology
GA 612PO
UT WOS:000278913200018
PM 19863517
DA 2018-12-27
ER

PT J
AU Ahmad, A
   Wang, ZW
   Kong, DJ
   Ali, S
   Li, YW
   Banerjee, S
   Ali, R
   Sarkar, FH
AF Ahmad, Aamir
   Wang, Zhiwei
   Kong, Dejuan
   Ali, Shadan
   Li, Yiwei
   Banerjee, Sanjeev
   Ali, Raza
   Sarkar, Fazlul H.
TI RETRACTED: FoxM1 down-regulation leads to inhibition of proliferation,
   migration and invasion of breast cancer cells through the modulation of
   extra-cellular matrix degrading factors (Retracted article. See vol.
   158, pg. 607, 2016)
SO BREAST CANCER RESEARCH AND TREATMENT
LA English
DT Article; Retracted Publication
DE FoxM1; uPA; Invasion; Migration; VEGF; Extra cellular matrix; Matrix
   metalloproteinases
ID FORKHEAD BOX M1; TRANSCRIPTION FACTOR FOXM1; ENDOTHELIAL GROWTH-FACTOR;
   FACTOR-KAPPA-B; PANCREATIC-CANCER; PROSTATE-CANCER; GLIOMA-CELLS;
   LIVER-REGENERATION; LUNG-CANCER; EXPRESSION
AB Forkhead box M1 (FoxM1) transcription factor is known to play important role in human cancers which, in part, is mediated by its ability to modulate cell cycle regulatory proteins as well as genes involved in cell proliferation and differentiation. In breast cancer, FoxM1 down-regulation is increasingly being recognized as an important mechanism for the targeted activity of anti-cancer agents. However, the mechanistic insight in support of the role of FoxM1 in aggressive breast cancer is poorly understood. We have tested the biological consequence of FoxM1 down-regulation and up-regulation in breast cancer cell lines and found that the down-regulation of FoxM1 in MDA-MB-231 and SUM149 cells by siRNA approach inhibited cell growth, clonogenicity, migration, and invasion. We also found decreased expression of CDK2 and E2F1 with concomitant increase in p21 and p27 proteins, suggesting an important role of FoxM1 in cell cycle progression. In contrast, over-expression of FoxM1 by cDNA transfection, in breast cancer cells (SUM102 and SKBR3) expressing low levels of FoxM1, resulted in increased cell proliferation, migration, and invasion. Moreover, down-regulation of FoxM1 inhibited the expression of many factors that are involved in the degradation of extra cellular matrix and angiogenesis such as uPA, uPAR, MMP-2, MMP-9, and vascular endothelial growth factor (VEGF) as well as inhibited the activity of MMP-9 and VEGF. Interestingly, over-expression of uPA by cDNA transfection abrogated the cellular effects that were observed by the down-regulation of FoxM1. Taken together, these results suggest the potential application of FoxM1 down-regulation as a novel approach for the treatment of aggressive breast cancer.
C1 [Sarkar, Fazlul H.] Karmanos Canc Inst, Dept Pathol, Detroit, MI 48201 USA.
   [Ahmad, Aamir; Wang, Zhiwei; Kong, Dejuan; Ali, Shadan; Li, Yiwei; Banerjee, Sanjeev; Ali, Raza; Sarkar, Fazlul H.] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Ctr, Dept Pathol, Detroit, MI 48201 USA.
RP Sarkar, FH (reprint author), Karmanos Canc Inst, Dept Pathol, 740 HWCRC Bldg,4160 John R St, Detroit, MI 48201 USA.
EM fsarkar@med.wayne.edu
RI Wang, Zhiwei/A-6809-2011; Ahmad, Aamir/E-8747-2010
CR Adami Guy R, 2007, Future Oncol, V3, P1, DOI 10.2217/14796694.3.1.1
   Ahmad A, 2008, J CELL BIOCHEM, V105, P1461, DOI 10.1002/jcb.21966
   Ahmad A, 2009, J CELL BIOCHEM, V108, P916, DOI 10.1002/jcb.22323
   Ahmad A, 2009, J CELL BIOCHEM, V107, P516, DOI 10.1002/jcb.22152
   Ali S, 2008, MOL CANCER THER, V7, P1708, DOI 10.1158/1535-7163.MCT-08-0354
   Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005
   Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592
   Chan DW, 2008, J PATHOL, V215, P245, DOI 10.1002/path.2355
   Chetty C, 2009, INT J CANCER, V124, P2468, DOI 10.1002/ijc.24209
   Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0
   Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108
   Curran S, 2000, EUR J CANCER, V36, P1621, DOI 10.1016/S0959-8049(00)00156-8
   Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443
   Halasi M, 2009, CELL CYCLE, V8, P1966, DOI 10.4161/cc.8.12.8708
   Han B, 2005, ONCOL REP, V14, P105
   Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138
   Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704
   Katoh M, 2004, INT J ONCOL, V25, P1495
   Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003
   Kong DJ, 2007, CANCER RES, V67, P3310, DOI 10.1158/0008-5472.CAN-06-4277
   Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188
   Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217
   Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006
   Lee MH, 2001, CELL MOL LIFE SCI, V58, P1907, DOI 10.1007/PL00000826
   Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045
   Li YW, 2005, MOL CANCER THER, V4, P389
   Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912
   Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007
   Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004
   McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805
   Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223
   Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277
   Pillay V, 2007, TRENDS BIOTECHNOL, V25, P33, DOI 10.1016/j.tibtech.2006.10.011
   Radhakrishnan Senthil K, 2008, Nat Rev Cancer, V8, pc2, DOI 10.1038/nrc2223-c1
   Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576
   Rahman KMW, 2006, CANCER RES, V66, P4952, DOI 10.1158/0008-5472.CAN-05-3918
   Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06
   Wang IC, 2008, ONCOGENE, V27, P4137, DOI 10.1038/onc.2008.60
   Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200
   Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005
   Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299
   Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200
   Wang ZW, 2007, CANCER RES, V67, P11377, DOI 10.1158/0008-5472.CAN-07-2803
   Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265
   Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281
   Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059
   Ye HG, 1999, MOL CELL BIOL, V19, P8570
   Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036
   Zhang YJ, 2008, CANCER RES, V68, P8733, DOI 10.1158/0008-5472.CAN-08-1968
NR 49
TC 98
Z9 107
U1 3
U2 28
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0167-6806
EI 1573-7217
J9 BREAST CANCER RES TR
JI Breast Cancer Res. Treat.
PD JUL
PY 2010
VL 122
IS 2
BP 337
EP 346
DI 10.1007/s10549-009-0572-1
PG 10
WC Oncology
SC Oncology
GA 611JF
UT WOS:000278810700004
PM 19813088
DA 2018-12-27
ER

PT J
AU Terzis, JK
   Dryer, MM
   Bodner, BI
AF Terzis, Julia K.
   Dryer, Marylou M.
   Bodner, Bruce I.
TI RETRACTED: Corneal Neurotization: A Novel Technique for the Anesthetic
   Cornea (Retracted article. See vol. 29, pg. 1332, 2010)
SO CORNEA
LA English
DT Article; Retracted Publication
DE corneal neurotization; anesthetic cornea; neurotrophic keratopathy;
   facial palsy
ID FACIAL-NERVE PALSY; MANAGEMENT; EYE; PARALYSIS; TRANSPLANTATION;
   SUSPENSION; GRAFT
AB Purpose: This report describes and evaluates the efficacy of a novel procedure, direct corneal neurotization using contralateral, supraorbital, and supratrochlear nerves in patients with unilateral facial palsy and corneal anesthesia.
   Methods: The charts of 6 patients were thoroughly reviewed. Evaluated outcome parameters included corneal sensibility, improvement in best-corrected visual acuity, blink reflex, donor deficit, synesthesia, long-term corneal health, several psychosocial measures, and overall patient satisfaction.
   Results: The mean age at time of surgery in our study was 41.7 +/- 9.07 years. Average time from denervation to surgery was 7.00 +/- 8.56 years with an average follow-up time of 16.3 +/- 2.42 years. After surgery, all 6 eyes showed improvement of corneal sensibility, visual acuity, and corneal health and remained free of ulcers without adjunctive surgical treatment. Average time to sensibility was 2.80 +/- 2.17 years, and average corneal sensibility improved from 2.00 +/- 4.47 mm before surgery to 27.8 +/- 22.6 mm after corneal neurotization (P < 0.016).
   Conclusions: Direct neurotization of the cornea using the contralateral, supraorbital, and supratrochlear branches of the ophthalmic division of the trigeminal nerve seems to be an effective method for restoration of corneal sensibility in patients with unilateral facial palsy and anesthetic cornea. This procedure preserves ocular anatomy and cosmesis while restoring function by improving corneal health and visual acuity and by reestablishing the blink reflex.
C1 [Terzis, Julia K.] Eastern Virginia Med Sch, Microsurg Res Ctr, Int Inst Reconstruct Microsurg, Div Plast & Reconstruct Surg,Dept surg, Norfolk, VA 23501 USA.
   [Bodner, Bruce I.] Virginia Eye Consultants, Norfolk, VA USA.
   [Bodner, Bruce I.] Lions Med Eye Bank, Norfolk, VA USA.
   [Bodner, Bruce I.] Res Ctr Eastern Virginia Inc, Norfolk, VA USA.
   [Bodner, Bruce I.] Laser Optic Ctr, Norfolk, VA USA.
RP Terzis, JK (reprint author), Eastern Virginia Med Sch, Microsurg Res Ctr, Int Inst Reconstruct Microsurg, Div Plast & Reconstruct Surg,Dept surg, 700 Olney Rd,Lewis Hall Room 2055, Norfolk, VA 23501 USA.
EM mrc@jkterzis.com
OI Terzis, Julia K/0000-0002-3153-2435
CR Belmonte C, 2004, EXP EYE RES, V78, P513, DOI 10.1016/j.exer.2003.09.023
   CATALANO PJ, 1995, ARCH OTOLARYNGOL, V121, P81
   CATALANO PJ, 1994, NEUROSURGERY, V35, P259, DOI 10.1227/00006123-199408000-00011
   Dictionary.com, AM HER STEDM MED DIC
   FLOWERS RS, 1994, PLAST RECONSTR SURG, V94, P544, DOI 10.1097/00006534-199409000-00022
   Frey M, 2004, PLAST RECONSTR SURG, V114, P865, DOI 10.1097/01.PRS.0000133028.02305.16
   Frueh BR, 2002, OPHTHALMIC PLAST REC, V18, P133, DOI 10.1097/00002341-200203000-00007
   GRAY H, 2000, GRAYS ANATOMY HUMAN, pCH5
   Hashikawa K, 2005, PLAST RECONSTR SURG, V115, P880, DOI 10.1097/01.PRS.000015233.87258.5D
   Kauffmann T, 1997, GER J OPHTHALMOL, V5, P508
   Khokhar S, 2005, CORNEA, V24, P654, DOI 10.1097/01.ico.0000153102.19776.80
   Kirkman TW, 1996, STAT USE
   Levine R E, 2000, Facial Plast Surg, V16, P325, DOI 10.1055/s-2000-15548
   MARTINUZZI A, 1991, ITAL J OPHTHALMOL, V5, P23
   Morris LG, 2006, LARYNGOSCOPE, V116, P1293, DOI 10.1097/01.mlg.0000225378.11938.6a
   Nazzi V, 2006, J Neurosurg Sci, V50, P107
   Pushker Neelam, 2001, CLAO Journal, V27, P100
   Riedel K G, 1991, Fortschr Ophthalmol, V88, P569
   SEIFF SR, 1993, OPHTHALMIC PLAST REC, V9, P241, DOI 10.1097/00002341-199312000-00003
   SEIFF SR, 2002, INT OPHTHALMOL CLIN, V24, P103
   Sodhi PK, 2005, J CRANIO MAXILL SURG, V33, P205, DOI 10.1016/j.jcms.2005.01.006
   Terzis JK, 2008, PLAST RECONSTR SURG, V121, P1206, DOI 10.1097/01.prs.0000305520.07311.fb
   Terzis JK, 2008, PLAST RECONSTR SURG, V121, P806, DOI 10.1097/01.prs.0000299919.18076.b4
   Terzis Julia K, 2002, Facial Plast Surg, V18, P101, DOI 10.1055/s-2002-32200
   Terzis JK, 2009, PLAST RECONSTR SURG, V124, P1486, DOI 10.1097/PRS.0b013e3181b98924
   Zwick Orin M, 2006, Optometry, V77, P340, DOI 10.1016/j.optm.2006.03.004
NR 26
TC 4
Z9 4
U1 2
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0277-3740
EI 1536-4798
J9 CORNEA
JI Cornea
PD JUL
PY 2010
VL 29
IS 7
BP 812
EP 819
DI 10.1097/ICO.0b013e3181ca2984
PG 8
WC Ophthalmology
SC Ophthalmology
GA 630DS
UT WOS:000280253300017
PM 20489582
DA 2018-12-27
ER

PT J
AU Chowdhury, S
   Hall, K
AF Chowdhury, Shakhawat
   Hall, Kevin
TI RETRACTED: Human health risk assessment from exposure to trihalomethanes
   in Canadian cities (Retracted article. See vol. 39, pg. 1, 2012)
SO ENVIRONMENT INTERNATIONAL
LA English
DT Article; Retracted Publication
DE Disinfection byproducts; Human health risks; Exposure routes; Exposure
   models; Canadian cities
ID DISINFECTION BY-PRODUCTS; DRINKING-WATER; HALOACETIC ACIDS;
   BLADDER-CANCER; TAP WATER; HALOKETONES; CHLOROFORM; PERFORMANCE; COST
AB Lifetime exposure to trihalomethanes (THMs) through ingestion, inhalation and dermal contacts may pose risks to human health. Current approaches may under predict THMs exposure by using THMs in cold water during showering and bathing. Warming of chlorinated water during showering may increase THMs formation through reactions between organics and residual chlorine, which can increase human health risks. In this study, THMs concentrations in shower water were estimated using THMs rate increase model. Using cold water THMs, exposure through ingestion was estimated, while THMs exposure during showering was estimated using THMs in warm water. Human health cancer risks and additional expenses for 20 most populated Canadian cities from exposure to THMs were estimated. Inhalation and dermal contact during showering contributed 30% to 50% of total cancer risks, while risks from inhalation and dermal contacts were comparable for all cities. Overall cancer risks were estimated between 7.2 x 10(-6) and 6.4 x 10(-5) for these cities. Cancer incidents were estimated highest for Montreal (94/year) followed by Toronto (53/year), which may require additional medical expenses of 18.8 and 10.7 million dollars/year for Montreal and Toronto respectively. Cancer risks from exposure to THMs can be controlled by reducing THMs in water supply and varying shower stall volume, shower duration and air exchange rate in shower stall. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Chowdhury, Shakhawat] Univ Laval, Ecole Super Amenagement Terr, Quebec City, PQ G1V 0A6, Canada.
   [Hall, Kevin] Univ Guelph, Guelph, ON N1G 2W1, Canada.
RP Chowdhury, S (reprint author), Univ Laval, Ecole Super Amenagement Terr, 1628 Pavillon Felix Antoine Savard, Quebec City, PQ G1V 0A6, Canada.
EM Shakhawat.Chowdhury.1@ulaval.ca
OI Chowdhury, Shakhawat/0000-0002-0329-2630
FU NSERC
FX The financial support from NSERC is gratefully acknowledged. The author
   acknowledges the cooperation of the Provincial Drinking Water Offices
   across Canada. The cooperation of Dave Fellowes of the Ministry of the
   Environment is gratefully acknowledged.
CR Al-Omari A, 2004, ENVIRON MODEL ASSESS, V9, P245
   *ALB ENV, 2007, THMS BDCM DAT DRINK
   *BRIT COL ENV, 2007, GREATT VANC WAT DIST
   Cantor KP, 1998, EPIDEMIOLOGY, V9, P21, DOI 10.1097/00001648-199801000-00007
   Chowdhury S, 2009, SCI TOTAL ENVIRON, V407, P1570, DOI 10.1016/j.scitotenv.2008.11.025
   Chowdhury S, 2007, J WATER SUPPLY RES T, V56, P75, DOI 10.2166/aqua.2007.090
   Chowdhury S, 2008, WATER QUAL RES J CAN, V43, P189
   Clark RM, 1998, J WATER SERV RES TEC, V47, P255
   CLARK RM, 1994, J ENVIRON ENG-ASCE, V120, P759, DOI 10.1061/(ASCE)0733-9372(1994)120:4(759)
   *DEP DOE, 2007, THMS DRINK WAT
   Dodds L, 2004, EPIDEMIOLOGY, V15, P179, DOI 10.1097/01.ede.0000112209.47765.d9
   GOLD LS, 1993, RISK ANAL, V13, P399, DOI 10.1111/j.1539-6924.1993.tb00739.x
   Golden RJ, 1997, REGUL TOXICOL PHARM, V26, P142, DOI 10.1006/rtph.1997.1161
   *HLTH CAN, 2008, GUID CAN DRNIK WAT Q
   Hrudey SE, 2009, WATER RES, V43, P2057, DOI 10.1016/j.watres.2009.02.011
   *IPCS, 2006, ENV HLTH CRIT, V216
   JO WK, 1990, RISK ANAL, V10, P581, DOI 10.1111/j.1539-6924.1990.tb00542.x
   King WD, 2000, CANCER EPIDEM BIOMAR, V9, P813
   Lee SC, 2004, ENVIRON RES, V94, P47, DOI 10.1016/S0013-9351(03)0067-7
   Liang L, 2003, ENVIRON SCI TECHNOL, V37, P2920, DOI 10.1021/es026230q
   Louvar JF, 1998, HLTH ENV RISK ANAL
   LYKINS BW, 1994, J ENVIRON ENG-ASCE, V120, P745, DOI 10.1061/(ASCE)0733-9372(1994)120:4(745)
   LYNCH CF, 1989, ARCH ENVIRON HEALTH, V44, P252, DOI 10.1080/00039896.1989.9935891
   *MAN ENV, 2009, THMS DAT YEARS 2001
   *MAN ENV, 2007, THMS DAT YEARS 2001
   MCKONE TE, 1987, ENVIRON SCI TECHNOL, V21, P1194, DOI 10.1021/es00165a006
   Richardson S. D., 2005, GLOBAL NEST J, V7, P43
   Sadiq R, 2004, SCI TOTAL ENVIRON, V321, P21, DOI 10.1016/j.scitotenv.2003.05.001
   Savitz DA, 2006, AM J EPIDEMIOL, V164, P1043, DOI 10.1093/aje/kwj300
   Tan YM, 2007, J EXPO SCI ENV EPID, V17, P591, DOI 10.1038/sj.jes.7500540
   United States. Department of Education National Center for Education Statistics, 2005, FED REG
   *USEPA, 1999, EXP FACT HDB
   *USEPA, 1991, 92006309911 USEPA OE
   *USEPA, 2002, COST ILL HDB
   *USEPA, 1997, EXP FACT HDB
   USEPA (U.S. Environmental Protection Agency), 1998, EPA530D98001A OFF SO
   Villanueva CM, 2004, EPIDEMIOLOGY, V15, P357, DOI 10.1097/01.ede.0000121380.02594.fc
   WEISEL CP, 1994, RISK ANAL, V14, P101, DOI 10.1111/j.1539-6924.1994.tb00032.x
   WHO, 2002, WAT SAN FACTS FIG
   Wigle D T, 1998, Chronic Dis Can, V19, P103
   Xu X, 2003, ENVIRON SCI TECHNOL, V37, P569, DOI 10.1021/es025747
   Xu X, 2005, J EXPO ANAL ENV EPID, V15, P6, DOI 10.1038/sj.jea.7500374
   Xu X, 2002, TOXICOL APPL PHARM, V184, P19, DOI 10.1006/taap.2002.9494
NR 43
TC 17
Z9 18
U1 3
U2 47
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0160-4120
EI 1873-6750
J9 ENVIRON INT
JI Environ. Int.
PD JUL
PY 2010
VL 36
IS 5
BP 453
EP 460
DI 10.1016/j.envint.2010.04.001
PG 8
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 617PL
UT WOS:000279293100008
PM 20434775
DA 2018-12-27
ER

PT J
AU Alshatwi, AA
AF Alshatwi, Ali A.
TI RETRACTED: Breast cancer risk, dietary intake, and
   methylenetetrahydrofolate reductase (MTHFR) single nucleotide
   polymorphisms (Retracted article. See vol. 118, pg. 973, 2018)
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article; Retracted Publication
DE MTHFR; Diet intake; Folate metabolism; SNP; Breast cancer
ID FOLATE-DEFICIENCY; SUSCEPTIBILITY; WOMEN; GENE; DNA; ASSOCIATION;
   GENOMICS; LUNG
AB Diet plays an important role in DNA methylation, synthesis, and repair; intake has been associated with breast cancer. The folate-metabolizing enzyme, methylenetetrahydrofolate reductase (MTHFR) is polymorphic at nucleotides 677 (C -> T). resulting in allozymes with altered activity and is thus believed to cause interindividual differences in cancer risk susceptibility. I evaluated this polymorphism and its effect on the food intake and breast cancer risk association in a population-based case-control study of 100 breast cancer cases and 100 controls using a real-time PCR based assay. All subjects completed in-person interviews, which included a food-frequency questionnaire. Unconditional logistic regression models were used to calculate odds ratios and their 95% confidence intervals, after adjusting for potential confounding factors. Cases and controls were similar in the distribution of MTHFR polymorphisms at codon 677 (41.4% cases and 41.8% controls carried the T allele). An inverse association of breast cancer risk with food intake was observed in all genotype groups, particularly among subjects with the 677TT genotype. Compared with those with the 677CC genotype and high food intake frequency, the adjusted odds ratios (95% confidence intervals) associated with low food intake were 1.94 (1.15-3.26), 2.17 (1.34-3.51), and 2.51 (1.37-4.60) for subjects who had CC, CT, and TT genotypes (P for interaction, 0.05). Results of this study suggest that the MTHFR C677T polymorphism may modify the association between dietary intake and breast cancer risk. (C) 2010 Elsevier Ltd. All rights reserved.
C1 King Saud Univ, MCBRL, Dept Food Sci & Nutr, Riyadh 11451, KSA, Saudi Arabia.
RP Alshatwi, AA (reprint author), King Saud Univ, MCBRL, Dept Food Sci & Nutr, Riyadh 11451, KSA, Saudi Arabia.
EM alialshatwi@gmail.com
CR Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107
   Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290
   Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691
   Campbell IG, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr457
   Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887
   FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111
   Gershoni-Baruch R, 2000, EUR J CANCER, V36, P2313, DOI 10.1016/S0959-8049(00)00306-3
   JIAN Z, 2010, BREAST CANC RES TREA, DOI DOI 10.1007/S10549-010-0783-5
   Kim YI, 1997, AM J CLIN NUTR, V65, P46
   Levi F, 2001, INT J CANCER, V91, P260, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1041>3.3.CO;2-R
   Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9
   Ma E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-122
   Martin YN, 2006, PHARMACOGENET GENOM, V16, P265, DOI 10.1097/01.fpc.0000194423.20393.08
   McGlynn KA, 2000, 91 ANN AACR M APR 1
   Nomura M, 2000, VIRCHOWS ARCH, V437, P17, DOI 10.1007/s004280000198
   Oldenburg RA, 2007, CRIT REV ONCOL HEMAT, V63, P125, DOI 10.1016/j.critrevonc.2006.12.004
   Rampersaud GC, 2000, AM J CLIN NUTR, V72, P998
   Roberti A, 2006, J CELL PHYSIOL, V207, P571, DOI 10.1002/jcp.20515
   Rohan TE, 2000, J NATL CANCER I, V92, P266, DOI 10.1093/jnci/92.3.266
   Rossi E, 2006, ANN EPIDEMIOL, V16, P206, DOI 10.1016/j.annepidem.2005.03.010
   Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x
   Semenza JC, 2003, BREAST CANCER RES TR, V77, P217, DOI 10.1023/A:1021843019755
   Sharp L, 2002, CANCER LETT, V181, P65, DOI 10.1016/S0304-3835(02)00030-7
   Shen HB, 2001, INT J CANCER, V95, P332, DOI 10.1002/1097-0215(20010920)95:5<332::AID-IJC1058>3.0.CO;2-9
   Shen HB, 2001, CANCER EPIDEM BIOMAR, V10, P397
   Shrubsole MJ, 2001, CANCER RES, V61, P7136
   Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984
   Ulrich CM, 2005, J NUTR, V135, P2698
   Weinstein SJ, 2002, J NUTR, V132, P762
NR 29
TC 30
Z9 31
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD JUL
PY 2010
VL 48
IS 7
BP 1881
EP 1885
DI 10.1016/j.fct.2010.04.028
PG 5
WC Food Science & Technology; Toxicology
SC Food Science & Technology; Toxicology
GA 620VY
UT WOS:000279530500017
PM 20417243
DA 2018-12-27
ER

PT J
AU Steensma, DP
AF Steensma, David P.
TI RETRACTED: P39/Tsugane cells are a false cell line contaminated with
   HL-60 cells and are not suitable for mechanistic studies in
   myelodysplastic syndromes (Retracted Article. See vol 95, pg 1620, 2010)
SO HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
LA English
DT Letter; Retracted Publication
C1 Dana Farber Canc Inst, Dept Hematol Malignancies, Luekemia Grp, Boston, MA 02115 USA.
RP Steensma, DP (reprint author), Dana Farber Canc Inst, Dept Hematol Malignancies, Luekemia Grp, 44 Binney St,Suite D1B30,Mayer 1B21, Boston, MA 02115 USA.
OI Steensma, David/0000-0001-5130-9284
CR COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0
   Drexler HG, 2009, LEUKEMIA RES, V33, P1011, DOI 10.1016/j.leukres.2009.03.005
   Drexler HG, 2003, LEUKEMIA, V17, P416, DOI 10.1038/sj.leu.2402799
   NAGAI M, 1984, GANN, V75, P1100
NR 4
TC 2
Z9 2
U1 1
U2 10
PU FERRATA STORTI FOUNDATION
PI PAVIA
PA VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY
SN 0390-6078
EI 1592-8721
J9 HAEMATOL-HEMATOL J
JI Haematol-Hematol. J.
PD JUL
PY 2010
VL 95
IS 7
BP 1229
EP 1230
DI 10.3324/haematol.2010.022988
PG 2
WC Hematology
SC Hematology
GA 624WT
UT WOS:000279853500030
PM 20421273
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Bechange, S
AF Bechange, Stevens
TI RETRACTED: Determinants of project success among HIV/AIDS
   nongovernmental organizations (NGOs) in Rakai, Uganda (Retracted
   article. See vol. 28, pg. 236, 2013)
SO INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT
LA English
DT Article; Retracted Publication
DE project success; nongovernmental organizations (NGOs); HIV and AIDS;
   Africa; Uganda
ID NON-GOVERNMENTAL ORGANIZATIONS; HIV-INFECTION; HEALTH; BEHAVIOR
AB The aim of the study was to identify the main determinants of grassroots project success among HIV/AIDS NGOs operating in Rakai, Uganda. It was a cross-sectional study using face-to-face interviews in a mixed-methods approach among community members and NGOs involved in providing HIV/AIDS and related health services. The study found that the success of grassroots projects of HIV/AIDS NGOs essentially relies on adequate financial resources, competent human resources, strong organizational leadership, and NGO networking. These data suggest that to increase grassroots project success, HIV and AIDS NGOs in Rakai need to improve not only the budget base and human capacities but as well decision-making processes, organizational vision, mission and strategies, gender allocation in staffing, and beneficiary involvement. Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [Bechange, Stevens] UMI, Kampala, Uganda.
RP Bechange, S (reprint author), Uganda Virus Res Inst, POB 49,51-59 Nakiwogo Rd, Entebbe, Uganda.
EM bechanges@ug.cdc.gov
CR AHMAD T, 2005, AIDS, V15, P2171
   Akukwe C, 1998, J ROY SOC HEALTH, V118, P107, DOI 10.1177/146642409811800212
   Barr A, 2006, J DEV STUD, V42, P611, DOI 10.1080/00220380600682009
   Barr A, 2005, WORLD DEV, V33, P657, DOI 10.1016/j.worlddev.2004.09.010
   CANNON C, 2000, DEV NGOS CIVIL SOC
   Glaser B. G., 1967, DISCOVERY GROUNDED T
   *GLOB FUND, 2005, REP ASS COUNTR COORD
   Green EC, 2006, AIDS BEHAV, V10, P335, DOI 10.1007/s10461-006-9073-y
   Hawe P, 1997, HEALTH POLICY, V39, P29, DOI 10.1016/S0168-8510(96)00847-0
   Johnson R. B., 2004, ED RES, V33, P14, DOI DOI 10.3102/0013189X033007014
   Kinsman J, 2001, HEALTH EDUC RES, V16, P85, DOI 10.1093/her/16.1.85
   *LUTH WORLD FED, 2006, LWF UG COMM PART RAK
   Matovu JKB, 2005, AIDS, V19, P503, DOI 10.1097/01.aids.0000162339.43310.33
   *MOH KAMP, 2005, UG HIV AIDS SER BEH
   Morgan DL, 2007, J MIX METHOD RES, V1, P48, DOI 10.1177/2345678906292462
   Mosse D., 2005, CULTIVATING DEV ETHN
   Mugisha F, 2005, INT J HEALTH PLAN M, V20, P227, DOI 10.1002/hpm.811
   OKELLO D, 2003, SOC SCI MED, V46, P13
   Okware S, 2001, B WORLD HEALTH ORGAN, V79, P1113
   Parkhurst JO, 2005, DEV CHANGE, V36, P571, DOI 10.1111/j.0012-155X.2005.00424.x
   PATTON MQ, 1999, CANADIAN J PROGRAM E, V14, P93
   *SAL SHIELD FDN, 2004, FAC IND AUNT UNCL ME
   Sawhill J. C., 2001, NONPROFIT MANAGEMENT, V11, P371, DOI [10.1002/nml.11309, DOI 10.1002/NML.11309]
   SERWADDA D, 1985, LANCET, V2, P849, DOI 10.1016/S0140-6736(85)90122-9
   SEWANKAMBO NK, 1994, AIDS, V8, P1707, DOI 10.1097/00002030-199412000-00011
   SMITH K, 1989, SOC SCI MED, V29, P395, DOI 10.1016/0277-9536(89)90288-8
   Sowa JE, 2004, NONPROF VOLUNT SEC Q, V33, P711, DOI 10.1177/0899764004269146
   Spittal P., 1997, NURTURED KNOWLEDGE L, P86
   *UG AIDS COMM, 2003, DISTR RESP INT HIV A
   Uganda Bureau of Statistics, 2003, UG NAT HOUS SURV 200
   *UNAIDS, 2009, FIN RESP AIDS LOW MI
   *UNAIDS, 2005, UNAIDS WHO AIDS EP U
   *USAID, 2006, STRAT PLANN DEV PROG
   WALKER S, 2006, STRONG VOICES HOPEFU
   WAWER M, 2005, 12 C RETR OPP INF
   Were WA, 2006, JAIDS-J ACQ IMM DEF, V43, P91, DOI 10.1097/01.qai.0000225021.81384.28
   WILLMS DG, 2003, NAT DEV RES I NDRI N
   WILLMS DG, 2000, CAREER SCI PRO UNPUB
NR 38
TC 4
Z9 4
U1 2
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0749-6753
EI 1099-1751
J9 INT J HEALTH PLAN M
JI Int. J. Health Plan. Manag.
PD JUL-SEP
PY 2010
VL 25
IS 3
BP 215
EP 230
DI 10.1002/hpm.1025
PG 16
WC Health Policy & Services; Public, Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA 640TQ
UT WOS:000281075900003
PM 20066669
DA 2018-12-27
ER

PT J
AU Aflatoonian, A
   Oskouian, H
   Ahmadi, S
   Oskouian, L
AF Aflatoonian, Abbas
   Oskouian, Homa
   Ahmadi, Shahnaz
   Oskouian, Leila
TI RETRACTED: Can fresh embryo transfers be replaced by
   cryopreserved-thawed embryo transfers in assisted reproductive cycles? A
   randomized controlled trial (Retracted article. See vol. 30, pg. 1245,
   2013)
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Article; Retracted Publication
DE Endometrial receptivity; Fresh embryo transfer; Frozen-thawed embryo
   transfer; Ongoing pregnancy; Vitrification
ID OVARIAN HYPERSTIMULATION SYNDROME; HIGHLY EFFICIENT VITRIFICATION; HUMAN
   CHORIONIC-GONADOTROPIN; LIQUID-NITROGEN; HUMAN OOCYTES; ENDOMETRIAL
   RECEPTIVITY; INVITRO FERTILIZATION; PRONUCLEAR OOCYTES; STIMULATED
   CYCLES; IMPLANTATION
AB Controlled ovarian hyperstimulation has been shown to advance endometrial maturation and adversely affects implantation in ART. It has been reported that there is a better embryo-endometrium synchrony in frozen-thawed embryo transfer cycles than fresh embryo transfer cycles. The objective of this study was to compare ongoing pregnancy rates between fresh ET and FET cycles.
   In an open prospective, controlled study, the patients who were classified as high responders, were randomized to either fresh ET or FET. The embryos in FET group were cryopreserved with vitrification by Cryotop method.
   A total of 374 patients were included, 187 of which were randomized to FET and 187 to fresh ET. There were 39% (n = 73) ongoing pregnancy in FET group compared with 27.8% (n = 52) in fresh ET group[odds ratio = 1.66;95% confidence interval = 1.07-2.56; p = 0.02].
   FETs can be performed instead of fresh ETs to improve the outcome of ART in highly selected patients.
C1 [Aflatoonian, Abbas; Oskouian, Homa; Ahmadi, Shahnaz; Oskouian, Leila] Shahid Sadoughi Univ Med Sci, Dept Obstet & Gynecol, Res & Clin Ctr Infertil, Safaieh 8916877391, Yazd, Iran.
RP Oskouian, H (reprint author), Shahid Sadoughi Univ Med Sci, Dept Obstet & Gynecol, Res & Clin Ctr Infertil, Bouali Ave, Safaieh 8916877391, Yazd, Iran.
EM abbas_aflatoonian@yahoo.com; homaoskouian@gmail.com;
   AHMADISHAHNAZ2005@yahoo.com; leilaoskouian0695@gmail.com
RI AFLATOONIAN, ABBAS/A-8707-2017
OI AFLATOONIAN, ABBAS/0000-0002-2896-6136; ahmadi,
   shahnaz/0000-0002-2136-4474
CR Acosta AA, 2000, FERTIL STERIL, V73, P788, DOI 10.1016/S0015-0282(99)00605-6
   Balaban B, 2008, HUM REPROD, V23, P1976, DOI 10.1093/humrep/den222
   Bielanski A, 2000, CRYOBIOLOGY, V40, P110, DOI 10.1006/cryo.1999.2227
   Check JH, 1999, J ASSIST REPROD GEN, V16, P416, DOI 10.1023/A:1020565408018
   Devroey P, 2004, TRENDS ENDOCRIN MET, V15, P84, DOI 10.1016/j.tem.2004.01.009
   Donaghay M, 2007, SEMIN REPROD MED, V25, P461, DOI 10.1055/s-2007-991044
   Ferraretti AP, 1999, HUM REPROD, V14, P1457, DOI 10.1093/humrep/14.6.1457
   GARCIA JE, 1984, FERTIL STERIL, V41, P31
   Guerif F, 2002, HUM REPROD, V17, P1321, DOI 10.1093/humrep/17.5.1321
   Haouzi D, 2009, HUM REPROD, V24, P1436, DOI 10.1093/humrep/dep039
   Isachenko V, 2005, FERTIL STERIL, V84, pS400, DOI 10.1016/j.fertnstert.2005.07.1045
   Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021
   Kolibianakis E, 2002, FERTIL STERIL, V78, P1025, DOI 10.1016/S0015-0282(02)03323-X
   Kuleshova LL, 2002, FERTIL STERIL, V78, P449, DOI 10.1016/S0015-0282(02)03305-8
   Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300, DOI 10.1016/S1472-6483(10)60837-1
   Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014
   Kyuwa S, 2003, EXP ANIM TOKYO, V52, P67, DOI 10.1538/expanim.52.67
   Larman MG, 2006, REPROD BIOMED ONLINE, V12, P66, DOI 10.1016/S1472-6483(10)60982-0
   Liebermann J, 2002, BIOL REPROD, V67, P1671, DOI 10.1095/bioreprod.102.006833
   Liu Y, 2008, FERTIL STERIL, V90, P2152, DOI 10.1016/j.fertnstert.2007.10.020
   PAULSON RJ, 1990, AM J OBSTET GYNECOL, V163, P2020, DOI 10.1016/0002-9378(90)90790-E
   Pegg David E, 2007, Methods Mol Biol, V368, P39
   Raju GAR, 2009, FERTIL STERIL, V92, P143, DOI 10.1016/j.fertnstert.2008.05.014
   Shaker AG, 1996, FERTIL STERIL, V65, P992, DOI 10.1016/S0015-0282(16)58275-2
   Shapiro BS, 2008, FERTIL STERIL, V90, P302, DOI 10.1016/j.fertnstert.2007.06.062
   Shapiro BS, 2008, FERTIL STERIL, V89, P20, DOI 10.1016/j.fertnstert.2006.08.092
   Takahashi K, 2005, FERTIL STERIL, V84, P88, DOI 10.1016/j.fertnstert.2004.12.051
   Vajta G, 2006, THERIOGENOLOGY, V65, P236, DOI 10.1016/j.theriogenology.2005.09.026
   Vajta G, 2006, REPROD BIOMED ONLINE, V12, P779, DOI 10.1016/S1472-6483(10)61091-7
   Van Royen E, 1999, HUM REPROD, V14, P2345, DOI 10.1093/humrep/14.9.2345
   VanderElst J, 1997, HUM REPROD, V12, P1513, DOI 10.1093/humrep/12.7.1513
   Yavin S, 2009, HUM REPROD, V24, P797, DOI 10.1093/humrep/den397
NR 32
TC 72
Z9 84
U1 3
U2 14
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD JUL
PY 2010
VL 27
IS 7
BP 357
EP 363
DI 10.1007/s10815-010-9412-9
PG 7
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA 638QC
UT WOS:000280908700003
PM 20373015
OA Green Published
DA 2018-12-27
ER

PT J
AU Zografos, GN
   Farfaras, A
   Vasiliadis, G
   Pappa, T
   Aggeli, C
   Vasilatou, E
   Kaltsas, G
   Piaditis, G
AF Zografos, George N.
   Farfaras, Athanasios
   Vasiliadis, George
   Pappa, Theodora
   Aggeli, Chrysanthi
   Vasilatou, Evagelina
   Kaltsas, Gregory
   Piaditis, George
TI RETRACTED: Laparoscopic Resection of Large Adrenal Tumors (Retracted
   article. See vol. 16, pg. 189, 2012)
SO JSLS-JOURNAL OF THE SOCIETY OF LAPAROENDOSCOPIC SURGEONS
LA English
DT Article; Retracted Publication
DE Large adrenal tumors; Laparoscopic adrenalectomy; Adrenalectomy
ID PHEOCHROMOCYTOMA; MASSES; SIZE; METASTASIS; RECURRENCE; CARCINOMA;
   SURGERY; GREATER; GLAND
AB Background: Laparoscopic adrenalectomy has rapidly replaced open adrenalectomy as the procedure of choice for benign adrenal tumors. It still remains to be clarified whether the laparoscopic resection of large (>= 8cm)or potentially malignant tumors is appropriate or not due to technical difficulties and concern about local recurrence. The aim of this study was to evaluate the short-and long-term outcome of 174 consecutive laparoscopic and open adrenalectomies performed in our surgical unit.
   Methods: Our data come from a retrospective analysis of 174 consecutive adrenalectomies performed on 166 patients from May 1997 to December 2008. Fifteen patients with tumors >= 8cm underwent laparoscopic adrenalectomy. Sixty-five patients were men and 101 were women, aged 16 years to 80 years. Nine patients underwent either synchronous or metachronous bilateral adrenalectomy. Tumor size ranged from 3.2cm to 27cm. The largest laparoscopically excised tumors were a ganglioneuroma with a mean diameter of 13cm and a myelolipoma of 14cm.
   Results: In 135 patients, a laparoscopic procedure was completed successfully, whereas in 14 patients the laparoscopic procedure was converted to open. Seventeen patients were treated with an open approach from the start. There were no conversions in the group of patients with tumors >8cm. Operative time for laparoscopic adrenalectomies ranged from 65 minutes to 240 minutes. In the large adrenal tumor group, operative time for laparoscopic resection ranged from 150 minutes to 240 minutes. The postoperative hospital stay for laparoscopic adrenalectomy ranged from 1 day to 2 days (mean, 1.5) and from 5 days to 20 days for patients undergoing the open or converted procedure. The mean postoperative stay was 2 days for the group with large tumors resected by laparoscopy.
   Conclusion: Laparoscopic resection of large (>= 8cm) adrenal tumors is feasible and safe. Short-and long-term results did not differ in the 2 groups.
C1 [Zografos, George N.; Farfaras, Athanasios; Vasiliadis, George; Aggeli, Chrysanthi] Athens Gen Hosp G Gennimatas, Dept Surg 3, Athens, Greece.
   [Pappa, Theodora; Vasilatou, Evagelina; Kaltsas, Gregory; Piaditis, George] Athens Gen Hosp G Gennimatas, Dept Endocrinol, Athens, Greece.
RP Zografos, GN (reprint author), 10 Oyrani St, Athens 15237, Greece.
EM gnzografos@yahoo.com
RI FARFARAS, ATHANASIOS/E-9234-2011
CR Barnett CC, 2000, SURGERY, V128, P973, DOI 10.1067/msy.2000.110237
   Bendinelli C, 1998, J LAPAROENDOSC ADV A, V8, P119, DOI 10.1089/lap.1998.8.119
   Boylu U, 2009, J ENDOUROL, V23, P971, DOI 10.1089/end.2008.0555
   Chen B, 2002, J UROLOGY, V168, P2528, DOI 10.1097/01.ju.0000036520.14371.52
   COPELAND PM, 1984, ANN SURG, V199, P116, DOI 10.1097/00000658-198401000-00021
   Dimas S, 2007, JSLS, V11, P30
   Dudley NE, 1999, BRIT J SURG, V86, P656
   Foxius A, 1999, SURG ENDOSC-ULTRAS, V13, P715, DOI 10.1007/s004649901080
   GAGNER M, 1992, NEW ENGL J MED, V327, P1033
   Gagner M, 1997, ANN SURG, V226, P238, DOI 10.1097/00000658-199709000-00003
   Gerber Eric, 2004, JSLS, V8, P314
   Gill IS, 2001, J UROLOGY, V166, P429, DOI 10.1016/S0022-5347(05)65958-7
   Gumbs AA, 2006, BEST PRACT RES CL EN, V20, P483, DOI 10.1016/j.beem.2006.07.010
   Hamoir E, 1998, ANN CHIR, V52, P364
   Heniford BT, 1999, SEMIN SURG ONCOL, V16, P293, DOI 10.1002/(SICI)1098-2388(199906)16:4<293::AID-SSU4>3.0.CO;2-E
   Henry JF, 2002, WORLD J SURG, V26, P1043, DOI 10.1007/s00268-002-6666-0
   Henry JF, 1999, LANGENBECK ARCH SURG, V384, P366, DOI 10.1007/s004230050215
   Imai T, 1999, AM J SURG, V178, P50, DOI 10.1016/S0002-9610(99)00126-9
   Indupur RR, 2007, BJU INT, V100, P1126, DOI 10.1111/j.1464-410X.2007.07179.x
   Kebebew E, 2002, ARCH SURG-CHICAGO, V137, P948, DOI 10.1001/archsurg.137.8.948
   Lau H, 1999, BRIT J SURG, V86, P385
   Liao CH, 2006, J CLIN ENDOCR METAB, V91, P3080, DOI 10.1210/jc.2005.2420
   MARANGOS IP, 2009, J LAPAROENDOSC ADV A, V19, P181
   Mellon MJ, 2008, JSLS-J SOC LAPAROEND, V12, P380
   Mohammad WM, 2009, SURG LAPARO ENDO PER, V19, P336, DOI 10.1097/SLE.0b013e3181b05dcc
   Naya Y, 2005, INT J UROL, V12, P134, DOI 10.1111/j.1442-2042.2005.01017.x
   Novitsky YW, 2003, SURG LAPARO ENDO PER, V13, P106, DOI 10.1097/00129689-200304000-00009
   Parnaby CN, 2008, SURG ENDOSC, V22, P617, DOI 10.1007/s00464-007-9709-7
   Sarela AI, 2003, ANN SURG ONCOL, V10, pS22
   Shen WT, 2004, SURGERY, V136, P1129, DOI 10.1016/j.surg.2004.05.058
   Smith CD, 1999, WORLD J SURG, V23, P389, DOI 10.1007/PL00012314
   STANLEY DG, 1994, INT SURG, V79, P253
   Sturgeon C, 2004, SURG CLIN N AM, V84, P755, DOI 10.1016/j.suc.2004.02.003
   Telem DA, 2009, JSLS-J SOC LAPAROEND, V13, P260
   Tsuru N, 2005, J ENDOUROL, V19, P537, DOI 10.1089/end.2005.19.537
   Valeri A, 2001, SURG ENDOSC-ULTRAS, V15, P90, DOI 10.1007/s004640000245
   Vassilopoulou-Sellin R, 2001, CANCER, V92, P1113, DOI 10.1002/1097-0142(20010901)92:5<1113::AID-CNCR1428>3.0.CO;2-I
   Zografos GN, 2009, JSLS-J SOC LAPAROEND, V13, P196
   Zografos G N, 2007, JSLS, V11, P261
   Zografos G N, 2007, JSLS, V11, P487
   Zografos George N, 2006, Hormones (Athens), V5, P52
   Zografos GN, 2002, INT J CLIN PRACT, V56, P319
NR 42
TC 24
Z9 28
U1 2
U2 11
PU SOC LAPAROENDOSCOPIC SURGEONS
PI MIAMI
PA 7330 SW 62 PL, STE 410, MIAMI, FL 33143-4825 USA
SN 1086-8089
J9 JSLS-J SOC LAPAROEND
JI JSLS-J. Soc. Laparoendosc. Surg.
PD JUL-SEP
PY 2010
VL 14
IS 3
BP 364
EP 368
DI 10.4293/108680810X12924466007160
PG 5
WC Surgery
SC Surgery
GA 720TT
UT WOS:000287305900008
PM 21333189
OA Green Published
DA 2018-12-27
ER

PT J
AU Schultz, ED
   Potts, EN
   Mason, SN
   Foster, WM
   Auten, RL
AF Schultz, Eric D.
   Potts, Erin N.
   Mason, Stanley N.
   Foster, William M.
   Auten, Richard L.
TI RETRACTED: Mast Cells Mediate Hyperoxia-Induced Airway Hyper-Reactivity
   in Newborn Rats (Retracted article. See vol. 77, pg. 606, 2015)
SO PEDIATRIC RESEARCH
LA English
DT Article; Retracted Publication
ID BRONCHOPULMONARY DYSPLASIA; 60-PERCENT OXYGEN; LUNG-FUNCTION; LAMB LUNG;
   ASTHMA; GROWTH; HYPERRESPONSIVENESS; INFLAMMATION; SURFACTANT;
   MATURATION
AB Premature infants are at increased risk of developing airway hyper-reactivity (AHR) after oxidative stress and inflammation. Mast cells contribute to AHR partly by mediator release, so we sought to determine whether blocking mast cell degranulation or recruitment prevents hyperoxia-induced AHR, mast cell accumulation, and airway smooth muscle (ASM) changes. Rats were exposed at birth to air or 60% O-2 for 14 d, inducing significantly increased AHR in the latter group, induced by nebulized methacholine challenge and measured by forced oscillometry. Daily treatment (postnatal d 1-14) with intraperitoneal cromolyn prevented hyperoxia-induced AHR, as did treatment with imatinib on postnatal d 5-14, compared with vehicle treated controls. Cromolyn prevented mast cell degranulation in the trachea but not hilar airways and blocked mast cell accumulation in the hilar airways. Imatinib treatment completely blocked mast cell accumulation in tracheal/hilar airway tissues. Hyperoxia-induced AHR in neonatal rats is mediated, at least in part, via the mast cell. (Pediatr Res 68: 70-74, 2010)
C1 [Schultz, Eric D.; Mason, Stanley N.; Auten, Richard L.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA.
   [Potts, Erin N.; Foster, William M.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.
RP Auten, RL (reprint author), Duke Univ, Med Ctr, Dept Pediat, DUMC Box 3373, Durham, NC 27710 USA.
EM auten@duke.edu
FU Children's Miracle Network; National Institutes of Child Health and
   Human Development [HD-043728]; National Heart, Lung and Blood Institute
   [HL-067021]; National Institute of Environmental Health Sciences
   [ES-011961, ES-012496]; NIEHS NIH HHS [ES-011961, ES-012496, P30
   ES011961]; NHLBI NIH HHS [R01 HL067021-01A1, R01 HL067021, HL-067021];
   NICHD NIH HHS [T32 HD043728, HD-043728]
FX Supported by Children's Miracle Network, grant HD-043728 from the
   National Institutes of Child Health and Human Development, grant
   HL-067021 from the National Heart, Lung and Blood Institute, and grants
   ES-011961 and -012496 from the National Institute of Environmental
   Health Sciences.
CR Akin C, 2003, EXP HEMATOL, V31, P686, DOI 10.1016/S0301-472X(03)00112-7
   Auten RL, 2009, AM J RESP CRIT CARE, V180, P1218, DOI 10.1164/rccm.200901-0116OC
   Baraldi E, 2005, AM J RESP CRIT CARE, V171, P68, DOI 10.1164/rccm.200403-298Oc
   Bates J, 2004, AM J RESP CELL MOL, V31, P373, DOI 10.1165/ajrcmb.31.3.1
   Baud O, 1999, ARCH DIS CHILD, V80, pF159
   Bauer O, 2000, NEWS PHYSIOL SCI, V15, P213
   Bland RD, 2005, BIOL NEONATE, V88, P181, DOI 10.1159/000087581
   Bostrom H, 2002, DEV DYNAM, V223, P155, DOI 10.1002/dvdy.1225.abs
   Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039
   Brightling CE, 2003, CLIN EXP ALLERGY, V33, P550, DOI 10.1046/j.1365-2222.2003.01636.x
   Brock TG, 2006, J HISTOCHEM CYTOCHEM, V54, P1239, DOI 10.1369/jhc.6A7007.2006
   BRUMLEY GW, 1967, J CLIN INVEST, V46, P863, DOI 10.1172/JCI105586
   Denis K, 2001, PEDIATR RES, V50, P515, DOI 10.1203/00006450-200110000-00015
   Halvorsen T, 2005, PEDIAT ALLERG IMM-UK, V16, P487, DOI 10.1111/j.1399-3038.2005.00314.x
   Han RNN, 1996, PEDIATR RES, V39, P921, DOI 10.1203/00006450-199606000-00001
   HERSHENSON MB, 1994, AM J RESP CELL MOL, V11, P296, DOI 10.1165/ajrcmb.11.3.8086167
   Irvin CG, 2003, RESPIR RES, V4, DOI 10.1186/rr199
   Jobe AJ, 1999, PEDIATR RES, V46, P641, DOI 10.1203/00006450-199912000-00001
   Kallapur SG, 2009, AM J PHYSIOL-LUNG C, V297, pL512, DOI 10.1152/ajplung.00105.2009
   Kennedy JD, 2000, PEDIATR PULM, V30, P32, DOI 10.1002/1099-0496(200007)30:1<32::AID-PPUL6>3.0.CO;2-9
   Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176
   Liu S, 2005, INFLAMM RES, V54, P221, DOI 10.1007/s00011-005-1346-9
   LYLE RE, 1995, PEDIATR PULM, V19, P336, DOI 10.1002/ppul.1950190605
   Martin RJ, 1999, NEW ENGL J MED, V340, P1036, DOI 10.1056/NEJM199904013401311
   McMenamin PG, 1996, J ALLERGY CLIN IMMUN, V97, P1375, DOI 10.1016/S0091-6749(96)70207-5
   MORTOLA JP, 1983, J APPL PHYSIOL, V54, P1236
   NIWA Y, 1991, BLOOD, V78, P1936
   Page S, 2001, AM J PHYSIOL-LUNG C, V281, pL1313
   Paus R, 2006, TRENDS IMMUNOL, V27, P32, DOI 10.1016/j.it.2005.10.002
   Piedimonte G, 2003, PEDIATR INFECT DIS J, V22, pS66, DOI 10.1097/00006454-200302001-00010
   Pillow JJ, 2001, J APPL PHYSIOL, V91, P2730
   Slominski AT, 2006, J INVEST DERMATOL, V126, P1934, DOI 10.1038/sj.jid.5700342
   STEPTOE RJ, 1994, BRIT J OPHTHALMOL, V78, P211, DOI 10.1136/bjo.78.3.211
   Subramaniam M, 2003, AM J RESP CRIT CARE, V168, P601, DOI 10.1164/rccm.200212-1434OC
   Theoharides TC, 2004, J NEUROIMMUNOL, V146, P1, DOI 10.1016/j.jneuroim.2003.10.041
   Viscardi RM, 1997, AM J RESP CRIT CARE, V156, P1523, DOI 10.1164/ajrccm.156.5.9611088
   Wenzel S, 2006, AM J RESP CRIT CARE, V174, P1173, DOI 10.1164/rccm.2609002
   WILKES LK, 1992, IMMUNOLOGY, V75, P535
   Yi M, 2004, AM J RESP CRIT CARE, V170, P1188, DOI 10.1164/rccm.200402-215OC
   Zhou JS, 2007, J EXP MED, V204, P2797, DOI 10.1084/jem.20071391
NR 40
TC 8
Z9 9
U1 2
U2 14
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0031-3998
EI 1530-0447
J9 PEDIATR RES
JI Pediatr. Res.
PD JUL
PY 2010
VL 68
IS 1
BP 70
EP 74
DI 10.1203/PDR.0b013e3181e0cd97
PG 5
WC Pediatrics
SC Pediatrics
GA 613XD
UT WOS:000279016700012
PM 20386143
OA Green Accepted, Bronze
DA 2018-12-27
ER

PT J
AU Smykowski, A
   Zimmermann, P
   Zentgraf, U
AF Smykowski, Anja
   Zimmermann, Petra
   Zentgraf, Ulrike
TI RETRACTED: G-Box Binding Factor1 Reduces CATALASE2 Expression and
   Regulates the Onset of Leaf Senescence in Arabidopsis (Retracted
   article. See vol. 173, pg. 2414, 2017)
SO PLANT PHYSIOLOGY
LA English
DT Article; Retracted Publication
ID WRKY53 TRANSCRIPTION FACTOR; LEUCINE-ZIPPER PROTEINS; CASEIN KINASE-II;
   OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION;
   GENE-EXPRESSION; FACTOR GBF1; CELL-DEATH; LIFE-SPAN
AB Hydrogen peroxide (H2O2) is discussed as being a signaling molecule in Arabidopsis (Arabidopsis thaliana) leaf senescence. Intracellular H2O2 levels are controlled by the H2O2-scavenging enzyme catalase in concert with other scavenging and producing systems. Catalases are encoded by a small gene family, and the expression of all three Arabidopsis catalase genes is regulated in a senescence-associated manner. CATALASE2 (CAT2) expression is down-regulated during bolting time at the onset of leaf senescence and appears to be involved in the elevation of the H2O2 level at this time point. To understand the role of CAT2 in senescence regulation in more detail, we used CAT2 promoter fragments in a yeast one-hybrid screen to isolate upstream regulatory factors. Among others, we could identify G-Box Binding Factor1 (GBF1) as a DNA-binding protein of the CAT2 promoter. Transient overexpression of GBF1 together with a CAT2:beta-glucuronidase construct in tobacco (Nicotiana benthamiana) plants and Arabidopsis protoplasts revealed a negative effect of GBF1 on CAT2 expression. In gbf1 mutant plants, the CAT2 decrease in expression and activity at bolting time and the increase in H2O2 could no longer be observed. Consequently, the onset of leaf senescence and the expression of senescence-associated genes were delayed in gbf1 plants, clearly indicating a regulatory function of GBF1 in leaf senescence, most likely via regulation of the intracellular H2O2 content.
C1 [Smykowski, Anja; Zimmermann, Petra; Zentgraf, Ulrike] Univ Tubingen, Ctr Plant Mol Biol, D-72076 Tubingen, Germany.
RP Zentgraf, U (reprint author), Univ Tubingen, Ctr Plant Mol Biol, D-72076 Tubingen, Germany.
EM ulrike.zentgraf@zmbp.uni-tuebingen.de
FU Deutsche Forschungsgemeinschaft [SFB446]
FX This work was supported by the Deutsche Forschungsgemeinschaft (grant
   no. SFB446).
CR ARMSTRONG GA, 1992, PLANT CELL, V4, P525
   ASADA K, 1997, SCANDALIOS OXIDATIVE, P715
   Balazadeh S, 2008, PLANT BIOLOGY, V10, P63, DOI 10.1111/j.1438-8677.2008.00088.x
   Barth C, 2004, PLANT PHYSIOL, V134, P1784, DOI 10.1104/pp.103.032185
   Bechtold N, 1998, METH MOL B, V82, P259
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHIA LS, 1981, PLANT PHYSIOL, V67, P415, DOI 10.1104/pp.67.3.415
   DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93
   Foyer CH, 2000, NEW PHYTOL, V146, P359, DOI 10.1046/j.1469-8137.2000.00667.x
   Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177
   GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089
   Harman D, 1998, EXP GERONTOL, V33, P95, DOI 10.1016/S0531-5565(97)00059-4
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARTER K, 1994, PLANT CELL, V6, P545
   Hinderhofer K, 2001, PLANTA, V213, P469, DOI 10.1007/s004250000512
   Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3
   JEFFERSON RA, 1987, EMBO J, V6, P3901
   Jimenez A, 1998, PLANT PHYSIOL, V118, P1327, DOI 10.1104/pp.118.4.1327
   Kircher S, 1998, MOL GEN GENET, V257, P595, DOI 10.1007/s004380050687
   Kirchler T, 2010, EUR J CELL BIOL, V89, P175, DOI 10.1016/j.ejcb.2009.11.023
   KLIMCZAK LJ, 1992, PLANT CELL, V4, P87
   KLIMCZAK LJ, 1995, PLANT CELL, V7, P105
   Kurepa J, 1998, PLANT J, V14, P759, DOI 10.1046/j.1365-313x.1998.00168.x
   Mallappa C, 2008, J BIOL CHEM, V283, P35772, DOI 10.1074/jbc.M803437200
   Mallappa C, 2006, J BIOL CHEM, V281, P22190, DOI 10.1074/jbc.M601172200
   Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25
   MCRAE DG, 1983, PLANTA, V158, P185, DOI 10.1007/BF01075253
   Miao Y, 2008, PLANT BIOLOGY, V10, P110, DOI 10.1111/j.1438-8677.2008.00083.x
   Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-004-2142-6
   Miao Y, 2007, PLANT MOL BIOL, V65, P63, DOI 10.1007/s11103-007-9198-z
   Miller JD, 1999, PLANT PHYSIOL, V120, P1015, DOI 10.1104/pp.120.4.1015
   Navabpour S, 2003, J EXP BOT, V54, P2285, DOI 10.1093/jxb/erg267
   Orendi G, 2001, PLANT SCI, V161, P301, DOI 10.1016/S0168-9452(01)00409-5
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   Panavas T, 1998, PLANT SCI, V133, P125, DOI 10.1016/S0168-9452(98)00034-X
   Panchuk II, 2005, PLANTA, V222, P926, DOI 10.1007/s00425-005-0028-8
   PASTORI GM, 1994, PLANTA, V193, P385, DOI 10.1007/BF00201817
   PAULS KP, 1984, PLANT PHYSIOL, V75, P1152, DOI 10.1104/pp.75.4.1152
   Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x
   Scandalios JG, 1997, OXIDATIVE STRESS MOL, P343
   SCHINDLER U, 1992, PLANT CELL, V4, P1309, DOI 10.1105/tpc.4.10.1309
   SCHINDLER U, 1992, EMBO J, V11, P1261, DOI 10.1002/j.1460-2075.1992.tb05170.x
   Schippers JHM, 2008, PLANT CELL, V20, P2909, DOI 10.1105/tpc.107.056341
   Sehnke PC, 2005, CELL RES, V15, P567, DOI 10.1038/sj.cr.7290326
   Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.127.4.1466
   Shen HS, 2008, BMB REP, V41, P132, DOI 10.5483/BMBRep.2008.41.2.132
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Tamai H, 2002, PLANT CELL PHYSIOL, V43, P99, DOI 10.1093/pcp/pcf011
   Terzaghi WB, 1997, PLANT J, V11, P967, DOI 10.1046/j.1365-313X.1997.11050967.x
   WEISSHAAR B, 1991, EMBO J, V10, P1777, DOI 10.1002/j.1460-2075.1991.tb07702.x
   Willemyns M, 1997, J LANG SOC PSYCHOL, V16, P3, DOI 10.1177/0261927X970161001
   Woo HR, 2004, PLANT CELL PHYSIOL, V45, P923, DOI 10.1093/pcp/pch110
   Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593
   Ye ZZ, 2000, PLANT SCI, V158, P115, DOI 10.1016/S0168-9452(00)00316-2
   Zentgraf U, 2010, EUR J CELL BIOL, V89, P133, DOI 10.1016/j.ejcb.2009.10.014
   Zentgraf Ulrike, 2008, V69, P117, DOI 10.1007/978-3-540-72954-9_5
   Zimmermann P, 2006, PLANT CELL ENVIRON, V29, P1049, DOI 10.1111/j.1365-3040.2005.01459.x
NR 57
TC 61
Z9 69
U1 4
U2 28
PU AMER SOC PLANT BIOLOGISTS
PI ROCKVILLE
PA 15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA
SN 0032-0889
EI 1532-2548
J9 PLANT PHYSIOL
JI Plant Physiol.
PD JUL
PY 2010
VL 153
IS 3
BP 1321
EP 1331
DI 10.1104/pp.110.157180
PG 11
WC Plant Sciences
SC Plant Sciences
GA 619AX
UT WOS:000279400200034
PM 20484024
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI RETRACTED: Consensus Statement on the Adoption of the COPE Guidelines
   (Retracted Article. See vol 35, pg 940, 2011)
SO WORLD JOURNAL OF SURGERY
LA English
DT Editorial Material; Retracted Publication
NR 0
TC 0
Z9 0
U1 2
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0364-2313
EI 1432-2323
J9 WORLD J SURG
JI World J.Surg.
PD JUL
PY 2010
VL 34
IS 7
BP 1399
EP 1400
DI 10.1007/s00268-010-0567-4
PG 2
WC Surgery
SC Surgery
GA 615AP
UT WOS:000279103400001
DA 2018-12-27
ER

PT J
AU Reddy, VJ
   Douglas, CJ
AF Reddy, Venkata Jaganmohan
   Douglas, Christopher J.
TI RETRACTED: Catalytic C-CN activation and asymmetric cyanoamidation of
   alkenes: total syntheses of (+)-horsfiline, (-)-coerulescine, and
   (-)-esermethole (Retracted article. See vol. 67, pg. 5360, 2011)
SO TETRAHEDRON
LA English
DT Article; Retracted Publication
DE C-C bond activation; Asymmetric catalysis; Total synthesis; Alkaloids
ID CARBON QUATERNARY STEREOCENTERS; INTRAMOLECULAR CYANOAMIDATION;
   3,3-DISUBSTITUTED OXINDOLES; EFFICIENT SYNTHESIS; CONJUGATE ADDITION;
   FORMAL SYNTHESIS; PALLADIUM; CYCLIZATION; HORSFILINE; (+/-)-HORSFILINE
AB The detailed study of Pd-catalyzed asymmetric cyanoamidation is reported. Excellent enantioselectivities are attributed to a chiral phosphosphoramidite ligand synthesized in one step from the commercially available materials. Cyanoamidation substrates are easy to prepare from the corresponding anilines. The 3,3-disubstituted oxindole products bear all-carbon quaternary stereocenters and contain a nitrile and an amide, which are valuable functional handles for the synthesis of many indole-containing natural products. Cyanoamidation tolerates free N-H groups, as demonstrated by the successful use of cyanoamidation in the syntheses of (+)-horsfiline and (-)-coerulescine. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Reddy, Venkata Jaganmohan; Douglas, Christopher J.] Univ Minnesota Twin Cities, Dept Chem, Minneapolis, MN 55455 USA.
RP Douglas, CJ (reprint author), Univ Minnesota Twin Cities, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.
EM cdouglas@umn.edu
FU University of Minnesota (UMN)
FX We thank the University of Minnesota (UMN) for start-up funds, Prof.
   Andrew Harned (UMN) for use of a shared HPLC, and Ms. Rosalind Douglas
   (UMN) for assistance in manuscript preparation.
CR Appukkuttan P, 2003, SYNLETT, P1204
   BASCOP SI, 1994, HETEROCYCLES, V38, P725
   Bui T, 2009, J AM CHEM SOC, V131, P8758, DOI 10.1021/ja903520c
   Chang MY, 2005, TETRAHEDRON LETT, V46, P8463, DOI 10.1016/j.tetlet.2005.10.015
   Christoffers J, 2005, QUATERNARY STEREOCENTERS: CHALLENGES AND SOLUTIONS FOR ORGANIC SYNTHESIS, P1, DOI 10.1002/3527606858
   Clay MD, 2005, ANGEW CHEM INT EDIT, V44, P4039, DOI 10.1002/anie.200500484
   Cravotto G, 2001, J ORG CHEM, V66, P8447, DOI 10.1021/jo015854w
   Cui CB, 1996, J ANTIBIOT, V49, P832, DOI 10.7164/antibiotics.49.832
   Denmark SE, 1999, J ORG CHEM, V64, P1958, DOI 10.1021/jo9820723
   Douglas CJ, 2004, P NATL ACAD SCI USA, V101, P5363, DOI 10.1073/pnas.0307113101
   Fischer C, 2000, HELV CHIM ACTA, V83, P1175, DOI 10.1002/1522-2675(20000607)83:6<1175::AID-HLCA1175>3.0.CO;2-D
   Garg NK, 2002, J AM CHEM SOC, V124, P13179, DOI 10.1021/ja027822b
   GOMEZBENGOA E, 1991, J ORG CHEM, V56, P3497, DOI 10.1021/jo00011a011
   GREIG NH, 1995, MED RES REV, V15, P3, DOI 10.1002/med.2610150103
   Huang A, 2004, J AM CHEM SOC, V126, P14043, DOI 10.1021/ja046690e
   JACOBS TL, 1946, J AM CHEM SOC, V68, P1310, DOI 10.1021/ja01211a061
   Jaegli S, 2009, SYNLETT, P2997, DOI 10.1055/s-0029-1218004
   Jensen T, 2008, ANGEW CHEM INT EDIT, V47, P888, DOI 10.1002/anie.200703763
   JONES K, 1992, J CHEM SOC CHEM COMM, P1767, DOI 10.1039/c39920001767
   KAMIYA N, 1990, SYNLETT, P675
   Kobayashi Y, 2007, TETRAHEDRON, V63, P2978, DOI 10.1016/j.tet.2007.01.060
   Kobayashi Y, 2006, ORG LETT, V8, P2711, DOI 10.1021/ol060733+
   Kulkarni MG, 2009, TETRAHEDRON LETT, V50, P2411, DOI 10.1016/j.tetlet.2009.03.012
   Kumar UKS, 2001, ORG LETT, V3, P4193, DOI 10.1021/ol016824l
   Lakshmaiah G, 1999, J ORG CHEM, V64, P1699, DOI 10.1021/jo981577q
   Linn W. J., 1969, ORG SYNTH, V49, P103
   Lippa B, 2007, BIOORG MED CHEM LETT, V17, P3081, DOI 10.1016/j.bmcl.2007.03.046
   Lizos DE, 2003, ORG BIOMOL CHEM, V1, P117, DOI 10.1039/b208114h
   MARTIN EL, 1971, ORG SYNTH, V51, P268
   McDonald IM, 2007, J MED CHEM, V50, P4789, DOI 10.1021/jm0707626
   MUCHOWSKI JM, 1980, J ORG CHEM, V45, P4798, DOI 10.1021/jo01311a059
   Mukai C, 2006, ORG LETT, V8, P83, DOI 10.1021/ol052562z
   Murphy JA, 2005, ORG LETT, V7, P3287, DOI 10.1021/ol051095i
   Myers AG, 1997, J AM CHEM SOC, V119, P6072, DOI 10.1021/ja9703741
   Nakao Y, 2008, J AM CHEM SOC, V130, P12874, DOI 10.1021/ja805088r
   Nicolaou KC, 2003, ANGEW CHEM INT EDIT, V42, P3643, DOI 10.1002/anie.200351825
   Nishida A, 2005, HETEROCYCLES, V66, P181, DOI 10.3987/COM-05-S(K)71
   PELLEGRINI C, 1994, TETRAHEDRON-ASYMMETR, V5, P1979, DOI 10.1016/S0957-4166(00)86273-4
   Pinto A, 2007, CHEM-EUR J, V13, P961, DOI 10.1002/chem.200601016
   Reddy VJ, 2010, ORG LETT, V12, P952, DOI 10.1021/ol902949d
   REDDY VJ, 2009, 238 NAT M AM CHEM SO
   Renaud J, 1998, J AM CHEM SOC, V120, P7995, DOI 10.1021/ja980958i
   Rigby JH, 2007, ORG LETT, V9, P1219, DOI 10.1021/ol062915+
   SANO M, 1993, CLIN NEUROPHARMACOL, V16, P61, DOI 10.1097/00002826-199302000-00007
   SATOH T, 1969, TETRAHEDRON LETT, P4555
   Selvakumar N, 2002, TETRAHEDRON LETT, V43, P9175, DOI 10.1016/S0040-4039(02)02267-0
   Shaw KTY, 2001, P NATL ACAD SCI USA, V98, P7605, DOI 10.1073/pnas.131152998
   Takahashi K, 2001, J ORGANOMET CHEM, V625, P47, DOI 10.1016/S0022-328X(00)00826-3
   Trost BM, 2006, J AM CHEM SOC, V128, P6314, DOI 10.1021/ja0608139
   Trost BM, 2006, J AM CHEM SOC, V128, P4590, DOI 10.1021/ja060560j
   Trost BM, 2006, ORG LETT, V8, P2027, DOI 10.1021/ol060298j
   Trost BM, 2006, SYNTHESIS-STUTTGART, P369, DOI 10.1055/s-2006-926302
   Ueno S, 2007, J AM CHEM SOC, V129, P6098, DOI 10.1021/ja0713431
   van den Berg M, 2003, ADV SYNTH CATAL, V345, P308, DOI 10.1002/adsc.200390026
   Watson MP, 2008, J AM CHEM SOC, V130, P12594, DOI 10.1021/ja805094j
   Yasui Y, 2008, ORG LETT, V10, P3303, DOI 10.1021/ol801168j
   Yasui Y, 2010, TETRAHEDRON, V66, P1980, DOI 10.1016/j.tet.2010.01.073
   Youn SW, 2008, J ORG CHEM, V73, P5658, DOI 10.1021/jo800914c
   Yu QS, 2001, J MED CHEM, V44, P4062, DOI 10.1021/jm010080x
   Zhang FY, 1998, TETRAHEDRON-ASYMMETR, V9, P1179, DOI 10.1016/S0957-4166(98)00092-5
   ZHU JP, 1993, J ORG CHEM, V58, P6451, DOI 10.1021/jo00075a048
NR 61
TC 17
Z9 17
U1 2
U2 28
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0040-4020
J9 TETRAHEDRON
JI Tetrahedron
PD JUN 26
PY 2010
VL 66
IS 26
BP 4719
EP 4729
DI 10.1016/j.tet.2010.02.096
PG 11
WC Chemistry, Organic
SC Chemistry
GA 613AE
UT WOS:000278947200007
DA 2018-12-27
ER

PT J
AU Owino, EA
AF Owino, Eunice A.
TI RETRACTED: Trapping mosquitoes using milk products as odour baits in
   western Kenya (Retracted article. See vol. 3, art no. 78, 2010)
SO PARASITES & VECTORS
LA English
DT Article; Retracted Publication
ID MM-X TRAPS; ANOPHELES-GAMBIAE; LIMBURGER CHEESE; HOST-SEEKING; BITING
   SITES; MALARIA; CULICIDAE; DIPTERA; ATTRACTION; RESPONSES
AB Background: Ample evidence has shown that blood seeking mosquitoes locate their hosts by following odours produced by the hosts. Odour baited traps would therefore, provide a solution in controlling diseases spread by mosquitoes. Comparative studies were undertaken to determine the relative efficacies of two odour baits i.e. Limburger cheese and African traditional milk cream in trapping mosquitoes in the field in western Kenya.
   Method: Comparative efficacy studies were carried out in the field using Latin square experimental designs. In the first study, a counterflow geometry (CFG) trap (MM-x model; American Biophysics Corp., USA.) baited with Limburger cheese, man landing catches (MLC), Centres for Disease Control (CDC) light trap and an entry trap were compared. In the second study, three CFG traps baited with either Limburger cheese, African traditional milk cream or with no bait were compared and in the third study four CDC traps baited with either Limburger cheese, African traditional milk cream, light or with no bait were compared. Parameters like species, catch size, abdominal status, parity status and size of the collected mosquitoes were compared.
   Results: A total of 1,806 mosquitoes were collected (60% An. gambiae s.l and 25% An.funestus, culicines 15%). There was no significant difference in the number of An. funestus trapped by the CFG trap baited with Limburger cheese from those trapped by the MLC (P = 0.351). The Limburger cheese baited CFG trap collected significantly more gravid An. funestus than the MLC (P = 0.022). Furthermore, when the CFG trap baited with Limburger cheese and the CFG trap baited with milk cream were compared, there was no significant difference in the number of An. funestus collected (P = 0.573). The same trend was observed in the comparison of Limburger cheese baited CDC trap and milk cream baited CDC trap.
   Conclusions: Limburger cheese and African traditional milk cream have a potential as effective odour baits for sampling/surveillance and as oviposition attractants for the malaria vector, Anopheles funestus.
C1 [Owino, Eunice A.] Univ Nairobi, Sch Biol Sci, Nairobi, Kenya.
   [Owino, Eunice A.] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya.
RP Owino, EA (reprint author), Univ Nairobi, Sch Biol Sci, POB 30197-00100, Nairobi, Kenya.
EM euniceowino@gmail.com
OI OWINO, EUNICE/0000-0001-6079-1797
FU University of Nairobi
FX A great many thanks go to the Center for Insect Physiology and Ecology
   (ICIPE), especially to Professor Ahmed Hassan Ali, who organized use of
   the laboratory facilities at the Thomas Odhiambo Campus in ICIPE Mbita
   Point. I would also like to thank Mr. Maurice Otieno who helped in
   collecting the data. My sincere appreciation goes to Professor Sinclair
   Mantell of Nakhlatec International, Sweden for helpful comments and
   suggestions during the editing of the manuscript. This work was funded
   by the University of Nairobi.
CR Ameneshewa B, 1996, MED VET ENTOMOL, V10, P170, DOI 10.1111/j.1365-2915.1996.tb00724.x
   BEEHLER JW, 1994, MED VET ENTOMOL, V8, P381, DOI 10.1111/j.1365-2915.1994.tb00103.x
   DEJONG R, 1995, EXPERIENTIA, V51, P80
   DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13
   Gillies MT, 1987, PUBLICATIONS S AFRIC, V55, P143
   GILLIES MT, 1968, S AFRICAN I MED RES, V54, P343
   Healy TP, 2000, MED VET ENTOMOL, V14, P195, DOI 10.1046/j.1365-2915.2000.00238.x
   Healy TP, 2002, MED VET ENTOMOL, V16, P126, DOI 10.1046/j.1365-2915.2002.00353.x
   KELLY R, 1992, J AM MOSQUITO CONTR, V8, P386
   Kline DL, 2006, J AM MOSQUITO CONTR, V22, P490, DOI 10.2987/8756-971X(2006)22[490:TATTFA]2.0.CO;2
   KLINE DL, J VECTOR ECOL, V2, P186
   KNOLS BG, 1997, SCI MED, P56
   Knols BGJ, 1997, B ENTOMOL RES, V87, P151, DOI 10.1017/S0007485300027292
   Knols BGJ, 1996, PARASITOL TODAY, V12, P159, DOI 10.1016/0169-4758(96)10002-8
   KNOLS BGJ, 1994, J AM MOSQUITO CONTR, V10, P423
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   LINES JD, 1991, PARASITOLOGY, V102, P167, DOI 10.1017/S0031182000062454
   Minakawa N, 1999, AM J TROP MED HYG, V61, P1010, DOI 10.4269/ajtmh.1999.61.1010
   Murphy MW, 2001, J MED ENTOMOL, V38, P242, DOI 10.1603/0022-2585-38.2.242
   Mutero CM, 1998, E AFR MED J, V75, P11
   Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39
   OKUMU F.O., 2010, PLOS ONE, V5
   Okumu FO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-12
   Olanga EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-6
   Qiu YT, 2007, J MED ENTOMOL, V44, P970, DOI 10.1603/0022-2585(2007)44[970:AOMTBW]2.0.CO;2
   SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520
   SERVICE MW, 2008, MED ENTOMOLOGY STUDE, V4, P53
   Smallegange RC, 2005, CHEM SENSES, V30, P145, DOI 10.1093/chemse/bji010
   Smallegange Renate, 2002, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V13, P147
   SMITH C, 1970, ANN ENTOMOL SOC AM, V63, P922
   Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131
   TAKKEN W, 1991, INSECT SCI APPL, V12, P287, DOI 10.1017/S1742758400020816
   VERLHUST NO, 2009, MALARIA J, V8, P302
   *WHO, 1975, MAN PRACT ENT MAL, V47, P13
NR 34
TC 2
Z9 2
U1 2
U2 14
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUN 24
PY 2010
VL 3
AR 55
DI 10.1186/1756-3305-3-55
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 658MU
UT WOS:000282494900001
PM 20573278
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Assaife-Lopes, N
   Sousa, VC
   Pereira, DB
   Ribeiro, JA
   Chao, MV
   Sebastiao, AM
AF Assaife-Lopes, Natalia
   Sousa, Vasco C.
   Pereira, Daniela B.
   Ribeiro, Joaquim A.
   Chao, Moses V.
   Sebastiao, Ana M.
TI RETRACTED: Activation of Adenosine A(2A) Receptors Induces TrkB
   Translocation and Increases BDNF-Mediated Phospho-TrkB Localization in
   Lipid Rafts: Implications for Neuromodulation (Retracted article. See
   vol. 33, pg. 1292, 2013)
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article; Retracted Publication
ID LONG-TERM POTENTIATION; INDUCED SYNAPTIC POTENTIATION; NEUROTROPHIC
   FACTOR; SIGNAL-TRANSDUCTION; HIPPOCAMPAL SLICES; TYROSINE KINASE;
   PLASMA-MEMBRANE; FREQUENCY STIMULATION; NEURONAL-ACTIVITY; RAT
   HIPPOCAMPAL
AB Brain-derived neurotrophic factor (BDNF) signaling is critical for neuronal development and transmission. Recruitment of TrkB receptors to lipid rafts has been shown to be necessary for the activation of specific signaling pathways and modulation of neurotransmitter release by BDNF. Since TrkB receptors are known to be modulated by adenosine A(2A) receptor activation, we hypothesized that activation of A(2A) receptors could influence TrkB receptor localization among different membrane microdomains. We found that adenosine A(2A) receptor agonists increased the levels of TrkB receptors in the lipid raft fraction of cortical membranes and potentiated BDNF-induced augmentation of phosphorylated TrkB levels in lipid rafts. Blockade of the clathrin-mediated endocytosis with monodansylcadaverine (100 mu M) did not modify the effects of the A(2A) receptor agonists but significantly impaired BDNF effects on TrkB recruitment to lipid rafts. The effect of A(2A) receptor activation in TrkB localization was mimicked by 5 mu M forskolin, an adenylyl cyclase activator. Also, it was blocked by the PKA inhibitors Rp-cAMPs and PKI-(14-22), and by the Src-family kinase inhibitor PP2. Moreover, removal of endogenous adenosine or disruption of lipid rafts reduced BDNF stimulatory effects on glutamate release from cortical synaptosomes. Lipid raft integrity was also required for the effects of BDNF on hippocampal long-term potentiation at CA1 synapses. Our data demonstrate, for the first time, a BDNF-independent recruitment of TrkB receptors to lipid rafts induced by activation of adenosine A(2A) receptors, with functional consequences for TrkB phosphorylation and BDNF-induced modulation of neurotransmitter release and hippocampal plasticity.
C1 [Sebastiao, Ana M.] Univ Lisbon, Fac Med, Inst Mol Med, Inst Pharmacol & Neurosci, P-1649028 Lisbon, Portugal.
   [Assaife-Lopes, Natalia; Sousa, Vasco C.; Ribeiro, Joaquim A.; Sebastiao, Ana M.] Univ Lisbon, Inst Mol Med, Unit Neurosci, P-1649028 Lisbon, Portugal.
   [Pereira, Daniela B.; Chao, Moses V.] NYU, Sch Med, Dept Physiol & Neurosci, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY 10016 USA.
RP Sebastiao, AM (reprint author), Univ Lisbon, Fac Med, Inst Mol Med, Inst Pharmacol & Neurosci, Ave Prof Egas Moniz,Edificio Egas Moniz,Piso 1B, P-1649028 Lisbon, Portugal.
EM anaseb@fm.ul.pt
OI B. Pereira, Daniela/0000-0003-4872-5505; Ribeiro,
   Joaquim/0000-0002-9330-3507; Sebastiao, Ana M/0000-0001-9030-6115; Chao,
   Moses/0000-0002-6969-3744
FU Fundacao para a Ciencia e a Tecnologia [SFRH/BD/21374/2005,
   SFRH/BD/21359/2005, SFRH/BPD/11528/2002]; European Union
FX This work, N.A.L., V.C.S., and D.B.P. were supported by Fundacao para a
   Ciencia e a Tecnologia (SFRH/BD/21374/2005 for N.A.L.,
   SFRH/BD/21359/2005 for V.C.S., and SFRH/BPD/11528/2002 for D. B. P.) and
   by the European Union [European Cooperation in Science and Technology
   (COST) COST B30 concerted action, Neural Regeneration and Plasticity
   (NEREPLAS)]. We thank Regeneron Pharmaceuticals for the gift of
   brain-derived neurotrophic factor, the Institute of Physiology of the
   Faculty of Medicine of Lisbon for the animal house facility, Ana Rita
   Costenla for help with the long-term potentiation experiments, W.W.
   Anderson (University of Bristol, Bristol, UK) for the gift of the
   electrophysiology data analysis (long-term potentiation) program, and
   Cristina Casalou from Centro de Investigacao em Patobiologia Molecular
   (CIPM), Instituto Portugues de Oncologia (IPO), for access to the
   ultracentrifuge.
CR Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0
   AWAD JA, 1983, J BIOL CHEM, V258, P2960
   Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535
   BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756
   Boulanger L, 1999, SCIENCE, V284, P1982, DOI 10.1126/science.284.5422.1982
   Boulanger L, 1999, NAT NEUROSCI, V2, P346
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Canas N, 2004, BRAIN RES, V1016, P72, DOI 10.1016/j.brainres.2004.04.070
   Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078
   Chen GQ, 1999, J NEUROSCI, V19, P7983
   Christian AE, 1997, J LIPID RES, V38, P2264
   CorreiadeSa P, 1996, J NEUROPHYSIOL, V76, P3910
   Cunha RA, 1996, BRIT J PHARMACOL, V119, P253, DOI 10.1111/j.1476-5381.1996.tb15979.x
   Cunha RA, 1996, J NEUROCHEM, V67, P2180
   Diogenes MJ, 2007, HIPPOCAMPUS, V17, P577, DOI 10.1002/hipo.20294
   Diogenes MJ, 2004, J NEUROSCI, V24, P2905, DOI 10.1523/JNEUROSCI.4454-03.2004
   Du J, 2003, J CELL BIOL, V163, P385, DOI 10.1083/jcb.200305134
   Fielding CJ, 2004, BIOCHEM SOC T, V32, P65, DOI 10.1042/BST0320065
   Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0
   Fontinha BM, 2008, NEUROPHARMACOLOGY, V54, P924, DOI 10.1016/j.neuropharm.2008.01.011
   Fredholm BB, 2003, CURR TOP MED CHEM, V3, P413, DOI 10.2174/1568026033392200
   Fredholm BB, 2001, PHARMACOL REV, V53, P527
   Grimes ML, 1996, J NEUROSCI, V16, P7950
   Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6
   HAIGLER HT, 1980, J BIOL CHEM, V255, P1239
   Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929
   Herincs Z, 2005, J CELL SCI, V118, P1687, DOI 10.1242/jcs.02296
   Higuchi H, 2003, EMBO J, V22, P1790, DOI 10.1093/emboj/cdg177
   Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2
   Kramar EA, 2004, J NEUROSCI, V24, P5151, DOI 10.1523/JNEUROSCI.0800-04.2004
   Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198
   Leemhuis J, 2002, J PHARMACOL EXP THER, V300, P1000, DOI 10.1124/jpet.300.3.1000
   Lim KI, 2005, BIOTECHNOL BIOENG, V90, P694, DOI 10.1002/bit.20464
   Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x
   Matsumoto T, 2006, MOL CELL NEUROSCI, V31, P70, DOI 10.1016/j.mcn.2005.09.002
   Mojsilovic-Petrovic J, 2006, J NEUROSCI, V26, P9250, DOI 10.1523/JNEUROSCI.1856-06.2006
   Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4
   Nagappan G, 2005, TRENDS NEUROSCI, V28, P464, DOI 10.1016/j.tins.2005.07.003
   Pereira DB, 2007, J NEUROSCI, V27, P4859, DOI 10.1523/JNEUROSCI.4587-06.2007
   Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200
   Pinto-Duarte A, 2005, J NEUROCHEM, V93, P595, DOI 10.1111/j.1471-4159.2005.03071.x
   Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004
   Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004
   Rajagopal R, 2006, MOL CELL NEUROSCI, V33, P36, DOI 10.1016/j.mcn.2006.06.002
   Sebastiao Ana M, 2009, Handb Exp Pharmacol, P471, DOI 10.1007/978-3-540-89615-9_16
   Sebastiao AM, 2009, BRIT J PHARMACOL, V158, P15, DOI 10.1111/j.1476-5381.2009.00157.x
   Sepulveda MR, 2006, J BIOL CHEM, V281, P447, DOI 10.1074/jbc.M506950200
   Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052
   Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106
   Tebano MT, 2008, J NEUROCHEM, V104, P279, DOI 10.1111/j.1471-4159.2007.05046.x
   WIERASZKO A, 1989, BRAIN RES, V485, P244, DOI 10.1016/0006-8993(89)90567-2
   Wu CB, 1997, J BIOL CHEM, V272, P3554, DOI 10.1074/jbc.272.6.3554
   Zheng J, 2008, J BIOL CHEM, V283, P13280, DOI 10.1074/jbc.M709930200
NR 53
TC 36
Z9 39
U1 2
U2 13
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD JUN 23
PY 2010
VL 30
IS 25
BP 8468
EP 8480
DI 10.1523/JNEUROSCI.5695-09.2010
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA 614RH
UT WOS:000279076900013
PM 20573894
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Valastyan, S
   Chang, A
   Benaich, N
   Reinhardt, F
   Weinberg, RA
AF Valastyan, Scott
   Chang, Amelia
   Benaich, Nathan
   Reinhardt, Ferenc
   Weinberg, Robert A.
TI RETRACTED: Concurrent Suppression of Integrin alpha(5), Radixin, and
   RhoA Phenocopies the Effects of miR-31 on Metastasis (Retracted article.
   See vol. 75, pg. 2760, 2015)
SO CANCER RESEARCH
LA English
DT Article; Retracted Publication
ID CANCER METASTASIS; BREAST-CANCER; MICRORNAS
AB miR-31 inhibits breast cancer metastasis via the pleiotropic suppression of a cohort of prometastatic target genes that include integrin alpha(5) (ITGA5), radixin (RDX), and RhoA. We previously showed that the concomitant overexpression of ITGA5, RDX, and RhoA was capable of overriding the antimetastatic effects of ectopically expressed miR-31 in vivo. However, these prior studies failed to investigate whether the combined suppression of the endogenous mRNAs encoding these three proteins recapitulated the in vivo consequences of miR-31 expression on metastasis. We show here that short hairpin RNA-mediated concurrent downregulation of ITGA5, RDX, and RhoA is sufficient to phenocopy the full spectrum of described influences of miR-31 on metastasis in vivo, including the effects of this microRNA (miRNA) on local invasion, early post-intravasation events, and metastatic colonization. These findings provide mechanistic insights into the metastatic process and have implications about the importance of pleiotropy for the biological actions of miRNAs. Cancer Res; 70(12); 5147-54. (C) 2010 AACR.
C1 [Valastyan, Scott; Chang, Amelia; Benaich, Nathan; Reinhardt, Ferenc; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.
   [Valastyan, Scott; Chang, Amelia; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA.
   [Weinberg, Robert A.] MIT, Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA.
   [Benaich, Nathan] Williams Coll, Dept Biol, Williamstown, MA 01267 USA.
RP Weinberg, RA (reprint author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.
EM weinberg@wi.mit.edu
FU NIH [RO1-CA078461]; MIT Ludwig Center for Molecular Oncology; U.S.
   Department of Defense; Breast Cancer Research Foundation
FX NIH grant RO1-CA078461, MIT Ludwig Center for Molecular Oncology, U.S.
   Department of Defense, and Breast Cancer Research Foundation. S.
   Valastyan is a U.S. Department of Defense Breast Cancer Research Program
   Predoctoral Fellow. R. A. Weinberg is an American Cancer Society
   Research Professor and a Daniel K. Ludwig Foundation Cancer Research
   Professor.
CR Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098
   Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001
   Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213
   Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385
   Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725
   Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375
   Valastyan S, 2009, CELL CYCLE, V8, P3506, DOI 10.4161/cc.8.21.9802
   Valastyan S, 2009, GENE DEV, V23, P2592, DOI 10.1101/gad.1832709
   Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047
   Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005
NR 15
TC 87
Z9 92
U1 2
U2 9
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD JUN 15
PY 2010
VL 70
IS 12
BP 5147
EP 5154
DI 10.1158/0008-5472.CAN-10-0410
PG 8
WC Oncology
SC Oncology
GA 610QP
UT WOS:000278749600037
PM 20530680
OA Bronze, Green Accepted
DA 2018-12-27
ER

PT J
AU Reid, HM
   Mulvaney, EP
   Turner, EC
   Kinsella, BT
AF Reid, Helen M.
   Mulvaney, Eamon P.
   Turner, Elizebeth C.
   Kinsella, B. Therese
TI RETRACTED: Interaction of the Human Prostacyclin Receptor with Rab11
   CHARACTERIZATION OF A NOVEL Rab11 BINDING DOMAIN WITHIN alpha-HELIX 8
   THAT IS REGULATED BY PALMITOYLATION (Retracted article. See vol. 293,
   pg. 12287, 2018)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID PROTEIN-COUPLED RECEPTOR; ALPHA-5-BETA-1 INTEGRIN; 3D MICROENVIRONMENTS;
   STRUCTURE PREDICTION; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; MYOSIN VB;
   I-TASSER; PALMITOYLATION; EFFECTOR
AB The human prostacyclin receptor (hIP) undergoes agonist-induced internalization and subsequent recyclization in slowly recycling endosomes involving its direct physical interaction with Rab11a. Moreover, interaction with Rab11a localizes to a 22-residue putative Rab11 binding domain (RBD) within the carboxyl-terminal tail of the hIP, proximal to the transmembrane 7 (TM7) domain. Because the proposed RBD contains Cys(308) and Cys(311), in addition to Cys(309), that are known to undergo palmitoylation, we sought to identify the structure/function determinants of the RBD, including the influence of palmitoylation, on agonist-induced trafficking of the hIP. Through complementary approaches in yeast and mammalian cells along with computational structural studies, the RBD was localized to a 14-residue domain, between Val(299) and Leu(312), and proposed to be organized into an eighth alpha-helical domain (alpha-helix 8), comprising Val(299)-Val(307), adjacent to the palmitoylated residues at Cys(308)-Cys(311). From mutational and [H-3] palmitate metabolic labeling studies, it is proposed that palmitoylation at Cys(311) in addition to agonist-regulated deacylation at Cys(309) > Cys(308) may dynamically position alpha-helix 8 in proximity to Rab11a, to regulate agonist-induced intracellular trafficking of the hIP. Moreover, Ala-scanning mutagenesis identified several hydrophobic residues within alpha-helix 8 as necessary for the interaction with Rab11a. Given the diverse membership of the G protein-coupled receptor superfamily, of which many members are also predicted to contain an alpha-helical 8 domain proximal to TM7 and, often, adjacent to palmitoylable cysteine(s), the identification of a functional role for alpha-helix 8, as exemplified as an RBD for the hIP, is likely to have broader significance for certain members of the superfamily.
C1 [Reid, Helen M.; Mulvaney, Eamon P.; Turner, Elizebeth C.; Kinsella, B. Therese] Natl Univ Ireland Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Sch Biomol & Biomed Sci, Dublin 4, Ireland.
RP Kinsella, BT (reprint author), Natl Univ Ireland Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Sch Biomol & Biomed Sci, Dublin 4, Ireland.
EM therese.kinsella@ucd.ie
OI Kinsella, B. Therese/0000-0003-3072-941X; Mulvaney,
   Eamon/0000-0003-3661-2116
FU Science Foundation of Ireland [SFI: 05/IN.1/B19]
FX This work was supported by Science Foundation of Ireland Grant SFI:
   05/IN.1/B19.
CR Borer JS, 2005, ARTHRITIS RES THER, V7, pS14, DOI 10.1186/ar1794
   Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140
   Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012
   Cheng KW, 2005, CANCER RES, V65, P2516, DOI 10.1158/0008-5472.CAN-05-0573
   Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125
   Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238
   de Graaf P, 2004, MOL BIOL CELL, V15, P2038, DOI 10.1091/mbc.E03-12-0862
   Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200
   Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1
   Egan KM, 2004, SCIENCE, V306, P1954, DOI 10.1126/science.1103333
   Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937
   Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706
   Fetalvero KM, 2007, PROSTAG OTH LIPID M, V82, P109, DOI 10.1016/j.prostaglandins.2006.05.011
   Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652
   Gryglewski RJ, 2008, PHARMACOL REP, V60, P3
   Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200
   Hayes JS, 1999, J BIOL CHEM, V274, P23707, DOI 10.1074/jbc.274.34.23707
   Horgan CP, 2007, TRAFFIC, V8, P414, DOI 10.1111/j.1600-0854.2007.00543.x
   Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772
   Katragadda M, 2004, BBA-BIOMEMBRANES, V1663, P74, DOI 10.1016/j.bbamem.2004.01.012
   Kinsella BT, 1997, J PHARMACOL EXP THER, V281, P957
   Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843
   Lawler OA, 2001, J BIOL CHEM, V276, P33596, DOI 10.1074/jbc.M104434200
   Lawler OA, 2001, BRIT J PHARMACOL, V132, P1639, DOI 10.1038/sj.bjp.0704033
   Mammoto A, 1999, J BIOL CHEM, V274, P25517, DOI 10.1074/jbc.274.36.25517
   McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272
   Miggin SM, 2003, J BIOL CHEM, V278, P6947, DOI 10.1074/jbc.M210637200
   Miggin SM, 2002, EUR J BIOCHEM, V269, P1714, DOI 10.1046/j.1432-1327.2002.02817.x
   MILLIGAN G, 1995, TRENDS BIOCHEM SCI, V20, P181, DOI 10.1016/S0968-0004(00)89004-0
   Mukhopadhyay S, 1999, BIOCHEMISTRY-US, V38, P3447, DOI 10.1021/bi981767v
   MUNCH G, 1991, EUR J BIOCHEM, V198, P357, DOI 10.1111/j.1432-1033.1991.tb16023.x
   Narumiya S, 1999, PHYSIOL REV, V79, P1193
   O'Keeffe MB, 2008, BBA-MOL CELL RES, V1783, P1914, DOI 10.1016/j.bbamcr.2008.04.010
   O'Meara SJ, 2004, BRIT J PHARMACOL, V143, P318, DOI 10.1038/sj.bjp.0705956
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867
   Pfeffer SR, 2005, J BIOL CHEM, V280, P15485, DOI 10.1074/jbc.R500003200
   Prekeris Rytis, 2003, ScientificWorldJournal, V3, P870
   PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1
   Reid HM, 2007, CELL SIGNAL, V19, P1056, DOI 10.1016/j.cellsig.2006.12.001
   Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013
   SAKAI A, 1990, LIFE SCI, V47, P711, DOI 10.1016/0024-3205(90)90626-3
   Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909
   Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009
   SHIRAI H, 1995, HYPERTENSION, V25, P726, DOI 10.1161/01.HYP.25.4.726
   Smyth EM, 2000, J BIOL CHEM, V275, P32037, DOI 10.1074/jbc.M003873200
   Takahashi M, 2007, MEDIAT INFLAMM, DOI 10.1155/2007/10767
   Topiol S, 2009, BIOCHEM PHARMACOL, V78, P11, DOI 10.1016/j.bcp.2009.02.012
   Turner EC, 2010, J MOL BIOL, V396, P473, DOI 10.1016/j.jmb.2010.01.010
   VANE JR, 1995, AM J CARDIOL, V75, pA3, DOI 10.1016/S0002-9149(99)80377-4
   Welsh GI, 2007, J CELL SCI, V120, P4197, DOI 10.1242/jcs.007310
   Wikstrom K, 2008, CELL SIGNAL, V20, P2332, DOI 10.1016/j.cellsig.2008.09.003
   Xiao CY, 2001, CIRCULATION, V104, P2210, DOI 10.1161/hc4301.098058
   Yeagle PL, 2007, BBA-BIOMEMBRANES, V1768, P808, DOI 10.1016/j.bbamem.2006.10.002
   Zachary I, 2001, AM J PHYSIOL-CELL PH, V280, pC1375
   Zeng JB, 1999, P NATL ACAD SCI USA, V96, P2840, DOI 10.1073/pnas.96.6.2840
   Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40
   Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702
NR 59
TC 28
Z9 28
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 11
PY 2010
VL 285
IS 24
BP 18709
EP 18726
DI 10.1074/jbc.M110.106476
PG 18
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 606UN
UT WOS:000278453900063
PM 20395296
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Kale, B
   Shinde, A
   Sonar, S
   Shingate, B
   Kumar, S
   Ghosh, S
   Venugopal, S
   Shingare, M
AF Kale, Bhima
   Shinde, Ananta
   Sonar, Swapnil
   Shingate, Bapurao
   Kumar, Sanjeev
   Ghosh, Samir
   Venugopal, Soodamani
   Shingare, Murlidhar
TI RETRACTED: 1-Decanethiol, a new reagent for the odorless deprotection of
   aryl methyl ethers (Retracted article. See vol. 54, pg. 1768, 2013)
SO TETRAHEDRON LETTERS
LA English
DT Article; Retracted Publication
DE 1-Decanethiol; Deprotection; Aryl methyl ether
ID ESTROGEN-RECEPTOR MODULATORS; REDUCTIVE CLEAVAGE; EFFICIENT LIGAND;
   AQUEOUS-MEDIA; ALKYL ETHERS; DEMETHYLATION; DEALKYLATION;
   REGIOSELECTIVITY; DERIVATIVES; THIOLS
AB 1-Decanethiol has been found to be an excellent reagent for the deprotection of aryl methyl ethers. This newly developed protocol afforded the corresponding phenols in good to excellent yields. A clear advantage of 1-decanethiol over the more commonly used thiols is the easy extraction of both the deprotecting reagent and the reaction byproduct into the aqueous phase, which allows an essentially odorless workup. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Kale, Bhima; Shinde, Ananta; Sonar, Swapnil; Shingate, Bapurao; Shingare, Murlidhar] Dr Babasaheb Ambedkar Marathwada Univ, Dept Chem, Aurangabad 431004, Maharashtra, India.
   [Kumar, Sanjeev; Ghosh, Samir; Venugopal, Soodamani] SV Natl Inst Technol, Dept Appl Chem, Surat 395007, India.
RP Shingare, M (reprint author), Dr Babasaheb Ambedkar Marathwada Univ, Dept Chem, Aurangabad 431004, Maharashtra, India.
EM prof_msshingare@rediffmail.com
CR AZZENA U, 1995, J CHEM SOC PERK T 1, P261, DOI 10.1039/p19950000261
   Basak A, 1998, TETRAHEDRON LETT, V39, P4883, DOI 10.1016/S0040-4039(98)00885-5
   BHATT MV, 1983, SYNTHESIS-STUTTGART, P249, DOI 10.1055/s-1983-30301
   Casado F, 2000, J ORG CHEM, V65, P322, DOI 10.1021/jo991059v
   CELINA M, 1989, J AM CHEM SOC, V111, P8640
   Chae J, 2008, ARCH PHARM RES, V31, P305, DOI 10.1007/s00000-001-1156-y
   Fernandes P. B., 2006, [No title captured], Patent No. [WO 2006012640 A2, 2006012640]
   FEUTRILL GI, 1970, TETRAHEDRON LETT, P1327
   GREENE TW, 1999, PROTECTIVE GROUPS OR
   Grese TA, 1998, J MED CHEM, V41, P1272, DOI 10.1021/jm970688z
   GRIECO PA, 1977, J AM CHEM SOC, V99, P5773, DOI 10.1021/ja00459a039
   Hwu JR, 1997, J ORG CHEM, V62, P4097, DOI 10.1021/jo961191k
   Jogdand NR, 2009, TETRAHEDRON LETT, V50, P6092, DOI 10.1016/j.tetlet.2009.08.064
   Jogdand NR, 2009, TETRAHEDRON LETT, V50, P4019, DOI 10.1016/j.tetlet.2009.03.028
   JUNG ME, 1978, TETRAHEDRON LETT, P3657
   JUNG ME, 1977, J ORG CHEM, V42, P3761, DOI 10.1021/jo00443a033
   KOCIENSKI PGP, 1994, PROTECTING GROUPS
   LAL K, 1987, J ORG CHEM, V52, P1072, DOI 10.1021/jo00382a018
   MAERCKER A, 1987, ANGEW CHEM INT EDIT, V26, P972, DOI 10.1002/anie.198709721
   Magano J, 2006, J ORG CHEM, V71, P7103, DOI 10.1021/jo0611059
   McOmie J. F. W., 1973, ORG SYNTH, V5, P412
   MIRRINGTON RN, 1988, ORG SYNTH, V50-9, P859
   Node M, 2001, TETRAHEDRON LETT, V42, P9207, DOI 10.1016/S0040-4039(01)02024-X
   NODE M, 1980, J ORG CHEM, V45, P4275, DOI 10.1021/jo01310a003
   OHSAWA T, 1992, TETRAHEDRON LETT, V33, P5555, DOI 10.1016/S0040-4039(00)61144-9
   Olah G. A., 1981, ANGEW CHEM, V93, P705
   Pawar SS, 2008, TETRAHEDRON LETT, V49, P5858, DOI 10.1016/j.terlet.2008.07.101
   Pawar SS, 2008, TETRAHEDRON LETT, V49, P4252, DOI 10.1016/j.tetlet.2008.04.148
   Ranu BC, 1996, ORG PREP PROCED INT, V28, P371, DOI 10.1080/00304949609356549
   Renaud J, 2005, J MED CHEM, V48, P364, DOI 10.1021/jm040858p
   Sadaphal SA, 2009, J KOREAN CHEM SOC, V53, P536, DOI 10.5012/jkcs.2009.53.5.536
   Sapkal SB, 2009, TETRAHEDRON LETT, V50, P1754, DOI 10.1016/j.tetlet.2009.01.140
   Sonar SS, 2009, B KOREAN CHEM SOC, V30, P825
   TIECCO M, 1988, SYNTHESIS-STUTTGART, P749
   Weissman SA, 2005, TETRAHEDRON, V61, P7833, DOI 10.1016/j.tet.2005.05.041
NR 35
TC 14
Z9 15
U1 3
U2 33
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0040-4039
J9 TETRAHEDRON LETT
JI Tetrahedron Lett.
PD JUN 9
PY 2010
VL 51
IS 23
BP 3075
EP 3078
DI 10.1016/j.tetlet.2010.04.012
PG 4
WC Chemistry, Organic
SC Chemistry
GA 606TP
UT WOS:000278451000011
DA 2018-12-27
ER

PT J
AU Hocker, J
   Raitschew, B
   Meybohm, P
   Broch, O
   Stapelfeldt, C
   Gruenewald, M
   Cavus, E
   Steinfath, M
   Bein, B
AF Hoecker, J.
   Raitschew, B.
   Meybohm, P.
   Broch, O.
   Stapelfeldt, C.
   Gruenewald, M.
   Cavus, E.
   Steinfath, M.
   Bein, B.
TI RETRACTED: Differences between bispectral index and spectral entropy
   during xenon anaesthesia: a comparison with propofol anaesthesia
   (Retracted article. See vol. 69, pg. 654, 2014)
SO ANAESTHESIA
LA English
DT Article; Retracted Publication
ID ELECTIVE SURGERY; STATE ENTROPY; ELECTROENCEPHALOGRAM; SEVOFLURANE;
   RECOVERY; ISOFLURANE; AGREEMENT; RECEPTOR; SUBUNIT; RISK
AB We enrolled 114 patients, aged 65-83 years, undergoing elective surgery (duration > 2h) into a randomised, controlled study to evaluate the performance of bispectral index and spectral entropy for monitoring depth of xenon versus propofol anaesthesia. In the propofol group, bispectral index and state entropy values were comparable. In the xenon group, bispectral index values resembled those in the propofol group, but spectral entropy levels were significantly lower. Mean arterial blood pressure was higher and heart rate was lower in the xenon group than in the propofol group. Bispectral index and spectral entropy considerably diverged during xenon but not during propofol anaesthesia. We therefore conclude that these measures are not interchangeable for the assessment of depth of hypnosis and that bispectral index is likely to reflect actual depth of anaesthesia more precisely compared with spectral entropy.
C1 [Hoecker, J.; Raitschew, B.; Meybohm, P.; Broch, O.; Stapelfeldt, C.; Gruenewald, M.; Cavus, E.; Steinfath, M.; Bein, B.] Univ Hosp Schleswig Holstein, Dept Anaesthesiol & Intens Care Med, Kiel, Germany.
RP Hocker, J (reprint author), Univ Hosp Schleswig Holstein, Dept Anaesthesiol & Intens Care Med, Campus Kiel, Kiel, Germany.
EM hoecker@anaesthesie.uni-kiel.de
OI Meybohm, Patrick/0000-0002-2666-8696; Cavus, Erol/0000-0003-1861-250X
FU Department of Anaesthesiology and Intensive Care Medicine, University
   Hospital Schleswig-Holstein, Campus Kiel, Germany
FX We are grateful to Air Liquide, Duesseldorf, Germany, for providing the
   xenon. No external funding and no competing interests declared. We are
   indebted to Birgit Zastrow, RN, and Bernd Kuhr, RN, (Department of
   Anaesthesiology and Intensive Care Medicine, University Hospital
   Schleswig-Holstein, Campus Kiel, Germany) for their enthusiastic
   support.
CR ALDRETE JA, 1995, J CLIN ANESTH, V7, P89, DOI 10.1016/0952-8180(94)00001-K
   Baumert JH, 2008, BRIT J ANAESTH, V100, P605, DOI 10.1093/bja/aen050
   Bein B, 2005, ANAESTHESIA, V60, P960, DOI 10.1111/j.1365-2044.2005.04326.x
   Bonhomme V, 2006, BRIT J ANAESTH, V97, P340, DOI 10.1093/bja/ael171
   Coburn M, 2008, BRIT J ANAESTH, V100, P787, DOI 10.1093/bja/aen077
   Coburn M, 2005, BRIT J ANAESTH, V94, P198, DOI 10.1093/bja/aei023
   CULLEN SC, 1969, ANESTHESIOLOGY, V31, P305, DOI 10.1097/00000542-196910000-00003
   Ekman A, 2004, ACTA ANAESTH SCAND, V48, P20, DOI 10.1111/j.1399-6576.2004.00260.x
   Ellerkmann RK, 2004, ANESTHESIOLOGY, V101, P1275
   Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525
   Gan TJ, 1997, ANESTHESIOLOGY, V87, P808, DOI 10.1097/00000542-199710000-00014
   Goto T, 2000, BRIT J ANAESTH, V85, P359, DOI 10.1093/bja/85.3.359
   Hans P, 2005, BRIT J ANAESTH, V94, P336, DOI 10.1093/bja/aei047
   JONES MV, 1995, J PHARMACOL EXP THER, V274, P962
   Laitio RM, 2008, ANESTHESIOLOGY, V108, P63, DOI 10.1097/01.anes.0000296106.52472.a6
   Liu SS, 2004, ANESTHESIOLOGY, V101, P311, DOI 10.1097/00000542-200408000-00010
   Ma DQ, 2004, ANESTHESIOLOGY, V100, P1313, DOI 10.1097/00000542-200405000-00040
   MARSH B, 1991, BRIT J ANAESTH, V67, P41, DOI 10.1093/bja/67.1.41
   Meybohm P, 2010, ACTA ANAESTH SCAND, V54, P169, DOI 10.1111/j.1399-6576.2009.02138.x
   Nishikawa K, 2003, ANESTHESIOLOGY, V99, P678, DOI 10.1097/00000542-200309000-00024
   Rampil IJ, 1998, ANESTHESIOLOGY, V89, P980, DOI 10.1097/00000542-199810000-00023
   Rasmussen LS, 2006, BRIT J ANAESTH, V97, P154, DOI 10.1093/bja/ae1141
   Rossaint R, 2003, ANESTHESIOLOGY, V98, P6, DOI 10.1097/00000542-200301000-00005
   Schmidt M, 2005, ANESTHESIOLOGY, V102, P929, DOI 10.1097/00000542-200505000-00011
   Viertio-Oja H, 2004, ACTA ANAESTH SCAND, V48, P154, DOI 10.1111/j.0001-5172.2004.00322.x
   Wappler F, 2007, ANESTHESIOLOGY, V106, P463, DOI 10.1097/00000542-200703000-00010
   White PF, 2006, ANESTH ANALG, V102, P160, DOI 10.1213/01.ane.0000183668.83139.fc
   Wilhelm S, 2002, ANESTHESIOLOGY, V96, P1485, DOI 10.1097/00000542-200206000-00031
NR 28
TC 11
Z9 12
U1 2
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0003-2409
EI 1365-2044
J9 ANAESTHESIA
JI Anaesthesia
PD JUN
PY 2010
VL 65
IS 6
BP 595
EP 600
DI 10.1111/j.1365-2044.2010.06344.x
PG 6
WC Anesthesiology
SC Anesthesiology
GA 594FS
UT WOS:000277522000010
PM 20412149
OA Bronze
DA 2018-12-27
ER

PT J
AU Zhao, XE
   Zheng, YM
AF Zhao, X. E.
   Zheng, Y. M.
TI RETRACTED: Development of cloned embryos from porcine neural stem cells
   and amniotic fluid-derived stem cells (Retracted article. See vol. 7,
   pg. 355, 2013)
SO ANIMAL
LA English
DT Article; Retracted Publication
DE neural stem cells; amniotic fluid-derived stem cells; cloned embryos;
   developmental ability; pig
ID ADULT SOMATIC-CELLS; NUCLEAR TRANSFER; IN-VITRO; PROGENITOR CELLS;
   PRECURSOR CELLS; MOUSE EMBRYOS; PIGS; CULTURE; CLONING; MICROINJECTION
AB The aim of this study was to determine the developmental ability of cloned embryos derived from porcine neural stem (NS) cells, amniotic fluid-derived stem (AFS) cells, differentiated cells from NS and AFS cells, fetal fibroblast (FF) cells, adult fibroblast (AF) cells and mammary gland epithelial (MGE) cells. NS, AFS and FF cells were isolated from embryonic day 30 porcine fetus, AF and MGE cells were isolated from adult pig. NS and AFS cells were induced to differentiate into different cell types, respectively Stem cells and their differentiated cells were harvested for analysis of the markers using reverse transcription PCR. NS and AFS cells, their differentiated cells, FF, AF and MGE cells were used for nuclear transfer respectively A total of 100 two-cell stage cloned embryos derived from each cell line were transferred into the oviducts of surrogate mothers. The results showed that the neurospheres were positive for the undifferentiated neural cell marker Nestin and NS cells widely expressed NogoA, DCX, CyclinD2, CD133, Hes1, Oct4, Desmin, CD-90, Nanog and Sox2. AFS cells widely expressed NogoA, DCX, CyclinD2, CD133, Hes1, Nanog, Sox2, Oct4, Desmin and CD-90. Both NS and AFS cells were differentiated into astrocyte (GFAP(+)), oligodendrocyte (GalC(+)), neuron (NF+, NSE+ and MAP2(+)), adipocyte (LPL+ and PPAR gamma-D+), osteoblast (Osteonectin(+) and Osteocalcin(+)), myocyte (myf-6(+) and myoD(+)) and endothelium (CD31(+), CD34(+), CD144(+) and eNOS(+)). Four cloned fetuses (28 and 32 days) derived from NS and AFS cells were obtained. The developmental potential of the cloned embryos derived from stem cells (NS and AFS cells) were higher (P <0.05) than that of the cloned embryos derived from somatic cells (the differentiated cells from NS and AFS cells, FF cells, AF cells and MGE cells), which suggests that the undifferentiated state of the donor cells increases cloning efficiency.
C1 [Zhao, X. E.] NW A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China.
   Minist Agr, Key Lab Anim Reprod Physiol & Embryo Technol, Yangling 712100, Shaanxi, Peoples R China.
RP Zheng, YM (reprint author), NW A&F Univ, Coll Vet Med, 1-06 Res Bldg, Yangling 712100, Shaanxi, Peoples R China.
EM zhengyuemao@163.com
FU Northwest A&F University Research Foundation [07ZR001]
FX The authors thank everyone for assistance with this project. This study
   was supported by a grant from Northwest A&F University Research
   Foundation (07ZR001).
CR Armstrong RJE, 2002, EXP NEUROL, V175, P98, DOI 10.1006/exnr.2002.7889
   Betthauser J, 2000, NAT BIOTECHNOL, V18, P1055, DOI 10.1038/80242
   Cai JL, 2002, DEV BIOL, V251, P221, DOI 10.1006/dbio.2002.0828
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   Du Y, 2007, THERIOGENOLOGY, V68, P1104, DOI 10.1016/j.theriogenology.2007.07.021
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   GOSDEN CM, 1983, BRIT MED BULL, V39, P348, DOI 10.1093/oxfordjournals.bmb.a071847
   in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291
   Jiang YH, 2002, EXP HEMATOL, V30, P896, DOI 10.1016/S0301-472X(02)00869-X
   Lagutina I, 2006, CLONING STEM CELLS, V8, P283, DOI 10.1089/clo.2006.8.283
   Lee JW, 2003, BIOL REPROD, V69, P995, DOI 10.1095/biolreprod.103.015917
   MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634
   Mizutani E, 2006, REPRODUCTION, V132, P849, DOI 10.1530/rep.1.01010
   Oback Bjorn, 2002, Cloning and Stem Cells, V4, P147, DOI 10.1089/153623002320253328
   Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188
   Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082
   Polejaeva IA, 2001, J REP FER S, P293
   POLGAR K, 1989, AM J HUM GENET, V45, P786
   Prather RS, 1999, THERIOGENOLOGY, V51, P487, DOI 10.1016/S0093-691X(98)00242-8
   PRIEST RE, 1978, LAB INVEST, V39, P106
   Prusa AR, 2004, AM J OBSTET GYNECOL, V191, P309, DOI 10.1016/j.ajog.2003.12.014
   Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753
   Samiec M, 2003, CZECH J ANIM SCI, V48, P499
   Schwartz PH, 2005, STEM CELLS, V23, P1286, DOI 10.1634/stemcells.2004-0306
   Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854
   Siddiqui M.M., 2004, HDB STEM CELLS, V2, P175
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279
   Uchida K, 2003, J NEUROSCI RES, V72, P661, DOI 10.1002/jnr.10628
   Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984
   Wolf E, 1998, J BIOTECHNOL, V65, P99, DOI 10.1016/S0168-1656(98)00132-1
   Yamazaki Y, 2001, P NATL ACAD SCI USA, V98, P14022, DOI 10.1073/pnas.231489398
   Yin XJ, 2002, BIOL REPROD, V67, P442, DOI 10.1095/biolreprod67.2.442
   Zheng YueMao, 2006, Chinese Journal of Agricultural Biotechnology, V3, P71, DOI 10.1079/CJB200585
NR 37
TC 8
Z9 8
U1 4
U2 42
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1751-7311
EI 1751-732X
J9 ANIMAL
JI Animal
PD JUN
PY 2010
VL 4
IS 6
BP 921
EP 929
DI 10.1017/S1751731110000121
PG 9
WC Agriculture, Dairy & Animal Science; Veterinary Sciences
SC Agriculture; Veterinary Sciences
GA 601GL
UT WOS:000278046200011
PM 22444263
OA Bronze
DA 2018-12-27
ER

PT J
AU Edirisinghe, I
   Arunachalam, G
   Wong, C
   Yao, HW
   Rahman, A
   Phipps, RP
   Jin, ZG
   Rahman, I
AF Edirisinghe, Indika
   Arunachalam, Gnanapragasam
   Wong, Chelsea
   Yao, Hongwei
   Rahman, Arshad
   Phipps, Richard P.
   Jin, Zheng-Gen
   Rahman, Irfan
TI RETRACTED: Cigarette Smoke-induced Oxidative/Nitrosative Stress Impairs
   VEGF- and Fluid Shear Stress-Media Signaling in Endothelial Cells
   (Retracted article. See vol. 18, pg. 1535, 2013)
SO ANTIOXIDANTS & REDOX SIGNALING
LA English
DT Article; Retracted Publication
ID NITRIC-OXIDE SYNTHASE; PROINFLAMMATORY CYTOKINE RELEASE; OBSTRUCTIVE
   PULMONARY-DISEASE; NF-KAPPA-B; OXIDATIVE STRESS; GROWTH-FACTOR; INDUCED
   EMPHYSEMA; EPITHELIAL-CELLS; TOBACCO-SMOKE; OXIDIZED LDL
AB VEGF receptor 2 (VEGFR2), a tyrosine kinase receptor, is activated by VEGF and fluid shear stress (FSS), and its downstream signaling is important in the regulation of endothelial functions, such as cell migration, endothelium-dependent relaxation, and angiogenesis. Cigarette smoke (CS) is known to cause oxidative/nitrosative stress, leading to modifications of tyrosine kinase receptors and impaired downstream signaling. We hypothesized that CS-induced oxidative/nitrosative stress impairs VEGF-and FSS-mediated VEGFR2 activation, leading to endothelial dysfunction. Human lung microvascular endothelial cells and human umbilical vein endothelial cells were treated with different concentrations of cigarette smoke extract (CSE) to investigate the VEGF-or FSS-mediated VEGFR2 phosphorylation and its downstream signaling involved in endothelial function. CSE treatment impaired both VEGF-and FSS-mediated VEGFR2 phosphorylation, resulting in impaired endothelial nitric oxide synthase (eNOS) phosphorylation by Akt. CS-derived reactive oxygen/nitrogen species react with VEGFR2, rendering VEGFR2 inactive for its downstream signaling. Pretreatment with nitric oxide scavenger (PTIO), reactive oxygen species scavengers (combination of SOD with catalase), and N-acetyl-l-cysteine, significantly attenuated the CSE-induced impairment of VEGF-mediated Akt and eNOS phosphorylation. These findings suggest that CSE-induced oxidative/nitrosative stress impairs VEGF-and FSS-mediated endothelial cell function and has important implications in the pathogenesis of CS-induced pulmonary and cardiovascular diseases associated with endothelial dysfunction. Antioxid. Redox Signal. 12, 1355-1369.
C1 [Edirisinghe, Indika; Arunachalam, Gnanapragasam; Yao, Hongwei; Rahman, Arshad; Phipps, Richard P.; Rahman, Irfan] Univ Rochester, Med Ctr, Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA.
   [Wong, Chelsea; Jin, Zheng-Gen] Univ Rochester, Med Ctr, Cardiovasc Res Inst, Rochester, NY 14642 USA.
   [Wong, Chelsea; Jin, Zheng-Gen] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA.
   [Rahman, Arshad] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA.
RP Rahman, I (reprint author), Univ Rochester, Med Ctr, Dept Environm Med, Lung Biol & Dis Program, Box 850,601 Elmwood Ave, Rochester, NY 14642 USA.
EM irfan_rahman@urmc.rochester.edu
FU NIH [R01-HL085613]; NIEHS Environmental Health Science Center [ES-01247]
FX This study was supported by the NIH R01-HL085613 and NIEHS Environmental
   Health Science Center grant ES-01247. We thank Dr. Isaac K Sundar and
   Ms. Suzanne E Cook for their technical assistance. We also thank J. Wood
   (Novartis pharma AG, Basel, Switzerland) for providing VEGF/KDR tyrosine
   kinase inhibitor NVP-AAD-777.
CR Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047
   Bagi Z, 2003, AM J PHYSIOL-HEART C, V285, pH2277, DOI 10.1152/ajpheart.00448.2003
   Barbera JA, 2003, EUR RESPIR J, V21, P892, DOI 10.1183/09031936.03.00115402
   Berk BC, 2008, CIRCULATION, V117, P1082, DOI 10.1161/CIRCULATIONAHA.107.720730
   Boo YC, 2003, AM J PHYSIOL-CELL PH, V285, pC499, DOI 10.1152/ajpcell.00122.2003
   Boo YC, 2002, AM J PHYSIOL-HEART C, V283, pH1819, DOI 10.1152/ajpheart.00214.2002
   Braam B, 2007, CURR PHARM DESIGN, V13, P1727, DOI 10.2174/138161207780831275
   CARP H, 1978, AM REV RESPIR DIS, V118, P617
   Celermajer DS, 1997, J AM COLL CARDIOL, V30, P325, DOI 10.1016/S0735-1097(97)00189-7
   Chavakis E, 2001, CIRCULATION, V103, P2102
   Conklin DJ, 2009, AM J PHYSIOL-HEART C, V296, pH1586, DOI 10.1152/ajpheart.00867.2008
   Corson MA, 1996, CIRC RES, V79, P984, DOI 10.1161/01.RES.79.5.984
   Dai G, 2007, CIRC RES, V101, P723, DOI 10.1161/CIRCRESAHA.107.152942
   Dalle-Donne I, 2005, MASS SPECTROM REV, V24, P55, DOI 10.1002/mas.20006
   DAVIES PF, 1995, PHYSIOL REV, V75, P519
   Edirisinghe I, 2008, FASEB J, V22, P2297, DOI 10.1096/fj.07-099481
   Ejaz S, 2009, FOOD CHEM TOXICOL, V47, P601, DOI 10.1016/j.fct.2008.12.018
   Fleming I, 2005, J CELL SCI, V118, P4103, DOI 10.1242/jcs.02541
   GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673
   Gimbrone MA, 1997, J CLIN INVEST, V99, P1809, DOI 10.1172/JCI119346
   Guzik TJ, 2002, HYPERTENSION, V39, P1088, DOI 10.1161/01.HYP.0000018041.48432.B5
   Heitzer T, 1996, CIRCULATION, V93, P1346, DOI 10.1161/01.CIR.93.7.1346
   Hermann C, 2000, ARTERIOSCL THROM VAS, V20, P402, DOI 10.1161/01.ATV.20.2.402
   Hirai N, 2000, AM J PHYSIOL-HEART C, V279, pH1172
   Jin ZG, 2005, J BIOL CHEM, V280, P12305, DOI 10.1074/jbc.M500294200
   Jin ZG, 2003, CIRC RES, V93, P354, DOI 10.1161/01.RES.0000089257.94002.96
   Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259
   Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117
   Kliche S, 2001, IUBMB LIFE, V52, P61, DOI 10.1080/15216540252774784
   Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007
   Kroll J, 1999, BIOCHEM BIOPH RES CO, V265, P636, DOI 10.1006/bbrc.1999.1729
   Kurtagic E, 2009, AM J PHYSIOL-LUNG C, V296, pL534, DOI 10.1152/ajplung.90505.2008
   Lee LH, 2005, AM J RESP CRIT CARE, V172, P987, DOI 10.1164/rccm.200501-041OC
   LIEBOW AA, 1959, AM REV RESPIR DIS, V80, P67
   Marwick JA, 2006, AM J PHYSIOL-LUNG C, V290, pL897, DOI 10.1152/ajplung.00116.2005
   Mercado C, 2007, CURR HYPERTENS REP, V9, P66, DOI 10.1007/s11906-007-0012-8
   Michaud SE, 2006, J MOL CELL CARDIOL, V41, P275, DOI 10.1016/j.yjmcc.2006.05.004
   Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje
   Moroi M, 1998, J CLIN INVEST, V101, P1225, DOI 10.1172/JCI1293
   Muller T, 1997, CARCINOGENESIS, V18, P295, DOI 10.1093/carcin/18.2.295
   Nakamura T, 2007, CELL MOL LIFE SCI, V64, P1609, DOI 10.1007/s00018-007-6525-0
   Neunteufl T, 2002, J AM COLL CARDIOL, V39, P251, DOI 10.1016/S0735-1097(01)01732-6
   Okuda M, 1999, J BIOL CHEM, V274, P26803, DOI 10.1074/jbc.274.38.26803
   Peluffo G, 2009, AM J PHYSIOL-HEART C, V296, pH1781, DOI 10.1152/ajpheart.00930.2008
   PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x
   Puranik R, 2003, PROG CARDIOVASC DIS, V45, P443, DOI 10.1053/pcad.2003.YPCAD13
   Raij L, 2001, J HYPERTENS, V19, P891, DOI 10.1097/00004872-200105000-00009
   Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146
   Sakao S, 2007, FASEB J, V21, P3640, DOI 10.1096/fj.07-8432com
   Schmidt-Lucke C, 2005, INT J CARDIOL, V100, P207, DOI 10.1016/j.ijcard.2004.05.046
   Soghomonians A, 2004, TOXICOL SCI, V81, P408, DOI 10.1093/toxsci/kfh210
   Su YC, 1998, AM J RESP CELL MOL, V19, P819, DOI 10.1165/ajrcmb.19.5.3091
   Thaikoottathil JV, 2009, EUR RESPIR J, V33, P835, DOI 10.1183/09031936.00080708
   Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002.0228OC
   Ushio-Fukai M, 2007, ANTIOXID REDOX SIGN, V9, P731, DOI 10.1089/ars.2007.1556
   Wagner L, 2007, ENDOTHELIUM-J ENDOTH, V14, P245, DOI 10.1080/10623320701606707
   Woo KS, 1997, ANN INTERN MED, V127, P372, DOI 10.7326/0003-4819-127-5-199709010-00006
   Wright JL, 2006, J APPL PHYSIOL, V100, P672, DOI 10.1152/japplphysiol.00274.2005
   Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008
   Yamato H, 1996, LAB INVEST, V75, P211
   Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005
   Yu CR, 2004, ONCOGENE, V23, P1364, DOI 10.1038/sj.onc.1207248
   Zeiher AM, 1996, LANCET, V348, pS10, DOI 10.1016/S0140-6736(96)98004-6
NR 63
TC 31
Z9 32
U1 2
U2 16
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1523-0864
EI 1557-7716
J9 ANTIOXID REDOX SIGN
JI Antioxid. Redox Signal.
PD JUN
PY 2010
VL 12
IS 12
BP 1355
EP 1369
DI 10.1089/ars.2009.2874
PG 15
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 592AA
UT WOS:000277345500002
PM 19929443
OA Green Published
DA 2018-12-27
ER

PT J
AU Altinel, L
   Kose, KC
   Ergan, V
AF Altinel, Levent
   Kose, Kamil Cagri
   Ergan, Volkan
TI RETRACTED: Shed blood transfusion and its effect on postoperative fever:
   a comparative study (Retracted Article)
SO ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
LA English
DT Editorial Material; Retracted Publication
C1 [Altinel, Levent; Kose, Kamil Cagri; Ergan, Volkan] Afyon Kocatepe Univ, Sch Med, Dept Orthoped & Traumatol, Afyon, Turkey.
RP Altinel, L (reprint author), Karaman Mah Leylak Cad Manolya Aprt 13 D 10, TR-03200 Afyon, Turkey.
EM levent_altinel@hotmail.com
NR 0
TC 0
Z9 0
U1 2
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0936-8051
EI 1434-3916
J9 ARCH ORTHOP TRAUM SU
JI Arch. Orthop. Trauma Surg.
PD JUN
PY 2010
VL 130
IS 6
BP 717
EP 717
DI 10.1007/s00402-006-0215-5
PG 1
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 595QE
UT WOS:000277626500001
DA 2018-12-27
ER

PT J
AU Ravindran, J
   Nair, HB
   Sung, BY
   Prasad, S
   Tekmal, RR
   Aggarwal, BB
AF Ravindran, Jayaraj
   Nair, Hareesh B.
   Sung, Bokyung
   Prasad, Sandeo
   Tekmal, Rajeshwar R.
   Aggarwal, Bharat B.
TI RETRACTED: Thymoquinone poly (lactide-co-glycolide) nanoparticles
   exhibit enhanced anti-proliferative, anti-inflammatory, and
   chemosensitization potential (Retracted article. See vol. 102, pg. 146,
   2016)
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article; Retracted Publication
DE Nanoparticles; Thymoquinone; Apoptosis; Inflammation; NF-kappa B
ID FACTOR-KAPPA-B; ANTITUMOR-ACTIVITY; CANCER-THERAPY; IN-VITRO; PLGA
   NANOPARTICLES; PROSTATE-CANCER; NIGELLA-SATIVA; DRUG-DELIVERY;
   TUMOR-GROWTH; APOPTOSIS
AB Thymoquinone (TQ), derived from the medicinal spice Nigella sativa (also called black cumin), has been shown to exhibit anti-inflammatory and anti-cancer activities. In this report we employed polymer-based nanoparticle approach to improve upon its effectiveness and bioavailability. TQ was encapsulated with 97.5% efficiency in biodegradable nanoparticulate formulation based on poly (lactide-co-glycolide) (PLGA) and the stabilizer polyethylene glycol (PEG)-5000. Dynamic laser light scattering and transmission electron microscopy confirmed particle diameter between 150 and 200 nm. Electrophoretic gel shift mobility assay showed that TQ nanoparticles (NP) were more active than TQ in inhibiting NF-kappa B activation and in suppressing the expression of cyclin D1, matrix metalloproteinase (MMP)-9, vascular endothelial growth factor (VEGF), those are markers of cell proliferation, metastasis and angiogenesis, respectively. TQ-NP were also more potent than TQ in suppressing proliferation of colon cancer, breast cancer, prostate cancer, and multiple myeloma cells. Esterase staining for plasma membrane integrity revealed that TQ-NP were more potent than TQ in sensitizing leukemic cells to TNF- and paclitaxel-induced apoptosis. Overall our results demonstrate that encapsulation of TQ into nanoparticles enhances its anti-proliferative, anti-inflammatory, and chemosensitizing effects. Published by Elsevier Inc.
C1 [Ravindran, Jayaraj; Sung, Bokyung; Prasad, Sandeo; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, 1515 Holcombe Blvd,Box 143, Houston, TX 77030 USA.
   [Nair, Hareesh B.; Tekmal, Rajeshwar R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA.
RP Aggarwal, BB (reprint author), Univ Texas MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, 1515 Holcombe Blvd,Box 143, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI Aggarwal, Bharat/G-3388-2013
FU Clayton Foundation for Research; National Institutes of Health [CA-16
   672]; National Institutes of Health (NIH) [CA-124787-01A2]; Center for
   Targeted Therapy of M.D. Anderson Cancer Center
FX We thank Walter Pagel for carefully proofreading the manuscript and
   providing valuable comments. Dr. Aggarwal is the Ransom Horne, Jr.,
   Professor of Cancer Research. This work was supported by a grant from
   the Clayton Foundation for Research (B.B.A.), a core grant from the
   National Institutes of Health (CA-16 672), a program project grant from
   National Institutes of Health (NIH CA-124787-01A2), and grant from
   Center for Targeted Therapy of M.D. Anderson Cancer Center.
CR Adhami VM, 2009, CLIN CANCER RES, V15, P1947, DOI 10.1158/1078-0432.CCR-08-2332
   Aggarwal BB, 2004, EXPERT OPIN INV DRUG, V13, P1327, DOI 10.1517/13543784.13.10.1327
   Al-Ali Amein, 2008, J Ayub Med Coll Abbottabad, V20, P25
   Anand P, 2010, BIOCHEM PHARMACOL, V79, P330, DOI 10.1016/j.bcp.2009.09.003
   Ankola DD, 2007, EUR J PHARM BIOPHARM, V67, P361, DOI 10.1016/j.ejpb.2007.03.010
   Badary OA, 2003, DRUG CHEM TOXICOL, V26, P87, DOI 10.1081/DCT-120020404
   Badary OA, 1999, EUR J CANCER PREV, V8, P435, DOI 10.1097/00008469-199910000-00009
   Badary OA, 2001, CANCER DETECT PREV, V25, P362
   Badary OA, 2007, FOOD CHEM TOXICOL, V45, P88, DOI 10.1016/j.fct.2006.08.004
   Bala I, 2006, J PHARMACEUT BIOMED, V40, P206, DOI 10.1016/j.jpba.2005.07.006
   Banerjee S, 2009, CANCER RES, V69, P5575, DOI 10.1158/0008-5472.CAN-08-4235
   Bhatt RL, 2003, J MED CHEM, V46, P190, DOI 10.1021/jm020022r
   Bisht Savita, 2007, Journal of Nanobiotechnology, V5, P3, DOI 10.1186/1477-3155-5-3
   Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3
   Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441
   El-Mahdy MA, 2005, INT J CANCER, V117, P409, DOI 10.1002/ijc.21205
   Gali-Muhtasib H, 2004, INT J ONCOL, V25, P857
   Gali-Muhtasib H, 2008, J CELL MOL MED, V12, P330, DOI 10.1111/j.1582-4934.2007.00095.x
   Gali-Muhtasib HU, 2004, ANTI-CANCER DRUG, V15, P389, DOI 10.1097/01.cad.0000125054.43188.56
   Gaucher G, 2005, J CONTROL RELEASE, V109, P169, DOI 10.1016/j.jconrel.2005.09.034
   Gleeson MP, 2008, J MED CHEM, V51, P817, DOI 10.1021/jm701122q
   Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937
   Gupta V, 2009, INT J NANOMED, V4, P115
   Hariharan S, 2006, PHARM RES, V23, P184, DOI 10.1007/s11095-005-8418-y
   Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100
   Kaseb AO, 2007, CANCER RES, V67, P7782, DOI 10.1158/0008-5472.CAN-07-1483
   Kim DW, 2004, CIRCULATION, V109, P1558, DOI 10.1161/01.CIR.0000124063.74526.BE
   Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720
   Mansour MA, 2002, CELL BIOCHEM FUNCT, V20, P143, DOI 10.1002/cbf.968
   Morikawa T, 2004, ORG LETT, V6, P869, DOI 10.1021/ol036239c
   Mu L, 2003, J CONTROL RELEASE, V86, P33, DOI 10.1016/S0168-3659(02)00320-6
   Newman DJ, 2008, J MED CHEM, V51, P2589, DOI 10.1021/jm0704090
   Roepke M, 2007, CANCER BIOL THER, V6, P160, DOI 10.4161/cbt.6.2.3575
   Sethi G, 2008, MOL CANCER RES, V6, P1059, DOI 10.1158/1541-7786.MCR-07-2088
   Shoieb AM, 2003, INT J ONCOL, V22, P107
   Simberg D, 2007, P NATL ACAD SCI USA, V104, P932, DOI 10.1073/pnas.0610298104
   Tan M, 2006, BIOMED SCI INSTRUM, V42, P363
   Torchilin VP, 2007, PHARM RES-DORDR, V24, P1, DOI 10.1007/s11095-006-9132-0
   van Vlerken Lilian E, 2006, Expert Opin Drug Deliv, V3, P205, DOI 10.1517/17425247.3.2.205
   Vasey PA, 1999, CLIN CANCER RES, V5, P83
   von Maltzahn G, 2008, BIOCONJUGATE CHEM, V19, P1570, DOI 10.1021/bc800077y
   Worthen DR, 1998, ANTICANCER RES, V18, P1527
   Wu TH, 2008, INT J PHARM, V346, P160, DOI 10.1016/j.ijpharm.2007.06.036
   Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315
   Yi TF, 2008, MOL CANCER THER, V7, P1789, DOI 10.1158/1535-7163.MCT-08-0124
NR 45
TC 73
Z9 78
U1 1
U2 27
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0006-2952
EI 1873-2968
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD JUN 1
PY 2010
VL 79
IS 11
BP 1640
EP 1647
DI 10.1016/j.bcp.2010.01.023
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 581RA
UT WOS:000276540800013
PM 20105430
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Dalla Costa, AP
   Clemente, CFMZ
   Carvalho, HF
   Carvalheira, JB
   Nadruz, W
   Franchini, KG
AF Dalla Costa, Ana Paula
   Clemente, Carolina F. M. Z.
   Carvalho, Hernandes F.
   Carvalheira, Jose B.
   Nadruz, Wilson, Jr.
   Franchini, Kleber G.
TI RETRACTED: FAK mediates the activation of cardiac fibroblasts induced by
   mechanical stress through regulation of the mTOR complex (Retracted
   article. See vol. 104, pg. 512, 2014)
SO CARDIOVASCULAR RESEARCH
LA English
DT Article; Retracted Publication
DE Cell proliferation; Cell differentiation; Fibrosis; Cell stretch; Heart
   failure
ID FOCAL ADHESION KINASE; MYOFIBROBLAST DIFFERENTIATION; MAPK ACTIVATION;
   CELL MOTILITY; CYCLIN D1; PHOSPHORYLATION; PROLIFERATION; HYPERTROPHY;
   EXPRESSION; STRETCH
AB Cardiac fibroblasts are activated by mechanical stress, but the underlying mechanisms involved remain poorly understood. In this study, we investigated whether focal adhesion kinase (FAK) plays a role in the activation of cardiac fibroblasts in response to cyclic stretch.
   Neonatal (NF-P3/80-third passage, 80% confluence) and adult (AF-P1/80-first passage, 80% confluence) rat cardiac fibroblasts were exposed to cyclic stretch (biaxial, 1 Hz), which enhanced FAK phosphorylation at Tyr397. Proliferation (anti-5-bromo-2'-deoxyuridine and anti-Ki67 nuclear labelling), differentiation into myofibroblasts (expression of alpha-smooth muscle actin-alpha-SMA), and the activity of matrix metalloproteinase-2 were equally enhanced in stretched NF-P3/80 and AF-P1/80. Treatment with the integrin inhibitor RGD peptide impaired FAK phosphorylation and increased apoptosis (TUNEL) in non-stretched and stretched NF-P3/80, whereas FAK silencing induced by small interfering RNA modestly enhanced apoptosis only in stretched cells. RGD peptide or FAK silencing suppressed the activation of NF-P3/80 invoked by cyclic stretch. In addition, NF-P3/80 depleted of FAK were defective in AKT Ser473, TSC-2 Thr1462, and S6 kinase Thr389 phosphorylation induced by cyclic stretch. The activation of NF-P3/80 invoked by cyclic stretch was prevented by pre-treatment with the mammalian target of rapamycin (mTOR) inhibitor rapamycin, whereas supplementation with the amino acid, leucine, activated S6K and rescued the stretch-induced activation of NF-P3/80 depleted of FAK.
   These findings demonstrate a critical role for the mTOR complex, downstream from FAK, in mediating the activation of cardiac fibroblasts in response to mechanical stress.
C1 Univ Estadual Campinas, Dept Cell Biol, Campinas, SP, Brazil.
   Univ Estadual Campinas, Sch Med, Dept Internal Med, Campinas, SP, Brazil.
RP Franchini, KG (reprint author), Univ Estadual Campinas, Dept Clin Med, Fac Ciencias Med, Cidade Univ Zeferino Vaz, BR-13081970 Campinas, SP, Brazil.
EM franchin@unicamp.br
RI 5, INCT/H-4505-2013; Infabic, Inct/I-2128-2013; Carvalheira,
   Jose/H-8405-2012; Nadruz Junior, Wilson/I-3643-2013; Diabetes,
   Inct/I-2186-2013; Carvalho, Hernandes/C-2046-2012; 6, INCT/H-4795-2013
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2006/54878-3]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) [305604/2006-6, 474650/2006-5]; Laboratorio Cristalia
FX This work was supported by grants from Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP-Proc.: 2006/54878-3), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq-Proc.: 305604/2006-6 and
   474650/2006-5) and Laboratorio Cristalia.
CR Barreto-Chaves MLM, 2001, AM J PHYSIOL-REG I, V280, pR25
   Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006
   Bayer AL, 2002, AM J PHYSIOL-HEART C, V283, pH695, DOI 10.1152/ajpheart.00021.2002
   Bryant P, 2006, MOL CELL BIOL, V26, P4201, DOI 10.1128/MCB.01612-05
   Clemente CFMZ, 2007, CIRC RES, V101, P1339, DOI 10.1161/CIRCRESAHA.107.160978
   Clemente CFMZ, 2005, AM J PHYSIOL-REG I, V289, pR862, DOI 10.1152/ajpregu.00348.2004
   Ding Q, 2008, J BIOL CHEM, V283, P26839, DOI 10.1074/jbc.M803645200
   Fujita N, 2003, J BIOL CHEM, V278, P49254, DOI 10.1074/jbc.M306614200
   Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427
   Gao XM, 2006, J HYPERTENS, V24, P1663, DOI 10.1097/01.hjh.0000239304.01496.83
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200
   Gilmore AP, 1996, MOL BIOL CELL, V7, P1209
   HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487
   Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484
   Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112
   Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027
   Iijima Y, 2002, J BIOL CHEM, V277, P23065, DOI 10.1074/jbc.M200328200
   Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753
   Liu SX, 2007, MOL BIOL CELL, V18, P2169, DOI 10.1091/mbc.E06-12-1121
   Lopes MM, 2007, CLIN SCI, V113, P195, DOI 10.1042/CS20070036
   Manso AM, 2009, AM J PHYSIOL-HEART C, V296, pH627, DOI 10.1152/ajpheart.00444.2008
   Marin TM, 2008, CIRC RES, V103, P813, DOI 10.1161/CIRCRESAHA.108.179754
   MAX XM, 2009, NAT REV MOL CELL BIO, V10, P307
   Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549
   NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0
   Pedrotty DM, 2008, AM J PHYSIOL-HEART C, V295, pH390, DOI 10.1152/ajpheart.91531.2007
   Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268
   Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002
   Soucek T, 1998, P NATL ACAD SCI USA, V95, P15653, DOI 10.1073/pnas.95.26.15653
   Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026
   Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200
   Torsoni AS, 2003, CIRC RES, V93, P140, DOI 10.1161/01.RES.0000081595.25297.1B
   TORSONI AS, 2005, AM J PHYSIOL-HEART C, V289, P1488
   Wang J, 2003, AM J PHYSIOL-HEART C, V285, pH1871, DOI 10.1152/ajpheart.00387.2003
   Wang JG, 2005, LIFE SCI, V76, P2817, DOI 10.1016/j.lfs.2004.10.050
   Wang JG, 2001, BIOCHEM BIOPH RES CO, V288, P356, DOI 10.1006/bbrc.2001.5775
   WEBER KT, 1992, J AM COLL CARDIOL, V20, P3, DOI 10.1016/0735-1097(92)90130-F
   Winbanks CE, 2007, INT J BIOCHEM CELL B, V39, P206, DOI 10.1016/j.biocel.2006.08.004
   Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042
   Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200
   Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066
NR 42
TC 34
Z9 34
U1 1
U2 20
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0008-6363
EI 1755-3245
J9 CARDIOVASC RES
JI Cardiovasc. Res.
PD JUN 1
PY 2010
VL 86
IS 3
BP 421
EP 431
DI 10.1093/cvr/cvp416
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 597BY
UT WOS:000277732000011
PM 20038548
OA Bronze
DA 2018-12-27
ER

PT J
AU Evagelopoulos, V
   Albanis, TA
   Kodona, E
   Zoras, S
AF Evagelopoulos, V.
   Albanis, T. A.
   Kodona, El
   Zoras, S.
TI RETRACTED: Particle-associated polycyclic aromatic hydrocarbons near
   power plants as determined by large volume injection - GC/MS (Retracted
   article. See vol. 86, pg. 216, 2012)
SO CHEMOSPHERE
LA English
DT Article; Retracted Publication
DE PAHs; GC/MS; Particulate matter; Power plants; Large volume injection;
   Diagnostic ratios
ID RESPIRABLE PARTICULATE MATTER; SOURCE APPORTIONMENT; URBAN ATMOSPHERE;
   GAS-CHROMATOGRAPHY; PROFILE ANALYSIS; BURNING AREA; GREECE; PAHS; AIR;
   ENVIRONMENT
AB PM10 and PM2.5 samples were collected at two locations in the heavy industrialized prefecture of Kozani, in North-western Greece; in the open-cast mines of Klitos area and in the urban area of city of Kozani. The samples were collected by the use of low volume samplers, for a period of 1 year every 6 d.
   An analytical method has been adapted for determining 16 particle-bound polycyclic aromatic hydrocarbons (PAHs) in PM10 and PM2.5. Samples were collected on poly-tetra-fluorinated-ethylene (PTFE) filters using low volume samplers, considered to be ideal for trapping various organic pollutants including PAHs. The extraction has been made in two stages. Firstly, by reflux and then by using ultrasound bath. Chromatographic analysis has been carried out by GC/MS with programmable temperature vaporizers (PTV) injector and large volume injection (LVI) technique.
   Mean daily concentrations of B[a]Py in PM10 - bound particles were 0.57 ng m(-3) in Kozani and 0.58 ng m(-3) at Klitos, while in PM2.5 - bound PAHs were 0.35 ng m(-3) and 0.30 ng m(-3) respectively. We were able to verify the sources of PAHs by the use of diagnostic ratios, which indicate oil or/and coal burning as the, possible, major PAHs pollutant source(s). (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Evagelopoulos, V.] Technol Educ Inst W Macedonia, Koila 50100, Kozani, Greece.
   [Albanis, T. A.; Kodona, El] Univ Ioannina, Dept Chem, Epirus 45110, Greece.
   [Zoras, S.] Democritus Univ Thrace, Polytech Sch Xanthi, Dept Environm Engn, Komotini, Greece.
RP Evagelopoulos, V (reprint author), Technol Educ Inst W Macedonia, Koila 50100, Kozani, Greece.
EM v.evagelopoulos@gmail.com
FU Greek Ministry of Education and Religion Affairs [2.6.1IA]
FX This work was funded by the Greek Ministry of Education and Religion
   Affairs, within the framework of "Archimedes II", enhancement of
   research activities in Technological Educational Institutes, Project
   2.6.1IA, "Study of the adsorption and transport processes from
   particulate matter to urban and rural areas situated close to coal mines
   and electricity production power plants".
CR Agency for Toxic Substance Disease Registry (ATSDR), 1995, TOX PROF POL AR HYDR
   *AND INSTR, 2001, AND INSTR OP MAN
   Cecinato A, 1998, ANN CHIM-ROME, V88, P369
   CRETNEY JR, 1985, ENVIRON SCI TECHNOL, V19, P397, DOI 10.1021/es00135a002
   De Martinis BS, 2002, ATMOS ENVIRON, V36, P307, DOI 10.1016/S1352-2310(01)00334-X
   Engewald W, 1999, J CHROMATOGR A, V856, P259, DOI 10.1016/S0021-9673(99)00723-2
   EVAGELOPOULOS VG, 2006, 6 INT S ADV ENV MON
   GRIMMER G, 1983, FRESEN Z ANAL CHEM, V314, P29, DOI 10.1007/BF00476507
   GROSJEAN D, 1983, ATMOS ENVIRON, V17, P2112, DOI 10.1016/0004-6981(83)90376-1
   Harrison RM, 1996, ENVIRON SCI TECHNOL, V30, P825, DOI 10.1021/es950252d
   *IARC, 1987, IARC MON EV CARC RIS, V43
   Kalaitzoglou M, 2004, ATMOS ENVIRON, V38, P2545, DOI 10.1016/j.atmosenv.2004.01.042
   Kavouras IG, 1999, ATMOS ENVIRON, V33, P4977, DOI 10.1016/S1352-2310(99)00281-2
   Kulkarni P, 2000, ATMOS ENVIRON, V34, P2785, DOI 10.1016/S1352-2310(99)00312-X
   Larsen RK, 2003, ENVIRON SCI TECHNOL, V37, P1873, DOI 10.1021/es0206184
   Li CL, 2005, BUILD ENVIRON, V40, P329, DOI 10.1016/j.buildenv.2004.05.015
   Manoli E, 2004, CHEMOSPHERE, V56, P867, DOI 10.1016/j.chemosphere.2004.03.013
   Mantis J, 2005, CHEMOSPHERE, V59, P593, DOI 10.1016/j.chemosphere.2004.10.019
   Mastral AM, 2000, FUEL PROCESS TECHNOL, V67, P1, DOI 10.1016/S0378-3820(00)00088-6
   Muller JF, 1998, CHEMOSPHERE, V37, P1369, DOI 10.1016/S0045-6535(98)00119-2
   Odabasi M, 1999, SCI TOTAL ENVIRON, V227, P57, DOI 10.1016/S0048-9697(99)00004-2
   Panther BC, 1999, ATMOS ENVIRON, V33, P4087, DOI 10.1016/S1352-2310(99)00150-8
   Pineiro-Iglesias M, 2004, SCI TOTAL ENVIRON, V334, P377, DOI 10.1016/j.scitotenv.2004.04.041
   Pleil JD, 2004, J CHROMATOGR A, V1033, P9, DOI 10.1016/j.chrome.2003.12.074
   Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485
   Richter H, 2000, PROG ENERG COMBUST, V26, P565, DOI 10.1016/S0360-1285(00)00009-5
   ROGGE WF, 1993, ENVIRON SCI TECHNOL, V27, P1892, DOI 10.1021/es00046a019
   Samara C, 2005, ATMOS ENVIRON, V39, P6430, DOI 10.1016/j.atmosenv.2005.07.027
   SCHWARTZ J, 1994, ENVIRON RES, V64, P36, DOI 10.1006/enrs.1994.1005
   Sienra MD, 2005, ATMOS RES, V75, P267, DOI 10.1016/j.atmosres.2005.01.003
   Simcik MF, 1999, ATMOS ENVIRON, V33, P5071, DOI 10.1016/S1352-2310(99)00233-2
   Sun P, 2006, CHEMOSPHERE, V65, P2268, DOI 10.1016/j.chemosphere.2006.05.029
   Triantafyllou AG, 2006, ENVIRON MONIT ASSESS, V122, P41, DOI 10.1007/s10661-005-9162-9
   Triantafyllou AG, 2002, J AIR WASTE MANAGE, V52, P287, DOI 10.1080/10473289.2002.10470788
   Triantafyllou AG, 2007, FRESEN ENVIRON BULL, V16, P508
   Tsapakis M, 2005, ENVIRON POLLUT, V133, P147, DOI 10.1016/j.envpol.2004.05.012
   VENKATARAMAN C, 1994, ENVIRON SCI TECHNOL, V28, P555, DOI 10.1021/es00053a005
   Voutsa D, 2004, CHEMOSPHERE, V55, P595, DOI 10.1016/j.chemosphere.2003.11.023
   Yusa V, 2006, TALANTA, V69, P807, DOI 10.1016/j.talanta.2005.11.018
   ZIOMAS IC, 1995, ATMOS ENVIRON, V29, P3703, DOI 10.1016/1352-2310(95)00131-H
NR 40
TC 7
Z9 8
U1 3
U2 21
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0045-6535
EI 1879-1298
J9 CHEMOSPHERE
JI Chemosphere
PD JUN
PY 2010
VL 80
IS 3
BP 235
EP 240
DI 10.1016/j.chemosphere.2010.04.034
PG 6
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 615KC
UT WOS:000279132900006
PM 20452642
DA 2018-12-27
ER

PT J
AU Douay, L
AF Douay, Luc
TI RETRACTED: From Stem Cell to Red Blood Cells In Vitro: "The 12 Labors of
   Hercules" (Retracted Article. See vol 31, pg 359, 2011)
SO CLINICS IN LABORATORY MEDICINE
LA English
DT Article; Retracted Publication
DE Artificial blood; Stem cells; Hemoglobin; Transfusion medicine
ID EX-VIVO; HEMATOPOIETIC STEM; ERYTHROID-DIFFERENTIATION; ENUCLEATION;
   PROLIFERATION; TRANSFUSION; PROGENITORS; GENERATION
AB This article describes the research in progress that will permit the large-scale production of human red blood cells from hematopoietic stem cells. It also discusses the current state of this research, suggests the obstacles to be overcome to pass from the laboratory model to clinical practice, and analyzes the possible indications in the medium and long term. The potential interest of pluripotent stem cells as an unlimited source of red blood cells is considered. If it succeeds, this new approach could mark a considerable advance in the field of transfusion.
C1 Univ Paris 06, INSERM, UMR S938, F-94200 Ivry, France.
RP Douay, L (reprint author), Univ Paris 06, INSERM, UMR S938, F-94200 Ivry, France.
EM luc.douay@trs.aphp.fr
CR Bagnis C, 2009, TRANSFUSION, V49, P967, DOI 10.1111/j.1537-2995.2008.02078.x
   Douay L, 2001, J HEMATOTH STEM CELL, V10, P341, DOI 10.1089/152581601750288948
   Douay L, 2007, TRANSFUS MED REV, V21, P91, DOI 10.1016/j.tmrv.2006.11.004
   FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83
   Fujimi A, 2008, INT J HEMATOL, V87, P339, DOI 10.1007/s12185-008-0062-y
   Garderet L, 2010, HAEMATOL-HEMATOL J, V95, P398, DOI [10.3324/haemato1.2009.012773, 10.3324/haematol.2009.012773]
   Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047
   Group USCSW, 2005, US CANC STAT 2002 IN
   HANNA J, 1920, SCIENCE, V318, P2007
   JC D, 1996, CURRENT POPULATION R, P25
   LU L, 1993, BLOOD, V81, P41
   Lu SJ, 2008, BLOOD, V112, P4475, DOI 10.1182/blood-2008-05-157198
   McAdams TA, 1998, BRIT J HAEMATOL, V103, P317, DOI 10.1046/j.1365-2141.1998.00975.x
   Migliaccio AR, 2009, CURR OPIN HEMATOL, V16, P259, DOI 10.1097/MOH.0b013e32832bcaa2
   Miharada K, 2006, NAT BIOTECHNOL, V24, P1255, DOI 10.1038/nbt1245
   Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007
   Neildez-Nguyen TMA, 2002, NAT BIOTECHNOL, V20, P467, DOI 10.1038/nbt0502-467
   OGAWA M, 1993, BLOOD, V81, P2844
   Qiu CH, 2005, EXP HEMATOL, V33, P1450, DOI 10.1016/j.exphem.2005.09.003
   ROBERTBOBEE I, 2006, PROJECTIONS POPULATI
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Timmins NE, 2009, TRENDS BIOTECHNOL, V27, P415, DOI 10.1016/j.tibtech.2009.03.008
   VERFAILLIE CM, 1993, BLOOD, V82, P2045
   Vlaski M, 2009, EXP HEMATOL, V37, P573, DOI 10.1016/j.exphem.2009.01.007
NR 24
TC 3
Z9 4
U1 3
U2 15
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0272-2712
EI 1557-9832
J9 CLIN LAB MED
JI Clin. Lab. Med.
PD JUN
PY 2010
VL 30
IS 2
BP 391
EP +
DI 10.1016/j.cll.2010.02.003
PG 15
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA 617BM
UT WOS:000279255800004
PM 20513558
DA 2018-12-27
ER

PT J
AU Madbouly, KM
   Hussein, A
   Omar, W
   Farid, M
AF Madbouly, Khaled M.
   Hussein, Ahmed
   Omar, Waleed
   Farid, Mohamed
TI RETRACTED: Regenerated Oxidized Cellulose Reinforcement of Low Rectal
   Anastomosis: Do We Still Need Diversion? (Retracted article. See vol.
   54, pg. 656, 2011)
SO DISEASES OF THE COLON & RECTUM
LA English
DT Article; Proceedings Paper; Retracted Publication
CT Annual Meeting of the American-Society-of-Colon-and-Rectal-Surgeons
CY JUN 03-07, 2006
CL Seattle, WA
SP Amer Soc Colon & Rectal Surg
DE Leak; Rectal anastomosis; Regenerated oxidized cellulose; Reinforcement
ID LOW ANTERIOR RESECTION; STAPLE-LINE; COLORECTAL SURGERY; CANCER;
   LEAKAGE; RISK; SEAMGUARD; EXCISION; EFFICACY; THERAPY
AB PURPOSE: The leak rate after low anterior resection is in the region of 10% to 15%. The highest risks of anastomotic leak are in anastomoses less than 5 cm from the anal verge. We evaluated the outcome of oxidized regenerated cellulose reinforcement of low rectal anastomosis.
   METHODS: The study group consisted of 108 patients with rectal cancer. Patients with low rectal cancer had low anterior resection with stapled straight low colorectal or coloanal anastomosis without proximal diversion. They were prospectively randomized to either oxidized regenerated cellulose reinforcement or no reinforcement. Data collected included age, sex, hemoglobin percentage, albumin level, histopathologic type of the tumor, anastomotic leak, and stricture.
   RESULTS: The mean age of patients was 56 years, and sex was matched in both groups. Clinical leak occurred in 6 of 38 cases (15.7%) in the group that did not undergo reinforcement versus 2 of 33 (6.1%) in the oxidized regenerated cellulose reinforcement group (P < .01). In the case of a leak, diversion was needed in 3 of 6 patients in the group that did not undergo reinforcement vs no patients in the oxidized regenerated cellulose reinforcement group (P = .05). Generalized peritonitis occurred in 3 patients in the group that did not undergo reinforcement versus no patients in the oxidized regenerated cellulose reinforcement group (P < .01). Length of stay was 4.8 days in the oxidized regenerated cellulose reinforcement group versus 5.9 days in the group that did not undergo reinforcement (P = .047), with no mortalities in either group.
   CONCLUSION: Oxidized regenerated cellulose reinforcement of low rectal anastomosis significantly decreases the risk of postoperative leak in low rectal anastomosis and may reduce the requirement for proximal diversion. Potential benefits include avoidance of a stoma, lower morbidity, shorter hospital stay, and a lower cost of care.
C1 [Madbouly, Khaled M.] Univ Alexandria, Dept Surg, El Raml Stn, Alexandria, Egypt.
   [Omar, Waleed; Farid, Mohamed] Univ Mansoura, Dept Surg, Mansoura, Egypt.
RP Madbouly, KM (reprint author), Univ Alexandria, Dept Surg, El Raml Stn, Alexandria, Egypt.
EM khaled.madbouly@alexmed.edu.eg
OI Madbouly, khaled/0000-0002-9795-653X
CR Barbuscia M, 2002, G Chir, V23, P310
   BORNEMISZA G, 1976, ACTA CHIR HUNG, V17, P67
   Brisinda G, 2009, J AM COLL SURGEONS, V208, P1152, DOI 10.1016/j.jamcollsurg.2009.02.048
   Buie WD, 2005, DIS COLON RECTUM, V48, P1868, DOI 10.1007/s10350-005-0154-1
   Consten ECJ, 2004, OBES SURG, V14, P549, DOI 10.1381/096089204323013604
   Consten Esther C J, 2004, Surg Technol Int, V13, P59
   Cullen B, 2002, INT J BIOCHEM CELL B, V34, P1544, DOI 10.1016/S1357-2725(02)00054-7
   de Montbrun SL, 2009, DIS COLON RECTUM, V52, P1178, DOI 10.1007/DCR.0b013e31819f24fc
   Franklin ME, 2005, SURG LAPARO ENDO PER, V15, P9, DOI 10.1097/01/sle0000154019.83584.2e
   Franklin ME, 2006, SURG LAPARO ENDO PER, V16, P411, DOI 10.1097/SLE.0b013e31802b68fe
   GRAFFNER H, 1983, DIS COLON RECTUM, V26, P87, DOI 10.1007/BF02562579
   Hagerman GF, 2007, DIS COLON RECTUM, V50, P1053, DOI 10.1007/s10350-007-0212-y
   Hoeppner J, 2009, INT J COLORECTAL DIS, V24, P543, DOI 10.1007/s00384-009-0637-y
   Jeschke MG, 2005, WOUND REPAIR REGEN, V13, P324, DOI 10.1111/j.1067-1927.2005.130316.x
   Kasalicky M, 2008, OBES SURG, V18, P1257, DOI 10.1007/s11695-008-9635-3
   Kheirabadi BS, 2002, J SURG RES, V106, P99, DOI 10.1006/jsre.2002.6426
   Kingham TP, 2009, J AM COLL SURGEONS, V208, P269, DOI 10.1016/j.jamcollsurg.2008.10.015
   KRAM HB, 1988, J VASC SURG, V8, P563, DOI 10.1067/mva.1988.avs0080563
   Krizova P, 2007, J BIOMED MATER RES A, V82A, P274, DOI 10.1002/jbm.a.31060
   Lipska MA, 2006, ANZ J SURG, V76, P579, DOI 10.1111/j.1445-2197.2006.03780.x
   Luh SP, 2004, INT SURG, V89, P190
   Malik AH, 2008, COLORECTAL DIS, V10, P616, DOI 10.1111/j.1463-1318.2007.01459.x
   Martel G, 2008, DIS COLON RECTUM, V51, P1195, DOI 10.1007/s10350-008-9368-3
   McArdle CS, 2005, BRIT J SURG, V92, P1150, DOI 10.1002/bjs.5054
   POWELL FC, 1984, J AM ACAD DERMATOL, V10, P59, DOI 10.1016/S0190-9622(84)80044-4
   Pronio Annamaria, 2007, Chir Ital, V59, P599
   Spangler Daniel, 2003, Surg Infect (Larchmt), V4, P255, DOI 10.1089/109629603322419599
   Tan WS, 2009, BRIT J SURG, V96, P462, DOI 10.1002/bjs.6594
   Testini M, 2000, Ann Ital Chir, V71, P433
NR 29
TC 5
Z9 5
U1 4
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0012-3706
EI 1530-0358
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD JUN
PY 2010
VL 53
IS 6
BP 889
EP 895
DI 10.1007/DCR.0b013e3181d3206e
PG 7
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 601XQ
UT WOS:000278101300008
PM 20485002
DA 2018-12-27
ER

PT J
AU Shin, SG
AF Shin, Soon-Gi
TI RETRACTED: A Study on the Percolation Threshold of Polyethylene Matrix
   Composites Filled Carbon Powder (Retracted article. See vol. 14, pg.
   215, 2018)
SO ELECTRONIC MATERIALS LETTERS
LA English
DT Article; Retracted Publication
DE percolation threshold; carbon powder; polyethylene; composites;
   tunneling conduction
ID INDUCED TUNNELING CONDUCTION
AB This paper investigates the percolation threshold of carbon powder-filled polyethylene matrix composites using the experimental results of the changes in resistivity and relative permittivity for filled carbon powder, the electric field dependence of current, and the critical exponent of conductivity. We found that a formation of infinite clusters is interrupted by a tunneling gap in the volume fraction section of filled carbon powder where the change in resistivity is extremely large. We also found that the critical exponent of conductivity for the universal law of conductivity is satisfied if the percolation threshold is estimated at the volume fraction of carbon powder where a nonohmic current behavior changes into an ohmic one. It is concluded that the percolation threshold should be defined at this volume fraction of carbon powder.
C1 Kangwon Natl Univ, Dept Adv Mat Engn, Coll Samcheok, Samcheok Si 245711, Gangwon, South Korea.
RP Shin, SG (reprint author), Kangwon Natl Univ, Dept Adv Mat Engn, Coll Samcheok, Samcheok Si 245711, Gangwon, South Korea.
EM ssg@kangwon.ac.kr
CR BALBERG I, 1987, PHYS REV LETT, V59, P1305, DOI 10.1103/PhysRevLett.59.1305
   JULIN PC, 1992, CARBON BLACK, P236
   Kim MJ, 2008, ELECTRON MATER LETT, V4, P57
   Kim SW, 2009, J KOREAN INST MET MA, V47, P50
   KIRKPATRICK S, 1973, REV MOD PHYS, V45, P574, DOI 10.1103/RevModPhys.45.574
   KOGUT PM, 1979, PHYSICA C, V12, P2150
   KUHNER G, 1992, CARBON BLACK, P8
   MATSUSHITA R, 1977, J MATER SCI, V12, P509, DOI 10.1007/BF00540275
   MIYASAKA K, 1982, J MATER SCI, V17, P1610, DOI 10.1007/BF00540785
   MULCHOPADHYAY R, 1976, J APPL POLYM SCI, V20, P2575
   Nakamura S., 1997, Transactions of the Institute of Electrical Engineers of Japan, Part A, V117-A, P371
   OHTSUKI T, 1984, J PHYS A-MATH GEN, V17, pL559, DOI 10.1088/0305-4470/17/11/001
   PARK SH, 2009, ELECTRON MATER LETT, V5, P2
   PIKE GE, 1974, PHYS REV B, V10, P1421, DOI 10.1103/PhysRevB.10.1421
   Reboul J. P., 1982, CARBON BLACK POLYM C, P80
   SHENG P, 1978, PHYS REV LETT, V40, P1197, DOI 10.1103/PhysRevLett.40.1197
   SHENG P, 1980, PHYS REV B, V21, P2180, DOI 10.1103/PhysRevB.21.2180
   SHIN SG, J MET MAT IN PRESS
   SHIN SG, 2009, J MATER RES, V19, P644
   SICHEL EK, 1982, CARBON BLACK POLYM C, P45
   SONG Y, 1986, PHYS REV B, V33, P904, DOI 10.1103/PhysRevB.33.904
   STAUFFER D, 1992, INTRO PRECOLATION TH, P21
   TANAKA T, 1973, J APPL PHYS, V44, P2430, DOI 10.1063/1.1662586
   VERHELST WF, 1977, RUBBER CHEM TECHNOL, V50, P735, DOI 10.5254/1.3535171
NR 24
TC 20
Z9 20
U1 1
U2 3
PU KOREAN INST METALS MATERIALS
PI SEOUL
PA KIM BLDG 6TH FLOOR, SEOCHO-DAERO 56 GIL 38, SEOCHO-GU, SEOUL 137-881,
   SOUTH KOREA
SN 1738-8090
EI 2093-6788
J9 ELECTRON MATER LETT
JI Electron. Mater. Lett.
PD JUN
PY 2010
VL 6
IS 2
BP 65
EP 70
DI 10.3365/eml.2010.06.065
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 641LJ
UT WOS:000281127300004
DA 2018-12-27
ER

PT J
AU Aoki, N
   Yokoyama, R
   Asai, N
   Ohki, M
   Ohki, Y
   Kusubata, K
   Heissig, B
   Hattori, K
   Nakagawa, Y
   Matsuda, T
AF Aoki, Naohito
   Yokoyama, Rumi
   Asai, Noriyuki
   Ohki, Makiko
   Ohki, Yuichi
   Kusubata, Kaori
   Heissig, Beate
   Hattori, Koichi
   Nakagawa, Yoshimi
   Matsuda, Tsukasa
TI RETRACTED: Adipocyte-Derived Microvesicles Are Associated with Multiple
   Angiogenic Factors and Induce Angiogenesis in Vivo and in Vitro
   (Retracted article. See vol. 154, pg. 4437, 2013)
SO ENDOCRINOLOGY
LA English
DT Article; Retracted Publication
ID ADIPOSE-TISSUE DEVELOPMENT; ENDOTHELIAL GROWTH-FACTOR; OBESITY; LEPTIN;
   CELLS; MICE; NEOVASCULARIZATION; DIFFERENTIATION; EXPRESSION; INHIBITOR
AB We previously reported that 3T3-L1 and rat primary adipocytes secreted microvesicles, known as adipocyte-derived microvesicles (ADMs). In the present study, we further characterized the 3T3-L1 ADMs and found that they exhibited angiogenic activity in vivo. Antibody arrays and gelatin zymography analyses revealed that several angiogenic and antiangiogenic proteins, including leptin, TNF alpha, acidic fibroblast growth factor (FGFa), interferon-gamma, and matrix metalloprotease (MMP)-2 and MMP-9, were present in the ADMs. Gene expression of most of these angiogenic factors was induced in the adipose tissue of diet-induced obese mice. Furthermore, leptin, TNF alpha, and MMP-2 were up-regulated at the protein level in the adipocyte fractions prepared from epididymal adipose tissues of high-fat-diet-induced obese mice. ADMs induced cell migration and tube formation of human umbilical vein endothelial cells, which were partially suppressed by neutralizing antibodies to leptin, TNF alpha, or FGFa but not to interferon-gamma. Supporting these data, a mixture of leptin, TNF alpha, and FGFa induced tube formation. ADMs also promoted cell invasion of human umbilical vein endothelial cells through Matrigel, which was suppressed by the addition of the MMP inhibitor 1,10'-phenanthroline and a neutralizing antibody to MMP-2 but not to MMP-9. These results suggest that ADMs are associated with multiple angiogenic factors and play a role in angiogenesis in adipose tissue. (Endocrinology 151: 2567-2576, 2010)
C1 [Aoki, Naohito; Yokoyama, Rumi; Asai, Noriyuki] Mie Univ, Grad Sch Bioresources, Dept Life Sci, Tsu, Mie 5148507, Japan.
   [Ohki, Makiko; Ohki, Yuichi; Kusubata, Kaori; Heissig, Beate; Hattori, Koichi] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Minato Ku, Tokyo 1088639, Japan.
   [Nakagawa, Yoshimi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Internal Med Endocrinol & Metab, Tsukuba, Ibaraki 3058575, Japan.
   [Nakagawa, Yoshimi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Diagnost Biochem, Tsukuba, Ibaraki 3058575, Japan.
   [Matsuda, Tsukasa] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.
RP Aoki, N (reprint author), Mie Univ, Grad Sch Bioresources, Dept Life Sci, 1577 Kurimamachiya Cho, Tsu, Mie 5148507, Japan.
EM n-aoki@bio.mie-u.ac.jp
FU Ministry of Education, Culture, Sports, Science, and Technology of
   Japan; Graduate School of Bioresources, Mie University; Japanese
   Government [2008-2010]
FX This work was supported by a Grant-in-Aid for Scientific Research from
   the Ministry of Education, Culture, Sports, Science, and Technology of
   Japan and by the Centre of Excellence Program of the Graduate School of
   Bioresources, Mie University.; Disclosure Summary: Na.A. received grant
   support (2008-2010) from the Japanese Government. R.Y., No.A., M.O.,
   Y.O., K.K., B.H., K.H., Y.N., and T.M. have nothing to declare.
CR AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231
   Aoki N, 1997, BBA-GEN SUBJECTS, V1334, P182, DOI 10.1016/S0304-4165(96)00091-8
   Aoki N, 2007, ENDOCRINOLOGY, V148, P3850, DOI 10.1210/en.2006-1479
   Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059
   Bouloumie A, 2002, ANN ENDOCRINOL-PARIS, V63, P91
   Brakenhielm E, 2004, CIRC RES, V94, P1579, DOI 10.1161/01.RES.0000132745.76882.70
   Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JC132239
   Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200
   Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786
   FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277
   Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657
   Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008
   Kopelman PG, 2000, NATURE, V404, P635
   LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0
   LI J, 2002, AM J PHYSIOL-ENDOC M, V282, P1334
   Lijnen HR, 2006, DIABETES, V55, P2698, DOI 10.2338/db06-0526
   Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194
   Matsuzawa Y, 2005, BEST PRACT RES CL EN, V19, P637, DOI 10.1016/j.beem.2005.07.001
   MCALLISTER FF, 1951, ANN SURG, V133, P153, DOI 10.1097/00000658-195102000-00002
   Mu H, 2006, CARDIOVASC RES, V70, P146, DOI 10.1016/j.cardiores.2006.01.015
   Neels JG, 2004, FASEB J, V18, P983, DOI 10.1096/fj.03-1101fje
   Ohki Y, 2005, FASEB J, V19, P2005, DOI 10.1096/fj.04-3496fje
   Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799
   Saiki A, 2006, INT J OBESITY, V30, P1676, DOI 10.1038/sj.ijo.0803316
   Samad F, 1998, P NATL ACAD SCI USA, V95, P7591, DOI 10.1073/pnas.95.13.7591
   Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683
   Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233
   Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   VINEBERG AM, 1965, J THORAC CARDIOV SUR, V49, P103
   Voros G, 2005, ENDOCRINOLOGY, V146, P4545, DOI 10.1210/en.2005-0532
   Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200
   Zhang QX, 1997, J SURG RES, V67, P147, DOI 10.1006/jsre.1996.4983
   ZIMRIN AB, 1995, BIOCHEM BIOPH RES CO, V213, P630, DOI 10.1006/bbrc.1995.2178
NR 34
TC 40
Z9 41
U1 3
U2 10
PU ENDOCRINE SOC
PI CHEVY CHASE
PA 8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA
SN 0013-7227
EI 1945-7170
J9 ENDOCRINOLOGY
JI Endocrinology
PD JUN
PY 2010
VL 151
IS 6
BP 2567
EP 2576
DI 10.1210/en.2009-1023
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 599XY
UT WOS:000277948800019
PM 20382694
OA Bronze
DA 2018-12-27
ER

PT J
AU Abou-Elenain, K
AF Abou-Elenain, Khaled
TI RETRACTED: Study of the systemic and pulmonary oxidative stress status
   during exposure to propofol and sevoflurane anaesthesia during thoracic
   surgery (Retracted Article. See vol 28, pg 74, 2011)
SO EUROPEAN JOURNAL OF ANAESTHESIOLOGY
LA English
DT Article; Retracted Publication
DE oxidative stress; propofol; sevoflurane; thoracic surgery
ID ALVEOLAR MACROPHAGES; PROINFLAMMATORY CYTOKINES; MECHANICAL VENTILATION;
   ANTIOXIDANT STATUS; PERIPHERAL-BLOOD; EXPIRED BREATH; RAT; CELLS;
   INFLAMMATION; EXPRESSION
AB Background and objective General anaesthesia during mechanical ventilation can induce variable systemic and pulmonary immune effects that may affect postoperative outcome. The aim of the present study was to evaluate evidence of oxidative stress in the blood and bronchoalveolar lavage (BAL) fluid of patients exposed to propofol or sevoflurane anaesthesia during thoracic surgery.
   Methods Sixty adult patients undergoing thoracic surgery were randomly allocated to receive propofol (n=30) or sevoflurane (n=30) anaesthesia. Blood samples and bronchoscopic BAL specimens were evaluated for oxidative activity measurements: malondialdehyde, glutathione peroxidase and superoxide dismutase. Also BAL specimens were evaluated for numbers of cells, albumin concentrations, proinflammatory cytokines (tumour necrosis factor-alpha, interleukin-8) and proteinases (polymorphonuclear elastase).
   Results We found a significant decrease for malondialdehyde and higher values of glutathione peroxidase measurements in the plasma and BAL during propofol anaesthesia. Significantly higher levels of malondialdehyde and lower concentrations of glutathione peroxidase in plasma and BAL were found during sevoflurane anaesthesia. Superoxide dismutase showed no significant changes during exposure to either anaesthetic. In both groups, intraalveolar cell numbers, albumin concentrations as well as interleukin-8, tumour necrosis factor and polymorphonuclear elastase concentrations increased over time. However, they were significantly higher in the sevoflurane than in the propofol group.
   Conclusion Sevoflurane seemed to induce a local and systemic oxidative stress, whereas propofol is more likely to have antioxidant properties. Sevoflurane appears to cause a greater intrapulmonary proinflammatory response than propofol during thoracic surgery. Eur J Anaesthesiol 2010;27:566-571
C1 Minoufiya Univ, Minoufiya Fac Med, Dept Anaesthesiol, Damanhour, Beheira, Egypt.
RP Abou-Elenain, K (reprint author), Minoufiya Univ, Minoufiya Fac Med, Dept Anaesthesiol, Egypt 8 Fawzy St,Via Elmaqreezy St, Damanhour, Beheira, Egypt.
EM kh69193@yahoo.com
FU Minoufiya University
FX Minoufiya University is funding the research.
CR BALDWIN SR, 1986, LANCET, V1, P11
   Boya P, 1999, J HEPATOL, V31, P808, DOI 10.1016/S0168-8278(99)80281-5
   Cho EJ, 2009, J CARDIOTHOR VASC AN, V23, P639, DOI 10.1053/j.jvca.2009.01.025
   De la Cruz JP, 1999, ANESTH ANALG, V89, P1050, DOI 10.1097/00000539-199910000-00043
   De la Cruz JP, 1998, ANESTH ANALG, V87, P1141, DOI 10.1097/00000539-199811000-00031
   DOHLMAN AW, 1993, AM REV RESPIR DIS, V148, P955, DOI 10.1164/ajrccm/148.4_Pt_1.955
   Frass OM, 2001, CHEST, V120, P1599, DOI 10.1378/chest.120.5.1599
   Giraud O, 2003, ANESTHESIOLOGY, V98, P74, DOI 10.1097/00000542-200301000-00015
   GOODE HF, 1995, CRIT CARE MED, V23, P646, DOI 10.1097/00003246-199504000-00011
   HALL JC, 1991, CHEST, V99, P923, DOI 10.1378/chest.99.4.923
   HERNANDEZSAAVED.D, 2007, REV MED I MEX SEGURO, V5, P477
   Kooguchi K, 1998, INFECT IMMUN, V66, P3164
   Kotani N, 1999, ANESTH ANALG, V89, P1250, DOI 10.1213/00000539-199911000-00032
   KOTANI N, 1995, ANESTH ANALG, V81, P1255, DOI 10.1097/00000539-199512000-00023
   Kotani N, 1998, ANESTHESIOLOGY, V89, P1125, DOI 10.1097/00000542-199811000-00012
   Kotani N, 1999, ANESTHESIOLOGY, V91, P187, DOI 10.1097/00000542-199907000-00027
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   MURPHY PG, 1992, BRIT J ANAESTH, V68, P613, DOI 10.1093/bja/68.6.613
   MUSACCHIO E, 1991, PHARMACOL TOXICOL, V69, P75, DOI 10.1111/j.1600-0773.1991.tb00414.x
   OREILLY M, 1992, J SURG RES, V52, P518
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   RICHARD MJ, 1992, CLIN CHEM, V38, P704
   Shirai R, 1997, CLIN EXP IMMUNOL, V109, P73, DOI 10.1046/j.1365-2249.1997.4211317.x
   Suter D, 2007, ANESTH ANALG, V104, P638, DOI 10.1213/01.ane.0000255046.06058.58
   Takala RSK, 2004, ACTA ANAESTH SCAND, V48, P40, DOI 10.1111/j.1399-6576.2004.00266.x
   THOMPSON PJ, 1993, AM REV RESPIR DIS, V147, P164, DOI 10.1164/ajrccm/147.1.164
   VANVYVE T, 1992, AM REV RESPIR DIS, V146, P116, DOI 10.1164/ajrccm/146.1.116
   Wrigge H, 2000, ANESTHESIOLOGY, V93, P1413, DOI 10.1097/00000542-200012000-00012
NR 28
TC 12
Z9 15
U1 3
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0265-0215
EI 1365-2346
J9 EUR J ANAESTH
JI Eur. J. Anaesth.
PD JUN
PY 2010
VL 27
IS 6
BP 566
EP 571
DI 10.1097/EJA.0b013e3283392c1d
PG 6
WC Anesthesiology
SC Anesthesiology
GA 591YY
UT WOS:000277342700013
PM 20442581
DA 2018-12-27
ER

PT J
AU Liu, SG
   Jin, FL
   Dai, WX
   Yu, YF
AF Liu, Shiguo
   Jin, Fengling
   Dai, Wuxing
   Yu, Yongfeng
TI RETRACTED: Antisense treatment of IGF-IR enhances chemosensitivity in
   squamous cell carcinomas of the head and neck (Retracted article. See
   vol. 47, pg. 809, 2011)
SO EUROPEAN JOURNAL OF CANCER
LA English
DT Article; Retracted Publication
DE IGF-IR; AS[S]ODN; Chemosensitivity; SCCHN; Apoptosis; Chemotherapy
ID GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; INDUCED APOPTOSIS;
   THERAPEUTIC TARGET; MELANOMA-CELLS; LUNG-CANCER; SYSTEM; TUMORS; DEATH;
   INHIBITION
AB To evaluate whether targeting IGF-IR therapeutic can increased chemosensitivity of squamous cell carcinomas of the head and neck (SCCHN) to doxorubicin and cisplatin, Insulin-like growth factor type I receptor (IGF-IR) expression was down-regulated by treatment with AS[S]ODN. Different doses of AS[S]ODN with doxorubicin or cisplatin were tested in TU159 and 183A SCCHN cell lines. Compared to phosphorothioate sense oligonucleotides (SS[S]ODN), AS[S]ODN treatment inhibited cancer cell proliferation and attenuated activation of IGF-IR. AS[S]ODN treatment was shown to enhance the sensitivity of SCCHN cell lines to doxorubicin and cisplatin. This observation correlated closely with the induction of apoptosis as measured by Annexin-V/PI and caspase activation assays. The in vivo results showed that treatment with AS[S]ODN/doxorubicin in combination also resulted in a significant suppression in TU159 xenografts. In conclusion, this study provides evidence for the efficacy of IGF-IR down-regulation combined with chemotherapy and raises the possibility that SCCHN treatment may be improved by pharmaceutical strategies directed towards the IGF-IR. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Dai, Wuxing] Huazhong Univ Sci & Technol, Dept Biochem & Mol Biol, Tongji Med Coll, Wuhan 430030, Peoples R China.
   [Yu, Yongfeng] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai, Peoples R China.
RP Dai, WX (reprint author), Huazhong Univ Sci & Technol, Dept Biochem & Mol Biol, Tongji Med Coll, 13 Hangkong Rd, Wuhan 430030, Peoples R China.
EM dwxtongji@163.com; yuyongfeng212@sina.com
FU Society Development Foundation of Jingmen [20-06-16-41]
FX This work was supported by grants from the Society Development
   Foundation of Jingmen (No. 20-06-16-41).
CR Barnes CJ, 2007, CLIN CANCER RES, V13, P4291, DOI 10.1158/1078-0432.CCR-06-2040
   BASERGA R, 1997, BIOCHIM BIOPHYS ACTA, V1332, P105
   Belinsky MG, 2008, CELL CYCLE, V7, P2949, DOI 10.4161/cc.7.19.6760
   Benini S, 2001, CLIN CANCER RES, V7, P1790
   BURFEIND P, 1996, PNAS US, V5693, P7263
   Curado MP, 2009, CURR OPIN ONCOL, V21, P194, DOI 10.1097/CCO.0b013e32832a68ca
   D'cunja J, 2007, EUR J CANCER, V43, P1581, DOI 10.1016/j.ejca.2007.03.003
   Dunn SE, 1997, CANCER RES, V57, P2687
   EASTMAN A, 1990, CANCER CELL-MON REV, V2, P275
   Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574
   Gooch JL, 1999, BREAST CANCER RES TR, V56, P1, DOI 10.1023/A:1006208721167
   Kurihara S, 2000, ENDOCR J, V47, P739, DOI 10.1507/endocrj.47.739
   Lee Chang Youl, 2008, Korean Journal of Internal Medicine, V23, P116, DOI 10.3904/kjim.2008.23.3.116
   Lee TKW, 2002, CANCER CHEMOTH PHARM, V49, P78, DOI 10.1007/s00280-001-0376-4
   LEEN CT, 1996, CANCER RES, V56, P3038
   Liu XD, 1998, CANCER RES, V58, P5432
   Macaulay VM, 2001, ONCOGENE, V20, P4029, DOI 10.1038/sj.onc.1204565
   Maloney EK, 2003, CANCER RES, V63, P5073
   Mitsiades CS, 2005, EXPERT REV ANTICANC, V5, P487, DOI 10.1586/14737140.5.3.487
   Nakamura S, 1997, EXP CELL RES, V235, P287, DOI 10.1006/excr.1997.3683
   Playford MP, 2000, P NATL ACAD SCI USA, V97, P12103, DOI 10.1073/pnas.210394297
   Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387
   Qin LF, 2002, CANCER LETT, V175, P27, DOI 10.1016/S0304-3835(01)00720-0
   Reinmuth N, 2002, LAB INVEST, V82, P1377, DOI 10.1097/01.LAB.0000032411.41603.C2
   RESNICOFF M, 1994, CANCER RES, V54, P4848
   SELL C, 1995, CANCER RES, V55, P303
   Slomiany MG, 2007, CANCER LETT, V248, P269, DOI 10.1016/j.canlet.2006.08.004
   Tang YC, 2003, CANCER RES, V63, P1166
   Turner BC, 1997, CANCER RES, V57, P3079
   Waldman T, 1997, NAT MED, V3, P1034, DOI 10.1038/nm0997-1034
   Warshamana-Greene GS, 2005, CLIN CANCER RES, V11, P1563, DOI 10.1158/1078-0432.CCR-04-1544
   Yang L, 2009, CANCER LETT, V276, P180, DOI 10.1016/j.canlet.2008.11.015
NR 32
TC 10
Z9 10
U1 3
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0959-8049
EI 1879-0852
J9 EUR J CANCER
JI Eur. J. Cancer
PD JUN
PY 2010
VL 46
IS 9
BP 1744
EP 1751
DI 10.1016/j.ejca.2010.03.038
PG 8
WC Oncology
SC Oncology
GA 618WV
UT WOS:000279387700037
PM 20451373
DA 2018-12-27
ER

PT J
AU Abou-Jaoude, MM
   Nawfal, N
   Shaheen, J
   Daoud, Z
   Almawi, WY
AF Abou-Jaoude, Maroun M.
   Nawfal, Naji
   Shaheen, Joseph
   Daoud, Ziad
   Almawi, Wassim Y.
TI RETRACTED: Infectious Complications in Kidney Transplant: A Lebanese
   Perspective (Retracted article. See vol. 11, pg. 84, 2013)
SO EXPERIMENTAL AND CLINICAL TRANSPLANTATION
LA English
DT Article; Retracted Publication
DE Immunosuppression; Infection
ID SINGLE-CENTER EXPERIENCE; URINARY-TRACT-INFECTION;
   RENAL-TRANSPLANTATION; RECIPIENTS; EPIDEMIOLOGY; SURVEILLANCE;
   MANAGEMENT; SURVIVAL
AB Objectives: Infections remain a frequent, potentially life-threatening complication of kidney transplant.
   Subjects and Methods: Between 1998 and 2006, we evaluated the incidence of infections in 114 kidney transplant patients, with a 1-year follow-up. All patients received a posttransplant anti-infectious prophylaxis regimen. Induction therapy was given to 94 patients (82.4%), and maintenance immunosuppression consisted of calcineurin inhibitor (cyclosporin microemulsion or tacrolimus), together with mycophenolate mofetil and prednisone.
   Results: In total, 56 patients (49.1%) developed a total of 95 infections up to 1-year after kidney transplant, including 46 in-hospital infections in 38 patients. Bacterial infections were the most frequent (97.8%), and were mainly urinary, followed by drain, central line catheter, and pulmonary infections. The most-frequent isolated bacteria were E. coli, followed by Klebsiella, Acinetobacter, and Pseudomonas. No viral infections were detected. Up to 1 year after discharge from the hospital, 49 infections occurred in 26 patients, of which 79.5% were bacterial; mainly urinary tract infections due to E. coli, in addition to 7 cases of cytomegalovirus, 1 herpes, and 2 cases of fungal infections.
   Conclusions: This is the first Lebanese study that deals with posttransplant infections in kidney transplant patients and underscores the importance of close patient monitoring and follow-up. Comparison with international data shows similar patterns.
C1 [Almawi, Wassim Y.] Arabian Gulf Univ, Dept Med Biochem, Coll Med & Med Sci, Manama, Bahrain.
   [Abou-Jaoude, Maroun M.; Nawfal, Naji; Shaheen, Joseph] Sacre Coeur Hosp, Transplant Unit, Beirut, Lebanon.
   [Abou-Jaoude, Maroun M.] St Georges Univ Hosp, Transplant Unit, Beirut, Lebanon.
   [Abou-Jaoude, Maroun M.; Daoud, Ziad] Univ Balamand, Fac Med, Beirut, Lebanon.
RP Almawi, WY (reprint author), Arabian Gulf Univ, Dept Med Biochem, Coll Med & Med Sci, POB 22979, Manama, Bahrain.
EM wassim@agu.edu.bh
CR Alangaden GJ, 2006, CLIN TRANSPLANT, V20, P401, DOI 10.1111/j.1399-0012.2006.00519.x
   Aquino VH, 2001, BRAZ J MED BIOL RES, V34, P93, DOI 10.1590/S0100-879X2001000100011
   Cavdar C, 2008, RENAL FAILURE, V30, P503, DOI 10.1080/08860220802064705
   de Souza RM, 2008, NAT CLIN PRACT NEPHR, V4, P252, DOI 10.1038/ncpneph0781
   Ferraresso M, 2005, TRANSPLANT P, V37, P2495, DOI 10.1016/j.transproceed.2005.06.029
   Fishman JA, 1998, NEW ENGL J MED, V338, P1741, DOI 10.1056/NEJM199806113382407
   GUECO IP, 1985, TRANSPLANT P, V17, P108
   Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901
   Hirsch HH, 2005, TRANSPLANTATION, V79, P1277, DOI 10.1097/01.TP.0000156165.83160.09
   Karam G, 2007, ANN UROL, V41, P261, DOI 10.1016/j.anuro.2007.08.007
   Keven K, 2008, MED MYCOL, V46, P713, DOI 10.1080/13693780802227282
   Knirsch CA, 2000, AM J MED, V108, P290, DOI 10.1016/S0002-9343(99)00459-3
   Lopez-Medrano F, 2007, TRANSPLANTATION, V84, P851, DOI 10.1097/01.tp.0000282788.70383.8b
   MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301
   Maraha B, 2001, CLIN MICROBIOL INFEC, V7, P619, DOI 10.1046/j.1198-743x.2001.00329.x
   Martins C, 2004, TRANSPLANT P, V36, P1650, DOI 10.1016/j.transproceed.2004.06.065
   Mattner F, 2007, J HEART LUNG TRANSPL, V26, P241, DOI 10.1016/j.healun.2006.12.009
   Mehrabi A, 2006, CLIN TRANSPLANT, V20, P97, DOI 10.1111/j.1399-0012.2006.00608.x
   Melchor JL, 1996, TRANSPLANT P, V28, P3305
   Moreno A, 2007, AM J TRANSPLANT, V7, P2579, DOI 10.1111/j.1600-6143.2007.01964.x
   Padiyar A, 2008, PRIMARY CARE, V35, P433, DOI 10.1016/j.pop.2008.03.003
   Patel R, 1997, CLIN MICROBIOL REV, V10, P86, DOI 10.1128/CMR.10.1.86
   RUBIN RH, 2002, CLIN APPROACH INFECT, pCH17
   Saemann M, 2008, EUR J CLIN INVEST, V38, P58, DOI 10.1111/j.1365.2362.2008.02014.x
   Schmidt A, 1999, Curr Opin Urol, V9, P45, DOI 10.1097/00042307-199901000-00008
   Tanphaichitr NT, 2000, ADV RENAL REPLACE TH, V7, P131, DOI 10.1053/rr.2000.5270
   Valera B, 2006, TRANSPLANT P, V38, P2414, DOI 10.1016/j.transproceed.2006.08.018
   Weikert BC, 2008, CLIN J AM SOC NEPHRO, V3, pS76, DOI 10.2215/CJN.02900707
NR 28
TC 3
Z9 3
U1 1
U2 9
PU BASKENT UNIV
PI ANKARA
PA TASKENT CADDESI NO 77, KAT 4, BAHCELIEVLER, ANKARA, 06490, TURKEY
SN 1304-0855
J9 EXP CLIN TRANSPLANT
JI Exp. Clin. Transplant.
PD JUN
PY 2010
VL 8
IS 2
BP 136
EP 141
PG 6
WC Transplantation
SC Transplantation
GA 633KW
UT WOS:000280502400008
PM 20565370
DA 2018-12-27
ER

PT J
AU Haribalaganesh, R
   Sheikpranbabu, S
   Banumathi, E
   Gurunathan, S
AF Haribalaganesh, Ravinarayanan
   Sheikpranbabu, Sardarpasha
   Banumathi, Elayappan
   Gurunathan, Sangiliyandi
TI RETRACTED: Pigment epithelium-derived factor inhibits
   erythropoietin-induced retinal endothelial cell angiogenesis by
   suppression of PI3K/Akt pathway (Retracted article. See vol. 90, pg.
   726, 2012)
SO EXPERIMENTAL EYE RESEARCH
LA English
DT Article; Retracted Publication
DE endothelial cells; erythropoietin; pigment epithelium-derived factor;
   proliferation; vascular permeability
ID MACULAR DEGENERATION; PEDF
AB Erythropoietin (EPO) plays a critical role in the vascular system and exhibits angiogenic activity in endothelial cells (ECs) such as stimulation of cell proliferation, migration and tube formation in vitro. EPO is the major regulator of cell proliferation and differentiation of erythroid precursors and there by preventing the apoptosis. Pigment epithelial derived factor (PEDF) is a potent anti-angiogenic factor whose effects are partially mediated through the induction of EC apoptosis. The mechanism of EPO and PEDF in retinal neovascularization has not been well documented yet. The effect of EPO and PEDF on cell proliferation was determined by MTT assay. In vitro wound-scratch assay was performed to study the migration of ECs and in vitro tube formation was assessed by the on-gel assay system using gelatin. Inhibitor assay was carried out using LY294002, a phosphatidylinositol 3-kinase (PI3K) inhibitor. Further, PI3K/Akt activity was assessed by transient transfection assay using constitutively active (CA) and dominant negative (DN) Akt mutants. Dextran permeability assay was performed to determine the vascular permeability. We report that EPO stimulates EC proliferation, migration, tube formation and permeability whereas PEDF inhibits the EPO-induced ECs proliferation and permeability. Over expression of DN Akt blocked EPO stimulation of proliferation and permeability, while over expression of CA Akt rescues the inhibitory effect of PEDF on proliferation and permeability. These results demonstrate that PEDF may inhibit the EPO-induced proliferation and permeability via PI3K/Akt-dependent pathway. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Haribalaganesh, Ravinarayanan; Sheikpranbabu, Sardarpasha; Banumathi, Elayappan; Gurunathan, Sangiliyandi] Kalasalingam Univ, Kalasalingam Acad Res & Educ, Dept Biotechnol, Div Mol & Cellular Biol, Krishnankoil 626190, Tamil Nadu, India.
RP Gurunathan, S (reprint author), Kalasalingam Univ, Kalasalingam Acad Res & Educ, Dept Biotechnol, Div Mol & Cellular Biol, Krishnankoil 626190, Tamil Nadu, India.
EM lvsangs@yahoo.com
FU Department of Science and Technology [SR/FT/L-118/2006]; Department of
   Biotechnology [BT/PR770/Med/14/1065/2006]; Indian Council of Medial
   Research Government of India, New Delhi [53/5/2006-BMS]
FX This work was supported in part by Department of Science and Technology
   (Grant No: SR/FT/L-118/2006), Department of Biotechnology (Grant No:
   BT/PR770/Med/14/1065/2006) and Indian Council of Medial Research (Grant
   No: 53/5/2006-BMS) Government of India, New Delhi. The author has
   gratefully acknowledged to Mr. V. Deepak for the critical reading of
   this manuscript.
CR BANUMATHI E, 2009, ANGIOGENESIS, V12, P313
   Bilak MM, 1999, J NEUROPATH EXP NEUR, V58, P719, DOI 10.1097/00005072-199907000-00006
   Bocker-Meffert S, 2002, INVEST OPHTH VIS SCI, V43, P2021
   Campochiaro PA, 2006, HUM GENE THER, V17, P167, DOI 10.1089/hum.2006.17.167
   DAISUKE W, 2005, NEW ENGL J MED, V353, P782
   Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245
   DOLORES LM, 2002, ONCOGENE, V21, P1556
   DOMENICO R, 1999, BLOOD, V93, P2627
   FRANK RN, 1991, OPHTHALMOLOGY, V98, P586
   Galeano M, 2004, DIABETES, V53, P2509, DOI 10.2337/diabetes.53.9.2509
   GERALD MY, 2005, CALCIFIED TISSUE INT, V76, P146
   HARIBALAGANESH R, 2009, PIGMENT EPITHELIUM D
   HUGO HM, 2006, EUR J NEUROSCI, V8, P666
   Jelkmann W, 1996, ANN ANAT, V178, P391, DOI 10.1016/S0940-9602(96)80124-5
   JOYCE TT, 1996, MOL VIS, V2, P11
   Juul SE, 1998, PEDIATR RES, V43, P40, DOI 10.1203/00006450-199801000-00007
   KAYAKO M, 2008, MOL VIS, V14, P992
   KOURY MJ, 1992, EUR J BIOCHEM, V210, P649, DOI 10.1111/j.1432-1033.1992.tb17466.x
   Kuncl RW, 2002, J NEUROCHEM, V81, P178, DOI 10.1046/j.1471-4159.2002.00813.x
   LEILING C, 2006, BIOCHEM BIOPH RES CO, V348, P1288
   MARY AM, 2005, PATHOPHYSIOL HAEMO T, V34, P164
   Mori K, 2002, INVEST OPHTH VIS SCI, V43, P1994
   NAHOKO O, 2002, AM J OPHTHALMOL, V133, P851
   OLGA VV, 2002, NAT MED, V8, P349
   RACHEL Z, 2007, AM J PHYSIOL-HEART C, V292, pH2467
   RAUL GC, 1995, KIDNEY INT, V47, P740
   RAY GF, 2005, NATURE, V438, P960
   SARAH M, 1997, J BIOL CHEM, V272, P6850
   Sawant S, 2004, BIOCHEM BIOPH RES CO, V325, P408, DOI 10.1016/j.bbrc.2004.10.041
   Semkova I, 2002, P NATL ACAD SCI USA, V99, P13090, DOI 10.1073/pnas.202486199
   Sheikpranbabu Sardarpasha, 2009, Journal of Nanobiotechnology, V7, P8, DOI 10.1186/1477-3155-7-8
   Sheikpranbabu S, 2009, LIFE SCI, V85, P719, DOI 10.1016/j.lfs.2009.09.015
   STEEN VP, 2003, BIOCHEM J, V374, P199
   TOMBRANTINK J, 1989, INVEST OPHTH VIS SCI, V30, P1700
   VERONICA S, 2001, P NATL ACAD SCI USA, V98, P2593
   XIYUAN Z, 2009, CHIN MED J, V122, P2711
   YOSHIYA K, 2005, DIABETES CARE, V28, P2252
NR 37
TC 12
Z9 12
U1 2
U2 15
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0014-4835
EI 1096-0007
J9 EXP EYE RES
JI Exp. Eye Res.
PD JUN
PY 2010
VL 90
IS 6
BP 726
EP 733
DI 10.1016/j.exer.2010.03.005
PG 8
WC Ophthalmology
SC Ophthalmology
GA 602UR
UT WOS:000278164900010
PM 20298690
DA 2018-12-27
ER

PT J
AU Haribalaganesh, R
   Banumathi, E
   Sheikpranbabu, S
   Deepak, V
   Sirishkumar, N
   Gurunathan, S
AF Haribalaganesh, Ravinarayanan
   Banumathi, Elayappan
   Sheikpranbabu, Sardarpasha
   Deepak, Venkataraman
   Sirishkumar, Namagiri
   Gurunathan, Sangiliyandi
TI RETRACTED: Isolation and characterization of goat retinal microvascular
   endothelial cells (Retracted article. See vol. 47, pg. 742, 2011)
SO IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
LA English
DT Article; Retracted Publication
DE Diabetic retinopathy; Retinal endothelial cells; Angiogenesis;
   Endothelial characterization
ID VASCULAR ENDOTHELIUM; DIABETIC-RETINOPATHY; MATRIX COMPONENTS;
   BLOOD-VESSELS; GROWTH-FACTOR; IN-VITRO; CULTURE; CAPILLARY;
   ANGIOGENESIS; MIGRATION
AB In this report, we demonstrate a method for the isolation of pure homogeneous endothelial cell population from goat's eye without using multi-step procedure and sophisticated instrument facilities. Microvascular endothelial cell from goat's retina were isolated using enzymatic method and cultured in Iscove's Modified Dulbecco's Medium supplemented with 10% fetal bovine serum. Five to 7 d after plating, a monolayer of endothelial cells was formed. These cells were identified as endothelial cells by morphology and confirmed by positive immunocytochemistry for vWF, CD31, VE-cadherin, CD146, VCAM-1, and ICAM-1, a specific marker for endothelial cells. We have compared both the mechanical and non-mechanical enzymatic methods in isolating pure endothelial cells. Cells plated on 4% gelatin-coated dishes resulted in tubular morphology, a characteristic of endothelial cells. This method is simpler and cost-effective when compared with other previously reported methods. These endothelial cells will be more helpful to identify the role of various factors in angiogenic-related disease such as diabetic retinopathy.
C1 [Haribalaganesh, Ravinarayanan; Banumathi, Elayappan; Sheikpranbabu, Sardarpasha; Deepak, Venkataraman; Gurunathan, Sangiliyandi] Kalasalingam Univ, Kalasalingam Acad Res & Educ, Dept Biotechnol, Div Mol & Cellular Biol, Krishnankoil 629190, Tamil Nadu, India.
   [Sirishkumar, Namagiri] Meenakshi Mission Hosp & Res Ctr, Dept Ophthalmol, Madurai 625107, Tamil Nadu, India.
RP Gurunathan, S (reprint author), Kalasalingam Univ, Kalasalingam Acad Res & Educ, Dept Biotechnol, Div Mol & Cellular Biol, Krishnankoil 629190, Tamil Nadu, India.
EM lvsangs@yahoo.com
FU Department of Science and Technology [SR/FT/L-118/2006]; Department of
   Biotechnology [BT/PR770/Med/14/1065/2006]; Indian Council of Medical
   Research, Government of India [53/5/2006-BMS]
FX This study was supported by a grant from the Department of Science and
   Technology (Grant No: SR/FT/L-118/2006), Department of Biotechnology
   (Grant No: BT/PR770/Med/14/1065/2006), and Indian Council of Medical
   Research (Grant No: 53/5/2006-BMS), Government of India.
CR ABBOT SE, 1992, ARTHRITIS RHEUM, V35, P401, DOI 10.1002/art.1780350407
   Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183
   AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203
   Banumathi E, 2009, MICROVASC RES, V77, P377, DOI 10.1016/j.mvr.2008.12.005
   BOOYSE FM, 1975, THROMB DIATH HAEMOST, V34, P825, DOI 10.1055/s-0038-1654001
   CARLEY WW, 1988, EXP CELL RES, V178, P426, DOI 10.1016/0014-4827(88)90411-9
   Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8
   Funatsu H, 2001, JPN J OPHTHALMOL, V45, P577, DOI 10.1016/S0021-5155(01)00420-8
   GRANT MB, 1991, INVEST OPHTH VIS SCI, V32, P53
   GUMKOWSKI F, 1987, BLOOD VESSELS, V24, P11
   HARLAN JM, 1985, BLOOD, V66, P167
   HELBER SMJ, 1998, MOL CELL BIOL, V18, P3699
   Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014
   KIM N-S, 1991, Yonsei Medical Journal, V32, P303
   KING GL, 1983, J CLIN INVEST, V71, P974, DOI 10.1172/JCI110852
   KLEINMAN HK, 1987, ANAL BIOCHEM, V166, P1, DOI 10.1016/0003-2697(87)90538-0
   KOURY MJ, 1992, EUR J BIOCHEM, V210, P649, DOI 10.1111/j.1432-1033.1992.tb17466.x
   KUMAR S, 1987, DIFFERENTIATION, V36, P57, DOI 10.1111/j.1432-0436.1987.tb00181.x
   MADRI JA, 1983, J CELL BIOL, V97, P153, DOI 10.1083/jcb.97.1.153
   MANDARINO LJ, 1993, EXP EYE RES, V57, P609, DOI 10.1006/exer.1993.1166
   MASUYAMA J, 1986, J CLIN INVEST, V77, P1596, DOI 10.1172/JCI112475
   NICOSIA RF, 1990, IN VITRO CELL DEV B, V26, P119
   ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455
   PAGE C, 1992, AM J PATHOL, V141, P673
   Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533
   Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053
   SAGE H, 1981, ARTERIOSCLEROSIS, V1, P427, DOI 10.1161/01.ATV.1.6.427
   Schlingemann RO, 1997, BRIT J OPHTHALMOL, V81, P501, DOI 10.1136/bjo.81.6.501
   Sheibani N, 2000, BIOCHEM BIOPH RES CO, V267, P257, DOI 10.1006/bbrc.1999.1903
   SPEISER W, 1987, BLOOD, V69, P964
   SU T, 1992, INVEST OPHTH VIS SCI, V33, P2809
   TAYLOR RF, 1981, J CLIN INVEST, V67, P584, DOI 10.1172/JCI110071
   VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034
   WALLIS WJ, 1985, J IMMUNOL, V135, P2323
   Watanabe D, 2005, NEW ENGL J MED, V353, P782, DOI 10.1056/NEJMoa041773
   Yan Q, 1996, INVEST OPHTH VIS SCI, V37, P2185
   ZETTER BR, 1981, DIABETES, V30, P24, DOI 10.2337/diab.30.2.S24
   ZETTER BR, 1980, NATURE, V285, P41, DOI 10.1038/285041a0
NR 38
TC 3
Z9 3
U1 3
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1071-2690
EI 1543-706X
J9 IN VITRO CELL DEV-AN
JI In Vitro Cell. Dev. Biol.-Anim.
PD JUN
PY 2010
VL 46
IS 6
BP 529
EP 537
DI 10.1007/s11626-010-9292-4
PG 9
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 600ZF
UT WOS:000278027000006
DA 2018-12-27
ER

PT J
AU Singhal, RK
   Samariya, A
   Kumar, S
   Xing, YT
   Jain, DC
   Dolia, SN
   Deshpande, UP
   Shripathi, T
   Saitovitch, EB
AF Singhal, R. K.
   Samariya, Arvind
   Kumar, Sudhish
   Xing, Y. T.
   Jain, D. C.
   Dolia, S. N.
   Deshpande, U. P.
   Shripathi, T.
   Saitovitch, Elisa B.
TI RETRACTED: Study of defect-induced ferromagnetism in hydrogenated
   anatase TiO2:Co (Retracted article. See vol. 116, 079901, 2014)
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article; Retracted Publication
DE annealing; cobalt; crystal structure; electrical resistivity;
   ferromagnetic materials; hydrogen; magnetisation; semimagnetic
   semiconductors; titanium compounds; vacancies (crystal); weak
   ferromagnetism; X-ray diffraction; X-ray photoelectron spectra
ID ROOM-TEMPERATURE FERROMAGNETISM; CO; FILMS; SEMICONDUCTORS; XPS
AB Electronic and magnetic properties of Co-doped TiO2 polycrystalline pellets (Ti0.95Co0.05O2) have been investigated using x-ray diffraction, x-ray photoemission, magnetization, and resistance measurements. The as-synthesized and hydrogenated specimens crystallize in the anatase type tetragonal structure containing very small (similar to 4.4%) rutile phase. The dopant ions of Co are found to be divalent and well incorporated into TiO2 lattice, substituting the Ti site within the anatase phase, with no evidence of metallic Co or any other oxides of Co. The Co doping induces a weak ferromagnetic ordering in the diamagnetic TiO2 host matrix. Interestingly, when the Co-doped TiO2 is annealed in hydrogen atmosphere, it shows a giant enhancement in magnetization. However, an extended reheating in air causes this H-induced magnetization to vanish and the sample regains the as-prepared status. Our findings indicate that ferromagnetism originates from the doped matrix rather than any magnetic clusters and strongly correlated with oxygen vacancies in the doped TiO2. The induced ferromagnetic ordering is found to be a reversible process with regard to oxygen vacancy defects that could be induced or removed, respectively, upon introduction or removal of these defects. (C) 2010 American Institute of Physics. [doi: 10.1063/1.3431396]
C1 [Singhal, R. K.; Samariya, Arvind; Jain, D. C.; Dolia, S. N.] Univ Rajasthan, Dept Phys, Jaipur 302004, Rajasthan, India.
   [Kumar, Sudhish] ML Sukhadia Univ, Dept Phys, Udaipur 313002, India.
   [Xing, Y. T.; Saitovitch, Elisa B.] Urca, CBPF, BR-22290180 Rio De Janeiro, Brazil.
   [Deshpande, U. P.; Shripathi, T.] Univ Campus, UGC DAE CSR, Indore 452001, India.
RP Singhal, RK (reprint author), Univ Rajasthan, Dept Phys, Jaipur 302004, Rajasthan, India.
EM singhal46@yahoo.co.in
CR Bondino F, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/27/275205
   Chen XB, 2004, J PHYS CHEM B, V108, P15446, DOI 10.1021/jp0469160
   Cho JH, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2179607
   Coey JMD, 2005, NAT MATER, V4, P173, DOI 10.1038/nmat1310
   Dietl T, 2000, SCIENCE, V287, P1019, DOI 10.1126/science.287.5455.1019
   GOPEL W, 1984, SURF SCI, V139, P333, DOI 10.1016/0039-6028(84)90054-2
   Griffin KA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.157204
   Hong NH, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/3/036219
   Huang CM, 2006, CHEM PHYS LETT, V432, P468, DOI 10.1016/j.cplett.2006.10.010
   Jaffe JE, 2005, J APPL PHYS, V97, DOI 10.1063/1.1868056
   Jain AK, 2008, INT J HYDROGEN ENERG, V33, P346, DOI 10.1016/j.ijhydene.2007.07.036
   Jeong BS, 2004, APPL PHYS LETT, V84, P2608, DOI 10.1063/1.1691499
   Kapilashrami M, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3180708
   Kim JY, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.017401
   Lee HJ, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2171789
   Manivannan A, 2003, APPL PHYS LETT, V83, P111, DOI 10.1063/1.1590744
   Matsumoto Y, 2001, SCIENCE, V291, P854, DOI 10.1126/science.1056186
   McCluskey MD, 2009, J APPL PHYS, V106, DOI 10.1063/1.3216464
   Ohno H, 1998, SCIENCE, V281, P951, DOI 10.1126/science.281.5379.951
   Orendorz A, 2005, APPL SURF SCI, V252, P85, DOI 10.1016/j.apsusc.2005.02.002
   Park YD, 2002, SCIENCE, V295, P651, DOI 10.1126/science.1066348
   Pinto JV, 2005, J MAGN MAGN MATER, V294, pE73, DOI 10.1016/j.jmmm.2005.03.057
   Roberts KG, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.014409
   Rodriguez-Carvajal J., 2003, FULLPROF VERSION 3 0
   Singhal RK, 2009, J ALLOY COMPD, V477, P379, DOI 10.1016/j.jallcom.2008.10.005
   SPURR RA, 1957, ANAL CHEM, V29, P760, DOI 10.1021/ac60125a006
   Straumal BB, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.205206
   TAN BJ, 1991, J AM CHEM SOC, V113, P855, DOI 10.1021/ja00003a019
   Van de Walle CG, 2000, PHYS REV LETT, V85, P1012, DOI 10.1103/PhysRevLett.85.1012
   Vijay YK, 2008, INT J HYDROGEN ENERG, V33, P340, DOI 10.1016/j.ijhydene.2007.07.062
   Wang ZH, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2948863
   Yan WS, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3075844
   Yang JH, 2009, J ALLOY COMPD, V473, P543, DOI 10.1016/j.jallcom.2008.06.030
NR 33
TC 41
Z9 41
U1 3
U2 56
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0021-8979
EI 1089-7550
J9 J APPL PHYS
JI J. Appl. Phys.
PD JUN 1
PY 2010
VL 107
IS 11
AR 113916
DI 10.1063/1.3431396
PG 7
WC Physics, Applied
SC Physics
GA 612NU
UT WOS:000278907100097
DA 2018-12-27
ER

PT J
AU Boldt, J
   Mengistu, A
AF Boldt, Joachim
   Mengistu, Andinet
TI RETRACTED: A New Plasma-Adapted Hydroxyethyl Starch Preparation: In
   Vitro Coagulation Studies (Retracted article. See vol. 25, pg. 756,
   2011)
SO JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
LA English
DT Article; Retracted Publication
DE cardiac surgery; coagulation; hydroxyethyl starch; HES solution;
   platelet function; balanced fluids; volume; colloids; bleeding
ID LACTATED RINGERS SOLUTION; WHOLE-BLOOD AGGREGOMETRY; PLATELET-FUNCTION;
   CARDIAC-SURGERY; MOLAR SUBSTITUTION; MOLECULAR-WEIGHT; MAJOR SURGERY;
   HETASTARCH; THROMBELASTOGRAPHY; HEMODILUTION
AB Objective: Preparing hydroxyethyl starch (HES) in a plasma-adapted solution is supposed to improve safety with regard to coagulation. The influence of a new plasma-adapted HES preparation on coagulation was studied.
   Design: Operator-blinded, randomized study.
   Setting: Laboratory in vitro study.
   Participants: Fifteen healthy young men scheduled for blood donation.
   Interventions: Blood was diluted by 10%, 30%, and 50% using either a plasma-adapted or nonplasma-adapted (prepared in saline solution) potato-derived 6% HES 130/0.42. Only the composition of the solvent of the 2 HES preparations was different.
   Measurements and Main Results: Rotation thromboelastometry (ROTEM; Pentapharm, Munich, Germany) was used to assess changes in coagulation; whole blood aggregometry with 3 inducers was used to assess effects of dilution with HES on platelet function. Clotting time (CT) and clot formation time were significantly prolonged by 30% and 50% dilution, showing significantly longer times in the non plasma-adapted than in the plasma-adapted HES group leg, intrinsic CT at the 30% dilution level: plasma-adapted HES 228 +/- 26 seconds [within normal range] v269 +/- 29 seconds in the nonplasma-adapted HES group). Clot strengthening and clot firmness were significantly reduced by the non plasma-adapted HES at the 30% dilution level. Platelet aggregation was significantly more reduced by the non plasma-adapted HES at the 30% and 50% dilution levels.
   Conclusions: Dilution with the nonplasma-adapted HES 130/0.42 was associated with more negative effects on thromboelastometry and platelet aggregation than the same HES 130/0.4 dissolved in a plasma-adapted solution. The benefits of using a plasma-adapted modern HES preparation on blood loss and use of blood/blood products in cardiac surgery need to be studied. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Boldt, Joachim; Mengistu, Andinet] Klinikum Stadt Ludwigshafen, Dept Anesthesiol & Intens Care Med, D-67063 Ludwigshafen, Germany.
RP Boldt, J (reprint author), Klinikum Stadt Ludwigshafen, Dept Anesthesiol & Intens Care Med, Bremserstr 79, D-67063 Ludwigshafen, Germany.
EM BoldtJ@gmx.net
CR Boldt J, 2007, VOX SANG, V93, P139, DOI 10.1111/j.1423-0410,2007,00946.x
   BOLDT J, 2010, EUR J ANAES IN PRESS
   Boldt J, 2007, ANESTH ANALG, V104, P425, DOI 10.1213/01.ane.0000253484.19070.87
   de Jonge E, 2001, CRIT CARE MED, V29, P1261, DOI 10.1097/00003246-200106000-00038
   Deusch E, 2004, ANESTH ANALG, V99, P665, DOI 10.1213/01.ANE.0000130349.99727.58
   Franz A, 2001, ANESTH ANALG, V92, P1402, DOI 10.1097/00000539-200106000-00008
   Fries D, 2002, ANESTH ANALG, V94, P1280, DOI 10.1097/00000539-200205000-00043
   Gan TJ, 1999, ANESTH ANALG, V88, P992, DOI 10.1097/00000539-199905000-00005
   Ganter MT, 2008, ANESTH ANALG, V106, P1366, DOI 10.1213/ane.0013e318168067
   Gorton H, 2000, BRIT J ANAESTH, V84, P403
   Green RS, 2008, J CARDIOTHOR VASC AN, V22, P485, DOI 10.1053/j.jvca.2008.03.002
   Haisch G, 2001, J CARDIOTHOR VASC AN, V15, P316, DOI 10.1053/jcan.2001.23276
   Handy JM, 2008, BRIT J ANAESTH, V101, P141, DOI 10.1093/bja/aen148
   Haynes GR, 2004, ANESTHESIOLOGY, V101, P560, DOI 10.1097/00000542-200408000-00055
   James MFM, 2008, J CARDIOTHOR VASC AN, V22, P482, DOI 10.1053/j.jvca.2008.02.017
   Kozek-Langenecker SA, 2005, ANESTHESIOLOGY, V103, P654, DOI 10.1097/00000542-200509000-00031
   Kozek-Langenecker SA, 2008, ANESTH ANALG, V107, P382, DOI 10.1213/ane.0b013e31817e6eac
   Lang T, 2005, BLOOD COAGUL FIBRIN, V16, P301, DOI 10.1097/01.mbc.0000169225.31173.19
   Mengistu AM, 2008, J CARDIOTHOR VASC AN, V22, P40, DOI 10.1053/j.jvca.2007.02.015
   Paulitsch FS, 2009, CORONARY ARTERY DIS, V20, P100, DOI 10.1097/MCA.0b013e3283219e8b
   Payen JF, 1998, BRIT J ANAESTH, V80, P464, DOI 10.1093/bja/80.4.464
   Roche AM, 2002, ANAESTHESIA, V57, P950, DOI 10.1046/j.1365-2044.2002.02707.x
   Ruttmann TG, 2002, BRIT J ANAESTH, V89, P226, DOI 10.1093/bja/aef179
   Ruttmann TG, 2001, ANAESTH INTENS CARE, V29, P489
   SANFELIPPO MJ, 1987, AM J CLIN PATHOL, V88, P653, DOI 10.1093/ajcp/88.5.653
   Stogermuller B, 2000, ANESTH ANALG, V91, P823
   Strauss RG, 2002, TRANSFUSION, V42, P27, DOI 10.1046/j.1537-2995.2002.00003.x
   Taneja R, 2008, J CARDIOTHOR VASC AN, V22, P662, DOI 10.1053/j.jvca.2008.02.005
   von Roten I, 2006, BRIT J ANAESTH, V96, P455, DOI 10.1093/bja/ael019
   Westphal M, 2009, ANESTHESIOLOGY, V111, P187, DOI 10.1097/ALN.0b013e3181a7ec82
NR 30
TC 3
Z9 3
U1 2
U2 12
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1053-0770
EI 1532-8422
J9 J CARDIOTHOR VASC AN
JI J. Cardiothorac. Vasc. Anesth.
PD JUN
PY 2010
VL 24
IS 3
BP 394
EP 398
DI 10.1053/j.jvca.2009.09.014
PG 5
WC Anesthesiology; Cardiac & Cardiovascular Systems; Respiratory System;
   Peripheral Vascular Disease
SC Anesthesiology; Cardiovascular System & Cardiology; Respiratory System
GA 604ON
UT WOS:000278288500002
PM 20005132
DA 2018-12-27
ER

PT J
AU Boldt, J
   Mayer, J
   Brosch, C
   Lehmann, A
   Mengistu, A
AF Boldt, Joachim
   Mayer, Jochen
   Brosch, Christian
   Lehmann, Andreas
   Mengistu, Andinet
TI RETRACTED: Volume Replacement With a Balanced Hydroxyethyl Starch (HES)
   Preparation in Cardiac Surgery Patients (Retracted article. See vol. 25,
   pg. 756, 2011)
SO JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
LA English
DT Article; Retracted Publication
DE cardiac surgery; balanced volume replacement; hydroxyethyl starch;
   kidney function; hemostasis; inflammatory response
ID FLUID RESUSCITATION; HETASTARCH; CHLORIDE; PENTASTARCH; COLLOIDS;
   ACIDOSIS; ALBUMIN; SEPSIS; TRIAL; PRO
AB Objective: Balanced fluids appear to be have advantages over unbalanced fluids for correcting hypovolemia. The effects of a new balanced hydroxyethyl starch (HES) were studied in cardiac surgery patients.
   Design: Prospective, randomized, unblinded study.
   Setting: Clinical study in a single cardiac surgery institution.
   Participants: Sixty patients undergoing elective cardiac surgery with cardiopulmonary bypass.
   Intervention: Patients received either a balanced 6% HES 130/0.4 plus a balanced crystalloid (n = 30) or an unbalanced HES-in-saline plus saline (n = 30) to keep cardiac index >2.5 L/min/m(2).
   Measurements and Main Results: Base excess (BE), kidney function, inflammatory response (interleukins-6, -10), endothelial activation (intercellular adhesion molecule-1 [ICAM]), and coagulation (thromboelastometry, whole blood aggregation) were measured after induction of anesthesia, after surgery and 5 hours later, and at the 1st and 2nd postoperative days; 2,950 +/- 530 mL of balanced and 3,050 +/- 560 mL of unbalanced HES were given. BE was reduced significantly in the unbalanced group (from 1.11 +/- 0.71 mmol/L to -5.11 +/- 0.48 mmol/L after surgery) and remained unchanged in the balanced group. Balanced volume replacement resulted in significantly lower IL-6, IL-10, and ICAM plasma concentrations and lower urine concentrations of kidney-specific proteins than in the unbalanced group. After surgery, thromboelastometry data and platelet function were changed significantly in both groups; 5 hours thereafter they were significantly changed only in the unbalanced group.
   Conclusion: A plasma-adapted HES preparation in addition to a balanced crystalloid resulted in significantly less decline in BE, less increase in concentrations of kidney-specific proteins, less inflammatory response and endothelial damage, and fewer changes in hemostasis compared with an unbalanced fluid strategy. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Boldt, Joachim; Mayer, Jochen; Brosch, Christian; Lehmann, Andreas; Mengistu, Andinet] Klinikum Stadt Ludwigshafen, Dept Anesthesiol & Intens Care Med, D-67063 Ludwigshafen, Germany.
RP Boldt, J (reprint author), Klinikum Stadt Ludwigshafen, Dept Anesthesiol & Intens Care Med, Bremserstr 79, D-67063 Ludwigshafen, Germany.
EM BoldtJ@gmx.net
CR BASE E, 2006, CRIT CARE S1, V10, pP176
   Boldt J, 2007, BRIT J ANAESTH, V99, P312, DOI 10.1093/bja/aem219
   Boldt J, 2007, J CARDIOTHOR VASC AN, V21, P453, DOI 10.1053/j.jvca.2007.02.020
   Boldt J, 2009, ANESTH ANALG, V109, P1752, DOI 10.1213/ANE.0b013e3181b5a24b
   Boldt J, 2009, INTENS CARE MED, V35, P462, DOI 10.1007/s00134-008-1287-1
   Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716
   Conlon PJ, 1999, NEPHROL DIAL TRANSPL, V14, P1158, DOI 10.1093/ndt/14.5.1158
   Cook D, 2001, ANN INTERN MED, V135, P205, DOI 10.7326/0003-4819-135-3-200108070-00013
   Deusch E, 2004, ANESTH ANALG, V99, P665, DOI 10.1213/01.ANE.0000130349.99727.58
   Dubin A, 2009, INTENS CARE MED, V35, P556, DOI 10.1007/s00134-008-1385-0
   Gan TJ, 1999, ANESTH ANALG, V88, P992, DOI 10.1097/00000539-199905000-00005
   Ganter MT, 2008, ANESTH ANALG, V106, P1366, DOI 10.1213/ane.0013e318168067
   Han Won K, 2004, Curr Opin Crit Care, V10, P476, DOI 10.1097/01.ccx.0000145095.90327.f2
   Haynes GR, 2004, ANESTHESIOLOGY, V101, P560, DOI 10.1097/00000542-200408000-00055
   James MFM, 2008, J CARDIOTHOR VASC AN, V22, P482, DOI 10.1053/j.jvca.2008.02.017
   Jungheinrich C, 2005, CLIN PHARMACOKINET, V44, P681, DOI 10.2165/00003088-200544070-00002
   Kellum JA, 2002, CRIT CARE MED, V30, P259, DOI 10.1097/00003246-200201000-00046
   Kellum JA, 2006, CHEST, V130, P962, DOI 10.1378/chest.130.4.962
   KOTCHEN TA, 1983, ANN INTERN MED, V98, P817, DOI 10.7326/0003-4819-98-5-817
   Lang T, 2005, BLOOD COAGUL FIBRIN, V16, P301, DOI 10.1097/01.mbc.0000169225.31173.19
   Mills GH, 2007, BRIT J ANAESTH, V98, P157, DOI 10.1093/bja/ael359
   MYTHEN MG, 1993, BLOOD REV, V7, P223, DOI 10.1016/0268-960X(93)90009-S
   NUTTALL GA, 2007, J CARDIOTHOR VASC AN, V21, P453
   QUILLEY CP, 1993, BRIT J PHARMACOL, V108, P106, DOI 10.1111/j.1476-5381.1993.tb13447.x
   Roche AM, 2006, ANESTH ANALG, V102, P1274, DOI 10.1213/01.ane.0000197694.48429.94
   Strauss RG, 2002, TRANSFUSION, V42, P27, DOI 10.1046/j.1537-2995.2002.00003.x
   Wang PF, 2009, INFLAMMATION, V32, P71, DOI 10.1007/s10753-009-9105-7
   Warren OJ, 2009, J CARDIOTHOR VASC AN, V23, P223, DOI 10.1053/j.jvca.2008.08.007
   WILCOX CS, 1983, J CLIN INVEST, V71, P726, DOI 10.1172/JCI110820
   Wilkes NJ, 2001, ANESTH ANALG, V93, P811, DOI 10.1097/00000539-200110000-00003
   Winkelmayer WC, 2003, KIDNEY INT, V64, P1046, DOI 10.1046/j.1523-1755.2003.00186.x
   BRIT GUIDELINES INTR
NR 32
TC 14
Z9 15
U1 2
U2 14
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1053-0770
J9 J CARDIOTHOR VASC AN
JI J. Cardiothorac. Vasc. Anesth.
PD JUN
PY 2010
VL 24
IS 3
BP 399
EP 407
DI 10.1053/j.jvca.2010.03.001
PG 9
WC Anesthesiology; Cardiac & Cardiovascular Systems; Respiratory System;
   Peripheral Vascular Disease
SC Anesthesiology; Cardiovascular System & Cardiology; Respiratory System
GA 604ON
UT WOS:000278288500003
PM 20510247
DA 2018-12-27
ER

PT J
AU Chung, IM
   Seo, SH
   Kang, EY
   Park, WH
   Moon, HI
AF Chung, Ill-Min
   Seo, Su-Hyun
   Kang, Eun-Young
   Park, Won-Hwan
   Moon, Hyung-In
TI RETRACTED: Larvicidal effects of the major essential oil of Pittosporum
   tobira against Aedes aegypti (L.) (Retracted article. See vol. 27, pg.
   758, 2012)
SO JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
LA English
DT Article; Retracted Publication
DE Aedes aegypti; essential oils; larvicidal effects; Pittosporum tobira;
   I-limonene
ID CAROTENOIDS; MOSQUITO; CONSTITUENTS; EXTRACTS; FLOWER; HERBS; LEAF; A1;
   A2
AB Essential oil obtained from the leaves of Pittosporum tobira was extracted and its chemical composition and larvicidal effects were studied. Analyses were conducted by gas chromatography and mass spectroscopy (GC-MS) to determine the primary constituents of the essential oil of P. tobira. The yield of P. tobira essential oil (PTEO) was 0.1%, and GC-MS analysis identified its major constituents as undecane (31.11%), 4-methyl-1,3-pentadiene (11.34%), (1,3-dimethyl-2-butenyl)benzene (5.45%), and l-limonene (14.08%). The essential oil had a significant toxic effect against early fourth-stage larvae of Aedes aegypti (L.), with an LC50 value of 58.92 ppm and an LC90 value of 111.31 ppm. Finally, the LC50 and LC90 values of l-limonene were 39.7 ppm and 78.11 ppm. These results could be useful for seeking newer, safer, and more effective natural larvicidal agents against A. aegypti.
C1 [Park, Won-Hwan; Moon, Hyung-In] Dongguk Univ, Cardiovasc Med Res Ctr, Coll Korean Med, Gyeong Ju 780714, South Korea.
   [Chung, Ill-Min; Seo, Su-Hyun; Kang, Eun-Young] Konkuk Univ, Dept Appl Life Sci, Seoul, South Korea.
   [Park, Won-Hwan] Dongguk Univ, Dept Diagnost, Coll Korean Med, Gyeong Ju 780714, South Korea.
   [Moon, Hyung-In] Wonkwang Univ, Sanbon Med Ctr, Inam Neurosci Res Ctr, Kyonggi Do, South Korea.
RP Moon, HI (reprint author), Dongguk Univ, Cardiovasc Med Res Ctr, Coll Korean Med, Gyeong Ju 780714, South Korea.
EM dipwh@dongguk.ac.kr; himun68@gmail.com
FU MOST/KOSEF, Korea [R13-2005-013-01000-0]
FX This work was supported by the MRC program of MOST/KOSEF (grant #:
   R13-2005-013-01000-0), Korea. The authors report no conflicts of
   interest. The authors alone are responsible for the content and writing
   of the paper.
CR ADEBAYO TA, 1999, NIGER J NAT PROD MED, V3, P74
   Cheng SS, 2004, J AGR FOOD CHEM, V52, P4395, DOI 10.1021/jf0497152
   D'Acquarica I, 2002, TETRAHEDRON, V58, P10127, DOI 10.1016/S0040-4020(02)01364-9
   Elhag EA, 2001, INDIAN VET J, V78, P199
   Fujiwara Y, 2002, TETRAHEDRON LETT, V43, P4385, DOI 10.1016/S0040-4039(02)00779-7
   Fujiwara Y, 2001, CHEM PHARM BULL, V49, P985, DOI 10.1248/cpb.49.985
   Fujiwara Y, 2001, TETRAHEDRON LETT, V42, P2693, DOI 10.1016/S0040-4039(01)00244-1
   Gbolade A. A., 2000, Journal of Tropical Medicinal Plants, V1, P146
   Knio KM, 2008, BIORESOURCE TECHNOL, V99, P763, DOI 10.1016/j.biortech.2007.01.026
   Lee CK, 1998, ARCH PHARM RES, V21, P62, DOI 10.1007/BF03216754
   LEE TB, 1982, ILLUSTRATED FLORA KO, P423
   Maoka T, 2008, J NAT PROD, V71, P622, DOI 10.1021/np070650h
   Maoka T, 2006, PHYTOCHEMISTRY, V67, P2120, DOI 10.1016/j.phytochem.2006.05.040
   Nickavar B, 2004, Z NATURFORSCH C, V59, P174
   NOZAKI H, 1990, CHEM LETT, P219, DOI 10.1246/cl.1990.219
   OGIHARA K, 1989, PHYTOCHEMISTRY, V28, P3085, DOI 10.1016/0031-9422(89)80285-7
   Prabakar K, 2004, BIORESOURCE TECHNOL, V95, P113, DOI 10.1016/j.biortech.2003.05.001
   Rodrigues FSLM, 2007, FLAVOUR FRAG J, V22, P311, DOI 10.1002/ffj.1798
   SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922
   SUGA T, 1988, CHEM LETT, P445, DOI 10.1246/cl.1988.445
   SUKUMAR K, 1991, J AM MOSQUITO CONTR, V7, P210
   TAKAOKA D, 1986, CHEM LETT, P1121, DOI 10.1246/cl.1986.1121
   *WHO, 1981, WHO VBC, V81, P807
NR 23
TC 6
Z9 9
U1 4
U2 22
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1475-6366
EI 1475-6374
J9 J ENZYM INHIB MED CH
JI J. Enzym. Inhib. Med. Chem.
PD JUN
PY 2010
VL 25
IS 3
BP 391
EP 393
DI 10.3109/14756360903185952
PG 3
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 585YO
UT WOS:000276866900013
PM 19874194
DA 2018-12-27
ER

PT J
AU Yoshida, H
   Shimizu, M
   Ikewaki, K
   Taniguchi, I
   Tada, N
   Yoshimura, M
   Rosano, G
   Dahlof, B
   Mochizuki, S
AF Yoshida, Hiroshi
   Shimizu, Mitsuyuki
   Ikewaki, Katsunori
   Taniguchi, Ikuo
   Tada, Norio
   Yoshimura, Michihiro
   Rosano, Giuseppe
   Dahlof, Bjorn
   Mochizuki, Seibu
CA Jikei Heart Study Grp
TI RETRACTED: Sex differences in effects of valsartan administration on
   cardiovascular outcomes in hypertensive patients: findings from the
   Jikei Heart Study (Retracted article. See vol. 31, pg. 2324, 2013)
SO JOURNAL OF HYPERTENSION
LA English
DT Article; Retracted Publication
DE angiotensin II receptor blocker; cardiovascular outcomes; hypertension;
   sex; valsartan
ID LEFT-VENTRICULAR HYPERTROPHY; ACUTE MYOCARDIAL-INFARCTION; END-POINT
   REDUCTION; RANDOMIZED-TRIAL; LOSARTAN INTERVENTION; JAPANESE PATIENTS;
   RISK-FACTORS; MORTALITY; DISEASE; WOMEN
AB Objectives The randomized Jikei Heart Study has demonstrated that the addition of valsartan to conventional treatments prevents more cardiovascular events in Japanese patients with hypertension. This substudy analyses the sex difference in cardiovascular disease risk reduction in the Jikei Heart Study.
   Methods Treatment effects were evaluated by sex (1038 women and 2043 men) as hazard ratios with 95% confidence intervals (CIs) using Cox regression models adjusted for age, BMI, smoking, dyslipidemia, diabetes, antihypertensives, and statin use at baseline.
   Results Women were older, had higher SBP, total and low-density lipoprotein cholesterol but were less frequently smokers or diabetics, and had a lower DBP and incidence of coronary artery disease. A greater incidence of primary endpoint, a composite of cardiovascular events, occurred in men versus women [hazard ratio 1.37 (95% CI 1.02-1.85)]. Men in the valsartan group had a significant reduction in the primary endpoint [hazard ratio 0.6 (95% CI 0.44-0.82), P = 0.001], whereas a nonsignificant effect was found in women [hazard ratio 0.64 (95% CI 0.39-1.06), P = 0.075]. However, statistical heterogeneity of this valsartan effect was not found between sexes, and women of at least 55 years of age, mostly after menopause, in the valsartan group showed a significant risk reduction for the primary endpoint [hazard ratio 0.60 (95% CI 0.36-0.99)].
   Conclusion The valsartan effect was significant in men and in elderly women but consistent in both sexes. A potential cardiovascular protection by valsartan therapy might be attributed to the cardiovascular risk level but not to the sex difference. J Hypertens 28: 1150-1157 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
C1 [Yoshida, Hiroshi] Jikei Univ, Kashiwa Hosp, Dept Lab Med, Chiba 2778567, Japan.
   [Yoshida, Hiroshi; Tada, Norio] Jikei Univ, Kashiwa Hosp, Div Gen Med, Chiba 2778567, Japan.
   [Shimizu, Mitsuyuki] Jikei Univ, Kashiwa Hosp, Div Cardiol, Dept Internal Med, Chiba 2778567, Japan.
   [Shimizu, Mitsuyuki; Ikewaki, Katsunori; Taniguchi, Ikuo; Yoshimura, Michihiro; Mochizuki, Seibu] Jikei Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo, Japan.
   [Ikewaki, Katsunori] Natl Def Med Coll, Dept Internal Med, Div Antiaging, Saitama, Japan.
   [Rosano, Giuseppe] IRCCS San Raffaele Pisana, Dept Med Sci & Rehabil, Ctr Clin & Basic Res, Rome, Italy.
   [Dahlof, Bjorn] Sahlgrens Univ Hosp, Dept Emergency & Cardiovasc Med, Inst Med, Gothenburg, Sweden.
RP Yoshida, H (reprint author), Jikei Univ, Kashiwa Hosp, Dept Lab Med, 163-1 Kashiwashita, Chiba 2778567, Japan.
EM hyoshida@jikei.ac.jp
RI Lamonaca, Palma/K-9473-2016
OI Lamonaca, Palma/0000-0003-4891-2255
FU Jikei University; Astellas; Bayer; Kowa; Novartis; Daiichi-Sankyo;
   Shionogi; Kissei; Sankyo; Boehringer-Ingelheim; Merck; Pfizer; Servier;
   Astra
FX Research funds were provided in part by the Jikei University Research
   Fund (H. Y.), and the study was funded by the Jikei University School of
   Medicine. We thank all trial physicians and nurses and all the patients
   for their important contributions to this study. We thank Dr Hidekatsu
   Yanai MD, PhD (Jikei University Kashiwa Hospital); Professor Naoko
   Tajima, MD, PhD (Jikei University School of Medicine); Shingo Seki, MD,
   PhD (Jikei University Aoto Hospital); and Takahiro Shibata, MD, PhD and
   Masayuki Taniguchi, MD, PhD (Jikei University Daisan Hospital) for their
   helpful coordination of clinical practice and investigations. We also
   thank Nobuo Shiraishi, PhD (Osaka City University Graduate School,
   Japan) for his excellent work on statistical analysis.; H. Y. and N. T.
   have received lecture fees from Astellas, Bayer, Kowa, Novartis, and
   Daiichi-Sankyo; M. S. has received lecture fees from Shionogi; K. I. has
   served as a consultant for Japan Tobacco and received lecture fees from
   Kissei, Sankyo, Astellas, Kowa, and Novartis; B. D. has served as a
   consultation for and received lecture fees from Boehringer- Ingelheim,
   Novartis, Merck, Pfizer, Servier, and Astra; S. M. has received lecture
   fees from Novartis and Daiichi-Sankyo. However, basically none had any
   potential conflict of interest in this subanalysis paper.
CR Arima H, 2003, ARCH INTERN MED, V163, P361, DOI 10.1001/archinte.163.3.361
   BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305
   Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713
   Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3
   Dzau V, 2005, J HYPERTENS, V23, pS9, DOI 10.1097/01.hjh.0000165623.72310.dd
   DZAU V, 1991, AM HEART J, V121, P1244, DOI 10.1016/0002-8703(91)90694-D
   *JAS, 2009, J ATHEROSCLER THRO S, V16, P15
   Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9
   Kannel W B, 1995, Hypertens Res, V18, P181, DOI 10.1291/hypres.18.181
   Kawano H, 2006, CIRC J, V70, P513, DOI 10.1253/circj.70.513
   Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2
   Mann Jessica, 1998, Blood Pressure, V7, P176
   *MIN HLTH LAB WELF, 2004, STAT ABSTR
   Miyake Y, 2000, JPN CIRC J, V64, P103, DOI 10.1253/jcj.64.103
   Mizuno K, 2008, CIRCULATION, V117, P494, DOI 10.1161/CIRCULATIONAHA.106.671826
   Mochizuki S, 2004, CARDIOVASC DRUG THER, V18, P305, DOI 10.1023/B:CARD.0000041250.00079.84
   Mochizuki S, 2007, LANCET, V369, P1431, DOI 10.1016/S0140-6736(07)60669-2
   Os I, 2008, HYPERTENSION, V51, P1103, DOI 10.1161/HYPERTENSIONAHA.107.105296
   Saruta Takao, 2005, Nihon Rinsho, V63, P952
   Sawada T, 2009, EUR HEART J, V30, P2461, DOI 10.1093/eurheartj/ehp363
   Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516
   Teramoto T, 2008, J ATHEROSCLER THROMB, V15, P283, DOI 10.5551/jat.E622
   Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600
   Trenkwalder P, 2005, BLOOD PRESSURE, V14, P31, DOI 10.1080/08037050510008823
   Wassertheil-Smoller S, 2000, HYPERTENSION, V36, P780, DOI 10.1161/01.HYP.36.5.780
   Weber MA, 2004, LANCET, V363, P2049, DOI 10.1016/S0140-6736(04)16456-8
   Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716
   Yasunari K, 2004, J AM COLL CARDIOL, V43, P2116, DOI 10.1016/j.jacc.2003.12.051
   Zanchetti A, 2006, J HYPERTENS, V24, P2163, DOI 10.1097/01.hjh.0000249692.96488.46
NR 29
TC 4
Z9 7
U1 3
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0263-6352
EI 1473-5598
J9 J HYPERTENS
JI J. Hypertens.
PD JUN
PY 2010
VL 28
IS 6
BP 1150
EP 1157
DI 10.1097/HJH.0b013e328338a8b6
PG 8
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 595PG
UT WOS:000277623500008
PM 20467269
DA 2018-12-27
ER

PT J
AU Kolev, MV
   Ruseva, MM
   Morgan, BP
   Donev, RM
AF Kolev, Martin V.
   Ruseva, Marieta M.
   Morgan, B. Paul
   Donev, Rossen M.
TI RETRACTED: Targeting Neural-Restrictive Silencer Factor Sensitizes Tumor
   Cells to Antibody-Based Cancer Immunotherapy In Vitro via Multiple
   Mechanisms (Retracted article. See vol. 187, pg. 6581, 2011)
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article; Retracted Publication
ID COMPLEMENT-REGULATORY PROTEINS; HUMAN NEUROBLASTOMA; EXPRESSION; CD59;
   KINASE; RESISTANCE; RITUXIMAB; GROWTH; TRANSFORMATION; MODULATION
AB Tumor cells escape clearance by complement by abundantly expressing CD59 and other membrane complement regulators. Recently, we designed a peptide derived from the neural-restrictive silencer factor (REST), REST68, which we showed to inhibit expression of CD59 in tumors lacking the full-length REST and proposed a detailed model for regulation of CD59 expression via interplay between REST and nucleolin (NCL) transcription factors. In this paper, we study in detail the mechanisms for sensitization of malignant cells to Ab-based cancer immunotherapy by the REST68 peptide and the implications of the REST/NCL model for the design of treatment resulting in higher tumor susceptibility. REST68 inhibited CD59 expression in malignant cells expressing either truncated or full-length REST, but not in nonmalignant cells. However, activation of protein kinase C (PKC) in nonmalignant cells, a process that contributes to cellular transformation, phosphorylated NCL and enabled suppression of CD59 expression by the REST68. Combined treatment of different tumor types with REST68 and PKC inhibitor synergized to further suppress CD59 expression and reduce resistance to complement lysis. The combined treatment also increased susceptibility of tumors expressing either of the REST isoforms to PBMC-mediated killing, which, at least in part, accounted for the strong promotion of apoptosis by the REST68/PKC inhibitor. These data demonstrate that REST68 sensitizes tumors to Ab-based cancer immunotherapy via multiple mechanisms. Furthermore, the REST/NCL interplay model for regulation of expression of cd59 and other genes involved in cell survival enables the design of treatments for different tumor types to achieve more efficient tumor clearance. The Journal of Immunology, 2010, 184: 6035-6042.
C1 [Donev, Rossen M.] Swansea Univ, Inst Life Sci, Sch Med, Swansea SA2 8PP, W Glam, Wales.
   [Kolev, Martin V.; Ruseva, Marieta M.; Morgan, B. Paul; Donev, Rossen M.] Cardiff Univ, Dept Infect Immun & Biochem, Sch Med, Cardiff, S Glam, Wales.
RP Donev, RM (reprint author), Swansea Univ, Inst Life Sci, Sch Med, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.
EM r.m.donev@swansea.ac.uk
RI kolev, mihail/D-1476-2015; Donev, Rossen/C-5105-2009
OI kolev, mihail/0000-0002-5226-4759; Kolev, Martin/0000-0002-7208-3875
FU Medical Research Council [G0700102]
FX This work was supported by Medical Research Council New Investigator
   Grant G0700102 (to R. M. D.).
CR Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1035/nbt1137
   BELENGUER P, 1990, MOL CELL BIOL, V10, P3607, DOI 10.1128/MCB.10.7.3607
   Chen SH, 2000, CANCER RES, V60, P3013
   Donev R, 2007, MOL PSYCHIATR, V12, P681, DOI 10.1038/sj.mp.4001971
   Donev R, 2003, J BIOL CHEM, V278, P5214, DOI 10.1074/jbc.M206621200
   Donev RM, 2006, CANCER RES, V66, P2451, DOI 10.1158/0008-5472.CAN-05-3191
   Donev RM, 2008, CANCER RES, V68, P5979, DOI 10.1158/0008-5472.CAN-07-6828
   Fishelson Z, 2003, MOL IMMUNOL, V40, P109, DOI 10.1016/S0161-5890(03)00112-3
   Gelderman KA, 2003, MOL IMMUNOL, V40, P13, DOI 10.1016/S0161-5890(03)00048-8
   Gelderman KA, 2002, EUR J IMMUNOL, V32, P128
   Golay J, 2001, BLOOD, V98, P3383, DOI 10.1182/blood.V98.12.3383
   Golubovskaya VM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-280
   Kolev MV, 2010, PHARMACOGENOMICS J, V10, P12, DOI 10.1038/tpj.2009.52
   Le Good JA, 2004, BIOCHEM J, V378, P83, DOI 10.1042/BJ20031194
   Macor P, 2007, CANCER RES, V67, P10556, DOI 10.1158/0008-5472.CAN-07-1811
   Mason JC, 2004, J BIOL CHEM, V279, P41611, DOI 10.1074/jbc.M407981200
   MUJOO K, 1987, CANCER RES, V47, P1098
   Stolz C, 2008, BLOOD, V112, P3312, DOI 10.1182/blood-2007-11-124487
   Tediose T, 2010, NUCLEIC ACIDS RES, V38, P2799, DOI 10.1093/nar/gkq013
   Treon SP, 2001, J IMMUNOTHER, V24, P263, DOI 10.1097/00002371-200105000-00011
   Varela JC, 2008, CANCER RES, V68, P6734, DOI 10.1158/0008-5472.CAN-08-0502
   Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406
   Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780
   Yan J, 2008, ADV EXP MED BIOL, V632, P159, DOI 10.1007/978-0-387-78952-1_12
   Zell S, 2007, CLIN EXP IMMUNOL, V150, P576, DOI 10.1111/j.1365-2249.2007.03507.x
   Zhou GS, 1997, J BIOL CHEM, V272, P31130, DOI 10.1074/jbc.272.49.31130
   Ziller F, 2005, EUR J IMMUNOL, V35, P2175, DOI 10.1002/eji.200425920
NR 27
TC 5
Z9 7
U1 2
U2 11
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD JUN 1
PY 2010
VL 184
IS 11
BP 6035
EP 6042
DI 10.4049/jimmunol.1000045
PG 8
WC Immunology
SC Immunology
GA 606PP
UT WOS:000278439600015
PM 20421646
OA Other Gold
DA 2018-12-27
ER

PT J
AU Wang, J
   Wang, SH
   Shang, LX
   Dong, X
   Wang, X
   Zhang, F
   Wu, N
   Xu, LM
   Ye, YY
AF Wang, Jing
   Wang, Shu-He
   Shang, Li-Xin
   Dong, Xing
   Wang, Xin
   Zhang, Fang
   Wu, Nan
   Xu, Li-Ming
   Ye, Yuan-Yuan
TI RETRACTED: Relationship of adiponectin and resistin levels in umbilical
   and maternal serum with fetal macrosomia (Retracted article)
SO JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
LA English
DT Article; Retracted Publication
DE adiponectin; body mass index; fetal macrosomia; resistin
ID DEVELOPMENTAL ORIGINS; PLASMA ADIPONECTIN; INSULIN-RESISTANCE; METABOLIC
   SYNDROME; BIRTH-WEIGHT; ASSOCIATION; OBESITY; DISEASE; COMPONENTS;
   EXPRESSION
AB Aim:
   Adiponectin and resistin are novel hormones secreted by human adipocytes and mononuclear cells, which have been postulated to play roles in the regulation of energy metabolism during pregnancy. However, correlations between adiponectin and resistin levels in umbilical and maternal serum and fetal macrosomia remain poorly understood. The purpose of this study was to clarify the relationship of adiponectin and resistin levels in umbilical and maternal serum with fetal macrosomia.
   Methods:
   Serum adiponectin and resistin levels were prospectively measured by enzyme immunoassay in 70 mothers and their 70 neonates. The study group included 30 neonates with macrosomia and the control group included 40 neonates that were appropriate for gestational age. The correlations of cord serum adiponectin and resistin with maternal serum adiponectin and resistin, birth weight, body mass index (BMI), and placental weight were analyzed.
   Results:
   Serum adiponectin and resistin levels were significantly decreased in macrosomic mothers compared with those in control women. The levels of adiponectin and resistin were diminished in macrosomic babies in comparison with control newborns. Umbilical serum adiponectin levels were inversely correlated with birth weight, newborn BMI, and placental weight, but not with maternal serum adiponectin levels. Umbilical serum resistin levels had a positive correlation with maternal serum resistin and a negative correlation with birth weight, newborn BMI, and placental weight. In addition, maternal serum resistin levels were inversely correlated with newborn birth weight.
   Conclusion:
   It is suggested that adiponectin and resistin play important roles in controlling body weight and may be related to the occurrence of fetal macrosomia.
C1 [Wang, Jing; Shang, Li-Xin; Wang, Xin; Zhang, Fang; Wu, Nan; Xu, Li-Ming; Ye, Yuan-Yuan] Capital Med Univ, Gen Hosp Beijing Mil Command, Dept Obstet & Gynecol, Beijing 100700, Peoples R China.
   [Wang, Shu-He] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Obstet & Gynecol, Beijing 100700, Peoples R China.
   [Dong, Xing] 205 Hosp PLA, Dept Gen Surg, Liaoning, Peoples R China.
RP Shang, LX (reprint author), Capital Med Univ, Gen Hosp Beijing Mil Command, Dept Obstet & Gynecol, Beijing 100700, Peoples R China.
EM x2728@tom.com
FU Beijing Military Command
FX This work was supported by grants from Beijing Military Command.
CR Caminos JE, 2005, J CLIN ENDOCR METAB, V90, P4276, DOI 10.1210/jc.2004-0930
   Chen DQ, 2005, CLIN SCI, V108, P81, DOI 10.1042/CS20040225
   Cho YM, 2004, DIABETOLOGIA, V47, P1337, DOI 10.1007/s00125-004-1419-2
   Corbetta S, 2005, J CLIN ENDOCR METAB, V90, P2397, DOI 10.1210/jc.2004-1553
   Gil-Campos M, 2004, CLIN NUTR, V23, P963, DOI 10.1016/j.clnu.2004.04.010
   Kajantie E, 2004, J CLIN ENDOCR METAB, V89, P4031, DOI 10.1210/jc.2004-0018
   Kim KH, 2001, J BIOL CHEM, V276, P11252, DOI 10.1074/jbc.C100028200
   Kotani Y, 2004, CLIN ENDOCRINOL, V61, P418, DOI 10.1111/j.1365-2265.2004.02041.x
   Langley-Evans SC, 1998, NUTRITION, V14, P39, DOI 10.1016/S0899-9007(97)00391-2
   Lihn AS, 2005, OBES REV, V6, P13, DOI 10.1111/j.1467-789X.2005.00159.x
   Maeda K, 2007, DIABETES RES CLIN PR, V77, pS17, DOI 10.1016/j.diabres.2007.01.028
   McMillen IC, 2008, BASIC CLIN PHARMACOL, V102, P82, DOI [10.1111/j.1742-7843.2007.00188, 10.1111/j.1742-7843.2007.00188.x]
   Silveira PP, 2007, J PEDIAT, V83, P494, DOI [10.1590/S0021-75572007000800004, 10.2223/JPED.1728]
   SIMONE ND, 2006, J ENDOCRINOL, V189, P691
   Sivan E, 2003, J CLIN ENDOCR METAB, V88, P5656, DOI 10.1210/jc.2003-031174
   Skalkidou A, 2002, J PEDIATR ENDOCR MET, V15, P1479
   Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000
   Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930
   Winer JC, 2006, J CLIN ENDOCR METAB, V91, P4415, DOI 10.1210/jc.2006-0733
   Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788
   Youn BS, 2004, J CLIN ENDOCR METAB, V89, P150, DOI 10.1210/jc.2003-031121
   YUE J, 2004, GYNECOLOGY OBSTET, P130
   Yura S, 2003, J CLIN ENDOCR METAB, V88, P1394, DOI 10.1210/jc.2002-011926
NR 23
TC 13
Z9 15
U1 2
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1341-8076
EI 1447-0756
J9 J OBSTET GYNAECOL RE
JI J. Obstet. Gynaecol. Res.
PD JUN
PY 2010
VL 36
IS 3
BP 533
EP 537
DI 10.1111/j.1447-0756.2010.01228.x
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 608DS
UT WOS:000278563400012
PM 20598033
DA 2018-12-27
ER

PT J
AU Li, J
AF Li, J.
TI RETRACTED: The Effect of Kevlar Pulp Content on Mechanical and
   Tribological Properties of Thermoplastic Polyimide Composites (Retracted
   article. See vol. 29, pg. 3297, 2010)
SO JOURNAL OF REINFORCED PLASTICS AND COMPOSITES
LA English
DT Article; Retracted Publication
DE tribological; polyimide; SEM; wear reduction
ID CARBON-FIBER SURFACE; BEHAVIOR; PERFORMANCE; PLASMA; WEAR
AB Different contents of Kevlar pulps were employed as reinforcement for polyimide ( PI) composite. All filled and unfilled polyimide composites were tested against CGr15 ball and representative testing was performed. The effects of Kevlar pulps content on tribological properties of the PI composites were investigated. The worn surface morphologies of neat PI and its composites were examined by scanning electron microscopy ( SEM) and the wear mechanisms were discussed. Results show that all the filled polyimides have superior tribological characteristics compared to the unfilled ones. The optimum wear reduction was obtained when the content of Kevlar pulps is 15 vol%.
C1 Shanghai Second Polytech Univ, Sch Mech & Elect Engn, Shanghai 201209, Peoples R China.
RP Li, J (reprint author), Shanghai Second Polytech Univ, Sch Mech & Elect Engn, Shanghai 201209, Peoples R China.
EM lijian2008d@gmail.com
FU Shanghai Education Commission [09YZ449]
FX The authors would like to thank Shanghai Education Commission ( Project
   No. 09YZ449) for help received.
CR Benabdallah HS, 2006, J TRIBOL-T ASME, V128, P96, DOI 10.1115/1.2000264
   Bolvari A, 1997, WEAR, V203, P697, DOI 10.1016/S0043-1648(96)07446-7
   Chang N, 2000, WEAR, V241, P109, DOI 10.1016/S0043-1648(00)00393-8
   DRZAL LT, 1993, J MATER SCI, V28, P569, DOI 10.1007/BF01151234
   Fukunaga A, 1999, CARBON, V37, P1081, DOI 10.1016/S0008-6223(98)00307-8
   Guo F, 2009, TRIBOL INT, V42, P243, DOI 10.1016/j.triboint.2008.06.004
   HUANG CH, 1997, RARE EARTHS COORDINA
   Huang YD, 2003, J MATER SCI, V38, P759, DOI 10.1023/A:1021852829723
   Leal AA, 2009, POLYMER, V50, P1228, DOI 10.1016/j.polymer.2009.01.018
   Lee JS, 1997, CARBON, V35, P209, DOI 10.1016/S0008-6223(96)00138-8
   Liu L, 2002, J RARE EARTH, V20, P241
   Marouf BT, 2009, MAT SCI ENG A-STRUCT, V515, P49, DOI 10.1016/j.msea.2009.03.028
   Song DY, 2009, COMPOS STRUCT, V90, P28, DOI 10.1016/j.compstruct.2009.01.002
   Stavropoulos CD, 1997, J MATER SCI, V32, P931, DOI 10.1023/A:1018553617046
   Wan YZ, 2007, MAT SCI ENG A-STRUCT, V452, P202, DOI 10.1016/j.msea.2006.11.090
   Wang A, 1998, TRIBOL INT, V31, P661, DOI 10.1016/S0301-679X(98)00088-7
   XIA LG, 2006, MAT REV, V20, P254
   YANG YG, 1997, CARBON TECHNOL, V6, P12
   Zhang ZQ, 2002, COMPOS SCI TECHNOL, V62, P331, DOI 10.1016/S0266-3538(01)00222-6
NR 19
TC 2
Z9 4
U1 5
U2 22
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0731-6844
EI 1530-7964
J9 J REINF PLAST COMP
JI J. Reinf. Plast. Compos.
PD JUN
PY 2010
VL 29
IS 11
BP 1601
EP 1608
DI 10.1177/0731684409344900
PG 8
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA 602DB
UT WOS:000278117600001
DA 2018-12-27
ER

PT J
AU Shah, S
   Qureshi, R
   Azam, I
AF Shah, Sameena
   Qureshi, Riaz
   Azam, Iqbal
TI RETRACTED: Is Chaalia/Pan Masala harmful for health? Practices and
   knowledge of children of schools in Mahmoodabad and Chanesar Goth,
   Karachi (Retracted Article)
SO JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION
LA English
DT Correction; Retracted Publication
C1 [Shah, Sameena; Qureshi, Riaz; Azam, Iqbal] Aga Khan Univ Hosp, Karachi, Pakistan.
RP Shah, S (reprint author), Aga Khan Univ Hosp, Karachi, Pakistan.
CR GOTH C, 2008, J PAK MED ASSOC, V12, P678
NR 1
TC 0
Z9 0
U1 1
U2 6
PU PAKISTAN MEDICAL ASSOC
PI KARACHI
PA PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN
SN 0030-9982
J9 J PAK MED ASSOC
JI J. Pak. Med. Assoc.
PD JUN
PY 2010
VL 60
IS 6
BP 515
EP 515
PG 1
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA 596LX
UT WOS:000277687600035
DA 2018-12-27
ER

PT J
AU Baek, JI
   Park, ST
AF Baek, Jong-Il
   Park, Sung-Tae
TI RETRACTED: Convergence of Weighted Sums for Arrays of Negatively
   Dependent Random Variables and Its Applications (Retracted article. See
   vol. 18, pg. NP1, 2013)
SO JOURNAL OF THEORETICAL PROBABILITY
LA English
DT Article; Retracted Publication
DE Complete convergence; Negatively dependent random variables; Linear
   processes
ID MOVING AVERAGE PROCESSES; DISTRIBUTED RANDOM-VARIABLES;
   CENTRAL-LIMIT-THEOREM; LARGE NUMBERS; STRONG LAW; SUMMABILITY METHODS;
   SURE CONVERGENCE; LARGE DEVIATIONS; RANDOM ELEMENTS; INEQUALITIES
AB We discuss the complete convergence of weighted sums for arrays of rowwise negatively dependent random variables (ND r.v.'s) to linear processes. As an application, we obtain the complete convergence of linear processes based on ND r.v.'s which extends the result of Li et al. (Stat. Probab. Lett. 14:111-114, 1992), including the results of Baum and Katz (Trans. Am. Math. Soc. 120:108-123, 1965), from the i.i.d. case to a negatively dependent (ND) setting. We complement the results of Ahmed et al. (Stat. Probab. Lett. 58:185-194, 2002) and confirm their conjecture on linear processes in the ND case.
C1 [Baek, Jong-Il] Wonkwang Univ, Div Math & Informat Stat, Iksan 570749, South Korea.
   [Baek, Jong-Il] Wonkwang Univ, Inst Basic Nat Sci, Iksan 570749, South Korea.
   [Park, Sung-Tae] Wonkwang Univ, Div Business, Iksan 570749, South Korea.
   [Park, Sung-Tae] Wonkwang Univ, Business & Econ Res Inst, Iksan 570749, South Korea.
RP Baek, JI (reprint author), Wonkwang Univ, Div Math & Informat Stat, Iksan 570749, South Korea.
EM jibaek@wonkwang.ac.kr; pst@wonkwang.ac.kr
FU Wonkwang University
FX This paper was supported by a Wonkwang University Grant in 2008.
CR Ahmed SE, 2002, STAT PROBABIL LETT, V58, P185, DOI 10.1016/S0167-7152(02)00126-8
   Amini M., 2004, WSEAS T MATH, V3, P637
   Baek JI, 2003, AUST NZ J STAT, V45, P331, DOI 10.1111/1467-842X.00287
   BAUM LE, 1965, T AM MATH SOC, V120, P108, DOI 10.2307/1994170
   Bingham NH, 2004, J APPL PROBAB, V41A, P231, DOI 10.1239/jap/1082552201
   BINGHAM NH, 1991, ALMOST EVERYWHERE CO, V2, P69
   BINGHAM NH, 1985, DEP PROBAB STAT, P291
   BLOCK HW, 1981, COMMUN STAT A-THEOR, V10, P749, DOI 10.1080/03610928108828072
   BOZORGNIA A, 1996, WORLD C NONLINEAR AN, V92, P1639
   BRINDLEY EC, 1972, J AM STAT ASSOC, V67, P822, DOI 10.2307/2284644
   BURTON RM, 1990, STAT PROBABIL LETT, V9, P397, DOI 10.1016/0167-7152(90)90031-2
   Chandra TK, 1996, J THEOR PROBAB, V9, P797, DOI 10.1007/BF02214087
   Chandra TK, 1996, ACTA MATH HUNG, V71, P327, DOI 10.1007/BF00114421
   Chen Y, 2007, STAT PROBABIL LETT, V77, P530, DOI 10.1016/j.spl.2006.08.021
   CHOW Y. S., 1973, B I MATH ACAD SINICA, V1, P207
   CHOW YS, 1971, ANN MATH STAT, V42, P401, DOI 10.1214/aoms/1177693533
   Davis RA, 1990, SPRINGER SERIES STAT
   EBRAHIMI N, 1981, COMMUN STAT-THEOR M, V89, P625
   ESARY JD, 1972, ANN MATH STAT, V43, P651, DOI 10.1214/aoms/1177692646
   ESARY JD, 1967, ANN MATH STAT, V38, P1466, DOI 10.1214/aoms/1177698701
   FakhreZakeri I, 1997, STAT PROBABIL LETT, V35, P417, DOI 10.1016/S0167-7152(97)00040-0
   Ghosal S, 1998, J THEOR PROBAB, V11, P621, DOI 10.1023/A:1022646429754
   GUT A, 1993, PROBAB THEORY REL, V97, P169, DOI 10.1007/BF01199318
   Gut A, 2000, J MATH ANAL APPL, V248, P233, DOI 10.1006/jmaa.2000.6892
   Gut A, 1992, PERIOD MATH HUNG, V25, P51, DOI DOI 10.1007/BF02454383
   Hannan EJ, 1970, MULTIVARIATE TIME SE
   HARRIS R, 1970, ANN MATH STAT, V41, P713, DOI 10.1214/aoms/1177697121
   HSU PL, 1947, P NATL ACAD SCI USA, V33, P25, DOI 10.1073/pnas.33.2.25
   Hu TC, 1999, STOCH ANAL APPL, V17, P963, DOI 10.1080/07362999908809645
   HU TC, 2001, THEOR PROBAB APPL, V47, P455
   Ibragimov I.A, 1962, THEOR PROBAB APPL, V7, P349, DOI DOI 10.1137/1107036
   JOAGDEV K, 1983, ANN STAT, V11, P286, DOI 10.1214/aos/1176346079
   JOGDEO K, 1975, SANKHYA B, V37, P158
   KARLIN S, 1980, J MULTIVARIATE ANAL, V10, P499, DOI 10.1016/0047-259X(80)90066-4
   Kim TS, 2001, STAT PROBABIL LETT, V51, P299, DOI 10.1016/S0167-7152(00)00168-1
   KUCZMASZEWSKA A, 1994, INT J MATH MATH SCI, V17, P1
   LAI TL, 1974, P AM MATH SOC, V45, P253, DOI 10.2307/2040073
   LEHMANN EL, 1966, ANN MATH STAT, V37, P1137, DOI 10.1214/aoms/1177699260
   LI DL, 1992, STAT PROBABIL LETT, V14, P111, DOI 10.1016/0167-7152(92)90073-E
   LI DL, 1995, J THEOR PROBAB, V8, P49, DOI 10.1007/BF02213454
   MATULA P, 1992, STAT PROBABIL LETT, V15, P209, DOI 10.1016/0167-7152(92)90191-7
   Matula P, 2003, PUBL MATH-DEBRECEN, V63, P511
   Taylor RL, 2002, STOCH ANAL APPL, V20, P643
   Wang JF, 2006, ACTA MATH HUNG, V110, P293, DOI 10.1007/s10474-006-0024-x
   WANG XC, 1993, STOCH ANAL APPL, V11, P115, DOI 10.1080/07362999308809305
   Zhang LX, 1996, STAT PROBABIL LETT, V30, P165, DOI 10.1016/0167-7152(95)00215-4
NR 46
TC 10
Z9 10
U1 1
U2 12
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0894-9840
J9 J THEOR PROBAB
JI J. Theor. Probab.
PD JUN
PY 2010
VL 23
IS 2
BP 362
EP 377
DI 10.1007/s10959-008-0198-y
PG 16
WC Statistics & Probability
SC Mathematics
GA 586IU
UT WOS:000276901200002
DA 2018-12-27
ER

PT J
AU Bernardino, S
AF Bernardino, Saccomanni
TI RETRACTED: ACL prosthesis: any promise for the future? (Retracted
   Article. See vol 18, pg 1814, 2010)
SO KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY
LA English
DT Article; Retracted Publication
DE Anterior cruciate ligament; Biomaterials; Prosthetics; Synthetic grafts;
   Tissue engineering
ID ANTERIOR CRUCIATE LIGAMENT; 2-YEAR FOLLOW-UP; GROWTH-FACTORS; LONG-TERM;
   AUGMENTATION DEVICE; DEFICIENT KNEES; RECONSTRUCTION; REPLACEMENT;
   EXPERIENCE; SCAFFOLD
AB Biological tissue autograft reconstruction using the patellar tendon or quadrupled semitendinosus/gracilis tendons has become the most popular procedure in surgical treatment of a ruptured anterior cruciate ligament (ACL). This article provides a review of the history of the use of prosthetics with respect to ACL reconstruction grafts including Carbon Fibre, Gore-Tex and Dacron prosthetics, as well as the Leeds-Keio Artificial Ligament and the Kennedy Ligament Augmentation Device (LAD). Emphasis is placed on the ligament advanced reinforcement system (LARS) as preliminary investigations of its use have been encouraging. Significant progress has been made recently with respect to the understanding of ACL anatomy, composition, biomechanics, and healing processes, leading to innovative techniques using approaches based in tissue engineering principles. Most of grafts that have been developed to date have failed due to unsatisfactory long-term physiological and functional performance. Most permanent ACL prostheses are prone to creep, fatigue, and mechanical failure within several years after implantation. In view of these factors, prosthetics are not widely used today in ACL reconstruction, and autogenous tissue grafts remain the gold standard used by the majority of surgeons. Perhaps development of resorbable, tissue inducing and cell-seeded biomaterials will improve the long-term biomechanical performance of the reconstructed ACL. Tissue ingrowth scaffolds and ligament augmentation devices require further refinement to provide effective mechanical support while avoiding stress shielding of the host tissue. While research into improved ACL treatment options continues, the synthesis of recent advancements provides some new optimism towards the regeneration of an ACL mirroring its original stability, function, and longevity.
C1 Gabriele DAnnunzio Univ, Dept Orthopaed & Traumatol Surg, I-66013 Chieti, Italy.
RP Bernardino, S (reprint author), Gabriele DAnnunzio Univ, Dept Orthopaed & Traumatol Surg, Via Vestini, I-66013 Chieti, Italy.
EM bernasacco@yahoo.it
CR AHLFELD SK, 1987, AM J SPORT MED, V15, P326, DOI 10.1177/036354658701500406
   Alexander H, 1983, Aktuelle Probl Chir Orthop, V26, P78
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   ARNOCZKY SP, 1986, AM J SPORT MED, V14, P1, DOI 10.1177/036354658601400101
   BARRETT GR, 1993, AM J SPORT MED, V21, P367, DOI 10.1177/036354659302100307
   Bellincampi LD, 1998, J ORTHOP RES, V16, P414, DOI 10.1002/jor.1100160404
   BOLTON CW, 1985, CLIN ORTHOP RELAT R, P202
   Bourke SL, 2004, TISSUE ENG, V10, P43, DOI 10.1089/107632704322791682
   BURNETT QM, 1985, ORTHOP CLIN N AM, V16, P143
   CAO Y, 1994, TRANSPLANT P, V26, P3390
   Caruso AB, 2005, J BIOMED MATER RES A, V73A, P388, DOI 10.1002/jbm.a.30233
   Fanelli GC, 2003, ARTHROSCOPY, V19, P30, DOI 10.1016/j.arthro.2003.09.045
   FUJIKAWA K, 1989, J BONE JOINT SURG BR, V71, P566
   GLOUSMAN R, 1988, AM J SPORT MED, V16, P321, DOI 10.1177/036354658801600402
   HANLEY P, 1989, AM J SPORT MED, V17, P414, DOI 10.1177/036354658901700317
   INDELICATO PA, 1989, AM J SPORT MED, V17, P55, DOI 10.1177/036354658901700109
   James S L, 1983, Aktuelle Probl Chir Orthop, V26, P116
   JENKINS DHR, 1978, J BONE JOINT SURG BR, V60, P520
   Kdolsky RK, 1997, J ORTHOP RES, V15, P1, DOI 10.1002/jor.1100150102
   KENNEDY JC, 1980, AM J SPORT MED, V8, P1, DOI 10.1177/036354658000800101
   Koski JA, 2000, ORTHOP CLIN N AM, V31, P437, DOI 10.1016/S0030-5898(05)70162-0
   Krudwig WK, 2002, BIO-MED MATER ENG, V12, P59
   LEE J, 1995, J ORTHOP RES, V13, P435, DOI 10.1002/jor.1100130318
   Liden M, 2007, AM J SPORT MED, V35, P740, DOI 10.1177/0363546506298275
   LOPEZVAZQUEZ E, 1991, J BONE JOINT SURG AM, V73A, P1294, DOI 10.2106/00004623-199173090-00003
   LUKIANOV AV, 1989, AM J SPORT MED, V17, P380, DOI 10.1177/036354658901700312
   MACNICOL MF, 1991, J BONE JOINT SURG BR, V73, P377
   MCLOUGHLIN SJ, 1992, CLIN ORTHOP RELAT R, P215
   MODY BS, 1993, J BONE JOINT SURG BR, V75, P818
   Murray MM, 2003, J ORTHOPAED RES, V21, P238, DOI 10.1016/S0736-0266(02)00142-0
   Nau T, 2002, J BONE JOINT SURG BR, V84B, P356, DOI 10.1302/0301-620X.84B3.12400
   Ouyang HW, 2005, J BIOMED MATER RES B, V75B, P264, DOI 10.1002/jbm.b.30281
   Petrigliano FA, 2006, ARTHROSCOPY, V22, P441, DOI 10.1016/j.arthro.2006.01.017
   RADING J, 1995, AM J SPORT MED, V23, P316, DOI 10.1177/036354659502300311
   RICHMOND JC, 1992, AM J SPORT MED, V20, P24, DOI 10.1177/036354659202000107
   SCHINDHELM K, 1991, CLIN ORTHOP RELAT R, P278
   SCHMIDT CC, 1995, J ORTHOP RES, V13, P184, DOI 10.1002/jor.1100130206
   Talbot M, 2004, CAN J SURG, V47, P20
   WEISS AB, 1985, CLIN ORTHOP RELAT R, P77
   WOODS GA, 1991, AM J SPORT MED, V19, P48, DOI 10.1177/036354659101900108
   WOODS GW, 1985, ORTHOP CLIN N AM, V16, P227
   ZOLTAN DJ, 1988, CLIN SPORT MED, V7, P773
NR 42
TC 12
Z9 19
U1 3
U2 33
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0942-2056
EI 1433-7347
J9 KNEE SURG SPORT TR A
JI Knee Surg. Sports Traumatol. Arthrosc.
PD JUN
PY 2010
VL 18
IS 6
BP 797
EP 804
DI 10.1007/s00167-009-0982-y
PG 8
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 597VF
UT WOS:000277789600019
PM 19915821
DA 2018-12-27
ER

PT J
AU Peng, FL
   Li, FL
   Tan, Y
   Kongkitkul, W
AF Peng, Fang-le
   Li, Fu-lin
   Tan, Yong
   Kongkitkul, Warat
TI RETRACTED: A rate-dependent constitutive model for polymer geosynthetics
   (Retracted article. See vol. 43, pg. 108, 2012)
SO MECHANICS RESEARCH COMMUNICATIONS
LA English
DT Article; Retracted Publication
DE Rate-dependent; Elasto-viscoplastic; Polymer geosynthetic; Strain rate;
   Creep
ID VISCOUS BEHAVIOR; GEOGRIDS; RELAXATION; REINFORCEMENT; DEFORMATION;
   CREEP; LOAD
AB The rate-dependent behaviors of polymer geosynthetics have been observed in the special tensile tests under various loading histories, including the step-changed strain rate loading, creep and stress relaxation applied during otherwise monotonic loading. All the investigated polymer geosynthetics show significant loading rate effects, creep deformation and stress relaxation. An elasto-viscoplastic constitutive model described in a non-linear three-component model framework is developed to simulate the rate-dependent behaviors of polymer geosynthetics. The developed constitutive model is verified by comparing its simulated results with the experimental data of polymer geosynthetics presented in this study and those available from the literature. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Peng, Fang-le; Li, Fu-lin; Tan, Yong] Tongji Univ, Dept Geotech Engn, Shanghai 200092, Peoples R China.
   [Li, Fu-lin] China Univ Min & Technol, Sch Mech & Civil Engn, Jiangsu 221116, Peoples R China.
   [Kongkitkul, Warat] King Mongkuts Univ Technol Thonburi, Dept Civil Engn, Bangkok 10140, Thailand.
RP Peng, FL (reprint author), Tongji Univ, Dept Geotech Engn, 1239 Siping Rd, Shanghai 200092, Peoples R China.
EM pengfangle@tongji.edu.cn
FU NSFC [50679056, 40972176]; NCET [06-0378]; Shanghai Leading Academic
   Discipline Project [B308]
FX The authors would like to express their sincere thanks to Prof. Fumio
   Tatsuoka, Department of Civil Engineering, Tokyo University of Science,
   for his erudite guidance and discussions. The authors acknowledges
   gratefully the support provided by NSFC (No.50679056, 40972176), NCET
   (06-0378), and Shanghai Leading Academic Discipline Project (B308).
CR Bathurst R.J., 1994, GEOSYNTH INT, V1, P1
   Di Benedetto H, 2002, SOILS FOUND, V42, P1
   Hirakawa D, 2003, GEOSYNTH INT, V10, P176, DOI 10.1680/gein.10.6.176.37246
   HOQUE E, 1998, SOILS FOUND, V38, P163, DOI DOI 10.3208/SANDF.38.163
   Kaliakin VN, 2002, GEOSYNTH INT, V9, P319, DOI 10.1680/gein.9.0221
   Kaliakin VN, 2000, GEOSYNTH INT, V7, P79, DOI 10.1680/gein.7.0167
   Kazimierowicz-Frankowska K, 2005, GEOSYNTH INT, V12, P269, DOI 10.1680/gein.2005.12.5.269
   KOERNER RM, 1993, GEOTEXT GEOMEMBRANES, V12, P1, DOI 10.1016/0266-1144(93)90035-M
   Kongkitkul W, 2007, SOILS FOUND, V47, P265, DOI 10.3208/sandf.47.265
   Leshchinsky D, 1997, GEOSYNTH INT, V4, P463, DOI 10.1680/gein.4.0102
   Li ALZ, 2008, GEOTEXT GEOMEMBRANES, V26, P317, DOI 10.1016/j.geotexmem.2007.12.002
   Sawicki A, 2002, GEOSYNTH INT, V9, P1
   Shinoda M, 2004, GEOTEXT GEOMEMBRANES, V22, P205, DOI 10.1016/j.geotexmem.2004.03.003
   Tatsuoka F, 2002, SOILS FOUND, V42, P103, DOI 10.3208/sandf.42.2_103
   XIAO CZ, 2006, P GEOSHANGHAI 2006 G, V152, P281
   YAN QR, 2008, P 4 AS REG C GEOS SH, P105
NR 16
TC 0
Z9 0
U1 3
U2 16
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0093-6413
J9 MECH RES COMMUN
JI Mech. Res. Commun.
PD JUN
PY 2010
VL 37
IS 4
BP 384
EP 388
DI 10.1016/j.mechrescom.2010.05.002
PG 5
WC Mechanics
SC Mechanics
GA 635KV
UT WOS:000280655000005
DA 2018-12-27
ER

PT J
AU Sakr, MF
   Moussa, MM
   Elserafy, M
AF Sakr, M. F.
   Moussa, M. M.
   Elserafy, M.
TI RETRACTED: Ligasure (TM) hemorrhoidectomy versus Stapled
   hemorrhoidopexy: a prospective randomized clinical trial (Retracted
   article. See vol. 57, pg. 1151, 2014)
SO MINERVA CHIRURGICA
LA English
DT Article; Retracted Publication
DE Hemorrhoids; Prolapse; Surgical procedures, operative
ID MILLIGAN-MORGAN HEMORRHOIDECTOMY; CIRCUMFERENTIAL MUCOSECTOMY; DIATHERMY
   HEMORRHOIDECTOMY; MULTICENTER TRIAL; PAIN
AB Aim. The aim of this study was to compare the outcome of Ligasure (TM) hemorrhoidectomy (LH) and Stapled hemorrhoidopexy (SH) for prolapsed hemorrhoids.
   Methods. Sixty-eight patients with grades III and IV hemorrhoids were randomized into two groups of 34 each, to undergo LH (Group 1) or SH (Group 2). Patient demographics, operative details, postoperative pain score, number of parenteral analgesic injections, hospital stay, and time to return to work were all prospectively collected. Postoperative complications and recurrence of prolapse were also recorded. All patients were regularly followed-up for a total period of 18 months.
   Results. Patient demographics and clinical characteristics were similar between both groups. The mean operating time, postoperative pain score, parenteral analgesics, hospital stay and time off work were not statistically significant between both groups. Likewise, both groups had similar postoperative complications except for a residual prolapse that was observed, at four weeks postoperatively, in eight patients (23.53%) in the SH group as compared to two patients (5.89%) in the LH group (P=0.040). Although hemorrhoid recurrence, at 18 months, was also higher among the SH group as compared to the LH group (11.76% vs. 2.94%, respectively), yet the difference was not statistically significant (P=0.163).
   Conclusion. Both LH and SH yield comparable good results and minimal side effects for the treatment of grades III and IV hemorrhoids, with less residual prolapses observed with LH. Further, owing to their low postoperative pain, short hospital stay and rapid return to work, both procedures offer an excellent therapeutic option for prolapsed grades III and IV hemorrhoids.
C1 [Sakr, M. F.] Univ Alexandria, Fac Med, Dept Surg, Alexandria, Egypt.
   [Moussa, M. M.] Ahmadi Hosp, KOC, Dept Surg, Kuwait, Kuwait.
   [Elserafy, M.] Ain Shams Univ, Fac Med, Dept Surg, Cairo, Egypt.
RP Sakr, MF (reprint author), 14th Ave,21, N Ahmadi, Ahmadi, Kuwait.
EM mah_sakr@yahoo.com
OI Sakr, Mahmoud/0000-0002-0176-6070
CR Arbman G, 2000, DIS COLON RECTUM, V43, P31, DOI 10.1007/BF02237240
   Bikhchandani J, 2005, AM J SURG, V189, P56, DOI 10.1016/j.amjsurg.2004.03.014
   Boccasanta P, 2001, AM J SURG, V182, P64, DOI 10.1016/S0002-9610(01)00654-7
   Cepeda MS, 2003, PAIN, V105, P151, DOI 10.1016/S0304-3959(03)00176-3
   CHUNG YC, 2001, DIS COLON RECTUM, V44, P558
   Correa-Rovelo JM, 2003, DIS COLON RECTUM, V46, P955, DOI 10.1097/01.DCR.0000074728.77120.43
   FRANCESCO C, 2008, DIS COLON RECTUM, V51, P1107
   FRANKLIN EJ, 2004, DIS COLON RECTUM, V47, P1557
   Ganio E, 2001, BRIT J SURG, V88, P669, DOI 10.1046/j.0007-1323.2001.01772.x
   Gencosmanoglu R, 2002, DIS COLON RECTUM, V45, P70, DOI 10.1007/s10350-004-6116-1
   Gravie JF, 2005, ANN SURG, V242, P29, DOI 10.1097/01.sla.0000169570.64579.31
   Ho YH, 1997, BRIT J SURG, V84, P1729, DOI 10.1002/bjs.1800841223
   Ho YH, 2000, DIS COLON RECTUM, V43, P1666, DOI 10.1007/BF02236847
   Huang WS, 2007, INT J COLORECTAL DIS, V22, P955, DOI 10.1007/s00384-006-0244-0
   Jayne DG, 2002, BRIT J SURG, V89, P428, DOI 10.1046/j.0007-1323.2002.02056.x
   Kairaluoma M, 2003, DIS COLON RECTUM, V46, P93, DOI 10.1097/01.DCR.0000044722.20821.40
   Kanellos I, 2006, Tech Coloproctol, V10, P47, DOI 10.1007/s10151-006-0250-9
   Kirsch JJ, 2001, CHIRURG, V72, P180, DOI 10.1007/s001040051289
   Kraemer M, 2005, DIS COLON RECTUM, V48, P1517, DOI 10.1007/s10350-005-0067-z
   Longo A, 1998, P 6 WORLD C END SURG, P777
   MACRAE HM, 1995, DIS COLON RECTUM, V38, P687, DOI 10.1007/BF02048023
   Mehigan BJ, 2000, LANCET, V355, P782, DOI 10.1016/S0140-6736(99)08362-2
   MUZI MG, 2007, BRIT J SURG, V94, P1024
   Ng KH, 2006, BRIT J SURG, V93, P226, DOI 10.1002/bjs.5214
   Palazzo FF, 2002, BRIT J SURG, V89, P154, DOI 10.1046/j.0007-1323.2001.01993.x
   Pattana-Arun Jirawat, 2006, Journal of the Medical Association of Thailand, V89, P453
   Pavlidis T, 2002, INT J COLORECTAL DIS, V17, P50, DOI 10.1007/s003840100342
   Peng BC, 2003, DIS COLON RECTUM, V46, P291, DOI 10.1097/01.DCR.0000049484.40711.12
   Ramcharan KS, 2005, DIS COLON RECTUM, V48, P1670, DOI 10.1007/s10350-005-0016-x
   Rowsell M, 2000, LANCET, V355, P779, DOI 10.1016/S0140-6736(99)06122-X
   SAKR M, TECH COLOPR IN PRESS
   Shalaby R, 2001, BRIT J SURG, V88, P1049, DOI 10.1046/j.0007-1323.2001.01830.x
   Tan KY, 2008, TECH COLOPROCTOL, V12, P93, DOI 10.1007/s10151-008-0405-y
   Thorbeck CV, 2002, EUR J SURG, V168, P482, DOI 10.1080/110241502321116497
   WANG JY, 2007, DIS COLON RECTUM, V50, P1
   Wilson MS, 2002, DIS COLON RECTUM, V45, P1437, DOI 10.1097/01.DCR.0000034513.32571.51
NR 36
TC 3
Z9 3
U1 1
U2 6
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 0026-4733
EI 1827-1626
J9 MINERVA CHIR
JI Minerva Chir.
PD JUN
PY 2010
VL 65
IS 3
BP 251
EP 258
PG 8
WC Surgery
SC Surgery
GA 654JG
UT WOS:000282163700002
PM 20668414
DA 2018-12-27
ER

PT J
AU Roy, N
   Stoyanova, T
   Dominguez-Brauer, C
   Park, HJ
   Bagchi, S
   Raychaudhuri, P
AF Roy, Nilotpal
   Stoyanova, Tanya
   Dominguez-Brauer, Carmen
   Park, Hyun Jung
   Bagchi, Srilata
   Raychaudhuri, Pradip
TI RETRACTED: DDB2, an Essential Mediator of Premature Senescence(Retracted
   article. See vol. 37, unsp e00135-17, 2017)
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article; Retracted Publication
ID DNA-BINDING PROTEIN; PIGMENTOSUM GROUP-E; NUCLEOTIDE EXCISION-REPAIR;
   COMPLEMENTATION GROUP-E; HUMAN CANCER-CELLS; CELLULAR SENESCENCE;
   UBIQUITIN LIGASE; DAMAGED DNA; REPLICATIVE SENESCENCE; UV-IRRADIATION
AB Reactive oxygen species (ROS) is critical for premature senescence, a process significant in tumor suppression and cancer therapy. Here, we reveal a novel function of the nucleotide excision repair protein DDB2 in the accumulation of ROS in a manner that is essential for premature senescence. DDB2-deficient cells fail to undergo premature senescence induced by culture shock, exogenous oxidative stress, oncogenic stress, or DNA damage. These cells do not accumulate ROS following DNA damage. The lack of ROS accumulation in DDB2 deficiency results from high-level expression of the antioxidant genes in vitro and in vivo. DDB2 represses antioxidant genes by recruiting Cul4A and Suv39h and by increasing histone-H3K9 trimethylation. Moreover, expression of DDB2 also is induced by ROS. Together, our results show that, upon oxidative stress, DDB2 functions in a positive feedback loop by repressing the antioxidant genes to cause persistent accumulation of ROS and induce premature senescence.
C1 [Bagchi, Srilata] Univ Illinois, Ctr Canc, Coll Dent, Ctr Mol Biol Oral Dis MC 860, Chicago, IL 60612 USA.
   [Roy, Nilotpal; Stoyanova, Tanya; Dominguez-Brauer, Carmen; Park, Hyun Jung; Raychaudhuri, Pradip] Univ Illinois, Ctr Canc, Dept Biochem & Mol Genet MC 669, Chicago, IL 60607 USA.
RP Bagchi, S (reprint author), Univ Illinois, Ctr Canc, Coll Dent, Ctr Mol Biol Oral Dis MC 860, 801 S Paulina Ave, Chicago, IL 60612 USA.
EM sbagchi@uic.edu; pradip@uic.edu
FU National Cancer Institute [CA77637, CA156164]
FX The work was supported by grants from the National Cancer Institute
   (CA77637 to P.R. and CA156164 to P.R. and S.B.).
CR Berube NG, 1998, AM J HUM GENET, V62, P1015, DOI 10.1086/301848
   Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028
   Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629
   Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026
   Cadenas E, 1997, BIOFACTORS, V6, P391, DOI 10.1002/biof.5520060404
   Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Campisi J, 2009, J GERONTOL A-BIOL, V64, P175, DOI 10.1093/gerona/gln065
   Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681
   Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043
   Chung YM, 2008, J BIOL CHEM, V283, P33763, DOI 10.1074/jbc.M805334200
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013
   El-Mahdy MA, 2006, J BIOL CHEM, V281, P13404, DOI 10.1074/jbc.M511834200
   Hong Z, 2007, J CELL PHYSIOL, V210, P567, DOI 10.1002/jcp.20919
   Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512
   HWANG BJ, 1993, BIOCHEMISTRY-US, V32, P1657, DOI 10.1021/bi00057a033
   Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649
   Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10
   Itoh T, 2004, P NATL ACAD SCI USA, V101, P2052, DOI 10.1073/pnas.0306551101
   Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300
   Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103
   KEENEY S, 1993, J BIOL CHEM, V268, P21293
   Kotake Y, 2009, CANCER RES, V69, P1809, DOI 10.1158/0008-5472.CAN-08-2739
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994
   Kulaksiz G, 2005, MOL CELL BIOL, V25, P9784, DOI 10.1128/MCB.25.22.9784-9792.2005
   Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936
   Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001
   Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180
   Minig V, 2009, J BIOL CHEM, V284, P14165, DOI 10.1074/jbc.M808208200
   Nichols AF, 2000, J BIOL CHEM, V275, P21422, DOI 10.1074/jbc.M000960200
   Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003
   O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014
   Park HJ, 2008, ONCOGENE, V27, P1696, DOI 10.1038/sj.onc.1210814
   Park HJ, 2008, MOL CELL BIOL, V28, P5162, DOI 10.1128/MCB.00387-08
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Preto A, 2004, ONCOGENE, V23, P4136, DOI 10.1038/sj.onc.1207564
   Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003
   Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3
   Rowe LA, 2008, FREE RADICAL BIO MED, V45, P1167, DOI 10.1016/j.freeradbiomed.2008.07.018
   Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7
   Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061
   Shiyanov P, 1999, J BIOL CHEM, V274, P35309, DOI 10.1074/jbc.274.50.35309
   Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015
   Stoyanova T, 2008, MOL CELL BIOL, V28, P177, DOI 10.1128/MCB.00880-07
   Stoyanova T, 2009, P NATL ACAD SCI USA, V106, P10690, DOI 10.1073/pnas.0812254106
   Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035
   Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370
   Tan T, 2002, MOL CELL BIOL, V22, P3247, DOI 10.1128/MCB.22.10.3247-3254.2002
   Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6
   von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034
   Wakasugi M, 2002, J BIOL CHEM, V277, P1637, DOI 10.1074/jbc.C100610200
   WALDMAN T, 1995, CANCER RES, V55, P5187
   Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035
   Wang YC, 1999, ONCOGENE, V18, P2643, DOI 10.1038/sj.onc.1202632
   Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200
   Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005
   Zolezzi F, 2000, GENE, V245, P151, DOI 10.1016/S0378-1119(00)00022-6
NR 62
TC 27
Z9 27
U1 3
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD JUN
PY 2010
VL 30
IS 11
BP 2681
EP 2692
DI 10.1128/MCB.01480-09
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 594SQ
UT WOS:000277558300009
PM 20351176
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Beltaief, I
   Arfaoui, A
   Amri, H
AF Beltaief, Imen
   Arfaoui, Aicha
   Amri, Hassen
TI RETRACTED: An Expeditious Synthesis of [1,2]Isoxazolidin-5-ones and
   [1,2]Oxazin-6-ones from Functional Allyl Bromide Derivatives (Retracted
   article. See vol. 19, pg. 16810, 2014)
SO MOLECULES
LA English
DT Article; Retracted Publication
DE functional allyl bromides; conjugate addition; N-substituted
   hydroxylamines; isoxazolidin-5-ones; oxazin-6-ones
ID METHYLENE-GAMMA-BUTYROLACTONES; RING-CLOSING METATHESIS; BAYLIS-HILLMAN
   ACETATES; ENANTIOSELECTIVE SYNTHESIS; REFORMATSKY REACTION; ACID;
   ISOXAZOLIDIN-5-ONES; BENZYLHYDROXYLAMINE; HYDROXYLAMINES; LACTONES
AB Reaction of allyl bromide (Z)-1 and (Z)-2 with N-substituted hydroxylamine hydrochlorides in presence of tert-butoxide in tert-butanol at reflux provides a short and effective route to [1,2]isoxazolidin-5-ones 3 and [1,2]oxazin-6-ones 4.
C1 [Beltaief, Imen; Arfaoui, Aicha; Amri, Hassen] Univ Tunis El Manar, Fac Sci, Lab Chim Organ & Organometall, Tunis, Tunisia.
RP Amri, H (reprint author), Univ Tunis El Manar, Fac Sci, Lab Chim Organ & Organometall, Campus Univ 2092, Tunis, Tunisia.
EM hassen.amri@fst.rnu.tn
CR Arfaoui A., 2009, TETRAHEDRON, V65, P4904
   BALDWIN JE, 1986, TETRAHEDRON LETT, V27, P5423, DOI 10.1016/S0040-4039(00)85228-4
   BALDWIN JE, 1976, J CHEM SOC CHEM COMM, P736, DOI 10.1039/c39760000736
   BALDWIN SW, 1987, TETRAHEDRON LETT, V28, P179, DOI 10.1016/S0040-4039(00)95680-6
   Basavaiah D, 2004, TETRAHEDRON LETT, V45, P1621, DOI 10.1016/j.tetlet.2003.12.133
   Beji F, 2001, TETRAHEDRON, V57, P9959, DOI 10.1016/S0040-4020(01)01018-3
   Beji F, 2000, SYNTHETIC COMMUN, V30, P3947, DOI 10.1080/00397910008086954
   Beltaief I, 1998, SYNTHESIS-STUTTGART, P1765
   Beltaief I, 1999, TETRAHEDRON, V55, P3949, DOI 10.1016/S0040-4020(99)00118-0
   Besbes R, 1997, INDIAN J CHEM B, V36, P5
   CHARLTON JL, 1981, SYNTHETIC COMMUN, V11, P931, DOI 10.1080/00397918108065750
   ELALAMI N, 1987, J ORGANOMET CHEM, V319, P303, DOI 10.1016/S0022-328X(00)99603-7
   ELALAMI N, 1987, TETRAHEDRON LETT, V28, P59
   FERRIS AF, 1955, J ORG CHEM, V20, P780, DOI 10.1021/jo01124a011
   FURSTNER A, 1989, SYNTHESIS-STUTTGART, P571
   Hbaieb S, 1999, SYNTHETIC COMMUN, V29, P981, DOI 10.1080/00397919908086061
   HOFFMANN HMR, 1985, ANGEW CHEM INT EDIT, V24, P94, DOI 10.1002/anie.198500941
   HOLM A, 1980, TETRAHEDRON LETT, V21, P1125, DOI 10.1016/S0040-4039(01)83930-7
   Inami M, 2002, CANCER LETT, V181, P39, DOI 10.1016/S0304-3835(02)00044-7
   Ishikawa T, 1998, TETRAHEDRON, V54, P2433, DOI 10.1016/S0040-4020(98)00008-8
   Koide K, 2001, J AM CHEM SOC, V123, P398, DOI 10.1021/ja0023377
   Le Flohic A, 2003, TETRAHEDRON LETT, V44, P8577, DOI 10.1016/j.tetlet.2003.09.125
   Lee KY, 2006, TETRAHEDRON LETT, V47, P3913, DOI 10.1016/j.tetlet.2006.03.167
   Lee KY, 2006, TETRAHEDRON LETT, V47, P977, DOI 10.1016/j.tetlet.2005.11.142
   Lee KY, 2004, B KOR CHEM SOC, V25, P33
   Lee MJ, 2006, B KOR CHEM SOC, V27, P140
   MACIEJEWSKI S, 1992, TETRAHEDRON, V48, P10363, DOI 10.1016/S0040-4020(01)88341-1
   MATTES H, 1985, TETRAHEDRON LETT, V26, P5697, DOI 10.1016/S0040-4039(01)80923-0
   Merino P, 1998, TETRAHEDRON-ASYMMETR, V9, P3945, DOI 10.1016/S0957-4166(98)00412-1
   Miyata O, 2004, ORG BIOMOL CHEM, V2, P1274, DOI 10.1039/b403694h
   Naoe Y, 1998, CANCER CHEMOTH PHARM, V42, P31, DOI 10.1007/s002800050781
   PANFIL I, 1989, TETRAHEDRON LETT, V30, P1527, DOI 10.1016/S0040-4039(00)99509-1
   Patel SK, 2003, ORG LETT, V5, P4081, DOI 10.1021/ol035470n
   PETRAGNANI N, 1986, SYNTHESIS-STUTTGART, P157
   Redd VK, 2008, TETRAHEDRON, V64, P1040, DOI 10.1016/j.tet.2007.07.071
   Sibi MP, 2003, J AM CHEM SOC, V125, P11796, DOI 10.1021/ja0372309
   Sibi MP, 2001, ORG LETT, V3, P4181, DOI 10.1021/ol016807t
   Sibi MP, 2000, ORG LETT, V2, P3393, DOI 10.1021/ol006500e
   SOCHA D, 1995, TETRAHEDRON LETT, V36, P135, DOI 10.1016/0040-4039(94)02194-G
   Socha D, 1997, TETRAHEDRON, V53, P739, DOI 10.1016/S0040-4020(96)01016-2
   STAMM H, 1976, TETRAHEDRON LETT, P3607
   STAMM H, 1979, TETRAHEDRON, V35, P647, DOI 10.1016/0040-4020(79)87010-6
   TERANO H, 1989, J ANTIBIOT, V42, P145, DOI 10.7164/antibiotics.42.145
   VAUGHAN WR, 1951, J AM CHEM SOC, V73, P5497, DOI 10.1021/ja01155a564
   VILLIERAS J, 1988, ORG SYNTH, V66, P220
   VILLIERAS J, 1982, SYNTHESIS-STUTTGART, P924, DOI 10.1055/s-1982-29998
   Yang YK, 2003, SYNLETT, P2017, DOI 10.1055/s-2003-42038
NR 47
TC 2
Z9 2
U1 3
U2 8
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1420-3049
J9 MOLECULES
JI Molecules
PD JUN
PY 2010
VL 15
IS 6
BP 4094
EP 4101
DI 10.3390/molecules15064094
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 616KD
UT WOS:000279207300021
PM 20657429
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Saracco, MG
   Valfre, W
   Cavallini, M
   Aguggia, M
AF Saracco, Maria Gabriella
   Valfre, W.
   Cavallini, M.
   Aguggia, M.
TI RETRACTED: Greater occipital nerve block in chronic migraine (Retracted
   Article. See vol 32, pg 535, 2011)
SO NEUROLOGICAL SCIENCES
LA English
DT Article; Proceedings Paper; Retracted Publication
CT 4th National Congress of the
   Associazione-Neurologica-Italiana-per-la-Ricerca-sulle-Cefalee
CY JUN 02-05, 2010
CL Genoa, ITALY
SP Assoc Neurol Italiana Ric Celfalee
DE Greater occipital nerve block; Chronic migraine; Local anaesthetic;
   Triamcinolone
ID CLUSTER HEADACHE; STIMULATION; INPUT; PAIN
AB Headache syndromes often involve occipital and neck symptoms suggesting a functional connectivity between nociceptive trigeminal and cervical afferents. Several studies have suggested that pain relief in migraine and other types of headache can be achieved by local injections of steroids, local anaesthetics or a mixture of both in the area of greater occipital nerve (GON). Usually greater occipital nerve block (GONB) is performed by using local anaesthetics alone or with steroid. The rationale of performing a GONB for the treatment of chronic headache states is on the anatomical connections between trigeminal and upper cervical sensory fibres at the level of the trigeminal nucleus caudalis. However, the reason for the improvement after GONB in primary headache is unknown. The objective of this study is to determine whether adding triamcinolone to local anaesthetics increased the efficacy of GONB and trigger point injections (TPIs) for chronic migraine (TM). Patients with TM were randomized to receive GONB and TPIs using lidocaine 2% and bupivacaine 0.5% + either saline or triamcinolone 40 mg. Particularly, a 10-ml syringe containing 4.5 ml of lidocaine 2%, 4.5 ml of bupivacaine 0.5% and 1 ml of either saline (group A) or triamcinolone 40 mg/ml (group B) was prepared for each patients. Patients were given bilateral GONB and TPIs in the cervical paraspinal and trapezius muscles bilaterally. 2 ml were injected into each GON at the medial third of the distance between the occipital protuberance and the mastoid process. In addition, 0.5 ml was injected into each of the 12 trigger points. The total injected volume was 10 ml. The primary outcome measure was the change in mean headache severity from before injection to 20 min after in the two groups. Secondary outcome measures were the change in mean neck pain, photophobia and phonofobia severity from before injection to 20 min after in the two groups. Patients documented headache and severity of associated symptoms for 4 weeks after injection. Changes in symptom severity were compared between the two groups. Thirty-seven patients were included. Twenty minutes after injection, mean headache severity decreased by 3.2 points in group A (p < 0.01) and by 3.1 points in group B (p < 0.01). Mean neck pain severity decreased by 1.5 points in group A (p < 0.01) and by 1.7 points in group B (p < 0.01). Mean duration of being headache-free was 2.7 +/- 3.8 days in group A and 1.0 +/- 1.1 days in group B (p = 0.67). None of the outcome measures differed significantly between the two groups. Both treatments were full tolerated. In our study, adding triamcinolone to local anaesthetic when perfoming GONB and TPIs was not associated with improved outcome in the sample of patients with TM. In both groups, the procedure resulted in significant and rapid relief of headache, neck pain, photophobia and phonofobia.
C1 [Saracco, Maria Gabriella; Valfre, W.; Cavallini, M.; Aguggia, M.] Osped Cardinal Massaia, Dept Neurol, ASL AT Asti, Asti, Italy.
RP Saracco, MG (reprint author), Osped Cardinal Massaia, Dept Neurol, ASL AT Asti, Via Conte Verde 125, Asti, Italy.
EM saraccomg@asl.at.it
CR ASKENAZI A, 2005, HEADACHE, V45, P350
   Bartsch T, 2002, BRAIN, V125, P1496, DOI 10.1093/brain/awf166
   Bartsch T, 2003, BRAIN, V126, P1801, DOI 10.1093/brain/awg190
   Bigal ME, 2008, HEADACHE, V48, P7, DOI 10.1111/j.1526-4610.2007.00969.x
   Busch V, 2007, CEPHALALGIA, V27, P1206, DOI 10.1111/j.1468-2982.2007.01424.x
   GAWEL MJ, 1992, CEPHALALGIA, V12, P9, DOI 10.1046/j.1468-2982.1992.1201009.x
   KERR FWL, 1972, BRAIN RES, V43, P561, DOI 10.1016/0006-8993(72)90408-8
   Lipton RB, 2008, HEADACHE, V48, P58, DOI 10.1111/j.1526-4610.2007.00976.x
   Lovati C, 2009, EXPERT REV NEUROTHER, V9, P395, DOI 10.1586/14737175.9.3.395
   Peres MFP, 2002, CEPHALALGIA, V22, P520, DOI 10.1046/j.1468-2982.2002.00410.x
   Piovesan EJ, 2001, CEPHALALGIA, V21, P107, DOI 10.1046/j.1468-2982.2001.00166.x
NR 11
TC 16
Z9 19
U1 2
U2 13
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD JUN
PY 2010
VL 31
SU 1
BP 179
EP 180
DI 10.1007/s10072-010-0320-7
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 595WN
UT WOS:000277644500044
PM 20464617
DA 2018-12-27
ER

PT J
AU Velik, R
AF Velik, Rosemarie
TI RETRACTED: From single neuron-firing to consciousness-Towards the true
   solution of the binding problem (Retracted article. See vol. 36, pg.
   736, 2012)
SO NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
LA English
DT Review; Retracted Publication
DE Binding problem; Perception; Combination coding; Population coding;
   Temporal coding; Focus of attention; Knowledge
ID VISUAL FEATURE INTEGRATION; OBJECT RECOGNITION; SPATIAL ATTENTION;
   PERCEPTION; CORTEX; BRAIN; MECHANISMS; INFORMATION; SYNCHRONIZATION;
   REPRESENTATION
AB The human brain consists of millions of neural nerve cells being interconnected and firing in parallel in order to process information. A fundamental question is how this parallel neuron-firing can result in a unified experience. This is the so-called binding problem - a problem that is one of today's key questions about brain function and that has puzzled researchers for decades. This article gives a review about the last 50 years of research in this area. It explains what the binding problem is, what classes of binding problems exist, and what the potential solutions suggested so far look like. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Velik, Rosemarie] Tecnalia Fatron, Biorobot, E-20009 Donostia San Sebastian, Spain.
   [Velik, Rosemarie] Vienna Univ Technol, Inst Comp Technol, A-1040 Vienna, Austria.
RP Velik, R (reprint author), Tecnalia Fatron, Biorobot, Paseo Mikeletegi 7,Parque Tecnol, E-20009 Donostia San Sebastian, Spain.
EM velik.rosi@gmx.ar
CR Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371
   BAUER F, 2005, THESIS LUDWIG MAXIMI
   CHUN MM, 2001, BLACKWELL HDB PERCEP, P272
   Colzato LS, 2006, J EXP PSYCHOL HUMAN, V32, P705, DOI 10.1037/0096-1523.32.3.705
   Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565
   Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002
   Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011
   Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465
   Frith C, 1997, PHILOS T R SOC B, V352, P1221, DOI 10.1098/rstb.1997.0104
   GABRIEL AC, 2004, THESIS PHILIPPS U MA
   Ghose GM, 1999, NEURON, V24, P79, DOI 10.1016/S0896-6273(00)80823-5
   GOLDSTEIN EB, 2002, WAHRNEHMUNGSPSYCHOLO
   Golledge HDR, 1996, CURR BIOL, V6, P1092, DOI 10.1016/S0960-9822(02)70675-1
   Gray CM, 1999, NEURON, V24, P31, DOI 10.1016/S0896-6273(00)80820-X
   Hommel B, 2004, TRENDS COGN SCI, V8, P494, DOI 10.1016/j.tics.2004.08.007
   Hommel B, 1998, VIS COGN, V5, P183, DOI 10.1080/713756773
   Hommel B, 2007, PSYCHOL RES-PSYCH FO, V71, P1, DOI 10.1007/s00426-005-0030-6
   Hommel B, 2009, VIS COGN, V17, P120, DOI 10.1080/13506280802349787
   HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837
   ISOKAWA T, 2003, SICE ANN C, V3, P2774
   JACKENDOFF R., 2002, FDN LANGUAGE BRAIN M
   Jacobs J, 2007, J NEUROSCI, V27, P3839, DOI 10.1523/JNEUROSCI.4636-06.2007
   JOHNSTON JC, 1990, J EXP PSYCHOL HUMAN, V16, P843, DOI 10.1037//0096-1523.16.4.843
   MASHOUR GA, 2004, NEUROQUANTOLOGY, V1, P29
   Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167
   MONHEIT MA, 1994, J EXP PSYCHOL HUMAN, V20, P691, DOI 10.1037//0096-1523.20.4.691
   NISSEN MJ, 1985, ATTENTION PERFORM, V11, P205
   Quiroga RQ, 2008, TRENDS COGN SCI, V12, P87, DOI 10.1016/j.tics.2007.12.003
   Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687
   Reynolds JH, 1999, NEURON, V24, P19, DOI 10.1016/S0896-6273(00)80819-3
   Riesenhuber M, 1999, NEURON, V24, P87, DOI 10.1016/S0896-6273(00)80824-7
   Riesenhuber M, 2002, CURR OPIN NEUROBIOL, V12, P162, DOI 10.1016/S0959-4388(02)00304-5
   Robertson LC, 2003, NAT REV NEUROSCI, V4, P93, DOI 10.1038/nrn1030
   Roskies AL, 1999, NEURON, V24, P7, DOI 10.1016/S0896-6273(00)80817-X
   SCHOLZ J, 2001, BINDING PROBLEM THEO
   Schultz SR, 2001, LECT NOTES ARTIF INT, V2036, P212
   SHARKEY AJC, 1998, COMBINING ARTIFICIAL
   SHASTRI L, 1993, BEHAV BRAIN SCI, V16, P417, DOI 10.1017/S0140525X00030910
   Singer W, 2001, ANN NY ACAD SCI, V929, P123
   Singer W., 2003, HDB BRAIN THEORY NEU, P1136
   Solms Mark, 2002, BRAIN INNER WORLD IN
   Stefanics G, 2004, BRAIN TOPOGR, V16, P261
   Stevens CF, 1996, ADV NEUR IN, V8, P75
   Stoet G, 1999, J EXP PSYCHOL HUMAN, V25, P1625, DOI 10.1037/0096-1523.25.6.1625
   STOET G, 2002, COMMON MECH PERCEPTI, V19, P538
   Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5
   Treisman A, 1999, NEURON, V24, P105, DOI 10.1016/S0896-6273(00)80826-0
   TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5
   TRIESCH J, 1996, P ICANN 96, P685
   ULLMAN S, 1995, CEREB CORTEX, V5, P1, DOI 10.1093/cercor/5.1.1
   Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000
   van der Velde F, 2006, BEHAV BRAIN SCI, V29, P37
   VanRullen R, 2009, VIS COGN, V17, P103, DOI 10.1080/13506280802196451
   VELIK R, 2008, P C HUM SYST INT MAY
   VELIK R, 2008, BIONIC MODEL HUMAN L
   VELIK R, 2008, THESIS VIENNA U TECH
   Velik R., 2009, INT J INTELL SYST, V4, P1
   von der Malsburg C, 1999, NEURON, V24, P95, DOI 10.1016/S0896-6273(00)80825-9
   von der Malsburg Christoph, 1981, CORRELATION THEORY B
   VONDERMALSBURG C, 1995, CURR OPIN NEUROBIOL, V5, P520, DOI 10.1016/0959-4388(95)80014-X
   Wolfe JM, 1999, NEURON, V24, P11, DOI 10.1016/S0896-6273(00)80818-1
   ZIMMER H, 2006, HDB BINDING MEMORY P
NR 62
TC 16
Z9 16
U1 2
U2 23
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0149-7634
EI 1873-7528
J9 NEUROSCI BIOBEHAV R
JI Neurosci. Biobehav. Rev.
PD JUN
PY 2010
VL 34
IS 7
SI SI
BP 993
EP 1001
DI 10.1016/j.neubiorev.2009.11.014
PG 9
WC Behavioral Sciences; Neurosciences
SC Behavioral Sciences; Neurosciences & Neurology
GA 599PX
UT WOS:000277926700003
PM 19932130
DA 2018-12-27
ER

PT J
AU Asghar, S
   Magnusson, A
   Khan, A
   Ali, K
   Hussain, A
AF Asghar, Shaheen
   Magnusson, Andres
   Khan, Azad
   Ali, Keramat
   Hussain, Akhtar
TI RETRACTED: In Bangladesh, Overweight Individuals Have Fewer Symptoms of
   Depression Than Nonoverweight Individuals (Retracted article. See vol.
   23, pg. 2521, 2015)
SO OBESITY
LA English
DT Article; Retracted Publication
ID OBESITY
AB The aim of this study was to examine whether the association between overweight and depression usually found in western societies would also be found in locations where overweight is not stigmatized. A total of 1,271 individuals from rural Bangladesh were randomly selected; the response rate was 76%. Depressive symptoms were measured with the Montgomery-Asberg Depression Rating Scale (MADRS). The sum MADRS scores were 13.4 (s.d. = 5.8) and 18.5 (8.1) for overweight vs. nonoverweight (t = 6.6; P < 0.000) men, respectively, and 19.7 (7.8) and 23.2 (7.9) for overweight vs. nonoverweight women, respectively (t = 4.2; P < 0.000). Thus the MADRS score was lower in overweight individuals. After adjusting for sex and age, BMI significantly predicted the MADRS score (beta = -0.3; t = 10.2; P < 0.000). These findings suggest that overweight may be related to fewer depressive symptoms in non-western cultures.
C1 [Magnusson, Andres] Natl Univ Hosp Reykjavik, Dept Psychiat, Reykjavik, Iceland.
   [Asghar, Shaheen] Univ Oslo, Inst Psychiat, Oslo, Norway.
   [Khan, Azad] Bangladesh Inst Res & Rehabil Diabet Endocrine &, Dhaka, Bangladesh.
   [Ali, Keramat] Univ Dhaka, Inst Nutr & Food Sci, Dhaka 1000, Bangladesh.
   [Hussain, Akhtar] Univ Oslo, Dept Int Hlth, Inst Gen Practice & Community Med, Oslo, Norway.
RP Magnusson, A (reprint author), Natl Univ Hosp Reykjavik, Dept Psychiat, Reykjavik, Iceland.
EM andresm@lsh.is
FU University of Oslo
FX We express our gratitude to the survey team members, participants, the
   village leaders, and the Department of Psychology (Rumana Ali),
   University of Dhaka for their guidance and participation in the study.
   S. A. is a clinical research fellow, financed by the University of Oslo.
   We also acknowledge the national Hospital, Norway and Diabetic
   Association of Bangladesh.
CR Hussain A, 2005, DIABETIC MED, V22, P931, DOI 10.1111/j.1464-5491.2005.01558.x
   Li ZB, 2004, INT J GERIATR PSYCH, V19, P68, DOI 10.1002/gps.1040
   McElroy SL, 2004, J CLIN PSYCHIAT, V65, P634
   Miyaoka Y, 1997, PSYCHIAT CLIN NEUROS, V51, P203, DOI 10.1111/j.1440-1819.1997.tb02583.x
   Uher R, 2008, PSYCHOL MED, V38, P289, DOI 10.1017/S0033291707001730
   Vaidya V, 2006, ADV PSYCHOSOM MED, V27, P73
NR 6
TC 4
Z9 4
U1 2
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 1930-739X
J9 OBESITY
JI Obesity
PD JUN
PY 2010
VL 18
IS 6
BP 1143
EP 1145
DI 10.1038/oby.2009.332
PG 3
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 600RQ
UT WOS:000278005300013
PM 19798062
OA Bronze
DA 2018-12-27
ER

PT J
AU Zeng, YY
   Xiong, NX
   Park, JH
   Zheng, GL
AF Zeng, Yuanyuan
   Xiong, Naixue
   Park, Jong Hyuk
   Zheng, Guilin
TI RETRACTED: An Emergency-Adaptive Routing Scheme for Wireless Sensor
   Networks for Building Fire Hazard Monitoring (Retracted article. See
   vol. 11, pg. 2898, 2011)
SO SENSORS
LA English
DT Article; Retracted Publication
DE wireless sensor networks; building fires; real-time; power adaptation
AB Fire hazard monitoring and evacuation for building environments is a novel application area for the deployment of wireless sensor networks. In this context, adaptive routing is essential in order to ensure safe and timely data delivery in building evacuation and fire fighting resource applications. Existing routing mechanisms for wireless sensor networks are not well suited for building fires, especially as they do not consider critical and dynamic network scenarios. In this paper, an emergency-adaptive, real-time and robust routing protocol is presented for emergency situations such as building fire hazard applications. The protocol adapts to handle dynamic emergency scenarios and works well with the routing hole problem. Theoretical analysis and simulation results indicate that our protocol provides a real-time routing mechanism that is well suited for dynamic emergency scenarios in building fires when compared with other related work.
C1 [Zeng, Yuanyuan] Wuhan Univ, Sch Elect Informat, Wuhan, Peoples R China.
   [Xiong, Naixue] Georgia State Univ, Dept Comp Sci, Atlanta, GA 30303 USA.
   [Park, Jong Hyuk] Seoul Natl Univ Technol, Dept Comp Sci & Engn, Seoul, South Korea.
   [Zeng, Yuanyuan; Zheng, Guilin] Wuhan Univ, Sch Power & Mech Engn, Wuhan, Peoples R China.
RP Zeng, YY (reprint author), Wuhan Univ, Sch Elect Informat, Wuhan, Peoples R China.
EM zyywhu@gmail.com; nxiong@cs.gsu.edu; jhpark1@snut.ac.kr;
   glzheng@whu.edu.cn
FU 45th Chinese Postdoc General Program Foundation
FX The project is funded by the 45th Chinese Postdoc General Program
   Foundation
CR Ahmed AA, 2008, COMPUT COMMUN, V31, P3190, DOI 10.1016/j.comcom.2008.04.030
   Barnes M., 2007, P 32 IEEE C LOC COMP
   Boukerche A, 2004, P 7 ACM INT S MOD AN, P157
   Chipara O., 2006, P 14 IEEE INT WORKSH
   Deng J., 2004, P 1 WORKSH DEP ISS W
   Fang Q, 2006, MOBILE NETW APPL, V11, P187, DOI 10.1007/s11036-006-4471-y
   FELEMBAN E, 2005, P 24 ANN JOINT C IEE
   He T., 2003, P 23 INT C DISTR COM
   JACOBSON V, 1988, P ACM S S COMM ARCH
   Karp B., 2000, P 6 ANN INT C MOB CO
   KIM YJ, 2006, P 4 INT C EMB NETW S
   PAN MS, 2006, INT J SENS NETW, V1, P2, DOI DOI 10.1504/IJSNET.2006.010829
   Peacock RD, 1999, FIRE SAFETY J, V33, P167, DOI 10.1016/S0379-7112(99)00029-6
   ROCKETT JA, 1993, FIRE SCI TECHNOL, V13, P61
   TABIRCA T, 2009, P 8 INT S PAR DISTR
   TSENG YC, 2006, IEEE COMPUT, V39, P55
   Wenning BL, 2010, TELECOMMUN SYST, V43, P3, DOI 10.1007/s11235-009-9191-8
   Zeng Y., 2009, P 9 INF TECHN TEL C
   ZHANG Y, 2006, INT J INTERCONNECTIO, V7, P549
   NS2 SIMULATOR
NR 20
TC 3
Z9 3
U1 3
U2 17
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1424-8220
J9 SENSORS-BASEL
JI Sensors
PD JUN
PY 2010
VL 10
IS 6
BP 6128
EP 6148
DI 10.3390/s100606128
PG 21
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA 616IJ
UT WOS:000279202100045
PM 22219706
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Wright, CY
   Darko, N
   Standen, PJ
   Patel, TG
AF Wright, Cecile Yvonne
   Darko, Natalie
   Standen, P. J.
   Patel, Tina G.
TI RETRACTED: Visual Research Methods: Using Cameras to Empower Socially
   Excluded Black Youth (Retracted article. See vol. 45, pg. 531, 2011)
SO SOCIOLOGY-THE JOURNAL OF THE BRITISH SOCIOLOGICAL ASSOCIATION
LA English
DT Article; Retracted Publication
DE agency; black young people; Goffman; marginalization; participant
   photography; visual sociology
ID CHILDREN; FASHION
AB Research with groups of people who are identified as 'marginalized', 'vulnerable' or 'hard-to-reach' faces a variety of methodological challenges. This article describes the reflections and experiences of conducting research with a group of excluded young people of African Caribbean descent. The project used par ticipant photography to engage the participants and draws on Goffman's dramaturgical model to analyse the photographs, the strategies developed by young people to achieve successful transitions and the support or resources that helped them in this process. It concludes that visual research methods empower young people, minimizing the power relationship that can exist between the researcher and young person in conventional interviews. Their involvement in this type of research also allows access to semi-public, 'back regions' of their lives that are often inaccessible to the researcher through traditional qualitative methods and opens up productive dialogue between them and researchers, thus eliciting further oral material.
C1 [Wright, Cecile Yvonne; Darko, Natalie] Nottingham Trent Univ, Sch Social Sci, Div Sociol & Polit, Nottingham NG1 4BU, England.
   [Standen, P. J.] QMC, Floor Med Sch B, Div Rehabil & Ageing, Nottingham NG7 2UH, England.
   [Patel, Tina G.] Univ Salford, Sch English Sociol Polit & Contemporary, Salford M5 4WT, Lancs, England.
RP Wright, CY (reprint author), Nottingham Trent Univ, Sch Social Sci, Div Sociol & Polit, Burton St, Nottingham NG1 4BU, England.
EM cecile.wright@ntu.ac.uk; natalie.darko@ntu.ac.uk;
   p.standen@nottingham.ac.uk; t.patel@salford.ac.uk
OI Patel, Tina/0000-0002-2578-3393
CR Alexander CE, 1996, ART BEING BLACK CREA
   Allen D, 2002, DRUG-EDUC PREV POLIC, V9, P275, DOI 10.1080/09687630210129547
   Banks Marcus, 2001, VISUAL METHODS SOCIA
   Barn R, 2001, BLACK YOUTH MARGINS
   BECKER HS, 1998, IMAGE BASED RES SOUR, P84
   BHOPAL K, 1997, J GENDER STUD, V4, P153
   Christensen Pia, 2000, RES CHILDREN
   Cieslik M., 2002, YOUNG PEOPLE RISK SO
   Collier John, 1967, VISUAL ANTHR PHOTOGR
   CRONIN O, 1998, IMAGE BASED RES
   Dean C, 2007, J RES SPEC EDUC NEED, V7, P16, DOI 10.1111/j.1471-3802.2007.00077.x
   Eder D, 1999, J CONTEMP ETHNOGR, V28, P520, DOI 10.1177/089124199129023640
   Goffman E, 1959, PRESENTATION SELF EV
   Goffman Erving, 1971, RELATIONS PUBLIC
   GOODE S, 2000, SOCIOLOGICAL RES ONL, V5
   HARPER D, 1998, IMAGE BASED RES
   Harrist A. W., 1991, VISUAL ANTHR, V4, P175
   Hill Collins P, 1990, BLACK FEMINIST THOUG
   Hills J., 2002, UNDERSTANDING SOCIAL
   HOLLIDAY R, 2004, PICTURING SOCIAL LAN
   hooks B., 1989, TALKING BACK THINKIN
   Horstman Marie, 2002, Eur J Oncol Nurs, V6, P75, DOI 10.1054/ejon.2002.0185
   Hubbard J., 1991, SHOOTING BACK PHOTOG
   Larson Heidi J., 1988, VISUAL ANTHR, V1, P415
   LEVITAS R, 1998, INCLUSIVE SOC
   MacDonald R, 2005, SOCIOLOGY, V39, P873, DOI 10.1177/0038038505058370
   McRobbie Angela, 1982, FEMINIST REV, V12, P46
   MERTON B, 1998, FINDING MISSING
   Oakley A., 1994, CHILDRENS CHILDHOODS, P13
   PINK S, 2007, VISUAL ETHNOGRAPHY
   Pole C, 2007, CHILDHOOD, V14, P67, DOI 10.1177/0907568207072530
   PROSSER J, 1998, IMAGE BASED RES, P30
   Richards M., 1996, CHILDREN SOC, V10, P90, DOI DOI 10.1111/J.1099-0860.1996.TB00461.X
   *SEU, 1999, TRUANC SCH EXCL
   Walker R, 1993, QUALITATIVE VOICES E
   Woodward S, 2008, SOCIOLOGY, V42, P857, DOI 10.1177/0038038508094566
   Worth S., 1972, THROUGH NAVAJO EYES
   Wright C., 2005, SCH EXCLUSION TRANSI
NR 38
TC 10
Z9 10
U1 2
U2 17
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0038-0385
EI 1469-8684
J9 SOCIOLOGY
JI Sociol.-J. Brit. Sociol. Assoc.
PD JUN
PY 2010
VL 44
IS 3
BP 541
EP 558
DI 10.1177/0038038510362483
PG 18
WC Sociology
SC Sociology
GA 612ZP
UT WOS:000278945600009
DA 2018-12-27
ER

PT J
AU Aly, HAA
   Lightfoot, DA
   El-Shemy, HA
AF Aly, Hamdy A. A.
   Lightfoot, David A.
   El-Shemy, Hany A.
TI RETRACTED: Bacterial lipopolysaccharide-induced oxidative stress in
   adult rat Sertoli cells in vitro (Retracted article. See vol. 27, pg.
   2116, 2013)
SO TOXICOLOGY IN VITRO
LA English
DT Article; Retracted Publication
DE Sertoli cells; Inflammation; Lipopolysaccharide (LPS); Testicular
   toxicity; Lipid peroxidation; Antioxidants
ID GAMMA-GLUTAMYL-TRANSPEPTIDASE; ANTIOXIDANT DEFENSE SYSTEM; GLUTATHIONE
   S-TRANSFERASES; FOLLICLE-STIMULATING-HORMONE; LIPID-PEROXIDATION;
   LEYDIG-CELLS; GERM-CELLS; INDUCED INFLAMMATION; FREE-RADICALS; LIPOIC
   ACID
AB Inflammatory reactions that result from microbial infections, both localized and systemic, are reported to cause transient or permanent male infertility. The cellular mechanisms underlying the inhibitory effect of microbial infection on spermatogenesis is not fully understood. However, there is evidence that spermatogenesis is affected by bacterial lipopolysaccharides (LPS) that induce acute inflammatory responses. The aim here was to use LPS treatments to investigate the potential oxidative stress and toxicity in primary cultures of adult rat Sertoli cells. The Sertoli cells were established and incubated with different concentrations of LPS (5, 10 or 20 mu g/ml) for 6, 12 and 24 h. Lipid peroxidation (LPO) and hydrogen peroxide (H2O2) production, along with superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione-S-transferase (GST), glutathione reductase (GR), reduced glutathione (GSH), lactate, lactic acid dehydrogenase (LDH), gamma-glutamyl transpeptidase (gamma-CT) and beta-glucuronidase were measured in these cells. LPO as well as H2O2 production were significantly increased while antioxidant enzyme activities and GSH concentration were significantly depressed. Effects were dose and time-dependent at all incubation periods with 10 and 20 mu g/ml LPS. Moreover, markers of Sertoli cell function such as lactate production, LDH, gamma-GT and beta-glucuronidase activities were decreased in a time and dose-dependent manner. Incubation of Sertoli cells with 5 mu g/ml LPS for 12 and 24 h significantly increased oxidative status but significantly decreased the antioxidant enzyme activities, GSH concentration and Sertoli cell markers. In contrast, the oxidative and antioxidant status and markers of Sertoli cell function did not show any significant change in treated Sertoli cells with 5 mu g/ml LPS for 6 h. Therefore, it may be concluded that LPS induces oxidative stress in Sertoli cells and adversely affects Sertoli cell functions. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [El-Shemy, Hany A.] Cairo Univ, Fac Agr, Dept Biochem, FARP, Giza 12613, Egypt.
   [Aly, Hamdy A. A.] Al Azhar Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.
   [Aly, Hamdy A. A.] Catholic Univ Louvain, Unit Cellular & Mol Pharmacol, B-1200 Brussels, Belgium.
   [Lightfoot, David A.] SIUC, Dept Plant Soil & Agr Syst, Genom Core Facil, Carbondale, IL USA.
RP El-Shemy, HA (reprint author), Cairo Univ, Fac Agr, Dept Biochem, FARP, Giza 12613, Egypt.
EM helshemy@hotmail.com
OI Lightfoot, David/0000-0002-5725-4381
CR ADAMOPOULOS DA, 1978, BRIT MED J, V1, P1177, DOI 10.1136/bmj.1.6121.1177
   Agarwal A, 2008, AM J REPROD IMMUNOL, V59, P2, DOI 10.1111/j.1600-0897.2007.00559.x
   AITKEN RJ, 1989, BIOL REPROD, V41, P183, DOI 10.1095/biolreprod41.1.183
   ALDRED LF, 1983, J STEROID BIOCHEM, V18, P411, DOI 10.1016/0022-4731(83)90059-6
   Aly HAA, 2009, CHEM-BIOL INTERACT, V182, P112, DOI 10.1016/j.cbi.2009.08.013
   Barker SB, 1941, J BIOL CHEM, V138, P535
   BAUCHE F, 1994, FEBS LETT, V349, P392, DOI 10.1016/0014-5793(94)00709-8
   Bernardini S, 1999, J CELL BIOCHEM, V75, P375, DOI 10.1002/(SICI)1097-4644(19991201)75:3<375::AID-JCB3>3.0.CO;2-I
   Bindu MP, 2004, INDIAN J BIOCHEM BIO, V41, P40
   BRAY TM, 1993, CAN J PHYSIOL PHARM, V71, P746, DOI 10.1139/y93-111
   BROOKS DE, 1976, BIOCHEM J, V156, P527, DOI 10.1042/bj1560527
   BUCH JP, 1991, FERTIL STERIL, V55, P844
   BUEGE JA, 1976, BIOCHIM BIOPHYS ACTA, V444, P192, DOI 10.1016/0304-4165(76)90236-1
   Chasseaud L F, 1979, Adv Cancer Res, V29, P175, DOI 10.1016/S0065-230X(08)60848-9
   CUTOLO M, 1988, ARTHRITIS RHEUM, V31, P1314, DOI 10.1002/art.1780311015
   FISHMANN WH, 1974, METHOD ENZYMAT AN, V2, P923
   Gerdprasert O, 2002, MOL HUM REPROD, V8, P518, DOI 10.1093/molehr/8.6.518
   Gerdprasert O, 2002, CELL TISSUE RES, V308, P277, DOI 10.1007/s00441-002-0547-6
   GRISWOLD MD, 1995, BIOL REPROD, V52, P211, DOI 10.1095/biolreprod52.2.211
   GROOTEGOED JA, 1984, BIOCHIM BIOPHYS ACTA, V767, P248, DOI 10.1016/0005-2728(84)90194-4
   Guitton N, 2000, INT J ANDROL, V23, P332, DOI 10.1046/j.1365-2605.2000.00248.x
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Halliwell B, 1997, J NEUROCHEM, V69, P1330
   HODGEN GD, 1973, ENDOCRINOLOGY, V93, P985, DOI 10.1210/endo-93-4-985
   Jacobson CF, 1998, REPROD TOXICOL, V12, P49, DOI 10.1016/S0890-6238(97)00099-3
   JEGOU B, 1992, BAILLIERE CLIN ENDOC, V6, P273, DOI 10.1016/S0950-351X(05)80151-X
   Kajihara T, 2006, MED MOL MORPHOL, V39, P203, DOI 10.1007/s00795-006-0334-7
   Krishnamoorthy G, 2005, TOXICOLOGY, V212, P195, DOI 10.1016/j.tox.2005.04.014
   KUKUCKA MA, 1993, MOL CELL BIOCHEM, V126, P1, DOI 10.1007/BF01772202
   Kumar TR, 2002, TOXICOL IN VITRO, V16, P675, DOI 10.1016/S0887-2333(02)00092-9
   Lampa J, 1999, J ANDROL, V20, P399
   Luo LD, 2006, J ANDROL, V27, P240, DOI 10.2164/jandrol.05075
   Markey CM, 1998, J ANDROL, V19, P92
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1
   MITA M, 1982, ENDOCRINOLOGY, V110, P1535, DOI 10.1210/endo-110-5-1535
   MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7
   MOVIGLIA GA, 1982, J REPROD FERTIL, V66, P123
   O'Bryan MK, 2000, ENDOCRINOLOGY, V141, P238, DOI 10.1210/en.141.1.238
   Ojha P, 2006, CONTRACEPTION, V73, P102, DOI 10.1016/j.contraception.2005.06.069
   ORLOWSKI M, 1965, J BIOL CHEM, V240, P338
   Papas AM, 1996, LIPIDS, V31, pS77, DOI 10.1007/BF02637055
   PICK E, 1981, CELL IMMUNOL, V59, P301, DOI 10.1016/0008-8749(81)90411-1
   PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T
   Powers SK, 1999, P NUTR SOC, V58, P1025, DOI 10.1017/S0029665199001342
   Rajeswary S, 2007, REPROD TOXICOL, V24, P371, DOI 10.1016/j.reprotox.2007.03.010
   Rao AVSK, 2000, FREE RADICAL BIO MED, V29, P1015, DOI 10.1016/S0891-5849(00)00408-1
   Raychoudhury SS, 2003, ENVIRON HEALTH PERSP, V111, P33, DOI 10.1289/ehp.5458
   ROBINSON BS, 1992, J BIOL CHEM, V267, P1746
   ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588
   SEAL US, 1972, AM J ANAT, V134, P263, DOI 10.1002/aja.1001340209
   Selvakumar E, 2004, REPROD TOXICOL, V19, P163, DOI 10.1016/j.reprotox.2004.06.015
   Sharlip ID, 2002, FERTIL STERIL, V77, P873, DOI 10.1016/S0015-0282(02)03105-9
   SHERINS RJ, 1976, J REPROD FERTIL, V48, P191
   Sikka SC, 2004, J ANDROL, V25, P5
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   SREINBERGER A, 1993, REPROD TOXICOL, V7, P23
   STAAL GEJ, 1969, BIOCHIM BIOPHYS ACTA, V185, P39, DOI 10.1016/0005-2744(69)90280-0
   SYED V, 1993, ENDOCRINOLOGY, V132, P293, DOI 10.1210/en.132.1.293
   Wu H, 2008, ENDOCRINOLOGY, V149, P4402, DOI 10.1210/en.2007-1776
NR 60
TC 17
Z9 23
U1 2
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD JUN
PY 2010
VL 24
IS 4
BP 1266
EP 1272
DI 10.1016/j.tiv.2010.01.009
PG 7
WC Toxicology
SC Toxicology
GA 615HH
UT WOS:000279124900029
PM 20123013
DA 2018-12-27
ER

PT J
AU Yao, JP
   Li, W
   Zhang, L
   Wang, FJ
   Xue, MS
   Jiang, HL
   Lu, JS
AF Yao, Junping
   Li, Wen
   Zhang, Lei
   Wang, Fajun
   Xue, Mingshan
   Jiang, Hongliu
   Lu, Jinshan
TI RETRACTED: Wear Mechanism for In Situ TiC Particle Reinforced AZ91
   Magnesium Matrix Composites (Retracted article. See vol. 58, 29, 2015)
SO TRIBOLOGY LETTERS
LA English
DT Article; Retracted Publication
DE TiC/AZ91 Mg composites; Spray deposition; Microstructure; Wear mechanism
ID ALLOY; FABRICATION; BEHAVIOR
AB TiC reinforced AZ91 magnesium matrix composites have been fabricated by a melt in situ reaction spray deposition. The microstructures of spray-deposited alloys were studied by using scanning electron microscopy (SEM) and X-ray diffraction (XRD). The dry sliding wear behavior of the alloys was investigated by using a pin-on-disc machine under five loads, namely 10, 20, 30, 40, and 50 N. The composites had much better wear-resistance than the matrix alloy. The wear behavior of the composites was dependent on the TiC content in the microstructure and the applied load. The improvement in the wear resistance of the composites became more prominent at larger normal load. At a lower load (10 N), with increasing TiC content, the wear rate of the composite was decreased, and the dominant wear mechanism was an oxidative mechanism. At a higher loads (50 N), a spray-deposited AZ91/TiC composites exhibited superior wear resistance to the AZ91 magnesium alloy, and the dominant wear mechanism was delamination.
C1 [Yao, Junping; Li, Wen; Zhang, Lei; Wang, Fajun; Xue, Mingshan; Jiang, Hongliu; Lu, Jinshan] Nanchang Hangkong Univ, Sch Mat Sci & Engn, Nanchang 330063, Peoples R China.
RP Li, W (reprint author), Nanchang Hangkong Univ, Sch Mat Sci & Engn, Nanchang 330063, Peoples R China.
EM wenl@ualberta.ca
FU Natural Science Foundation of Hangkong [2007ZF56015]; Natural Science
   Foundation of Jiangxi [2007GZC1500]
FX This work is supported by The Natural Science Foundation of Hangkong
   (No. 2007ZF56015) and The Natural Science Foundation of Jiangxi (No.
   2007GZC1500).
CR Anand S, 1997, J MATER SCI, V32, P2835, DOI 10.1023/A:1018668332318
   Chen CY, 2005, MATER SCI FORUM, V475-479, P2789, DOI 10.4028/www.scientific.net/MSF.475-479.2789
   CHEN ZH, 2004, MAGNESIUM ALLOYS, P57
   GOVIND K, 2001, MAT SCI ENG A-STRUCT, V304, P520
   Gui MC, 2000, WEAR, V240, P186, DOI 10.1016/S0043-1648(00)00354-9
   Imai T, 1997, SCRIPTA MATER, V36, P611, DOI 10.1016/S1359-6462(96)00429-0
   Jiang QC, 2003, SCRIPTA MATER, V48, P713, DOI 10.1016/S1359-6462(02)00551-1
   LIM SW, 1995, SCRIPTA MATER, V32, P713
   Liu DM, 2004, MAT SCI ENG A-STRUCT, V372, P229, DOI 10.1016/j.msea.2003.12.041
   Saheb N, 2001, WEAR, V249, P656, DOI 10.1016/S0043-1648(01)00687-1
   Song IH, 2003, SCRIPTA MATER, V48, P413, DOI 10.1016/S1359-6462(02)00435-9
   Tee KL, 2003, MAT SCI ENG A-STRUCT, V339, P227, DOI 10.1016/S0921-5093(02)00150-8
   Venkataraman B, 1996, ACTA MATER, V44, P461, DOI 10.1016/1359-6454(95)00218-9
   Wang HY, 2004, MAT SCI ENG A-STRUCT, V372, P109, DOI 10.1016/j.msea.2003.10.250
   Wen G, 2001, ACTA MATER, V49, P1463, DOI 10.1016/S1359-6454(01)00034-9
NR 15
TC 13
Z9 15
U1 7
U2 21
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1023-8883
EI 1573-2711
J9 TRIBOL LETT
JI Tribol. Lett.
PD JUN
PY 2010
VL 38
IS 3
BP 253
EP 257
DI 10.1007/s11249-010-9600-x
PG 5
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA 607BT
UT WOS:000278474000007
DA 2018-12-27
ER

PT J
AU Isobe, S
   Ono, A
   Yao, H
   Wang, YM
   Hashimoto, N
   Ohnuki, S
AF Isobe, Shigehito
   Ono, Akifumi
   Yao, Hao
   Wang, Yongming
   Hashimoto, Naoyuki
   Ohnuki, Somei
TI RETRACTED: Study on reaction mechanism of dehydrogenation of magnesium
   hydride by in situ transmission electron microscopy (Retracted article.
   See vol. 110, pg. 269901, 2017)
SO APPLIED PHYSICS LETTERS
LA English
DT Article; Retracted Publication
ID HYDROGEN SORPTION KINETICS; NI NANO-PARTICLE; BALL-MILLED MGH2; NB2O5;
   CATALYST; STORAGE; OXIDE; TEM
AB In situ observation on dehydrogenation of MgH2 was performed by using transmission electron microscope (TEM). The dehydrogenation of MgH2 with 1 mol % Nb2O5 and formation of nanosized Mg particles were observed at 150 degrees C. Nb2O5 was not confirmed in diffraction patterns and TEM images probably due to wide dispersion. On MgH2 with 10 mol % Nb2O5, the high resolution TEM could recognize the dehydrogenation at the interface between MgH2 and Nb2O5, proceeding with increasing temperature. This suggests that hydrogen atoms could diffuse from MgH2 phase to the interface between Mg and Nb2O5, resulting in formation of hydrogen molecules at the interface. (C) 2010 American Institute of Physics. [doi:10.1063/1.3442910]
C1 [Isobe, Shigehito; Ono, Akifumi; Yao, Hao; Wang, Yongming; Hashimoto, Naoyuki; Ohnuki, Somei] Hokkaido Univ, Grad Sch Engn, N-13,W-8, Sapporo, Hokkaido 0608278, Japan.
RP Isobe, S (reprint author), Hokkaido Univ, Grad Sch Engn, N-13,W-8, Sapporo, Hokkaido 0608278, Japan.
EM isobe@eng.hokudai.ac.jp
RI HASHIMOTO, Naoyuki/D-6366-2012
FU NEDO
FX This work has been partially supported by NEDO under "Advanced
   Fundamental Research Project on Hydrogen Storage Materials."
CR Barkhordarian G, 2006, J ALLOY COMPD, V407, P249, DOI 10.1016/j.jallcom.2005.05.037
   Barkhordarian G, 2003, SCRIPTA MATER, V49, P213, DOI 10.1016/S1359-6462(03)00259-8
   Barkhordarian G, 2004, J ALLOY COMPD, V364, P242, DOI 10.1016/S0925-8388(03)00530-9
   Hanada N, 2005, J ALLOY COMPD, V404, P716, DOI 10.1016/j.jallcom.2004.12.166
   Hanada N, 2008, J ALLOY COMPD, V450, P395, DOI 10.1016/j.jallcom.2006.10.128
   Hanada N, 2006, PHYSICA B, V383, P49, DOI 10.1016/j.physb.2006.03.051
   Hanada N, 2006, J ALLOY COMPD, V420, P46, DOI 10.1016/j.jallcom.2005.08.084
   Hanada N, 2009, J PHYS CHEM C, V113, P13450, DOI 10.1021/jp901859f
   Porcu M, 2008, J ALLOY COMPD, V453, P341, DOI 10.1016/j.jallcom.2006.11.147
   Prigent J, 2007, J ALLOY COMPD, V446, P90, DOI 10.1016/j.jallcom.2006.11.104
   SCHLAPBACH L, 1979, MATER RES BULL, V14, P1235, DOI 10.1016/0025-5408(79)90220-4
   Wang XL, 2007, INT J HYDROGEN ENERG, V32, P3406, DOI 10.1016/j.ijhydene.2007.03.003
NR 12
TC 24
Z9 24
U1 3
U2 27
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0003-6951
EI 1077-3118
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD MAY 31
PY 2010
VL 96
IS 22
AR 223109
DI 10.1063/1.3442910
PG 3
WC Physics, Applied
SC Physics
GA 606EL
UT WOS:000278404800058
OA Green Published
DA 2018-12-27
ER

PT J
AU Panagiotopoulou, O
   Curtis, N
   Higgins, PO
   Cobb, SN
AF Panagiotopoulou, O.
   Curtis, N.
   Higgins, P. O'
   Cobb, S. N.
TI RETRACTED: Modelling subcortical bone in finite element analyses: A
   validation and sensitivity study in the macaque mandible (Retracted
   article. See vol. 48, pg. 1233, 2015)
SO JOURNAL OF BIOMECHANICS
LA English
DT Article; Retracted Publication
DE Subcortical bone geometry; Material properties; Finite element analysis;
   Macaque mandible
ID SPECKLE PATTERN INTERFEROMETRY; ELASTIC PROPERTIES; CORTICAL BONE;
   COMPUTED-TOMOGRAPHY; TRABECULAR BONE; MECHANICAL-PROPERTIES;
   SUPRAORBITAL REGION; CRANIAL MECHANICS; CANCELLOUS BONE; PROXIMAL FEMUR
AB Finite element analysis (FEA) is a fundamental method to study stresses and strains in complex structures, with the accuracy of an FEA being reliant on a number of variables, not least the precision and complexity of the model's geometry. Techniques such as computed tomography (CT) allow general geometries to be derived relatively quickly; however, constraints on CT image resolution mean defining subcortical geometries can be problematic. In relation to the overall mechanical response of a complex structure during FEA, the consequence of variable subcortical modelling is not known. Here we test this sensitivity with a series of FE models of a macaque mandible with different subcortical geometries and comparing the FEA strain magnitudes and orientations. The validity of the FE models was tested by carrying out experimental strain measurements on the same mandible. These strain measurements matched the FE predictions, providing confidence that material properties and model geometry were suitably defined. Results of this study show that cortical bone alone is not as effective in resisting bending as it is when coupled with subcortical bone, and as such subcortical geometries must be modelled during an FEA. This study demonstrates that the fine detail of the mandibular subcortical structure can be adequately modelled as a solid when assigned an appropriate Young's modulus value, in this case ranging from 1 to 2 GPa. This is an important and encouraging result for the creation of FE models of materials where CT image resolution or poor preservation prevent the accurate modelling of subcortical bone. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Panagiotopoulou, O.] Univ London, Dept Vet Basic Sci, Struct & Mot Lab, Royal Vet Coll, Hatfield AL9 9TA, Herts, England.
   [Panagiotopoulou, O.; Higgins, P. O'] Univ York, Hull York Med Sch, Funct Morphol & Evolut Unit, York YO10 5DD, N Yorkshire, England.
   [Curtis, N.] Univ Hull, Ctr Med Engn & Technol, Kingston Upon Hull HU6 7RX, N Humberside, England.
   [Cobb, S. N.] Univ Hull, Hull York Med Sch, Funct Morphol & Evolut Unit, Kingston Upon Hull HU6 7RX, N Humberside, England.
RP Panagiotopoulou, O (reprint author), Univ London, Dept Vet Basic Sci, Struct & Mot Lab, Royal Vet Coll, Room 21,Hawkshead Lane, Hatfield AL9 9TA, Herts, England.
EM opanagiotopoulou@rvc.ac.uk
FU Marie Curie Palaeo EST Host Fellowship [MEST-CT-2005-020601];
   Biotechnology and Biological Sciences Research Council [BB/E013805/1]
FX Special thanks to Jia Liu and Lee Page for programming Vox-FE, and Sue
   Taft for technical assistance. We are also grateful to J. Currey, M.
   Fagan, and L. Fitton for useful discussions. This study was funded by a
   Marie Curie Palaeo EST Host Fellowship (MEST-CT-2005-020601).
CR ASHMAN RB, 1989, J BIOMECH, V22, P895, DOI 10.1016/0021-9290(89)90073-0
   BAXTER BS, 1981, INVEST RADIOL, V16, P337, DOI 10.1097/00004424-198107000-00017
   BOUVIER M, 1981, J MORPHOL, V167, P1, DOI 10.1002/jmor.1051670102
   CURREY JD, 1995, BIOMATERIALS, V16, P1267, DOI 10.1016/0142-9612(95)98135-2
   CURREY JD, 1989, J BIOMECH, V22, P469, DOI 10.1016/0021-9290(89)90207-8
   DALSTRA M, 1993, J BIOMECH, V26, P523, DOI 10.1016/0021-9290(93)90014-6
   Dechow PC, 2000, AM J PHYS ANTHROPOL, V112, P553, DOI 10.1002/1096-8644(200008)112:4<553::AID-AJPA9>3.0.CO;2-R
   Fagan MJ, 2007, J MORPHOL, V268, P1071
   FARKE A, 2008, J VERTEBR PALEONTOL, pA76
   Francillon-Vieillot H., 1990, P471
   Groning F, 2009, J BIOMECH, V42, P1224, DOI 10.1016/j.jbiomech.2009.03.025
   Guo XE, 1997, FORMA, V12, P185
   HODGSKINSON R, 1989, J ORTHOPAED RES, V7, P754, DOI 10.1002/jor.1100070518
   HYLANDER WL, 1984, AM J PHYS ANTHROPOL, V64, P1, DOI 10.1002/ajpa.1330640102
   HYLANDER WL, 1991, AM J PHYS ANTHROPOL, V86, P1, DOI 10.1002/ajpa.1330860102
   HYLANDER WL, 1991, ARCH ORAL BIOL, V36, P273, DOI 10.1016/0003-9969(91)90097-E
   HYLANDER WL, 1985, AM ZOOL, V25, P315
   Kessler O, 2006, CLIN BIOMECH, V21, P603, DOI 10.1016/j.clinbiomech.2006.01.011
   Kupczik K, 2007, J ANAT, V210, P41, DOI 10.1111/j.1469-7580.2006.00662.x
   Kupczik K, 2009, AM J PHYS ANTHROPOL, V139, P193, DOI 10.1002/ajpa.20972
   Macho GA, 2005, INT J OSTEOARCHAEOL, V15, P421, DOI 10.1002/oa.797
   Martin R. B., 1998, SKELETAL TISSUE MECH
   Moreno K, 2008, J ANAT, V212, P736, DOI 10.1111/j.1469-7580.2008.00899.x
   O'Mahony AM, 2000, CLIN ORAL IMPLAN RES, V11, P415, DOI 10.1034/j.1600-0501.2000.011005415.x
   Pahr DH, 2009, J BIOMECH, V42, P455, DOI 10.1016/j.jbiomech.2008.11.028
   Panagiotopoulou O, 2009, AM J PHYS ANTHROPOL, P205
   PANAGIOTOPOULOU O, J ANATOMY IN PRESS
   Rayfield EJ, 2005, ANAT REC PART A, V283A, P349, DOI 10.1002/ar.a.20168
   Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070
   Rayfield EJ, 2008, PALEOBIOLOGY, V34, P494, DOI 10.1666/07006.1
   RHO JY, 1993, J BIOMECH, V26, P111, DOI 10.1016/0021-9290(93)90042-D
   Ryan TM, 2006, J HUM EVOL, V51, P591, DOI 10.1016/j.jhevol.2006.06.004
   Schwartz GT, 1998, J HUM EVOL, V35, P523, DOI 10.1006/jhev.1998.0239
   SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405
   SPOOR F, 1995, J ANAT, V186, P271
   Strait DS, 2009, P NATL ACAD SCI USA, V106, P2124, DOI 10.1073/pnas.0808730106
   Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172
   SU M, 2005, J HOLOGR SPECKLE, V2, P34
   TYRER JR, 1995, OPT LASER ENG, V23, P291, DOI 10.1016/0143-8166(95)00035-M
   ULLRICH CG, 1980, RADIOLOGY, V134, P137, DOI 10.1148/radiology.134.1.7350593
   VanRietbergen B, 1996, INT J NUMER METH ENG, V39, P2743
   VANRIETBERGEN B, 1994, P ASME CED HIGH PERF, V6, P47
   Verhulp E, 2006, J BIOMECH, V39, P2951, DOI 10.1016/j.jbiomech.2005.10.027
   Volpato V, 2008, PRIMATES, V49, P16, DOI 10.1007/s10329-007-0053-2
   Wang Q, 2006, AM J PHYS ANTHROPOL, V131, P402, DOI 10.1002/ajpa.20438
   Wroe S, 2007, ANAT REC, V290, P1248, DOI 10.1002/ar.20594
   YANG L, 2007, EXPT ANAL NANO ENG M, P581
   Yanga L, 2007, OPT LASER ENG, V45, P843, DOI 10.1016/j.optlaseng.2007.02.004
   Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6
NR 49
TC 28
Z9 28
U1 2
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PD MAY 28
PY 2010
VL 43
IS 8
BP 1603
EP 1611
DI 10.1016/j.jbiomech.2009.12.027
PG 9
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 609JH
UT WOS:000278652000025
PM 20176361
DA 2018-12-27
ER

PT J
AU Barre, B
   Perkins, ND
AF Barre, Benjamin
   Perkins, Neil D.
TI RETRACTED: The Skp2 Promoter Integrates Signaling through the NF-kappa
   B, p53, and Akt/GSK3 beta Pathways to Regulate Autophagy and Apoptosis
   (Retracted article. See vol. 55, pg. 342, 2014)
SO MOLECULAR CELL
LA English
DT Article; Retracted Publication
ID CELL-CYCLE; PHOSPHORYLATION; ACTIVATION; SUBUNIT; BCL-3; STABILIZATION;
   DEGRADATION; INHIBITION; EXPRESSION; P27(KIP1)
AB NF-kappa B and p53 are important regulators of the cellular response to stress. Here, we identify the Skp2 gene as being both an NF-kappa B and p53 target after DNA damage. However, Skp2 expression can be either induced or repressed in a manner requiring both the p52 NF-kappa B subunit and p53, with subsequent effects on autophagy, apoptosis, and p53 function. This process is regulated by the Akt(PKB)/ GSK3 beta pathway. When Akt is active, GSK3 beta is repressed, allowing p52 and p53 to cooperatively induce Skp2 expression. However, if Akt is inactive, GSK3 beta phosphorylates p52 at Ser 222. This modification disrupts p52 homodimer/Bcl-3 complexes and facilitates transcriptional repression by p52/c-Rel. The Skp2 promoter therefore integrates signaling through the NF-kappa B, p53, and Akt/GSK3 beta pathways to regulate cell fate in response to DNA damage.
C1 [Barre, Benjamin; Perkins, Neil D.] Univ Bristol, Sch Med Sci, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England.
RP Perkins, ND (reprint author), Newcastle Univ, Sch Med, ICaMB, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM n.d.perkins@newcastle.ac.uk
FU Association of International Cancer Research [08-0430]
FX We thank Ron Hay, Mark Bond, and Kevin Ryan for supplying reagents. We
   thank all members of the NDP Laboratory and Helena Smartt for their help
   and assistance; and John O'Shea, Sonia Rocha, and Derek Mann for their
   critical reading of the manuscript. B.B. is funded by a project grant
   from the Association of International Cancer Research (08-0430).
CR Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797
   Barisic S, 2008, CELL DEATH DIFFER, V15, P1681, DOI 10.1038/cdd.2008.98
   Barre B, 2007, EMBO J, V26, P4841, DOI 10.1038/sj.emboj.7601899
   Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052
   Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024
   Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904
   Cramer P, 1997, EMBO J, V16, P7078, DOI 10.1093/emboj/16.23.7078
   Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105
   DUCKETT CS, 1993, MOL CELL BIOL, V13, P1315, DOI 10.1128/MCB.13.3.1315
   Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296
   Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11
   Fusco AJ, 2008, J BIOL CHEM, V283, P12324, DOI 10.1074/jbc.M707898200
   Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847
   Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Kashatus D, 2006, GENE DEV, V20, P225, DOI 10.1101/gad.1352206
   Kitagawa M, 2008, MOL CELL, V29, P217, DOI 10.1016/j.molcel.2007.11.036
   Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537
   Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010
   Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083
   Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003
   Savinova OV, 2009, MOL CELL, V34, P591, DOI 10.1016/j.molcel.2009.04.033
   Schneider G, 2006, EMBO J, V25, P3801, DOI 10.1038/sj.emboj.7601259
   Schumm K, 2006, EMBO J, V25, P4820, DOI 10.1038/sj.emboj.7601343
   Tergaonkar V, 2002, CANCER CELL, V1, P493, DOI 10.1016/S1535-6108(02)00068-5
   Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7
   Viatour P, 2004, MOL CELL, V16, P35, DOI 10.1016/j.molcel.2004.09.004
   Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5
   Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127
   Xia YF, 2009, P NATL ACAD SCI USA, V106, P2629, DOI 10.1073/pnas.0812256106
NR 30
TC 54
Z9 58
U1 2
U2 15
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1097-2765
EI 1097-4164
J9 MOL CELL
JI Mol. Cell
PD MAY 28
PY 2010
VL 38
IS 4
BP 524
EP 538
DI 10.1016/j.molcel.2010.03.018
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 606SQ
UT WOS:000278448100008
PM 20513428
OA Bronze
DA 2018-12-27
ER

PT J
AU Kovalova, A
   Ledvina, M
   Saman, D
   Zyka, D
   Kubickova, M
   Zidek, L
   Sklenar, V
   Pompach, P
   Kavan, D
   Bily, J
   Vanek, O
   Kubinkova, Z
   Libigerova, M
   Ivanova, L
   Antolikova, M
   Mrazek, H
   Rozbesky, D
   Hofbauerova, K
   Kren, V
   Bezouska, K
AF Kovalova, Anna
   Ledvina, Miroslav
   Saman, David
   Zyka, Daniel
   Kubickova, Monika
   Zidek, Lukas
   Sklenar, Vladimir
   Pompach, Petr
   Kavan, Daniel
   Bily, Jan
   Vanek, Ondrej
   Kubinkova, Zuzana
   Libigerova, Martina
   Ivanova, Ljubina
   Antolikova, Maria
   Mrazek, Hynek
   Rozbesky, Daniel
   Hofbauerova, Katerina
   Kren, Vladimir
   Bezouska, Karel
TI RETRACTED: Synthetic N-Acetyl-D-glucosamine Based Fully Branched
   Tetrasaccharide, a Mimetic of the Endogenous Ligand for CD69, Activates
   CD69(+) Killer Lymphocytes upon Dimerization via a Hydrophilic Flexible
   Linker (Retracted article. See vol. 57, pg. 5477, 2014)
SO JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID CARBOHYDRATE-BINDING PROTEIN; RECEPTOR NKR-P1; CELL ACTIVATION;
   OLIGOSACCHARIDE LIGANDS; ANIMAL LECTINS; ANTIGEN; DISACCHARIDE;
   ACETYLGLUCOSAMINE; TRISACCHARIDE; DERIVATIVES
AB On the basis of the highly branched ovomucoid-type undecasaccharide that had been shown previously to be an endogenous ligand for CD69 leukocyte receptor, a systematic investigation of smaller oligosaccharide mimetics was performed based on linear and branched N-acetyl-D-hexosamine homooligomers prepared synthetically using hitherto unexplored reaction schemes. The systematic structure activity studies revealed the tetrasaccharide GlcNAc beta 1-3(GlcNAc beta 1-4)(GlcNAc beta 1-6)GlcNAc (compound 52) and its alpha-benzyl derivative 49 as the best ligand for CD69 with IC50 as high as 10(-9) M. This compound thus approaches the affinity of the classical high-affinity neoglycoprotein ligand GlcNAc(23)BSA. Compound 68, GlcNAc tetrasaccharide 52 dimerized through a hydrophilic flexible linker, turned out to be effective in activating CD69(+) lymphocytes. It also proved efficient in enhancing natural killing in vitro, decreasing the growth of tumors in vivo, and activating the CD69(+) tumor infiltrating lymphocytes examined ex vivo. This compound is thus a candidate for carbohydrate-based immunomodulators with promising antitumor potential.
C1 [Pompach, Petr; Kavan, Daniel; Bily, Jan; Vanek, Ondrej; Kubinkova, Zuzana; Libigerova, Martina; Ivanova, Ljubina; Antolikova, Maria; Mrazek, Hynek; Rozbesky, Daniel; Bezouska, Karel] Charles Univ Prague, Fac Sci, Dept Biochem, Prague 12840, Czech Republic.
   [Kovalova, Anna; Ledvina, Miroslav; Saman, David; Zyka, Daniel] Acad Sci Czech Republ, Inst Organ Chem & Biochem, VVI, CR-16610 Prague, Czech Republic.
   [Kubickova, Monika; Zidek, Lukas; Sklenar, Vladimir] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, CS-61137 Brno, Czech Republic.
   [Pompach, Petr; Kavan, Daniel; Vanek, Ondrej; Kubinkova, Zuzana; Libigerova, Martina; Ivanova, Ljubina; Antolikova, Maria; Mrazek, Hynek; Rozbesky, Daniel; Hofbauerova, Katerina; Kren, Vladimir; Bezouska, Karel] Acad Sci Czech Republ, Inst Microbiol, VVI, CR-14220 Prague, Czech Republic.
RP Bezouska, K (reprint author), Charles Univ Prague, Fac Sci, Dept Biochem, Hlavova 8, Prague 12840, Czech Republic.
EM bezouska@biomed.cas.cz
RI Vanek, Ondrej/I-7022-2016; Kren, Vladimir/H-8461-2014; Zyka,
   Daniel/H-2597-2014; Rozbesky, Daniel/N-7742-2018; Sklenar,
   Vladimir/F-9118-2011; Mrazek, Hynek/J-8484-2014; Ivanova,
   Lyubina/J-8528-2014; Pompach, Petr/J-6209-2014; Saman, David/G-5272-2014
OI Vanek, Ondrej/0000-0003-1190-8535; Rozbesky, Daniel/0000-0001-6546-8219;
   Sklenar, Vladimir/0000-0001-9988-4093; Ivanova,
   Lyubina/0000-0002-6458-1604; Pompach, Petr/0000-0002-0606-0851; Saman,
   David/0000-0001-5578-1930; Kavan, Daniel/0000-0003-2693-1199;
   Hofbauerova, Katerina/0000-0001-7608-793X
FU Ministry of Education of Czech Republic [MSM_21620808, 1M0505,
   AVOZ50200510, Z4 055 0506, MSM0021622413, LC06030]; Czech Grant Agency
   [303/09/0477, 305/09/H008, 203/09/P024]; Grant Agency of Czech Academy
   of Science [KAN200520703, 200100801]; EU [LSHG-CT-2006-02/220]
FX The authors thank to Marketa Vancurova for her helpful comments on the
   manuscript. This work was supported by grants from Ministry of Education
   of Czech Republic (Grants MSM_21620808, 1M0505, and AVOZ50200510 to KB.,
   Grant Z4 055 0506 to M.L., and Grants MSM0021622413 and LC06030 to VS.),
   from Czech Grant Agency (Grants 303/09/0477 and 305/09/H008 to K.B. and
   Grant 203/09/P024 to P.P.), from Grant Agency of Czech Academy of
   Science (Grants KAN200520703 and 200100801 to M.L.), and by EU Project
   Spine 2 (Contract LSHG-CT-2006-02/220 to KB.).
CR BANOUB J, 1992, CHEM REV, V92, P1167, DOI 10.1021/cr00014a002
   Berkin A, 2000, CARBOHYD RES, V326, P250, DOI 10.1016/S0008-6215(00)00049-5
   Bezouska K, 2008, FEBS J, V275, P81
   Bezouska K, 2004, COLLECT CZECH CHEM C, V69, P535, DOI 10.1135/cccc20040535
   BEZOUSKA K, 1994, J BIOL CHEM, V269, P16945
   BEZOUSKA K, 1995, BIOCHEM BIOPH RES CO, V208, P68, DOI 10.1006/bbrc.1995.1306
   BEZOUSKA K, 1994, NATURE, V372, P150, DOI 10.1038/372150a0
   Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189
   Bojarova P, 2009, GLYCOBIOLOGY, V19, P509, DOI 10.1093/glycob/cwp010
   Bongat AFG, 2007, CARBOHYD RES, V342, P374, DOI 10.1016/j.carres.2006.10.021
   Bottino C, 2005, TRENDS IMMUNOL, V26, P221, DOI 10.1016/j.it.2005.02.007
   CHIPMAN DM, 1967, J BIOL CHEM, V242, P4388
   Chung SM, 2009, NAT CHEM BIOL, V5, P407, DOI 10.1038/nchembio.163
   Crich D, 2001, J AM CHEM SOC, V123, P6819, DOI 10.1021/ja010086b
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b
   Eller S, 2007, ANGEW CHEM INT EDIT, V46, P4173, DOI 10.1002/anie.200604788
   FARKAS J, 1987, CARBOHYD RES, V163, P63, DOI 10.1016/0008-6215(87)80165-9
   Fowler P, 1996, HELV CHIM ACTA, V79, P269, DOI 10.1002/hlca.19960790127
   GEROSA F, 1991, MOL IMMUNOL, V28, P159, DOI 10.1016/0161-5890(91)90100-X
   GRONBERG G, 1994, CARBOHYD RES, V257, P35, DOI 10.1016/0008-6215(94)84106-3
   Hansson J, 2001, J ORG CHEM, V66, P6234, DOI 10.1021/jo001302m
   Holeman A, 2004, CURR OPIN BIOTECH, V15, P615, DOI 10.1016/j.copbio.2004.10.001
   KANTOCI D, 1987, CARBOHYD RES, V162, P227, DOI 10.1016/0008-6215(87)80218-5
   Kavan D, 2010, BIOCHEMISTRY-US, V49, P4060, DOI 10.1021/bi100181a
   Krist P, 2001, BIOCHEM BIOPH RES CO, V287, P11, DOI 10.1006/bbrc.2001.5537
   Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526
   Ledvina M, 1998, COLLECT CZECH CHEM C, V63, P577, DOI 10.1135/cccc19980577
   LIKHOSHERSTOV LM, 1986, CARBOHYD RES, V146, pC1, DOI 10.1016/0008-6215(86)85037-6
   Lindhorst TK, 1996, ANGEW CHEM INT EDIT, V35, P1953, DOI 10.1002/anie.199619531
   MALOISEL JL, 1992, HELV CHIM ACTA, V75, P1491, DOI 10.1002/hlca.19920750505
   Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197
   MORETTA A, 1991, J EXP MED, V174, P1393, DOI 10.1084/jem.174.6.1393
   Moretta A, 2005, CURR OPIN IMMUNOL, V17, P306, DOI 10.1016/j.coi.2005.03.004
   Moretta L, 2004, TRENDS IMMUNOL, V25, P670, DOI 10.1016/j.it.2004.09.008
   NILSSON U, 1990, CARBOHYD RES, V208, P260, DOI 10.1016/0008-6215(90)80107-E
   PAULSEN H, 1982, ANGEW CHEM INT EDIT, V21, P155, DOI 10.1002/anie.198201553
   Pavlicek J, 2004, BIOCHEM SOC T, V32, P1124, DOI 10.1042/BST0321124
   Pavlicek J, 2003, BIOCHEMISTRY-US, V42, P9295, DOI 10.1021/bi0272981
   Plihal O, 2004, COLLECT CZECH CHEM C, V69, P631, DOI 10.1135/cccc20040631
   Pospisil M, 2000, INT J ONCOL, V16, P267
   POSTE G, 1980, CANCER RES, V40, P1636
   Rohlenova A, 2004, COLLECT CZECH CHEM C, V69, P1781, DOI 10.1135/cccc20041781
   Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006
   Seeberger PH, 2005, NATURE, V437, P1239, DOI 10.1038/4371239a
   Semenuk T, 2001, GLYCOCONJUGATE J, V18, P817, DOI 10.1023/A:1021111703443
   TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7
   TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1
   Vanek O, 2008, FEBS J, V275, P5589, DOI 10.1111/j.1742-4658.2008.06683.x
   Vannucci L, 2003, INT J ONCOL, V23, P285
   VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97
   Vasella A, 1995, HELV CHIM ACTA, V78, P1971, DOI 10.1002/hlca.19950780806
   Vesely J, 2004, COLLECT CZECH CHEM C, V69, P1914, DOI 10.1135/cccc20041914
   Vesely J, 2003, COLLECT CZECH CHEM C, V68, P1264, DOI 10.1135/cccc20031264
   Westerlind U, 2002, CARBOHYD RES, V337, P1517, DOI 10.1016/S0008-6215(02)00222-7
   WILSTERMANN M, 1995, J AM CHEM SOC, V117, P4742, DOI 10.1021/ja00122a002
NR 56
TC 14
Z9 14
U1 4
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-2623
EI 1520-4804
J9 J MED CHEM
JI J. Med. Chem.
PD MAY 27
PY 2010
VL 53
IS 10
BP 4050
EP 4065
DI 10.1021/jm100055b
PG 16
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 597OF
UT WOS:000277766900018
PM 20433142
DA 2018-12-27
ER

PT J
AU Dunoyer, P
   Brosnan, CA
   Schott, G
   Wang, Y
   Jay, F
   Alioua, A
   Himber, C
   Voinnet, O
AF Dunoyer, Patrice
   Brosnan, Christopher A.
   Schott, Gregory
   Wang, Yu
   Jay, Florence
   Alioua, Abdelmalek
   Himber, Christophe
   Voinnet, Olivier
TI RETRACTED: An endogenous, systemic RNAi pathway in plants (Retracted
   article. See vol. 34, pg. 2596, 2015)
SO EMBO JOURNAL
LA English
DT Article; Retracted Publication
DE endogenous hairpins; long distance; RdDM; RNAi
ID DSRNA-BINDING PROTEINS; DOUBLE-STRANDED-RNA; DICER-LIKE PROTEINS; DNA
   METHYLATION; ARABIDOPSIS-THALIANA; SILENCING SIGNAL;
   NICOTIANA-BENTHAMIANA; TRANSPOSABLE ELEMENTS; INVERTED DUPLICATION;
   SIRNA ACCUMULATION
AB Recent work on metazoans has uncovered the existence of an endogenous RNA-silencing pathway that functionally recapitulates the effects of experimental RNA interference (RNAi) used for gene knockdown in organisms such as Caenorhabditis elegans and Drosophila. The endogenous short interfering (si) RNA involved in this pathway are processed by Dicer-like nucleases from genomic loci re-arranged to form extended inverted repeats (IRs) that produce perfect or near-perfect dsRNA molecules. Although such IR loci are commonly detected in plant genomes, their genetics, evolution and potential contribution to plant biology through endogenous silencing have remained largely unexplored. Through an exhaustive analysis performed using Arabidopsis, we provide here evidence that at least two such endogenous IRs are genetically virtually indistinguishable from the transgene constructs commonly used for RNAi in plants. We show how these loci can be useful probes of the cellular mechanism and fluidity of RNA-silencing pathways in plants, and provide evidence that they may arise and disappear on an ecotype scale, show highly cell-specific expression patterns and respond to various stresses. IR loci thus have the potential to act as molecular sensors of the local environments found within distinct ecological plant niches. We further show that the various siRNA size classes produced by at least one of these IR loci are functionally loaded into cognate effector proteins and mediate both post-transcriptional gene silencing and RNA-directed DNA methylation (RdDM) of endogenous as well as exogenous targets. Finally, and as previously reported during plant experimental RNAi, we provide evidence that endogenous IR-derived siRNAs of all size classes are not cell-autonomous and can be transported through graft junctions over long distances, in target tissues where they are functional, at least in mediating RdDM. Collectively, these results define the existence of a bona fide, endogenous and systemic RNAi pathway in plants that may have implications in adaptation, epiallelism and trans-generational memory. The EMBO Journal (2010) 29, 1699-1712. doi: 10.1038/ emboj. 2010.65; Published online 22 April 2010
C1 [Dunoyer, Patrice; Brosnan, Christopher A.; Schott, Gregory; Wang, Yu; Jay, Florence; Alioua, Abdelmalek; Himber, Christophe; Voinnet, Olivier] Univ Strasbourg, CNRS, UPR2357, Inst Biol Mol Plantes, F-67084 Strasbourg, France.
RP Voinnet, O (reprint author), Univ Strasbourg, CNRS, UPR2357, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.
EM patrice.dunoyer@ibmp-ulp.u-strasbg.fr;
   Olivier.voinnet@ibmp-ulp.u-strasbg.fr
FU Bettencourt Foundation for Life Science Research; European Research
   Council [ERC 210890]; Agence National pour la Recherche
   [ANR-08-JCJC-0063-01]
FX Research in OV's laboratory is funded by a prize from the Bettencourt
   Foundation for Life Science Research and a starting grant from the
   European Research Council 'Frontiers of RNAi' ERC 210890. PD and GS are
   also supported by a research grant from Agence National pour la
   Recherche (ANR-08-JCJC-0063-01). We thank J Mutterrer for help with
   image acquisition, R Wagner's team for plant care and members of OV's
   laboratory and Emily McCallum for critical reading of the paper.
CR Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035
   Alcazar RM, 2008, GENETICS, V180, P1275, DOI 10.1534/genetics.108.089433
   Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478
   BANKS JA, 1988, GENE DEV, V2, P1364, DOI 10.1101/gad.2.11.1364
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874
   Bechtold N, 1998, METH MOL B, V82, P259
   Beclin C, 2002, CURR BIOL, V12, P684, DOI 10.1016/S0960-9822(02)00792-3
   Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217
   Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151
   Brosnan CA, 2007, P NATL ACAD SCI USA, V104, P14741, DOI 10.1073/pnas.0706701104
   Chitwood DH, 2009, GENE DEV, V23, P549, DOI 10.1101/gad.1770009
   Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745
   Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657
   Curtin SJ, 2008, FEBS LETT, V582, P2753, DOI 10.1016/j.febslet.2008.07.004
   Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979
   Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214
   Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039
   Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675
   Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719
   Dunoyer P, 2007, NAT GENET, V39, P848, DOI 10.1038/ng2081
   Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880
   Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877
   Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219
   Finnegan EJ, 2002, CURR OPIN PLANT BIOL, V5, P101, DOI 10.1016/S1369-5266(02)00233-9
   Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092
   Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100
   Havelda Z, 2003, J VIROL, V77, P6082, DOI 10.1128/JVI.77.10.6082-6086.2003
   Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804
   Hernandez-Pinzon I, 2007, PLANT J, V50, P140, DOI 10.1111/j.1365-313X.2007.03043.x
   Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910
   Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431
   Hiraguri A, 2005, PLANT MOL BIOL, V57, P173, DOI 10.1007/s11103-004-6853-5
   Jacobsen SE, 1999, DEVELOPMENT, V126, P5231
   Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI DOI 10.1007/BF02667740
   Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3
   Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580
   Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057
   Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101
   Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957
   Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029
   Lindow M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-119
   Lindow M, 2007, PLOS COMPUT BIOL, V3, P2379, DOI 10.1371/journal.pcbi.0030238
   Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744
   Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029
   Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351
   Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007
   MCCLINTOCK B, 1956, COLD SPRING HARB SYM, V21, P197, DOI 10.1101/SQB.1956.021.01.017
   Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034
   Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959
   Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196
   Okamura K, 2008, NAT REV MOL CELL BIO, V9, P673, DOI 10.1038/nrm2479
   Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738
   Pant BD, 2008, PLANT J, V53, P731, DOI 10.1111/j.1365-313X.2007.03363.x
   Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804
   Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102
   Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804
   Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405
   Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014
   Raja P, 2008, J VIROL, V82, P8997, DOI 10.1128/JVI.00719-08
   Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654
   Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138
   Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038
   Slotkin RK, 2005, NAT GENET, V37, P641, DOI 10.1038/ng1576
   Smith LM, 2007, PLANT CELL, V19, P1507, DOI 10.1105/tpc.107.051540
   Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313
   Turnbull CGN, 2002, PLANT J, V32, P255, DOI 10.1046/j.1365-313X.2002.01419.x
   Vaillant I, 2007, CURR OPIN PLANT BIOL, V10, P528, DOI 10.1016/j.pbi.2007.06.008
   VAUCHERET H, 2005, SCI STKE, pPE43, DOI DOI 10.1126/STKE.3002005PE42
   Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007
   Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3
   Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7
   Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046
   Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104
   Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130
   Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603
   Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695
NR 77
TC 161
Z9 166
U1 5
U2 51
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD MAY 19
PY 2010
VL 29
IS 10
BP 1699
EP 1712
DI 10.1038/emboj.2010.65
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 598JU
UT WOS:000277833100009
PM 20414198
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Renaudet, O
   Krenek, K
   Bossu, I
   Dumy, P
   Kadek, A
   Adamek, D
   Vanek, O
   Kavan, D
   Gazak, R
   Sulc, M
   Bezouska, K
   Kren, V
AF Renaudet, Olivier
   Krenek, Karel
   Bossu, Isabelle
   Dumy, Pascal
   Kadek, Alan
   Adamek, David
   Vanek, Ondrej
   Kavan, Daniel
   Gazak, Radek
   Sulc, Miroslav
   Bezouska, Karel
   Kren, Vladimir
TI RETRACTED: Synthesis of Multivalent Glycoconjugates Containing the
   Immunoactive LELTE Peptide: Effect of Glycosylation on Cellular
   Activation and Natural Killing by Human Peripheral Blood Mononuclear
   Cells (Retracted article. See vol. 136, pg. 1156, 2014)
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article; Retracted Publication
ID KILLER-CELLS; RECEPTOR NKR-P1; TN ANTIGEN; CD69; CARBOHYDRATE; LIGANDS;
   BINDING; GLYCODENDRIMERS; MOLECULE; CALCIUM
AB Pentapeptide diacidic sequence LELTE, derived from the mycobacterial heat shock protein hsp65, has been recently identified as a "danger" signal of the immune system effective via specific binding to the universal leukocyte triggering receptor CD69. This sequence is not active per se, only after its presentation within the multivalent environment of its parent protein, or after artificial dimerization using a standard bifunctional reagents. Here we describe an entirely new way of presenting of this peptide based on its attachment to a cyclopeptide RAFT scaffold (K-K-K-P-G)2 through the c-amino group of lysine residues, alone or in combination with the carbohydrate epitope alpha GaINAc. The ability of such RAFT scaffolds to precipitate the target CD69 receptor or to activate CD69-positive cells is enhanced in compounds 2 and 4 possessing combined peptide/carbohydrate expression. Compounds 2 and 4 are highly efficient activators of natural killer lymphocytes, but they are completely inactive from the point of view of activation-induced apoptosis of lymphocytes by the target cells. These unique properties make the combined peptide/carbohydrate RAFTs highly suitable for future evaluation in animal tumor therapies in vivo and predict them to be readily available and efficient immunoactivators.
C1 [Renaudet, Olivier; Bossu, Isabelle; Dumy, Pascal] Univ Grenoble 1, CNRS, UMR 5250, Dept Chim Mol, F-38041 Grenoble 9, France.
   [Renaudet, Olivier; Bossu, Isabelle; Dumy, Pascal] Univ Grenoble 1, ICMG FR 2607, F-38041 Grenoble 9, France.
   [Krenek, Karel; Kadek, Alan; Adamek, David; Vanek, Ondrej; Kavan, Daniel; Gazak, Radek; Sulc, Miroslav; Bezouska, Karel; Kren, Vladimir] Acad Sci Czech Republic, Inst Microbiol, CZ-14220 Prague 4, Czech Republic.
   [Krenek, Karel; Kadek, Alan; Adamek, David; Vanek, Ondrej; Kavan, Daniel; Bezouska, Karel] Charles Univ Prague, Fac Sci, Dept Biochem, CZ-12840 Prague 2, Czech Republic.
RP Renaudet, O (reprint author), Univ Grenoble 1, CNRS, UMR 5250, Dept Chim Mol, BP53, F-38041 Grenoble 9, France.
EM olivier.renaudet@ujf-grenoble.fr; kren@biomed.cas.cz
RI Gazak, Radek/H-2443-2014; Kadek, Alan/J-6159-2014; dumy,
   pascal/C-4863-2008; Kren, Vladimir/H-8461-2014; Renaudet,
   Olivier/B-6120-2014; Sulc, Miroslav/K-1029-2014; Vanek,
   Ondrej/I-7022-2016
OI Gazak, Radek/0000-0003-3881-0327; Kadek, Alan/0000-0002-7953-5870; dumy,
   pascal/0000-0002-7660-763X; Renaudet, Olivier/0000-0003-4963-3848; Sulc,
   Miroslav/0000-0002-2659-0489; Vanek, Ondrej/0000-0003-1190-8535; Kavan,
   Daniel/0000-0003-2693-1199
FU Universite Joseph Fourier; Centre National de la Recherche Scientifique
   (CNRS); EU ESF [D-34]; Ministry of Education of the Czech Republic
   [LC06010, MSM21620808, 1M0505]; Agency of the Academy of Sciences of the
   Czech Republic [IAA400200503]; Czech Science Foundation [303/09/0477,
   305/09/H008]; Institutional Research Concept for the Institute of
   Microbiology [AVOZ50200510]
FX This work was supported by the Universite Joseph Fourier, the Centre
   National de la Recherche Scientifique (CNRS) and EU ESF COST Chemistry
   project D-34. We thank the NanoBio Program for access to the facilities
   of the Chemistry Platform. Further, this work was supported by the
   Grants LC06010, MSM21620808, and 1M0505 from the Ministry of Education
   of the Czech Republic, IAA400200503 from Grant Agency of the Academy of
   Sciences of the Czech Republic, 303/09/0477 and 305/09/H008 from the
   Czech Science Foundation, and by the Institutional Research Concept for
   the Institute of Microbiology (AVOZ50200510). Dr. K. Hofbauerova,
   Institute of Microbiology, Prague, is thanked for the preparation of
   soluble CD69 protein.
CR Bezouska K, 2008, FEBS J, V275, P81
   Bezouska K, 2004, COLLECT CZECH CHEM C, V69, P535, DOI 10.1135/cccc20040535
   BEZOUSKA K, 1994, J BIOL CHEM, V269, P16945
   Bezouska K, 1997, BIOCHEM BIOPH RES CO, V238, P149, DOI 10.1006/bbrc.1997.7260
   Bezouska K, 1998, FEBS LETT, V426, P243, DOI 10.1016/S0014-5793(98)00340-8
   BEZOUSKA K, 2001, SCAND J IMMUNOL, V54, P26
   Bezouska K, 2010, BIOORGAN MED CHEM, V18, P1434, DOI 10.1016/j.bmc.2010.01.015
   Bojarova P, 2009, GLYCOBIOLOGY, V19, P509, DOI 10.1093/glycob/cwp010
   Boturyn D, 2008, J PEPT SCI, V14, P224, DOI 10.1002/psc.964
   BOYUM RB, 1967, SCAND J CLIN LAB INV, V21, P77
   BRUNNER KT, 1968, IMMUNOLOGY, V14, P181
   BYCROFT BW, 1993, J CHEM SOC CHEM COMM, P778, DOI 10.1039/c39930000778
   Di Santo JP, 2008, NAT IMMUNOL, V9, P473, DOI 10.1038/ni.f.201
   Dulery V, 2007, TETRAHEDRON, V63, P11952, DOI 10.1016/j.tet.2007.09.015
   DUMY P, 1995, TETRAHEDRON LETT, V36, P1255, DOI 10.1016/0040-4039(94)02481-P
   Foillard S, 2008, J ORG CHEM, V73, P983, DOI 10.1021/jo701628k
   GEOGHEGAN KF, 1992, BIOCONJUGATE CHEM, V3, P138, DOI 10.1021/bc00014a008
   GIORDA R, 1990, SCIENCE, V249, P1298, DOI 10.1126/science.2399464
   Grigalevicius S, 2005, BIOCONJUGATE CHEM, V16, P1149, DOI 10.1021/bc050010v
   Krenek K, 2007, CARBOHYD RES, V342, P1781, DOI 10.1016/j.carres.2007.04.026
   Krist P, 2004, CHEMBIOCHEM, V5, P445, DOI 10.1002/cbic.200300669
   Krist P, 2001, BIOCHEM BIOPH RES CO, V287, P11, DOI 10.1006/bbrc.2001.5537
   LANGER LL, 2008, NAT IMMUNOL, V9, P495
   Pavlicek J, 2003, BIOCHEMISTRY-US, V42, P9295, DOI 10.1021/bi0272981
   Pospisil M, 2000, INT J ONCOL, V16, P267
   Renaudet O, 2003, ORG LETT, V5, P243, DOI 10.1021/ol0270935
   Renaudet O, 2006, ORG BIOMOL CHEM, V4, P2628, DOI 10.1039/b604391g
   Renaudet O, 2008, MINI-REV ORG CHEM, V5, P274, DOI 10.2174/157019308786242142
   Renaudet O, 2009, BIOORG MED CHEM LETT, V19, P3880, DOI 10.1016/j.bmcl.2009.03.119
   RYAN JC, 1991, J IMMUNOL, V147, P3244
   TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7
   Vanek O, 2008, FEBS J, V275, P5589, DOI 10.1111/j.1742-4658.2008.06683.x
   Vannucci L, 2003, INT J ONCOL, V23, P285
   Veprek P, 2006, J MED CHEM, V49, P6400, DOI 10.1021/jm050741g
   Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582
NR 35
TC 17
Z9 17
U1 4
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD MAY 19
PY 2010
VL 132
IS 19
BP 6800
EP 6808
DI 10.1021/ja101296t
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 596YJ
UT WOS:000277721500040
PM 20420392
DA 2018-12-27
ER

PT J
AU Gou, DW
   Rubalcava, M
   Sauer, S
   Mora-Bermudez, F
   Erdjument-Bromage, H
   Tempst, P
   Kremmer, E
   Sauer, F
AF Gou, Dawei
   Rubalcava, Monica
   Sauer, Silvia
   Mora-Bermudez, Felipe
   Erdjument-Bromage, Hediye
   Tempst, Paul
   Kremmer, Elisabeth
   Sauer, Frank
TI RETRACTED: SETDB1 Is Involved in Postembryonic DNA Methylation and Gene
   Silencing in Drosophila (Retracted article. See vol. 13, art no
   E0194869, 2018)
SO PLOS ONE
LA English
DT Article; Retracted Publication
ID CPG-BINDING DOMAIN; HISTONE H3 METHYLTRANSFERASE; EPIGENETIC REGULATION;
   ARABIDOPSIS-THALIANA; NEUROSPORA-CRASSA; GENOME; MELANOGASTER;
   TRANSCRIPTION; EXPRESSION; CELLS
AB DNA methylation is fundamental for the stability and activity of genomes. Drosophila melanogaster and vertebrates establish a global DNA methylation pattern of their genome during early embryogenesis. Large-scale analyses of DNA methylation patterns have uncovered revealed that DNA methylation patterns are dynamic rather than static and change in a gene-specific fashion during development and in diseased cells. However, the factors and mechanisms involved in dynamic, postembryonic DNA methylation remain unclear. Methylation of lysine 9 in histone H3 (H3-K9) by members of the Su(var)3-9 family of histone methyltransferases (HMTs) triggers embryonic DNA methylation in Arthropods and Chordates. Here, we demonstrate that Drosophila SETDB1 (dSETDB1) can mediate DNA methylation and silencing of genes and retrotransposons. We found that dSETDB1 tri-methylates H3-K9 and binds methylated CpA motifs. Tri-methylation of H3-K9 by dSETDB1 mediates recruitment of DNA methyltransferase 2 (Dnmt2) and Su(var) 205, the Drosophila ortholog of mammalian "Heterochromatin Protein 1'', to target genes for dSETDB1. By enlisting Dnmt2 and Su(var) 205, dSETDB1 triggers DNA methylation and silencing of genes and retrotransposons in Drosophila cells. DSETDB1 is involved in postembryonic DNA methylation and silencing of Rt1b{} retrotransposons and the tumor suppressor gene retinoblastoma family protein 1 (Rb) in imaginal discs. Collectively, our findings implicate dSETDB1 in postembryonic DNA methylation, provide a model for silencing of the tumor suppressor Rb, and uncover a role for cell type-specific DNA methylation in Drosophila development.
C1 [Gou, Dawei; Rubalcava, Monica; Sauer, Silvia; Sauer, Frank] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.
   [Mora-Bermudez, Felipe; Sauer, Frank] Heidelberg Univ, Zentrum Mol Biol, D-6900 Heidelberg, Germany.
   [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA.
   [Kremmer, Elisabeth] German Res Ctr Environm Hlth, Inst Mol Immunol, Helmholtz Zentrum Munchen, Munich, Germany.
RP Gou, DW (reprint author), Univ Calif Los Angeles, Los Angeles, CA 90024 USA.
EM frank.sauer@ucr.edu
OI Tempst, Paul/0000-0002-6680-3987
FU National Institute of General Medical Sciences [GM073776]
FX This research was supported in part by a grant (GM073776) from the
   National Institute of General Medical Sciences (www.nigms.nih.gov) to
   FS. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Ashburner M, 2005, DROSOPHILA LAB HDB
   Baron U, 1997, NUCLEIC ACIDS RES, V25, P2723, DOI 10.1093/nar/25.14.2723
   Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354
   Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102
   Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9
   Blomen VA, 2007, CELL MOL LIFE SCI, V64, P3084, DOI 10.1007/s00018-007-7271-z
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Brower-Toland B, 2009, GENETICS, V181, P1303, DOI 10.1534/genetics.108.100271
   Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601
   Clough E, 2007, DEVELOPMENT, V134, P157, DOI 10.1242/dev.02698
   Crew JR, 1997, DEV GENES EVOL, V206, P481, DOI 10.1007/s004270050079
   Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206
   Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909
   EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709
   Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376
   Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976
   Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918
   Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x
   Hallstrom TC, 2009, CELL CYCLE, V8, P532, DOI 10.4161/cc.8.4.7609
   Hark AT, 2000, NATURE, V405, P486
   Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352
   Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917
   Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5
   Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022
   Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731
   Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089
   Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029
   Kaminker J.S., 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-12-RFESEARCH84
   Keller SA, 2005, GENE EXPR PATTERNS, V5, P411, DOI 10.1016/j.modgep.2004.09.005
   Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719
   Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008
   Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716
   Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9
   Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205
   Lyko F, 2006, CURR TOP MICROBIOL, V310, P23
   Maile T, 2004, SCIENCE, V304, P1010, DOI 10.1126/science.1095001
   MONK M, 1987, DEVELOPMENT, V99, P371
   MORATA G, 1993, CURR OPIN GENET DEV, V3, P606, DOI 10.1016/0959-437X(93)90096-8
   NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886
   Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360
   Reddy MN, 2003, ONCOGENE, V22, P6301, DOI 10.1038/sj.onc.1206650
   Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X
   Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383
   Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658
   Salzberg A, 2004, BIOCHEM BIOPH RES CO, V322, P465, DOI 10.1016/j.bbrc.2004.07.134
   SEUM C, 2007, PLOS GENET, V11, pE76
   Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807
   Stabell M, 2006, HEREDITAS, V143, P177, DOI 10.1111/j.2006.0018-0661.01970.x
   Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341
   Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508
   Tzeng TY, 2007, P NATL ACAD SCI USA, V104, P12691, DOI 10.1073/pnas.0705534104
   Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174
   Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431
   Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598
   WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101
   Xin SJ, 2002, DEVELOPMENT, V129, P1345
   Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366
   Zemach A, 2007, TRENDS PLANT SCI, V12, P80, DOI 10.1016/j.tplants.2006.12.004
   Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003
   Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929
NR 60
TC 20
Z9 21
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 17
PY 2010
VL 5
IS 5
AR e10581
DI 10.1371/journal.pone.0010581
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 597QK
UT WOS:000277773700002
PM 20498723
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Tomkins, JL
   Penrose, MA
   Greeff, J
   Lebas, NR
AF Tomkins, Joseph L.
   Penrose, Marissa A.
   Greeff, Johan
   Lebas, Natasha R.
TI RETRACTED: Additive Genetic Breeding Values Correlate with the Load of
   Partially Deleterious Mutations (Retracted article. See vol. 333, pg.
   1220, 2011)
SO SCIENCE
LA English
DT Article; Retracted Publication
ID CALLOSOBRUCHUS-MACULATUS; INBREEDING DEPRESSION; SEXUAL SELECTION;
   FITNESS COMPONENTS; MIMULUS-GUTTATUS; FEEDING BEETLES; LEK PARADOX;
   LIFE-SPAN; MAINTENANCE; SIZE
AB The mutation-selection-balance model predicts most additive genetic variation to arise from numerous mildly deleterious mutations of small effect. Correspondingly, "good genes" models of sexual selection and recent models for the evolution of sex are built on the assumption that mutational loads and breeding values for fitness-related traits are correlated. In support of this concept, inbreeding depression was negatively genetically correlated with breeding values for traits under natural and sexual selection in the weevil Callosobruchus maculatus. The correlations were stronger in males and strongest for condition. These results confirm the role of existing, partially recessive mutations in maintaining additive genetic variation in outbred populations, reveal the nature of good genes under sexual selection, and show how sexual selection can offset the cost of sex.
C1 [Tomkins, Joseph L.; Penrose, Marissa A.; Greeff, Johan; Lebas, Natasha R.] Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol, Nedlands, WA 6009, Australia.
   [Greeff, Johan] Dept Agr & Food, S Perth, WA 6151, Australia.
RP Tomkins, JL (reprint author), Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol, Nedlands, WA 6009, Australia.
EM jtomkins@cyllene.uwa.edu.au
RI Tomkins, Joseph/A-8091-2011; LeBas, Natasha/E-7339-2015
OI LeBas, Natasha/0000-0003-4706-3909; Tomkins, Joseph/0000-0003-1259-7898
FU Australian Research Council
FX We thank J. Chan for the maintenance of the pedigree and the collection
   and management of the data set; R. Black and F. Gonzalez for statistical
   advice; B. Booth, A. Sutton, and S. Jennings for their assistance with
   the experiment; and N. Colegrave, W. Hazel, M. Puurtinen, J. Radwan, M.
   Ritchie, and L. Simmons for their comments on the manuscript. This work
   was supported by Australian Research Council fellowships to J. L. T. and
   N. R. L.
CR Agrawal AF, 2001, NATURE, V411, P692, DOI 10.1038/35079590
   Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700
   Charlesworth B., 1999, EVOL GENET, V1, P369
   Charlesworth B, 2007, GENET RES, V89, P85, DOI 10.1017/S001667230700866X
   Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664
   EADY PE, 1995, BEHAV ECOL SOCIOBIOL, V36, P25, DOI 10.1007/BF00175725
   Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915
   Fox CW, 2006, FUNCT ECOL, V20, P1003, DOI 10.1111/j.1365-2435.2006.01197.x
   Fox CW, 2007, B ENTOMOL RES, V97, P49, DOI 10.1017/S0007485307004737
   Fox CW, 2006, GENETICS, V174, P763, DOI 10.1534/genetics.106.060392
   Fox CW, 2004, J EVOLUTION BIOL, V17, P1007, DOI 10.1111/j.1420-9101.2004.00752.x
   Fox CW, 2005, AM J BOT, V92, P1929, DOI 10.3732/ajb.92.11.1929
   Halligan DL, 2009, ANNU REV ECOL EVOL S, V40, P151, DOI 10.1146/annurev.ecolsys.39.110707.173437
   HOULE D, 1991, EVOLUTION, V45, P630, DOI 10.1111/j.1558-5646.1991.tb04334.x
   IWASA Y, 1991, EVOLUTION, V45, P1431, DOI 10.1111/j.1558-5646.1991.tb02646.x
   Kelly JK, 2003, GENETICS, V164, P1071
   Kelly JK, 2001, EVOLUTION, V55, P937, DOI 10.1554/0014-3820(2001)055[0937:DMAGVF]2.0.CO;2
   Lynch M, 1998, EVOLUTION, V52, P727, DOI 10.1111/j.1558-5646.1998.tb03697.x
   Lynch M, 1998, GENETICS ANAL QUANTI
   MESSINA FJ, 1993, HEREDITY, V71, P623, DOI 10.1038/hdy.1993.187
   Paukku S, 2005, J INSECT PHYSIOL, V51, P1220, DOI 10.1016/j.jinsphys.2005.06.012
   Radwan J, 2008, GENETICA, V134, P113, DOI 10.1007/s10709-007-9203-0
   Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207
   Savalli UM, 1999, ETHOL ECOL EVOL, V11, P49, DOI 10.1080/08927014.1999.9522841
   SCHULTZ ST, 1995, GENETICS, V141, P1209
   Siller S, 2001, NATURE, V411, P689, DOI 10.1038/35079578
   Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029
NR 27
TC 17
Z9 17
U1 2
U2 37
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD MAY 14
PY 2010
VL 328
IS 5980
BP 892
EP 894
DI 10.1126/science.1188013
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 595NT
UT WOS:000277618800049
PM 20466931
DA 2018-12-27
ER

PT J
AU Beygi, JM
   Nourinia, J
   Ghobadi, C
AF Beygi, J. Mohammad
   Nourinia, J.
   Ghobadi, Ch.
TI RETRACTED: Compact ultra-wideband antenna with dual band-stop
   characteristic (Retracted article. See vol. 8, pg. 1855, 2011)
SO IEICE ELECTRONICS EXPRESS
LA English
DT Article; Retracted Publication
DE monopole; slot; band-notch; ultra-wideband (UWB)
AB A simple and compact ultra-wideband microstrip-fed planar antenna with a novel technique for rejecting the WLAN and WiMax bands from the UWB frequency band is presented. By using two 4-shaped slots on the ground plane, not only the bandwidth needed for UWB systems is achieved, but also the impedance matching improves. Two notched frequency bands are achieved by embedding four rectangular slots in the radiation patch. Experimental results show that the designed antenna, with a compact size of 15 x 20 mm(2), has a very impedance bandwidth from 2.9 to 11.5 GHz for voltage standing wave ratio (VSWR) less than 2, except two frequency stop-bands of 3.4-4.2 GHz and 5.1-5.9 GHz.
C1 [Beygi, J. Mohammad; Nourinia, J.; Ghobadi, Ch.] Urmia Univ, Dept Elect Engn, Orumiyeh 57153, Iran.
RP Beygi, JM (reprint author), Urmia Univ, Dept Elect Engn, Orumiyeh 57153, Iran.
EM st_j.mohammadbeygi@mail.urmia.ac.ir
RI Ghobadi, Changiz/F-1853-2014
OI nourinia, javad/0000-0002-0436-3883
FU Iran Telecommunication Research Center (ITRC)
FX The authors would like to acknowledge Iran Telecommunication Research
   Center (ITRC), for the financial support of the work.
CR KERKHOFF A, 2004, IEEE ANT PROP SOC IN, V2, P1768
   KIM KH, 2005, ELECTRON LETT, V41, P456
   Lee WS, 2006, IEEE T MICROW THEORY, V54, P2800, DOI 10.1109/TMTT.2006.874895
   Movahedinia R, 2010, Microwave and Optical Technology Letters, V52, P229, DOI 10.1002/mop.24853
   Zhang Y, 2008, IEEE T ANTENN PROPAG, V56, P3063, DOI 10.1109/TAP.2008.928815
NR 5
TC 3
Z9 3
U1 1
U2 15
PU IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG
PI TOKYO
PA KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011,
   JAPAN
SN 1349-2543
J9 IEICE ELECTRON EXPR
JI IEICE Electron. Express
PD MAY 10
PY 2010
VL 7
IS 9
BP 596
EP 600
DI 10.1587/elex.7.596
PG 5
WC Engineering, Electrical & Electronic
SC Engineering
GA 605VP
UT WOS:000278375700006
OA Bronze
DA 2018-12-27
ER

PT J
AU Rottlaender, D
   Boengler, K
   Wolny, M
   Michels, G
   Endres-Becker, J
   Motloch, LJ
   Schwaiger, A
   Buechert, A
   Schulz, R
   Heusch, G
   Hoppe, UC
AF Rottlaender, Dennis
   Boengler, Kerstin
   Wolny, Martin
   Michels, Guido
   Endres-Becker, Jeannette
   Motloch, Lukas J.
   Schwaiger, Astrid
   Buechert, Astrid
   Schulz, Rainer
   Heusch, Gerd
   Hoppe, Uta C.
TI RETRACTED: Connexin 43 acts as a cytoprotective mediator of signal
   transduction by stimulating mitochondrial K-ATP channels in mouse
   cardiomyocytes (Retracted article. See vol. 122, pg. 4748, 2012)
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article; Retracted Publication
ID PROTEIN-KINASE-C; PKC-EPSILON; INNER MEMBRANE; INDUCED CARDIOPROTECTION;
   I-F; GAP; HEART; MICE; MITOK(ATP); DIAZOXIDE
AB Potassium (K+) channels in the inner mitochondrial membrane influence cell function and survival. Increasing evidence indicates that multiple signaling pathways and pharmacological actions converge on mitochondrial ATP-sensitive K+ (mitoK(ATP)) channels and PKC to confer cytoprotection against necrotic and apoptotic cell injury. However, the molecular structure of mitoK(ATP) channels remains unresolved, and the mitochonclrial phosphoprotein(s) that mediate cytoprotection by PKC remain to be determined. As mice deficient in the main sarcolemmal gap junction protein connexin 43 (Cx43) lack this cytoprotecdon, we set out to investigate a possible link among mitochondrial Cx43, mitoK(ATP) channel function, and PKC activation. By patch-clamping the inner membrane of subsarcolemmal murine cardiac mitochondria, we found that genetic Cx43 deficiency, pharmacological connexin inhibition by carbenoxolone, and Cx43 blockade by the mimetic peptide (43)GAP27 each substantially reduced diazoxide-mediated stimulation of mitoK(ATP) channels. Suppression of mitochondrial Cx43 inhibited mitoK(ATP) channel activation by PKC. MitoK(ATP) channels of interfibrillar mitochondria, which do not contain any detectable Cx43, were insensitive to both PKC activation and diazoxide, further demonstrating the role of Cx43 in mitoK(ATP) channel stimulation and the compartmentation of mitochondria in cell signaling. Our results define a role for mitochondrial Cx43 in protecting cardiac cells from death and provide a link between cytoprotective stimuli and mitoK(ATP) channel opening, making Cx43 an attractive therapeutic target for protection against cell injury.
C1 [Rottlaender, Dennis; Wolny, Martin; Michels, Guido; Endres-Becker, Jeannette; Motloch, Lukas J.; Schwaiger, Astrid; Hoppe, Uta C.] Univ Cologne, Dept Internal Med 3, D-50937 Cologne, Germany.
   [Boengler, Kerstin; Buechert, Astrid; Schulz, Rainer; Heusch, Gerd] Univ Essen Gesamthsch, Inst Pathophysiol, Essen, Germany.
   [Hoppe, Uta C.] Univ Cologne CMMC, Ctr Mol Med, Cologne, Germany.
RP Hoppe, UC (reprint author), Univ Cologne, Dept Internal Med 3, Kerpener Str 62, D-50937 Cologne, Germany.
EM uta.hoppe@uni-koeln.de
OI Schulz, Rainer/0000-0003-3017-0476
FU Deutsche Forschungsgemeinschaft [Ho 2146/3-3, Schu 843/7-1, Schu
   843/7-2]; Koln Fortune; Marga and Walter Boll-Stiftung
FX We thank Nadine Henn and Iris Berg for technical assistance. This work
   was supported by grants from the Deutsche Forschungsgemeinschaft (Ho
   2146/3-3, Schu 843/7-1, 7-2), Koln Fortune, and the Marga and Walter
   Boll-Stiftung (to U.C. Hoppe).
CR Ardehali H, 2006, CIRC RES, V99, P798, DOI 10.1161/01.RES.0000247029.31997.a4
   Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D
   Boengler K, 2005, CARDIOVASC RES, V67, P234, DOI 10.1016/j.cardiores.2005.04.014
   Boengler K, 2009, BASIC RES CARDIOL, V104, P141, DOI 10.1007/s00395-009-0007-5
   Chaytor AT, 1997, J PHYSIOL-LONDON, V503, P99, DOI 10.1111/j.1469-7793.1997.099bi.x
   Cortassa S, 2004, BIOPHYS J, V87, P2060, DOI 10.1529/biophysj.104.041749
   Costa ADT, 2008, AM J PHYSIOL-HEART C, V295, pH874, DOI 10.1152/ajpheart.01189.2007
   Doble BW, 2000, CIRC RES, V86, P293, DOI 10.1161/01.RES.86.3.293
   Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798
   Drose S, 2009, BBA-GEN SUBJECTS, V1790, P558, DOI 10.1016/j.bbagen.2009.01.011
   Eckardt D, 2004, J MOL CELL CARDIOL, V36, P101, DOI 10.1016/j.yjmcc.2003.10.006
   Er F, 2004, CIRCULATION, V110, P3100, DOI 10.1161/01.CIR.0000146900.84943.E0
   Forbes RA, 2001, CIRC RES, V88, P802, DOI 10.1161/hh0801.089342
   Foster DB, 2008, BIOCHEM BIOPH RES CO, V366, P649, DOI 10.1016/j.bbrc.2007.11.154
   Gassanov N, 2006, CELL CALCIUM, V39, P175, DOI 10.1016/j.ceca.2005.10.008
   Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072
   GOTO M, 1995, CIRC RES, V77, P611, DOI 10.1161/01.RES.77.3.611
   Guo YR, 1998, AM J PHYSIOL-HEART C, V275, pH1375, DOI 10.1152/ajpheart.1998.275.4.H1375
   Heinzel FR, 2005, CIRC RES, V97, P583, DOI 10.1161/01.RES.0000181171.65293.65
   Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242
   Inagaki K, 2005, CIRCULATION, V111, P44, DOI 10.1161/01.CIR.0000151614.22282.F1
   INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0
   Jaburek M, 2006, CIRC RES, V99, P878, DOI 10.1161/01.RES.0000245106.80628.d3
   Jiang JX, 2005, BBA-BIOMEMBRANES, V1711, P208, DOI 10.1016/j.bbamem.2004.10.001
   Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246
   Lange PS, 2003, CARDIOVASC RES, V59, P321, DOI 10.1016/S0008-6363(03)00434-6
   Li X, 2004, J MOL CELL CARDIOL, V36, P161, DOI 10.1016/j.yjmcc.2003.10.019
   Michels G, 2005, CIRCULATION, V111, P399, DOI 10.1161/01.CIR.0000153799.65783.3A
   Michels G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001511
   Michels G, 2009, CIRCULATION, V119, P2435, DOI 10.1161/CIRCULATIONAHA.108.835389
   MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516
   Murphy E, 2004, CIRC RES, V94, P7, DOI 10.1161/01.RES.0000108082.76667.F4
   O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804
   PALMER JW, 1977, J BIOL CHEM, V252, P8731
   Pong K, 2004, EXPERT OPIN THER TAR, V8, P125, DOI 10.1517/eott.8.2.125.30244
   REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609
   Riva A, 2005, AM J PHYSIOL-HEART C, V289, pH868, DOI 10.1152/ajpheart.00866.2004
   Rottlaender D, 2007, J PHARMACOL EXP THER, V321, P608, DOI 10.1124/jpet.106.118422
   Saez JC, 2005, BBA-BIOMEMBRANES, V1711, P215, DOI 10.1016/j.bbamem.2005.01.014
   Schwanke U, 2002, AM J PHYSIOL-HEART C, V283, pH1740, DOI 10.1152/ajpheart.00442.2002
   Siemen D, 1999, BIOCHEM BIOPH RES CO, V257, P549, DOI 10.1006/bbrc.1999.0496
   SUGIURA H, 1990, CIRC RES, V66, P1095, DOI 10.1161/01.RES.66.4.1095
   Weiss JN, 2001, CIRC RES, V89, P108, DOI 10.1161/res.89.2.108
   Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360
   Ye ZC, 2003, J NEUROSCI, V23, P3588
   Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391
NR 46
TC 70
Z9 77
U1 2
U2 23
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD MAY
PY 2010
VL 120
IS 5
BP 1441
EP 1453
DI 10.1172/JCI40927
PG 13
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 590SN
UT WOS:000277248000013
PM 20364086
OA Green Published
DA 2018-12-27
ER

PT J
AU Hunton, JE
   Gold, A
AF Hunton, James E.
   Gold, Anna
TI RETRACTED: A Field Experiment Comparing the Outcomes of Three Fraud
   Brainstorming Procedures: Nominal Group, Round Robin, and Open
   Discussion (Retracted article. See vol. 88, pg. 357, 2013)
SO ACCOUNTING REVIEW
LA English
DT Article; Retracted Publication
DE SAS 99; fraud; brainstorming; nominal group; round robin; open
   discussion; auditing; field experiment
ID SAS NO. 82; PRODUCTIVITY LOSS; IDEA GENERATION; DECISION-MAKING;
   RISK-ASSESSMENT; PERFORMANCE; TASK; INTEGRATION
AB The current study examines the outcomes of three fraud brainstorming procedures-nominal group, round robin, and open discussion-via a randomized between-participant field experiment involving 150 audit clients and 2,614 auditors who participated in natural, hierarchical audit teams. The results indicate that nominal group and round robin brainstorming resulted in equivalent numbers of unique fraud risks and comparable increases in planned audit hours, while open discussion brainstorming yielded the least number of unique ideas and the smallest increase in planned audit hours. Furthermore, nominal group and round robin brainstorming yielded more changes/additions to the nature and timing of substantive testing than open discussion brainstorming. Study findings offer theoretical and practical insight into fraud brainstorming.
C1 [Hunton, James E.] Bentley Univ, Waltham, MA USA.
   [Hunton, James E.; Gold, Anna] Erasmus Univ, NL-3000 DR Rotterdam, Netherlands.
RP Hunton, JE (reprint author), Bentley Univ, Waltham, MA USA.
CR Albrecht C. C., 2001, J FORENSIC ACCOUNTIN, V2, P1
   American Institute of Certified Public Accountants (AICPA), 2002, STAT AUD STAND AICPA
   American Institute of Certified Public Accountants (AICPA), 1997, STAT AUD STAND AICPA
   Asare SK, 2004, CONTEMP ACCOUNT RES, V21, P325, DOI 10.1506/L20L-7FUM-FPCB-7BE2
   Augustinova M, 2005, J PERS SOC PSYCHOL, V88, P619, DOI 10.1037/0022-3514.88.4.619
   Bartunek JM, 1984, GROUP ORGAN STUD, V9, P417, DOI DOI 10.1177/105960118400900307
   BEASLEY MS, 2003, J ACCOUNTANCY    DEC, P6
   Bellovary JL, 2007, CURR ISS AUDIT, V1, pA1, DOI 10.2308/ciia.2007.1.1.A1
   Bonner S. E., 2008, JUDGMENT DECISION MA
   Brazel JF, 2004, ACCOUNT REV, V79, P949, DOI 10.2308/accr.2004.79.4.949
   Brown VR, 2002, CURR DIR PSYCHOL SCI, V11, P208, DOI 10.1111/1467-8721.00202
   Carpenter TA, 2007, ACCOUNT REV, V82, P1119, DOI 10.2308/accr.2007.82.5.1119
   Delbecq AL, 1975, GROUP TECHNIQUES PRO
   Dennis AR, 1999, MIS QUART, V23, P95, DOI 10.2307/249411
   DENNIS AR, 1993, J APPL PSYCHOL, V78, P531, DOI 10.1037/0021-9010.78.4.531
   DENNIS AR, 1994, J MANAGE, V20, P723, DOI 10.1016/0149-2063(94)90027-2
   DIEHL M, 1991, J PERS SOC PSYCHOL, V61, P392, DOI 10.1037/0022-3514.61.3.392
   DIEHL M, 1987, J PERS SOC PSYCHOL, V53, P497, DOI 10.1037/0022-3514.53.3.497
   FOX WM, 1989, J MANAGEMENT DEV, V8, P20
   Glover SM, 2003, AUDITING-J PRACT TH, V22, P237, DOI 10.2308/aud.2003.22.2.237
   HEGEDUS DM, 1986, J MANAGE, V12, P545, DOI 10.1177/014920638601200409
   Hoffman VB, 2009, ACCOUNT REV, V84, P811, DOI 10.2308/accr.2009.84.3.811
   KARAU SJ, 1993, J PERS SOC PSYCHOL, V65, P681, DOI 10.1037//0022-3514.65.4.681
   LAMM H, 1973, EUR J SOC PSYCHOL, V3, P361, DOI 10.1002/ejsp.2420030402
   Lynch AL, 2009, ACCOUNT REV, V84, P1209, DOI 10.2308/accr.2009.84.4.1209
   MAHLER JG, 1987, PUBLIC ADMIN REV, V47, P336, DOI 10.2307/975314
   MULLEN B, 1991, BASIC APPL SOC PSYCH, V12, P3, DOI 10.1207/s15324834basp1201_1
   Nijstad BA, 2006, PERS SOC PSYCHOL REV, V10, P186, DOI 10.1207/s15327957pspr1003_1
   Osborn A. F., 1957, APPL IMAGINATION
   PAULUS PB, 1995, BASIC APPL SOC PSYCH, V17, P249, DOI 10.1207/s15324834basp1701&2_15
   PAULUS PB, 2000, GROUPS WORK ADV THEO
   RAMOS M, 2003, J ACCOUNTANCY    JAN, P10
   Rietzschel EF, 2006, J EXP SOC PSYCHOL, V42, P244, DOI 10.1016/j.jesp.2005.04.005
   SHEPPERD JA, 1993, PSYCHOL BULL, V113, P67, DOI 10.1037/0033-2909.113.1.67
   VANDEVEN A, 1971, ACAD MANAGE J, V14, P203, DOI 10.2307/255307
   VanGundy A. B., 1984, J CONSUMER MARKETING, V1, P67, DOI DOI 10.1108/EB008097
   WITTENBAUM GM, 1995, J EXP SOC PSYCHOL, V31, P82, DOI 10.1006/jesp.1995.1005
   Wittenbaum GM, 1996, J EXP SOC PSYCHOL, V32, P129, DOI 10.1006/jesp.1996.0006
   Zimbelman MF, 1997, J ACCOUNTING RES, V35, P75, DOI 10.2307/2491454
NR 39
TC 16
Z9 16
U1 3
U2 26
PU AMER ACCOUNTING ASSOC
PI SARASOTA
PA 5717 BESSIE DR, SARASOTA, FL 34233 USA
SN 0001-4826
EI 1558-7967
J9 ACCOUNT REV
JI Account. Rev.
PD MAY
PY 2010
VL 85
IS 3
BP 911
EP 935
DI 10.2308/accr.2010.85.3.911
PG 25
WC Business, Finance
SC Business & Economics
GA 594XO
UT WOS:000277574700006
DA 2018-12-27
ER

PT J
AU Shiyovich, A
   Jafari, J
   Blaer, Y
   Rehby, H
   Orlov, I
   Cohen, D
   Katz, A
AF Shiyovich, Arthur
   Jafari, Jamal
   Blaer, Yosi
   Rehby, Harvey
   Orlov, Ian
   Cohen, Dganit
   Katz, Amos
TI RETRACTED: Respiratory Stress Response: A Novel Diagnostic Method for
   Detection of Significant Coronary Artery Disease From Finger Pulse Wave
   Analysis During Brief Respiratory Exercise (Retracted Article. See vol
   341, pg 169, 2011)
SO AMERICAN JOURNAL OF THE MEDICAL SCIENCES
LA English
DT Article; Retracted Publication
DE Respiratory stress response; Significant coronary artery disease;
   Detection
ID LEFT-VENTRICULAR FUNCTION; HEART-RATE-VARIABILITY;
   MYOCARDIAL-INFARCTION; PRESSURE; VOLUME; ANGIOGRAPHY; STIFFNESS;
   SEVERITY; SOCIETY; STROKE
AB Introduction: Respiratory maneuvers can uncover manifestations of myocardial ischemia. Some pulse wave characteristics are associated with significant coronary artery disease (S-CAD). An innovative test using the respiratory stress response (RSR) has been developed for the detection of S-CAD based on spectral analysis of finger pulse wave oscillations measured using photoplethysmography (PPG) during deep, paced breathing at a rate of 6 breaths per minute (0.1 Hz) for 70 seconds. We evaluated this test (RSR) as an indicator of S-CAD. Methods: The study consisted of 2 stages-feasibility and validation assessing RSR in patients referred for coronary angiography. RSR was calculated by proprietary software analysis of the relative spectral power of the respiratory peak area at 0.1 Hz. The coronary angiograms were analyzed visually (stage I) and by quantitative coronary angiography (stage II) by 1 cardiologist blinded to the RSR results. S-CAD was defined as luminal stenosis >70% of at least 1 coronary artery or LM stenosis >50%. Results: A total of 193 consecutive patients (stage I: 98 and stage II: 95) with a mean age of 63.2 +/- 11.9 years, 70% men, 112 (58%) with S-CAD, were included. S-CAD patients had significantly lower RSR compared with patients without S-CAD, P < 0.001. RSR yielded a sensitivity of 83% (95% confidence interval = 75-90) and specificity of 70% (95% confidence interval = 59-80) for indicating S-CAD. Multivariate logistic regression analysis, adjusted for risk factors, showed that RSR is a strong independent indicator of S-CAD [OR = 18.9 (7.2-49.5), P < 0.001]. Conclusion: Reduced RSR is an accurate noninvasive indicator of S-CAD.
C1 [Shiyovich, Arthur; Jafari, Jamal; Blaer, Yosi; Rehby, Harvey; Orlov, Ian; Cohen, Dganit; Katz, Amos] Barzilai Govt Hosp, Dept Cardiol, IL-78278 Ashqelon, Israel.
RP Shiyovich, A (reprint author), Barzilai Govt Hosp, Dept Cardiol, 2 Hahistadrut St, IL-78278 Ashqelon, Israel.
EM arthur.shiyovich@gmail.com
FU SPIROCOR, Tel-Aviv, Israel
FX This research was supported in part by SPIROCOR, Tel-Aviv, Israel.
CR AIRAKSINEN KEJ, 1987, BRIT HEART J, V58, P592
   Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01
   Avolio A, 2002, J HYPERTENS, V20, P2341, DOI 10.1097/00004872-200212000-00007
   BAIM D, 1996, CARDIAC CATHETERIZAT
   Brosh D, 2010, EUROINTERVENTION, V5, P847, DOI 10.4244/EIJV5I7A142
   Cooke WH, 1998, AM J PHYSIOL-HEART C, V274, pH709, DOI 10.1152/ajpheart.1998.274.2.H709
   Davies LC, 2000, EXP PHYSIOL, V85, P857, DOI 10.1111/j.1469-445X.2000.02032.x
   Fessler HE, 1997, EUR RESPIR J, V10, P226, DOI 10.1183/09031936.97.10010226
   Fukuta H, 2009, CIRC J, V73, P1740, DOI 10.1253/circj.CJ-09-0185
   Gershlick AH, 2007, HEART, V93, P423, DOI 10.1136/hrt.2006.108779
   GOLDBERG RK, 1990, AM HEART J, V119, P178, DOI 10.1016/S0002-8703(05)80098-5
   HAYANO J, 1990, CIRCULATION, V81, P1217, DOI 10.1161/01.CIR.81.4.1217
   Karlocai K, 1998, J AUTONOM NERV SYST, V73, P86, DOI 10.1016/S0165-1838(98)00116-7
   Katz A, 1999, AM HEART J, V138, P32, DOI 10.1016/S0002-8703(99)70242-5
   Kullo IJ, 2006, HYPERTENSION, V47, P174, DOI 10.1161/01.HYP.0000199605.35173.14
   Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235
   Maughan WL, 1989, HEART LUNG INTERACTI, V42, P198
   MCINTYRE K, 1989, HEART LUNG INTERACTI, V42, P1021
   Miller TD, 2002, CIRCULATION, V106, P189
   Murray WB, 1996, J CLIN MONITOR, V12, P365, DOI 10.1007/BF02077634
   Okrainec K, 2004, AM HEART J, V148, P7, DOI 10.1016/j.ahj.2003.11.027
   Pitzalis MV, 1998, CARDIOVASC RES, V38, P332, DOI 10.1016/S0008-6363(98)00029-7
   Rozanski A, 2001, CIRCULATION, V103, P2084
   SANTAMORE WP, 1984, J APPL PHYSIOL, V57, P1520
   Scanlon PJ, 1999, CIRCULATION, V99, P2345, DOI 10.1161/01.CIR.99.17.2345
   SCHARF SM, 1979, J APPL PHYSIOL, V47, P582
   SCHARF SM, 1981, CIRCULATION, V63, P871, DOI 10.1161/01.CIR.63.4.871
   SCHARF SM, 1973, AM J PHYSIOL, V224, P918
   SCHARF SM, 1987, AM J CARDIOL, V59, P1305, DOI 10.1016/0002-9149(87)90909-X
   SCHARF SM, 2001, RESP CIRCULATORY INT, V157, P1
   Shannon CE, 1998, P IEEE, V86, P447, DOI 10.1109/JPROC.1998.659497
   Waksman R, 2010, CARDIOVASC REVASCULA, V11, P20, DOI 10.1016/j.carrev.2009.09.005
   Wennerblom B, 2000, HEART, V83, P290, DOI 10.1136/heart.83.3.290
   Yasuma F, 2004, CHEST, V125, P683, DOI 10.1378/chest.125.2.683
NR 34
TC 2
Z9 2
U1 2
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9629
EI 1538-2990
J9 AM J MED SCI
JI Am. J. Med. Sci.
PD MAY
PY 2010
VL 339
IS 5
BP 440
EP 447
DI 10.1097/MAJ.0b013e3181d6566a
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA 595KZ
UT WOS:000277610700007
PM 20234302
DA 2018-12-27
ER

PT J
AU Neligan, PJ
   Malhotra, G
   Fraser, M
   Williams, N
   Greenblatt, EP
   Cereda, M
   Ochroch, EA
AF Neligan, Patrick J.
   Malhotra, Guarav
   Fraser, Michael
   Williams, Noel
   Greenblatt, Eric P.
   Cereda, Maurizio
   Ochroch, E. Andrew
TI RETRACTED: Noninvasive Ventilation Immediately After Extubation Improves
   Lung Function in Morbidly Obese Patients with Obstructive Sleep Apnea
   Undergoing Laparoscopic Bariatric Surgery (Retracted Article. See vol
   111, pg 576, 2010)
SO ANESTHESIA AND ANALGESIA
LA English
DT Article; Retracted Publication
ID POSITIVE AIRWAY PRESSURE; END-EXPIRATORY PRESSURE; RANDOMIZED
   CONTROLLED-TRIAL; GENERAL-ANESTHESIA; ATELECTASIS FORMATION;
   POSTOPERATIVE HYPOXEMIA; GAS-EXCHANGE; ARTERIAL OXYGENATION; NONHYPOXIC
   APNEA; BODY-MASS
AB BACKGROUND: Noninvasive positive pressure ventilation (NIPPV) may improve postoperative lung function and reduce postoperative complications in patients undergoing abdominal surgery. The purpose of our study was to determine whether the timing of postoperative NIPPV affects lung function 1 day postoperatively.
   METHODS: Forty morbidly obese patients with known obstructive sleep apnea undergoing laparoscopic bariatric surgery with standardized anesthesia care were randomly assigned to receive NIPPV immediately after tracheal extubation (immediate group) or supplemental oxygen (standard group). All patients had continuous positive airway pressure initiated 30 minutes after extubation in the postanesthesia care unit (PACU) via identical noninvasive ventilators. Spirometry was performed by a blinded observer in the perioperative holding area 1 hour after admission to the PACU and 1 day postoperatively. The primary outcome was the change in forced vital capacity (FVC) from baseline to 24 hours (FVC baseline-FVC 24 hours).
   RESULTS: Forty patients, 20 in each group, were enrolled in the study. Forced expiratory volume in 1 second, FVC, and peak expiratory flow rate were significantly reduced in both groups from perioperative values throughout the study. At 24 hours, the intervention group had lost only 0.7 L FVC, versus 1.3 L for the intervention group (P = 0.0005). An analysis of covariance confirmed this and indicated that the immediate postoperative NIPPV better preserved spirometric function at 1 and 24 hours postoperatively. Specifically, the differences in the primary outcome were statistically significant.
   CONCLUSIONS: NIPPV given immediately after extubation significantly improves spirometric lung function at 1 hour and 1 day postoperatively, compared with continuous positive airway pressure started in the PACU, in morbidly obese patients with obstructive sleep apnea undergoing laparoscopic bariatric surgery. (Anesth Ana Ig 2010;110:1360-5)
C1 [Neligan, Patrick J.] Univ Coll Hosp Galway, Dept Anaesthesia & Intens Care, Galway, Ireland.
   [Neligan, Patrick J.; Greenblatt, Eric P.; Cereda, Maurizio; Ochroch, E. Andrew] Hosp Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.
   [Malhotra, Guarav] Univ Penn, Sch Med, Philadelphia, PA 19104 USA.
   [Fraser, Michael] Hosp Univ Penn, Dept Resp Care, Philadelphia, PA 19104 USA.
   [Williams, Noel] Hosp Univ Penn, Dept Surg, Philadelphia, PA 19104 USA.
RP Neligan, PJ (reprint author), Univ Coll Hosp Galway, Dept Anaesthesia & Intens Care, Newcastle Rd, Galway, Ireland.
EM patrick.neligan@hse.ie
CR Ahmad S, 2008, ANESTH ANALG, V107, P138, DOI 10.1213/ane.0b013e318174df8b
   BERTHOUD MC, 1991, BRIT J ANAESTH, V67, P464, DOI 10.1093/bja/67.4.464
   Brodsky JB, 2003, ANESTH ANALG, V96, P1841, DOI 10.1213/01.ANE.0000063165.15467.1B
   Chung SA, 2008, ANESTH ANALG, V107, P1543, DOI 10.1213/ane.0b013e318187c83a
   Coussa M, 2004, ANESTH ANALG, V98, P1491, DOI 10.1213/01.ANE.0000111743.61132.99
   Dixon BJ, 2005, ANESTHESIOLOGY, V102, P1110, DOI 10.1097/00000542-200506000-00009
   Ebeo C, 2002, RESP MED, V96, P672, DOI 10.1053/rmed.2002.1357
   Edmark L, 2003, ANESTHESIOLOGY, V98, P28, DOI 10.1097/00000542-200301000-00008
   Eichenberger AS, 2002, ANESTH ANALG, V95, P1788, DOI 10.1213/01.ANE.0000065081.21607.4C
   Gander S, 2005, ANESTH ANALG, V100, P580, DOI 10.1213/01.ANE.0000143339.40385.1B
   Gudmundsson G, 1997, AM J RESP CRIT CARE, V156, P998, DOI 10.1164/ajrccm.156.3.9609089
   GUNNARSSON L, 1991, BRIT J ANAESTH, V66, P423, DOI 10.1093/bja/66.4.423
   Hakala K, 2000, CHEST, V118, P1315, DOI 10.1378/chest.118.5.1315
   Hedenstierna G, 2005, INTENS CARE MED, V31, P1327, DOI 10.1007/s00134-005-2761-7
   Hedenstierna G, 2003, CLIN PHYSIOL FUNCT I, V23, P123, DOI 10.1046/j.1475-097X.2003.00483.x
   Herriger A, 2004, ANAESTHESIA, V59, P243, DOI 10.1111/j.1365-2044.2004.03615.x
   Hillman DR, 2004, SLEEP MED REV, V8, P459, DOI 10.1016/j.smrv.2004.07.002
   Jensen C, 2008, SURG OBES RELAT DIS, V4, P512, DOI 10.1016/j.soard.2008.05.003
   Jones RL, 2006, CHEST, V130, P827, DOI 10.1378/chest.130.3.827
   Joris JL, 1997, CHEST, V111, P665, DOI 10.1378/chest.111.3.665
   Keenan SP, 2002, JAMA-J AM MED ASSOC, V287, P3238, DOI 10.1001/jama.287.24.3238
   Kindgen-Milles D, 2005, CHEST, V128, P821, DOI 10.1378/chest.128.2.821
   LUNDQUIST H, 1995, ACTA RADIOL, V36, P626, DOI 10.3109/02841859509176761
   Magnusson L, 2003, BRIT J ANAESTH, V91, P61, DOI 10.1093/bja/aeg085
   Omalu BI, 2007, ARCH SURG-CHICAGO, V142, P923, DOI 10.1001/archsurg.142.10.923
   Pelosi P, 1998, ANESTH ANALG, V87, P654, DOI 10.1097/00000539-199809000-00031
   Pelosi P, 1999, ANESTHESIOLOGY, V91, P1221, DOI 10.1097/00000542-199911000-00011
   Perilli V, 2003, OBES SURG, V13, P605, DOI 10.1381/096089203322190826
   Reber A, 1996, BRIT J ANAESTH, V76, P760
   Reber A, 1998, ANAESTHESIA, V53, P1054, DOI 10.1046/j.1365-2044.1998.00569.x
   ROTHEN HU, 1993, BRIT J ANAESTH, V71, P788, DOI 10.1093/bja/71.6.788
   Rusca M, 2003, ANESTH ANALG, V97, P1835, DOI 10.1213/01.ANE.0000087042.02266F6
   Squadrone V, 2005, JAMA-J AM MED ASSOC, V293, P589, DOI 10.1001/jama.293.5.589
   STRANDBERG A, 1987, ACTA ANAESTH SCAND, V31, P21, DOI 10.1111/j.1399-6576.1987.tb02513.x
   von Ungern-Sternberg BS, 2005, ACTA ANAESTH SCAND, V49, P940, DOI 10.1111/j.1399-6576.2005.00754.x
   von Ungern-Sternberg BS, 2004, BRIT J ANAESTH, V92, P202, DOI 10.1093/bja/aeh046
   Whalen FX, 2006, ANESTH ANALG, V102, P298, DOI 10.1213/01.ane.0000183655.57275.7a
   Xue FS, 1999, ANESTH ANALG, V88, P213, DOI 10.1097/00000539-199901000-00040
   Yoshino J, 2003, ACTA ANAESTH SCAND, V47, P742, DOI 10.1034/j.1399-6576.2003.00147.x
NR 39
TC 22
Z9 23
U1 1
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0003-2999
J9 ANESTH ANALG
JI Anesth. Analg.
PD MAY
PY 2010
VL 110
IS 5
BP 1360
EP 1365
DI 10.1213/ANE.0b013e3181d5e3ef
PG 6
WC Anesthesiology
SC Anesthesiology
GA 589EZ
UT WOS:000277130700020
PM 20418299
DA 2018-12-27
ER

PT J
AU Ali, S
   Ahmad, A
   Banerjee, S
   Padhye, S
   Dominiak, K
   Schaffert, JM
   Wang, ZW
   Philip, PA
   Sarkar, FH
AF Ali, Shadan
   Ahmad, Aamir
   Banerjee, Sanjeev
   Padhye, Subhash
   Dominiak, Kristin
   Schaffert, Jacqueline M.
   Wang, Zhiwei
   Philip, Philip A.
   Sarkar, Fazlul H.
TI RETRACTED: Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer
   Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or
   Its Analogue CDF (Retracted article. See vol. 78, pg. 5466, 2018)
SO CANCER RESEARCH
LA English
DT Article; Retracted Publication
ID FACTOR-KAPPA-B; TO-MESENCHYMAL TRANSITION; GROWTH-FACTOR RECEPTOR;
   ORTHOTOPIC MODEL; DOWN-REGULATION; APOPTOSIS; ADENOCARCINOMA;
   MICRORNA-21; INHIBITION; LINES
AB Curcumin induces cancer cell growth arrest and apoptosis in vitro, but its poor bioavailability in vivo limits its antitumor efficacy. We have previously evaluated the bioavailability of novel analogues of curcumin compared with curcumin, and we found that the analogue CDF exhibited greater systemic and pancreatic tissue bioavailability. In this study, we evaluated the effects of CDF or curcumin alone or in combination with gemcitabine on cell viability and apoptosis in gemcitabine-sensitive and gemcitabine-resistant pancreatic cancer (PC) cell lines. Mechanistic investigations revealed a significant reduction in cell viability in CDF-treated cells compared with curcumin-treated cells, which were also associated with the induction of apoptosis, and these results were consistent with the downregulation of Akt, cyclooxygenase-2, prostaglandin E-2, vascular endothelial growth factor, and NF-kappa B DNA binding activity. We have also documented attenuated expression of miR-200 and increased expression of miR-21 (a signature of tumor aggressiveness) in gemcitabine-resistant cells relative to gemcitabine-sensitive cells. Interestingly, CDF treatment upregulated miR-200 expression and downregulated the expression of miR-21, and the downregulation of miR-21 resulted in the induction of PTEN. These results prompt further interest in CDF as a drug modality to improve treatment outcome of patients diagnosed with PC as a result of its greater bioavailability in pancreatic tissue. Cancer Res; 70(9); 3606-17. (C) 2010 AACR.
C1 [Sarkar, Fazlul H.] Wayne State Univ, Dept Pathol, Karmanos Canc Inst, Sch Med, Detroit, MI 48201 USA.
   [Ali, Shadan; Philip, Philip A.] Wayne State Univ, Div Hematol Oncol, Detroit, MI 48201 USA.
   [Padhye, Subhash] Dr DY Patil Univ, Pune, Maharashtra, India.
RP Sarkar, FH (reprint author), Wayne State Univ, Dept Pathol, Karmanos Canc Inst, Sch Med, 740 Hudson Webber Canc Res Ctr,4100 John R St, Detroit, MI 48201 USA.
EM fsarkar@med.wayne.edu
RI Ahmad, Aamir/E-8747-2010; Wang, Zhiwei/A-6809-2011
FU National Cancer Institute, NIH [5R01CA131151, 3R01CA131151-02S1,
   5R01CA132794]
FX Grant Support; National Cancer Institute, NIH grants 5R01CA131151,
   3R01CA131151-02S1, and 5R01CA132794 (F. H. Sarkar).
CR Ali S, 2005, MOL CANCER THER, V4, P1943, DOI 10.1158/1535-7163.MCT-05-0065
   Ali S, 2008, MOL CANCER THER, V7, P1708, DOI 10.1158/1535-7163.MCT-08-0354
   Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r
   Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390
   Asano T, 2004, ONCOGENE, V23, P8571, DOI 10.1038/sj.onc.1207902
   BISHT S, 2009, CURR DRUG DISCOV TEC
   Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137
   Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x
   El-Rayes BF, 2006, CANCER RES, V66, P10553, DOI 10.1158/0008-5472.CAN-06-2333
   El-Rayes BF, 2004, MOL CANCER THER, V3, P1421
   Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460
   Fuchs JR, 2009, BIOORG MED CHEM LETT, V19, P2065, DOI 10.1016/j.bmcl.2009.01.104
   Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851
   Hasan S, 2008, PANCREAS, V37, P121, DOI 10.1097/MPA.0b013e31816618ba
   Holcomb B, 2008, J GASTROINTEST SURG, V12, P288, DOI 10.1007/s11605-007-0406-6
   Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022
   Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317
   Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783
   Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006
   Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009
   Kunnumakkara AB, 2007, CANCER RES, V67, P3853, DOI 10.1158/0008-5472.CAN-06-4257
   Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394
   Lev-Ari S, 2005, BIOMED PHARMACOTHER, V59, pS276, DOI 10.1016/S0753-3322(05)80045-9
   Lev-Ari S, 2007, CANCER INVEST, V25, P411, DOI 10.1080/07357900701359577
   Lev-Ari S, 2006, ANTICANCER RES, V26, P4423
   Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36
   Li L, 2004, CANCER-AM CANCER SOC, V101, P2351, DOI 10.1002/cncr.20605
   Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298
   Lin L, 2009, CANCER SCI, V100, P1719, DOI 10.1111/j.1349-7006.2009.01220.x
   Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022
   Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057
   PADHYE S, 2009, PHARM RES
   Padhye S, 2009, PHARM RES-DORDR, V26, P1874, DOI 10.1007/s11095-009-9900-8
   Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1
   Paterson EL, 2008, THESCIENTIFICWORLDJO, V8, P901, DOI 10.1100/tsw.2008.115
   Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001
   Sahu RP, 2009, BRIT J CANCER, V100, P1425, DOI 10.1038/sj.bjc.6605039
   Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425
   Shen XH, 2009, MOL REPROD DEV, V76, P854, DOI 10.1002/mrd.21048
   SHI Q, 2009, AGENTS MED CHEM
   Sun M, 2008, MOL CANCER THER, V7, P464, DOI 10.1158/1535-7163.MCT-07-2272
   Swamy MV, 2008, NUTR CANCER, V60, P81, DOI 10.1080/01635580802416703
   Tetzlaff MT, 2007, ENDOCR PATHOL, V18, P163, DOI 10.1007/s12022-007-0023-7
   Tong Z, 2009, CELL RES, V19, P710, DOI 10.1038/cr.2009.42
   VandenBoom TG, 2008, CURR GENOMICS, V9, P97, DOI 10.2174/138920208784139555
   WAHLSTROM B, 1978, ACTA PHARMACOL TOX, V43, P86
   Zhu Z, 2009, ACTA BIOCH BIOPH SIN, V41, P407, DOI 10.1093/abbs/gmp023
NR 47
TC 283
Z9 293
U1 4
U2 25
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD MAY 1
PY 2010
VL 70
IS 9
BP 3606
EP 3617
DI 10.1158/0008-5472.CAN-09-4598
PG 12
WC Oncology
SC Oncology
GA 607GD
UT WOS:000278486200020
PM 20388782
OA Green Accepted, Bronze
DA 2018-12-27
ER

PT J
AU Dursun, IH
   Guvenc, ZB
   Kasap, E
AF Dursun, Ibrahim H.
   Guvenc, Ziya B.
   Kasap, E.
TI RETRACTED: A simple analytical EAM model for some bcc metals (Retracted
   article. See vol. 16, pg. 4547, 2011)
SO COMMUNICATIONS IN NONLINEAR SCIENCE AND NUMERICAL SIMULATION
LA English
DT Article; Retracted Publication
DE Alloys; Surface; Impurity; Molecular Dynamics Simulation (MDS); Embedded
   Atom Method (EAM); Heat capacity; Under-cooled; Specific heat; bcc
   metals
ID EMBEDDED-ATOM METHOD; THERMODYNAMIC PROPERTIES; PHASE-DIAGRAMS;
   IRON-VANADIUM; ALLOYS; SYSTEM
AB An analytical embedded atom method which can treat bcc transition metal iron has been developed. In this model, a new potential was presented and a modified term has been introduced to fit the negative Cauchy pressure P-C = (C-12 - C-44)/2 for Fe element. The new model was applied to calculate thermodynamic properties of binary alloys of the bcc transition metals: Fe, V and Cr. The calculated dilute-solution enthalpies and formation enthalpies of random alloys are in good agreement with the results of first principles calculations and that of the thermodynamic calculations. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Guvenc, Ziya B.] Cankaya Univ, TR-06500 Balgat Ankara, Turkey.
   [Dursun, Ibrahim H.] Univ Aksaray, Fac Sci & Literature, TR-68100 Aksaray, Turkey.
   [Kasap, E.] Gazi Univ, Fac Sci & Literature, TR-06500 Ankara, Turkey.
RP Guvenc, ZB (reprint author), Cankaya Univ, TR-06500 Balgat Ankara, Turkey.
EM hidursun@aksaray.edu.tr; guvenc@cankaya.edu.tr; ergun@gazi.edu.tr
CR ADAMS JB, 1990, PHYS REV B, V41, P3316, DOI 10.1103/PhysRevB.41.3316
   BANGWEI Z, 1996, J PHYS B ATOM MOL PH, V101, P161
   BASKES MI, 1989, PHYS REV B, V40, P6085, DOI 10.1103/PhysRevB.40.6085
   CAMPBELL JL, 1979, APPL PHYS, V19, P149, DOI 10.1007/BF00932389
   CLEMENTI E, 1974, ATOM DATA NUCL DATA, V14, P3
   COLINET C, 1988, J PHYS F MET PHYS, V18, P903, DOI 10.1088/0305-4608/18/5/010
   DAW MS, 1984, PHYS REV B, V29, P6443, DOI 10.1103/PhysRevB.29.6443
   FREDERIKSE HPR, 1972, AM I PHYS HDB
   HEARMON RFS, 1983, LONDOLTBORNSTEIN
   JOHNSON RA, 1989, J MATER RES, V4, P1195, DOI 10.1557/JMR.1989.1195
   JOHNSON RA, 1989, PHYS REV B, V39, P12554, DOI 10.1103/PhysRevB.39.12554
   Kittle Ch, 1976, INTRO SOLID STATE PH
   KUBASCHEWSKI O, 1977, Z PHYS CHEM NEUE FOL, V104, P23, DOI 10.1524/zpch.1977.104.1-3.023
   MAIER K, 1991, PHILOS MAG A, V40, P701
   MIEDEMA AR, 1980, PHYSICA B & C, V100, P1, DOI 10.1016/0378-4363(80)90054-6
   PASIANOT R, 1991, PHYS REV B, V43, P6952, DOI 10.1103/PhysRevB.43.6952
   QUYANG Y, 1996, Z PHYS B, V101, P161
   SIGLI C, 1986, PHYS REV LETT, V57, P253, DOI 10.1103/PhysRevLett.57.253
   SINGHAL SC, 1973, METALL TRANS, V4, P895, DOI 10.1007/BF02645586
   SINGHAL SC, 1973, METALL TRANS, V4, P1125, DOI 10.1007/BF02645616
   SPENCER PJ, 1973, J IRON STEEL I, V211, P293
   ZHANG BW, 1993, PHYS REV B, V48, P3022, DOI 10.1103/PhysRevB.48.3022
NR 22
TC 7
Z9 7
U1 3
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1007-5704
EI 1878-7274
J9 COMMUN NONLINEAR SCI
JI Commun. Nonlinear Sci. Numer. Simul.
PD MAY
PY 2010
VL 15
IS 5
BP 1259
EP 1266
DI 10.1016/j.cnsns.2009.05.034
PG 8
WC Mathematics, Applied; Mathematics, Interdisciplinary Applications;
   Mechanics; Physics, Fluids & Plasmas; Physics, Mathematical
SC Mathematics; Mechanics; Physics
GA 535AV
UT WOS:000272939800017
DA 2018-12-27
ER

PT J
AU Sammelson, RE
   Heidari, A
   Tayyari, SF
AF Sammelson, Robert Erik
   Heidari, Alireza
   Tayyari, Sayyed Faramarz
TI RETRACTED: An analytical approach to the Klein-Gordon and the Dirac
   relativistic oscillators in a non-commutative space under a constant
   magnetic field (Retracted article. See vol. 16, pg. 1106, 2011)
SO COMMUNICATIONS IN NONLINEAR SCIENCE AND NUMERICAL SIMULATION
LA English
DT Article; Retracted Publication
DE Klein-Gordon oscillator; Dirac oscillator; Non-commutative space;
   Constant magnetic field
ID QUANTUM-MECHANICS; DECOMPOSITION METHOD; EQUATIONS
AB In this paper, we investigate the Klein-Gordon and the Dirac relativistic oscillators in a non-commutative space under a constant magnetic field. In addition, we show that. for a particular magnetic field, the form of these oscillators can be mapped from a non-commutative space to a commutative space. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Heidari, Alireza; Tayyari, Sayyed Faramarz] Ferdowsi Univ Mashhad, Dept Chem, Mashhad 917751436, Iran.
   [Sammelson, Robert Erik] Ball State Univ, Dept Chem, Muncie, IN 47306 USA.
RP Tayyari, SF (reprint author), Ferdowsi Univ Mashhad, Dept Chem, Mashhad 917751436, Iran.
EM tayyari@ferdowsi.um.ac.ir
CR ACTRINEI C, 2001, JHEP, V109
   Basak KC, 2009, COMMUN NONLINEAR SCI, V14, P718, DOI 10.1016/j.cnsns.2007.09.018
   Bellucci S, 2001, PHYS LETT B, V502, P279, DOI 10.1016/S0370-2693(01)00142-3
   BENITEZ J, 1990, PHYS REV LETT, V64, P1643
   Biswas A, 2008, APPL MATH COMPUT, V203, P153, DOI 10.1016/j.amc.2008.04.013
   Douglas MR, 2001, REV MOD PHYS, V73, P977, DOI 10.1103/RevModPhys.73.977
   Gamboa J, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.067901
   Gamboa J, 2002, INT J MOD PHYS A, V17, P2555, DOI 10.1142/S0217751X02010960
   Gamboa J, 2001, MOD PHYS LETT A, V16, P2075, DOI 10.1142/S0217732301005345
   ITO D, 1967, NUOVO CIMENT A, V51, P1119, DOI 10.1007/BF02721775
   MEZINCESCU L, 2000, JHEP UMTG, V233
   MORENO M, 1989, J PHYS A-MATH GEN, V22, pL821, DOI 10.1088/0305-4470/22/17/003
   MOSHINSKY M, 1989, J PHYS A-MATH GEN, V22, pL817, DOI 10.1088/0305-4470/22/17/002
   Nair VP, 2001, PHYS LETT B, V505, P267, DOI 10.1016/S0370-2693(01)00339-2
   Ray SS, 2008, COMMUN NONLINEAR SCI, V13, P1311, DOI 10.1016/j.cnsns.2006.12.010
   Sassaman R, 2009, COMMUN NONLINEAR SCI, V14, P3239, DOI 10.1016/j.cnsns.2008.12.020
   Seiberg N, 1999, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/1999/09/032
   Strange P., 1998, RELATIVISTIC QUANTUM
   Wazwaz AM, 2008, COMMUN NONLINEAR SCI, V13, P889, DOI 10.1016/j.cnsns.2006.08.005
   Wazwaz AM, 2005, APPL MATH COMPUT, V167, P1179, DOI 10.1016/j.amc.2004.08.006
NR 20
TC 2
Z9 2
U1 2
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1007-5704
EI 1878-7274
J9 COMMUN NONLINEAR SCI
JI Commun. Nonlinear Sci. Numer. Simul.
PD MAY
PY 2010
VL 15
IS 5
BP 1368
EP 1371
DI 10.1016/j.cnsns.2009.05.033
PG 4
WC Mathematics, Applied; Mathematics, Interdisciplinary Applications;
   Mechanics; Physics, Fluids & Plasmas; Physics, Mathematical
SC Mathematics; Mechanics; Physics
GA 535AV
UT WOS:000272939800027
DA 2018-12-27
ER

PT J
AU Kamel, RM
   Chaouachi, A
   Nagasaka, K
AF Kamel, Rashad M.
   Chaouachi, Aymen
   Nagasaka, Ken
TI RETRACTED: Wind power smoothing using fuzzy logic pitch controller and
   energy capacitor system for improvement Micro-Grid performance in
   islanding mode (Retracted article. See vol. 85, pg. 688, 2015)
SO ENERGY
LA English
DT Article; Retracted Publication
DE Micro-Grid; Islanding; Fuzzy pitch controller; Wind power smoothing;
   Ultra capacitor
ID FUEL-CELL; DISTRIBUTED GENERATION; SIMULATION; OPERATION; STABILITY
AB The need of reducing CO2 emissions in electricity generation field for solving global warming problems has led to increase interest in Micro-Grid (MG) especially the one with renewable sources such as solar and wind generations. Wind speed fluctuations cause high fluctuations in output power of wind turbine which cause fluctuations in fr and voltages of the MG in the islanding mode and originate stability problems. In this study, a new fuzzy logic pitch controller and an energy storage ultra capacitor are proposed and developed to smooth the output power of wind turbine and enhance MG's performance in islanding mode. These two proposed controllers are compared with the conventional PI pitch controller, which is usually used to control wind generation system when the wind speed exceeds a rated value. Obtained results proved that our two proposed strategies are effective for the MG performance improvement during islanding mode. All models and controllers are developed using Matlab (R) Simulink (R) environment. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Kamel, Rashad M.; Chaouachi, Aymen; Nagasaka, Ken] Tokyo Univ Agr & Technol, Tokyo, Japan.
RP Kamel, RM (reprint author), Tokyo Univ Agr & Technol, Tokyo, Japan.
EM r_m_kamel@yahoo.com; a.chaouachi@gmail.com; bahman@cc.tuat.ac.jp
RI Nagasaka, Ken/B-9989-2013
OI Nagasaka, Ken/0000-0002-0923-6269
CR Ali A, 2008, J POWER SOURCES, V185, P961, DOI 10.1016/j.jpowsour.2008.09.032
   Barsali S, 2002, 2002 IEEE POWER ENGINEERING SOCIETY WINTER MEETING, VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P789, DOI 10.1109/PESW.2002.985115
   CALDON R, 2003, P 17 INT C EL DISTR
   Clastres C, 2010, ENERGY, V35, P55, DOI 10.1016/j.energy.2009.08.025
   Driankov D., 1993, INTRO FUZZY CONTROL
   Estanqueiro AI, 2007, IEEE T POWER SYST, V22, P920, DOI 10.1109/TPWRS.2007.901654
   *EU, 2002, MICROGRIDS LARG SCAL
   Gebregergis A, 2009, IEEE T IND ELECTRON, V56, P139, DOI 10.1109/TIE.2008.2009516
   Georgakis D, 2004, IEEE POWER ELECTRON, P2521
   Gil HA, 2008, IEEE T POWER SYST, V23, P327, DOI 10.1109/TPWRS.2008.920718
   HATZIARGYRIOU N, 2004, P CIGRE SESS
   KANELLOS FD, 2005, INT C POW SYST TRANS
   Katiraei F, 2005, IEEE T POWER DELIVER, V20, P248, DOI 10.1109/TPWRD.2004.835051
   Kwon JM, 2009, IEEE T IND ELECTRON, V56, P826, DOI 10.1109/TIE.2008.2004393
   Lasseter R., WHITE PAPER INTEGRAT
   Lopes JAP, 2006, IEEE T POWER SYST, V21, P916, DOI 10.1109/TPWRS.2006.873018
   Mohamed YARI, 2009, IEEE T POWER SYST, V24, P489, DOI 10.1109/TPWRS.2008.2006996
   Moreira CL, 2007, IEEE T POWER SYST, V22, P395, DOI 10.1109/TPWRS.2006.888989
   Muyeen SM, 2008, WIND ENERGY, V11, P335, DOI 10.1002/we.265
   Muyeen S.M., 2008, STABILITY AUGMENTATI
   Onar OC, 2006, J POWER SOURCES, V161, P707, DOI 10.1016/j.jpowsour.2006.03.055
   Onar OC, 2008, J POWER SOURCES, V185, P1273, DOI 10.1016/j.jpowsour.2008.08.083
   Ong CM, 1998, DYNAMIC SIMULATION E
   Ozgener O, 2010, ENERGY, V35, P262, DOI 10.1016/j.energy.2009.09.018
   Padulles J, 2000, J POWER SOURCES, V86, P495, DOI 10.1016/S0378-7753(99)00430-9
   Papathanassiou S., 2005, P CIGRE S POW SYST D
   Pearce JM, 2009, ENERGY, V34, P1947, DOI 10.1016/j.energy.2009.08.012
   RASHADKAMEL M, 2009, MICROGRID DYNAMIC PE, P65
   RASHADKAMEL M, 2009, DESIGN IMPLEMENTATIO, P61
   Sao CK, 2008, IEEE T POWER SYST, V23, P1088, DOI 10.1109/TPWRS.2008.922232
   Siegfried H., 1998, GRID INTEGRATION WIN
   Soultanis NL, 2007, IEEE T POWER SYST, V22, P294, DOI 10.1109/TPWRS.2006.887961
   Thounthong P, 2007, IEEE T IND ELECTRON, V54, P3225, DOI 10.1109/TIE.2007.896477
   Tran-Quoc T, 2004, 2004 IEEE PES POWER SYSTEMS CONFERENCE & EXPOSITION, VOLS 1 - 3, P815
   Yee SK, 2008, IEEE T POWER SYST, V23, P108, DOI 10.1109/TPWRS.2007.907384
   Zhu Y, 2002, ELECTR POW SYST RES, V62, P1, DOI 10.1016/S0378-7796(02)00033-0
NR 36
TC 58
Z9 61
U1 4
U2 35
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-5442
EI 1873-6785
J9 ENERGY
JI Energy
PD MAY
PY 2010
VL 35
IS 5
BP 2119
EP 2129
DI 10.1016/j.energy.2010.01.030
PG 11
WC Thermodynamics; Energy & Fuels
SC Thermodynamics; Energy & Fuels
GA 598XL
UT WOS:000277873100027
DA 2018-12-27
ER

PT J
AU Pschierer, J
   Plenio, H
AF Pschierer, Jan
   Plenio, Herbert
TI RETRACTED: Suzuki-Miyaura Coupling of Aryl Tosylates and Mesylates in
   Water (Retracted article. See May, pg. 5722, 2010)
SO EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
LA English
DT Article; Retracted Publication
DE C-C coupling; Palladium; Water; Suzuki-Miyaura reactions; Phosphanes
ID ARYLBORONIC ACIDS; ROOM-TEMPERATURE; SOLVENTS; SONOGASHIRA; CATALYST;
   GREEN; ARENESULFONATES; CHLORIDES
AB The palladium complex (0.5 mol-%) of a water-soluble sulfonated fluorenylphosphane (cataCXium Fsulf) enables the facile Suzuki-Miyaura coupling of various (heterocyclic) aryl tosylates and aryl mesylate with various (heterocyclic) boronic acids in excellent yields (> 95%) using water as the reaction solvent.
C1 [Pschierer, Jan; Plenio, Herbert] Tech Univ Darmstadt, D-64287 Darmstadt, Germany.
RP Plenio, H (reprint author), Tech Univ Darmstadt, Petersenstr 18, D-64287 Darmstadt, Germany.
EM Plenio@tu-darmstadt.de
FU Deutsche Forschungsgemeinschaft (DFG)
FX Support of this work by the Deutsche Forschungsgemeinschaft (DFG) is
   gratefully acknowledged. Additional support was provided by Dr. R.
   Kadyrov/Evonik.
CR Bhayana B, 2009, ORG LETT, V11, P3954, DOI 10.1021/ol9015892
   BURTSCHER D, 2008, ANGEW CHEM INT ED, V47
   Capello C, 2007, GREEN CHEM, V9, P927, DOI 10.1039/b617536h
   Clark JH, 2007, ORG PROCESS RES DEV, V11, P149, DOI 10.1021/op060160g
   Fleckenstein C, 2007, CHEM COMMUN, P2870, DOI 10.1039/b703658b
   Fleckenstein CA, 2008, CHEM-EUR J, V14, P4267, DOI 10.1002/chem.200701877
   Fleckenstein CA, 2008, J ORG CHEM, V73, P3236, DOI 10.1021/jo8001886
   Fleckenstein CA, 2008, GREEN CHEM, V10, P563, DOI 10.1039/b800154e
   Fleckenstein CA, 2008, ORG PROCESS RES DEV, V12, P475, DOI 10.1021/op7001479
   Fleckenstein CA, 2007, GREEN CHEM, V9, P1287, DOI 10.1039/b711965h
   Fleckenstein CA, 2007, CHEM-EUR J, V13, P2701, DOI 10.1002/chem.200601142
   Fleckenstein CA, 2010, CHEM SOC REV, V39, P694, DOI 10.1039/b903646f
   Gogsig TM, 2008, J ORG CHEM, V73, P3404, DOI 10.1021/jo7027097
   Kuroda JI, 2009, EUR J ORG CHEM, P2251, DOI 10.1002/ejoc.200900067
   Li CJ, 2006, CHEM SOC REV, V35, P68, DOI 10.1039/b507207g
   Nguyen HN, 2003, J AM CHEM SOC, V125, P11818, DOI 10.1021/ja036947t
   Pschierer J, 2010, GREEN CHEM, V12, P636, DOI 10.1039/b924772f
   Pschierer J, 2009, ORG LETT, V11, P2551, DOI 10.1021/ol9007475
   Roca FX, 2003, CHEM COMMUN, P3002, DOI 10.1039/b310526a
   Roy AH, 2003, J AM CHEM SOC, V125, P8704, DOI 10.1021/ja035835z
   Shaughnessy KH, 2009, CHEM REV, V109, P643, DOI 10.1021/cr800403r
   Shaughnessy KH, 2005, CURR ORG CHEM, V9, P585, DOI 10.2174/1385272053765042
   Sheldon RA, 2005, GREEN CHEM, V7, P267, DOI 10.1039/b418069k
   So CM, 2008, J ORG CHEM, V73, P7731, DOI 10.1021/jo8014819
   So CM, 2008, ANGEW CHEM INT EDIT, V47, P8059, DOI 10.1002/anie.200803193
   Tang ZY, 2004, J AM CHEM SOC, V126, P3058, DOI 10.1021/ja038752r
   Zhang LA, 2007, J ORG CHEM, V72, P9346, DOI 10.1021/jo7019064
   Zim D, 2001, ORG LETT, V3, P3049, DOI 10.1021/ol016526l
NR 28
TC 12
Z9 12
U1 4
U2 23
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1434-193X
EI 1099-0690
J9 EUR J ORG CHEM
JI Eur. J. Org. Chem.
PD MAY
PY 2010
IS 15
BP 2934
EP 2937
DI 10.1002/ejoc.201000251
PG 4
WC Chemistry, Organic
SC Chemistry
GA 608UQ
UT WOS:000278611900015
DA 2018-12-27
ER

PT J
AU Pandey, A
   Leech, M
   Milton, A
   Singh, P
   Verma, PK
AF Pandey, Anju
   Leech, Mary
   Milton, Andy
   Singh, Preeti
   Verma, Pramod K.
TI RETRACTED: Evidence of former majoritic garnet in Himalayan eclogite
   points to 200-km-deep subduction of Indian continental crust (Retracted
   article. See vol. 39, pg. 606, 2011)
SO GEOLOGY
LA English
DT Article; Retracted Publication
ID HIGH-PRESSURE; TRANSITION ZONE; SOLID-SOLUTION; DABIE-SHAN; XENOLITHS;
   COESITE; GREATER; DIAMOND; LADAKH; ROCKS
AB Relict majorite, recognized petrographically and confirmed by in situ laser-ablation microprobe analyses, is reported from eclogites of the Tso Morari Complex, India, and represents the first record of relict majorite in the Himalaya. Previous studies have established that the Tso Morari Complex eclogites represent continental metamorphosed basic rocks within the sequence of paragneisses and metapelites interbedded with granitic augen gneisses. Our study provides evidence for subduction of the Indian continental crust to majorite-forming depths (similar to 200 km), and even more significant, its exhumation from such depth without being completely overprinted. This estimated depth is almost double the previous depth approximations and hence has important implications on the estimation of the angle of subduction and average rates of exhumation of the Indian plate in the Himalayan collisional zone.
C1 [Pandey, Anju; Milton, Andy] Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England.
   [Leech, Mary] San Francisco State Univ, San Francisco, CA 94132 USA.
   [Singh, Preeti; Verma, Pramod K.] Univ Delhi, Dept Geol, Delhi 110007, India.
RP Pandey, A (reprint author), Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England.
EM anju.pandey@noc.soton.ac.uk
OI Leech, Mary/0000-0003-2871-5297
FU Department of Science and Technology, India
FX Pandey thanks the Natural Environment Research Council (UK), and Lindsay
   Parson for a postdoctoral position at the National Oceanography Centre,
   Southampton. We thank the Department of Science and Technology, India,
   for support during field sessions in Tso Morari, Himalaya, and Jane
   Gilotti, Jean-Luc Epard, and an anonymous reviewer for their extremely
   useful and constructive journal review comments. We also thank Sandra
   Wyld for editorial comments that led to a better presentation of this
   study.
CR AKAOGI M, 1977, PHYS EARTH PLANET IN, V15, P90, DOI 10.1016/0031-9201(77)90013-9
   COLEMAN RG, 1995, ULTRAHIGH PRESSURE M
   Collerson KD, 2000, SCIENCE, V288, P1215, DOI 10.1126/science.288.5469.1215
   de Sigoyer J, 2000, GEOLOGY, V28, P487, DOI 10.1130/0091-7613(2000)28<487:DTICSA>2.0.CO;2
   DeSigoyer J, 1997, EUR J MINERAL, V9, P1073
   Epard JL, 2008, TECTONOPHYSICS, V451, P242, DOI 10.1016/j.tecto.2007.11.050
   Guillot S, 1997, CONTRIB MINERAL PETR, V128, P197, DOI 10.1007/s004100050303
   HACKER BF, 1998, PETROLOGY STRUCTURAL, V10
   HAGGERTY SE, 1990, SCIENCE, V248, P993, DOI 10.1126/science.248.4958.993
   IRIFUNE T, 1986, EARTH PLANET SC LETT, V77, P245, DOI 10.1016/0012-821X(86)90165-2
   Leech ML, 2005, EARTH PLANET SC LETT, V234, P83, DOI 10.1016/j.epsl.2005.02.038
   Malaspina N, 2006, EARTH PLANET SC LETT, V249, P173, DOI 10.1016/j.epsl.2006.07.017
   MOORE RO, 1985, NATURE, V318, P553, DOI 10.1038/318553a0
   Mposkos ED, 2001, EARTH PLANET SC LETT, V192, P497, DOI 10.1016/S0012-821X(01)00478-2
   Mukherjee BK, 2001, CURR SCI INDIA, V81, P1358
   MUKHERJEE BK, 2004, HIMALAYAN J SCI, V2, P209
   Murton BJ, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000798
   O'Brien PJ, 2001, GEOLOGY, V29, P435, DOI 10.1130/0091-7613(2001)029<0435:CIHEAI>2.0.CO;2
   Okamoto K, 1998, ISL ARC, V7, P52, DOI 10.1046/j.1440-1738.1998.00179.x
   Ono S, 1996, PHYS EARTH PLANET IN, V96, P171, DOI 10.1016/0031-9201(96)03149-4
   SAUTTER V, 1991, SCIENCE, V252, P827, DOI 10.1126/science.252.5007.827
   Scambelluri M, 2008, GEOLOGY, V36, P59, DOI 10.1130/G24056A.1
   Song SG, 2004, AM MINERAL, V89, P1330
   Thakur V. C., 1979, HIMAL GEOL, V9, P63
   van Roermund HLM, 1998, TERRA NOVA, V10, P295
   Ye K, 2000, NATURE, V407, P734, DOI 10.1038/35037566
NR 26
TC 5
Z9 5
U1 3
U2 24
PU GEOLOGICAL SOC AMER, INC
PI BOULDER
PA PO BOX 9140, BOULDER, CO 80301-9140 USA
SN 0091-7613
EI 1943-2682
J9 GEOLOGY
JI Geology
PD MAY
PY 2010
VL 38
IS 5
BP 399
EP 402
DI 10.1130/G30584.1
PG 4
WC Geology
SC Geology
GA 590JE
UT WOS:000277220900004
DA 2018-12-27
ER

PT J
AU Mandal, D
   Levine, AD
AF Mandal, Debasmita
   Levine, Alan D.
TI RETRACTED: Elevated IL-13R alpha 2 in Intestinal Epithelial Cells from
   Ulcerative Colitis or Colorectal Cancer Initiates MAPK Pathway
   (Retracted article. See vol. 21, pg. 1736, 2015)
SO INFLAMMATORY BOWEL DISEASES
LA English
DT Article; Retracted Publication
DE IL-13 receptor; colorectal cancer; ulcerative colitis; STAT6; MAP kinase
ID NK-T-CELLS; COLON-CANCER; IL-13 RECEPTOR; INTERLEUKIN-13 RECEPTOR;
   SIGNAL-TRANSDUCTION; HUMAN KERATINOCYTES; INFLAMMATION; MICE; STAT6;
   INVOLVEMENT
AB Background: Chronic inflammation in ulcerative colitis (UC) is a sizeable risk factor for colorectal cancer (CRC). Interleukin-13 (IL-13) is elevated in the UC mucosa and may induce dysregulated signaling in neighboring intestinal epithelial cells (IECs) and thus function as a tumorogenic cytokine.
   Methods: Expression of IL-13 receptor chains on IECs obtained from control or chronically inflamed mucosa and colonic tumors was quantified by flow cytometry and immunoblot. IL-13R alpha 1 and IL-13R alpha 2 expression was significantly increased on IEC from UC and CRC patients compared to control and Crohn's disease (CD) subjects. Purified IEC from these subjects and cell lines expressing varying ratios of IL-13R alpha 1 and IL-3R alpha 2 chains were stimulated with IL-13 in vitro to investigate by immunoblot the activation of the signal transducer and activator of transcription 6 (STAT6) and mitogen activated protein kinase (MAPK) signaling pathways.
   Results: Despite similarly elevated receptor expression in UC and CRC, IL-13 does not activate the STAT6 or MAPK pathways in UC, while in colonic tumors only the STAT6 pathway is activated. Using neutralizing antibodies and cell lines expressing a range of surface densities for IL-13R alpha 1 and IL-3R alpha 2, we demonstrate that IL-13R alpha 2 serves a dual role, initiating MAPK signaling at low concentrations and as an inhibitory, decoy receptor at high IL-13R alpha 2 to IL-13R alpha 1 ratios.
   Conclusions: IL-13R alpha 2 is both a decoy receptor and induces MAPK signal transduction, depending on its relative expression and the local concentration of IL-13, which together modulate the balance and intensity of the signaling pathways initiated in UC and CRC.
C1 [Levine, Alan D.] Case Western Reserve Univ, Sch Med, Dept Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.
   [Mandal, Debasmita; Levine, Alan D.] Case Western Reserve Univ, Sch Med, Dept Pathol, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.
   [Levine, Alan D.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.
RP Levine, AD (reprint author), Case Western Reserve Univ, Sch Med, Dept Med, Case Comprehens Canc Ctr, BRB426,10900 Euclid Ave, Cleveland, OH 44106 USA.
EM alan.levine@case.edu
FU Comprehensive Cancer Center of Case Western Reserve University;
   University Hospitals Case Medical Center (NIH/NCI) [P30 CA43703];
   National Institutes of Health [DK-54213, AI-53188]; American Cancer
   Society, Ohio Division
FX Supported by the Tissue Procurement and Histology Core Facility of the
   Comprehensive Cancer Center of Case Western Reserve University and
   University Hospitals Case Medical Center (NIH/NCI P30 CA43703), and by
   grants from the National Institutes of Health (DK-54213 and AI-53188)
   and the American Cancer Society, Ohio Division (to A.D.L.).
CR Atherton HC, 2003, AM J PHYSIOL-LUNG C, V285, pL730, DOI 10.1152/ajplung.00089.2003
   Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0
   Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861
   Blanchard C, 2004, J IMMUNOL, V172, P3775, DOI 10.4049/jimmunol.172.6.3775
   Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132
   Chambers WM, 2005, BRIT J SURG, V92, P928, DOI 10.1002/bjs.5106
   Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005
   Daines MO, 2006, J IMMUNOL, V176, P7495, DOI 10.4049/jimmunol.176.12.7495
   Das L, 2008, J IMMUNOL, V180, P1490, DOI 10.4049/jimmunol.180.3.1490
   Das S, 2007, PROSTATE, V67, P1550, DOI 10.1002/pros.20640
   David M, 2001, ONCOGENE, V20, P6660, DOI 10.1038/sj.onc.1204629
   Donaldson DD, 1998, J IMMUNOL, V161, P2317
   Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526
   Endo Y, 2008, GASTROENTEROLOGY, V135, P889, DOI 10.1053/j.gastro.2008.06.091
   Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6
   Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332
   Fujisawa T, 2008, RESPIROLOGY, V13, P191, DOI 10.1111/j.1440-1843.2008.01237.x
   Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836
   Germano G, 2008, CYTOKINE, V43, P374, DOI 10.1016/j.cyto.2008.07.014
   Grossmann J, 2001, GASTROENTEROLOGY, V120, P79, DOI 10.1053/gast.2001.20879
   Hashimoto S, 2001, J ALLERGY CLIN IMMUN, V107, P1001, DOI 10.1067/mai.2001.114702
   Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002
   Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3
   Kanai T, 2000, BRIT J CANCER, V82, P1717
   Kawakami M, 2003, CLIN CANCER RES, V9, P6381
   KEDAR E, 1982, EUR J CANCER CLIN ON, V18, P991, DOI 10.1016/0277-5379(82)90248-6
   KELLYWELCH A, 2005, SCI STKE, pCM8
   Klampfer L, 2008, FRONT BIOSCI-LANDMRK, V13, P2888, DOI 10.2741/2893
   Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205
   Miloux B, 1997, FEBS LETT, V401, P163, DOI 10.1016/S0014-5793(96)01462-7
   Mintz A, 2002, NEOPLASIA, V4, P388, DOI 10.1038/sj.neo.7900234
   Mudter J, 2005, AM J GASTROENTEROL, V100, P64, DOI 10.1111/j.1572-0241.2005.40615.x
   Obiri NI, 1997, J IMMUNOL, V158, P756
   Ohshima K, 2001, HISTOPATHOLOGY, V38, P368, DOI 10.1046/j.1365-2559.2001.01083.x
   RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143
   Skinnider BF, 2002, BLOOD, V99, P618, DOI 10.1182/blood.V99.2.618
   Spencer DM, 2003, FASEB J, V17, pC230
   Spencer DM, 2002, GASTROENTEROLOGY, V122, P94, DOI 10.1053/gast.2002.30308
   Trejdosiewicz LK, 1998, CYTOKINE, V10, P756, DOI 10.1006/cyto.1998.0361
   van den Blink B, 2002, ANN NY ACAD SCI, V973, P349
   Wongpiyabovorn J, 2003, J DERMATOL SCI, V33, P31, DOI 10.1016/S0923-1811(03)00148-8
   Wood N, 2003, J EXP MED, V197, P703, DOI 10.1084/jem.20020906
   Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142
   Zhang MS, 2006, CANCER LETT, V243, P38, DOI 10.1016/j.canlet.2005.11.020
NR 44
TC 35
Z9 37
U1 5
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1078-0998
EI 1536-4844
J9 INFLAMM BOWEL DIS
JI Inflamm. Bowel Dis.
PD MAY
PY 2010
VL 16
IS 5
BP 753
EP 764
DI 10.1002/ibd.21133
PG 12
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 592ND
UT WOS:000277385200011
PM 20014020
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Nasiri, GR
   Davoudpour, H
   Karimi, B
AF Nasiri, G. Reza
   Davoudpour, Hamid
   Karimi, Behrooz
TI RETRACTED: A LAGRANGIAN-BASED SOLUTION ALGORITHM FOR STRATEGIC SUPPLY
   CHAIN DISTRIBUTION DESIGN IN UNCERTAIN ENVIRONMENT (Retracted article.
   See vol. 12, pg. 173, 2013)
SO INTERNATIONAL JOURNAL OF INFORMATION TECHNOLOGY & DECISION MAKING
LA English
DT Article; Retracted Publication
DE Mathematical programming; supply chain management; distribution planning
   decisions; inventory control policy; Lagrangian relaxation
ID FACILITY LOCATION PROBLEM; DISTRIBUTION NETWORK DESIGN; GENETIC
   ALGORITHM; DISTRIBUTION CENTERS; SERVICE LEVEL; SYSTEM; MODEL;
   MULTICOMMODITY; TRANSPORTATION; FORMULATION
AB In this paper a multi-product, multi-echelon location-allocation model for the optimization of a supply chain design is proposed. This model integrated inventory decisions into distribution network design with stochastic market demands. The goal is to select the optimum numbers, locations, and capacities of the opening warehouses so that all customer demands to be satisfied at minimum total costs of the distribution network. We develop a nonlinear mixed-integer model and propose an efficient heuristic solution procedure for the problem. The solution approach is based on Lagrangian relaxation, improved with efficient heuristic to solve complex sub-problems. Computational results indicate that the proposed method yields good solutions with high quality within a reasonable computational time for various real-size problems.
C1 [Nasiri, G. Reza; Davoudpour, Hamid; Karimi, Behrooz] Amirkabir Univ Technol, Dept Ind Engn, Tehran, Iran.
RP Davoudpour, H (reprint author), Amirkabir Univ Technol, Dept Ind Engn, Hafez Ave,POB 15875-4413, Tehran, Iran.
EM reza_nasiri@aut.ac.ir; hamidp@aut.ac.ir
OI Karimi, Behrooz/0000-0003-3556-8643
CR Altiparmak F, 2006, COMPUT IND ENG, V51, P196, DOI 10.1016/j.cie.2006.07.011
   Amiri A, 2006, EUR J OPER RES, V171, P567, DOI 10.1016/j.ejor.2004.09.018
   BROWN GG, 1987, MANAGE SCI, V33, P1469, DOI 10.1287/mnsc.33.11.1469
   Chan FTS, 2005, OMEGA-INT J MANAGE S, V33, P345, DOI 10.1016/j.omega.2004.05.004
   Chen CL, 2004, COMPUT CHEM ENG, V28, P1131, DOI 10.1016/j.compchemeng.2003.09.014
   CHUNG SH, 1992, EUR J OPER RES, V62, P105, DOI 10.1016/0377-2217(92)90181-8
   Cohen M. A., 1990, Journal of Manufacturing and Operations Management, V3, P269
   DANTZIG GB, 1957, OPER RES, V5, P266, DOI 10.1287/opre.5.2.266
   Daskin MS, 2002, ANN OPER RES, V110, P83, DOI 10.1023/A:1020763400324
   Ding D, 2007, INT J INF TECH DECIS, V6, P163, DOI 10.1142/S0219622007002332
   Eksioglu SD, 2006, COMPUT OPER RES, V33, P3231, DOI 10.1016/j.cor.2005.02.038
   Eskigun E, 2005, EUR J OPER RES, V165, P182, DOI 10.1016/j.ejor.2003.11.029
   Farahani RZ, 2008, INT J PROD ECON, V111, P229, DOI 10.1016/j.ijpe.2006.11.028
   Gou QL, 2008, INT J INF TECH DECIS, V7, P225, DOI 10.1142/S0219622008002892
   Gourdin E, 2000, OPER RES, V48, P671, DOI 10.1287/opre.48.5.671.12410
   HAN BT, 2003, INT J INFORM TECHNOL, V2, P597
   HURTER AP, 1989, FACILITY LOCATION TH
   Hwang HS, 2002, COMPUT IND ENG, V43, P283, DOI 10.1016/S0360-8352(02)00075-X
   Jayaraman V, 1998, DECISION SCI, V29, P729, DOI 10.1111/j.1540-5915.1998.tb01361.x
   Jayaraman V, 2003, EUR J OPER RES, V144, P629, DOI 10.1016/S0377-2217(02)00153-4
   Jayaraman V, 2001, EUR J OPER RES, V133, P394, DOI 10.1016/S0377-2217(00)00033-3
   Liang TF, 2006, FUZZY SET SYST, V157, P1303, DOI 10.1016/j.fss.2006.01.014
   Melachrinoudis E, 2005, INT J PROD ECON, V97, P1, DOI 10.1016/j.ijpe.2004.04.009
   Melachrinoudis E, 2000, EUR J OPER RES, V123, P1, DOI 10.1016/S0377-2217(99)00166-6
   Miranda PA, 2004, TRANSPORT RES E-LOG, V40, P183, DOI 10.1016/j.tre.2003.08.006
   Miranda PA, 2008, TRANSPORT RES E-LOG, V44, P47, DOI 10.1016/j.tre.2006.04.002
   Nie LS, 2008, INT J INF TECH DECIS, V7, P183, DOI 10.1142/S0219622008002879
   Nozick LK, 2001, TRANSPORT RES E-LOG, V37, P281, DOI 10.1016/S1366-5545(00)00018-1
   Pirkul H, 1996, TRANSPORT SCI, V30, P291, DOI 10.1287/trsc.30.4.291
   Pirkul H, 1998, COMPUT OPER RES, V25, P869, DOI 10.1016/S0305-0548(97)00096-8
   Qu WW, 1999, EUR J OPER RES, V115, P254, DOI 10.1016/S0377-2217(98)00301-4
   Sabri EH, 2000, OMEGA-INT J MANAGE S, V28, P581, DOI 10.1016/S0305-0483(99)00080-8
   Shen ZJM, 2003, TRANSPORT SCI, V37, P40
   Syam SS, 2002, COMPUT OPER RES, V29, P1173, DOI 10.1016/S0305-0548(01)00023-5
   Syarif A, 2002, COMPUT IND ENG, V43, P299, DOI 10.1016/S0360-8352(02)00076-1
   TEITZ MB, 1968, OPER RES, V16, P955, DOI 10.1287/opre.16.5.955
   Tragantalerngsak S, 2000, EUR J OPER RES, V123, P473, DOI 10.1016/S0377-2217(99)00105-8
   Vasant PM, 2005, INT J INF TECH DECIS, V4, P647, DOI 10.1142/S0219622005001751
   Wang W, 2004, INT J PROD ECON, V91, P101, DOI [10.1016/S0925-5273(03)00212-3, 10.1016/S0928-5273(03)00212-3]
   Yang FM, 2006, INT J INF TECH DECIS, V5, P531, DOI 10.1142/S0219622006002118
   Zhou GG, 2002, COMPUT IND ENG, V43, P251, DOI 10.1016/S0360-8352(02)00067-0
NR 41
TC 4
Z9 4
U1 4
U2 50
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0219-6220
EI 1793-6845
J9 INT J INF TECH DECIS
JI Int. J. Inf. Technol. Decis. Mak.
PD MAY
PY 2010
VL 9
IS 3
BP 393
EP 418
DI 10.1142/S0219622010003877
PG 26
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Computer Science, Interdisciplinary Applications; Operations
   Research & Management Science
SC Computer Science; Operations Research & Management Science
GA 596MN
UT WOS:000277689300004
DA 2018-12-27
ER

PT J
AU Topcu, FT
   Erdemir, U
   Sahinkesen, G
   Mumcu, E
   Yildiz, E
   Uslan, I
AF Topcu, Fulya Toksoy
   Erdemir, Ugur
   Sahinkesen, Gunes
   Mumcu, Emre
   Yildiz, Esra
   Uslan, Ibrahim
TI RETRACTED: Push-out bond strengths of two fiber post types bonded with
   different dentin bonding agents (Retracted article. See vol. 100, pg.
   1458, 2012)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article; Retracted Publication
DE fiber-reinforced post; dentin bonding agents; push-out test
ID ENDODONTICALLY TREATED TEETH; TOOTH-COLORED POSTS; ROOT-CANAL DENTIN;
   STRUCTURAL CHARACTERISTICS; ADHESIVE; CEMENTS; MICROTENSILE; RESISTANCE;
   RETENTION; SYSTEMS
AB The aim of this study was to evaluate the regional push-out bond strengths for two fiber-reinforced post types using three different dentin bonding agents Sixty single-rooted extracted human first premolar teeth were sectioned below the cemento-enamel junction, and the roots were endodontically treated Following standardized post space preparations, the roots were divided into two fiber-post groups (Glassix (R) and Carbopost (R)), and further divided into three subgroups of 10 specimens each for the bonding systems self-etching dentin bonding agents (Clearfil (TM) SE Bond and Optibond (R) all-in-one), and total-etching dentin bonding agent (XP Bond (TM)) A dual-cure resin luting cement (Maxcem (TM)) was then placed in the post spaces and posts were then seated into the root canals polymerized through the cervical portion The roots were then cut into 3-mm thick sections Push-out tests were performed at a crosshead speed of 0 5 mm/min. The data were analyzed with multivariate ANOVA (alpha = 0 05) The morphology of interface between different dentin bonding agents from the cervical sections were analyzed with SEM Glass fiber-reinforced posts demonstrated significantly higher push-out bond strengths than carbon fiber-reinforced posts (p < 00011 Bond strength values decreased significantly from the cervical to the apical root canal regions (p < 0 001) Self-etching dentin adhesive Clearfil SE Bond and total-etching dentin adhesive XP Bond demonstrated similar bond strengths values and this was significantly higher compared with the Optibond (R) all-in-one in cervical root canal region In conclusion, in all root segments, the glass fiber-reinforced posts provided significantly increased post retention than the carbon fiber-reinforced posts, regardless of the adhesive used (C) 2010 Wiley Periodicals, Inc J Biomed Mater Res Part B Appl Biomater 938 359-366, 2010
C1 [Erdemir, Ugur; Yildiz, Esra] Istanbul Univ, Dept Operat Dent, Fac Dent, TR-34300 Istanbul, Turkey.
   [Topcu, Fulya Toksoy; Sahinkesen, Gunes] Gulhane Mil Med Acad, Dept Endodont & Conservat Dent, TR-06018 Ankara, Turkey.
   [Mumcu, Emre] Istanbul Univ, Dept Prosthet Dent, Fac Dent, TR-34300 Istanbul, Turkey.
   [Uslan, Ibrahim] Gazi Univ, Dept Mech Engn, Fac Engn & Architecture, TR-06570 Ankara, Turkey.
RP Erdemir, U (reprint author), Istanbul Univ, Dept Operat Dent, Fac Dent, TR-34300 Istanbul, Turkey.
RI Erdemir, Ugur/F-3139-2010
FU Gazi University [2001K120590]
FX Contract grant sponsor Gazi University, contract grant number
   2001K120590
CR Akkayan B, 2002, J PROSTHET DENT, V87, P431, DOI 10.1067/mpr.2002.123227
   Aksornmuang J, 2004, J DENT, V32, P443, DOI 10.1016/j.jdent.2004.03.001
   Asmussen E, 1999, J DENT, V27, P275, DOI 10.1016/S0300-5712(98)00066-9
   Bouillaguet S, 2003, DENT MATER, V19, P199, DOI 10.1016/S0109-5641(02)00030-1
   Cardoso Paulo Eduardo Capel, 2002, J Adhes Dent, V4, P291
   CHAPPELL RP, 1994, J PROSTHET DENT, V72, P183, DOI 10.1016/0022-3913(94)90078-7
   Cohen BI, 1998, J PROSTHET DENT, V79, P520, DOI 10.1016/S0022-3913(98)70172-6
   Duret B, 1990, Chir Dent Fr, V60, P69
   Ferrari M, 2001, DENT MATER, V17, P422, DOI 10.1016/S0109-5641(00)00102-0
   Ferrari M, 2000, AM J DENT, V13, P255
   Ferrari M, 2000, AM J DENT, V13, P9
   Foxton RM, 2003, OPER DENT, V28, P543
   Fredriksson M, 1998, J PROSTHET DENT, V80, P151, DOI 10.1016/S0022-3913(98)70103-9
   GOLDSTEIN GR, 1986, J PROSTHET DENT, V55, P209, DOI 10.1016/0022-3913(86)90345-8
   Goracci C, 2005, OPER DENT, V30, P627
   Goracci C, 2004, EUR J ORAL SCI, V112, P353, DOI 10.1111/j.1600-0722.2004.00146.x
   Grandini S, 2005, DENT MATER, V21, P75, DOI 10.1016/j.dental.2004.02.012
   Kurtz JS, 2003, AM J DENT, V16, p31A
   Molla Karlheinz, 2002, J Adhes Dent, V4, P171
   Pegoretti A, 2002, BIOMATERIALS, V23, P2667, DOI 10.1016/S0142-9612(01)00407-0
   Perdigao J, 2004, AM J DENT, V17, P422
   Perdigao J, 2006, DENT MATER, V22, P752, DOI 10.1016/j.dental.2005.11.002
   Pest LB, 2002, DENT MATER, V18, P596, DOI 10.1016/S0109-5641(02)00003-9
   PEUTZFELDT A, 1995, ACTA ODONTOL SCAND, V53, P29, DOI 10.3109/00016359509005941
   SORENSEN JA, 1984, J PROSTHET DENT, V51, P780, DOI 10.1016/0022-3913(84)90376-7
   Tay F R, 2000, J Adhes Dent, V2, P83
   Tay FR, 2005, J ENDODONT, V31, P584, DOI 10.1097/01.don.0000168891.23486.de
   Tay FR, 1996, J DENT RES, V75, P1034, DOI 10.1177/00220345960750040601
   Terry D A, 2001, J Esthet Restor Dent, V13, P228, DOI 10.1111/j.1708-8240.2001.tb00269.x
   TORBJORNER A, 1995, J PROSTHET DENT, V73, P439, DOI 10.1016/S0022-3913(05)80072-1
   Van Meerbeek B, 2003, OPER DENT, V28, P215
   Vano M, 2006, J ENDODONT, V32, P882, DOI 10.1016/j.joen.2006.02.025
NR 32
TC 10
Z9 13
U1 2
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2010
VL 93B
IS 2
BP 359
EP 366
DI 10.1002/jbm.b.31590
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 583YG
UT WOS:000276715800009
PM 20091920
DA 2018-12-27
ER

PT J
AU Ochiai, E
   Kitagawa, H
   Takada, I
   Fujiyama, S
   Sawatsubashi, S
   Kim, M
   Mezaki, Y
   Tsushima, Y
   Takagi, K
   Azuma, Y
   Takeyama, K
   Yamaoka, K
   Kato, S
   Kamimura, T
AF Ochiai, Eiji
   Kitagawa, Hirochika
   Takada, Ichiro
   Fujiyama, Sally
   Sawatsubashi, Shun
   Kim, Mi-sun
   Mezaki, Yoshihiro
   Tsushima, Yu
   Takagi, Ken-ichiro
   Azuma, Yoshiaki
   Takeyama, Ken-ichi
   Yamaoka, Kazuyoshi
   Kato, Shigeaki
   Kamimura, Takashi
TI RETRACTED: CDP/Cut Is an Osteoblastic Coactivator of the Vitamin D
   Receptor (VDR) (Retracted article. See vol. 28, pg. 432, 2013)
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Article; Retracted Publication
DE 1A,25-DIHYDROXYVITAMIN D-3; VDR; OSTEOBLAST; DIFFERENTIATION;
   COREGULATOR COMPLEX
ID CCAAT DISPLACEMENT PROTEIN; NUCLEAR RECEPTOR; TRANSCRIPTION FACTOR;
   HOMEODOMAIN PROTEIN; 1,25-DIHYDROXYVITAMIN D-3; GENE-EXPRESSION;
   1-ALPHA,25-DIHYDROXYVITAMIN D-3; ALKALINE-PHOSPHATASE; DRIP COMPLEX;
   DNA-BINDING
AB Vitamin D plays an important role in regulating bone and calcium metabolism. The actions of vitamin D are mediated through the nuclear vitamin D receptor (VDR), and gene disruption of the VDR in mice causes skeletal disorders. However, the precise role of the VDR in each stage of osteoblastogenesis is not well understood. To address this issue, we used a biochemical approach to identify an osteoblast-specific coregulator of the VDR. Using a GST-fused VDR ligand-binding domain as bait, proteins associated with liganded VDR were purified from nuclear extracts of HOS osteoblastic cells and compared with those of HeLa cells. Among the interactants identified by mass fingerprinting, CCAAT displacement protein (CDP) was found as a novel ligand-dependent VDR interactant in HOS cells, together with other previously reported DRIP/TRAP complex components. Further biochemical analysis showed that complex formation between the VDR and CDP was distinct from the previously known DRIP/TRAP complex and the p160 family coactivator complexes. Transient expression of CDP potentiated VDR-mediated transcriptional activation in HOS cells. Furthermore, modulation of CDP expression levels in osteoblastic SaM-1 cells affected vitamin D-dependent osteoblast differentiation before the maturation (mineralization) stage. These findings suggest that CDP is a novel differentiation stage-specific coactivator of the VDR in osteoblasts. (C) 2010 American Society for Bone and Mineral Research.
C1 [Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.
   [Ochiai, Eiji; Tsushima, Yu; Takagi, Ken-ichiro; Azuma, Yoshiaki; Yamaoka, Kazuyoshi; Kamimura, Takashi] Teijin Pharma Ltd, Teijin Inst Biomed Res, Tokyo, Japan.
   [Fujiyama, Sally; Sawatsubashi, Shun; Kim, Mi-sun; Yamaoka, Kazuyoshi; Kato, Shigeaki] Japan Sci & Technol, ERATO, Saitama, Japan.
RP Kato, S (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.
EM uskato@mail.ecc.u-tokyo.ac.jp
OI Sawatsubashi, Shun/0000-0003-3093-8334
CR Aubin JE, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P649
   BailleulForestier I, 1996, PEDIATR RES, V39, P636, DOI 10.1203/00006450-199604000-00013
   Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004
   Davideau JL, 1996, ENDOCRINOLOGY, V137, P3577, DOI 10.1210/en.137.8.3577
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Eckey M, 2007, MOL CELL BIOL, V27, P3557, DOI 10.1128/MCB.01106-06
   Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101
   Erben RG, 1998, ENDOCRINOLOGY, V139, P4319, DOI 10.1210/en.139.10.4319
   Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4
   Fujiki R, 2005, EMBO J, V24, P3881, DOI 10.1038/sj.emboj.7600853
   Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954
   Glass CK, 2000, GENE DEV, V14, P121
   Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6
   Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1
   Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325
   Johnson JA, 1996, J BONE MINER RES, V11, P56
   Jurutka P W, 2001, Rev Endocr Metab Disord, V2, P203, DOI 10.1023/A:1010062929140
   Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06
   Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7
   KOSHIHARA Y, 1989, IN VITRO CELL DEV B, V25, P37
   Koshihara Y, 1996, CALCIFIED TISSUE INT, V59, P466, DOI 10.1007/s002239900159
   Li JP, 2007, MOL CELL BIOL, V27, P7345, DOI 10.1128/MCB.02201-06
   Li S, 1999, J BIOL CHEM, V274, P7803, DOI 10.1074/jbc.274.12.7803
   Li SD, 2000, P NATL ACAD SCI USA, V97, P7166, DOI 10.1073/pnas.130028697
   Mailly F, 1996, MOL CELL BIOL, V16, P5346
   MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X
   MATSUMOTO T, 1991, BONE, V12, P27, DOI 10.1016/8756-3282(91)90051-J
   Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031
   Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001
   MULKINS MA, 1983, J BIOL CHEM, V258, P6219
   Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359
   Murayama A, 2004, EMBO J, V23, P1598, DOI 10.1038/sj.emboj.7600157
   Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1
   NEUFELD EJ, 1992, NAT GENET, V1, P50, DOI 10.1038/ng0492-50
   Rachez C, 1999, NATURE, V398, P824
   Rachez C, 2000, MOL CELL BIOL, V20, P2718, DOI 10.1128/MCB.20.8.2718-2726.2000
   Rachez C, 1998, GENE DEV, V12, P1787, DOI 10.1101/gad.12.12.1787
   Rachez C, 2000, GENE, V246, P9, DOI 10.1016/S0378-1119(00)00052-4
   Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537
   Shiraishi A, 2000, J BONE MINER RES, V15, P770, DOI 10.1359/jbmr.2000.15.4.770
   Sinclair AM, 2001, BLOOD, V98, P3658, DOI 10.1182/blood.V98.13.3658
   Sutton ALM, 2005, MOL ENDOCRINOL, V19, P2234, DOI 10.1210/me.2005-0081
   Sutton ALM, 2003, MOL ENDOCRINOL, V17, P777, DOI 10.1210/me.2002.0363
   Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942
   Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647
   Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827
   Takeyama KI, 1999, MOL CELL BIOL, V19, P1049
   Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/.jmb.2005.04.057
   van Gurp MF, 1999, CANCER RES, V59, P5980
   vanWijnen AJ, 1996, P NATL ACAD SCI USA, V93, P11516, DOI 10.1073/pnas.93.21.11516
   Yanagisawa J, 2002, MOL CELL, V9, P553, DOI 10.1016/S1097-2765(02)00478-1
   Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391
NR 52
TC 6
Z9 6
U1 1
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0884-0431
EI 1523-4681
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD MAY
PY 2010
VL 25
IS 5
BP 1157
EP 1166
DI 10.1359/jbmr.091105
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 604PX
UT WOS:000278292100026
PM 19888899
DA 2018-12-27
ER

PT J
AU Ali, S
   Banerjee, S
   Schaffert, JM
   El-Rayes, BF
   Philip, PA
   Sarkar, FH
AF Ali, Shadan
   Banerjee, Sanjeev
   Schaffert, Jacqueline M.
   El-Rayes, Bassel F.
   Philip, Philip A.
   Sarkar, Fazlul H.
TI RETRACTED: Concurrent Inhibition of NF-kappa B, Cyclooxygenase-2, and
   Epidermal Growth Factor Receptor Leads to Greater Anti-Tumor Activity in
   Pancreatic Cancer (Retracted article. See vol. 117, pg. 1961, 2016)
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article; Retracted Publication
DE PANCREATIC CANCER; 3,3 '-DIINDOLYLMETHANE; ERLOTINIB; GEMCITABINE;
   NF-kappa B; COX-2
ID KAPPA-B; INCREASED APOPTOSIS; CELL-LINES; EXPRESSION; ERLOTINIB; COX-2;
   GEMCITABINE; ACTIVATION; CURCUMIN; THERAPY
AB Inactivation of survival pathways such as NF-kappa B, cyclooxygenase (COX-2), or epidermal growth factor receptor (EGFR) signaling individually may not be sufficient for the treatment of advanced pancreatic cancer (PC) as suggested by recent clinical trials. 3,3'-Diindolylmethane (B-DIM) is an inhibitor of NF-kappa B and COX-2 and is a well-known chemopreventive agent. We hypothesized that the inhibition of NF-kappa B and COX-2 by B-DIM concurrently with the inhibition of EGFR by erlotinib will potentiate the anti-tumor effects of cytotoxic drug gemcitabine, which has been tested both in vitro and in vivo. Inhibition of viable cells in seven PC cell lines treated with B-DIM, erlotinib, or gemcitabine alone or their combinations was evaluated using 3-(4,5-dimetylthiazol-2-y1)-2,5-diphenyltetrazolium bromide (MU) assay. Significant inhibition in cell viability was observed in PC cells expressing high levels of COX-2, EGFR, and NF-kappa B proteins. The observed inhibition was associated with an increase in apoptosis as assessed by ELISA. A significant down-regulation in the expression of COX-2, NF-kappa B, and EGFR in BxPC-3, COLO-357, and HPAC cells was observed, suggesting that simultaneous targeting of EGFR, NF-kappa B, and COX-2 is more effective than targeting either signaling pathway separately. Our in vitro results were further supported by in vivo studies showing that B-DIM in combination with erlotinib and gemcitabine was significantly more effective than individual agents. Based on our preclinical in vitro and in vivo results, we conclude that this multi-targeted combination could be developed for the treatment of PC patients whose tumors express high levels of COX-2. EGFR, and NF-kappa B. J. Cell. Biochem. 110: 171-181, 2010. (C) 2010 Wiley-Liss, Inc.
C1 [Sarkar, Fazlul H.] Wayne State Univ, Sch Med, Karmanos Canc Inst, Dept Pathol, Detroit, MI 48201 USA.
   [Ali, Shadan; El-Rayes, Bassel F.; Philip, Philip A.] Wayne State Univ, Karmanos Canc Inst, Div Hematol Oncol, Detroit, MI 48201 USA.
RP Sarkar, FH (reprint author), Wayne State Univ, Sch Med, Karmanos Canc Inst, Dept Pathol, 740 Hudson Webber Canc Res Ctr,4100 John R St, Detroit, MI 48201 USA.
EM fsarkar@med.wayne.edu
FU Guido Foundation; National Cancer Institute (NIH) [R01CA131151,
   R01CA132794]; Puschelberg Foundation
FX Grant sponsor: Guido Foundation; Grant sponsor: National Cancer
   Institute (NIH): Grant numbers: R01CA131151, R01CA132794; Grant sponsor:
   Puschelberg Foundation.
CR Ali S, 2005, MOL CANCER THER, V4, P1943, DOI 10.1158/1535-7163.MCT-05-0065
   Ali S, 2008, MOL CANCER THER, V7, P1708, DOI 10.1158/1535-7163.MCT-08-0354
   Bergmann F, 2009, AM J GASTROENTEROL, V104, P171, DOI 10.1038/ajg.2008.33
   Cai Y, 2008, INT J CANCER, V123, P195, DOI 10.1002/ijc.23481
   Colby JK, 2008, NEOPLASIA, V10, P782, DOI 10.1593/neo.08330
   Dediu M, 2007, J BUON, V12, pS137
   Dong M, 1998, ANTICANCER RES, V18, P4613
   El-Rayes BF, 2004, MOL CANCER THER, V3, P1421
   Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008
   Hasan S, 2008, PANCREAS, V37, P121, DOI 10.1097/MPA.0b013e31816618ba
   Hong CB, 2002, CARCINOGENESIS, V23, P1297, DOI 10.1093/carcin/23.8.1297
   Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006
   Kourelis K, 2008, EUR ARCH OTO-RHINO-L, V265, P79, DOI 10.1007/s00405-007-0441-7
   Lev-Ari S, 2007, CANCER INVEST, V25, P411, DOI 10.1080/07357900701359577
   Lev-Ari S, 2006, ANTICANCER RES, V26, P4423
   Logan RM, 2007, ORAL ONCOL, V43, P395, DOI 10.1016/j.oraloncology.2006.04.011
   Mohammad RM, 2007, CLIN CANCER RES, V13, P2226, DOI 10.1158/1078-0432.CCR-06-1574
   Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525
   Niu JG, 2004, J BIOL CHEM, V279, P16452, DOI 10.1074/jbc.M309789200
   Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289
   Papouchado B, 2005, MODERN PATHOL, V18, P1329, DOI 10.1038/modpathol.3800427
   Rahman KMW, 2007, MOL CANCER THER, V6, P2757, DOI 10.1158/1535-7163.MCT-07-0336
   TIWARI RK, 1994, J NATL CANCER I, V86, P126, DOI 10.1093/jnci/86.2.126
   Woodburn JR, 1999, PHARMACOL THERAPEUT, V82, P241, DOI 10.1016/S0163-7258(98)00045-X
NR 24
TC 23
Z9 24
U1 2
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD MAY 1
PY 2010
VL 110
IS 1
BP 171
EP 181
DI 10.1002/jcb.22523
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 593CO
UT WOS:000277429700019
PM 20213764
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Li, J
   Zhang, LQ
AF Li, J.
   Zhang, L. Q.
TI RETRACTED: Carbon Nanotube as a Reinforcing Additive for PEEK Composite
   Filled with Carbon Fiber (Retracted article. See vol. 29, pg. 3297,
   2010)
SO JOURNAL OF REINFORCED PLASTICS AND COMPOSITES
LA English
DT Article; Retracted Publication
DE carbon fiber; multiwall carbon nanotubes; polyether ether ketone; wear
   resistance
ID WEAR; FRICTION; PERFORMANCE; PLASTICS; WOVEN
AB The main objective of this article is to develop high wear resistance carbon fiber reinforced polyether ether ketone (PEEK) composite, with addition of multiwall carbon nanotube (MWCNT). These compounds were well mixed in a Haake batch mixer and compounded polymers were fabricated into sheets of known thickness by compression molding. Samples were tested for wear resistance with respect to different concentration of fillers. The wear resistance properties of these samples depend on filler aspect ratio. Wear resistance of composite with 20 wt% carbon fabric increased when MWCNT was introduced. The worn surface features have been examined using scanning electron microscope. Photomicrographs of the worn surfaces revealed higher wear resistance with the addition of carbon nanotube. In addition, better interfacial adhesion was observed between carbon and vinyl ester in carbon-reinforced vinyl ester composite.
C1 [Li, J.; Zhang, L. Q.] Shanghai Second Polytech Univ, Sch Mech & Elect Engn, Shanghai 201209, Peoples R China.
RP Zhang, LQ (reprint author), Shanghai Second Polytech Univ, Sch Mech & Elect Engn, Shanghai 201209, Peoples R China.
EM bingxue456456@sina.com
FU Shanghai Education Commission [RJD309002]
FX The authors thank Shanghai Education Commission (Project No. RJD309002)
   for their help.
CR Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Bijwe J, 2008, POLYM COMPOSITE, V29, P337, DOI 10.1002/pc.20544
   Cadek M, 2002, CARBON, V40, P923, DOI 10.1016/S0008-6223(01)00221-4
   CHAND N, 1994, J MATER SCI LETT, V13, P230, DOI 10.1007/BF00571759
   Dalton AB, 2003, NATURE, V423, P703, DOI 10.1038/423703a
   Friedrich K, 1995, WEAR, V190, P139, DOI 10.1016/0043-1648(96)80012-3
   LANCASTER JK, 1968, J PHYS D APPL PHYS, V1, P549, DOI 10.1088/0022-3727/1/5/303
   LU Z, 1993, WEAR, V162, P1103, DOI 10.1016/0043-1648(93)90129-A
   Rajesh JJ, 2002, WEAR, V252, P769, DOI 10.1016/S0043-1648(02)00039-X
   Rekha R., 2006, MAT SCI ENG A-STRUCT, VA420, P342
   Ryan KP, 2007, COMPOS SCI TECHNOL, V67, P1640, DOI 10.1016/j.compscitech.2006.07.006
   Shivakumar KN, 2006, J REINF PLAST COMP, V25, P1101, DOI 10.1177/0731684406065194
   Soutis C, 2005, MAT SCI ENG A-STRUCT, V412, P171, DOI 10.1016/j.msea.2005.08.064
   Suresha B, 2006, J REINF PLAST COMP, V25, P771, DOI 10.1177/0731684406063540
   VISHWANATH B, 1993, WEAR, V167, P93, DOI 10.1016/0043-1648(93)90313-B
   Wei CY, 2004, NANO LETT, V4, P1949, DOI 10.1021/nl048845m
   Zhang QH, 2006, MACROMOLECULES, V39, P658, DOI 10.1021/ma051031n
   Zhang S, 2008, POLYMER, V49, P1356, DOI 10.1016/j.polymer.2008.01.018
NR 18
TC 4
Z9 5
U1 4
U2 37
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0731-6844
EI 1530-7964
J9 J REINF PLAST COMP
JI J. Reinf. Plast. Compos.
PD MAY
PY 2010
VL 29
IS 10
BP 1523
EP 1533
DI 10.1177/0731684409337555
PG 11
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA 602DA
UT WOS:000278117500009
DA 2018-12-27
ER

PT J
AU Bukhari, U
   Sadiq, S
   Memon, JH
   Baig, F
AF Bukhari, Uzma
   Sadiq, Saleem
   Memon, Jawaid Hussin
   Baig, Farooq
TI RETRACTED: Thyroid Carcinoma - Experience at Jinnah Postgraduate Medical
   Centre Karachi (Retracted article. See vol. 61, pg. 620, 2011)
SO JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION
LA English
DT Article; Retracted Publication
ID CANCER; NODULES
AB Objective: To evaluate the frequency and types of thyroid carcinoma with respect to age and sex groups.
   Methods: This was a retrospective study conducted at the Department of Pathology, Basic Medical Sciences Institute, Jinnah postgraduate medical centre Karachi. A total of 998 thyroid lesions over a period of 05 years, from July 2000 to June 2005 were reviewed. H and E slides were studied to determine the types and frequencies of malignant lesions of thyroid. Special stains were performed whenever required.
   Results: A total of 998 thyroid lesions were reviewed, of which 153 were found to be malignant. Papillary carcinoma was the commonest malignant lesion with a frequency of 90.2% followed by 4.5% medullary carcinoma, 2% follicular carcinoma, 2% undifferentiated carcinoma and 0.7% each of mixed medullary and papillary carcinoma and poorly differentiated carcinoma. Females were predominant 82.4% as compared to males 17.6% with female to male ratio 4.7:1. Maximum number of the patients were seen in 4th decade of life followed by 3rd and 2nd decades.
   Conclusion: The commonest malignant thyroid lesion was papillary carcinoma. Thyroid cancer was more common in females. Patients of papillary, medullary and follicular carcinomas were found in 3rd and 4th decades of life while poorly. and undifferentiated carcinomas were diagnosed from 5th to 7th decades of life (JPMA 60:365; 2010).
C1 [Bukhari, Uzma; Memon, Jawaid Hussin; Baig, Farooq] Muhammad Med Coll, Dept Pathol, Mirpurkhas, Pakistan.
   [Sadiq, Saleem] Jinnah Postgrad Med Ctr, Dept Pathol, Karachi, Pakistan.
RP Bukhari, U (reprint author), Muhammad Med Coll, Dept Pathol, Mirpurkhas, Pakistan.
CR Abdullah M, 2002, ANZ J SURG, V72, P660, DOI 10.1046/j.1445-2197.2002.02517.x
   Abdulmughni YA, 2004, SAUDI MED J, V25, P55
   ABUESHY SA, 1995, ANN SAUDI MED, V15, P74, DOI 10.5144/0256-4947.1995.74
   AHMED I, 1999, BIOMEDICA, V15, P39
   Ahmed M, 1995, ANN SAUDI MED, V15, P579, DOI 10.5144/0256-4947.1995.579
   Al-Mashat FMH, 2004, ANN SAUDI MED, V24, P213, DOI 10.5144/0256-4947.2004.213
   AXELRAD AA, 1955, CANCER, V8, P339, DOI 10.1002/1097-0142(1955)8:2<339::AID-CNCR2820080214>3.0.CO;2-M
   BELFIORE A, 1992, AM J MED, V93, P363, DOI 10.1016/0002-9343(92)90164-7
   CARCANGIU ML, 2000, ANDERSONS PATHOLOGY, P1943
   DELELLIS RA, 2004, WHO CLASSIFICATION T, P51
   El-Helal TA, 1997, ANN SAUDI MED, V17, P506, DOI 10.5144/0256-4947.1997.506
   HAY ID, 1990, ENDOCRIN METAB CLIN, V19, P545, DOI 10.1016/S0889-8529(18)30310-4
   Hundahl SA, 2000, CANCER, V89, P202, DOI 10.1002/1097-0142(20000701)89:1<202::AID-CNCR27>3.0.CO;2-A
   Hussain N, 2005, BIOMEDICA, V21, P18
   KHAN SH, 1993, J SURG PIMS, V7, P1
   KHAN SH, 1993, J SURG PIMS, V6, P1
   Larijani B, 2005, MED PRIN PRACT, V14, P396, DOI 10.1159/000088112
   MEIER CA, 1994, J CLIN ENDOCR METAB, V78, P188, DOI 10.1210/jc.78.1.188
   Sarfraz T, 2000, PAK ARMED FORCES MED, V50, P98
   Shah Sajid H., 1999, JPMA (Journal of the Pakistan Medical Association), V49, P131
   SIMOES SM, 1995, CURR DIAGNOSTIC PATH, V2, P15
   SOCOLOW EL, 1963, NEW ENGL J MED, V268, P406, DOI 10.1056/NEJM196302212680803
   Sondik EJ, 1998, CANCER, V83, P1757, DOI 10.1002/(SICI)1097-0142(19981015)83:8+<1757::AID-CNCR18>3.0.CO;2-2
   Tai P, 2003, CURRENT ONCOLOGY, V10, P54
   Weiss RE, 2002, CURR OPIN ONCOL, V14, P46, DOI 10.1097/00001622-200201000-00009
   WILLIAMS ED, 1977, CANCER, V39, P215, DOI 10.1002/1097-0142(197701)39:1<215::AID-CNCR2820390134>3.0.CO;2-#
NR 26
TC 4
Z9 4
U1 1
U2 8
PU PAKISTAN MEDICAL ASSOC
PI KARACHI
PA PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN
SN 0030-9982
J9 J PAK MED ASSOC
JI J. Pak. Med. Assoc.
PD MAY
PY 2010
VL 60
IS 5
BP 365
EP 367
PG 3
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA 582ZI
UT WOS:000276639700012
PM 20527608
DA 2018-12-27
ER

PT J
AU Nassirpour, R
   Shao, LH
   Flanagan, P
   Abrams, T
   Jallal, B
   Smeal, T
   Yin, MJ
AF Nassirpour, Rounak
   Shao, Lihua
   Flanagan, Peter
   Abrams, Tinya
   Jallal, Bahija
   Smeal, Tod
   Yin, Min-Jean
TI RETRACTED: Nek6 Mediates Human Cancer Cell Transformation and Is a
   Potential Cancer Therapeutic Target(Retracted article. See vol. 15, pg.
   358, 2017)
SO MOLECULAR CANCER RESEARCH
LA English
DT Article; Retracted Publication
ID NIMA-RELATED KINASES; MITOTIC SPINDLE FORMATION; ASPERGILLUS-NIDULANS;
   SERINE/THREONINE KINASE; VERTEBRATE CELLS; PROTEIN-KINASES; CYCLE
   KINASES; FAMILY KINASE; EXPRESSION; PHOSPHORYLATION
AB We investigated the role of Nek6, a member of the NIMA-related serine/ threonine kinase family, in tumorigenesis. Transcript, protein, and kinase activity levels of Nek6 were highly elevated in the malignant tumors and human cancer cell lines compared with normal tissue and fibroblast cells. Expression of exogenous wild-type Nek6 increased anchorage-independent growth of a variety of human cancer cell lines, whereas overexpression of the kinase-dead Nek6 and RNAi knockdown of endogenous Nek6 suppressed cancer cell transformation and induced apoptosis. Additionally, in in vivo xenograft nude mouse model, knockdown of Nek6 in HeLa cells resulted in reduction of tumor size relative to control siRNA tumors. Most importantly, knocking down endogenous Nek6 levels or exogenous expression of the kinase-dead form did not inhibit cell proliferation, nor did it induce apoptosis in normal fibroblast cells. Taken together, our data indicate a pivotal role for Nek6 in tumorigenesis and establish Nek6 as a potential target for treatment of a variety of human cancers. Mol Cancer Res; 8(5); 717-28. (C)2010 AACR.
C1 [Nassirpour, Rounak; Shao, Lihua; Flanagan, Peter; Abrams, Tinya; Jallal, Bahija; Smeal, Tod; Yin, Min-Jean] Pfizer Global Res & Dev, La Jolla Labs, San Diego, CA 92121 USA.
RP Yin, MJ (reprint author), Pfizer Global Res & Dev, La Jolla Labs, 10724 Sci Ctr Dr, San Diego, CA 92121 USA.
EM min-jean.yin@pfizer.com
CR Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200
   Capra M, 2006, CANCER RES, V66, P8147, DOI 10.1158/0008-5472-CAN-05-3489
   Chen J, 2006, BIOCHEM BIOPH RES CO, V341, P1059, DOI 10.1016/j.bbrc.2005.12.228
   De Souza CPC, 2000, CELL, V102, P293, DOI 10.1016/S0092-8674(00)00035-0
   Deep G, 2008, CURR OPIN INVEST DR, V9, P591
   Fry AM, 1997, METHOD ENZYMOL, V283, P270
   Giet R, 1999, J CELL SCI, V112, P3591
   Hames RS, 2001, EMBO J, V20, P7117, DOI 10.1093/emboj/20.24.7117
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   Hayashi K, 1999, BIOCHEM BIOPH RES CO, V264, P449, DOI 10.1006/bbrc.1999.1536
   Hayward DG, 2006, CANCER LETT, V237, P155, DOI 10.1016/j.canlet.2005.06.017
   Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710
   Kokuryo T, 2007, CANCER RES, V67, P9637, DOI 10.1158/0008-5472.CAN-07-1489
   Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907
   Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JC126252
   Lee MY, 2008, CELL CYCLE, V7, P2705, DOI 10.4161/cc.7.17.6551
   LEIBOVITZ A, 1976, CANCER RES, V36, P4562
   Li JJ, 2006, PHARMACOL THERAPEUT, V111, P974, DOI 10.1016/j.pharmthera.2006.02.006
   Lu K P, 1995, Prog Cell Cycle Res, V1, P187
   LU KP, 1995, CELL, V81, P413, DOI 10.1016/0092-8674(95)90394-1
   Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008
   Minoguchi S, 2003, BIOCHEM BIOPH RES CO, V301, P899, DOI 10.1016/S0006-291X(03)00049-4
   Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096
   O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4
   O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25
   O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08
   Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9
   OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495
   PU RT, 1995, EMBO J, V14, P995, DOI 10.1002/j.1460-2075.1995.tb07080.x
   Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681
   Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360
   ROBERT EH, 2000, J PATHOL, V192, P446
   Roig J, 2002, GENE DEV, V16, P1640, DOI 10.1101/gad.972202
   Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672
   Smith MR, 1997, BIOCHEM BIOPH RES CO, V234, P397, DOI 10.1006/bbrc.1997.6633
   Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968
   Takeno A, 2008, BRIT J CANCER, V99, P1307, DOI 10.1038/sj.bjc.6604682
   Wu L, 1998, J CELL BIOL, V141, P1575, DOI 10.1083/jcb.141.7.1575
   Ye XS, 1997, METHOD ENZYMOL, V283, P520
   Yin MJ, 2003, J BIOL CHEM, V278, P52454, DOI 10.1074/jbc.M308080200
   Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3
NR 41
TC 39
Z9 41
U1 2
U2 3
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1541-7786
EI 1557-3125
J9 MOL CANCER RES
JI Mol. Cancer Res.
PD MAY
PY 2010
VL 8
IS 5
BP 717
EP 728
DI 10.1158/1541-7786.MCR-09-0291
PG 12
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA 607GM
UT WOS:000278487100008
PM 20407017
OA Bronze
DA 2018-12-27
ER

PT J
AU Noordewier, MK
   Stapel, DA
AF Noordewier, Marret K.
   Stapel, Diederik A.
TI RETRACTED: Affects of the Unexpected: When Inconsistency Feels Good (or
   Bad) (Retracted article. See vol. 38, pg. 1378, 2012)
SO PERSONALITY AND SOCIAL PSYCHOLOGY BULLETIN
LA English
DT Article; Retracted Publication
DE expectancies; disconfirmation; consistency; affect; judgment
ID STEREOTYPE DISCONFIRMATION; INDIVIDUAL-DIFFERENCES; TERROR MANAGEMENT;
   PERSON PERCEPTION; CONSEQUENCES; DISSONANCE; PROMOTION; CURIOSITY;
   THREAT; NEED
AB Affective responses to disconfirmation of expectancies have paradoxical features: Incongruency is uncomfortable and elicits negative affect, but how do people feel when the incongruent outcome is positive? This article shows that affective responses to disconfirmed expectancies depend on whether people value consistency and thus focus on the expectancy-congruency of the outcome or on its valence. People with high need for structure, a prevention focus, or for whom mortality is salient, assign more value to consistency and are more congruency focused:They feel more positive after congruent outcomes than after incongruent outcomes (independent of valence). People with low need for structure, a promotion focus, or for whom mortality is not salient, value consistency less and are more outcome focused:They feel more positive after positive outcomes than after negative outcomes (independent of congruency). This article furthermore shows how responses to the unexpected unfold and that a congruency focus requires less cognitive resources than an outcome focus.
C1 [Noordewier, Marret K.] Tilburg Univ, Dept Social Psychol, Tilburg Inst Behav Econ Res, NL-5000 LE Tilburg, Netherlands.
RP Noordewier, MK (reprint author), Tilburg Univ, Dept Social Psychol, Tilburg Inst Behav Econ Res, POB 90153, NL-5000 LE Tilburg, Netherlands.
EM m.k.noordewier@uvt.nl
CR Abelson R. P., 1968, THEORIES COGNITIVE C
   ARONSON E, 1962, J ABNORM PSYCHOL, V65, P178, DOI 10.1037/h0042291
   Aronson E., 1968, THEORIES COGNITIVE C, P5
   Berlyne DE, 1954, BRIT J PSYCHOL, V45, P180, DOI 10.1111/j.2044-8295.1954.tb01243.x
   Biernat M., 2005, STANDARDS EXPECTANCI
   CARLSMITH JM, 1963, J ABNORM PSYCHOL, V66, P151, DOI 10.1037/h0042692
   Cooper J. M., 2007, COGNITIVE DISSONANCE
   ELLIOT AJ, 1994, J PERS SOC PSYCHOL, V67, P382, DOI 10.1037/0022-3514.67.3.382
   Festinger L., 1957, THEORY COGNITIVE DIS
   Forster J, 2004, SOC COGNITION, V22, P54
   Forster J, 2000, SOC COGNITION, V18, P178, DOI 10.1521/soco.2000.18.2.178
   Friedman RS, 2005, PERS SOC PSYCHOL B, V31, P1217, DOI 10.1177/0146167204274077
   Friedman RS, 2001, J PERS SOC PSYCHOL, V81, P1001, DOI 10.1037//0022-3514.81.6.1001
   GILBERT DT, 1989, THINKING LIGHTLY OTH
   Greenberg J, 1997, TERROR MANAGEMENT TH
   Harmon-Jones E, 1999, SCI CON SER, P71, DOI 10.1037/10318-004
   Harmon-Jones Eddie, 1999, COGNITIVE DISSONANCE
   Heider F., 1958, PSYCHOL INTERPERSONA
   KLEIN WM, 1992, J EXP SOC PSYCHOL, V28, P145, DOI 10.1016/0022-1031(92)90036-J
   Landau MJ, 2004, J PERS SOC PSYCHOL, V87, P190, DOI 10.1037/0022-3514.87.2.190
   Liberman N, 1999, J PERS SOC PSYCHOL, V77, P1135, DOI 10.1037//0022-3514.77.6.1135
   Lockwood P, 2002, J PERS SOC PSYCHOL, V83, P854, DOI 10.1037//0022-3514.83.4.854
   LOEWENSTEIN G, 1994, PSYCHOL BULL, V116, P75, DOI 10.1037/0033-2909.116.1.75
   Macrae CN, 1999, J PERS SOC PSYCHOL, V76, P200, DOI 10.1037//0022-3514.76.2.200
   Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93
   Mendes WB, 2007, J PERS SOC PSYCHOL, V92, P698, DOI 10.1037/0022-3514.92.4.698
   NEUBERG SL, 1993, J PERS SOC PSYCHOL, V65, P113, DOI 10.1037/0022-3514.65.1.113
   NOORDEWIER MK, 2009, FAILURE FEELS BETTER
   Olson J. M., 1996, SOCIAL PSYCHOL HDB B, P211
   Roese N. J., 2007, SOCIAL PSYCHOL HDB B, P91
   Schwarz N., 1990, HDB MOTIVATION COGNI, V2, P527, DOI DOI 10.1016/J.NEUBIOREV.2008.01.001
   Shepperd JA, 2002, PSYCHOL SCI, V13, P85, DOI 10.1111/1467-9280.00416
   SNYDER M, 1978, J PERS SOC PSYCHOL, V36, P1202, DOI 10.1037/0022-3514.36.11.1202
   Swann Jr. W. B., 1983, PSYCHOL PERSPECTIVES, V2, P33
   SWANN WB, 1990, HDB MOTIVATION COGNI, V2, P408
   TAVRIS C, 2007, MISTAKES MADE ME WHY
   Thompson M. M., 1989, ANN M CAN PSYCH ASS
   WEBSTER DM, 1994, J PERS SOC PSYCHOL, V67, P1049, DOI 10.1037/0022-3514.67.6.1049
   West S. G, 1991, MULTIPLE REGRESSION
   ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848
NR 40
TC 8
Z9 9
U1 2
U2 17
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0146-1672
EI 1552-7433
J9 PERS SOC PSYCHOL B
JI Pers. Soc. Psychol. Bull.
PD MAY
PY 2010
VL 36
IS 5
BP 642
EP 654
DI 10.1177/0146167209357746
PG 13
WC Psychology, Social
SC Psychology
GA 594XH
UT WOS:000277573700005
PM 20231375
DA 2018-12-27
ER

PT J
AU Scabini, S
   Rimini, E
   Romairone, E
   Scordamaglia, R
   Damiani, G
   Pertile, D
   Ferrando, V
AF Scabini, Stefano
   Rimini, Edoardo
   Romairone, Emanuele
   Scordamaglia, Renato
   Damiani, Giampiero
   Pertile, Davide
   Ferrando, Valter
TI RETRACTED: Colon and rectal surgery for cancer without mechanical bowel
   preparation: One-center randomized prospective trial (Retracted article.
   See vol. 10, 196, 2012)
SO WORLD JOURNAL OF SURGICAL ONCOLOGY
LA English
DT Article; Retracted Publication
ID ELECTIVE COLORECTAL SURGERY; OBSTRUCTED LEFT COLON; PRIMARY ANASTOMOSIS;
   SUBTOTAL COLECTOMY; CLEANSING METHODS; SODIUM-PHOSPHATE; PRIMARY REPAIR;
   RESECTION; LAVAGE; MANAGEMENT
AB Background: Mechanical bowel preparation is routinely done before colon and rectal surgery, aimed at reducing the risk of postoperative infectious complications. The aim of the study was to assess whether elective colon and rectal surgery can be safely performed without preoperative mechanical bowel preparation.
   Methods: Patients undergoing elective colon and rectal resections with primary anastomosis were prospectively randomized into two groups. Group A had mechanical bowel preparation with polyethylene glycol before surgery, and group B had their surgery without preoperative mechanical bowel preparation. Patients were followed up for 30 days for wound, anastomotic, and intra-abdominal infectious complications.
   Results: Two hundred forty four patients were included in the study, 120 in group A and 124 in group B. Demographic characteristics, type of surgical procedure and type of anastomosis did not significantly differ between the two groups. There was no difference in the rate of surgical infectious complications between the two groups but the overall infectious complications rate was 20.0% in group A and 11.3% in group B (p.05). Wound infection (p = 0.18), anastomotic leak (p = 0.52), and intra-abdominal abscess (p = 0.36) occurred in 9.2%, 5.8%, and 5.0% versus 4.8%, 4.0%, and 2.4%, respectively. No mechanical bowel preparation seems to be safe also in rectal surgery.
   Conclusions: These results suggest that elective colon and rectal surgery may be safely performed without mechanical preparation.
C1 [Scabini, Stefano; Rimini, Edoardo; Romairone, Emanuele; Scordamaglia, Renato; Damiani, Giampiero; Pertile, Davide; Ferrando, Valter] San Martino Hosp, Dept Ematooncol, Unit Surg Oncol, Genoa, Italy.
RP Scabini, S (reprint author), San Martino Hosp, Dept Ematooncol, Unit Surg Oncol, Genoa, Italy.
EM stefanoscabini@libero.it
CR BECK DE, 1990, DIS COLON RECTUM, V33, P12, DOI 10.1007/BF02053194
   BRACHMAN PS, 1980, SURG CLIN N AM, V60, P15
   Bretagnol F, 2007, BRIT J SURG, V94, P1266, DOI 10.1002/bjs.5524
   BURKE P, 1994, BRIT J SURG, V81, P907, DOI 10.1002/bjs.1800810639
   COHEN SM, 1994, DIS COLON RECTUM, V37, P689, DOI 10.1007/BF02054413
   Conrad JK, 2000, DIS COLON RECTUM, V43, P466, DOI 10.1007/BF02237188
   Curran TJ, 1999, AM J SURG, V177, P42, DOI 10.1016/S0002-9610(98)00293-1
   DORUDI S, 1990, ANN ROY COLL SURG, V72, P393
   GLENN F, 1966, ANN SURG, V163, P838, DOI 10.1097/00000658-196606000-00004
   Gonzalez RP, 1996, J TRAUMA, V41, P271, DOI 10.1097/00005373-199608000-00012
   Guenaga KKFG, 2009, COCHRANE DATABASE SY
   Harris LJ, 2009, AM SURGEON, V75, P828
   IRVIN TT, 1976, SURG GYNECOL OBSTET, V143, P443
   KEIGHLEY MRB, 1982, WORLD J SURG, V6, P464, DOI 10.1007/BF01657683
   Mainar A, 1999, RADIOLOGY, V210, P65, DOI 10.1148/radiology.210.1.r99ja0665
   MEALY K, 1988, BRIT J SURG, V75, P1216, DOI 10.1002/bjs.1800751224
   Miettinen RPJ, 2000, DIS COLON RECTUM, V43, P669
   MURRAY JJ, 1991, DIS COLON RECTUM, V34, P527
   Naraynsingh V, 1999, BRIT J SURG, V86, P1341, DOI 10.1046/j.1365-2168.1999.01230.x
   Nichols RL, 1997, CLIN INFECT DIS, V24, P609, DOI 10.1093/clind/24.4.609
   ODWYER PJ, 1989, BRIT J SURG, V76, P756, DOI 10.1002/bjs.1800760738
   Oliveira L, 1997, DIS COLON RECTUM, V40, P585, DOI 10.1007/BF02055384
   PITOT D, 2009, ACTA CHIR BELG, V52, P5
   SANTOS JCM, 1994, BRIT J SURG, V81, P1673, DOI 10.1002/bjs.1800811139
   SASAKI LS, 1995, J TRAUMA, V39, P895, DOI 10.1097/00005373-199511000-00013
   SCHEIN M, 1995, DIS COLON RECTUM, V38, P749, DOI 10.1007/BF02048035
   Single-stage treatment for malignant left-sided colonic obstruction: a prospective randomized clinical trial comparing subtotal colectomy with segmental resection following intraoperative irrigation. The SCOTIA Study Group, 1995, BR J SURG, V82, P1622
   SOLLA JA, 1990, DIS COLON RECTUM, V33, P154, DOI 10.1007/BF02055549
   STEWART J, 1993, SURGERY, V114, P502
   Tejero E, 1997, DIS COLON RECTUM, V40, P432, DOI 10.1007/BF02258387
   Torralba JA, 1998, DIS COLON RECTUM, V41, P18, DOI 10.1007/BF02236890
   WHITE CM, 1985, DIS COLON RECTUM, V28, P155, DOI 10.1007/BF02554230
   Yoshioka K, 2000, DIGEST SURG, V17, P66, DOI 10.1159/000018802
   1992, BR J SURG, V79, P461
NR 34
TC 25
Z9 28
U1 2
U2 13
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1477-7819
J9 WORLD J SURG ONCOL
JI World J. Surg. Oncol.
PD APR 30
PY 2010
VL 8
AR 35
DI 10.1186/1477-7819-8-35
PG 5
WC Oncology; Surgery
SC Oncology; Surgery
GA 605HP
UT WOS:000278338800001
PM 20433721
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Qian, FP
   Wang, HG
AF Qian, Fuping
   Wang, Haigang
TI RETRACTED: Study of the filtration performance of a plain wave fabric
   filter using response surface methodology (Retracted article. See vol.
   182, pg. 946, 2010)
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article; Retracted Publication
DE Plain wave fabric filter; Filtration performance; Geometry parameter;
   Operating condition; Response surface methodology
ID AEROSOL FILTRATION; WOVEN FABRICS; VISCOUS FLOW; PERMEABILITY;
   SIMULATION; EFFICIENCY; MEDIA; COLLECTION; CYLINDERS; MODELS
AB The gas-solid two-phase flows in the plain wave fabric filter were simulated by computational fluid dynamics (CFD) technology, and the warps and wefts of the fabric filter were made of filaments with different dimensions. The numerical solutions were carried out using commercial computational fluid dynamics (CFD) code Fluent 6.1. The filtration performances of the plain wave fabric filter with different geometry parameters and operating condition, including the horizontal distance, the vertical distance and the face velocity were calculated. The effects of geometry parameters and operating condition on filtration efficiency and pressure drop were studied using response surface methodology (RSM) by means of the statistical software (Minitab V14), and two second-order polynomial models were obtained with regard to the effect of the three factors as stated above. Moreover, the models were modified by dismissing the insignificant terms. The results show that the horizontal distance, vertical distance and the face velocity all play an important role in influencing the filtration efficiency and pressure drop of the plane wave fabric filters. The horizontal distance of 3.8 times the fiber diameter, the vertical distance of 4.0 times the fiber diameter and Reynolds number of 0.98 are found to be the optimal conditions to achieve the highest filtration efficiency at the same face velocity, while maintaining an acceptable pressure drop. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Qian, Fuping; Wang, Haigang] Anhui Univ Technol, Sch Civil Engn & Architecture, Maanshan 243002, Anhui, Peoples R China.
RP Qian, FP (reprint author), Anhui Univ Technol, Sch Civil Engn & Architecture, Hu Dong Rd 59, Maanshan 243002, Anhui, Peoples R China.
EM fpingqian@gmail.com
RI Lv, Henry/C-9692-2011
FU National Natural Science Foundation of China [50708001]
FX This research was financially supported by the National Natural Science
   Foundation of China Project No. 50708001.
CR An En-ke, 2005, Journal of Tongji University (Natural Science), V33, P121
   Benesse M, 2006, J AEROSOL SCI, V37, P974, DOI 10.1016/j.jaerosci.2005.10.003
   Box G. E., 1987, EMPIRICAL MODEL BUIL
   Brasquet C, 2000, CHEM ENG SCI, V55, P2767, DOI 10.1016/S0009-2509(99)00549-7
   Breard J, 2003, POLYM COMPOSITE, V24, P391, DOI 10.1002/pc.10038
   DAVIES CN, 1973, AIR FILTRATION
   Denschlag R, 2008, CHEM PHYS LETT, V458, P244, DOI 10.1016/j.cplett.2008.04.114
   Green SI, 2008, COMPUT FLUIDS, V37, P1148, DOI 10.1016/j.compfluid.2007.10.013
   HAPPEL J, 1959, AICHE J, V5, P174, DOI 10.1002/aic.690050211
   Hinkelmann K., 1994, DESIGN ANAL EXPT, VI
   Jaganathan S, 2008, CHEM ENG SCI, V63, P244, DOI 10.1016/j.ces.2007.09.020
   Klemm RJ, 2000, J AIR WASTE MANAGE, V50, P1433, DOI 10.1080/10473289.2000.10464188
   Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165
   KUWABARA S, 1959, J PHYS SOC JPN, V14, P527, DOI 10.1143/JPSJ.14.527
   LI A, 1992, AEROSOL SCI TECH, V16, P209, DOI 10.1080/02786829208959550
   MAINI SM, 1994, TEXTILE PROGR, V26, P1
   OUNIS H, 1990, AEROSOL SCI TECH, V13, P47, DOI 10.1080/02786829008959423
   Patankar SV, 1980, NUMERICAL HEAT TRANS
   Pavageau M, 2000, CHEM ENG SCI, V55, P2699, DOI 10.1016/S0009-2509(99)00547-3
   Pericin D, 2009, FOOD CHEM, V115, P753, DOI 10.1016/j.foodchem.2008.12.040
   Qian FP, 2005, COMPUT CHEM ENG, V29, P2155, DOI 10.1016/j.compchemeng.2005.07.011
   Qian FP, 2009, CHEM ENG TECHNOL, V32, P789, DOI 10.1002/ceat.200800669
   RAO N, 1988, AEROSOL SCI TECH, V8, P133, DOI 10.1080/02786828808959178
   Sakano T, 2000, SEP PURIF TECHNOL, V19, P145, DOI 10.1016/S1383-5866(99)00086-6
   Wang Q, 2007, MODEL SIMUL MATER SC, V15, P855, DOI 10.1088/0965-0393/15/8/003
   Wang Q, 2006, CHEM ENG SCI, V61, P4871, DOI 10.1016/j.ces.2006.03.039
   Wang Q, 2006, CHEM ENG SCI, V61, P8085, DOI 10.1016/j.ces.2006.09.043
   Zhao JZ, 2007, J HAZARD MATER, V147, P363, DOI 10.1016/j.jhazmat.2007.01.046
   Zobel S, 2007, CHEM ENG SCI, V62, P6285, DOI 10.1016/j.ces.2007.07.007
NR 29
TC 4
Z9 7
U1 3
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
EI 1873-3336
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD APR 15
PY 2010
VL 176
IS 1-3
BP 559
EP 568
DI 10.1016/j.jhazmat.2009.11.065
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 559PZ
UT WOS:000274839700075
PM 20004514
DA 2018-12-27
ER

PT J
AU Yu, T
   Tan, X
   Zhao, L
AF Yu, Tao
   Tan, Xin
   Zhao, Lin
TI RETRACTED: Characterization and mechanistic analysis of the visible
   light response of cerium and nitrogen co-doped TiO2 nano-photocatalyst
   synthesized using a one-step technique (Retracted article. See vol. 182,
   pg. 945, 2010)
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article; Retracted Publication
DE TiO2; Cerium doping; Nitrogen doping; Photocatalyst; Sol-gel processes
ID TITANIUM-DIOXIDE PHOTOCATALYSTS; RAY PHOTOELECTRON-SPECTROSCOPY;
   ENHANCED DEGRADATION; RAMAN-SPECTRA; OXIDE; IRRADIATION; ANATASE;
   PERFORMANCE; SOLAR; FILMS
AB Cerium and nitrogen co-doped anatase TiO2 nanoparticles were synthesized using a one-step technique via a modified sol-gel process and characterized by XRD, BET, DRS, Raman and XPS. The photocatalytic mechanism of the degradation of methylene blue (MB) under fluorescent light and visible light irradiation was studied. Co-doping cerium and nitrogen in the crystal lattice of TiO2 narrowed the band gap from 2.40 eV (Ce-doped TiO2) to 2.21 eV (Ce/N co-doped TiO2). Ce4+/Ce3+ pairs, oxynitride species and Ti-O-N and Ti-O-Ce bonds were determined by XPS. The recombination of photogenerated electron-hole pairs was inhibited due to the synergistic effect of doping with Ce4+/Ce3+ ions and N atoms. The optimal doping ratio was 0.70% Ce and 0.70% N using MB photocatalytic degradation under fluorescent light and visible light irradiation (lambda > 420 nm). The enhanced photocatalytic degradation under visible light irradiation was attributed to the increasing number of photogenerated center dot OH radicals. The recombination of photogenerated e(-)-h(+) was attributed to be the key factor for the decrease in the photocatalytic degradation efficiency of MB. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Yu, Tao; Tan, Xin; Zhao, Lin] Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China.
   [Tan, Xin] Tianjin Univ, Sch Chem Engn, Tianjin 300072, Peoples R China.
RP Yu, T (reprint author), Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China.
EM lisat.yu@gmail.com
FU National Natural Science Foundation of China [20776103]
FX This project was financially supported by National Natural Science
   Foundation of China (20776103).
CR Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051
   BALACHANDRAN U, 1982, J SOLID STATE CHEM, V42, P276, DOI 10.1016/0022-4596(82)90006-8
   BENJARAM MR, 2008, J PHYS CHEM B, V107, P5162
   BERGER H, 1993, J CRYST GROWTH, V130, P108, DOI 10.1016/0022-0248(93)90842-K
   Bernard M, 2000, THIN SOLID FILMS, V380, P252, DOI 10.1016/S0040-6090(00)01531-5
   Diwald O, 2004, J PHYS CHEM B, V108, P6004, DOI 10.1021/jp031267y
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2
   Gole JL, 2004, J PHYS CHEM B, V108, P1230, DOI 10.1021/jp.030843n
   Gyorgy E, 2003, SURF COAT TECH, V173, P265, DOI 10.1016/S0257-8972(03)00520-6
   HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004
   Hou XG, 2006, NUCL INSTRUM METH B, V243, P99, DOI 10.1016/j.nimb.2005.07.195
   Irie H, 2003, J PHYS CHEM B, V107, P5483, DOI 10.1021/jp030133h
   Izumi Y, 2009, J PHYS CHEM C, V113, P6706, DOI 10.1021/jp810817y
   Jo WK, 2009, J HAZARD MATER, V164, P360, DOI 10.1016/j.jhazmat.2008.08.033
   Li D, 2005, CHEM MATER, V17, P2588, DOI 10.1021/cm049100k
   Li FB, 2005, APPL CATAL A-GEN, V285, P181, DOI 10.1016/j.apcata.2005.02.025
   Liu C, 2008, J SOLID STATE CHEM, V181, P913, DOI 10.1016/j.jssc.2008.01.031
   Liu ZL, 2005, J PHYS CHEM SOLIDS, V66, P161, DOI 10.1016/j.jpcs.2004.09.002
   Nagaveni K, 2004, J PHYS CHEM B, V108, P20204, DOI 10.1021/jp047917v
   OHSAKA T, 1978, J RAMAN SPECTROSC, V7, P321, DOI 10.1002/jrs.1250070606
   OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0
   Prokes SM, 2005, ADV FUNCT MATER, V15, P161, DOI 10.1002/adfm.200305109
   Ranjit KT, 2001, J CATAL, V204, P305, DOI 10.1006/jcat.2001.3388
   Ranjit KT, 2001, ENVIRON SCI TECHNOL, V35, P1544, DOI 10.1021/es001613e
   Reddy BM, 2003, LANGMUIR, V19, P3025, DOI 10.1021/la0208528
   SAHA NC, 1992, J APPL PHYS, V72, P3072, DOI 10.1063/1.351465
   Sakatani Y, 2003, CHEM LETT, V32, P1156, DOI 10.1246/cl.2003.1156
   Sakthivel S, 2004, J PHYS CHEM B, V108, P19384, DOI 10.1021/jp046857q
   Sasirekha N, 2006, APPL CATAL B-ENVIRON, V62, P169, DOI 10.1016/j.apcatb.2005.07.009
   SATO S, 1986, CHEM PHYS LETT, V123, P126, DOI 10.1016/0009-2614(86)87026-9
   TURCHI CS, 1990, J CATAL, V122, P178, DOI 10.1016/0021-9517(90)90269-P
   WEI H, 2004, J MATER SCI, V4, P1305
   Wu JCS, 2004, J PHOTOCH PHOTOBIO A, V163, P509, DOI 10.1016/j.jphotochem.2004.02.007
   Xu AW, 2002, J CATAL, V207, P151, DOI 10.1006/jcat.2002.3539
   Xu JJ, 2009, J HAZARD MATER, V164, P762, DOI 10.1016/j.jhazmat.2008.08.108
   Xu YH, 2008, J MOL CATAL A-CHEM, V279, P77, DOI 10.1016/j.molcata.2007.09.016
   YANG WZ, 2009, J HAZARD MATER, V164, P615
   Zabek P, 2009, PHOTOCH PHOTOBIO SCI, V8, P264, DOI 10.1039/b812798k
   Zou ZG, 2003, INT J HYDROGEN ENERG, V28, P663, DOI 10.1016/S0360-3199(02)00159-3
NR 40
TC 9
Z9 11
U1 4
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
EI 1873-3336
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD APR 15
PY 2010
VL 176
IS 1-3
BP 829
EP 835
DI 10.1016/j.jhazmat.2009.11.111
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 559PZ
UT WOS:000274839700113
PM 20005630
DA 2018-12-27
ER

PT J
AU Patil, CB
   Shisode, PS
   Kapadi, UR
   Hundiwale, DG
   Mahulikar, PP
AF Patil, Chetan B.
   Shisode, Priyanka S.
   Kapadi, Uday R.
   Hundiwale, Dilip G.
   Mahulikar, Pramod P.
TI RETRACTED: Preparation and characterization of poly(vinyl chloride)
   calcium phosphate nanocomposites (Retracted article. See vol. 175, pg.
   94, 2010)
SO MATERIALS SCIENCE AND ENGINEERING B-ADVANCED FUNCTIONAL SOLID-STATE
   MATERIALS
LA English
DT Article; Proceedings Paper; Retracted Publication
CT Conference on Specialty Advanced Materials and Polymers for Aerospace
   and Defense and Applications (SAMPADA-2008)
CY DEC 08-12, 2008
CL Univ Pune, Pune, INDIA
HO Univ Pune
DE Poly(vinyl chloride); Calcium phosphate; Nanoparticles; Transmission
   Electron Microscopy (TEM); Wide angle X-ray diffraction (WAXD); Tensile
   strength; Thermal stability (TGA), Dynamic; mechanical properties (DMA)
ID CARBONATE NANOCOMPOSITES; RHEOLOGICAL BEHAVIOR; COMPOSITES; PARTICLES;
   MATRIX; CACO3
AB Calcium phosphate [Ca-3(PO4)(2)] was synthesized by in situ deposition technique and its nano-size (47-97 nm) was confirmed by Transmission Electron Microscopy (TEM). Composites of the filler Ca-3(PO4)(2) (micro and nano) and the matrix poly(vinyl chloride) (PVC) were prepared with different filler loadings (0-5 wt.%) by melt intercalation. The Brabender torque rheometer equipped with an internal mixer was used for the preparation of composites of different formulations. The effect of nano-and microCa(3)(PO4)(2) content on the structure and properties of composites was studied. The nanostructures were studied by wide angle X-ray diffraction (WAXD) and scanning electron microscopy (SEM). The mechanical, thermal and dynamic mechanical properties of PVC/micro- and nano-Ca-3(PO4)(2) composites were characterized using Universal Testing Machine (UTM), Thermo Gravimetric Analyzer (TGA) and dynamic mechanical analyzer (DMA). The thermal analysis results showed that the first thermal degradation onset (T-onset) of PVC/nano-Ca-3(PO4)(2) composites was lower as compared with corresponding microcomposites and higher than that of pristine PVC. However, the tensile strength was found to be maximum at 1% of nano-Cal(PO4)(2) and again decreased with increasing loading of nano-Ca-3(PO4)(2). Further storage modulus of PVC/micro- and nano-Ca-3(PO4)(2) composites was decreased with increasing loading while the glass transition temperature increased marginally. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Patil, Chetan B.; Shisode, Priyanka S.] SSVPSLK Dr PR Ghogrey Sci Coll, Dhule 424001, MS, India.
   [Kapadi, Uday R.; Hundiwale, Dilip G.; Mahulikar, Pramod P.] N Maharashtra Univ, Sch Chem Sci, Jalgaon 425001, MS, India.
RP Patil, CB (reprint author), SSVPSLK Dr PR Ghogrey Sci Coll, Dhule 424001, MS, India.
EM cbpatil82@rediffmail.com
CR Bao YZ, 2006, J APPL POLYM SCI, V102, P1471, DOI 10.1002/app.24317
   Chan CM, 2002, POLYMER, V43, P2981, DOI 10.1016/S0032-3861(02)00120-9
   Chen CH, 2006, J POLYM SCI POL PHYS, V44, P451, DOI 10.1002/polb.20721
   Chen CH, 2005, J POLYM SCI POL PHYS, V43, P1465, DOI 10.1002/POLB.20444
   Chen CH, 2006, J POLYM SCI POL PHYS, V44, P2145, DOI 10.1002/polb.20880
   Chen GM, 2007, J APPL POLYM SCI, V106, P817, DOI 10.1002/app.26514
   DONGYAN W, 2001, J VINYL ADDIT TECHN, V7, P203
   DONGYAN W, 2002, J VINYL ADDIT TECHN, V8, P238
   Gong FL, 2004, J MATER SCI, V39, P293, DOI 10.1023/B:JMSC.0000007758.00802.1a
   HAIYAN H, 2004, POLYM INT, V53, P225
   Hussain F, 2006, J COMPOS MATER, V40, P1511, DOI 10.1177/0021998306067321
   Ismail H, 2007, J REINF PLAST COMP, V26, P1681, DOI 10.1177/0731684407081446
   Liang ZM, 2004, J APPL POLYM SCI, V92, P567, DOI 10.1002/app.20041
   Liu P, 2006, J MACROMOL SCI B, V45, P1135, DOI 10.1080/00222340600962650
   Mishra S, 2007, J APPL POLYM SCI, V103, P670, DOI 10.1002/app.23954
   Mishra S, 2006, J APPL POLYM SCI, V100, P4190, DOI 10.1002/app.23595
   Mishra S, 2005, J POLYM SCI POL PHYS, V43, P107, DOI 10.1002/polb.20296
   Pan MW, 2004, J APPL POLYM SCI, V94, P277, DOI 10.1002/app.20896
   Patil CB, 2008, POLYM-PLAST TECHNOL, V47, P1174, DOI 10.1080/03602550802391987
   Patil CB, 2009, J MATER SCI, V44, P3118, DOI 10.1007/s10853-009-3414-y
   Peprnicek T, 2006, POLYM DEGRAD STABIL, V91, P1855, DOI 10.1016/j.polymdegradstab.2005.11.003
   Ray SS, 2003, PROG POLYM SCI, V28, P1539, DOI 10.1016/j.progpolymsci.2003.08.002
   Ren J, 2005, POLYM TEST, V24, P316, DOI 10.1016/j.polymertesting.2004.11.004
   Saujanya C, 2001, POLYMER, V42, P2255, DOI 10.1016/S0032-3861(00)00474-2
   Saujanya C, 2001, POLYMER, V42, P6723, DOI 10.1016/S0032-3861(01)00140-9
   Sun SS, 2006, POLYM INT, V55, P158, DOI 10.1002/pi.1932
   Thomas PS, 2008, COMPOS SCI TECHNOL, V68, P3220, DOI 10.1016/j.compscitech.2008.08.008
   Thomas SP, 2009, J PHYS CHEM C, V113, P97, DOI 10.1021/jp8065579
   TIANBIN R, 2006, J POLYM COMPOS, V27, P55
   Wan CY, 2003, POLYM TEST, V22, P453, DOI 10.1016/S0142-9418(02)00126-5
   Wan CY, 2003, J APPL POLYM SCI, V89, P2184, DOI 10.1002/app.12402
   Wu DZ, 2004, J APPL POLYM SCI, V92, P2714, DOI 10.1002/app.20295
   XIAOLIN X, 2004, POLYMER, V45, P6665
   Yalcin B, 2004, POLYMER, V45, P6623, DOI 10.1016/j.polymer.2004.06.061
   Zhang L, 2005, J MATER SCI, V40, P2097, DOI 10.1007/s10853-005-1244-0
NR 35
TC 4
Z9 4
U1 5
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-5107
EI 1873-4944
J9 MATER SCI ENG B-ADV
JI Mater. Sci. Eng. B-Adv. Funct. Solid-State Mater.
PD APR 15
PY 2010
VL 168
IS 1-3
SI SI
BP 231
EP 236
DI 10.1016/j.mseb.2009.12.034
PG 6
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 604VT
UT WOS:000278307300040
DA 2018-12-27
ER

PT J
AU Sung, B
   Park, B
   Yadav, VR
   Aggarwal, BB
AF Sung, Bokyung
   Park, Byoungduck
   Yadav, Vivek R.
   Aggarwal, Bharat B.
TI RETRACTED: Celastrol, a Triterpene, Enhances TRAIL-induced Apoptosis
   through the Down-regulation of Cell Survival Proteins and Up-regulation
   of Death Receptors (Retracted article. See vol. 291, pg. 16920, 2016)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID CCAAT/ENHANCER-BINDING PROTEIN; SYSTEMIC-LUPUS-ERYTHEMATOSUS;
   ENDOPLASMIC-RETICULUM STRESS; PROSTATE-CANCER CELLS; NF-KAPPA-B;
   PROTEASOME INHIBITOR; HOMOLOGOUS PROTEIN; DR5 EXPRESSION; GENE-PRODUCTS;
   HEAT-SHOCK
AB Whether celastrol, a triterpene from traditional Chinese medicine, can modulate the anticancer effects of TRAIL, the cytokine that is currently in clinical trial, was investigated. As indicated by assays that measure plasma membrane integrity, phosphatidylserine exposure, mitochondrial activity, and activation of caspase-8, caspase-9, and caspase-3, celastrol potentiated the TRAIL-induced apoptosis in human breast cancer cells, and converted TRAIL-resistant cells to TRAIL-sensitive cells. When examined for its mechanism, we found that the triterpene down-regulated the expression of cell survival proteins including cFLIP, IAP-1, Bcl-2, Bcl-xL, survivin, and XIAP and up-regulated Bax expression. In addition, we found that celastrol induced the cell surface expression of both the TRAIL receptors DR4 and DR5. This increase in receptors was noted in a wide variety of cancer cells including breast, lung, colorectal, prostate, esophageal, and pancreatic cancer cells, and myeloid and leukemia cells. Gene silencing of the death receptor abolished the effect of celastrol on TRAIL-induced apoptosis. Induction of the death receptor by the triterpenoid was found to be p53-independent but required the induction of CAAT/enhancer-binding protein homologous protein ( CHOP), inasmuch as gene silencing of CHOP abolished the induction of DR5 expression by celastrol and associated enhancement of TRAIL-induced apoptosis. We found that celastrol also induced reactive oxygen species (ROS) generation, and ROS sequestration inhibited celastrol-induced expression of CHOP and DR5, and consequent sensitization to TRAIL. Overall, our results demonstrate that celastrol can potentiate the apoptotic effects of TRAIL through down-regulation of cell survival proteins and up-regulation of death receptors via the ROS-mediated up-regulation of CHOP pathway.
C1 [Sung, Bokyung; Park, Byoungduck; Yadav, Vivek R.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA.
RP Aggarwal, BB (reprint author), 1515 Holcombe Blvd,Box 143, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI Aggarwal, Bharat/G-3388-2013
FU National Institutes of Health [CA-16 672, CA-124787-01A2]; Clayton
   Foundation for Research; Center for Targeted Therapy of M. D. Anderson
   Cancer Center
FX This work was supported, in whole or in part, by National Institutes of
   Health Core Grant CA-16 672 and Program Project Grant CA-124787-01A2.
   This work was also supported by a grant from the Clayton Foundation for
   Research (to B. B. A.) and the Center for Targeted Therapy of M. D.
   Anderson Cancer Center.
CR Abbas S, 2007, CLIN CANCER RES, V13, P6769, DOI 10.1158/1078-0432.CCR-07-1536
   Baritaki S, 2008, J IMMUNOL, V180, P6199, DOI 10.4049/jimmunol.180.9.6199
   Bhardwaj A, 2003, J CLIN IMMUNOL, V23, P317, DOI 10.1023/A:1025319031417
   Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416
   Cleren C, 2005, J NEUROCHEM, V94, P995, DOI 10.1111/j.1471-4159.2005.03253.x
   Dyer MJS, 2007, J CLIN ONCOL, V25, P4505, DOI 10.1200/JCO.2007.13.1011
   Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735
   He MF, 2009, J ETHNOPHARMACOL, V121, P61, DOI 10.1016/j.jep.2008.09.033
   He Q, 2004, ONCOGENE, V23, P2554, DOI 10.1038/sj.onc.1207351
   Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005
   Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936
   Holen I, 2002, CANCER RES, V62, P1619
   Huang YL, 2008, CANCER LETT, V264, P101, DOI 10.1016/j.canlet.2008.01.043
   Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657
   Jung EM, 2005, CARCINOGENESIS, V26, P1905, DOI 10.1093/carcin/bgi167
   Jung HW, 2007, EXP MOL MED, V39, P715, DOI 10.1038/emm.2007.78
   Kim H, 2006, CANCER RES, V66, P1740, DOI 10.1158/0008-5472.CAN-05-1568
   Kim YH, 2008, FREE RADICAL BIO MED, V44, P1055, DOI 10.1016/j.freeradbiomed.2007.12.001
   Kim Y, 2009, EUR J PHARMACOL, V612, P131, DOI [10.1016/j,ejphar.2009.03.071, 10.1016/j.ejphar.2009.03.071]
   Li H, 2005, EUR J PHARMACOL, V512, P231, DOI 10.1016/j.ejphar.2005.02.030
   Liu XG, 2004, J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322
   Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274
   Lu M, 2008, CANCER RES, V68, P1180, DOI 10.1158/0008-5472.CAN-07-2978
   Ma YL, 2006, MOL CANCER THER, V5, P170, DOI 10.1158/1535-7163.MCT-05-0129
   Mahalingam D, 2009, CANCER TREAT REV, V35, P280, DOI 10.1016/j.ctrv.2008.11.006
   Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815
   Pinna GF, 2004, BIOCHEM BIOPH RES CO, V322, P778, DOI 10.1016/j.bbrc.2004.07.186
   Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687
   Ravi R, 2002, CANCER RES, V62, P1583
   Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006
   Rowinsky EK, 2005, J CLIN ONCOL, V23, P9394, DOI 10.1200/JCO.2005.02.2889
   Schimmer AD, 2004, CANCER CELL, V5, P25, DOI 10.1016/S1535-6108(03)00332-5
   Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807
   Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818
   Sun SY, 2007, J BIOL CHEM, V282, P18800, DOI 10.1074/jbc.M611438200
   Sung B, 2007, MOL PHARMACOL, V71, P1703, DOI 10.1124/mol.107.034512
   Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770
   Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004
   Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627
   Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200
   Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8
   Wu GS, 1999, ONCOGENE, V18, P6411, DOI 10.1038/sj.onc.1203025
   Xu X, 2003, ANN RHEUM DIS, V62, P377, DOI 10.1136/ard.62.4.377
   Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200
   Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529
   Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693
   Yoshida T, 2009, MOL CANCER RES, V7, P1835, DOI 10.1158/1541-7786.MCR-09-0244
   Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484
   Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238
   Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318
NR 50
TC 97
Z9 106
U1 5
U2 26
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD APR 9
PY 2010
VL 285
IS 15
BP 11498
EP 11507
DI 10.1074/jbc.M109.090209
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 578IF
UT WOS:000276286200056
PM 20154087
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Hoskins, W
   Pollard, H
AF Hoskins, Wayne
   Pollard, Henry
TI RETRACTED: The effect of a sports chiropractic manual therapy
   intervention on the prevention of back pain, hamstring and lower limb
   injuries in semi-elite Australian Rules footballers: a randomized
   controlled trial (Retracted article. See vol. 12, 200, 2011)
SO BMC MUSCULOSKELETAL DISORDERS
LA English
DT Article; Retracted Publication
ID MUSCLE STRAIN INJURY; RISK-FACTORS; SPINAL MANIPULATION; SACROILIAC
   JOINT; TRANSVERSUS ABDOMINIS; LUMBAR SPINE; MANAGEMENT; ACTIVATION;
   MEDICINE; RECOVERY
AB Background: Hamstring injuries are the most common injury in Australian Rules football. It was the aims to investigate whether a sports chiropractic manual therapy intervention protocol provided in addition to the current best practice management could prevent the occurrence of and weeks missed due to hamstring and other lower-limb injuries at the semi-elite level of Australian football.
   Methods: Sixty male subjects were assessed for eligibility with 59 meeting entry requirements and randomly allocated to an intervention (n = 29) or control group (n = 30), being matched for age and hamstring injury history. Twenty-eight intervention and 29 control group participants completed the trial. Both groups received the current best practice medical and sports science management, which acted as the control. Additionally, the intervention group received a sports chiropractic intervention. Treatment for the intervention group was individually determined and could involve manipulation/mobilization and/or soft tissue therapies to the spine and extremity. Minimum scheduling was: 1 treatment per week for 6 weeks, 1 treatment per fortnight for 3 months, 1 treatment per month for the remainder of the season (3 months). The main outcome measure was an injury surveillance with a missed match injury definition.
   Results: After 24 matches there was no statistical significant difference between the groups for the incidence of hamstring injury (OR:0.116, 95% CI:0.013-1.019, p = 0.051) and primary non-contact knee injury (OR:0.116, 95% CI:0.013-1.019, p = 0.051). The difference for primary lower-limb muscle strains was significant (OR:0.097, 95% CI: 0.011-0.839, p = 0.025). There was no significant difference for weeks missed due to hamstring injury (4 v14, chi 2:1.12, p = 0.29) and lower-limb muscle strains (4 v 21, chi 2:2.66, p = 0.10). A significant difference in weeks missed due to non-contact knee injury was noted (1 v 24, chi 2:6.70, p = 0.01).
   Conclusions: This study demonstrated a trend towards lower limb injury prevention with a significant reduction in primary lower limb muscle strains and weeks missed due to non-contact knee injuries through the addition of a sports chiropractic intervention to the current best practice management.
C1 [Hoskins, Wayne; Pollard, Henry] Macquarie Univ, Fac Sci, Macquarie Injury Management Grp, Dept Chiropract, N Ryde, NSW 2109, Australia.
RP Hoskins, W (reprint author), Macquarie Univ, Fac Sci, Macquarie Injury Management Grp, Dept Chiropract, N Ryde, NSW 2109, Australia.
EM waynehoskins@iinet.net.au
CR Abalos E, 2005, BEST PRACT RES CL OB, V19, P15, DOI 10.1016/j.bpogyn.2004.10.008
   Bahr R, 2003, BRIT J SPORT MED, V37, P384, DOI 10.1136/bjsm.37.5.384
   Brenner AK, 2007, J ORTHOP SPORT PHYS, V37, P613, DOI 10.2519/jospt.2007.2470
   Cholewicki J, 2002, J ORTHOP SPORT PHYS, V32, P568, DOI 10.2519/jospt.2002.32.11.568
   CIBULKA MT, 1986, PHYS THER, V66, P1220, DOI 10.1093/ptj/66.8.1220
   Demoulin C., 2007, Annales de Readaptation et de Medecine Physique, V50, P677, DOI 10.1016/j.annrmp.2007.05.007
   Flynn TW, 2006, J ORTHOP SPORT PHYS, V36, P577, DOI 10.2519/jospt.2006.2159
   Gibbs NJ, 2004, J SCI MED SPORT, V7, P248, DOI 10.1016/S1440-2440(04)80016-1
   Gill NW, 2007, MANUAL THER, V12, P280, DOI 10.1016/j.math.2006.06.014
   Hodges PW, 1996, SPINE, V21, P2640, DOI 10.1097/00007632-199611150-00014
   Hoskins W, 2005, MANUAL THER, V10, P180, DOI 10.1016/j.math.2005.05.001
   Hoskins W, 2005, MANUAL THER, V10, P96, DOI 10.1016/j.math.2005.03.006
   Hoskins W, 2006, J MANIP PHYSIOL THER, V29, P658, DOI 10.1016/j.jmpt.2006.08.004
   Hoskins Wayne, 2009, Chiropr Osteopat, V17, P3, DOI 10.1186/1746-1340-17-3
   Hoskins W, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-38
   HOSKINS WT, 2003, AUSTRALAS CHIROPR OS, V11, P49
   Hoskins WT, 2005, CHIROPR OSTEOPAT, V13, P4
   Hungerford B, 2003, SPINE, V28, P1593, DOI 10.1097/00007632-200307150-00022
   Marshall P, 2006, J MANIP PHYSIOL THER, V29, P196, DOI 10.1016/j.jmpt.2006.01.010
   MASON DL, 2007, COCHRANE DB SYST REV, V24, P4575
   McManus A, 2004, J SCI MED SPORT, V7, P384, DOI 10.1016/S1440-2440(04)80033-1
   MCNEIL D, 1996, EPIDEMIOLOGICAL RES, P97
   MIERAU D, 1999, MANAGING LOW BACK PA, P326
   Norton K I, 1999, J Sci Med Sport, V2, P389, DOI 10.1016/S1440-2440(99)80011-5
   Orchard J, 2002, BRIT J SPORT MED, V36, P39, DOI 10.1136/bjsm.36.1.39
   Orchard J, 2007, CLIN J SPORT MED, V17, P192, DOI 10.1097/JSM.0b013e3180547527
   Orchard JW, 2001, AM J SPORT MED, V29, P300, DOI 10.1177/03635465010290030801
   Panjabi MM, 2006, EUR SPINE J, V15, P668, DOI 10.1007/s00586-005-0925-3
   Petersen J, 2005, BRIT J SPORT MED, V39, P319, DOI 10.1136/bjsm.2005.018549
   Pickar JG, 2001, J MANIP PHYSIOL THER, V24, P2, DOI 10.1067/mmt.2001.112017
   Pickar Joel G, 2002, Spine J, V2, P357, DOI 10.1016/S1529-9430(02)00400-X
   Pollard Henry, 2007, Chiropr Osteopat, V15, P14, DOI 10.1186/1746-1340-15-14
   Schneider-Kolsky ME, 2006, AM J SPORT MED, V34, P1008, DOI 10.1177/0363546505283835
   SEWARD H, 1993, MED J AUSTRALIA, V159, P298
   Sherry MA, 2004, J ORTHOP SPORT PHYS, V34, P116, DOI 10.2519/jospt.2004.34.3.116
   Solomonow M, 1998, SPINE, V23, P2552, DOI 10.1097/00007632-199812010-00010
   Suter E, 2000, J MANIP PHYSIOL THER, V23, P76, DOI 10.1016/S0161-4754(00)90071-X
   SUTER E, 2001, SPINE, V26, P361
   Tubbs RS, 2006, CLIN ANAT, V19, P517, DOI 10.1002/ca.20168
   Verrall GM, 2006, J SCI MED SPORT, V9, P87, DOI 10.1016/j.jsams.2006.03.007
   Verrall GM, 2001, BRIT J SPORT MED, V35, P435, DOI 10.1136/bjsm.35.6.435
   Watson AWS, 1995, J SPORT MED PHYS FIT, V35, P289
   Watson AWS, 2001, INT J SPORTS MED, V22, P222, DOI 10.1055/s-2001-16383
   WILKE HJ, 1995, SPINE, V20, P192, DOI 10.1097/00007632-199501150-00011
NR 44
TC 5
Z9 5
U1 4
U2 30
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2474
J9 BMC MUSCULOSKEL DIS
JI BMC Musculoskelet. Disord.
PD APR 8
PY 2010
VL 11
AR 64
DI 10.1186/1471-2474-11-64
PG 11
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA 585TF
UT WOS:000276851400001
PM 20374662
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Calvino-Casilda, V
   Guerrero-Perez, MO
   Banares, MA
AF Calvino-Casilda, Vanesa
   Olga Guerrero-Perez, M.
   Banares, Miguel A.
TI RETRACTED: Microwave-activated direct synthesis of acrylonitrile from
   glycerol under mild conditions: Effect of niobium as dopant of the V-Sb
   oxide catalytic system (Retracted article. See vol. 236, pg. 588. 2018)
SO APPLIED CATALYSIS B-ENVIRONMENTAL
LA English
DT Article; Retracted Publication
DE Glycerol; Acrylonitrile; Biomass; Microwave activation; Catalytic
   process; Sustainability
ID O CATALYSTS; PROPANE AMMOXIDATION; MOLECULAR-STRUCTURE; METAL-OXIDES
AB Glycerol is a major by-product in biodiesel production, which raises a critical need to develop efficient valorization processes. This study shows how both conventional thermal activation and microwave irradiation are able to selectively transform glycerol into acrylonitrile, this performance is modulated by niobium doping of SbnV/Al2O3 catalysts under mild reaction conditions. To the best of our knowledge, we report the highest selectivity (83.8%) to acrylonitrile from glycerol at good conversion values (46.8%). (C) 2010 Elsevier B.V. All rights reserved.
C1 [Calvino-Casilda, Vanesa; Banares, Miguel A.] CSIC, Catalyt Spect Lab, Inst Catalisis & Petroleoquim, E-28049 Madrid, Spain.
   [Olga Guerrero-Perez, M.] Univ Malaga, Dept Ingn Quim, E-29071 Malaga, Spain.
RP Calvino-Casilda, V (reprint author), CSIC, Catalyt Spect Lab, Inst Catalisis & Petroleoquim, Marie Curie 2, E-28049 Madrid, Spain.
EM vcalvino@icp.csic.es
RI Banares, Miguel A./C-3873-2013
OI Banares, Miguel A./0000-0003-3875-4468; Guerrero-Perez, M.
   Olga/0000-0002-3786-5839
FU Spanish Ministry of Education and Science [CTQ2008-04261/PPQ]
FX This research was funded by Spanish Ministry of Education and Science
   (CTQ2008-04261/PPQ). VCC is indebted to CSIC for a JAE-DOC fellowship.
   The authors thank Prof. Martin-Aranda, Department of Inorganic Chemistry
   and Technical Chemistry (UNED, Madrid), for her help with the microwave
   system.
CR [Anonymous], 2002, ULLMANNS ENCY IND CH
   Banares MA, 2002, J RAMAN SPECTROSC, V33, P359, DOI 10.1002/jrs.866
   Brazdil JF, 2006, TOP CATAL, V38, P289, DOI 10.1007/s11244-006-0027-4
   Fernando S, 2006, ENERG FUEL, V20, P1727, DOI 10.1021/ef060097w
   Guerrero-Perez MO, 2006, TOP CATAL, V41, P43, DOI 10.1007/s11244-006-0093-7
   Guerrero-Perez M. Olga, 2009, Recent Patents on Chemical Engineering, V2, P11, DOI 10.2174/1874478810902010011
   Guerrero-Perez M. O., 2008, RECENT PAT CHEM ENG, V1, P201
   Guerrero-Perez MO, 2008, J PHYS CHEM C, V112, P16858, DOI 10.1021/jp801701m
   Guerrero-Perez MO, 2007, CHEM MATER, V19, P6621, DOI 10.1021/cm702022d
   Guerrero-Perez MO, 2007, J PHYS CHEM C, V111, P1315, DOI 10.1021/jp065387s
   Guerrero-Perez MO, 2006, CATAL TODAY, V118, P366, DOI 10.1016/j.cattod.2006.07.011
   Guerrero-Perez MO, 2006, IND ENG CHEM RES, V45, P4537, DOI 10.1021/ie051000g
   Guerrero-Perez MO, 2006, APPL CATAL A-GEN, V298, P1, DOI 10.1016/j.apcata.2005.09.013
   Guerrero-Perez MO, 2004, CATAL TODAY, V96, P265, DOI 10.1016/j.cattod.2004.06.150
   Guerrero-Perez MO, 2003, PHYS CHEM CHEM PHYS, V5, P4032, DOI 10.1039/b307030a
   Guerrero-Perez MO, 2002, J CATAL, V206, P339, DOI 10.1006/jcat.2001.3494
   Haas T, 2005, APPL CATAL A-GEN, V280, P83, DOI 10.1016/j.apcata.2004.08.027
   Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d
   Irigoyen B., 2005, CATAL TODAY, V40, P107
   Kappe CO, 2006, NAT REV DRUG DISCOV, V5, P51, DOI 10.1038/nrd1926
   Kappe CO, 2004, ANGEW CHEM INT EDIT, V43, P6250, DOI 10.1002/anie.200400655
   Kappe CO, 2005, METH PRIN MED CHEM, V52, P1, DOI 10.1002/3527606556
   LANDACANOVAS A, 1995, J SOLID STATE CHEM, V116, P369, DOI 10.1006/jssc.1995.1228
   LOUPY A, 2006, MICROWAVES ORGANIC S
   Luque R, 2008, APPL CATAL B-ENVIRON, V82, P157, DOI 10.1016/j.apcatb.2008.01.015
   Guerrero-Perez MO, 2008, CHEMSUSCHEM, V1, P511, DOI 10.1002/cssc.200800023
   Guerrero-Perez MO, 2009, CATAL TODAY, V142, P245, DOI 10.1016/j.cattod.2008.10.041
   Rojas E, 2009, CATAL COMMUN, V10, P1555, DOI 10.1016/j.catcom.2009.04.016
   Wachs IE, 2000, CATAL TODAY, V57, P323, DOI 10.1016/S0920-5861(99)00343-0
   Watanabe M, 2007, BIORESOURCE TECHNOL, V98, P1285, DOI 10.1016/j.biortech.2006.05.007
   Xiong G, 2005, J CATAL, V230, P317, DOI 10.1016/j.jcat.2004.11.046
NR 31
TC 22
Z9 22
U1 3
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0926-3373
EI 1873-3883
J9 APPL CATAL B-ENVIRON
JI Appl. Catal. B-Environ.
PD APR 6
PY 2010
VL 95
IS 3-4
BP 192
EP 196
DI 10.1016/j.apcatb.2009.12.017
PG 5
WC Chemistry, Physical; Engineering, Environmental; Engineering, Chemical
SC Chemistry; Engineering
GA 584MI
UT WOS:000276755700002
DA 2018-12-27
ER

PT J
AU Hou, FF
   Yang, H
AF Hou Fen-Fei
   Yang Hong
TI RETRACTED: Phase-shifted compensation of channel-space on fiber grating
   comb filter (Retracted Article)
SO ACTA PHYSICA SINICA
LA Chinese
DT Article; Retracted Publication
DE fiber Bragg grating; chirped sampled fiber Bragg grating; phase shift;
   comb filter
ID 511-CHIP; PERIOD
AB As the channel-space of the comb filter based on chirped sampled fiber Bragg grating and phase shift is not accurate and the multi-channel is linable to channel the standard frequency, we discussed and calculated the error between theory and practice, which has been verified by simulation Then a compensation method by introducing phase shift between the samples was proposed, and a 100 channel comb filter with accurate 40 GHz. channel-spacing was simulated, which lays a good foundation for fabricating comb filters with accurate transmission peak in the future
C1 [Hou Fen-Fei; Yang Hong] Nanjing Normal Univ, Sch Phys & Technol, Nanjing 210096, Peoples R China.
RP Hou, FF (reprint author), Nanjing Normal Univ, Sch Phys & Technol, Nanjing 210096, Peoples R China.
FU National Natural Science Foundation of China [60272048]
FX Project supported by the National Natural Science Foundation of China
   (Grant No 60272048)
CR Chen XF, 2000, IEEE PHOTONIC TECH L, V12, P1501, DOI 10.1109/68.887715
   Dai YT, 2005, IEEE PHOTONIC TECH L, V17, P1040, DOI 10.1109/LPT.2005.846760
   Dai YT, 2004, IEEE PHOTONIC TECH L, V16, P2284, DOI 10.1109/LPT.2004.834530
   Hamanaka T, 2006, J LIGHTWAVE TECHNOL, V24, P95, DOI 10.1109/JLT.2005.861126
   *ITU R, G692 ITUT
   Li D, 2007, ACTA PHYS SIN-CH ED, V56, P2223
   Wang CH, 2004, OPT LETT, V29, P1590, DOI 10.1364/OL.29.001590
   Wang CH, 2004, IEEE PHOTONIC TECH L, V16, P1867, DOI 10.1109/LPT.2004.831276
   Wang MG, 2003, ACTA PHYS SIN-CH ED, V52, P609
   Wang X, 2005, OPT LETT, V30, P355, DOI 10.1364/OL.30.000355
   Zhang Y, 2007, ACTA PHYS SIN-CH ED, V56, P7034
NR 11
TC 0
Z9 0
U1 3
U2 8
PU CHINESE PHYSICAL SOC
PI BEIJING
PA P O BOX 603, BEIJING 100080, PEOPLES R CHINA
SN 1000-3290
J9 ACTA PHYS SIN-CH ED
JI Acta Phys. Sin.
PD APR
PY 2010
VL 59
IS 4
BP 2577
EP 2581
PG 5
WC Physics, Multidisciplinary
SC Physics
GA 587AE
UT WOS:000276957500063
DA 2018-12-27
ER

PT J
AU El Azab, SR
   Vrakking, R
   Verhage, G
   Rosseel, PMJ
AF El Azab, S. R.
   Vrakking, R.
   Verhage, G.
   Rosseel, P. M. J.
TI RETRACTED: Safety of cardiac surgery without blood transfusion: a
   retrospective study in Jehovah's Witness patients (Retracted article.
   See vol. 65, pg. 1257, 2010)
SO ANAESTHESIA
LA English
DT Article; Retracted Publication
ID RECOMBINANT-HUMAN-ERYTHROPOIETIN; ARTERY-BYPASS SURGERY; CARDIOPULMONARY
   BYPASS; CELL TRANSFUSION; RISKS; MORTALITY; HEMODILUTION; PRODUCTS;
   IMPACT
AB The aim of this retrospective study was to compare the utilisation of blood products and outcomes following cardiac surgery for 123 Jehovah's Witnesses and 4219 non-Jehovah's Witness patient controls. The study took place over a 7-year period at the Amphia Hospital in Breda, the Netherlands. A specific protocol was used in the management of Jehovah's Witness patients, while the control group received blood without restriction according to their needs. Patients' characteristics were comparable in both groups. Pre-operatively, the mean (SD) Euro Score was higher in the Jehovah's Witness group (3.2 (2.6) vs 2.7 (2.5), respectively; p<0.02). Pre-operative haemoglobin concentration was higher in the Jehovah's Witness group (8.9 (0.7) vs 8.6 (0.9) g.dl(-1), respectively; p<0.001). The total cardiopulmonary bypass time did not differ between groups. The requirement for allogenic blood transfusion was 0% in the Jehovah's Witness group compared to 65% in the control group. Postoperatively, there was a lower incidence of Q-wave myocardial infarction (2 (1.8%) vs 323 (7.7%), respectively; p<0.02), and non Q-wave infarction (11 (9.8%) vs 559 (13.2%), respectively; p<0.02) in the Jehovah's Witness group compared with controls. Mean (SD) length of stay in the intensive care unit (2.3 (3.2) vs 2.6 (4.2) days; p=0.26), re-admission rate to the intensive care unit (5 (4.5%) vs 114 (2.7%); p=0.163), and mortality (3 (2.7%) vs 65 (1.5%); p=0.59), did not differ between the Jehovah's Witness and control groups, respectively.
C1 [El Azab, S. R.] King Fahd Specialist Hosp, Burraidah, Saudi Arabia.
   [El Azab, S. R.] Al Azhar Univ, Cairo, Egypt.
   [Vrakking, R.; Verhage, G.; Rosseel, P. M. J.] Amphia Hosp, Breda, Netherlands.
RP El Azab, SR (reprint author), King Fahd Specialist Hosp, Burraidah, Saudi Arabia.
EM Samia87@hotmail.com
CR Belisle S, 1996, ANN THORAC SURG, V62, P1908, DOI 10.1016/S0003-4975(96)00944-7
   Bojanov George, 2005, Ann Card Anaesth, V8, P75
   Carson JL, 2002, TRANSFUSION, V42, P812, DOI 10.1046/j.1537-2995.2002.00123.x
   COSGROVE DM, 1992, ANN THORAC SURG, V54, P1031, DOI 10.1016/0003-4975(92)90066-D
   Covin R, 2003, ARCH PATHOL LAB MED, V127, P415
   D'Ambra MN, 1997, ANN THORAC SURG, V64, P1686, DOI 10.1016/S0003-4975(97)00839-4
   Eder AF, 2007, ARCH PATHOL LAB MED, V131, P708
   Fang WC, 1997, CIRCULATION, V96, P194
   Goodnough LT, 2003, CRIT CARE MED, V31, pS678, DOI 10.1097/01.CCM.0000100124.50579.D9
   Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601
   Kleinman S, 2003, TRANSFUS MED REV, V17, P120, DOI 10.1053/tmrv.2003.50009
   Kuduvalli M, 2005, EUR J CARDIO-THORAC, V27, P592, DOI 10.1016/j.ejcts.2005.01.030
   Licker M, 2005, CHEST, V128, P838, DOI 10.1378/chest.128.2.838
   Madjdpour C, 2005, BRIT J ANAESTH, V95, P33, DOI 10.1093/bja/aeh290
   Mahonen MS, 2004, TOB CONTROL, V13, P244, DOI 10.1136/tc.2003.003269
   Marcucci C, 2004, BRIT MED BULL, V70, P15, DOI 10.1093/bmb/ldh023
   Silliman CC, 2005, BLOOD, V105, P2266, DOI 10.1182/blood-2004-07-2929
   Steiner ME, 2007, HEMATOL ONCOL CLIN N, V21, P177, DOI 10.1016/j.hoc.2006.11.009
   Surgenor SD, 2006, CIRCULATION, V114, pI43, DOI 10.1161/CIRCULATIONAHA.105.001271
   Taylor RW, 2002, CRIT CARE MED, V30, P2249, DOI 10.1097/01.CCM.0000030457.48434.17
   TROUWBORST A, 1990, BRIT J ANAESTH, V64, P646, DOI 10.1093/bja/64.5.646
   Van der Linden PJ, 2007, BRIT J ANAESTH, V99, P646, DOI 10.1093/bja/aem252
   Weinberg PD, 2002, ANN INTERN MED, V136, P312, DOI 10.7326/0003-4819-136-4-200202190-00011
   Williams FG, 1997, BRIT MED J, V315, P380, DOI 10.1136/bmj.315.7105.380
   Williamson LM, 1999, BRIT MED J, V319, P16, DOI 10.1136/bmj.319.7201.16
   Yazicioglu L, 2001, J THORAC CARDIOV SUR, V122, P741, DOI 10.1067/mtc.2001.115426
   2004, WATCHTOWER      0615, P24
NR 27
TC 9
Z9 9
U1 2
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0003-2409
EI 1365-2044
J9 ANAESTHESIA
JI Anaesthesia
PD APR
PY 2010
VL 65
IS 4
BP 348
EP 352
DI 10.1111/j.1365-2044.2009.06232.x
PG 5
WC Anesthesiology
SC Anesthesiology
GA 571BV
UT WOS:000275725200006
PM 20402872
OA Bronze
DA 2018-12-27
ER

PT J
AU Memis, D
   Inal, MT
   Temizoz, O
   Genchallac, H
   Ozdemir, H
   Sut, N
AF Memis, Dilek
   Inal, Mehmet Turan
   Temizoz, Osman
   Genchallac, Hakan
   Ozdemir, Huseyin
   Sut, Necdet
TI RETRACTED: The Effect of Celiac Plexus Block in Critically III Patients
   Intolerant of Enteral Nutrition: A Randomized, Placebo-Controlled Study
   (Retracted article. See vol. 111, pg. 1551, 2010)
SO ANESTHESIA AND ANALGESIA
LA English
DT Article; Retracted Publication
ID ILL PATIENTS; GASTRIC-MOTILITY; CRITICAL-CARE; ERYTHROMYCIN;
   COMPLICATIONS; METOCLOPRAMIDE; GUIDELINES; MORPHINE; SUPPORT;
   GASTROPARESIS
AB BACKGROUND: In this study, we evaluated the efficacy of celiac plexus block for the treatment of feeding intolerance in critically ill patients.
   METHODS: Nineteen mechanically ventilated medical patients intolerant of enteral nutrition and receiving metoclopramide underwent bilateral celiac plexus block. The anterior procedure was accomplished under sonographic guidance with the injection of either 25 mL bupivacaine 0.25% (celiac group, n = 10) or saline (control group, n = 9) bilaterally. Gastric emptying was assessed by the acetaminophen absorption method. After the block, nasogastric feeding was commenced, and nasogastric aspirates were collected once every 24 hours. Successful feeding was defined as 24-hourly gastric residual volume <250 mL with a feeding rate >= 40 mL/h.
   RESULTS: Demographic data were similar for the 2 groups. The area under the plasma paracetamol absorption curve (383.8 +/- 248.1 mg . min . L-1) and the peak plasma paracetamol concentration (C-max; 3.28 +/- 2.15 mg/L) in the celiac group were significantly lower than the area under the curve value (1233.5 +/- 771.2) and C-max value (10.14 +/- 6.04) in controls (P < 0.001 for all). After treatment, celiac plexus block reduced the mean gastric residual volume (celiac group: 430 32 mL to 205 30 mL, P < 0.001; control group: 450 +/- 33 mL to 461 +/- 19 mL, P>0.05) and improved the proportion of patients with successful feeding (celiac block 80% vs controls 0%, P < 0.001).
   CONCLUSION: In critical illness, celiac plexus block is effective for treating feeding intolerance when IV drug therapy has failed to improve gastrointestinal dysfunction. (Anesth Analg 2010; 110:1071-5)
C1 [Memis, Dilek; Inal, Mehmet Turan] Trakya Univ, Fac Med, Dept Anesthesiol & Reanimat, TR-22030 Edirne, Turkey.
   [Temizoz, Osman; Genchallac, Hakan; Ozdemir, Huseyin] Trakya Univ, Fac Med, Dept Radiol, TR-22030 Edirne, Turkey.
   [Sut, Necdet] Trakya Univ, Fac Med, Dept Biostat, TR-22030 Edirne, Turkey.
RP Memis, D (reprint author), Trakya Univ, Fac Med, Dept Anesthesiol & Reanimat, TR-22030 Edirne, Turkey.
EM dilmemis@mynet.com
CR Boivin MA, 2001, CRIT CARE MED, V29, P1916, DOI 10.1097/00003246-200110000-00011
   Booth CM, 2002, CRIT CARE MED, V30, P1429, DOI 10.1097/00003246-200207000-00005
   Chapman MJ, 2000, CRIT CARE MED, V28, P2334, DOI 10.1097/00003246-200007000-00026
   CHRISTMAN JW, 1993, INTENS CARE MED, V19, P129, DOI 10.1007/BF01720527
   Crighton IM, 1998, ANESTH ANALG, V87, P445, DOI 10.1097/00000539-199808000-00040
   De Beaux I, 2001, ANAESTH INTENS CARE, V29, P619
   DEAN AP, 1991, AUST NZ J MED, V21, P47, DOI 10.1111/j.1445-5994.1991.tb03001.x
   Dhir R, 2004, J CLIN GASTROENTEROL, V38, P237, DOI 10.1097/00004836-200403000-00008
   Doherty WL, 2003, CRIT CARE, V7, P206, DOI 10.1186/cc1849
   Dvir D, 2006, CLIN NUTR, V25, P37, DOI 10.1016/j.clnu.2005.10.010
   EISENBERG E, 1995, ANESTH ANALG, V80, P290, DOI 10.1097/00000539-199502000-00015
   FIELD M, 1989, NEW ENGL J MED, V321, P879
   Gafanovich I, 1998, J CLIN GASTROENTEROL, V26, P300, DOI 10.1097/00004836-199806000-00018
   Glatzle J, 2004, J GASTROINTEST SURG, V8, P645, DOI 10.1016/j.gassur.2004.05.009
   HEYLAND D, 1995, CRIT CARE MED, V23, P1055, DOI 10.1097/00003246-199506000-00010
   Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355
   JANSSENS J, 1990, NEW ENGL J MED, V322, P1028, DOI 10.1056/NEJM199004123221502
   Jooste CA, 1999, INTENS CARE MED, V25, P464, DOI 10.1007/s001340050881
   KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009
   MacLaren R, 2000, PHARMACOTHERAPY, V20, P1486, DOI 10.1592/phco.20.19.1486.34853
   MacLaren R, 2001, CLIN THER, V23, P1855, DOI 10.1016/S0149-2918(00)89081-5
   Marino LV, 2003, BRIT J NEUROSURG, V17, P24, DOI 10.1080/026889031000093708
   MCMAHON MM, 1993, MAYO CLIN PROC, V68, P911, DOI 10.1016/S0025-6196(12)60702-2
   Mentec H, 2001, CRIT CARE MED, V29, P1955, DOI 10.1097/00003246-200110000-00018
   MITTAL RK, 1986, DIGEST DIS SCI, V31, P936, DOI 10.1007/BF01303214
   Mutlu GM, 2001, CHEST, V119, P1222, DOI 10.1378/chest.119.4.1222
   Nguyen NQ, 2006, WORLD J GASTROENTERO, V12, P4383, DOI 10.3748/wjg.v12.i27.4383
   OTT L, 1991, J NEUROSURG, V74, P738, DOI 10.3171/jns.1991.74.5.0738
   Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022
   Ritz MA, 2001, CRIT CARE MED, V29, P1744, DOI 10.1097/00003246-200109000-00015
   SATOH T, 1990, J PHARMACOL EXP THER, V254, P940
   SAX HC, 1993, MED CLIN N AM, V77, P863, DOI 10.1016/S0025-7125(16)30229-2
   Shuster M H, 1994, AACN Clin Issues Crit Care Nurs, V5, P459
   Stroud M, 2003, GUT, V52, P1
   Tisherman SA, 2002, CRIT CARE MED, V30, P1653, DOI 10.1097/00003246-200207000-00044
   WEINSTABL C, 1993, ANAESTHESIA, V48, P162
   Yuan CS, 1998, J CLIN PHARMACOL, V38, P1017, DOI 10.1177/009127009803801105
NR 37
TC 1
Z9 1
U1 2
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0003-2999
J9 ANESTH ANALG
JI Anesth. Analg.
PD APR
PY 2010
VL 110
IS 4
BP 1071
EP 1075
DI 10.1213/ANE.0b013e3181cde870
PG 5
WC Anesthesiology
SC Anesthesiology
GA 575YL
UT WOS:000276109200015
PM 20103540
DA 2018-12-27
ER

PT J
AU Struys, MMRF
   Fechner, J
   Schuttler, J
   Schwilden, H
AF Struys, Michel M. R. F.
   Fechner, Joerg
   Schuettler, Juergen
   Schwilden, Helmut
TI RETRACTED: Erroneously Published Fospropofol
   Pharmacokinetic-Pharmacodynamic Data and Retraction of the Affected
   Publications (Retracted Article)
SO ANESTHESIOLOGY
LA English
DT Letter; Retracted Publication
ID SEE VOL. 112; WATER-SOLUBLE PRODRUG; PG. 1058; GPI 15715; ASSAY ISSUES;
   BOLUS INJECTION; PROPOFOL; IMPACT
C1 [Struys, Michel M. R. F.] Univ Groningen, Groningen, Netherlands.
   [Struys, Michel M. R. F.] Univ Ghent, B-9000 Ghent, Belgium.
   [Fechner, Joerg; Schuettler, Juergen; Schwilden, Helmut] Univ Erlangen Nurnberg, Erlangen, Germany.
RP Struys, MMRF (reprint author), Univ Groningen, Groningen, Netherlands.
EM m.m.r.f.struys@anest.umcg.nl
CR Fechner J, 2005, ANESTH ANALG, V100, P701, DOI 10.1213/01.ANE.0000144772.13372.F4
   Fechner J, 2004, ANESTHESIOLOGY, V101, P626, DOI 10.1097/00000542-200409000-00011
   Fechner J, 2003, ANESTHESIOLOGY, V99, P303, DOI 10.1097/00000542-200308000-00012
   Gibiansky E, 2005, ANESTHESIOLOGY, V103, P718, DOI 10.1097/00000542-200510000-00010
   Schywalsky M, 2003, EUR J ANAESTH, V20, P182, DOI 10.1097/00003643-200303000-00002
   Shah A, 2008, ANESTHESIOLOGY, V109, P937, DOI 10.1097/ALN.0b013e31818aa6e1
   Shah A, 2009, ANESTH ANALG, V108, P382, DOI 10.1213/ane.0b013e31818ce924
   Shah A, 2009, EUR J ANAESTH, V26, P81, DOI 10.1097/EJA.0b013e32831bc285
   Struys MMRF, 2005, ANESTHESIOLOGY, V103, P730, DOI 10.1097/00000542-200510000-00011
NR 9
TC 10
Z9 11
U1 1
U2 28
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0003-3022
EI 1528-1175
J9 ANESTHESIOLOGY
JI Anesthesiology
PD APR
PY 2010
VL 112
IS 4
BP 1056
EP 1057
DI 10.1097/ALN.0b013e3181d536df
PG 2
WC Anesthesiology
SC Anesthesiology
GA 576HG
UT WOS:000276134500037
PM 20177373
OA Bronze
DA 2018-12-27
ER

PT J
AU Takamatsu, R
   Takeshima, E
   Ishikawa, C
   Yamamoto, K
   Teruya, H
   Heuner, K
   Higa, F
   Fujita, J
   Mori, N
AF Takamatsu, Reika
   Takeshima, Eriko
   Ishikawa, Chie
   Yamamoto, Kei
   Teruya, Hiromitsu
   Heuner, Klaus
   Higa, Futoshi
   Fujita, Jiro
   Mori, Naoki
TI RETRACTED: Inhibition of Akt/GSK3 beta signalling pathway by Legionella
   pneumophila is involved in induction of T-cell apoptosis (Retracted
   article. See vol. 434, pg. 573, 2011)
SO BIOCHEMICAL JOURNAL
LA English
DT Article; Retracted Publication
DE Akt/protein kinase B; apoptosis; beta-catenin; Dot/Icm; flagellin;
   glycogen synthase kinase 3 beta (GSK3 beta); Legionella pneumophila
ID ALVEOLAR EPITHELIAL-CELLS; PROTEIN-KINASE; CONFORMATIONAL-CHANGE;
   CASPASE ACTIVATION; MOUSE MACROPHAGES; BETA-CATENIN; INFECTION; BAX;
   DEATH; XIAP
AB Legionella pneumophila is the causative agent of human Legionnaires' disease. L. pneumophila has been shown to induce apoptosis of T-cells and this may be important pathologically and clinically. The present study has determined the molecular mechanisms underlying L. pneumophila-induced apoptosis, which were unclear. Wild-type L. pneumophila and flagellin-deficient Legionella, but not L. pneumophila lacking a functional type IV secretion system Dot/Icm, replicated in T-cells. However, apoptosis was efficiently induced in T-cells only by wildtype L. pneumophila, and not flagellin-deficient or Dot/Icm-deficient Legionella. Induction of apoptosis involved activation of the initiator caspase 9 and effector caspase 3. Infection with L. pneumophila inhibited phosphorylation of Akt (also known as protein kinase B) and the Akt substrate GSK3 beta (glycogen synthase kinase 3 beta), and reduced the levels of beta-catenin, a transcriptional activator regulated by GSK3 beta. It also caused the activation of the pro-apoptotic protein Bax and inhibited the expression of the anti-apoptotic protein XIAP (X-linked inhibitor of apoptosis) via inhibition of the Akt pathway. In conclusion, L. pneumophila induces mitochondria-mediated T-cell apoptosis through inhibition of the Akt/GSK3 beta signalling pathway.
C1 [Takamatsu, Reika; Takeshima, Eriko; Ishikawa, Chie; Yamamoto, Kei; Teruya, Hiromitsu; Mori, Naoki] Univ Ryukyus, Grad Sch Med, Div Mol Virol & Oncol, Okinawa 9030215, Japan.
   [Takeshima, Eriko; Teruya, Hiromitsu; Higa, Futoshi; Fujita, Jiro] Univ Ryukyus, Grad Sch Med, Div Control & Prevent Infect Dis, Okinawa 9030215, Japan.
   [Ishikawa, Chie] Univ Ryukyus, Transdisciplinary Res Org Subtrop & Isl Studies, Okinawa 9030213, Japan.
   [Heuner, Klaus] Robert Koch Inst, Project Grp Nosocomial Infect Elderly 26, D-13353 Berlin, Germany.
RP Mori, N (reprint author), Univ Ryukyus, Grad Sch Med, Div Mol Virol & Oncol, 207 Uehara, Okinawa 9030215, Japan.
EM n-mori@med.u-ryukyu.ac.jp
FU Japan Society for the Promotion of Science [21591211]; Ministry of
   Education, Culture, Sports, Science and Technology [20012044]; Takeda
   Science Foundation
FX This work was supported by Grants-in-Aid for Scientific Research (C)
   [grant number 21591211] from the Japan Society for the Promotion of
   Science; Scientific Research on Priority Areas [grant number 20012044]
   from the Ministry of Education, Culture, Sports, Science and Technology;
   and the Takeda Science Foundation.
CR Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9
   Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200
   Andrews HL, 1998, INFECT IMMUN, V66, P950
   Autret A, 2007, J VIROL, V81, P7504, DOI 10.1128/JVI.02690-06
   Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017
   Carter BZ, 2005, BLOOD, V105, P4043, DOI 10.1182/blood-2004-08-3168
   Chang B, 2004, MICROB PATHOGENESIS, V37, P295, DOI 10.1016/j.micpath.2004.10.002
   Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631
   Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846
   Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200
   Dewson G, 2003, ONCOGENE, V22, P2643, DOI 10.1038/sj.onc.1206326
   Dey R, 2007, INFECT IMMUN, V75, P2136, DOI 10.1128/IAI.01589-06
   Dietrich C, 2001, INFECT IMMUN, V69, P2116, DOI 10.1128/IAI.69.4.2116-2122.2001
   Edelstein PH, 1999, P NATL ACAD SCI USA, V96, P8190, DOI 10.1073/pnas.96.14.8190
   Fischer SF, 2006, MICROBES INFECT, V8, P662, DOI 10.1016/j.micinf.2005.08.016
   Gao LY, 1999, INFECT IMMUN, V67, P862
   Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8
   Joshi AD, 2001, CELL MICROBIOL, V3, P99, DOI 10.1046/j.1462-5822.2001.00093.x
   Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883
   Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91
   Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   Molofsky AB, 2005, INFECT IMMUN, V73, P5720, DOI 10.1128/IAI.73.9.5720-5734.2005
   Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659
   Neild AL, 2004, CELL MICROBIOL, V6, P1011, DOI 10.1111/j.1462-5822.2004.00450.x
   Neumeister B, 2002, MICROBIOL-SGM, V148, P3639, DOI 10.1099/00221287-148-11-3639
   Masahiro N, 2007, J MOL CELL CARDIOL, V43, P564, DOI 10.1016/j.yjmcc.2007.08.010
   Nogueira CV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000478
   Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k
   Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920
   Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163
   Park SS, 2006, J MOL CELL CARDIOL, V40, P708, DOI 10.1016/j.yjmcc.2006.01.024
   Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018
   Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964
   Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x
   Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826
   Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000
   Susa M, 1998, J IMMUNOL, V160, P316
   Tateda K, 2001, INFECT IMMUN, V69, P2017, DOI 10.1128/IAI.69.4.2017-2024.2001
   Teruya H, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-102
   Tsuruta F, 2002, J BIOL CHEM, V277, P14040, DOI 10.1074/jbc.M108975200
   Walz JM, 2000, APMIS, V108, P398, DOI 10.1034/j.1600-0463.2000.d01-75.x
   Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253
   Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155
   Weissgerber P, 2003, FEMS MICROBIOL LETT, V219, P173, DOI 10.1016/S0378-1097(03)00051-X
   Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281
   Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984
   Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305
   Zhang CH, 1996, J IMMUNOL, V157, P3980
NR 49
TC 7
Z9 7
U1 1
U2 15
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD APR 1
PY 2010
VL 427
BP 57
EP 67
DI 10.1042/BJ20091768
PN 1
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 582GA
UT WOS:000276583300006
PM 20102336
DA 2018-12-27
ER

PT J
AU Banerjee, P
   Tripp, A
   Lairmore, MD
   Crawford, L
   Sieburg, M
   Ramos, JC
   Harrington, W
   Beilke, MA
   Feuer, G
AF Banerjee, Prabal
   Tripp, Adam
   Lairmore, Michael D.
   Crawford, Lindsey
   Sieburg, Michelle
   Ramos, Juan Carlos
   Harrington, William, Jr.
   Beilke, Mark A.
   Feuer, Gerold
TI RETRACTED: Adult T-cell leukemia/lymphoma development in HTLV-1-infected
   humanized SCID mice (Retracted article. See vol. 124, pg. 305, 2014)
SO BLOOD
LA English
DT Article; Retracted Publication
ID VIRUS TYPE-I; HEMATOPOIETIC PROGENITOR CELLS; LEUKEMIA-LYMPHOMA; HTLV-I;
   TYPE-1 HTLV-1; CD34(+) CELLS; STEM-CELLS; CYCLE ARREST; BONE-MARROW; TAX
AB The molecular and genetic factors induced by human T-lymphotropic virus type-1 (HTLV-1) that initiate adult T-cell leukemia/lymphoma (ATLL) remain unclear, in part from the lack of an animal model that accurately recapitulates leukemogenesis. HTLV-1-infected humanized nonobese diabetic severe combined immunodeficiency (HU-NOD/SCID) mice were generated by inoculation of NOD/SCID mice with CD34(+) hematopoietic progenitor and stem cells (CD34(+) HP/HSCs) infected ex vivo with HTLV-1.HTLV-1-HU-NOD/SCID mice exclusively developed CD4(+) T-cell lymphomas with characteristics similar to ATLL and elevated proliferation of infected human stem cells (CD34(+)CD38(-)) in the bone marrow were observed in mice developing malignancies. Purified CD34(+) HP/HSCs from HTLV-1-infected patient peripheral blood mononuclear cells revealed proviral integrations suggesting viral infection of human bone marrow-derived stem cells. NOD/SCID mice reconstituted with CD34(+) HP/HSCs transduced with a lentivirus vector expressing the HTLV-1 oncoprotein (Tax1) also developed CD4(+) lymphomas. The recapitulation of a CD4(+) T-cell lymphoma in HU-NOD/SCID mice suggests that HSCs provide a viral reservoir in vivo and act as cellular targets for cell transformation in humans. This animal model of ATLL will provide an important tool for the identification of molecular and cellular events that control the initiation and progression of the lymphoma and potential therapeutic targets to block tumor development. (Blood. 2010;115(13):2640-2648)
C1 [Banerjee, Prabal; Tripp, Adam; Crawford, Lindsey; Sieburg, Michelle; Feuer, Gerold] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.
   [Banerjee, Prabal; Crawford, Lindsey; Sieburg, Michelle; Feuer, Gerold] SUNY Upstate Med Univ, Ctr Humanized SCID Mouse Models, Syracuse, NY 13210 USA.
   [Lairmore, Michael D.] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA.
   [Lairmore, Michael D.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA.
   [Lairmore, Michael D.] Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, Columbus, OH 43210 USA.
   [Lairmore, Michael D.] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA.
   [Ramos, Juan Carlos; Harrington, William, Jr.] Univ Miami, Sch Med, Sylvester Comprehens Canc Ctr, Div Hematol Oncol, Coral Gables, FL 33124 USA.
   [Beilke, Mark A.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA.
RP Feuer, G (reprint author), SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.
EM feuerg@upstate.edu
RI Crawford, Lindsey/C-7396-2011
FU National Institutes of Health [CA124595, P01 CA100730]; New York State
   Department of Health [C023059, N08G-127]
FX This work was supported by grants from the National Institutes of Health
   (CA124595 to G.F. and P01 CA100730 to M.D.L.) and by the Empire State
   Stem Cell Fund through New York State Department of Health Contract
   (NYSTEM #C023059 and #N08G-127) to G.F.
CR Banerjee P, 2007, J VIROL, V81, P1690, DOI 10.1128/JVI.01513-06
   Banerjee P, 2008, STEM CELLS, V26, P3047, DOI 10.1634/stemcells.2008-0353
   Bartholomew C, 1998, J Hum Virol, V1, P302
   Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845
   Feuer G, 1996, J VIROL, V70, P4038
   FEUER G, 1993, BLOOD, V82, P722
   Fujino T, 2000, J REPROD IMMUNOL, V47, P197, DOI 10.1016/S0165-0378(00)00054-1
   Gessain A, 2000, B SOC PATHOL EXOT, V93, P163
   Gessain A, 2000, PRESSE MED, V29, P2233
   Grant C, 2002, J CELL PHYSIOL, V190, P133, DOI 10.1002/JCP.10053
   HANAOKA M, 1979, ACTA PATHOL JAPON, V29, P723
   Hasegawa H, 2006, NAT MED, V12, P466, DOI 10.1038/nm1389
   HINO S, 1989, Acta Paediatrica Japonica, V31, P428
   HUANG S, 1994, BLOOD, V83, P1515
   Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516
   Kikuchi H, 2000, BONE MARROW TRANSPL, V26, P1235, DOI 10.1038/sj.bmt.1702698
   Lairmore MD, 2005, ONCOGENE, V24, P6005, DOI 10.1038/sj.onc.1208974
   Matsuoka M, 2003, ONCOGENE, V22, P5131, DOI 10.1038/sj.onc.1206551
   Matsuoka M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-27
   Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111
   Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431
   NAGAFUJI K, 1993, BLOOD, V82, P2823
   Nagatani T, 1992, Exp Dermatol, V1, P248, DOI 10.1111/j.1600-0625.1992.tb00084.x
   Ohsugi T, 2007, NAT MED, V13, P527, DOI 10.1038/nm0507-527
   Okochi K, 1984, Princess Takamatsu Symp, V15, P129
   Pflumio F, 1996, BLOOD, V88, P3731
   Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
   SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x
   Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477
   SHULTZ LD, 1995, J IMMUNOL, V154, P180
   Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017
   STUVER SO, 1993, J INFECT DIS, V167, P57, DOI 10.1093/infdis/167.1.57
   Tripp A, 2005, J VIROL, V79, P14069, DOI 10.1128/JVI.79.22.14069-14078.2005
   Tripp A, 2003, J VIROL, V77, P12152, DOI 10.1128/JVI.77.22.12152-12164.2003
   Uchiyama T, 1983, Gan To Kagaku Ryoho, V10, P642
   Wu W, 2006, BLOOD, V108, P141, DOI 10.1182/blood-2005-04-1697
   Yamazaki J, 2009, BLOOD, V114, P2709, DOI 10.1182/blood-2008-08-174425
   Yasunaga JI, 2003, INT J HEMATOL, V78, P312, DOI 10.1007/BF02983555
NR 38
TC 39
Z9 40
U1 1
U2 10
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD APR 1
PY 2010
VL 115
IS 13
BP 2640
EP 2648
DI 10.1182/blood-2009-10-246959
PG 9
WC Hematology
SC Hematology
GA 577DI
UT WOS:000276201000013
PM 20124219
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Gangadharan, C
   Thoh, M
   Manna, SK
AF Gangadharan, Charitha
   Thoh, Maikho
   Manna, Sunil Kumar
TI RETRACTED: Late phase activation of nuclear transcription factor kappaB
   by doxorubicin is mediated by interleukin-8 and induction of apoptosis
   via FasL (Retracted article. See vol. 138, pg. 977, 2013)
SO BREAST CANCER RESEARCH AND TREATMENT
LA English
DT Article; Retracted Publication
DE NF-kappa B; Doxorubicin; Apoptosis; IL-8; FasL
ID CELL-DEATH; RELA PHOSPHORYLATION; ANTICANCER DRUG; TUMOR-CELLS;
   CALCINEURIN; INHIBITION; PATHWAY; MECHANISM; NETWORK; FAMILY
AB Doxorubicin is one of the most effective molecules used in the treatment of various tumors. Contradictory reports often open windows to understand the doxorubicin-mediated signaling to exert its apoptosis effect. In this report, we provide evidences that doxorubicin induced biphasic induction of nuclear factor kappaB (NF-kappa B) of immediate activation followed by decrease in the amount of RelA (p65) subunit possibly by inducing the activity of proteasome, but not proteases. Further induction of NF-kappa B was observed through interleukin 8 (IL-8), expressed by doxorubicin treatment. Increased amount of IL-8 induced apoptosis via increase in the releases of intracellular Ca2+, activation of calcineurin, nuclear translocation of nuclear factor activated T cell (NF-AT), and NF-AT-dependent FasL expression. Anti-IL-8 or -FasL antibody, dominant negative TRAF6 (TRAF6-DN), or TRAF6 binding peptide (TRAF6-BP) inhibited doxorubicin-mediated late phase induction of NF-kappa B and diminished cell death. Thus, our study clearly demonstrated that doxorubicin-mediated cell death is obtained through expression of IL-8. IL-8-mediated calcification is required for enhancement of doxorubicin-mediated cell death. Overall, this study will help to understand the much studied chemotherapeutic drug, doxorubicin-mediated cell signaling cascade to exert its effect during chemotherapy.
C1 [Gangadharan, Charitha; Thoh, Maikho; Manna, Sunil Kumar] Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India.
RP Manna, SK (reprint author), Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India.
EM manna@cdfd.org.in
FU Centre for DNA Fingerprinting and Diagnostics (CDFD); Council for
   Scientific & Industrial Research (CSIR), New Delhi
FX This work was supported by the core grant of Centre for DNA
   Fingerprinting and Diagnostics (CDFD). We acknowledge the Department of
   Science and Technology (DST) for providing SEARC Fast Track proposal for
   Young Scientists grant to SKM and Council for Scientific & Industrial
   Research (CSIR), New Delhi for providing fellowship to CG and MT. We
   thank Drs. T. Ramasarma and A. K. Khar for critically and carefully
   reading the manuscript.
CR Abbasi S, 2005, J BIOL CHEM, V280, P36737, DOI 10.1074/jbc.M506493200
   Andrassy M, 2002, CLIN NEPHROL, V58, P179
   Barre B, 2007, EMBO J, V26, P4841, DOI 10.1038/sj.emboj.7601899
   BLUM RH, 1974, ANN INTERN MED, V80, P249, DOI 10.7326/0003-4819-80-2-249
   Bose JS, 2009, J CELL PHYSIOL, V218, P653, DOI 10.1002/jcp.21640
   Chuang SE, 2002, BIOCHEM PHARMACOL, V63, P1709, DOI 10.1016/S0006-2952(02)00931-0
   Clarke DL, 2008, J IMMUNOL, V181, P3503, DOI 10.4049/jimmunol.181.5.3503
   Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101
   Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2
   ECUYER T, 2006, AM J PHYSIOL-HEART C, V291, pH1273
   Eom YW, 2005, ONCOGENE, V24, P4765, DOI 10.1038/sj.onc.1208627
   Fischer Uwe M, 2006, Interact Cardiovasc Thorac Surg, V5, P531, DOI 10.1510/icvts.2006.130765
   Gangadharan C, 2009, J CELL BIOCHEM, V107, P203, DOI 10.1002/jcb.22115
   HARRIS GR, 1993, CANC BREAST, V126, P4
   Kingsbury TJ, 2000, GENE DEV, V14, P1595
   Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367
   Kotamraju S, 2002, J BIOL CHEM, V277, P17179, DOI 10.1074/jbc.M111604200
   Levina V, 2008, INT J CANCER, V123, P2031, DOI 10.1002/ijc.23732
   Liu SF, 1997, EMBO J, V16, P143, DOI 10.1093/emboj/16.1.143
   Manna SK, 2007, CELL DEATH DIFFER, V14, P158, DOI 10.1038/sj.cdd.4401929
   Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245
   Manna SK, 2005, J BIOL CHEM, V280, P7010, DOI 10.1074/jbc.M410994200
   Manna SK, 1999, J IMMUNOL, V162, P1510
   Manna SK, 2009, MOL IMMUNOL, V46, P1340, DOI 10.1016/j.molimm.2008.11.014
   Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1
   Niu JL, 2009, J PHARMACOL EXP THER, V328, P740, DOI 10.1124/jpet.108.146423
   Ostrakhovitch EA, 2005, APOPTOSIS, V10, P111, DOI 10.1007/s10495-005-6066-7
   Raghavendra PB, 2007, APOPTOSIS, V12, P307, DOI 10.1007/s10495-006-0626-3
   Rusnak F, 2000, PHYSIOL REV, V80, P1483
   Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8
   Sarkar A, 2004, J BIOL CHEM, V279, P33768, DOI 10.1074/jbc.M403424200
   SHIMOKAWA I, 2004, GERIATR GERONTOL INT, V4, pS149
   Sreenivasan Y, 2003, ONCOGENE, V22, P4356, DOI 10.1038/sj.onc.1206486
   Srivastava RK, 1999, J EXP MED, V190, P253, DOI 10.1084/jem.190.2.253
   Ujhazy P, 2003, CANCER IMMUNOL IMMUN, V52, P463, DOI 10.1007/s00262-003-0391-x
   Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888
   Yeh YC, 2007, BIOCHEM PHARMACOL, V74, P969, DOI 10.1016/j.bcp.2007.06.031
   Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2
NR 38
TC 14
Z9 14
U1 3
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0167-6806
EI 1573-7217
J9 BREAST CANCER RES TR
JI Breast Cancer Res. Treat.
PD APR
PY 2010
VL 120
IS 3
BP 671
EP 683
DI 10.1007/s10549-009-0493-z
PG 13
WC Oncology
SC Oncology
GA 571LH
UT WOS:000275752800015
PM 19649704
DA 2018-12-27
ER

PT J
AU Huang, WY
   Sheehy, TM
   Moore, LE
   Hsing, AW
   Purdue, MP
AF Huang, Wen-Yi
   Sheehy, Timothy M.
   Moore, Lee E.
   Hsing, Ann W.
   Purdue, Mark P.
TI RETRACTED: Simultaneous Recovery of DNA and RNA from Formalin-Fixed
   Paraffin-Embedded Tissue and Application in Epidemiologic Studies
   (Retracted article. See vol. 23, pg. 1132, 2014)
SO CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
LA English
DT Review; Retracted Publication
ID EXPRESSION ANALYSIS; GENE-EXPRESSION; COPY NUMBER; MICROARRAYS;
   VALIDATION; EXTRACTION; TUMORS; ASSAY
AB Analysis of DNA, RNA, and protein extracted from tissue specimens in epidemiologic studies is useful for assessing etiologic heterogeneity, mechanisms of carcinogenesis, and biomarkers for prognosis and prediction of treatment responses. Fresh-frozen tissue samples may provide optimal quality nucleic acids, but pose multiple logistical considerations, including rapid access to tissues before histopathologic examination and specialized equipment for freezing, transport, and storage; in addition, morphology is often compromised. In contrast, formalin-fixed paraffin-embedded (FFPE) tissue samples, including enormous archives of existing specimens, represent a valuable source of retrospective biological material for epidemiologic research, although presenting different limitations compared with frozen samples. Recent efforts have made progress toward enhancing the utility of FFPE specimens for molecular analyses, including DNA studies, and increasingly for RNA and other macromolecules. Here, we report the method that we used to simultaneously recover DNA and RNA from FFPE tissue specimens with appreciable quantity and quality and discuss briefly the application of tumor markers in epidemiologic studies. Cancer Epidemiol Biomarkers Prev; 19(4); 973-7. (C)2010 AACR.
C1 [Huang, Wen-Yi; Moore, Lee E.; Hsing, Ann W.; Purdue, Mark P.] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA.
   [Sheehy, Timothy M.] Sci Applicat Int Corp Frederick Inc, DNA Extract & Staging Lab, NCI Frederick, Frederick, MD USA.
RP Huang, WY (reprint author), NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, 6120 Execut Blvd,EPS 8110,MSC 7240, Bethesda, MD 20892 USA.
EM huangw@mail.nih.gov
FU National Cancer Institute; National Cancer Institute, NIH
   [HHSN261200800001E]
FX Intramural Research Program of the National Cancer Institute and federal
   funds from the National Cancer Institute, NIH, under contract no.
   HHSN261200800001E. The content of this publication does not necessarily
   reflect the views or policies of the Department of Health and Human
   services, nor does mention of trade names, commercial products, or
   organizations imply endorsement by the U.S. Government.
CR Abramovitz M, 2008, BIOTECHNIQUES, V44, P417, DOI 10.2144/000112703
   Chung JY, 2008, J HISTOCHEM CYTOCHEM, V56, P1033, DOI 10.1369/jhc.2008.951863
   Coudry RA, 2007, J MOL DIAGN, V9, P70, DOI 10.2353/jmoldx.2007.060004
   Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3
   Doleshal M, 2008, J MOL DIAGN, V10, P203, DOI 10.2353/jmoldx.2008.070153
   Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7
   Garcia-Closas M, 2006, CANC EPIDEMIOLOGY PR, P70
   Hewitt SM, 2006, METHOD ENZYMOL, V410, P400, DOI 10.1016/S0076-6879(06)10020-8
   Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279
   Jacobs S, 2007, CANCER RES, V67, P2544, DOI 10.1158/0008-5472.CAN-06-3597
   Killian JK, 2009, CANCER RES, V69, P758, DOI 10.1158/0008-5472.CAN-08-2984
   Linton KM, 2008, BRIT J CANCER, V98, P1403, DOI 10.1038/sj.bjc.6604316
   Little SE, 2006, GENOMICS, V87, P298, DOI 10.1016/j.ygeno.2005.09.019
   Oosting J, 2007, GENOME RES, V17, P368, DOI 10.1101/gr.5686107
   Penland SK, 2007, LAB INVEST, V87, P383, DOI 10.1038/labinvest.3700529
   Santos S, 2009, RES VET SCI, V86, P421, DOI 10.1016/j.rvsc.2008.08.007
   Tang Weining, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5138
NR 17
TC 25
Z9 25
U1 2
U2 13
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1055-9965
EI 1538-7755
J9 CANCER EPIDEM BIOMAR
JI Cancer Epidemiol. Biomarkers Prev.
PD APR
PY 2010
VL 19
IS 4
BP 973
EP 977
DI 10.1158/1055-9965.EPI-10-0091
PG 5
WC Oncology; Public, Environmental & Occupational Health
SC Oncology; Public, Environmental & Occupational Health
GA 607FL
UT WOS:000278484400014
PM 20332269
OA Bronze, Green Accepted
DA 2018-12-27
ER

PT J
AU Saccomanni, B
AF Saccomanni, Bernardino
TI RETRACTED: Unicompartmental knee arthroplasty: a review of literature
   (Retracted Article. See vol 30, pg 153, 2011)
SO CLINICAL RHEUMATOLOGY
LA English
DT Review; Retracted Publication
DE Functional outcomes; Knee OA; Unicompartmental knee arthroplasty
ID FOLLOW-UP; REPLACEMENT; OSTEOARTHRITIS; 10-YEAR; SPORTS; PERCEPTIONS;
   PROSTHESIS; CONVERSION; RATIONALE; ALIGNMENT
AB There has been a resurgence of interest in unicompartmental knee arthroplasty (UKA) for treatment of medial unicompartmental knee osteoarthritis (OA). Improved prosthetic design, minimally invasive surgical techniques, and strict patient selection criteria have resulted in improved survivorship and functional outcomes. A review of orthopedic literature was conducted regarding the advantages of UKA versus total knee arthroplasty (TKA), UKA indications, survivorship, conversion of UKA to TKA, rehabilitation, and outcomes. The UKA appears to be a viable option for patients with knee medial compartment OA, including younger and active patients. Survivorship rates of 94% to 97% at 10 years have been reported.
C1 Univ G dAnnunzio, I-66013 Chieti, Scalo, Italy.
RP Saccomanni, B (reprint author), Univ G dAnnunzio, Via Vestini, I-66013 Chieti, Scalo, Italy.
EM bernasacco@yahoo.it
CR Amin AK, 2006, CLIN ORTHOP RELAT R, P101, DOI 10.1097/01.blo.0000224052.01873.20
   Argenson JNA, 2002, J BONE JOINT SURG AM, V84A, P2235, DOI 10.2106/00004623-200212000-00017
   BEDSON J, 2004, FAM PRACT, V21, P1
   Berger RA, 2004, CLIN ORTHOP RELAT R, P92, DOI 10.1097/01.blo.0000147700.89433.a5
   BERNASEK TL, 1988, CLIN ORTHOP RELAT R, P52
   Bert JM, 2005, ORTHOP CLIN N AM, V36, P513, DOI 10.1016/j.ocl.2005.05.001
   Borjesson M, 2005, KNEE, V12, P121, DOI 10.1016/j.knee.2004.04.002
   Bradbury N, 1998, AM J SPORT MED, V26, P530, DOI 10.1177/03635465980260041001
   Cartier P, 1996, J ARTHROPLASTY, V11, P782, DOI 10.1016/S0883-5403(96)80177-X
   Dawson J, 1998, J BONE JOINT SURG BR, V80B, P63, DOI 10.1302/0301-620X.80B1.7859
   ENGH GA, 1992, J BONE JOINT SURG BR, V74, P9
   Engh GA, 2004, CLIN ORTHOP RELAT R, P170, DOI 10.1097/01.blo.0000148895.78766.8a
   Fisher N, 2006, KNEE, V13, P296, DOI 10.1016/j.knee.2006.03.004
   Harrysson OLA, 2004, CLIN ORTHOP RELAT R, P162, DOI 10.1097/01.blo.0000127115.05754.ce
   Hassaballa MA, 2007, MED SCI MONITOR, V13, pCR77
   Hernigou P, 2004, CLIN ORTHOP RELAT R, P161, DOI 10.1097/01.blo.0000128285.90459.12
   Hootman JM, 2006, ARTHRITIS RHEUM, V54, P226, DOI 10.1002/art.21562
   INSALL JN, 1989, CLIN ORTHOP RELAT R, P13
   Johnson S, 2007, KNEE, V14, P154, DOI 10.1016/j.knee.2006.11.012
   Kasodekar V. B., 2006, SMJ Singapore Medical Journal, V47, P796
   Kleijn LLA, 2007, KNEE SURG SPORT TR A, V15, P1187, DOI 10.1007/s00167-007-0351-7
   Kort NP, 2007, KNEE SURG SPORT TR A, V15, P356, DOI 10.1007/s00167-006-0204-9
   Koskinen E, 2007, ACTA ORTHOP, V78, P128, DOI 10.1080/17453670610013538
   KOZINN SC, 1989, J BONE JOINT SURG AM, V71A, P145, DOI 10.2106/00004623-198971010-00023
   Kuster MS, 2002, SPORTS MED, V32, P433, DOI 10.2165/00007256-200232070-00003
   Kuster MS, 2000, MED SCI SPORT EXER, V32, P721, DOI 10.1097/00005768-200004000-00001
   LASKIN RS, 2001, CLIN ORTHOP RELAT R, V392, P267
   Levine WN, 1996, J ARTHROPLASTY, V11, P797, DOI 10.1016/S0883-5403(96)80179-3
   MARMOR L, 1988, CLIN ORTHOP RELAT R, P14
   Meek RMD, 2004, ORTHOP CLIN N AM, V35, P191, DOI 10.1016/S0030-5898(03)00115-9
   Murray DW, 1998, J BONE JOINT SURG BR, V80B, P983, DOI 10.1302/0301-620X.80B6.8177
   Naal FD, 2007, AM J SPORT MED, V35, P1688, DOI 10.1177/0363546507303562
   Naudie D, 2004, J BONE JOINT SURG AM, V86A, P1931, DOI 10.2106/00004623-200409000-00011
   O'Rourke MR, 2005, CLIN ORTHOP RELAT R, P27, DOI 10.1097/01.blo.0000185451.96987.aa
   Patil S, 2005, J BONE JOINT SURG AM, V87A, P332, DOI 10.2106/JBJS.C.01467
   Saldanha KAN, 2007, KNEE, V14, P275, DOI 10.1016/j.knee.2007.03.005
   Satku K, 2003, Singapore Med J, V44, P554
   SooHoo NF, 2006, J BONE JOINT SURG AM, V88A, P1975, DOI 10.2106/JBJS.E.00597
   Springer BD, 2006, CLIN ORTHOP RELAT R, P214, DOI 10.1097/01.blo.0000214431.19033.fa
   SWIENCKOWSKI J, 1989, CLIN ORTHOP RELAT R, P161
   Swienckowski John J, 2004, J Bone Joint Surg Am, V86-A Suppl 1, P131
   Tabor Owen B Jr, 2005, J Surg Orthop Adv, V14, P59
   Walton Neil P, 2006, J Knee Surg, V19, P112
   Weale AE, 2001, CLIN ORTHOP RELAT R, P143
   WHITE SH, 1991, J BONE JOINT SURG BR, V73, P582
NR 45
TC 24
Z9 27
U1 2
U2 14
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0770-3198
EI 1434-9949
J9 CLIN RHEUMATOL
JI Clin. Rheumatol.
PD APR
PY 2010
VL 29
IS 4
BP 339
EP 346
DI 10.1007/s10067-009-1354-1
PG 8
WC Rheumatology
SC Rheumatology
GA 563SK
UT WOS:000275153800001
PM 20069325
DA 2018-12-27
ER

PT J
AU Luna, CM
   Navarro, IDB
AF Luna, Carlos M.
   Boyeras Navarro, Iris D.
TI RETRACTED: Management of methicillin-resistant Staphylococcus aureus
   pneumonia (Retracted article. See vol. 23, pg. 402, 2010)
SO CURRENT OPINION IN INFECTIOUS DISEASES
LA English
DT Review; Retracted Publication
DE community acquired pneumonia; hospital acquired pneumonia;
   healthcare-associated pneumonia; management; methicillin-resistant
   Staphylococcus aureus; pneumonia; ventilator-associated pneumonia
ID VENTILATOR-ASSOCIATED PNEUMONIA; COMMUNITY-ACQUIRED PNEUMONIA;
   PANTON-VALENTINE LEUKOCIDIN; CARE-ASSOCIATED PNEUMONIA; UNITED-STATES;
   NOSOCOMIAL PNEUMONIA; LATIN-AMERICA; VANCOMYCIN; INFECTIONS; IMPACT
AB Purpose of review
   Staphylococcus aureus, and particularly methicillin-resistant Staphylococcus aureus (MRSA) has become an increasingly important etiology of pneumonia, both in healthcare and community settings. Associated with highest morbidity, mortality and costs in public health, it represents a major challenge for the management of this group of patients.
   Recent findings
   MRSA is one of the most common pathogens of ventilator associated pneumonia, whereas its estimated incidence for hospital acquired pneumonia, healthcare associated pneumonia and community acquired pneumonia has risen in the past decades. Although vancomycin at standard doses remains as the mainstay for its treatment, the increasing rate of treatment failure has prompted other strategies of use (more frequent administration, continuous infusion, combination therapy), and the use of newer antimicrobials, particularly linezolid, with pharmacokinetic and pharmacodynamic profiles which produce promisingly improved clinical results.
   Summary
   Overall, MRSA is an important cause of pneumonia; optimal management strategies for improving morbidity and mortality are still under development.
C1 [Luna, Carlos M.; Boyeras Navarro, Iris D.] Univ Buenos Aires, Dept Med, Div Pulm, Hosp Clin, RA-1053 Buenos Aires, DF, Argentina.
RP Luna, CM (reprint author), Acevedo 1070, RA-1828 Buenos Aires, DF, Argentina.
EM cymluna@advancedsl.com.ar
FU Pfizer
FX Dr Boyeras has no conflict of interests; Dr Luna has acted on the
   Advisory Board for Pfizer, Wyeth and Bayer-Schering and received
   honorarium for giving talks from Merck and received an Independent
   Research Grant from Pfizer.
CR [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST
   Arnold FW, 2007, AM J RESP CRIT CARE, V175, P1086, DOI 10.1164/rccm.200603-350OC
   Athanassa Z, 2008, EUR RESPIR J, V31, P625, DOI 10.1183/09031936.00081007
   Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5
   Boselli E, 2005, CRIT CARE MED, V33, P1529, DOI 10.1097/01.CCM.0000168206.59873.80
   CHAMBERS HF, 1985, J CLIN INVEST, V76, P325, DOI 10.1172/JCI111965
   Chang FY, 2003, MEDICINE, V82, P333, DOI 10.1097/01.md.0000091184.93122.09
   Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588
   Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476
   Couto I, 1996, MICROB DRUG RESIST, V2, P377, DOI 10.1089/mdr.1996.2.377
   Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184
   Gauduchon V, 2004, J INFECT DIS, V189, P346, DOI 10.1086/380909
   Gonzalez C, 1999, CLIN INFECT DIS, V29, P1171, DOI 10.1086/313440
   Guzman-Blanco M, 2009, INT J ANTIMICROB AG, V34, P304, DOI 10.1016/j.ijantimicag.2009.06.005
   Ito T, 2003, DRUG RESIST UPDATE, V6, P41, DOI 10.1016/S1368-7646(03)00003-7
   Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001
   IWAHARA T, 1994, CHEST, V105, P826, DOI 10.1378/chest.105.3.826
   Iwamoto T, 2003, BIOL PHARM BULL, V26, P876
   Jeffres MN, 2006, CHEST, V130, P947, DOI 10.1378/chest.130.4.947
   KALLEN AJ, 2009, ANN EMERG MED, V53, P1358
   Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763
   Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367
   Kollef MH, 2006, CURR OPIN INFECT DIS, V19, P161
   Kollef MH, 1998, CHEST, V113, P412, DOI 10.1378/chest.113.2.412
   Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854
   Kopp BJ, 2004, ANN PHARMACOTHER, V38, P1377, DOI 10.1345/aph.1E028
   LABANDEIRAREY M, 2007, SCIENCE, P315
   Luna CM, 2009, CHEST, V135, P1564, DOI 10.1378/chest.08-2169
   Luna CM, 1997, CHEST, V111, P676, DOI 10.1378/chest.111.3.676
   Luna CM, 2005, ARCH BRONCONEUMOL, V41, P439, DOI 10.1157/13077956
   Ma XX, 2002, ANTIMICROB AGENTS CH, V46, P1147, DOI 10.1128/AAC.46.4.1147-1152.2002
   MacGowan AP, 2008, J ANTIMICROB CHEMOTH, V62, pI11, DOI 10.1093/jac/dkn242
   Maclayton DO, 2007, ANN PHARMACOTHER, V41, P235, DOI 10.1345/aph.1H414
   Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159
   MASTERTON RG, 2008, ANTIMICROB CHEMOTHER, V62, P5
   Mizell KN, 2008, J CLIN MICROBIOL, V46, P3534, DOI 10.1128/JCM.00989-08
   Moise PA, 2000, INT J ANTIMICROB AG, V16, pS31
   Moise-Broder PA, 2004, CLIN INFECT DIS, V38, P1700, DOI 10.1086/421092
   Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356
   Neofytos D, 2007, INFECT CONT HOSP EP, V28, P1206, DOI 10.1086/520746
   PANLILIO AL, 1992, INFECT CONT HOSP EP, V13, P582
   Pea F, 2008, CLIN PHARMACOKINET, V47, P147, DOI 10.2165/00003088-200847030-00001
   Pogue M., 2007, Morbidity and Mortality Weekly Report, V56, P325
   RELLO J, 1994, AM J RESP CRIT CARE, V150, P1545, DOI 10.1164/ajrccm.150.6.7952612
   Rubinstein E, 2008, CLIN INFECT DIS, V46, pS378, DOI 10.1086/533594
   Sakoulas G, 2004, J CLIN MICROBIOL, V42, P2398, DOI 10.1128/JCM.42.6.2398-2402.2004
   Salgado CD, 2003, CLIN INFECT DIS, V36, P131, DOI 10.1086/345436
   Scheetz MH, 2006, PHARMACOTHERAPY, V26, P539, DOI 10.1592/phco.26.4.539
   Shorr AF, 2007, PHARMACOECONOMICS, V25, P751, DOI 10.2165/00019053-200725090-00004
   Shorr AF, 2006, CRIT CARE, V10, DOI 10.1186/cc4934
   Stryjewski ME, 2007, CLIN INFECT DIS, V44, P190, DOI 10.1086/510386
   Tacconelli E, 2007, EXPERT OPIN PHARMACO, V8, P2505, DOI 10.1517/14656566.8.15.2505
   Vardakas KZ, 2009, EUR RESPIR J, V34, P1148, DOI 10.1183/09031936.00041009
   Vidaur L, 2008, CHEST, V133, P625, DOI 10.1378/chest.07-2020
   Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053
   Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208
   Wunderink RG, 2003, CHEST, V124, P1789, DOI 10.1378/chest.124.5.1789
   Wunderink RG, 2008, CHEST, V134, P1200, DOI 10.1378/chest.08-0011
   YOKAL Q, 2009, MANDELL DOUGLAS BENN
   Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2
   Zhanel GG, 2008, AM J CLIN DERMATOL, V9, P245, DOI 10.2165/00128071-200809040-00004
NR 61
TC 8
Z9 14
U1 2
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0951-7375
EI 1473-6527
J9 CURR OPIN INFECT DIS
JI Curr. Opin. Infect. Dis.
PD APR
PY 2010
VL 23
IS 2
BP 178
EP 184
DI 10.1097/QCO.0b013e328336a23f
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA 597ZD
UT WOS:000277800300013
PM 20075728
DA 2018-12-27
ER

PT J
AU Manivannan, V
   Chennabasappa, M
   Garrett, J
AF Manivannan, Venkatesan
   Chennabasappa, Madhu
   Garrett, Joshua
TI RETRACTED: Optimization and Characterization of Lithium Ion Cathode
   Materials in the System (1-x-y)LiNi0.8Co0.2O2 center dot
   xLi(2)MnO(3)center dot yLiCoO(2) (Retracted article. See vol. 4, pg.
   1336, 2011)
SO ENERGIES
LA English
DT Article; Retracted Publication
DE Li-ion battery; battery efficiency; battery life; cycle life
ID POSITIVE-ELECTRODE MATERIALS; STRUCTURAL-CHARACTERIZATION;
   ELECTROCHEMICAL-BEHAVIOR; INSERTION MATERIAL; THIN-FILMS; BATTERIES;
   LINIO2; LICOO2; OXIDES; INTERCALATION
AB There is ongoing effort to identify novel materials that have performance better than LiCoO2. The objective of this work is to explore materials in the system (1 - x - y) LiNi0.8Co0.2O2 center dot xLi(2)MnO(3) center dot yLiCoO(2). A ternary composition diagram was used to identify sample points, and compositions for testing were initially chosen. Detailed characterization of the synthesized materials was done, including Rietveld Refinement of XRD data, XPS analysis for valence state of transition-metals, SEM for microstructure details, and TGA for thermal stability of the materials. Electrochemical performance showed that discharge capacities on the order of 230 mAh/g were obtained. Preliminary results showed that these materials exhibit good cycling capabilities thereby positioning these materials as promising for Li-ion battery applications.
C1 [Manivannan, Venkatesan; Chennabasappa, Madhu; Garrett, Joshua] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
RP Manivannan, V (reprint author), Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
EM mani@engr.colostate.edu; chanabasappa.madhu@gmail.com;
   joshgarrett@gmail.com
OI Chennabasappa, Dr. Madhu/0000-0002-5646-5363
CR Alcantara R, 1999, J SOLID STATE ELECTR, V3, P121, DOI 10.1007/s100080050138
   Ammundsen B, 2001, ADV MATER, V13, P943, DOI 10.1002/1521-4095(200107)13:12/13<943::AID-ADMA943>3.0.CO;2-J
   Armstrong AR, 1996, NATURE, V381, P499, DOI 10.1038/381499a0
   *CRYSTALMAKER SOFT, 2010, CRYSTALMAKER CRYST M
   DAHN JR, 1990, SOLID STATE IONICS, V44, P87, DOI 10.1016/0167-2738(90)90049-W
   Endo E, 2001, J POWER SOURCES, V93, P87, DOI 10.1016/S0378-7753(00)00549-8
   GALAKHOV VR, 1995, SOLID STATE COMMUN, V95, P347, DOI 10.1016/0038-1098(95)00279-0
   GOODENOUGH JB, 1976, MATER RES BULL, V11, P203, DOI 10.1016/0025-5408(76)90077-5
   GOODENOUGH JB, 1980, JPN J APPL PHYS, V19, P305, DOI 10.7567/JJAPS.19S3.305
   *JCPDF, 2010, 440145 JCPDF INT CTR
   Johnson CS, 2004, ELECTROCHEM COMMUN, V6, P1085, DOI 10.1016/j.elecom.2004.08.002
   Johnson CS, 2003, CHEM MATER, V15, P2313, DOI 10.1021/cm0204728
   Kim JS, 2004, CHEM MATER, V16, P1996, DOI 10.1021/cm0306461
   Kim WS, 2003, J POWER SOURCES, V115, P101, DOI 10.1016/S0378-7753(02)00614-6
   Kosova NV, 2009, RUSS J ELECTROCHEM+, V45, P277, DOI 10.1134/S1023193509030069
   Liu HS, 2004, ELECTROCHIM ACTA, V49, P1151, DOI 10.1016/j.electacta.2003.11.001
   Lu ZH, 2002, J ELECTROCHEM SOC, V149, pA778, DOI 10.1149/1.1471541
   Lu ZH, 2003, CHEM MATER, V15, P3214, DOI 10.1021/cm030194s
   Mansour A.N., 1994, SURF SCI SPECTRA, V3, P279
   MIZUSHIMA K, 1980, MATER RES BULL, V15, P783, DOI 10.1016/0025-5408(80)90012-4
   MORALES J, 1990, MATER RES BULL, V25, P623, DOI 10.1016/0025-5408(90)90028-Z
   Moses AW, 2007, APPL SURF SCI, V253, P4782, DOI 10.1016/j.apsusc.2006.10.044
   Neudecker BJ, 1998, J ELECTROCHEM SOC, V145, P4148, DOI 10.1149/1.1838929
   NISHI Y, 1988, LITHIUM ION BATTERIE
   OHZUKU T, 1993, ELECTROCHIM ACTA, V38, P1159, DOI 10.1016/0013-4686(93)80046-3
   Ohzuku T, 1997, J POWER SOURCES, V68, P131, DOI 10.1016/S0378-7753(97)02516-0
   Ohzuku T, 2001, CHEM LETT, P744
   Ohzuku T, 2001, CHEM LETT, P642
   Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1188, DOI 10.1149/1.1837571
   Padhi AK, 1997, J ELECTROCHEM SOC, V144, P2581, DOI 10.1149/1.1837868
   ROISNEL T, 2010, FULLPROF MANUAL
   Rougier A, 1996, J ELECTROCHEM SOC, V143, P1168, DOI 10.1149/1.1836614
   Rougier A, 1996, SOLID STATE IONICS, V90, P83, DOI 10.1016/S0167-2738(96)00370-0
   Saadoune I, 1996, J MATER CHEM, V6, P193, DOI 10.1039/jm9960600193
   SAARDOUNE I, 1998, J SOLID STATE CHEM, V136, P8
   Shaju KM, 2002, ELECTROCHIM ACTA, V48, P145, DOI 10.1016/S0013-4686(02)00593-5
   Shin SS, 2002, J POWER SOURCES, V112, P634, DOI 10.1016/S0378-7753(02)00439-1
   STOYANOVA R, 1994, SOLID STATE IONICS, V73, P233, DOI 10.1016/0167-2738(94)90039-6
   Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644
   THACKERAY MM, 1984, MATER RES BULL, V19, P179, DOI 10.1016/0025-5408(84)90088-6
   THOMAS MGSR, 1985, MATER RES BULL, V20, P1137, DOI 10.1016/0025-5408(85)90087-X
   Vani VK, 2007, IONICS, V13, P473, DOI 10.1007/s11581-007-0141-8
   Wang GX, 1998, J POWER SOURCES, V76, P141, DOI 10.1016/S0378-7753(98)00153-0
   WHITTINGHAM MS, 1976, SCIENCE, V192, P1126, DOI 10.1126/science.192.4244.1126
   WILES DB, 1981, J APPL CRYSTALLOGR, V14, P149, DOI 10.1107/S0021889881008996
   WU Y, 2003, NEUROEMBRYOLOGY, V2, P1
   Yabuuchi N, 2003, J POWER SOURCES, V119, P171, DOI 10.1016/S0378-7753(03)00173-3
   Zhang LQ, 2005, J ELECTROCHEM SOC, V152, pA171, DOI 10.1149/1.1829416
NR 48
TC 9
Z9 9
U1 2
U2 23
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1073
J9 ENERGIES
JI Energies
PD APR
PY 2010
VL 3
IS 4
BP 847
EP 865
DI 10.3390/en3040847
PG 19
WC Energy & Fuels
SC Energy & Fuels
GA 588XP
UT WOS:000277108300015
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Khattab, AM
   El-Seify, ZA
   Shaaban, A
   Radojevic, D
   Jankovic, I
AF Khattab, Ahmed M.
   El-Seify, Zeinab A.
   Shaaban, Ashraf
   Radojevic, Dobrila
   Jankovic, Ivanka
TI RETRACTED: Sevoflurane-emergence agitation: effect of supplementary
   low-dose oral ketamine premedication in preschool children undergoing
   dental surgery (Retracted Article. See vol 28, pg 310, 2011)
SO EUROPEAN JOURNAL OF ANAESTHESIOLOGY
LA English
DT Article; Retracted Publication
DE agitation; ketamine; premedication; sevoflurane
ID RECOVERY CHARACTERISTICS; PEDIATRIC-PATIENTS; ANESTHESIA; HALOTHANE;
   MIDAZOLAM; DELIRIUM; DEXMEDETOMIDINE; MYRINGOTOMY; PREVENTION;
   DESFLURANE
AB Background and objective The use of sevoflurane in paediatric anaesthesia which could enable rapid recovery is complicated by the frequent occurrence of emergence agitation. The aim of this study was to test the efficacy of supplementing midazolam-based oral premedication with low-dose oral ketamine in reducing sevoflurane-related emergence agitation.
   Methods Ninety-two healthy preschool children who have been scheduled for elective dental procedures under general anaesthesia were allocated into two groups (46 patients for each): group M received oral midazolam 0.5mgkg(-1), whereas group KM received similar premedication in addition to ketamine 2mgkg(-1). Acceptance of drug mixture and onset of action were monitored over the next 30 min. Induction of anaesthesia was carried out using sevoflurane 8 vol% in 100% oxygen via face mask. Anaesthesia was maintained with sevoflurane 1.5-2 vol% in oxygen-nitrous oxide mixture. Following extubation, standard scoring scale was used for assessing quality of emergence. Agitation parameters were measured using a five-point scale. Agitated children were managed by giving intravenous increments of fentanyl 1mgkg(-1). The time of hospital discharge allowance was recorded.
   Results Vast majority of children accepted the premedication. There were no significant differences between both groups regarding recovery from sevoflurane and allowance of hospital discharge. Onset of action of premedication was shorter in group KM. Similarly, postoperative agitation score and rescue fentanyl consumption were markedly lower in group KM upon admission to the postanaesthesia care unit (P<0.01).
   Conclusion Adding a low dose of oral ketamine to midazolam-based oral premedication in preschool children undergoing dental surgery reduced emergence agitation without delaying hospital discharge. Eur J Anaesthesiol 2010; 27: 353-358
C1 [Khattab, Ahmed M.] Doha Clin Hosp, Dept Anesthesia, Doha, Qatar.
RP Khattab, AM (reprint author), Doha Clin Hosp, Dept Anesthesia, POB 9958, Doha, Qatar.
EM akhattab68@yahoo.co.uk
CR Abu-Shahwan I, 2007, PEDIATR ANESTH, V17, P846, DOI 10.1111/j.1460-9592.2007.02298.x
   Aono J, 1997, ANESTHESIOLOGY, V87, P1298, DOI 10.1097/00000542-199712000-00006
   BRENNAN LJ, 1999, TXB PAEDIAT ANAESTHE
   Breschan C, 2007, PEDIATR ANESTH, V17, P347, DOI 10.1111/j.1460-9592.2006.02101.x
   Cohen IT, 2002, ANESTH ANALG, V94, P1178, DOI 10.1097/00000539-200205000-00023
   Dalens BJ, 2006, ANESTH ANALG, V102, P1056, DOI 10.1213/013.ane.0000200282.38041.1f
   Davis PJ, 1999, ANESTH ANALG, V88, P34, DOI 10.1097/00000539-199901000-00007
   Funk W, 2000, BRIT J ANAESTH, V84, P335
   Galinkin JL, 2000, ANESTHESIOLOGY, V93, P1378, DOI 10.1097/00000542-200012000-00006
   GRANT IS, 1981, BRIT J ANAESTH, V53, P805, DOI 10.1093/bja/53.8.805
   Houghton AK, 2001, PAIN, V91, P201, DOI 10.1016/S0304-3959(00)00428-0
   Humphries Yvonne, 1997, Journal of Burn Care and Rehabilitation, V18, P34
   Ibacache ME, 2004, ANESTH ANALG, V98, P60, DOI 10.1213/01.ANE.0000094947.20838.8E
   Isik B, 2006, PEDIATR ANESTH, V16, P748, DOI 10.1111/j.1460-9592.2006.01845.x
   Kawaraguchi Yoshitaka, 2002, Japanese Journal of Anesthesiology, V51, P1343
   Kulka PJ, 2001, ANESTH ANALG, V93, P335, DOI 10.1097/00000539-200108000-00019
   Kulka PJ, 2001, ANAESTHESIST, V50, P401, DOI 10.1007/s001010100134
   Lapin SL, 1999, PAEDIATR ANAESTH, V9, P299, DOI 10.1046/j.1460-9592.1999.00351.x
   Pandit UA, 2001, CAN J ANAESTH, V48, P191, DOI 10.1007/BF03019734
   Pang CS, 2001, BIOL SIGNAL RECEPT, V10, P310
   Samarkandi A, 2005, EUR J ANAESTH, V22, P189, DOI 10.1017/S0265021505000335
   Schmidt AP, 2007, PEDIATR ANESTH, V17, P667, DOI 10.1111/j.1460-9592.2006.02185.x
   Sikich N, 2004, ANESTHESIOLOGY, V100, P1138, DOI 10.1097/00000542-200405000-00015
   Tazeroualti N, 2007, BRIT J ANAESTH, V98, P667, DOI 10.1093/bja/aem071
   Uezono S, 2000, ANESTH ANALG, V91, P563, DOI 10.1213/00000539-200009000-00012
   Veyckemans F, 2001, Curr Opin Anaesthesiol, V14, P339, DOI 10.1097/00001503-200106000-00010
   Viitanen H, 1999, ANESTH ANALG, V89, P75, DOI 10.1097/00000539-199907000-00014
   Welborn LG, 1996, ANESTH ANALG, V83, P917, DOI 10.1097/00000539-199611000-00005
   Weldon BC, 2004, ANESTH ANALG, V98, P321, DOI 10.1213/01.ANE.0000096004.96603.08
   Yli-Hankala A, 1999, ANESTHESIOLOGY, V91, P1596, DOI 10.1097/00000542-199912000-00009
NR 30
TC 10
Z9 12
U1 3
U2 16
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0265-0215
EI 1365-2346
J9 EUR J ANAESTH
JI Eur. J. Anaesth.
PD APR
PY 2010
VL 27
IS 4
BP 353
EP 358
DI 10.1097/EJA.0b013e328335b2ec
PG 6
WC Anesthesiology
SC Anesthesiology
GA 574VT
UT WOS:000276023000009
PM 20035226
DA 2018-12-27
ER

PT J
AU Fermento, ME
   Gandini, NA
   Lang, CA
   Perez, JE
   Maturi, HV
   Curino, AC
   Facchinetti, MM
AF Fermento, Maria E.
   Gandini, Norberto A.
   Lang, Cecilia A.
   Perez, Juan E.
   Maturi, Horacio V.
   Curino, Alejandro C.
   Facchinetti, Maria M.
TI RETRACTED: Intracellular distribution of p300 and its differential
   recruitment to aggresomes in breast cancer (Retracted article. See vol.
   94, pg. 418, 2013)
SO EXPERIMENTAL AND MOLECULAR PATHOLOGY
LA English
DT Article; Retracted Publication
DE p300; Aggresomes; Breast cancer; Cytoplasmic localization
ID ESTROGEN-RECEPTOR-ALPHA; PROTEASOME-MEDIATED DEGRADATION; ACUTE
   MYELOID-LEUKEMIA; CREB-BINDING-PROTEIN; COACTIVATOR P300; T-ANTIGEN;
   EXPRESSION; CBP; ACETYLTRANSFERASE; TRANSCRIPTION
AB It has been recently suggested that p300 cytoplasmic redistribution and degradation are important for controlling the availability and activity of the protein as a transcriptional coactivator. As a step towards determining the functional relevance of p300 intracellular redistribution in mammary cancer, we aimed at studying p300 localization in two different animal models of mammary carcinoma as well as in human primary breast carcinoma samples. Analysis of p300 protein levels showed stronger expression in tumor epithelia than in normal mammary gland. Cytoplasmic localization of p300 was observed in malignant cells. Furthermore, cytoplasmic p300 was found in tumor epithelia whereas nuclear localization was observed in normal mammary glands in both animal models and in non-malignant adjacent areas of human breast cancer specimens. Interestingly, proteasomal inhibition induced p300 redistribution to perinuclear inclusion bodies in tumor but not in normal mammary gland-derived cells. These inclusions were confirmed to be aggresomes by doing immunofluorescence for ubiquitin, vimentin and 20S proteasomal subunit. Taken together, these findings show that both the localization of p300 and the recruitment to aggresomes differ between mammary tumors and normal mammary glands, and suggest that the formation of these inclusions could be a potential target for therapeutic intervention. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Facchinetti, Maria M.] Ctr Cient Tecnol Bahia Blanca, Inst Invest Bioquim Bahia Blanca, CONICET, Lab Biol Basica Canc, RA-8000 Bahia Blanca, Buenos Aires, Argentina.
   [Perez, Juan E.; Maturi, Horacio V.] Univ Nacl Sur, RA-8000 Bahia Blanca, Buenos Aires, Argentina.
RP Facchinetti, MM (reprint author), Ctr Cient Tecnol Bahia Blanca, Inst Invest Bioquim Bahia Blanca, CONICET, Lab Biol Basica Canc, Camino Carrindanga Km 7 CC 857, RA-8000 Bahia Blanca, Buenos Aires, Argentina.
EM facchinm@criba.edu.ar
FU Scientific Comission of Buenos Aires Province (CIC); Technical Secretary
   of the Universidad Nacional del Sur; CONICET
FX This work was supported by grants from the Scientific Comission of
   Buenos Aires Province (CIC) and from the Technical Secretary of the
   Universidad Nacional del Sur. Fermento ME is a recipient of fellowship
   from CIC and Gandini AN from CONICET. We are very grateful to Dr Elisa
   Bal de Kier Joffe (Institut Roffo, Buenos Aires, Argentina) for
   providing the LM3 cells. We thank Dr Stuart Schreiber from the Howard
   Hughes Medical Institute for providing tubacin.
CR Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361
   ADAMS J, 1999, PHILOS T R SOC LON B, V354, P1501
   Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9
   Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33
   Brouillard F, 2003, J BIOL CHEM, V278, P39509, DOI 10.1074/jbc.M307123200
   Bugge TH, 1998, ONCOGENE, V16, P3097, DOI 10.1038/sj.onc.1201869
   Chan HM, 2001, J CELL SCI, V114, P2363
   Chen J, 2004, CELL MOL LIFE SCI, V61, P1675, DOI 10.1007/s00018-004-4103-9
   Chen JH, 2005, MOL CELL BIOL, V25, P525, DOI 10.1128/MCB.25.2.525-532.2005
   Chen YH, 2007, EXP PHYSIOL, V92, P99, DOI 10.1113/expphysiol.2006.036079
   Curino AC, 2005, J CELL BIOL, V169, P977, DOI 10.1083/jcb.200411153
   Debes JD, 2003, CANCER RES, V63, P7638
   DRAN G, 1995, BREAST CANCER RES TR, V35, P173, DOI 10.1007/BF00668207
   ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869
   Eckner R, 1996, MOL CELL BIOL, V16, P3454
   Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x
   Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536
   Giles RH, 1997, LEUKEMIA, V11, P2087, DOI 10.1038/sj.leu.2400882
   Green AR, 2008, BREAST CANCER RES TR, V110, P427, DOI 10.1007/s10549-007-9737-y
   GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954
   Han Y, 2009, BIOCHEM BIOPH RES CO, V383, P88, DOI 10.1016/j.bbrc.2009.03.147
   Hudelist G, 2003, BREAST CANCER RES TR, V78, P193, DOI 10.1023/A:1022930710850
   Ishihama K, 2007, J CLIN PATHOL, V60, P1205, DOI 10.1136/jcp.2005.029165
   Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883
   Karamouzis MV, 2007, CELL RES, V17, P324, DOI 10.1038/cr.2007.10
   Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3
   Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4
   Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112
   Kurebayashi J, 2000, CLIN CANCER RES, V6, P512
   Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200
   Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7
   Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2
   Macaluso M, 2003, ONCOGENE, V22, P3511, DOI 10.1038/sj.onc.1206578
   Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081
   Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439
   Muraoka M, 1996, ONCOGENE, V12, P1565
   Nawrocki ST, 2006, CANCER RES, V66, P3773, DOI 10.1158/0008-5472.CAN-05-2961
   Nencioni A, 2007, LEUKEMIA, V21, P30, DOI 10.1038/sj.leu.2404444
   Panagopoulos I, 2001, HUM MOL GENET, V10, P395, DOI 10.1093/hmg/10.4.395
   Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000
   Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989
   Shi DD, 2009, P NATL ACAD SCI USA, V106, P16275, DOI 10.1073/pnas.0904305106
   Stossi F, 2009, MOL CELL BIOL, V29, P1749, DOI 10.1128/MCB.01476-08
   Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200
   Urtreger AJ, 1997, INT J ONCOL, V11, P489
   Vleugel MM, 2006, HUM PATHOL, V37, P1085, DOI 10.1016/j.humpath.2006.03.015
   YACIUK P, 1991, MOL CELL BIOL, V11, P5389, DOI 10.1128/MCB.11.11.5389
   Yang Y, 2007, J MOL BIOL, V369, P917, DOI 10.1016/j.jmb.2007.04.004
NR 48
TC 24
Z9 24
U1 2
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4800
EI 1096-0945
J9 EXP MOL PATHOL
JI Exp. Mol. Pathol.
PD APR
PY 2010
VL 88
IS 2
BP 256
EP 264
DI 10.1016/j.yexmp.2010.01.007
PG 9
WC Pathology
SC Pathology
GA 584HB
UT WOS:000276741000006
PM 20097195
DA 2018-12-27
ER

PT J
AU Pschierer, J
   Peschek, N
   Plenio, H
AF Pschierer, Jan
   Peschek, Natalie
   Plenio, Herbert
TI RETRACTED: Cross coupling in water: Suzuki-Miyaura vinylation and
   difluorovinylation of arylboronic acids (Retracted article)
SO GREEN CHEMISTRY
LA English
DT Article; Retracted Publication
ID ROOM-TEMPERATURE PREPARATION; NICKEL-CATALYZED VINYLATION; ASYMMETRIC
   HYDROSILYLATION; HCFC-133A CF3CH2CL; BLOCK-COPOLYMERS; ARYL HALIDES;
   HIGH-YIELD; PALLADIUM; ALPHA-CHLORO-BETA,BETA-DIFLUOROSTYRENES; BROMIDES
AB A general and efficient protocol for the Suzuki-Miyaura coupling of aryl boronic acids with vinylmesylate or difluorovinylmesylate or Cl2C=CF2 in water or water/n-butanol is reported, utilizing Na2PdCl4 (1 mol%) and a highly water-soluble fluorenylphosphine (CataCXium F sulf).
C1 [Pschierer, Jan; Peschek, Natalie; Plenio, Herbert] Tech Univ Darmstadt, Anorgan Chem Zintl Inst, D-64287 Darmstadt, Germany.
RP Plenio, H (reprint author), Tech Univ Darmstadt, Anorgan Chem Zintl Inst, Petersenstr 18, D-64287 Darmstadt, Germany.
EM plenio@tu-darmstadt.de
FU DFG; Fonds der Chemischen Industrie
FX This work was supported by the DFG and the Fonds der Chemischen
   Industrie.
CR Alunni S, 2003, J ORG CHEM, V68, P718, DOI 10.1021/jo020603o
   Anilkumar R, 2005, J FLUORINE CHEM, V126, P1174, DOI 10.1016/j.jfluchem.2005.05.005
   Anilkumar R, 2005, J FLUORINE CHEM, V126, P835, DOI 10.1016/j.jfluchem.2005.03.021
   Anilkumar R, 2002, TETRAHEDRON LETT, V43, P6979, DOI 10.1016/S0040-4039(02)01591-5
   Barluenga J, 2006, ADV SYNTH CATAL, V348, P347, DOI 10.1002/adsc.200505302
   Baumert M, 1999, MACROMOL RAPID COMM, V20, P203, DOI 10.1002/(SICI)1521-3927(19990401)20:4<203::AID-MARC203>3.3.CO;2-9
   Begue J.-P, 2008, BIOORGANIC MED CHEM
   Beletskaya IP, 2000, CHEM REV, V100, P3009, DOI 10.1021/cr9903048
   BURTON DE, COMMUNICATION
   Burton DJ, 1996, CHEM REV, V96, P1641, DOI 10.1021/cr941140s
   CANNON SJ, 2003, ANGEW CHEM INT EDIT, V42, P1900
   Chatterjee AK, 2003, J AM CHEM SOC, V125, P11360, DOI 10.1021/ja0214882
   Coleman CM, 2003, J AM CHEM SOC, V125, P4054, DOI 10.1021/ja034283h
   Denmark SE, 2009, CHEM COMMUN, P20, DOI 10.1039/b809676g
   Denmark SE, 2006, ORG LETT, V8, P63, DOI 10.1021/ol052517r
   Fleckenstein CA, 2008, CHEM-EUR J, V14, P4267, DOI 10.1002/chem.200701877
   Fleckenstein CA, 2008, J ORG CHEM, V73, P3236, DOI 10.1021/jo8001886
   Fleckenstein CA, 2007, GREEN CHEM, V9, P1287, DOI 10.1039/b711965h
   Fleckenstein CA, 2007, CHEM-EUR J, V13, P2701, DOI 10.1002/chem.200601142
   Fleckenstein CA, 2010, CHEM SOC REV, V39, P694, DOI 10.1039/b903646f
   Gogsig TM, 2008, J ORG CHEM, V73, P3404, DOI 10.1021/jo7027097
   Grasa GA, 2001, ORG LETT, V3, P119, DOI 10.1021/ol006827f
   HERRMANN WA, 1996, SYNTHETIC METHODS OR, P136
   Higashihara T, 2007, MACROMOLECULES, V40, P7453, DOI 10.1021/ma070903d
   Kroemer J, 2006, TETRAHEDRON LETT, V47, P6339, DOI 10.1016/j.tetlet.2006.07.003
   Lando VR, 2003, ORG LETT, V5, P2891, DOI 10.1021/ol034948k
   Limmert ME, 2005, J ORG CHEM, V70, P9364, DOI 10.1021/jo0513941
   Molander GA, 2006, J ORG CHEM, V71, P9681, DOI 10.1021/jo0617013
   Nowak I, 2005, ORG LETT, V7, P721, DOI 10.1021/ol047416s
   NUYKEN O, 2005, HDB POLYM SYNTHESIS, V70, P73
   Ogasawara M, 2006, ORGANOMETALLICS, V25, P2715, DOI 10.1021/om060138b
   Pedersen HL, 2002, J ORG CHEM, V67, P7982, DOI 10.1021/jo0257804
   Peyroux E, 2004, EUR J ORG CHEM, P1075, DOI 10.1002/ejoc.200300627
   Plenio H, 2004, CHEMBIOCHEM, V5, P650, DOI 10.1002/cbic.200300752
   Pschierer J, 2009, ORG LETT, V11, P2551, DOI 10.1021/ol9007475
   Raghavanpillai A, 2006, J ORG CHEM, V71, P194, DOI 10.1021/jo051842p
   Utsunomiya M, 2004, J AM CHEM SOC, V126, P2702, DOI 10.1021/ja031542u
   Vastra J, 2006, ORG PROCESS RES DEV, V10, P194, DOI 10.1021/op050105s
   Wright JA, 2006, CHEM-EUR J, V12, P949, DOI 10.1002/chem.200400644
   Yamamoto T, 2009, J ORG CHEM, V74, P3603, DOI 10.1021/jo900290t
   Yoshida M, 2002, J CHEM SOC PERK T 1, P384, DOI 10.1039/b108796g
   Yu SC, 2009, ORG LETT, V11, P241, DOI 10.1021/ol802479y
NR 42
TC 7
Z9 7
U1 3
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9262
EI 1463-9270
J9 GREEN CHEM
JI Green Chem.
PD APR
PY 2010
VL 12
IS 4
BP 636
EP 642
DI 10.1039/b924772f
PG 7
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY
SC Chemistry; Science & Technology - Other Topics
GA 587ES
UT WOS:000276973200016
DA 2018-12-27
ER

PT J
AU Patel, SS
   Owida, AA
   Morsi, YS
AF Patel, Shital S.
   Owida, Amal A.
   Morsi, Yos S.
TI RETRACTED: Microwave sterilization of bovine pericardium for heart valve
   applications (Retracted Article. See vol 13, pg 182, 2010)
SO JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article; Retracted Publication
DE Bioprosthetic valve; Fixation; Sterilization; Microwaves; Bovine
   pericardium
ID FIXATION; CELLS; CALCIFICATION; DESTRUCTION; IRRADIATION; PREVENTION;
   RADIATION; TISSUE; ENERGY
AB It is widely recognised that the bioprosthetic valves widely used for heart valve replacements have some drawbacks, for example tearing and occurrence of infections, which can be attributed to the fixation and sterilization techniques currently available. These techniques adversely affect the physical properties, functionality, and lifespan of the leaflets. In the work discussed in this paper we examined a novel procedure of using high-frequency microwaves to fix and disinfect the pericardium, without causing any harmful affects. The test bacteria used were Escherichia coli and Staphylococcus aureus. The pericardium was exposed to microwaves at a frequency of 18 GHz for three consecutive replicates. The findings indicated that there was almost complete inactivation of the bacteria on the biomaterial without compromising the biocompatibility, which was studied using ovine fibroblasts. An effective fixation and sterilization procedure, that is quick and has no adverse effects is presented and discussed.
C1 [Patel, Shital S.; Owida, Amal A.] Swinburne Univ Technol, Fac Engn & Ind Sci, AD220, Hawthorn, Vic 3122, Australia.
   [Morsi, Yos S.] Swinburne Univ Technol, Fac Engn & Ind Sci, EN707C, Hawthorn, Vic 3122, Australia.
RP Patel, SS (reprint author), Swinburne Univ Technol, Fac Engn & Ind Sci, AD220, 533-545 Burwood Rd, Hawthorn, Vic 3122, Australia.
EM spatel@swin.edu.au
CR Acton A, 2005, DEV DYNAM, V233, P1464, DOI 10.1002/dvdy.20448
   An YH, 1996, J HOSP INFECT, V33, P93, DOI 10.1016/S0195-6701(96)90094-8
   Avci B, 2006, BIOTECH HISTOCHEM, V81, P63, DOI 10.1080/10520290600783044
   Banik S, 2003, BIORESOURCE TECHNOL, V87, P155, DOI 10.1016/S0960-8524(02)00169-4
   Bazinet RP, 2005, NEUROCHEM RES, V30, P597, DOI 10.1007/s11064-005-2746-5
   DARDANONI L, 1985, J BIOELECTRICITY, V4, P171, DOI 10.3109/15368378509040371
   Dincer AH, 2004, CRIT REV MICROBIOL, V30, P197, DOI 10.1080/10408410490468803
   DREYFUSS MS, 1980, APPL ENVIRON MICROB, V39, P13
   Dunsmuir RA, 2003, J CLIN MICROBIOL, V41, P4755, DOI 10.1128/JCM.41.10.4755-4757.2003
   Gedikli S., 2008, J APPL BIOL SCI, V2, P67
   HAMMERMEISTER KE, 1993, NEW ENGL J MED, V328, P1289, DOI 10.1056/NEJM199305063281801
   HEDDLESON RA, 1994, J FOOD PROTECT, V57, P1025, DOI 10.4315/0362-028X-57.11.1025
   HEDDLESON RA, 1994, J FOOD SCI, V59, P447, DOI 10.1111/j.1365-2621.1994.tb06987.x
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hyland G. J., 1998, Engineering Science and Education Journal, V7, P261, DOI 10.1049/esej:19980606
   Kozempel M, 2000, J FOOD PROCESS PRES, V24, P287, DOI 10.1111/j.1745-4549.2000.tb00420.x
   Morsi YS, 2004, INT J ARTIF ORGANS, V27, P445
   Ozawa H, 2004, J ENDOCRINOL, V183, P507, DOI 10.1677/joe.1.05656
   PATHAK YV, 1990, BIOMATERIALS, V11, P718, DOI 10.1016/0142-9612(90)90034-N
   PHILLIP S, 2008, WASHINGTON MANUAL CA, P212
   Shamis Y, 2008, INT J FOOD ENG, V4, DOI 10.2202/1556-3758.1360
   Shazman A., 2007, Food Chemistry, V103, P444, DOI 10.1016/j.foodchem.2006.08.024
   Stein PD, 2001, CHEST, V119, p220S, DOI 10.1378/chest.119.1_suppl.220S
   Sung HW, 1997, J BIOMED MATER RES, V37, P376, DOI 10.1002/(SICI)1097-4636(19971205)37:3<376::AID-JBM8>3.0.CO;2-I
   THUERY J, 1985, MICROWAVES IND SCI M
   Uchiyama K, 2005, J ORTHOP SCI, V10, P77, DOI 10.1007/s00776-004-0857-5
   Vasudev SC, 1999, J MATER SCI-MATER M, V10, P121, DOI 10.1023/A:1008925204988
   Woo IS, 2000, APPL ENVIRON MICROB, V66, P2243, DOI 10.1128/AEM.66.5.2243-2247.2000
NR 28
TC 2
Z9 2
U1 2
U2 11
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 1434-7229
EI 1619-0904
J9 J ARTIF ORGANS
JI J. Artif. Organs
PD APR
PY 2010
VL 13
IS 1
BP 24
EP 30
DI 10.1007/s10047-010-0489-9
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 578AB
UT WOS:000276264500005
PM 20213454
DA 2018-12-27
ER

PT J
AU Smeesters, D
   Mussweiler, T
   Mandel, N
AF Smeesters, Dirk
   Mussweiler, Thomas
   Mandel, Naomi
TI RETRACTED: The Effects of Thin and Heavy Media Images on Overweight and
   Underweight Consumers: Social Comparison Processes and Behavioral
   Implications (Retracted article. See vol. 41, pg. 236, 2014)
SO JOURNAL OF CONSUMER RESEARCH
LA English
DT Article; Retracted Publication
ID SELF-EVALUATIONS; BODY DISSATISFACTION; CONTRAST; JUDGMENT;
   ASSIMILATION; WOMEN; CONSEQUENCES; IMPACT; METAANALYSIS; MECHANISMS
AB This study examines how advertisements containing thin or heavy models influence the self-esteem of overweight, normal, and underweight consumers. Previous research has mainly examined the influences of variations of the comparison standard on self-evaluative outcomes, whereas we examine how the relative position of the self on the comparison dimension may moderate these effects. Three studies manipulated the size (thin vs. heavy) and extremity of the size (moderate vs. extreme) of advertising models and exposed these images to individuals differing in Body Mass Index (BMI) levels. Our findings indicate that social comparison processes and subsequent self-evaluative and behavioral outcomes are different for individuals differing in their BMI.
C1 [Smeesters, Dirk] Erasmus Univ, Rotterdam Sch Management, NL-3000 DR Rotterdam, Netherlands.
   [Mussweiler, Thomas] Univ Cologne, D-50931 Cologne, Germany.
   [Mandel, Naomi] Arizona State Univ, WP Carey Sch Business, Tempe, AZ 85287 USA.
RP Smeesters, D (reprint author), Erasmus Univ, Rotterdam Sch Management, POB 1738, NL-3000 DR Rotterdam, Netherlands.
EM DSmeesters@rsm.nl; Thomas.Mussweiler@uni-koeln.de; Naomi.Mandel@asu.edu
CR Argo JJ, 2006, J CONSUM RES, V33, P99, DOI 10.1086/504140
   Bargh J. A, 2000, HDB RES METHODS SOCI, P253
   Bearman SK, 2006, J YOUTH ADOLESCENCE, V35, P229, DOI 10.1007/s10964-005-9010-9
   BRAY GA, 1978, INT J OBESITY, V2, P99
   Chandon P, 2007, J CONSUM RES, V34, P301, DOI 10.1086/519499
   Collins RL, 1996, PSYCHOL BULL, V119, P51, DOI 10.1037//0033-2909.119.1.51
   Dijksterhuis A, 1998, J PERS SOC PSYCHOL, V75, P862, DOI 10.1037//0022-3514.75.4.862
   Dohnt HK, 2006, J YOUTH ADOLESCENCE, V35, P141, DOI 10.1007/s10964-005-9020-7
   Epstude K, 2009, EMOTION, V9, P1, DOI 10.1037/a0014148
   FESTINGER L, 1954, HUM RELAT, V7, P2
   Fitzsimons GJ, 2008, J CONSUM RES, V35, P5, DOI 10.1086/589561
   Forster J, 2008, J PERS SOC PSYCHOL, V94, P579, DOI 10.1037/0022-3514.94.4.579
   Forster J, 2009, J EXP PSYCHOL GEN, V138, P88, DOI 10.1037/a0014484
   Gardner WL, 1999, PSYCHOL SCI, V10, P321, DOI 10.1111/1467-9280.00162
   GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6
   GILBERT DT, 1995, J PERS SOC PSYCHOL, V69, P227, DOI 10.1037/0022-3514.69.2.227
   Grabe S, 2008, PSYCHOL BULL, V134, P460, DOI 10.1037/0033-2909.134.3.460
   Grabe S, 2006, PSYCHOL BULL, V132, P622, DOI 10.1037/0033-2909.132.4.622
   GRANBERG D, 1974, J PERS SOC PSYCHOL, V29, P687, DOI 10.1037/h0036631
   Hafner M, 2004, J CONSUM PSYCHOL, V14, P187, DOI 10.1207/s15327663jcp1401&2_21
   Hargreaves Duane A, 2004, Body Image, V1, P351, DOI 10.1016/j.bodyim.2004.10.002
   HERR PM, 1983, J EXP SOC PSYCHOL, V19, P323, DOI 10.1016/0022-1031(83)90026-4
   HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037/0033-295X.94.3.319
   JOHNSTON CW, 2002, J PHYS D, V35, P1
   Kuhn MH, 1954, AM SOCIOL REV, V19, P68, DOI 10.2307/2088175
   Lockwood P, 1997, J PERS SOC PSYCHOL, V73, P91, DOI 10.1037//0022-3514.73.1.91
   LYNCH JG, 1991, J CONSUM RES, V18, P284, DOI 10.1086/209260
   Mandel N, 2008, J CONSUM RES, V35, P309, DOI 10.1086/587626
   MCFERRAN B, 2010, J CONSUMER RES, V36
   Mick DG, 2008, J CONSUM RES, V35, P377, DOI 10.1086/591482
   Mills JS, 2002, PERS SOC PSYCHOL B, V28, P1687, DOI 10.1177/014616702237650
   Muller D, 2005, J PERS SOC PSYCHOL, V89, P852, DOI 10.1037/0022-3514.89.6.852
   Mussweiler T, 2004, J PERS SOC PSYCHOL, V87, P832, DOI 10.1037/0022-3514.87.6.832
   Mussweiler T, 2004, J EXP SOC PSYCHOL, V40, P689, DOI 10.1016/j.jesp.2004.01.004
   Mussweiler T, 2003, PSYCHOL REV, V110, P472, DOI 10.1037/0033-295X.110.3.472
   Mussweiler T, 2001, EUR J SOC PSYCHOL, V31, P499, DOI 10.1002/ejsp.75.abs
   Mussweiler T, 2000, J PERS SOC PSYCHOL, V79, P23, DOI 10.1037/0022-3514.79.1.23
   MUSSWEILER T, 2000, HDB SOCIAL COMP THEO, P253
   Mussweiler T, 2007, ASSIMILATION AND CONTRAST IN SOCIAL PSYCHOLOGY, P165
   Mussweiler T, 2008, J PERS SOC PSYCHOL, V95, P1295, DOI 10.1037/a0013261
   MYERS PN, 1992, J COMMUN, V42, P108, DOI 10.1111/j.1460-2466.1992.tb00802.x
   Polivy J, 2002, ANNU REV PSYCHOL, V53, P187, DOI 10.1146/annurev.psych.53.100901.135103
   Polivy J., 1988, DICT BEHAV ASSESSMEN, P377
   Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316
   Quetelet A, 1842, TREATISE MAN DEV HIS
   RICHINS ML, 1991, J CONSUM RES, V18, P71, DOI 10.1086/209242
   Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87
   SCHWARZ N, 1992, CONSTRUCTION OF SOCIAL JUDGMENTS, P217
   Scott ML, 2008, J CONSUM RES, V35, P391, DOI 10.1086/591103
   Seddon L, 1996, BRIT J HEALTH PSYCH, V1, P27, DOI 10.1111/j.2044-8287.1996.tb00489.x
   SHERIF CW, 1965, ATTITUDE ATTITUDE CH, P92
   Shrum LJ, 2005, J CONSUM RES, V32, P473, DOI 10.1086/497559
   Smeesters D, 2006, J CONSUM RES, V32, P576, DOI 10.1086/500489
   Stapel DA, 2004, J PERS SOC PSYCHOL, V87, P860, DOI 10.1037/0022-3514.87.6.860
   Stapel DA, 2004, J PERS SOC PSYCHOL, V87, P468, DOI 10.1037/0022-3514.87.4.468
   Stapel DA, 2001, COGNITIVE SOCIAL PSYCHOLOGY, P229
   Stapel DA, 2000, J PERS SOC PSYCHOL, V79, P1068, DOI 10.1037//0022-3514.79.6.1068
   Stapel DA, 2007, EUR J SOC PSYCHOL, V37, P824, DOI 10.1002/ejsp.390
   STICE E, 1994, J SOC CLIN PSYCHOL, V13, P288, DOI 10.1521/jscp.1994.13.3.288
   Swami Viren, 2005, Body Image, V2, P115, DOI 10.1016/j.bodyim.2005.02.002
   TAN CLL, 2007, WALL STREET J   0108, pB4
   Tiggemann M, 2004, INT J EAT DISORDER, V35, P48, DOI 10.1002/eat.10214
   Tiggemann M, 2001, INT J EAT DISORDER, V29, P65, DOI 10.1002/1098-108X(200101)29:1<65::AID-EAT10>3.3.CO;2-P
   Tovee MJ, 2000, P ROY SOC B-BIOL SCI, V267, P1987, DOI 10.1098/rspb.2000.1240
   Trampe D, 2007, J PERS SOC PSYCHOL, V92, P106, DOI 10.1037/0022-3514.92.1.106
   Wang J, 2002, J CONSUM PSYCHOL, V12, P327, DOI 10.1207/15327660260382360
   WEGENER DT, 1995, J PERS SOC PSYCHOL, V68, P36, DOI 10.1037/0022-3514.68.1.36
   Wertheim EH, 1997, J PSYCHOSOM RES, V42, P345, DOI 10.1016/S0022-3999(96)00368-6
   WISEMAN CV, 1992, INT J EAT DISORDER, V11, P85, DOI 10.1002/1098-108X(199201)11:1<85::AID-EAT2260110112>3.0.CO;2-T
   World Health Organization, 1995, WHO TECHN REP SER, V854, P1
NR 70
TC 48
Z9 49
U1 5
U2 87
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0093-5301
EI 1537-5277
J9 J CONSUM RES
JI J. Consum. Res.
PD APR
PY 2010
VL 36
IS 6
BP 930
EP 949
DI 10.1086/648688
PG 20
WC Business
SC Business & Economics
GA 563WO
UT WOS:000275167000004
OA Green Published
DA 2018-12-27
ER

PT J
AU Jinnin, M
   Ishihara, T
   Boye, E
   Olsen, BR
AF Jinnin, Masatoshi
   Ishihara, Tsuyoshi
   Boye, Eileen
   Olsen, Bjorn R.
TI RETRACTED: Recent progress in studies of infantile hemangioma (Retracted
   Article. See vol 38, pg 417, 2011)
SO JOURNAL OF DERMATOLOGY
LA English
DT Review; Retracted Publication
DE cytokine; skin tumor; vascular anomalies
ID ENDOTHELIAL GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; BLOOD-VESSEL
   FORMATION; VASCULAR MALFORMATIONS; TRANSCRIPTIONAL REGULATION;
   SIGNAL-TRANSDUCTION; CELL-ADHESION; PATHOLOGICAL ANGIOGENESIS; CLINICAL
   CHARACTERISTICS; CONGENITAL HEMANGIOMAS
AB A hallmark of infantile hemangioma, the most common tumor of infancy, is its dramatic growth after birth, by diffuse proliferation of immature endothelial cells, followed by spontaneous regression. The growth and involution of infantile hemangioma is quite different from other vascular anomalies, which do not regress and can occur at any time during life. Some hemangioma lesions can be extremely disfiguring and destructive to normal tissue and may even be life-threatening. Unfortunately, existing therapeutic approaches have limited success and significant adverse effects of some treatment modalities limit their use. Better understanding of the pathogenesis of hemangioma will enable the development of better therapeutic strategies. Here, we review recent studies and new hypotheses on the pathogenesis of the tumor. Detailed mechanisms of activated vascular endothelial growth factor signaling in tumor cells, identification of their origin and characterization of multipotent stem cells that can give rise to infantile hemangioma are shedding new light on this intriguing vascular tumor.
C1 [Jinnin, Masatoshi; Ishihara, Tsuyoshi] Kumamoto Univ, Dept Dermatol & Plast Surg, Grad Sch Med & Pharmaceut Sci, Kumamoto, Japan.
   [Boye, Eileen; Olsen, Bjorn R.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA.
RP Jinnin, M (reprint author), Kumamoto Univ, Dept Dermatol & Plast Surg, Grad Sch Med & Pharmaceut Sci, 1-1-1 Honjo, Kumamoto, Japan.
EM mjin@kumamoto-u.ac.jp
CR Amir J, 1986, Pediatr Dermatol, V3, P331, DOI 10.1111/j.1525-1470.1986.tb00535.x
   Aplin AE, 1998, PHARMACOL REV, V50, P197
   Bakaris S, 2004, PEDIATR DEVEL PATHOL, V7, P258, DOI 10.1007/s10024-003-4042-1
   Barnes CM, 2005, P NATL ACAD SCI USA, V102, P19097, DOI 10.1073/pnas.0509579102
   Barry SM, 2003, BLOOD, V102, P1771, DOI 10.1182/blood-2002-11-3551
   Berard M, 1997, AM J PATHOL, V150, P1315
   Berenguer B, 2003, PEDIATR DEVEL PATHOL, V6, P495, DOI 10.1017/s10024-003-2134-6
   Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232
   Bischoff J, 2002, TRENDS CARDIOVAS MED, V12, P220, DOI 10.1016/S1050-1738(02)00165-2
   Blei F, 1998, ARCH DERMATOL, V134, P718, DOI 10.1001/archderm.134.6.718
   Boscolo E, 2009, ANGIOGENESIS, V12, P197, DOI 10.1007/s10456-009-9148-2
   Boye E, 2001, J CLIN INVEST, V107, P745, DOI 10.1172/JCI11432
   Boye E, 2009, J CRANIOFAC SURG, V20, P678, DOI 10.1097/SCS.0b013e318193d6c1
   Brouillard P, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.024174
   BURROWS PE, 1983, AM J ROENTGENOL, V141, P483, DOI 10.2214/ajr.141.3.483
   BURTON BK, 1995, PRENATAL DIAG, V15, P209, DOI 10.1002/pd.1970150302
   Calicchio ML, 2009, AM J PATHOL, V174, P1638, DOI 10.2353/ajpath.2009.080517
   Carson-Walter EB, 2001, CANCER RES, V61, P6649
   Chang J, 1999, PLAST RECONSTR SURG, V103, P1, DOI 10.1097/00006534-199901000-00001
   Chang LC, 2008, PEDIATRICS, V122, P360, DOI 10.1542/peds.2007-2767
   Cheung DSM, 1997, ANN PLAS SURG, V38, P269, DOI 10.1097/00000637-199703000-00014
   Chiller Katarina G, 2003, Lymphat Res Biol, V1, P267, DOI 10.1089/153968503322758076
   Chiller KG, 2002, ARCH DERMATOL, V138, P1567, DOI 10.1001/archderm.138.12.1567
   Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661
   Dadras SS, 2004, MODERN PATHOL, V17, P1068, DOI 10.1038/modpathol.3800153
   Dosanjh A, 2000, J CUTAN PATHOL, V27, P441, DOI 10.1034/j.1600-0560.2000.027009441.x
   Drolet BA, 1999, NEW ENGL J MED, V341, P173, DOI 10.1056/NEJM199907153410307
   Drolet BA, 2008, J PEDIATR, V153, P712, DOI 10.1016/j.jpeds.2008.05.043
   Dubois J, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781541
   Dubois J, 1998, AM J ROENTGENOL, V171, P247, DOI 10.2214/ajr.171.1.9648798
   Dudziak D, 2003, J VIROL, V77, P8290, DOI 10.1128/JVI.77.15.8290-8298.2003
   Enis DR, 2005, P NATL ACAD SCI USA, V102, P425, DOI 10.1073/pnas.0408357102
   Enjoras O, 2004, ARCH PEDIATRIE, V11, P99, DOI 10.1016/j.arcped.2003.10.014
   Esterly N B, 1996, Curr Probl Pediatr, V26, P3, DOI 10.1016/S0045-9380(96)80023-5
   ESTERLY NB, 1995, CURR PROBL DERMATOL, V7, P65, DOI DOI 10.1016/S1040-0486(09)80020-3
   EZEKOWITZ RAB, 1992, NEW ENGL J MED, V326, P1456, DOI 10.1056/NEJM199205283262203
   Ferrara N, 2005, EXP SUPPL, V94, P209
   Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C
   FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0
   Garzon MC, 2008, ARCH DERMATOL, V144, P1231, DOI 10.1001/archderm.144.9.1231
   Garzon MC, 2005, J AM ACAD DERMATOL, V52, P281, DOI 10.1016/j.jaad.2004.09.004
   Girard C, 2006, ARCH DERMATOL, V142, P884, DOI 10.1001/archderm.142.7.884
   Gorincour G, 2005, PEDIATR RADIOL, V35, P1178, DOI 10.1007/s00247-005-1557-9
   Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8
   Haggstrom AN, 2006, PEDIATRICS, V117, P698, DOI 10.1542/peds.2005-1092
   Haggstrom AN, 2007, J PEDIATR-US, V150, P291, DOI 10.1016/j.jpeds.2006.12.003
   Haggstrom AN, 2006, PEDIATRICS, V118, P882, DOI 10.1542/peds.2006-0413
   Hidano A, 1986, Pediatr Dermatol, V3, P140
   Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703
   HOLMDAHL K, 1955, Acta Paediatr, V44, P370, DOI 10.1111/j.1651-2227.1955.tb04151.x
   Hotchkiss KA, 2005, EXP CELL RES, V305, P133, DOI 10.1016/j.yexcr.2004.12.025
   Huang SA, 2000, NEW ENGL J MED, V343, P185, DOI 10.1056/NEJM200007203430305
   Isik FF, 1996, J SURG RES, V61, P71, DOI 10.1006/jsre.1996.0083
   JACOBS ALVIN H., 1957, CALIFORNIA MED, V86, P8
   Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685
   Jang YC, 2000, J SURG RES, V93, P144, DOI 10.1006/jsre.2000.5973
   Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877
   Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374
   Khan ZA, 2008, J CLIN INVEST, V118, P2592, DOI 10.1172/JCI33493
   Khan ZA, 2006, BLOOD, V108, P915, DOI 10.1182/blood-2006-03-006478
   Kleinman Mark E, 2003, Lymphat Res Biol, V1, P301, DOI 10.1089/153968503322758102
   Kraling BM, 1996, AM J PATHOL, V148, P1181
   Leaute-Labreze C, 2008, NEW ENGL J MED, V358, P2649, DOI 10.1056/NEJMc0708819
   LEAVESLEY DI, 1993, J CELL BIOL, V121, P163, DOI 10.1083/jcb.121.1.163
   Lei L, 2008, MOL CELL BIOL, V28, P794, DOI 10.1128/MCB.00443-07
   Leon-Villapalos J, 2005, BRIT J PLAST SURG, V58, P348, DOI 10.1016/j.bjps.2004.05.029
   Li Q, 2003, J PATHOL, V201, P296, DOI 10.1002/path.1443
   Mancini AJ, 1996, AM J DERMATOPATH, V18, P505, DOI 10.1097/00000372-199610000-00009
   McCuaig CC, 2009, PEDIATR DERMATOL, V26, P203, DOI 10.1111/j.1525-1470.2008.00857.x
   McKinsey TA, 2000, MOL IMMUNOL, V37, P783, DOI 10.1016/S0161-5890(00)00099-7
   Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590
   Metry DW, 2000, ARCH DERMATOL, V136, P905, DOI 10.1001/archderm.136.7.905
   Metry DW, 2006, AM J MED GENET A, V140A, P975, DOI 10.1002/ajmg.a.31189
   Metz BJ, 2004, ARCH DERMATOL, V140, P867, DOI 10.1001/archderm.140.7.867
   MEYER JS, 1991, AM J ROENTGENOL, V157, P559, DOI 10.2214/ajr.157.3.1872245
   MOROZ B, 1982, LONG TERM FOLLOW UP, P27
   Moukaddam H, 2009, SKELETAL RADIOL, V38, P535, DOI 10.1007/s00256-008-0609-2
   Mulligan-Kehoe MJ, 2008, RHEUM DIS CLIN N AM, V34, P73, DOI 10.1016/j.rdc.2007.12.006
   Mulliken J B, 1993, Semin Vasc Surg, V6, P204
   Mulliken JB, 2004, J AM ACAD DERMATOL, V50, P875, DOI 10.1016/j.jaad.2003.10.670
   MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002
   MULLIKEN JB, 1982, SURGERY, V92, P348
   Mulliken JB, 1999, PEDIATR INT, V14, P132
   MULLIKEN JB, 2000, VASCULAR ANOMALIES, P517
   MULLIKEN JB, 1988, VASCULAR BIRTHMARKS, P64
   Nguyen J, 2009, SEMIN OPHTHALMOL, V24, P178, DOI 10.1080/08820530902805602
   Nguyen VA, 2004, HUM PATHOL, V35, P739, DOI 10.1016/j.humpath.2004.02.005
   North PE, 2006, CARDIOVASC PATHOL, V15, P303, DOI 10.1016/j.carpath.2006.03.001
   North PE, 2000, HUM PATHOL, V31, P11, DOI 10.1016/S0046-8177(00)80192-6
   North PE, 2001, ARCH DERMATOL, V137, P559
   Olferiev M, 2007, J BIOL CHEM, V282, P1738, DOI 10.1074/jbc.M605808200
   PACK G T, 1950, Angiology, V1, P405, DOI 10.1177/000331975000100504
   Pandey A, 2008, OSTOMY WOUND MANAG, V54, P16
   Pandey A, 2009, J PEDIATR SURG, V44, P688, DOI 10.1016/j.jpedsurg.2008.10.038
   PASYK KA, 1984, PLAST RECONSTR SURG, V73, P69, DOI 10.1097/00006534-198401000-00015
   Perry BN, 2006, J INVEST DERMATOL, V126, P2316, DOI 10.1038/sj.jid.5700413
   Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003
   Picard A, 2008, PEDIATR RES, V63, P263, DOI 10.1203/PDR.0b013e318163a243
   Pittman KM, 2006, J INVEST DERMATOL, V126, P2533, DOI 10.1038/sj.jid.5700516
   Pramanik K, 2009, BLOOD, V113, P1184, DOI 10.1182/blood-2008-06-162180
   Przewratil P, 2009, PEDIATR DERMATOL, V26, P399, DOI 10.1111/j.1525-1470.2009.00910.x
   Qian F, 2005, DEV DYNAM, V233, P1163, DOI 10.1002/dvdy.20444
   Regnier S, 2007, BRIT J DERMATOL, V157, P158, DOI 10.1111/j.1365-2133.2007.07922.x
   Ritter Matthew R, 2003, Lymphat Res Biol, V1, P291, DOI 10.1089/153968503322758094
   Ritter MR, 2002, P NATL ACAD SCI USA, V99, P7455, DOI 10.1073/pnas.102185799
   Ritter MR, 2006, AM J PATHOL, V168, P621, DOI 10.2353/ajpath.2006.050618
   Roberts DM, 2004, AM J PATHOL, V164, P1531, DOI 10.1016/S0002-9440(10)63711-X
   RUBIN GD, 2008, CT MR ANGIOGRAPHY CO, P1118
   Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003
   SANGUEZA OP, 2003, PATHOLOGY VASCULAR S, P136
   Sato Y, 2000, ANN NY ACAD SCI, V902, P201
   SCHWARTZ MA, 1993, J CELL BIOL, V120, P1003, DOI 10.1083/jcb.120.4.1003
   Shan SG, 2009, J HUAZHONG U SCI-MED, V29, P335, DOI 10.1007/s11596-009-0314-y
   SHAW WC, 1981, BRIT J PLAST SURG, V34, P237, DOI 10.1016/0007-1226(81)90001-1
   Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012
   Shibuya M, 2001, INT J BIOCHEM CELL B, V33, P409, DOI 10.1016/S1357-2725(01)00026-7
   Shih I-Hsin, 2007, Chang Gung Med J, V30, P220
   Sjaastad MD, 1997, BIOESSAYS, V19, P47, DOI 10.1002/bies.950190109
   SLOAN GM, 1989, PLAST RECONSTR SURG, V83, P459, DOI 10.1097/00006534-198903000-00009
   SMOLLER BR, 1993, J CUTAN PATHOL, V20, P330, DOI 10.1111/j.1600-0560.1993.tb01271.x
   St Croix B, 2000, SCIENCE, V289, P1197
   Stockman A, 2007, DERMATOLOGY, V214, P40, DOI 10.1159/000096911
   TAKAHASHI K, 1994, J CLIN INVEST, V93, P2357, DOI 10.1172/JCI117241
   Tan ST, 2004, PLAST RECONSTR SURG, V113, P999, DOI 10.1097/01.PRS.0000105683.10752.A6
   Timur AA, 2005, CELL MOL LIFE SCI, V62, P1434, DOI 10.1007/s00018-005-4523-7
   Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0
   Wakiya K, 1996, J BIOL CHEM, V271, P30823, DOI 10.1074/jbc.271.48.30823
   Walter JW, 2002, GENE CHROMOSOME CANC, V33, P295, DOI 10.1002/gcc.10028
   Walter JW, 1999, AM J MED GENET, V82, P77, DOI 10.1002/(SICI)1096-8628(19990101)82:1<77::AID-AJMG15>3.0.CO;2-A
   Waner M, 2003, ARCH DERMATOL, V139, P869, DOI 10.1001/archderm.139.7.869
   Yu HJ, 2009, MED HYPOTHESES, V73, P495, DOI 10.1016/j.mehy.2009.06.015
   Yu Y, 2001, AM J PATHOL, V159, P2271, DOI 10.1016/S0002-9440(10)63077-5
   Yu Y, 2006, STEM CELLS, V24, P1605, DOI 10.1634/stemcells.2005-0298
   Zhang L, 2005, PLAST RECONSTR SURG, V116, P200, DOI 10.1097/01.PRS.0000170804.80834.5F
   Zhang ZQ, 2006, MATH COMPUT MODEL, V44, P188, DOI 10.1016/j.mcm.2006.01.011
   Zvulunov A, 2002, CLIN DERMATOL, V20, P660, DOI 10.1016/S0738-081X(02)00287-0
NR 136
TC 29
Z9 38
U1 3
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0385-2407
EI 1346-8138
J9 J DERMATOL
JI J. Dermatol.
PD APR
PY 2010
VL 37
IS 4
BP 283
EP 298
DI 10.1111/j.1346-8138.2010.00813.x
PG 16
WC Dermatology
SC Dermatology
GA 574UQ
UT WOS:000276019900001
PM 20507397
DA 2018-12-27
ER

PT J
AU Taghvaei, AH
   Ebrahimi, A
   Ghaffari, M
   Janghorban, K
AF Taghvaei, A. H.
   Ebrahimi, A.
   Ghaffari, M.
   Janghorban, K.
TI RETRACTED: Magnetic properties of iron-based soft magnetic composites
   with MgO coating obtained by sol-gel method (Retracted article. See vol.
   324, pg. 3227, 2012)
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article; Retracted Publication
DE Soft magnetic composite; Coercivity; Electrical resistivity; Eddy
   current loss
ID FLUXES
AB Soft magnetic composites with a thin MgO insulating layer were produced by a sol-gel method. Energy dispersive X-ray spectroscopy, X-ray analysis, Fourier transform infrared spectroscopy, density measurement and compositional maps confirmed that thin layers of MgO covered the iron powders. Coercivity measurement showed that the stress relaxation and reduction of hysteresis loss efficiently occurred at 600 degrees C. At this temperature, the phosphate insulation of commercial SOMALOY (TM) samples degrade and their electrical resistivity, magnetic permeability and operating frequency decreases noticeably. The results show that the MgO insulation has a greater heat resistance than conventional phosphate insulation, which enables stress-relief at higher temperatures (600 degrees C) without a large increase in eddy current loss. The results of annealing at 600 degrees C show that the electrical resistivity and ferromagnetic resonance frequency increased from 11 mu Omega m and 1 kHz for SOMALOY (TM) samples to 145 mu Omega m and 100 kHz for the MgO insulated composites produced in this work. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Taghvaei, A. H.; Ebrahimi, A.; Janghorban, K.] Shiraz Univ, Sch Engn, Dept Mat Sci & Engn, Shiraz, Iran.
   [Ghaffari, M.] Nanyang Technol Univ, Sch Elect Elect Engn, Singapore 639798, Singapore.
RP Taghvaei, AH (reprint author), Shiraz Univ, Sch Engn, Dept Mat Sci & Engn, Shiraz, Iran.
EM amirtaghvaei@gmail.com
CR BARRUE R, 2001, HDB ADV ELECT PHOTON
   Colthup N.B., 1964, INTRO INFRARED RAMAN
   Gimenez S, 2006, J ALLOY COMPD, V419, P299, DOI 10.1016/j.jallcom.2005.09.053
   Hemmati I, 2006, J MAGN MAGN MATER, V305, P147, DOI 10.1016/j.jmmm.2005.12.004
   Maeda T., 2005, SEI Technical Review, P3
   MONMA H, 1994, J MATER SCI, V29, P949, DOI 10.1007/BF00351415
   MOSES A, 2007, CRYST RES TECHNOL, V42, P867
   Shokrollahi H, 2007, J MAGN MAGN MATER, V313, P182, DOI 10.1016/j.jmmm.2006.12.022
   Shokrollahi H, 2007, J MATER PROCESS TECH, V189, P1, DOI 10.1016/j.jmatprotec.2007.02.034
   SNELLING EC, 1983, FERRITES INDUCTORS T
   Taghvaei AH, 2009, J ALLOY COMPD, V481, P681, DOI 10.1016/j.jallcom.2009.03.074
   WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6
   Zhong JJ, 2006, J MAGN MAGN MATER, V299, P29, DOI 10.1016/j.jmmm.2005.03.016
   Zhong JJ, 2005, J MAGN MAGN MATER, V290, P1567, DOI 10.1016/j.jmmm.2004.11.240
NR 14
TC 30
Z9 37
U1 2
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
EI 1873-4766
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD APR
PY 2010
VL 322
IS 7
BP 808
EP 813
DI 10.1016/j.jmmm.2009.11.008
PG 6
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 544QC
UT WOS:000273672700011
DA 2018-12-27
ER

PT J
AU Tucker, P
   Folkard, S
   Ansiau, D
   Marquie, JC
AF Tucker, Philip
   Folkard, Simon
   Ansiau, David
   Marquie, Jean-Claude
TI RETRACTED: The Effects of Age and Shiftwork on Perceived Sleep Problems:
   Results From the VISAT-Combined Longitudinal and Cross-Sectional Study
   (Retracted article. See vol. 52, pg. 846, 2010)
SO JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
LA English
DT Article; Retracted Publication
ID SUBJECTIVE HEALTH; WORK
AB Objectives: With the workforces in industrialized countries getting older, this study sought to determine how shiftworking affects sleep in later life. Method: Longitudinal data were collected from a large sample in 1996, 2001, and 2006 from employees who were 32, 42, 52, and 62 years old in 1996. Results: The effects of shift work were most apparent in the early and middle years of working life. Former shiftworkers reported more sleep problems than both current shiftworkers and those who had never worked shifts. Giving up shift work off-set the age-related accumulation of sleep problems, with the net result that former shiftworkers showed little or no change in sleep problems over the three measurement occasions. Conclusions: The effects of shift work on sleep may persist for a long time after giving up shift work but they are not permanent.
C1 [Tucker, Philip; Folkard, Simon] Swansea Univ, Dept Psychol, Swansea SA2 8PP, W Glam, Wales.
   [Folkard, Simon] Univ Paris 05, Dept Anthropol Appl, Paris, France.
   [Ansiau, David] Int Univ Monaco, Dept Int Management & Mkt, Monte Carlo, Monaco.
   [Marquie, Jean-Claude] Univ Toulouse, CNRS, CLLE LTC, Toulouse, France.
RP Tucker, P (reprint author), Swansea Univ, Dept Psychol, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.
EM p.t.tucker@swan.ac.uk
FU Institute of Occupational Safety & Health (United Kingdom); Centre
   National de la Recherche Scientifique (CNRS); Midi-Pyrenees Regional
   Council; Ministere de l'Enseignement Superieur; Midi-Pyrenees CRAM;
   Ministere du Travail (France)
FX This study was funded by grants from the Institute of Occupational
   Safety & Health (United Kingdom), the Centre National de la Recherche
   Scientifique (CNRS), Midi-Pyrenees Regional Council, Ministere de
   l'Enseignement Superieur, Midi-Pyrenees CRAM, and Ministere du Travail
   (France).
CR Akerstedt T, 1998, Sleep Med Rev, V2, P117, DOI 10.1016/S1087-0792(98)90004-1
   AKERSTEDT T, 2009, 19 INT S SHIFTW WORK
   BRUGERE D, 1997, INT J OCCUP ENV HEAL, V3, P15
   BUTAT C, 1993, ARCH MAL PROF, V54, P209
   DUMONT M, 1997, INT J OCCUP ENV HEAL, V3, P10
   Ingre M, 2004, J SLEEP RES, V13, P45, DOI 10.1111/j.1365-2869.2004.00390.x
   KECKLUND G, 1992, J SLEEP RES, V1, P30, DOI 10.1111/j.1365-2869.1992.tb00005.x
   Marquie JC, 2002, TRAV HUMAIN, V65, P243, DOI 10.3917/th.653.0243
   Marquie JC, 1999, J SLEEP RES, V8, P297, DOI 10.1046/j.1365-2869.1999.00170.x
   MEERS A, 1978, ERGONOMICS, V21, P857, DOI 10.1080/00140137808931789
   Radosevic-Vidacek B, 1995, WORK STRESS, V9, P272, DOI 10.1080/02678379508256563
   VERHAEGEN P, 1987, CONT ADV SHIFTWORK R, P269
   VERHAEGEN P, 1986, NIGHT SHIFTWORK LONG, P67
NR 13
TC 2
Z9 3
U1 2
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1076-2752
EI 1536-5948
J9 J OCCUP ENVIRON MED
JI J. Occup. Environ. Med.
PD APR
PY 2010
VL 52
IS 4
BP 392
EP 398
DI 10.1097/JOM.0b013e3181d8d9e4
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 583IS
UT WOS:000276668300004
PM 20357676
DA 2018-12-27
ER

PT J
AU Letton, RW
   Worrell, V
   Tuggle, DW
AF Letton, Robert W., Jr.
   Worrell, Veronica
   Tuggle, David W.
CA Amer Pediat Surgical Assoc
TI RETRACTED: Delay in Diagnosis and Treatment of Blunt Intestinal
   Perforation Does Not Adversely Affect Prognosis in the Pediatric Trauma
   Patient (Retracted article. See vol. 70, pg. 767, 2011)
SO JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
LA English
DT Article; Proceedings Paper; Retracted Publication
CT 68th Annual Meeting of the
   American-Association-for-the-Surgery-of-Trauma
CY OCT 01-03, 2009
CL Pittsburgh, PA
SP Amer Assoc Surg Trauma
DE Pediatric trauma; Blunt intestinal injury; Intestinal perforation; Delay
   in diagnosis
ID EMERGENT OPERATIVE INTERVENTION; SURGEON-DIRECTED ULTRASOUND;
   EVIDENCE-BASED GUIDELINES; HOURS PRODUCE MORBIDITY; SOLID-ORGAN INJURY;
   SMALL-BOWEL INJURY; INTRAABDOMINAL INJURY; MULTICENTER EXPERIENCE;
   RESOURCE UTILIZATION; COMPUTED-TOMOGRAPHY
AB Background: Blunt intestinal injury (BII) requiring surgical intervention in the pediatric trauma population remains difficult to diagnose. We sought to analyze whether delay in treatment in the event of perforation had an adverse affect on patient outcome.
   Methods: A multi-institutional retrospective chart review by the members of the American Pediatric Surgical Association Committee on Trauma was initiated after the approval of Institutional Review Board at each of the 18 institutions. All children <= 15 years of age diagnosed with a BII were identified and only those with BII noted during surgery or autopsy from January, 2002, through December, 2007, were included. The data form was designed and approved before chart review and all data were combined into one database.
   Results: Three hundred fifty-eight patients were accrued into the study. Two hundred fourteen patients had sufficient data to analyze the interval between injury and operation. These were divided into six groups (<6 hours, 6-12 hours, and >12 hours) based on time from injury to intervention and whether they had perforation or not. Early and late complications as well as hospital days, injury severity score, and time to full feeds were compared in each group. There were two deaths from an abdominal source in the <6-hour nonperforation group, one in the 6-hour perforation group, and one in the 6-hour to 12-hour nonperforation group. Injury severity score was significantly greater in the <6-hour intervention group regardless of perforation status. There was no correlation between time to surgery and complication rate nor was there a significant increase in hospital days.
   Conclusions: These data suggest that delay in operative intervention does not have a significant effect on prognosis after pediatric blunt intestinal perforation. Appropriate observation and serial examination rather than repeat computed tomography and/or urgent exploration would appear adequate when the diagnosis is in question.
C1 [Letton, Robert W., Jr.; Worrell, Veronica; Tuggle, David W.] Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Pediat Surg Sect, Oklahoma City, OK USA.
   [Amer Pediat Surgical Assoc] Amer Pediat Surg Assoc Comm Trauma, Deerfield, IL USA.
RP Letton, RW (reprint author), OU Med Ctr, 1200 Everett Dr,Suite NP 2320, Oklahoma City, OK 73104 USA.
EM robert-letton@ouhsc.edu
CR Acierno SP, 2004, J TRAUMA, V56, P960, DOI 10.1097/01.TA.0000123495.90747.BB
   Albanese CT, 1996, J TRAUMA, V40, P417, DOI 10.1097/00005373-199603000-00016
   ANDERSON PA, 1991, J TRAUMA, V31, P60, DOI 10.1097/00005373-199101000-00012
   Bruny Jennifer L, 2004, Semin Pediatr Surg, V13, P112, DOI 10.1053/j.sempedsurg.2004.01.007
   Cotton BA, 2004, J TRAUMA, V56, P1068, DOI 10.1097/01.TA.0000082153.38386.20
   COTTON BA, 2004, J TRAUMA, V56, P1074
   DOUGLAS GJ, 1971, J PEDIATR SURG, V6, P565, DOI 10.1016/0022-3468(71)90380-0
   Engelhardt S, 2001, J TRAUMA, V51, P633, DOI 10.1097/00005373-200110000-00002
   Fakhry SM, 2000, J TRAUMA, V48, P408, DOI 10.1097/00005373-200003000-00007
   Fallat ME, 2004, J TRAUMA, V56, P965
   Flint LM, 2000, J TRAUMA, V48, P414
   Frush DP, 2002, PEDIATR RADIOL, V32, P714, DOI 10.1007/s00247-002-0797-1
   Holmes JH, 2005, J TRAUMA, V59, P1309, DOI 10.1097/01.ta.0000197366.38404.79
   Miller D, 2006, AM J SURG, V192, P738, DOI 10.1016/j.amjsurg.2006.08.036
   Miller FB, 2001, J TRAUMA, V51, P637
   Nance ML, 2000, J PEDIATR SURG, V35, P1300, DOI 10.1053/jpsu.2000.9301
   NATHENS AB, 2008, NATL TRAUMA DATA BAN, P1
   NEWMAN KD, 1990, J TRAUMA, V30, P1133, DOI 10.1097/00005373-199009000-00009
   Newman KD, 1990, J TRAUMA, V30, P1138
   Nwomeh BC, 2004, J TRAUMA, V56, P537, DOI 10.1097/01.TA.0000112328.81051.FC
   Ong AW, 2003, J TRAUMA, V54, P503, DOI 10.1097/01.TA.0000051587.50251.3D
   Pearl RH, 2000, J PEDIATR SURG, V35, P167
   Poznanski A, 2002, PEDIATR RADIOL, V32, P751, DOI 10.1007/s00247-002-0805-5
   Rice HE, 2007, J PEDIATR SURG, V42, P603, DOI 10.1016/j.jpedsurg.2006.12.009
   RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627
   Shepherd Michael, 2006, Emerg Med Australas, V18, P57, DOI 10.1111/j.1742-6723.2006.00809.x
   Smith RS, 2004, AM SURGEON, V70, P167
   Soundappan SVS, 2004, J TRAUMA, V57, P114, DOI 10.1097/01.TA.0000108992.51091.F7
   Stassen NA, 2002, ARCH SURG-CHICAGO, V137, P718, DOI 10.1001/archsurg.137.6.718
   Stassen NA, 2002, ARCH SURG-CHICAGO, V137, P722
   Stylianos S, 2005, CURR OPIN PEDIATR, V17, P402, DOI 10.1097/01.mop.0000163693.96101.84
   Stylianos S, 2000, J PEDIATR SURG, V35, P164, DOI 10.1016/S0022-3468(00)90003-4
   Suthers SE, 2004, AM SURGEON, V70, P164
NR 33
TC 7
Z9 7
U1 1
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5282
J9 J TRAUMA
JI J. Trauma-Injury Infect. Crit. Care
PD APR
PY 2010
VL 68
IS 4
BP 790
EP 794
DI 10.1097/TA.0b013e3181d27957
PG 5
WC Critical Care Medicine; Surgery
SC General & Internal Medicine; Surgery
GA 583GY
UT WOS:000276663100008
PM 20386275
DA 2018-12-27
ER

PT J
AU Oh, CS
   Han, CS
   Chun, CH
   Koo, KW
   Kim, JW
   Kim, YW
   Han, SO
   Bae, CH
   Lee, JH
AF Oh, Chang-Sup
   Han, Chang-Suk
   Chun, Chang-Hwan
   Koo, Kyung-Wan
   Kim, Jang-Woo
   Kim, Young-Woo
   Han, Seung-Oh
   Bae, Chang-Hwan
   Lee, Ju-Hee
TI RETRACTED: Microstructure of Co Precipitation Strengthened B2-Ordered
   NiAl (Retracted article. See vol. 21, pg. 612, 2015)
SO METALS AND MATERIALS INTERNATIONAL
LA English
DT Article; Retracted Publication
DE intermetallics; aging; microstructure; transmission electron microscopy
   (TEM); hardness test
ID TWEED MICROSTRUCTURES; MARTENSITIC-TRANSFORMATION; ELECTRON-DIFFRACTION;
   NI2AL PHASE; ALLOYS; AL
AB A transmission electron microscopy investigation on the phase decomposition of B2-ordered (Ni,Co)Al supersaturated with Ni and Co has revealed the precipitation of (Ni, Co)(2)Al which has not been expected from the reported equilibrium phase diagram. The (Ni,Co)(2)Al phase has a hexagonal structure and takes a rodlike shape with the long axis of the rod parallel to the < 111 > directions of the B2 matrix. By aging at temperatures below 873 K, a long period superlattice structure appears in the hexagonal (Ni,Co)(2)Al phase. The orientation relationship between the (Ni, Co)(2)Al precipitates and the B2-(Ni,Co) Al matrix is found to be (0001)(p)//(111)(B2) and [(1) over bar2 (1) over bar0](p)//[(1) over bar 10](B2), where the suffix p and B2 denote the (Ni,Co)(2)Al precipitate and the B2-(Ni,Co)Al matrix, respectively. (Ni,Co)Al hardens appreciably by the fine precipitation of the (Ni,Co)(2)Al phase.
C1 [Han, Chang-Suk; Chun, Chang-Hwan; Koo, Kyung-Wan] Hoseo Univ, Dept Def Sci & Technol, Asan 336795, Chungnam, South Korea.
   [Oh, Chang-Sup] Korea Inst Sci & Technol Informat, Reseat Program, Taejon 305806, South Korea.
   [Kim, Jang-Woo] Hoseo Univ, Sch Display Engn, Chungnam 336795, South Korea.
   [Kim, Young-Woo] Hoseo Univ, Dept Automot Engn, Chungnam 336795, South Korea.
   [Han, Seung-Oh] Hoseo Univ, Inst Fus Technol, Chungnam 336795, South Korea.
   [Bae, Chang-Hwan; Lee, Ju-Hee] Hoseo Univ, Grad Sch MT&M, Dept Mechatron Eng, Chungnam 336795, South Korea.
RP Han, CS (reprint author), Hoseo Univ, Dept Def Sci & Technol, Asan 336795, Chungnam, South Korea.
CR Hubert-Protopescu M., 1991, TERNARY ALLOYS, V4, P234
   ISHIDA K, 1991, METALL TRANS A, V22, P441, DOI 10.1007/BF02656811
   Jeong SH, 1998, MET MATER-KOREA, V4, P1077, DOI 10.1007/BF03025979
   KHADKIKAR PS, 1993, METALL TRANS A, V24, P83, DOI 10.1007/BF02669606
   Kim G M., 2004, J KOREAN INST MET MA, V42, P815
   KIMURA T, 1993, HIGH TEMPERATURE ORD, V288, P697
   Lee HY, 2009, J KOREAN INST MET MA, V47, P267
   Matsuura K, 2001, MATER T JIM, V42, P263, DOI 10.2320/matertrans.42.263
   MURTHY AS, 1993, ACTA METALL MATER, V41, P2135, DOI 10.1016/0956-7151(93)90383-4
   MUTO S, 1993, ACTA METALL MATER, V41, P2377, DOI 10.1016/0956-7151(93)90317-L
   PARK HS, 1998, J KOREAN INST MET MA, V36, P691
   PARK HS, 1998, J KOREAN INST MET MA, V36, P684
   PASCOE RT, 1968, METAL SCI J, V2, P138
   REYNAUD F, 1976, J APPL CRYSTALLOGR, V9, P263, DOI 10.1107/S0021889876011333
   ROBERTSON IM, 1983, PHILOS MAG A, V48, P443, DOI 10.1080/01418618308234903
   ROBERTSON IM, 1983, PHILOS MAG A, V48, P421, DOI 10.1080/01418618308234902
   ROBERTSON IM, 1983, PHILOS MAG A, V48, P629, DOI 10.1080/01418618308234917
   Ur SC, 2002, MET MATER INT, V8, P333, DOI 10.1007/BF03186104
NR 18
TC 2
Z9 2
U1 2
U2 15
PU KOREAN INST METALS MATERIALS
PI SEOUL
PA KIM BLDG 6TH FLOOR, SEOCHO-DAERO 56 GIL 38, SEOCHO-GU, SEOUL 137-881,
   SOUTH KOREA
SN 1598-9623
EI 2005-4149
J9 MET MATER INT
JI Met. Mater.-Int.
PD APR
PY 2010
VL 16
IS 2
BP 175
EP 183
DI 10.1007/s12540-010-0404-1
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 596VH
UT WOS:000277713100004
DA 2018-12-27
ER

PT J
AU Cheng, YZ
   Yang, HL
AF Cheng, Yongzhi
   Yang, Helin
TI RETRACTED: DESIGN, SIMULATION, AND MEASUREMENT OF METAMATERIAL ABSORBER
   (Retracted article. See vol. 52, pg. 1922, 2010)
SO MICROWAVE AND OPTICAL TECHNOLOGY LETTERS
LA English
DT Article; Retracted Publication
DE transmission coefficients; reflectance coefficients; absorptivity;
   metamaterial absorber
ID MICROWAVE-FREQUENCIES; PLASMONS
AB We present a new design for metamaterial (MM) absorber that is resonant with strong absorbance in the microwave frequency range. Our fabricated MM consists of two resonators and a metal wire that couple separately so as to absorb all incident electric and magnetic fields within a single-unit cell layer. Experiments demonstrated that the transmission coefficients (S21) are lower than -10 dB across the entire measurement frequency range, and the reflectance coefficients (S11) are about -20 dB around 10.4 GHz. The absorptivity. which can be obtained through S parameter, is greater than 98% around 10.4 GHz in experiments and 99.9% in simulations. (C) 2010 Wiley Periodicals, Inc. Microwave Opt Technol Lett 52: 877-880. 2010 Published online in Wiley InterScience (www.interscience.wiley.com). DOI:10.1002/mop.25068
C1 [Cheng, Yongzhi; Yang, Helin] Huazhong Normal Univ, Coll Phys Sci & Technol, Wuhan 430079, Peoples R China.
RP Yang, HL (reprint author), Huazhong Normal Univ, Coll Phys Sci & Technol, Wuhan 430079, Peoples R China.
EM emyang@mail.ccnu.edu.cn
RI Cheng, Yongzhi/N-6123-2014
CR Avitzour Y, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.045131
   Dolling G, 2007, OPT LETT, V32, P53, DOI 10.1364/OL.32.000053
   Kisel VN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.065601
   Landy NI, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.207402
   Landy NI, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125104
   Li YX, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/9/095408
   Padilla WJ, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.041102
   Pendry JB, 1996, PHYS REV LETT, V76, P4773, DOI 10.1103/PhysRevLett.76.4773
   Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628
   Schurig D, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2166681
   SERDYUKOV A, 2003, PHYS REV E, V67
   Smith DR, 2006, J APPL PHYS, V100, DOI 10.1063/1.2218033
   Smith DR, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.195104
   Smith DR, 2006, J OPT SOC AM B, V23, P391, DOI 10.1364/JOSAB.23.000391
   Smith DR, 1999, APPL PHYS LETT, V75, P1425, DOI 10.1063/1.124714
   Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184
   Tao H, 2008, OPT EXPRESS, V16, P7181, DOI 10.1364/OE.16.007181
   Tao H, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.241103
   VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699
   Wiltshire MCK, 2001, SCIENCE, V291, P849, DOI 10.1126/science.291.5505.849
NR 20
TC 8
Z9 8
U1 3
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0895-2477
EI 1098-2760
J9 MICROW OPT TECHN LET
JI Microw. Opt. Technol. Lett.
PD APR
PY 2010
VL 52
IS 4
BP 877
EP 880
DI 10.1002/mop.25068
PG 4
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA 569YZ
UT WOS:000275640100030
DA 2018-12-27
ER

PT J
AU Prasad, S
   Ravindran, J
   Sung, B
   Pandey, MK
   Aggarwal, BB
AF Prasad, Sahdeo
   Ravindran, Jayaraj
   Sung, Bokyung
   Pandey, Manoj K.
   Aggarwal, Bharat B.
TI RETRACTED: Garcinol Potentiates TRAIL-Induced Apoptosis through
   Modulation of Death Receptors and Antiapoptotic Proteins (Retracted
   article. See vol. 17, pg. 2073, 2018)
SO MOLECULAR CANCER THERAPEUTICS
LA English
DT Article; Retracted Publication
ID MEDIATED UP-REGULATION; CYTOCHROME-C RELEASE; LIGAND (TRAIL)-INDUCED
   APOPTOSIS; DOWN-REGULATION; CANCER-CELLS; CASPASE ACTIVATION;
   HEPATOMA-CELLS; BCL-XL; DR5; RESISTANCE
AB Whether garcinol, the active component of Garcinia indica, can modulate the sensitivity of cancer cells to TRAIL, a cytokine currently in phase II clinical trial, was investigated. We found that garcinol potentiated TRAIL-induced apoptosis of cancer cells as indicated by intracellular esterase activity, DNA strand breaks, accumulation of the membrane phospholipid phosphatidylserine, mitochondrial activity, and activation of caspase-8, -9, and -3. We found that garcinol, independent of the cell type, induced both of the TRAIL receptors, death receptor 4 (DR4) and DR5. Garcinol neither induced the receptors on normal cells nor sensitized them to TRAIL. Deletion of DR5 or DR4 by small interfering RNA significantly reduced the apoptosis induced by TRAIL and garcinol. In addition, garcinol downregulated various cell survival proteins including survivin, bcl-2, XIAP, and cFLIP, and induced bid cleavage, bax, and cytochrome c release. Induction of death receptors by garcinol was found to be independent of modulation of CCAAT/enhancer-binding protein-homologous protein, p53, bax, extracellular signal-regulated kinase, or c-Jun-NH2-kinase. The effect of garcinol was mediated through the generation of reactive oxygen species, in as much as induction of both death receptors, modulation of antiapoptotic and proapoptotic proteins, and potentiation of TRAIL-induced apoptosis were abolished by N-acetyl cysteine and glutathione. Interestingly, garcinol also converted TRAIL-resistant cells into TRAIL-sensitive cells. Overall, our results indicate that garcinol can potentiate TRAIL-induced apoptosis through upregulation of death receptors and downregulation of antiapoptotic proteins. Mol Cancer Ther; 9(4); 856-68. (C) 2010 AACR.
C1 [Prasad, Sahdeo; Ravindran, Jayaraj; Sung, Bokyung; Pandey, Manoj K.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, Houston, TX 77030 USA.
RP Aggarwal, BB (reprint author), 1515 Holcombe Blvd,Box 143, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI Pandey, Manoj/K-9706-2015; Aggarwal, Bharat/G-3388-2013
OI Pandey, Manoj/0000-0002-2767-2929; 
FU National Institutes of Health [CA-16 672, NIH CA-124787-01A2]; Center
   for Targeted Therapy of M.D. Anderson Cancer Center
FX Grant Support; Clayton Foundation for Research (B. B. Aggarwal), a core
   grant from the National Institutes of Health (CA-16 672), a program
   project grant from National Institutes of Health (NIH CA-124787-01A2),
   and grant from Center for Targeted Therapy of M.D. Anderson Cancer
   Center.
CR Aggarwal BB, 2004, VITAM HORM, V67, P453
   Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200
   Burns TF, 2001, ONCOGENE, V20, P4601, DOI 10.1038/sj.onc.1204484
   Chatterjee A, 2003, MOL CELL BIOCHEM, V243, P29, DOI 10.1023/A:1021649427988
   Chen JJ, 2008, J IMMUNOL, V180, P8030, DOI 10.4049/jimmunol.180.12.8030
   Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891
   Eggert A, 2001, CANCER RES, V61, P1314
   Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225
   Gross A, 2000, MOL CELL BIOL, V20, P3125, DOI 10.1128/MCB.20.9.3125-3136.2000
   Hong JG, 2006, CARCINOGENESIS, V27, P278, DOI 10.1093/carcin/bgi208
   Hong J, 2007, FREE RADICAL BIO MED, V42, P1211, DOI 10.1016/j.freeradbiomed.2007.01.016
   Huang J, 2008, J PHARMACOL SCI, V107, P370, DOI 10.1254/jphs.08044FP
   Izeradjene K, 2005, CANCER RES, V65, P7436, DOI 10.1158/0008-5472.CAN-04-2628
   Jacobson MD, 1996, TRENDS BIOCHEM SCI, V21, P83, DOI 10.1016/0968-0004(96)20008-8
   Jung EM, 2005, CARCINOGENESIS, V26, P1905, DOI 10.1093/carcin/bgi167
   Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006
   Kim H, 2006, CANCER RES, V66, P1740, DOI 10.1158/0008-5472.CAN-05-1568
   Kim JY, 2008, J CELL BIOCHEM, V105, P1386, DOI 10.1002/jcb.21958
   Kim YH, 2008, FREE RADICAL BIO MED, V44, P1055, DOI 10.1016/j.freeradbiomed.2007.12.001
   Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200
   Koeberle A, 2009, BIOCHEM PHARMACOL, V77, P1513, DOI 10.1016/j.bcp.2009.02.005
   Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200
   Lee SH, 2001, ONCOGENE, V20, P399, DOI 10.1038/sj.onc.1204103
   Lee TJ, 2009, FREE RADICAL BIO MED, V46, P1639, DOI 10.1016/j.freeradbiomed.2009.03.022
   Liao CH, 2005, J CELL BIOCHEM, V96, P155, DOI 10.1002/jcb.20540
   Liao CH, 2004, MOL CARCINOGEN, V41, P140, DOI 10.1002/mc.20050
   Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5
   Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l
   Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111
   Pan MH, 2001, J AGR FOOD CHEM, V49, P1464, DOI 10.1021/jf001129v
   Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914
   Schimmer AD, 2004, CANCER CELL, V5, P25, DOI 10.1016/S1535-6108(03)00332-5
   Seol DW, 2001, CANCER RES, V61, P1138
   Shin MS, 2001, CANCER RES, V61, P4942
   Song JJ, 2007, J BIOL CHEM, V282, P319, DOI 10.1074/jbc.M608065200
   Tanaka H, 2009, MOL CANCER RES, V7, P557, DOI 10.1158/1541-7786.MCR-08-0197
   Tanaka T, 2000, CARCINOGENESIS, V21, P1183, DOI 10.1093/carcin/21.6.1183
   Taniguchi H, 2008, CANCER RES, V68, P8918, DOI 10.1158/0008-5472.CAN-08-1120
   Tomasetti M, 2006, FEBS LETT, V580, P1925, DOI 10.1016/j.febslet.2006.02.054
   Wu WG, 2000, ANTICANCER RES, V20, P4525
   Yamaguchi F, 2000, J AGR FOOD CHEM, V48, P180, DOI 10.1021/jf990845y
   Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129
   Yoshida K, 2005, CANCER LETT, V221, P29, DOI 10.1016/j.canlet.2004.08.016
   Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792
   Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549
NR 45
TC 61
Z9 63
U1 0
U2 5
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1535-7163
EI 1538-8514
J9 MOL CANCER THER
JI Mol. Cancer Ther.
PD APR
PY 2010
VL 9
IS 4
BP 856
EP 868
DI 10.1158/1535-7163.MCT-09-1113
PG 13
WC Oncology
SC Oncology
GA 607GP
UT WOS:000278487400008
PM 20371723
OA Green Accepted, Bronze
DA 2018-12-27
ER

PT J
AU Benghanem, M
AF Benghanem, M.
TI RETRACTED: A low cost wireless data acquisition system for weather
   station monitoring (Retracted article. See vol. 85, pg. 1425, 2016)
SO RENEWABLE ENERGY
LA English
DT Article; Retracted Publication
DE Data acquisition system; Remote weather station; LabVIEW monitoring;
   Micro-controller; Renewable energy sources
ID PHOTOVOLTAIC SYSTEMS; SOLAR-RADIATION
AB In this paper, the development of wireless data acquisition system (WDAS) for weather station monitoring is described. It is based on the Emitter/Receiver architecture and it does not require the physical connection of the monitored systems to the data collection server. The proposed system consists of a set of sensors for measuring meteorological parameters (solar radiation, temperature, humidity, pressure, wind speed & direction, rain fall, etc.). The collected data are first conditioned using precision electronic circuits and then interfaced to a PC using RS232 connection via wireless unit. The LabVIEW program is used to further process, display and store the collected data in the PC disk. The proposed architecture permits the rapid system development and has the advantage of flexibility and it can be easily extended for controlling the renewable energy systems like photovoltaic system. The measured parameters are available on-line over the internet to any user. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Benghanem, M.] Taibah Univ, Fac Sci, Dept Phys, Medina, Saudi Arabia.
RP Benghanem, M (reprint author), Abdus Salaam Int Ctr Theoret Phys, Int Ctr Theoret Phys, Trieste, Italy.
EM benghanem_mohamed@yahoo.fr
OI Benghanem, Mohamed/0000-0002-2527-8741
CR Benghanem M, 1998, IEEE T INSTRUM MEAS, V47, P30, DOI 10.1109/19.728784
   Benghanem M, 1999, RENEW ENERG, V17, P385, DOI 10.1016/S0960-1481(98)00126-8
   Blaesser G, 1997, SOL ENERG MAT SOL C, V47, P167, DOI 10.1016/S0927-0248(97)80008-6
   EFTICHIOS K, 2003, RENEW ENERG, V28, P139
   *HUMIREL, 2007, HPC052 HUMIREL
   Kim M, 1997, J POWER SOURCES, V64, P193, DOI 10.1016/S0378-7753(96)02521-9
   Lundqvist M, 1997, SOL ENERG MAT SOL C, V47, P289, DOI 10.1016/S0927-0248(97)00051-2
   Mukaro R, 1998, SOL ENERGY, V63, P313, DOI 10.1016/S0038-092X(98)00072-3
   Mukaro R, 1999, IEEE T INSTRUM MEAS, V48, P1232, DOI 10.1109/19.816142
   SUMANTH VL, 2003, APPL PROJECT REPORT
   TAMIZHMANI G, 1998, 19981753OPJ04081998
   Wichert B, 2001, RENEW ENERG, V22, P311, DOI 10.1016/S0960-1481(00)00024-0
   Wilshaw AR, 1997, SOL ENERGY, V59, P19, DOI 10.1016/S0038-092X(96)00123-5
NR 13
TC 31
Z9 31
U1 1
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-1481
J9 RENEW ENERG
JI Renew. Energy
PD APR
PY 2010
VL 35
IS 4
BP 862
EP 872
DI 10.1016/j.renene.2009.08.024
PG 11
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA 532RY
UT WOS:000272768400016
DA 2018-12-27
ER

PT J
AU Coldwell, I
AF Coldwell, Ian
TI RETRACTED: Masculinities in the Rural and the Agricultural: A Literature
   Review (Retracted article. See vol. 52, pg. 145, 2012)
SO SOCIOLOGIA RURALIS
LA English
DT Review; Retracted Publication
ID FRENCH FARMING COMMUNITY; GENDER IDENTITY; NEW-ZEALAND; MEN; FARMERS;
   POWER; CONSTRUCTION; WOMEN; LIFE; REPRESENTATION
AB This article provides a summary of social science studies at the nexus of masculinity and the rural, particularly the agricultural. These studies began to emerge in the rural social science literature in 1995, when Berit Brandth pioneered the study of masculinities and farming practices in Norway. The studies reviewed here are particularly important as they begin to focus on men and masculinities in the rural and the agricultural, categories that previously had been the assumed, yet invisible subject of rural studies. The studies also link masculinity to farming practices in a number of ways that clearly have implications for the future of farming in terms of ecological crises across social, economic and environmental rural landscapes. The aim of this article is twofold; to gain a deeper understanding of the relationship between masculine identities and farming practices and to identify possible theoretical pathways for future research that might assist us to identify and develop more sustainable ways of farming and rural life.
C1 Univ Melbourne, Sch Rural Hlth, Fac Med Dent & Hlth Sci, Shepparton, Vic, Australia.
RP Coldwell, I (reprint author), Univ Melbourne, Sch Rural Hlth, Fac Med Dent & Hlth Sci, 49 Graham St, Shepparton, Vic, Australia.
EM ianlc@unimelb.edu.au
CR Alloway N., 2004, INT J QUALITATIVE ST, V17, P99
   ALSTON M, 1997, LEGACY THREAT FAMILY, P99
   Alston M, 1995, WOMEN LAND HIDDEN HE
   Alston M, 2008, J SOCIOL, V44, P133, DOI 10.1177/1440783308089166
   Alston M, 2006, SOCIOL RURALIS, V46, P154, DOI 10.1111/j.1467-9523.2006.00409.x
   Anahita S, 2006, GENDER SOC, V20, P332, DOI 10.1177/0891243206286319
   Bakhtin M, 1984, RABELAIS HIS WORLD
   BARTLETT P, 2004, MEN MASC, P205
   BARTLETT P, 2006, COUNTRY BOYS MASCULI, P46
   Bartlett P. F., 1993, AM DREAMS RURAL REAL
   Bell D, 2000, RURAL SOCIOL, V65, P547
   BELL D, 2005, RURAL GENDER RELATIO, P345
   Bell Michael, 2004, FARMING US ALL PRACT
   Bell MM, 1997, THEOR SOC, V26, P813
   BERLANDARQUE M, 1991, J RURAL STUD, V7, P1
   BLEKESAUNE A, 1993, RURAL SOCIOL, V58, P111
   Bonanno A, 1994, COLUMBUS CONAGRA GLO
   Bonnett A, 1996, ANTIPODE, V28, P273, DOI 10.1111/j.1467-8330.1996.tb00463.x
   Bourdieu Pierre, 2001, MASCULINE DOMINATION
   Brandth B., 2005, Men and Masculinities, V8, P148, DOI 10.1177/1097184X05277716
   BRANDTH B, 1995, J RURAL STUD, V11, P123, DOI 10.1016/0743-0167(95)00007-A
   Brandth B, 2005, J GENDER STUD, V14, P13, DOI 10.1080/0958923042000331452
   BRANDTH B, 1994, SOCIOL RURALIS, V34, P127, DOI 10.1111/j.1467-9523.1994.tb00805.x
   Brandth B, 2002, SOCIOL RURALIS, V42, P181, DOI 10.1111/1467-9523.00210
   BRANDTH B, 1998, SOCIOLOGIC RURALIS, V38, P107
   Bryant L, 2003, SOC SCI COMPUT REV, V21, P464, DOI 10.1177/0894439393256098
   Bryant L, 1999, SOCIOL RURALIS, V39, P236, DOI 10.1111/1467-9523.00104
   Bryant L, 2006, RURAL SOC, V16, P62, DOI 10.5172/rsj.351.16.1.62
   BUCHBINDER D, 1998, MASCULINITIES IDENTI
   Bye L. M., 2003, NORWEGIAN J GEOGRAPH, V57, P145
   Camp BW, 1998, EARLY HUM DEV, V50, P159, DOI 10.1016/S0378-3732(97)00034-9
   Campbell H, 2000, RURAL SOCIOL, V65, P562, DOI 10.1111/j.1549-0831.2000.tb00044.x
   Campbell H, 2000, RURAL SOCIOL, V65, P532
   Campbell H., 1995, COMMUNICATIONS CULTU, P107
   Campbell Hugh, 2006, COUNTRY BOYS MASCULI
   CLOKE P, 1997, CONTESTED COUNTRYSID
   Coad D., 2002, GENDER TROUBLE AUSTR
   Coldwell I, 2007, RURAL SOC, V17, P19, DOI 10.5172/rsj.351.17.1.19
   Coldwell I, 2007, J SOCIOL, V43, P87, DOI 10.1177/1440783307073936
   COLLIER R, 1998, MASCULINITIES CRIME
   Connell R., 2007, SO THEORY
   Connell R. W., 2000, MEN BOYS
   Connell R. W., 1995, MASCULINITIES
   Connell Raewyn, 2006, COUNTRY BOYS MASCULI, P255
   Courtenay W. H., 2006, COUNTRY BOYS MASCULI, P139
   DEMPSEY K, 1992, MANS TOWN INEQUALITY
   Dessein J, 2007, SOCIOL RURALIS, V47, P273, DOI 10.1111/j.1467-9523.2007.00437.x
   FELLOWS Will, 1996, FARM BOYS LIVES GAY
   Foucault M, 1980, POWER KNOWLEDGE SELE
   FRIEDMANN H, 1993, NEW LEFT REV, P29
   FRIEDMANN H, 1986, SOCIOL RURALIS, V26, P186, DOI 10.1111/j.1467-9523.1986.tb00781.x
   GLENN C, 2004, UPSPOKEN RHETORIC SI
   HALFACREE KH, 1995, J RURAL STUD, V11, P1, DOI 10.1016/0743-0167(94)00039-C
   Haraway D., 2003, COMPANION SPECIES MA
   Haraway Donna, 1997, MODEST WITNESS 2 MIL
   HAUGEN MS, 1994, GENDER SOC, V8, P206, DOI 10.1177/089124394008002005
   Howden P., 1998, Rural Society, V8, P109
   JONES O, 1995, J RURAL STUD, V11, P35, DOI 10.1016/0743-0167(94)00057-G
   JONES O, 2006, HDB RURAL STUDIES, P185
   Kenway J, 2006, MASCULINITY BEYOND THE METROPOLIS, P1, DOI 10.1057/9780230625785
   Leyshon M., 2005, CRITICAL STUDIES RUR, P104
   Liepins R, 1998, AUST GEOGR, V29, P371, DOI 10.1080/00049189808703230
   Liepins R, 2000, RURAL SOCIOL, V65, P605
   Little J, 2003, SOCIOL RURALIS, V43, P401, DOI 10.1046/j.1467-9523.2003.00252.x
   Little J, 2002, PROG HUM GEOG, V26, P665, DOI 10.1191/0309132502ph394pr
   LITTLE J, 2007, SOCIOL RURALIS, V47, P3
   Long N, 1992, BATTLEFIELDS KNOWLED, P16
   LUCAS R, 2006, J AUSTR STUDIES, V56, P138
   McMichael P. D., 1994, GLOBAL RESTRUCTURING
   Morris C, 2004, J RURAL STUD, V20, P95, DOI 10.1016/S0743-0167(03)00041-X
   MURRIE L, 1998, J AUSTR STUDIES, V56, P68
   Ni Laoire C, 2001, SOCIOL RURALIS, V41, P220
   Ni Laoire C., 2005, IRISH J SOCIOLOGY, V14, P94, DOI DOI 10.1177/079160350501400206
   NILAOIRE C, 1999, MIGRATION GENDER DEV, P223
   NILAOIRE C, 2002, IRISH GEOGRAPHY, V35, P16
   NILAOIRE C, 2005, GEOGRAPHIES RURAL CU, P283
   Peter G, 2000, RURAL SOCIOL, V65, P215
   PFEFFER MJ, 1989, RURAL SOCIOL, V54, P60
   PHILLIPS E, 1995, AUST GEOGR, V26, P127, DOI 10.1080/00049189508703141
   PHILLIPS E, 1998, THESIS C STURT U
   Pini B., 2005, International Journal of Sociology of Agriculture and Food, V13, P1
   Pini B, 2003, SOCIOL RURALIS, V43, P418, DOI 10.1046/j.1467-9523.2003.00253.x
   Pini B, 2008, MASCULINITIES MANAGE
   Poiner G., 1990, GOOD OLD RULE GENDER
   PROULX A, 1997, CLOSE RANGE, P281
   Ramirez-Ferrero E., 2005, TROUBLED FIELDS MEN
   Saugeres L, 2002, WOMEN STUD INT FORUM, V25, P641, DOI 10.1016/S0277-5395(02)00342-4
   Saugeres L, 2002, SOCIOL RURALIS, V42, P143, DOI 10.1111/1467-9523.00207
   Saugeres L, 2002, J RURAL STUD, V18, P373, DOI 10.1016/S0743-0167(02)00010-4
   SAUGERES L, 1998, THESIS MANCHESTER ME
   Seidler Victor J., 1994, UNREASONABLE MEN MAS
   SHORTALL S, 1992, SOCIOL RURALIS, V32, P431, DOI 10.1111/j.1467-9523.1992.tb00941.x
   Shortall S., 1999, WOMEN FARMING PROPER
   Silvasti T, 2003, SOCIOL RURALIS, V43, P154, DOI 10.1111/1467-9523.00236
   Stone S., 1994, RESTORING LAND ENV V, P202
   VAN DER PLOEG J.D., 1990, LABOUR MARKETS AGR P
   WHATMORE S, 1991, J RURAL STUD, V7, P71, DOI 10.1016/0743-0167(91)90043-R
   Woodward R, 2000, RURAL SOCIOL, V65, P640
   Woodward R., 1998, GENDER PLACE CULT, V5, P277, DOI DOI 10.1080/09663699825214
NR 99
TC 9
Z9 9
U1 4
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0038-0199
EI 1467-9523
J9 SOCIOL RURALIS
JI Sociol. Rural.
PD APR
PY 2010
VL 50
IS 2
BP 171
EP 197
DI 10.1111/j.1467-9523.2009.00504.x
PG 27
WC Geography; Sociology
SC Geography; Sociology
GA 571NT
UT WOS:000275760700006
OA Bronze
DA 2018-12-27
ER

PT J
AU Abou-Jaoude, MM
   Nawfal, N
   Najm, R
   Honeidi, M
   Shaheen, J
   Almawi, WY
AF Abou-Jaoude, M. M.
   Nawfal, N.
   Najm, R.
   Honeidi, M.
   Shaheen, J.
   Almawi, W. Y.
TI RETRACTED: Effect of Pretransplantation Hemoglobin Blood Concentration
   on Renal Allograft Survival and Function (Retracted article. See vol.
   45, pg. 2858, 2013)
SO TRANSPLANTATION PROCEEDINGS
LA English
DT Article; Proceedings Paper; Retracted Publication
CT 11th Congress of the Asian-Society-of-Transplantation
CY OCT 01-04, 2009
CL Beirut, LEBANON
SP Asian Soc Transplantat
ID ANEMIA; TRANSPLANTATION; HEMATOCRIT; EFFICACY; STAGE
AB The effect of pretransplantation hemoglobin (Hb) concentration on the outcome of kidney transplantation (KTx) was studied in 188 adult kidney transplant recipients. Patients were divided into 2 groups: high Hb (>= 10 g/dL; n = 97) and low Hb (<10 g/dL; n = 91). Both groups were matched for recipient sex, donor age and sex, donor-recipient blood groups, indications for kidney transplantation, and degree of sensitization. Acute rejection episodes occurred in 20 patients in the high-Hb group (20.6%) and 18 in the low-Hb group (19.8%). Antithymocyte globulin-Fresenius therapy was required in 6 patients in the high-Hb group compared with 5 patients in the low-Hb group. Infection rate, 1-year actuarial patient and graft survival, incidence of delayed and slow graft function, and number of surgical complications were comparable between groups. Compared with the low Hb group, in the high-Hb group, hospital stay was longer, creatinine concentration at 12 months post-KTx and serum glucose concentration at 6 months post-KTx were significantly higher, and pre- and posttransplantation Hb concentrations were higher. The need for post-KTx transfusions was comparable between groups. Pretransplantation Hb concentration did not affect outcome except for longer initial hospital stay and 1-year creatinine concentration.
C1 [Almawi, W. Y.] Arabian Gulf Univ, Dept Med Biochem, Coll Med & Med Sci, Manama, Bahrain.
   [Abou-Jaoude, M. M.; Nawfal, N.; Shaheen, J.] Sacre Coeur Hosp, Dept Surg, Baabda Hazmieh, Bahrain.
   [Najm, R.; Honeidi, M.] Lebanese Hosp, Beirut, Lebanon.
RP Almawi, WY (reprint author), Arabian Gulf Univ, Dept Med Biochem, Coll Med & Med Sci, POB 22979, Manama, Bahrain.
EM wassim@agu.edu.bh
CR Campise M, 2005, NEPHROL DIAL TRANSPL, V20, P8, DOI 10.1093/ndt/gfh1110
   Einollahi B, 2005, TRANSPLANT P, V37, P3101, DOI 10.1016/j.transproceed.2005.08.023
   Fresnedo GF, 2005, TRANSPL P, V37, P3821, DOI 10.1016/j.transproceed.2005.10.054
   GLICKLICH D, 1990, AM J KIDNEY DIS, V15, P46, DOI 10.1016/S0272-6386(12)80591-9
   Joist H, 2006, ADV CHRONIC KIDNEY D, V13, P4, DOI 10.1053/j.ackd.2005.10.002
   Kawaguchi T, 2004, TRANSPLANT P, V36, P1293, DOI 10.1016/j.transproceed.2004.04.089
   Lorenz M, 2005, EUR J CLIN INVEST, V35, P89, DOI 10.1111/j.1365-2362.2005.01535.x
   McMahon LP, 2000, NEPHROL DIAL TRANSPL, V15, P1425, DOI 10.1093/ndt/15.9.1425
   Molnar MZ, 2005, CLIN TRANSPLANT, V19, P825, DOI 10.1111/j.1399-0012.2005.00428.x
   MUIRHEAD N, 1999, KIDNEY INT, V69, P86
   Stigant CE, 2000, AM J KIDNEY DIS, V35, P58, DOI 10.1016/S0272-6386(00)70302-7
   Turkowski-Duhem A, 2005, TRANSPLANTATION, V80, P903, DOI 10.1097/01.tp.0000173791.42893.08
   Van Biesen W, 2005, TRANSPLANTATION, V79, P367, DOI 10.1097/01.TP.0000150370.51700.99
NR 13
TC 7
Z9 7
U1 2
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0041-1345
J9 TRANSPL P
JI Transplant. Proc.
PD APR
PY 2010
VL 42
IS 3
BP 760
EP 762
DI 10.1016/j.transproceed.2010.02.035
PG 3
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 588VV
UT WOS:000277103500022
PM 20430165
DA 2018-12-27
ER

PT J
AU Guh, JH
   Chang, WL
   Yang, J
   Lee, SL
   Wei, S
   Wang, DS
   Kulp, SK
   Chen, CS
AF Guh, Jih-Hwa
   Chang, Wei-Ling
   Yang, Jian
   Lee, Su-Lin
   Wei, Shuo
   Wang, Dasheng
   Kulp, Samuel K.
   Chen, Ching-Shih
TI RETRACTED: Development of Novel Adenosine Monophosphate-Activated
   Protein Kinase Activators (Retracted article. See vol. 61, pg. 5055,
   2018)
SO JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID METABOLIC SYNDROME; PHARMACOLOGICAL EXPLOITATION; SIGNALING PATHWAYS;
   SKELETAL-MUSCLE; CELLULAR-ENERGY; AMPK ACTIVATOR; REDUCES IL-6; CELLS;
   EXPRESSION; CANCER
AB In light of the unique ability of thiazolidinediones to mediate peroxisome proliferator-activated receptor (PPAR)gamma-independent activation of adenosine monophosphate-activated protein kinase (AMPK) and suppression of interleukin (IL)-6 production, we conducted a screening of an in-house, thiazolidinedione-based focused compound library to identify novel agents with these dual pharmacological activities. Cell-based assays pertinent to the activation status of AMPK and mammalian homologue of target of rapamycin (i.e., phosphorylation of AMPK and p70 ribosomal protein S6 kinase, respectively) and IL-6/IL-6 receptor signaling (i.e.. IL-6 production and signal transducer and activator of transcription 3 phosphorylation, respectively) in lipopolysaccharide (LPS)-stimulated THP-1 human macrophages were used to screen this compound library, which led to the identification of compound 53 (N-{4-[3-(1-methyl-cyclohexylmethyl)-2,4-dioxo-thiazolidin-5-ylidene-methyl]-phenyl}-4-nitro-3-tri-fluoro-methyl-benzenesulfonamide) as the lead agent. Evidence indicates that this drug-induced suppression of LPS-stimulated IL-6 production was attributable to AMPK activation. Furthermore, compound 53-mediated AMPK activation was demonstrated in C-26 colon adenocarcinoma cells, indicating that it is not it cell line-specific event.
C1 [Guh, Jih-Hwa; Chang, Wei-Ling; Yang, Jian; Lee, Su-Lin; Wei, Shuo; Wang, Dasheng; Kulp, Samuel K.; Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem, Columbus, OH 43210 USA.
   [Guh, Jih-Hwa] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei 10764, Taiwan.
RP Chen, CS (reprint author), Ohio State Univ, Coll Pharm, Div Med Chem, 336 Pk Hall,500 W 12th Ave, Columbus, OH 43210 USA.
EM chen.844@osu.edu
RI Yang, Jian/B-9451-2012; Lee, Su-Lin/B-9544-2013
FU National Institutes of Health [CA 112250]; Ohio State University
FX This work is supported by National Institutes of Health Grant CA 112250
   and the Lucius A. Wing Endowed Chair Fund at The Ohio State University.
CR Asbagh LA, 2008, INT BRAZ J UROL, V34, P355, DOI 10.1590/S1677-55382008000300013
   AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244
   Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005
   Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005
   CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.tb20498.x
   Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200
   FUJIMOTOOUCHI K, 1995, INT J CANCER, V61, P522, DOI 10.1002/ijc.2910610416
   Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106
   Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249
   Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005
   Huang JW, 2006, J MED CHEM, V49, P4684, DOI 10.1021/jm060057h
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   Jang CH, 2006, RHEUMATOLOGY, V45, P703, DOI 10.1093/rheumatology/kei282
   Jang S, 2008, P NATL ACAD SCI USA, V105, P7534, DOI 10.1073/pnas.0802865105
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Konrad D, 2005, DIABETOLOGIA, V48, P954, DOI 10.1007/s00125-005-1713-7
   Lihn AS, 2008, MOL CELL ENDOCRINOL, V292, P36, DOI 10.1016/j.mce.2008.06.004
   Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011
   Nishioka C, 2009, LEUKEMIA, V23, P2304, DOI 10.1038/leu.2009.163
   Pang T, 2008, J BIOL CHEM, V283, P16051, DOI 10.1074/jbc.M710114200
   Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200
   Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633
   Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200
   Schnoor M, 2009, J IMMUNOL METHODS, V344, P109, DOI 10.1016/j.jim.2009.03.014
   Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05
   Viollet B, 2007, DIABETES METAB, V33, P395, DOI 10.1016/j.diabet.2007.10.004
   Wang L, 2008, CANCER RES, V68, P4640, DOI 10.1158/0008-5472.CAN-07-5988
   Wang TH, 2006, ONCOGENE, V25, P4857, DOI 10.1038/sj.onc.1209498
   Yang CC, 2007, CANCER RES, V67, P3229, DOI 10.1158/0008-5472.CAN-06-2759
   Yang J, 2008, J MED CHEM, V51, P2100, DOI 10.1021/jm701212m
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
   Zhao G, 2007, BIOORG MED CHEM LETT, V17, P3254, DOI 10.1016/j.bmcl.2007.04.011
NR 32
TC 40
Z9 41
U1 0
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-2623
EI 1520-4804
J9 J MED CHEM
JI J. Med. Chem.
PD MAR 25
PY 2010
VL 53
IS 6
BP 2552
EP 2561
DI 10.1021/jm901773d
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 570XE
UT WOS:000275711000022
PM 20170185
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Sawada, S
   Ishikawa, C
   Tanji, H
   Nakachi, S
   Senba, M
   Okudaira, T
   Uchihara, JN
   Taira, N
   Ohshiro, K
   Yamada, Y
   Tanaka, Y
   Uezato, H
   Ohshima, K
   Sasai, K
   Burgering, BMT
   Dodon, MD
   Fujii, M
   Sunakawa, H
   Mori, N
AF Sawada, Shigeki
   Ishikawa, Chie
   Tanji, Hiroe
   Nakachi, Sawako
   Senba, Masachika
   Okudaira, Taeko
   Uchihara, Jun-Nosuke
   Taira, Naoya
   Ohshiro, Kazuiku
   Yamada, Yasuaki
   Tanaka, Yuetsu
   Uezato, Hiroshi
   Ohshima, Koichi
   Sasai, Ken
   Burgering, Boudewijn M. T.
   Dodon, Madeleine Duc
   Fujii, Masahiro
   Sunakawa, Hajime
   Mori, Naoki
TI RETRACTED: Overexpression of caveolin-1 in adult T-cell leukemia
   (Retracted article. See vol. 116, pg. 1386, 2010)
SO BLOOD
LA English
DT Article; Retracted Publication
ID VIRUS TYPE-I; NF-KAPPA-B; GROWTH-FACTOR-BETA; PROSTATE-CANCER; HTLV-I;
   POTENTIAL MECHANISM; ADHESION MOLECULE; GENE-EXPRESSION; TAX PROTEIN;
   ACTIVATION
AB Caveolin-1 is implicated in the regulation of signal pathways. Adult T-cell leukemia (ATL) is a T-cell malignancy causatively associated with human T-cell leukemia virus type 1 (HTLV-1). To determine the role of caveolin-1 in leukemogenesis, we examined caveolin-1 expression levels in HTLV-1-infected T-cell lines and ATL cells. These cells expressed high levels of caveolin-1 compared with uninfected T-cell lines and normal peripheral blood mononuclear cells (PBMCs). Caveolin-1positive ATL cells were detected in ATL lymph nodes and skin lesions, and caveolin-1 was also detected in the plasma of patients with ATL. Infection of a human T-cell line, an epithelial cell line, and normal PBMCs with HTLV-1 induced caveolin-1 expression. The viral protein Tax transcriptionally activated caveolin-1 gene through nuclear factor-beta B and cAMP response element binding protein signal pathways. HTLV-1infected T-cell lines, and ATL cells are known to be resistant to transforming growth factor beta (TGF-beta)-induced growth inhibition. Caveolin-1 was colocalized with TGF-beta type I receptor in HTLV-1-infected T-cell lines and suppressed TGF-beta signaling. Caveolin-1 knockdown in an HTLV-1infected T-cell line exhibited susceptibility to TGF-beta. Thus, we describe a new function for Tax, repression of TGF-beta signaling through caveolin-1 expression, which may play a critical role in ATL leukemogenesis. (Blood. 2010;115:2220-2230)
C1 [Sawada, Shigeki; Ishikawa, Chie; Tanji, Hiroe; Nakachi, Sawako; Mori, Naoki] Univ Ryukyus, Div Mol Virol & Oncol, Grad Sch Med, Okinawa 9030215, Japan.
   [Sawada, Shigeki; Sunakawa, Hajime] Univ Ryukyus, Div Oral & Maxillofacial Funct Rehabil, Okinawa 9030215, Japan.
   [Ishikawa, Chie] Univ Ryukyus, Transdisciplinary Res Org Subtrop & Isl Studies, Okinawa 9030215, Japan.
   [Nakachi, Sawako; Okudaira, Taeko] Univ Ryukyus, Div Endocrinol & Metab, Okinawa 9030215, Japan.
   [Senba, Masachika] Nagasaki Univ, Dept Pathol, Inst Trop Med, Nagasaki 852, Japan.
   [Uchihara, Jun-Nosuke] Naha City Hosp, Dept Internal Med, Okinawa, Japan.
   [Taira, Naoya] Heartlife Hosp, Dept Internal Med, Nakagusu Ku, Okinawa, Japan.
   [Ohshiro, Kazuiku] Okinawa Prefectural Nanbu Med Ctr, Dept Internal Med, Okinawa, Japan.
   [Ohshiro, Kazuiku] Childrens Med Ctr, Dept Internal Med, Okinawa, Japan.
   [Yamada, Yasuaki] Nagasaki Univ, Dept Lab Med, Grad Sch Biomed Sci, Nagasaki 852, Japan.
   [Tanaka, Yuetsu] Univ Ryukyus, Div Immunol, Fac Med, Okinawa 9030215, Japan.
   [Uezato, Hiroshi] Univ Ryukyus, Div Dermatol, Fac Med, Okinawa 9030215, Japan.
   [Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan.
   [Sasai, Ken] Knowledge Act Network KAN Res Inst Inc, Kobe MI R&D Ctr, Kobe, Hyogo, Japan.
   [Burgering, Boudewijn M. T.] Univ Med Ctr Utrecht, Physiol Chem Lab, Utrecht, Netherlands.
   [Burgering, Boudewijn M. T.] Univ Med Ctr Utrecht, Ctr Biomed Genet, Utrecht, Netherlands.
   [Dodon, Madeleine Duc] Ecole Normale Super Lyon, IFR BioSci Lyon Gerland 128, INSERM, U758, F-69364 Lyon, France.
   [Mori, Naoki] Niigata Univ, Grad Sch Med & Dent Sci, Div Virol, Niigata, Japan.
RP Mori, N (reprint author), Univ Ryukyus, Div Mol Virol & Oncol, Grad Sch Med, 207 Uehara, Okinawa 9030215, Japan.
EM n-mori@med.u-ryukyu.ac.jp
RI Duc-Dodon, Madeleine/I-6580-2016
FU Japan Society for the Promotion of Science; Ministry of Education,
   Culture, Sports, Science, and Technology; Takeda Science Foundation;
   Japan Leukemia Research Fund
FX This work was supported in part by Grants-in-Aid for Scientific Research
   (C) from Japan Society for the Promotion of Science; Scientific Research
   on Priority Areas from the Ministry of Education, Culture, Sports,
   Science, and Technology; the Takeda Science Foundation; and Japan
   Leukemia Research Fund.
CR Arnulf B, 2002, BLOOD, V100, P4129, DOI 10.1182/blood-2001-12-0372
   Ayala GE, 2006, CANCER RES, V66, P5159, DOI 10.1158/0008-5472.CAN-05-1847
   Bartz R, 2008, INT J CANCER, V122, P520, DOI 10.1002/ijc.23142
   Burgermeister E, 2008, CANCER LETT, V268, P187, DOI 10.1016/j.canlet.2008.03.055
   Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091
   FRA AM, 1994, J BIOL CHEM, V269, P30745
   Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157
   Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9
   GOH WC, 1985, SCIENCE, V227, P1227, DOI 10.1126/science.2983419
   Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704
   Hatanaka M, 1998, BIOCHEM BIOPH RES CO, V253, P382, DOI 10.1006/bbrc.1998.9744
   Hidaka T, 2008, BLOOD, V112, P383, DOI 10.1182/blood-2008-01-131185
   HOLLSBERG P, 1994, J IMMUNOL, V153, P566
   Iha H, 2003, ONCOGENE, V22, P8912, DOI 10.1038/sj.onc.1207058
   INOUE J, 1986, EMBO J, V5, P2883, DOI 10.1002/j.1460-2075.1986.tb04583.x
   Jeremias I, 1998, BLOOD, V91, P4624
   KAMIHIRA S, 1994, CANCER, V73, P2753, DOI 10.1002/1097-0142(19940601)73:11<2753::AID-CNCR2820731117>3.0.CO;2-X
   KOEFFLER HP, 1984, BLOOD, V64, P482
   Lee DK, 2002, J BIOL CHEM, V277, P33766, DOI 10.1074/jbc.M200150200
   MAEDA M, 1985, J EXP MED, V162, P2169, DOI 10.1084/jem.162.6.2169
   Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745
   Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9
   Matsumoto K, 1997, J VIROL, V71, P4445
   Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111
   McKinsey TA, 1996, MOL CELL BIOL, V16, P2083
   MIYOSHI I, 1980, GANN, V71, P155
   MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0
   Mori N, 2001, BLOOD, V97, P2137, DOI 10.1182/blood.V97.7.2137
   Mori N, 1999, BLOOD, V93, P2360
   OHTANI K, 1989, NUCLEIC ACIDS RES, V17, P1589, DOI 10.1093/nar/17.4.1589
   Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096
   POPOVIC M, 1983, SCIENCE, V219, P856, DOI 10.1126/science.6600519
   Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200
   Sasai K, 2003, J BIOL CHEM, V278, P25295, DOI 10.1074/jbc.M301913200
   Sasaki H, 2005, BLOOD, V105, P1204, DOI 10.1182/blood-2004-03-1222
   Satou Y, 2006, P NATL ACAD SCI USA, V103, P720, DOI 10.1073/pnas.0507631103
   Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337
   Schlegel A, 2001, J BIOL CHEM, V276, P4398, DOI 10.1074/jbc.M005448200
   SUGAMURA K, 1984, INT J CANCER, V34, P221, DOI 10.1002/ijc.2910340213
   Suzuoki M, 2002, BRIT J CANCER, V87, P1140, DOI 10.1038/sj.bjc.6600619
   Tahir SA, 2003, CLIN CANCER RES, V9, P3653
   Tahir SA, 2001, CANCER RES, V61, P3882
   TANAKA Y, 1990, JPN J CANCER RES, V81, P225, DOI 10.1111/j.1349-7006.1990.tb02554.x
   Teruya H, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-86
   van den Heuvel APJ, 2005, BIOCHEM J, V385, P795, DOI 10.1042/BJ20041449
   Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004
   WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0
   Yang G, 2007, HUM PATHOL, V38, P1688, DOI 10.1016/j.humpath.2007.03.024
   YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031
   Yoshida M, 2004, BLOOD, V103, P2753, DOI 10.1182/blood-2003-07-2482
   Yoshida T, 2001, INT J CANCER, V91, P99, DOI 10.1002/1097-0215(20010101)91:1<99::AID-IJC1016>3.0.CO;2-O
NR 51
TC 10
Z9 14
U1 1
U2 14
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD MAR 18
PY 2010
VL 115
IS 11
BP 2220
EP 2230
DI 10.1182/blood-2009-08-240044
PG 11
WC Hematology
SC Hematology
GA 571KT
UT WOS:000275751400018
PM 20061557
OA Bronze
DA 2018-12-27
ER

PT J
AU Wiggins, KM
   Hudnall, TW
   Shen, QL
   Kryger, MJ
   Moore, JS
   Bielawski, CW
AF Wiggins, Kelly M.
   Hudnall, Todd W.
   Shen, Qilong
   Kryger, Matthew J.
   Moore, Jeffrey S.
   Bielawski, Christopher W.
TI RETRACTED: Mechanical Reconfiguration of Stereoisomers (Retracted
   article. See vol. 137, pg. 3428, 2015)
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article; Retracted Publication
ID ASYMMETRIC CATALYSIS; 1,1'-BINAPHTHYL; POLYMERS; FORCE; BARRIERS; BINOL;
   BONDS
AB Poly(methyl acrylate) of varying molecular weight was grown from the enantiopure ditopic initiator (R)- or (S)-1,1'-binaphthy1-2,2'-bis-(2-bromoisobutyrate). Subjecting CH3CN solutions of high-molecular-weight derivatives (M-N > 25 kDa) to sonication at 0 degrees C resulted in >95% racemization after 24 h, as determined by circular dichroism; no appreciable racemization was observed in low-molecular-weight derivatives. Control experiments excluded the possibility fa thermal racemization mechanism.
C1 [Wiggins, Kelly M.; Hudnall, Todd W.; Bielawski, Christopher W.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.
   [Shen, Qilong; Kryger, Matthew J.; Moore, Jeffrey S.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA.
RP Bielawski, CW (reprint author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.
EM bielawski@cm.utexas.edu
RI Hudnall, Todd/K-8354-2014
OI chen, qi long/0000-0001-5622-153X
FU Army Research Office [N00014-08-1-0729]; Robert A. Welch Foundation
   [F-1621]
FX We are grateful to the Army Research Office (Grant N00014-08-1-0729) and
   the Robert A. Welch Foundation (Grant F-1621) for their generous
   financial support. We thank Dr. A. G. Tennyson for fruitful suggestions
   and comments.
CR Azzaroni O, 2006, ANGEW CHEM INT EDIT, V45, P7440, DOI 10.1002/anie.200602666
   Berkowski KL, 2005, MACROMOLECULES, V38, P8975, DOI 10.1021/ma051394n
   Bringmann G, 2005, ANGEW CHEM INT EDIT, V44, P5384, DOI 10.1002/anie.200462661
   Brunel JM, 2005, CHEM REV, V105, P857, DOI 10.1021/cr040079g
   Cai DW, 2002, TETRAHEDRON LETT, V43, P4055, DOI 10.1016/S0040-4039(02)00730-X
   CARTER RE, 1976, TETRAHEDRON, V32, P2915, DOI 10.1016/0040-4020(76)80145-7
   Caruso MM, 2009, CHEM REV, V109, P5755, DOI 10.1021/cr9001353
   COOKE AS, 1963, J CHEM SOC, P2365, DOI 10.1039/jr9630002365
   Davis DA, 2009, NATURE, V459, P68, DOI 10.1038/nature07970
   Dayananda K, 2004, J POLYM SCI POL CHEM, V42, P902, DOI 10.1002/pola.11036
   Eliel E., 1994, STEREOCHEMISTRY ORGA
   Hickenboth CR, 2007, NATURE, V446, P423, DOI 10.1038/nature05681
   KRANZ M, 1993, J ORG CHEM, V58, P3317, DOI 10.1021/jo00064a018
   Lenhardt JM, 2009, J AM CHEM SOC, V131, P10818, DOI 10.1021/ja9036548
   McCarthy M, 2001, TETRAHEDRON, V57, P3809, DOI 10.1016/S0040-4020(01)00087-4
   Meca L, 2003, J ORG CHEM, V68, P5677, DOI 10.1021/jo034344u
   MIYASHITA A, 1980, J AM CHEM SOC, V102, P7932, DOI 10.1021/ja00547a020
   Percec V, 2006, J AM CHEM SOC, V128, P14156, DOI 10.1021/ja065484z
   Piermattei A, 2009, NAT CHEM, V1, P133, DOI [10.1038/NCHEM.167, 10.1038/nchem.167]
   Potisek SL, 2007, J AM CHEM SOC, V129, P13808, DOI 10.1021/ja076189x
   Pu L, 1998, CHEM REV, V98, P2405, DOI 10.1021/cr970463w
   Sheiko SS, 2006, NATURE, V440, P191, DOI 10.1038/nature04576
   SUSLICK KS, 1983, J AM CHEM SOC, V105, P5781, DOI 10.1021/ja00356a014
NR 23
TC 60
Z9 61
U1 3
U2 69
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD MAR 17
PY 2010
VL 132
IS 10
BP 3256
EP +
DI 10.1021/ja910716s
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA 570GP
UT WOS:000275660600013
PM 20166664
DA 2018-12-27
ER

PT J
AU Zhang, LF
AF Zhang, Lifeng
TI RETRACTED: Analysis of Risedronate and Related Substances by Ion-Pair
   Reversed-Phase High-Performance Liquid Chromatography with Evaporative
   Light-Scattering Detection (Retracted article. See vol. 29, pg. 931,
   2013)
SO ANALYTICAL SCIENCES
LA English
DT Article; Retracted Publication
ID FLUORESCENCE DETECTION; PHARMACEUTICAL-PREPARATIONS; EXCHANGE
   CHROMATOGRAPHY; BISPHOSPHONATES; URINE; DERIVATIZATION; PAMIDRONATE;
   PLASMA; BONE
AB A simple method has been developed for the analysis of risedronate and related substances by ion-pair reversed-phase high-performance liquid chromatography (RPLC) with evaporative light-scattering detection (ELSD). After optimization of the chromatographic conditions, satisfactory separation of the compounds was achieved on an Intersil C-8 column with an isocratic mobile phase: 8:4:88 (v/v) acetonitrile-methanol-12 mM ammonium acetate buffer containing 35 mM n-amylamine (pH 7.0). The mobile-phase flow rate was 1.0 mL min(-1). The calibration plot was linear in the range of 352 to 1760 mu g mL(-1) for risedronate. The precision and reproducibility were 0.3 and 0.5%, respectively. The average recovery of risedronate was 100.4% and the RSD was 0.6%. The method was validated and shown to be precise, accurate, and specific for the assay of risedronate in both bulk material and dosage forms. The proposed liquid-chromatographic method can be satisfactorily used for the quality control of risedronate.
EM 816601@163.com
CR Bauss F, 2002, J RHEUMATOL, V29, P2200
   Bauss F, 2004, OSTEOPOROSIS INT, V15, P423, DOI 10.1007/s00198-004-1612-7
   CHESTER TL, 1981, J CHROMATOGR, V225, P17, DOI 10.1016/S0378-4347(00)80239-X
   DREUX M, 1996, LC GC EUR, P138
   Hu M Y, 2000, Se Pu, V18, P254
   KLINE WF, 1990, J CHROMATOGR-BIOMED, V534, P139, DOI 10.1016/S0378-4347(00)82156-8
   KLINE WF, 1996, J CHROMATOGR B, V678, P325
   Lovdahl MJ, 1999, J CHROMATOGR A, V850, P143, DOI 10.1016/S0021-9673(99)00622-6
   Peng SX, 2001, J CHROMATOGR A, V914, P105, DOI 10.1016/S0021-9673(00)01118-3
   QIN XZ, 1984, J CHROMATOGR A, V686, P205
   QUITASOL J, 1994, J CHROMATOGR A, V671, P273, DOI 10.1016/0021-9673(94)80250-5
   Sparidans RW, 1997, J PHARMACEUT BIOMED, V16, P491, DOI 10.1016/S0731-7085(97)00090-3
   Sparidans RW, 1995, J PHARMACEUT BIOMED, V13, P1545, DOI 10.1016/0731-7085(95)01572-8
   TASI EW, 1982, J CHROMATOGR, V596, P217
   TSAI EW, 1992, J CHROMATOGR, V596, P217, DOI 10.1016/0021-9673(92)85010-Q
   USUI T, 1994, J CHROMATOGR B, V652, P67, DOI 10.1016/0378-4347(93)E0397-9
   USUI T, 1992, J CHROMATOGR-BIOMED, V584, P213, DOI 10.1016/0378-4347(92)80578-E
NR 17
TC 3
Z9 3
U1 2
U2 12
PU JAPAN SOC ANALYTICAL CHEMISTRY
PI TOKYO
PA 26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN
SN 0910-6340
EI 1348-2246
J9 ANAL SCI
JI Anal. Sci.
PD MAR
PY 2010
VL 26
IS 3
BP 325
EP 329
DI 10.2116/analsci.26.325
PG 5
WC Chemistry, Analytical
SC Chemistry
GA 575GX
UT WOS:000276056200007
PM 20215681
OA Bronze
DA 2018-12-27
ER

PT J
AU Kou, SB
   Xu, G
   Jiang, XD
   Xu, RX
   Tang, YP
   Xu, G
   Cai, YQ
   Du, MX
   Xiao, ZC
AF Kou, Sheng-Bin
   Xu, Gang
   Jiang, Xiao-Dan
   Xu, Ru-Xiang
   Tang, Yan-Ping
   Xu, Gang
   Cai, Ying-Qian
   Du, Mou-Xuan
   Xiao, Zhi-Cheng
TI RETRACTED: Therapeutic DNA Vaccination as a Repair Strategy Following
   Spinal Cord Injury (Retracted Article. See vol 30, pg 977, 2010)
SO CELLULAR AND MOLECULAR NEUROBIOLOGY
LA English
DT Article; Retracted Publication
DE DNA vaccine; Spinal cord injury; Axonal regeneration; Myelin-associated
   protein (MAG); Tenascin-R (TN-R); Oligodendrocyte-myelin glycoprotein
   (OMgp); Nogo-A
ID MYELIN-ASSOCIATED GLYCOPROTEIN; NEURITE OUTGROWTH; NOGO-A; AXON
   REGENERATION; AUTOIMMUNE ENCEPHALOMYELITIS; INHIBITOR; RECOMBINANT;
   RATS; IDENTIFICATION; RECOVERY
AB Myelin-derived proteins, such as tenascin-R (TN-R), myelin associate glycoprotein (MAG), oligodendrocyte-myelin glycoprotein (OMgp), and Nogo-A, inhibit the central nervous system regeneration. In this study, the DNA vaccine encoding for oligodendrocyte and myelin-related antigens was employed to attenuate the axonal growth inhibitory properties of myelin in the setting of spinal cord injury. Using a rat spinal cord dorsal hemisection model, the vaccine directed against the inhibitory epitopes of Nogo-A, MAG, OMgp, and TN-R was administered intramuscularly once a week following spinal cord injury, supplemented with local application of specific anti-sera against the four antigens. Anterograde labeling of dorsal column fibers showed active axonal regeneration through the lesion site at the eighth week following the treatment in experimental group but not in control groups. Light microscopic and ultrastructural analysis revealed that vaccination with these myelin-related antigens did not lead to demyelinating disease. OMgp and TN-R levels were down-regulated at the lesion site together with a parallel increase in growth-associated protein 43 levels in the treatment groups. This study reveals the effective approach of a DNA vaccine strategy by attaining the special antibody to direct neutralization of the myelin inhibitors during spinal cord injury.
C1 [Kou, Sheng-Bin; Jiang, Xiao-Dan; Xu, Ru-Xiang; Tang, Yan-Ping; Cai, Ying-Qian; Du, Mou-Xuan; Xiao, Zhi-Cheng] So Med Univ, Neurosurg Inst Guangdong, Key Lab Brain Funct Repair & Regenerat Guangdong, Zhujiang Hosp,Dept Neurosurg, Guangzhou 510282, Guangdong, Peoples R China.
   [Xu, Gang; Xiao, Zhi-Cheng] Kunming Med Coll, Inst Mol & Clin Med, Kunming, Peoples R China.
   [Xu, Gang; Xiao, Zhi-Cheng] GlaxoSmithKline, R&D China, Shanghai, Peoples R China.
   [Xu, Ru-Xiang] Beijing PLA, Mil Gen Hosp, Dept Neurosurg, Beijing 100700, Peoples R China.
   [Xu, Gang] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Neurosurg, Xian 710049, Peoples R China.
RP Jiang, XD (reprint author), So Med Univ, Neurosurg Inst Guangdong, Key Lab Brain Funct Repair & Regenerat Guangdong, Zhujiang Hosp,Dept Neurosurg, 253 Gongye Rd, Guangzhou 510282, Guangdong, Peoples R China.
EM jiangxiao_dan@163.com; ZHICHENG.Z.XIAO@GSK.COM
RI xiao, zhicheng/A-1529-2011
FU Foundation for Key Sci-Tech Research Projects of Guangdong
   [2008A030201019, 2007-05/06-7005206]; Guangzhou [09B52120112,
   2008A1-E4011-6]; Natural Science Foundation of China [U0632008]
FX This work was supported by grants from the Foundation for Key Sci-Tech
   Research Projects of Guangdong ( No. 2008A030201019, 2007-05/06-7005206)
   and Guangzhou ( No. 09B52120112, 2008A1-E4011-6) to Prof. Xiaodan Jiang;
   Talent Program Yunnan, China to Dr. Zhicheng Xiao; and Natural Science
   Foundation of China ( No. U0632008) to Prof. Ruxiang Xu.
CR Ahn M, 2001, NEUROSCI LETT, V308, P41, DOI 10.1016/S0304-3940(01)01979-6
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   Bourquin C, 2008, EUR J PHARMACOL, V588, P99, DOI 10.1016/j.ejphar.2008.04.026
   Brosamle C, 2000, J NEUROSCI, V20, P8061
   Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219
   DU M, 2009, CHIN J NEURO MED, V8, P109
   Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436
   Goverman J, 1997, CRIT REV IMMUNOL, V17, P469
   GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226
   Herzog A, 1997, J NEUROSCI METH, V72, P57, DOI 10.1016/S0165-0270(96)00156-2
   Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6
   Jensen MB, 1997, EXP NEUROL, V143, P103, DOI 10.1006/exnr.1996.6337
   Kottis V, 2002, J NEUROCHEM, V82, P1566, DOI 10.1046/j.1471-4159.2002.01146.x
   Liao H, 2004, J NEUROCHEM, V90, P1156, DOI 10.1111/j.1471-4159.2004.02573.x
   Marusic S, 1997, J EXP MED, V186, P507, DOI 10.1084/jem.186.4.507
   MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X
   Merkler D, 2001, J NEUROSCI, V21, P3665, DOI 10.1523/JNEUROSCI.21-10-03665.2001
   MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6
   Nie DY, 2003, EMBO J, V22, P5666, DOI 10.1093/emboj/cdg570
   Okuda T, 2004, MOL CELL BIOL, V24, P3949, DOI 10.1128/MCB.24.9.3949-3956.2004
   Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196
   Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287
   Quarles RH, 2007, J NEUROCHEM, V100, P1431, DOI 10.1111/j.1471-4159.2006.04319.x
   Ruff RL, 2008, ANN NY ACAD SCI, V1142, P1, DOI 10.1196/annals.1444.004
   Sicotte M, 2003, MOL CELL NEUROSCI, V23, P251, DOI 10.1016/S1044-7431(03)00053-8
   Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867
   WEINER HL, 1994, ANNU REV IMMUNOL, V12, P809, DOI 10.1146/annurev.iy.12.040194.004113
   Xiao ZC, 1996, EUR J NEUROSCI, V8, P766, DOI 10.1111/j.1460-9568.1996.tb01262.x
   Xie F, 2008, EXP NEUROL, V209, P302, DOI 10.1016/j.expneurol.2007.07.005
   Xu G, 2004, J NEUROCHEM, V91, P1018, DOI 10.1111/j.1471-4159.2004.02803.x
NR 30
TC 1
Z9 3
U1 4
U2 15
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0272-4340
EI 1573-6830
J9 CELL MOL NEUROBIOL
JI Cell. Mol. Neurobiol.
PD MAR
PY 2010
VL 30
IS 2
BP 275
EP 282
DI 10.1007/s10571-009-9449-4
PG 8
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA 570UW
UT WOS:000275704800011
PM 19757023
DA 2018-12-27
ER

PT J
AU Marrouchi, M
AF Marrouchi, Mustapha
TI RETRACTED: A Passion for Excess or Just Another Way of Telling
   (Retracted article. See vol. 42, pg. 536, 2015)
SO COLLEGE LITERATURE
LA English
DT Article; Retracted Publication
AB Caryl Phillips's narrative is painfully concerned with the relationship of Empire, Colony, and the In-between; Europe, Africa, and the Caribbean; slavery, rebellion, and freedom; Men, women and children; absent or useless fathers and damaged, aimless sons. It explores what hold in common while never losing sight of the painful quotidian, the specific. It is a narrative where the picaresque shakes hands with the epic and the linearity is broken, encircled, and put fast forward or in reverse by a mise-en-abime of sorts: the tale-within-the-tale-within-the-tale even if interrupted by the tapestry of an emergent voice that finally proposes itself as both the identity and the difference of its verbal universe. "Enter your own self and discover the world," Phillips seems to be saying, "but also go out into the world and discover yourself." Once that call is answered, fiction itself becomes another way of questioning truth as we strive for it through the paradox of a lie. That lie can be called the imagination. It can also be seen as a parallel reality. For it may be observed as a critical mirror of what passes for the truth in the world of convention. It certainly sets up a second universe of being, where the narrator, say Cambridge in Cambridge, has a reality greater, though no less important, than the host of hastily met and then forgotten people we deal with on a daily basis. It is in this sense that Phillips brings into light another way of telling in that his narrative gives weight and presence to the virtues and vices the fugitive personalities of our daily acquaintance. This is the prerogative of his style, which I try to discuss in this essay. It has the power to render disenchantment and pleasure without resolving the contradiction between them. In fact, what holds them in tension, as equal forces straining in opposite directions, is the artist's mature subjectivity, stripped of hubris, unashamed either of its fallibility or of the modest assurance it has gained as a result of being out of place and not quite right.
C1 UNLV, Las Vegas, NV USA.
RP Marrouchi, M (reprint author), UNLV, Las Vegas, NV USA.
CR ALLISON RJ, 1995, INTERESTING LIFE O E
   Anderson David, 2005, HIST HANGED DIRTY WA
   ANDERSON J, 2005, BRITAIN YESTERDAY TO
   ANTHONY I, 1995, WASAFIRI, V22, P2
   ARNOLD B, 2005, SCANDAL ULYSSES LIFE
   ASKOLOVITCH C, 2005, NOUVEL OBSERVAT 1208
   Baldwin J., 1964, NOTES NATIVE SON
   BALDWIN J, 1982, PRICE TICKET COLLECT
   Baldwin J., 1955, NOTES NATIVE SON
   Baldwin James, 1998, COLLECTED ESSAYS
   BERENDT JE, 2005, JAZZ LIFE
   Bewes T, 2006, CULT CRIT, P33
   BHABHA HK, 1998, ARTFORUM         MAY, P21
   BIONDI JP, 1996, ANTICOLONIALISTES 18
   BOUSSON JB, 2006, JAMAICA KINCAID
   BUGG J, 2006, PMLA             OCT, P1424
   BULMER M, 1986, KEY VARIABLES SOCIOL
   CAMBELL J, 1991, LRB             0711, P20
   Casanova P, 1999, REPUBLIQUE MONDIALE
   Casanova Pascale, 2004, WORLD REPUBLIC LETT
   CESAIRE A, 2006, MONDE           0306, P5
   CHAMOISEAU P, 2000, TEXACO
   CHEYETTE B, 2000, READING NEW LIT POST
   COMTE G, 2006, MONDE DOSSIERS D OCT, P2
   Cooper R., 2002, REORDERING WORLD
   CUDJOE W, 1990, CARIBBEAN WOMEN WRIT
   DABYDEEN D, 2005, INTENDED
   DABYDEEN D, 2002, NEW SELECTED POEMS
   Davis David Brion, 2006, INHUMAN BONDAGE RISE
   Deleuze Gilles, 1986, KAFKA MINOR LIT
   DERRIDA J, 2005, IDIOMES NATL DECONST
   DERRIDA JACQUES, 2005, PARDONNER IMPARDONNA
   Dirks N., 2006, SCANDAL EMPIRE INDIA
   DIRLIK A, 1999, POSTCOLONIAL AURA 3
   ETEMAD B, 2001, ALTERNATIVES EC  MAI, P45
   Fanon F, 1967, BLACK SKIN WHITE MAS
   FANON F, 2006, ECRITS COLONIALISME
   FANON F., 2004, WRETCHED EARTH
   Ferguson N., 2004, EMPIRE RISE DEMISE B
   FORD J, 2004, NEW PERSPECTIVES CAR
   Friedland Roger, 1990, MARKETPLACE RETHINKI
   GARIS L, 1990, NY TIMES BOOK R 1007, P39
   GATES LH, 1993, T MORRISON CRITICAL
   GILMAN L, 1998, PMLA             JAN, P19
   Gilroy Paul, 1993, BLACK ATLANTIC MODER
   Glissant E, 1990, POETIQUE RELATION
   GREENBLATT S, 1989, SHAKESPEARIAN NEGOCI
   Greenblatt S., 1992, MARVELOUS POSSESSION
   Greenblatt S., 1990, LEARNING CURSE ESSAY
   Grimshaw A., 1992, CLR JAMES READER
   HOMER, 1999, ODYSSEY BOOK 5
   James C. L. R., 1963, BLACK JACOBINS TOUSS
   James C. L. R., 1993, BOUNDARY
   JAMES CLR, 1970, HIST NEGRO REVOLT
   Kincaid Jamaica, 2005, BEST AM TRAVEL WRITI, pxiii
   LEDENT B, 1992, C PHILLIPS
   LEWIS R, 2006, ENDS BRIT IMPERIALIS
   Lubiano Wahneema, 1998, HOUSE RACE BUILT
   MacMaster Neil, 1997, COLONIAL MIGRANTS RA
   MINHA TT, 1999, OUT THERE MARGINALIZ
   MORRISON T, 1983, BLACK WOMEN WRITERS
   Morrison Toni, 1987, BELOVED
   NAIPAUL VS, 1991, READING WRITING PERS
   NAIPAUL VS, 1991, OUR UNIVERSAL CIVILI
   Owusu Kwesi, 2000, BLACK BRIT CULTURE S
   Phillips C., 1991, CAMBRIDGE
   PHILLIPS C, 1985, WASTED YEARS
   PHILLIPS C, 2000, NOVELISTS WORK
   PHILLIPS C, 1987, EUROPEAN TRIBE
   PHILLIPS C, 2005, DANCING DARK
   PHILLIPS C, 2003, GUARDIAN        0222, P3
   Phillips C., 1989, HIGHER GROUND
   PHILLIPS C, 1999, KUNAPIPI, V21, P106
   PHILLIPS C, 1997, NATURE BLOOD
   Phillips Caryl, 1998, COMMONQUEST, V3, P4
   Pratt Mary Louise, 1992, IMPERIAL EYES STUDIE
   Said Edward, 2006, LATE STYLE
   Said Edward., 2004, HUMANISM DEMOCRATIC
   SELVON S, 1989, LONELY LONDONERS
   SUTCLIFFE D, 1992, SYSTEM BLACK LANGUAG
   SUTCLIFFE D, 1997, SLAVE TRADE HIST ATL
   THOMAS H, 2005, RIVERS BLOOD RISE SP
   Walvin James, 1997, FRUITS EMPIRE EXOTIC
   Werbner Richard, 2002, POSTCOLONIAL SUBJECT
   Williams P. J., 1997, SEEING COLOUR BLIND
   WINCHESTER S, 2004, OUTPOSTS JOURNEYS SU
   Young R., 1990, WHITE MYTHOLOGIES WR
   Young Robert J. C., 1995, COLONIAL DESIRE HYBR
   ZUKERMAN M, 1988, COLONIAL IDENTITY AT
   1991, KUNAPIPI, V13, P96
   1994, WASAFIRI, V20, P25
   2002, NEGOTIATED EMPIRES C
NR 92
TC 1
Z9 1
U1 2
U2 4
PU WEST CHESTER UNIV
PI W CHESTER
PA SPECIAL FUNDS OFFICE, W CHESTER, PA 19383 USA
SN 0093-3139
EI 1542-4286
J9 COLL LITERATURE
JI Coll. Lit.
PD SPR
PY 2010
VL 37
IS 2
BP 48
EP +
PG 31
WC Literature
SC Literature
GA 587TT
UT WOS:000277016600003
DA 2018-12-27
ER

PT J
AU Tohidian, I
   Tabatabaie, SMM
AF Tohidian, Iman
   Tabatabaie, Seyed Mahmoud Mir
TI RETRACTED: Considering the Relationship Between Language, Culture and
   Cognition to Scrutinize the Lexical Influences on Cognition (Retracted
   article. See vol. 31, pg. 335, 2012)
SO CURRENT PSYCHOLOGY
LA English
DT Article; Retracted Publication
DE Lexical influences; Cognition; Language; Culture; Whorf hypothesis;
   Codability; Color terms; Object terms; Spatial terms
ID SAPIR-WHORF HYPOTHESIS; MATHEMATICS ACHIEVEMENT; COLOR CATEGORIES;
   ENGLISH; NUMBER; REPRESENTATION; UNIVERSALS; JAPANESE; CHINESE; THOUGHT
AB In this paper, we examine the interrelationships among language, culture, and cognition. The central notion that individuals with different linguistic and cultural backgrounds think differently is not far from our everyday experience. If you have had the opportunity to engage in a conversation with a person whose native language is not English, you may have found that communication breaks down at times and that some concepts are not easily translated into another language. Or if you happen to be a fluent bilingual or multilingual, you may agree with those bilinguals or multilinguals who mention that they think differently in each of their language. A number of intriguing questions arise here. Is there a particular style of thinking that is natural for speakers of each language? If so, is it possible for a person to think in a different way, one that is not natural for that individual? Is this style of thinking imparted by the language, the culture, or both? These and lots of other questions have engaged the attention of anthropologists, linguists and psychologists, but the point that we are going to explore is the lexical influences on cognition considering the relationship between language, culture and cognition.
C1 [Tohidian, Iman; Tabatabaie, Seyed Mahmoud Mir] Iran Univ Sci & Technol, Dept Foreign Languages, Tehran, Iran.
RP Tohidian, I (reprint author), Iran Univ Sci & Technol, Dept Foreign Languages, Tehran, Iran.
EM tohid_483@yahoo.com; mtabatabaie@iust.ac.ir
CR Agar M, 1994, LANGUAGE SHOCK UNDER
   BAGHRAMIAN M, 2004, RELATIVISM
   Berlin Brent, 1969, BASIC COLOR TERMS TH
   Boroditsky L, 2001, COGNITIVE PSYCHOL, V43, P1, DOI 10.1006/cogp.2001.0748
   BOWERMAN M, 1996, LANGUAGE SPACE, P385
   BROWN R, 1958, WORDS THINGS
   BROWN RW, 1954, J ABNORM SOC PSYCH, V49, P454, DOI 10.1037/h0057814
   CARROLL JB, 1956, LANGUAGE THOUGHT REA
   Choi S, 1999, COGNITIVE DEV, V14, P241, DOI 10.1016/S0885-2014(99)00004-0
   CHOI S, 1991, COGNITION, V41, P83, DOI 10.1016/0010-0277(91)90033-Z
   Choi S, 2001, LANG ACQUIS, P475, DOI DOI 10.1017/CBO9780511620669.018
   CLANCY PM, 1985, CROSSLINGUISTIC STUD, V1, P373
   Clark H., 1973, COGNITIVE DEV ACQUIS, P27, DOI DOI 10.1016/B978-0-12-505850-6.50008-6
   Clark H.H, 1977, PSYCHOL LANGUAGE INT
   Crystal D., 1997, ENGLISH GLOBAL LANGU
   Devitt M, 1999, LANGUAGE REALITY INT
   ELLIS NC, 1980, BRIT J PSYCHOL, V71, P43, DOI 10.1111/j.2044-8295.1980.tb02728.x
   Feist M.I., 2001, P 23 ANN C COGN SCI, P279
   FOX T, 2001, H KANG J TEFL, V7, P137
   Fuson KC, 1997, J RES MATH EDUC, V28, P738, DOI 10.2307/749640
   GOLINKOFF RM, 1987, J CHILD LANG, V14, P23, DOI 10.1017/S030500090001271X
   Gopnik A, 1996, COGNITIVE DEV, V11, P197, DOI 10.1016/S0885-2014(96)90003-9
   Gopnik A., 1995, NAMES THINGS YOUNG C, P63
   Gopnik A., 1990, FIRST LANG, V10, P199, DOI DOI 10.1177/014272379001003002
   Gopnik A, 2001, LANG ACQUIS, P45
   HEIDER ER, 1972, J EXP PSYCHOL, V93, P10, DOI 10.1037/h0032606
   Hespos SJ, 2004, NATURE, V430, P453, DOI 10.1038/nature02634
   Hockett C. F, 1954, LANGUAGE CULTURE, P106
   Holmes J., 2001, INTRO SOCIOLINGUISTI
   HOOSAIN R, 1987, PSYCHOLOGIA, V30, P34
   HOOSAIN R, 1986, INT J BEHAV DEV, V9, P507, DOI 10.1177/016502548600900407
   Hurford J.R., 1987, LANGUAGE NUMBER
   Kay P, 2003, P NATL ACAD SCI USA, V100, P9085, DOI 10.1073/pnas.1532837100
   Kay P, 2006, TRENDS COGN SCI, V10, P51, DOI 10.1016/j.tics.2005.12.007
   KAY P, 1984, AM ANTHROPOL, V86, P65, DOI 10.1525/aa.1984.86.1.02a00050
   KELLER CM, 1996, RETHINKING LINGUISTI, P115
   LENNEBERG EH, 1953, LANGUAGE, V29, P463, DOI DOI 10.2307/409956
   Levinson S. C, 1996, LANGUAGE SPACE, P109
   Levinson S. C., 2001, LANG ACQUIS, P566
   Levinson Stephen C., 2003, SPACE LANGUAGE COGNI
   Lucy J., 1992, GRAMMATICAL CATEGORI
   Lucy J.A., 1992, LANGUAGE DIVERSITY T
   LUCY JA, 1979, AM ANTHROPOL, V81, P581, DOI 10.1525/aa.1979.81.3.02a00040
   MARTIN L, 1986, AM ANTHROPOL, V88, P418, DOI 10.1525/aa.1986.88.2.02a00080
   MILLER KF, 1995, PSYCHOL SCI, V6, P56, DOI 10.1111/j.1467-9280.1995.tb00305.x
   MIURA IT, 1988, CHILD DEV, V59, P1445, DOI 10.2307/1130659
   MIURA IT, 1989, J EDUC PSYCHOL, V81, P109, DOI 10.1037/0022-0663.81.1.109
   MIURA IT, 1987, J EDUC PSYCHOL, V79, P79
   Pederson E, 1998, LANGUAGE, V74, P557, DOI 10.2307/417793
   Piaget J., 1952, ORIGINS INTELLIGENCE
   Pullum G.K., 1991, GREAT ESKIMO VOCABUL
   Roberson D, 2005, COGNITIVE PSYCHOL, V50, P378, DOI 10.1016/j.cogpsych.2004.10.001
   Roberson D, 2000, J EXP PSYCHOL GEN, V129, P369, DOI 10.1037//0096-3445.129.3.369
   Rosch E. H., 1973, COGNITIVE DEV ACQUIS, P111
   SCHWANENFLUGEL PJ, 1991, PSYCHOLOGY OF WORD MEANINGS, P71
   Slobin DI, 1996, RETHINKING LINGUISTI, P70, DOI DOI 10.1016/S0378-2166(97)83851-9
   STEVENSON HW, 1986, SCIENCE, V231, P693, DOI 10.1126/science.3945803
   Varley RA, 2005, P NATL ACAD SCI USA, V102, P3519, DOI 10.1073/pnas.0407470102
   Whorf Benjamin Lee, 1956, LANGUAGE THOUGHT REA
   WHORF BL, 1956, LANGUAGE THOUGHT REA, P208
   Zipf George Kingsley, 1935, PSYCHOBIOLOGY LANGUA
NR 61
TC 3
Z9 3
U1 4
U2 30
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1046-1310
EI 1936-4733
J9 CURR PSYCHOL
JI Curr. Psychol.
PD MAR
PY 2010
VL 29
IS 1
BP 52
EP 70
DI 10.1007/s12144-010-9072-z
PG 19
WC Psychology, Multidisciplinary
SC Psychology
GA 555FX
UT WOS:000274495000006
DA 2018-12-27
ER

PT J
AU Sahoo, PK
   Behera, P
AF Sahoo, Prasanta Kumar
   Behera, Pritishova
TI RETRACTED: Synthesis and biological evaluation of [1,2,4]triazino[4,3-a]
   benzimidazole acetic acid derivatives as selective aldose reductase
   inhibitors (Retracted article. See vol. 46, pg. 5225, 2011)
SO EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article; Retracted Publication
DE Benzimidazole; Aldose reductase; Acetic acid derivative; ALR1; ALR2
ID GLUTATHIONE-REDUCTASE; RABBIT CORNEA; IN-VITRO; POTENT; COMPLICATIONS;
   PERMEABILITY; PREVENTION; TOLRESTAT; CATARACT; SORBINIL
AB The acetic acid derivatives of [1,2,4]triazino[4,3-a]benzimidazole (TBI) were synthesized and tested in vitro and in vivo as selective aldose reductase (ALR2) inhibitors. Compound PS11 showed highest inhibitory activity (IC50) 0.32 mu M and was found to be effective in preventing cataract development in severely galactosemic rats when administered as an eyedrop solution. All the compounds investigated were selective for ALR2, since none of them inhibited appreciably aldehyde reductase, sorbitol dehydrogenase, or glutathione reductase. (C) 2009 Elsevier Masson SAS. All rights reserved.
C1 [Sahoo, Prasanta Kumar] Sri Vasavi Inst Pharmaceut Sci, Tadepalligudem 534101, Andhra Pradesh, India.
   [Behera, Pritishova] KGRL Coll Pharm, Bhimabharam, Andhra Pradesh, India.
RP Sahoo, PK (reprint author), Sri Vasavi Inst Pharmaceut Sci, Tadepalligudem 534101, Andhra Pradesh, India.
EM psahoo.phar@gmail.com
CR AMMON HPT, 1996, ADV DRUG RES, V27, P171
   BADR MZA, 1988, CHEM SOC JPN, V61, P1339
   Banditelli S, 1999, EXP EYE RES, V69, P533, DOI 10.1006/exer.1999.0729
   BEDNYAGINA NP, 1960, ZH OBSHCH KHIM+, V30, P1431
   CAMBER O, 1987, INT J PHARM, V37, P27, DOI 10.1016/0378-5173(87)90006-8
   CAROTI P, 1989, FARMACO, V44, P227
   CARPER DA, 1989, EXP EYE RES, V49, P377, DOI 10.1016/0014-4835(89)90048-1
   Chien DS, 1997, J PHARM SCI, V86, P1180, DOI 10.1021/js950373b
   Costantino L, 1999, MED RES REV, V19, P3, DOI 10.1002/(SICI)1098-1128(199901)19:1<3::AID-MED2>3.0.CO;2-7
   Costantino L, 1996, J MED CHEM, V39, P4396, DOI 10.1021/jm960124f
   Da Settimo F, 2001, J MED CHEM, V44, P316, DOI 10.1021/jm001054m
   deParrodi CA, 1996, SYNTHETIC COMMUN, V26, P3323, DOI 10.1080/00397919608004642
   DERUITER J, 1987, J PHARM SCI, V76, P149, DOI 10.1002/jps.2600760213
   FITZGERALD GB, 1991, BIOCHEM PHARMACOL, V41, P185, DOI 10.1016/0006-2952(91)90475-K
   GIBLIN FJ, 1987, EXP EYE RES, V45, P77, DOI 10.1016/S0014-4835(87)80080-5
   HARRISON DH, 1994, BIOCHEMISTRY-US, V33, P2011, DOI 10.1021/bi00174a006
   Harrison DHT, 1997, BIOCHEMISTRY-US, V36, P16134, DOI 10.1021/bi9717136
   HAYMAN S, 1965, J BIOL CHEM, V240, P877
   HOCKWIN O, 1989, OPHTHALMIC RES, V21, P285, DOI 10.1159/000266871
   HU TS, 1984, INVEST OPHTH VIS SCI, V25, P603
   IEMURA R, 1986, J MED CHEM, V29, P1178, DOI 10.1021/jm00157a010
   KADOR PF, 1988, MED RES REV, V8, P325, DOI 10.1002/med.2610080302
   LINDSTAD RI, 1994, EUR J BIOCHEM, V221, P847, DOI 10.1111/j.1432-1033.1994.tb18799.x
   MASSON EA, 1990, DRUGS, V39, P190, DOI 10.2165/00003495-199039020-00003
   MAYFIELD CA, 1987, J MED CHEM, V30, P1595, DOI 10.1021/jm00392a012
   MULLER P, 1985, OPHTHALMIC RES, V17, P115
   Primofiore G, 2000, J MED CHEM, V43, P96, DOI 10.1021/jm991131h
   REDDAN JR, 1988, EXP EYE RES, V46, P209, DOI 10.1016/S0014-4835(88)80078-2
   Sarges R, 1993, Prog Drug Res, V40, P99
   SESTANJ K, 1984, J MED CHEM, V27, P255, DOI 10.1021/jm00369a003
   Sharma R, 2008, INDIAN J CHEM B, V47, P957
   SUHONEN P, 1991, INT J PHARM, V74, P221, DOI 10.1016/0378-5173(91)90241-F
   TACCONI G, 1973, J PRAKT CHEM, V315, P339, DOI 10.1002/prac.19733150221
   TOMLISON DR, 1994, TRENDS PHARM SCI, V293
   Urzhumtsev A, 1997, STRUCTURE, V5, P601, DOI 10.1016/S0969-2126(97)00216-5
   WARD WHJ, 1990, BIOCHEM PHARMACOL, V39, P337, DOI 10.1016/0006-2952(90)90033-H
   WILSON DK, 1993, P NATL ACAD SCI USA, V90, P9847, DOI 10.1073/pnas.90.21.9847
NR 37
TC 11
Z9 14
U1 5
U2 19
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0223-5234
EI 1768-3254
J9 EUR J MED CHEM
JI Eur. J. Med. Chem.
PD MAR
PY 2010
VL 45
IS 3
BP 909
EP 914
DI 10.1016/j.ejmech.2009.11.031
PG 6
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 566WT
UT WOS:000275404900008
PM 19962793
DA 2018-12-27
ER

PT J
AU Portin, P
AF Portin, Petter
TI RETRACTED: The effect of the mus309 mutation, defective in DNA
   double-strand break repair, on crossing over in Drosophila melanogaster
   suggests a mechanism for the centromere effect of crossing over
   (Retracted Article. See vol 138, pg 1307, 2010)
SO GENETICA
LA English
DT Article; Retracted Publication
DE Centromere effect; Crossing-over; Crossover interference; Meiosis
ID SYNDROME GENE-PRODUCT; MEIOTIC RECOMBINATION; X-CHROMOSOME; BLM
   HELICASE; MUTANTS; INTERFERENCE; INITIATION; RESOLUTION; MEIOSIS
AB The mus309 gene in Drosophila melanogaster encodes a RecQ helicase which is involved in DNA double-strand break (DSB) repair. In a brood pattern analysis, it was observed that in mus309 mutant females, the frequency of single crossovers in the central cv-v interval of the X chromosome was reduced in young females but returned to the level of the wild type control as the females aged. In the proximal v-f interval, the frequency of single crossovers was increased during the entire experimental period. In particular, it was observed that the frequency of double crossovers, as well as the coefficient of coincidence first increased but then gradually decreased, finally reaching the level of the control flies, as the females aged. Map distances increased due to the mus309 mutation in both gene interval studies, but they did not change as the females aged, a result suggesting that the mus309 gene controls the distribution of DSBs to be repaired as crossovers instead of non-crossovers. The results suggest a mechanism for the centromere effect of crossing over in Drosophila, viz the fact the frequency of meiotic crossing over reduces with the age of the female, and that the reduction is more pronounced the closer the interval is to the proximal heterochromatin of the chromosome arm. According to the model suggested, the centromere effect is simply a matter of the balance between different pathways of the repair of the DSBs of DNA.
C1 Univ Turku, Genet Lab, Dept Biol, Turku 20014, Finland.
RP Portin, P (reprint author), Univ Turku, Genet Lab, Dept Biol, Turku 20014, Finland.
EM petter.portin@utu.fi
CR Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198
   Baker B. S., 1976, GENETICS BIOL DROS B, V1, P351
   BAKER BS, 1972, GENETICS, V71, P255
   Beadle GW, 1932, P NATL ACAD SCI USA, V18, P160, DOI 10.1073/pnas.18.2.160
   Beall EL, 1996, GENE DEV, V10, P921, DOI 10.1101/gad.10.8.921
   BOYD JB, 1981, GENETICS, V97, P607
   BOYD JB, 1987, J CELL SCI, P39
   Bridges CB, 1915, J EXP ZOOL, V19, P1, DOI 10.1002/jez.1400190102
   Bridges CB, 1927, J GEN PHYSIOL, V8, P689, DOI 10.1085/jgp.8.6.689
   ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1
   GRELL RF, 1973, GENETICS, V73, P87
   Heyer WD, 2003, TRENDS BIOCHEM SCI, V28, P548, DOI 10.1016/j.tibs.2003.08.011
   Heyer WD, 2004, CURR BIOL, V14, pR56, DOI 10.1016/j.cub.2003.12.043
   Hillers KJ, 2004, CURR BIOL, V14, pR1036, DOI 10.1016/j.cub.2004.11.038
   Johnson-Schlitz D, 2006, P NATL ACAD SCI USA, V103, P16840, DOI 10.1073/pnas.0607904103
   Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611
   Keeney S, 2006, BIOCHEM SOC T, V34, P523, DOI 10.1042/BST0340523
   Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6
   Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0
   Kusano K, 2001, SCIENCE, V291, P2600, DOI 10.1126/science.291.5513.2600
   LAKE S, 1984, HEREDITAS, V100, P121, DOI 10.1111/j.1601-5223.1984.tb00113.x
   Laurencon A, 2004, GENETICS, V167, P217, DOI 10.1534/genetics.167.1.217
   Lorenz A, 2006, BIOCHEM SOC T, V34, P537, DOI 10.1042/BST0340537
   LUNING KG, 1983, HEREDITAS, V99, P57, DOI 10.1111/j.1601-5223.1983.tb00732.x
   Mather K, 1939, GENETICS, V24, P413
   Mcvey M, 2007, GENETICS, V176, P1979, DOI 10.1534/genetics.106.070052
   Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843
   Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534
   OLSENKROGH B, 2004, ANNU REV GENET, V38, P233
   Portin P, 2005, GENET RES, V86, P185, DOI 10.1017/S0016672305007883
   Portin P, 2008, GENET RES, V90, P297, DOI 10.1017/S0016672308009397
   Rockmill B, 2003, CURR BIOL, V13, P1954, DOI 10.1016/j.cub.2003.10.059
   SANDLER L, 1968, GENETICS, V60, P525
   Stevens WL, 1936, J GENET, V32, P51, DOI 10.1007/BF02982501
   Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906
   van Brabant AJ, 2000, ANNU REV GENOM HUM G, V1, P409, DOI 10.1146/annurev.genom.1.1.409
   Weinert BT, 2007, NUCLEIC ACIDS RES, V35, P1367, DOI 10.1093/nar/gkl831
   Weinstein A, 1936, GENETICS, V21, P155
   Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200
NR 39
TC 2
Z9 2
U1 2
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0016-6707
EI 1573-6857
J9 GENETICA
JI Genetica
PD MAR
PY 2010
VL 138
IS 3
BP 333
EP 342
DI 10.1007/s10709-009-9422-7
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA 549XL
UT WOS:000274087700006
PM 19882364
DA 2018-12-27
ER

PT J
AU Herzschuh, U
   Birks, HJB
   Liu, XQ
   Kubatzki, C
   Lohmann, G
AF Herzschuh, Ulrike
   Birks, H. John B.
   Liu, Xingqi
   Kubatzki, Claudia
   Lohmann, Gerrit
TI RETRACTED: What caused the mid-Holocene forest decline on the eastern
   Tibet-Qinghai Plateau? (Retracted article. See vol. 20, pg. 366, 2011)
SO GLOBAL ECOLOGY AND BIOGEOGRAPHY
LA English
DT Article; Retracted Publication
DE Climate change; forest decline; general circulation models; Holocene;
   human activity; oxygen isotopes; pollen; transfer functions;
   Tibet-Qinghai Plateau; vegetation
ID OXYGEN-ISOTOPE RECORD; LAST 18,000 YEARS; SOUTHERN TIBET; LAKE QINGHAI;
   STABLE-ISOTOPES; PALEOENVIRONMENTAL IMPLICATIONS; NIANBAOYEZE MOUNTAINS;
   ENVIRONMENTAL-CHANGES; HOLOCENE VEGETATION; MOISTURE EVOLUTION
AB Aim
   Atmospheric CO(2) concentrations depend, in part, on the amount of biomass locked up in terrestrial vegetation. Information on the causes of a broad-scale vegetation transition and associated loss of biomass is thus of critical interest for understanding global palaeoclimatic changes. Pollen records from the north-eastern Tibet-Qinghai Plateau reveal a dramatic and extensive forest decline beginning c. 6000 cal. yr bp. The aim of this study is to elucidate the causes of this regional-scale change from high-biomass forest to low-biomass steppe on the Tibet-Qinghai Plateau during the second half of the Holocene.
   Location
   Our study focuses on the north-eastern Tibet-Qinghai Plateau. Stratigraphical data used are from Qinghai Lake (3200 m a.s.l., 36 degrees 32'-37 degrees 15' N, 99 degrees 36'-100 degrees 47' E).
   Methods
   We apply a modern pollen-precipitation transfer function from the eastern and north-eastern Tibet-Qinghai Plateau to fossil pollen spectra from Qinghai Lake to reconstruct annual precipitation changes during the Holocene. The reconstructions are compared to a stable oxygen-isotope record from the same sediment core and to results from two transient climate model simulations.
   Results
   The pollen-based precipitation reconstruction covering the Holocene parallels moisture changes inferred from the stable oxygen-isotope record. Furthermore, these results are in close agreement with simulated model-based past annual precipitation changes.
   Main conclusions
   In the light of these data and the model results, we conclude that it is not necessary to attribute the broad-scale forest decline to human activity. Climate change as a result of changes in the intensity of the East Asian Summer Monsoon in the mid-Holocene is the most parsimonious explanation for the widespread forest decline on the Tibet-Qinghai Plateau. Moreover, climate feedback from a reduced forest cover accentuates increasingly drier conditions in the area, indicating complex vegetation-climate interactions during this major ecological change.
C1 [Herzschuh, Ulrike] Alfred Wegener Inst Polar & Marine Res, D-14473 Potsdam, Germany.
   [Herzschuh, Ulrike] Univ Potsdam, Dept Geosci, D-14476 Potsdam, Germany.
   [Birks, H. John B.] Univ Bergen, Dept Biol, N-5007 Bergen, Norway.
   [Birks, H. John B.] Univ Bergen, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway.
   [Birks, H. John B.] UCL, Environm Change Res Ctr, London WC1E 6BT, England.
   [Liu, Xingqi] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Nanjing 210008, Peoples R China.
   [Kubatzki, Claudia; Lohmann, Gerrit] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany.
RP Herzschuh, U (reprint author), Alfred Wegener Inst Polar & Marine Res, Telegraphenberg A43, D-14473 Potsdam, Germany.
EM Ulrike.Herzschuh@awi.de
RI Lohmann, Gerrit/M-7453-2016; Birks, H John B/C-3103-2008
OI Lohmann, Gerrit/0000-0003-2089-733X; Birks, H John
   B/0000-0002-5891-9859; Herzschuh, Ulrike/0000-0003-0999-1261
FU CLIMBER; Deutsches Klimarechenzentrum (DKRZ)
FX We thank Hilary Birks, Anne Bjune, La Duo, Hans-Wolfgang Hubberten,
   Richard Telford and two anonymous referees for discussions and Cathy
   Jenks for invaluable assistance. The modern pollen-climate dataset would
   not have been possible without the help of Steffen Mischke and Chengjun
   Zhang. We thank the CLIMBER team and the Deutsches Klimarechenzentrum
   (DKRZ) for providing the model. This is Bjerknes Centre for Climate
   Research publication A242.
CR Aldenderfer M, 2004, J WORLD PREHIST, V18, P1, DOI 10.1023/B:JOWO.0000038657.79035.9e
   Aldenderfer MS, 2007, DEV QUATER SCI, V9, P151, DOI 10.1016/S1571-0866(07)09011-2
   Birks HJB, 1998, J PALEOLIMNOL, V20, P307, DOI 10.1023/A:1008038808690
   Brantingham PJ, 2007, DEV QUATER SCI, V9, P129, DOI 10.1016/S1571-0866(07)09010-0
   Brantingham PJ, 2006, WORLD ARCHAEOL, V38, P387, DOI 10.1080/00438240600813301
   Brovkin V, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001662
   Calov R, 2005, CLIM DYNAM, V24, P545, DOI 10.1007/s00382-005-0007-6
   Chen FH, 2008, QUATERNARY SCI REV, V27, P351, DOI 10.1016/j.quascirev.2007.10.017
   Claussen M, 1999, GEOPHYS RES LETT, V26, P2037, DOI 10.1029/1999GL900494
   DUO L, 2008, THESIS U BERGEN
   Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036
   Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130
   Fontes JC, 1996, PALAEOGEOGR PALAEOCL, V120, P25, DOI 10.1016/0031-0182(95)00032-1
   GASSE F, 1991, NATURE, V353, P742, DOI 10.1038/353742a0
   Grotzner A, 1996, CLIM DYNAM, V12, P477, DOI 10.1007/s003820050122
   Guo SC, 2006, BMC EVOL BIOL, V6, DOI 10.1086/1471-2148-6-73
   Henderson ACG, 2003, CHINESE SCI BULL, V48, P1463, DOI 10.1360/02wd0272
   Henderson ACG, 2009, QUATERN INT, V194, P134, DOI 10.1016/j.quaint.2008.09.008
   Herzschuh U, 2006, QUATERNARY RES, V66, P133, DOI 10.1016/j.yqres.2006.03.001
   Herzschuh U, 2006, QUATERNARY SCI REV, V25, P163, DOI 10.1016/j.quascirev.2005.02.006
   HERZSCHUH U, J BIOGEOGRA IN PRESS
   Hong YT, 2003, EARTH PLANET SC LETT, V211, P371, DOI 10.1016/S0012-821X(03)00207-3
   JACOBSON GL, 1988, VEGETATION HIST, P3
   Ji JF, 2009, QUATERNARY SCI REV, V28, P1304, DOI 10.1016/j.quascirev.2008.12.015
   Kaiser K, 2009, PALAEOGEOGR PALAEOCL, V271, P329, DOI 10.1016/j.palaeo.2008.11.004
   Kaiser K, 2008, CATENA, V73, P300, DOI 10.1016/j.catena.2007.12.001
   Kaiser K, 2007, CATENA, V69, P91, DOI 10.1016/j.catena.2006.04.028
   Kurschner H., 2005, BOT JB SYSTEMATIK, V126, P273, DOI DOI 10.1127/0006-8152/2005/0126-0273
   KUTZBACH JE, 1981, SCIENCE, V214, P59, DOI 10.1126/science.214.4516.59
   Legutke S., 1999, 18 DTSCH KLIM
   LISTER GS, 1991, PALAEOGEOGR PALAEOCL, V84, P141, DOI 10.1016/0031-0182(91)90041-O
   Liu XQ, 2007, CHINESE SCI BULL, V52, P539, DOI 10.1007/s11434-007-0086-3
   Lorenz SJ, 2004, CLIM DYNAM, V23, P727, DOI 10.1007/s00382-004-0469-y
   Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x
   Miehe G, 2008, PLANT ECOL, V194, P157, DOI 10.1007/s11258-007-9282-0
   Miehe G, 2007, MT RES DEV, V27, P169, DOI 10.1659/mrd.0792
   Miehe G, 2006, PALAEOGEOGR PALAEOCL, V242, P54, DOI 10.1016/j.palaeo.2006.05.010
   Miehe G, 2009, PALAEOGEOGR PALAEOCL, V276, P130, DOI 10.1016/j.palaeo.2009.03.005
   Petoukhov V, 2000, CLIM DYNAM, V16, P1, DOI 10.1007/PL00007919
   Ren GY, 2007, VEG HIST ARCHAEOBOT, V16, P119, DOI 10.1007/s00334-006-0075-5
   Ren GY, 2000, J QUATERNARY SCI, V15, P273, DOI 10.1002/(SICI)1099-1417(200003)15:3<273::AID-JQS504>3.3.CO;2-U
   Rhode D, 2007, J ARCHAEOL SCI, V34, P600, DOI 10.1016/j.jas.2006.06.016
   ROECKNER E, 1996, 218 M PLANCK I MET
   Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa
   Schlutz F, 2009, QUATERNARY SCI REV, V28, P1449, DOI 10.1016/j.quascirev.2009.01.009
   SCHLUTZ F, 2007, QUATERN INT, V167, P368
   Shen CM, 2008, ECOLOGY, V89, P1079, DOI 10.1890/06-2016.1
   Shen J, 2005, QUATERN INT, V136, P131, DOI 10.1016/j.quaint.2004.11.014
   Shen J, 2006, HOLOCENE, V16, P265, DOI 10.1191/0959683606hl923rp
   Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406
   TERBRAAK CJF, 1993, HYDROBIOLOGIA, V269, P485, DOI 10.1007/BF00028046
   Thompson LG, 1997, SCIENCE, V276, P1821, DOI 10.1126/science.276.5320.1821
   Wang RL, 2002, EARTH PLANET SC LETT, V203, P461, DOI 10.1016/S0012-821X(02)00829-4
   Wei K, 1999, QUATERNARY SCI REV, V18, P1315, DOI 10.1016/S0277-3791(98)00115-2
   Wirtz KW, 2003, CLIMATIC CHANGE, V59, P333, DOI 10.1023/A:1024858532005
   Wu YH, 2006, PALAEOGEOGR PALAEOCL, V234, P328, DOI 10.1016/j.palaeo.2005.09.017
   Xu H, 2007, PALAEOGEOGR PALAEOCL, V254, P541, DOI 10.1016/j.palaeo.2007.07.007
   Xu H, 2006, CHEM GEOL, V235, P262, DOI 10.1016/j.chemgeo.2006.07.005
   Yan G, 1999, PALAEOGEOGR PALAEOCL, V153, P147, DOI 10.1016/S0031-0182(99)00064-4
   Zhang CJ, 2009, QUATERNARY SCI REV, V28, P1970, DOI 10.1016/j.quascirev.2009.03.007
   ZHANG Y, 2000, ANN WATER MANAGEMENT, P330
   Zhao CY, 2006, ECOL MODEL, V191, P487, DOI 10.1016/j.ecolmodel.2005.05.018
   Zhao Y, 2009, QUATERN INT, V194, P6, DOI 10.1016/j.quaint.2007.12.002
   Zhu LP, 2008, HOLOCENE, V18, P831, DOI 10.1177/0959683608091801
NR 64
TC 22
Z9 26
U1 3
U2 36
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1466-822X
J9 GLOBAL ECOL BIOGEOGR
JI Glob. Ecol. Biogeogr.
PD MAR
PY 2010
VL 19
IS 2
BP 278
EP 286
DI 10.1111/j.1466-8238.2009.00501.x
PG 9
WC Ecology; Geography, Physical
SC Environmental Sciences & Ecology; Physical Geography
GA 552VB
UT WOS:000274320600012
DA 2018-12-27
ER

PT J
AU Salama, N
   Kishimoto, T
   Kanayama, HO
   Kagawa, S
AF Salama, N.
   Kishimoto, T.
   Kanayama, H-O
   Kagawa, S.
TI RETRACTED: Effects of exposure to a mobile phone on sexual behavior in
   adult male rabbit: an observational study (Retracted article. See vol.
   24, pg. 170, 2012)
SO INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH
LA English
DT Article; Retracted Publication
DE mobile phone; sexual behavior; rabbit; radiofrequency
ID RAT-BRAIN; LIPID-PEROXIDATION; ELECTROMAGNETIC-RADIATION;
   MICROWAVE-RADIATION; CELL PHONE; STRESS; MELATONIN; DYSFUNCTION
AB The accumulating effects of exposure to electromagnetic radiation emitted by a conventional mobile phone (MP) on male sexual behaviour have not yet been analyzed. Therefore, we studied these effects in 18 male rabbits that were randomly divided into phone and control groups. Six female teasers were taken successively to the male's cage and the copulatory behavior was recorded. Serum total testosterone, dopamine and cortisol were evaluated. The animals of the phone group were exposed to MPs (800 MHz) in a standby position for 8 h daily for 12 weeks. At the end of the study, the copulatory behavior and hormonal assays were re-evaluated. Mounts without ejaculation were the main mounts in the phone group and its duration and frequency increased significantly compared with the controls, whereas the reverse was observed in its mounts with ejaculation. Ejaculation frequency dropped significantly, biting/grasping against teasers increased notably and mounting latency in accumulated means from the first to the fourth teasers were noted in the phone group. The hormonal assays did not show any significant differences between the study groups. Therefore, the pulsed radiofrequency emitted by a conventional MP, which was kept on a standby position, could affect the sexual behavior in the rabbit. International Journal of Impotence Research (2010) 22, 127-133; doi:10.1038/ijir.2009.57; published online 26 November 2009
C1 [Salama, N.] Alexandria Fac Med, Dept Urol, Alexandria 11111, Egypt.
   [Salama, N.; Kishimoto, T.; Kanayama, H-O; Kagawa, S.] Tokushima Sch Med, Dept Urol, Tokushima, Japan.
RP Salama, N (reprint author), Alexandria Fac Med, Dept Urol, Alexandria 11111, Egypt.
EM nadersalama58@yahoo.com
CR Agarwal A, 2008, FERTIL STERIL, V89, P124, DOI 10.1016/j.fertnstert.2007.01.166
   Almeida SA, 2000, BRAZ J MED BIOL RES, V33, P1105, DOI 10.1590/S0100-879X2000000900019
   Ammari M, 2008, BIOMED PHARMACOTHER, V62, P273, DOI 10.1016/j.biopha.2008.03.002
   BALDWIN JD, 2002, ENCY HUMAN BRAIN, P309
   Baydas G, 2003, J PINEAL RES, V34, P36, DOI 10.1034/j.1600-079X.2003.02939.x
   Dasdag S, 2003, BIOELECTROMAGNETICS, V24, P182, DOI 10.1002/bem.10083
   DEWSBURY DA, 1975, EFFECTS DRUGS ALTER, P169
   Dubreuil D, 2002, BEHAV BRAIN RES, V129, P203, DOI 10.1016/S0166-4328(01)00344-8
   Giuliano F, 2000, NEUROSCI BIOBEHAV R, V24, P517, DOI 10.1016/S0149-7634(00)00020-8
   HAGEN WK, 1982, BIOL LAB RABBIT, P23
   Halliwell B, 1997, J NEUROCHEM, V69, P1330
   HEATON JP, 1994, J UROLOGY, V151, P775
   Hossmann KA, 2003, BIOELECTROMAGNETICS, V24, P49, DOI 10.1002/bem.10068
   Hull E.M., 2002, HORMONES BRAIN BEHAV, V1, P3, DOI DOI 10.1016/B978-012532104-4/50003-2
   HULL EM, 1995, NEUROBIOLOGICAL EFFE, P234
   Irmak MK, 2002, CELL BIOCHEM FUNCT, V20, P279, DOI 10.1002/cbf.976
   Jung JH, 2008, UROLOGY, V71, P99, DOI 10.1016/j.urology.2007.08.045
   Koylu H, 2006, TOXICOL IND HEALTH, V22, P211, DOI 10.1191/0748233706th263oa
   Kumar P, 2009, PROG NEURO-PSYCHOPH, V33, P100, DOI 10.1016/j.pnpbp.2008.10.013
   MASTERS WH, 1980, HUMAN SEXUAL RESPONS
   Meco G, 2008, PARKINSONISM RELAT D, V14, P451, DOI 10.1016/j.parkreldis.2007.10.008
   MELIN P, 1963, ENDOCRINOLOGY, V73, P433, DOI 10.1210/endo-73-4-433
   Paulraj R, 2006, MUTAT RES-FUND MOL M, V596, P76, DOI 10.1016/j.mrfmmm.2005.12.006
   SALAMA N, SYST BIOL R IN PRESS
   Salama N, 2010, INT J ANDROL, V33, P88, DOI 10.1111/j.1365-2605.2008.00940.x
   Sato Y, 1996, J ANDROL, V17, P83
   Sokolovic D, 2008, J RADIAT RES, V49, P579, DOI 10.1269/jrr.07077
   Szeto A, 2004, PSYCHONEUROENDOCRINO, V29, P861, DOI 10.1016/j.S0306-4530(03)00153-7
   Villagran C, 2003, ANIM REPROD SCI, V76, P251, DOI 10.1016/S0378-4320(02)00242-7
   WILSON JR, 1963, J COMP PHYSIOL PSYCH, V56, P636, DOI 10.1037/h0042469
   Wommack JC, 2003, PHYSIOL BEHAV, V80, P303, DOI 10.1016/j.physbeh.2003.08.002
   Yan JG, 2007, FERTIL STERIL, V88, P957, DOI 10.1016/j.fertnstert.2006.12.022
NR 32
TC 8
Z9 9
U1 2
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0955-9930
EI 1476-5489
J9 INT J IMPOT RES
JI Int. J. Impot. Res.
PD MAR
PY 2010
VL 22
IS 2
BP 127
EP 133
DI 10.1038/ijir.2009.57
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA 569XI
UT WOS:000275635700006
PM 19940851
OA Bronze
DA 2018-12-27
ER

PT J
AU Hou, SB
AF Hou, Songbo
TI RETRACTED: CRITICAL DOMAINS OF THE EIGENVALUE RATIOS OF THE DIRICHLET
   LAPLACIAN (RETRACTED ARTICLE)
SO INTERNATIONAL JOURNAL OF MATHEMATICS
LA English
DT Article; Retracted Publication
DE Critical domain; Dirichlet Laplacian; Eigenvalue ratios
ID RIEMANNIAN MANIFOLD
AB Let M be a real analytic Riemannian manifold. We denote by lambda(k)(Omega) the k-th eigenvalue of the Dirichlet Laplacian of any regular bounded domain Omega of M. In this paper, we consider the eigenvalue ratios as functionals upon the set of domains. We investigate critical domains of the eigenvalue ratios lambda(k+1)/lambda(k) and obtain necessary and sufficient conditions for a domain to be critical.
C1 China Agr Univ, Dept Appl Math, Coll Sci, Beijing 100083, Peoples R China.
RP Hou, SB (reprint author), China Agr Univ, Dept Appl Math, Coll Sci, East Campus, Beijing 100083, Peoples R China.
EM housb10@163.com
FU NSFC [10926109, 60772038]; Chinese Universities Scientific Fund
   [2009JS32]
FX The author is supported by grants of NSFC (10926109) and Chinese
   Universities Scientific Fund (2009JS32), and is partially supported by
   the grant of NSFC (60772038). He would like to express gratitude to
   Professor Jiayu Li for his constant encouragement.
CR Ashbaugh MS, 2002, P INDIAN AS-MATH SCI, V112, P3, DOI 10.1007/BF02829638
   ASHBAUGH MS, 1992, ANN MATH, V135, P601, DOI 10.2307/2946578
   CHEN SY, 1975, MATH Z, V143, P289, DOI 10.1007/BF01214381
   El Soufi A, 2007, ILLINOIS J MATH, V51, P645
   Henrot A, 2003, J EVOL EQU, V3, P443, DOI 10.1007/s00028-003-0111-0
   Kato T, 1995, PERTURBATION THEORY
   NADIRASHVILI N, 1996, GEOM FUNCT ANAL, V6, P879
   REILLY RC, 1977, INDIANA U MATH J, V26, P459, DOI 10.1512/iumj.1977.26.26036
   Rockafellar R. T., 1972, CONVEX ANAL
   WEINBERGER HF, 1956, J RATION MECH ANAL, V5, P633
NR 10
TC 0
Z9 0
U1 7
U2 14
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0129-167X
J9 INT J MATH
JI Int. J. Math.
PD MAR
PY 2010
VL 21
IS 3
BP 349
EP 355
DI 10.1142/S0129167X10006069
PG 7
WC Mathematics
SC Mathematics
GA 575PX
UT WOS:000276080700005
DA 2018-12-27
ER

PT J
AU Ernstberger, T
   Buchhorn, G
   Heidrich, G
AF Ernstberger, T.
   Buchhorn, G.
   Heidrich, G.
TI RETRACTED: Magnetic resonance imaging evaluation of intervertebral test
   spacers: an experimental comparison of magnesium versus titanium and
   carbon fiber reinforced polymers as biomaterials (Retracted article. See
   vol. 184, pg. 263, 2015)
SO IRISH JOURNAL OF MEDICAL SCIENCE
LA English
DT Article; Retracted Publication
DE Magnesium alloys; Innovative biomaterials; Interbody test implants; MRI
   artifacting
ID PEDICLE SCREWS; LUMBAR SPINE; ARTIFACTS; IMPLANTS; MRI; PARAMETERS;
   ALLOYS; FUSION
AB Introduction Intervertebral spacers are made of different materials, which can affect the postfusion magnetic resonance imaging (MRI) scans. Susceptibility artifacts, especially for metallic implants, can decrease the image quality. This study aimed to determine whether magnesium as a lightweight and biocompatible metal is suitable as a biomaterial for spinal implants based on its MRI artifacting behavior.
   Materials and methods To compare artifacting behaviors, we implanted into one porcine cadaveric spine different test spacers made of magnesium, titanium, and CFRP. All test spacers were scanned using two T1-TSE MRI sequences. The artifact dimensions were traced on all scans and statistically analyzed.
   Results The total artifact volume and median artifact area of the titanium spacers were statistically significantly larger than magnesium spacers (P < 0.001), while magnesium and CFRP spacers produced almost identical artifacting behaviors (P > 0.05).
   Conclusion Our results suggest that spinal implants made with magnesium alloys will behave more like CFRP devices in MRI scans.
C1 [Ernstberger, T.; Buchhorn, G.] Univ Gottingen, Dept Orthopaed Surg, Biomat Lab, D-37075 Gottingen, Germany.
   [Heidrich, G.] Univ Gottingen, Dept Diagnost Radiol, D-37075 Gottingen, Germany.
RP Ernstberger, T (reprint author), Univ Gottingen, Dept Orthopaed Surg, Biomat Lab, Robert Koch Str 40, D-37075 Gottingen, Germany.
EM ternstberger@med.uni-goettingen.de
CR BRANTIGAN JW, 1993, SPINE, V18, P2106, DOI 10.1097/00007632-199310001-00030
   DEBATIN JF, 1992, INVEST RADIOL, V27, P198, DOI 10.1097/00004424-199203000-00003
   ERNSTBERGER T, 2006, EUR SPINE J, V7, P1
   Ernstberger T, 2007, SPINE J, V7, P353, DOI 10.1016/j.spinee.2006.03.016
   Henk C B, 1999, Top Magn Reson Imaging, V10, P247, DOI 10.1097/00002142-199908000-00006
   Herold T, 2004, ROFO-FORTSCHR RONTG, V176, P1296, DOI 10.1055/s-2004-813404
   Lambotte A., 1932, B MEM SOC NAT CHIR, V28, P1325
   Malik AS, 2001, ACTA RADIOL, V42, P291, DOI 10.1034/j.1600-0455.2001.042002291.x
   Ortiz O, 1996, NEUROSURGERY, V38, P741, DOI 10.1227/00006123-199604000-00022
   Petersilge CA, 1996, AM J ROENTGENOL, V166, P1213, DOI 10.2214/ajr.166.5.8615272
   Rudisch A, 1998, SPINE, V23, P692, DOI 10.1097/00007632-199803150-00009
   RUPP R, 1993, SPINE, V18, P379
   Schreiner U, 2000, Z ORTHOP GRENZGEB, V138, P540, DOI 10.1055/s-2000-9598
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Thomsen M, 2001, ORTHOPADE, V30, P540, DOI 10.1007/s001320170063
   Troitskii V., 1944, KHIRURGIIA, V8, P41
   VACCARO AR, 1994, SPINE, V19, P1237, DOI 10.1097/00007632-199405310-00008
   Van Goethem JWM, 2002, NEURORADIOLOGY, V44, P723, DOI 10.1007/s00234-002-0790-2
   Waldman ID, 2005, AM J MED GENET B, V138B, P144
   Wang JC, 1997, J SPINAL DISORD, V10, P27
   Znamenskii M. S., 1945, KHIRURGIIA, V12, P60
NR 21
TC 7
Z9 8
U1 2
U2 15
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0021-1265
EI 1863-4362
J9 IRISH J MED SCI
JI Irish J. Med. Sci.
PD MAR
PY 2010
VL 179
IS 1
BP 107
EP 111
DI 10.1007/s11845-009-0394-5
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA 608JK
UT WOS:000278579700019
PM 19693644
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Zhao, YF
   He, TH
AF Zhao, Yu-Feng
   He, Tian-Hu
TI RETRACTED: Numerical simulations of alternating current loss of high
   temperature superconductors in the liquid nitrogen region (Retracted
   article. See vol. 111, 073911, 2012)
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article; Retracted Publication
ID CRITICAL-CURRENT-DENSITY; AC LOSSES; FLUX JUMPS; J(C); DISTRIBUTIONS;
   TAPES; FIELD; AG
AB The frequency f and amplitude B-0 of applied magnetic field dependence of the loss behavior in the liquid nitrogen region is studied in high temperature superconducting slabs. The magnetothermal diffusion equations based on the power-law model are presented in this paper to estimate the effect of f and B-0 on the loss. Numerical results obtained show that, generally, the loss is proportional to B-0(3) in the nonpenetration field and to B-0 in the penetration field, and the loss power is proportional to f whether the magnetic field penetrates it or not. (C) 2010 American Institute of Physics. [doi:10.1063/1.3327235]
C1 [Zhao, Yu-Feng; He, Tian-Hu] Lanzhou Univ Technol, Sch Sci, Lanzhou 730050, Peoples R China.
RP Zhao, YF (reprint author), Lanzhou Univ Technol, Sch Sci, Lanzhou 730050, Peoples R China.
EM zhaoyf09@lut.cn
FU Natural Science Foundation of China [10602021]
FX This research was supported by a grant of the Fund of Natural Science
   Foundation of China (Grant No. 10602021). The authors gratefully
   acknowledge the support.
CR CISZEK M, 1988, PHYSICA C, V152, P247, DOI 10.1016/0921-4534(88)90135-9
   Gomory F, 1997, PHYSICA C, V280, P151, DOI 10.1016/S0921-4534(97)00180-9
   Inada R, 2007, SUPERCOND SCI TECH, V20, P138, DOI 10.1088/0953-2048/20/3/005
   Mawatari Y, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2180875
   Mawatari Y, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2829793
   McDonald J, 1996, PHYS REV B, V53, P8643, DOI 10.1103/PhysRevB.53.8643
   Mikheenko PN, 1997, PHYSICA C, V274, P9, DOI 10.1016/S0921-4534(96)00640-5
   MULLER KH, 1994, PHYS REV B, V49, P1294, DOI 10.1103/PhysRevB.49.1294
   OREHOTSKY J, 1990, J APPL PHYS, V67, P1433, DOI 10.1063/1.345674
   Sekine N, 2005, PHYSICA C, V426, P1284, DOI 10.1016/j.physc.2005.03.051
   Shantsev DV, 1999, PHYS REV B, V60, P13112, DOI 10.1103/PhysRevB.60.13112
   Sokolovsky V, 1998, PHYSICA C, V308, P215, DOI 10.1016/S0921-4534(98)00546-2
   VLAKHOV ES, 1992, PHYSICA C, V195, P345, DOI 10.1016/0921-4534(92)90359-K
   XU YH, 1989, APPL PHYS LETT, V54, P1699, DOI 10.1063/1.101433
   Zhao YF, 2008, EUR PHYS J B, V61, P391, DOI 10.1140/epjb/e2008-00090-4
   Zhao YF, 2009, J LOW TEMP PHYS, V156, P30, DOI 10.1007/s10909-009-9887-x
NR 16
TC 2
Z9 2
U1 4
U2 14
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0021-8979
EI 1089-7550
J9 J APPL PHYS
JI J. Appl. Phys.
PD MAR 1
PY 2010
VL 107
IS 5
AR 053913
DI 10.1063/1.3327235
PG 4
WC Physics, Applied
SC Physics
GA 570FK
UT WOS:000275657500083
DA 2018-12-27
ER

PT J
AU Wang, ZW
   Li, YW
   Banerjee, S
   Kong, DJ
   Ahmad, A
   Nogueira, V
   Hay, N
   Sarkar, FH
AF Wang, Zhiwei
   Li, Yiwei
   Banerjee, Sanjeev
   Kong, Dejuan
   Ahmad, Aamir
   Nogueira, Veronique
   Hay, Nissim
   Sarkar, Fazlul H.
TI RETRACTED: Down-Regulation of Notch-1 and Jagged-1 Inhibits Prostate
   Cancer Cell Growth, Migration and Invasion, and Induces Apoptosis Via
   Inactivation of Akt, mTOR, and NF-kappa B Signaling Pathways (Retracted
   article. See vol. 117, pg. 1960, 2016)
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article; Retracted Publication
DE NOTCH-1; JAGGED-1; PROSTATE CANCER; CELL GROWTH; INVASION
ID KAPPA-B; THERAPEUTIC TARGET; EXPRESSION; ACTIVATION; LEUKEMIA
AB Notch signaling is involved in a variety of cellular processes, such as cell fate specification, differentiation, proliferation, and survival. Notch-1 over-expression has been reported in prostate cancer metastases. Likewise, Notch ligand Jagged-1 was found to be over-expressed in metastatic prostate cancer compared to localized prostate cancer or benign prostate tissues, suggesting the biological significance of Notch signaling in prostate cancer progression. However, the mechanistic role of Notch signaling and the consequence of its down-regulation in prostate cancer have not been fully elucidated. Using multiple cellular and molecular approaches such as MTT assay, apoptosis assay, gene transfection, real-time RT-PCR, Western blotting, migration, invasion assay and ELISA, we found that down-regulation of Notch-1 or Jagged-1 was mechanistically associated with inhibition of cell growth, migration, invasion and induction of apoptosis in prostate cancer cells, which was mediated via inactivation of Akt, mTOR, and NF-kappa B signaling. Consistent with these results, we found that the down-regulation of Notch-1 or Jagged-1 led to decreased expression and the activity of NF-kappa B downstream genes such as MMP-9, VEGF, and uPA, contributing to the inhibition of cell migration and invasion. Taken together, we conclude that the down-regulation of Notch-1 or Jagged-1 mediated inhibition of cell growth, migration and invasion, and the induction of apoptosis was in part due to inactivation of Akt, mTOR, and NF-kappa B signaling pathways. Our results further suggest that inactivation of Notch signaling pathways by innovative strategies could be a potential targeted approach for the treatment of metastatic prostate cancer. J. Cell. Biochem. 109: 726-736, 2010. (C) 2010 Wiley-Liss. Inc.
C1 [Wang, Zhiwei] Wayne State Univ, Sch Med, Karmanos Canc Inst, Dept Pathol, Detroit, MI 48201 USA.
   [Nogueira, Veronique; Hay, Nissim] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA.
RP Wang, ZW (reprint author), Wayne State Univ, Sch Med, Karmanos Canc Inst, Dept Pathol, 9374 Scott Hall,540 E Canfield, Detroit, MI 48201 USA.
EM zhiweiwang@med.wayne.edu; fsarkar@med.wayne.edu
RI Ahmad, Aamir/E-8747-2010; Wang, Zhiwei/A-6809-2011
FU Department of Defense Postdoctoral Training Award [W81XWH-08-1-0196];
   National Cancer Institute; NIH [5R01CA083695, 1R01CA101870]
FX This work was funded by grants from Department of Defense Postdoctoral
   Training Award W81XWH-08-1-0196 (Zhiwei Wang) and the National Cancer
   Institute, NIH (5R01CA083695, 1R01CA101870) to F.H.S.
CR Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803
   Bedogni B, 2008, J CLIN INVEST, V118, P3660, DOI 10.1172/JCI36157
   BIN HB, 2009, CLIN CANCER RES, V15, P452
   Calzavara E, 2008, J CELL BIOCHEM, V103, P1405, DOI 10.1002/jcb.21527
   Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883
   de Souza PL, 2009, CURR CANCER DRUG TAR, V9, P163, DOI 10.2174/156800909787581006
   Gutierrez A, 2007, CANCER CELL, V12, P411, DOI 10.1016/j.ccr.2007.10.027
   Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006
   Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045
   Leong KG, 2008, DIFFERENTIATION, V76, P699, DOI 10.1111/j.1432-0436.2008.00288.x
   Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589
   Martin DB, 2004, CANCER RES, V64, P347, DOI 10.1158/0008-5472.CAN-03-2062
   Meurette O, 2009, CANCER RES, V69, P5015, DOI 10.1158/0008-5472.CAN-08-3478
   Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771
   Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570
   Miele L, 1999, J CELL PHYSIOL, V181, P393, DOI 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6
   Mungamuri SK, 2006, CANCER RES, V66, P4715, DOI 10.1158/0008-5472.CAN-05-3830
   Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700
   Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753
   Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636
   Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226
   Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500
   Shou JY, 2001, CANCER RES, V61, P7291
   Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022
   Song LL, 2008, ONCOGENE, V27, P5833, DOI 10.1038/onc.2008.190
   Villaronga MA, 2008, CURR CANCER DRUG TAR, V8, P566, DOI 10.2174/156800908786241096
   Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265
   Wang ZW, 2008, ANTICANCER RES, V28, P3621
   Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281
   Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299
   Zayzafoon M, 2004, J BIOL CHEM, V279, P3662, DOI 10.1074/jbc.M308158200
   Zhang YX, 2006, INT J CANCER, V119, P2071, DOI 10.1002/ijc.22077
NR 32
TC 151
Z9 167
U1 2
U2 31
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD MAR 1
PY 2010
VL 109
IS 4
BP 726
EP 736
DI 10.1002/jcb.22451
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 568XH
UT WOS:000275559000011
PM 20052673
DA 2018-12-27
ER

PT J
AU Kadam, RS
   Kompella, UB
AF Kadam, Rajendra S.
   Kompella, Uday B.
TI RETRACTED: Influence of Lipophilicity on Drug Partitioning into Sclera,
   Choroid-Retinal Pigment Epithelium, Retina, Trabecular Meshwork, and
   Optic Nerve (Retracted article. See vol. 352, pg. 326, 2015)
SO JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
LA English
DT Article; Retracted Publication
ID INTRAVITREAL TRIAMCINOLONE ACETONIDE; TISSUE DISTRIBUTION;
   PHYSICOCHEMICAL FACTORS; MOLECULAR-WEIGHT; OCULAR MELANIN;
   BETA-BLOCKERS; BINDING; PHARMACOKINETICS; COEFFICIENTS; ANTAGONISTS
AB In vitro bovine eye tissue/phosphate-buffered saline, pH 7.4, partition coefficients (Kt:b), in vitro binding to natural melanin, and in vivo delivery at 1 h after posterior subconjunctival injection in Brown Norway rats were determined for eight beta-blockers. The Kt:b was in the order intact tissue, dry weight method >= intact tissue, wet weight method corrected for tissue water and drug in tissue water >> intact tissue, wet weight method > homogenized tissue. In intact tissue methods, Kt: b followed the order choroid-retinal pigment epithelium (RPE) > trabecular meshwork > retina > sclera similar to optic nerve; propranolol > betaxolol > pindolol similar to timolol similar to metoprolol > sotalol similar to atenolol similar to nadolol. Intact tissue, wet weight log ( Kt: b) correlated positively with log D for all tissues (R-2 of 0.7-0.9). Log (melanin binding capacity) correlated positively with choroid-RPE log (Kt:b) (R-2 of 0.5). With an increase in concentration, Kt: b decreased in trabecular meshwork for all beta-blockers and for some lipophilic beta-blockers in choroid-RPE and sclera. With an increase in drug lipophilicity, in vivo tissue distribution increased in choroid-RPE, iris-ciliary body, sclera, and cornea but exhibited a declining trend in retina, vitreous, and lens. In vitro bovine intact tissue, wet weight Kt: b correlated positively with rat in vivo tissue/vitreous humor distribution for sclera, choroid-RPE, and retina (R-2 of 0.985-0.993). In vitro tissue partition coefficients might be useful in predicting in vivo drug distribution after trans-scleral delivery. Less lipophilic solutes exhibiting limited nonproductive binding in choroid-RPE might exhibit greater trans-scleral delivery to the retina and vitreous.
C1 [Kadam, Rajendra S.; Kompella, Uday B.] Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO 80045 USA.
   [Kompella, Uday B.] Univ Colorado Denver, Dept Ophthalmol, Aurora, CO 80045 USA.
RP Kompella, UB (reprint author), Univ Colorado Denver, Dept Pharmaceut Sci, 12700 E 19th Ave, Aurora, CO 80045 USA.
EM uday.kompella@ucdenver.edu
FU National Institutes of Health National Eye Institute [EY017533]; Pfizer
   Global Research
FX This work was supported by National Institutes of Health National Eye
   Institute [Grant EY017533]; and by an unrestricted research gift from
   Pfizer Global Research.
CR ABRAHAMSSON T, 1988, EXP EYE RES, V47, P565, DOI 10.1016/0014-4835(88)90095-4
   Amrite AC, 2006, INVEST OPHTH VIS SCI, V47, P1149, DOI 10.1167/iovs.05-0531
   Amrite AC, 2008, MOL VIS, V14, P150
   Amrite AC, 2008, INVEST OPHTH VIS SCI, V49, P320, DOI 10.1167/iovs.07-0593
   Ayalasomayajula SP, 2004, PHARM RES-DORDR, V21, P1797, DOI 10.1023/B:PHAM.0000045231.51924.e8
   Ballard P, 2000, PHARM RES-DORDR, V17, P660, DOI 10.1023/A:1007565828856
   BUSCH MJWM, 1993, INVEST OPHTH VIS SCI, V34, P3028
   Chen YN, 2007, BRAIN RES, V1148, P28, DOI 10.1016/j.brainres.2007.02.027
   Cheruvu NPS, 2008, INVEST OPHTH VIS SCI, V49, P333, DOI 10.1167/iovs.07-0214
   Cheruvu NPS, 2006, INVEST OPHTH VIS SCI, V47, P4513, DOI 10.1167/iovs.06-0404
   Durairaj C, 2009, INVEST OPHTH VIS SCI, V50, P4887, DOI 10.1167/iovs.09-3565
   Durairaj C, 2009, PHARM RES-DORDR, V26, P1236, DOI 10.1007/s11095-008-9728-7
   Fan BJ, 2008, INVEST OPHTH VIS SCI, V49, P1886, DOI 10.1167/iovs.07-0414
   FLOYD RA, 1975, P NATL ACAD SCI USA, V72, P56, DOI 10.1073/pnas.72.1.56
   Friden M, 2009, DRUG METAB DISPOS, V37, P1226, DOI 10.1124/dmd.108.026377
   GALE DC, 2005, INVEST OPHTH VIS SCI, V46, P5381
   GARGAS ML, 1989, TOXICOL APPL PHARM, V98, P87, DOI 10.1016/0041-008X(89)90137-3
   Hosoya K, 2009, J PHARMACOL EXP THER, V329, P87, DOI 10.1124/jpet.108.146381
   Jones R, 2006, CURR OPIN OPHTHALMOL, V17, P163
   Kadam RS, 2009, J CHROMATOGR B, V877, P253, DOI 10.1016/j.jchromb.2008.12.027
   Kubota T, 2006, J GLAUCOMA, V15, P117, DOI 10.1097/00061198-200604000-00007
   Leblanc B, 1998, REGUL TOXICOL PHARM, V28, P124, DOI 10.1006/rtph.1998.1243
   Majumdar S, 2006, J OCUL PHARMACOL TH, V22, P231, DOI 10.1089/jop.2006.22.231
   Mannermaa E, 2009, PHARM RES-DORD, V26, P1785, DOI 10.1007/s11095-009-9890-6
   Maurice DM, 2002, SURV OPHTHALMOL, V47, pS41, DOI 10.1016/S0039-6257(02)00326-0
   MURPHY JE, 1995, J APPL TOXICOL, V15, P147, DOI 10.1002/jat.2550150215
   Osborne NN, 2005, J OCUL PHARMACOL TH, V21, P175, DOI 10.1089/jop.2005.21.175
   Ozkiris A, 2005, CAN J OPHTHALMOL, V40, P63, DOI 10.1016/S0008-4182(05)80119-X
   Pitkanen L, 2005, INVEST OPHTH VIS SCI, V46, P641, DOI 10.1167/iovs.04-1051
   Poulin P, 2000, J PHARM SCI-US, V89, P16, DOI 10.1002/(SICI)1520-6017(200001)89:1<16::AID-JPS3>3.0.CO;2-E
   Proksch JW, 2008, J PHARM SCI-US, V97, P3411, DOI 10.1002/jps.21188
   Raghava Swita, 2004, Expert Opin Drug Deliv, V1, P99, DOI 10.1517/17425247.1.1.99
   Rodgers T, 2005, J PHARM SCI-US, V94, P1237, DOI 10.1002/jps.20323
   SCHOENWALD RD, 1983, J PHARM SCI-US, V72, P1266, DOI 10.1002/jps.2600721108
   Smith NF, 2007, MOL CANCER THER, V6, P428, DOI 10.1158/1535-7163-MCT-06-0324
   Smithen LM, 2004, AM J OPHTHALMOL, V138, P740, DOI 10.1016/j.ajo.2004.06.067
   STEPIEN KB, 1982, BIOCHEM PHARMACOL, V31, P3359, DOI 10.1016/0006-2952(82)90612-8
   Wiczling P, 2006, ANAL CHEM, V78, P239, DOI 10.1021/ac0512103
   Wood JPM, 2003, EXP EYE RES, V76, P505, DOI 10.1016/S0014-4835(02)00335-4
   ZANE PA, 1990, PHARMACEUT RES, V7, P935, DOI 10.1023/A:1015997823755
NR 40
TC 37
Z9 39
U1 2
U2 9
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0022-3565
EI 1521-0103
J9 J PHARMACOL EXP THER
JI J. Pharmacol. Exp. Ther.
PD MAR
PY 2010
VL 332
IS 3
BP 1107
EP 1120
DI 10.1124/jpet.109.161570
PG 14
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 559DF
UT WOS:000274800200046
PM 19926800
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Li, J
   Xia, YC
AF Li, J.
   Xia, Y. C.
TI RETRACTED: The Influence of Carbon Fiber Content on the Tribological
   Properties of PA6 Composites (Retracted article. See vol. 29, pg. 1915,
   2010)
SO JOURNAL OF REINFORCED PLASTICS AND COMPOSITES
LA English
DT Article; Retracted Publication
DE tribological; polyamide 6; wear reduction
ID WEAR BEHAVIOR; ABRASIVE WEAR; POLYETHERIMIDE COMPOSITES; SLIDING
   FRICTION; PEEK; REINFORCEMENT; CONTACT; POLYAMIDE-6; COATINGS; BLENDS
AB The tribological performance of PA6 and carbon fiber-reinforced polyamide 6 (CF/PA6) under dry sliding condition was examined. Different contents of carbon fibers were employed as reinforcement. All filled and unfilled polyamide 6 composites were tested against CGr15 ball and representative testing was performed. The effects of carbon fiber content on tribological properties of the composites were investigated. All filled polyamide 6 has superior tribological characteristics to unfilled polyamide 6. The optimum wear reduction is obtained when the content of carbon fiber is 20 vol%.
C1 [Li, J.; Xia, Y. C.] Shanghai Second Polytechn Univ, Sch Mech & Elect Engn, Shanghai 201209, Peoples R China.
RP Xia, YC (reprint author), Shanghai Second Polytechn Univ, Sch Mech & Elect Engn, Shanghai 201209, Peoples R China.
EM xiayanchun2@sina.com
FU Shanghai Second Polytechnic University [JD208001]
FX The authors would like to thank the School Fund (Project No. JD208001),
   Shanghai Second Polytechnic University, for their help.
CR Amash A, 1997, J APPL POLYM SCI, V63, P1143, DOI 10.1002/(SICI)1097-4628(19970228)63:9<1143::AID-APP6>3.0.CO;2-H
   BAHADUR S, 1994, WEAR, V178, P123, DOI 10.1016/0043-1648(94)90137-6
   BIJWE J, 1990, WEAR, V138, P61, DOI 10.1016/0043-1648(90)90168-A
   Bijwe J, 2001, WEAR, V249, P715, DOI 10.1016/S0043-1648(01)00696-2
   Flock J, 1999, WEAR, V225, P304, DOI 10.1016/S0043-1648(99)00022-8
   Friedrich K, 2001, WEAR, V251, P1202, DOI 10.1016/S0043-1648(01)00725-6
   Friedrich K, 1995, WEAR, V190, P139, DOI 10.1016/0043-1648(96)80012-3
   GOPAL P, 1994, WEAR, V174, P119, DOI 10.1016/0043-1648(94)90093-0
   Hanmin Z., 1987, WEAR, V116, P59
   HU MS, 1991, SCRIPTA METALL MATER, V25, P695, DOI 10.1016/0956-716X(91)90117-J
   Ibarra L, 1998, J APPL POLYM SCI, V67, P1819, DOI 10.1002/(SICI)1097-4628(19980307)67:10<1819::AID-APP15>3.0.CO;2-R
   JAHANMIR S, 1997, WEAR, V44, P235
   Kukureka SN, 1999, TRIBOL INT, V32, P107, DOI 10.1016/S0301-679X(99)00017-1
   LHYMN C, 1985, COMPOSITES, V16, P127, DOI 10.1016/0010-4361(85)90619-6
   Li JF, 2002, WEAR, V252, P824, DOI 10.1016/S0043-1648(02)00053-4
   LIU J, 1993, MAT WEAR PRINCIPLE W
   LU ZP, 1995, WEAR, V181, P624
   MCGEE AC, 1987, WEAR, V114, P97, DOI 10.1016/0043-1648(87)90019-6
   Palabiyik M, 2000, WEAR, V246, P149, DOI 10.1016/S0043-1648(00)00501-9
   Palabiyik M, 2002, WEAR, V253, P369, DOI 10.1016/S0043-1648(02)00144-8
   Pihtili H, 2002, WEAR, V252, P979
   Reinicke R, 1998, COMPOS PART A-APPL S, V29, P763, DOI 10.1016/S1359-835X(98)00052-9
   SIMM W, 1989, WEAR, V129, P105, DOI 10.1016/0043-1648(89)90283-4
   THORP JM, 1982, TRIBOL INT, V15, P59, DOI 10.1016/0301-679X(82)90054-8
   VanDeVelde F, 1997, WEAR, V209, P106, DOI 10.1016/S0043-1648(96)07500-X
   Wang JX, 2003, WEAR, V255, P774, DOI [10.1016/S0043-1648(03)00268-0, 10.1016/S0043-1648(03)000268-0]
   Xian GJ, 2005, WEAR, V258, P776, DOI 10.1016/j.wear.2004.09.054
   YOO JH, 1993, WEAR, V162, P418
   Zhang G, 2006, WEAR, V260, P594, DOI 10.1016/j.wear.2005.03.017
NR 29
TC 2
Z9 2
U1 3
U2 16
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0731-6844
EI 1530-7964
J9 J REINF PLAST COMP
JI J. Reinf. Plast. Compos.
PD MAR
PY 2010
VL 29
IS 5
BP 771
EP 778
DI 10.1177/0731684408100695
PG 8
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA 566LF
UT WOS:000275371000013
DA 2018-12-27
ER

PT J
AU Pan, Q
   Luo, XP
   Chegini, N
AF Pan, Qun
   Luo, Xiaoping
   Chegini, Nasser
TI RETRACTED: microRNA 21: response to hormonal therapies and regulatory
   function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells
   (Retracted article. See vol. 18, pg. 613, 2012)
SO MOLECULAR HUMAN REPRODUCTION
LA English
DT Article; Retracted Publication
DE leiomyoma; miRNA; ovarian steroids; GnRHa; TGF-beta receptors
ID GROWTH-FACTOR-BETA; CATECHOL-O-METHYLTRANSFERASE;
   ESTROGEN-RECEPTOR-ALPHA; SMOOTH-MUSCLE-CELLS; BREAST-CANCER CELLS;
   UTERINE LEIOMYOMA; GENE-EXPRESSION; TGF-BETA; HEPATOCELLULAR-CARCINOMA;
   DIFFERENTIAL EXPRESSION
AB Aberrant expression of microRNAs (miRNAs), including miR-21, and alteration of their target genes stability have been associated with cellular transformation and tumorigenesis. We investigated the expression, regulation and function of miR-21 in leiomyomas which develop from myometrial cellular transformation. The results indicated that miR-21 is over-expressed in leiomyomas with specific elevation during the secretory phase of the menstrual cycle and in women who received Depo-Provera and oral contraceptives, but reduced due to GnRHa therapy (P < 0.05). Bioinformatic analysis of microarray gene expression profiles previously obtained from the above cohorts, and myometrial smooth muscle cells (MSMC) and leiomyoma smooth muscle cells (LSMC) treated with GnRHa, transforming growth factor (TGF)-beta and TGF-beta receptor type II (TGF-beta RII) antisense oligomer, indicated that a number of miR-21-predicted target genes were co-expressed and differentially regulated in these cohorts. Gain- and loss-of-function of miR-21 in MSMC, LSMC, transformed LSMC and leiomyosarcoma cell line (SKLM-S1) resulted in differential expression of many genes, including some of the miR-21-predicted/validated target genes, PTEN, PDCD4 and E2F1, and TGF-beta RII, in a cell-specific manner. Gain-of miR-21 function in MSMC and LSMC reduced TGF-beta-induced expression of fibromodulin and TGF-beta-induced factor (P < 0.05), and moderately altered the rate of cell growth and caspase-3/7 activity in these cells. We concluded that miR-21 is aberrantly expressed and hormonally regulated in leiomyomas where, through functional interaction with ovarian steroids and the TGF-beta signaling pathway, either directly or indirectly regulates a number of genes whose products are critical in leiomyoma growth and regression as well as their potential cellular transformation.
C1 [Pan, Qun; Luo, Xiaoping; Chegini, Nasser] Univ Florida, Dept OB GYN, Gainesville, FL 32610 USA.
RP Chegini, N (reprint author), Univ Florida, Dept OB GYN, Box 100294, Gainesville, FL 32610 USA.
EM cheginin@ufl.edu
FU National Institutes of Health [RO1HD37432, RO1HD58664, RO3HD58779]
FX This work was supported by grants RO1HD37432 and RO1HD58664 (N. C.) and
   RO3HD58779 (X. L.) from the National Institutes of Health.
CR Al-Hendy A, 2006, J SOC GYNECOL INVEST, V13, P136, DOI 10.1016/j.jsgi.2005.10.007
   Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Bu S, 2008, J BIOL CHEM, V283, P19593, DOI 10.1074/jbc.M802417200
   Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910
   Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997
   Chan SH, 2008, ANTICANCER RES, V28, P907
   Chegini N, 2002, MOL HUM REPROD, V8, P1071, DOI 10.1093/molehr/8.12.1071
   CHEGINI N, 2005, UTERINE LEIOMYOMATA, P41
   Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60
   Chow JYC, 2008, CANCER BIOL THER, V7, P1694, DOI 10.4161/cbt.7.10.6665
   Connolly E, 2008, AM J PATHOL, V173, P856, DOI 10.2353/ajpath.2008.080096
   Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045
   Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086
   Denschlag D, 2006, FERTIL STERIL, V85, P462, DOI 10.1016/j.fertnstert.2005.07.1308
   Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x
   Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909
   Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200
   Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015
   Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589
   Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08
   Garcia-Alvarez J, 2006, EXP LUNG RES, V32, P201, DOI 10.1080/01902140600817481
   Hjelmeland AB, 2005, CANCER RES, V65, P11276, DOI 10.1158/0008-5472.CAN-05-3016
   Hu XT, 2000, BIOCHEM BIOPH RES CO, V276, P930, DOI 10.1006/bbrc.2000.3556
   Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936
   KRICHEVSKY AM, 2009, J CELL MOL MED, V13, P39, DOI DOI 10.1111/J.1582-4934.2008.00556.X
   Ku G, 2008, HUM GENE THER, V19, P17, DOI 10.1089/hum.2007.1226
   Lacerte A, 2008, CELL SIGNAL, V20, P50, DOI 10.1016/j.cellsig.2007.08.012
   Levens E, 2005, MOL HUM REPROD, V11, P489, DOI 10.1093/molehr/gah187
   Ligon AH, 2001, HUM REPROD UPDATE, V7, P8, DOI 10.1093/humupd/7.1.8
   Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72
   Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561
   Luo X, 2008, SEMIN REPROD MED, V26, P500, DOI 10.1055/s-0028-1096130
   Luo XP, 2006, MOL HUM REPROD, V12, P245, DOI 10.1093/molehr/ga1015
   Luo XP, 2005, ENDOCRINOLOGY, V146, P1074, DOI 10.1210/en.2004-1384
   Luo XP, 2005, ENDOCRINOLOGY, V146, P1097, DOI 10.1210/en.2004-1377
   Marsh EE, 2008, FERTIL STERIL, V89, P1771, DOI 10.1016/j.fertnstert.2007.05.074
   Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022
   Pan Q, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-34
   Pan Q, 2008, J CELL MOL MED, V12, P227, DOI 10.1111/j.1582-4934.2007.00207.x
   Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370
   Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013
   Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083
   Talotta F, 2008, ONCOGENE, V28, P73
   Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137
   Villanova FE, 2006, STEROIDS, V71, P960, DOI 10.1016/j.steroids.2006.07.005
   Wang TS, 2007, GENE CHROMOSOME CANC, V46, P336, DOI 10.1002/gcc.20415
   Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117
   Zeng Y, 2006, ONCOGENE, V25, P6156, DOI 10.1038/sj.onc.1209908
   Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634
   Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24
NR 53
TC 37
Z9 40
U1 2
U2 17
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1360-9947
J9 MOL HUM REPROD
JI Mol. Hum. Reprod.
PD MAR
PY 2010
VL 16
IS 3
BP 215
EP 227
DI 10.1093/molehr/gap093
PG 13
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 553CO
UT WOS:000274342700009
PM 19906824
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Clement, V
   Marino, D
   Cudalbu, C
   Hamou, MF
   Mlynarik, V
   de Tribolet, N
   Dietrich, PY
   Gruetter, R
   Hegi, ME
   Radovanovic, I
AF Clement, Virginie
   Marino, Denis
   Cudalbu, Cristina
   Hamou, Marie-France
   Mlynarik, Vladimir
   de Tribolet, Nicolas
   Dietrich, Pierre-Yves
   Gruetter, Rolf
   Hegi, Monika E.
   Radovanovic, Ivan
TI RETRACTED: Marker-independent identification of glioma-initiating cells
   (Retracted article. See vol. 10, pg. 1035, 2013)
SO NATURE METHODS
LA English
DT Article; Retracted Publication
ID CANCER STEM-CELLS; BRAIN-TUMORS; GLIOBLASTOMA; FLUORESCENCE; CULTURES;
   DISEASE; GROWTH; NICHE; CD133; RAT
AB Tumor-initiating cells with stem cell properties are believed to sustain the growth of gliomas, but proposed markers such as CD133 cannot be used to identify these cells with sufficient specificity. We report an alternative isolation method purely based on phenotypic qualities of glioma-initiating cells (GICs), avoiding the use of molecular markers. We exploited intrinsic autofluorescence properties and a distinctive morphology to isolate a subpopulation of cells (FL1(+)) from human glioma or glioma cultures. FL1(+) cells are capable of self-renewal in vitro, tumorigenesis in vivo and preferentially express stem cell genes. The FL1(+) phenotype did not correlate with the expression of proposed GIC markers. Our data propose an alternative approach to investigate tumor-initiating potential in gliomas and to advance the development of new therapies and diagnostics.
C1 [Clement, Virginie; Marino, Denis; de Tribolet, Nicolas; Radovanovic, Ivan] Univ Hosp Geneva, Div Neurosurg, Geneva, Switzerland.
   [Clement, Virginie; Marino, Denis; de Tribolet, Nicolas; Dietrich, Pierre-Yves; Radovanovic, Ivan] Univ Geneva, Geneva, Switzerland.
   [Cudalbu, Cristina; Mlynarik, Vladimir; Gruetter, Rolf] Ecole Polytech Fed Lausanne, Lab Funct & Metab Imaging, Lausanne, Switzerland.
   [Hamou, Marie-France; Hegi, Monika E.] Univ Lausanne Hosp, Dept Neurosurg, Lab Brain Tumor Biol & Genet, Lausanne, Switzerland.
   [Hamou, Marie-France; Hegi, Monika E.] Univ Lausanne, Lausanne, Switzerland.
   [Dietrich, Pierre-Yves] Univ Hosp Geneva, Dept Oncol, Geneva, Switzerland.
RP Radovanovic, I (reprint author), Univ Hosp Geneva, Div Neurosurg, Geneva, Switzerland.
EM ivan.radovanovic@hcuge.ch
RI Hegi, Monika/O-4796-2015; Mlynarik, Vladimir/D-8884-2011; Centre
   d'imagerie Biomedicale, CIBM/B-5740-2012; Gruetter, Rolf/H-6260-2011
OI Hegi, Monika/0000-0003-0855-6495; Gruetter, Rolf/0000-0003-1870-4025;
   Cudalbu, Cristina/0000-0003-4582-2465
FU foundations "Anita et Werner Damm-Etienne" and "Ernest and Lucie
   Schmidheiny"; Centre d'Imagerie Biomedicale of the Ecole Polytechnique
   Federale de Lausanne; University of Lausanne; University of Geneva;
   Leenaards and Jeantet foundations; European Union [MRTN-CT-2006-035801];
   Swiss National Science Foundation [3100AO-108266/1]
FX This work was supported by the foundations "Anita et Werner
   Damm-Etienne" and "Ernest and Lucie Schmidheiny" and in part by the
   Centre d'Imagerie Biomedicale of the Ecole Polytechnique Federale de
   Lausanne, the University of Lausanne, the University of Geneva and by
   the Leenaards and Jeantet foundations, as well as by Marie Curie action
   of the European Union (MRTN-CT-2006-035801) and the Swiss National
   Science Foundation (3100AO-108266/1). We thank K. Burkhardt for
   providing access to tissue sample collection and S. G. Clarkson for
   critical input.
CR Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180
   Buzzeo MP, 2007, LEUKEMIA, V21, P1619, DOI 10.1038/sj.leu.2404766
   Campbell LL, 2007, CELL CYCLE, V6, P2332, DOI 10.4161/cc.6.19.4914
   Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033
   Clement V, 2009, INT J CANCER, V125, P244, DOI 10.1002/ijc.24352
   Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7
   Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x
   Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364
   Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246
   Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949
   Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100
   Hill RP, 2006, CANCER RES, V66, P1891, DOI 10.1158/0008-5472.CAN-05-3450
   Kann O, 2003, NEUROSCIENCE, V119, P87, DOI 10.1016/S0306-4522(03)00026-5
   Kaplan RN, 2007, TRENDS MOL MED, V13, P72, DOI 10.1016/j.molmed.2006.12.003
   Kern SE, 2007, CANCER RES, V67, P8985, DOI 10.1158/0008-5472.CAN-07-1971
   Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.NEU.0000297079.43917.79
   Park DM, 2007, CELL CYCLE, V6, P467, DOI 10.4161/cc.6.4.3856
   Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019
   Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349
   Read TA, 2006, ANN NEUROL, V60, P3, DOI 10.1002/ana.20912
   Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167
   Reyes JMG, 2006, STEM CELLS, V24, P1213, DOI 10.1634/stemcells.2004-0324
   Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666
   Schuchmann S, 2001, BRAIN RES PROTOC, V7, P267, DOI 10.1016/S1385-299X(01)00080-0
   Singh SK, 2003, CANCER RES, V63, P5821
   Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128
   Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130
   Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385
   Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311
NR 29
TC 55
Z9 58
U1 3
U2 15
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1548-7091
EI 1548-7105
J9 NAT METHODS
JI Nat. Methods
PD MAR
PY 2010
VL 7
IS 3
BP 224
EP U88
DI 10.1038/NMETH.1430
PG 6
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 562NI
UT WOS:000275058200025
PM 20173750
OA Green Published
DA 2018-12-27
ER

PT J
AU El-Wakil, SA
   Abdou, MA
   El-Shewy, EK
   Hendi, A
   Abdelwahed, HG
AF El-Wakil, S. A.
   Abdou, M. A.
   El-Shewy, E. K.
   Hendi, A.
   Abdelwahed, H. G.
TI RETRACTED: (G '/G)-expansion method equivalent to the extended
   tanh-function method (Retracted article. See vol. 82, Article no.
   059803, 2010)
SO PHYSICA SCRIPTA
LA English
DT Article; Retracted Publication
ID PARTIAL-DIFFERENTIAL-EQUATIONS; TRAVELING-WAVE SOLUTIONS; EXP-FUNCTION
   METHOD; NONLINEAR EVOLUTION-EQUATIONS; PERIODIC-SOLUTIONS; MAPPING
   METHOD
AB Very recently, Wang et al (2008 Phys. Lett. A 327 417-23) proposed a method, namely the (G'/G)-expansion method, for constructing multiple travelling wave solutions of nonlinear evolution equations arising in mathematical physics. They believe that the (G'/G)-expansion method is a new method and more travelling wave solutions of many nonlinear evolution equations can be obtained. In this paper, we show that the (G'/G)-expansion method is equivalent to the extended tanh function method.
C1 [El-Wakil, S. A.; Abdou, M. A.; El-Shewy, E. K.; Abdelwahed, H. G.] Mansoura Univ, Fac Sci, Theoret Res Grp, Dept Phys, Mansoura 35516, Egypt.
   [Hendi, A.] King Saud Univ, Dept Phys, Fac Sci, Riyadh 11321, Saudi Arabia.
RP El-Wakil, SA (reprint author), Mansoura Univ, Fac Sci, Theoret Res Grp, Dept Phys, Mansoura 35516, Egypt.
EM m-abdou_eg@yahoo.com
CR Abdou MA, 2009, COMMUN NONLINEAR SCI, V14, P2, DOI 10.1016/j.cnsns.2007.06.010
   Abdou MA, 2007, COMMUN NONLINEAR SCI, V12, P1229, DOI 10.1016/j.cnsns.2006.01.013
   Abdou MA, 2008, NONLINEAR DYNAM, V52, P1, DOI 10.1007/s11071-007-9250-1
   Abdou MA, 2007, PHYS LETT A, V366, P61, DOI 10.1016/j.physleta.2007.01.073
   Abdou MA, 2006, PHYS LETT A, V353, P487, DOI 10.1016/j.physleta.2006.01.013
   ABDOU MA, 2008, INT J NONLINEAR SCI, V5, P1
   ABDOU MA, 2007, J NONLINEAR DYNAMICS, V52, P277
   Ablowitz M. J., 1991, SOLITON NONLINEAR EV
   Abulwafa EM, 2006, CHAOS SOLITON FRACT, V29, P313, DOI 10.1016/j.chaos.2005.08.044
   Ei-Wakil SA, 2008, PHYS LETT A, V372, P830, DOI 10.1016/j.physleta.2007.08.033
   El-Waki SA, 2006, PHYS LETT A, V358, P275, DOI 10.1016/j.physleta.2006.05.040
   El-Wakil SA, 2008, NONLINEAR ANAL-THEOR, V68, P235, DOI 10.1016/j.na.2006.10.045
   El-Wakil SA, 2007, CHAOS SOLITON FRACT, V31, P840, DOI 10.1016/j.chaos.2005.10.032
   El-Wakil SA, 2007, CHAOS SOLITON FRACT, V31, P1256, DOI 10.1016/j.chaos.2005.10.072
   Elwakil SA, 2002, PHYS LETT A, V299, P179, DOI 10.1016/S0375-9601(02)00669-2
   Elwakil SA, 2005, APPL MATH COMPUT, V161, P403, DOI 10.1016/j.amc.2003.12.035
   ELWAKIL SA, 2008, Z NATURFORSCH A, V63, P1
   Fan EG, 2000, PHYS LETT A, V277, P212, DOI 10.1016/S0375-9601(00)00725-8
   He J. H., 2003, GEN VARIATIONAL PRIN
   HE JH, 2006, THESIS VERLAG INTERN
   He JH, 2007, CHAOS SOLITON FRACT, V34, P1421, DOI 10.1016/j.chaos.2006.05.072
   He JH, 2006, CHAOS SOLITON FRACT, V30, P700, DOI 10.1016/j.chaos.2006.03.020
   Liu CP, 2009, COMMUN THEOR PHYS, V51, P985, DOI 10.1088/0253-6102/51/6/05
   Wang ML, 2008, APPL MATH COMPUT, V206, P321, DOI 10.1016/j.amc.2008.08.045
   Wang ML, 2008, PHYS LETT A, V372, P417, DOI 10.1016/j.physleta.2007.07.051
   Zayed EME, 2009, APPL MATH COMPUT, V212, P1, DOI 10.1016/j.amc.2009.02.009
   Zhang HQ, 2009, COMMUN NONLINEAR SCI, V14, P3220, DOI 10.1016/j.cnsns.2009.01.006
NR 27
TC 9
Z9 9
U1 2
U2 11
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0031-8949
EI 1402-4896
J9 PHYS SCRIPTA
JI Phys. Scr.
PD MAR
PY 2010
VL 81
IS 3
AR 035011
DI 10.1088/0031-8949/81/03/035011
PG 4
WC Physics, Multidisciplinary
SC Physics
GA 564NY
UT WOS:000275223000011
DA 2018-12-27
ER

PT J
AU Clair, B
   Almeras, T
   Pilate, G
   Jullien, D
   Sugiyama, J
   Riekel, C
AF Clair, Bruno
   Almeras, Tancrede
   Pilate, Gilles
   Jullien, Delphine
   Sugiyama, Junji
   Riekel, Christian
TI RETRACTED: Maturation Stress Generation in Poplar Tension Wood Studied
   by Synchrotron Radiation Microdiffraction (Retracted Article. See vol
   154, pg 1013, 2010)
SO PLANT PHYSIOLOGY
LA English
DT Article; Retracted Publication
ID CELLULOSE CRYSTALLITE WIDTH; X-RAY MICRODIFFRACTION; FIBER-TYPE
   SYMMETRY; GROWTH STRESSES; GELATINOUS LAYER; CELL-WALLS;
   PHYSICAL-PROPERTIES; MICROFIBRIL ANGLE; NORWAY SPRUCE;
   EUCALYPTUS-GLOBULUS
AB Tension wood is widespread in the organs of woody plants. During its formation, it generates a large tensile mechanical stress, called maturation stress. Maturation stress performs essential biomechanical functions such as optimizing the mechanical resistance of the stem, performing adaptive movements, and ensuring long-term stability of growing plants. Although various hypotheses have recently been proposed, the mechanism generating maturation stress is not yet fully understood. In order to discriminate between these hypotheses, we investigated structural changes in cellulose microfibrils along sequences of xylem cell differentiation in tension and normal wood of poplar (Populus deltoides x Populus trichocarpa 'I45-51'). Synchrotron radiation microdiffraction was used to measure the evolution of the angle and lattice spacing of crystalline cellulose associated with the deposition of successive cell wall layers. Profiles of normal and tension wood were very similar in early development stages corresponding to the formation of the S1 and the outer part of the S2 layer. The microfibril angle in the S2 layer was found to be lower in its inner part than in its outer part, especially in tension wood. In tension wood only, this decrease occurred together with an increase in cellulose lattice spacing, and this happened before the G-layer was visible. The relative increase in lattice spacing was found close to the usual value of maturation strains, strongly suggesting that microfibrils of this layer are put into tension and contribute to the generation of maturation stress.
C1 [Clair, Bruno; Almeras, Tancrede; Jullien, Delphine] Univ Montpellier 2, Lab Mecan & Genie Civil, CNRS, F-34095 Montpellier, France.
   [Pilate, Gilles] INRA, Ameliorat Genet & Physiol Forestieres UR588, F-45075 Orleans 2, France.
   [Sugiyama, Junji] Kyoto Univ, Res Inst Sustainable Humanosphere, Kyoto 6110011, Japan.
   [Riekel, Christian] European Synchrotron Radiat Facil, F-38043 Grenoble, France.
RP Clair, B (reprint author), Univ Montpellier 2, Lab Mecan & Genie Civil, CNRS, F-34095 Montpellier, France.
EM clair@lmgc.univ-montp2.fr
RI Bruno, Clair/B-7503-2013
OI Pilate, Gilles/0000-0003-4802-8849
CR Almeras T, 2005, HOLZFORSCHUNG, V59, P347, DOI 10.1515/HF.2005.057
   Almeras T, 2009, J THEOR BIOL, V256, P370, DOI 10.1016/j.jtbi.2008.10.011
   Almeras T, 2006, J WOOD SCI, V52, P452, DOI 10.1007/s10086-005-0788-6
   Archer RR, 1986, GROWTH STRESSES STRA
   BAMBER RK, 1987, IAWA BULL, V8, P80, DOI 10.1163/22941932-90001032
   Bamber RK, 2001, IAWA J, V22, P205, DOI 10.1163/22941932-90000279
   Blanton T.N., 1995, POWDER DIFFR, V10, P91, DOI DOI 10.1017/S0885715600014421
   Bowling AJ, 2008, AM J BOT, V95, P655, DOI 10.3732/ajb.2007368
   Bowling AJ, 2009, AM J BOT, V96, P719, DOI 10.3732/ajb.0800373
   BOYD JD, 1972, WOOD SCI TECHNOL, V6, P251, DOI 10.1007/BF00357047
   CAVE I. D., 1966, FOREST PRODJ, V16, P37
   Cave ID, 1997, WOOD SCI TECHNOL, V31, P225, DOI 10.1007/s002260050030
   Cave ID, 1997, WOOD SCI TECHNOL, V31, P143, DOI 10.1007/s002260050023
   Chang SS, 2009, J EXP BOT, V60, P3023, DOI 10.1093/jxb/erp133
   Clair B, 2005, IAWA J, V26, P189, DOI 10.1163/22941932-90000110
   Clair B, 2003, HOLZFORSCHUNG, V57, P189, DOI 10.1515/HF.2003.028
   Clair B, 2001, IAWA J, V22, P121, DOI 10.1163/22941932-90000273
   Clair B, 2008, BIOMACROMOLECULES, V9, P494, DOI 10.1021/bm700987q
   Clair B, 2006, IAWA J, V27, P329, DOI 10.1163/22941932-90000158
   Clair B, 2006, BIOPHYS J, V91, P1128, DOI 10.1529/biophysj.105.078485
   Davidson TC, 2004, CARBOHYD RES, V339, P2889, DOI 10.1016/j.carres.2004.10.005
   Donaldson L, 2005, TREES-STRUCT FUNCT, V19, P644, DOI 10.1007/s00468-005-0428-1
   Fang CH, 2008, IAWA J, V29, P237, DOI 10.1163/22941932-90000183
   Fang CH, 2007, WOOD SCI TECHNOL, V41, P659, DOI 10.1007/s00226-007-0148-3
   Fisher JB, 2008, AM J BOT, V95, P1337, DOI 10.3732/ajb.0800083
   FOURNIER M, 1991, ANN SCI FOREST, V48, P527, DOI 10.1051/forest:19910504
   Fujita M., 1974, Mokuzai Gakkaishi (Journal of the Japan Wood Research Society), V20, P147
   Goswami L, 2008, PLANT J, V56, P531, DOI 10.1111/j.1365-313X.2008.03617.x
   Hori R, 2000, WOOD RES, V87, P19
   Ishikawa A, 1997, POLYMER, V38, P463, DOI 10.1016/S0032-3861(96)00516-2
   Jourez B, 2001, IAWA J, V22, P133, DOI 10.1163/22941932-90000274
   Kennedy CJ, 2007, CELLULOSE, V14, P235, DOI 10.1007/s10570-007-9116-1
   Mellerowicz EJ, 2008, ANN BOT-LONDON, V102, P659, DOI 10.1093/aob/mcn170
   Mellerowicz EJ, 2008, CURR OPIN PLANT BIOL, V11, P293, DOI 10.1016/j.pbi.2008.03.003
   Moulia B, 2006, AM J BOT, V93, P1477, DOI 10.3732/ajb.93.10.1477
   Muller M, 2006, HOLZFORSCHUNG, V60, P474, DOI 10.1515/HF.2006.078
   Muller M, 2002, BIOMACROMOLECULES, V3, P182, DOI 10.1021/bm015605h
   Munch E, 1938, FLORA, V32, P357
   Nakai T, 2005, J WOOD SCI, V51, P193, DOI 10.1007/s10086-005-0697-8
   Nishikubo N, 2007, PLANT CELL PHYSIOL, V48, P843, DOI 10.1093/pcp/pcm055
   Nishiyama Y, 2009, J WOOD SCI, V55, P241, DOI 10.1007/s10086-009-1029-1
   Okuyama T., 1995, Mokuzai Gakkaishi = Journal of the Japan Wood Research Society, V41, P1070
   OKUYAMA T, 1994, ANN SCI FOREST, V51, P291, DOI 10.1051/forest:19940308
   ONAKA F, 1949, MOKUZAI KENKYU, V1, P1
   Peura M, 2005, NUCL INSTRUM METH B, V238, P16, DOI 10.1016/j.nimb.2005.06.011
   Peura M, 2008, TREES-STRUCT FUNCT, V22, P499, DOI 10.1007/s00468-008-0210-2
   Peura M, 2008, TREES-STRUCT FUNCT, V22, P49, DOI 10.1007/s00468-007-0168-5
   Peura M, 2007, WOOD SCI TECHNOL, V41, P565, DOI 10.1007/s00226-007-0141-x
   Pilate G, 2004, CR BIOL, V327, P889, DOI 10.1016/j.crvi.2004.07.006
   Riekel C, 2000, REP PROG PHYS, V63, P233, DOI 10.1088/0034-4885/63/3/201
   Ruelle J, 2007, BIORESOURCES, V2, P235
   Washusen R, 2005, WOOD SCI TECHNOL, V39, P569, DOI 10.1007/s00226-005-0012-2
   Washusen R, 2001, IAWA J, V22, P235, DOI 10.1163/22941932-90000281
   Yamamoto H, 1998, WOOD SCI TECHNOL, V32, P171
   Yamamoto H, 2005, J WOOD SCI, V51, P222, DOI 10.1007/s10086-004-0639-x
   Yamamoto H, 2004, J WOOD SCI, V50, P197, DOI 10.1007/s10086-003-0556-4
NR 56
TC 12
Z9 12
U1 6
U2 28
PU AMER SOC PLANT BIOLOGISTS
PI ROCKVILLE
PA 15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA
SN 0032-0889
J9 PLANT PHYSIOL
JI Plant Physiol.
PD MAR
PY 2010
VL 152
IS 3
BP 1650
EP 1658
DI 10.1104/pp.109.149542
PG 9
WC Plant Sciences
SC Plant Sciences
GA 578XG
UT WOS:000276329500042
PM 20071605
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Bezouska, K
   Snajdrova, R
   Krenek, K
   Vancurova, M
   Kadek, A
   Adamek, D
   Lhotak, P
   Kavan, D
   Hofbauerova, K
   Man, P
   Bojarova, P
   Kren, V
AF Bezouska, Karel
   Snajdrova, Renata
   Krenek, Karel
   Vancurova, Marketa
   Kadek, Alan
   Adamek, David
   Lhotak, Pavel
   Kavan, Daniel
   Hofbauerova, Katerina
   Man, Petr
   Bojarova, Pavla
   Kren, Vladimir
TI RETRACTED: Carboxylated calixarenes bind strongly to CD69 and protect
   CD69(+) killer cells from suicidal cell death induced by tumor cell
   surface ligands (Retracted article. See vol. 22, pg. 3227, 2014)
SO BIOORGANIC & MEDICINAL CHEMISTRY
LA English
DT Article; Retracted Publication
DE Carboxylated calixarenes; Lymphocyte activation; Receptor cross-linking;
   Apoptosis
ID TYROSINE SULFATION; HUMAN EOSINOPHILS; P-SELECTIN; ACTIVATION; NKR-P1;
   LYMPHOCYTES; APOPTOSIS; RECEPTOR; MOLECULE; CALCIUM
AB We have recently identified a new class of high affinity ligands for CD69 leukocyte membrane receptor, carboxylated calixarenes. Of the three compounds investigated here, thiacalix[4] arene had the highest affinity for CD69 in direct binding assays, and proved to be the most specific inhibitor of CD69 identified so far in receptor precipitation and cellular activation experiments. Carboxylated calixarenes also proved effective at protection of CD69(high) lymphocytes from apoptosis triggered by a multivalent ligand or antibody. Thus, carboxylated calixarenes set a new paradigm for noncarbohydrate ligands for CD69 making them attractive for protection of killer cells in combined animal tumor therapies. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Bezouska, Karel; Snajdrova, Renata; Krenek, Karel; Vancurova, Marketa; Kadek, Alan; Adamek, David; Kavan, Daniel; Man, Petr; Bojarova, Pavla] Charles Univ Prague, Fac Sci, Dept Biochem, CZ-12840 Prague 2, Czech Republic.
   [Bezouska, Karel; Krenek, Karel; Vancurova, Marketa; Kavan, Daniel; Hofbauerova, Katerina; Man, Petr; Bojarova, Pavla; Kren, Vladimir] Acad Sci Czech Republic, Inst Microbiol Vvi, CZ-14220 Prague 4, Czech Republic.
   [Lhotak, Pavel] Inst Chem Technol, CZ-16628 Prague 6, Czech Republic.
RP Bezouska, K (reprint author), Charles Univ Prague, Fac Sci, Dept Biochem, Hlavova 8, CZ-12840 Prague 2, Czech Republic.
EM bezouska@biomed.cas.cz
RI Kren, Vladimir/H-8461-2014; Lhotak, Pavel/J-6989-2018; Kadek,
   Alan/J-6159-2014; Kavan, Daniel/J-9703-2014
OI Lhotak, Pavel/0000-0003-3617-6596; Kadek, Alan/0000-0002-7953-5870;
   Kavan, Daniel/0000-0003-2693-1199; Hofbauerova,
   Katerina/0000-0001-7608-793X; Man, Petr/0000-0002-1485-2197
FU Ministry of Education of the Czech Republic [MSM_21620808, OC136 and
   1M0505]; Institutional Research Concept [AVOZ 50200510]; Agency of the
   Czech Republic [303/09/0477, 305/09/H008)]; Agency of the Academy of
   Sciences of the Czech Republic [IAA400200503, KJB500200612]
FX The authors acknowledge the technical help by Michal Navratil, and the
   contributions by the reviewers of the paper in improving the quality of
   the presentation. This work was supported in part by the Ministry of
   Education of the Czech Republic (MSM_21620808, OC136 and 1M0505), by the
   Institutional Research Concept for the Institute of Microbiology (AVOZ
   50200510), and by grants from the Grant Agency of the Czech Republic
   (303/09/0477 and 305/09/H008) and from Grant Agency of the Academy of
   Sciences of the Czech Republic (IAA400200503 and KJB500200612).
CR Andre S, 2008, CHEMBIOCHEM, V9, P1649, DOI 10.1002/cbic.200800035
   Anthony RS, 1998, BONE MARROW TRANSPL, V21, P441, DOI 10.1038/sj.bmt.1701134
   Baldini L, 2007, CHEM SOC REV, V36, P254, DOI 10.1039/b603082n
   BEZOUSKA K, 1994, J BIOL CHEM, V269, P16945
   BEZOUSKA K, 1995, BIOCHEM BIOPH RES CO, V208, P68, DOI 10.1006/bbrc.1995.1306
   BEZOUSKA K, 1994, NATURE, V372, P150, DOI 10.1038/372150a0
   Bojarova P, 2009, GLYCOBIOLOGY, V19, P509, DOI 10.1093/glycob/cwp010
   CHIPMAN DM, 1967, J BIOL CHEM, V242, P4388
   Esplugues E, 2003, J EXP MED, V197, P1093, DOI 10.1084/jem.20021337
   Fialova P, 2005, ADV SYNTH CATAL, V347, P997, DOI 10.1002/adsc.200505041
   Fieger CB, 2003, J BIOL CHEM, V278, P27390, DOI 10.1074/jbc.M304204200
   Foerster M, 2002, SCAND J IMMUNOL, V56, P417, DOI 10.1046/j.1365-3083.2002.01111.x
   GIORDA R, 1990, SCIENCE, V249, P1298, DOI 10.1126/science.2399464
   Gordo S, 2008, P NATL ACAD SCI USA, V105, P16426, DOI 10.1073/pnas.0805658105
   Holmberg Leona A, 2004, Expert Rev Vaccines, V3, P655, DOI 10.1586/14760584.3.6.655
   Kircheis R, 2005, BIOCONJUGATE CHEM, V16, P1519, DOI 10.1021/bc050157m
   Krenek K, 2007, CARBOHYD RES, V342, P1781, DOI 10.1016/j.carres.2007.04.026
   Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581
   Leppanen A, 2003, J BIOL CHEM, V278, P26391, DOI 10.1074/jbc.M303551200
   Lhotak P, 2000, COLLECT CZECH CHEM C, V65, P757, DOI 10.1135/cccc20000757
   Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417
   Martos V, 2009, P NATL ACAD SCI USA, V106, P10482, DOI 10.1073/pnas.0813396106
   MORETTA A, 1991, J EXP MED, V174, P1393, DOI 10.1084/jem.174.6.1393
   North J, 2007, J IMMUNOL, V178, P85, DOI 10.4049/jimmunol.178.1.85
   Pavlicek J, 2003, BIOCHEMISTRY-US, V42, P9295, DOI 10.1021/bi0272981
   Pospisil M, 2000, INT J ONCOL, V16, P267
   POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4
   Ragupathi G, 1999, CANCER IMMUNOL IMMUN, V48, P1, DOI 10.1007/s002620050542
   Ramirez R, 1996, CELL IMMUNOL, V172, P192, DOI 10.1006/cimm.1996.0232
   RISSO A, 1991, J IMMUNOL, V146, P4105
   RYAN JC, 1991, J IMMUNOL, V147, P3244
   Sambrook J., 1989, MOL CLONING LAB MANU
   Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006
   Stastny V, 2004, TETRAHEDRON, V60, P3383, DOI 10.1016/j.tet.2004.036
   Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580
   TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7
   Vanek O, 2008, FEBS J, V275, P5589, DOI 10.1111/j.1742-4658.2008.06683.x
   Vannucci L, 2003, INT J ONCOL, V23, P285
   VIVIER E, 2008, NAT IMMUNOL, V9, P504
   Walsh GM, 1996, BLOOD, V87, P2815
   Zhou HC, 2006, ORG BIOMOL CHEM, V4, P2376, DOI 10.1039/b515483a
   Zlatuskova P, 2004, TETRAHEDRON, V60, P11383, DOI 10.1016/j.tet.2004.09.088
NR 42
TC 20
Z9 20
U1 1
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-0896
EI 1464-3391
J9 BIOORGAN MED CHEM
JI Bioorg. Med. Chem.
PD FEB 15
PY 2010
VL 18
IS 4
BP 1434
EP 1440
DI 10.1016/j.bmc.2010.01.015
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry,
   Organic
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry
GA 554HG
UT WOS:000274425500008
PM 20116265
DA 2018-12-27
ER

PT J
AU Pan, FS
   Yang, MB
   Cheng, L
AF Pan, Fusheng
   Yang, Mingbo
   Cheng, Liang
TI RETRACTED: Effects of minor scandium on as-cast microstructure,
   mechanical properties and casting fluidity of ZA84 magnesium
   alloy(Retracted article. See vol. 587, pg. 397, 2013)
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Retracted Publication
DE Magnesium alloy; Mg-Zn-Al alloys; ZA84 alloy; Sc addition
ID ZN-AL ALLOYS; CREEP DEFORMATION; TEMPERATURE; SC
AB The effects of minor Sc on the as-cast microstructure, mechanical properties and casting fluidity of the ZA84 magnesium alloy were investigated. The results indicate that the Mg-32(Al,Zn)(49) phase in the ZA84 alloy is refined with the addition of 0.12-0.35 wt.% Sc, and the formation of the Mg-32(Al,Zn)(49) phase is suppressed. An increase in Sc amount from 0.12 wt.% to 0.35 wt.% causes the morphology of the Mg-32(Al,Zn)(49) phase to gradually change from coarse continuous and/or quasi-continuous net to relatively fine quasi-continuous and/or disconnected shapes. In addition, it is shown that the tensile and creep properties of the ZA84 alloy are improved, but the casting fluidity of the alloy is decreased with the addition of 0.12-0.35 wt.% Sc. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Yang, Mingbo; Cheng, Liang] Chongqing Univ Technol, Mat Sci & Engn Coll, Chongqing 400050, Peoples R China.
   [Pan, Fusheng] Chongqing Univ, Natl Engn Res Ctr Magnesium Alloys, Chongqing 400045, Peoples R China.
RP Yang, MB (reprint author), Chongqing Univ Technol, Mat Sci & Engn Coll, Chongqing 400050, Peoples R China.
EM yangmingbo@cqut.edu.cn
FU National Natural Science Foundation of China [50725413]; National Basic
   Research Program of China (973 Program) [2007CB613704]; Chongqing
   Education Commission in China [KJ090628]
FX The present work was supported by the National Natural Science
   Foundation of China (No. 50725413) and the National Basic Research
   Program of China (973 Program) (No. 2007CB613704), and the Chongqing
   Education Commission in China (KJ090628).
CR Balasubramani N, 2008, J ALLOY COMPD, V457, P118, DOI [10.1016/j.jallcom.2007.02.147, 10.1016/j.jailcom.2007.02.147]
   Balasubramani NB, 2008, J ALLOY COMPD, V455, P168, DOI 10.1016/j.jallcom.2007.01.031
   Bourgeois L, 2001, ACTA MATER, V49, P2701, DOI 10.1016/S1359-6454(01)00162-8
   Chen JH, 2008, J ALLOY COMPD, V461, P209, DOI 10.1016/j.jallcom.2007.07.066
   Grobner J, 2001, J ALLOY COMPD, V320, P296, DOI 10.1016/S0925-8388(00)01480-8
   LUO A, 1994, J MATER SCI, V29, P5259, DOI 10.1007/BF01171534
   Mordike BL, 2005, METALL MATER TRANS A, V36A, P1729, DOI 10.1007/s11661-005-0037-z
   Ravi KR, 2008, J ALLOY COMPD, V456, P201, DOI 10.1016/j.jallcom.2007.02.038
   Wang YX, 2006, MAT SCI ENG A-STRUCT, V416, P109, DOI 10.1016/j.msea.2005.09.104
   Wu HY, 2009, J ALLOY COMPD, V474, P158, DOI 10.1016/j.jallcom.2008.06.145
   Xiao DH, 2009, J ALLOY COMPD, V484, P416, DOI 10.1016/j.jallcom.2009.04.113
   Xiao Daihong, 2008, Special Casting & Nonferrous Alloys, V28, P332
   Yang MB, 2008, INT J CAST METAL RES, V21, P364, DOI 10.1179/136404608X336411
   Yang MB, 2005, MATER SCI FORUM, V488-489, P923, DOI 10.4028/www.scientific.net/MSF.488-489.923
   Yang MB, 2008, T NONFERR METAL SOC, V18, P566, DOI 10.1016/S1003-6326(08)60099-0
   Yao SJ, 2007, MATER SCI FORUM, V546-549, P139, DOI 10.4028/www.scientific.net/MSF.546-549.139
   Zhang Z, 2000, CAN METALL QUART, V39, P503, DOI 10.1179/cmq.2000.39.4.503
   Zhang Z, 1998, SCRIPTA MATER, V39, P45, DOI 10.1016/S1359-6462(98)00122-5
   Zhu SM, 2008, MAT SCI ENG A-STRUCT, V483-84, P583, DOI 10.1016/j.msea.2006.09.154
NR 19
TC 4
Z9 7
U1 4
U2 24
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD FEB 15
PY 2010
VL 527
IS 4-5
BP 1074
EP 1081
DI 10.1016/j.msea.2009.09.025
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 548RM
UT WOS:000273983900031
DA 2018-12-27
ER

PT J
AU Schuerwegh, AJM
   Ioan-Facsinay, A
   Dorjee, AL
   Roos, J
   Bajema, IM
   van der Voort, EIH
   Huizinga, TWJ
   Toes, REM
AF Schuerwegh, A. J. M.
   Ioan-Facsinay, A.
   Dorjee, A. L.
   Roos, J.
   Bajema, I. M.
   van der Voort, E. I. H.
   Huizinga, T. W. J.
   Toes, R. E. M.
TI RETRACTED: Evidence for a functional role of IgE anticitrullinated
   protein antibodies in rheumatoid arthritis (Retracted article. See vol.
   110, pg. 20345, 2013)
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article; Retracted Publication
DE basophil; histamine; mast cell; citrullination; synovium
ID CYCLIC CITRULLINATED PEPTIDE; MAST-CELLS; IMMUNE-COMPLEXES;
   AUTOANTIBODIES; DISEASE; CLASSIFICATION; INFLAMMATION; SPECIFICITY;
   PROGRESSION; ASSOCIATION
AB Rheumatoid arthritis (RA) is a systemic autoimmune disease involving inflammation of the joints. Among the autoantibodies described in RA, anticitrullinated protein antibodies (ACPAs) are highly specific and predictive for RA. In addition, ACPAs have been implicated in the pathogenesis of RA. However, a direct functional response of immune cells from ACPA(+) RA patients toward citrullinated proteins has not been demonstrated. In this study, we show that exposure to citrullinated antigens leads to activation of basophils from ACPA(+) RA patients within 20 minutes. This was not observed after exposure of basophils to noncitrullinated control antigens or after stimulation of basophils from ACPA-RA patients and healthy controls. Basophil activation was correlated with the binding of citrullinated proteins to basophils. Furthermore, serum from ACPA(+) RA patients in contrast to that from ACPA-RA patients could specifically sensitize human Fc epsilon RI expressing rat basophil cells (RBL), enabling activation by citrullinated proteins. Mast cell degranulation products such as histamine levels were enhanced in synovial fluid of ACPA(+) RA patients as compared with ACPA-RA and osteoarthritis patients. In addition, histamine levels in synovial fluid from ACPA(+) RA patients correlated with IgE levels, suggesting degranulation of mast cells by cross-linking IgE. Immunohistochemistry on synovial biopsies demonstrated an increased number of degranulated CD117(+) mast cells in ACPA(+) RA patients; IgE and Fc epsilon RI expression in synovial mast cells from ACPA(+) RA patients was increased. In conclusion, our results show an immunological response of immune cells from ACPA(+) RA patients in a citrulline-specific manner. Moreover, these data indicate a role for IgE-ACPAs and Fc epsilon RI-positive cells in the pathogenesis of RA.
C1 [Schuerwegh, A. J. M.; Ioan-Facsinay, A.; Dorjee, A. L.; van der Voort, E. I. H.; Huizinga, T. W. J.; Toes, R. E. M.] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands.
   [Bajema, I. M.] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands.
   [Roos, J.] Leiden Univ, Med Ctr, Cent Med Immunol Lab, NL-2300 RC Leiden, Netherlands.
RP Schuerwegh, AJM (reprint author), Leiden Univ, Med Ctr, Dept Rheumatol, Albinusdreef 2,POB 9600, NL-2300 RC Leiden, Netherlands.
EM a.j.m.schuerwegh@lumc.nl
FU ZonMw; Dutch Organization for Scientific Research; Research Foundation
   Sole Mio; Leiden Research Foundation (STROL); Centre for Medical Systems
   Biology; FP06 AUTOCURE; FP07 MASTERSWITCH; Dutch Arthritis Foundation
FX We thank A. C. van der Linden (Leiden University Medical Center), J.H.
   Lens (Leiden University Medical Center), and Prof. D. G. Ebo and C. H.
   Bridts (Unite Associee, Belgium). RBLs were a gift from Dr. L. Vogel
   (Langen, Germany). Prof. Dr. R. G. H. H Nellissen and colleagues (Leiden
   University Medical Center) are thanked for synovium tissue sampling. R.
   E. M. T. is supported by the Dutch Organization for Scientific Research
   (VIDI and VICI grants). A.J.M.S. is supported by ZonMw (Clinical Fellow
   grant), the Dutch Organization for Scientific Research, the Research
   Foundation Sole Mio, and the Leiden Research Foundation (STROL). This
   study was supported by a grant from the Centre for Medical Systems
   Biology within the framework of the Netherlands Genomics Initiative,
   FP06 AUTOCURE, FP07 MASTERSWITCH, and the Dutch Arthritis Foundation.
CR ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816
   ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302
   BARTHOLOMEW JS, 1991, RHEUMATOL INT, V11, P37, DOI 10.1007/BF00290249
   Clavel C, 2008, ARTHRITIS RHEUM-US, V58, P678, DOI 10.1002/art.23284
   CRISP AJ, 1984, ARTHRITIS RHEUM, V27, P845, DOI 10.1002/art.1780270802
   DECLERCK LS, 1989, CLIN EXP RHEUMATOL, V7, P485
   Dimson OG, 2003, J INVEST DERMATOL, V120, P784, DOI 10.1046/j.1523-1747.2003.12146.x
   Ding B, 2009, ARTHRITIS RHEUM, V60, P30, DOI 10.1002/art.24135
   Ebo DG, 2006, ALLERGY, V61, P1028, DOI 10.1111/j.1398-9995.2006.01039.x
   Fairley JA, 2007, J INVEST DERMATOL, V127, P2605, DOI 10.1038/sj.jid.5700958
   Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204
   Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385
   Ioan-Facsinay A, 2002, IMMUNITY, V16, P391, DOI 10.1016/S1074-7613(02)00294-7
   Ioan-Facsinay A, 2008, ARTHRITIS RHEUM, V58, P3000, DOI 10.1002/art.23763
   Kraan TCTMV, 2003, ARTHRITIS RHEUM-US, V48, P2132, DOI 10.1002/art.11096
   Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422
   Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176
   MacGlashan D, 1998, BLOOD, V91, P1633
   MALONE DG, 1986, ARTHRITIS RHEUM, V29, P956, DOI 10.1002/art.1780290803
   MALONE DG, 1988, ARTHRITIS RHEUM, V31, P1063, DOI 10.1002/art.1780310820
   MARCELLETTI JF, 1991, J IMMUNOL, V147, P4185
   MERETEY K, 1982, ANN RHEUM DIS, V41, P405, DOI 10.1136/ard.41.4.405
   Meyer O, 2003, ANN RHEUM DIS, V62, P120, DOI 10.1136/ard.62.2.120
   Nigrovic PA, 2007, P NATL ACAD SCI USA, V104, P2325, DOI 10.1073/pnas.0610852103
   Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015
   Schellekens GA, 2000, ARTHRITIS RHEUM, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3
   Uysal H, 2009, J EXP MED, V206, P449, DOI 10.1084/jem.20081862
   van Aken J, 2003, CLIN EXP RHEUMATOL, V21, pS100
   van der Helm-van Mil AHM, 2005, ARTHRITIS RES THER, V7, pR949, DOI 10.1186/ar1767
   van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P709, DOI 10.1002/art.20044
   van Oosterhout M, 2008, ARTHRITIS RHEUM, V58, P53, DOI 10.1002/art.23148
   Verpoort KN, 2005, ARTHRITIS RHEUM, V52, P3058, DOI 10.1002/art.21302
   Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x
   Yamaguchi M, 1999, J IMMUNOL, V162, P5455
   Youssef PP, 1998, ARTHRITIS RHEUM, V41, P663, DOI 10.1002/1529-0131(199804)41:4<663::AID-ART13>3.3.CO;2-C
NR 35
TC 58
Z9 63
U1 3
U2 14
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 9
PY 2010
VL 107
IS 6
BP 2586
EP 2591
DI 10.1073/pnas.0913054107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 554AO
UT WOS:000274408100042
PM 20133791
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Lee, JH
   Kim, SH
   Pascua, PNQ
   Song, MS
   Baek, YH
   Jin, X
   Choi, JK
   Kim, CJ
   Kim, H
   Choi, YK
AF Lee, Jun Han
   Kim, Sung-Hak
   Pascua, Philippe Noriel Q.
   Song, Min-Suk
   Baek, Yun Hee
   Jin, Xun
   Choi, Joong-Kook
   Kim, Chul-Joong
   Kim, Hyunggee
   Choi, Young Ki
TI RETRACTED: Direct interaction of cellular hnRNP-F and NS1 of influenza A
   virus accelerates viral replication by modulation of viral
   transcriptional activity and host gene expression (Retracted article.
   See vol. 436, pg. 245, 2013)
SO VIROLOGY
LA English
DT Article; Retracted Publication
DE hnRNP-F; Immunoprecipitation; Influenza A virus; NS1; Virus replication
ID RNA-BINDING PROTEINS; PRE-MESSENGER-RNAS; DOUBLE-STRANDED-RNA;
   TRANSLATION INITIATION; NUCLEAR EXPORT; INFECTED-CELLS;
   NUCLEOCYTOPLASMIC TRANSPORT; POLYMERASE COMPLEX; EFFECTOR DOMAIN; SITE
AB To investigate novel NS1-interacting proteins, we conducted a yeast two-hybrid analysis, followed by co-immunoprecipitation assays. We identified heterogeneous nuclear ribonucleoprotein F (hnRNP-F) as a Cellular protein interacting with NS1 during influenza A virus infection. Co-precipitation assays suggest that interaction between hnRNP-F and NS1 is a common and direct event among human or avian influenza viruses. NS1 and hnRNP-F co-localize in the nucleus of host cells, and the RNA-binding domain of NS1 directly interacts with the GY-rich region of hnRNP-F determined by GST pull-down assays with truncated proteins. Importantly, hnRNP-F expression levels in host cells indicate regulatory role on virus replication. hnRNP-F depletion by small interfering RNA (siRNA) shows 10- to 100-fold increases in virus titers corresponding to enhanced viral RNA polymerase activity. Our results delineate novel mechanism of action by which NS1 accelerates influenza virus replication by modulating normal cellular mRNA processes through direct interaction with cellular hnRNP-F protein. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Kim, Sung-Hak; Jin, Xun; Kim, Hyunggee] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136713, South Korea.
   [Lee, Jun Han; Pascua, Philippe Noriel Q.; Song, Min-Suk; Baek, Yun Hee; Choi, Joong-Kook; Choi, Young Ki] Chungbuk Natl Univ, Coll Med, Cheongju 361763, South Korea.
   [Lee, Jun Han; Pascua, Philippe Noriel Q.; Song, Min-Suk; Baek, Yun Hee; Choi, Joong-Kook; Choi, Young Ki] Chungbuk Natl Univ, Med Res Inst, Cheongju 361763, South Korea.
   [Kim, Chul-Joong] Chungnam Natl Univ, Coll Vet Med, Taejon 305764, South Korea.
RP Kim, H (reprint author), Korea Univ, Sch Life Sci & Biotechnol, Seoul 136713, South Korea.
EM hg-kim@korea.ac.kr; choiki55@chungbuk.ac.kr
RI Kim, Hyunggee/F-2673-2013
OI Kim, Hyunggee/0000-0002-4738-0990; jin, xun/0000-0002-1550-2199
FU National Research Foundation of Korea [E00375]; Korea Research Council
   of Fundamental Science Technology; KRIBB Initiative Program [NTM1300811]
FX This work was supported by grant E00375 from the National Research
   Foundation of Korea and in part by an NAP grant from Korea Research
   Council of Fundamental Science & Technology and KRIBB Initiative Program
   (NTM1300811).
CR Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000
   BIAMONTI G, 1994, FEBS LETT, V340, P1, DOI 10.1016/0014-5793(94)80162-2
   Bolinger C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-8
   BURD CG, 1989, P NATL ACAD SCI USA, V86, P9788, DOI 10.1073/pnas.86.24.9788
   Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0
   DELALUNA S, 1995, J VIROL, V69, P2427
   Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003
   DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445
   ENAMI K, 1994, J VIROL, V68, P1432
   FORTES P, 1994, EMBO J, V13, P704, DOI 10.1002/j.1460-2075.1994.tb06310.x
   Garaigorta U, 2007, NUCLEIC ACIDS RES, V35, P4573, DOI 10.1093/nar/gkm230
   GREENSPAN D, 1988, J VIROL, V62, P3020
   Gupta AK, 1998, J VIROL, V72, P8532
   Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0
   Hale BG, 2008, VIROLOGY, V378, P1, DOI 10.1016/j.virol.2008.05.026
   Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103
   HERZ C, 1981, CELL, V26, P391, DOI 10.1016/0092-8674(81)90208-7
   Honore B, 2004, EXP CELL RES, V294, P199, DOI 10.1016/j.yexcr.2003.11.011
   Hwang B, 2009, BIOCHEM BIOPH RES CO, V378, P584, DOI 10.1016/j.bbrc.2008.11.091
   Jablonski JA, 2009, J VIROL, V83, P981, DOI 10.1128/JVI.01801-08
   Jackel-Cram C, 2007, J HEPATOL, V46, P999, DOI 10.1016/j.jhep.2006.10.019
   Jorba N, 2008, PROTEOMICS, V8, P2077, DOI 10.1002/pmic.200700508
   Kash JC, 2006, VIRUS RES, V119, P111, DOI 10.1016/j.virusres.2005.10.013
   Kawaoka Y, 1998, VIRUS RES, V55, P143, DOI 10.1016/S0168-1702(98)00038-0
   Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-07
   Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9
   Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3
   Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005
   Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864
   Lin JY, 2009, J VIROL, V83, P6106, DOI 10.1128/JVI.02476-08
   LU Y, 1994, GENE DEV, V8, P1817, DOI 10.1101/gad.8.15.1817
   MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059
   Michael WM, 1995, COLD SPRING HARB SYM, V60, P663, DOI 10.1101/SQB.1995.060.01.071
   Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103
   Murayama R, 2007, BIOCHEM BIOPH RES CO, V362, P880, DOI 10.1016/j.bbrc.2007.08.091
   Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4
   Newby CM, 2007, J VIROL, V81, P9469, DOI 10.1128/JVI.00989-07
   Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7
   Noisakran S, 2008, BIOCHEM BIOPH RES CO, V372, P67, DOI 10.1016/j.bbrc.2008.04.165
   Paek KY, 2008, J VIROL, V82, P12082, DOI 10.1128/JVI.01405-08
   Paragas J, 2001, J VIROL, V75, P7375, DOI 10.1128/JVI.75.16.7375-7383.2001
   PETRI T, 1982, J GEN VIROL, V61, P217, DOI 10.1099/0022-1317-61-2-217
   Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938
   Shimizu K, 1999, VIROLOGY, V254, P213, DOI 10.1006/viro.1998.9555
   Sikora D, 2009, VIROLOGY, V390, P71, DOI 10.1016/j.virol.2009.04.022
   Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396
   Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542
   Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08
   WEBSTER RG, 1992, MICROBIOL REV, V56, P152
   Wolff T, 1998, J VIROL, V72, P7170
   Yin CF, 2007, J BIOL CHEM, V282, P20584, DOI 10.1074/jbc.M611619200
   Yoshida T, 1999, GENES CELLS, V4, P707, DOI 10.1046/j.1365-2443.1999.00295.x
   Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169
NR 53
TC 12
Z9 14
U1 2
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD FEB 5
PY 2010
VL 397
IS 1
BP 89
EP 99
DI 10.1016/j.virol.2009.10.041
PG 11
WC Virology
SC Virology
GA 550MS
UT WOS:000274132700011
PM 19926108
OA Bronze
DA 2018-12-27
ER

PT J
AU Abu-Hilal, MA
   Mookadam, F
AF Abu-Hilal, Mohannad A.
   Mookadam, Farouk
TI RETRACTED: Pulsus paradoxus; historical and clinical perspectives
   (Retracted article. See vol. 150, pg. 121, 2011)
SO INTERNATIONAL JOURNAL OF CARDIOLOGY
LA English
DT Review; Retracted Publication
DE Pulsus paradoxus; Tamponade; Kussmaul; Pericarditis
ID CARDIAC-TAMPONADE; SIGN; MECHANISM; ASTHMA; SHOCK
AB Pulsus paradoxus or the paradoxical pulse is an exaggeration of the normal inspiratory decrease in systolic blood pressure. The current definition of pulsus paradoxus is an inspiratory drop in systolic blood pressure>10 mm Hg. This physical sign can occur in conditions like cardiac tamponade, constrictive pericarditis, asthma and several other clinical conditions. The reduction in pulse volume during inspiration was first described by Richard Lower in 1669. Later, in 1850, Floyer described this sign in bronchial asthma. In 1873, Adolf Kussmaul coined the term "pulsus paradoxus" in three patients with constrictive pericarditis. In this article, we discuss both the historical and clinical perspectives of pulsus paradoxus. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
C1 [Abu-Hilal, Mohannad A.] Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA.
   [Mookadam, Farouk] Mayo Clin, Coll Med, Dept Internal Med, Div Cardiol, Scottsdale, AZ USA.
RP Abu-Hilal, MA (reprint author), Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA.
EM abuhilal.mohannad@yahoo.com
CR ADOLF K, 1902, LEBENSJAHR DTSCH ARC, V73, P1
   Bilchick KC, 2002, LANCET, V359, P1940, DOI 10.1016/S0140-6736(02)08763-9
   Coats AJS, 2009, INT J CARDIOL, V131, P149, DOI 10.1016/j.ijcard.2008.11.048
   COHEN SI, 1973, AM J CARDIOL, V32, P271, DOI 10.1016/S0002-9149(73)80132-8
   COHN JN, 1967, J CLIN INVEST, V46, P1744, DOI 10.1172/JCI105665
   DEWHURST K, 1980, T WILLIS OXFORD LECT, P7
   DORNHORST AC, 1952, LANCET, V262, P746
   ESTEBAN A, 1982, CHEST, V81, P47, DOI 10.1378/chest.81.1.47
   Felts JH, 2000, ANN INTERN MED, V132, P420, DOI 10.7326/0003-4819-132-5-200003070-00023
   FUSTER V, HURSTS HEART
   GOLINKO RJ, 1963, J CLIN INVEST, V42, P249, DOI 10.1172/JCI104711
   HOFF PM, 1936, B I HIST MED, V4, P521
   HOOPER TL, 1986, POSTGRAD MED J, V62, P377, DOI 10.1136/pgmj.62.727.377
   HUGHES JT, 1991, T WILLIS 1621 1675 H, P35
   Katz LN, 1924, ARCH INTERN MED, V33, P371, DOI 10.1001/archinte.1924.00110270092009
   KNOWLES GK, 1973, LANCET, V2, P1356
   KUSSMAUL A, 1866, Z RATION MED, V26, P99
   KUSSMAUL A, 1873, BERL KLIN WOCHENSCHR, V10, P433
   Lee JC, 2006, J AM COLL CARDIOL, V47, P1907, DOI 10.1016/j.jacc.2006.02.019
   Lower Richard, 1669, TRACTATUS CORDE ITEM
   MASSUMI RA, 1973, NEW ENGL J MED, V289, P1272, DOI 10.1056/NEJM197312132892403
   Matteson EL, 2003, CURR OPIN RHEUMATOL, V15, P29, DOI 10.1097/00002281-200301000-00006
   MCGREGOR M, 1979, NEW ENGL J MED, V301, P480, DOI 10.1056/NEJM197908303010905
   REBUCK AS, 1973, NEW ENGL J MED, V288, P66, DOI 10.1056/NEJM197301112880203
   REDDY PS, 1978, CIRCULATION, V58, P265, DOI 10.1161/01.CIR.58.2.265
   SALEL A, 1973, CHEST, V64, P671, DOI 10.1378/chest.64.5.671
   SANTAMORE WP, 1986, AM REV RESPIR DIS, V134, P101
   SETTLE HP, 1980, CIRCULATION, V62, P1297, DOI 10.1161/01.CIR.62.6.1297
   SHABETAI R, 1970, AM J CARDIOL, V26, P480, DOI 10.1016/0002-9149(70)90706-X
   SHABETAI R, 1965, J CLIN INVEST, V44, P1882, DOI 10.1172/JCI105295
   SHIM C, 1978, LANCET, V1, P530
   SHIOMI T, 1991, CHEST, V100, P894, DOI 10.1378/chest.100.4.894
   Tubbs RS, 2008, INT J CARDIOL, V128, P17, DOI 10.1016/j.ijcard.2007.11.069
   WAGNER HR, 1973, AM J CARDIOL, V32, P91, DOI 10.1016/S0002-9149(73)80090-6
   WARD GLH, 1992, CHEST, V101, P589, DOI 10.1378/chest.101.2.589a
   Yalamanchili K, 2005, AM J MED SCI, V329, P45, DOI 10.1097/00000441-200501000-00008
   PULSUS PARADOXUS PER
NR 37
TC 5
Z9 5
U1 3
U2 13
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-5273
EI 1874-1754
J9 INT J CARDIOL
JI Int. J. Cardiol.
PD FEB 4
PY 2010
VL 138
IS 3
BP 229
EP 232
DI 10.1016/j.ijcard.2009.04.045
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 546ZL
UT WOS:000273854200003
PM 19464740
DA 2018-12-27
ER

PT J
AU Liu, CH
   Ding, CH
AF Liu, C. H.
   Ding, C. H.
TI RETRACTED: Microstructure and tribological characterizations of Ni-based
   self-lubricating coating (Retracted article. See vol. 414, pg. 390,
   2018)
SO WEAR
LA English
DT Article; Retracted Publication
DE Sliding friction; Lubricant additives; Solid lubricant coatings; High
   temperature; Wear testing; Wear modelling
ID SLIDING WEAR; COMPOSITE; BEHAVIOR; ALUMINA
AB In this study, HFIS304 coating comprising NiCr (80/20) matrix (60 wt%) combined with Cr2O3 (20 wt%), Ag (10 wt%) and eutectic BaF2/CaF2 (10wt%) as solid self-lubricants additives has been successfully prepared by cold isostatic pressing and high-frequency induction sintering (HFIS) on a Ni-based superalloy rod. The microstructure of HFIS304 was fine and dense, the size of Cr2O3, BaF2/CaF2 particles was below 1 mu m, and that of Ag particles about 1 mu m. The tribological properties of HFIS304 composites against Inconel X-750 were examined. The wear resistance and friction coefficient of the HFIS304 were superior to that of the PS304 in the temperature range from room temperature to 600 degrees C. The improvement in wear resistance of the HFIS304 was discussed in the terms of its microstructural characteristics. Additionally, the model of high temperature self-lubricating particles was proposed. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Ding, C. H.] Xi An Jiao Tong Univ, Sch Aerosp, MOE Key Lab Strength & Vibrat, Xian 710049, Shaanxi, Peoples R China.
   [Liu, C. H.] MOE Key Lab Nonequilibrium Synth & Modulat Conden, Xian 710049, Shaanxi, Peoples R China.
RP Ding, CH (reprint author), Xi An Jiao Tong Univ, Sch Aerosp, MOE Key Lab Strength & Vibrat, Xian 710049, Shaanxi, Peoples R China.
EM chding@mail.xjtu.edu.cn
FU National Science Foundation of China [50601019, 50635060, 50771077]
FX The authors wish to thank the National Science Foundation of China
   (Grant Nos. 50601019, 50635060, 50771077) for providing financial
   support for this work.
CR ARMSTRONG RW, 1970, ADVANCES MATERIALS R, V4, P101
   CHO SJ, 1992, ACTA METALL MATER, V40, P185, DOI 10.1016/0956-7151(92)90212-W
   DEADMORE DL, 1987, TM88979 NASA
   DELLACORTE BJ, 1995, TM107056 NASA
   Dellacorte C, 2002, TRIBOL T, V45, P499, DOI 10.1080/10402000208982580
   DellaCorte C, 1996, SURF COAT TECH, V86-7, P486, DOI 10.1016/S0257-8972(96)02959-3
   DING CX, 1984, THIN SOLID FILMS, V118, P485, DOI 10.1016/0040-6090(84)90277-3
   DONG X, 1991, J AM CERAM SOC, V74, P1036, DOI 10.1111/j.1151-2916.1991.tb04340.x
   GAHR KHZ, 1993, WEAR, V162, P269
   Jia K, 1997, WEAR, V203, P310, DOI 10.1016/S0043-1648(96)07423-6
   Kim HC, 2005, J MATER SCI, V40, P2849, DOI 10.1007/s10853-005-2422-9
   Luo H, 2003, MAT SCI ENG A-STRUCT, V346, P237, DOI 10.1016/S0921-5093(02)00523-3
   Moumeni H, 2006, J ALLOY COMPD, V419, P140, DOI 10.1016/j.jallcom.2006.03.040
   Qin XY, 2003, MAT SCI ENG A-STRUCT, V363, P62, DOI 10.1016/S0921-5093(03)00497-0
   Wang WC, 2004, SURF COAT TECH, V177, P12, DOI 10.1016/j.surfcoat.2003.06.025
NR 15
TC 4
Z9 6
U1 2
U2 21
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
EI 1873-2577
J9 WEAR
JI Wear
PD FEB 4
PY 2010
VL 268
IS 3-4
BP 599
EP 604
DI 10.1016/j.wear.2009.10.008
PG 6
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 550XM
UT WOS:000274167200030
DA 2018-12-27
ER

PT J
AU Nazer, DW
   Tilmant, A
   Mimi, Z
   Siebel, MA
   Van der Zaag, P
   Gijzen, HJ
AF Nazer, Dima W.
   Tilmant, Amaury
   Mimi, Ziad
   Siebel, Maarten A.
   Van der Zaag, Pieter
   Gijzen, Huub J.
TI RETRACTED: Optimizing irrigation water use in the West Bank, Palestine
   (Retracted article. See vol. 98, pg. 732, 2011)
SO AGRICULTURAL WATER MANAGEMENT
LA English
DT Article; Retracted Publication
DE Agriculture; Cropping patterns; Linear programming; Profit maximization;
   Water scarcity
ID OPTIMAL RESERVOIR OPERATION; MULTIPLE CROPS; RESOURCES
AB We examine optimal irrigation water allocation on the West Bank using a linear mathematical programming model. Our analysis involves five agricultural zones and five fruit and vegetable crops: tomatoes, cucumbers, eggplant, squash and citrus. We analyze three scenarios: (1) maintaining the existing cropping patterns, (2) maximizing profit under water and land availability constraints, and (3) maximizing profit under water and land availability constraints, while also imposing an additional constraint requiring production of crops for local consumption. The water used for irrigation is reduced by 10% (4% of all agricultural water use) by changing the cropping patterns of the five crops we analyze under land and water availability constraints. The total value added in irrigated agriculture increases by 38%, equivalent to 4% of the entire agricultural sector. Imposing the additional constraint requiring production for local consumption also reduces irrigation water use by 10%, while the increase in value added is only 12% (11% for the entire agricultural sector). (C) 2009 Elsevier B.V. All rights reserved.
C1 [Nazer, Dima W.] Palestine Tech Coll, Hebron, West Bank, Israel.
   [Tilmant, Amaury; Siebel, Maarten A.; Van der Zaag, Pieter] UNESCO IHE Inst Water Educ, Delft, Netherlands.
   [Tilmant, Amaury; Siebel, Maarten A.; Van der Zaag, Pieter] Birzeit Univ, Inst Environm & Water Studies, Ramallah, Israel.
   [Gijzen, Huub J.] Reg Bur Sci Asia & Pacific, UNESCO Jakarta Off, Jakarta, Indonesia.
   [Van der Zaag, Pieter] Delft Univ Technol, Water Resources Sect, Delft, Netherlands.
RP Nazer, DW (reprint author), POB 606, Hebron, West Bank, Israel.
EM d.nazer@unesco-ihe.org
RI van der Zaag, Pieter/B-8247-2008
OI van der Zaag, Pieter/0000-0002-1215-2656
FU Saudi Arabian government; Ministry of Higher Education in the West Bank;
   NUFFIC fellowship program in the Netherlands
FX The authors thank the Saudi Arabian government, Ministry of Higher
   Education in the West Bank and the NUFFIC fellowship program in the
   Netherlands for sponsoring the research. Thanks are also extended to all
   farmers who participated in the study.
CR Al-Weshah RA, 2000, WATER RESOUR MANAG, V14, P327, DOI 10.1023/A:1011152318711
   Allan J. A., 1997, 1997 BRIT ASS FEST S
   COHEN A, 2007, ISRAEL OKAYS RENEWAL
   DOORENBOS J, 1979, 33 FAO
   FALKENMARK M, 1986, AMBIO, V15, P192
   Falkenmark M, 2007, WATER RESOUR MANAG, V21, P3, DOI 10.1007/s11269-006-9037-z
   Haouari M, 2001, EUR J OPER RES, V130, P133, DOI 10.1016/S0377-2217(00)00028-X
   HILLIER FS, 2005, INTRO OPERATION RES, V8
   Hoekstra AY, 2007, WATER RESOUR MANAG, V21, P35, DOI 10.1007/s11269-006-9039-x
   Hoekstra AY, 2005, GLOBAL ENVIRON CHANG, V15, P45, DOI 10.1016/j.gloenvcha.2004.06.004
   Karamouz M, 2003, WATER RESOURCES SYST
   Loucks D. P., 1981, WATER RESOURCE SYSTE
   MIMI ZA, 2001, EUR WATER MANAGE, V4, P39
   Nazer DW, 2008, J AM WATER RESOUR AS, V44, P449, DOI 10.1111/j.1752-1688.2008.00174.x
   *PCBS, 2007, PAL EXP CONS SURV 20
   *PCBS, 2006, AGR STAT 2004 2005
   PCBS, 1999, POP PAL TERR 1997 20
   PCBS, 2008, POP HOUS EST CENS 20
   Playan E, 2006, AGR WATER MANAGE, V80, P100, DOI 10.1016/j.agwat.2005.07.007
   *PWA, 2004, DAT COLL PERS COMM P
   Qadir M, 2007, AGR WATER MANAGE, V87, P2, DOI 10.1016/j.agwat.2006.03.018
   ROGERS P, 1998, WATER SOCIAL EC GOOD, P10
   Rogers P., 2002, WATER POLICY, V4, P1, DOI DOI 10.1016/S1366-7017(02)00004-1
   Rosegrant M.W., 2002, GLOBAL WATER OUTLOOK
   Sunantara JD, 1997, J WATER RES PL-ASCE, V123, P39
   VEDULA S, 1992, WATER RESOUR RES, V28, P1, DOI 10.1029/91WR02360
   Vedula S, 1996, WATER RESOUR RES, V32, P1101, DOI 10.1029/95WR03110
   WALSH GR, 1985, INTRO LINEAR PROGRAM, V2
   *WWC, 2004, WWC PUBL, V2
   YANG H, 2006, WATER MAGAZINE INT W, V21, P14
   1995, OSLO 2 AGREEMENT ISR
NR 31
TC 4
Z9 4
U1 3
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-3774
J9 AGR WATER MANAGE
JI Agric. Water Manage.
PD FEB
PY 2010
VL 97
IS 2
BP 339
EP 345
DI 10.1016/j.agwat.2009.10.006
PG 7
WC Agronomy; Water Resources
SC Agriculture; Water Resources
GA 538EI
UT WOS:000273166600019
DA 2018-12-27
ER

PT J
AU Jamal, SA
   Swan, VJD
   Brown, JP
   Hanley, DA
   Prior, JC
   Papaioannou, A
   Langsetmo, L
   Josse, RG
AF Jamal, Sophie A.
   Swan, Victoria J. D.
   Brown, Jacques P.
   Hanley, David A.
   Prior, Jerilynn C.
   Papaioannou, Alexandra
   Langsetmo, Lisa
   Josse, Robert G.
CA Canadian Multictr Osteoporosis
TI RETRACTED: Kidney Function and Rate of Bone Loss at the Hip and Spine:
   The Canadian Multicentre Osteoporosis Study (Retracted article. See vol.
   68, pg. 333, 2016)
SO AMERICAN JOURNAL OF KIDNEY DISEASES
LA English
DT Article; Retracted Publication
DE Impaired kidney function; bone loss; osteoporosis; bone mineral density
ID STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; MINERAL DENSITY; DIALYSIS
   PATIENTS; RISK-FACTORS; CREATININE CLEARANCE; BIOCHEMICAL MARKERS;
   VERTEBRAL FRACTURE; OSTEODYSTROPHY; MORTALITY
AB Background: The relationship between kidney function and bone loss is unclear.
   Study Design: A prospective observational study.
   Setting & Participants: 191 men and 444 women aged >= 50 years participating in a population-based observational study designed to determine risk factors for bone loss and fractures.
   Predictors: The primary predictor of change in bone mineral density (BMD) was estimated creatinine clearance (using the Cockcroft-Gault formula) measured at baseline and stratified by quartiles. Our secondary predictor was estimated glomerular filtration rate using the Modification of Diet in Renal Disease Study equation, also stratified by quartiles.
   Outcomes & Measurements: Changes in BMD at the lumbar spine, total hip, and femoral neck during 5 years.
   Results: Compared with participants in the first quartile of estimated creatinine clearance (> 101.2 mL/min), those in remaining quartiles were older (quartile 1, 50.0 years; quartile 2 [101.2-83.4 mL/min], 54.7 years; quartile 3 [83.4-68.3 mL/min], 60.5 years; and quartile 4 [<68.3 mL/min], 68.3 years); weighed less; reported more sedentary hours; were less likely to report excellent, very good, or good self-reported health; consumed less caffeine; and had lower serum calcium and phosphate and higher serum parathyroid hormone levels. After adjusting for age, weight, sex, baseline BMD, and these differences, compared with those in the first quartile, those in the fourth quartile had decreases in BMD of 0.08 g/cm(2) (95% CI, 0.04-0.1) at the lumbar spine, 0.08 g/cm(2) (95% CI, 0.06-0.1) at the femoral neck, and 0.09 g/cm(2) (95% CI, 0.07-0.1) at the total hip. Bone loss did not increase with worsening kidney function (P for trend >0.05). Results were not substantially different using estimated glomerular filtration rate.
   Limitations: Observational study design and indirect measures of kidney function.
   Conclusions: Men and women with impaired kidney function are at increased risk of bone loss, even with minimal reduction in kidney function. Am J Kidney Dis 55: 291-299. (C) 2010 by the National Kidney Foundation, Inc.
C1 [Jamal, Sophie A.; Josse, Robert G.] Univ Toronto, Toronto, ON, Canada.
   [Swan, Victoria J. D.] Womens Coll Hosp, Toronto, ON M5S 1B2, Canada.
   [Brown, Jacques P.] Univ Laval, Quebec City, PQ, Canada.
   [Hanley, David A.] Univ Calgary, Calgary, AB, Canada.
   [Prior, Jerilynn C.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.
   [Papaioannou, Alexandra] McMaster Univ, Hamilton, ON L8S 4L8, Canada.
   [Langsetmo, Lisa] McGill Univ, Montreal, PQ, Canada.
RP Jamal, SA (reprint author), 76 Grenville St,Ste 805, Toronto, ON, Canada.
EM sophie.jamal@utoronto.ca
RI Langsetmo, Lisa/G-8669-2013; Langsetmo, Lisa/T-2619-2017
OI Langsetmo, Lisa/0000-0003-2245-1657
CR Atsumi K, 1999, AM J KIDNEY DIS, V33, P287, DOI 10.1016/S0272-6386(99)70302-1
   CHAN YL, 1985, MEDICINE, V64, P296, DOI 10.1097/00005792-198509000-00002
   COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580
   Coco M, 2000, AM J KIDNEY DIS, V36, P1115, DOI 10.1053/ajkd.2000.19812
   Cummings SR, 2002, OSTEOPOROSIS EVIDENC
   Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002
   Eknoyan G, 1999, MINER ELECTROL METAB, V25, P100, DOI 10.1159/000057429
   Fiske CH, 1925, J BIOL CHEM, V66, P375
   Fontaine MA, 2000, CLIN NEPHROL, V54, P218
   GOROMI GA, 1942, J LAB CLIN MED, V27, P955
   Hsu CY, 2002, KIDNEY INT, V61, P1814, DOI 10.1046/j.1523-1755.2002.00306.x
   Inaba M, 2005, CALCIFIED TISSUE INT, V76, P256, DOI 10.1007/s00223-004-0094-0
   Ishani A, 2008, OSTEOPOROSIS INT, V19, P1549, DOI 10.1007/s00198-008-0608-0
   Jackson SA, 2000, OSTEOPOROSIS INT, V11, P680, DOI 10.1007/s001980070066
   JAMAL S, 2003, ENDOCRINOL ROUNDS, V3, P1
   Jamal SA, 2006, OSTEOPOROSIS INT, V17, P1390, DOI 10.1007/s00198-006-0133-y
   Jamal SA, 2006, J BONE MINER RES, V21, P543, DOI 10.1359/JBMR.060105
   Jamal SA, 2002, AM J KIDNEY DIS, V39, P843, DOI 10.1053/ajkd.2002.32006
   Jamal SA, 2007, AM J KIDNEY DIS, V49, P674, DOI 10.1053/j.ajkd.2007.02.264
   Jassal SK, 2007, J BONE MINER RES, V22, P203, DOI 10.1359/JBMR.061014
   Kaji H, 2002, AM J NEPHROL, V22, P325, DOI 10.1159/000065222
   KIEL DP, 1995, J BONE MINER RES, V10, pS189
   Kreiger N, 1999, CAN J AGING, V18, P376, DOI 10.1017/S0714980800009934
   Lindberg JS, 1999, SEMIN NEPHROL, V19, P115
   MALLUCHE HH, 1989, NEW ENGL J MED, V321, P317, DOI 10.1056/NEJM198908033210509
   *NAT KIDN FDN, 2002, AM J KIDNEY DIS S, V39, pS1, DOI DOI 10.1053/AJKD.2002.30571.PUBMED:11904577
   *ORTH DIAGN JOHNS, 2004, VITROS CHEM PROD CRE
   *ORTH DIAGN JOHNS, 2004, VITROS CHEM PROD CAL
   *ORTH DIAGN JOHNS, 2004, VITROS CHEM PROD PHO
   Papaioannou A, 2005, OSTEOPOROSIS INT, V16, P568, DOI 10.1007/s00198-004-1735-x
   Rix M, 1999, KIDNEY INT, V56, P1084, DOI 10.1046/j.1523-1755.1999.00617.x
   SCHAAB PC, 1990, CLIN ORTHOP RELAT R, P224
   Urena P, 2003, NEPHROL DIAL TRANSPL, V18, P2325, DOI 10.1093/ndt/gfg403
   Vassalotti JA, 2008, AM J KIDNEY DIS, V51, pS56, DOI 10.1053/j.ajkd.2007.12.018
   Vonesh EF, 1999, J AM SOC NEPHROL, V10, P354
   Ware JE, 1993, SF 36 HLTH SURVEY MA
   Yamaguchi T, 1996, BONE, V19, P549, DOI 10.1016/S8756-3282(96)00246-3
   YENDT ER, 1991, J BONE MINER RES, V6, P1043
NR 38
TC 34
Z9 37
U1 2
U2 19
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0272-6386
EI 1523-6838
J9 AM J KIDNEY DIS
JI Am. J. Kidney Dis.
PD FEB
PY 2010
VL 55
IS 2
BP 291
EP 299
DI 10.1053/j.ajkd.2009.10.049
PG 9
WC Urology & Nephrology
SC Urology & Nephrology
GA 555TA
UT WOS:000274537000018
PM 20042259
DA 2018-12-27
ER

PT J
AU Fernandez-Gil, A
   Swenson, JE
   Granda, C
   Perez, T
   Dominguez, A
   Ordiz, A
   Naves, J
   Delibes, M
AF Fernandez-Gil, Alberto
   Swenson, Jon E.
   Granda, Carlos
   Perez, Trinidad
   Dominguez, Ana
   Ordiz, Andres
   Naves, Javier
   Delibes, Miguel
TI RETRACTED: Evidence of sexually selected infanticide in an endangered
   brown bear population (Retracted article. See vol. 82, pg. 1215, 2011)
SO ANIMAL BEHAVIOUR
LA English
DT Editorial Material; Retracted Publication
DE brown bear; Cantabrian Mountains; conservation; intraspecific killing;
   population; sexually selected infanticide; Ursus arctos
ID OF-THE-YEAR; URSUS-ARCTOS; GRIZZLY BEARS; NORTHERN SPAIN; CENTRAL
   ALASKA; ADULT MALE; CONSERVATION; STRATEGIES; BEHAVIOR; EUROPE
C1 [Fernandez-Gil, Alberto; Naves, Javier] Univ Oviedo, Inst Cantabr Biodiversidad, Principado Asturias CSIC, Dept BOS, E-33006 Oviedo, Spain.
   [Fernandez-Gil, Alberto; Ordiz, Andres; Naves, Javier; Delibes, Miguel] CSIC, Estac Biol Donana, E-41080 Seville, Spain.
   [Swenson, Jon E.; Ordiz, Andres] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway.
   [Swenson, Jon E.] Norwegian Inst Nat Res, N-7004 Trondheim, Norway.
   [Granda, Carlos] Principado Asturias, Viceconsejeria Medio Ambiente & Ordenac Terr, Oviedo, Spain.
   [Perez, Trinidad; Dominguez, Ana] Univ Oviedo, Dept Biol Func Genet, E-33006 Oviedo, Spain.
RP Fernandez-Gil, A (reprint author), Univ Oviedo, Inst Cantabr Biodiversidad, Principado Asturias CSIC, Dept BOS, E-33006 Oviedo, Spain.
EM albertofg.uo@uniovi.es
RI Dominguez, Ana/E-4412-2010; Delibes, Miguel/K-2744-2014; CSIC, EBD
   Donana/C-4157-2011
OI Delibes, Miguel/0000-0002-3569-567X; CSIC, EBD
   Donana/0000-0003-4318-6602; Dominguez-Sanjurjo, Ana/0000-0002-8610-5553
CR Agrell J, 1998, OIKOS, V83, P507, DOI 10.2307/3546678
   Angeloni L, 2008, ANIM BEHAV, V75, P731, DOI 10.1016/j/anbehav.2007.08.007
   AUNE K. E., 1994, INT C BEAR RES MANAG, V9, P451
   BALLARD WB, 1981, J WILDLIFE MANAGE, V45, P335, DOI 10.2307/3807916
   Bellemain E, 2006, ETHOLOGY, V112, P238, DOI 10.1111/j.1439-0310.2006.01152.x
   BOERTJE RD, 1988, CAN J ZOOL, V66, P2492, DOI 10.1139/z88-369
   Caro T, 1999, TRENDS ECOL EVOL, V14, P366, DOI 10.1016/S0169-5347(99)01663-8
   Caro T, 2007, TRENDS ECOL EVOL, V22, P394, DOI 10.1016/j.tree.2007.06.003
   Cercueil A, 2002, J HERED, V93, P458, DOI 10.1093/jhered/93.6.458
   Clemmons J.R., 1997, BEHAV APPROACHES CON
   CLEVENGER AP, 1992, MAMMALIA, V56, P3, DOI 10.1515/mamm.1992.56.1.3
   CRAIGHEAD J. J, 1995, GRIZZLY BEARS YELLOW
   Dahle B, 2003, J ZOOL, V260, P329, DOI 10.1017/S0952836903003753
   Dahle B, 2003, J ANIM ECOL, V72, P660, DOI 10.1046/j.1365-2656.2003.00737.x
   Ebensperger LA, 1998, BIOL REV, V73, P321, DOI 10.1017/S0006323198005209
   EBERHARDT LL, 1994, CAN J ZOOL, V72, P360, DOI 10.1139/z94-049
   Fernandez-Gil A, 2006, WILDLIFE BIOL, V12, P367, DOI 10.2981/0909-6396(2006)12[367:COBBUA]2.0.CO;2
   FERNANDEZGIL A, URSUS IN PRESS
   GARLEA D, 1999, INT C BEAR RES MANAG, V12, P37
   Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2
   Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x
   Haroldson MA, 2002, URSUS, V13, P29
   Hausfater G, 1984, INFANTICIDE COMP EVO
   HRDY SB, 1979, LANGURS ABU FEMALE M
   Kovach SD, 2006, URSUS, V17, P16, DOI 10.2192/1537-6176(2006)17[16:RASOBB]2.0.CO;2
   LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580
   Mace RD, 1998, CONSERV BIOL, V12, P1005, DOI 10.1046/j.1523-1739.1998.97031.x
   Mattson DJ, 1997, BIOL CONSERV, V81, P161, DOI 10.1016/S0006-3207(96)00142-5
   McLellan B., 1994, MONOGRAPH SERIES, V3, P15
   McLellan BN, 2005, URSUS, V16, P141, DOI 10.2192/1537-6176(2005)016[0141:SSIIGB]2.0.CO;2
   McLoughlin PD, 2003, CAN J ZOOL, V81, P294, DOI 10.1139/Z02-245
   MILLER S. D, 1997, WILDLIFE MONOGRAPHS, V133
   MILLER SD, 1990, WILDLIFE SOC B, V18, P462
   Miller Sterling D., 2003, Ursus (Knoxville), V14, P130
   *MIN ENV SPAIN, 2001, ESTR CONS OS PARD CA
   Naves J, 2003, CONSERV BIOL, V17, P1276, DOI 10.1046/j.1523-1739.2003.02144.x
   Naves J, 2001, URSUS-SERIES, V12, P135
   Naves J., 1999, RIESGO EXTINCION OSO
   ORDIZ A, 2008, ECOLOGY, V89, P3317
   Ordiz A, 2007, URSUS, V18, P158, DOI 10.2192/1537-6176(2007)18[158:DCTIMN]2.0.CO;2
   PACKER A, 1984, INFANTICIDE COMP EVO, P32
   PALOMERO G, 2007, OSAS COMPORTAMIENTO
   Palomero G, 2007, URSUS, V18, P145, DOI 10.2192/1537-6176(2007)18[145:TINADO]2.0.CO;2
   Perez T, 2009, CONSERV GENET, V10, P291, DOI 10.1007/s10592-008-9578-1
   REYNOLDS HV, 1987, INT C BEAR RES MANAG, V7, P59
   SCHWARTZ CC, 2005, WILDLIFE MONOGR, V161, P69
   Sellers R.A., 1994, INT C BEAR RES MANAG, V9, P283, DOI [10.2307/3872712, DOI 10.2307/3872712]
   SERVHEEN C, 1999, BEARS STATUS SURVEY
   Sutherland WJ, 1998, ANIM BEHAV, V56, P801, DOI 10.1006/anbe.1998.0896
   SWENSON J. E, 2000, ACTION PLAN CONSERVA
   Swenson JE, 2001, URSUS-SERIES, V12, P81
   Swenson JE, 2001, URSUS-SERIES, V12, P69
   Swenson JE, 2003, ANIMAL BEHAVIOR AND WILDLIFE CONSERVATION, P171
   Swenson JE, 1997, NATURE, V386, P450, DOI 10.1038/386450a0
   Swenson JE, 2007, OECOLOGIA, V153, P37, DOI 10.1007/s00442-007-0715-1
   TABERLET P, 1994, P ROY SOC B-BIOL SCI, V255, P195, DOI 10.1098/rspb.1994.0028
   van Noordwijk Maria A., 2000, P322, DOI 10.1017/CBO9780511542312.016
   Wiegand T, 1998, ECOL MONOGR, V68, P539, DOI 10.1890/0012-9615(1998)068[0539:ATROEF]2.0.CO;2
   Wielgus RB, 2000, BIOL CONSERV, V93, P145, DOI 10.1016/S0006-3207(99)00152-4
   WIELGUS RB, 1995, J WILDLIFE MANAGE, V59, P552, DOI 10.2307/3802462
   WIELGUS RB, 1994, J WILDLIFE MANAGE, V58, P405, DOI 10.2307/3809310
   WOLFF JO, 1993, OIKOS, V68, P364, DOI 10.2307/3544853
   Zedrosser A, 2004, ACTA THERIOL, V49, P427, DOI 10.1007/BF03192540
   Zedrosser A, 2001, URSUS-SERIES, V12, P9
   Zedrosser A, 2009, OECOLOGIA, V160, P847, DOI 10.1007/s00442-009-1343-8
NR 65
TC 7
Z9 7
U1 6
U2 34
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0003-3472
J9 ANIM BEHAV
JI Anim. Behav.
PD FEB
PY 2010
VL 79
IS 2
BP 521
EP 527
DI 10.1016/j.anbehav.2009.11.027
PG 7
WC Behavioral Sciences; Zoology
SC Behavioral Sciences; Zoology
GA 548SJ
UT WOS:000273986300034
DA 2018-12-27
ER

PT J
AU Al-Dabbas, M
   Al-Jassim, J
   Al-Jumaily, S
AF Al-Dabbas, Moutaz
   Al-Jassim, Jassim
   Al-Jumaily, Saad
TI RETRACTED: Depositional environments and porosity distribution in
   regressive limestone reservoirs of the Mishrif Formation, Southern
   Iraq(Retracted article. See vol. 10, Artn no. 200, 2017)
SO ARABIAN JOURNAL OF GEOSCIENCES
LA English
DT Article; Retracted Publication
DE Mishrif Formation; Porosity; Facies analysis; Depositional environment
ID RUDIST-BEARING CARBONATES; MARKOV-CHAIN ANALYSIS; CLASSIFICATION
AB Eight subsurface sections and a large number of thin sections of the Mishrif Limestone were studied to unravel the depositional facies and environments. The allochems in the Mishrif Formation are dominated by bioclasts, whereas peloids, ooids, and intraclasts are less abundant. The sedimentary microfacies of the Mishrif Formation includes mudstone, wackestone, packstone, grainstone, floatstone, and rudstone, which have been deposited in basinal, outer shelf, slop followed by shoal reef and lagoonal environments. The formation displays various extents of dolomitization and is cemented by calcite and dolomite. The formation has gradational contact with the underlying Rumaila Formation but is unconformably overlain by the Khasib Formation. The unconformity is recognized because the skeletal grains are dominated by Chaophyta (algae), which denotes the change of environment from fully marine to lacustrine environment. Thus, the vertical bioclast analysis indicates that the Mishrif Formation is characterized by two regressive cycles, which control the distribution of reservoir quality as well as the patterns of calcite and dolomite cement distribution. Mishrif Formation gradationally overlies Rumaila Formation. This was indicated by the presence of the green parts of Chaophyta (algae) as main skeletal grains at the uppermost part of well Zb-47, which refer to lacustrine or fresh water environment. Petrographical study shows that the fossils, peloids, oolitis, and intraclasts represent the main allochem. Calcite and dolomite (as diagenetic products) are the predominant mineral components of Mishrif Formation. Fossils were studied as an environmental age and facial boundaries indicators, which are located in a chart using personal computer programs depending on their distributions on the first appearance of species. Fifteen principal sedimentary microfacies have been identified in the Mishrif Formation, which includes lime mudstone, mudstone-wackestone, wackestone, wackestone-packstone, packstone, packstone-grainstone, grainstone-floatstone, packstone-floatstone, packstone-rudstone, and wackestone-floatstone. Markov chain analysis has been used to study the transitional pattern of different microfacies types vertically in each well and laterally in all wells as a composite section. The vertical analysis indicates that the Mishrif Formation characterized by two regressive cycles, the main one started with basinal or outer shelf environment, slop environment followed by shoal or reefal environment, and ended with a lagoonal environment. The lateral analysis shows the same regressive cycle, and by using the lithofacies association concepts, we built the depositional model of the Mishrif Formation environment.
C1 [Al-Dabbas, Moutaz; Al-Jassim, Jassim; Al-Jumaily, Saad] Univ Baghdad, Coll Sci, Baghdad, Iraq.
RP Al-Dabbas, M (reprint author), Univ Baghdad, Coll Sci, POB 47138, Baghdad, Iraq.
EM prof_aldabbas@yahoo.com
CR ALJUMAILY S, 2001, THESIS BAGHDAD U IRA
   ALKHAFAJE AJ, 2006, THESIS BAGHDAD U IRA
   ALSHARHAN AS, 1995, AAPG BULL, V79, P531
   ALSHARHAN AS, 1993, CRETACEOUS CARBONATE, P173
   ALSIDDIQI AAM, 1978, 10 AR PET C TRIP LIB, V141, P47
   AQRAWI AAM, 1995, J GEOL SOC LONDON, V152, P259, DOI 10.1144/gsjgs.152.2.0259
   Aqrawi AAM, 1998, J PETROL GEOL, V21, P57, DOI 10.1111/j.1747-5457.1998.tb00646.x
   BADIOZAMANI K, 1977, J SEDIMENT PETROL, V47, P529
   BELLEN RC, 1959, IR INT GEOL C COMM S, V3, P333
   Buday T, 1980, REGIONAL GEOLOGY IRA, V1, P445
   CHATTON M, 1960, REVISION TITHONIAN A
   CHATTON M, 1961, 2141 INOC LIB
   CHOQUETTE PW, 1970, AM ASSOC PETR GEOL B, V54, P207
   Ditmar V, 1971, GEOLOGICAL CON UNPUB
   Dunham R. J, 1962, AAPG BULL, V1, P108
   EMBRY ZR, 1972, ABSOLUTE WATER DEPTH
   Flugel E, 1982, MICROFACIES ANAL LIM, P663
   Folk R., 1962, CLASSIFICATION CARBO, V1, P62
   FOLK RI, 1980, UN INT M PETR GEOL B, P16
   Folk RL, 1965, DOLOMITIZATION LIMES, V13, P14
   LONGMAN MW, 1982, AAPG ED COURSE NOTES, V21, P159
   MIALL AD, 1973, SEDIMENTOLOGY, V20, P347, DOI 10.1111/j.1365-3091.1973.tb01615.x
   Reulet J, 1982, EXPLORATION CARBONAT, P165
   SHERWANI GH, 1983, THESIS BAGHDAD U IRA
   SIBLEY DF, 1982, J SEDIMENT PETROL, V52, P1087
   TUCKER ME, 1985, SEDIMENTARY PETROLOG
   VIDETICH PE, 1988, AAPG BULL, V72, P1143
   WELLS NA, 1989, COMPUT GEOSCI, V15, P143, DOI 10.1016/0098-3004(89)90061-7
   WILSON JL, 1975, CARBONATE FACIES GEO, P439
   WRIGHT VP, 1992, SEDIMENT GEOL, V76, P177, DOI 10.1016/0037-0738(92)90082-3
NR 30
TC 9
Z9 17
U1 4
U2 12
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1866-7511
EI 1866-7538
J9 ARAB J GEOSCI
JI Arab. J. Geosci.
PD FEB
PY 2010
VL 3
IS 1
BP 67
EP 78
DI 10.1007/s12517-009-0057-x
PG 12
WC Geosciences, Multidisciplinary
SC Geology
GA 586SJ
UT WOS:000276932800007
DA 2018-12-27
ER

PT J
AU Anand, P
   Nair, HB
   Sung, BK
   Kunnumakkara, AB
   Yadav, VR
   Tekmal, RR
   Aggarwal, BB
AF Anand, Preetha
   Nair, Hareesh B.
   Sung, Bokyung
   Kunnumakkara, Ajaikumar B.
   Yadav, Vivek R.
   Tekmal, Rajeshwar R.
   Aggarwal, Bharat B.
TI RETRACTED: Design of curcumin-loaded PLGA nanoparticles formulation with
   enhanced cellular uptake, and increased bioactivity in vitro and
   superior bioavailability in vivo (Retracted article. See vol. 102, pg.
   143, 2016)
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article; Retracted Publication
DE Nanoparticles; Apoptosis; Inflammation; TNF-alpha
ID KAPPA-B; PHASE-I; INHIBITS PROLIFERATION; ENCAPSULATED CURCUMIN;
   DOWN-REGULATION; CANCER-THERAPY; GENE-PRODUCTS; CELLS; ANGIOGENESIS;
   ACTIVATION
AB Curcumin, a yellow pigment present in the spice turmeric (Curcuma longa), has been linked with antioxidant, anti-inflammatory, antiproliferative, anticancer, antidiabetic, antirheumatic, and antiviral effects, but its optimum potential is limited by its lack of solubility in aqueous solvents and poor oral bioavailability. We employed a polymer-based nanoparticle approach to improve bioavailability. Curcumin was encapsulated with 97.5% efficiency in biodegradable nanoparticulate formulation based on poly (lactide-co-glycolide) (PLGA) and a stabilizer polyethylene glycol (PEG)-5000. Dynamic laser light scattering and transmission electron microscopy indicated a particle diameter of 80.9 nm. This curcumin, renamed from hereon "as curcumin (NP)", was characterized for its biological activity. In vitro curcumin (NP) exhibited very rapid and more efficient cellular uptake than curcumin. Estrase staining revealed that curcumin (NP) was at least as potent as or more potent than curcumin in inducing apoptosis of leukemic cells and in suppressing proliferation of various tumor cell lines. When examined by electrophoretic gel shift mobility assay, curcumin (NP) was more active than curcumin in inhibiting TNF-induced NF-kappa B activation and in suppression of NF-kappa B-regulated proteins involved in cell proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF). In mice, curcumin (NP) was more bioavailable and had a longer half-life than curcumin. Overall we demonstrate that curcumin-loaded PLGA nanoparticles formulation has enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo over curcumin. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Anand, Preetha; Sung, Bokyung; Kunnumakkara, Ajaikumar B.; Yadav, Vivek R.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, 1515 Holcombe Blvd,Box 143, Houston, TX 77030 USA.
   [Nair, Hareesh B.; Tekmal, Rajeshwar R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA.
RP Aggarwal, BB (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, 1515 Holcombe Blvd,Box 143, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI Kunnumakkara, Ajaikumar/H-8566-2012; Aggarwal, Bharat/G-3388-2013
OI Kunnumakkara, Ajaikumar/0000-0001-9121-6816; 
FU National Institutes of Health [CA-124787-01A2]; Center for Targeted
   Therapy; University of Texas M.D. Anderson Cancer Center
FX Dr. Aggarwal is the Ransom Horne, Jr., Professor of Cancer Research.
   This work was supported by a grant from a program project grant from
   National Institutes of Health (NIH CA-124787-01A2), and a grant from
   Center for Targeted Therapy of The University of Texas M.D. Anderson
   Cancer Center.
CR Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002
   Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010
   Aggarwal S, 2006, MOL PHARMACOL, V69, P195, DOI 10.1124/mol.105.017400
   Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025
   Ankola DD, 2007, EUR J PHARM BIOPHARM, V67, P361, DOI 10.1016/j.ejpb.2007.03.010
   Bae MK, 2006, ONCOL REP, V15, P1557
   Bala I, 2006, J DRUG TARGET, V14, P27, DOI 10.1080/10611860600565987
   Began G, 1999, J AGR FOOD CHEM, V47, P4992, DOI 10.1021/jf9900837
   Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988
   Bisht Savita, 2007, Journal of Nanobiotechnology, V5, P3, DOI 10.1186/1477-3155-5-3
   Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441
   Cruz-Correa M, 2006, CLIN GASTROENTEROL H, V4, P1035, DOI 10.1016/j.cgh.2006.03.020
   Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024
   FESSI H, 1989, INT J PHARM, V55, pR1, DOI 10.1016/0378-5173(89)90281-0
   Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016
   Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937
   Gupta V, 2009, INT J NANOMED, V4, P115
   Hariharan S, 2006, PHARM RES, V23, P184, DOI 10.1007/s11095-005-8418-y
   HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292
   Jaiswal AS, 2002, ONCOGENE, V21, P8414, DOI 10.1038/sj.onc.1205947
   Kim TY, 2004, CLIN CANCER RES, V10, P3708, DOI 10.1158/1078-0432.CCR-03-0655
   Kumar Virender, 2002, Indian Journal of Physiology and Pharmacology, V46, P209
   Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009
   Kunwar A, 2006, BBA-GEN SUBJECTS, V1760, P1513, DOI 10.1016/j.bbagen.2006.06.012
   Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300
   Ma ZS, 2007, BIOMED CHROMATOGR, V21, P546, DOI 10.1002/bmc.795
   Maiti K, 2007, INT J PHARMACEUT, V330, P155, DOI 10.1016/j.ijpharm.2006.09.025
   Marczylo TH, 2007, CANCER CHEMOTH PHARM, V60, P171, DOI 10.1007/s00280-006-0355-x
   Mu L, 2003, J CONTROL RELEASE, V86, P33, DOI 10.1016/S0168-3659(02)00320-6
   Salmaso S, 2007, J DRUG TARGET, V15, P379, DOI 10.1080/10611860701349752
   Sharma RA, 2001, CLIN CANCER RES, V7, P1894
   Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744
   Shishodia S, 2005, ANN NY ACAD SCI, V1056, P206, DOI 10.1196/annals.1352.010
   SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995
   Sou K, 2008, INT J PHARM, V352, P287, DOI 10.1016/j.ijpharm.2007.10.033
   Strimpakos AS, 2008, ANTIOXID REDOX SIGN, V10, P511, DOI 10.1089/ars.2007.1769
   Sun Y, 2008, BIOPHYS J, V95, P2318, DOI 10.1529/biophysj.108.133736
   Takahashi M, 2008, BIOSCI BIOTECH BIOCH, V72, P1199, DOI 10.1271/bbb.706591
   Thangapazham RL, 2008, INT J ONCOL, V32, P1119
   Tonnesen HH, 2002, PHARMAZIE, V57, P820
   Vasey PA, 1999, CLIN CANCER RES, V5, P83
NR 41
TC 350
Z9 362
U1 9
U2 185
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0006-2952
EI 1873-2968
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD FEB 1
PY 2010
VL 79
IS 3
BP 330
EP 338
DI 10.1016/j.bcp.2009.09.003
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 544XW
UT WOS:000273694900004
PM 19735646
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Shen, J
   Barrios, RJ
   Jaiswal, AK
AF Shen, Jun
   Barrios, Roberto J.
   Jaiswal, Anil K.
TI RETRACTED: Inactivation of the Quinone Oxidoreductases NQO1 and NQO2
   Strongly Elevates the Incidence and Multiplicity of Chemically Induced
   Skin Tumors (Retracted article. See vol. 78, pg. 6345, 2018)
SO CANCER RESEARCH
LA English
DT Article; Retracted Publication
ID MOUSE SKIN; INCREASES SUSCEPTIBILITY; MENADIONE TOXICITY; DT-DIAPHORASE;
   HUMAN NAD(P)H; BONE-MARROW; IN-VIVO; CARCINOGENESIS; P53; GENE
AB The cytosolic quinone oxidoreductases NQO1 and NQO2 protect cells against oxidative stress by detoxifying quinones and preventing redox cycling. In this study, we used double knockout (DKO) mice deficient for NQO1 and NQO2 to investigate the role of these antioxidative enzymes in a two-stage model of inflammatory skin carcinogenesis. In this model, tumors are caused by exposure to topical carcinogen dimethylbenz( a) anthracene or benzo( a) pyrene ( BP) followed by twice weekly application of proinflammatory phorbol 12-myristate 13-acetate. On this classic chemical carcinogenesis protocol, DKO mice showed a significantly higher skin tumor frequency and multiplicity compared with control wild-type or single knockout mice. Analysis of skin from wild-type and DKO mice exposed to BP for 6, 12, or 24 hours revealed a relative delay in the activation of p53, p63, p19ARF, and apoptosis in DKO mice, consistent with a negative modifier role for NQO1/NQO2 in carcinogenesis. Our findings offer genetic evidence of the significance of quinone oxidoreductases NQO1 and NQO2 in limiting chemical skin carcinogenesis. Cancer Res; 70(3); 1006-14. (C)2010 AACR.
C1 [Shen, Jun; Jaiswal, Anil K.] Univ Maryland, Dept Pharmacol & Expt Therapeut, Sch Med, Baltimore, MD 21201 USA.
   [Barrios, Roberto J.] Methodist Hosp, Dept Pathol, Houston, TX 77030 USA.
RP Jaiswal, AK (reprint author), Univ Maryland, Dept Pharmacol & Expt Therapeut, Sch Med, 655 W Baltimore St, Baltimore, MD 21201 USA.
EM ajaiswal@som.umaryland.edu
FU National Institute of Environmental Health Sciences [RO1 ES07943]
FX National Institute of Environmental Health Sciences grant RO1 ES07943.
CR Anwar A, 2003, J BIOL CHEM, V278, P10368, DOI 10.1074/jbc.M211981200
   BOGOVSKI P, 1979, PATHOLOGY TUMOURS LA, V2, P1
   Das A, 2006, FREE RADICAL BIO MED, V40, P1843, DOI 10.1016/j.freeradbiomed.2006.01.025
   DIGIOVANNI J, 1992, PHARMACOL THERAPEUT, V54, P63, DOI 10.1016/0163-7258(92)90051-Z
   FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7
   Gaikwad A, 2001, J BIOL CHEM, V276, P22559, DOI 10.1074/jbc.M101053200
   Gong X, 2007, CANCER RES, V67, P5380, DOI 10.1158/0008-5472.CAN-07-0323
   Guo XC, 2007, CELL CYCLE, V6, P305, DOI 10.4161/cc.6.3.3794
   Harada S, 2001, BIOCHEM BIOPH RES CO, V288, P887, DOI 10.1006/bbrc.2001.5868
   Housman TS, 2003, J AM ACAD DERMATOL, V48, P425, DOI 10.1067/mjd.2003.186
   *IARC, 1983, IARC MON EV CARC RIS, V32, P211
   Iida A, 2001, J HUM GENET, V46, P225, DOI 10.1007/s100380170093
   Iskander K, 2005, CANCER RES, V65, P2054, DOI 10.1158/0008-5472.CAN-04-3157
   Iskander K, 2004, CANCER RES, V64, P5925, DOI 10.1158/0008-5472.CAN-04-0763
   Jaiswal AK, 1999, PHARMACOGENETICS, V9, P413, DOI 10.1097/00008571-199906000-00020
   JAISWAL AK, 1991, BIOCHEMISTRY-US, V30, P10647, DOI 10.1021/bi00108a007
   Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389
   KASTAN MB, 1991, CANCER RES, V51, P6304
   Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242
   Knox RJ, 2000, CANCER RES, V60, P4179
   Koster MI, 2007, CELL CYCLE, V6, P269, DOI 10.4161/cc.6.3.3792
   Koster MI, 2006, CANCER RES, V66, P3981, DOI 10.1158/0008-5472.CAN-06-0027
   Larson RA, 1999, BLOOD, V94, P803
   Long DJ, 2000, CANCER RES, V60, P5913
   Long DJ, 2002, CANCER RES, V62, P3030
   Long DJ, 2002, J BIOL CHEM, V277, P46131, DOI 10.1074/jbc.M208675200
   Long DJ, 2001, JNCI-J NATL CANCER I, V93, P1166, DOI 10.1093/jnci/93.15.1166
   Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027
   Melnikova VO, 2005, MUTAT RES-FUND MOL M, V571, P91, DOI 10.1016/j.mrfmmm.2004.11.015
   Motiwale L, 2005, CANCER LETT, V223, P27, DOI 10.1016/j.canlet.2004.10.020
   OBrien TG, 1997, CANCER RES, V57, P2630
   OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O
   Oren M, 2007, CELL, V128, P826, DOI 10.1016/j.cell.2007.02.027
   Patel R, 2008, CELL PROLIFERAT, V41, P532, DOI 10.1111/j.1365-2184.2008.00528.x
   Pietsch EC, 2006, ONCOGENE, V25, P1602, DOI 10.1038/sj.onc.1209367
   Prince M, 2006, CARCINOGENESIS, V27, P1204, DOI 10.1093/carcin/bgi303
   Pugalendhi P, 2009, PHARMACOL REP, V61, P296, DOI 10.1016/S1734-1140(09)70035-0
   Radjendirane V, 1998, J BIOL CHEM, V273, P7382, DOI 10.1074/jbc.273.13.7382
   Radjendirane Venugopal, 1997, P441
   Ross D, 2004, DRUG METAB REV, V36, P639, DOI 10.1081/DMR-200033465
   Rothman N, 1997, CANCER RES, V57, P2839
   Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4
   SIMIC MG, 1994, CANCER RES, V54, pS1918
   Wang W, 2004, FREE RADICAL BIO MED, V37, P1231, DOI 10.1016/j.freeradbiomed.2004.06.042
   Wang XD, 2001, GENE DEV, V15, P2922
   Weinberg WC, 1999, CANCER RES, V59, P2050
   Wu KB, 1997, ARCH BIOCHEM BIOPHYS, V347, P221, DOI 10.1006/abbi.1997.0344
   Yi S, 2006, MOL CARCINOGEN, V45, P409, DOI 10.1002/mc.20231
   Zhao QJ, 1997, P NATL ACAD SCI USA, V94, P1669, DOI 10.1073/pnas.94.5.1669
NR 49
TC 32
Z9 33
U1 0
U2 2
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD FEB 1
PY 2010
VL 70
IS 3
BP 1006
EP 1014
DI 10.1158/0008-5472.CAN-09-2938
PG 9
WC Oncology
SC Oncology
GA 607FX
UT WOS:000278485600018
PM 20103645
OA Green Accepted, Bronze
DA 2018-12-27
ER

PT J
AU Wang, BW
   Chang, H
   Shyu, KG
AF Wang, Bao-Wei
   Chang, Hang
   Shyu, Kou-Gi
TI RETRACTED: Regulation of resistin by cyclic mechanical stretch in
   cultured rat vascular smooth muscle cells(Retracted article.See
   vol.130,pg.1841, 2016)
SO CLINICAL SCIENCE
LA English
DT Article; Retracted Publication
DE atherosclerosis; mitogen-activated protein kinase (MAPK); reactive
   oxygen species (ROS); resistin; smooth muscle cell; signal transducer
   and activator of transcription (STAT); stretch
ID SMOOTH-MUSCLE-CELLS; ANGIOTENSIN-II; ATHEROSCLEROSIS; EXPRESSION;
   ACTIVATION; ADIPOCYTE; ADIPOKINE; HYPOXIA; GLUCOSE; STAT-3
AB Resistin has a potential role in atherosclerosis; however, the molecular mechanism underlying the increase in resistin expression in atherosclerosis remains unclear. As mechanical stretch plays an important role in atherosclerosis, in the present study we sought to investigate the cellular and molecular mechanisms underlying the regulation of resistin by cyclic mechanical stretch in VSMCs (vascular smooth muscle cells). VSMCs from thoracic aorta of adult Wistar rats were cultured and subjected to cyclic stretch. Cyclic mechanical stretch significantly increased resistin protein and mRNA expression as compared with control cells without stretch. The specific p38 MAPK (mitogen-activated protein kinase) inhibitor SB203580, the antioxidant N-acetylcysteine and p38 MAPK siRNA (small interfering RNA) attenuated the induction of resistin protein by cyclic stretch. Cyclic stretch significantly increased the phosphorylation of p38 MAPK, whereas pre-treatment with SB203580 and N-acetylcysteine significantly inhibited this effect. Cyclic stretch significantly increased ROS (reactive oxygen species) production, and pre-treatment with N-acetylcysteine significantly inhibited stretch-induced ROS production. Cyclic stretch also increased STAT3 (signal transducer and activator of transcription 3)-binding activity and resistin promoter activity, and resistin promoter activity was abolished when STAT3 in the promoter area was mutated. Pre-treatment with SB203580 and N-acetylcysteine significantly attenuated resistin promoter activity induced by cyclic stretch. Cyclic stretch increased the secretion of AngII (angiotensin II) and resistin from cultured VSMCs. Exogenous AngII increased resistin expression, and AngII receptor inhibition attenuated this effect. In conclusion, cyclic mechanical stretch increases resistin expression in cultured rat VSMCs. Stretch-induced resistin expression is mediated through ROS, and the p38 MAPK and STAT3 pathways. Therefore resistin induced by cyclic stretch may contribute to the pathogenesis of atherosclerosis under haemodynamic overload.
C1 [Shyu, Kou-Gi] Shin Kong Wu Ho Su Mem Hosp, Div Cardiol, Taipei, Taiwan.
   [Wang, Bao-Wei] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan.
   [Wang, Bao-Wei; Chang, Hang] Shin Kong Wu Ho Su Mem Hosp, Dept Med Educ & Res, Taipei, Taiwan.
   [Shyu, Kou-Gi] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.
RP Shyu, KG (reprint author), Shin Kong Wu Ho Su Mem Hosp, Div Cardiol, Taipei, Taiwan.
EM shyukg@ms12.hinetnet
FU National Science Council, Taiwan [NSC96-2628-B341-001-MY3]
FX This work was supported, in part, from the National Science Council,
   Taiwan [grant number NSC96-2628-B341-001-MY3].
CR Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341
   Bokarewa M, 2005, J IMMUNOL, V174, P5789, DOI 10.4049/jimmunol.174.9.5789
   Burnett MS, 2005, ATHEROSCLEROSIS, V182, P241, DOI 10.1016/j.atherosclerosis.2005.02.014
   CAE D, 2005, NAT MED, V11, P183
   Calabro P, 2004, CIRCULATION, V110, P3335, DOI 10.1161/01.CIR.0000147825.97879.E7
   Chang H, 2003, CLIN SCI, V105, P447, DOI 10.1042/CS20030088
   Chang H, 2003, BIOCHEM BIOPH RES CO, V302, P95, DOI 10.1016/S0006-291X(03)00111-6
   Choi DS, 2008, INT J CARDIOL, V125, P79, DOI 10.1016/j.ijcard.2007.02.028
   Choi SO, 2007, BIOCHEM BIOPH RES CO, V356, P312, DOI 10.1016/j.bbrc.2007.02.137
   Chrysant Steven G, 2006, J Clin Hypertens (Greenwich), V8, P261, DOI 10.1111/j.1524-6175.2005.05264.x
   Di Bona D, 2006, J HEPATOL, V45, P271, DOI 10.1016/j.jhep.2006.01.037
   Hamada T, 2008, AM J HYPERTENS, V21, P1157, DOI 10.1038/ajh.2008.245
   Hung HF, 2008, J HYPERTENS, V26, P2349, DOI 10.1097/HJH.0b013e328311fa30
   Jung HS, 2006, CARDIOVASC RES, V69, P76, DOI 10.1016/j.cardiores.2005.09.015
   Kougias P, 2005, J VASC SURG, V41, P691, DOI 10.1016/j.jvs.2004.12.046
   Lavrentyev EN, 2007, CIRC RES, V101, P455, DOI 10.1161/CIRCRESAHA.107.151852
   McLennan HR, 2000, J BIOENERG BIOMEMBR, V32, P153, DOI 10.1023/A:1005507913372
   Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580
   Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43
   Rothwell SE, 2006, BIOCHEM BIOPH RES CO, V349, P400, DOI 10.1016/j.bbrc.2006.08.052
   Shyu KG, 2005, HYPERTENSION, V46, P614, DOI 10.1161/01.HYP.0000175811.79863.e2
   Shyu KG, 2009, CLIN SCI, V116, P377, DOI 10.1042/CS20080163
   STAVRI GT, 1995, CIRCULATION, V92, P11, DOI 10.1161/01.CIR.92.1.11
   Stephanou A, 2005, GROWTH FACTORS, V23, P177, DOI 10.1080/08977190500178745
   Takata Y, 2008, HYPERTENSION, V51, P534, DOI 10.1161/HYPERTENSIONAHA.107.103077
   Verma S, 2003, CIRCULATION, V108, P736, DOI 10.1161/01.CIR.0000084503.91330.49
   Wang BW, 2007, AM J PHYSIOL-HEART C, V293, pH2305, DOI 10.1152/ajpheart.00361.2007
   Wang D, 2007, CIRC RES, V100, P807, DOI 10.1161/01.RES.0000261350.61711.9e
   Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137
NR 29
TC 8
Z9 9
U1 2
U2 5
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0143-5221
EI 1470-8736
J9 CLIN SCI
JI Clin. Sci.
PD FEB
PY 2010
VL 118
IS 3-4
BP 221
EP 230
DI 10.1042/CS20090155
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 558TA
UT WOS:000274768000008
DA 2018-12-27
ER

PT J
AU Shi, RQ
   Chen, LS
AF Shi, Ruiqing
   Chen, Lansun
TI RETRACTED: An impulsive predator-prey model with disease in the prey for
   integrated pest management(Retracted article.See vol.47,pg.455, 2017)
SO COMMUNICATIONS IN NONLINEAR SCIENCE AND NUMERICAL SIMULATION
LA English
DT Article; Retracted Publication
DE Predator-prey model; Impulsive; Permanent; Susceptible pest-eradication
   periodic solution
ID PEST-MANAGEMENT; DYNAMICS; STRATEGY
AB In this paper, an impulsive predator-prey model with disease in the prey is investigated for the purpose of integrated pest management. in the first part of the main results, we get the sufficient condition for the global stability of the susceptible pest-eradication periodic solution. This means if the release amount of infective prey and predator satisfy the condition, then the pest will be doomed. In the second part of the main results, we also get the sufficient condition for the permanence of the system. This means if the release amount of infective prey and predator satisfy the condition, then the prey and the predator will coexist. In the last section, we interpret our mathematical results. We also point Out some possible future work. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Shi, Ruiqing; Chen, Lansun] Dalian Univ Technol, Dept Appl Math, Dalian 116024, Liaoning, Peoples R China.
   [Shi, Ruiqing] Shanxi Normal Univ, Sch Math & Comp Sci, Linfen 041004, Shanxi, Peoples R China.
RP Shi, RQ (reprint author), Dalian Univ Technol, Dept Appl Math, Dalian 116024, Liaoning, Peoples R China.
EM shirq1979@163.com
FU National Natural Science Foundation of China [10471117]
FX This work is partly supported by the National Natural Science Foundation
   of China (10471117).
CR Bainov D., 1993, IMPULSIVE DIFFERENTI
   Burges HD, 1971, MICROBIAL CONTROL IN
   Cherry AJ, 1999, BIOCONTROL, V44, P301, DOI 10.1023/A:1009991724251
   DAVIS PE, 1976, THEORY PRACTICE BIOL
   DeBach P, 1991, BIOL CONTROL NATURAL
   FALCON LA, 1976, ANNU REV ENTOMOL, V21, P305, DOI 10.1146/annurev.en.21.010176.001513
   FREEDMAN HI, 1976, MATH BIOSCI, V31, P207, DOI 10.1016/0025-5564(76)90080-8
   FUNASAKI E, 1993, THEOR POPUL BIOL, V44, P203, DOI 10.1006/tpbi.1993.1026
   Goh BS, 1980, MANAGEMENT ANAL BIOL
   Grasman J, 2001, MATH BIOSCI, V169, P207, DOI 10.1016/S0025-5564(00)00051-1
   Hui J, 2004, DISCRETE CONT DYN-B, V4, P595
   Jiao JJ, 2008, CHAOS SOLITON FRACT, V38, P658, DOI 10.1016/j.chaos.2007.01.003
   Lakmeche A, 2000, DYN CONTIN DISCRET I, V7, P265
   Lakshmikantham V, 1989, THEORY IMPULSIVE DIF
   Liu B, 2005, APPL MATH COMPUT, V169, P305, DOI 10.1016/j.amc.2004.09.053
   Liu XN, 2003, CHAOS SOLITON FRACT, V16, P311, DOI 10.1016/S0960-0779(02)00408-3
   LUFF ML, 1983, AGR ECOSYST ENVIRON, V10, P159, DOI 10.1016/0167-8809(83)90060-9
   MARY LF, 1981, INTRO INTEGRATED PES
   MCEWEN FL, 1979, USE SIGNIFICANCE PES
   Tanada Y., 1964, BIOL CONTROL INSECT
   Van Lenteren J. C., 1995, INTEGRATED PEST MANA
   van Lenteren JC, 2000, MEASURES SUCCESS BIO, P77
   VANLENTEREN JC, 1988, ANNU REV ENTOMOL, V33, P239, DOI 10.1146/annurev.en.33.010188.001323
   Zhang H, 2008, NONLINEAR ANAL-REAL, V9, P1714, DOI 10.1016/j.nonrwa.2007.05.004
   Zhang H, 2007, BIOSYSTEMS, V90, P350, DOI 10.1016/j.biosystems.2006.09.038
NR 25
TC 17
Z9 17
U1 4
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1007-5704
EI 1878-7274
J9 COMMUN NONLINEAR SCI
JI Commun. Nonlinear Sci. Numer. Simul.
PD FEB
PY 2010
VL 15
IS 2
BP 421
EP 429
DI 10.1016/j.cnsns.2009.04.001
PG 9
WC Mathematics, Applied; Mathematics, Interdisciplinary Applications;
   Mechanics; Physics, Fluids & Plasmas; Physics, Mathematical
SC Mathematics; Mechanics; Physics
GA 504PG
UT WOS:000270628600028
DA 2018-12-27
ER

PT J
AU Ricci, Z
   Ronco, C
AF Ricci, Zaccaria
   Ronco, Claudio
TI RETRACTED: Pulmonary/renal interaction (Retracted article. See vol. 18,
   pg. 294, 2012)
SO CURRENT OPINION IN CRITICAL CARE
LA English
DT Review; Retracted Publication
DE acute kidney injury; acute lung injury; acute respiratory distress
   syndrome; renal replacement therapy
ID RESPIRATORY-DISTRESS-SYNDROME; ACUTE-RENAL-FAILURE; ACUTE KIDNEY INJURY;
   EXTRACORPOREAL MEMBRANE-OXYGENATION; CRITICALLY-ILL PATIENTS; ACUTE LUNG
   INJURY; CONTINUOUS VENOVENOUS HEMOFILTRATION; POSITIVE-PRESSURE
   VENTILATION; EPITHELIAL-CELL APOPTOSIS; REMOVAL IMPROVES SURVIVAL
AB Purpose of review
   Acute kidney injury contributes to the development of acute lung injury and vice-versa. Volume overload that may occur during renal impairment increases pulmonary capillary hydrostatic pressure. However, experimental evidence clearly shows that lung damage occurs even in the absence of positive fluid balance. However, acute lung injury with its attendant hypoxemia, hypercapnia and mechanical ventilation worsens renal hemodynamics and function.
   Recent findings
   An increasing body of evidence suggests that kidney and lung interact (crosstalk) during severe insults, such as shock, trauma, and sepsis, due to a loss of the normal balance of immune, inflammatory and soluble mediators. Kidney-lung crosstalk in the critically ill constitutes a possibility to analyze mechanisms of multiple organ failure in which the kidney and the lung can play an important role. Consequently, on the clinical side, specific therapeutic options can be hypothesized for kidney/lung dysfunction.
   Summary
   Fluid management optimization and prevention of inflammation and lung stretching are currently recommended for the treatment of acute lung and renal injury. Extracorporeal CO2 removal and renal replacement associated with extracorporeal membrane oxygenation might be interesting options for a future approach to pulmonary/renal syndrome.
C1 [Ricci, Zaccaria] Bambino Gesu Pediat Hosp, Dept Pediat Cardiosurg, I-00165 Rome, Italy.
   [Ronco, Claudio] San Bortolo Hosp, Dept Nephlol Dialysis & Transplantat, Vicenza, Italy.
RP Ricci, Z (reprint author), Bambino Gesu Pediat Hosp, Dept Pediat Cardiosurg, Piazza S Onofrio 4, I-00165 Rome, Italy.
EM z.ricci@libero.it
OI Ronco, Claudio/0000-0002-6697-4065
CR *AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801
   ANNAT G, 1983, ANESTHESIOLOGY, V58, P136, DOI 10.1097/00000542-198302000-00006
   Bagshaw SM, 2008, CRIT CARE, V12, DOI 10.1186/cc6948
   Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872
   BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706
   Blijdorp K, 2009, CRIT CARE, V13, DOI 10.1186/cc7771
   Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159
   BRUNET F, 1994, AM J RESP CRIT CARE, V149, P1557, DOI 10.1164/ajrccm.149.6.8004313
   Cressoni M, 2009, CRIT CARE MED, V37, P2612, DOI 10.1097/CCM.0b013e3181a5668a
   Feltes CM, 2008, NEPHRON PHYSIOL, V109, pP80, DOI 10.1159/000142940
   Foland JA, 2004, CRIT CARE MED, V32, P1771, DOI 10.1097/01.CCM.0000132897.52737.49
   Goldstein SL, 2005, KIDNEY INT, V67, P653, DOI 10.1111/j.1523-1755.2005.67121.x
   Gurkan OU, 2003, AM J PHYSIOL-LUNG C, V285, pL710, DOI 10.1152/ajplung.00044.2003
   HABASHI NM, 1995, INTENS CARE MED, V21, P594, DOI 10.1007/BF01700166
   HALL SV, 1974, ANESTHESIOLOGY, V41, P452, DOI 10.1097/00000542-197411000-00009
   Hassoun HT, 2007, AM J PHYSIOL-RENAL, V293, pF30, DOI 10.1152/ajprenal.00023.2007
   Hassoun HT, 2009, AM J PHYSIOL-RENAL, V297, pF125, DOI 10.1152/ajprenal.90666.2008
   Hebbar KB, 2009, CRIT CARE, V13, DOI 10.1186/cc7735
   Hoke TS, 2007, J AM SOC NEPHROL, V18, P155, DOI 10.1681/ASN.2006050494
   Hoover NG, 2008, INTENS CARE MED, V34, P2241, DOI 10.1007/s00134-008-1200-y
   Hotter G, 2004, LAB INVEST, V84, P213, DOI 10.1038/labinvest.3700026
   Imai Y, 2003, JAMA-J AM MED ASSOC, V289, P2104, DOI 10.1001/jama.289.16.2104
   Kelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46
   Klein CL, 2008, KIDNEY INT, V74, P901, DOI 10.1038/ki.2008.314
   Ko GJ, 2009, BLOOD PURIFICAT, V28, P75, DOI 10.1159/000218087
   Kuiper JW, 2005, CRIT CARE MED, V33, P1408, DOI 10.1097/01.CCM.0000165808.30416.EF
   Livigni S, 2006, CRIT CARE, V10, DOI 10.1186/cc5082
   Marasco SF, 2008, HEART LUNG CIRC, V17, pS41, DOI 10.1016/j.hlc.2008.08.009
   Matute-Bello G, 1999, J IMMUNOL, V163, P2217
   Metnitz PGH, 2002, CRIT CARE MED, V30, P2051, DOI 10.1097/01.CCM.0000026732.62103.DF
   MOORE ES, 1974, PEDIATR RES, V8, P792, DOI 10.1203/00006450-197409000-00003
   Murphy CV, 2009, CHEST, V136, P102, DOI 10.1378/chest.08-2706
   Payen D, 2008, CRIT CARE, V12, DOI 10.1186/cc6916
   Piccinni P, 2006, INTENS CARE MED, V32, P80, DOI 10.1007/s00134-005-2815-x
   Rabb H, 2003, KIDNEY INT, V63, P600, DOI 10.1046/j.1523-1755.2003.00753.x
   Ranieri VM, 2000, JAMA-J AM MED ASSOC, V284, P43, DOI 10.1001/jama.284.1.43
   Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54
   Ricci Z, 2007, INT J ARTIF ORGANS, V30, P896
   Ricci Zaccaria, 2009, Interact Cardiovasc Thorac Surg, V9, P33, DOI 10.1510/icvts.2009.201848
   Rivers EP, 2008, CURR OPIN ANESTHESIO, V21, P128, DOI 10.1097/ACO.0b013e3282f4db7a
   Rodrigo R, 2006, EXP BIOL MED, V231, P1430, DOI 10.1177/153537020623100817
   Schmalstieg FC, 2007, ANN SURG, V246, P512, DOI 10.1097/SLA.0013018148c6e6
   Shaheen IS, 2007, PEDIATR CRIT CARE ME, V8, P362, DOI 10.1097/01.PCC.0000269378.76179.A0
   Valenza F, 2000, CRIT CARE MED, V28, P3697, DOI 10.1097/00003246-200011000-00027
   Vieira JM, 2007, CRIT CARE MED, V35, P184, DOI 10.1097/01.CCM.0000249828.81705.65
   Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564
   Zanella A, 2009, INTENS CARE MED, V35, P1484, DOI 10.1007/s00134-009-1513-5
   Zwischenberger JB, 2001, J THORAC CARDIOV SUR, V121, P542, DOI 10.1067/mtc.2001.112828
NR 48
TC 24
Z9 27
U1 2
U2 15
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1070-5295
EI 1531-7072
J9 CURR OPIN CRIT CARE
JI Curr. Opin. Crit. Care
PD FEB
PY 2010
VL 16
IS 1
BP 13
EP 18
DI 10.1097/MCC.0b013e328334b13b
PG 6
WC Critical Care Medicine
SC General & Internal Medicine
GA 544ZJ
UT WOS:000273700200003
PM 19935063
DA 2018-12-27
ER

PT J
AU Kanadia, RN
   Cepko, CL
AF Kanadia, Rahul N.
   Cepko, Constance L.
TI RETRACTED: Alternative splicing produces high levels of noncoding
   isoforms of bHLH transcription factors during development (Retracted
   article. See vol. 25, pg. 1344, 2011)
SO GENES & DEVELOPMENT
LA English
DT Article; Retracted Publication
DE Alternative splicing; Math5; Ngn3; noncoding; retina; progenitor cells;
   post-mitotic cells
ID RETINAL GANGLION-CELL; MYOTONIC-DYSTROPHY; EXPRESSION; PANCREAS;
   DIFFERENTIATION; MATH5; RNA; HETEROGENEITY; REQUIREMENT; NEUROGENIN3
AB During development, multiple cell types within a tissue often arise from a common pool of progenitor cells (PCs). PCs typically expand in number, while simultaneously producing post-mitotic cells (PMCs). This balance is partly regulated by transcription factors that are expressed within PCs, such as the basic helix-loop-helix (bHLH) gene mouse atonal homolog 7 (Math5), which is expressed in retinal PCs. Here we report that alternative splicing (AS) of Math5 serves as another layer of regulation of Math5 activity. Specifically, Math5, a single exon gene, is alternatively spliced such that the major isoform lacks the entire coding sequence. Similarly, neurogenin 3 (Ngn3), a Math5 paralog expressed in pancreatic PCs, is also alternatively spliced such that the major isoform fails to code for Ngn3 protein. The consequence of reducing the abundance of protein-coding isoforms is likely crucial, as we found that introduction of coding isoforms leads to a reduction in cycling PCs. Thus, AS can limit the number of PCs expressing key regulatory proteins that control PC expansion versus PMC production.
C1 [Cepko, Constance L.] Harvard Univ, Howard Hughes Med Inst, Sch Med, Dept Genet, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Ophthalmol, Boston, MA 02115 USA.
RP Cepko, CL (reprint author), Harvard Univ, Howard Hughes Med Inst, Sch Med, Dept Genet, Boston, MA 02115 USA.
EM cepko@genetics.med.harvard.edu
FU Howard Hughes Medical Institute
FX This work was funded by the Howard Hughes Medical Institute.
CR Apelqvist A, 1999, NATURE, V400, P877
   Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X
   Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8
   Brown NL, 1998, DEVELOPMENT, V125, P4821
   Brown NL, 2001, DEVELOPMENT, V128, P2497
   Burlison JS, 2008, DEV BIOL, V316, P74, DOI 10.1016/j.ydbio.2008.01.011
   Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011
   CRESCENZI M, 1990, P NATL ACAD SCI USA, V87, P8442, DOI 10.1073/pnas.87.21.8442
   Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607
   Grapin-Botton A, 2001, GENE DEV, V15, P444, DOI 10.1101/gad.846001
   Kanadia RN, 2008, DEVELOPMENT, V135, P3923, DOI 10.1242/dev.024620
   Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103
   Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583
   Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9
   Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447
   Le TT, 2006, DEV BIOL, V295, P764, DOI 10.1016/j.ydbio.2006.03.055
   Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017
   Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100
   Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737
   Saul SM, 2008, MOL CELL NEUROSCI, V37, P153, DOI 10.1016/j.mcn.2007.09.006
   Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533
   Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060
   SORRENTINO V, 1990, NATURE, V345, P813, DOI 10.1038/345813a0
   Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368
   van Eyll JM, 2006, GENE EXPR PATTERNS, V6, P353, DOI 10.1016/j.modgep.2005.09.010
   Villasenor A, 2008, DEV DYNAM, V237, P3270, DOI 10.1002/dvdy.21740
   Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509
   Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301
NR 28
TC 8
Z9 9
U1 1
U2 12
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 0890-9369
J9 GENE DEV
JI Genes Dev.
PD FEB 1
PY 2010
VL 24
IS 3
BP 229
EP 234
DI 10.1101/gad.1847110
PG 6
WC Cell Biology; Developmental Biology; Genetics & Heredity
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA 550UZ
UT WOS:000274157300002
PM 20080942
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Salama, N
   Kishimoto, T
   Kanayama, H
AF Salama, Nader
   Kishimoto, Tomoteru
   Kanayama, Hiro-omi
TI RETRACTED: Effects of exposure to a mobile phone on testicular function
   and structure in adult rabbit (Retracted article. See vol. 35, pg. 629,
   2012)
SO INTERNATIONAL JOURNAL OF ANDROLOGY
LA English
DT Article; Retracted Publication
DE mobile phone; rabbit; radio frequency; sperm; testis
ID ELECTROMAGNETIC-RADIATION; CELL PHONE; MALE REPRODUCTION;
   RADIO-FREQUENCY; HUMAN-SPERM; SEMEN; RATS; SPERMATOZOA; MICROWAVES;
   INTEGRITY
AB P>The accumulating effects of exposure to electromagnetic radiation emitted by a conventional mobile phone (standby position) on the testicular function and structure are not yet fully investigated. To study these effects longitudinally, a total of 24 adult male rabbits were randomly and equally divided into three groups. Rabbits in the first (phone) group were exposed, in specially designed cages, to radio frequency emitted from the mobile phone (800 MHz) in a standby position opposite to that of testes for 8 h daily for 12 weeks. The second group consisted of the stress controls which were kept in the same kind of cages to appreciate any cage-induced anxiety. The third group included the ordinary controls which were kept in the conventional roomy cages. Semen analysis and sperm function tests (viability, hypo-osmotic swelling and acridine orange) were conducted weekly. Histological testicular sections and serum total testosterone were also evaluated. A drop in the sperm concentration appeared in the phone group at week 6. This became statistically significant at week 8, compared with the two control (stress and ordinary) groups (133, 339 and 356 x 106/mL, respectively) and to the initial sperm count (341 x 106/mL) of this group. Motile sperm population showed similarity amongst the three study groups until week 10 when it declined significantly, and thereafter in the phone and stress control groups, with more significant decline in the phone animals (50, 61 and 72.4%, respectively). Histological examination showed also a significant decrease in the diameter of seminiferous tubules in the phone group vs. the stress and ordinary controls (191 mu m vs. 206 and 226 mu m, respectively). The other study points did not show any difference. In conclusion, low intensity pulsed radio frequency emitted by a conventional mobile phone kept in the standby position could affect the testicular function and structure in the adult rabbit.
C1 [Salama, Nader; Kishimoto, Tomoteru; Kanayama, Hiro-omi] Tokushima Sch Med, Dept Urol, Tokushima, Japan.
RP Salama, N (reprint author), Alexandria Fac Med, Dept Urol & Androl, Alexandria, Egypt.
EM nadersalama58@yahoo.com
CR Agarwal A, 2008, FERTIL STERIL, V89, P124, DOI 10.1016/j.fertnstert.2007.01.166
   Ahlbom A, 1998, HEALTH PHYS, V74, P494
   AITKEN RJ, 1995, HUM REPROD, V10, P1736, DOI 10.1093/oxfordjournals.humrep.a136165
   Aitken RJ, 2005, INT J ANDROL, V28, P171, DOI 10.1111/j.1365-2605.2005.00531.x
   BLACKWELL RP, 1979, NATURE, V282, P360, DOI 10.1038/282360a0
   BLOM E, 1950, FERTIL STERIL, V1, P176
   BREDDERMAN PJ, 1964, J REPROD FERTIL, V7, P401
   Burch JB, 1998, SCAND J WORK ENV HEA, V24, P183, DOI 10.5271/sjweh.297
   CAIRNIE AB, 1981, RADIAT RES, V87, P100, DOI 10.2307/3575544
   CHEMES HE, 1987, FERTIL STERIL, V48, P664
   Chohan KR, 2006, J ANDROL, V27, P53, DOI 10.2164/jandrol.05068
   Creasy DM, 1997, TOXICOL PATHOL, V25, P119, DOI 10.1177/019262339702500201
   Darszon A, 2001, DEV BIOL, V240, P1, DOI 10.1006/dbio.2001.0387
   Dasdag S, 2003, BIOELECTROMAGNETICS, V24, P182, DOI 10.1002/bem.10083
   Dasdag S, 1999, UROL RES, V27, P219, DOI 10.1007/s002400050113
   Ducci M, 2002, EUR J OBSTET GYN R B, V102, P53, DOI 10.1016/S0301-2115(01)00578-4
   EggertKruse W, 1996, HUM REPROD, V11, P784
   Fejes I, 2005, ARCH ANDROLOGY, V51, P385, DOI 10.1080/014850190924520
   Fouquet JP, 1998, MOL HUM REPROD, V4, P1122, DOI 10.1093/molehr/4.12.1122
   Freude G, 1998, BIOELECTROMAGNETICS, V19, P384, DOI 10.1002/(SICI)1521-186X(1998)19:6<384::AID-BEM6>3.0.CO;2-Y
   Irmak MK, 2003, J CUTAN PATHOL, V30, P135, DOI 10.1046/j.0303-6987.2003.00002.x
   JEYENDRAN RS, 1984, J REPROD FERTIL, V70, P219
   Kunz K. S., 1993, FINITE DIFFERENCE TI
   Linares V, 2005, TOXICOL LETT, V158, P186, DOI 10.1016/j.toxlet.2005.03.015
   Malyapa RS, 1997, RADIAT RES, V148, P618, DOI 10.2307/3579738
   Morelli G, 2000, BIOL PSYCHOL, V53, P1, DOI 10.1016/S0301-0511(00)00041-7
   Ono T, 2004, TOHOKU J EXP MED, V202, P93, DOI 10.1620/tjem.202.93
   Pace AJ, 2000, J CLIN INVEST, V105, P441, DOI 10.1172/JCI8553
   Ribeiro EP, 2007, J UROLOGY, V177, P395, DOI 10.1016/j.juro.2006.08.083
   SWIERSTRA EE, 1965, AM J ANAT, V116, P401, DOI 10.1002/aja.1001160206
   TEJADA RI, 1984, FERTIL STERIL, V42, P87
   VARMA M M, 1975, Experientia (Basel), V31, P301, DOI 10.1007/BF01922549
   Veeramachaneni DNR, 2006, REPRODUCTION, V131, P805, DOI 10.1530/rep.1.01048
   Veeramachaneni DNR, 2001, HUM REPROD, V16, P979, DOI 10.1093/humrep/16.5.979
   Wang Shui-Ming, 2003, Zhonghua Nan Ke Xue, V9, P327
   WEARDEN G, 2004, NOKIA 2 BILLION CELL
   Whittington K, 1999, INT J ANDROL, V22, P236, DOI 10.1046/j.1365-2605.1999.00174.x
   Yan JG, 2007, FERTIL STERIL, V88, P957, DOI 10.1016/j.fertnstert.2006.12.022
   Zhao R, 2007, TOXICOLOGY, V235, P167, DOI 10.1016/j.tox.2007.03.015
NR 39
TC 41
Z9 50
U1 2
U2 33
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0105-6263
J9 INT J ANDROL
JI Int. J. Androl.
PD FEB
PY 2010
VL 33
IS 1
BP 88
EP 94
DI 10.1111/j.1365-2605.2008.00940.x
PG 7
WC Andrology
SC Endocrinology & Metabolism
GA 541YH
UT WOS:000273457000011
PM 19076254
OA Bronze
DA 2018-12-27
ER

PT J
AU Jayapal, M
   Bhattacharjee, RN
   Melendez, AJ
   Hande, MP
AF Jayapal, Manikandan
   Bhattacharjee, Rabindra N.
   Melendez, Alirio J.
   Hande, M. Prakash
TI RETRACTED: Environmental toxicogenomics: A post-genomic approach to
   analysing biological responses to environmental toxins (Retracted
   article. See vol. 45, pg. 2713, 2013)
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Review; Retracted Publication
DE Biomarkers; Environmental toxicants; Genomics; Toxicogenomics; DNA
   damage; Genomic instability
ID GENE-EXPRESSION PROFILES; MICROARRAY ANALYSIS; OXIDATIVE DAMAGE; DNA
   MICROARRAYS; CELLS; TOXICOLOGY; TOXICITY; EXPOSURE; CADMIUM; REVEALS
AB Environmental genomics has revolutionised how researchers can study the molecular basis of adverse effects of environmental toxicants. It is expected that the new discipline will afford efficient and high-throughput means to delineate mechanisms of action, risk assessment, identify and understand basic pathogenic mechanisms that are critical to disease progression, predict toxicity of unknown agents and to more precisely phenotype disease subtypes. Previously, we have demonstrated the potential of environmental genomics in a toxicant exposure model and, perhaps, this might become a crucial tool in biological response marker or biomarker discovery. To illustrate how toxicogenomics can be useful, we provide here an overview of some of the past and potential future aspects of environmental genomics. The present article also reviews the principles and technological concerns, and the standards and databases of toxicogenomics. In addition, applications of toxicogenomics in drug target identifications and validation strategies are also discussed. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Hande, M. Prakash] Natl Univ Singapore, Genome Stabil Lab, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117597, Singapore.
   [Bhattacharjee, Rabindra N.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada.
RP Hande, MP (reprint author), Natl Univ Singapore, Genome Stabil Lab, Dept Physiol, Yong Loo Lin Sch Med, Block MD9,2 Med Dr, Singapore 117597, Singapore.
EM phsmph@nus.edu.sg
RI Jayapal, Manikandan/H-9847-2012; Hande, M. Prakash/B-1645-2008
OI Hande, M. Prakash/0000-0002-4511-6256
FU Academic Research Fund; Ministry of Education, Singapore [T206B3108,
   WBS: 185-000-153-112]; Singapore Delft Water Alliance and Defence
   Innovative Research Programme; Defence Science and Technology Agency,
   Singapore [POD: 0613592, WBS: 185-000-150-422]; Medical Research Council
   [G0700794]
FX This work was supported by the grants from Academic Research Fund,
   Ministry of Education, Singapore (T206B3108; WBS: 185-000-153-112),
   Singapore Delft Water Alliance and Defence Innovative Research
   Programme, Defence Science and Technology Agency, Singapore (POD:
   0613592,WBS: 185-000-150-422). The authors thank Dr. Birendranath
   Banerjee, Dr. Anuradha Poonepalli, Ms. Lakshmidevi Balakrishnan and Mr.
   Aik Kia Khaw for their help during the study. Dr. Veena Hande is thanked
   for critically reading the manuscript. The authors apologise to
   colleagues whose work could not be referred to here because of space
   limitations.
CR Aardema MJ, 2002, MUTAT RES-FUND MOL M, V499, P13, DOI 10.1016/S0027-5107(01)00292-5
   Abouhamed M, 2007, AM J PHYSIOL-RENAL, V293, pF705, DOI 10.1152/aj.prenal.00198.2007
   Afshari CA, 2002, ENDOCRINOLOGY, V143, P1983, DOI 10.1210/en.143.6.1983
   Amin RP, 2002, TOXICOLOGY, V181, P555, DOI 10.1016/S0300-483X(02)00481-X
   Ball C, 2004, ENVIRON HEALTH PERSP, V112, pA666
   Bearer CF, 1998, ENVIRON HEALTH PERSP, V106, P813, DOI 10.2307/3434194
   Benninghoff AD, 2008, TOXICOL SCI, V101, P65, DOI 10.1093/toxsci/kfm238
   Bombail V, 2004, TOXICOL LETT, V149, P51, DOI 10.1016/j.toxlet.2004.01.003
   Boorman GA, 2002, TOXICOL PATHOL, V30, P15, DOI 10.1080/01926230252824671
   Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365
   Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091
   Brown M, 2004, MUTAT RES-FUND MOL M, V552, P35, DOI 10.1016/j.mrfmmm.2004.06.002
   Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462
   Bulera SJ, 2001, HEPATOLOGY, V33, P1239, DOI 10.1053/jhep.2001.23560
   Burczynski ME, 2000, TOXICOL SCI, V58, P399, DOI 10.1093/toxsci/58.2.399
   Chaussabel D, 2002, GENOME BIOL, V3
   Cherkasova E, 2003, P NATL ACAD SCI USA, V100, P9398, DOI 10.1073/pnas.1633511100
   Cunningham ML, 2005, TOXICOL SCI, V83, P205, DOI 10.1093/toxsci/kfi047
   Dillman JF, 2009, CHEM RES TOXICOL, V22, P633, DOI 10.1021/tx800466v
   Dong G, 2001, CANCER RES, V61, P4797
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Erlich PM, 2006, HUM MOL GENET, V15, P77, DOI 10.1093/hmg/ddi428
   Fertuck KC, 2003, PHYSIOL GENOMICS, V15, P127, DOI 10.1152/physiolgenomics.00058.2003
   Freeman K, 2005, ENVIRON HEALTH PERSP, V113, pA388, DOI 10.1289/ehp.113-a388
   Fuhrman S, 2000, BIOSYSTEMS, V55, P5, DOI 10.1016/S0303-2647(99)00077-5
   Furness LM, 2002, CURR OPIN DRUG DI DE, V5, P98
   Habeebu SS, 2000, TOXICOL SCI, V55, P223, DOI 10.1093/toxsci/55.1.223
   Hamadeh HK, 2002, TOXICOL SCI, V67, P219, DOI 10.1093/toxsci/67.2.219
   Hamadeh HK, 2004, MUTAT RES-FUND MOL M, V549, P169, DOI 10.1016/j.mrfmmm.2003.12.021
   Hamadeh HK, 2002, TOXICOL SCI, V67, P232, DOI 10.1093/toxsci/67.2.232
   Irwin Richard D, 2004, Toxicol Pathol, V32 Suppl 1, P72, DOI 10.1080/01926230490424752
   Iwao K, 2001, INT J CANCER, V91, P433, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1059>3.0.CO;2-B
   Jayapal M, 2006, CLIN EXP PHARMACOL P, V33, P496, DOI 10.1111/j.1440-1681.2006.04398.x
   Kaput J, 2004, PHYSIOL GENOMICS, V16, P166, DOI 10.1152/physiolgenomics.00107.2003
   Konig R, 2008, CHEM RES TOXICOL, V21, P572, DOI 10.1021/tx7002728
   Kurreck J, 2003, EUR J BIOCHEM, V270, P1628, DOI 10.1046/j.1432-1033.2003.03555.x
   Lewis F, 2001, J PATHOL, V195, P66, DOI 10.1002/1096-9896(200109)195:1<66::AID-PATH921>3.0.CO;2-F
   Liao VHC, 2002, J BIOL CHEM, V277, P42049, DOI 10.1074/jbc.M206740200
   Lindon JC, 2003, TOXICOL APPL PHARM, V187, P137, DOI 10.1016/S0041-008X(02)00079-0
   Low GKM, 2008, INT J BIOCHEM CELL B, V40, P2583, DOI 10.1016/j.biocel.2008.05.009
   Manna D, 2004, P NATL ACAD SCI USA, V101, P9780, DOI 10.1073/pnas.0400745101
   Newman JPA, 2008, J CELL PHYSIOL, V214, P796, DOI 10.1002/jcp.21276
   Nishigaki M, 2005, CANCER RES, V65, P2115, DOI 10.1158/0008-5472.CAN-04-3340
   Nishimoto M, 2006, BIOL PHARM BULL, V29, P543, DOI 10.1248/bpb.29.543
   Nuwaysir EF, 1999, MOL CARCINOGEN, V24, P153, DOI 10.1002/(SICI)1098-2744(199903)24:3<153::AID-MC1>3.0.CO;2-P
   OECD, 2005, OECD SER TEST ASS, V34, P14
   Okamoto T, 2000, NAT BIOTECHNOL, V18, P438
   Opalinska JB, 2002, NAT REV DRUG DISCOV, V1, P503, DOI 10.1038/nrd837
   Orphanides G, 2003, TOXICOL LETT, V140, P145, DOI 10.1016/S0378-4274(02)00500-3
   Pachiappan A, 2009, CHEM RES TOXICOL, V22, P990, DOI 10.1021/tx8003467
   Perera FP, 1997, SCIENCE, V278, P1068, DOI 10.1126/science.278.5340.1068
   Poonepalli A, 2005, CANCER RES, V65, P10977, DOI 10.1158/0008-5472.CAN-05-2336
   ROGAN WJ, 1995, ENVIRON HEALTH PERSP, V103, P19, DOI 10.2307/3432339
   Ruepp Stefan, 2005, Toxicol Appl Pharmacol, V207, P161, DOI 10.1016/j.taap.2005.05.008
   Saeed M, 2006, NEUROLOGY, V67, P771, DOI 10.1212/01.wnl.0000227187.52002.88
   Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200
   Sokol RZ, 2002, ENVIRON HEALTH PERSP, V110, P871, DOI 10.1289/ehp.02110871
   Stears RL, 2003, NAT MED, V9, P140, DOI 10.1038/nm0103-140
   Tennant RW, 2002, ENVIRON HEALTH PERSP, V110, pA8, DOI 10.1289/ehp.110-a8
   Thomas RS, 2002, ENVIRON HEALTH PERSP, V110, P919, DOI 10.1289/ehp.02110s6919
   Waring JF, 2001, TOXICOL LETT, V120, P359, DOI 10.1016/S0378-4274(01)00267-3
   Waring JF, 2001, TOXICOL APPL PHARM, V175, P28, DOI 10.1006/taap.2001.9243
   Waters MD, 2003, MUTAT RES-REV MUTAT, V544, P415, DOI 10.1016/j.mrrev.2003.06.014
   Waters Michael, 2003, Environmental Health Perspectives, V111, P15
   Wheeler DB, 2004, NAT METHODS, V1, P127, DOI 10.1038/NMETH711
   WHITE J, 2004, PHARM DISCOV     OCT, P30
   Wu XF, 2004, ONCOGENE, V23, P6500, DOI 10.1038/sj.onc.1207811
   Yamanaka Y, 2001, BIOCHEM BIOPH RES CO, V287, P198, DOI 10.1006/bbrc.2001.5550
   Zhang HG, 2004, ARTHRITIS RHEUM, V50, P420, DOI 10.1002/art.20037
   Zhou T, 2004, TOXICOL LETT, V154, P191, DOI 10.1016/j.toxlet.2004.07.015
   Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912
NR 71
TC 11
Z9 15
U1 1
U2 16
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD FEB
PY 2010
VL 42
IS 2
BP 230
EP 240
DI 10.1016/j.biocel.2009.10.007
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 558CR
UT WOS:000274718600009
PM 19836462
DA 2018-12-27
ER

PT J
AU Domain, F
   Levy, SB
AF Domain, Francis
   Levy, Stuart B.
TI RETRACTED: GyrA Interacts with MarR To Reduce Repression of the marRAB
   Operon in Escherichia coli (Retracted article. See vol. 193, pg. 2674,
   2011)
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article; Retracted Publication
ID MULTIPLE ANTIBIOTIC-RESISTANCE; BACTERIAL 2-HYBRID SYSTEM; DNA GYRASE;
   NEGATIVE REGULATOR; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE;
   GENE-EXPRESSION; IN-VITRO; SEQUENCES; PROTEIN
AB Bacterial two-hybrid studies of randomly cloned Escherichia coli DNA identified a physical interaction between GyrA, subunit A of gyrase, and MarR, a repressor of the marRAB operon. GyrA-His immobilized on Ni-nitrilotriacetic acid (NiNTA) resin bound MarR, while MarR alone did not bind. GyrA interfered with MarR binding to marO, as detected by electrophoretic mobility assays. In a strain bearing the marRAB operon and a marO-lacZ reporter, overexpression of GyrA increased LacZ activity, indicating decreased repression of marO-lacZ by MarR. These results were confirmed by an increased survival of cells treated with quinolones and other antibiotics when GyrA was overexpressed. This work, like a previous study examining TktA (12), shows that unrelated proteins can regulate MarR activity. The findings reveal an unexpected regulatory function of GyrA in antibiotic resistance.
C1 [Levy, Stuart B.] Tufts Univ, Sch Med, Ctr Adaptat Genet & Drug Resistance, Boston, MA 02111 USA.
   Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA.
RP Levy, SB (reprint author), Tufts Univ, Sch Med, Ctr Adaptat Genet & Drug Resistance, 136 Harrison Ave, Boston, MA 02111 USA.
EM stuart.levy@tufts.edu
FU NIH [AI56021]
FX This work was supported by NIH grant AI56021.
CR Alekshun MN, 1997, ANTIMICROB AGENTS CH, V41, P2067, DOI 10.1128/AAC.41.10.2067
   Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429
   Alekshun MN, 1999, J BACTERIOL, V181, P4669
   Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9
   Alekshun MN, 1999, J BACTERIOL, V181, P3303
   Alekshun MN, 2000, MOL MICROBIOL, V35, P1394, DOI 10.1046/j.1365-2958.2000.01802.x
   Barbosa TM, 2005, FRONTIERS IN ANTIMICROBIAL RESISTANCE: A TRIBUTE TO STUART B. LEVY, P209
   Barbosa TM, 2000, J BACTERIOL, V182, P3467, DOI 10.1128/JB.182.12.3467-3474.2000
   Casaz P, 2006, MICROBIOL-SGM, V152, P3643, DOI 10.1099/mic.0.2006/000604-0
   COHEN SP, 1993, J BACTERIOL, V175, P7856
   COHEN SP, 1993, J INFECT DIS, V168, P484, DOI 10.1093/infdis/168.2.484
   Domain F, 2007, MOL MICROBIOL, V66, P383, DOI 10.1111/j.1365-2958.2007.05928.x
   FRANCO RJ, 1988, J MOL BIOL, V201, P229, DOI 10.1016/0022-2836(88)90449-4
   GomezGomez JM, 1997, FEMS MICROBIOL LETT, V154, P271, DOI 10.1016/S0378-1097(97)00339-X
   Gore J, 2006, NATURE, V439, P100, DOI 10.1038/nature04319
   Griffith KL, 2002, BIOCHEM BIOPH RES CO, V290, P397, DOI 10.1006/bbrc.2001.6152
   Guerrier-Takada C, 2000, METHOD ENZYMOL, V313, P442
   Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752
   Karimova G, 2001, J MOL MICROB BIOTECH, V3, P73
   Kleefeld A, 2009, J BIOL CHEM, V284, P265, DOI 10.1074/jbc.M807856200
   Maneewannakul K, 1996, ANTIMICROB AGENTS CH, V40, P1695, DOI 10.1128/AAC.40.7.1695
   MARTIN RG, 1995, P NATL ACAD SCI USA, V92, P5456, DOI 10.1073/pnas.92.12.5456
   Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016
   Nicoloff H, 2006, J BACTERIOL, V188, P4413, DOI 10.1128/JB.01502-05
   Nollmann M, 2007, BIOCHIMIE, V89, P490, DOI 10.1016/j.biochi.2007.02.012
   Ogura M, 2008, BIOSCI BIOTECH BIOCH, V72, P186, DOI 10.1271/bbb.70548
   Patton WF, 2000, ELECTROPHORESIS, V21, P1123, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1123::AID-ELPS1123>3.0.CO;2-E
   Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001
   Tanous C, 2008, J BIOL CHEM, V283, P35551, DOI 10.1074/jbc.M805951200
   Wilke MS, 2008, P NATL ACAD SCI USA, V105, P14832, DOI 10.1073/pnas.0805489105
   Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51
   ZHAO GS, 1994, J BACTERIOL, V176, P6134, DOI 10.1128/jb.176.19.6134-6138.1994
NR 32
TC 2
Z9 2
U1 2
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
J9 J BACTERIOL
JI J. Bacteriol.
PD FEB
PY 2010
VL 192
IS 4
BP 942
EP 948
DI 10.1128/JB.01259-09
PG 7
WC Microbiology
SC Microbiology
GA 549DF
UT WOS:000274021900005
PM 19933356
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Ewais, HA
   Taha, M
   Salm, HN
AF Ewais, Hassan A.
   Taha, Mohamed
   Salm, Hania N.
TI RETRACTED: Palladium(II) Complexes Containing Dipicolinic Acid (DPA),
   Iminodiacetic Acid (IDA), and Various Biologically Important Ligands
   (Retracted article. See vol. 62, pg. 4045, 2017)
SO JOURNAL OF CHEMICAL AND ENGINEERING DATA
LA English
DT Article; Retracted Publication
ID CYTOTOXIC ACTIVITY; PT(II) COMPLEXES; AMINO-ACIDS; PD(II); AGENTS
AB Ternary 1:1:1 complexes of Pd(II) with dipicolinic acid (DPA) or iminodiacetic acid (IDA) as primary ligands and some selected mono- and dicarboxylic amino acids (glycine, alpha-alanine, leucine, valine, phenylalanine, tryptophan, methionine, histadiene aspartic acid, and glutamic acid), aromatic carboxylic acids (salicylic and phthalic), and aliphatic carboxylic acids (succinic, oxalic, malic, maleic, malonic, and tartaric) as secondary ligands have been investigated by using the potentiometric technique at T = 30 degrees C and I = 0.1 mol.dm(-3). The ternary complexes are formed in a stepwise mechanism. Confirmation of the ternary complexes in solution has been carried out using conductometric measurements.
C1 [Ewais, Hassan A.] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia.
   [Taha, Mohamed] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei, Taiwan.
   [Salm, Hania N.] Al Tahadi Univ, Dept Chem, Fac Sci, Sirt, Libya.
RP Ewais, HA (reprint author), King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia.
EM hshalby2002@yahoo.com
RI Ewais, hassan/H-4761-2012; Ewais, Hassan/L-3745-2013; Amin,
   Mohamed/E-6263-2011; Faculty of, Sciences, KAU/E-7305-2017
OI Amin, Mohamed/0000-0002-5367-2009; 
CR BJERRUM J, 1941, METAL AMINE COMPLEX
   CALVIN M, 1945, J AM CHEM SOC, V67, P2003, DOI 10.1021/ja01227a043
   CHIDAMBA.MV, 1970, J INORG NUCL CHEM, V32, P3271, DOI 10.1016/0022-1902(70)80210-X
   DAS M, 1978, BRIT J CANCER, V37, P466, DOI 10.1038/bjc.1978.68
   Garoufis A, 2009, COORDIN CHEM REV, V253, P1384, DOI 10.1016/j.ccr.2008.09.011
   Humbert B, 1998, SPECTROCHIM ACTA A, V54, P465, DOI 10.1016/S1386-1425(97)00239-4
   IRVING H, 1953, J CHEM SOC, P3397, DOI 10.1039/jr9530003397
   IRVING HM, 1954, J CHEM SOC, P2904, DOI 10.1039/jr9540002904
   Khalil MM, 1997, TALANTA, V44, P1365, DOI 10.1016/S0039-9140(96)02173-X
   KovalaDemertzi D, 1997, J INORG BIOCHEM, V68, P147, DOI 10.1016/S0162-0134(97)00087-1
   KRAGTEN J, 1980, TALANTA, V27, P685, DOI 10.1016/0039-9140(80)80213-X
   LIM MC, 1977, J CHEM SOC DALTON, P1398, DOI 10.1039/dt9770001398
   LIM MC, 1976, J INORG NUCL CHEM, V38, P1911, DOI 10.1016/0022-1902(76)80121-2
   LIM MC, 1978, J CHEM SOC DALTON, P726, DOI 10.1039/dt9780000726
   LIM MC, 1981, INORG CHEM, V20, P1377, DOI 10.1021/ic50219a009
   Martin BL, 1997, ARCH BIOCHEM BIOPHYS, V345, P332, DOI 10.1006/abbi.1997.0271
   Matesanz AI, 1999, J INORG BIOCHEM, V76, P29, DOI 10.1016/S0162-0134(99)00105-1
   Murakami K, 2003, J NUTR BIOCHEM, V14, P99, DOI 10.1016/S0955-2863(02)00252-8
   NELSON DJ, 1976, BIOINORG CHEM, V5, P353, DOI 10.1016/S0006-3061(00)80295-1
   PETTIT LD, 1985, COORDIN CHEM REV, V61, P97, DOI 10.1016/0010-8545(85)80003-5
   POCKER Y, 1980, BIOCHEMISTRY-US, V19, P2045, DOI 10.1021/bi00551a006
   Quiroga AG, 1999, J INORG BIOCHEM, V75, P293, DOI 10.1016/S0162-0134(99)00102-6
   ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0
   SMITH RM, 1997, 46 NIST US DEP COMM
   TOCHIKUBO K, 1974, J BACTERIOL, V117, P1017
NR 25
TC 8
Z9 8
U1 3
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-9568
J9 J CHEM ENG DATA
JI J. Chem. Eng. Data
PD FEB
PY 2010
VL 55
IS 2
BP 754
EP 758
DI 10.1021/je900447n
PG 5
WC Thermodynamics; Chemistry, Multidisciplinary; Engineering, Chemical
SC Thermodynamics; Chemistry; Engineering
GA 553HC
UT WOS:000274356100029
DA 2018-12-27
ER

PT J
AU Ficker, T
AF Ficker, Tomas
TI RETRACTED: Fractal Dimensions of Fracture Surfaces (Retracted article.
   See vol. 136, pg. 174, 2010)
SO JOURNAL OF ENGINEERING MECHANICS
LA English
DT Article; Retracted Publication
ID CONCRETE
AB Compressive strength of porous materials, especially of cement gels, has been estimated by means of fractal dimension of fracture surfaces. The relationship between mechanical strength and fractal characteristics of porous gels has been derived and tested experimentally using samples of cement gels. The dimensions of fracture surfaces have been found to be general parameters independent on the fractal dimensions of inner material components.
C1 Brno Univ Technol, Fac Civil Engn, Dept Phys, Brno 60200, Czech Republic.
RP Ficker, T (reprint author), Brno Univ Technol, Fac Civil Engn, Dept Phys, Veveri 95, Brno 60200, Czech Republic.
EM ficker.t@fce.vutbr.cz
FU Ministry of Education, Youth, and Sports [ME 09046]; Internal Grant 2007
FX This work was partly supported by the Ministry of Education, Youth, and
   Sports under Contract No. ME 09046 and partly by Internal Grant 2007
   assigned by the Faculty of Civil Engineering, Brno University of
   Technology.
CR ALLEN AJ, 1987, PHILOS MAG B, V56, P263, DOI 10.1080/13642818708221317
   Arandigoyen M, 2007, CEMENT CONCRETE RES, V37, P767, DOI 10.1016/j.cemconres.2007.02.023
   Balankin AS, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.065101
   Balshin M., 1949, DOKL AKAD NAUK SSSR, V67, P831
   BOUCHAUD E, 1990, EUROPHYS LETT, V13, P73, DOI 10.1209/0295-5075/13/1/013
   Carpinteri A, 2000, INT J SOLIDS STRUCT, V37, P4623, DOI 10.1016/S0020-7683(99)00249-8
   CARPINTERI A, 1999, INT J SOLIDS STRUCT, V36, P3073
   Czernin W., 1980, CEMENT CHEM PHYS CIV
   Ficker T, 2005, J PHYS D APPL PHYS, V38, P483, DOI 10.1088/0022-3727/38/3/021
   MANDELBROT BB, 1984, NATURE, V308, P721, DOI 10.1038/308721a0
   MILLARD DJ, 1958, MECH PROPERTIES NONM
   Narayanan N, 2000, CEMENT CONCRETE COMP, V22, P321, DOI 10.1016/S0958-9465(00)00016-0
   RYSHKEWITCH E, 1953, J AM CERAM SOC, V36, P65, DOI 10.1111/j.1151-2916.1953.tb12837.x
   SAOUMA VE, 1994, J ENG MECH-ASCE, V120, P835, DOI 10.1061/(ASCE)0733-9399(1994)120:4(835)
   Scherer GW, 1999, CEMENT CONCRETE RES, V29, P1149, DOI 10.1016/S0008-8846(99)00003-4
   Schiller K. K, 1958, MECHANICAL PROPERTIE, P35
   Yan A, 2001, CEMENT CONCRETE RES, V31, P1601, DOI 10.1016/S0008-8846(01)00610-X
NR 17
TC 1
Z9 1
U1 2
U2 7
PU ASCE-AMER SOC CIVIL ENGINEERS
PI RESTON
PA 1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA
SN 0733-9399
EI 1943-7889
J9 J ENG MECH
JI J. Eng. Mech.
PD FEB
PY 2010
VL 136
IS 2
BP 174
EP 178
DI 10.1061/(ASCE)0733-9399(2010)136:2(174)
PG 5
WC Engineering, Mechanical
SC Engineering
GA 544QJ
UT WOS:000273673500005
DA 2018-12-27
ER

EF